Citrus Sinensis ID: 016959

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380
Protein Sequence
MRPVLPPPPSGLSSSSSSSSSSPSSSLANRRGQRRRPDLTLPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPLSS
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEEcccccEEEEEEEEccccHHHHHHHHHHHHHHHHcccccccEEcEEEEEccEEEEEEEEccccccccccccccHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEEcccHHHHHHHcccccccccccccccccccccccccccccccccccHHHHHHHHHHHHcccccccccccccHHHHHHHccccccccccccccHHHHHHHHHHHcccccccccHHHHHccccccccccccccHHHHHHccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEEccccccEEEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHcccccEEEEEEEEEccccEEEEEEEccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccccccccccccHHHccHHHHcccccccccccccEEHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHHHHcccHcccccHHHHHccHHHHccccHHHHccccccccccccccc
Coil and Loop (DISEMBL)
mrpvlppppsglsssssssssspssslanrrgqrrrpdltlpipqrdpslavplplpptsnsssssgqstshqnhhphqqqqnqtqnnhqnrhqlinpaelqkgnrigsgsggtvwrvvhpptsrVFALKVIYGNHEDSVRSQICREIEilrdvnhpnvvkchdmydrnGEIEVLLEYmdggslegahiRQEHILSDLARQVLSGLAYLHKrkivhrdikpsnllinssknvkiadfGVSRILAQtmdpcnsavgtiaymsperintdlnhgkydgyagdIWSLGVSILEFYlgrfpfavgrqgdWASLMFAICfaqppeapemASREFRDFISRclqkdphsrwpaaqllqhpfilragQSQVNQNlrqilppprplss
Flexible Loop (DISEMBL)
mrpvlppppsglsssssssssspssslanrrgqrrrpdltlpipqrdpslaVPLPLPPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEilrdvnhpnvvkcHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRkivhrdikpsnllinssknvKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQnlrqilppprplss
Low Complexity Region (SEG)
MRPVlppppsglsssssssssspssslANRRGQRRRPDLTLPIPQRDPSLAVplplpptsnsssssgqstshqnhhphqqqqnqtqnnhqnrhqLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPLSS
Disordered region (IsUnstruct)
***************************************************************************************************************GGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ***********FRDFISRCLQKDPHSRWPAAQLLQHPFILRA*********************
Disordered Region (DISOPRED)
***************************************************************************************************ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV*QNLRQ***PP*****
Disordered Region (DISEMBL)
***********************************RPDLTLPIPQRDPSLAVPLPL***********************************RHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPLSS
Disordered Region (DISPRO)
**********************************************************************************************LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPP*****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MRPVLPPPPSGLSSSSSSSSSSPSSSLANRRGQRRRPDLTLPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPLSS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	380	2.2.26 [Sep-21-2011]
O80397	366	Mitogen-activated protein	yes	no	0.902	0.937	0.707	1e-135
Q8RXG3	348	Mitogen-activated protein	no	no	0.897	0.979	0.671	1e-135
Q5QN75	355	Mitogen-activated protein	no	no	0.868	0.929	0.394	6e-54
Q9FJV0	356	Mitogen-activated protein	no	no	0.836	0.893	0.394	8e-52
Q9S7U9	363	Mitogen-activated protein	no	no	0.689	0.721	0.447	1e-51
Q94A06	354	Mitogen-activated protein	no	no	0.689	0.740	0.440	6e-51
P29678	393	Dual specificity mitogen-	yes	no	0.823	0.796	0.321	3e-49
Q01986	393	Dual specificity mitogen-	yes	no	0.823	0.796	0.321	4e-49
Q02750	393	Dual specificity mitogen-	yes	no	0.823	0.796	0.321	4e-49
P31938	393	Dual specificity mitogen-	yes	no	0.823	0.796	0.321	5e-49

>sp|O80397|M2K4_ARATH Mitogen-activated protein kinase kinase 4 OS=Arabidopsis thaliana GN=MKK4 PE=1 SV=1

 Score =  481 bits (1237), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 249/352 (70%), Positives = 283/352 (80%), Gaps = 9/352 (2%)

Query: 21  SSPSSSLANRRGQRRRPDLTLPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQ 80
           S P  S+  +   RRRPDLTLP+PQRD SLAVPLPLPPTS  S  S  S           
Sbjct: 6   SPPGVSVPVKSRPRRRPDLTLPLPQRDVSLAVPLPLPPTSGGSGGSSGSAP-------SS 58

Query: 81  QQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSV 140
             + +  N  +  +  N ++L +GNRIGSG+GGTV++V+H P+SR++ALKVIYGNHE++V
Sbjct: 59  GGSASSTNTNSSIEAKNYSDLVRGNRIGSGAGGTVYKVIHRPSSRLYALKVIYGNHEETV 118

Query: 141 RSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR 200
           R QICREIEILRDVNHPNVVKCH+M+D+NGEI+VLLE+MD GSLEGAH+ +E  L+DL+R
Sbjct: 119 RRQICREIEILRDVNHPNVVKCHEMFDQNGEIQVLLEFMDKGSLEGAHVWKEQQLADLSR 178

Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYM 260
           Q+LSGLAYLH R IVHRDIKPSNLLINS+KNVKIADFGVSRILAQTMDPCNS+VGTIAYM
Sbjct: 179 QILSGLAYLHSRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYM 238

Query: 261 SPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE 320
           SPERINTDLN GKYDGYAGDIWSLGVSILEFYLGRFPF V RQGDWASLM AIC +QPPE
Sbjct: 239 SPERINTDLNQGKYDGYAGDIWSLGVSILEFYLGRFPFPVSRQGDWASLMCAICMSQPPE 298

Query: 321 APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN--QNLRQ 370
           AP  AS EFR FIS CLQ++P  R  A QLLQHPFILRA  SQ    QNL Q
Sbjct: 299 APATASPEFRHFISCCLQREPGKRRSAMQLLQHPFILRASPSQNRSPQNLHQ 350

Involved in the second phase of hydrogen peroxide generation during hypersensitive response-like cell death. Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. Activates by phosphorylation the downstream MPK3 and MPK6.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 2

>sp|Q8RXG3|M2K5_ARATH Mitogen-activated protein kinase kinase 5 OS=Arabidopsis thaliana GN=MKK5 PE=1 SV=2

 Score =  480 bits (1235), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 243/362 (67%), Positives = 277/362 (76%), Gaps = 21/362 (5%)

Query: 19  SSSSPSSSLANRRGQRRRPDLTLPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPH 78
           S S  +S + NR   R+RPDL+LP+P RD              + +         +    
Sbjct: 6   SPSGVASPMKNR--LRKRPDLSLPLPHRD-------------VALAVPLPLPPPSSSSSA 50

Query: 79  QQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED 138
               +    N      L   +EL++ NRIGSG+GGTV++V+H PTSR FALKVIYGNHED
Sbjct: 51  PASSSAISTNISAAKSL---SELERVNRIGSGAGGTVYKVIHTPTSRPFALKVIYGNHED 107

Query: 139 SVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDL 198
           +VR QICREIEILR V+HPNVVKCHDM+D NGEI+VLLE+MD GSLEGAHI QE  L+DL
Sbjct: 108 TVRRQICREIEILRSVDHPNVVKCHDMFDHNGEIQVLLEFMDQGSLEGAHIWQEQELADL 167

Query: 199 ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIA 258
           +RQ+LSGLAYLH+R IVHRDIKPSNLLINS+KNVKIADFGVSRILAQTMDPCNS+VGTIA
Sbjct: 168 SRQILSGLAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIA 227

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP 318
           YMSPERINTDLNHG+YDGYAGD+WSLGVSILEFYLGRFPFAV RQGDWASLM AIC +QP
Sbjct: 228 YMSPERINTDLNHGRYDGYAGDVWSLGVSILEFYLGRFPFAVSRQGDWASLMCAICMSQP 287

Query: 319 PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPL 378
           PEAP  AS+EFR F+S CLQ DP  RW A QLLQHPFIL+A       NLRQ+LPPPRPL
Sbjct: 288 PEAPATASQEFRHFVSCCLQSDPPKRWSAQQLLQHPFILKATG---GPNLRQMLPPPRPL 344

Query: 379 SS 380
            S
Sbjct: 345 PS 346

Involved in the second phase of hydrogen peroxide generation during hypersensitive response-like cell death. Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. Activates by phosphorylation the downstream MPK3 and MPK6.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q5QN75|M2K1_ORYSJ Mitogen-activated protein kinase kinase 1 OS=Oryza sativa subsp. japonica GN=MEK1 PE=1 SV=1

 Score =  211 bits (538), Expect = 6e-54,   Method: Compositional matrix adjust.
 Identities = 140/355 (39%), Positives = 195/355 (54%), Gaps = 25/355 (7%)

Query: 44  PQRDPSLAVPLPLPPTSNSSSSSGQSTSHQ---NHHPHQQQQNQTQNNHQNRHQLINPAE 100
           P ++  L+VP    P     ++SG     +   N    Q    +T +  Q+ +  +   +
Sbjct: 6   PHKELKLSVPAQETPVDKFLTASGTFKDGELRLNQRGLQLISEETADEPQSTNLKVEDVQ 65

Query: 101 LQKGNR-----IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           L   +      IG GSGG V  V H     ++ALK I  N +++VR QI +E++I +   
Sbjct: 66  LSMDDLEMIQVIGKGSGGIVQLVRHKWVGTLYALKGIQMNIQEAVRKQIVQELKINQATQ 125

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLH 210
           + ++V CH  +  NG I ++LEYMD GSL    I+Q     E  L+ L +QVL GL YLH
Sbjct: 126 NAHIVLCHQSFYHNGVIYLVLEYMDRGSLADI-IKQVKTILEPYLAVLCKQVLEGLLYLH 184

Query: 211 -KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
            +R ++HRDIKPSNLL+N    VKI DFGVS +LA +M   ++ VGT  YM+PERI+   
Sbjct: 185 HERHVIHRDIKPSNLLVNRKGEVKITDFGVSAVLASSMGQRDTFVGTYNYMAPERISG-- 242

Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWAS---LMFAICFAQPPEAP-EMA 325
               YD Y  DIWSLG+ ILE  +GRFP+       W S   L+ AI    PP AP +  
Sbjct: 243 --SSYD-YKSDIWSLGLVILECAIGRFPYIPSEGEGWLSFYELLEAIVDQPPPSAPADQF 299

Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN-QNLRQILPPPRPLS 379
           S EF  FIS C+QKDP  R  A++LL HPFI +     ++ + L + L PP  +S
Sbjct: 300 SPEFCAFISSCIQKDPAERMSASELLNHPFIKKFEDKDLDLRILVESLEPPMNIS 354

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q9FJV0|M2K6_ARATH Mitogen-activated protein kinase kinase 6 OS=Arabidopsis thaliana GN=MKK6 PE=1 SV=1

 Score =  204 bits (519), Expect = 8e-52,   Method: Compositional matrix adjust.
 Identities = 137/347 (39%), Positives = 191/347 (55%), Gaps = 29/347 (8%)

Query: 50  LAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQQ-----QNQTQNNHQNRHQL---INPAEL 101
           L+VP    P S+  ++SG  T H       Q+      ++ Q+   +  +L   I   +L
Sbjct: 13  LSVPAQESPISSFLTASG--TFHDGDFLLNQKGLRLTSDEKQSRQSDSKELDFEITAEDL 70

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH-PNVV 160
           +    IG GSGG V  V H    + FA+KVI  N ++ +R QI +E++I +  +  P+VV
Sbjct: 71  ETVKVIGKGSGGVVQLVRHKWVGKFFAMKVIQMNIQEEIRKQIVQELKINQASSQCPHVV 130

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLH-KRKI 214
            C+  +  NG   ++LEYMD GSL    IRQ     E  L+ + +QVL GL YLH +R +
Sbjct: 131 VCYHSFYHNGAFSLVLEYMDRGSLADV-IRQVKTILEPYLAVVCKQVLLGLVYLHNERHV 189

Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           +HRDIKPSNLL+N    VKI+DFGVS  LA +M   ++ VGT  YMSPERI+     G  
Sbjct: 190 IHRDIKPSNLLVNHKGEVKISDFGVSASLASSMGQRDTFVGTYNYMSPERIS-----GST 244

Query: 275 DGYAGDIWSLGVSILEFYLGRFPFAVGRQG----DWASLMFAICFAQPPEAP-EMASREF 329
             Y+ DIWSLG+S+LE  +GRFP+           +  L+ AI    PP AP +  S EF
Sbjct: 245 YDYSSDIWSLGMSVLECAIGRFPYLESEDQQNPPSFYELLAAIVENPPPTAPSDQFSPEF 304

Query: 330 RDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQN-LRQILPPP 375
             F+S C+QKDP +R  +  LL HPFI +     ++   L   L PP
Sbjct: 305 CSFVSACIQKDPPARASSLDLLSHPFIKKFEDKDIDLGILVGTLEPP 351

Involved in the regulation of plant cytokinesis during meiosis and mitosis. Activates MPK13 in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q9S7U9|M2K2_ARATH Mitogen-activated protein kinase kinase 2 OS=Arabidopsis thaliana GN=MKK2 PE=1 SV=2

 Score =  204 bits (519), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 124/277 (44%), Positives = 160/277 (57%), Gaps = 15/277 (5%)

Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
           ++L     IG GS G V  V H  T + FALKVI  N ++++R  I +E++I +    PN
Sbjct: 68  SDLDMVKVIGKGSSGVVQLVQHKWTGQFFALKVIQLNIDEAIRKAIAQELKINQSSQCPN 127

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLH-KRK 213
           +V  +  +  NG I ++LEYMDGGSL    +      +  LS + RQVL GL YLH  R 
Sbjct: 128 LVTSYQSFYDNGAISLILEYMDGGSLADFLKSVKAIPDSYLSAIFRQVLQGLIYLHHDRH 187

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           I+HRD+KPSNLLIN    VKI DFGVS ++  T    N+ VGT  YMSPERI      G 
Sbjct: 188 IIHRDLKPSNLLINHRGEVKITDFGVSTVMTNTAGLANTFVGTYNYMSPERI-----VGN 242

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD-WAS---LMFAICFAQPPEAPE-MASRE 328
             G   DIWSLG+ +LE   G+FP+A   Q + W S   LM AI    PP  P    S E
Sbjct: 243 KYGNKSDIWSLGLVVLECATGKFPYAPPNQEETWTSVFELMEAIVDQPPPALPSGNFSPE 302

Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN 365
              FIS CLQKDP+SR  A +L++HPF+ +   S +N
Sbjct: 303 LSSFISTCLQKDPNSRSSAKELMEHPFLNKYDYSGIN 339

May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates by phosphorylation the downstream MPK4 and MPK6.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q94A06|M2K1_ARATH Mitogen-activated protein kinase kinase 1 OS=Arabidopsis thaliana GN=MKK1 PE=1 SV=2

 Score =  201 bits (512), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 122/277 (44%), Positives = 161/277 (58%), Gaps = 15/277 (5%)

Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
           A+L+    IG GS G V  V H  T + FALKVI  N E+S    I +E+ I      P 
Sbjct: 66  ADLEVIKVIGKGSSGNVQLVKHKLTQQFFALKVIQLNTEESTCRAISQELRINLSSQCPY 125

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLH-KRK 213
           +V C+  +  NG + ++LE+MDGGSL     +     E++LS + ++VL GL Y+H +R+
Sbjct: 126 LVSCYQSFYHNGLVSIILEFMDGGSLADLLKKVGKVPENMLSAICKRVLRGLCYIHHERR 185

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           I+HRD+KPSNLLIN    VKI DFGVS+IL  T    NS VGT  YMSPERI+  L   K
Sbjct: 186 IIHRDLKPSNLLINHRGEVKITDFGVSKILTSTSSLANSFVGTYPYMSPERISGSLYSNK 245

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFA-VGRQGDWAS---LMFAICFAQPPEAPE-MASRE 328
                 DIWSLG+ +LE   G+FP+     +  W+S   L+ AI    PP AP  + S E
Sbjct: 246 -----SDIWSLGLVLLECATGKFPYTPPEHKKGWSSVYELVDAIVENPPPCAPSNLFSPE 300

Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN 365
           F  FIS+C+QKDP  R  A +LL+H F+     S  N
Sbjct: 301 FCSFISQCVQKDPRDRKSAKELLEHKFVKMFEDSDTN 337

May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Phosphorylates MPK4 in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P29678|MP2K1_RABIT Dual specificity mitogen-activated protein kinase kinase 1 OS=Oryctolagus cuniculus GN=MAP2K1 PE=1 SV=2

 Score =  196 bits (497), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 122/380 (32%), Positives = 199/380 (52%), Gaps = 67/380 (17%)

Query: 43  IPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQL------- 95
           +P++ P+   P+ L P  + S+ +G S++  N    Q++  + + + Q R +L       
Sbjct: 1   MPKKKPT---PIQLNPAPDGSAVNGTSSAETNLEALQKKLEELELDEQQRKRLEAFLTQK 57

Query: 96  -----INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI 150
                +   + +K + +G+G+GG V++V H P+  V A K+I+   + ++R+QI RE+++
Sbjct: 58  QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 117

Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGL 206
           L + N P +V  +  +  +GEI + +E+MDGGSL+    +     E IL  ++  V+ GL
Sbjct: 118 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 177

Query: 207 AYL-HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERI 265
            YL  K KI+HRD+KPSN+L+NS   +K+ DFGVS  L  +M   NS VGT +YMSPER+
Sbjct: 178 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERL 235

Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYLGRFP------------FAVGRQGDWA------ 307
                 G +     DIWS+G+S++E  +GR+P            F    +GD A      
Sbjct: 236 -----QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 290

Query: 308 ---------------------SLMFAICFAQPPEAPE-MASREFRDFISRCLQKDPHSRW 345
                                 L+  I    PP+ P  + S EF+DF+++CL K+P  R 
Sbjct: 291 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERA 350

Query: 346 PAAQLLQHPFILRAGQSQVN 365
              QL+ H FI R+   +V+
Sbjct: 351 DLKQLMVHAFIKRSDAEEVD 370

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Oryctolagus cuniculus (taxid: 9986)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q01986|MP2K1_RAT Dual specificity mitogen-activated protein kinase kinase 1 OS=Rattus norvegicus GN=Map2k1 PE=1 SV=2

 Score =  196 bits (497), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 122/380 (32%), Positives = 199/380 (52%), Gaps = 67/380 (17%)

Query: 43  IPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQL------- 95
           +P++ P+   P+ L P  + S+ +G S++  N    Q++  + + + Q R +L       
Sbjct: 1   MPKKKPT---PIQLNPAPDGSAVNGTSSAETNLEALQKKLEELELDEQQRKRLEAFLTQK 57

Query: 96  -----INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI 150
                +   + +K + +G+G+GG V++V H P+  V A K+I+   + ++R+QI RE+++
Sbjct: 58  QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 117

Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGL 206
           L + N P +V  +  +  +GEI + +E+MDGGSL+    +     E IL  ++  V+ GL
Sbjct: 118 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 177

Query: 207 AYL-HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERI 265
            YL  K KI+HRD+KPSN+L+NS   +K+ DFGVS  L  +M   NS VGT +YMSPER+
Sbjct: 178 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERL 235

Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYLGRFP------------FAVGRQGDWA------ 307
                 G +     DIWS+G+S++E  +GR+P            F    +GD A      
Sbjct: 236 -----QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELLFGCQVEGDAAETPPRP 290

Query: 308 ---------------------SLMFAICFAQPPEAPE-MASREFRDFISRCLQKDPHSRW 345
                                 L+  I    PP+ P  + S EF+DF+++CL K+P  R 
Sbjct: 291 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 350

Query: 346 PAAQLLQHPFILRAGQSQVN 365
              QL+ H FI R+   +V+
Sbjct: 351 DLKQLMVHAFIKRSDAEEVD 370

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q02750|MP2K1_HUMAN Dual specificity mitogen-activated protein kinase kinase 1 OS=Homo sapiens GN=MAP2K1 PE=1 SV=2

 Score =  195 bits (496), Expect = 4e-49,   Method: Compositional matrix adjust.
 Identities = 122/380 (32%), Positives = 199/380 (52%), Gaps = 67/380 (17%)

Query: 43  IPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQL------- 95
           +P++ P+   P+ L P  + S+ +G S++  N    Q++  + + + Q R +L       
Sbjct: 1   MPKKKPT---PIQLNPAPDGSAVNGTSSAETNLEALQKKLEELELDEQQRKRLEAFLTQK 57

Query: 96  -----INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI 150
                +   + +K + +G+G+GG V++V H P+  V A K+I+   + ++R+QI RE+++
Sbjct: 58  QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 117

Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGL 206
           L + N P +V  +  +  +GEI + +E+MDGGSL+    +     E IL  ++  V+ GL
Sbjct: 118 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 177

Query: 207 AYL-HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERI 265
            YL  K KI+HRD+KPSN+L+NS   +K+ DFGVS  L  +M   NS VGT +YMSPER+
Sbjct: 178 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERL 235

Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYLGRFP------------FAVGRQGDWA------ 307
                 G +     DIWS+G+S++E  +GR+P            F    +GD A      
Sbjct: 236 -----QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 290

Query: 308 ---------------------SLMFAICFAQPPEAPE-MASREFRDFISRCLQKDPHSRW 345
                                 L+  I    PP+ P  + S EF+DF+++CL K+P  R 
Sbjct: 291 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 350

Query: 346 PAAQLLQHPFILRAGQSQVN 365
              QL+ H FI R+   +V+
Sbjct: 351 DLKQLMVHAFIKRSDAEEVD 370

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P31938|MP2K1_MOUSE Dual specificity mitogen-activated protein kinase kinase 1 OS=Mus musculus GN=Map2k1 PE=1 SV=2

 Score =  195 bits (495), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 122/380 (32%), Positives = 199/380 (52%), Gaps = 67/380 (17%)

Query: 43  IPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQL------- 95
           +P++ P+   P+ L P  + S+ +G S++  N    Q++  + + + Q R +L       
Sbjct: 1   MPKKKPT---PIQLNPAPDGSAVNGTSSAETNLEALQKKLEELELDEQQRKRLEAFLTQK 57

Query: 96  -----INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI 150
                +   + +K + +G+G+GG V++V H P+  V A K+I+   + ++R+QI RE+++
Sbjct: 58  QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV 117

Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGL 206
           L + N P +V  +  +  +GEI + +E+MDGGSL+    +     E IL  ++  V+ GL
Sbjct: 118 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 177

Query: 207 AYL-HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERI 265
            YL  K KI+HRD+KPSN+L+NS   +K+ DFGVS  L  +M   NS VGT +YMSPER+
Sbjct: 178 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERL 235

Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYLGRFP------------FAVGRQGDWA------ 307
                 G +     DIWS+G+S++E  +GR+P            F    +GD A      
Sbjct: 236 -----QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELLFGCHVEGDAAETPPRP 290

Query: 308 ---------------------SLMFAICFAQPPEAPE-MASREFRDFISRCLQKDPHSRW 345
                                 L+  I    PP+ P  + S EF+DF+++CL K+P  R 
Sbjct: 291 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 350

Query: 346 PAAQLLQHPFILRAGQSQVN 365
              QL+ H FI R+   +V+
Sbjct: 351 DLKQLMVHAFIKRSDAEEVD 370

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	380
224110016	348	predicted protein [Populus trichocarpa]	0.85	0.928	0.724	1e-137
224097472	356	predicted protein [Populus trichocarpa]	0.860	0.918	0.717	1e-137
42601216	356	mitogen-activated protein kinase kinase	0.892	0.952	0.669	1e-135
225443266	355	PREDICTED: mitogen-activated protein kin	0.807	0.864	0.738	1e-135
312281759	367	unnamed protein product [Thellungiella h	0.905	0.937	0.698	1e-135
297847538	363	hypothetical protein ARALYDRAFT_474280 [	0.894	0.936	0.701	1e-134
99083581	398	double MYC-tagged mitogen activated prot	0.902	0.861	0.707	1e-133
15217998	366	mitogen-activated protein kinase kinase	0.902	0.937	0.707	1e-133
95114268	380	double MYC-tagged mitogen activated prot	0.897	0.897	0.671	1e-133
15232491	348	mitogen-activated protein kinase kinase	0.897	0.979	0.671	1e-133

>gi|224110016|ref|XP_002315388.1| predicted protein [Populus trichocarpa] gi|222864428|gb|EEF01559.1| predicted protein [Populus trichocarpa]

 Score =  493 bits (1270), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 250/345 (72%), Positives = 279/345 (80%), Gaps = 22/345 (6%)

Query: 34  RRRPDLTLPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRH 93
           RRRPDL LP+PQRDP LAVPLPLPP S  S+SS  S++                    R 
Sbjct: 25  RRRPDLKLPLPQRDPQLAVPLPLPPNSGGSNSSSSSSA--------------------RA 64

Query: 94  QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRD 153
           QL + +EL + NRIGSGSGGTV++VVH PTSR++ALKVIYGNHEDSVR+ ICREIEILRD
Sbjct: 65  QL-SFSELDRINRIGSGSGGTVYKVVHRPTSRLYALKVIYGNHEDSVRNSICREIEILRD 123

Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           VNHPNVVKCHDM+D NGEI+VLLE+MDGGSLEG HI  E  LSD+ARQ+L+G+AYLHKRK
Sbjct: 124 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHINHEGYLSDVARQILNGIAYLHKRK 183

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           IVHRDIKPSNLLINS  NVKIADFGVSRILAQTMDPCNS+VGTIAYMSPERINTDLN G 
Sbjct: 184 IVHRDIKPSNLLINSKNNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNKGM 243

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
           YDGYAGDIWSLGVSILEFYLGRFPF VGRQGDWASLM AIC +QPPEAP  ASREFRDFI
Sbjct: 244 YDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRDFI 303

Query: 334 SRCLQKDPHSRWPAAQLLQHPFIL-RAGQSQVNQNLRQILPPPRP 377
           + CLQ++P  R+ A QLLQHPFI+ RAG+         ++ PP P
Sbjct: 304 ACCLQREPARRFTANQLLQHPFIVRRAGEGSGGNGTHSLMLPPPP 348

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224097472|ref|XP_002310949.1| predicted protein [Populus trichocarpa] gi|222850769|gb|EEE88316.1| predicted protein [Populus trichocarpa]

 Score =  493 bits (1269), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 252/351 (71%), Positives = 279/351 (79%), Gaps = 24/351 (6%)

Query: 34  RRRPDLTLPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRH 93
           RRRPDLTLP+PQRDP+LAVPLPLPP S  S+ S  S S                    R 
Sbjct: 25  RRRPDLTLPLPQRDPALAVPLPLPPNSVGSNPSSSSVSSA------------------RA 66

Query: 94  QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRD 153
           QL + +EL + NRIGSGSGGTV++VVH PT R +ALKVIYGNHEDSVR+QICREIEILRD
Sbjct: 67  QL-SFSELDRINRIGSGSGGTVYKVVHRPTGRFYALKVIYGNHEDSVRNQICREIEILRD 125

Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           VNHPNVVKCHDM+D NGEI+VLLE+MD GSLEG HI  E  LSD+ARQ+L+G+AYLHKRK
Sbjct: 126 VNHPNVVKCHDMFDHNGEIQVLLEFMDNGSLEGTHINHEAYLSDVARQILNGIAYLHKRK 185

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           IVHRDIKPSNLLINS KNVKIADFGVSRILAQTMDPCNS+VGTIAYMSPERINTDLN G 
Sbjct: 186 IVHRDIKPSNLLINSKKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNQGL 245

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
           YDGYAGDIWSLGVSILEFYLGRFPF VGRQGDWASLM AIC +QPPEAP  ASREFR+FI
Sbjct: 246 YDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPASASREFRNFI 305

Query: 334 SRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLR-----QILPPPRPLS 379
           + CLQ++P  RW A QLLQHPFI+R G               + PPPRP++
Sbjct: 306 ACCLQREPSRRWTANQLLQHPFIVRRGGGGEGGGGNGTHSLMLPPPPRPIA 356

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|42601216|gb|AAS21305.1| mitogen-activated protein kinase kinase 5 [Petroselinum crispum]

 Score =  487 bits (1253), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 247/369 (66%), Positives = 287/369 (77%), Gaps = 30/369 (8%)

Query: 19  SSSSPSSSLANRRGQRRRPDLTLPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPH 78
           S+  P  + ANR+  RRRPDLTLP+PQRDP++AVPLPLPP S  SS++  S +       
Sbjct: 3   SAQPPPPTAANRQRPRRRPDLTLPLPQRDPAIAVPLPLPPNSAPSSTTAASAAAAI---- 58

Query: 79  QQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED 138
                          Q IN +EL + NRIGSGSGGTV++V H PT +++ALKVIYGNHE+
Sbjct: 59  ---------------QPINFSELDRINRIGSGSGGTVYKVAHRPTGKLYALKVIYGNHEE 103

Query: 139 SVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDL 198
           SVR QICREIEILRDV++ NVVKCHDMYD  GEI+VLLEYMD GSLEG HI  E  L+DL
Sbjct: 104 SVRRQICREIEILRDVDNLNVVKCHDMYDHAGEIQVLLEYMDRGSLEGIHITNEAALADL 163

Query: 199 ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIA 258
            RQ+LSG+ YLH+++IVHRDIKPSNLL+NS K VKIADFGVSR+LAQTMDPCNS+VGTIA
Sbjct: 164 TRQILSGIHYLHRKRIVHRDIKPSNLLVNSRKQVKIADFGVSRVLAQTMDPCNSSVGTIA 223

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP 318
           YMSPERINTDLN G+YDGYAGDIWSLGVSILEFY+GRFPFAV R GDWASLM AIC +QP
Sbjct: 224 YMSPERINTDLNQGRYDGYAGDIWSLGVSILEFYMGRFPFAVSRGGDWASLMCAICMSQP 283

Query: 319 PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR----------AGQSQVNQNL 368
           PEAP  ASR+FR+FIS CLQ+DPH RW A QLL+HPF+++           G SQVNQ  
Sbjct: 284 PEAPPTASRQFREFISCCLQRDPHRRWTANQLLRHPFVVQTNNGTPPNGSGGGSQVNQ-A 342

Query: 369 RQILPPPRP 377
            Q+LPPPRP
Sbjct: 343 HQLLPPPRP 351

Source: Petroselinum crispum

Species: Petroselinum crispum

Genus: Petroselinum

Family: Apiaceae

Order: Apiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225443266|ref|XP_002273313.1| PREDICTED: mitogen-activated protein kinase kinase 5 [Vitis vinifera]

 Score =  487 bits (1253), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 248/336 (73%), Positives = 274/336 (81%), Gaps = 29/336 (8%)

Query: 34  RRRPDLTLPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRH 93
           RRRPDLTLP+PQRDPSLAVPLPLPPTS  SSSSG + +                      
Sbjct: 23  RRRPDLTLPLPQRDPSLAVPLPLPPTSAQSSSSGGAAAAA-------------------- 62

Query: 94  QLINPA--ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEIL 151
               PA  EL++ NRIGSGSGGTV++V+H PT R++ALKVIYGNH+D V  QICREIEIL
Sbjct: 63  ---TPAFSELERINRIGSGSGGTVYKVLHRPTGRLYALKVIYGNHDDDVLRQICREIEIL 119

Query: 152 RDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           RDV++PNVVKCHDMYD  GEI+VLLE+MDGGSLEG HI  E  LSDLA Q+LSGL YLH+
Sbjct: 120 RDVDNPNVVKCHDMYDHAGEIQVLLEHMDGGSLEGTHIADELALSDLAFQILSGLHYLHR 179

Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
           RKIVHRDIKPSNLLIN+ + VKIADFGVSRILAQTMDPCNS+VGTIAYMSPERINTDLNH
Sbjct: 180 RKIVHRDIKPSNLLINARRQVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNH 239

Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
           G+YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLM AIC +QPPEAP  ASREFRD
Sbjct: 240 GRYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMCAICMSQPPEAPVTASREFRD 299

Query: 332 FISRCLQKDPHSRWPAAQLLQHPFIL----RAGQSQ 363
           FISRCLQ+DP  RW A +LL+HPF+L    R GQSQ
Sbjct: 300 FISRCLQRDPAVRWSADKLLRHPFVLQSQRRRGQSQ 335

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|312281759|dbj|BAJ33745.1| unnamed protein product [Thellungiella halophila]

 Score =  486 bits (1251), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 246/352 (69%), Positives = 284/352 (80%), Gaps = 8/352 (2%)

Query: 21  SSPSSSLANRRGQRRRPDLTLPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQ 80
           S P  S+  +   RRRPDLTLP+PQRD SLAVPLPLPPTS  S+ S   ++  +      
Sbjct: 6   SPPGVSVPVKSRPRRRPDLTLPLPQRDVSLAVPLPLPPTSGGSAPSSAGSAPSSGGSASS 65

Query: 81  QQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSV 140
             +   +  ++   L+      +G+RIGSG+GGTV++VVH PTSR++ALKVIYGNHE++V
Sbjct: 66  TSSNNTSESKSYSDLV------RGSRIGSGAGGTVYKVVHRPTSRLYALKVIYGNHEETV 119

Query: 141 RSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR 200
           R QICREIEILRDVNHPNVVKCH+M+D+NGEI+VLLE+MD GSLEGAH+ +EH L+DL+R
Sbjct: 120 RRQICREIEILRDVNHPNVVKCHEMFDQNGEIQVLLEFMDKGSLEGAHVWKEHQLADLSR 179

Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYM 260
           Q+LSGLAYLH R IVHRDIKPSNLLINS+KNVKIADFGVSRILAQTMDPCNS+VGTIAYM
Sbjct: 180 QILSGLAYLHGRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYM 239

Query: 261 SPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE 320
           SPERINTDLN G+YDGYAGDIWSLGVSILEF+LGRFPF V RQGDWASLM AIC +QPPE
Sbjct: 240 SPERINTDLNQGQYDGYAGDIWSLGVSILEFFLGRFPFPVSRQGDWASLMCAICMSQPPE 299

Query: 321 APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN--QNLRQ 370
           AP  AS EFR FIS CLQ++P  R  A QLLQHPFI RA QSQ    QNL Q
Sbjct: 300 APPTASPEFRHFISCCLQREPARRQTAMQLLQHPFIRRASQSQNRSPQNLHQ 351

Source: Thellungiella halophila

Species: Eutrema halophilum

Genus: Eutrema

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297847538|ref|XP_002891650.1| hypothetical protein ARALYDRAFT_474280 [Arabidopsis lyrata subsp. lyrata] gi|297337492|gb|EFH67909.1| hypothetical protein ARALYDRAFT_474280 [Arabidopsis lyrata subsp. lyrata]

 Score =  484 bits (1247), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 247/352 (70%), Positives = 284/352 (80%), Gaps = 12/352 (3%)

Query: 21  SSPSSSLANRRGQRRRPDLTLPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQ 80
           S P  S+  +   RRRPDLTLP+PQRD SLAVPLPLPPTS  S+ S   ++      +  
Sbjct: 6   SPPGVSVPVKSRPRRRPDLTLPLPQRDVSLAVPLPLPPTSGGSAPSSGGSASSAPSTNTN 65

Query: 81  QQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSV 140
             ++++N           ++L +GNRIGSG+GGTV++VVH P+SR++ALKVIYGNHE++V
Sbjct: 66  SSSESKNY----------SDLVRGNRIGSGAGGTVYKVVHRPSSRLYALKVIYGNHEETV 115

Query: 141 RSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR 200
           R QICREIEILRDVNHPNVVKCH+M+D+NGEI+VLLE+MD GSLEGAH+ +E  L+DL+R
Sbjct: 116 RRQICREIEILRDVNHPNVVKCHEMFDQNGEIQVLLEFMDKGSLEGAHVWKEQQLADLSR 175

Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYM 260
           Q+LSGLAYLH R IVHRDIKPSNLLINS+KNVKIADFGVSRILAQTMDPCNS+VGTIAYM
Sbjct: 176 QILSGLAYLHSRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYM 235

Query: 261 SPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE 320
           SPERINTDLN G YDGYAGDIWSLGVSILEFYLGRFPF V RQGDWASLM AIC +QPPE
Sbjct: 236 SPERINTDLNQGLYDGYAGDIWSLGVSILEFYLGRFPFPVSRQGDWASLMCAICMSQPPE 295

Query: 321 APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN--QNLRQ 370
           AP  AS EFR FIS CLQ++P  R  A QLLQHPFILRA  SQ    QNL Q
Sbjct: 296 APPTASPEFRHFISCCLQREPGKRRSAMQLLQHPFILRASPSQNRSPQNLHQ 347

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|99083581|gb|ABF55664.2| double MYC-tagged mitogen activated protein kinase kinase 4 [synthetic construct]

 Score =  481 bits (1239), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 249/352 (70%), Positives = 283/352 (80%), Gaps = 9/352 (2%)

Query: 21  SSPSSSLANRRGQRRRPDLTLPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQ 80
           S P  S+  +   RRRPDLTLP+PQRD SLAVPLPLPPTS  S  S  S           
Sbjct: 6   SPPGVSVPVKSRPRRRPDLTLPLPQRDVSLAVPLPLPPTSGGSGGSSGSAP-------SS 58

Query: 81  QQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSV 140
             + +  N  +  +  N ++L +GNRIGSG+GGTV++V+H P+SR++ALKVIYGNHE++V
Sbjct: 59  GGSASSTNTNSSIEAKNYSDLVRGNRIGSGAGGTVYKVIHRPSSRLYALKVIYGNHEETV 118

Query: 141 RSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR 200
           R QICREIEILRDVNHPNVVKCH+M+D+NGEI+VLLE+MD GSLEGAH+ +E  L+DL+R
Sbjct: 119 RRQICREIEILRDVNHPNVVKCHEMFDQNGEIQVLLEFMDKGSLEGAHVWKEQQLADLSR 178

Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYM 260
           Q+LSGLAYLH R IVHRDIKPSNLLINS+KNVKIADFGVSRILAQTMDPCNS+VGTIAYM
Sbjct: 179 QILSGLAYLHSRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYM 238

Query: 261 SPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE 320
           SPERINTDLN GKYDGYAGDIWSLGVSILEFYLGRFPF V RQGDWASLM AIC +QPPE
Sbjct: 239 SPERINTDLNQGKYDGYAGDIWSLGVSILEFYLGRFPFPVSRQGDWASLMCAICMSQPPE 298

Query: 321 APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN--QNLRQ 370
           AP  AS EFR FIS CLQ++P  R  A QLLQHPFILRA  SQ    QNL Q
Sbjct: 299 APATASPEFRHFISCCLQREPGKRRSAMQLLQHPFILRASPSQNRSPQNLHQ 350

Source: synthetic construct

Species: synthetic construct

Genus: N/A

Family: N/A

Order: N/A

Class: N/A

Phylum: N/A

>gi|15217998|ref|NP_175577.1| mitogen-activated protein kinase kinase 4 [Arabidopsis thaliana] gi|75318633|sp|O80397.1|M2K4_ARATH RecName: Full=Mitogen-activated protein kinase kinase 4; Short=AtMKK4; Short=MAP kinase kinase 4 gi|11692830|gb|AAG40018.1|AF324667_1 At1g51660 [Arabidopsis thaliana] gi|11908062|gb|AAG41460.1|AF326878_1 putative MAP kinase kinase 4 [Arabidopsis thaliana] gi|12321661|gb|AAG50863.1|AC025294_1 MAP kinase kinase 4 (ATMKK4) [Arabidopsis thaliana] gi|13194804|gb|AAK15564.1|AF349517_1 putative MAP kinase kinase 4 (ATMKK4) [Arabidopsis thaliana] gi|14030615|gb|AAK52982.1|AF375398_1 At1g51660/F19C24_26 [Arabidopsis thaliana] gi|3219271|dbj|BAA28830.1| MAP kinase kinase 4 [Arabidopsis thaliana] gi|22136538|gb|AAM91055.1| At1g51660/F19C24_26 [Arabidopsis thaliana] gi|332194575|gb|AEE32696.1| mitogen-activated protein kinase kinase 4 [Arabidopsis thaliana]

 Score =  481 bits (1237), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 249/352 (70%), Positives = 283/352 (80%), Gaps = 9/352 (2%)

Query: 21  SSPSSSLANRRGQRRRPDLTLPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQ 80
           S P  S+  +   RRRPDLTLP+PQRD SLAVPLPLPPTS  S  S  S           
Sbjct: 6   SPPGVSVPVKSRPRRRPDLTLPLPQRDVSLAVPLPLPPTSGGSGGSSGSAP-------SS 58

Query: 81  QQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSV 140
             + +  N  +  +  N ++L +GNRIGSG+GGTV++V+H P+SR++ALKVIYGNHE++V
Sbjct: 59  GGSASSTNTNSSIEAKNYSDLVRGNRIGSGAGGTVYKVIHRPSSRLYALKVIYGNHEETV 118

Query: 141 RSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR 200
           R QICREIEILRDVNHPNVVKCH+M+D+NGEI+VLLE+MD GSLEGAH+ +E  L+DL+R
Sbjct: 119 RRQICREIEILRDVNHPNVVKCHEMFDQNGEIQVLLEFMDKGSLEGAHVWKEQQLADLSR 178

Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYM 260
           Q+LSGLAYLH R IVHRDIKPSNLLINS+KNVKIADFGVSRILAQTMDPCNS+VGTIAYM
Sbjct: 179 QILSGLAYLHSRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYM 238

Query: 261 SPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE 320
           SPERINTDLN GKYDGYAGDIWSLGVSILEFYLGRFPF V RQGDWASLM AIC +QPPE
Sbjct: 239 SPERINTDLNQGKYDGYAGDIWSLGVSILEFYLGRFPFPVSRQGDWASLMCAICMSQPPE 298

Query: 321 APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN--QNLRQ 370
           AP  AS EFR FIS CLQ++P  R  A QLLQHPFILRA  SQ    QNL Q
Sbjct: 299 APATASPEFRHFISCCLQREPGKRRSAMQLLQHPFILRASPSQNRSPQNLHQ 350

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|95114268|gb|ABF55665.1| double MYC-tagged mitogen activated protein kinase kinase 5 [synthetic construct]

 Score =  480 bits (1236), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 243/362 (67%), Positives = 277/362 (76%), Gaps = 21/362 (5%)

Query: 19  SSSSPSSSLANRRGQRRRPDLTLPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPH 78
           S S  +S + NR   R+RPDL+LP+P RD              + +         +    
Sbjct: 6   SPSGVASPMKNRL--RKRPDLSLPLPHRD-------------VALAVPLPLPPPSSSSSA 50

Query: 79  QQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED 138
               +    N      L   +EL++ NRIGSG+GGTV++V+H PTSR FALKVIYGNHED
Sbjct: 51  PASSSAISTNISAAKSL---SELERVNRIGSGAGGTVYKVIHTPTSRPFALKVIYGNHED 107

Query: 139 SVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDL 198
           +VR QICREIEILR V+HPNVVKCHDM+D NGEI+VLLE+MD GSLEGAHI QE  L+DL
Sbjct: 108 TVRRQICREIEILRSVDHPNVVKCHDMFDHNGEIQVLLEFMDQGSLEGAHIWQEQELADL 167

Query: 199 ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIA 258
           +RQ+LSGLAYLH+R IVHRDIKPSNLLINS+KNVKIADFGVSRILAQTMDPCNS+VGTIA
Sbjct: 168 SRQILSGLAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIA 227

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP 318
           YMSPERINTDLNHG+YDGYAGD+WSLGVSILEFYLGRFPFAV RQGDWASLM AIC +QP
Sbjct: 228 YMSPERINTDLNHGRYDGYAGDVWSLGVSILEFYLGRFPFAVSRQGDWASLMCAICMSQP 287

Query: 319 PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPL 378
           PEAP  AS+EFR F+S CLQ DP  RW A QLLQHPFIL+A       NLRQ+LPPPRPL
Sbjct: 288 PEAPATASQEFRHFVSCCLQSDPPKRWSAQQLLQHPFILKATG---GPNLRQMLPPPRPL 344

Query: 379 SS 380
            S
Sbjct: 345 PS 346

Source: synthetic construct

Species: synthetic construct

Genus: N/A

Family: N/A

Order: N/A

Class: N/A

Phylum: N/A

>gi|15232491|ref|NP_188759.1| mitogen-activated protein kinase kinase 5 [Arabidopsis thaliana] gi|110279040|sp|Q8RXG3.2|M2K5_ARATH RecName: Full=Mitogen-activated protein kinase kinase 5; Short=AtMAP2Kalpha; Short=AtMKK5; Short=MAP kinase kinase 5 gi|3219273|dbj|BAA28831.1| MAP kinase kinase 5 [Arabidopsis thaliana] gi|9280224|dbj|BAB01714.1| MAP kinase kinase 5 [Arabidopsis thaliana] gi|332642957|gb|AEE76478.1| mitogen-activated protein kinase kinase 5 [Arabidopsis thaliana]

 Score =  480 bits (1235), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 243/362 (67%), Positives = 277/362 (76%), Gaps = 21/362 (5%)

Query: 19  SSSSPSSSLANRRGQRRRPDLTLPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPH 78
           S S  +S + NR   R+RPDL+LP+P RD              + +         +    
Sbjct: 6   SPSGVASPMKNR--LRKRPDLSLPLPHRD-------------VALAVPLPLPPPSSSSSA 50

Query: 79  QQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED 138
               +    N      L   +EL++ NRIGSG+GGTV++V+H PTSR FALKVIYGNHED
Sbjct: 51  PASSSAISTNISAAKSL---SELERVNRIGSGAGGTVYKVIHTPTSRPFALKVIYGNHED 107

Query: 139 SVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDL 198
           +VR QICREIEILR V+HPNVVKCHDM+D NGEI+VLLE+MD GSLEGAHI QE  L+DL
Sbjct: 108 TVRRQICREIEILRSVDHPNVVKCHDMFDHNGEIQVLLEFMDQGSLEGAHIWQEQELADL 167

Query: 199 ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIA 258
           +RQ+LSGLAYLH+R IVHRDIKPSNLLINS+KNVKIADFGVSRILAQTMDPCNS+VGTIA
Sbjct: 168 SRQILSGLAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIA 227

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP 318
           YMSPERINTDLNHG+YDGYAGD+WSLGVSILEFYLGRFPFAV RQGDWASLM AIC +QP
Sbjct: 228 YMSPERINTDLNHGRYDGYAGDVWSLGVSILEFYLGRFPFAVSRQGDWASLMCAICMSQP 287

Query: 319 PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPL 378
           PEAP  AS+EFR F+S CLQ DP  RW A QLLQHPFIL+A       NLRQ+LPPPRPL
Sbjct: 288 PEAPATASQEFRHFVSCCLQSDPPKRWSAQQLLQHPFILKATG---GPNLRQMLPPPRPL 344

Query: 379 SS 380
            S
Sbjct: 345 PS 346

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	380
TAIR|locus:2017662	366	MKK4 "mitogen-activated protei	0.747	0.775	0.790	7e-128
TAIR|locus:2094761	348	MKK5 "MAP kinase kinase 5" [Ar	0.734	0.801	0.801	3e-127
TAIR|locus:2206885	310	MKK9 "MAP kinase kinase 9" [Ar	0.686	0.841	0.516	1.3e-70
TAIR|locus:2014099	307	MKK7 "MAP kinase kinase 7" [Ar	0.684	0.846	0.490	2.8e-66
TAIR|locus:2082390	293	MKK8 "MAP kinase kinase 8" [Ar	0.626	0.812	0.466	7e-54
TAIR|locus:2164981	356	MKK6 "MAP kinase kinase 6" [Ar	0.721	0.769	0.433	3.2e-49
TAIR|locus:2028301	305	MKK10 "MAP kinase kinase 10" [	0.657	0.819	0.433	1.1e-48
TAIR|locus:2120855	354	MEK1 "MAP kinase/ ERK kinase 1	0.689	0.740	0.440	2.3e-48
UNIPROTKB|Q0VD16	393	MAP2K1 "MAP2K1 protein" [Bos t	0.502	0.486	0.408	2e-45
UNIPROTKB|Q02750	393	MAP2K1 "Dual specificity mitog	0.502	0.486	0.408	2e-45

TAIR|locus:2017662 MKK4 "mitogen-activated protein kinase kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1189 (423.6 bits), Expect = 7.0e-128, Sum P(2) = 7.0e-128
 Identities = 226/286 (79%), Positives = 254/286 (88%)

Query:    97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH 156
             N ++L +GNRIGSG+GGTV++V+H P+SR++ALKVIYGNHE++VR QICREIEILRDVNH
Sbjct:    75 NYSDLVRGNRIGSGAGGTVYKVIHRPSSRLYALKVIYGNHEETVRRQICREIEILRDVNH 134

Query:   157 PNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVH 216
             PNVVKCH+M+D+NGEI+VLLE+MD GSLEGAH+ +E  L+DL+RQ+LSGLAYLH R IVH
Sbjct:   135 PNVVKCHEMFDQNGEIQVLLEFMDKGSLEGAHVWKEQQLADLSRQILSGLAYLHSRHIVH 194

Query:   217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
             RDIKPSNLLINS+KNVKIADFGVSRILAQTMDPCNS+VGTIAYMSPERINTDLN GKYDG
Sbjct:   195 RDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNQGKYDG 254

Query:   277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
             YAGDIWSLGVSILEFYLGRFPF V RQGDWASLM AIC +QPPEAP  AS EFR FIS C
Sbjct:   255 YAGDIWSLGVSILEFYLGRFPFPVSRQGDWASLMCAICMSQPPEAPATASPEFRHFISCC 314

Query:   337 LQKDPHSRWPAAQLLQHPFILRAGQSQVN--QNLRQILPPPRPLSS 380
             LQ++P  R  A QLLQHPFILRA  SQ    QNL Q+LPPPRPLSS
Sbjct:   315 LQREPGKRRSAMQLLQHPFILRASPSQNRSPQNLHQLLPPPRPLSS 360

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009814 "defense response, incompatible interaction" evidence=RCA;IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0010227 "floral organ abscission" evidence=IMP

GO:0000165 "MAPK cascade" evidence=IC;RCA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0010229 "inflorescence development" evidence=IGI

GO:0004708 "MAP kinase kinase activity" evidence=ISS;IDA

TAIR|locus:2094761 MKK5 "MAP kinase kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1198 (426.8 bits), Expect = 3.0e-127, Sum P(2) = 3.0e-127
 Identities = 226/282 (80%), Positives = 251/282 (89%)

Query:    99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
             +EL++ NRIGSG+GGTV++V+H PTSR FALKVIYGNHED+VR QICREIEILR V+HPN
Sbjct:    68 SELERVNRIGSGAGGTVYKVIHTPTSRPFALKVIYGNHEDTVRRQICREIEILRSVDHPN 127

Query:   159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
             VVKCHDM+D NGEI+VLLE+MD GSLEGAHI QE  L+DL+RQ+LSGLAYLH+R IVHRD
Sbjct:   128 VVKCHDMFDHNGEIQVLLEFMDQGSLEGAHIWQEQELADLSRQILSGLAYLHRRHIVHRD 187

Query:   219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
             IKPSNLLINS+KNVKIADFGVSRILAQTMDPCNS+VGTIAYMSPERINTDLNHG+YDGYA
Sbjct:   188 IKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGRYDGYA 247

Query:   279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ 338
             GD+WSLGVSILEFYLGRFPFAV RQGDWASLM AIC +QPPEAP  AS+EFR F+S CLQ
Sbjct:   248 GDVWSLGVSILEFYLGRFPFAVSRQGDWASLMCAICMSQPPEAPATASQEFRHFVSCCLQ 307

Query:   339 KDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPLSS 380
              DP  RW A QLLQHPFIL+A       NLRQ+LPPPRPL S
Sbjct:   308 SDPPKRWSAQQLLQHPFILKATGGP---NLRQMLPPPRPLPS 346

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005739 "mitochondrion" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009814 "defense response, incompatible interaction" evidence=IMP

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:0010227 "floral organ abscission" evidence=IMP

GO:0015824 "proline transport" evidence=RCA

GO:0010229 "inflorescence development" evidence=IGI

GO:0004708 "MAP kinase kinase activity" evidence=ISS

TAIR|locus:2206885 MKK9 "MAP kinase kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 715 (256.8 bits), Expect = 1.3e-70, P = 1.3e-70
 Identities = 137/265 (51%), Positives = 185/265 (69%)

Query:    96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
             I+  +L+K N +G G+GG V++V H  TS ++ALK + G+ +     Q+ RE+EILR  +
Sbjct:    42 ISACDLEKLNVLGCGNGGIVYKVRHKTTSEIYALKTVNGDMDPIFTRQLMREMEILRRTD 101

Query:   156 HPNVVKCHDMYDRN--GEIEVLLEYMDGGSLEGAHIR-QEHILSDLARQVLSGLAYLHKR 212
              P VVKCH ++++   GE+ +L+EYMDGG+LE       E  L+  A+Q+L GL+YLH  
Sbjct:   102 SPYVVKCHGIFEKPVVGEVSILMEYMDGGTLESLRGGVTEQKLAGFAKQILKGLSYLHAL 161

Query:   213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
             KIVHRDIKP+NLL+NS   VKIADFGVS+IL +++D CNS VGT AYMSPER +++ + G
Sbjct:   162 KIVHRDIKPANLLLNSKNEVKIADFGVSKILVRSLDSCNSYVGTCAYMSPERFDSESSGG 221

Query:   273 KYDGYAGDIWSLGVSILEFYLGRFPFAV-GRQGDWASLMFAICFAQPPEAPEMASREFRD 331
               D YAGDIWS G+ +LE  +G FP    G++ DWA+LM A+CF +PP APE  S EFR 
Sbjct:   222 SSDIYAGDIWSFGLMMLELLVGHFPLLPPGQRPDWATLMCAVCFGEPPRAPEGCSEEFRS 281

Query:   332 FISRCLQKDPHSRWPAAQLLQHPFI 356
             F+  CL+KD   RW A QLL HPF+
Sbjct:   282 FVECCLRKDSSKRWTAPQLLAHPFL 306

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005739 "mitochondrion" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IDA;TAS

GO:0009611 "response to wounding" evidence=IEP

GO:0009873 "ethylene mediated signaling pathway" evidence=IMP

GO:0009651 "response to salt stress" evidence=IMP

GO:0009693 "ethylene biosynthetic process" evidence=RCA;IDA

GO:0010120 "camalexin biosynthetic process" evidence=IDA

GO:0030295 "protein kinase activator activity" evidence=IDA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0006569 "tryptophan catabolic process" evidence=RCA

GO:0009684 "indoleacetic acid biosynthetic process" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

TAIR|locus:2014099 MKK7 "MAP kinase kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 674 (242.3 bits), Expect = 2.8e-66, P = 2.8e-66
 Identities = 130/265 (49%), Positives = 181/265 (68%)

Query:    96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
             I+ ++++K + +G GS G V++V H  T  ++ALK + G+   +   Q+ RE+EILR  +
Sbjct:    40 ISASDVEKLHVLGRGSSGIVYKVHHKTTGEIYALKSVNGDMSPAFTRQLAREMEILRRTD 99

Query:   156 HPNVVKCHDMYDRN--GEIEVLLEYMDGGSLEGAH-IRQEHILSDLARQVLSGLAYLHKR 212
              P VV+C  ++++   GE+ +L+EYMDGG+LE       E  L+  +RQ+L GL+YLH  
Sbjct:   100 SPYVVRCQGIFEKPIVGEVSILMEYMDGGNLESLRGAVTEKQLAGFSRQILKGLSYLHSL 159

Query:   213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
             KIVHRDIKP+NLL+NS   VKIADFGVS+I+ +++D CNS VGT AYMSPER ++     
Sbjct:   160 KIVHRDIKPANLLLNSRNEVKIADFGVSKIITRSLDYCNSYVGTCAYMSPERFDSAAGEN 219

Query:   273 KYDGYAGDIWSLGVSILEFYLGRFPFAV-GRQGDWASLMFAICFAQPPEAPEMASREFRD 331
               D YAGDIWS GV ILE ++G FP    G++ DWA+LM  +CF +PP APE  S EFR 
Sbjct:   220 S-DVYAGDIWSFGVMILELFVGHFPLLPQGQRPDWATLMCVVCFGEPPRAPEGCSDEFRS 278

Query:   332 FISRCLQKDPHSRWPAAQLLQHPFI 356
             F+  CL+K+   RW A+QLL HPF+
Sbjct:   279 FVDCCLRKESSERWTASQLLGHPFL 303

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=TAS

GO:0009926 "auxin polar transport" evidence=IMP

GO:0002229 "defense response to oomycetes" evidence=IMP

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2082390 MKK8 "MAP kinase kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 557 (201.1 bits), Expect = 7.0e-54, P = 7.0e-54
 Identities = 117/251 (46%), Positives = 168/251 (66%)

Query:    99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
             A L + + +GSG+GGTV++V    TS ++ALK +  N +    S   REIEILR VN P 
Sbjct:    51 ANLDRISVLGSGNGGTVFKVKDKTTSEIYALKKVKENWD----STSLREIEILRMVNSPY 106

Query:   159 VVKCHDMYDR-NGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
             V KCHD++   +GE+ +L++YMD GSLE      E  L+ ++RQVL G  YLH+ KIVHR
Sbjct:   107 VAKCHDIFQNPSGEVSILMDYMDLGSLESLRGVTEKQLALMSRQVLEGKNYLHEHKIVHR 166

Query:   218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN----HGK 273
             DIKP+NLL +S + VKIADFGVS+I+ ++++ CNS VGT AYMSPER++++ +      K
Sbjct:   167 DIKPANLLRSSKEEVKIADFGVSKIVVRSLNKCNSFVGTFAYMSPERLDSEADGVTEEDK 226

Query:   274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
              + YAGDIWS G+++LE  +G +P       D A+++ A+CF +PP+APE  S + + F+
Sbjct:   227 SNVYAGDIWSFGLTMLEILVGYYPMLP----DQAAIVCAVCFGEPPKAPEECSDDLKSFM 282

Query:   334 SRCLQKDPHSR 344
               CL+K    R
Sbjct:   283 DCCLRKKASER 293

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=TAS

TAIR|locus:2164981 MKK6 "MAP kinase kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 513 (185.6 bits), Expect = 3.2e-49, P = 3.2e-49
 Identities = 127/293 (43%), Positives = 173/293 (59%)

Query:    96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
             I   +L+    IG GSGG V  V H    + FA+KVI  N ++ +R QI +E++I +  +
Sbjct:    65 ITAEDLETVKVIGKGSGGVVQLVRHKWVGKFFAMKVIQMNIQEEIRKQIVQELKINQASS 124

Query:   156 H-PNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYL 209
               P+VV C+  +  NG   ++LEYMD GSL    IRQ     E  L+ + +QVL GL YL
Sbjct:   125 QCPHVVVCYHSFYHNGAFSLVLEYMDRGSLADV-IRQVKTILEPYLAVVCKQVLLGLVYL 183

Query:   210 H-KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
             H +R ++HRDIKPSNLL+N    VKI+DFGVS  LA +M   ++ VGT  YMSPERI+  
Sbjct:   184 HNERHVIHRDIKPSNLLVNHKGEVKISDFGVSASLASSMGQRDTFVGTYNYMSPERISGS 243

Query:   269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPF--AVGRQG--DWASLMFAICFAQPPEAP-E 323
                  YD Y+ DIWSLG+S+LE  +GRFP+  +  +Q    +  L+ AI    PP AP +
Sbjct:   244 T----YD-YSSDIWSLGMSVLECAIGRFPYLESEDQQNPPSFYELLAAIVENPPPTAPSD 298

Query:   324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQN-LRQILPPP 375
               S EF  F+S C+QKDP +R  +  LL HPFI +     ++   L   L PP
Sbjct:   299 QFSPEFCSFVSACIQKDPPARASSLDLLSHPFIKKFEDKDIDLGILVGTLEPP 351

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IDA;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0006275 "regulation of DNA replication" evidence=RCA

GO:0010389 "regulation of G2/M transition of mitotic cell cycle" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA

TAIR|locus:2028301 MKK10 "MAP kinase kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 508 (183.9 bits), Expect = 1.1e-48, P = 1.1e-48
 Identities = 114/263 (43%), Positives = 162/263 (61%)

Query:   100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV 159
             +L+K + +G GSGGTV++  H  T  ++ALKV+  N    + + +  E +IL+ +    +
Sbjct:    47 DLEKLSVLGQGSGGTVYKTRHRRTKTLYALKVLRPN----LNTTVTVEADILKRIESSFI 102

Query:   160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKIV 215
             +KC+ ++    ++  ++E M+ GSL  A + Q    E ++S LA ++L GL YL K  IV
Sbjct:   103 IKCYAVFVSLYDLCFVMELMEKGSLHDALLAQQVFSEPMVSSLANRILQGLRYLQKMGIV 162

Query:   216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL-NHGKY 274
             H DIKPSNLLIN    VKIADFG SRI+A      N   GT AYMSPER++ +    G  
Sbjct:   163 HGDIKPSNLLINKKGEVKIADFGASRIVAGGDYGSN---GTCAYMSPERVDLEKWGFGGE 219

Query:   275 DGYAGDIWSLGVSILEFYLGRFPFA-VGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
              G+AGD+WSLGV +LE Y+GR+P   VG + DWA+L  AIC  +  + P   S EFRDF+
Sbjct:   220 VGFAGDVWSLGVVVLECYIGRYPLTKVGDKPDWATLFCAICCNEKVDIPVSCSLEFRDFV 279

Query:   334 SRCLQKDPHSRWPAAQLLQHPFI 356
              RCL+KD   R    +LL+H F+
Sbjct:   280 GRCLEKDWRKRDTVEELLRHSFV 302

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=TAS

TAIR|locus:2120855 MEK1 "MAP kinase/ ERK kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 505 (182.8 bits), Expect = 2.3e-48, P = 2.3e-48
 Identities = 122/277 (44%), Positives = 161/277 (58%)

Query:    99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
             A+L+    IG GS G V  V H  T + FALKVI  N E+S    I +E+ I      P 
Sbjct:    66 ADLEVIKVIGKGSSGNVQLVKHKLTQQFFALKVIQLNTEESTCRAISQELRINLSSQCPY 125

Query:   159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLH-KRK 213
             +V C+  +  NG + ++LE+MDGGSL     +     E++LS + ++VL GL Y+H +R+
Sbjct:   126 LVSCYQSFYHNGLVSIILEFMDGGSLADLLKKVGKVPENMLSAICKRVLRGLCYIHHERR 185

Query:   214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
             I+HRD+KPSNLLIN    VKI DFGVS+IL  T    NS VGT  YMSPERI+  L   K
Sbjct:   186 IIHRDLKPSNLLINHRGEVKITDFGVSKILTSTSSLANSFVGTYPYMSPERISGSLYSNK 245

Query:   274 YDGYAGDIWSLGVSILEFYLGRFPFAVGR-QGDWAS---LMFAICFAQPPEAPE-MASRE 328
                   DIWSLG+ +LE   G+FP+     +  W+S   L+ AI    PP AP  + S E
Sbjct:   246 -----SDIWSLGLVLLECATGKFPYTPPEHKKGWSSVYELVDAIVENPPPCAPSNLFSPE 300

Query:   329 FRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN 365
             F  FIS+C+QKDP  R  A +LL+H F+     S  N
Sbjct:   301 FCSFISQCVQKDPRDRKSAKELLEHKFVKMFEDSDTN 337

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IDA;TAS

GO:0042542 "response to hydrogen peroxide" evidence=IEP;IDA

GO:0000165 "MAPK cascade" evidence=IC;RCA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA;IDA

GO:0009414 "response to water deprivation" evidence=IMP

GO:0009814 "defense response, incompatible interaction" evidence=IGI;RCA

GO:0000023 "maltose metabolic process" evidence=RCA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0019252 "starch biosynthetic process" evidence=RCA

GO:0019684 "photosynthesis, light reaction" evidence=RCA

GO:0019761 "glucosinolate biosynthetic process" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0009611 "response to wounding" evidence=IEP

UNIPROTKB|Q0VD16 MAP2K1 "MAP2K1 protein" [Bos taurus (taxid:9913)]

 Score = 396 (144.5 bits), Expect = 2.0e-45, Sum P(2) = 2.0e-45
 Identities = 83/203 (40%), Positives = 130/203 (64%)

Query:   100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV 159
             + +K + +G+G+GG V++V H P+  V A K+I+   + ++R+QI RE+++L + N P +
Sbjct:    67 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 126

Query:   160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLH-KRKI 214
             V  +  +  +GEI + +E+MDGGSL+    +     E IL  ++  V+ GL YL  K KI
Sbjct:   127 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 186

Query:   215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
             +HRD+KPSN+L+NS   +K+ DFGVS  L  +M   NS VGT +YMSPER+      G +
Sbjct:   187 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ-----GTH 239

Query:   275 DGYAGDIWSLGVSILEFYLGRFP 297
                  DIWS+G+S++E  +GR+P
Sbjct:   240 YSVQSDIWSMGLSLVEMAVGRYP 262

GO:0090398 "cellular senescence" evidence=IEA

GO:0060711 "labyrinthine layer development" evidence=IEA

GO:0060674 "placenta blood vessel development" evidence=IEA

GO:0048870 "cell motility" evidence=IEA

GO:0045597 "positive regulation of cell differentiation" evidence=IEA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA

GO:0030216 "keratinocyte differentiation" evidence=IEA

GO:0030182 "neuron differentiation" evidence=IEA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA

GO:0007050 "cell cycle arrest" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q02750 MAP2K1 "Dual specificity mitogen-activated protein kinase kinase 1" [Homo sapiens (taxid:9606)]

 Score = 396 (144.5 bits), Expect = 2.0e-45, Sum P(2) = 2.0e-45
 Identities = 83/203 (40%), Positives = 130/203 (64%)

Query:   100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV 159
             + +K + +G+G+GG V++V H P+  V A K+I+   + ++R+QI RE+++L + N P +
Sbjct:    67 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 126

Query:   160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLH-KRKI 214
             V  +  +  +GEI + +E+MDGGSL+    +     E IL  ++  V+ GL YL  K KI
Sbjct:   127 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 186

Query:   215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
             +HRD+KPSN+L+NS   +K+ DFGVS  L  +M   NS VGT +YMSPER+      G +
Sbjct:   187 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQ-----GTH 239

Query:   275 DGYAGDIWSLGVSILEFYLGRFP 297
                  DIWS+G+S++E  +GR+P
Sbjct:   240 YSVQSDIWSMGLSLVEMAVGRYP 262

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0003056 "regulation of vascular smooth muscle contraction" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005938 "cell cortex" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0008283 "cell proliferation" evidence=IEA

GO:0017016 "Ras GTPase binding" evidence=IEA

GO:0030216 "keratinocyte differentiation" evidence=IEA

GO:0030335 "positive regulation of cell migration" evidence=IEA

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=IEA

GO:0032320 "positive regulation of Ras GTPase activity" evidence=IEA

GO:0032402 "melanosome transport" evidence=IEA

GO:0032839 "dendrite cytoplasm" evidence=IEA

GO:0032968 "positive regulation of transcription elongation from RNA polymerase II promoter" evidence=IEA

GO:0033267 "axon part" evidence=IEA

GO:0034111 "negative regulation of homotypic cell-cell adhesion" evidence=IEA

GO:0043204 "perikaryon" evidence=IEA

GO:0045597 "positive regulation of cell differentiation" evidence=IEA

GO:0046579 "positive regulation of Ras protein signal transduction" evidence=IEA

GO:0047496 "vesicle transport along microtubule" evidence=IEA

GO:0048313 "Golgi inheritance" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0048678 "response to axon injury" evidence=IEA

GO:0048870 "cell motility" evidence=IEA

GO:0051291 "protein heterooligomerization" evidence=IEA

GO:0051384 "response to glucocorticoid stimulus" evidence=IEA

GO:0060674 "placenta blood vessel development" evidence=IEA

GO:0060711 "labyrinthine layer development" evidence=IEA

GO:0005816 "spindle pole body" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=TAS

GO:0005634 "nucleus" evidence=TAS

GO:0000187 "activation of MAPK activity" evidence=TAS

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

GO:0005794 "Golgi apparatus" evidence=TAS

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0005739 "mitochondrion" evidence=TAS

GO:0005925 "focal adhesion" evidence=TAS

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=IDA

GO:0004708 "MAP kinase kinase activity" evidence=IDA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IDA

GO:0004672 "protein kinase activity" evidence=TAS

GO:0006928 "cellular component movement" evidence=TAS

GO:0006935 "chemotaxis" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0000165 "MAPK cascade" evidence=TAS

GO:0000186 "activation of MAPKK activity" evidence=TAS

GO:0002224 "toll-like receptor signaling pathway" evidence=TAS

GO:0002755 "MyD88-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0002756 "MyD88-independent toll-like receptor signaling pathway" evidence=TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=TAS

GO:0007173 "epidermal growth factor receptor signaling pathway" evidence=TAS

GO:0007264 "small GTPase mediated signal transduction" evidence=TAS

GO:0007265 "Ras protein signal transduction" evidence=TAS

GO:0007411 "axon guidance" evidence=TAS

GO:0008063 "Toll signaling pathway" evidence=TAS

GO:0008286 "insulin receptor signaling pathway" evidence=TAS

GO:0008543 "fibroblast growth factor receptor signaling pathway" evidence=TAS

GO:0034130 "toll-like receptor 1 signaling pathway" evidence=TAS

GO:0034134 "toll-like receptor 2 signaling pathway" evidence=TAS

GO:0034138 "toll-like receptor 3 signaling pathway" evidence=TAS

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=TAS

GO:0035666 "TRIF-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0045087 "innate immune response" evidence=TAS

GO:0048011 "neurotrophin TRK receptor signaling pathway" evidence=TAS

GO:0051403 "stress-activated MAPK cascade" evidence=TAS

GO:0007050 "cell cycle arrest" evidence=IMP

GO:0008285 "negative regulation of cell proliferation" evidence=IDA

GO:0090398 "cellular senescence" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O80397	M2K4_ARATH	2, ., 7, ., 1, 2, ., 2	0.7073	0.9026	0.9371	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.12.2	0.991
3rd Layer	2.7.12	0.976
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	380
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	0.0
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-137
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-92
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-86
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-81
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-81
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-80
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-74
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-70
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-70
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-68
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-66
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-66
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-63
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-60
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-60
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-60
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-59
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-58
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-57
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-56
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-54
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-53
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-52
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-52
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-51
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-50
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-50
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-50
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-49
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-46
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-46
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-46
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-46
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-45
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-45
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-45
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-44
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-44
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-44
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-43
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-43
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-43
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-42
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-42
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-42
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-41
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-41
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-41
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-41
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-41
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-41
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-41
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-41
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-40
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-40
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-40
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-39
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-39
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-39
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-39
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-39
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-38
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-38
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-37
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-37
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-37
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-35
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-35
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-35
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-35
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-34
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-34
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-34
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-34
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-33
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-33
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-33
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-33
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-33
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-33
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-33
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-33
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-32
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-32
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-32
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-32
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-32
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-32
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-31
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-31
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-31
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-31
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-31
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-31
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-31
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-30
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-30
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-30
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-29
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-29
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-29
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-29
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-28
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-28
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-28
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-28
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-28
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-27
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-27
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-27
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-27
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-27
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-27
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-26
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-26
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-26
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-26
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-26
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-26
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-25
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-25
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-25
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-25
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-25
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-25
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-25
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-25
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-25
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-25
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	7e-25
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-25
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-25
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-24
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-24
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-24
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-24
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-24
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-24
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-24
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	8e-24
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-23
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-23
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-23
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-23
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-23
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-23
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-23
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-23
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-22
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-22
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-22
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-22
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-22
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-22
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-22
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-22
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-22
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-21
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-21
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-21
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-21
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-21
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-21
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-20
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-20
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-20
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-19
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-19
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-19
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-19
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-19
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-19
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-19
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-19
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-19
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-19
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-19
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-19
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-18
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-18
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-18
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-18
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-18
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-18
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-18
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-17
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-17
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-17
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-17
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-17
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-17
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-17
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-17
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-17
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	8e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-16
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-16
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-16
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-16
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-16
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-16
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-16
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-16
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-16
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-16
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-16
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-15
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-15
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-15
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	9e-15
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-14
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-14
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-13
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-12
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	9e-12
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-11
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-11
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-10
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-09
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-08
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-08
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-08
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	8e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-07
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	4e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-07
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	5e-05
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	6e-05
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	7e-05
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	1e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	6e-04

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  587 bits (1516), Expect = 0.0
 Identities = 267/378 (70%), Positives = 302/378 (79%), Gaps = 27/378 (7%)

Query: 1   MRPVLPPPPSGLSSSSSSSSSSPSSSLANRRGQRRRPDLTLPIPQRDPSLAVPLPLPPTS 60
           M+P+ PPP   L S++  ++ S           RRRPDLTLP+PQRDPSLAVPLPLPP S
Sbjct: 1   MKPIQPPPGVPLPSTARHTTKSRP---------RRRPDLTLPLPQRDPSLAVPLPLPPPS 51

Query: 61  NSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVH 120
           +SSSSS  S+S     P   +               + +EL++ NRIGSG+GGTV++V+H
Sbjct: 52  SSSSSSS-SSSASGSAPSAAK---------------SLSELERVNRIGSGAGGTVYKVIH 95

Query: 121 PPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMD 180
            PT R++ALKVIYGNHED+VR QICREIEILRDVNHPNVVKCHDM+D NGEI+VLLE+MD
Sbjct: 96  RPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155

Query: 181 GGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS 240
           GGSLEG HI  E  L+D+ARQ+LSG+AYLH+R IVHRDIKPSNLLINS+KNVKIADFGVS
Sbjct: 156 GGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVS 215

Query: 241 RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAV 300
           RILAQTMDPCNS+VGTIAYMSPERINTDLNHG YDGYAGDIWSLGVSILEFYLGRFPF V
Sbjct: 216 RILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275

Query: 301 GRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA- 359
           GRQGDWASLM AIC +QPPEAP  ASREFR FIS CLQ++P  RW A QLLQHPFILRA 
Sbjct: 276 GRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335

Query: 360 -GQSQVNQNLRQILPPPR 376
            GQ Q   NL Q+LPPPR
Sbjct: 336 PGQGQGGPNLHQLLPPPR 353

Length = 353

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  390 bits (1004), Expect = e-137
 Identities = 137/264 (51%), Positives = 177/264 (67%), Gaps = 11/264 (4%)

Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
           ++L++   +G GS G V++V H PT +++ALK I+ + ++  R Q+ RE++ LR    P 
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI----LSDLARQVLSGLAYLH-KRK 213
           VVKC+  + + GEI ++LEYMDGGSL     +   I    L+ +ARQ+L GL YLH KR 
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           I+HRDIKPSNLLINS   VKIADFG+S++L  T+D CN+ VGT+ YMSPERI      G+
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ-----GE 175

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAP-EMASREFRDF 332
              YA DIWSLG+++LE  LG+FPF    Q  +  LM AIC   PP  P E  S EFRDF
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235

Query: 333 ISRCLQKDPHSRWPAAQLLQHPFI 356
           IS CLQKDP  R  AA+LLQHPFI
Sbjct: 236 ISACLQKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  275 bits (706), Expect = 8e-92
 Identities = 93/263 (35%), Positives = 140/263 (53%), Gaps = 18/263 (6%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           +   ++G GS G V+      T ++ A+KVI        R +I REI+IL+ + HPN+V+
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61

Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVH 216
            +D+++   ++ +++EY +GG L    +++   LS+       RQ+LS L YLH + IVH
Sbjct: 62  LYDVFEDEDKLYLVMEYCEGGDLF-DLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120

Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KP N+L++   +VK+ADFG++R L    +   + VGT  YM+PE +        Y  
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFVGTPEYMAPEVL----LGKGYG- 174

Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE---MASREFRDFI 333
            A DIWSLGV + E   G+ PF    Q      +F       P  P      S E +D I
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLL---ELFKKIGKPKPPFPPPEWDISPEAKDLI 231

Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
            + L KDP  R  A + LQHPF 
Sbjct: 232 RKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  261 bits (669), Expect = 4e-86
 Identities = 96/268 (35%), Positives = 151/268 (56%), Gaps = 19/268 (7%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS-QICREIEILRDVNHPN 158
           E  +G  +G GS G+V+  +   T  + A+K +  + +       + REI IL  + HPN
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 159 VVKCHDMY--DRNGEIEVLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHK 211
           +V+ +     +    + + LEY+ GGSL  + ++      E ++    RQ+L GLAYLH 
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ--TMDPCNSAVGTIAYMSPERINTDL 269
             IVHRDIK +N+L++S   VK+ADFG ++ L    T +   S  GT  +M+PE I    
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR--- 176

Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA-QPPEAPEMASRE 328
             G+  G A DIWSLG +++E   G+ P++    G+  + ++ I  + +PPE PE  S E
Sbjct: 177 --GEEYGRAADIWSLGCTVIEMATGKPPWS--ELGNPMAALYKIGSSGEPPEIPEHLSEE 232

Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +DF+ +CL++DP  R  A +LLQHPF+
Sbjct: 233 AKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  249 bits (637), Expect = 2e-81
 Identities = 98/264 (37%), Positives = 145/264 (54%), Gaps = 19/264 (7%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPN 158
             +   +IG G  G V++  H  T +  A+KVI    E   + + I  EI+IL+   HPN
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI--KLESKEKKEKIINEIQILKKCKHPN 58

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGA-----HIRQEHILSDLARQVLSGLAYLHKRK 213
           +VK +  Y +  E+ +++E+  GGSL+           E  ++ + +++L GL YLH   
Sbjct: 59  IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           I+HRDIK +N+L+ S   VK+ DFG+S  L+ T    N+ VGT  +M+PE IN     GK
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK-ARNTMVGTPYWMAPEVIN-----GK 172

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--APEMASREFRD 331
              Y  DIWSLG++ +E   G+ P+    +      +F I    PP    PE  S EF+D
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKWSDEFKD 229

Query: 332 FISRCLQKDPHSRWPAAQLLQHPF 355
           F+ +CLQK+P  R  A QLL+HPF
Sbjct: 230 FLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  247 bits (634), Expect = 6e-81
 Identities = 91/268 (33%), Positives = 141/268 (52%), Gaps = 20/268 (7%)

Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNV 159
            +   ++GSGS GTV++  H  T ++ A+K++    E S       REI ILR ++HPN+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYLHKRKI 214
           V+  D ++    + +++EY +GG L   ++ +   LS      +A Q+L GL YLH   I
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLF-DYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           +HRD+KP N+L++ +  VKIADFG+++ L ++     + VGT  YM+PE +      G  
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVL----LGGNG 175

Query: 275 DGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM------ASRE 328
            G   D+WSLGV + E   G+ PF      +    +  I     P            S E
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPF---SGENILDQLQLIRRILGPPLEFDEPKWSSGSEE 232

Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +D I +CL KDP  R  A ++LQHP+ 
Sbjct: 233 AKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  247 bits (632), Expect = 2e-80
 Identities = 106/269 (39%), Positives = 153/269 (56%), Gaps = 18/269 (6%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV 159
           +L+    +G+G+ G V +V+H PT ++ A+K I     ++++ QI RE++IL   N P +
Sbjct: 2   DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYI 61

Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLH-KRK 213
           V  +  +  NG+I + +EYMDGGSL+           E IL  +A  VL GL YLH K K
Sbjct: 62  VGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           I+HRD+KPSN+L+NS   +K+ DFGVS  L  ++    + VGT +YM+PERI        
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--AKTFVGTSSYMAPERIQG----ND 175

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWAS---LMFAICFAQPPEAP-EMASREF 329
           Y     DIWSLG+S++E   GRFP+             L+  I    PP  P    S +F
Sbjct: 176 Y-SVKSDIWSLGLSLIELATGRFPYP-PENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233

Query: 330 RDFISRCLQKDPHSRWPAAQLLQHPFILR 358
           +DF++ CL KDP  R    +LL+HPFI +
Sbjct: 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  228 bits (583), Expect = 8e-74
 Identities = 85/254 (33%), Positives = 125/254 (49%), Gaps = 45/254 (17%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G  GTV+      T +  A+K+I      S+  ++ REIEIL+ +NHPN+VK + ++
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 167 DRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYLHKRKIVHRDIKP 221
           +    + +++EY +GGSL+      E  LS      +  Q+L GL YLH   I+HRD+KP
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120

Query: 222 SNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
            N+L++S    VK+ADFG+S++L        + VGT AYM+PE     L    Y     D
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEV----LLGKGYYSEKSD 176

Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKD 340
           IWSLGV + E                                     E +D I + LQKD
Sbjct: 177 IWSLGVILYEL-----------------------------------PELKDLIRKMLQKD 201

Query: 341 PHSRWPAAQLLQHP 354
           P  R  A ++L+H 
Sbjct: 202 PEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  221 bits (565), Expect = 2e-70
 Identities = 99/261 (37%), Positives = 142/261 (54%), Gaps = 21/261 (8%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           IG GS G V+ V      +++ LK I   N  +  R     E++IL+ +NHPN++K ++ 
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67

Query: 166 YDRNGEIEVLLEYMDGGSL---------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVH 216
           ++  G++ +++EY DGG L         EG    +E IL D   Q+   L YLH RKI+H
Sbjct: 68  FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQIL-DWFVQLCLALKYLHSRKILH 126

Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RDIKP N+ + S+  VK+ DFG+S++L+ T+D   + VGT  Y+SPE       +  Y+ 
Sbjct: 127 RDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC----QNKPYN- 181

Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGD-WASLMFAICFAQPPEAPEMASREFRDFISR 335
           Y  DIWSLG  + E    + PF    +G+    L   I   Q P  P   S E R+ +S 
Sbjct: 182 YKSDIWSLGCVLYELCTLKHPF----EGENLLELALKILKGQYPPIPSQYSSELRNLVSS 237

Query: 336 CLQKDPHSRWPAAQLLQHPFI 356
            LQKDP  R   AQ+LQ PFI
Sbjct: 238 LLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  219 bits (561), Expect = 8e-70
 Identities = 96/268 (35%), Positives = 145/268 (54%), Gaps = 19/268 (7%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS---QICREIEILRDVNHPN 158
           Q+GN+IG G+ G V+  V+  T  + A+K I    +D+      +I  E+++L  + HPN
Sbjct: 3   QRGNKIGGGTFGKVYTAVNLDTGELMAVKEI--RIQDNDPKTIKEIADEMKVLELLKHPN 60

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGA----HIRQEHILSDLARQVLSGLAYLHKRKI 214
           +VK + +     ++ + +EY  GG+LE       I  EH++     Q+L GLAYLH   I
Sbjct: 61  LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI 120

Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC----NSAVGTIAYMSPERINTDLN 270
           VHRDIKP+N+ ++ +  +K+ DFG +  L            S  GT AYM+PE I     
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180

Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE--MASRE 328
            G   G A DIWSLG  +LE   G+ P++     ++  +MF +     P  P+    S E
Sbjct: 181 KGH--GRAADIWSLGCVVLEMATGKRPWS-ELDNEFQ-IMFHVGAGHKPPIPDSLQLSPE 236

Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +DF+ RCL+ DP  R  A++LLQHPF+
Sbjct: 237 GKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  215 bits (549), Expect = 7e-68
 Identities = 103/280 (36%), Positives = 149/280 (53%), Gaps = 27/280 (9%)

Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
           +R+G G+GG+V +     T  +FALK I  +    ++ QI RE+EI +    P +VK + 
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 165 MY--DRNGEIEVLLEYMDGGSLE---------GAHIRQEHILSDLARQVLSGLAYLHKRK 213
            +  + +  I + +EY +GGSL+         G  I  E +L  +A  VL GL+YLH RK
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRI-GEKVLGKIAESVLKGLSYLHSRK 125

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           I+HRDIKPSN+L+     VK+ DFGVS  L  ++    +  GT  YM+PERI      GK
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA--GTFTGTSFYMAPERIQ-----GK 178

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWA--SLMFAICFAQPPEAPEMA------ 325
                 D+WSLG+++LE    RFPF    +       L+  I     PE  +        
Sbjct: 179 PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW 238

Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN 365
           S EF+DFI +CL+KDP  R     +L+HP+I    + +VN
Sbjct: 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVN 278

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  210 bits (537), Expect = 2e-66
 Identities = 97/257 (37%), Positives = 140/257 (54%), Gaps = 18/257 (7%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G GS G+V++ +H  T +V A+KV+    +     +I +EI IL+  + P +VK +  Y
Sbjct: 11  LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ---EIIKEISILKQCDSPYIVKYYGSY 67

Query: 167 DRNGEIEVLLEYMDGGSLEGA-HIRQ----EHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            +N ++ +++EY   GS+     I      E  ++ +  Q L GL YLH  K +HRDIK 
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKA 127

Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDI 281
            N+L+N     K+ADFGVS  L  TM   N+ +GT  +M+PE I        Y+  A DI
Sbjct: 128 GNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVI----QEIGYNNKA-DI 182

Query: 282 WSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP--EAPEMASREFRDFISRCLQK 339
           WSLG++ +E   G+ P++          +F I    PP    PE  S EF DF+ +CL K
Sbjct: 183 WSLGITAIEMAEGKPPYSDIHP---MRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVK 239

Query: 340 DPHSRWPAAQLLQHPFI 356
           DP  R  A QLLQHPFI
Sbjct: 240 DPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  210 bits (536), Expect = 3e-66
 Identities = 91/264 (34%), Positives = 140/264 (53%), Gaps = 17/264 (6%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALK-VIYGNHEDSVRSQICREIEILRDVNHPN 158
             Q G+ IG G+ G V++ ++  T    A+K +     ++     I +EI++L+++ HPN
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKI 214
           +VK     + +  + ++LEY + GSL     +     E +++    QVL GLAYLH++ +
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120

Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           +HRDIK +N+L      VK+ADFGV+  L        S VGT  +M+PE I         
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM------- 173

Query: 275 DGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
            G   A DIWSLG +++E   G  P+         + +F I     P  PE  S E +DF
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAALFRIVQDDHPPLPEGISPELKDF 230

Query: 333 ISRCLQKDPHSRWPAAQLLQHPFI 356
           + +C QKDP+ R  A QLL+HP+I
Sbjct: 231 LMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  204 bits (521), Expect = 2e-63
 Identities = 109/305 (35%), Positives = 166/305 (54%), Gaps = 46/305 (15%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV 159
           + +K   +G+G+GG V +V+H P+  + A K+I+   + ++R+QI RE+++L + N P +
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI 61

Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLH-KRKI 214
           V  +  +  +GEI + +E+MDGGSL+    +     E+IL  ++  VL GL YL  K KI
Sbjct: 62  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKI 121

Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           +HRD+KPSN+L+NS   +K+ DFGVS  L  +M   NS VGT +YMSPER+      G +
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERL-----QGTH 174

Query: 275 DGYAGDIWSLGVSILEFYLGRFP------------FAVGRQGDWASLMFAICFAQPPEAP 322
                DIWSLG+S++E  +GR+P            F        A          PP++P
Sbjct: 175 YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234

Query: 323 E-MA---------------------SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG 360
             MA                     S EF+DF+ +CL+K+P  R    +L +HPFI RA 
Sbjct: 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294

Query: 361 QSQVN 365
             +V+
Sbjct: 295 LEEVD 299

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  196 bits (500), Expect = 1e-60
 Identities = 96/268 (35%), Positives = 137/268 (51%), Gaps = 31/268 (11%)

Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
            RIGSG+ G V++     T  + A+KVI     D     I +EI +L++  HPN+V    
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDF-EIIQQEISMLKECRHPNIVAYFG 67

Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDL-----ARQVLSGLAYLHKRKIVHRDI 219
            Y R  ++ +++EY  GGSL+  +      LS+L      R+ L GLAYLH+   +HRDI
Sbjct: 68  SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDI 127

Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           K +N+L+    +VK+ADFGVS  L  T+    S +GT  +M+PE    +   G YDG   
Sbjct: 128 KGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERK-GGYDGKC- 185

Query: 280 DIWSLGVSILEFYLGRFP----------FAVGRQGDWASLMFAICFAQPP--EAPEMASR 327
           DIW+LG++ +E    + P          F + +               PP  +  E  S 
Sbjct: 186 DIWALGITAIELAELQPPMFDLHPMRALFLISKSN-----------FPPPKLKDKEKWSP 234

Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPF 355
            F DFI +CL KDP  R  A +LLQHPF
Sbjct: 235 VFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  196 bits (500), Expect = 1e-60
 Identities = 95/267 (35%), Positives = 143/267 (53%), Gaps = 16/267 (5%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPN 158
                  IG GS G V++ +   T++V A+KVI     ED +   I +EI+ L     P 
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI-EDIQQEIQFLSQCRSPY 60

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRKI 214
           + K +  + +  ++ +++EY  GGS    L+   + + +I + + R+VL GL YLH+   
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYI-AFILREVLLGLEYLHEEGK 119

Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           +HRDIK +N+L++   +VK+ADFGVS  L  TM   N+ VGT  +M+PE I        Y
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI----KQSGY 175

Query: 275 DGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE-MASREFRDFI 333
           D  A DIWSLG++ +E   G  P +         ++F I    PP       S+ F+DF+
Sbjct: 176 DEKA-DIWSLGITAIELAKGEPPLS---DLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFV 231

Query: 334 SRCLQKDPHSRWPAAQLLQHPFILRAG 360
           S CL KDP  R  A +LL+H FI +A 
Sbjct: 232 SLCLNKDPKERPSAKELLKHKFIKKAK 258

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  194 bits (495), Expect = 8e-60
 Identities = 108/286 (37%), Positives = 154/286 (53%), Gaps = 24/286 (8%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           +   +L+  + +G+G+GG+V +V H PT  V A KV++   + SVR QI RE++I+ +  
Sbjct: 2   LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR 61

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLH- 210
            P +V  +  +     I + +E+MD GSL+  + +       IL  +A  V+ GL YL+ 
Sbjct: 62  SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN 121

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
             +I+HRDIKPSN+L+NS   +K+ DFGVS  L  ++   ++ VGT  YMSPERI     
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFVGTSTYMSPERIQG--- 176

Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWAS--------LMFAICFAQPPEAP 322
            GKY     D+WSLG+SI+E  LG+FPFA     D           L+  I    PP  P
Sbjct: 177 -GKYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP 234

Query: 323 EMA-SREFRDFISRCLQKDPHSRWPAAQLL--QHPFILRAGQSQVN 365
                 + RDF+  CL KDP  R P  Q L    PFI     S V+
Sbjct: 235 SSDFPEDLRDFVDACLLKDPTER-PTPQQLCAMPPFIQALRASNVD 279

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  193 bits (494), Expect = 1e-59
 Identities = 104/279 (37%), Positives = 146/279 (52%), Gaps = 32/279 (11%)

Query: 97  NPAELQK-GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           +P EL K   +IG G+ G V++     T +  A+K +        +  I  EI I++D  
Sbjct: 16  DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM--RLRKQNKELIINEILIMKDCK 73

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLSGLAYL 209
           HPN+V  +D Y    E+ V++EYMDGGSL    I Q      E  ++ + R+VL GL YL
Sbjct: 74  HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDI-ITQNFVRMNEPQIAYVCREVLQGLEYL 132

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
           H + ++HRDIK  N+L++   +VK+ADFG +  L +     NS VGT  +M+PE I    
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK--- 189

Query: 270 NHGKYDGYAGDIWSLGVSILEF------YLGRFPFAVGRQGDWASLMFAICFAQPPE--A 321
              K  G   DIWSLG+  +E       YL R P            +F I     P    
Sbjct: 190 --RKDYGPKVDIWSLGIMCIEMAEGEPPYL-REPP--------LRALFLITTKGIPPLKN 238

Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG 360
           PE  S EF+DF+++CL KDP  R  A +LLQHPF+ +A 
Sbjct: 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  191 bits (487), Expect = 1e-58
 Identities = 101/264 (38%), Positives = 148/264 (56%), Gaps = 12/264 (4%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV 159
           ++Q    +G G+GGTV++  H  T R+ A+KVI  +    ++ QI  E+EIL   + P +
Sbjct: 2   DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61

Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDI 219
           +  +  +     I +  E+MDGGSL+      EH+L  +A  V+ GL YL   KI+HRD+
Sbjct: 62  IGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDV 121

Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           KPSN+L+N+   VK+ DFGVS  L  ++    + VGT AYM+PERI+     G+  G   
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPERIS-----GEQYGIHS 174

Query: 280 DIWSLGVSILEFYLGRFPFA--VGRQGDWASLMFAICFA--QPPEAPE-MASREFRDFIS 334
           D+WSLG+S +E  LGRFP+      QG    L    C     PP  P    S +F  FI+
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT 234

Query: 335 RCLQKDPHSRWPAAQLLQHPFILR 358
           +C++K P  R     L+ HPFI++
Sbjct: 235 QCMRKQPKERPAPENLMDHPFIVQ 258

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  188 bits (478), Expect = 3e-57
 Identities = 87/270 (32%), Positives = 146/270 (54%), Gaps = 13/270 (4%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V++  H  T    A K+I    E+ +      EI+IL +  HPN+V  ++ Y
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL-EDFMVEIDILSECKHPNIVGLYEAY 71

Query: 167 DRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRDIKP 221
               ++ +L+E+ DGG+L+   +  E  L++     + RQ+L  L +LH  K++HRD+K 
Sbjct: 72  FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKA 131

Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD-LNHGKYDGYAGD 280
            N+L+    +VK+ADFGVS     T+   ++ +GT  +M+PE +  +      YD Y  D
Sbjct: 132 GNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYD-YKAD 190

Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP--EAPEMASREFRDFISRCLQ 338
           IWSLG++++E      P     + +   ++  I  ++PP  + P   S  F DF+  CL 
Sbjct: 191 IWSLGITLIELAQMEPPHH---ELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLV 247

Query: 339 KDPHSRWPAAQLLQHPFILRAGQSQVNQNL 368
           KDP  R  AA+LL+HPF+     ++  ++L
Sbjct: 248 KDPDDRPTAAELLKHPFVSDQSDNKAIKDL 277

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  184 bits (468), Expect = 8e-56
 Identities = 93/276 (33%), Positives = 153/276 (55%), Gaps = 13/276 (4%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV 159
           E++  + +G G+ G+V++V+H PT    A+K I    ++S  +QI  E++IL     P +
Sbjct: 2   EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYI 61

Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLE-------GAHIRQEHILSDLARQVLSGLAYLHKR 212
           V  +  +   G + + +EYMD GSL+             E +L  +   V+ GL +L + 
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 213 -KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN--TDL 269
             I+HRD+KP+N+L+N +  VK+ DFGVS  L  ++   N  +G  +YM+PERI      
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIKSGGPN 179

Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF 329
            +  Y     D+WSLG+SILE  LGR+P+      +  + + AI    PP  P   S + 
Sbjct: 180 QNPTYT-VQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA 238

Query: 330 RDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN 365
           +DF+++CL K P+ R   AQLL+HP++++   + V+
Sbjct: 239 QDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVD 274

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  180 bits (458), Expect = 1e-54
 Identities = 85/263 (32%), Positives = 131/263 (49%), Gaps = 28/263 (10%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI------YGNHEDSVRSQICREIEILRDVNHPNVV 160
           +G GS G V  V    T +++A+KV+           +        E  IL  +NHP +V
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL----TERNILSRINHPFIV 56

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIV 215
           K H  +    ++ ++LEY  GG L  +H+ +E   S + AR    +++  L YLH   I+
Sbjct: 57  KLHYAFQTEEKLYLVLEYAPGGELF-SHLSKEGRFSEERARFYAAEIVLALEYLHSLGII 115

Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           +RD+KP N+L+++  ++K+ DFG+++ L+      N+  GT  Y++PE +      GK  
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLL-----GKGY 170

Query: 276 GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISR 335
           G A D WSLGV + E   G+ PF      +    ++      P   PE  S E RD IS 
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPPF----YAEDRKEIYEKILKDPLRFPEFLSPEARDLISG 226

Query: 336 CLQKDPHSR---WPAAQLLQHPF 355
            LQKDP  R     A ++  HPF
Sbjct: 227 LLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  176 bits (447), Expect = 6e-53
 Identities = 91/274 (33%), Positives = 141/274 (51%), Gaps = 37/274 (13%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVI----YGNHEDSVRSQICREIEILRDVNHP 157
           +KG  +GSGS G+V+  ++      FA+K +     G        Q+ +EI +L  + HP
Sbjct: 3   RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62

Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRK 213
           N+V+          + + LE + GGSL     +     E ++    RQ+L GL YLH R 
Sbjct: 63  NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN 122

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
            VHRDIK +N+L++++  VK+ADFG+++ ++  +     S  G+  +M+PE I     + 
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQQGGY- 179

Query: 273 KYDGYAGDIWSLGVSILEFYLGRFP----------FAVGRQGDWASLMFAICFAQPPEAP 322
              G A DIWSLG ++LE   G+ P          F +GR  +             P  P
Sbjct: 180 ---GLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL------------PPIP 224

Query: 323 EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           +  S E +DFI +CLQ+DP  R  AA+LL+HPF+
Sbjct: 225 DHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  176 bits (447), Expect = 2e-52
 Identities = 97/292 (33%), Positives = 153/292 (52%), Gaps = 30/292 (10%)

Query: 90  QNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIY--GNHEDSVRSQICRE 147
             +    +  +L+    IGSG+ G V+++    T  V A+K +   GN E++ R      
Sbjct: 6   DGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKR------ 59

Query: 148 IEILRDVN-----H--PNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR-----QEHIL 195
             IL D++     H  P +VKC+  +  + ++ + +E M    L+    R      E IL
Sbjct: 60  --ILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQGPIPEDIL 116

Query: 196 SDLARQVLSGLAYL-HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV 254
             +   ++  L YL  K  ++HRD+KPSN+L+++S NVK+ DFG+S  L  +     SA 
Sbjct: 117 GKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA- 175

Query: 255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC 314
           G  AYM+PERI+    + KYD  A D+WSLG+S++E   G+FP+    + ++  ++  I 
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRA-DVWSLGISLVELATGQFPYK-NCKTEF-EVLTKIL 232

Query: 315 FAQPPEAP--EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV 364
             +PP  P  E  S +F  F+  CL KD   R    +LLQHPFI R   ++V
Sbjct: 233 QEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV 284

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  173 bits (441), Expect = 6e-52
 Identities = 89/269 (33%), Positives = 130/269 (48%), Gaps = 26/269 (9%)

Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNVVK-C 162
             IG GS GTV +V      ++   K I YGN  +  + Q+  E+ ILR++ HPN+V+  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 163 HDMYDR-NGEIEVLLEYMDGGSLEGAHIRQ---------EHILSDLARQVLSGLAYLHKR 212
             + DR N  + +++EY +GG L    I++         E  +  +  Q+L  L   H R
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDL-AQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124

Query: 213 -----KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
                 ++HRD+KP+N+ ++++ NVK+ DFG+++IL        + VGT  YMSPE++  
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL-- 182

Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR 327
             NH  YD    DIWSLG  I E      PF    Q     L   I   +    P   S 
Sbjct: 183 --NHMSYDE-KSDIWSLGCLIYELCALSPPFTARNQ---LQLASKIKEGKFRRIPYRYSS 236

Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           E  + I   L  DP  R    +LLQ P I
Sbjct: 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  172 bits (437), Expect = 3e-51
 Identities = 94/272 (34%), Positives = 134/272 (49%), Gaps = 35/272 (12%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI----YGNHEDSVRSQICREIEILRDVNHPNVVKC 162
           IG G+   V+  +  P +   A+K I         D +R    +E++ +   NHPNVVK 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELR----KEVQAMSQCNHPNVVKY 64

Query: 163 HDMYDRNGEIEVLLEYMDGGSLEGAHIRQ---------EHILSDLARQVLSGLAYLHKRK 213
           +  +    E+ +++ Y+ GGSL    I +         E I++ + ++VL GL YLH   
Sbjct: 65  YTSFVVGDELWLVMPYLSGGSL--LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA----VGTIAYMSPERINTDL 269
            +HRDIK  N+L+    +VKIADFGVS  LA   D         VGT  +M+PE +    
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV- 181

Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA---- 325
            HG YD  A DIWS G++ +E   G  P++  +      LM  +    PP     A    
Sbjct: 182 -HG-YDFKA-DIWSFGITAIELATGAAPYS--KYPPMKVLMLTL-QNDPPSLETGADYKK 235

Query: 326 -SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            S+ FR  IS CLQKDP  R  A +LL+H F 
Sbjct: 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  169 bits (431), Expect = 3e-50
 Identities = 91/283 (32%), Positives = 146/283 (51%), Gaps = 29/283 (10%)

Query: 95  LINPAEL-QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRD 153
           L +P  + +    IG G+ G V++  H  T ++ A+K++    ++     I  E  ILR 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE--IKEEYNILRK 58

Query: 154 V-NHPNVVKCHDMYDRNG------EIEVLLEYMDGGS---------LEGAHIRQEHILSD 197
             NHPN+   +  + +        ++ +++E   GGS          +G  +++E I + 
Sbjct: 59  YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWI-AY 117

Query: 198 LARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI 257
           + R+ L GLAYLH+ K++HRDIK  N+L+  +  VK+ DFGVS  L  T+   N+ +GT 
Sbjct: 118 ILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTP 177

Query: 258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASL--MFAICF 315
            +M+PE I  D           D+WSLG++ +E   G+ P       D   +  +F I  
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC-----DMHPMRALFKIPR 232

Query: 316 AQPP--EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             PP  ++PE  S++F DFIS CL K+   R    +LL+HPFI
Sbjct: 233 NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score =  171 bits (434), Expect = 3e-50
 Identities = 107/313 (34%), Positives = 167/313 (53%), Gaps = 54/313 (17%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV 159
           + +K + +G+G+GG V++V H P+  + A K+I+   + ++R+QI RE+++L + N P +
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYL-HKRKI 214
           V  +  +  +GEI + +E+MDGGSL+    +     E IL  ++  V+ GL YL  K KI
Sbjct: 66  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 125

Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           +HRD+KPSN+L+NS   +K+ DFGVS  L  +M   NS VGT +YMSPER+      G +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERL-----QGTH 178

Query: 275 DGYAGDIWSLGVSILEFYLGRFP------------FAVGRQGDWAS-------------- 308
                DIWS+G+S++E  +GR+P            F    +GD A               
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL 238

Query: 309 ---------------LMFAICFAQPPEAPEMA-SREFRDFISRCLQKDPHSRWPAAQLLQ 352
                          L+  I    PP+ P      EF+DF+++CL K+P  R    QL+ 
Sbjct: 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298

Query: 353 HPFILRAGQSQVN 365
           H FI R+   +V+
Sbjct: 299 HAFIKRSEAEEVD 311

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  169 bits (430), Expect = 5e-50
 Identities = 96/291 (32%), Positives = 150/291 (51%), Gaps = 42/291 (14%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDVNHPN 158
           +L+    +G G+ G V ++ H PT  + A+K I        + ++  +++I +R V+ P 
Sbjct: 2   DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPY 61

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLE---------GAHIRQEHILSDLARQVLSGLAYL 209
            V  +    R G++ + +E MD  SL+         G  I  E IL  +A  ++  L YL
Sbjct: 62  TVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTI-PEDILGKIAVSIVKALEYL 119

Query: 210 HKR-KIVHRDIKPSNLLINSSKNVKIADFGVSRIL----AQTMDPCNSAVGTIAYMSPER 264
           H +  ++HRD+KPSN+LIN +  VK+ DFG+S  L    A+T+D      G   YM+PER
Sbjct: 120 HSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID-----AGCKPYMAPER 174

Query: 265 INTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ------- 317
           IN +LN   YD  + D+WSLG++++E   GRFP+       W +      F Q       
Sbjct: 175 INPELNQKGYDVKS-DVWSLGITMIELATGRFPYD-----SWKTP-----FQQLKQVVEE 223

Query: 318 -PPEAP-EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQ 366
             P+ P E  S EF+DF+++CL+K+   R    +LLQHPF         + 
Sbjct: 224 PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDV 274

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  168 bits (426), Expect = 1e-49
 Identities = 93/263 (35%), Positives = 147/263 (55%), Gaps = 16/263 (6%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH---PN 158
           Q+   IG G+ G V+R  H PT RV ALK+I  +  D   S I RE+ +L  +     PN
Sbjct: 4   QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPN 63

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRKI 214
           + K +  Y +   + +++EY +GGS    ++   I +++I S + R+VL  L Y+HK  +
Sbjct: 64  ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYI-SVIIREVLVALKYIHKVGV 122

Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           +HRDIK +N+L+ ++ NVK+ DFGV+ +L Q     ++ VGT  +M+PE I      GKY
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI----TEGKY 178

Query: 275 DGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA-SREFRDFI 333
                DIWSLG++I E   G  P++     D    M  I  ++PP   +   S+  R+F+
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYS---DVDAFRAMMLIPKSKPPRLEDNGYSKLLREFV 235

Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           + CL ++P  R  A +LL+  +I
Sbjct: 236 AACLDEEPKERLSAEELLKSKWI 258

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  159 bits (405), Expect = 1e-46
 Identities = 93/283 (32%), Positives = 141/283 (49%), Gaps = 44/283 (15%)

Query: 103 KGNRIGSGSGGTVWRVVHPPTSRVFALK------VIYGNHEDSVRS---QICREIEILRD 153
           KG  IG G+ G V+  ++  T  + A+K       I G H+   +     +  EIE L+D
Sbjct: 5   KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64

Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAY 208
           ++H N+V+          + + LEY+ GGS+ G+ +R     +E ++     QVL GLAY
Sbjct: 65  LDHLNIVQYLGFETTEEYLSIFLEYVPGGSI-GSCLRTYGRFEEQLVRFFTEQVLEGLAY 123

Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERIN 266
           LH + I+HRD+K  NLL+++    KI+DFG+S+      D     S  G++ +M+PE I 
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI- 182

Query: 267 TDLNHGKYDGYAG--DIWSLGVSILEFYLGRFPFAVGRQGDWASL-----MFAICFAQ-- 317
               H    GY+   DIWSLG  +LE + GR P        W+       MF +   +  
Sbjct: 183 ----HSYSQGYSAKVDIWSLGCVVLEMFAGRRP--------WSDEEAIAAMFKL-GNKRS 229

Query: 318 ----PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
               PP+     S    DF++ C   +P +R  A +LLQHPFI
Sbjct: 230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  160 bits (406), Expect = 2e-46
 Identities = 83/296 (28%), Positives = 130/296 (43%), Gaps = 51/296 (17%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED--SVRSQICREIEILRDVNHPNV 159
           +K  +IG G+ G V++  +  T  + ALK I   +E      + I REI++L+ + HPN+
Sbjct: 2   EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAI-REIKLLQKLRHPNI 60

Query: 160 VKCHDMY--DRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKR 212
           V+  ++      G I ++ EYMD   L G     E   ++       +Q+L GL YLH  
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119

Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-PCNSAVGTIAYMSPERINTDLNH 271
            I+HRDIK SN+LIN+   +K+ADFG++R   +       + V T+ Y  PE +   L  
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL---LGA 176

Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG--------------------DWASLM- 310
            +Y G   D+WS+G  + E +LG+  F    QG                    +W  +  
Sbjct: 177 TRY-GPEVDMWSVGCILAELFLGKPIF----QGSTELEQLEKIFELCGSPTDENWPGVSK 231

Query: 311 --FAICFAQPPEAP--------EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +                    +      D + + L  DP  R  A Q LQH + 
Sbjct: 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  159 bits (405), Expect = 2e-46
 Identities = 85/293 (29%), Positives = 132/293 (45%), Gaps = 50/293 (17%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVV 160
           +K  ++G G+ G V++     T  + ALK I  ++E + + S   REI +L+++ HPN+V
Sbjct: 2   EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIV 61

Query: 161 KCHDMYDRNGEIEVLLEYMD----------GGSLEGAHIRQEHILSDLARQVLSGLAYLH 210
           K  D+     ++ ++ EY D           G L    I+       +  Q+L GLAY H
Sbjct: 62  KLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKS------IMYQLLRGLAYCH 115

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
             +I+HRD+KP N+LIN    +K+ADFG++R     +      V T+ Y +PE +   L 
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEIL---LG 172

Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGR-QGDWASLMFAICFAQPPEA--PEMAS- 326
              Y   A DIWS+G    E   G+ P   G  + D    +F I    P E   P +   
Sbjct: 173 SKHY-STAVDIWSVGCIFAEMITGK-PLFPGDSEIDQLFKIFQIL-GTPTEESWPGVTKL 229

Query: 327 -----------------------REFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                                   E  D +S+ LQ +P  R  A + L+HP+ 
Sbjct: 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  158 bits (401), Expect = 7e-46
 Identities = 84/289 (29%), Positives = 128/289 (44%), Gaps = 52/289 (17%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVN-HPNV 159
           G  IG GS  TV       T++ +A+K++       E  V   +  E E+L  +N HP +
Sbjct: 6   GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKV-KYVKIEKEVLTRLNGHPGI 64

Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKRKI 214
           +K +  +     +  +LEY   G L   +IR+     E      A ++L  L YLH + I
Sbjct: 65  IKLYYTFQDEENLYFVLEYAPNGELLQ-YIRKYGSLDEKCTRFYAAEILLALEYLHSKGI 123

Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP--------------------CNSAV 254
           +HRD+KP N+L++   ++KI DFG +++L     P                      S V
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183

Query: 255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMF--- 311
           GT  Y+SPE +N      K  G + D+W+LG  I +   G+ PF    +G    L F   
Sbjct: 184 GTAEYVSPELLN-----EKPAGKSSDLWALGCIIYQMLTGKPPF----RGSNEYLTFQKI 234

Query: 312 -AICFAQPPEAPEMASREFRDFISRCLQKDPHSR----WPAAQLLQHPF 355
             + ++ PP  P  A    +D I + L  DP  R        +L  HPF
Sbjct: 235 LKLEYSFPPNFPPDA----KDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  157 bits (398), Expect = 2e-45
 Identities = 89/277 (32%), Positives = 136/277 (49%), Gaps = 24/277 (8%)

Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICRE-----IEILR 152
            + L    +IG GS G V       T R  A+K +       +R Q  RE     + I+R
Sbjct: 18  RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM------DLRKQQRRELLFNEVVIMR 71

Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG--AHIR-QEHILSDLARQVLSGLAYL 209
           D  HPN+V+ +  Y    E+ V++E+++GG+L     H R  E  ++ +   VL  L++L
Sbjct: 72  DYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFL 131

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
           H + ++HRDIK  ++L+ S   VK++DFG    +++ +    S VGT  +M+PE I+   
Sbjct: 132 HAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP 191

Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA--PEMASR 327
               Y     DIWSLG+ ++E   G  P+        A  M  I    PP+       S 
Sbjct: 192 ----YGTEV-DIWSLGIMVIEMVDGEPPY-FNEPPLQA--MKRIRDNLPPKLKNLHKVSP 243

Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV 364
             R F+ R L +DP  R  AA+LL HPF+ +AG    
Sbjct: 244 RLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  156 bits (395), Expect = 4e-45
 Identities = 86/269 (31%), Positives = 148/269 (55%), Gaps = 12/269 (4%)

Query: 96  INPAEL-QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV 154
           +NP E  +    +G G+ G V++  +  T  + A KVI    E+ +   +  EI+IL   
Sbjct: 1   LNPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV-EIDILASC 59

Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYL 209
           +HPN+VK  D +     + +L+E+  GG+++   +  E  L++     + +Q L  L YL
Sbjct: 60  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
           H+ KI+HRD+K  N+L     ++K+ADFGVS    +T+   +S +GT  +M+PE +  + 
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179

Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP--EAPEMASR 327
           +  +   Y  D+WSLG++++E      P     + +   ++  I  ++PP    P   S 
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPPH---HELNPMRVLLKIAKSEPPTLAQPSRWSS 236

Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           EF+DF+ +CL+K+  +RW   QLLQHPF+
Sbjct: 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  154 bits (392), Expect = 7e-45
 Identities = 84/257 (32%), Positives = 132/257 (51%), Gaps = 15/257 (5%)

Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           N+IG GS G V++VV     RV+A+K I         R +   E  +L  ++   +++ +
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLSGLAYLHKRKIVHR 217
           + +   G++ +++EY + G L      Q      E  +     Q+L GLA+LH +KI+HR
Sbjct: 66  ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHR 125

Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           DIK  NL +++  NVKI D GV+++L+   +  N+ VGT  Y+SPE     L   K    
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE-----LCEDKPYNE 180

Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL 337
             D+W+LGV + E   G+ PF    QG   +L+  I     P   +M S++    I +CL
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQG---ALILKIIRGVFPPVSQMYSQQLAQLIDQCL 237

Query: 338 QKDPHSRWPAAQLLQHP 354
            KD   R    QLL++P
Sbjct: 238 TKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  155 bits (392), Expect = 1e-44
 Identities = 81/272 (29%), Positives = 144/272 (52%), Gaps = 24/272 (8%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-----YGNHEDSVRSQICREIEILRDV 154
           E  KG ++G+G+  + ++     T  + A+K +       + ++ V   + +EI ++  +
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLE------GAHIRQEHILSDLARQVLSGLAY 208
           NHP++++       +    + +E+M GGS+       GA   +E ++ +   Q+L GL+Y
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAF--KEAVIINYTEQLLRGLSY 118

Query: 209 LHKRKIVHRDIKPSNLLINSS-KNVKIADFGVSRILAQTMDPCN----SAVGTIAYMSPE 263
           LH+ +I+HRD+K +NLLI+S+ + ++IADFG +  LA             +GTIA+M+PE
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI-CFAQPPEAP 322
            +      G+  G + D+WS+G  I+E    + P+   +  +  +L+F I      P  P
Sbjct: 179 VL-----RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIP 233

Query: 323 EMASREFRDFISRCLQKDPHSRWPAAQLLQHP 354
           E  S   RD   RCL+  P  R P+ +LL+HP
Sbjct: 234 EHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score =  155 bits (393), Expect = 3e-44
 Identities = 102/308 (33%), Positives = 161/308 (52%), Gaps = 56/308 (18%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G+G+GG V +V H P+  + A K+I+   + ++R+QI RE+++L + N P +V  +  +
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 167 DRNGEIEVLLEYMDGGSLEG----AHIRQEHILSDLARQVLSGLAYL-HKRKIVHRDIKP 221
             +GEI + +E+MDGGSL+     A    E IL  ++  VL GLAYL  K +I+HRD+KP
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKP 132

Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDI 281
           SN+L+NS   +K+ DFGVS  L  +M   NS VGT +YMSPER+      G +     DI
Sbjct: 133 SNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERL-----QGTHYSVQSDI 185

Query: 282 WSLGVSILEFYLGRFPF------------------AVGRQGDWAS--------------- 308
           WS+G+S++E  +GR+P                       +    S               
Sbjct: 186 WSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGM 245

Query: 309 ----------LMFAICFAQPPEAPE-MASREFRDFISRCLQKDPHSRWPAAQLLQHPFIL 357
                     L+  I    PP+ P  + + +F++F+++CL K+P  R     L+ H FI 
Sbjct: 246 DSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK 305

Query: 358 RAGQSQVN 365
           R+   +V+
Sbjct: 306 RSEVEEVD 313

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  156 bits (395), Expect = 3e-44
 Identities = 86/283 (30%), Positives = 136/283 (48%), Gaps = 31/283 (10%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS--QICREIEILRDVNHP 157
             +   ++G GS G V+        ++ ALKV+    E   +   +  REI+IL  +NHP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 158 -NVVKCHDMYDRNGEIEVLLEYMDGGSLE-------GAHIRQEHILSDLARQVLSGLAYL 209
            N+VK +D +   G + +++EY+DGGSLE             E     +  Q+LS L YL
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 210 HKRKIVHRDIKPSNLLINS-SKNVKIADFGVSRILAQTMDP------CNSAVGTIAYMSP 262
           H + I+HRDIKP N+L++   + VK+ DFG++++L             +++VGT  YM+P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI--------- 313
           E +        Y   + DIWSLG+++ E   G  PF   +     S    I         
Sbjct: 178 EVLL--GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235

Query: 314 CFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                P  PE+ S+   D + + L KDP +R  ++  L H  +
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278

Length = 384

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  152 bits (384), Expect = 2e-43
 Identities = 92/276 (33%), Positives = 150/276 (54%), Gaps = 20/276 (7%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V++  +  T  + A KVI    E+ +   +  EIEIL   NHP +VK    +
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV-EIEILATCNHPYIVKLLGAF 78

Query: 167 DRNGEIEVLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
             +G++ +++E+  GG+++   +       E  +  + RQ+L  L YLH  KI+HRD+K 
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKA 138

Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD-LNHGKYDGYAGD 280
            N+L+    ++K+ADFGVS    +T+   +S +GT  +M+PE +  + +    YD Y  D
Sbjct: 139 GNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD-YKAD 197

Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP--EAPEMASREFRDFISRCLQ 338
           IWSLG++++E      P     + +   ++  I  ++PP    P   S EFRDF+   L 
Sbjct: 198 IWSLGITLIEMAQIEPPH---HELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALD 254

Query: 339 KDPHSRWPAAQLLQHPFILRAGQSQVNQN--LRQIL 372
           K P +R  AAQLL+HPF+     S V  N  LR+++
Sbjct: 255 KHPETRPSAAQLLEHPFV-----SSVTSNRPLRELV 285

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  150 bits (380), Expect = 6e-43
 Identities = 97/262 (37%), Positives = 135/262 (51%), Gaps = 21/262 (8%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVKCHDM 165
           +G G+ G V+      T    A+K I     DS   Q +  EI +   + H N+V+    
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEI--PERDSRYVQPLHEEIALHSYLKHRNIVQYLGS 73

Query: 166 YDRNGEIEVLLEYMDGGSLE-------GAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
              NG  ++ +E + GGSL        G     E  +    +Q+L GL YLH  +IVHRD
Sbjct: 74  DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRD 133

Query: 219 IKPSNLLINS-SKNVKIADFGVSRILAQTMDPCNSA-VGTIAYMSPERINTDLNHG-KYD 275
           IK  N+L+N+ S  VKI+DFG S+ LA  ++PC     GT+ YM+PE I    + G +  
Sbjct: 134 IKGDNVLVNTYSGVVKISDFGTSKRLAG-INPCTETFTGTLQYMAPEVI----DKGPRGY 188

Query: 276 GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI-CFAQPPEAPEMASREFRDFIS 334
           G   DIWSLG +I+E   G+ PF     G+  + MF +  F   PE PE  S E ++FI 
Sbjct: 189 GAPADIWSLGCTIVEMATGKPPFI--ELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246

Query: 335 RCLQKDPHSRWPAAQLLQHPFI 356
           RC + DP  R  A  LLQ PF+
Sbjct: 247 RCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  150 bits (380), Expect = 6e-43
 Identities = 75/262 (28%), Positives = 119/262 (45%), Gaps = 23/262 (8%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ----ICREIEILRDVNHPNVVKC 162
           IG G+ G V  V    T ++FA+K  Y N +  V       +  E  IL+++NHP +V  
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMK--YMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 163 HDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKRKIVHR 217
              +     + ++++ + GG L   H+ Q     E  +     +++  L YLH + I+HR
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDLR-YHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHR 124

Query: 218 DIKPSNLLINSSKNVKIADFGVSRIL-AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           DIKP N+L++   +V I DF ++  +   T+    S  GT  YM+PE +       +   
Sbjct: 125 DIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPEVLCR-----QGYS 177

Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
            A D WSLGV+  E   G+ P+  G        + A         P   S E  D I++ 
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYR-GHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236

Query: 337 LQKDPHSRW--PAAQLLQHPFI 356
           L++DP  R       L  HP+ 
Sbjct: 237 LERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  149 bits (377), Expect = 1e-42
 Identities = 84/278 (30%), Positives = 139/278 (50%), Gaps = 34/278 (12%)

Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS----QICREIEILRD 153
           P   ++G  +G G+ G V+      T R  A+K +  + +          +  EI++L++
Sbjct: 1   PTNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKN 60

Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAY 208
           + H  +V+ +     +  + + +EYM GGS++   ++    L++       RQ+L G+ Y
Sbjct: 61  LQHERIVQYYGCLRDDETLSIFMEYMPGGSVKD-QLKAYGALTETVTRKYTRQILEGVEY 119

Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM----DPCNSAVGTIAYMSPER 264
           LH   IVHRDIK +N+L +S+ NVK+ DFG S+ L QT+        S  GT  +MSPE 
Sbjct: 120 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICSSGTGMKSVTGTPYWMSPEV 178

Query: 265 INTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASL--MFAI--CFAQP-- 318
           I+     G+  G   D+WS+G +++E    + P        WA    M AI     QP  
Sbjct: 179 IS-----GEGYGRKADVWSVGCTVVEMLTEKPP--------WAEFEAMAAIFKIATQPTN 225

Query: 319 PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           P+ P   S + R+F+ R   ++   R  A +LL+H F+
Sbjct: 226 PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  149 bits (376), Expect = 2e-42
 Identities = 92/267 (34%), Positives = 144/267 (53%), Gaps = 14/267 (5%)

Query: 97  NPAEL-QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           +P EL  K  RIG GS G V++ +   T  V A+K+I     +     I +EI +L   +
Sbjct: 1   DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHK 211
            P + + +  Y +  ++ +++EY+ GGS    L+   + + +I + L R++L GL YLH 
Sbjct: 61  SPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATIL-REILKGLDYLHS 119

Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            + +HRDIK +N+L++   +VK+ADFGV+  L  T    N+ VGT  +M+PE I      
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI----KQ 175

Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
             YD +  DIWSLG++ +E   G  P +         ++F I    PP      S+ F++
Sbjct: 176 SAYD-FKADIWSLGITAIELAKGEPPNSDLHP---MRVLFLIPKNSPPTLEGQYSKPFKE 231

Query: 332 FISRCLQKDPHSRWPAAQLLQHPFILR 358
           F+  CL KDP  R  A +LL+H FI R
Sbjct: 232 FVEACLNKDPRFRPTAKELLKHKFITR 258

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  146 bits (372), Expect = 7e-42
 Identities = 82/246 (33%), Positives = 121/246 (49%), Gaps = 16/246 (6%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHD 164
           +G G  G V  V     +R FALK +   H  E   +  I  E EIL + NHP +VK + 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-LAR----QVLSGLAYLHKRKIVHRDI 219
            +     I +L+EY  GG L    +R   +  +  AR     V+    YLH R I++RD+
Sbjct: 61  TFKDKKYIYMLMEYCLGGEL-WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119

Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           KP NLL++S+  VK+ DFG ++ L ++     +  GT  Y++PE I   LN G YD ++ 
Sbjct: 120 KPENLLLDSNGYVKLVDFGFAKKL-KSGQKTWTFCGTPEYVAPEII---LNKG-YD-FSV 173

Query: 280 DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI-CFAQPPEAPEMASREFRDFISRCLQ 338
           D WSLG+ + E   GR PF      D   +   I       E P    +  +D I + L+
Sbjct: 174 DYWSLGILLYELLTGRPPFG-EDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLR 232

Query: 339 KDPHSR 344
           ++P  R
Sbjct: 233 RNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  146 bits (370), Expect = 2e-41
 Identities = 68/258 (26%), Positives = 114/258 (44%), Gaps = 24/258 (9%)

Query: 101 LQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH 156
           L+ G ++G G+ G V     +     T    A+K +     +  R +   E  I++ ++H
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 157 PNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLH 210
           PN+V+   +  +   + ++ EYM GG L       G  +  + +L  +A Q+  G+ YL 
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQ-MALQIAKGMEYLE 119

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINT 267
            +  VHRD+   N L+  +  VKI+DFG+SR +    D      G    I +M+PE +  
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDI-YEDDYYRKRGGGKLPIKWMAPESL-- 176

Query: 268 DLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS 326
               GK+     D+WS GV + E F LG  P+          ++  +        PE   
Sbjct: 177 --KDGKFT-SKSDVWSFGVLLWEIFTLGEQPYP---GMSNEEVLELLEDGYRLPRPENCP 230

Query: 327 REFRDFISRCLQKDPHSR 344
            E  + + +C   DP  R
Sbjct: 231 DELYELMLQCWAYDPEDR 248

Length = 258

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  145 bits (368), Expect = 3e-41
 Identities = 84/262 (32%), Positives = 130/262 (49%), Gaps = 25/262 (9%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKV--IYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           +IG G    V++ +     RV ALK   I+   +   R    +EI++L+ ++HPNV+K  
Sbjct: 9   KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68

Query: 164 DMYDRNGEIEVLLEYMDGGSL--------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
             +  N E+ ++LE  D G L        +   +  E  +     Q+ S L ++H ++I+
Sbjct: 69  ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIM 128

Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           HRDIKP+N+ I ++  VK+ D G+ R  +      +S VGT  YMSPERI     H    
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI-----HENGY 183

Query: 276 GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC-----FAQPPEAPEMASREFR 330
            +  DIWSLG  + E    + PF     GD  +L +++C        PP   +  S E R
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPF----YGDKMNL-YSLCKKIEKCDYPPLPADHYSEELR 238

Query: 331 DFISRCLQKDPHSRWPAAQLLQ 352
           D +SRC+  DP  R   + +LQ
Sbjct: 239 DLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  145 bits (367), Expect = 5e-41
 Identities = 95/266 (35%), Positives = 143/266 (53%), Gaps = 12/266 (4%)

Query: 97  NPAEL-QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           +P EL  K  RIG GS G V++ +   T +V A+K+I     +     I +EI +L   +
Sbjct: 1   DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKR 212
            P V K +  Y +  ++ +++EY+ GGS   L  A    E  ++ + +++L GL YLH  
Sbjct: 61  SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120

Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           K +HRDIK +N+L++   +VK+ADFGV+  L  T    N+ VGT  +M+PE I       
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI----QQS 176

Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
            YD  A DIWSLG++ +E   G  P           ++F I    PP      S+ F++F
Sbjct: 177 AYDSKA-DIWSLGITAIELAKGEPP---NSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEF 232

Query: 333 ISRCLQKDPHSRWPAAQLLQHPFILR 358
           I  CL KDP  R  A +LL+H FI++
Sbjct: 233 IDACLNKDPSFRPTAKELLKHKFIVK 258

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  145 bits (368), Expect = 5e-41
 Identities = 88/289 (30%), Positives = 147/289 (50%), Gaps = 35/289 (12%)

Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIE-ILRDVNHP 157
            +L+    IG G+ GTV +++H P+  + A+K I    ++  + ++  +++ ++R  + P
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63

Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEG----AHIRQ-----EHILSDLARQVLSGLAY 208
            +VK +    R G+  + +E MD  SL+      +        E IL  +A   +  L Y
Sbjct: 64  YIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122

Query: 209 LHKR-KIVHRDIKPSNLLINSSKNVKIADFGVSRIL----AQTMDPCNSAVGTIAYMSPE 263
           L +  KI+HRD+KPSN+L++ + N+K+ DFG+S  L    A+T D      G   YM+PE
Sbjct: 123 LKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-----AGCRPYMAPE 177

Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE 323
           RI+     G YD    D+WSLG+++ E   G+FP+       W S+   +      + P 
Sbjct: 178 RIDPSARDG-YD-VRSDVWSLGITLYEVATGKFPYP-----KWNSVFDQLTQVVKGDPPI 230

Query: 324 MA-------SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN 365
           ++       S  F +FI+ CL KD   R    +LL+HPFI    +  V+
Sbjct: 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVD 279

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  145 bits (367), Expect = 6e-41
 Identities = 94/267 (35%), Positives = 145/267 (54%), Gaps = 14/267 (5%)

Query: 97  NPAEL-QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           +P EL  K  +IG GS G V++ +   T +V A+K+I     +     I +EI +L   +
Sbjct: 1   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHK 211
            P V K +  Y ++ ++ +++EY+ GGS    LE   + +  I + L R++L GL YLH 
Sbjct: 61  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL-REILKGLDYLHS 119

Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            K +HRDIK +N+L++    VK+ADFGV+  L  T    N+ VGT  +M+PE I      
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI----KQ 175

Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
             YD  A DIWSLG++ +E   G  P +   +     ++F I    PP      S+  ++
Sbjct: 176 SAYDSKA-DIWSLGITAIELAKGEPPHS---ELHPMKVLFLIPKNNPPTLEGNYSKPLKE 231

Query: 332 FISRCLQKDPHSRWPAAQLLQHPFILR 358
           F+  CL K+P  R  A +LL+H FI+R
Sbjct: 232 FVEACLNKEPSFRPTAKELLKHKFIVR 258

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  145 bits (367), Expect = 7e-41
 Identities = 88/288 (30%), Positives = 133/288 (46%), Gaps = 39/288 (13%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNVV 160
           QK  +IG G+ G V++     T  + A+K I      + +     REI++L+++NHPN++
Sbjct: 2   QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNII 61

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLE-----GAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           K  D++   G++ ++ E+MD    +        + +  I S L  Q+L GLA+ H   I+
Sbjct: 62  KLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYL-YQLLQGLAFCHSHGIL 120

Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           HRD+KP NLLIN+   +K+ADFG++R     + P    V T  Y +PE +  D    K  
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGD----KGY 176

Query: 276 GYAGDIWSLGVSILEFYLGRFPFAVGR-----------------QGDW---ASLMFAICF 315
               DIWS+G    E    R P   G+                    W    SL     F
Sbjct: 177 STPVDIWSVGCIFAELLSRR-PLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235

Query: 316 AQPPEAP-------EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           + P +A          AS +  D +S+ L  DPH R  A Q L HP+ 
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  144 bits (365), Expect = 8e-41
 Identities = 88/272 (32%), Positives = 142/272 (52%), Gaps = 26/272 (9%)

Query: 103 KGNRIGSGSGGTVWRVVHPPTSRVFALK-----VIYGNHEDSVRSQI---CREIEILRDV 154
           KG  IGSGS G+V+  ++  +  + A+K      +  + +D  RS +    REI +L+++
Sbjct: 4   KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLH 210
            H N+V+          + + LEY+ GGS+          +E ++ +  RQ+L GL YLH
Sbjct: 64  QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH 123

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL-AQTMDPCN-----SAVGTIAYMSPER 264
            R I+HRDIK +N+L+++   +KI+DFG+S+ L A ++         S  G++ +M+PE 
Sbjct: 124 NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183

Query: 265 INTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM 324
           +       K      DIWSLG  ++E   G+ PF    Q      +F I     PE P  
Sbjct: 184 VKQTSYTRK-----ADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIFKIGENASPEIPSN 235

Query: 325 ASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            S E  DF+ +  + D + R  AA+LL+HPF+
Sbjct: 236 ISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  145 bits (367), Expect = 9e-41
 Identities = 83/287 (28%), Positives = 129/287 (44%), Gaps = 44/287 (15%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNVVKCHD 164
            +G G+ G V +  +  T  + A+K    + +D  V+    RE+++LR + H N+V   +
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIK 220
            + R G + ++ EY++   LE        +  D  R    Q+L  +AY H   I+HRDIK
Sbjct: 68  AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIK 127

Query: 221 PSNLLINSSKNVKIADFGVSRIL-AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           P N+L++ S  +K+ DFG +R L A+   P    V T  Y +PE +  D N+GK      
Sbjct: 128 PENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK----PV 183

Query: 280 DIWSLGVSILEFYLGR--FPFAVGRQ------------GDWASLMFAICFAQP------- 318
           D+W++G  + E   G   FP   G              G        +  + P       
Sbjct: 184 DVWAIGCIMAELLDGEPLFP---GDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240

Query: 319 PEAPEMASREFR----------DFISRCLQKDPHSRWPAAQLLQHPF 355
           PE  +  S E R          DF+  CL+ DP  R    +LLQHP+
Sbjct: 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  144 bits (365), Expect = 1e-40
 Identities = 68/261 (26%), Positives = 114/261 (43%), Gaps = 31/261 (11%)

Query: 105 NRIGSGSGGTVWR-VVHPPTSRVF--ALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
            ++G G+ G V++  +     +    A+K +  +  +  R    +E  +++ + HPNVV+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 162 CHDMYDRNGEIEVLLEYMDGGSL--------------EGAHIRQEHILSDLARQVLSGLA 207
              +      + ++LEYM+GG L              E + +  + +LS  A Q+  G+ 
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLS-FAIQIAKGME 119

Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSPERI 265
           YL  +K VHRD+   N L+     VKI+DFG+SR +           G   I +M+PE +
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179

Query: 266 NTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQG-DWASLMFAICFAQPPEAPE 323
                 G +     D+WS GV + E F LG  P+     G     ++  +        PE
Sbjct: 180 ----KDGIFT-SKSDVWSFGVLLWEIFTLGATPYP----GLSNEEVLEYLRKGYRLPKPE 230

Query: 324 MASREFRDFISRCLQKDPHSR 344
               E  + +  C Q DP  R
Sbjct: 231 YCPDELYELMLSCWQLDPEDR 251

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  144 bits (366), Expect = 2e-40
 Identities = 91/283 (32%), Positives = 143/283 (50%), Gaps = 19/283 (6%)

Query: 97  NPAELQKGNR-IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR--SQICREIEILRD 153
           +P +L    R IG GS G V+      T+ V A+K +  + + S      I +E+  L+ 
Sbjct: 12  DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQ 71

Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYL 209
           + HPN ++    Y R     +++EY  G + +   +     QE  ++ +    L GLAYL
Sbjct: 72  LRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYL 131

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
           H  + +HRDIK  N+L+     VK+ADFG + +    + P NS VGT  +M+PE I   +
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASL----VSPANSFVGTPYWMAPEVI-LAM 186

Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGRFP-FAVGRQGDWASLMFAICFAQPPEAPEMA-SR 327
           + G+YDG   D+WSLG++ +E    + P F +    +  S ++ I     P       S 
Sbjct: 187 DEGQYDGKV-DVWSLGITCIELAERKPPLFNM----NAMSALYHIAQNDSPTLSSNDWSD 241

Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQ 370
            FR+F+  CLQK P  R  + +LL+H F+LR     V  +L Q
Sbjct: 242 YFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQ 284

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  144 bits (365), Expect = 5e-40
 Identities = 89/313 (28%), Positives = 139/313 (44%), Gaps = 71/313 (22%)

Query: 92  RHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEI 150
           R++L+ P        IGSG+ G V   V   T R  A+K I    +D + ++ I REI++
Sbjct: 1   RYELLKP--------IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKL 52

Query: 151 LRDVNHPNVVKCHDM-----YDRNGEIEVLLEYMD---------GGSLEGAHIRQEHILS 196
           LR + H N++   D+      +   ++ ++ E M+            L   HI+  + L 
Sbjct: 53  LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQ--YFLY 110

Query: 197 DLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA--- 253
               Q+L GL YLH   ++HRD+KPSN+L+NS+ ++KI DFG    LA+ +DP       
Sbjct: 111 ----QILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFG----LARGVDPDEDEKGF 162

Query: 254 ----VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR--FP---------- 297
               V T  Y +PE +   L+  +Y   A DIWS+G    E    +  FP          
Sbjct: 163 LTEYVVTRWYRAPELL---LSSSRYT-KAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL 218

Query: 298 -FAV-GRQG----DWASLMFAICF--AQPPEAPE-------MASREFRDFISRCLQKDPH 342
              V G        + +   A  +  + P +  +        AS E  D + + L  DP 
Sbjct: 219 IVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPK 278

Query: 343 SRWPAAQLLQHPF 355
            R  A + L HP+
Sbjct: 279 KRITADEALAHPY 291

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  142 bits (360), Expect = 1e-39
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 56/295 (18%)

Query: 103 KGNRIGSGSGGTVWRVVHPPTSRVFALKVI----YGNHEDSV-RSQICREIEILRDVNHP 157
           KG ++G G+   V++     T R+ A+K I        +D +  + + REI++L+++ HP
Sbjct: 4   KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL-REIKLLQELKHP 62

Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEG-----------AHIRQEHILSDLARQVLSGL 206
           N++   D++     I ++ E+M+   LE            A I+            L GL
Sbjct: 63  NIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKS------YMLMTLRGL 115

Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN 266
            YLH   I+HRD+KP+NLLI S   +K+ADFG++R            V T  Y +PE   
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPE--- 172

Query: 267 TDLNHG-KYDGYAGDIWSLGVSILEFYLGRFPFAVG----RQ-------------GDWA- 307
             L  G ++ G   D+WS+G    E  L R PF  G     Q              +W  
Sbjct: 173 --LLFGARHYGVGVDMWSVGCIFAELLL-RVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229

Query: 308 --SLMFAICFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
             SL   + F   P  P       AS +  D + R L  +P+ R  A Q L+HP+
Sbjct: 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  139 bits (354), Expect = 3e-39
 Identities = 69/270 (25%), Positives = 116/270 (42%), Gaps = 32/270 (11%)

Query: 101 LQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH 156
           L  G ++G G+ G V     +          A+K +  +  +    +  RE  I+R ++H
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 157 PNVVK----CHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSG 205
           PN+VK    C +       + +++EYM GG L           +    +LS  A Q+  G
Sbjct: 61  PNIVKLLGVCTE----EEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLS-FALQIARG 115

Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT-MDPCNSAVGTIAYMSPER 264
           + YL  +  +HRD+   N L+  +  VKI+DFG+SR L              I +M+PE 
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES 175

Query: 265 INTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFAVGRQG-DWASLMFAICFAQPPEAP 322
           +      GK+     D+WS GV + E + LG  P+     G   A ++  +        P
Sbjct: 176 L----KEGKF-TSKSDVWSFGVLLWEIFTLGEEPYP----GMSNAEVLEYLKKGYRLPKP 226

Query: 323 EMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
                E    + +C  +DP  R   ++L++
Sbjct: 227 PNCPPELYKLMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  139 bits (353), Expect = 4e-39
 Identities = 70/262 (26%), Positives = 113/262 (43%), Gaps = 33/262 (12%)

Query: 101 LQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH 156
           L  G ++G G+ G V     +          A+K +  +  +    +  RE  I+R ++H
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 157 PNVVK----CHDMYDRNGEIEVLLEYMDGGSLEGA-HIRQEHI-LSDL---ARQVLSGLA 207
           PNVVK    C +       + +++EYM+GG L       +  + LSDL   A Q+  G+ 
Sbjct: 61  PNVVKLLGVCTE----EEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGME 116

Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT----MDPCNSAVGTIAYMSPE 263
           YL  +  +HRD+   N L+  +  VKI+DFG+SR L                 I +M+PE
Sbjct: 117 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL---PIRWMAPE 173

Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFAICFAQPPEAP 322
            +      GK+     D+WS GV + E + LG  P+          ++  +        P
Sbjct: 174 SL----KEGKF-TSKSDVWSFGVLLWEIFTLGEQPYP---GMSNEEVLEYLKNGYRLPQP 225

Query: 323 EMASREFRDFISRCLQKDPHSR 344
                E  D + +C  +DP  R
Sbjct: 226 PNCPPELYDLMLQCWAEDPEDR 247

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  139 bits (351), Expect = 8e-39
 Identities = 78/257 (30%), Positives = 130/257 (50%), Gaps = 19/257 (7%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +G GS G+V++V     ++ +ALK +  G+     R     EI IL  VNHPN++   + 
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67

Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIRQ--------EHILSDLARQVLSGLAYLHKRKIVHR 217
           +    ++ +++EY   G L  A  ++        E  +  +  Q+L GL  LH++KI+HR
Sbjct: 68  FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHR 127

Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           D+K +N+L+ ++  VKI D G+S++L + M    + +GT  YM+PE     +  G+   Y
Sbjct: 128 DLKSANILLVANDLVKIGDLGISKVLKKNM--AKTQIGTPHYMAPE-----VWKGRPYSY 180

Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL 337
             DIWSLG  + E      PF   R      L + +   + P  P + S++ ++FI   L
Sbjct: 181 KSDIWSLGCLLYEMATFAPPFE-AR--SMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSML 237

Query: 338 QKDPHSRWPAAQLLQHP 354
           Q  P  R    ++L  P
Sbjct: 238 QVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  140 bits (353), Expect = 8e-39
 Identities = 85/260 (32%), Positives = 133/260 (51%), Gaps = 16/260 (6%)

Query: 103 KGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVK 161
           +  +IG G+ GTV+  +   T +  A+K +  N +   + + I  EI ++R+  HPN+V 
Sbjct: 23  RFEKIGQGASGTVYTAIDVATGQEVAIKQM--NLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRD 218
             D Y    E+ V++EY+ GGSL          E  ++ + R+ L  L +LH  +++HRD
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRD 140

Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           IK  N+L+    +VK+ DFG    +       ++ VGT  +M+PE +       K  G  
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-----KAYGPK 195

Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--APEMASREFRDFISRC 336
            DIWSLG+  +E   G  P+      +    ++ I     PE   PE  S  FRDF++RC
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYL---NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 252

Query: 337 LQKDPHSRWPAAQLLQHPFI 356
           L+ D   R  A +LLQHPF+
Sbjct: 253 LEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  138 bits (351), Expect = 2e-38
 Identities = 91/290 (31%), Positives = 140/290 (48%), Gaps = 53/290 (18%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVN-HPNVVK 161
           ++G G+ G+V+   +  T  + A+K +   + + E+ +     RE++ LR +N HPN+VK
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN---LREVKSLRKLNEHPNIVK 62

Query: 162 CHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKI 214
             +++  N E+  + EYM+G +L       +G     E ++  +  Q+L GLA++HK   
Sbjct: 63  LKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPF-SESVIRSIIYQILQGLAHIHKHGF 120

Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
            HRD+KP NLL++  + VKIADFG++R + ++  P    V T  Y +PE +   L    Y
Sbjct: 121 FHRDLKPENLLVSGPEVVKIADFGLAREI-RSRPPYTDYVSTRWYRAPEIL---LRSTSY 176

Query: 275 DGYAGDIWSLGVSILEFYLGR--FPFAVGR-----------------QGDW---ASLMFA 312
                DIW+LG  + E Y  R  FP   G                  + DW     L   
Sbjct: 177 SS-PVDIWALGCIMAELYTLRPLFP---GSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232

Query: 313 ICFAQPPEAPEM-------ASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
           + F  P  AP         AS E  D I   L+ DP  R  A+Q LQHP+
Sbjct: 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  138 bits (350), Expect = 3e-38
 Identities = 79/257 (30%), Positives = 121/257 (47%), Gaps = 44/257 (17%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIEILRDVNHPNVVKC 162
           +G+GS G V  V H  + + +ALK++  +    V+      +  E  IL+ + HP +V  
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKIL--SKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66

Query: 163 HDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIVHR 217
           +  +  +  + +++EY+ GG L  +H+R+       +AR    QV+  L YLH   IV+R
Sbjct: 67  YGSFQDDSNLYLVMEYVPGGEL-FSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYR 125

Query: 218 DIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           D+KP NLL++S   +KI DFG + R+  +T   C    GT  Y++PE I   L+ G   G
Sbjct: 126 DLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAPEII---LSKG--YG 176

Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC---------FAQPPEAPEMASR 327
            A D W+LG+ I E   G  PF       +      I          F      P   S 
Sbjct: 177 KAVDWWALGILIYEMLAGYPPF-------FDDNPIQIYEKILEGKVRF------PSFFSP 223

Query: 328 EFRDFISRCLQKDPHSR 344
           + +D I   LQ D   R
Sbjct: 224 DAKDLIRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  136 bits (344), Expect = 2e-37
 Identities = 90/295 (30%), Positives = 135/295 (45%), Gaps = 51/295 (17%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALK-VIYGNHEDSVRSQICREIEILRDV---NHP 157
           ++   IG G+ GTV++     T R  ALK V     E+ +     REI +L+ +    HP
Sbjct: 2   EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHP 61

Query: 158 NVVK----CHDMYDRNGEIEVLL--EYMD---GGSLEGAHIR--QEHILSDLARQVLSGL 206
           N+V+    CH       E+++ L  E++D      L            + DL RQ+L G+
Sbjct: 62  NIVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120

Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN 266
            +LH  +IVHRD+KP N+L+ S   VKIADFG++RI +  M    S V T+ Y +PE + 
Sbjct: 121 DFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM-ALTSVVVTLWYRAPEVL- 178

Query: 267 TDLNHGKYDGYAG--DIWSLGVSILEFYLGR--FP-----------FAV-GR--QGDWA- 307
             L       YA   D+WS+G    E +  R  F            F V G   + +W  
Sbjct: 179 --LQ----SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232

Query: 308 -SLMFAICFAQ----PPEA--PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
              +    F        ++  PE+   E  D + + L  +PH R  A + LQHP+
Sbjct: 233 NVSLPRSSFPSYTPRSFKSFVPEI-CEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  133 bits (338), Expect = 7e-37
 Identities = 87/286 (30%), Positives = 128/286 (44%), Gaps = 62/286 (21%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI------YGNHEDSVRSQICREIEILRDVNHPNVV 160
           I  G+ G V+      T  ++A+KVI        N  D V +    E +IL     P VV
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLT----ERDILSQAQSPYVV 56

Query: 161 KCHDMY-----DRNGEIEVLLEYMDGGSLEGAHIRQEHILS-------DLAR----QVLS 204
           K   +Y      +N  + +++EY+ GG L         +L        D+AR    +++ 
Sbjct: 57  K---LYYSFQGKKN--LYLVMEYLPGGDLA-------SLLENVGSLDEDVARIYIAEIVL 104

Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI--------LAQTMDPCNSAVGT 256
            L YLH   I+HRD+KP N+LI+S+ ++K+ DFG+S++        L          VGT
Sbjct: 105 ALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164

Query: 257 IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFA-ICF 315
             Y++PE I      G+      D WSLG  + EF +G  PF     G+    +F  I  
Sbjct: 165 PDYIAPEVIL-----GQGHSKTVDWWSLGCILYEFLVGIPPF----HGETPEEIFQNILN 215

Query: 316 A--QPPEAPEMASREFRDFISRCLQKDPHSRWPAA---QLLQHPFI 356
              + PE  E  S E  D IS+ L  DP  R  A    ++  HPF 
Sbjct: 216 GKIEWPEDVE-VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  134 bits (340), Expect = 8e-37
 Identities = 85/283 (30%), Positives = 125/283 (44%), Gaps = 38/283 (13%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIY-GNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
           RIG G+ G V++     T    ALK +     E  + +Q  REI+ L+   HP VVK  D
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRDI 219
           ++       +++EYM    L      +E  L +       R +L G+AY+H   I+HRD+
Sbjct: 67  VFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDL 125

Query: 220 KPSNLLINSSKNVKIADFGVSRILA-QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           KP+NLLI++   +KIADFG++R+ + +     +  V T  Y +PE +       KYD   
Sbjct: 126 KPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL---YGARKYDP-G 181

Query: 279 GDIWSLGVSILEFYLGR--FP--------------FAVGRQGDWASLMF-----AICF-A 316
            D+W++G    E   G   FP                   +  W  L        I F  
Sbjct: 182 VDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPE 241

Query: 317 QPPEAPEM----ASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
             P   E     AS E  D +   L  DP  R  AA+ L+HP+
Sbjct: 242 SKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  133 bits (336), Expect = 1e-35
 Identities = 87/303 (28%), Positives = 151/303 (49%), Gaps = 60/303 (19%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIY---GNHEDSVRSQICREIEILRDV-N 155
           E+ +  ++G G+ G VW+ +   T  V ALK I+    N  D+ R+   REI  L+++ +
Sbjct: 10  EILQ--KLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRT--FREIMFLQELGD 65

Query: 156 HPNVVKCHDMY--DRNGEIEVLLEYMD--------GGSLEGAHIRQEHILSDLARQVLSG 205
           HPN+VK  ++   + + +I ++ EYM+           LE  H R  +I+     Q+L  
Sbjct: 66  HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKR--YIMY----QLLKA 119

Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IA---YM 260
           L Y+H   ++HRD+KPSN+L+NS   VK+ADFG++R L++  +   + V T  +A   Y 
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179

Query: 261 SPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR--FP------------FAVGR---- 302
           +PE +   L   +Y     D+WS+G  + E  LG+  FP              +G     
Sbjct: 180 APEIL---LGSTRYT-KGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235

Query: 303 -----QGDWASLMFAICFAQPPEAPE----MASREFRDFISRCLQKDPHSRWPAAQLLQH 353
                +  +A+ M     ++P +  +     AS +  D + + L  +P+ R  A + L+H
Sbjct: 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295

Query: 354 PFI 356
           P++
Sbjct: 296 PYV 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  130 bits (329), Expect = 1e-35
 Identities = 82/261 (31%), Positives = 127/261 (48%), Gaps = 25/261 (9%)

Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALK--VIYGNHEDSVRSQICREIEILRDVNH 156
           A  Q   +IG G    V+R       +  ALK   I+   +   R    +EI++L+ +NH
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61

Query: 157 PNVVKCHDMYDRNGEIEVLLEYMDGGSLEG--AHIRQ------EHILSDLARQVLSGLAY 208
           PNV+K  D +  + E+ ++LE  D G L     + ++      E  +     Q+ S + +
Sbjct: 62  PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121

Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
           +H R+++HRDIKP+N+ I ++  VK+ D G+ R  +      +S VGT  YMSPERI   
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI--- 178

Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA-----QPPEAPE 323
             H     +  DIWSLG  + E    + PF     GD  +L F++C        PP   E
Sbjct: 179 --HENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNL-FSLCQKIEQCDYPPLPTE 231

Query: 324 MASREFRDFISRCLQKDPHSR 344
             S + R+ +S C+  DP  R
Sbjct: 232 HYSEKLRELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  130 bits (327), Expect = 4e-35
 Identities = 92/267 (34%), Positives = 140/267 (52%), Gaps = 23/267 (8%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDM 165
           IG G+ G V++V +     + A+K++  +    V  +I  E  IL+ + NHPNVVK + M
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKIL--DPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87

Query: 166 YDR-----NGEIEVLLEYMDGGS----LEGAHIR----QEHILSDLARQVLSGLAYLHKR 212
           + +      G++ ++LE  +GGS    ++G  I      E ++S +    L GL +LH  
Sbjct: 88  FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN 147

Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           +I+HRD+K +N+L+ +   VK+ DFGVS  L  T    N++VGT  +M+PE I  +  + 
Sbjct: 148 RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYD 207

Query: 273 -KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA--PEMASREF 329
             YD    D+WSLG++ +E   G  P            +F I    PP    PE   R F
Sbjct: 208 YSYDARC-DVWSLGITAIELGDGDPPLF---DMHPVKTLFKIPRNPPPTLLHPEKWCRSF 263

Query: 330 RDFISRCLQKDPHSRWPAAQLLQHPFI 356
             FIS+CL KD  +R     LL+HPFI
Sbjct: 264 NHFISQCLIKDFEARPSVTHLLEHPFI 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  129 bits (326), Expect = 5e-35
 Identities = 95/269 (35%), Positives = 144/269 (53%), Gaps = 27/269 (10%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDM 165
           IG G+ G V++V++       A+K++   H+  +  +I  E  IL+ + +HPNVVK + M
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 166 Y----DRNG-EIEVLLEYMDGGS--------LEGAHIRQEHILSDLARQVLSGLAYLHKR 212
           Y     +NG ++ ++LE  +GGS        L+     +E I++ +  + L GL +LH  
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN 143

Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN-H 271
           K +HRD+K +N+L+ +   VK+ DFGVS  L  T    N++VGT  +M+PE I  +    
Sbjct: 144 KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLD 203

Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASL--MFAICFAQPP--EAPEMASR 327
             YD    D+WSLG++ +E   G  P A     D   +  +F I    PP    PE+ S 
Sbjct: 204 STYDARC-DVWSLGITAIELGDGDPPLA-----DLHPMRALFKIPRNPPPTLHQPELWSN 257

Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           EF DFI +CL KD   R   + LLQH FI
Sbjct: 258 EFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  128 bits (323), Expect = 2e-34
 Identities = 88/262 (33%), Positives = 138/262 (52%), Gaps = 22/262 (8%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQ-ICREIEILRDVNHPNVVKCHD 164
           IG GS G V+      T+ V A+K + Y   + + + Q I +E++ L+ + HPN ++   
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIK 220
            Y R     +++EY  G + +   +     QE  ++ +    L GLAYLH   ++HRDIK
Sbjct: 93  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 152

Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
             N+L+     VK+ADFG + I +    P NS VGT  +M+PE I   ++ G+YDG   D
Sbjct: 153 AGNILLTEPGQVKLADFGSASIAS----PANSFVGTPYWMAPEVI-LAMDEGQYDGKV-D 206

Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE----FRDFISRC 336
           +WSLG++ +E    + P          + M A+      E+P + S E    FR+F+  C
Sbjct: 207 VWSLGITCIELAERKPPLFN------MNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC 260

Query: 337 LQKDPHSRWPAAQLLQHPFILR 358
           LQK P  R  + +LL+H F+LR
Sbjct: 261 LQKIPQDRPTSEELLKHMFVLR 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  129 bits (326), Expect = 3e-34
 Identities = 88/294 (29%), Positives = 132/294 (44%), Gaps = 50/294 (17%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSV-RSQICR---EIEILRDVNHP 157
           +    IG G+ G VW V    T +V+A+KV+     D + R+QI     E +IL D + P
Sbjct: 4   EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL--RKSDMIKRNQIAHVRAERDILADADSP 61

Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRK 213
            +VK +  +     + +++EYM GG L    IR++    + AR    +++  L  +HK  
Sbjct: 62  WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG 121

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVS-----------------------------RILA 244
            +HRDIKP N+LI++  ++K+ADFG+                              R   
Sbjct: 122 FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181

Query: 245 QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF-AVGRQ 303
           Q     NS VGT  Y++PE +      G   G   D WSLGV + E   G  PF +   Q
Sbjct: 182 QRRVRANSTVGTPDYIAPEVL-----RGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236

Query: 304 GDWASLM-FAICFAQPPEAPEMASREFRDFISRCLQKDPHSRW-PAAQLLQHPF 355
             +  ++ +      PP+ P   S E  D I R L  DP  R     ++  HPF
Sbjct: 237 ETYNKIINWKESLRFPPDPP--VSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  128 bits (323), Expect = 3e-34
 Identities = 90/285 (31%), Positives = 146/285 (51%), Gaps = 23/285 (8%)

Query: 97  NPAELQKG-NRIGSGSGGTVWRVVHPPTSRVFALKVIY--GNHEDSVRSQICREIEILRD 153
           +P E+  G + IG GS G V+   +  T+ V A+K +   G   +     I +E++ L+ 
Sbjct: 18  DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQ 77

Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYL 209
           + HPN ++    Y +     +++EY  G + +   +     QE  ++ +    L GLAYL
Sbjct: 78  LKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYL 137

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
           H   ++HRDIK  N+L+     VK+ADFG +   +    P NS VGT  +M+PE I   +
Sbjct: 138 HSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANSFVGTPYWMAPEVI-LAM 192

Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE- 328
           + G+YDG   D+WSLG++ +E    + P          + M A+      ++P + S E 
Sbjct: 193 DEGQYDGKV-DVWSLGITCIELAERKPPLFN------MNAMSALYHIAQNDSPTLQSNEW 245

Query: 329 ---FRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQ 370
              FR F+  CLQK P  R  +A+LL+H F+ R   ++V  +L Q
Sbjct: 246 TDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQ 290

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  127 bits (319), Expect = 6e-34
 Identities = 83/256 (32%), Positives = 130/256 (50%), Gaps = 14/256 (5%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +IG G+ GTV+  +   T +  A+K +    +   +  I  EI ++R+  +PN+V   D 
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           Y    E+ V++EY+ GGSL          E  ++ + R+ L  L +LH  +++HRDIK  
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSD 144

Query: 223 NLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           N+L+    +VK+ DFG    +       ++ VGT  +M+PE +       K  G   DIW
Sbjct: 145 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-----KAYGPKVDIW 199

Query: 283 SLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA--PEMASREFRDFISRCLQKD 340
           SLG+  +E   G  P+      +    ++ I     PE   PE  S  FRDF++RCL+ D
Sbjct: 200 SLGIMAIEMVEGEPPYL---NENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMD 256

Query: 341 PHSRWPAAQLLQHPFI 356
              R  A +LLQHPF+
Sbjct: 257 VDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  126 bits (317), Expect = 1e-33
 Identities = 82/256 (32%), Positives = 131/256 (51%), Gaps = 14/256 (5%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +IG G+ GTV+  +   T +  A+K I    +   +  I  EI +++++ +PN+V   D 
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           +    E+ V++EY+ GGSL          E  ++ + R+ L  L +LH  +++HRDIK  
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSD 144

Query: 223 NLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           N+L+    +VK+ DFG    +       ++ VGT  +M+PE +       K  G   DIW
Sbjct: 145 NVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-----KAYGPKVDIW 199

Query: 283 SLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA--PEMASREFRDFISRCLQKD 340
           SLG+  +E   G  P+      +    ++ I     PE   PE  S  FRDF++RCL+ D
Sbjct: 200 SLGIMAIEMVEGEPPYL---NENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMD 256

Query: 341 PHSRWPAAQLLQHPFI 356
              R  A +LLQHPF+
Sbjct: 257 VEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  125 bits (316), Expect = 2e-33
 Identities = 80/281 (28%), Positives = 126/281 (44%), Gaps = 36/281 (12%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNVVKCHDM 165
           +G GS G V +  H  T ++ A+K    + +D  V+    REI +L+ + H N+V   ++
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIKP 221
           + R   + ++ E++D   L+        +     R    Q+L G+ + H   I+HRDIKP
Sbjct: 69  FRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKP 128

Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDI 281
            N+L++ S  VK+ DFG +R LA   +     V T  Y +PE +  D  +G+    A DI
Sbjct: 129 ENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGR----AVDI 184

Query: 282 WSLGVSILEFYLGR--FP---------FAVGRQGDWASLMFAICFAQP-------PEAPE 323
           W++G  + E   G   FP           +   G+       I    P       PE  E
Sbjct: 185 WAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKE 244

Query: 324 MASREFR---------DFISRCLQKDPHSRWPAAQLLQHPF 355
           +   E R         D   +CL+ DP  R  ++QLL H F
Sbjct: 245 IEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  125 bits (314), Expect = 2e-33
 Identities = 79/254 (31%), Positives = 124/254 (48%), Gaps = 25/254 (9%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALK--VIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           +IG G    V+R          ALK   I+   +   R+   +EI++L+ +NHPNV+K +
Sbjct: 9   KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGA--HIRQ------EHILSDLARQVLSGLAYLHKRKIV 215
             +  + E+ ++LE  D G L     H ++      E  +     Q+ S L ++H R+++
Sbjct: 69  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVM 128

Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           HRDIKP+N+ I ++  VK+ D G+ R  +      +S VGT  YMSPERI     H    
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI-----HENGY 183

Query: 276 GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA-----QPPEAPEMASREFR 330
            +  DIWSLG  + E    + PF     GD  +L +++C        PP   +  S E R
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPF----YGDKMNL-YSLCKKIEQCDYPPLPSDHYSEELR 238

Query: 331 DFISRCLQKDPHSR 344
             ++ C+  DP  R
Sbjct: 239 QLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  123 bits (311), Expect = 4e-33
 Identities = 84/264 (31%), Positives = 129/264 (48%), Gaps = 23/264 (8%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVI----YGNHEDSVRSQICREIEILRDVNHPNVVK 161
           R+G GS GTV+ V          LKV+     G    +   Q  +E ++L  ++HP +VK
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66

Query: 162 CHDMYDRNGEIEVLLEYMDGGSLE---------GAHIRQEHILSDLARQVLSGLAYLHKR 212
            H  +       ++ EY +G  L+         G  + +  +      Q+L G+ Y+H+R
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFI-QLLLGVHYMHQR 125

Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           +I+HRD+K  N+ + ++  +KI DFGVSR+L  + D   +  GT  YMSPE     L H 
Sbjct: 126 RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA----LKHQ 180

Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
            YD  + DIWSLG  + E       F      ++ S++  I     P  PE  SR+    
Sbjct: 181 GYDSKS-DIWSLGCILYEMCCLAHAFE---GQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236

Query: 333 ISRCLQKDPHSRWPAAQLLQHPFI 356
           +   L KDP  R  AA++L++PFI
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  124 bits (313), Expect = 5e-33
 Identities = 89/288 (30%), Positives = 133/288 (46%), Gaps = 41/288 (14%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVV 160
           QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+V
Sbjct: 3   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 62

Query: 161 KCHDMYDRNGEIEVLLE--------YMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKR 212
           K  D+     ++ ++ E        +MD   L G  +    ++     Q+L GLA+ H  
Sbjct: 63  KLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPL---PLIKSYLFQLLQGLAFCHSH 119

Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L   
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI----LLGC 175

Query: 273 KYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGR------QGDWASLM----FA 312
           KY   A DIWSLG    E    R  FP        F + R      +  W  +     + 
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235

Query: 313 ICFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
             F +               + RD +S+ L  DP+ R  A   L HPF
Sbjct: 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  123 bits (310), Expect = 5e-33
 Identities = 71/263 (26%), Positives = 126/263 (47%), Gaps = 17/263 (6%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNVV 160
            K  +IG GS G    V      + + +K I         R +  +E+ +L ++ HPN+V
Sbjct: 3   VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           +  + ++ NG + ++++Y +GG L        G    ++ IL D   Q+   L ++H RK
Sbjct: 63  QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQIL-DWFVQICLALKHVHDRK 121

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           I+HRDIK  N+ +     +K+ DFG++R+L  T++   + +GT  Y+SPE       + K
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNK 181

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 DIW+LG  + E    +  F     G+  +L+  I     P      S + R+ +
Sbjct: 182 -----SDIWALGCVLYEMCTLKHAF---EAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLV 233

Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           S+  +++P  R     +L+  FI
Sbjct: 234 SQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  124 bits (314), Expect = 7e-33
 Identities = 85/302 (28%), Positives = 128/302 (42%), Gaps = 58/302 (19%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHD 164
           ++G G+ G V++     T RV ALK I  ++E D       REI+IL+ + HPNVV   D
Sbjct: 15  KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLID 74

Query: 165 M-YDRN-------GEIEVLLEYMD---GGSLEGAHIRQEHILSDLA---RQVLSGLAYLH 210
           M  +R        G + ++  YMD    G LE   ++     S +     Q+L G+ YLH
Sbjct: 75  MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTE--SQIKCYMLQLLEGINYLH 132

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL--AQTMDPCNSAVGTIAYMS------- 261
           +  I+HRDIK +N+LI++   +KIADFG++R               GT  Y +       
Sbjct: 133 ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWY 192

Query: 262 --PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC----- 314
             PE +  +  +      A DIW +G    E +  R         D   L+F +C     
Sbjct: 193 RPPELLLGERRYTT----AVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTE 248

Query: 315 -----------------FAQPPEAPEMASREFR----DFISRCLQKDPHSRWPAAQLLQH 353
                            F   P   E    +      D +S+ L  DP+ R  A+  L+H
Sbjct: 249 ETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308

Query: 354 PF 355
           P+
Sbjct: 309 PY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  123 bits (309), Expect = 9e-33
 Identities = 81/274 (29%), Positives = 138/274 (50%), Gaps = 26/274 (9%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALK--VIYGNHEDSVRSQ---ICREIEILRDV 154
           E  KG  +G G+ GTV+  +     ++ A+K   +  ++  +   +   +  E+++L+ +
Sbjct: 1   EWTKGEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59

Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLH 210
            H N+V+       +  I + +E++ GGS+     R     E +     +Q+L G+AYLH
Sbjct: 60  KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT------MDPCNSAVGTIAYMSPER 264
              +VHRDIK +N+++  +  +K+ DFG +R LA         +   S  GT  +M+PE 
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 265 INTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP--PEAP 322
           IN +  +G+      DIWS+G ++ E   G+ P A     D  + MF I   +   P  P
Sbjct: 180 IN-ESGYGR----KSDIWSIGCTVFEMATGKPPLA---SMDRLAAMFYIGAHRGLMPRLP 231

Query: 323 EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           +  S    DF++ CL +D H R  A QLL+H F+
Sbjct: 232 DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  122 bits (308), Expect = 1e-32
 Identities = 64/226 (28%), Positives = 106/226 (46%), Gaps = 16/226 (7%)

Query: 138 DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIR 190
           +  R     EI IL  + HPN++  ++ +  +  + + +EY +GG+L       +G    
Sbjct: 40  EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE 99

Query: 191 QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
           +E +L     Q++S ++Y+HK  I+HRDIK  N+ +  +  +K+ DFG+S+IL       
Sbjct: 100 EEMVL-WYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158

Query: 251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLM 310
            + VGT  YMSPE     L  G    +  DIW+LG  + E    +  F         +L+
Sbjct: 159 ETVVGTPYYMSPE-----LCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---LNLV 210

Query: 311 FAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             I          + S E    +   LQ+DP  R  A ++L  P +
Sbjct: 211 VKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  122 bits (308), Expect = 1e-32
 Identities = 89/269 (33%), Positives = 140/269 (52%), Gaps = 17/269 (6%)

Query: 97  NPAE-LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIY---GNHEDSVRSQICREIEILR 152
           NP E  +   RIGSG+ G V++  +  T  + A+KVI    G     V+    +EI +++
Sbjct: 6   NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ----QEIIMMK 61

Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGA-HIR---QEHILSDLARQVLSGLAY 208
           D  H N+V     Y R  ++ + +E+  GGSL+   H+     E  ++ ++R+ L GL Y
Sbjct: 62  DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121

Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
           LH +  +HRDIK +N+L+  + +VK+ADFGVS  +  T+    S +GT  +M+PE    +
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA--S 326
              G Y+    DIW++G++ +E    + P           LM    F QPP+  +    S
Sbjct: 182 -RKGGYNQLC-DIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF-QPPKLKDKMKWS 238

Query: 327 REFRDFISRCLQKDPHSRWPAAQLLQHPF 355
             F  F+   L K+P  R  A +LLQHPF
Sbjct: 239 NSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  122 bits (309), Expect = 2e-32
 Identities = 80/287 (27%), Positives = 129/287 (44%), Gaps = 38/287 (13%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQIC-REIEILRDVNHPNVV 160
           +K ++IG GS G V++  +  T ++ A+K    + +D V  +I  REI +L+ + HPN+V
Sbjct: 4   EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLV 63

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLE--GAHIR--QEHILSDLARQVLSGLAYLHKRKIVH 216
              +++ R  ++ ++ EY D   L     + R   EH++  +  Q L  + + HK   +H
Sbjct: 64  NLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIH 123

Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KP N+LI     +K+ DFG +RIL    D     V T  Y +PE +  D  +G    
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGP--- 180

Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQ------------GDW----ASLMFAICF---AQ 317
              D+W++G    E   G+ P   G+             GD       +     F     
Sbjct: 181 -PVDVWAIGCVFAELLTGQ-PLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238

Query: 318 PPEAPEMASREFR---------DFISRCLQKDPHSRWPAAQLLQHPF 355
            PE       E +          F+  CLQ DP  R    +LL+HP+
Sbjct: 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  122 bits (307), Expect = 3e-32
 Identities = 81/256 (31%), Positives = 128/256 (50%), Gaps = 14/256 (5%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +IG G+ GTV+  +   T +  A++ +    +   +  I  EI ++R+  +PN+V   D 
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           Y    E+ V++EY+ GGSL          E  ++ + R+ L  L +LH  +++HRDIK  
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145

Query: 223 NLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           N+L+    +VK+ DFG    +       ++ VGT  +M+PE +       K  G   DIW
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-----KAYGPKVDIW 200

Query: 283 SLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA--PEMASREFRDFISRCLQKD 340
           SLG+  +E   G  P+      +    ++ I     PE   PE  S  FRDF++RCL  D
Sbjct: 201 SLGIMAIEMIEGEPPYL---NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257

Query: 341 PHSRWPAAQLLQHPFI 356
              R  A +LLQH F+
Sbjct: 258 VEKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  121 bits (306), Expect = 6e-32
 Identities = 86/295 (29%), Positives = 132/295 (44%), Gaps = 48/295 (16%)

Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALK-VIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
            +IG G+ G V++     T  + ALK V   N ++       REI+ILR +NH N+V   
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 164 ----------DMYDRNGEIEVLLEYMDG---GSLEGA--HIRQEHILSDLARQVLSGLAY 208
                     D     G   ++ EYMD    G LE    H  ++HI S   +Q+L GL Y
Sbjct: 73  EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS-FMKQLLEGLNY 131

Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL-AQTMDPCNSAVGTIAYMSPERINT 267
            HK+  +HRDIK SN+L+N+   +K+ADFG++R+  ++   P  + V T+ Y  PE +  
Sbjct: 132 CHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELL-- 189

Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA-PE--- 323
            L   +Y G A D+WS G  + E +  +  F   ++     L+  +C +  P   P+   
Sbjct: 190 -LGEERY-GPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIK 247

Query: 324 -----------MASREFR-----------DFISRCLQKDPHSRWPAAQLLQHPFI 356
                         R  R           D +   L  DP  R  A + L  P++
Sbjct: 248 LPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  120 bits (303), Expect = 9e-32
 Identities = 85/267 (31%), Positives = 144/267 (53%), Gaps = 25/267 (9%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH-PNVVKCHDM 165
           +G+G+ G V++  H  T ++ A+KV+  +  +    +I  EI +L+  +H  N+   +  
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVM--DVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 166 YDR------NGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKR 212
           + +      + ++ +++E+   GS+       +G  ++++ I + + R++L GLA+LH  
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI-AYICREILRGLAHLHAH 140

Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           K++HRDIK  N+L+  +  VK+ DFGVS  L +T+   N+ +GT  +M+PE I  D N  
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 200

Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASL--MFAICFAQPPEAPEMA-SREF 329
               Y  DIWSLG++ +E   G  P       D   +  +F I    PP+      S++F
Sbjct: 201 ATYDYRSDIWSLGITAIEMAEGAPPLC-----DMHPMRALFLIPRNPPPKLKSKKWSKKF 255

Query: 330 RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            DFI  CL K+  SR    QLL+HPFI
Sbjct: 256 IDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  120 bits (302), Expect = 2e-31
 Identities = 84/268 (31%), Positives = 132/268 (49%), Gaps = 30/268 (11%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +IG GS G V       + R  A+K++    +   R  +  E+ I+RD  H NVV+ +  
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR-RELLFNEVVIMRDYQHQNVVEMYKS 86

Query: 166 YDRNGEIEVLLEYMDGGSLEG--AHIR-QEHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           Y    E+ VL+E++ GG+L    +  R  E  ++ +   VL  L YLH + ++HRDIK  
Sbjct: 87  YLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSD 146

Query: 223 NLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           ++L+     VK++DFG    +++ +    S VGT  +M+PE I+         G   DIW
Sbjct: 147 SILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPY-----GTEVDIW 201

Query: 283 SLGVSILEFYLGRFPF-------AVGRQGDWASLMFAICFAQPPEAPEMASRE---FRDF 332
           SLG+ ++E   G  P+       A+ R  D            PP   + A +     RDF
Sbjct: 202 SLGIMVIEMVDGEPPYFSDSPVQAMKRLRD-----------SPPPKLKNAHKISPVLRDF 250

Query: 333 ISRCLQKDPHSRWPAAQLLQHPFILRAG 360
           + R L ++P  R  A +LL HPF+L+ G
Sbjct: 251 LERMLTREPQERATAQELLDHPFLLQTG 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  120 bits (302), Expect = 2e-31
 Identities = 77/231 (33%), Positives = 118/231 (51%), Gaps = 17/231 (7%)

Query: 157 PNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKR 212
           P +V  H  +  + ++ ++L+Y++GG L     ++EH      R    +++  L +LH+ 
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124

Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRI-LAQTMDPCNSAVGTIAYMSPERINT-DLN 270
            I++RDIK  N+L++S  +V + DFG+S+  LA+  +   S  GTI YM+PE I      
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGG 184

Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAV-GRQGDWASLMFAICFAQPPEAPEMASREF 329
           H K    A D WSLGV   E   G  PF V G Q   + +   I  ++PP    M S E 
Sbjct: 185 HDK----AVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTM-SAEA 239

Query: 330 RDFISRCLQKDPHSRW---PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           RDFI + L+KDP  R     A ++  HPF    G    +   ++I  P +P
Sbjct: 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFF--QGIDWDDLAAKRIPAPFKP 288

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  120 bits (302), Expect = 2e-31
 Identities = 83/289 (28%), Positives = 129/289 (44%), Gaps = 43/289 (14%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNVV 160
           QK  +IG G+ G V++     T  + ALK I    ED  V S   REI +L+++NHPN+V
Sbjct: 2   QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIV 61

Query: 161 KCHDMYDRNGEIEVLLE--------YMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKR 212
           +  D+     ++ ++ E        YMD   L G       ++     Q+L G+AY H  
Sbjct: 62  RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG---LDPPLIKSYLYQLLQGIAYCHSH 118

Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           +++HRD+KP NLLI+    +K+ADFG++R     +      V T+ Y +PE     L   
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI----LLGS 174

Query: 273 KYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGR------QGDWASLM----FA 312
           +      DIWS+G    E    R  FP        F + R      +  W  +     + 
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234

Query: 313 ICFAQPPEAPEMAS------REFRDFISRCLQKDPHSRWPAAQLLQHPF 355
             F +     +++        +  D +S+ L  DP  R  A   LQHP+
Sbjct: 235 PTFPKWA-RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  119 bits (299), Expect = 3e-31
 Identities = 82/271 (30%), Positives = 149/271 (54%), Gaps = 33/271 (12%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKV--IYGNHEDSVRSQICREIEILRDVNH-PNVVKCH 163
           +G+G+ G V++  H  T ++ A+KV  + G+ E+ ++    +EI +L+  +H  N+   +
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK----QEINMLKKYSHHRNIATYY 69

Query: 164 DMYDR------NGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLH 210
             + +      + ++ +++E+   GS+       +G  +++E I + + R++L GL++LH
Sbjct: 70  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI-AYICREILRGLSHLH 128

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
           + K++HRDIK  N+L+  +  VK+ DFGVS  L +T+   N+ +GT  +M+PE I  D N
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 188

Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA----S 326
                 +  D+WSLG++ +E   G  P       D   +       + P AP +     S
Sbjct: 189 PDATYDFKSDLWSLGITAIEMAEGAPPLC-----DMHPMRALFLIPRNP-APRLKSKKWS 242

Query: 327 REFRDFISRCLQKDPHSRWPAA-QLLQHPFI 356
           ++F+ FI  CL K+ HS+ P   QL++HPFI
Sbjct: 243 KKFQSFIESCLVKN-HSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  119 bits (299), Expect = 3e-31
 Identities = 89/274 (32%), Positives = 139/274 (50%), Gaps = 27/274 (9%)

Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR----EIEILRD 153
           P   ++G  +G G+ G V+      T R  A K +  + E    S+       EI++L++
Sbjct: 1   PINWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKN 60

Query: 154 VNHPNVVKCHDMYDRNGE--IEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLA 207
           + H  +V+ +       E  + + +EYM GGS    L+      E +     RQ+L G++
Sbjct: 61  LQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS 120

Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM----DPCNSAVGTIAYMSPE 263
           YLH   IVHRDIK +N+L +S+ NVK+ DFG S+ L QT+        S  GT  +MSPE
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICMSGTGIRSVTGTPYWMSPE 179

Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP--PEA 321
            I+     G+  G   D+WSLG +++E    + P+A   + +  + +F I   QP  P+ 
Sbjct: 180 VIS-----GEGYGRKADVWSLGCTVVEMLTEKPPWA---EYEAMAAIFKIA-TQPTNPQL 230

Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
           P   S   RDF+  C+  +   R  A +LL+HPF
Sbjct: 231 PSHISEHARDFL-GCIFVEARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  118 bits (298), Expect = 3e-31
 Identities = 87/276 (31%), Positives = 143/276 (51%), Gaps = 18/276 (6%)

Query: 86  QNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQIC 145
           + N Q+ ++LI         R+GSG+ G V++  +  T  + A+K+I     D   S I 
Sbjct: 4   RRNPQHDYELIQ--------RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF-SLIQ 54

Query: 146 REIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGA-HIR---QEHILSDLARQ 201
           +EI ++++  H N+V     Y    ++ + +EY  GGSL+   H+     E  ++ + R+
Sbjct: 55  QEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRE 114

Query: 202 VLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
            L GLAYLH +  +HRDIK +N+L+  + +VK+ADFGV+  +  T+    S +GT  +M+
Sbjct: 115 TLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMA 174

Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE    + N G Y+    DIW++G++ +E    + P           LM    F QPP+ 
Sbjct: 175 PEVAAVEKN-GGYNQLC-DIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF-QPPKL 231

Query: 322 PEMA--SREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
            +    S  F +F+   L K+P  R  A +LL H F
Sbjct: 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 6e-31
 Identities = 79/261 (30%), Positives = 120/261 (45%), Gaps = 23/261 (8%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH-----PNVVK 161
           I  G+ G+V+      T   FA+KV+  +   + ++Q+   ++  R +       P V K
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA-KNQV-TNVKAERAIMMIQGESPYVAK 61

Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQ----VLSGLAYLHKRKIVHR 217
            +  +     + +++EY++GG           +  D A+Q    V+ G+  LH+R I+HR
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121

Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           DIKP NLLI+ + ++K+ DFG+SR   +        VGT  Y++PE I      G  D  
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRNGLENKK----FVGTPDYLAPETIL-----GVGDDK 172

Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL 337
             D WSLG  I EF  G  PF           + +     P E  E  S E  D I+R L
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232

Query: 338 QKDPHSRWPA---AQLLQHPF 355
             DP  R  A    ++  HPF
Sbjct: 233 CMDPAKRLGANGYQEIKSHPF 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  118 bits (297), Expect = 1e-30
 Identities = 84/262 (32%), Positives = 131/262 (50%), Gaps = 22/262 (8%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIY--GNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
           IG GS G V+       S V A+K +   G   +     I +E+  L+ + HPN ++   
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIK 220
            Y R     +++EY  G + +   +     QE  ++ +    L GLAYLH   ++HRD+K
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 142

Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
             N+L++    VK+ DFG + I+A    P N  VGT  +M+PE I   ++ G+YDG   D
Sbjct: 143 AGNILLSEPGLVKLGDFGSASIMA----PANXFVGTPYWMAPEVI-LAMDEGQYDGKV-D 196

Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE----FRDFISRC 336
           +WSLG++ +E    + P          + M A+      E+P + S      FR+F+  C
Sbjct: 197 VWSLGITCIELAERKPPLFN------MNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250

Query: 337 LQKDPHSRWPAAQLLQHPFILR 358
           LQK P  R  +  LL+H F+LR
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  117 bits (294), Expect = 3e-30
 Identities = 79/291 (27%), Positives = 138/291 (47%), Gaps = 47/291 (16%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           ++  ++G G+  TV++  +  T  + ALK I+ + E+   S   REI +++++ H N+V+
Sbjct: 3   KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVR 62

Query: 162 CHDMYDRNGEIEVLLEYMDG------------GSLEGAHIRQEHILSDLARQVLSGLAYL 209
            HD+     ++ ++ EYMD             G+L+   ++          Q+L G+A+ 
Sbjct: 63  LHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVK------SFTYQLLKGIAFC 116

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
           H+ +++HRD+KP NLLIN    +K+ADFG++R     ++  ++ V T+ Y +P+ +   L
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVL---L 173

Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC----------FAQPP 319
               Y   + DIWS+G  + E   GR  F      D    +F I            +Q P
Sbjct: 174 GSRTYST-SIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232

Query: 320 E----APEMASREFR-----------DFISRCLQKDPHSRWPAAQLLQHPF 355
           E     P    ++ +           D + R LQ +P  R  A   LQHP+
Sbjct: 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  117 bits (295), Expect = 3e-30
 Identities = 76/285 (26%), Positives = 132/285 (46%), Gaps = 27/285 (9%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYG---NHEDSVRSQICREIEILRDV-NHPNVVKC 162
           +G GS G V       T  ++A+KV+       +D V   +  E  +L     HP + + 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMT-EKRVLALAGKHPFLTQL 61

Query: 163 HDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHR 217
           H  +     +  ++EY++GG L   HI++     +      A +++ GL +LH+R I++R
Sbjct: 62  HSCFQTKDRLFFVMEYVNGGDLM-FHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           D+K  N+L++S  ++KIADFG+ +         ++  GT  Y++PE ++       Y G 
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ----PY-GP 175

Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL 337
           A D W+LGV + E   G+ PF    +GD    +F          P   S+E +  +   L
Sbjct: 176 AVDWWALGVLLYEMLAGQSPF----EGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFL 231

Query: 338 QKDPHSR-----WPAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
            K+P  R          +  HPF       ++ +  ++I PP +P
Sbjct: 232 TKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLER--KEIKPPFKP 274

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  115 bits (290), Expect = 1e-29
 Identities = 87/297 (29%), Positives = 136/297 (45%), Gaps = 49/297 (16%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS---VRSQICREIEILRDVNH 156
           E +K NRI  G+ G V+R     T  + ALK +    E     + S   REI IL  + H
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS--LREINILLKLQH 63

Query: 157 PNVVKCHDMY--DRNGEIEVLLEYMD---GGSLEGAHIRQEHILSD---LARQVLSGLAY 208
           PN+V   ++       +I +++EY++      +E   ++Q  + S+   L  Q+LSG+A+
Sbjct: 64  PNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLME--TMKQPFLQSEVKCLMLQLLSGVAH 121

Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
           LH   I+HRD+K SNLL+N+   +KI DFG++R     + P    V T+ Y +PE +   
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELL--- 178

Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGR--FP-----------F-AVGRQGD-----WASL 309
           L   +Y   A D+WS+G    E    +  FP           F  +G   +     ++ L
Sbjct: 179 LGAKEY-STAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237

Query: 310 MFAICFAQPPEAPEMASRE-FR---------DFISRCLQKDPHSRWPAAQLLQHPFI 356
             A       + P    R+ F          D ++R L  DP  R  A   L+HP+ 
Sbjct: 238 PGAKKK-TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  113 bits (283), Expect = 5e-29
 Identities = 71/252 (28%), Positives = 121/252 (48%), Gaps = 16/252 (6%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G GS G    V H  + + +A+K I      S      +E  +L  + HPN+V   + +
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67

Query: 167 DRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDI 219
           + +G + +++EY DGG L        G    ++ IL     Q+  G+ ++H+++++HRDI
Sbjct: 68  EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV-QMCLGVQHIHEKRVLHRDI 126

Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           K  N+ +  +  VK+ DFG +R+L        + VGT  Y+ PE I  ++ +        
Sbjct: 127 KSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE-IWENMPYNN----KS 181

Query: 280 DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQK 339
           DIWSLG  + E    + PF   +   W +L+  +C       P   S E R  I +  ++
Sbjct: 182 DIWSLGCILYELCTLKHPF---QANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR 238

Query: 340 DPHSRWPAAQLL 351
           +P SR  A  +L
Sbjct: 239 NPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  114 bits (287), Expect = 5e-29
 Identities = 95/320 (29%), Positives = 140/320 (43%), Gaps = 62/320 (19%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR---EIEILRDVNHPNVVKCH 163
           +G G  G V+ V    T ++FALKV+    E   R+++ R   E EIL  ++HP +   +
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKK-EMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQ-EHILS-DLAR----QVLSGLAYLHKRKIVHR 217
             +     + ++++Y  GG L     RQ    LS ++AR    +VL  L YLH   IV+R
Sbjct: 68  ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYR 127

Query: 218 DIKPSNLLINSSKNVKIADFGVS-----------------------------RILAQTMD 248
           D+KP N+L++ S ++ ++DF +S                                 +   
Sbjct: 128 DLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSF 187

Query: 249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWAS 308
             NS VGT  Y++PE I+ D  H    G A D W+LG+ + E   G  PF     G    
Sbjct: 188 RSNSFVGTEEYIAPEVISGD-GH----GSAVDWWTLGILLYEMLYGTTPFK----GSNRD 238

Query: 309 LMFAICFAQPPEAPEMA--SREFRDFISRCLQKDPH----SRWPAAQLLQHPFILRAGQS 362
             F+    +    P     S   RD I + L KDP     S+  AA++ QHPF       
Sbjct: 239 ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF-----R 293

Query: 363 QVN-QNLRQILPP--PRPLS 379
            VN   +R   PP  PRP  
Sbjct: 294 GVNWALIRHTTPPIIPRPDD 313

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  114 bits (287), Expect = 5e-29
 Identities = 89/290 (30%), Positives = 140/290 (48%), Gaps = 27/290 (9%)

Query: 107 IGSGSGGTVW---RVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNH-PNV 159
           +G+G+ G V+   +V    T +++A+KV+       +         E  +L  V   P +
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSG-----LAYLHKRKI 214
           V  H  +    ++ ++L+Y+ GG +   H+ Q    S+   +  SG     L +LHK  I
Sbjct: 68  VTLHYAFQTEAKLHLILDYVSGGEM-FTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGI 126

Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           V+RDIK  N+L++S  +V + DFG+S+  L++  +   S  GTI YM+PE I     HGK
Sbjct: 127 VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGK 186

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAV-GRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
               A D WSLG+ I E   G  PF + G +   + +   I    PP  P     E +D 
Sbjct: 187 ----AVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP-FPSFIGPEAQDL 241

Query: 333 ISRCLQKDPHSRWPAA-----QLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           + + L+KDP  R  A      ++ +HPF    G       LR++ PP RP
Sbjct: 242 LHKLLRKDPKKRLGAGPQGASEIKEHPFF--KGLDWEALALRKVNPPFRP 289

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  111 bits (279), Expect = 2e-28
 Identities = 71/220 (32%), Positives = 110/220 (50%), Gaps = 19/220 (8%)

Query: 146 REIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDL 198
           +E+ +L  + HPN+V     +  NG + +++EY DGG L        G    ++ ILS  
Sbjct: 48  KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF 107

Query: 199 ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTI 257
             Q+  GL ++H RKI+HRDIK  N+ ++ +  V K+ DFG++R L  +M+   + VGT 
Sbjct: 108 V-QISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTP 166

Query: 258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ 317
            Y+SPE       + K      DIWSLG  + E    + PF      +   L+  IC   
Sbjct: 167 YYLSPEICQNRPYNNK-----TDIWSLGCVLYELCTLKHPF---EGNNLHQLVLKICQGY 218

Query: 318 -PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             P +P   SR+ R  IS+  +  P  R     +L+ PF+
Sbjct: 219 FAPISPNF-SRDLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  111 bits (278), Expect = 5e-28
 Identities = 83/260 (31%), Positives = 132/260 (50%), Gaps = 14/260 (5%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +IG GS G V       T +  A+K +    +   R  +  E+ I+RD +H NVV  ++ 
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR-RELLFNEVVIMRDYHHENVVDMYNS 87

Query: 166 YDRNGEIEVLLEYMDGGSLEG--AHIR-QEHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           Y    E+ V++E+++GG+L     H R  E  ++ +   VL  L+YLH + ++HRDIK  
Sbjct: 88  YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSD 147

Query: 223 NLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           ++L+ S   +K++DFG    +++ +    S VGT  +M+PE I + L +G       DIW
Sbjct: 148 SILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI-SRLPYGT----EVDIW 202

Query: 283 SLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM--ASREFRDFISRCLQKD 340
           SLG+ ++E   G  P+           M  I    PP   +    S   R F+   L ++
Sbjct: 203 SLGIMVIEMIDGEPPYF---NEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259

Query: 341 PHSRWPAAQLLQHPFILRAG 360
           P  R  A +LLQHPF+  AG
Sbjct: 260 PSQRATAQELLQHPFLKLAG 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  111 bits (278), Expect = 5e-28
 Identities = 82/260 (31%), Positives = 135/260 (51%), Gaps = 14/260 (5%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +IG GS G V       + ++ A+K +    +   R  +  E+ I+RD  H NVV+ ++ 
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMYNS 85

Query: 166 YDRNGEIEVLLEYMDGGSLEG--AHIR-QEHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           Y    E+ V++E+++GG+L     H R  E  ++ +   VL  L+ LH + ++HRDIK  
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSD 145

Query: 223 NLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           ++L+     VK++DFG    +++ +    S VGT  +M+PE I + L +G       DIW
Sbjct: 146 SILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI-SRLPYGP----EVDIW 200

Query: 283 SLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM--ASREFRDFISRCLQKD 340
           SLG+ ++E   G  P+           M  I    PP+   +   S   + F+ R L +D
Sbjct: 201 SLGIMVIEMVDGEPPYF---NEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257

Query: 341 PHSRWPAAQLLQHPFILRAG 360
           P  R  AA+LL+HPF+ +AG
Sbjct: 258 PAQRATAAELLKHPFLAKAG 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 5e-28
 Identities = 88/275 (32%), Positives = 139/275 (50%), Gaps = 27/275 (9%)

Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIY---GNHEDS--VRSQICREIEILR 152
           P   + G  +G G+ G V+      T R  A+K +     + E S  V +  C EI++L+
Sbjct: 1   PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALEC-EIQLLK 59

Query: 153 DVNHPNVVKCHDMYDRNGE--IEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGL 206
           ++ H  +V+ +       E  + + +EYM GGS    L+      E++     RQ+L G+
Sbjct: 60  NLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGV 119

Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPC--NSAVGTIAYMSPE 263
           +YLH   IVHRDIK +N+L +S+ NVK+ DFG S RI    M      S  GT  +MSPE
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179

Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP--PEA 321
            I+     G+  G   D+WS+  +++E    + P+A   + +  + +F I   QP  P  
Sbjct: 180 VIS-----GEGYGRKADVWSVACTVVEMLTEKPPWA---EYEAMAAIFKIA-TQPTKPML 230

Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           P+  S   RDF+ +   ++   R  A  LL+HPF+
Sbjct: 231 PDGVSDACRDFLKQIFVEE-KRRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  109 bits (274), Expect = 7e-28
 Identities = 69/258 (26%), Positives = 124/258 (48%), Gaps = 16/258 (6%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNVVKCHDM 165
           +G GS G V  V H    + + +K +   +     R    +E ++L  + HPN+V   + 
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 166 YD-RNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
           ++  +G + +++ + +GG L      +   +  E+ + +   Q+   L YLH++ I+HRD
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRD 127

Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           +K  N+ +  +  +K+ D G++R+L    D  ++ +GT  YMSPE     L   K   Y 
Sbjct: 128 LKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-----LFSNKPYNYK 182

Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ 338
            D+W+LG  + E    +  F      D  SL++ I   + P  P+  S E  + I+  L 
Sbjct: 183 SDVWALGCCVYEMATLKHAF---NAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLS 239

Query: 339 KDPHSRWPAAQLLQHPFI 356
           K P  R     +L+ P+I
Sbjct: 240 KRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  109 bits (274), Expect = 1e-27
 Identities = 87/275 (31%), Positives = 137/275 (49%), Gaps = 27/275 (9%)

Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR----EIEILRD 153
           P   + G  +G G+ G V+      T R  A+K +  + E    S+       EI++L++
Sbjct: 1   PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKN 60

Query: 154 VNHPNVVKCHDMYDRNGE--IEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLA 207
           + H  +V+ +       E  + + +E+M GGS    L+      E++     RQ+L G++
Sbjct: 61  LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120

Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM----DPCNSAVGTIAYMSPE 263
           YLH   IVHRDIK +N+L +S  NVK+ DFG S+ L QT+        S  GT  +MSPE
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL-QTICLSGTGMKSVTGTPYWMSPE 179

Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP--PEA 321
            I+     G+  G   DIWS+G +++E    + P+A   + +  + +F I   QP  P  
Sbjct: 180 VIS-----GEGYGRKADIWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIA-TQPTNPVL 230

Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           P   S   RDF+ R    +   R  A +LL+H F+
Sbjct: 231 PPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  110 bits (276), Expect = 2e-27
 Identities = 90/293 (30%), Positives = 143/293 (48%), Gaps = 38/293 (12%)

Query: 107 IGSGSGGTVWRV---VHPPTSRVFALKV-----IYGNHEDSVRSQICREIEILRDVNHPN 158
           +G G  G V++V       T ++FA+KV     I  N +D+  ++   E  IL  V HP 
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA--ERNILEAVKHPF 61

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI-LSDLARQVLS----GLAYLHKRK 213
           +V     +   G++ ++LEY+ GG L   H+ +E I + D A   LS     L +LH++ 
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGEL-FMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           I++RD+KP N+L+++  +VK+ DFG+ +         ++  GTI YM+PE I     HGK
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE-ILMRSGHGK 179

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
               A D WSLG  + +   G  PF    +      +       PP      + E RD +
Sbjct: 180 ----AVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP----YLTPEARDLL 231

Query: 334 SRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNL---RQILPPPRPL 378
            + L+++P SR       AA++  HPF        VN +    R++ PP +PL
Sbjct: 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFF-----RHVNWDDLLARKVEPPFKPL 279

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  109 bits (275), Expect = 3e-27
 Identities = 85/294 (28%), Positives = 144/294 (48%), Gaps = 38/294 (12%)

Query: 107 IGSGSGGTVW---RVVHPPTSRVFALKVIYGNH---EDSVRSQICREIEILRDVNHPNVV 160
           +G GS G V+   ++  P   +++A+KV+        D VR+++  E +IL +VNHP +V
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM--ERDILAEVNHPFIV 61

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           K H  +   G++ ++L+++ GG L     +     +E +   LA   L  L +LH   I+
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL-ALDHLHSLGII 120

Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           +RD+KP N+L++   ++K+ DFG+S+          S  GT+ YM+PE +N      +  
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-----RGH 175

Query: 276 GYAGDIWSLGVSILEFYLGRFPFAVGRQG-DWASLMFAICFAQPPEAPEMASREFRDFIS 334
             + D WS GV + E   G  PF    QG D    M  I  A+    P+  S E +  + 
Sbjct: 176 TQSADWWSFGVLMFEMLTGSLPF----QGKDRKETMTMILKAK-LGMPQFLSPEAQSLLR 230

Query: 335 RCLQKDPHSRWPAA-----QLLQHPFILRAGQSQVNQNL---RQILPPPRPLSS 380
              +++P +R  A      ++ +HPF      S ++ N    R+I PP +P   
Sbjct: 231 ALFKRNPANRLGAGPDGVEEIKRHPFF-----STIDWNKLYRREIKPPFKPAVG 279

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  108 bits (272), Expect = 4e-27
 Identities = 79/289 (27%), Positives = 133/289 (46%), Gaps = 36/289 (12%)

Query: 103 KGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKC 162
           K  ++G G+  TV++     T  + ALK I   HE+       RE+ +L+D+ H N+V  
Sbjct: 10  KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 163 HDMYDRNGEIEVLLEYMDGGSLE----GAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
           HD+   +  + ++ EY+D    +      +I   H +     Q+L GLAY H+RK++HRD
Sbjct: 70  HDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRD 129

Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           +KP NLLIN    +K+ADFG++R  +      ++ V T+ Y  P+ +   L   +Y    
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL---LGSSEYSTQI 186

Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA--PEMAS-REFRDF--- 332
            D+W +G    E   GR  F      D   L+F +    P E   P ++S  EF+++   
Sbjct: 187 -DMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRL-LGTPTEETWPGISSNDEFKNYNFP 244

Query: 333 ---------------------ISRCLQKDPHSRWPAAQLLQHPFILRAG 360
                                +++ LQ +   R  A + ++H +    G
Sbjct: 245 KYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  109 bits (274), Expect = 7e-27
 Identities = 88/290 (30%), Positives = 142/290 (48%), Gaps = 26/290 (8%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQIC---REIEILRDVNHPNVVKCH 163
           IG G+ G V  V H  + +V+A+K++    E   RS       E +I+   N   +V+ H
Sbjct: 51  IGRGAFGEVQLVRHKSSKQVYAMKLL-SKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH 109

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDI 219
             +  +  + +++EYM GG L       + I    AR    +V+  L  +H    +HRD+
Sbjct: 110 YAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYTAEVVLALDAIHSMGFIHRDV 168

Query: 220 KPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           KP N+L++ S ++K+ADFG   ++ A  M  C++AVGT  Y+SPE + +    G Y G  
Sbjct: 169 KPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYY-GRE 227

Query: 279 GDIWSLGVSILEFYLGRFPF-AVGRQGDWASLM---FAICFAQPPEAPEMASREFRDFIS 334
            D WS+GV + E  +G  PF A    G ++ +M    ++ F   P+  E+ S++ +D I 
Sbjct: 228 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF---PDDIEI-SKQAKDLIC 283

Query: 335 RCLQKDPH--SRWPAAQLLQHPFILRAGQSQVN-QNLRQILPPPRP-LSS 380
             L        R    ++  HPF       Q    N+R+ + P  P LSS
Sbjct: 284 AFLTDREVRLGRNGVDEIKSHPFFKN---DQWTFDNIRETVAPVVPELSS 330

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  108 bits (272), Expect = 8e-27
 Identities = 79/314 (25%), Positives = 130/314 (41%), Gaps = 74/314 (23%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVI----YGNHEDSVRSQI---------CREI 148
           QKG  +G G+ G V +     T ++ A+K +      N     R  +          RE+
Sbjct: 12  QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71

Query: 149 EILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDG--GSLEGAHIRQEHILSD-----LARQ 201
           +I+ ++ H N++   D+Y     I ++++ M      +    IR    L++     +  Q
Sbjct: 72  KIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIR----LTESQVKCILLQ 127

Query: 202 VLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM--DPCN-------- 251
           +L+GL  LHK   +HRD+ P+N+ INS    KIADFG++R        D  +        
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 252 ----SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR--FPFA-----V 300
               S V T+ Y +PE +   +   KY  +A D+WS+G    E   G+  FP       +
Sbjct: 188 EEMTSKVVTLWYRAPELL---MGAEKY-HFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243

Query: 301 GR---------QGDWAS-----LMFAICFAQP-------PEAPEMASREFRDFISRCLQK 339
           GR         + +W       L       +P       P A + A     D +   L+ 
Sbjct: 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAI----DLLQSLLKL 299

Query: 340 DPHSRWPAAQLLQH 353
           +P  R  A + L+H
Sbjct: 300 NPLERISAKEALKH 313

Length = 335

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  106 bits (265), Expect = 4e-26
 Identities = 85/281 (30%), Positives = 131/281 (46%), Gaps = 42/281 (14%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR---EIEILRDVNHPNVVKCH 163
           I +G+ G V+ V H  T + FA+K I       +R+QI +   E +IL    +P VV   
Sbjct: 9   ISNGAYGAVYLVRHKETRQRFAMKKI-NKQNLILRNQIQQVFVERDILTFAENPFVVSMF 67

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDI 219
             ++    + +++EY++GG           +  D+AR    + +  L YLH   IVHRD+
Sbjct: 68  CSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDL 127

Query: 220 KPSNLLINSSKNVKIADFGVSRI-----------------LAQTMDPCNSAVGTIAYMSP 262
           KP NLLI S  ++K+ DFG+S+I                   + +D      GT  Y++P
Sbjct: 128 KPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD--KQVCGTPEYIAP 185

Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP---P 319
           E I   L  G   G   D W++G+ + EF +G  PF     GD    +F    +     P
Sbjct: 186 EVI---LRQGY--GKPVDWWAMGIILYEFLVGCVPFF----GDTPEELFGQVISDDIEWP 236

Query: 320 EAPEMASREFRDFISRCLQKDPHSRW---PAAQLLQHPFIL 357
           E  E    + +D ISR L+++P  R     A ++ QH F L
Sbjct: 237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  106 bits (266), Expect = 4e-26
 Identities = 76/284 (26%), Positives = 136/284 (47%), Gaps = 26/284 (9%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G G+ G V  V    T + +A+K++       +D V +    E  +L++  HP +    
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEV-AHTLTESRVLQNTRHPFLTALK 61

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIVHRD 218
             +  +  +  ++EY +GG L   H+ +E + S D AR    +++S L YLH   +V+RD
Sbjct: 62  YSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120

Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           +K  NL+++   ++KI DFG+ +          +  GT  Y++PE +  D ++G+    A
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE-DNDYGR----A 175

Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ 338
            D W LGV + E   GR PF   +  +    +F +   +    P   S E +  ++  L+
Sbjct: 176 VDWWGLGVVMYEMMCGRLPF-YNQDHE---KLFELILMEEIRFPRTLSPEAKSLLAGLLK 231

Query: 339 KDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           KDP  R       A ++++H F        V Q  +++ PP +P
Sbjct: 232 KDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQ--KKLEPPFKP 273

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  106 bits (265), Expect = 4e-26
 Identities = 85/286 (29%), Positives = 142/286 (49%), Gaps = 32/286 (11%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR---EIEILRDVNHPNVVKCH 163
           IG GS G V +V    T R++ALK I   H  S RS++     E  +L  VN P +V   
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVS-RSEVTHTLAERTVLAQVNCPFIVPLK 59

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR------QVLSGLAYLHKRKIVHR 217
             +    ++ ++L +++GG L   H+++E    DL+R      ++L  L  LHK  +++R
Sbjct: 60  FSFQSPEKLYLVLAFINGGEL-FHHLQREGRF-DLSRARFYTAELLCALENLHKFNVIYR 117

Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           D+KP N+L++   ++ + DFG+ ++  +  D  N+  GT  Y++PE +   L HG     
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELL---LGHGYTK-- 172

Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL 337
           A D W+LGV + E   G  PF      +  + M+     +P   P+   R+ +D +   L
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPF----YDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLL 228

Query: 338 QKDPHSRW---PAAQLLQHPFILRAGQSQVNQN---LRQILPPPRP 377
            +DP  R     A ++  HPF      SQ++     ++ I PP +P
Sbjct: 229 SRDPTRRLGYNGAQEIKNHPFF-----SQLSWKKLLMKGIQPPFKP 269

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  105 bits (264), Expect = 5e-26
 Identities = 78/290 (26%), Positives = 129/290 (44%), Gaps = 36/290 (12%)

Query: 103 KGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKC 162
           K +++G G+  TV++     T  + ALK I   HE+       RE+ +L+D+ H N+V  
Sbjct: 10  KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 163 HDMYDRNGEIEVLLEYMDGGSLE----GAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
           HD+      + ++ EY+D    +      +    H +     Q+L GL Y H+RK++HRD
Sbjct: 70  HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRD 129

Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           +KP NLLIN    +K+ADFG++R  +      ++ V T+ Y  P+ +   L    Y    
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDIL---LGSTDYSTQI 186

Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA--PEMAS-REFR----- 330
            D+W +G    E   GR  F      +    +F I    P E   P + S  EF+     
Sbjct: 187 -DMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRI-LGTPTEETWPGILSNEEFKSYNYP 244

Query: 331 -------------------DFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
                              + +S+ LQ +   R  A + ++HP+    G+
Sbjct: 245 KYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  104 bits (261), Expect = 6e-26
 Identities = 69/260 (26%), Positives = 122/260 (46%), Gaps = 21/260 (8%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI--YGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
           +G G+ G V         ++  +K I      +D  R     E ++L+ ++HPN+++ ++
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE-RLAAQNECQVLKLLSHPNIIEYYE 66

Query: 165 MYDRNGEIEVLLEYMDGGSLE-------GAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
            +  +  + +++EY  GG+L         + + ++ IL     Q+L  L ++H + I+HR
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTIL-HFFVQILLALHHVHTKLILHR 125

Query: 218 DIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           D+K  N+L++  K V KI DFG+S+IL+ +     + VGT  Y+SPE     L  GK   
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVVGTPCYISPE-----LCEGKPYN 179

Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
              DIW+LG  + E    +  F      +  +L+  I         +  S + R  I   
Sbjct: 180 QKSDIWALGCVLYELASLKRAF---EAANLPALVLKIMSGTFAPISDRYSPDLRQLILSM 236

Query: 337 LQKDPHSRWPAAQLLQHPFI 356
           L  DP  R   +Q++  P  
Sbjct: 237 LNLDPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  105 bits (263), Expect = 8e-26
 Identities = 69/224 (30%), Positives = 103/224 (45%), Gaps = 45/224 (20%)

Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALK-VIYGNHEDSVRSQICREIEILRDVNHP 157
            E +K NRIG G+ G V+R     +  + ALK V   N  D +     REI +L ++ HP
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66

Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----------------- 200
           N+V+             L E + G  L+   +  E+   DLA                  
Sbjct: 67  NIVE-------------LKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCL 113

Query: 201 --QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR---ILAQTMDPCNSAVG 255
             Q+L GL YLH+  I+HRD+K SNLL+     +KIADFG++R   + A+ M P    V 
Sbjct: 114 MLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK---VV 170

Query: 256 TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR--FP 297
           T+ Y +PE +     +      A D+W++G  + E    +   P
Sbjct: 171 TLWYRAPELLLGCTTYTT----AIDMWAVGCILAELLAHKPLLP 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 1e-25
 Identities = 79/296 (26%), Positives = 142/296 (47%), Gaps = 46/296 (15%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V++V    T R++A+KV+        + +I  + E+   +   N++    + 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVL-------SKKEIVAKKEVAHTIGERNILVRTLLD 53

Query: 167 D------------RNGEIEVLLEYMDGGSLEGAHIRQEHILSD------LARQVLSGLAY 208
           +             + ++ ++ +YM GG L   H+++E   S+      +A  VL+ L +
Sbjct: 54  ESPFIVGLKFSFQTDSDLYLVTDYMSGGEL-FWHLQKEGRFSEDRAKFYIAELVLA-LEH 111

Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
           LHK  IV+RD+KP N+L++++ ++ + DFG+S+         N+  GT  Y++PE +  +
Sbjct: 112 LHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDE 171

Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
             + K+     D WSLGV + E   G  PF      D   +   I F +      + S E
Sbjct: 172 KGYTKH----VDFWSLGVLVFEMCCGWSPFYA---EDTQQMYRNIAFGKVRFPKNVLSDE 224

Query: 329 FRDFISRCLQKDPHSRW----PAAQLLQHPFILRAGQSQVNQNL---RQILPPPRP 377
            R F+   L ++P  R      A +L +HPF      + ++ +L   +QI PP +P
Sbjct: 225 GRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF-----ADIDWDLLSKKQITPPFKP 275

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 1e-25
 Identities = 76/270 (28%), Positives = 125/270 (46%), Gaps = 36/270 (13%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPN 158
            L+   ++G+G  G VW      T++V A+K +      ++  +   +E +I++ + H  
Sbjct: 7   SLKLERKLGAGQFGEVWMGTWNGTTKV-AVKTL---KPGTMSPEAFLQEAQIMKKLRHDK 62

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHK 211
           +V+ + +      I ++ EYM  GSL       EG  +R    L D+A Q+  G+AYL  
Sbjct: 63  LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQ-LVDMAAQIAEGMAYLES 121

Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM-DPCNSAVGTIAYMSPERINTDLN 270
           R  +HRD+   N+L+  +   KIADFG++R++          A   I + +PE      N
Sbjct: 122 RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA----N 177

Query: 271 HGKYDGYAGDIWSLGVSILE-FYLGRFPFA------VGRQGDWASLMFAICFAQPPEAPE 323
           +G++     D+WS G+ + E    GR P+       V  Q +    M      +PP  PE
Sbjct: 178 YGRFT-IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-----PRPPNCPE 231

Query: 324 MASREFRDFISRCLQKDPHSRWPAAQLLQH 353
               E  D + +C  KDP  R P  + LQ 
Sbjct: 232 ----ELYDLMLQCWDKDPEER-PTFEYLQS 256

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  103 bits (259), Expect = 2e-25
 Identities = 67/213 (31%), Positives = 112/213 (52%), Gaps = 21/213 (9%)

Query: 103 KGNRIGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNVVK 161
           K  +IG G+ G V++  +  T ++ A+K I   + E+ V S   REI +L+++ HPN+V 
Sbjct: 4   KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 162 CHDMYDRNGEIEVLLE--------YMDGGSL-EGAHIRQEHILSDLARQVLSGLAYLHKR 212
             D+  +   + ++ E        Y+D  SL +G ++  E + S L  Q+L G+ + H R
Sbjct: 64  LQDVLMQESRLYLIFEFLSMDLKKYLD--SLPKGQYMDAELVKSYL-YQILQGILFCHSR 120

Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           +++HRD+KP NLLI++   +K+ADFG++R     +      V T+ Y +PE +   L   
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVL---LGSP 177

Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD 305
           +Y     DIWS+G    E    +  F     GD
Sbjct: 178 RYSTPV-DIWSIGTIFAEMATKKPLF----HGD 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  103 bits (258), Expect = 2e-25
 Identities = 80/269 (29%), Positives = 136/269 (50%), Gaps = 26/269 (9%)

Query: 107 IGSGSGGTVW---RVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNH-PNV 159
           +G+G+ G V+   +V    + +++A+KV+       +         E ++L  +   P +
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSG-----LAYLHKRKI 214
           V  H  +  + ++ ++L+Y++GG L   H+ Q     +   Q+ SG     L +LHK  I
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGEL-FTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGI 126

Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAVGTIAYMSPERI-NTDLNHG 272
           ++RDIK  N+L++S+ +V + DFG+S+      ++   S  GTI YM+P+ +   D  H 
Sbjct: 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHD 186

Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAV-GRQGDWASLMFAICFAQPPEAPEMASREFRD 331
           K    A D WS+GV + E   G  PF V G +   A +   I  ++PP   EM++   +D
Sbjct: 187 K----AVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA-KD 241

Query: 332 FISRCLQKDPHSRW-----PAAQLLQHPF 355
            I R L KDP  R       A ++ +HPF
Sbjct: 242 IIQRLLMKDPKKRLGCGPSDADEIKKHPF 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  104 bits (260), Expect = 3e-25
 Identities = 78/289 (26%), Positives = 133/289 (46%), Gaps = 25/289 (8%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDV-NHPNVVKCH 163
           IG GS   V  V    T R++A+KV+     ++D     +  E  +     NHP +V  H
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDI 219
             +     +  ++EY++GG L     RQ  +  + AR    ++   L YLH+R I++RD+
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122

Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           K  N+L++S  ++K+ D+G+ +   +  D  ++  GT  Y++PE +      G+  G++ 
Sbjct: 123 KLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL-----RGEDYGFSV 177

Query: 280 DIWSLGVSILEFYLGRFPFAVGRQGD-----WASLMFAICFAQPPEAPEMASREFRDFIS 334
           D W+LGV + E   GR PF +    D         +F +   +    P   S +    + 
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237

Query: 335 RCLQKDPHSRWPA------AQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
             L KDP  R         A +  HPF        + Q  +Q++PP +P
Sbjct: 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQ--KQVVPPFKP 284

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  103 bits (260), Expect = 3e-25
 Identities = 77/267 (28%), Positives = 119/267 (44%), Gaps = 32/267 (11%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKV-----IYGNHE-DSVRSQICREIEILRDVNHPNVV 160
           +G G  G V    +  T  ++A+K      I    E +S+  +  R  E      HP +V
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEK-RIFETANSERHPFLV 65

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVH 216
                +     +  ++EY  GG L   HI  +      A      V+ GL YLH+ KIV+
Sbjct: 66  NLFACFQTEDHVCFVMEYAAGGDLM-MHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVY 124

Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTM---DPCNSAVGTIAYMSPERINTDLNHGK 273
           RD+K  NLL+++   VKIADFG+ +   + M   D  ++  GT  +++PE + T+ ++ +
Sbjct: 125 RDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEFLAPE-VLTETSYTR 180

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
               A D W LGV I E  +G  PF     GD    +F          P   SRE    +
Sbjct: 181 ----AVDWWGLGVLIYEMLVGESPF----PGDDEEEVFDSIVNDEVRYPRFLSREAISIM 232

Query: 334 SRCLQKDPHSRW-----PAAQLLQHPF 355
            R L+++P  R       A  + + PF
Sbjct: 233 RRLLRRNPERRLGSGEKDAEDVKKQPF 259

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  102 bits (256), Expect = 3e-25
 Identities = 62/253 (24%), Positives = 110/253 (43%), Gaps = 23/253 (9%)

Query: 106 RIGSGSGGTVWRVV-HPPTSRVF--ALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKC 162
           ++G GS G V R        +V   A+K +  +    +     +E  I+  ++H N+++ 
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 163 HDMYDRNGEIEVLLEYMDGGSL-EGAHIRQE-----HILSDLARQVLSGLAYLHKRKIVH 216
           + +      + ++ E    GSL +              L D A Q+ +G+ YL  ++ +H
Sbjct: 62  YGVV-LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIH 120

Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N+L+ S   VKI DFG+ R L Q  D            A+ +PE     L    
Sbjct: 121 RDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE----SLRTRT 176

Query: 274 YDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFA-QPPEAPEMASREFRD 331
           +  +A D+W  GV++ E F  G  P+  G  G  + ++  I    +  E PE   ++  +
Sbjct: 177 FS-HASDVWMFGVTLWEMFTYGEEPW-AGLSG--SQILKKIDKEGERLERPEACPQDIYN 232

Query: 332 FISRCLQKDPHSR 344
            + +C   +P  R
Sbjct: 233 VMLQCWAHNPADR 245

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 4e-25
 Identities = 82/298 (27%), Positives = 135/298 (45%), Gaps = 59/298 (19%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           +K +++G GS  TV++     T ++ ALK I   HE+       RE  +L+D+ H N+V 
Sbjct: 8   KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVT 67

Query: 162 CHDMYDRNGEIEVLLEYMD----------GGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
            HD+      + ++ EY+D          GG L   ++R          Q+L GLAY H+
Sbjct: 68  LHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRL------FLFQLLRGLAYCHQ 121

Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSR---ILAQTMDPCNSAVGTIAYMSPERINTD 268
           R+++HRD+KP NLLI+    +K+ADFG++R   + ++T    ++ V T+ Y  P     D
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY---SNEVVTLWYRPP-----D 173

Query: 269 LNHGKYDGYAG--DIWSLGVSILEFYLGR--FP---------------FAVGRQGDWASL 309
           +  G  + Y+   D+W +G    E   GR  FP                    +  W  +
Sbjct: 174 VLLGSTE-YSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232

Query: 310 M-------FAICFAQPPEAPEMASREFR-----DFISRCLQKDPHSRWPAAQLLQHPF 355
                   ++  F  P      A R  R     +   + LQ +P  R  AA+ ++HP+
Sbjct: 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  103 bits (259), Expect = 4e-25
 Identities = 63/218 (28%), Positives = 110/218 (50%), Gaps = 24/218 (11%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALK-VIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           +K  +IG G+ G V++  H  T ++ ALK V+  N ++       REI+IL+ + H NVV
Sbjct: 15  EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVV 74

Query: 161 K----CHD---MYDRN-GEIEVLLEYMD---GGSLEGAHIR--QEHILSDLARQVLSGLA 207
                C      Y+R  G   ++ E+ +    G L   +++     I   + + +L+GL 
Sbjct: 75  NLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEI-KKVMKMLLNGLY 133

Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC----NSAVGTIAYMSPE 263
           Y+H+ KI+HRD+K +N+LI     +K+ADFG++R  + + +       + V T+ Y  PE
Sbjct: 134 YIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193

Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVG 301
            +  + ++G       D+W  G  + E +  R P   G
Sbjct: 194 LLLGERDYGP----PIDMWGAGCIMAEMWT-RSPIMQG 226

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  103 bits (259), Expect = 5e-25
 Identities = 81/296 (27%), Positives = 134/296 (45%), Gaps = 36/296 (12%)

Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ---ICREIEILRDVN 155
           ++ + G  +G+GS G V    H  T   +A+K      E     Q   + +E  IL +++
Sbjct: 18  SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIK-CLKKREILKMKQVQHVAQEKSILMELS 76

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQE-HILSDLAR----QVLSGLAYLH 210
           HP +V     +     +  LLE++ GG L   H+R+     +D+A+    +++    YLH
Sbjct: 77  HPFIVNMMCSFQDENRVYFLLEFVVGGEL-FTHLRKAGRFPNDVAKFYHAELVLAFEYLH 135

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPERINTDL 269
            + I++RD+KP NLL+++  +VK+ DFG + ++  +T   C    GT  Y++PE I +  
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC----GTPEYLAPEVIQSK- 190

Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF 329
            HGK    A D W++GV + EF  G  PF      D    ++    A   + P       
Sbjct: 191 GHGK----AVDWWTMGVLLYEFIAGYPPFF----DDTPFRIYEKILAGRLKFPNWFDGRA 242

Query: 330 RDFISRCLQKDPHSRWPA-----AQLLQHPFILRAGQSQVNQN--LRQILPPPRPL 378
           RD +   LQ D   R        A +  HP+         N +    +  P P P+
Sbjct: 243 RDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF-----HGANWDKLYARYYPAPIPV 293

Length = 329

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  103 bits (257), Expect = 6e-25
 Identities = 81/284 (28%), Positives = 138/284 (48%), Gaps = 26/284 (9%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G G+ G V  V    T R +A+K++       +D V   +  E  +L++  HP +    
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNTRHPFLTALK 61

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIVHRD 218
             +  +  +  ++EY +GG L   H+ +E + + + AR    +++S L YLH R +V+RD
Sbjct: 62  YAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           IK  NL+++   ++KI DFG+ +          +  GT  Y++PE +  D ++G+    A
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE-DNDYGR----A 175

Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ 338
            D W LGV + E   GR PF      D   L F +   +    P   S E +  ++  L+
Sbjct: 176 VDWWGLGVVMYEMMCGRLPF---YNQDHERL-FELILMEEIRFPRTLSPEAKSLLAGLLK 231

Query: 339 KDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           KDP  R       A ++++H F L      V Q  +++LPP +P
Sbjct: 232 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ--KKLLPPFKP 273

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  102 bits (255), Expect = 7e-25
 Identities = 66/242 (27%), Positives = 112/242 (46%), Gaps = 24/242 (9%)

Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ--EHILSD-----LA 199
           E +IL  V+   +V     ++   ++ +++  M+GG L+  HI    E    +      A
Sbjct: 43  EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLK-YHIYNVGEPGFPEARAIFYA 101

Query: 200 RQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIA 258
            Q++ GL +LH+R+IV+RD+KP N+L++   NV+I+D G++  +            GT  
Sbjct: 102 AQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPG 159

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP 318
           YM+PE     L    YD ++ D ++LG ++ E   GR PF   ++      +        
Sbjct: 160 YMAPEV----LQGEVYD-FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA 214

Query: 319 PEAPEMASREFRDFISRCLQKDPHSR-----WPAAQLLQHPFILRAGQSQVNQNLRQILP 373
            E P+  S E +D     LQKDP  R       A ++ +HP        ++      +L 
Sbjct: 215 VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEA---GMLE 271

Query: 374 PP 375
           PP
Sbjct: 272 PP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  102 bits (255), Expect = 7e-25
 Identities = 73/246 (29%), Positives = 121/246 (49%), Gaps = 12/246 (4%)

Query: 103 KGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKC 162
           K +++G G+  TV++     T  + ALK I   HE+       RE+ +L+++ H N+V  
Sbjct: 9   KLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTL 68

Query: 163 HDMYDRNGEIEVLLEYMDGGSLE----GAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
           HD+      + ++ EY+D    +      ++   H +     Q+L GL+Y HKRKI+HRD
Sbjct: 69  HDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRD 128

Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           +KP NLLIN    +K+ADFG++R  +      ++ V T+ Y  P+ +   L   +Y    
Sbjct: 129 LKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL---LGSTEYSTPI 185

Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA--PEMAS-REFRDFISR 335
            D+W +G  + E   GR  F      +   L+F +    P E   P + S  EFR ++  
Sbjct: 186 -DMWGVGCILYEMATGRPMFPGSTVKEELHLIFRL-LGTPTEETWPGITSNEEFRSYLFP 243

Query: 336 CLQKDP 341
             +  P
Sbjct: 244 QYRAQP 249

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  103 bits (258), Expect = 8e-25
 Identities = 84/299 (28%), Positives = 128/299 (42%), Gaps = 63/299 (21%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V   +   + +  A+K I   +     + R+   RE++ILR   H N++   
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT--LRELKILRHFKHDNIIAIR 70

Query: 164 DMYDRNGE----IEVLLEYMDG---------GSLEGAHIRQEHILSDLARQVLSGLAYLH 210
           D+    G     + V+++ M+            L   HIR  + L     Q+L GL Y+H
Sbjct: 71  DILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIR--YFLY----QLLRGLKYIH 124

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT-MDPCN---SAVGTIAYMSPERIN 266
              ++HRD+KPSNLL+N    ++I DFG++R L+ +  +        V T  Y +PE + 
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL- 183

Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA----- 321
             L+  +Y   A D+WS+G  I    LGR     G+       +       P E      
Sbjct: 184 --LSLPEYT-TAIDMWSVGC-IFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239

Query: 322 ------------------------PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                                   P+ AS E  D +S+ LQ DP  R    Q LQHPF+
Sbjct: 240 GSDRVRKYIQNLPRKQPVPWSKIFPK-ASPEALDLLSQMLQFDPEERITVEQALQHPFL 297

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  101 bits (254), Expect = 1e-24
 Identities = 76/291 (26%), Positives = 126/291 (43%), Gaps = 47/291 (16%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNVV 160
           +K  +IG G+ GTV++  +  T  + ALK +  + +D  V S   REI +L+++ H N+V
Sbjct: 3   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 62

Query: 161 KCHDMYDRNGEIEVLLEYMD----------GGSLEGAHIRQEHILSDLARQVLSGLAYLH 210
           + +D+   + ++ ++ EY D           G ++        I+     Q+L GLA+ H
Sbjct: 63  RLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDID------PEIVKSFMFQLLKGLAFCH 116

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
              ++HRD+KP NLLIN +  +K+ADFG++R     +   ++ V T+ Y  P+ +     
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL---FG 173

Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD-----------------WASLMFAI 313
              Y   + D+WS G    E      P   G   D                 W  +    
Sbjct: 174 AKLYST-SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232

Query: 314 CFAQPPEAPEMASREF---------RDFISRCLQKDPHSRWPAAQLLQHPF 355
            +   P  P   S            RD +   L  +P  R  A + LQHP+
Sbjct: 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  101 bits (253), Expect = 1e-24
 Identities = 72/260 (27%), Positives = 122/260 (46%), Gaps = 32/260 (12%)

Query: 107 IGSGSGGTVWRV-VHPPTSRVFALKVIYGNH---------EDSVRSQICREIEILRD-VN 155
           +GSG+ G V++V        + ALK I  ++          D     I  E+ I+++ + 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL---------EGAHIRQEHILSDLARQVLSGL 206
           HPN+V+ +  +  N  + ++++ ++G  L         +     +E I +   + VL+ L
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA-L 126

Query: 207 AYLHK-RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERI 265
            YLHK ++IVHRD+ P+N+++     V I DFG+++   Q      S VGTI Y  PE I
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVGTILYSCPE-I 184

Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE-M 324
             +  +G+      D+W+ G  + +    + PF      +  SL   I  A     PE M
Sbjct: 185 VKNEPYGE----KADVWAFGCILYQMCTLQPPF---YSTNMLSLATKIVEAVYEPLPEGM 237

Query: 325 ASREFRDFISRCLQKDPHSR 344
            S +  D I+ CL  D  +R
Sbjct: 238 YSEDVTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  101 bits (254), Expect = 1e-24
 Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 40/288 (13%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNVV 160
           +K  +IG G+ G V++     T+   ALK I    ED  V S   REI +L+++ H N+V
Sbjct: 5   EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64

Query: 161 KCHDMYDRNGEIEVLLEYMD-------GGSLEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           +  D+      + ++ EY+D         S + A  +   ++     Q+L G+AY H  +
Sbjct: 65  RLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFA--KNPRLIKTYLYQILRGIAYCHSHR 122

Query: 214 IVHRDIKPSNLLINSSKN-VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           ++HRD+KP NLLI+   N +K+ADFG++R     +      V T+ Y +PE +   L   
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEIL---LGSR 179

Query: 273 KYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGR-QGDWASLMFAICFAQP--- 318
            Y     DIWS+G    E    +  FP        F + R  G      +    + P   
Sbjct: 180 HYSTPV-DIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238

Query: 319 ---PEAPEM--------ASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
              P+ P                D +S+ L+ DP  R  A   L+H +
Sbjct: 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286

Length = 294

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  101 bits (255), Expect = 2e-24
 Identities = 79/297 (26%), Positives = 128/297 (43%), Gaps = 49/297 (16%)

Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G V       T R  A+K +    + ++ ++   RE+ +L+ ++H
Sbjct: 14  PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDH 73

Query: 157 PNVVKCHDMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSG 205
            NV+   D++     +E      ++   M G  L    ++ +  LSD     L  Q+L G
Sbjct: 74  ENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQ-KLSDDHIQFLVYQILRG 130

Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERI 265
           L Y+H   I+HRD+KPSN+ +N    +KI DFG++R     M      V T  Y +PE +
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIM 187

Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE----- 320
              LN   Y+    DIWS+G  + E   G+  F      D    +  +      E     
Sbjct: 188 ---LNWMHYNQTV-DIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243

Query: 321 -----------APEMASREFR-----------DFISRCLQKDPHSRWPAAQLLQHPF 355
                       P+M  ++F+           D + + L  DP  R  AA+ L HP+
Sbjct: 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  100 bits (251), Expect = 2e-24
 Identities = 85/294 (28%), Positives = 127/294 (43%), Gaps = 57/294 (19%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALK-VIYGNHEDSVRSQICREIEILRDV---NHPNVVKC 162
           IG G+ GTV++   P +    ALK V    +ED +     RE+ +L+ +   +HPN+V+ 
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 163 HDM-----YDRNGEIEVLLE--------YMDGGSLEGAHIRQEHILSDLARQVLSGLAYL 209
            D+      DR  ++ ++ E        Y+D     G        + DL RQ L GL +L
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAET---IKDLMRQFLRGLDFL 124

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
           H   IVHRD+KP N+L+ S   VK+ADFG++RI +  M      V T+ Y +PE +    
Sbjct: 125 HANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM-ALTPVVVTLWYRAPEVLLQST 183

Query: 270 NHGKYDGYAG--DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE------- 320
                  YA   D+WS+G    E +  +  F    + D    +F +    PPE       
Sbjct: 184 -------YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL-IGLPPEDDWPRDV 235

Query: 321 ------------------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                              PE+        +   L  +PH R  A + LQHPF 
Sbjct: 236 TLPRGAFSPRGPRPVQSVVPEIEESG-AQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  100 bits (250), Expect = 4e-24
 Identities = 66/217 (30%), Positives = 104/217 (47%), Gaps = 34/217 (15%)

Query: 101 LQKGNRIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNH 156
           L+   ++G G  G V    + P    T    A+K +  + E+  RS   REIEILR ++H
Sbjct: 6   LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH 65

Query: 157 PNVVK----CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSG 205
            N+VK    C     R+  + +++EY+  GSL      Q H        L   + Q+  G
Sbjct: 66  ENIVKYKGVCEKPGGRS--LRLIMEYLPSGSLR--DYLQRHRDQINLKRLLLFSSQICKG 121

Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD------PCNSAVGTIAY 259
           + YL  ++ +HRD+   N+L+ S   VKI+DFG++++L +  D      P  S    I +
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP---IFW 178

Query: 260 MSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGR 295
            +PE + T          A D+WS GV++ E F  G 
Sbjct: 179 YAPECLRTSKFS-----SASDVWSFGVTLYELFTYGD 210

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 99.4 bits (248), Expect = 5e-24
 Identities = 64/263 (24%), Positives = 112/263 (42%), Gaps = 32/263 (12%)

Query: 96  INPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNHEDSV-RSQICREIEI 150
           I+P+EL     +GSG  G V    WR          A+K+I    E ++       E ++
Sbjct: 1   IDPSELTFLKELGSGQFGVVHLGKWR-----GKIDVAIKMI---REGAMSEDDFIEEAKV 52

Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSG 205
           +  ++HPN+V+ + +  +   I ++ EYM  G L     E         L D+   V   
Sbjct: 53  MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEA 112

Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSP 262
           + YL     +HRD+   N L+     VK++DFG++R +    D   S+ GT   + +  P
Sbjct: 113 MEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD--DQYTSSQGTKFPVKWAPP 170

Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           E      ++ ++   + D+WS GV + E F  G+ P+      +      ++        
Sbjct: 171 EV----FDYSRFSSKS-DVWSFGVLMWEVFSEGKMPYERFSNSEVVE---SVSAGYRLYR 222

Query: 322 PEMASREFRDFISRCLQKDPHSR 344
           P++A  E    +  C  + P  R
Sbjct: 223 PKLAPTEVYTIMYSCWHEKPEDR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  101 bits (252), Expect = 7e-24
 Identities = 82/283 (28%), Positives = 137/283 (48%), Gaps = 19/283 (6%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ---ICREIEILRDVNHPNVVKCH 163
           IG G+ G V  V H  + +V+A+K++    E   RS       E +I+   N P VV+  
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLL-SKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 164 DMYDRNGEIEVLLEYMDGG---SLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIK 220
             +  +  + +++EYM GG   +L   +   E        +V+  L  +H   ++HRD+K
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVK 169

Query: 221 PSNLLINSSKNVKIADFGVSRILAQT-MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           P N+L++   ++K+ADFG    + +T M  C++AVGT  Y+SPE + +    G Y G   
Sbjct: 170 PDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYY-GREC 228

Query: 280 DIWSLGVSILEFYLGRFPF-AVGRQGDWASLM---FAICFAQPPEAPEMASREFRDFISR 335
           D WS+GV + E  +G  PF A    G ++ +M    ++ F +  E  + A      F++ 
Sbjct: 229 DWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTD 288

Query: 336 CLQKDPHSRWPAAQLLQHPFILRAGQSQVN-QNLRQILPPPRP 377
             ++    R    ++ QHPF       Q N  N+R+   P  P
Sbjct: 289 --REVRLGRNGVEEIKQHPFF---KNDQWNWDNIRETAAPVVP 326

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  100 bits (250), Expect = 7e-24
 Identities = 75/284 (26%), Positives = 137/284 (48%), Gaps = 26/284 (9%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G G+ G V  V    + + +A+K++       +D V +    E  +L++  HP +    
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEV-AHTLTESRVLKNTRHPFLTSLK 61

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRD 218
             +     +  ++EY++GG L   H+ +E + S+        +++S L YLH  KIV+RD
Sbjct: 62  YSFQTKDRLCFVMEYVNGGEL-FFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120

Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           +K  NL+++   ++KI DFG+ +          +  GT  Y++PE +  D ++G+    A
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE-DNDYGR----A 175

Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ 338
            D W LGV + E   GR PF      D   L F +   +  + P   S + +  +S  L 
Sbjct: 176 VDWWGLGVVMYEMMCGRLPF---YNQDHEKL-FELILMEDIKFPRTLSADAKSLLSGLLI 231

Query: 339 KDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           KDP+ R       A ++++H F    G +  +   ++++PP +P
Sbjct: 232 KDPNKRLGGGPDDAKEIMRHSFF--TGVNWQDVYDKKLVPPFKP 273

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 99.4 bits (248), Expect = 8e-24
 Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 22/202 (10%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIEILRDVNHPNVVKC 162
           +G+G+ G V  V    +   +ALKV+     + +R      +  E  +L++V+HP +++ 
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVM--AIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66

Query: 163 HDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHR 217
                    + +L+EY+ GG L  +++R     S+      A +++  L YLH ++IV+R
Sbjct: 67  FWTEHDQRFLYMLMEYVPGGEL-FSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYR 125

Query: 218 DIKPSNLLINSSKNVKIADFGVSRILA-QTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           D+KP N+L++   ++K+ DFG ++ L  +T   C    GT  Y++PE I +   H K   
Sbjct: 126 DLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC----GTPEYLAPEVIQSK-GHNK--- 177

Query: 277 YAGDIWSLGVSILEFYLGRFPF 298
            A D W+LG+ I E  +G  PF
Sbjct: 178 -AVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 79/288 (27%), Positives = 127/288 (44%), Gaps = 48/288 (16%)

Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVN-HPNVVK 161
            +IG G+   V +     T + +A+K +   H  S+  Q+   REI+ LR ++ HPN+++
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSL-EQVNNLREIQALRRLSPHPNILR 62

Query: 162 CHD-MYDR-NGEIEVLLEYMDGGSLEGAHIR-QEHILSDLA-----RQVLSGLAYLHKRK 213
             + ++DR  G + ++ E MD    E   I+ ++  L +        Q+L  L ++H+  
Sbjct: 63  LIEVLFDRKTGRLALVFELMDMNLYE--LIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           I HRDIKP N+LI     +K+ADFG  R +     P    + T  Y +PE + TD   G 
Sbjct: 121 IFHRDIKPENILIK-DDILKLADFGSCRGIYSKP-PYTEYISTRWYRAPECLLTD---GY 175

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVG-----------------------RQGDWASLM 310
           Y G   DIW++G    E  L  FP   G                       +      + 
Sbjct: 176 Y-GPKMDIWAVGCVFFEI-LSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233

Query: 311 FAICFAQPPEAPEM---ASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
           +     +     ++   AS E  D + + L  DP  R  A Q L+HP+
Sbjct: 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 99.5 bits (248), Expect = 1e-23
 Identities = 91/287 (31%), Positives = 135/287 (47%), Gaps = 24/287 (8%)

Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVK 161
           + +G G  G V  V    T  ++A+KV+  +    +++V S    E +IL   N P + +
Sbjct: 7   SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETV-SFFEEERDILSISNSPWIPQ 65

Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL-SDLARQVLSGLAY----LHKRKIVH 216
               +     + +++EY  GG L     R E     D+A+  L+ L      +H+   VH
Sbjct: 66  LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH 125

Query: 217 RDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE---RINTDLNHG 272
           RDIKP N+LI+ + ++K+ADFG + R+ A  M      VGT  Y++PE    +N D   G
Sbjct: 126 RDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK-G 184

Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD-WASLMFAICFAQPPEAPEMASREFRD 331
            Y G   D WSLGV   E   GR PF  G     + ++M    F + PE P+  S +F D
Sbjct: 185 TY-GVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK-VSSDFLD 242

Query: 332 FISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN-QNLRQILPPPRP 377
            I   L      R     L  HPF      S+++  N+R  LPP  P
Sbjct: 243 LIQSLLC-GQKERLGYEGLCCHPFF-----SKIDWNNIRNSLPPFVP 283

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 90/295 (30%), Positives = 125/295 (42%), Gaps = 56/295 (18%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVKCHDM 165
           IG G+ G VW V  P   +  ALK +    ++ V  + + RE+++L    H NV+   D+
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67

Query: 166 -----YDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVH 216
                 D   EI V+ E M    L    +  + + SD  +    Q+L GL YLH   I+H
Sbjct: 68  LQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILH 126

Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA-----VGTIAYMSPERINTDLNH 271
           RDIKP NLL+NS+  +KI DFG    LA+  +P  S      V T  Y +PE     L  
Sbjct: 127 RDIKPGNLLVNSNCVLKICDFG----LARVEEPDESKHMTQEVVTQYYRAPEI----LMG 178

Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASL--------------MFAICFA- 316
            ++   A DIWS+G    E    R  F    Q     L              M + C   
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRRILFQA--QSPIQQLDLITDLLGTPSLEAMRSACEGA 236

Query: 317 ---------QPPEAPEM------ASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                    +PP  P +      A+ E    + R L  DP  R  AA  L HP++
Sbjct: 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 98.9 bits (246), Expect = 2e-23
 Identities = 81/285 (28%), Positives = 140/285 (49%), Gaps = 27/285 (9%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G G+ G V  V    T R +A+K++       +D V +    E  +L++  HP +    
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEV-AHTLTENRVLQNSRHPFLTALK 61

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLH-KRKIVHR 217
             +  +  +  ++EY +GG L   H+ +E + S D AR    +++S L YLH ++ +V+R
Sbjct: 62  YSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120

Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           D+K  NL+++   ++KI DFG+ +   +      +  GT  Y++PE +  D ++G+    
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE-DNDYGR---- 175

Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL 337
           A D W LGV + E   GR PF      D   L F +   +    P   S E +  +S  L
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPF---YNQDHEKL-FELILMEEIRFPRTLSPEAKSLLSGLL 231

Query: 338 QKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           +KDP  R       A +++QH F   AG    +   ++++PP +P
Sbjct: 232 KKDPKQRLGGGPDDAKEIMQHKFF--AGIVWQDVYEKKLVPPFKP 274

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 98.9 bits (246), Expect = 2e-23
 Identities = 75/281 (26%), Positives = 131/281 (46%), Gaps = 23/281 (8%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G GS G V+      T++ FA+K +  +    +D V   +  +  +     HP +   +
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR------QVLSGLAYLHKRKIVHR 217
             +     +  ++EY++GG L   HI+  H   DL R      +++ GL +LH + IV+R
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLM-FHIQSCHKF-DLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           D+K  N+L+++  ++KIADFG+ +          +  GT  Y++PE +      G+    
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL-----LGQKYNT 175

Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL 337
           + D WS GV + E  +G+ PF     G     +F       P  P   +RE +D + +  
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPF----HGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLF 231

Query: 338 QKDPHSRWPA-AQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
            ++P  R      + QHPF      S + +  R+I PP +P
Sbjct: 232 VREPERRLGVKGDIRQHPFFREIDWSALEE--REIEPPFKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 86/295 (29%), Positives = 134/295 (45%), Gaps = 58/295 (19%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IG G+ G V    +  T+   A+K I   + N  D+ R+   REI++LR ++H NV+   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT--LREIKLLRHLDHENVIAIK 70

Query: 164 DMY-----DRNGEIEVLLEYMDGGSLEGAH--IRQEHILSD-----LARQVLSGLAYLHK 211
           D+      +   ++ ++ E MD       H  IR    LSD        Q+L GL Y+H 
Sbjct: 71  DIMPPPHREAFNDVYIVYELMD----TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS 126

Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
             ++HRD+KPSNLL+N++ ++KI DFG++R  ++  D     V T  Y +PE +   LN 
Sbjct: 127 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL---LNC 183

Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI------------CFAQPP 319
            +Y   A D+WS+G    E  LGR P   G+  D+   +  I             F +  
Sbjct: 184 SEY-TTAIDVWSVGCIFAEL-LGRKPLFPGK--DYVHQLKLITELLGSPSEEDLGFIRNE 239

Query: 320 EA-------PEMASREFR-----------DFISRCLQKDPHSRWPAAQLLQHPFI 356
           +A       P    + F            D + + L  DP  R    + L HP++
Sbjct: 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 97.5 bits (243), Expect = 3e-23
 Identities = 72/266 (27%), Positives = 122/266 (45%), Gaps = 42/266 (15%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G+G  G VW  +   T+ V A+K +     D        E +I++ + HP +++ + +
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTMDP--KDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I ++ E M  GSL        G  ++    L D+A QV SG+AYL  +  +HRD
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQ-LIDMAAQVASGMAYLEAQNYIHRD 128

Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYD 275
           +   N+L+  +   K+ADFG++R++ +  D   +  G    I + +PE          Y+
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKE--DIYEAREGAKFPIKWTAPEAAL-------YN 179

Query: 276 GYA--GDIWSLGVSILEFY-LGRFPFA------VGRQGDWASLMFAICFAQPPEAPEMAS 326
            ++   D+WS G+ + E    GR P+       V +Q D    M       PP  P+   
Sbjct: 180 RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM-----PCPPGCPK--- 231

Query: 327 REFRDFISRCLQKDPHSRWPAAQLLQ 352
            E  D +  C ++DP  R P  + LQ
Sbjct: 232 -ELYDIMLDCWKEDPDDR-PTFETLQ 255

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 98.3 bits (245), Expect = 3e-23
 Identities = 76/283 (26%), Positives = 133/283 (46%), Gaps = 27/283 (9%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G GS G V       T+  FA+K +  +    +D V   +     +     HP +    
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR------QVLSGLAYLHKRKIVHR 217
             +     +  ++EY++GG L   HI+      D AR      +++ GL +LHK+ I++R
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDLM-FHIQSSGRF-DEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 218 DIKPSNLLINSSKNVKIADFGVSR--ILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           D+K  N+L++   ++KIADFG+ +  +  +     ++  GT  Y++PE +       KY+
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKGQ----KYN 174

Query: 276 GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISR 335
             + D WS GV + E  +G+ PF     G+    +F       P  P   S+E +D +S+
Sbjct: 175 -ESVDWWSFGVLLYEMLIGQSPF----HGEDEDELFDSILNDRPHFPRWISKEAKDCLSK 229

Query: 336 CLQKDPHSRW-PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
             ++DP  R      + QHPF       ++ +  R+I PP +P
Sbjct: 230 LFERDPTKRLGVDGDIRQHPFFRGIDWERLEK--REIPPPFKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 98.6 bits (246), Expect = 3e-23
 Identities = 75/288 (26%), Positives = 123/288 (42%), Gaps = 32/288 (11%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDVNHPNVVKCH 163
           ++G G  G V+      T  + ALK +  +   + +    +  E +IL       +VK  
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDI 219
             +  +  + + +EY+ GG           +  D AR    ++   +  LH+   +HRD+
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDL 127

Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           KP N LI++S ++K+ DFG+S      +   NS VG+  YM+PE     L    YD +  
Sbjct: 128 KPENFLIDASGHIKLTDFGLS---KGIVTYANSVVGSPDYMAPEV----LRGKGYD-FTV 179

Query: 280 DIWSLGVSILEFYLGRFPFAVGRQGD-----WASLM-FAICFAQPP-EAPEMA-SREFRD 331
           D WSLG  + EF  G  PF+    G      W +L  +     +P  + P    S E  D
Sbjct: 180 DYWSLGCMLYEFLCGFPPFS----GSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235

Query: 332 FISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN-QNLRQILPPPRPL 378
            I++ +            +  HPF       +V+   LR++ PP  P 
Sbjct: 236 LITKLINDPSRRFGSLEDIKNHPFF-----KEVDWNELRELKPPFVPE 278

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 98.1 bits (245), Expect = 4e-23
 Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 31/203 (15%)

Query: 107 IGSGSGGTVWRVV--HPPTSRVFALKVIYG--NHEDSVRSQICREIEILRDVNHPNVVKC 162
           IG G+ G V++    +    + +A+K   G       +    CREI +LR++ H NVV  
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 163 HDMY--DRNGEIEVLLEYMDGGSLEGAHIRQEH-----------ILSDLARQVLSGLAYL 209
            +++    +  + +L +Y +        I + H           ++  L  Q+L+G+ YL
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLW---QIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124

Query: 210 HKRKIVHRDIKPSNLLINSSKN----VKIADFGVSRILAQTMDPC---NSAVGTIAYMSP 262
           H   ++HRD+KP+N+L+         VKI D G++R+    + P    +  V TI Y +P
Sbjct: 125 HSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAP 184

Query: 263 ERINTDLNHGKYDGYAGDIWSLG 285
           E +   L    Y   A DIW++G
Sbjct: 185 ELL---LGARHYTK-AIDIWAIG 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 95.6 bits (238), Expect = 1e-22
 Identities = 59/220 (26%), Positives = 113/220 (51%), Gaps = 24/220 (10%)

Query: 95  LINPAELQKGNRIGSGSGGTVWRVV-HPPTSRV---FALKVIYGNHEDSVRSQICREIEI 150
           ++   EL+K   +GSG+ GTV++ V  P   +V    A+KV+          +I  E  +
Sbjct: 3   ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV 62

Query: 151 LRDVNHPNVVK--CHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQV 202
           +  V+HP+VV+     +  +   ++++ + M  G L         +I  +++L+    Q+
Sbjct: 63  MASVDHPHVVRLLGICLSSQ---VQLITQLMPLGCLLDYVRNHKDNIGSQYLLN-WCVQI 118

Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYM 260
             G++YL ++++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M
Sbjct: 119 AKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 261 SPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFA 299
           + E I     H  Y  +  D+WS GV++ E    G  P+ 
Sbjct: 179 ALESI----LHRIYT-HKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 95.2 bits (237), Expect = 2e-22
 Identities = 52/207 (25%), Positives = 102/207 (49%), Gaps = 16/207 (7%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV 159
           E     ++GSG  G VW  +     RV A+K++  +     +    +E++ L+ + H ++
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQ-DFQKEVQALKRLRHKHL 64

Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKR 212
           +    +      + ++ E M+ GSL       EG  +    ++ D+A QV  G+AYL ++
Sbjct: 65  ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLI-DMACQVAEGMAYLEEQ 123

Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
             +HRD+   N+L+      K+ADFG++R++ + +   +       + +PE      +HG
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA----SHG 179

Query: 273 KYDGYAGDIWSLGVSILE-FYLGRFPF 298
            +   + D+WS G+ + E F  G+ P+
Sbjct: 180 TFSTKS-DVWSFGILLYEMFTYGQVPY 205

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 69/208 (33%), Positives = 102/208 (49%), Gaps = 26/208 (12%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQIC----REIEILRDVNHPNVVKC 162
           IG G+ G V    H PT    A+K I            C    REI+ILR   H N++  
Sbjct: 13  IGEGAYGMVCSATHKPTGVKVAIKKI----SPFEHQTFCQRTLREIKILRRFKHENIIGI 68

Query: 163 HDM-----YDRNGEIEVLLEYMDGG---SLEGAHIRQEHILSDLARQVLSGLAYLHKRKI 214
            D+     ++   ++ ++ E M+      ++  H+  +HI   L  Q+L GL Y+H   +
Sbjct: 69  LDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFL-YQILRGLKYIHSANV 127

Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP---CNSAVGTIAYMSPERINTDLNH 271
           +HRD+KPSNLL+N++ ++KI DFG++RI     D        V T  Y +PE +   LN 
Sbjct: 128 LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM---LNS 184

Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP 297
             Y   A DIWS+G  + E    R  FP
Sbjct: 185 KGYTK-AIDIWSVGCILAEMLSNRPLFP 211

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 96.4 bits (240), Expect = 2e-22
 Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 25/289 (8%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDV-NHPNVVKCH 163
           IG GS   V  V    T R++A+KVI     ++D     +  E  +     NHP +V  H
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDI 219
             +     +  ++E++ GG L     RQ  +  + AR    ++   L +LH+R I++RD+
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122

Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           K  N+L+++  ++K+ D+G+ +   +  D  ++  GT  Y++PE +      G+  G++ 
Sbjct: 123 KLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL-----RGEDYGFSV 177

Query: 280 DIWSLGVSILEFYLGRFPFAVGRQGDWASL-----MFAICFAQPPEAPEMASREFRDFIS 334
           D W+LGV + E   GR PF +    D         +F +   +    P   S +    + 
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237

Query: 335 RCLQKDPHSRWPA------AQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
             L KDP  R           +  HPF        + Q  +Q+LPP +P
Sbjct: 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQ--KQVLPPYKP 284

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 73/296 (24%), Positives = 117/296 (39%), Gaps = 55/296 (18%)

Query: 108 GSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
                  V    H PT+ + A+K I     + ED    Q  +EI   R + HPN++    
Sbjct: 9   CFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQ--QEIITSRQLQHPNILPYVT 66

Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHI---LSDLA-----RQVLSGLAYLHKRKIVH 216
            +  + E+ V+   M  GS E   + + H    L +LA     + VL+ L Y+H +  +H
Sbjct: 67  SFIVDSELYVVSPLMAYGSCE--DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIH 124

Query: 217 RDIKPSNLLINSSKNVKIADFGVSRIL-------AQTMDPCNSAVGTIAYMSPERINTDL 269
           R +K S++L++    V ++    S  +           D   S+V  + ++SPE +  +L
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184

Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGRFPFA----------------------------VG 301
             G Y+  + DI+S+G++  E   G  PF                               
Sbjct: 185 -QG-YNEKS-DIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241

Query: 302 RQGDWASLMFAICFAQPPEAP--EMASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
                 S           + P     S  F  F+  CLQ+DP SR  A+QLL H F
Sbjct: 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 94.7 bits (235), Expect = 4e-22
 Identities = 74/282 (26%), Positives = 124/282 (43%), Gaps = 39/282 (13%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDM 165
           +G G+ G V +  H  T  + A+K    + E + V+    RE+++LR +   N+V+  + 
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIKP 221
           + R G++ ++ EY++   LE        +  +  R    Q++  + + HK  IVHRDIKP
Sbjct: 69  FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKP 128

Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDPCNSA-VGTIAYMSPERINTDLNHGKYDGYAGD 280
            NLLI+ +  +K+ DFG +R L++  +   +  V T  Y SPE     L  G   G A D
Sbjct: 129 ENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE-----LLLGAPYGKAVD 183

Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA------------------- 321
           +WS+G  + E   G+  F    + D    +  +    P E                    
Sbjct: 184 MWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVN 243

Query: 322 -PEMASREFR--------DFISRCLQKDPHSRWPAAQLLQHP 354
            P+   R +         D +   L+ +P  R+   Q L HP
Sbjct: 244 HPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 95.9 bits (238), Expect = 5e-22
 Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 11/200 (5%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ---ICREIEILRDVNHPNVVKCH 163
           IG G+ G V  V H  T +V+A+K++    E   RS       E +I+   N P VV+  
Sbjct: 51  IGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDI 219
             +  +  + +++EYM GG L    +    +    AR    +V+  L  +H    +HRD+
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNL-MSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDV 168

Query: 220 KPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           KP N+L++ S ++K+ADFG   ++  + M  C++AVGT  Y+SPE + +    G Y G  
Sbjct: 169 KPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY-GRE 227

Query: 279 GDIWSLGVSILEFYLGRFPF 298
            D WS+GV + E  +G  PF
Sbjct: 228 CDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 95.1 bits (236), Expect = 5e-22
 Identities = 70/287 (24%), Positives = 131/287 (45%), Gaps = 23/287 (8%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDVN-HPNVVKCH 163
           IG GS   V  V      +++A+KV+     H+D     +  E  +    + +P +V  H
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDI 219
             +     + +++EY++GG L     RQ  +  + AR    ++   L +LH+R I++RD+
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122

Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           K  N+L+++  ++K+ D+G+ +      D  ++  GT  Y++PE +      G+  G++ 
Sbjct: 123 KLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL-----RGEEYGFSV 177

Query: 280 DIWSLGVSILEFYLGRFPFAV---GRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
           D W+LGV + E   GR PF +       +    +F +   +P   P   S +    +   
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237

Query: 337 LQKDPHSRWPA------AQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           L KDP  R         + +  H F        + +  +Q+ PP +P
Sbjct: 238 LNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEK--KQVTPPFKP 282

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 95.2 bits (237), Expect = 6e-22
 Identities = 87/306 (28%), Positives = 133/306 (43%), Gaps = 71/306 (23%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM- 165
           +G GS G V+  V     +  A+K I      SV+  + REI+I+R ++H N+VK +++ 
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKVYEVL 71

Query: 166 ----YDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR-----------------QVLS 204
                D   ++  L E      L   +I QE++ +DLA                  Q+L 
Sbjct: 72  GPSGSDLTEDVGSLTE------LNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR 125

Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVG-------T 256
           GL Y+H   ++HRD+KP+N+ IN+   V KI DFG++RI    +DP  S  G       T
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARI----VDPHYSHKGYLSEGLVT 181

Query: 257 IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFA----------------V 300
             Y SP  + +  N+ K    A D+W+ G    E   G+  FA                V
Sbjct: 182 KWYRSPRLLLSPNNYTK----AIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237

Query: 301 GRQGDWASLM-----FAICFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQL 350
            R+ D   L+     F       P  P        + E  DF+ + L  +P  R  A + 
Sbjct: 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEA 297

Query: 351 LQHPFI 356
           L HP++
Sbjct: 298 LMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 93.9 bits (233), Expect = 7e-22
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 20/204 (9%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G GS  TV++ +     ++ ALKVI    E+ V     RE  +L+ + H N+V  HD+
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 166 YDRNGEIEVLLEYMDG----------GSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
                 +  + EYM            G L   ++R          Q+L GLAY+H + I+
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL------FMFQLLRGLAYIHGQHIL 125

Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           HRD+KP NLLI+    +K+ADFG++R  +      +S V T+ Y  P+ +   L    Y 
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVL---LGATDYS 182

Query: 276 GYAGDIWSLGVSILEFYLGRFPFA 299
             A DIW  G   +E   G+  F 
Sbjct: 183 S-ALDIWGAGCIFIEMLQGQPAFP 205

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 91.8 bits (228), Expect = 4e-21
 Identities = 66/241 (27%), Positives = 108/241 (44%), Gaps = 22/241 (9%)

Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR-------QEHILSDLA 199
           E +IL  VN   VV     Y+    + ++L  M+GG L+  HI         E      A
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK-FHIYNMGNPGFDEERAVFYA 108

Query: 200 RQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAY 259
            ++  GL  LH+ +IV+RD+KP N+L++   +++I+D G++  + +  +     VGT+ Y
Sbjct: 109 AEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIRGRVGTVGY 167

Query: 260 MSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP 319
           M+PE +  +    +Y  ++ D W LG  I E   G+ PF   ++      +         
Sbjct: 168 MAPEVVKNE----RY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQE 222

Query: 320 EAPEMASREFRDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPP 374
           E  E  S   R    + L KDP  R       A ++  HPF   A   ++   +   L P
Sbjct: 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGM---LEP 279

Query: 375 P 375
           P
Sbjct: 280 P 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 91.4 bits (227), Expect = 5e-21
 Identities = 68/246 (27%), Positives = 110/246 (44%), Gaps = 29/246 (11%)

Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR---------QEHILSD 197
           E  IL  V+   +V     +    ++ +++  M+GG L   HI           E     
Sbjct: 43  EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLR-YHIYNVDEENPGFPEPRACF 101

Query: 198 LARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI 257
              Q++SGL +LH+R+I++RD+KP N+L+++  NV+I+D G++  L           GT 
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP 161

Query: 258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF-AVGRQGDWASLMFAICFA 316
            +M+PE +  +    +YD ++ D ++LGV++ E    R PF A G + +   L   I   
Sbjct: 162 GFMAPELLQGE----EYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI-LN 215

Query: 317 QPPEAPEMASREFRDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVN--QNLR 369
                P+  S   + F    L KDP  R          L  HP         +N  Q   
Sbjct: 216 DSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF-----RDLNWRQLEA 270

Query: 370 QILPPP 375
            +LPPP
Sbjct: 271 GMLPPP 276

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 90.8 bits (225), Expect = 5e-21
 Identities = 73/271 (26%), Positives = 127/271 (46%), Gaps = 31/271 (11%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILR 152
           I+P+EL     IGSG  G VW        +V A+K I     + ED +      E +++ 
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWLGYWLEKRKV-AIKTIREGAMSEEDFIE-----EAQVMM 54

Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGL 206
            ++HP +V+ + +      I ++ E+M+ G L      +     QE +L  +   V  G+
Sbjct: 55  KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLL-GMCLDVCEGM 113

Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPE 263
           AYL    ++HRD+   N L+  ++ VK++DFG++R +    D   S+ GT   + + SPE
Sbjct: 114 AYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD--DQYTSSTGTKFPVKWSSPE 171

Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAP 322
                 +  KY   + D+WS GV + E +  G+ P+      +   ++  I        P
Sbjct: 172 VF----SFSKYSSKS-DVWSFGVLMWEVFSEGKTPYENRSNSE---VVETINAGFRLYKP 223

Query: 323 EMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
            +AS+   + +  C ++ P  R P+  LL H
Sbjct: 224 RLASQSVYELMQHCWKERPEDR-PSFSLLLH 253

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 90.9 bits (226), Expect = 5e-21
 Identities = 67/257 (26%), Positives = 113/257 (43%), Gaps = 32/257 (12%)

Query: 105 NRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
             +G G+ G+V    + +       V A+K +   H  + + +  RE  ++  ++HP +V
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEV-AVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV 59

Query: 161 K----CHDMYDRNGEIEVL-LEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHK 211
           +    C       GE  +L +E    G     L+         L +LA QV  G+AYL  
Sbjct: 60  RLIGVCK------GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES 113

Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG---TIAYMSPERINTD 268
           +  VHRD+   N+L+ +    KI+DFG+SR L    D   +       + + +PE I   
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI--- 170

Query: 269 LNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR 327
            N+GK+     D+WS GV++ E F  G  P+    +G  A ++  +   +    PE   +
Sbjct: 171 -NYGKFS-SKSDVWSYGVTLWEAFSYGAKPYG-EMKG--AEVIAMLESGERLPRPEECPQ 225

Query: 328 EFRDFISRCLQKDPHSR 344
           E    +  C +  P  R
Sbjct: 226 EIYSIMLSCWKYRPEDR 242

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 90.5 bits (225), Expect = 6e-21
 Identities = 69/266 (25%), Positives = 114/266 (42%), Gaps = 24/266 (9%)

Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV 154
            IN  EL+ G  IG G  G V    +    +  A+K +    + +       E  ++  +
Sbjct: 2   AINSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCL--KDDSTAAQAFLAEASVMTTL 57

Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLA 207
            HPN+V+   +  +   + ++ EYM  GSL         A I     L   A  V  G+ 
Sbjct: 58  RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQL-GFALDVCEGME 116

Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           YL ++  VHRD+   N+L++     K++DFG+++  +Q  D   S    + + +PE    
Sbjct: 117 YLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEA--- 170

Query: 268 DLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS 326
            L   K+   + D+WS G+ + E Y  GR P+      D   ++  +      EAPE   
Sbjct: 171 -LREKKFSTKS-DVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHVEKGYRMEAPEGCP 225

Query: 327 REFRDFISRCLQKDPHSRWPAAQLLQ 352
            E    +  C + DP  R    QL +
Sbjct: 226 PEVYKVMKDCWELDPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 92.3 bits (229), Expect = 6e-21
 Identities = 79/287 (27%), Positives = 124/287 (43%), Gaps = 47/287 (16%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDM 165
           +GSG+ GTV   +   T    A+K +Y   + +    +  RE+ +L+ + H NV+   D+
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 166 Y------DRNGEIEVLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLAYLHKRKIV 215
           +      DR  +  +++ +M  G+  G  ++ E +  D    L  Q+L GL Y+H   I+
Sbjct: 83  FTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGII 140

Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           HRD+KP NL +N    +KI DFG++R   QT       V T  Y +PE I   LN   Y 
Sbjct: 141 HRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRWYRAPEVI---LNWMHYT 194

Query: 276 GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--------------- 320
               DIWS+G  + E   G+  F      D    +  +      E               
Sbjct: 195 QTV-DIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVK 253

Query: 321 -APEMASREFR-----------DFISRCLQKDPHSRWPAAQLLQHPF 355
             P    ++FR           + + + L  D  SR  AA+ L HP+
Sbjct: 254 KLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 91.8 bits (228), Expect = 7e-21
 Identities = 76/282 (26%), Positives = 121/282 (42%), Gaps = 22/282 (7%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEIL-RDVNHPNVVKCH 163
           IG GS G V    H    + +A+KV+      +   +  I  E  +L ++V HP +V  H
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDI 219
             +    ++  +L+Y++GG L     R+       AR    ++ S L YLH   I++RD+
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122

Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           KP N+L++S  +V + DFG+ +   +     ++  GT  Y++PE +        YD    
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQ----PYD-RTV 177

Query: 280 DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQK 339
           D W LG  + E   G  PF      D A  M+     +P       S   R  +   LQK
Sbjct: 178 DWWCLGAVLYEMLYGLPPF---YSRDTAE-MYDNILNKPLRLKPNISVSARHLLEGLLQK 233

Query: 340 DPHSRWPAA----QLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           D   R  A     ++  H F        +    ++I PP  P
Sbjct: 234 DRTKRLGAKDDFLEIKNHVFFSSINWDDLVN--KKITPPFNP 273

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 89.1 bits (222), Expect = 3e-20
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 37/213 (17%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV----- 154
           E+ K  ++  G  G V  + H PT ++F  K+I        +++    IE    V     
Sbjct: 17  EIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKII--------KAKNFNAIEP--MVHQLMK 66

Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHILSD-----LARQVLSGLAY 208
           ++PN +K +          ++++Y+  G L +   +++E  LS+     + RQ++  L  
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD--LLKKEGKLSEAEVKKIIRQLVEALND 124

Query: 209 LHKRKIVHRDIKPSNLLINSSKN-VKIADFGVSRILAQ--TMDPCNSAVGTIAYMSPERI 265
           LHK  I+H DIK  N+L + +K+ + + D+G+ +I+      D      GT+ Y SPE+I
Sbjct: 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFSPEKI 178

Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF 298
                   YD  + D W++GV   E   G+ PF
Sbjct: 179 ----KGHNYD-VSFDWWAVGVLTYELLTGKHPF 206

Length = 267

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 89.5 bits (222), Expect = 4e-20
 Identities = 84/283 (29%), Positives = 128/283 (45%), Gaps = 42/283 (14%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS-QICREIEILRDVNHPNVVKCHDM 165
           +G G+ G V       T +  A+K I       V + +  RE+++L+ + H N++   D+
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77

Query: 166 YDRNGE-IEVLLEYM--DGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           +    E I  + E +  D   L  +   ++  +     Q+L GL Y+H   +VHRD+KPS
Sbjct: 78  FISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPS 137

Query: 223 NLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           N+LIN + ++KI DFG++RI    M      V T  Y +PE +   L   KYD    DIW
Sbjct: 138 NILINENCDLKICDFGLARIQDPQM---TGYVSTRYYRAPEIM---LTWQKYD-VEVDIW 190

Query: 283 SLGVSILEFYLGR--FP-------FAV-----GRQGDWASLMFAIC------FAQ--PPE 320
           S G    E   G+  FP       F++     G   D   ++  IC      F Q  P  
Sbjct: 191 SAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD--DVINTICSENTLRFVQSLPKR 248

Query: 321 APEMASREF-------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P   S +F        D + + L  DP  R  AA+ L HP++
Sbjct: 249 EPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 91.3 bits (226), Expect = 7e-20
 Identities = 84/292 (28%), Positives = 135/292 (46%), Gaps = 46/292 (15%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
           +IG+G  G V+ V H  T   F  K I Y   ++  +SQ+  E+ ++R++ H N+V+  D
Sbjct: 20  KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYID 79

Query: 165 MY--DRNGEIEVLLEYMDGGSLEGAHIR--------QEHILSDLARQVLSGLAYLHKRK- 213
            +    N ++ +L+E+ D G L     +        +EH + D+ RQ+L  LAY H  K 
Sbjct: 80  RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD 139

Query: 214 ------IVHRDIKPSNLL-----------------INSSKNVKIADFGVSR-ILAQTMDP 249
                 ++HRD+KP N+                  +N     KI DFG+S+ I  ++M  
Sbjct: 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM-- 197

Query: 250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASL 309
            +S VGT  Y SPE +   L+  K      D+W+LG  I E   G+ PF   +  +++ L
Sbjct: 198 AHSCVGTPYYWSPELL---LHETKSYDDKSDMWALGCIIYELCSGKTPFH--KANNFSQL 252

Query: 310 MFAICFAQPPEAP-EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG 360
           +  +   + P+ P +  S+E    I   L      R  A Q L +  I   G
Sbjct: 253 ISEL--KRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302

Length = 1021

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 87.1 bits (216), Expect = 9e-20
 Identities = 65/258 (25%), Positives = 117/258 (45%), Gaps = 45/258 (17%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +IG G+ G V++ V    + V A+K         ++ +  +E EIL+  +HPN+VK   +
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 166 YDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDI 219
             +   I +++E + GGSL      +   +  + +L  ++    +G+ YL  +  +HRD+
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLL-QMSLDAAAGMEYLESKNCIHRDL 119

Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI--AYMSPERINTDLNHGKYDGY 277
              N L+  +  +KI+DFG+SR     +   +  +  I   + +PE     LN+G+Y   
Sbjct: 120 AARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEA----LNYGRYTS- 174

Query: 278 AGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
             D+WS G+ + E F LG  P+                       P M++++ R+ I   
Sbjct: 175 ESDVWSYGILLWETFSLGDTPY-----------------------PGMSNQQTRERI--- 208

Query: 337 LQKDPHSRWPAAQLLQHP 354
              +   R PA QL    
Sbjct: 209 ---ESGYRMPAPQLCPEE 223

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 87.2 bits (216), Expect = 1e-19
 Identities = 62/261 (23%), Positives = 121/261 (46%), Gaps = 23/261 (8%)

Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           L+   ++G+G  G VW   +   ++V    +  G+           E  +++ + HP +V
Sbjct: 8   LKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---FLAEANLMKQLQHPRLV 64

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           + + +  +   I ++ EYM+ GSL       EG  +    ++ D+A Q+  G+A++ ++ 
Sbjct: 65  RLYAVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLI-DMAAQIAEGMAFIERKN 122

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS-AVGTIAYMSPERINTDLNHG 272
            +HRD++ +N+L++ +   KIADFG++R++          A   I + +PE I    N+G
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI----NYG 178

Query: 273 KYDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
            +     D+WS G+ + E    GR P+  G             +  P   P+    E  +
Sbjct: 179 TFT-IKSDVWSFGILLTEIVTYGRIPYP-GMTNPEVIQNLERGYRMP--RPDNCPEELYE 234

Query: 332 FISRCLQKDPHSRWPAAQLLQ 352
            +  C ++ P  R P  + L+
Sbjct: 235 LMRLCWKEKPEER-PTFEYLR 254

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 68/281 (24%), Positives = 129/281 (45%), Gaps = 23/281 (8%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G GS G V           FA+K +  +    +D V   +  +  +     +P +   +
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR------QVLSGLAYLHKRKIVHR 217
             +     +  ++E+++GG L   HI Q+    DL R      +++ GL +LH + I++R
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLM-FHI-QDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           D+K  N++++   ++KIADFG+ +      +  ++  GT  Y++PE +      G    +
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL-----QGLKYTF 175

Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL 337
           + D WS GV + E  +G+ PF     GD    +F       P  P   ++E +D + +  
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPF----HGDDEDELFESIRVDTPHYPRWITKESKDILEKLF 231

Query: 338 QKDPHSRWP-AAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           ++DP  R      +  HPF      + + +  R++ PP +P
Sbjct: 232 ERDPTRRLGVVGNIRGHPFFKTINWTALEK--RELDPPFKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 88.6 bits (219), Expect = 1e-19
 Identities = 84/316 (26%), Positives = 133/316 (42%), Gaps = 55/316 (17%)

Query: 78  HQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE 137
           ++Q+ N+T      R+Q ++P        +GSG+ G+V       T    A+K +    +
Sbjct: 4   YRQELNKTIWEVPERYQNLSP--------VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 55

Query: 138 DSVRSQ-ICREIEILRDVNHPNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQ 191
             + ++   RE+ +L+ + H NV+   D++     +E      L+ ++ G  L   +I +
Sbjct: 56  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN--NIVK 113

Query: 192 EHILSD-----LARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT 246
              L+D     L  Q+L GL Y+H   I+HRD+KPSNL +N    +KI DFG++R    T
Sbjct: 114 CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HT 170

Query: 247 MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDW 306
            D     V T  Y +PE +   LN   Y+    DIWS+G  + E   GR  F      D 
Sbjct: 171 DDEMTGYVATRWYRAPEIM---LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQ 226

Query: 307 ASLMFAICFAQPPEA----------------PEMASREFR-----------DFISRCLQK 339
             L+  +      E                  +M    F            D + + L  
Sbjct: 227 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL 286

Query: 340 DPHSRWPAAQLLQHPF 355
           D   R  AAQ L H +
Sbjct: 287 DSDKRITAAQALAHAY 302

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 17/206 (8%)

Query: 96  INPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEIL 151
           I+P+ +     IG G  G V     ++       V A+K +     D  R     E  I+
Sbjct: 1   IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDV-AIKTLKAGSSDKQRLDFLTEASIM 59

Query: 152 RDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHI--LSDLARQVLSGL 206
              +HPN+++   +  ++  + ++ EYM+ GSL+     +  +  +  L  + R + SG+
Sbjct: 60  GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGM 119

Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIA--YMSPER 264
            YL +   VHRD+   N+L+NS+   K++DFG+SR L  +     +  G I   + +PE 
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA 179

Query: 265 INTDLNHGKYDGYAGDIWSLGVSILE 290
           I     + K+   A D+WS G+ + E
Sbjct: 180 I----AYRKFTS-ASDVWSFGIVMWE 200

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 86.8 bits (215), Expect = 2e-19
 Identities = 70/271 (25%), Positives = 123/271 (45%), Gaps = 32/271 (11%)

Query: 96  INPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEIL 151
           INP+EL     +GSG  G V    WR          A+K I  N           E +++
Sbjct: 1   INPSELTFMKELGSGQFGVVHLGKWR-----AQIKVAIKAI--NEGAMSEEDFIEEAKVM 53

Query: 152 RDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSG 205
             ++HP +V+ + +  +   + ++ E+M+ G L          + ++ +LS + + V  G
Sbjct: 54  MKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLS-MCQDVCEG 112

Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSP 262
           + YL +   +HRD+   N L++S+  VK++DFG++R +    D   S+ G    + +  P
Sbjct: 113 MEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD--DEYTSSSGAKFPVKWSPP 170

Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           E      N  KY   + D+WS GV + E F  G+ PF      +   ++  I        
Sbjct: 171 EV----FNFSKYSSKS-DVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMISRGFRLYR 222

Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
           P++AS    + +  C  + P  R   A+LL+
Sbjct: 223 PKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 86.6 bits (214), Expect = 2e-19
 Identities = 64/256 (25%), Positives = 119/256 (46%), Gaps = 22/256 (8%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G+G  G VW   +  +++V    +  G    SV++    E  +++ + H  +V+ + +
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQA-FLEEANLMKTLQHDKLVRLYAV 69

Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
             +   I ++ EYM  GSL       EG  +    ++ D + Q+  G+AY+ ++  +HRD
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI-DFSAQIAEGMAYIERKNYIHRD 128

Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L++ S   KIADFG++R++          A   I + +PE I    N G +   
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI----NFGSFT-I 183

Query: 278 AGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
             D+WS G+ + E    G+ P+  G     + +M A+         E    E  D +  C
Sbjct: 184 KSDVWSFGILLYEIVTYGKIPYP-GMSN--SDVMSALQRGYRMPRMENCPDELYDIMKTC 240

Query: 337 LQKDPHSRWPAAQLLQ 352
            ++    R P    LQ
Sbjct: 241 WKEKAEER-PTFDYLQ 255

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 72/263 (27%), Positives = 113/263 (42%), Gaps = 49/263 (18%)

Query: 107 IGSGSGGTVWR-VVHPPTSRVF--ALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK-- 161
           IG G  G V++ V   P +     A+K        SVR +  +E  I+R  +HP++VK  
Sbjct: 14  IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73

Query: 162 --CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR------QVLSGLAYLHKRK 213
               +       + +++E    G L  ++++      DLA       Q+ + LAYL  ++
Sbjct: 74  GVITEN-----PVWIVMELAPLGEL-RSYLQVNKYSLDLASLILYSYQLSTALAYLESKR 127

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSPERINTDLNH 271
            VHRDI   N+L++S   VK+ DFG+SR L        ++ G   I +M+PE IN     
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE-SYYKASKGKLPIKWMAPESINF---- 182

Query: 272 GKYDGYAGDIWSLGVSILE-FYLGRFPFA-------VGR--QGDWASLMFAICFAQPPEA 321
            +    A D+W  GV + E   LG  PF        +GR   G+           + P  
Sbjct: 183 -RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-----------RLP-M 229

Query: 322 PEMASREFRDFISRCLQKDPHSR 344
           P          +++C   DP  R
Sbjct: 230 PPNCPPTLYSLMTKCWAYDPSKR 252

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 70/259 (27%), Positives = 107/259 (41%), Gaps = 61/259 (23%)

Query: 146 REIEILRDV-NHPNVVKCHDM----YDRNGEIEVLLEYMD---------GGSLEGAHIRQ 191
           RE+++LR    H N+   +DM         E+ +  E M+         G  L  AH  Q
Sbjct: 50  RELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHF-Q 108

Query: 192 EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA----QTM 247
             I      Q+L GL Y+H   ++HRD+KP NLL+N+   +KI DFG++R  +    +  
Sbjct: 109 SFIY-----QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA 163

Query: 248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWA 307
                 V T  Y +PE +   L+   Y   A D+WS+G  + E  LGR P   G+  D+ 
Sbjct: 164 GFMTEYVATRWYRAPEIM---LSFQSYTK-AIDVWSVGCILAEL-LGRKPVFKGK--DYV 216

Query: 308 SLMFAI--CFAQPPE--------------------APEM--------ASREFRDFISRCL 337
             +  I      P E                     P+         A+    D + + L
Sbjct: 217 DQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLL 276

Query: 338 QKDPHSRWPAAQLLQHPFI 356
             DP  R    + L+HP++
Sbjct: 277 AFDPTKRISVEEALEHPYL 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 87.3 bits (216), Expect = 2e-19
 Identities = 72/287 (25%), Positives = 132/287 (45%), Gaps = 30/287 (10%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G GS G V       + R++A+KV+  +    +D V   +  +  +    NHP + + +
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRD 218
             +     +  ++E+++GG L   HI++     +      A ++ S L +LH + I++RD
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLM-FHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRD 121

Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV--GTIAYMSPERINTDLNHGKYDG 276
           +K  N+L++   + K+ADFG+ +      +   ++   GT  Y++PE +   L      G
Sbjct: 122 LKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLY-----G 174

Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
            + D W++GV + E   G  PF    + D    +F          P   S++  D +   
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEAENEDD----LFEAILNDEVVYPTWLSQDAVDILKAF 230

Query: 337 LQKDPHSRWPAAQL------LQHPFILRAGQSQVNQNLRQILPPPRP 377
           + K+P  R  +  L      L+HPF       ++N+  RQI PP RP
Sbjct: 231 MTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNR--RQIEPPFRP 275

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 82/289 (28%), Positives = 136/289 (47%), Gaps = 29/289 (10%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSV-RSQI-CREIEILRDV----NHPNVV 160
           IG G+ G V  V    T +V+A+K++  N  + + R++  C   E  RDV    +   + 
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKIL--NKWEMLKRAETACFREE--RDVLVNGDRRWIT 64

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIR-QEHILSDLAR----QVLSGLAYLHKRKIV 215
             H  +     + ++++Y  GG L     + ++ +  D+AR    +++  +  +H+   V
Sbjct: 65  NLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYV 124

Query: 216 HRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPERINT-DLNHGK 273
           HRDIKP N+L++ + ++++ADFG   R+LA      N AVGT  Y+SPE +   +   G+
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGR 184

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD-WASLM-FAICFAQPPEAPEMASREFRD 331
           Y G   D WSLGV + E   G  PF      + +  +M     F  PP+  ++ S E +D
Sbjct: 185 Y-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV-SEEAKD 242

Query: 332 FISR--CLQKDPHSRWPAAQLLQHPFILRAGQSQVN-QNLRQILPPPRP 377
            I R  C  +    R        HPF        ++  N+R    P  P
Sbjct: 243 LIRRLICSPETRLGRNGLQDFKDHPFF-----EGIDWDNIRNSTAPYVP 286

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 88.4 bits (219), Expect = 4e-19
 Identities = 77/269 (28%), Positives = 128/269 (47%), Gaps = 31/269 (11%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIY---GNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           +GSG+ GTV           FA+KV+     +  D  R+Q   E+  L + +  ++VKCH
Sbjct: 40  LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ--AEVCCLLNCDFFSIVKCH 97

Query: 164 DMY----DRNGE----IEVLLEYMDGGSL--------EGAHIRQEHILSDLARQVLSGLA 207
           + +     RN E    I ++L+Y + G L        +     +EH    L  QVL  + 
Sbjct: 98  EDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVH 157

Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM--DPCNSAVGTIAYMSPERI 265
           ++H + ++HRDIK +N+L+ S+  VK+ DFG S++ A T+  D   +  GT  Y++PE I
Sbjct: 158 HVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE-I 216

Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                + K      D++SLGV + E    + PF      +   +M      +    P   
Sbjct: 217 WRRKPYSK----KADMFSLGVLLYELLTLKRPF---DGENMEEVMHKTLAGRYDPLPPSI 269

Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHP 354
           S E ++ ++  L  DP  R  +++LL  P
Sbjct: 270 SPEMQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 86.6 bits (214), Expect = 5e-19
 Identities = 67/249 (26%), Positives = 115/249 (46%), Gaps = 24/249 (9%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSV-----RSQICREIEIL-RDVNHPNVV 160
           IG GS G V           +A+KV+    + ++     ++ I  E  +L +++ HP +V
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVL---QKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIV 215
             H  +    ++  +L+Y++GG L   H+++E    +      A +V S + YLH   I+
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGEL-FFHLQRERCFLEPRARFYAAEVASAIGYLHSLNII 118

Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           +RD+KP N+L++S  +V + DFG+ +   +  +  ++  GT  Y++PE     L    YD
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEV----LRKEPYD 174

Query: 276 GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISR 335
               D W LG  + E   G  PF   R     S M+     +P + P   +    D +  
Sbjct: 175 -RTVDWWCLGAVLYEMLYGLPPF-YSRD---VSQMYDNILHKPLQLPGGKTVAACDLLVG 229

Query: 336 CLQKDPHSR 344
            L KD   R
Sbjct: 230 LLHKDQRRR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 85.5 bits (211), Expect = 8e-19
 Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 8/201 (3%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           +K  ++G GS  TV++       ++ ALKVI    E+       RE  +L+ + H N+V 
Sbjct: 8   EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVL 67

Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHR 217
            HD+      + ++ EY+     +        +  +  +    Q+L GL+Y+H+R I+HR
Sbjct: 68  LHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHR 127

Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           D+KP NLLI+ +  +K+ADFG++R  +      ++ V T+ Y  P+ +   L   +Y   
Sbjct: 128 DLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL---LGSTEYSTC 184

Query: 278 AGDIWSLGVSILEFYLGRFPF 298
             D+W +G   +E   G   F
Sbjct: 185 L-DMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 86.1 bits (213), Expect = 9e-19
 Identities = 73/285 (25%), Positives = 123/285 (43%), Gaps = 44/285 (15%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQIC-REIEILRDVNHPNVVKCHDM 165
           +GSG+ G+V   +   T    A+K +    +  + ++   RE+ +L+ + H NV+   D+
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 166 ------YDRNGEIEVLLEYM--DGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
                  D   +  +++ YM  D   + G  + ++ +   L  Q+L GL Y+H   I+HR
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKV-QYLVYQMLCGLKYIHSAGIIHR 141

Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           D+KP NL +N    +KI DFG++R     M      V T  Y +PE I   LN   Y+  
Sbjct: 142 DLKPGNLAVNEDCELKILDFGLARHADAEM---TGYVVTRWYRAPEVI---LNWMHYNQT 195

Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE----------------A 321
             DIWS+G  + E   G+  F      D  + +  +     PE                 
Sbjct: 196 V-DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSL 254

Query: 322 PEMASREFR-----------DFISRCLQKDPHSRWPAAQLLQHPF 355
           P+   ++F            D + + L+ D   R  A + L+HP+
Sbjct: 255 PKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 84.3 bits (208), Expect = 9e-19
 Identities = 63/252 (25%), Positives = 117/252 (46%), Gaps = 26/252 (10%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           RIG G+ G V+       +   A+K         ++++  +E  IL+  +HPN+V+   +
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 166 YDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDI 219
             +   I +++E + GG        EG  ++ + ++  +     +G+ YL  +  +HRD+
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQ-MVENAAAGMEYLESKHCIHRDL 120

Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG-----TIAYMSPERINTDLNHGKY 274
              N L+     +KI+DFG+SR   +  D   ++ G      + + +PE     LN+G+Y
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEA----LNYGRY 173

Query: 275 DGYAGDIWSLGVSILE-FYLGRFPFA-VGRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
              + D+WS G+ + E F LG  P+A +  Q    ++   +    P   P+   R     
Sbjct: 174 SSES-DVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYR----L 228

Query: 333 ISRCLQKDPHSR 344
           + RC + DP  R
Sbjct: 229 MERCWEYDPGQR 240

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 84.3 bits (208), Expect = 1e-18
 Identities = 67/265 (25%), Positives = 122/265 (46%), Gaps = 21/265 (7%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           I    L+   ++G+G  G VW   +   ++V    +  G+   SV      E  +++ + 
Sbjct: 3   IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SV-EAFLAEANVMKTLQ 59

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYL 209
           H  +VK H +  +   I ++ E+M  GSL      +    +    L D + Q+  G+A++
Sbjct: 60  HDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTD 268
            +R  +HRD++ +N+L+++S   KIADFG++R++          A   I + +PE I   
Sbjct: 119 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI--- 175

Query: 269 LNHGKYDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR 327
            N G +     D+WS G+ ++E    GR P+  G       ++ A+        PE    
Sbjct: 176 -NFGSFT-IKSDVWSFGILLMEIVTYGRIPYP-GMSN--PEVIRALERGYRMPRPENCPE 230

Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQ 352
           E  + + RC +  P  R P  + +Q
Sbjct: 231 ELYNIMMRCWKNRPEER-PTFEYIQ 254

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 59/271 (21%), Positives = 109/271 (40%), Gaps = 30/271 (11%)

Query: 96  INPAELQKGNRIGSGSGGTVW-----RVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI 150
           +   ++     +G GS G V+      VV        A+K +  N     R +   E  +
Sbjct: 3   LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASV 62

Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHILS----------- 196
           +++ N  +VV+   +        V++E M  G L+    +   +                
Sbjct: 63  MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122

Query: 197 DLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT--MDPCNSAV 254
            +A ++  G+AYL  +K VHRD+   N ++     VKI DFG++R + +T         +
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGL 182

Query: 255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF-YLGRFPFAVGRQGDWASLMFAI 313
             + +M+PE     L  G +   + D+WS GV + E   L   P+  G   +   ++  +
Sbjct: 183 LPVRWMAPE----SLKDGVFTTKS-DVWSFGVVLWEMATLAEQPY-QGLSNE--EVLKFV 234

Query: 314 CFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
                 + PE    +  + +  C Q +P  R
Sbjct: 235 IDGGHLDLPENCPDKLLELMRMCWQYNPKMR 265

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 85.4 bits (211), Expect = 2e-18
 Identities = 67/238 (28%), Positives = 112/238 (47%), Gaps = 26/238 (10%)

Query: 73  QNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVH-----PPTS--R 125
           +N   H+++ + +      R   +   +      +G+GS G V    +     PP +  R
Sbjct: 5   KNLQLHKKKDSDS-TKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKR 63

Query: 126 VFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLE 185
               K+I     D V S    E +IL  +NHP  V  +  +     + ++LE++ GG   
Sbjct: 64  FEKSKIIKQKQVDHVFS----ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFF 119

Query: 186 GAHIRQEHILSDL----ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR 241
               R +   +D+    A Q++    YL    IV+RD+KP NLL++    +K+ DFG ++
Sbjct: 120 TFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179

Query: 242 IL-AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF 298
           ++  +T   C    GT  Y++PE I  ++ HGK    A D W+LG+ I E  +G  PF
Sbjct: 180 VVDTRTYTLC----GTPEYIAPE-ILLNVGHGK----AADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 30/205 (14%)

Query: 107 IGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK- 161
           +G G+ G+V    + P    T  V A+K +  +  + +R    REIEIL+ + H N+VK 
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD-FEREIEILKSLQHDNIVKY 70

Query: 162 ---CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRK 213
              C+    RN  + +++EY+  GSL     +    L        A Q+  G+ YL  ++
Sbjct: 71  KGVCYSAGRRN--LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD------PCNSAVGTIAYMSPERINT 267
            VHRD+   N+L+ S   VKI DFG++++L Q  +      P  S    I + +PE    
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP---IFWYAPE---- 181

Query: 268 DLNHGKYDGYAGDIWSLGVSILEFY 292
            L   K+   A D+WS GV + E +
Sbjct: 182 SLTESKFS-VASDVWSFGVVLYELF 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 83.8 bits (207), Expect = 2e-18
 Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 16/195 (8%)

Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IG+G  G V   R+  P    +  A+K +   + +  R     E  I+   +HPN++   
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 164 DMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHI--LSDLARQVLSGLAYLHKRKIVHRD 218
            +  ++  + ++ EYM+ GSL+     H  Q  +  L  + R + SG+ YL     VHRD
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 131

Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG---TIAYMSPERINTDLNHGKYD 275
           +   N+L+NS+   K++DFG+SR+L    +   +  G    I + +PE I     + K+ 
Sbjct: 132 LAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI----AYRKFT 187

Query: 276 GYAGDIWSLGVSILE 290
             A D+WS G+ + E
Sbjct: 188 S-ASDVWSYGIVMWE 201

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 83.4 bits (206), Expect = 3e-18
 Identities = 58/198 (29%), Positives = 102/198 (51%), Gaps = 20/198 (10%)

Query: 107 IGSGSGGTVW--RVVHPPTSRVF-ALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IG+G  G V   R+  P    +F A+K +   + +  R     E  I+   +HPN++   
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH------ILSDLARQVLSGLAYLHKRKIVHR 217
            +  ++  + ++ E+M+ G+L+ + +RQ         L  + R + +G+ YL +   VHR
Sbjct: 72  GVVTKSRPVMIITEFMENGALD-SFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHR 130

Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQ-TMDPC-NSAVG---TIAYMSPERINTDLNHG 272
           D+   N+L+NS+   K++DFG+SR L   T DP   S++G    I + +PE I     + 
Sbjct: 131 DLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI----AYR 186

Query: 273 KYDGYAGDIWSLGVSILE 290
           K+   A D+WS G+ + E
Sbjct: 187 KFTS-ASDVWSYGIVMWE 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 83.5 bits (206), Expect = 3e-18
 Identities = 68/232 (29%), Positives = 108/232 (46%), Gaps = 29/232 (12%)

Query: 142 SQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHI--------RQEH 193
           S    E +IL  VN   VV     Y+    + ++L  M+GG L+  HI         +E 
Sbjct: 45  SMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLK-FHIYNMGNPGFEEER 103

Query: 194 ILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA 253
            L   A ++L GL  LH+   V+RD+KP N+L++   +++I+D G++  + +  +     
Sbjct: 104 ALF-YAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRGR 161

Query: 254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI 313
           VGT+ YM+PE +N      +Y   + D W LG  I E   G+ PF    +G    +    
Sbjct: 162 VGTVGYMAPEVLNNQ----RY-TLSPDYWGLGCLIYEMIEGQSPF----RGRKEKVKREE 212

Query: 314 CFAQPPEAPEMASREF-RDFISRC---LQKDPHSRW-----PAAQLLQHPFI 356
              +  E  E+ S +F  +  S C   L KDP  R       A ++ +HPF 
Sbjct: 213 VDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 83.5 bits (206), Expect = 5e-18
 Identities = 76/285 (26%), Positives = 125/285 (43%), Gaps = 28/285 (9%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN------HEDSVRSQICREIEILRDVNHPNVV 160
           IG GS G V    H    + +A+KV+          E  + S+  R + +L++V HP +V
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSE--RNV-LLKNVKHPFLV 59

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVH 216
             H  +    ++  +L+Y++GG L     R+   L   AR    ++ S L YLH   IV+
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVY 119

Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KP N+L++S  ++ + DFG+ +   +     ++  GT  Y++PE     L+   YD 
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV----LHKQPYDR 175

Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
              D W LG  + E   G  PF      +    M+     +P +     +   R  +   
Sbjct: 176 TV-DWWCLGAVLYEMLYGLPPFYSRNTAE----MYDNILNKPLQLKPNITNSARHLLEGL 230

Query: 337 LQKDPHSRWPAA----QLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           LQKD   R  A     ++  H F        +    ++I PP  P
Sbjct: 231 LQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLIN--KKITPPFNP 273

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 83.4 bits (206), Expect = 6e-18
 Identities = 73/291 (25%), Positives = 125/291 (42%), Gaps = 37/291 (12%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G GS G V       T  V+A+KV+  +    +D V   +  +  +     HP +   H
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 164 DMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDI 219
             +     +  ++EY++GG L    + +    E      A +V   L +LH+  +++RD+
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122

Query: 220 KPSNLLINSSKNVKIADFGVSR------ILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           K  N+L+++  + K+ADFG+ +      +   T   C    GT  Y++PE     L   +
Sbjct: 123 KLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF--C----GTPDYIAPEI----LQELE 172

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
           Y G + D W+LGV + E   G+ PF    + D    +F          P   S+E    +
Sbjct: 173 Y-GPSVDWWALGVLMYEMMAGQPPFEADNEDD----LFESILHDDVLYPVWLSKEAVSIL 227

Query: 334 SRCLQKDPHSRWPAA-------QLLQHPFILRAGQSQVNQNLRQILPPPRP 377
              + K+P+ R            + QHPF        + Q  R+I PP +P
Sbjct: 228 KAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQ--RKIKPPFKP 276

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 83.3 bits (206), Expect = 6e-18
 Identities = 73/287 (25%), Positives = 127/287 (44%), Gaps = 31/287 (10%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPN-VVKC 162
           +G GS G V       T  ++A+K++  +    +D V   +  E  +L     P  + + 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMV-EKRVLALPGKPPFLTQL 66

Query: 163 HDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKRKIVHR 217
           H  +     +  ++EY++GG L   HI+Q     E      A ++  GL +LH + I++R
Sbjct: 67  HSCFQTMDRLYFVMEYVNGGDLM-YHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYR 125

Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           D+K  N+++++  ++KIADFG+ +          +  GT  Y++PE I        Y  Y
Sbjct: 126 DLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-------AYQPY 178

Query: 278 --AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISR 335
             + D W+ GV + E   G+ PF     G+    +F          P+  S+E       
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPF----DGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG 234

Query: 336 CLQKDPHSRW---PAAQ--LLQHPFILRAGQSQVNQNLRQILPPPRP 377
            L K P  R    P  +  + +H F  R    ++ +  R+I PP +P
Sbjct: 235 LLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLER--REIQPPFKP 279

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 82.5 bits (204), Expect = 6e-18
 Identities = 70/251 (27%), Positives = 97/251 (38%), Gaps = 55/251 (21%)

Query: 128 ALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL--- 184
           A+K +     +  R    RE E+L +  H N+VK + +        ++ EYM+ G L   
Sbjct: 39  AVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKF 98

Query: 185 ---EGAHIR---------QEHILSDL---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSS 229
               G              E  LS L   A Q+ SG+ YL  +  VHRD+   N L+   
Sbjct: 99  LRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD 158

Query: 230 KNVKIADFGVSR---------ILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA-- 278
             VKI DFG+SR         +   TM P       I +M PE I        Y  +   
Sbjct: 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLP-------IRWMPPESI-------MYRKFTTE 204

Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLM---FAICFAQPP--EAPEMASREFRDFI 333
            D+WS GV + E       F  G+Q  W  L       C  Q    + P     E  D +
Sbjct: 205 SDVWSFGVVLWEI------FTYGKQ-PWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIM 257

Query: 334 SRCLQKDPHSR 344
             C ++DP  R
Sbjct: 258 LGCWKRDPQQR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 83.2 bits (205), Expect = 9e-18
 Identities = 70/231 (30%), Positives = 112/231 (48%), Gaps = 26/231 (11%)

Query: 78  HQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE 137
           ++Q+ N+T      R+Q + P        +GSG+ G+V         +  A+K +    +
Sbjct: 2   YRQELNKTVWEVPERYQNLTP--------VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ 53

Query: 138 DSVRSQ-ICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGA---HIRQEH 193
             + ++   RE+ +L+ + H NV+   D++     IE   E     +L GA   +I +  
Sbjct: 54  SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ 113

Query: 194 ILSD-----LARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD 248
            LSD     L  Q+L GL Y+H   I+HRD+KPSN+ +N    ++I DFG++R   Q  D
Sbjct: 114 KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADD 170

Query: 249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR--FP 297
                V T  Y +PE +   LN   Y+    DIWS+G  + E   G+  FP
Sbjct: 171 EMTGYVATRWYRAPEIM---LNWMHYNQTV-DIWSVGCIMAELLKGKALFP 217

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 81.8 bits (202), Expect = 9e-18
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 29/217 (13%)

Query: 96  INPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNHEDSV-RSQICREIEI 150
           I+P +L     +G+G  G V    WR  +       A+K+I    E S+   +   E ++
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYD-----VAIKMI---KEGSMSEDEFIEEAKV 52

Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSG 205
           +  ++H  +V+ + +  +   I ++ EYM  G L     E     Q   L ++ + V  G
Sbjct: 53  MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEG 112

Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSP 262
           +AYL  ++ +HRD+   N L++    VK++DFG+SR +    D   S+VG+   + +  P
Sbjct: 113 MAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPP 170

Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E     L + K+   + D+W+ GV + E Y LG+ P+
Sbjct: 171 EV----LLYSKFSSKS-DVWAFGVLMWEVYSLGKMPY 202

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 72/260 (27%), Positives = 124/260 (47%), Gaps = 31/260 (11%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T+RV A+K +             +E ++++ + H  +V+ + +
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I ++ EYM  GSL        G ++R    L D+A Q+ SG+AY+ +   VHRD
Sbjct: 70  VSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ-LVDMAAQIASGMAYVERMNYVHRD 127

Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQT-MDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L+  +   K+ADFG++R++          A   I + +PE       +G++   
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA----LYGRFT-I 182

Query: 278 AGDIWSLGVSILEFYL-GRFPFA--VGRQG-DWASLMFAI-CFAQPPEAPEMASREFRDF 332
             D+WS G+ + E    GR P+   V R+  D     + + C   PPE PE       D 
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPE----SLHDL 235

Query: 333 ISRCLQKDPHSRWPAAQLLQ 352
           + +C +K+P  R P  + LQ
Sbjct: 236 MCQCWRKEPEER-PTFEYLQ 254

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 81.8 bits (202), Expect = 1e-17
 Identities = 76/300 (25%), Positives = 123/300 (41%), Gaps = 56/300 (18%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALK-VIYGNHEDSVRSQICREIEILRDVNH-PNV 159
           +K  +IG G+ G V++     T ++ ALK       E+ +     REI +L+ ++    +
Sbjct: 4   EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63

Query: 160 VKCHDMY---DRNGEIEVLL----------EYMDGGSLEGAHIRQEHILSDLARQVLSGL 206
           V+  D+    ++NG+  + L          ++MD              +     Q+L G+
Sbjct: 64  VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123

Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERI 265
           A+ HK  ++HRD+KP NLL++  K + KIAD G+ R  +  +      + T+ Y +PE +
Sbjct: 124 AHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVL 183

Query: 266 NTDLNHGKYDGYAGDIWSLGV---------------SILEFYLGRFPF----------AV 300
              L    Y     DIWS+G                S L+  L  F             V
Sbjct: 184 ---LGSTHYST-PVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239

Query: 301 GRQGDWASLMFAICFAQ-PPE----APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
            +  DW        F Q  P+    A    S E  D + + L+ DP  R  A   L HP+
Sbjct: 240 SKLRDWHE------FPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 69/244 (28%), Positives = 110/244 (45%), Gaps = 28/244 (11%)

Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHI---------RQEHILSD 197
           E  IL  VN   VV     Y+    + ++L  M+GG L+  HI          Q  I   
Sbjct: 50  EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLK-FHIYNMGNPGFDEQRAIF-- 106

Query: 198 LARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI 257
            A ++  GL  L + +IV+RD+KP N+L++   +++I+D G++  + +  +     VGT+
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVRGRVGTV 165

Query: 258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG-DWASLMFAICFA 316
            YM+PE IN +    KY  ++ D W LG  I E   G+ PF   ++      +   +   
Sbjct: 166 GYMAPEVINNE----KY-TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED 220

Query: 317 QPPEAPEMASREFRDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQI 371
           Q  E  E  S + +      L K+P  R       AA + QHP        ++  N   +
Sbjct: 221 Q-EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEAN---M 276

Query: 372 LPPP 375
           L PP
Sbjct: 277 LEPP 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 85/291 (29%), Positives = 133/291 (45%), Gaps = 52/291 (17%)

Query: 107 IGSGSGGTVWRVVHPPTS-RVFALK-VIYGNHEDSVRSQICREIEILRDVN---HPNVVK 161
           IG G+ G V++        R  ALK V     E+ +     RE+ +LR +    HPNVV+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 162 CHDM-----YDRNGEIEVLLEYMDGG---SLEGA---HIRQEHILSDLARQVLSGLAYLH 210
             D+      DR  ++ ++ E++D      L+      +  E I  D+  Q+L GL +LH
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI-KDMMFQLLRGLDFLH 127

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
             ++VHRD+KP N+L+ SS  +K+ADFG++RI +  M    S V T+ Y +PE +     
Sbjct: 128 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVVTLWYRAPEVL----- 181

Query: 271 HGKYDGYAG--DIWSLGVSILEFY--------------LGRFPFAVG--RQGDWASLM-- 310
                 YA   D+WS+G    E +              LG+    +G   + DW   +  
Sbjct: 182 --LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239

Query: 311 ----FAICFAQPPE--APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
               F    AQP E    ++     +D + +CL  +P  R  A   L HP+
Sbjct: 240 PRQAFHSKSAQPIEKFVTDIDELG-KDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 81.8 bits (202), Expect = 3e-17
 Identities = 66/235 (28%), Positives = 102/235 (43%), Gaps = 44/235 (18%)

Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIE--VLLEY---------MDGGSLEGAHIRQEHIL 195
           E  +L++VNHP+V++  D     G I   VL  Y              L    I Q  I+
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVS-GAITCMVLPHYSSDLYTYLTKRSRPLP---IDQALII 162

Query: 196 SDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV- 254
               +Q+L GL YLH ++I+HRD+K  N+ IN    V I D G ++     + P    + 
Sbjct: 163 E---KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLA 217

Query: 255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI- 313
           GT+   +PE +  D    KY+  A DIWS G+ + E     +P  +          +   
Sbjct: 218 GTVETNAPEVLARD----KYNSKA-DIWSAGIVLFEML--AYPSTIFEDPPSTPEEYVKS 270

Query: 314 CFAQ-----------PPEAP-EMASREFRDFI--SRCLQKDPHSRWPAAQLLQHP 354
           C +            P E P +  SR  R FI  +   ++ P++R+P  Q +  P
Sbjct: 271 CHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQ-PYTRYPCFQRVNLP 324

Length = 357

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 82.5 bits (204), Expect = 5e-17
 Identities = 73/285 (25%), Positives = 122/285 (42%), Gaps = 51/285 (17%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHPNVVKCHD 164
           IG G  G V+    P  SR  ALK I  +  ++  ++ +  RE +I  D+ HP +V  + 
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69

Query: 165 MYDRNGEIEVLLEYMDGGSLEG--AHIRQEHILS-DLARQ------------VLSGLAYL 209
           +      +   + Y++G +L+     + Q+  LS +LA +            + + + Y+
Sbjct: 70  ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV 129

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFG------------------VSRILAQTMDPCN 251
           H + ++HRD+KP N+L+     V I D+G                     I   +M    
Sbjct: 130 HSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPG 189

Query: 252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMF 311
             VGT  YM+PER+      G     + DI++LGV + +     FP+   R+     + +
Sbjct: 190 KIVGTPDYMAPERL-----LGVPASESTDIYALGVILYQMLTLSFPY---RRKKGRKISY 241

Query: 312 AICFAQPPE-APEMASREFRDFIS----RCLQKDPHSRWPAAQLL 351
                 P E AP    RE   F+S    + L  DP  R+ + Q L
Sbjct: 242 RDVILSPIEVAPY---REIPPFLSQIAMKALAVDPAERYSSVQEL 283

Length = 932

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 80.9 bits (200), Expect = 7e-17
 Identities = 80/330 (24%), Positives = 133/330 (40%), Gaps = 81/330 (24%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKV------IYGNHEDSVRSQICREIEILRDVNHPNVV 160
           IG G+ G V  V    T  ++A+K       +       VR+    E +IL + ++P VV
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRA----ERDILAEADNPWVV 64

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVH 216
           K +  +     + +++EY+ GG +    ++++    +  R    + +  +  +HK   +H
Sbjct: 65  KLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIH 124

Query: 217 RDIKPSNLLINSSKNVKIADFGVS------------RILAQTMDPCN------------- 251
           RDIKP NLL+++  ++K++DFG+             RIL+  +                 
Sbjct: 125 RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184

Query: 252 -------------SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF 298
                        S VGT  Y++PE     L  G Y     D WSLGV + E  +G  PF
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVF---LQTG-Y-NKECDWWSLGVIMYEMLVGYPPF 239

Query: 299 AVGRQGD-------W-ASLMFAICFAQPPEAPEMASREFRDFISR--CLQKDPHSRWPAA 348
                 +       W  +L F      P E P   S E +D I R  C  +         
Sbjct: 240 CSDNPQETYRKIINWKETLQF------PDEVP--LSPEAKDLIKRLCCEAERRLGNNGVN 291

Query: 349 QLLQHPFILRAGQSQVN-QNLRQILPPPRP 377
           ++  HPF        V+ +++R+   P  P
Sbjct: 292 EIKSHPFF-----KGVDWEHIRERPAPIIP 316

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 80.4 bits (198), Expect = 7e-17
 Identities = 76/282 (26%), Positives = 125/282 (44%), Gaps = 27/282 (9%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKV----IYGNHEDSVRSQICREIEILRDVNHPNVVKC 162
           IG GS G V         + +A+KV    I  N ++       R + +L++V HP +V  
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVGL 61

Query: 163 HDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHR 217
           H  +    ++  +L++++GG L   H+++E    +      A ++ S L YLH   IV+R
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGEL-FFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           D+KP N+L++S  +V + DFG+ +      D   +  GT  Y++PE I        YD  
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ----PYDNT 176

Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL 337
             D W LG  + E   G  PF      +    M+     +P      AS      +   L
Sbjct: 177 V-DWWCLGAVLYEMLYGLPPFYCRDVAE----MYDNILHKPLVLRPGASLTAWSILEELL 231

Query: 338 QKDPHSRWPAA----QLLQHPFILRAGQSQVNQNLRQILPPP 375
           +KD   R  A     ++ +HPF      + + Q   + +PPP
Sbjct: 232 EKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQ---KKIPPP 270

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 79.6 bits (196), Expect = 8e-17
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 21/211 (9%)

Query: 175 LLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRDIKPSNLLINSS 229
           +L+ M+GG L   H+ Q  + S+      A +++ GL ++H R +V+RD+KP+N+L++  
Sbjct: 75  ILDLMNGGDLH-YHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH 133

Query: 230 KNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSIL 289
            +V+I+D G++   ++     +++VGT  YM+PE +   +    YD  A D +SLG  + 
Sbjct: 134 GHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGV---AYDSSA-DWFSLGCMLF 187

Query: 290 EFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR----- 344
           +   G  PF   +  D   +          E P+  S E R  +   LQ+D + R     
Sbjct: 188 KLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLG 246

Query: 345 WPAAQLLQHPFILRAGQSQVNQNLRQILPPP 375
             A ++ +HPF        V     Q  PPP
Sbjct: 247 RGAQEVKEHPFFRSLDWQMVFL---QKYPPP 274

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 80.5 bits (198), Expect = 8e-17
 Identities = 80/303 (26%), Positives = 128/303 (42%), Gaps = 56/303 (18%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPN 158
           Q+   IGSG+ G V            A+K +   + N   + R+   RE+ +L+ VNH N
Sbjct: 24  QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY--RELVLLKCVNHKN 81

Query: 159 VVKCHDMYDRNGEIE------VLLEYMDGGSLEGAHIRQEH-ILSDLARQVLSGLAYLHK 211
           ++   +++     +E      +++E MD    +  H+  +H  +S L  Q+L G+ +LH 
Sbjct: 82  IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS 141

Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
             I+HRD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  
Sbjct: 142 AGIIHRDLKPSNIVVKSDCTLKILDFGLART-ACTNFMMTPYVVTRYYRAPEVI---LGM 197

Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD-W---------------ASLMFAI-- 313
           G  +    DIWS+G  + E   G   F      D W                 L   +  
Sbjct: 198 GYKENV--DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN 255

Query: 314 --------------------CFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
                                F    E  ++ + + RD +S+ L  DP  R    + L+H
Sbjct: 256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315

Query: 354 PFI 356
           P+I
Sbjct: 316 PYI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 65/274 (23%), Positives = 113/274 (41%), Gaps = 62/274 (22%)

Query: 124 SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGS 183
             + A+KV+  +  D+ R    +E++IL  ++ PN+ +   +   +  + +++EYM+ G 
Sbjct: 46  PVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105

Query: 184 LEGAHIRQEHILSD-----------------LARQVLSGLAYLHKRKIVHRDIKPSNLLI 226
           L      Q+H+                    +A Q+ SG+ YL     VHRD+   N L+
Sbjct: 106 L--NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163

Query: 227 NSSKNVKIADFGVSRILAQTMDPCN---SAVGTIAYMSPERINTDLNHGKYDGYAGDIWS 283
             +  +KIADFG+SR L  + D       A   I +M+ E +      GK+     D+W+
Sbjct: 164 GKNYTIKIADFGMSRNLYSS-DYYRVQGRAPLPIRWMAWESVLL----GKFTT-KSDVWA 217

Query: 284 LGVSILEFY-------------------LGRFPFAVGRQGDWASLMFAICFAQPPEAPEM 324
            GV++ E                      G F    GRQ         I   +PP  P  
Sbjct: 218 FGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQ---------IYLPRPPNCP-- 266

Query: 325 ASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR 358
             ++  + +  C ++D   R    ++  H F+ R
Sbjct: 267 --KDIYELMLECWRRDEEDRPTFREI--HLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 63/253 (24%), Positives = 119/253 (47%), Gaps = 28/253 (11%)

Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     ++ E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 69  GVCTREPPFYIITEFMTYGNLL-DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127

Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE----SLAYNK 181

Query: 274 YDGYAGDIWSLGVSILEF-YLGRFPF-AVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
           +   + D+W+ GV + E    G  P+  +     +  L       +P   P     +  +
Sbjct: 182 FSIKS-DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPP----KVYE 236

Query: 332 FISRCLQKDPHSR 344
            +  C Q +P  R
Sbjct: 237 LMRACWQWNPSDR 249

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 77/309 (24%), Positives = 122/309 (39%), Gaps = 74/309 (23%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALK------VIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           IG G+ G V  V    T+ ++A+K      V+  N    V++    E +IL + ++  VV
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKA----ERDILAEADNEWVV 64

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLA----YLHKRKIVH 216
           K +  +     +  +++Y+ GG +    IR      DLAR  ++ L      +HK   +H
Sbjct: 65  KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIH 124

Query: 217 RDIKPSNLLINSSKNVKIADFGV----------------SRILAQTMDPCN--------- 251
           RDIKP N+LI+   ++K+ DFG+                      +M+P           
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCR 184

Query: 252 ------------------SAVGTIAYMSPERINTDLNHGKYDGYAG--DIWSLGVSILEF 291
                             S VGT  Y++PE +          GY    D WS+GV + E 
Sbjct: 185 LKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-------TGYTQLCDWWSVGVILYEM 237

Query: 292 YLGRFPFAVGRQGD--WASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRW---P 346
            +G+ PF      +     + +      P +A    SRE  D I R L      R     
Sbjct: 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAK--LSREASDLILR-LCCGAEDRLGKNG 294

Query: 347 AAQLLQHPF 355
           A ++  HPF
Sbjct: 295 ADEIKAHPF 303

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 81/315 (25%), Positives = 133/315 (42%), Gaps = 68/315 (21%)

Query: 92  RHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREI 148
           R+Q + P        IGSG+ G V         R  A+K +   + N   + R+   RE+
Sbjct: 25  RYQNLKP--------IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--REL 74

Query: 149 EILRDVNHPNVVKCHDMYDRNGEIE------VLLEYMDGGSLEGAHIRQEH-ILSDLARQ 201
            +++ VNH N++   +++     +E      +++E MD    +   +  +H  +S L  Q
Sbjct: 75  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ 134

Query: 202 VLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT--MDPCNSAVGTIAY 259
           +L G+ +LH   I+HRD+KPSN+++ S   +KI DFG++R    +  M P    V T  Y
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYY 191

Query: 260 MSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFA-------------------- 299
            +PE I   L  G  +    DIWS+G  + E   G   F                     
Sbjct: 192 RAPEVI---LGMGYKENV--DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246

Query: 300 -------------VGRQGDWASLMFA-----ICFAQPPEAPEMASREFRDFISRCLQKDP 341
                        V  +  +A   F      + F    E  ++ + + RD +S+ L  D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306

Query: 342 HSRWPAAQLLQHPFI 356
             R    + LQHP+I
Sbjct: 307 SKRISVDEALQHPYI 321

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 79.4 bits (195), Expect = 2e-16
 Identities = 79/298 (26%), Positives = 128/298 (42%), Gaps = 56/298 (18%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIISLL 82

Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEH-ILSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 83  NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 142

Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 143 RDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 198

Query: 277 YAGDIWSLGVSILEFYLGRFPFA---------------------------------VGRQ 303
              DIWS+G  + E    +  F                                  V  +
Sbjct: 199 V--DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256

Query: 304 GDWASLMFAICFAQP-----PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A L F   F         E  ++ + + RD +S+ L  DP  R    + LQHP+I
Sbjct: 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 72/285 (25%), Positives = 129/285 (45%), Gaps = 27/285 (9%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVR-SQICREIEILRDVNHPNVVKC 162
           +G GS G V       T  ++A+K++  +    +D V  + + + +  L+D   P + + 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD-KPPFLTQL 66

Query: 163 HDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHR 217
           H  +     +  ++EY++GG L   HI+Q     +      A ++  GL +LH+R I++R
Sbjct: 67  HSCFQTVDRLYFVMEYVNGGDLM-YHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYR 125

Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           D+K  N++++S  ++KIADFG+ +          +  GT  Y++PE I     +  Y G 
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII----AYQPY-GK 180

Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL 337
           + D W+ GV + E   G+ PF     G+    +F          P+  S+E        +
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPF----DGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLM 236

Query: 338 QKDPHSRWPAAQ-----LLQHPFILRAGQSQVNQNLRQILPPPRP 377
            K P  R          + +H F  R    ++    R+I PP +P
Sbjct: 237 TKHPSKRLGCGPEGERDIREHAFFRRIDWDKLEN--REIQPPFKP 279

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 48/221 (21%)

Query: 107 IGSGSGGTVWR--VVHP----PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           +G G+ G V++  +  P      + V A+K +  N E  V+ +  +E E++ D+ HPN+V
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSV-AIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLE------------GAHIRQEHILSDL--------AR 200
               +  +     +L EY+  G L             GA    E + S L        A 
Sbjct: 72  CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR---------ILAQTMDPCN 251
           Q+ +G+ YL     VHRD+   N L+     VKI+DFG+SR         + ++++ P  
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP-- 189

Query: 252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY 292
                + +M PE I     +GK+   + DIWS GV + E +
Sbjct: 190 -----VRWMPPEAI----LYGKFTTES-DIWSFGVVLWEIF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 77.7 bits (191), Expect = 3e-16
 Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 16/160 (10%)

Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGA--HIRQEHILSDLAR---- 200
           E EIL  VN P +V     ++    + +++  M+GG L+    ++ +  +  ++ R    
Sbjct: 43  EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL--EMERVIHY 100

Query: 201 --QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIA 258
             Q+  G+ +LH   IV+RD+KP N+L++   N +++D G++ +  +         GT  
Sbjct: 101 SAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTITQRAGTNG 159

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF 298
           YM+PE     L    Y  Y  D +++G SI E   GR PF
Sbjct: 160 YMAPEI----LKEEPYS-YPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 77.7 bits (191), Expect = 3e-16
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 33/212 (15%)

Query: 101 LQKGNRIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNH 156
           L++   +G G  G V    + P    T    A+K +      +  + + +EIEILR++ H
Sbjct: 6   LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 65

Query: 157 PNVVK----CHDMYDRNGEIEVLLEYMDGGSLE------GAHIRQEHILSDLARQVLSGL 206
            N+VK    C +       I++++E++  GSL+         I  +  L   A Q+  G+
Sbjct: 66  ENIVKYKGICTEDGGNG--IKLIMEFLPSGSLKEYLPRNKNKINLKQQLK-YAVQICKGM 122

Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ------TMDPCNSAVGTIAYM 260
            YL  R+ VHRD+   N+L+ S   VKI DFG+++ +          D  +S V    + 
Sbjct: 123 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV---FWY 179

Query: 261 SPERINTDLNHGKYDGY-AGDIWSLGVSILEF 291
           +PE     L   K+  Y A D+WS GV++ E 
Sbjct: 180 APEC----LIQSKF--YIASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 77.8 bits (191), Expect = 4e-16
 Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 17/209 (8%)

Query: 94  QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIE 149
           +++   EL++   +GSG+ GTV++ +  P         A+K++          +   E  
Sbjct: 2   RILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 61

Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHILSDL----ARQVLS 204
           I+  ++HP++V+   +   +  I+++ + M  G L +  H  +++I S L      Q+  
Sbjct: 62  IMASMDHPHLVRLLGVC-LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120

Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL +R++VHRD+   N+L+ S  +VKI DFG++R+L       N+  G   I +M+ 
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180

Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           E I     H +   +  D+WS GV+I E 
Sbjct: 181 ECI-----HYRKFTHQSDVWSYGVTIWEL 204

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 69/281 (24%), Positives = 120/281 (42%), Gaps = 46/281 (16%)

Query: 101 LQKGNRIGSGSGGTV-----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           L  G  +G G  G V     +R+         A+K++  N   S    +  E  +L+ VN
Sbjct: 2   LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN 61

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLAR---------- 200
           HP+V+K +    ++G + +++EY   GSL     E   +   ++ SD  R          
Sbjct: 62  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121

Query: 201 -------------QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM 247
                        Q+  G+ YL + K+VHRD+   N+L+   + +KI+DFG+SR + +  
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181

Query: 248 DPCNSAVGTI--AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF-AVGRQ 303
                + G I   +M+ E +   +   +      D+WS GV + E   LG  P+  +  +
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQ-----SDVWSFGVLLWEIVTLGGNPYPGIAPE 236

Query: 304 GDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
             +  L          E PE  S E  + +  C +++P  R
Sbjct: 237 RLFNLLKTGYRM----ERPENCSEEMYNLMLTCWKQEPDKR 273

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 77.8 bits (191), Expect = 4e-16
 Identities = 66/227 (29%), Positives = 106/227 (46%), Gaps = 33/227 (14%)

Query: 103 KGNRIGSGSGGTVWRVVHP--PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           +G ++G G+ G V++         R +ALK I G     +    CREI +LR++ HPNV+
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT---GISMSACREIALLRELKHPNVI 61

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEH---------------ILSDLARQVLSG 205
               ++  + + +V L + D    +  HI + H               ++  L  Q+L G
Sbjct: 62  SLQKVFLSHADRKVWLLF-DYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120

Query: 206 LAYLHKRKIVHRDIKPSNLLINSS----KNVKIADFGVSRILAQTMDP---CNSAVGTIA 258
           + YLH   ++HRD+KP+N+L+         VKIAD G +R+    + P    +  V T  
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD 305
           Y +PE +    ++ K    A DIW++G    E  L   P    RQ D
Sbjct: 181 YRAPELLLGARHYTK----AIDIWAIGCIFAEL-LTSEPIFHCRQED 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 77.0 bits (189), Expect = 6e-16
 Identities = 77/288 (26%), Positives = 125/288 (43%), Gaps = 54/288 (18%)

Query: 89  HQNRHQLINPAELQKGNRIGSGSGGTVWRV----VHPPTSRVFALKVIYGNHEDSVRSQI 144
           H  RH ++   EL      G G+ G V+      + P   ++        +  D+ R   
Sbjct: 1   HIKRHNIVLKREL------GEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDF 54

Query: 145 CREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL---------------EG--- 186
            RE E+L ++ H ++VK + +      + ++ EYM  G L               EG   
Sbjct: 55  HREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRP 114

Query: 187 AHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS------ 240
           A + Q  +L  +A+Q+ +G+ YL  +  VHRD+   N L+  +  VKI DFG+S      
Sbjct: 115 AELTQSQMLH-IAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST 173

Query: 241 ---RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRF 296
              R+   TM P       I +M PE I     + K+   + D+WSLGV + E F  G+ 
Sbjct: 174 DYYRVGGHTMLP-------IRWMPPESI----MYRKFTTES-DVWSLGVVLWEIFTYGKQ 221

Query: 297 PFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
           P+    Q     ++  I   +  + P    +E  D +  C Q++PH R
Sbjct: 222 PW---YQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMR 266

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 77.8 bits (192), Expect = 6e-16
 Identities = 86/323 (26%), Positives = 138/323 (42%), Gaps = 68/323 (21%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V       T +  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHKNIIGLL 81

Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEH-ILSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 82  NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIH 141

Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQT--MDPCNSAVGTIAYMSPERINTDLNHGKY 274
           RD+KPSN+++ S   +KI DFG++R    +  M P    V T  Y +PE I   L  G  
Sbjct: 142 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRAPEVI---LGMGYK 195

Query: 275 DGYAGDIWSLGVSILEFYLGRFPFA---------------------------------VG 301
           +    DIWS+G  + E   G   F                                  V 
Sbjct: 196 ENV--DIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVE 253

Query: 302 RQGDWASLMFAICFAQ---PPEAPE---MASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
            +  +A   F   F     PP++     + + + RD +S+ L  DP  R      LQHP+
Sbjct: 254 NRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313

Query: 356 I-LRAGQSQVNQNLRQILPPPRP 377
           I +    S+V        PPP P
Sbjct: 314 INVWYDPSEVEA------PPPAP 330

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 77.5 bits (191), Expect = 7e-16
 Identities = 87/294 (29%), Positives = 124/294 (42%), Gaps = 54/294 (18%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKC- 162
           IG GS G V   +   T    A+K I   + +  D+ R  I REI++LR + HP++V+  
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR--ILREIKLLRLLRHPDIVEIK 65

Query: 163 HDMY--DRN--GEIEVLLEYM--DGGSLEGAH--IRQEHILSDLARQVLSGLAYLHKRKI 214
           H M    R    +I V+ E M  D   +  A+  +  EH    L  Q+L  L Y+H   +
Sbjct: 66  HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLY-QLLRALKYIHTANV 124

Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRIL---AQTMDPCNSAVGTIAYMSPERINTDLNH 271
            HRD+KP N+L N+   +KI DFG++R+      T       V T  Y +PE   +    
Sbjct: 125 FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF-- 182

Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FPFA-VGRQGDWASLMFAICFAQPPEA------- 321
            KY   A DIWS+G    E   G+  FP   V  Q D   L+  +     PE        
Sbjct: 183 SKYTP-AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD---LITDLLGTPSPETISRVRNE 238

Query: 322 -------------PEMASREFR-------DFISRCLQKDPHSRWPAAQLLQHPF 355
                        P   S++F          + R L  DP  R  A + L  P+
Sbjct: 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 76.5 bits (188), Expect = 7e-16
 Identities = 63/258 (24%), Positives = 122/258 (47%), Gaps = 38/258 (14%)

Query: 107 IGSGSGGTVWRVVHP--PTSRVFALKVIYGNHED-SVRSQICREIEILRDVNHPNVVK-- 161
           +GSG+ GTV + ++    + +  A+K++  ++ D +++ ++ RE  +++ +++P +V+  
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 162 --CHDMYDRNGEIEVLLEYMDGGSL--------EGAHIRQEHILSDLARQVLSGLAYLHK 211
             C        E E  +  M+   L        +  H+  E  +++L  QV  G+ YL +
Sbjct: 63  GIC--------EAESWMLVMELAELGPLNKFLQKNKHVT-EKNITELVHQVSMGMKYLEE 113

Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT----IAYMSPERINT 267
              VHRD+   N+L+ +    KI+DFG+S+ L    +    A       + + +PE    
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD-ENYYKAKTHGKWPVKWYAPEC--- 169

Query: 268 DLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS 326
            +N+ K+   + D+WS GV + E F  G+ P+  G +G+  + M  I   +  E P+   
Sbjct: 170 -MNYYKFSSKS-DVWSFGVLMWEAFSYGQKPYK-GMKGNEVTQM--IESGERMECPQRCP 224

Query: 327 REFRDFISRCLQKDPHSR 344
            E  D +  C       R
Sbjct: 225 PEMYDLMKLCWTYGVDER 242

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 78.2 bits (192), Expect = 7e-16
 Identities = 85/343 (24%), Positives = 145/343 (42%), Gaps = 68/343 (19%)

Query: 61  NSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQK-GNRIGSGSGGTVWRVV 119
           N      +  SH N+    + + +  +N  NR    +P +  K GN IG+GS G V+  +
Sbjct: 31  NDKKLDEEERSHNNNAGEDEDEEKMIDNDINR----SPNKSYKLGNIIGNGSFGVVYEAI 86

Query: 120 HPPTSRVFALKVI-----YGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY-------- 166
              TS   A+K +     Y N          RE+ I++++NH N++   D Y        
Sbjct: 87  CIDTSEKVAIKKVLQDPQYKN----------RELLIMKNLNHINIIFLKDYYYTECFKKN 136

Query: 167 DRNGEIEVLLEYMDGG--SLEGAHIRQEHILSDL-----ARQVLSGLAYLHKRKIVHRDI 219
           ++N  + V++E++          + R  H L        + Q+   LAY+H + I HRD+
Sbjct: 137 EKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDL 196

Query: 220 KPSNLLIN-SSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           KP NLLI+ ++  +K+ DFG ++ L        S + +  Y +PE +    N+  +    
Sbjct: 197 KPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV-SYICSRFYRAPELMLGATNYTTHI--- 252

Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA--------------PEM 324
            D+WSLG  I E  LG +P   G+      +        P E               P++
Sbjct: 253 -DLWSLGCIIAEMILG-YPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDV 310

Query: 325 ASREFR------------DFISRCLQKDPHSRWPAAQLLQHPF 355
             ++ +            +FIS+ L+ +P  R    + L  PF
Sbjct: 311 KPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353

Length = 440

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 77.0 bits (189), Expect = 9e-16
 Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 33/227 (14%)

Query: 103 KGNRIGSGSGGTVWRVVHP--PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           +G ++G G+ G V++         + +ALK I G     +    CREI +LR++ HPNV+
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT---GISMSACREIALLRELKHPNVI 61

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEH---------------ILSDLARQVLSG 205
               ++  + + +V L + D    +  HI + H               ++  L  Q+L G
Sbjct: 62  ALQKVFLSHSDRKVWLLF-DYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 206 LAYLHKRKIVHRDIKPSNLLINSS----KNVKIADFGVSRILAQTMDP---CNSAVGTIA 258
           + YLH   ++HRD+KP+N+L+         VKIAD G +R+    + P    +  V T  
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD 305
           Y +PE +    ++ K    A DIW++G    E  L   P    RQ D
Sbjct: 181 YRAPELLLGARHYTK----AIDIWAIGCIFAEL-LTSEPIFHCRQED 222

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSR---VFALKVIYGNHEDSVRSQICREIEILR 152
           I+P+ + K   IG+G  G V+R +     R     A+K +   + +  R     E  I+ 
Sbjct: 2   IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMG 61

Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQE------HILSDLARQVLSGL 206
             +H N+++   +  +     ++ EYM+ G+L+  ++R        + L  + R + +G+
Sbjct: 62  QFSHHNIIRLEGVVTKFKPAMIITEYMENGALD-KYLRDHDGEFSSYQLVGMLRGIAAGM 120

Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG---TIAYMSPE 263
            YL     VHRD+   N+L+NS+   K++DFG+SR+L    +   +  G    I + +PE
Sbjct: 121 KYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180

Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILE 290
            I     + K+   A D+WS G+ + E
Sbjct: 181 AI----AYRKFTS-ASDVWSFGIVMWE 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 23/223 (10%)

Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR-------QEHILSDLA 199
           E +IL  VN   VV     Y+    + ++L  M+GG L+  HI        +E      A
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK-FHIYHMGEAGFEEGRAVFYA 108

Query: 200 RQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL--AQTMDPCNSAVGTI 257
            ++  GL  LH+ +IV+RD+KP N+L++   +++I+D G++  +   QT+      VGT+
Sbjct: 109 AEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI---KGRVGTV 165

Query: 258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ 317
            YM+PE +  +    +Y  ++ D W+LG  + E   G+ PF   ++      +  +    
Sbjct: 166 GYMAPEVVKNE----RYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV 220

Query: 318 PPEAPEMASREFRDFISRCLQKDPHSRW-----PAAQLLQHPF 355
             E  E  S + R      L KDP  R       A ++ +HP 
Sbjct: 221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 76.1 bits (187), Expect = 1e-15
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 35/211 (16%)

Query: 101 LQKGNRIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNH 156
           L+K   +G G  G V    + P    T  + A+K +         S   +EI IL+ + H
Sbjct: 6   LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH 65

Query: 157 PNVVKCHDMYDRNGE--IEVLLEYMDGGSLEGAHIRQEHILSDL---ARQVLSGLAYLHK 211
            N+VK        G   +++++EY+  GSL     + +  L+ L   A+Q+  G+AYLH 
Sbjct: 66  ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHS 125

Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD--- 268
           +  +HRD+   N+L+++ + VKI DFG+++ + +         G   Y    R+  D   
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE---------GHEYY----RVREDGDS 172

Query: 269 ---------LNHGKYDGYAGDIWSLGVSILE 290
                    L   K+  YA D+WS GV++ E
Sbjct: 173 PVFWYAVECLKENKF-SYASDVWSFGVTLYE 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 67/261 (25%), Positives = 118/261 (45%), Gaps = 23/261 (8%)

Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           LQ   ++G+G  G VW       ++V A+K +              E +I++ + H  +V
Sbjct: 8   LQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSP--ESFLEEAQIMKKLRHDKLV 64

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           + + +      I ++ EYM  GSL       EG  ++  + L D+A QV +G+AY+ +  
Sbjct: 65  QLYAVVSEE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPN-LVDMAAQVAAGMAYIERMN 122

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHG 272
            +HRD++ +N+L+      KIADFG++R++          A   I + +PE       +G
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA----LYG 178

Query: 273 KYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
           ++     D+WS G+ + E    GR P+  G             +  P   P+       +
Sbjct: 179 RFT-IKSDVWSFGILLTELVTKGRVPYP-GMNNREVLEQVERGYRMP--CPQDCPISLHE 234

Query: 332 FISRCLQKDPHSRWPAAQLLQ 352
            + +C +KDP  R P  + LQ
Sbjct: 235 LMLQCWKKDPEER-PTFEYLQ 254

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 65/249 (26%), Positives = 116/249 (46%), Gaps = 24/249 (9%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V++      + V A+K    +    ++ +   E  IL+  +HPN+VK   + 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPV-AVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 167 DRNGEIEVLLEYMDGGS-LEGAHIRQEHI----LSDLARQVLSGLAYLHKRKIVHRDIKP 221
            +   I +++E + GG  L     +++ +    L   A    +G+AYL  +  +HRD+  
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAA 121

Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG----TIAYMSPERINTDLNHGKYDGY 277
            N L+  +  +KI+DFG+SR   Q  D   S+ G     I + +PE     LN+G+Y   
Sbjct: 122 RNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEA----LNYGRYSSE 174

Query: 278 AGDIWSLGVSILE-FYLGRFPF-AVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISR 335
           + D+WS G+ + E F LG  P+  +  Q     +      + P + P+   +     + R
Sbjct: 175 S-DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYK----VMQR 229

Query: 336 CLQKDPHSR 344
           C    P +R
Sbjct: 230 CWDYKPENR 238

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 69/271 (25%), Positives = 114/271 (42%), Gaps = 32/271 (11%)

Query: 101 LQKGN--RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
           LQ+G   RI  G    +     P       +K +  +  +   + + +E  +L  ++H N
Sbjct: 14  LQEGTFGRIFYG----ILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQN 69

Query: 159 VVK-CHDMYDRNGEIEVLLEYMDGGSLE------------GAHIRQEHILSDLARQVLSG 205
           ++   H   +      VL  YM+ G+L+                     L  +A Q+  G
Sbjct: 70  ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129

Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC--NSAVGTIAYMSPE 263
           ++YLHKR ++H+DI   N +I+    VKI D  +SR L      C  ++    + +M+ E
Sbjct: 130 MSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALE 189

Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFA-VGRQGDWASLMFAICFAQPPEA 321
                L + +Y   A D+WS GV + E   LG+ P+  +      A L      AQP   
Sbjct: 190 ----SLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINC 244

Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
           P+    E    ++ C   DP  R   +QL+Q
Sbjct: 245 PD----ELFAVMACCWALDPEERPSFSQLVQ 271

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 66/239 (27%), Positives = 101/239 (42%), Gaps = 51/239 (21%)

Query: 139 SVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHIL 195
           + R    RE E+L ++ H ++VK + +      + ++ EYM  G L     AH     IL
Sbjct: 49  AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 108

Query: 196 SD-----------------LARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFG 238
            D                 +A Q+ SG+ YL  +  VHRD+   N L+ ++  VKI DFG
Sbjct: 109 VDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFG 168

Query: 239 VS---------RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA--GDIWSLGVS 287
           +S         R+   TM P       I +M PE I        Y  +    D+WS GV 
Sbjct: 169 MSRDVYSTDYYRVGGHTMLP-------IRWMPPESI-------MYRKFTTESDVWSFGVI 214

Query: 288 ILE-FYLGRFP-FAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
           + E F  G+ P F +        ++  I   +  E P +  +E  D +  C Q++P  R
Sbjct: 215 LWEIFTYGKQPWFQLSN----TEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQR 269

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 74.7 bits (183), Expect = 7e-15
 Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 12/202 (5%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQIC---REIEILRDVNHPNVVKCH 163
           IG G+ G V  V      +VFA+K++    E   R++      E ++L + ++  +   H
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKIL-NKWEMLKRAETACFREERDVLVNGDNQWITTLH 67

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIR-QEHILSDLAR----QVLSGLAYLHKRKIVHRD 218
             +     + ++++Y  GG L     + ++ +  D+AR    +++  +  +H+   VHRD
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRD 127

Query: 219 IKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPERINT-DLNHGKYDG 276
           IKP N+L++ + ++++ADFG   +++       + AVGT  Y+SPE +   +   GKY G
Sbjct: 128 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKY-G 186

Query: 277 YAGDIWSLGVSILEFYLGRFPF 298
              D WSLGV + E   G  PF
Sbjct: 187 PECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 73.4 bits (180), Expect = 9e-15
 Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 35/266 (13%)

Query: 105 NRIGSGSGGTVWR-----VVHPPT--SRVFALKVIYGNHEDSVRSQICREIEILRDVNHP 157
           N +GSG+ G V+      ++ P +   RV A+K +     D  + +  +E  ++ + NHP
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRV-AVKTLRKGATDQEKKEFLKEAHLMSNFNHP 59

Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHI-------LSDLARQVLSGL 206
           N+VK   +   N    +++E M+GG L      A + +          L D+   V  G 
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 207 AYLHKRKIVHRDIKPSNLLINSS-----KNVKIADFGVSRILAQTMDPCNSAVGTIA--Y 259
            YL +   +HRD+   N L++       + VKI DFG++R + ++        G +   +
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179

Query: 260 MSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQP 318
           M+PE     L  GK+   + D+WS GV + E   LG+ P+      +    + A    Q 
Sbjct: 180 MAPE----SLLDGKFTTQS-DVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQK 234

Query: 319 PEAPEMASREFRDFISRCLQKDPHSR 344
              PE    +    ++ C  +DP  R
Sbjct: 235 ---PENCPDKIYQLMTNCWAQDPSER 257

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 12/202 (5%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQIC---REIEILRDVNHPNVVKCH 163
           IG G+ G V  V    T R++A+K++    E   R++      E  +L + +   +   H
Sbjct: 9   IGRGAFGEVAVVKMKHTERIYAMKIL-NKWEMLKRAETACFREERNVLVNGDCQWITTLH 67

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL-SDLAR----QVLSGLAYLHKRKIVHRD 218
             +     + ++++Y  GG L     + E  L  D+AR    +++  +  +H+   VHRD
Sbjct: 68  YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRD 127

Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS-AVGTIAYMSPERINT-DLNHGKYDG 276
           IKP N+L++ + ++++ADFG    + Q     +S AVGT  Y+SPE +   +   GKY G
Sbjct: 128 IKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKY-G 186

Query: 277 YAGDIWSLGVSILEFYLGRFPF 298
              D WSLGV + E   G  PF
Sbjct: 187 PECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 65/267 (24%), Positives = 105/267 (39%), Gaps = 58/267 (21%)

Query: 128 ALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGA 187
           A+K++  +   + R+   +EI+I+  + +PN+++   +   +  + ++ EYM+ G L   
Sbjct: 48  AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN-Q 106

Query: 188 HIRQEHILSDLAR-----------------QVLSGLAYLHKRKIVHRDIKPSNLLINSSK 230
            + Q  I S                     Q+ SG+ YL     VHRD+   N L+ +  
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHY 166

Query: 231 NVKIADFGVSRIL--AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSI 288
            +KIADFG+SR L           AV  I +M+ E I      GK+   A D+W+ GV++
Sbjct: 167 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL----GKFTT-ASDVWAFGVTL 221

Query: 289 LEFYL-------------------GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF 329
            E +                    G F    GRQ         I  +Q P  P       
Sbjct: 222 WEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQ---------IYLSQTPLCPS----PV 268

Query: 330 RDFISRCLQKDPHSRWPAAQLLQHPFI 356
              + RC  +D   R P    + H   
Sbjct: 269 FKLMMRCWSRDIKDR-PTFNKIHHFLR 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 33/211 (15%)

Query: 107 IGSGSGGTVWRVVHPPTSRVF--ALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK--- 161
           +GSG+ G V + V+    +    A+KV+   +E SVR ++ RE EI+  +++P +V+   
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 162 -CHDMYDRNGEIEVLLEYMD---GGSL------EGAHIRQEHILSDLARQVLSGLAYLHK 211
            C        E E L+  M+   GG L      +   I   +++ +L  QV  G+ YL  
Sbjct: 63  VC--------EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVV-ELMHQVSMGMKYLEG 113

Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG---TIAYMSPERINTD 268
           +  VHRD+   N+L+ +    KI+DFG+S+ L        +       + + +PE I   
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI--- 170

Query: 269 LNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
            N  K+   + D+WS G+++ E F  G+ P+
Sbjct: 171 -NFRKFSSRS-DVWSYGITMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 62/258 (24%), Positives = 119/258 (46%), Gaps = 27/258 (10%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T++V A+K +       +     +E +I++ + H  +V  + +
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKV-AIKTLKPG--TMMPEAFLQEAQIMKKLRHDKLVPLYAV 69

Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I ++ E+M  GSL       +G +++    L D+A Q+  G+AY+ +   +HRD
Sbjct: 70  VSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQ-LVDMAAQIADGMAYIERMNYIHRD 127

Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQT-MDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L+  +   KIADFG++R++          A   I + +PE       +G++   
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA----LYGRFT-I 182

Query: 278 AGDIWSLGVSILEFYL-GRFPFA--VGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS 334
             D+WS G+ + E    GR P+   V R+     ++  +        P+       + + 
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMVNRE-----VLEQVERGYRMPCPQGCPESLHELMK 237

Query: 335 RCLQKDPHSRWPAAQLLQ 352
            C +KDP  R P  + +Q
Sbjct: 238 LCWKKDPDER-PTFEYIQ 254

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 20/221 (9%)

Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ---------EHILSD 197
           E+  L   +H  +VK  D +  + ++ +++EY  GG L    I+Q         E+ +  
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLN-KQIKQRLKEHLPFQEYEVGL 173

Query: 198 LARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ--TMDPCNSAVG 255
           L  Q++  L  +H RK++HRD+K +N+ +  +  +K+ DFG S+  +   ++D  +S  G
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233

Query: 256 TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF 315
           T  Y++PE     L   K      D+WSLGV + E      PF    Q +   +M  + +
Sbjct: 234 TPYYLAPE-----LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQQVLY 285

Query: 316 AQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +    P   S   +  +   L K+P  R    QLL   F+
Sbjct: 286 GKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFL 326

Length = 478

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 71.5 bits (175), Expect = 3e-14
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 21/211 (9%)

Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV 154
           L+N  +L  G  IG G  G V +  +  T +  A+K I     D        E  ++  +
Sbjct: 2   LLNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKC---DVTAQAFLEETAVMTKL 56

Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAY 208
           +H N+V+   +   NG + +++E M  G+L       G  +     L   +  V  G+ Y
Sbjct: 57  HHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115

Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
           L  +K+VHRD+   N+L++     K++DFG++R+ +  +D   ++   + + +PE     
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD---NSKLPVKWTAPEA---- 168

Query: 269 LNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
           L H K+   + D+WS GV + E F  GR P+
Sbjct: 169 LKHKKFSSKS-DVWSYGVLLWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 50/175 (28%), Positives = 90/175 (51%), Gaps = 13/175 (7%)

Query: 175 LLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRDIKPSNLLINSS 229
           +L+ M+GG L   H+ Q  + S+      A +++ GL ++H R +V+RD+KP+N+L++  
Sbjct: 75  ILDLMNGGDLH-YHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH 133

Query: 230 KNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSIL 289
            +V+I+D G++   ++     +++VGT  YM+PE +        YD  A D +SLG  + 
Sbjct: 134 GHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGT---AYDSSA-DWFSLGCMLF 187

Query: 290 EFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
           +   G  PF   +  D   +   +      E P+  S E +  +   LQ+D   R
Sbjct: 188 KLLRGHSPFRQHKTKDKHEID-RMTLTVNVELPDSFSPELKSLLEGLLQRDVSKR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 71.0 bits (174), Expect = 8e-14
 Identities = 78/297 (26%), Positives = 118/297 (39%), Gaps = 71/297 (23%)

Query: 107 IGSGSGGTVWRVVHP---PTSR--VFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           IG G+ G V++   P   P     + A+K++       +++   RE  ++ + +HPN+VK
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 162 CHDMYDRNGEIEVLLEYMDGGSL-------------EGAHIRQEHILSDL---------- 198
              +      + +L EYM  G L               +H         L          
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 199 ---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC----N 251
              A+QV +G+AYL +RK VHRD+   N L+  +  VKIADFG+SR +    D      N
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA-DYYKASEN 191

Query: 252 SAVGTIAYMSPERINTDLNHGKYDGYA--GDIWSLGVSILE-FYLGRFPF---------A 299
            A+  I +M PE I        Y+ Y    D+W+ GV + E F  G  P+          
Sbjct: 192 DAI-PIRWMPPESI-------FYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243

Query: 300 VGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQL---LQH 353
             R G+  S             P+    E  + +  C  K P  R   A +   LQ 
Sbjct: 244 YVRDGNVLS------------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 71.2 bits (174), Expect = 9e-14
 Identities = 66/289 (22%), Positives = 125/289 (43%), Gaps = 29/289 (10%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G GS G V       T  ++A+K++  +    +D V   +  +  +      P + + H
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRD 218
             +     +  ++EY++GG L    I+Q     +      A ++  GL +LH + I++RD
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLM-YQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126

Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           +K  N++++S  ++KIADFG+ +          +  GT  Y++PE I        Y  Y 
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-------AYQPYG 179

Query: 279 G--DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
              D W+ GV + E   G+ PF    +G+    +F          P+  S+E        
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPF----EGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 235

Query: 337 LQKDPHSRW---PAAQ--LLQHPFILRAGQSQVNQNLRQILPPPRPLSS 380
           + K P  R    P  +  + +H F       ++ +  +++ PP +P + 
Sbjct: 236 MTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER--KEVQPPYKPKAC 282

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 68/242 (28%), Positives = 96/242 (39%), Gaps = 56/242 (23%)

Query: 138 DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHI 194
           +S R    RE E+L  + H ++V+ + +      + ++ EYM  G L     +H     I
Sbjct: 48  ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKI 107

Query: 195 LSD----------------LARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFG 238
           L+                 +A Q+ SG+ YL     VHRD+   N L+     VKI DFG
Sbjct: 108 LAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFG 167

Query: 239 VS---------RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA--GDIWSLGVS 287
           +S         R+  +TM P       I +M PE I        Y  +    DIWS GV 
Sbjct: 168 MSRDIYSTDYYRVGGRTMLP-------IRWMPPESI-------LYRKFTTESDIWSFGVV 213

Query: 288 ILEFYLGRFPFAVGRQGDWASL--MFAI-CFAQ--PPEAPEMASREFRDFISRCLQKDPH 342
           + E       F  G+Q  W  L    AI C  Q    E P     E    +  C Q++P 
Sbjct: 214 LWEI------FTYGKQ-PWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQ 266

Query: 343 SR 344
            R
Sbjct: 267 QR 268

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 62/233 (26%), Positives = 92/233 (39%), Gaps = 43/233 (18%)

Query: 96  INPAELQKGNRIGSGSGGTVWR--VVHPPTSRV---FALKVIYGNHEDSVRSQICREIEI 150
           +    +     +G G+ G V+           V    A+K +  +  +   S    E  I
Sbjct: 3   VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI 62

Query: 151 LRDVNHPNVVKCHDM-YDRNGEIEVLLEYMDGGSLEG----AHIRQEH----ILSDL--- 198
           +   NH N+V+   + ++R     +LLE M GG L+        R E      + DL   
Sbjct: 63  MSKFNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 199 ARQVLSGLAYLHKRKIVHRDIKPSNLLINS---SKNVKIADFGVS---------RILAQT 246
           AR V  G  YL +   +HRDI   N L+      +  KIADFG++         R   + 
Sbjct: 122 ARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRA 181

Query: 247 MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
           M P       I +M PE     +   K      D+WS GV + E F LG  P+
Sbjct: 182 MLP-------IKWMPPEAFLDGIFTSK-----TDVWSFGVLLWEIFSLGYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 67/276 (24%), Positives = 124/276 (44%), Gaps = 26/276 (9%)

Query: 94  QLINPAELQKGNRIGSGSGGTVWRVVHPPTSR----VFALKVIYGNHEDSVRSQICREIE 149
           +++   EL+K   +GSG+ GTV++ +  P         A+KV+  N       +I  E  
Sbjct: 2   RILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61

Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVL 203
           ++  V  P V +   +      ++++ + M  G L   ++R+         L +   Q+ 
Sbjct: 62  VMAGVGSPYVCRLLGIC-LTSTVQLVTQLMPYGCLLD-YVRENKDRIGSQDLLNWCVQIA 119

Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL--AQTMDPCNSAVGTIAYMS 261
            G++YL + ++VHRD+   N+L+ S  +VKI DFG++R+L   +T    +     I +M+
Sbjct: 120 KGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 179

Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFA-ICFAQPP 319
            E I     H ++  +  D+WS GV++ E    G  P+      +   L+       QPP
Sbjct: 180 LESI----LHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPP 234

Query: 320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
               + + +    + +C   D   R P  + L   F
Sbjct: 235 ----ICTIDVYMIMVKCWMIDSECR-PRFRELVDEF 265

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 74/274 (27%), Positives = 116/274 (42%), Gaps = 35/274 (12%)

Query: 101 LQKGNRIGSGSGG-----TVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV- 154
           L  G  +G+G+ G     T + +         A+K++      S R  +  E++I+  + 
Sbjct: 37  LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG 96

Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDL------ARQVLSGLAY 208
           NH N+V         G I V+ EY   G L     R+      L      + QV  G+A+
Sbjct: 97  NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156

Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN-----SAVGTIAYMSPE 263
           L  +  +HRD+   N+L+   K VKI DFG++R     M+  N     +A   + +M+PE
Sbjct: 157 LASKNCIHRDLAARNVLLTHGKIVKICDFGLAR---DIMNDSNYVVKGNARLPVKWMAPE 213

Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGD---WASLMFAICFAQPP 319
            I     +  Y  +  D+WS G+ + E F LG  P+  G   D   +  +      AQP 
Sbjct: 214 SI----FNCVYT-FESDVWSYGILLWEIFSLGSNPYP-GMPVDSKFYKLIKEGYRMAQPE 267

Query: 320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
            AP     E  D +  C   DP  R P  + +  
Sbjct: 268 HAPA----EIYDIMKTCWDADPLKR-PTFKQIVQ 296

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 69.1 bits (169), Expect = 6e-13
 Identities = 81/334 (24%), Positives = 136/334 (40%), Gaps = 73/334 (21%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR---EIEILRDVNHPNVVKCH 163
           IG G+ G V  V    T +++A+K +  + E   + Q+     E ++L + + P VV  +
Sbjct: 9   IGKGAFGEVRLVQKKDTGKIYAMKTLLKS-EMFKKDQLAHVKAERDVLAESDSPWVVSLY 67

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDI 219
             +     + +++E++ GG L    I+ +    D+ R    + +  +  +HK   +HRDI
Sbjct: 68  YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDI 127

Query: 220 KPSNLLINSSKNVKIADFGVS-------------RILAQT-------------MDPCN-- 251
           KP N+LI+   ++K++DFG+S             ++L                +D  N  
Sbjct: 128 KPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLT 187

Query: 252 -------------------SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY 292
                              S VGT  Y++PE     L  G   G   D WSLG  + E  
Sbjct: 188 MSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF---LQQGY--GQECDWWSLGAIMFECL 242

Query: 293 LGRFPFAVGRQGDWASLMFAICFAQPPEAPE--MASREFRDFISRCLQKDPH--SRWPAA 348
           +G  PF      +  +    I + +    P+    S E  D I R +    +   R  A 
Sbjct: 243 IGWPPFCSENSHE--TYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAH 300

Query: 349 QLLQHPFILRAGQSQVNQN-LRQILPPPRP-LSS 380
           ++  HPF        V+ + +RQI  P  P L S
Sbjct: 301 EIKSHPFF-----RGVDWDTIRQIRAPFIPQLKS 329

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 74/308 (24%), Positives = 138/308 (44%), Gaps = 38/308 (12%)

Query: 94  QLINPAELQKGNRIGSGSGGTVWRVVHPPTSR----VFALKVIYGNHEDSVRSQICREIE 149
           +++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  
Sbjct: 2   RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVL 203
           ++  V++P+V +   +      ++++ + M  G L         +I  +++L +   Q+ 
Sbjct: 62  VMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLL-NWCVQIA 119

Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMS 261
            G+ YL +R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179

Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFAIC-----F 315
            E I     H  Y  +  D+WS GV++ E    G  P+     G  AS + +I       
Sbjct: 180 LESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY----DGIPASEISSILEKGERL 230

Query: 316 AQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ----VNQNLRQI 371
            QPP    + + +    + +C   D  SR P  + L   F   A   Q    +  + R  
Sbjct: 231 PQPP----ICTIDVYMIMVKCWMIDADSR-PKFRELIIEFSKMARDPQRYLVIQGDERMH 285

Query: 372 LPPPRPLS 379
           LP P   +
Sbjct: 286 LPSPTDSN 293

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 52/180 (28%), Positives = 85/180 (47%), Gaps = 22/180 (12%)

Query: 128 ALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGA 187
           A+K++  +   + R+   +EI+I+  +  PN+++   +   +  + ++ EYM+ G L   
Sbjct: 50  AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQF 109

Query: 188 HIRQE---------------HILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNV 232
             R E                 L  +A Q+ SG+ YL     VHRD+   N L+  +  +
Sbjct: 110 LSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTI 169

Query: 233 KIADFGVSRIL--AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE 290
           KIADFG+SR L           AV  I +MS E I      GK+   A D+W+ GV++ E
Sbjct: 170 KIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL----GKFT-TASDVWAFGVTLWE 224

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 49/167 (29%), Positives = 71/167 (42%), Gaps = 28/167 (16%)

Query: 146 REIEILRDVNHPNVVKCHDMYDRNGEIEV---------LLEYMDGGS---LEGAHIRQEH 193
           REI+IL+ ++H  ++     Y R               L  Y+D      LE A   Q  
Sbjct: 135 REIDILKTISHRAIINLIHAY-RWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQ-- 191

Query: 194 ILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP--CN 251
                 R++L  LAYLH R I+HRD+K  N+ ++  +N  + DFG +  L    D   C 
Sbjct: 192 ------RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY 245

Query: 252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF 298
              GT+   SPE +  D    K      DIWS G+ + E  +     
Sbjct: 246 GWSGTLETNSPELLALDPYCAK-----TDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 40/265 (15%)

Query: 107 IGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHPN 158
           +G GS G V+       V   P +RV A+K +  N   S+R +I    E  ++++ N  +
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRV-AIKTV--NEAASMRERIEFLNEASVMKEFNCHH 70

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI---------------LSDLARQVL 203
           VV+   +  +     V++E M  G L+ +++R                   +  +A ++ 
Sbjct: 71  VVRLLGVVSQGQPTLVIMELMTRGDLK-SYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129

Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG--TIAYMS 261
            G+AYL+  K VHRD+   N ++     VKI DFG++R + +T        G   + +MS
Sbjct: 130 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189

Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEF-YLGRFPF-AVGRQGDWASLMFAICFAQPP 319
           PE     L  G +  Y+ D+WS GV + E   L   P+  +  +     +M      +P 
Sbjct: 190 PE----SLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPD 244

Query: 320 EAPEMASREFRDFISRCLQKDPHSR 344
             P+M      + +  C Q +P  R
Sbjct: 245 NCPDM----LFELMRMCWQYNPKMR 265

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 64/254 (25%), Positives = 112/254 (44%), Gaps = 50/254 (19%)

Query: 147 EIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------------EGAHIRQEH 193
           E+E+L  + +HPN++      +  G + + +EY   G+L            + A  ++  
Sbjct: 52  ELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHG 111

Query: 194 ILSDLARQVL--------SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR---- 241
             S L  Q L        +G+ YL +++ +HRD+   N+L+  +   KIADFG+SR    
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV 171

Query: 242 ILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFAV 300
            + +TM         + +M+ E +N  +   K      D+WS GV + E   LG  P+  
Sbjct: 172 YVKKTMGRL-----PVRWMAIESLNYSVYTTK-----SDVWSFGVLLWEIVSLGGTPY-- 219

Query: 301 GRQGDWASLMFAICFAQPP-----EAPEMASREFRDFISRCLQKDPHSRWPAAQL-LQHP 354
                   +  A  + + P     E P     E  + + +C +  P+ R P AQ+ +Q  
Sbjct: 220 ------CGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLS 273

Query: 355 FILRAGQSQVNQNL 368
            +L A ++ VN  L
Sbjct: 274 RMLEARKAYVNMAL 287

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 21/211 (9%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           +N  EL+    IG G  G V  ++        A+K I     D+       E  ++  + 
Sbjct: 3   LNMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCI---KNDATAQAFLAEASVMTQLR 57

Query: 156 HPNVVKCHD-MYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAY 208
           H N+V+    + +  G + ++ EYM  GSL       G  +     L   +  V   + Y
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117

Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
           L     VHRD+   N+L++     K++DFG+++  + T D   +    + + +PE +   
Sbjct: 118 LEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKLPVKWTAPEALREK 174

Query: 269 LNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
               K      D+WS G+ + E Y  GR P+
Sbjct: 175 KFSTK-----SDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 51/159 (32%), Positives = 71/159 (44%), Gaps = 9/159 (5%)

Query: 141 RSQICREIEILRDVNHPNVVKCHDMYDRNG-EIEVLLEYMDGGSLEGAHIRQEHILSDLA 199
           R     E  ILR +NHP++++    +  N     +L  Y        A  R   I   LA
Sbjct: 127 RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILA 186

Query: 200 --RQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ-TMDPCNSAVGT 256
             R VL  + YLH+ +I+HRDIK  N+ IN   +V + DFG +        +      GT
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246

Query: 257 IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR 295
           IA  +PE +  D     Y G A DIWS G+ + E     
Sbjct: 247 IATNAPELLARD----PY-GPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 65.2 bits (159), Expect = 5e-12
 Identities = 44/190 (23%), Positives = 89/190 (46%), Gaps = 22/190 (11%)

Query: 126 VFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLE 185
           +  +K +    +++++S+  RE+++ R ++H NVV+   +        ++LEY D G L+
Sbjct: 37  LVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLK 96

Query: 186 --------------GAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN 231
                            +  +  ++ L  Q+  G+ +L   + VHRD+   N L++S + 
Sbjct: 97  QFLRATKSKDEKLKPPPLSTKQKVA-LCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE 155

Query: 232 VKIADFGVSR-ILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE 290
           VK++   +S+ +         +A+  + +++PE +  D    K      D+WS GV + E
Sbjct: 156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTK-----SDVWSFGVLMWE 210

Query: 291 -FYLGRFPFA 299
            F  G  PF 
Sbjct: 211 VFTQGELPFY 220

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 59/230 (25%), Positives = 105/230 (45%), Gaps = 20/230 (8%)

Query: 94  QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIE---- 149
           +++   EL+K   +GSG  GTV + +  P      + V     +D    Q  +EI     
Sbjct: 2   RILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHML 61

Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQE------HILSDLARQVL 203
            +  ++H  +V+   +      ++++ +    GSL   H+RQ         L +   Q+ 
Sbjct: 62  AMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLL-DHVRQHRDSLDPQRLLNWCVQIA 119

Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC--NSAVGTIAYMS 261
            G+ YL + ++VHR++   N+L+ S   V+IADFGV+ +L         +     I +M+
Sbjct: 120 KGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLM 310
            E I      G+Y  +  D+WS GV++ E    G  P+A  R  +   L+
Sbjct: 180 LESI----LFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 65.5 bits (160), Expect = 6e-12
 Identities = 56/234 (23%), Positives = 106/234 (45%), Gaps = 46/234 (19%)

Query: 100 ELQKGNRIGSGSGGTVWR-----VVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV 154
            L  G  +G G+ G V +     + +P  +   A+K++  +  +   S +  E+E+++ +
Sbjct: 13  RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI 72

Query: 155 -NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLE---------------------GAHIRQE 192
             H N++    +  + G + V++EY   G+L                         + Q+
Sbjct: 73  GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 193 HILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD---P 249
            ++S  A QV  G+ +L  +K +HRD+   N+L+     +KIADFG++R +   +D    
Sbjct: 133 DLVS-FAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI-HHIDYYRK 190

Query: 250 CNSAVGTIAYMSPE----RINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
             +    + +M+PE    R+ T         +  D+WS GV + E F LG  P+
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYT---------HQSDVWSFGVLLWEIFTLGGSPY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 64.8 bits (158), Expect = 6e-12
 Identities = 51/160 (31%), Positives = 76/160 (47%), Gaps = 17/160 (10%)

Query: 142 SQICREIEILRDVNHPNVVKCHD-MYDRNGEIEVLLEYMDGGSLEGAHIRQEH---ILSD 197
            Q  +E  I++D +HPNV+          G   V+L YM  G L    IR E     + D
Sbjct: 41  EQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN-FIRSETHNPTVKD 99

Query: 198 L---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSA 253
           L     QV  G+ YL  +K VHRD+   N +++ S  VK+ADFG++R I  +     ++ 
Sbjct: 100 LIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159

Query: 254 VGT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE 290
            G    + +M+ E + T     K      D+WS GV + E
Sbjct: 160 TGAKLPVKWMALESLQTQKFTTK-----SDVWSFGVLLWE 194

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 64.5 bits (157), Expect = 9e-12
 Identities = 43/171 (25%), Positives = 80/171 (46%), Gaps = 16/171 (9%)

Query: 143 QICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG---------AHIRQEH 193
              +E++  R++NHPNV++C      +    ++LE+   G L+          A + Q+ 
Sbjct: 41  LFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD 100

Query: 194 ILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGV--SRILAQTMDPCN 251
           +L  +A +V SGL +LH+   +H D+   N  + +  +VKI D+G+   +         +
Sbjct: 101 VLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160

Query: 252 SAVGTIAYMSPERINT---DLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
                + +++PE +     DL          +IWSLGV++ E F     P+
Sbjct: 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKK-SNIWSLGVTMWELFTAADQPY 210

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 72/275 (26%), Positives = 117/275 (42%), Gaps = 56/275 (20%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHD 164
           IG G+ G V  V    T  V+A+K++      E      I  E +IL + +   VVK   
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68

Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRDI 219
            +     + +++E++ GG +    ++++ +  +     +A  VL+ +  +H+   +HRDI
Sbjct: 69  SFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLA-IDSIHQLGFIHRDI 127

Query: 220 KPSNLLINSSKNVKIADFGV---------------------SRILAQTMDP--------- 249
           KP NLL++S  +VK++DFG+                     S    Q M+          
Sbjct: 128 KPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKR 187

Query: 250 -----CNSAVGTIAYMSPERINTDLNHGKYDGYAG--DIWSLGVSILEFYLGRFPF-AVG 301
                  S VGT  Y++PE            GY    D WSLGV + E  +G  PF +  
Sbjct: 188 NRRQLAFSTVGTPDYIAPEVF-------MQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 302 RQGDWASLM-FAICFAQPPEAPEMASREFRDFISR 335
            Q  +  +M +      PPE P   S + +D I R
Sbjct: 241 PQETYKKVMNWKETLIFPPEVP--ISEKAKDLILR 273

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 64/277 (23%), Positives = 112/277 (40%), Gaps = 51/277 (18%)

Query: 107 IGSGSGGTVWRVVHPPTSRVF--ALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCH 163
           IG G+ G V +            A+K +              E+E+L  + +HPN++   
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 164 DMYDRNGEIEVLLEYMDGGSL------------EGAHIRQEHILSDLA-RQVL------- 203
              +  G + + +EY   G+L            + A        S L+ +Q+L       
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR----ILAQTMDPCNSAVGTIAY 259
            G+ YL +++ +HRD+   N+L+  +   KIADFG+SR     + +TM         + +
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL-----PVRW 177

Query: 260 MSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFAICFAQP 318
           M+ E +N  +          D+WS GV + E   LG  P+          +  A  + + 
Sbjct: 178 MAIESLNYSVYTTN-----SDVWSYGVLLWEIVSLGGTPY--------CGMTCAELYEKL 224

Query: 319 P-----EAPEMASREFRDFISRCLQKDPHSRWPAAQL 350
           P     E P     E  D + +C ++ P+ R   AQ+
Sbjct: 225 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 54/229 (23%), Positives = 101/229 (44%), Gaps = 27/229 (11%)

Query: 129 LKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAH 188
           LKV+  +H D +         ++R V+H ++V  + +  R+ E  ++ E+++ G L+   
Sbjct: 37  LKVLDPSHRD-ISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFM 95

Query: 189 IRQEHILS-----DLARQVLSGLAYLHKRKIVHRDIKPSNLLI-------NSSKNVKIAD 236
            R+  +L+      +A+Q+ S L+YL  + +VH ++   N+L+            +K++D
Sbjct: 96  HRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155

Query: 237 FGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF-YLGR 295
            G+  I   +   C   V  I +++PE +    N       A D WS G ++ E  Y G 
Sbjct: 156 PGIP-ITVLSRQEC---VERIPWIAPECVEDSKNL----SIAADKWSFGTTLWEICYNGE 207

Query: 296 FPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
            P       +        C    P   E+A     D ++ C+  DP+ R
Sbjct: 208 IPLKDKTLAEKERFYEGQCMLVTPSCKELA-----DLMTHCMNYDPNQR 251

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 70/260 (26%), Positives = 112/260 (43%), Gaps = 44/260 (16%)

Query: 123 TSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE-----VL 175
           T    A+K++  +   E+  R++  RE  +   + HPN+V   D    +GE        +
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLD----SGEAPPGLLFAV 57

Query: 176 LEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS- 229
            EY+ G +L    +  +  L       L  QVL  LA  H + IVHRD+KP N++++ + 
Sbjct: 58  FEYVPGRTLR-EVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTG 116

Query: 230 --KNVKIADFGVSRIL-------AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
              + K+ DFG+  +L         T+      +GT  Y +PE++  +      D YA  
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA-- 174

Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ--PPEA---PEMASREFRDFISR 335
            W  G+  LE   G+       QG  AS+   I + Q  P +    P +A       + +
Sbjct: 175 -W--GLIFLECLTGQ----RVVQG--ASVA-EILYQQLSPVDVSLPPWIAGHPLGQVLRK 224

Query: 336 CLQKDPHSRWPAAQLLQHPF 355
            L KDP  R  +A  L   F
Sbjct: 225 ALNKDPRQRAASAPALAERF 244

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 57/230 (24%), Positives = 102/230 (44%), Gaps = 44/230 (19%)

Query: 104 GNRIGSGSGGTVWRV-------VHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN- 155
           G  +G G  G V R          P  +   A+K++  N  D   + +  E+E+++ +  
Sbjct: 17  GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK 76

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL----------------EGAHIRQEHI----L 195
           H N++    +  + G + V++EY   G+L                +   + +E +    L
Sbjct: 77  HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136

Query: 196 SDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG 255
              A QV  G+ YL  R+ +HRD+   N+L+     +KIADFG++R +        ++ G
Sbjct: 137 VSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 256 --TIAYMSPE----RINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
              + +M+PE    R+ T         +  D+WS G+ + E F LG  P+
Sbjct: 197 RLPVKWMAPEALFDRVYT---------HQSDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 76/298 (25%), Positives = 131/298 (43%), Gaps = 60/298 (20%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHD 164
           IG G+ G V  V    T  ++A+K++      E    + I  E +IL + +   VVK   
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68

Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRDI 219
            +     + +++E++ GG +    ++++ +  +     +A  VL+ +  +H+   +HRDI
Sbjct: 69  SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLA-IDAIHQLGFIHRDI 127

Query: 220 KPSNLLINSSKNVKIADFGVSRILAQ----------TMDPCN------------------ 251
           KP NLL+++  +VK++DFG+   L +          T +P +                  
Sbjct: 128 KPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKK 187

Query: 252 -------SAVGTIAYMSPER-INTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF-AVGR 302
                  S VGT  Y++PE  + T  N         D WSLGV + E  +G  PF +   
Sbjct: 188 NRRQLAYSTVGTPDYIAPEVFMQTGYNK------LCDWWSLGVIMYEMLIGYPPFCSETP 241

Query: 303 QGDWASLM-FAICFAQPPEAPEMASREFRDFISR-CLQKDPHSRWPAA---QLLQHPF 355
           Q  +  +M +      PPE P   S + +D I R C   D  +R  +    ++  HPF
Sbjct: 242 QETYRKVMNWKETLVFPPEVP--ISEKAKDLILRFCT--DSENRIGSNGVEEIKSHPF 295

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 48/147 (32%), Positives = 70/147 (47%), Gaps = 10/147 (6%)

Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC--NSAVGTIA 258
           QV  G+ +L  RK +HRD+   N+L++ +  VKI DFG++R + +  D     SA   + 
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQ 317
           +M+PE I       K      D+WS GV + E F LG  P+  G Q +       +    
Sbjct: 242 WMAPESI-----FDKVYTTQSDVWSFGVLLWEIFSLGASPYP-GVQIN-EEFCQRLKDGT 294

Query: 318 PPEAPEMASREFRDFISRCLQKDPHSR 344
              APE A+ E    +  C Q DP  R
Sbjct: 295 RMRAPENATPEIYRIMLACWQGDPKER 321

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 62/256 (24%), Positives = 104/256 (40%), Gaps = 43/256 (16%)

Query: 115 VWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV 174
           V  V+   T + F LK +  + E S R    R   I   V  PN+V  H        + +
Sbjct: 9   VLLVMDTRTQQTFILKGLRKSSEYS-RE---RLTIIPHCV--PNMVCLHKYIVSEDSVFL 62

Query: 175 LLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS 229
           +L++ +GG L     +  +I +E +    A +++  L  LH+  IV RD+ P+N+L++  
Sbjct: 63  VLQHAEGGKLWSHISKFLNIPEECV-KRWAAEMVVALDALHREGIVCRDLNPNNILLDDR 121

Query: 230 KNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSIL 289
            ++++  F     +  +      AV  + Y +PE     +     +  A D WSLG  + 
Sbjct: 122 GHIQLTYFSRWSEVEDSC--DGEAVENM-YCAPE-----VGGISEETEACDWWSLGAILF 173

Query: 290 EFYLGR-----FPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
           E   G+      P  +       +L            PE  S E R  + + LQ +P  R
Sbjct: 174 ELLTGKTLVECHPSGINTH---TTL----------NIPEWVSEEARSLLQQLLQFNPTER 220

Query: 345 WPAA-----QLLQHPF 355
             A       +  HPF
Sbjct: 221 LGAGVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 79/337 (23%), Positives = 134/337 (39%), Gaps = 85/337 (25%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSV-RSQICR---EIEILRDVNHPNVVKC 162
           +G G+ G V       T  ++A+K +    +D + R+Q+     E +IL + ++  VVK 
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTL--RKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 163 HDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAY----LHKRKIVHRD 218
           +  +     +  +++Y+ GG +    IR E     LAR  ++ L      +HK   +HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126

Query: 219 IKPSNLLINSSKNVKIADFGV----------------SRILAQTMDPCN----------- 251
           IKP N+LI+   ++K+ DFG+                S I   +M+P +           
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186

Query: 252 --------------------SAVGTIAYMSPERINTDLNHGKYDGYAG--DIWSLGVSIL 289
                               S VGT  Y++PE +          GY    D WS+GV + 
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL-------LRKGYTQLCDWWSVGVILF 239

Query: 290 EFYLGRFPFAVGRQGD-------WASLMFAICFAQPPEAPEMASREFRDFISR--CLQKD 340
           E  +G+ PF      +       W + +       PP+     S E  D I++  C  ++
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVINWENTLHI-----PPQVK--LSPEAVDLITKLCCSAEE 292

Query: 341 PHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
              R  A  +  HPF     +   + ++R    P  P
Sbjct: 293 RLGRNGADDIKAHPFF---SEVDFSSDIRTQPAPYVP 326

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 50/203 (24%), Positives = 94/203 (46%), Gaps = 31/203 (15%)

Query: 121 PPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYM 179
           P  +   A+K++  +  +   S +  E+E+++ +  H N++       ++G + V++EY 
Sbjct: 44  PKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 103

Query: 180 DGGSLEGAHIRQEHILS-----DLAR----------------QVLSGLAYLHKRKIVHRD 218
             G+L   ++R           D+AR                QV  G+ YL  +K +HRD
Sbjct: 104 SKGNLR-EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRD 162

Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG--TIAYMSPERINTDLNHGKYDG 276
           +   N+L+  +  +KIADFG++R +        +  G   + +M+PE +       +   
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL-----FDRVYT 217

Query: 277 YAGDIWSLGVSILE-FYLGRFPF 298
           +  D+WS GV + E F LG  P+
Sbjct: 218 HQSDVWSFGVLMWEIFTLGGSPY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 30/188 (15%)

Query: 128 ALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLE-- 185
           A+K++  +   + R+   +E++IL  +  PN+++   +      + ++ EYM+ G L   
Sbjct: 50  AVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQF 109

Query: 186 -GAHIRQE--------------------HILSDLARQVLSGLAYLHKRKIVHRDIKPSNL 224
             +H   +                      L  +A Q+ SG+ YL     VHRD+   N 
Sbjct: 110 LSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNC 169

Query: 225 LINSSKNVKIADFGVSRIL--AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           L+  +  +KIADFG+SR L           AV  I +M+ E I      GK+   A D+W
Sbjct: 170 LVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM----GKFTT-ASDVW 224

Query: 283 SLGVSILE 290
           + GV++ E
Sbjct: 225 AFGVTLWE 232

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 68/267 (25%), Positives = 115/267 (43%), Gaps = 44/267 (16%)

Query: 107 IGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHPN 158
           +G GS G V+       +     +RV A+K +  N   S+R +I    E  +++     +
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRV-AVKTV--NESASLRERIEFLNEASVMKGFTCHH 70

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR-----------------QEHILSDLARQ 201
           VV+   +  +     V++E M  G L+ +++R                 QE I   +A +
Sbjct: 71  VVRLLGVVSKGQPTLVVMELMAHGDLK-SYLRSLRPEAENNPGRPPPTLQEMI--QMAAE 127

Query: 202 VLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG--TIAY 259
           +  G+AYL+ +K VHRD+   N ++     VKI DFG++R + +T        G   + +
Sbjct: 128 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 260 MSPERINTDLNHGKYDGYAGDIWSLGVSILEF-YLGRFPF-AVGRQGDWASLMFAICFAQ 317
           M+PE     L  G +   + D+WS GV + E   L   P+  +  +     +M      Q
Sbjct: 188 MAPE----SLKDGVFTTSS-DMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ 242

Query: 318 PPEAPEMASREFRDFISRCLQKDPHSR 344
           P   PE       D +  C Q +P  R
Sbjct: 243 PDNCPE----RVTDLMRMCWQFNPKMR 265

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 56/231 (24%), Positives = 107/231 (46%), Gaps = 32/231 (13%)

Query: 143 QICREIEILRDVNHPNVVKCHDMYDRN---GEIE---VLLEYMDGGSLEG----AHIRQE 192
           +  RE   +++ +HPNV+K   +  R+   G +    V+L +M  G L      + I +E
Sbjct: 47  EFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEE 106

Query: 193 ------HILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT 246
                   L      + SG+ YL  +  +HRD+   N ++N +  V +ADFG+S+ +   
Sbjct: 107 PFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG 166

Query: 247 ---MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFA-VG 301
                 C S +  + +++ E +  ++    Y  ++ D+W+ GV++ E    G+ P+A V 
Sbjct: 167 DYYRQGCASKL-PVKWLALESLADNV----YTTHS-DVWAFGVTMWEIMTRGQTPYAGVE 220

Query: 302 RQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
               +  L+      QPP+  E    +  + + +C   +P  R P+ Q L+
Sbjct: 221 NSEIYNYLIKGNRLKQPPDCLE----DVYELMCQCWSPEPKCR-PSFQHLR 266

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 31/203 (15%)

Query: 121 PPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYM 179
           P      A+K++  +  D   S +  E+E+++ +  H N++       ++G + VL+EY 
Sbjct: 41  PNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYA 100

Query: 180 DGGSL----------------EGAHIRQEHI----LSDLARQVLSGLAYLHKRKIVHRDI 219
             G+L                +   + +E +    L   A QV  G+ YL  +K +HRD+
Sbjct: 101 SKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDL 160

Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG---TIAYMSPERINTDLNHGKYDG 276
              N+L+     +KIADFG++R +   +D           + +M+PE +       +   
Sbjct: 161 AARNVLVTEDNVMKIADFGLARDV-HNIDYYKKTTNGRLPVKWMAPEAL-----FDRVYT 214

Query: 277 YAGDIWSLGVSILE-FYLGRFPF 298
           +  D+WS GV + E F LG  P+
Sbjct: 215 HQSDVWSFGVLLWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 59.1 bits (143), Expect = 6e-10
 Identities = 34/169 (20%), Positives = 78/169 (46%), Gaps = 22/169 (13%)

Query: 141 RSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEH------- 193
           +++  ++ +  R + HPN+++C           ++ EY + G L+  ++ QE        
Sbjct: 39  QNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKS-YLSQEQWHRRNSQ 97

Query: 194 --ILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGV--SRILAQTMDP 249
             +L  +A ++ +G+ ++HK   +H D+   N  + S   VK+ D+G+  SR     ++ 
Sbjct: 98  LLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157

Query: 250 CNSAVGTIAYMSPERINT------DLNHGKYDGYAGDIWSLGVSILEFY 292
            +     + +++PE +             K      ++W+LGV++ E +
Sbjct: 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKP----SNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 51/199 (25%), Positives = 91/199 (45%), Gaps = 37/199 (18%)

Query: 128 ALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG 186
           A+K++  +  +   S +  E+E+++ +  H N++       ++G + V++EY   G+L  
Sbjct: 54  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 113

Query: 187 ----------------AHIRQEHI----LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI 226
                             + +E +    L   A QV  G+ YL  +K +HRD+   N+L+
Sbjct: 114 YLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173

Query: 227 NSSKNVKIADFGVSRILAQTMDPCNSAVG--TIAYMSPE----RINTDLNHGKYDGYAGD 280
                +KIADFG++R +        +  G   + +M+PE    RI T         +  D
Sbjct: 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT---------HQSD 224

Query: 281 IWSLGVSILE-FYLGRFPF 298
           +WS GV + E F LG  P+
Sbjct: 225 VWSFGVLLWEIFTLGGSPY 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 58.9 bits (142), Expect = 7e-10
 Identities = 53/226 (23%), Positives = 93/226 (41%), Gaps = 30/226 (13%)

Query: 137 EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE------VLLEYMDGGSLEGAHIR 190
           ED +   +C     +++ +HPNV++   +  +  E E      V+L +M  G L    + 
Sbjct: 45  EDFLSEAVC-----MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLY 99

Query: 191 QE----------HILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS 240
                        +L      + SG+ YL  +  +HRD+   N ++N + NV +ADFG+S
Sbjct: 100 SRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159

Query: 241 RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPF- 298
           +   +  +      G IA M  + I  +    +      D+WS GV++ E    G+ P+ 
Sbjct: 160 K---KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP 216

Query: 299 AVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
            V     +  L       QPP+  +         +S C   +P  R
Sbjct: 217 GVENSEIYDYLRQGNRLKQPPDCLDG----LYSLMSSCWLLNPKDR 258

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 59.7 bits (144), Expect = 8e-10
 Identities = 42/161 (26%), Positives = 74/161 (45%), Gaps = 20/161 (12%)

Query: 142 SQICREIEILRDVNHPNVVKCHD---------MYDRNGEIEVLLEYMDGGSLEGAHIRQE 192
            Q+  EI  L  +NH N++K  +         M  +  + + L  +M   + +       
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFD-LYSFMYDEAFDWKDRPLL 266

Query: 193 HILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS 252
                + +Q+L  + Y+H +K++HRDIK  N+ +N    + + DFG +    +  +  + 
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326

Query: 253 A-VGTIAYMSPERINTDLNHGKYDGYA--GDIWSLGVSILE 290
             VGT+A  SPE +         DGY    DIWS G+ +L+
Sbjct: 327 GWVGTVATNSPEILAG-------DGYCEITDIWSCGLILLD 360

Length = 501

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 64/283 (22%), Positives = 109/283 (38%), Gaps = 51/283 (18%)

Query: 104 GNRIGSGSGGTVW--RVVHPPTSRV-FALKVI-YGNHEDSVRSQICREIEILRDVNHPNV 159
           G  +G G  G+V   ++     S++  A+K +    H  S   +   E   ++D +HPNV
Sbjct: 4   GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63

Query: 160 VK----CHDMYDRNGEIE--VLLEYMDGGSLEGAHIRQ------EHI----LSDLARQVL 203
           +K    C +        +  V+L +M  G L    +        E +    L      + 
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123

Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL----------AQTMDPCNSA 253
            G+ YL  R  +HRD+   N ++     V +ADFG+S+ +             M      
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM-----P 178

Query: 254 VGTIAYMS-PERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFA-VGRQGDWASLM 310
           V  IA  S  +R+ T  +         D+W+ GV++ E    G+ P+  V     +  L 
Sbjct: 179 VKWIAIESLADRVYTSKS---------DVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR 229

Query: 311 FAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
                 QP +  +    E  D +  C + DP  R    +L + 
Sbjct: 230 HGNRLKQPEDCLD----ELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 18/196 (9%)

Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDI 219
           V+     D++   E+L E  D  +L+      E +LS  + QV  G+++L  +  +HRD+
Sbjct: 189 VRSGSYIDQDVTSEILEE--DELALD-----TEDLLS-FSYQVAKGMSFLASKNCIHRDL 240

Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPC--NSAVGTIAYMSPERINTDLNHGKYDGY 277
              N+L+   +  KI DFG++R +    +     +A   + +M+PE I     +  Y  +
Sbjct: 241 AARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESI----FNCVYT-F 295

Query: 278 AGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
             D+WS G+ + E F LG  P+  G   D +     I       +PE A  E  D +  C
Sbjct: 296 ESDVWSYGILLWEIFSLGSSPYP-GMPVD-SKFYKMIKEGYRMLSPECAPSEMYDIMKSC 353

Query: 337 LQKDPHSRWPAAQLLQ 352
              DP  R    Q++Q
Sbjct: 354 WDADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 10/156 (6%)

Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS--AVGTIA 258
           QV  G+ +L  RK +HRD+   N+L++ +  VKI DFG++R + +  D      A   + 
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQ 317
           +M+PE I       +      D+WS GV + E F LG  P+  G + D       +    
Sbjct: 247 WMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKID-EEFCRRLKEGT 299

Query: 318 PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
              AP+  + E    +  C   +P  R   ++L++H
Sbjct: 300 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 55/239 (23%)

Query: 147 EIEIL-RDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL---------- 195
           E+E+L +  +HPN++      +  G + + +EY   G+L    +R+  +L          
Sbjct: 57  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIAN 115

Query: 196 ---SDLARQ--------VLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR--- 241
              S L+ Q        V  G+ YL +++ +HRD+   N+L+  +   KIADFG+SR   
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 175

Query: 242 -ILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA--GDIWSLGVSILEFY-LGRFP 297
             + +TM         + +M+ E +N       Y  Y    D+WS GV + E   LG  P
Sbjct: 176 VYVKKTMGRL-----PVRWMAIESLN-------YSVYTTNSDVWSYGVLLWEIVSLGGTP 223

Query: 298 FAVGRQGDWASLMFAICFAQPP-----EAPEMASREFRDFISRCLQKDPHSRWPAAQLL 351
           +          +  A  + + P     E P     E  D + +C ++ P+ R   AQ+L
Sbjct: 224 Y--------CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 37/144 (25%), Positives = 75/144 (52%), Gaps = 10/144 (6%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV----NHPNVVKC 162
           I  G+ G V+       S+++A+KV+     D +   +  +++  RD       P +V  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVV--KKADMINKNMVHQVQAERDALALSKSPFIVHL 69

Query: 163 HDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLS----GLAYLHKRKIVHRD 218
           +        + +++EY+ GG ++       +   ++A + +S     L YLH+  I+HRD
Sbjct: 70  YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRD 129

Query: 219 IKPSNLLINSSKNVKIADFGVSRI 242
           +KP N+LI++  ++K+ DFG+S++
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 36/110 (32%), Positives = 59/110 (53%), Gaps = 9/110 (8%)

Query: 192 EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN 251
           E ++S  + QV  G+ +L  RK +HRD+   N+L++ +  VKI DFG++R + +  D   
Sbjct: 173 EDLIS-YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 231

Query: 252 S--AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
              A   + +M+PE I   +   +      D+WS GV + E F LG  P+
Sbjct: 232 KGDARLPLKWMAPESIFDKVYTTQ-----SDVWSFGVLLWEIFSLGASPY 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 56.3 bits (136), Expect = 5e-09
 Identities = 57/238 (23%), Positives = 98/238 (41%), Gaps = 32/238 (13%)

Query: 129 LKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL---- 184
           LKV+  +H DS+         ++  ++H ++VK + +  R+  I V  EY+  G L    
Sbjct: 35  LKVLGSDHRDSLAFF--ETASLMSQLSHKHLVKLYGVCVRDENIMVE-EYVKFGPLDVFL 91

Query: 185 --EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI-------NSSKNVKIA 235
             E  ++   H   D+A+Q+ S L YL  +K+VH ++   N+L+            +K++
Sbjct: 92  HREKNNV-SLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLS 150

Query: 236 DFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLG 294
           D G+   +    +     V  I +++PE I    N       A D WS G ++LE    G
Sbjct: 151 DPGIPITVLSREER----VERIPWIAPECIR---NGQASLTIAADKWSFGTTLLEICSNG 203

Query: 295 RFPF-AVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLL 351
             P   +          F   +      P     E  + I++C   DP  R     +L
Sbjct: 204 EEPLSTLSSS---EKERF---YQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAIL 255

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 57.0 bits (137), Expect = 6e-09
 Identities = 44/147 (29%), Positives = 72/147 (48%), Gaps = 10/147 (6%)

Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN--SAVGTIA 258
           QV  G+ +L  +  VHRD+   N+L+   K VKI DFG++R +    +  +  S    + 
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK 304

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQ 317
           +M+PE I  +L    Y   + D+WS G+ + E F LG  P+  G   D ++    I    
Sbjct: 305 WMAPESIFDNL----YTTLS-DVWSYGILLWEIFSLGGTPYP-GMIVD-STFYNKIKSGY 357

Query: 318 PPEAPEMASREFRDFISRCLQKDPHSR 344
               P+ A++E  D + +C   +P  R
Sbjct: 358 RMAKPDHATQEVYDIMVKCWNSEPEKR 384

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 56.8 bits (137), Expect = 7e-09
 Identities = 36/116 (31%), Positives = 56/116 (48%), Gaps = 23/116 (19%)

Query: 195 LSDLAR---QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN 251
           L DL R   QV  G+ +L  +  +HRD+   N+L+   +  KI DFG++R     M+  N
Sbjct: 211 LDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR---DIMNDSN 267

Query: 252 SAVG-----TIAYMSPERINTDLNHGKYD---GYAGDIWSLGVSILE-FYLGRFPF 298
             V       + +M+PE I        +D       D+WS G+ + E F LG+ P+
Sbjct: 268 YVVKGNARLPVKWMAPESI--------FDCVYTVQSDVWSYGILLWEIFSLGKSPY 315

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 55.8 bits (134), Expect = 8e-09
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 33/179 (18%)

Query: 146 REIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHILSD------- 197
           +E  ++ +++HPN+V    +  +   + +L EY++ G L E   +R  H  SD       
Sbjct: 56  QEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPH--SDVGCSSDE 113

Query: 198 ---------------LARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI 242
                          +A Q+ +G+ YL     VH+D+   N+LI    +VKI+D G+SR 
Sbjct: 114 DGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSRE 173

Query: 243 L--AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
           +  A        ++  I +M PE I     +GK+   + DIWS GV + E F  G  P+
Sbjct: 174 IYSADYYRVQPKSLLPIRWMPPEAI----MYGKFSSDS-DIWSFGVVLWEIFSFGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 59/248 (23%), Positives = 102/248 (41%), Gaps = 64/248 (25%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR---EIEILRDVNHPNVVKCH 163
           +G G+ G V       T  ++A+K +    +  +R+Q+     E +IL + ++  VV+ +
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLR-KKDVLLRNQVAHVKAERDILAEADNEWVVRLY 67

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDI 219
             +     +  +++Y+ GG +    IR      DLAR    ++   +  +HK   +HRDI
Sbjct: 68  YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDI 127

Query: 220 KPSNLLINSSKNVKIADFGV----------------SRILAQTMDPCN------------ 251
           KP N+LI+   ++K+ DFG+                  +   +MD  N            
Sbjct: 128 KPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGD 187

Query: 252 -------------------SAVGTIAYMSPERINTDLNHGKYDGYAG--DIWSLGVSILE 290
                              S VGT  Y++PE +          GY    D WS+GV + E
Sbjct: 188 RLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL-------LRTGYTQLCDWWSVGVILYE 240

Query: 291 FYLGRFPF 298
             +G+ PF
Sbjct: 241 MLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 54/255 (21%), Positives = 99/255 (38%), Gaps = 32/255 (12%)

Query: 107 IGSGSGGTVWR-VVHPPTSR--VFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G+G  G + R  +  P+ R    A+  +     D  R     E   L   +H N+V+  
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYLHKRKIVHRD 218
            +  R   + ++ EYM  G+L+    + E  L       +   + SG+ YL +   VH+ 
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKG 132

Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG---TIAYMSPERINTDLNHGKYD 275
           +    +L+NS    KI+ F   R+     +   + +     + + +PE I     +  + 
Sbjct: 133 LAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAI----QYHHFS 186

Query: 276 GYAGDIWSLGVSILEFYLGRFPFAVGRQGDW----ASLMFAI--CFAQPPEAPEMASREF 329
             A D+WS G+ + E        + G +  W      ++ A+   F  P   P       
Sbjct: 187 S-ASDVWSFGIVMWEV------MSYGERPYWDMSGQDVIKAVEDGFRLPA--PRNCPNLL 237

Query: 330 RDFISRCLQKDPHSR 344
              +  C QK+   R
Sbjct: 238 HQLMLDCWQKERGER 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 52.8 bits (127), Expect = 2e-08
 Identities = 39/184 (21%), Positives = 65/184 (35%), Gaps = 27/184 (14%)

Query: 183 SLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI 242
            + G  + +E I + +  Q L  L  LH++      +   + L+    +V          
Sbjct: 8   EVRGRPLNEEEIWA-VCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSVAF-------- 58

Query: 243 LAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSI---LEFYLGRF-PF 298
                 P  S      +M+PE I      G+      DI+SLG+++   L++ L      
Sbjct: 59  ----KTPEQSRPDP-YFMAPEVIQ-----GQSYTEKADIYSLGITLYEALDYELPYNEER 108

Query: 299 AVGRQGDWA-SLM--FAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
            +    +   + M           E    A+R F DF+  C  + P  R  A   L H  
Sbjct: 109 ELSAILEILLNGMPADDPRDRSNLEGVS-AARSFEDFMRLCASRLPQRREAANHYLAHCR 167

Query: 356 ILRA 359
            L A
Sbjct: 168 ALFA 171

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 14/156 (8%)

Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN--SAVGTIA 258
           QV +G+ +L  +  VHRD+   N+LI   K VKI DFG++R + +  +  +  S    + 
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGD--WASLMFAICF 315
           +M+PE I  +L    Y   + D+WS G+ + E F LG  P+      +  + ++      
Sbjct: 307 WMAPESIFNNL----YTTLS-DVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM 361

Query: 316 AQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLL 351
           A+P      AS E  + + +C ++    R   +QL+
Sbjct: 362 AKPAH----ASDEIYEIMQKCWEEKFEIRPDFSQLV 393

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 54.7 bits (131), Expect = 3e-08
 Identities = 26/51 (50%), Positives = 34/51 (66%)

Query: 190 RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS 240
           R  +++  + RQVL+GL  LH+  IVHRDIKP NLL+     VKI DFG +
Sbjct: 306 RDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 50/200 (25%), Positives = 86/200 (43%), Gaps = 32/200 (16%)

Query: 124 SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGS 183
           ++  A+K +    E  +R +   E  +   + HPN+V    +  +   + ++  Y     
Sbjct: 35  TQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSD 94

Query: 184 L-EGAHIRQEHILSDLAR---------------------QVLSGLAYLHKRKIVHRDIKP 221
           L E   +R  H  SD+                       Q+ +G+ +L    +VH+D+  
Sbjct: 95  LHEFLVMRSPH--SDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLAT 152

Query: 222 SNLLINSSKNVKIADFGVSRIL--AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            N+L+    NVKI+D G+ R +  A       +++  I +MSPE I     +GK+     
Sbjct: 153 RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAI----MYGKFS-IDS 207

Query: 280 DIWSLGVSILE-FYLGRFPF 298
           DIWS GV + E F  G  P+
Sbjct: 208 DIWSYGVVLWEVFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 58/187 (31%), Positives = 91/187 (48%), Gaps = 18/187 (9%)

Query: 110 GSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRN 169
           GS G V+   HP   +   +K   G +  SV      E  +LR ++HP V+   D+    
Sbjct: 180 GSEGCVFESSHPDYPQRVVVKA--GWYASSVH-----EARLLRRLSHPAVLALLDVRVVG 232

Query: 170 G-EIEVLLEYM-DGGSLEGAHIRQEHIL--SDLARQVLSGLAYLHKRKIVHRDIKPSNLL 225
           G    VL +Y  D  +  GA +R   +   + +ARQ+LS + Y+H   I+HRDIK  N+L
Sbjct: 233 GLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVL 292

Query: 226 INSSKNVKIADFGVSRILAQTMD-PCNSAV-GTIAYMSPERINTDLNHGKYDGYAGDIWS 283
           +N  +++ + DFG +     +   P +  + GT+   +PE +  D     Y     DIWS
Sbjct: 293 VNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGD----PYTPSV-DIWS 347

Query: 284 LGVSILE 290
            G+ I E
Sbjct: 348 AGLVIFE 354

Length = 461

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 50.9 bits (122), Expect = 8e-08
 Identities = 32/142 (22%), Positives = 60/142 (42%), Gaps = 21/142 (14%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH-----PNVV 160
            +  G    V+ +        + LK+   N      +   RE+ IL+ +       P V+
Sbjct: 5   LLKGGLTNRVYLL--GTKDEDYVLKI---NPSREKGADREREVAILQLLARKGLPVPKVL 59

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-EHILSDLARQVLSGLAYLHKRKI---VH 216
                 + +G   +L+E+++G +L+     + E I   LA      LA LH+  +    H
Sbjct: 60  ---ASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLAEL----LAKLHQLPLLVLCH 112

Query: 217 RDIKPSNLLINSSKNVKIADFG 238
            D+ P N+L++  K + I D+ 
Sbjct: 113 GDLHPGNILVDDGKILGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 49/194 (25%), Positives = 86/194 (44%), Gaps = 34/194 (17%)

Query: 130 KVIYGNHEDSVRS-------------QICREIEILRDVNHPNVVKCH----DMYDRNGEI 172
           K I+ N E  +R+                 EI+ LR ++  N++K +    D+ D    +
Sbjct: 38  KGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL 97

Query: 173 EVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYLHKR-KIVHRDIKPSNLLI 226
            ++LEY   G L    + +E  LS     D+A     GL  L+K     ++++   + L+
Sbjct: 98  SLILEYCTRGYLREV-LDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV 156

Query: 227 NSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL--NHGKYDGYAGDIWSL 284
             +  +KI   G+ +IL+    P    V  + Y S  ++  D+   +   D    DI+SL
Sbjct: 157 TENYKLKIICHGLEKILS---SPPFKNVNFMVYFSY-KMLNDIFSEYTIKD----DIYSL 208

Query: 285 GVSILEFYLGRFPF 298
           GV + E + G+ PF
Sbjct: 209 GVVLWEIFTGKIPF 222

Length = 283

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 21/50 (42%), Positives = 30/50 (60%), Gaps = 1/50 (2%)

Query: 190 RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN-SSKNVKIADFG 238
           R+  I+  + RQ+L  L  LH   IVHRD+KP N++ +  S + KI D G
Sbjct: 252 RENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLG 301

Length = 566

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 49.9 bits (119), Expect = 7e-07
 Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 22/174 (12%)

Query: 143 QICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEH--------- 193
           +   E +  R + H N+++C           +++E+   G L+G ++R            
Sbjct: 41  KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKG-YLRSCRKAELMTPDP 99

Query: 194 -ILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT---MDP 249
             L  +A ++  GL +LHK   +H D+   N L+ +   VKI D+G+S    +    + P
Sbjct: 100 TTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159

Query: 250 CNSAVGTIAYMSPERINTDLNHGKY----DGYAGDIWSLGVSILE-FYLGRFPF 298
               V  + +++PE +  D  HG           ++WSLGV+I E F LG  P+
Sbjct: 160 DQLWV-PLRWIAPELV--DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 64/266 (24%), Positives = 108/266 (40%), Gaps = 62/266 (23%)

Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGS---LEGAHIR---QEHILSDLAR 200
           E+ + +  NHPN+V     +  + E+ V+  +M  GS   L   H      E  ++ + +
Sbjct: 49  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQ 108

Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ---------TMDPCN 251
            VL  L Y+H    VHR +K S++LI+    V ++  G+   L+            D   
Sbjct: 109 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPK 166

Query: 252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF------------- 298
            +V  + ++SPE +  +L    YD  + DI+S+G++  E   G  PF             
Sbjct: 167 YSVKVLPWLSPEVLQQNLQ--GYDAKS-DIYSVGITACELANGHVPFKDMPATQMLLEKL 223

Query: 299 --------------------AVGRQGDWASLMFAICFAQP-PEAPEMASREF-RDF---- 332
                                  R G  + L  +   + P P   E +S  + R F    
Sbjct: 224 NGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHF 283

Query: 333 ---ISRCLQKDPHSRWPAAQLLQHPF 355
              + +CLQ++P +R  A+ LL H F
Sbjct: 284 HHFVEQCLQRNPDARPSASTLLNHSF 309

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 72/329 (21%), Positives = 124/329 (37%), Gaps = 83/329 (25%)

Query: 114 TVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI 172
           +V+   H PT  +  +++    N  +     +  E+ +     HPN++    ++     +
Sbjct: 15  SVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74

Query: 173 EVLLEYMDGGSL---------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSN 223
            V+  +M  GS          EG     E ++ ++    L GL YLH+   +HR+IK S+
Sbjct: 75  WVISPFMAYGSANSLLKTYFPEGM---SEALIGNILFGALRGLNYLHQNGYIHRNIKASH 131

Query: 224 LLINSSKNVKIADFGVSRILAQ---------TMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           +LI+    V ++  G+S + +            D    +   + ++SPE +  DL     
Sbjct: 132 ILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLY---- 185

Query: 275 DGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAP---------- 322
            GY    DI+S+G++  E   GR PF    Q    + M       PP +P          
Sbjct: 186 -GYNVKSDIYSVGITACELATGRVPF----QDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240

Query: 323 -------------------------EMASREFR------------DFISRCLQKDPHSRW 345
                                     M S   R            + +  CLQ+DP  R 
Sbjct: 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRP 300

Query: 346 PAAQLLQHPFILRAGQSQVNQNLRQILPP 374
            A+ LL H F  +  + Q   ++  +LPP
Sbjct: 301 SASSLLSHAF-FKQVKEQTQGSILSLLPP 328

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.5 bits (105), Expect = 3e-05
 Identities = 57/247 (23%), Positives = 98/247 (39%), Gaps = 63/247 (25%)

Query: 129 LKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL---- 184
           LKV+  +H D +         ++  V+H ++   H +  R  E  ++ E+++ G L    
Sbjct: 49  LKVLDPSHRD-IALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL 107

Query: 185 --EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI-------NSSKNVKIA 235
             E   +     ++ +A+Q+ S L+YL  + +VH ++   N+L+        +S  +K++
Sbjct: 108 RKEKGRVPVAWKIT-VAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLS 166

Query: 236 DFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR 295
           D GVS     T       V  I +++PE +      G     A D WS G ++LE     
Sbjct: 167 DPGVSF----TALSREERVERIPWIAPECVPG----GNSLSTAADKWSFGTTLLE----- 213

Query: 296 FPFAVGRQGDWASLMFAICF--------AQPPEA----------PEMASREFRDFISRCL 337
                            ICF          P E           PE + +E    IS+CL
Sbjct: 214 -----------------ICFDGEVPLKERTPSEKERFYEKKHRLPEPSCKELATLISQCL 256

Query: 338 QKDPHSR 344
             +P  R
Sbjct: 257 TYEPTQR 263

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 59/241 (24%), Positives = 87/241 (36%), Gaps = 69/241 (28%)

Query: 195 LSDLARQVLSGLAYLHKR-KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC--- 250
           L+ +  Q    L Y H    ++H D+KP N+L+ +S  V   D   +R L    DPC   
Sbjct: 233 LAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTV--VDPVTNRALPP--DPCRVR 288

Query: 251 --------------NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRF 296
                          + V T  Y SPE +   L  G    Y+ D+WS+G  I E Y G+ 
Sbjct: 289 ICDLGGCCDERHSRTAIVSTRHYRSPEVV---LGLGWM--YSTDMWSMGCIIYELYTGKL 343

Query: 297 PF--------------AVGR-QGDWAS---------LMFAICFAQPPEAPEMASREFR-- 330
            +               +GR   +WA          L  +    +P   P+  +R  R  
Sbjct: 344 LYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARAR 403

Query: 331 ------------DFISRCLQKDPHSRWPAAQLLQHPFILR----AGQSQVNQNLRQILPP 374
                       D I   L  D   R  A Q+  HP++L+      Q     + R +L P
Sbjct: 404 PVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHPNYPDNRSMLRP 463

Query: 375 P 375
            
Sbjct: 464 T 464

Length = 467

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 43.4 bits (103), Expect = 6e-05
 Identities = 26/106 (24%), Positives = 47/106 (44%), Gaps = 19/106 (17%)

Query: 146 REIEIL-----RDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHILS 196
           RE  I+       VN P V   + +   N  I   +EY++G  L        + +  +  
Sbjct: 48  REARIMSRARKAGVNVPAV---YFVDPENFIIV--MEYIEGEPLKDLINSNGMEELELSR 102

Query: 197 DLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI 242
           ++ R V      LH   I+H D+  SN++++  K + + DFG++  
Sbjct: 103 EIGRLV----GKLHSAGIIHGDLTTSNMILSGGK-IYLIDFGLAEF 143

Length = 211

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 43.0 bits (102), Expect = 7e-05
 Identities = 33/102 (32%), Positives = 48/102 (47%), Gaps = 14/102 (13%)

Query: 146 REIEILRD-----VNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR 200
           RE  IL       V  P V   +D+   NG I  ++EY++G  L+ A         DL R
Sbjct: 48  REARILAKAREAGVPVPIV---YDVDPDNGLI--VMEYIEGELLKDALEE---ARPDLLR 99

Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI 242
           +V   +  LHK  IVH D+  SN+++ S   +   DFG+   
Sbjct: 100 EVGRLVGKLHKAGIVHGDLTTSNIIL-SGGRIYFIDFGLGEF 140

Length = 204

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 42.2 bits (100), Expect = 1e-04
 Identities = 30/103 (29%), Positives = 47/103 (45%), Gaps = 16/103 (15%)

Query: 146 REIEILRD-----VNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHILSDLA 199
            E  +L       VN P V    D+   N  I  ++EY++G  L +      + +L ++ 
Sbjct: 46  NEARLLSRARKAGVNTPVVY---DVDPDNKTI--VMEYIEGKPLKDVIEEGNDELLREIG 100

Query: 200 RQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI 242
           R V      LHK  IVH D+  SN+++   K   I DFG+ + 
Sbjct: 101 RLV----GKLHKAGIVHGDLTTSNIIVRDDKLYLI-DFGLGKY 138

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 26/114 (22%), Positives = 57/114 (50%), Gaps = 12/114 (10%)

Query: 194 ILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-------RILAQT 246
           ++ ++ + +L+ L Y+H+  I H DIKP N++++ +    I D+G++       + +  +
Sbjct: 127 LIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS 186

Query: 247 MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAV 300
            +  +   GT+ Y        D ++G      GD+ SLG  +L++   + P+  
Sbjct: 187 KEQKDLHRGTLYYAG-----LDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG 235

Length = 294

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	380
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.94
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
PRK12274	218	serine/threonine protein kinase; Provisional	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK10345	210	hypothetical protein; Provisional	99.87
smart00090	237	RIO RIO-like kinase.	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
PRK14879	211	serine/threonine protein kinase; Provisional	99.84
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.84
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.83
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.81
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.79
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.77
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.77
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.65
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.64
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.62
KOG1243	690	consensus Protein kinase [General function predict	99.61
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.59
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.56
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.47
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.42
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.4
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.38
COG4248	637	Uncharacterized protein with protein kinase and he	99.33
KOG3087	229	consensus Serine/threonine protein kinase [General	99.33
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.31
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.28
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.26
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.25
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.2
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.04
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.96
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.95
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.81
PRK09902	216	hypothetical protein; Provisional	98.81
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.77
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.74
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.7
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.66
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.65
PF01636	239	APH: Phosphotransferase enzyme family This family	98.65
PLN02876	822	acyl-CoA dehydrogenase	98.64
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.54
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.5
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.4
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.35
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.27
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.25
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.25
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.23
PRK10593	297	hypothetical protein; Provisional	98.21
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.18
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.16
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	98.15
PRK05231	319	homoserine kinase; Provisional	98.04
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.99
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.88
KOG2270	520	consensus Serine/threonine protein kinase involved	97.87
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.83
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.79
PLN02236	344	choline kinase	97.66
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.58
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.53
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.45
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.35
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.32
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.24
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.21
COG2334	331	Putative homoserine kinase type II (protein kinase	97.17
PRK12396	409	5-methylribose kinase; Reviewed	96.99
PTZ00384	383	choline kinase; Provisional	96.96
PLN02756	418	S-methyl-5-thioribose kinase	96.91
PRK11768	325	serine/threonine protein kinase; Provisional	96.8
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.76
PRK06148	1013	hypothetical protein; Provisional	96.75
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.7
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.47
PTZ00296	442	choline kinase; Provisional	96.47

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-63  Score=441.02  Aligned_cols=278  Identities=50%  Similarity=0.792  Sum_probs=253.8

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC-eEE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG-EIE  173 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~  173 (380)
                      .+..++++.++.||+|..|+||+|+++.|++.+|+|++..+.++..++++.+|++++++++||+||.+||.|...+ .+.
T Consensus        75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is  154 (364)
T KOG0581|consen   75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS  154 (364)
T ss_pred             ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence            3777899999999999999999999999999999999988888999999999999999999999999999999988 499


Q ss_pred             EEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          174 VLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHK-RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      |+||||++|+|...+.    .+|..+.+|+.+|++||.|||+ ++||||||||+||||+..|.+||||||.+..+.+.  
T Consensus       155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            9999999999988877    6899999999999999999996 99999999999999999999999999999988776  


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC--CCCCCHHHHHHHHhhCCCCCCCcc-c
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAV--GRQGDWASLMFAICFAQPPEAPEM-A  325 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~--~~~~~~~~~~~~~~~~~~~~~~~~-~  325 (380)
                      .+.+++||..|||||.+.     +..|+.++||||||++++|+++|+.||..  ....++.+.+..+....++..|.. +
T Consensus       233 ~a~tfvGT~~YMsPERi~-----g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~f  307 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERIS-----GESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEF  307 (364)
T ss_pred             hcccccccccccChhhhc-----CCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence            568999999999999996     46778899999999999999999999975  345688999999999999999997 9


Q ss_pred             cHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccccc--cccccCCCCCCCC
Q 016959          326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQ--NLRQILPPPRPLS  379 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~--~~~~~~~~~~~~~  379 (380)
                      ++++++||..||++||.+|+|+.|+|+|||+++........  -.++..++++++.
T Consensus       308 S~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd~~~~~~~~~~~~~~~~  363 (364)
T KOG0581|consen  308 SPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVDMASFVRKALSPPRSLP  363 (364)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccccHHHHHHHhcccCCCCC
Confidence            99999999999999999999999999999999886665543  3466666766653

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-62  Score=440.40  Aligned_cols=274  Identities=28%  Similarity=0.437  Sum_probs=234.2

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchH------HHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS------VRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      ..+.|.+.+.||+|+||.|-+|..+.+|+.||||++.+.....      ....+.+|+++|++|+|||||+++++|+..+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            3567889999999999999999999999999999996543211      2334679999999999999999999999999


Q ss_pred             eEEEEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CcEEEeeccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS---KNVKIADFGVSRIL  243 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~---~~~kl~Dfg~a~~~  243 (380)
                      ..|+||||++||+|.+....    .+..-..+++||+.|+.|||++||+||||||+|||+..+   ..+||+|||+|+..
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            99999999999999776443    355556789999999999999999999999999999866   56999999999987


Q ss_pred             cccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC-HHHHHHHHhhCCCCCCC
Q 016959          244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD-WASLMFAICFAQPPEAP  322 (380)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  322 (380)
                      . ......+.|||+.|.|||++...  ...++..++||||||||||-+++|..||....... ..+.+....+...+..|
T Consensus       330 g-~~sfm~TlCGTpsYvAPEVl~~k--g~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w  406 (475)
T KOG0615|consen  330 G-EGSFMKTLCGTPSYVAPEVLASK--GVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW  406 (475)
T ss_pred             c-cceehhhhcCCccccChhheecC--CeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence            6 33556889999999999999652  12344568999999999999999999998554444 67778888888889999


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccccccccccCC
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILP  373 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~  373 (380)
                      ..++.+..+||.+||..||++|+|++|+|+||||+.....+..+.+.++-|
T Consensus       407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s~~~~l~~~~~  457 (475)
T KOG0615|consen  407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLSKQDILKKLQP  457 (475)
T ss_pred             hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccchHHHHhhcCc
Confidence            999999999999999999999999999999999999887775555544433

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.9e-59  Score=443.96  Aligned_cols=350  Identities=75%  Similarity=1.235  Sum_probs=277.5

Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcch
Q 016959            1 MRPVLPPPPSGLSSSSSSSSSSPSSSLANRRGQRRRPDLTLPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQ   80 (380)
Q Consensus         1 ~~~~~~~~~~~~~~~ssss~~s~sss~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~p~~~~~~~~~~~~~~~~~~~~~~~   80 (380)
                      |||+.|+++++..+.++....+         ..+++++...+.++..+..+.|.+.|+.+..++++.+.....       
T Consensus         1 ~~p~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------   64 (353)
T PLN00034          1 MKPIQPPPGVPLPSTARHTTKS---------RPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSASG-------   64 (353)
T ss_pred             CCCCCCCCCCCCCCCCCCCCcC---------CCCCCCCCCCCCCCCCCCcCCCCCCCCCCCCCCCCcccccCC-------
Confidence            7888887665444433221111         223445566666777776666666665544333332222110       


Q ss_pred             hhhhhhhhccccccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCcee
Q 016959           81 QQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV  160 (380)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv  160 (380)
                               .........++|+..++||+|+||+||+|++..+++.||||++...........+.+|+++++.++|+||+
T Consensus        65 ---------~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv  135 (353)
T PLN00034         65 ---------SAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVV  135 (353)
T ss_pred             ---------CCCCCCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcc
Confidence                     01112234578889999999999999999999999999999997766666677899999999999999999


Q ss_pred             eeEeEEeeCCeEEEEEeccCCCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccc
Q 016959          161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS  240 (380)
Q Consensus       161 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  240 (380)
                      ++++++...+.+++||||+.+++|.......+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus       136 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~  215 (353)
T PLN00034        136 KCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVS  215 (353)
T ss_pred             eeeeEeccCCeEEEEEecCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccc
Confidence            99999999999999999999999988777778888899999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC
Q 016959          241 RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE  320 (380)
Q Consensus       241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  320 (380)
                      ..+...........||..|+|||++......+.+++.++|||||||++|||++|+.||......++..............
T Consensus       216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  295 (353)
T PLN00034        216 RILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE  295 (353)
T ss_pred             eecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCC
Confidence            87765444445678999999999986555556677789999999999999999999998666667777777766666777


Q ss_pred             CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc--ccccccccCCCC
Q 016959          321 APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ--VNQNLRQILPPP  375 (380)
Q Consensus       321 ~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~--~~~~~~~~~~~~  375 (380)
                      .+..++.++++||.+||..||++|||+.|+|+||||.+.....  ..+.+.+..|||
T Consensus       296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~  352 (353)
T PLN00034        296 APATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLPPP  352 (353)
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcccccCCCCccCCCCCC
Confidence            7788899999999999999999999999999999999974332  244556777775

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-61  Score=429.75  Aligned_cols=274  Identities=29%  Similarity=0.489  Sum_probs=242.1

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .+..++|++.++||+|+||+||.++.+.+++.||+|++++..  .....+...+|..+|.+++||+||+++..|++.+.+
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            467899999999999999999999999999999999997654  233467788999999999999999999999999999


Q ss_pred             EEEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          173 EVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      |+|+||+.||.|..++..    .+..++-++.+|+.||.|||++|||||||||+|||+|.+|+++|+|||+++......+
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            999999999999766653    5777888999999999999999999999999999999999999999999997766667


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHH
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE  328 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (380)
                      ...+.|||+.|||||++..     ..|+..+|+|||||++|||++|..||..   .+....+..+.....+..+..++.+
T Consensus       181 ~t~tfcGT~eYmAPEil~~-----~gy~~~vDWWsLGillYeML~G~pPF~~---~~~~~~~~~I~~~k~~~~p~~ls~~  252 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLG-----KGYDKAVDWWSLGILLYEMLTGKPPFYA---EDVKKMYDKILKGKLPLPPGYLSEE  252 (357)
T ss_pred             ccccccCCccccChHHHhc-----CCCCcccchHhHHHHHHHHhhCCCCCcC---ccHHHHHHHHhcCcCCCCCccCCHH
Confidence            7788999999999999964     5677899999999999999999999974   3444455555544456667779999


Q ss_pred             HHHHHHHhcccCcCCCC----CHHHHhcCccccccCcccccccccccCCCCCCC
Q 016959          329 FRDFISRCLQKDPHSRW----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRPL  378 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~----t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  378 (380)
                      ++||++++|..||++|+    ++.+|-+||||.+++|..+.+  ++..||++|-
T Consensus       253 ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~--k~l~PpF~P~  304 (357)
T KOG0598|consen  253 ARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLA--KKLSPPFKPN  304 (357)
T ss_pred             HHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHh--cCCCCCeecC
Confidence            99999999999999997    689999999999999999877  8888888873

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-59  Score=441.02  Aligned_cols=250  Identities=30%  Similarity=0.483  Sum_probs=223.9

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      .+|..++.||+|||+.||++++..+|..||+|++.+..  ....++++.+||++.+.|+|||||+++++|++.+++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            56999999999999999999999999999999996532  4556788999999999999999999999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      |+|..++|..++.    ..|.+++.+++||+.||.|||+++|+|||||..|++++++.++||+|||+|+.+....+...+
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T  177 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT  177 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence            9999999876655    368899999999999999999999999999999999999999999999999999887788899


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      .|||+.|+|||+++     ...+++.+||||+|||||.||+|+.||......+....++..    .-..|..++.+++||
T Consensus       178 lCGTPNYIAPEVl~-----k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~----~Y~~P~~ls~~A~dL  248 (592)
T KOG0575|consen  178 LCGTPNYIAPEVLN-----KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN----EYSMPSHLSAEAKDL  248 (592)
T ss_pred             ecCCCcccChhHhc-----cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc----CcccccccCHHHHHH
Confidence            99999999999996     366788999999999999999999999754443333333333    345566899999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCcccc
Q 016959          333 ISRCLQKDPHSRWPAAQLLQHPFIL  357 (380)
Q Consensus       333 i~~~l~~dp~~R~t~~eil~hp~~~  357 (380)
                      |.+||+.||.+|||+++||.|+||.
T Consensus       249 I~~lL~~~P~~Rpsl~~vL~h~Ff~  273 (592)
T KOG0575|consen  249 IRKLLRPNPSERPSLDEVLDHPFFK  273 (592)
T ss_pred             HHHHhcCCcccCCCHHHHhcCHhhh
Confidence            9999999999999999999999993

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-57  Score=421.50  Aligned_cols=275  Identities=30%  Similarity=0.471  Sum_probs=232.3

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCe
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  171 (380)
                      .-...||..++.||+|+|++|++|+++.+++.||||++.+..  .+.....+.+|-++|..| .||.|++|+..|.++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            456789999999999999999999999999999999986543  223345677899999999 79999999999999999


Q ss_pred             EEEEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          172 IEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      +|+|+||+++|+|.+++.+    .+...+.++.||+.||+|||++|||||||||+|||+|+||++||+|||.|+.+....
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            9999999999998766554    566788899999999999999999999999999999999999999999999875321


Q ss_pred             C-------------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh
Q 016959          248 D-------------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC  314 (380)
Q Consensus       248 ~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  314 (380)
                      .             ...+++||..|++||++..     ...++.+|+|+||||||+|+.|..||...+.-...+.+..  
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-----~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~--  301 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLND-----SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA--  301 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcC-----CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH--
Confidence            1             1256899999999999964     5667789999999999999999999975444333333333  


Q ss_pred             hCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccccccccccCCCCCCC
Q 016959          315 FAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPL  378 (380)
Q Consensus       315 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  378 (380)
                        ..-++++.+++.++|||+++|..||.+|+|+.||.+||||.+++|..+-+.-++.+=|.+|-
T Consensus       302 --l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~py~p~  363 (604)
T KOG0592|consen  302 --LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQPYKPA  363 (604)
T ss_pred             --hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCcccCCCCc
Confidence              34456667778999999999999999999999999999999999999766666555555543

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-56  Score=423.83  Aligned_cols=273  Identities=27%  Similarity=0.405  Sum_probs=242.9

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCC
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNG  170 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  170 (380)
                      ..++.++|.+.++||+|+||+|+++..+.+++.||||++++..  ..+..+....|..++.... ||++++++..|....
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            5688899999999999999999999999999999999998764  3445677888998888775 999999999999999


Q ss_pred             eEEEEEeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          171 EIEVLLEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      ++|+||||+.||++..+.+   ..+..++-++..|+.||.|||++||||||||.+|||+|.+|++||+|||+++......
T Consensus       443 ~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g  522 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG  522 (694)
T ss_pred             eEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence            9999999999999765544   3577788899999999999999999999999999999999999999999999877666


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                      ....++|||+.|||||++.     +..|+..+|+|||||+|||||.|+.||..++    ++.+..-.....+.+|..++.
T Consensus       523 ~~TsTfCGTpey~aPEil~-----e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd----Eee~FdsI~~d~~~yP~~ls~  593 (694)
T KOG0694|consen  523 DRTSTFCGTPEFLAPEVLT-----EQSYTRAVDWWGLGVLLYEMLVGESPFPGDD----EEEVFDSIVNDEVRYPRFLSK  593 (694)
T ss_pred             CccccccCChhhcChhhhc-----cCcccchhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHhcCCCCCCCcccH
Confidence            7789999999999999996     4677889999999999999999999996433    445555556677888999999


Q ss_pred             HHHHHHHHhcccCcCCCCC-----HHHHhcCccccccCcccccccccccCCCCCC
Q 016959          328 EFRDFISRCLQKDPHSRWP-----AAQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      ++.++|+++|.+||++|+.     +++|..||||+.++|..+..  +++-||++|
T Consensus       594 ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~--r~i~PPf~P  646 (694)
T KOG0694|consen  594 EAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLN--RRIKPPFVP  646 (694)
T ss_pred             HHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhh--ccCCCCCCc
Confidence            9999999999999999996     48899999999999988866  788888877

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-56  Score=387.13  Aligned_cols=268  Identities=28%  Similarity=0.434  Sum_probs=234.2

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      ...++|++.+.||.|+||+|.+++++.+|..||+|++.+..  .-...+...+|..+|+.+.||+++++++.|.+.+.+|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            67789999999999999999999999999999999996543  2334567889999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 016959          174 VLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  249 (380)
                      +||||+.||.|..++++    ++...+-++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+.+...   
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r---  197 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR---  197 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence            99999999998776654    67889999999999999999999999999999999999999999999999988643   


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      ..+.|||+.|+|||++..     +.+..++|.|||||++|||+.|..||...+.....+.+    ......+|..++.++
T Consensus       198 T~TlCGTPeYLAPEii~s-----k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI----~~~~v~fP~~fs~~~  268 (355)
T KOG0616|consen  198 TWTLCGTPEYLAPEIIQS-----KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI----LEGKVKFPSYFSSDA  268 (355)
T ss_pred             EEEecCCccccChHHhhc-----CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH----HhCcccCCcccCHHH
Confidence            578999999999999964     77788999999999999999999999865553333332    334567788899999


Q ss_pred             HHHHHHhcccCcCCCC-----CHHHHhcCccccccCcccccccccccCCCCCC
Q 016959          330 RDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~-----t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      +|||+++|+.|-.+|.     ...+|..||||++..|..+..  +++-||..|
T Consensus       269 kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~--r~ie~P~~p  319 (355)
T KOG0616|consen  269 KDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQ--RKIEPPFEP  319 (355)
T ss_pred             HHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhh--ccccCCCCC
Confidence            9999999999999994     578999999999999988865  456666555

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.6e-56  Score=411.53  Aligned_cols=279  Identities=26%  Similarity=0.401  Sum_probs=238.0

Q ss_pred             cccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC
Q 016959           92 RHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN  169 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  169 (380)
                      +...+..++|++++.||+|+||.||+|+.+.||..||+|++++..  .....+.+..|..+|...+++.||+++..|.+.
T Consensus       134 ~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~  213 (550)
T KOG0605|consen  134 RRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK  213 (550)
T ss_pred             ccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence            344688999999999999999999999999999999999997764  344567788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      .++||||||++||++..++..    .+...+.++.+++.|++.||+.|+|||||||+|+|||..|++||+|||+++-+..
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence            999999999999997665544    6788899999999999999999999999999999999999999999999863211


Q ss_pred             -----------------------cCC------------------------CCCCCCCCCccccccccccccCCCCCCCcc
Q 016959          246 -----------------------TMD------------------------PCNSAVGTIAYMSPERINTDLNHGKYDGYA  278 (380)
Q Consensus       246 -----------------------~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  278 (380)
                                             ...                        ...+.+|||.|||||++.     +..|+..
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll-----~kgY~~~  368 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL-----GKGYGKE  368 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh-----cCCCCcc
Confidence                                   000                        012457999999999995     4667889


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCC---HHHHhcCcc
Q 016959          279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWP---AAQLLQHPF  355 (380)
Q Consensus       279 ~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t---~~eil~hp~  355 (380)
                      +|+||||||+||||.|..||......+....+........-+....++.+++|||.+||+ ||++|+.   ++||.+|||
T Consensus       369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPf  447 (550)
T KOG0605|consen  369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPF  447 (550)
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCc
Confidence            999999999999999999998766666555555555444444455678999999999998 9999995   999999999


Q ss_pred             ccccCcccccccccccCCCCC
Q 016959          356 ILRAGQSQVNQNLRQILPPPR  376 (380)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~  376 (380)
                      |++++|..+.+.-..|+|...
T Consensus       448 F~~v~W~~l~~~~apfvP~v~  468 (550)
T KOG0605|consen  448 FKGVDWDHLREMPAPFVPQVN  468 (550)
T ss_pred             cccCCcchhhcCCCCCCCCCC
Confidence            999999999988888887643

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.3e-57  Score=392.72  Aligned_cols=260  Identities=27%  Similarity=0.435  Sum_probs=220.6

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      +.|+...++|+|+||.||+|+++.||+.||||++....+ +...+-..+|+++|+.++|+|+|.++++|...+.+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            468889999999999999999999999999999977665 4555666799999999999999999999999999999999


Q ss_pred             ccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          178 YMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       178 ~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      ||+..-|..+-..    ....+.++++|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+....+..+..
T Consensus        82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDY  161 (396)
T KOG0593|consen   82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDY  161 (396)
T ss_pred             ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhh
Confidence            9997666544332    467789999999999999999999999999999999999999999999999998777778889


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC--------------
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP--------------  319 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------  319 (380)
                      +.|.+|+|||.+.+.    ..|+..+||||+||++.||++|...|.....-|+...+........+              
T Consensus       162 VATRWYRaPELLvGD----tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G  237 (396)
T KOG0593|consen  162 VATRWYRAPELLVGD----TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG  237 (396)
T ss_pred             hhhhhccChhhhccc----CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence            999999999998653    45667899999999999999999999866655554444433322221              


Q ss_pred             -------------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          320 -------------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       320 -------------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                                   ...+.++.-+.||+++||..||++|++.+|+|.|+||.+....
T Consensus       238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er  293 (396)
T KOG0593|consen  238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER  293 (396)
T ss_pred             eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence                         0122366688999999999999999999999999999765443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-55  Score=393.78  Aligned_cols=256  Identities=28%  Similarity=0.501  Sum_probs=222.0

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ..+|.+.++||+|+||+||+|+++.++..||||.+.+.. .....+.+..|+.+|+.++|||||.+++++...+.+|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            468999999999999999999999999999999996654 5667788899999999999999999999999999999999


Q ss_pred             eccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC------CcEEEeecccccccccc
Q 016959          177 EYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS------KNVKIADFGVSRILAQT  246 (380)
Q Consensus       177 e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~------~~~kl~Dfg~a~~~~~~  246 (380)
                      |||.||+|..+++.    .+..++.++.||+.||++||+++||||||||.|||++..      -.+||+|||+|+.+...
T Consensus        89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~  168 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG  168 (429)
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence            99999999877655    578899999999999999999999999999999999864      34999999999988754


Q ss_pred             CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcccc
Q 016959          247 MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS  326 (380)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (380)
                       ....+.||++.|||||++..     ..|+.|+|+||+|+|||++++|..||......+....+ +......+..+..++
T Consensus       169 -~~a~tlcGSplYMAPEV~~~-----~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~-~k~~~~~~~~~~~~s  241 (429)
T KOG0595|consen  169 -SMAETLCGSPLYMAPEVIMS-----QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI-KKGNEIVPVLPAELS  241 (429)
T ss_pred             -hHHHHhhCCccccCHHHHHh-----ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-hccccccCchhhhcc
Confidence             44578899999999999963     45567999999999999999999999855554443322 222233455666778


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          327 REFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      ..+.+|+...|..|+..|.+..+.+.|+++....
T Consensus       242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  242 NPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             CchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            8889999999999999999999999999998875

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-54  Score=387.68  Aligned_cols=278  Identities=29%  Similarity=0.411  Sum_probs=235.0

Q ss_pred             cccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC
Q 016959           92 RHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQICREIEILRDVNHPNVVKCHDMYDRN  169 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  169 (380)
                      ....+..++|++.++||.|.-|+||+|+.++++..+|+|+|.+...  .....++..|.+||+.++||.++.||..|+.+
T Consensus        70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~  149 (459)
T KOG0610|consen   70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD  149 (459)
T ss_pred             CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence            4556788999999999999999999999999999999999965532  33455677899999999999999999999999


Q ss_pred             CeEEEEEeccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                      +..|++||||.||+|..++++      .+..++-++.+|+.||+|||..|||+|||||+||||.++|+|.|+||.++...
T Consensus       150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            999999999999999877665      46778889999999999999999999999999999999999999999987432


Q ss_pred             cc-----------------------------------c---------------------CCCCCCCCCCCcccccccccc
Q 016959          244 AQ-----------------------------------T---------------------MDPCNSAVGTIAYMSPERINT  267 (380)
Q Consensus       244 ~~-----------------------------------~---------------------~~~~~~~~gt~~y~aPE~~~~  267 (380)
                      ..                                   .                     .....+.+||-.|+|||+|. 
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~-  308 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR-  308 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee-
Confidence            10                                   0                     01124568999999999996 


Q ss_pred             ccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCC--ccccHHHHHHHHHhcccCcCCCC
Q 016959          268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAP--EMASREFRDFISRCLQKDPHSRW  345 (380)
Q Consensus       268 ~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~  345 (380)
                          |...+.++|+|+|||+||||+.|..||...++.+....   +. ..+..++  ..++..++|||+++|.+||++|+
T Consensus       309 ----G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N---Iv-~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRl  380 (459)
T KOG0610|consen  309 ----GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN---IV-GQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRL  380 (459)
T ss_pred             ----cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH---Hh-cCCCcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence                46677899999999999999999999986555433222   22 2223333  25788999999999999999999


Q ss_pred             C----HHHHhcCccccccCcccccccccccCCCCCCC
Q 016959          346 P----AAQLLQHPFILRAGQSQVNQNLRQILPPPRPL  378 (380)
Q Consensus       346 t----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  378 (380)
                      .    +.||.+||||++++|+.++-..++.||.|...
T Consensus       381 g~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~  417 (459)
T KOG0610|consen  381 GSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDG  417 (459)
T ss_pred             ccccchHHhhcCccccCCChhheeccCCCcCCCcccc
Confidence            8    99999999999999998899999999998654

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-53  Score=399.31  Aligned_cols=257  Identities=33%  Similarity=0.554  Sum_probs=221.6

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC----chHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCC
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH----EDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNG  170 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  170 (380)
                      ...+.|.+++.||+|+||+|++|.+..+++.||+|++....    .....+.+.+|+.+++.+. ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34568999999999999999999999999999999875431    1234567779999999998 999999999999999


Q ss_pred             eEEEEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CcEEEeeccccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS-KNVKIADFGVSRILAQ  245 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~  245 (380)
                      .+|+|||||.||+|.+++..    .|...+.+++||+.||+|||++||+||||||+|||++.+ +++||+|||++.....
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            99999999999998766443    577899999999999999999999999999999999999 9999999999987743


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                      ......+.+||+.|+|||++...   +.|.+.++||||+||+||.|++|..||..   .+...+... .......++..+
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~---~~Y~g~~aDvWS~GViLy~ml~G~~PF~d---~~~~~l~~k-i~~~~~~~p~~~  246 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGK---GTYSGKAADVWSLGVILYVLLCGRLPFDD---SNVPNLYRK-IRKGEFKIPSYL  246 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCC---CCcCCchhhhhhhHHHHHHHHhCCCCCCC---ccHHHHHHH-HhcCCccCCCCc
Confidence            34566889999999999999753   22667899999999999999999999974   333333333 445556677777


Q ss_pred             -cHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          326 -SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       326 -~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                       +.++++|+.+||..||.+|+|+.||++||||+..
T Consensus       247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  247 LSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence             9999999999999999999999999999999983

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.1e-53  Score=363.74  Aligned_cols=263  Identities=28%  Similarity=0.433  Sum_probs=220.7

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ++|...++||+|.||.||+|++..+|+.||||.++... .+.......+||+.|+.++|+||+.++++|...+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46889999999999999999999999999999997654 34445567899999999999999999999999999999999


Q ss_pred             ccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          178 YMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       178 ~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      |++. +|+..+.     .....+..++.++++||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+.........
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~  160 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH  160 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence            9985 5654433     356778999999999999999999999999999999999999999999999998876666566


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCC----------
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAP----------  322 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------  322 (380)
                      .+-|.+|+|||.+.+    .+.|+..+||||.|||+.||+.|..-|.....-++...+........+..|          
T Consensus       161 ~V~TRWYRAPELLfG----sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  161 QVVTRWYRAPELLFG----SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             ceeeeeccChHHhcc----chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence            688999999999865    356677899999999999999999888765555555555554433333222          


Q ss_pred             --------------ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccccc
Q 016959          323 --------------EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQ  366 (380)
Q Consensus       323 --------------~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~  366 (380)
                                    ..++.++.||+.+||..||.+|+|+.|+|+|+||+..+.-....
T Consensus       237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~  294 (318)
T KOG0659|consen  237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPS  294 (318)
T ss_pred             HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChh
Confidence                          22566889999999999999999999999999999765544433

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-53  Score=391.94  Aligned_cols=272  Identities=29%  Similarity=0.435  Sum_probs=230.6

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC--C
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN--G  170 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~  170 (380)
                      .....+.|+..++||+|+||.||+|++..+|+.||+|.++.+. ++.......+||.+|++|+||||++|.++..+.  +
T Consensus       112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~  191 (560)
T KOG0600|consen  112 GPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG  191 (560)
T ss_pred             cccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence            3345678999999999999999999999999999999997665 334455677999999999999999999988765  7


Q ss_pred             eEEEEEeccCCCC---cc-cccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          171 EIEVLLEYMDGGS---LE-GAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       171 ~~~lv~e~~~~~~---L~-~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      .+|+|+|||+...   |. ..+...+.++..++.||+.||+|+|++||+|||||..|||||.+|.+||+|||+|+++...
T Consensus       192 siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  192 SIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             eEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            8999999998632   22 2345678999999999999999999999999999999999999999999999999977654


Q ss_pred             CC-CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCc--
Q 016959          247 MD-PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE--  323 (380)
Q Consensus       247 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--  323 (380)
                      .. ..+..+-|.+|+|||.+.+.    ..|+..+|+||.||||.||++|+..|......++...+.+++.......|.  
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~----t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGA----TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             CCcccccceEEeeccChHHhcCC----cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            43 36777889999999998753    567789999999999999999999999888778888888888766554443  


Q ss_pred             -----------------------cccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccccccccc
Q 016959          324 -----------------------MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLR  369 (380)
Q Consensus       324 -----------------------~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~~~~  369 (380)
                                             .++..+.+|+..||..||.+|.|+.++|+|+||...........++
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~Lp  416 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSLP  416 (560)
T ss_pred             cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccCC
Confidence                                   2666889999999999999999999999999997665555444443

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-53  Score=398.13  Aligned_cols=256  Identities=33%  Similarity=0.552  Sum_probs=225.4

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ...|....+||+|+.|.||.+....+++.||||+|...... .++.+.+|+.+|+..+|+|||++++.|...+.+|+|||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            34577788999999999999999999999999999655433 35778899999999999999999999988899999999


Q ss_pred             ccCCCCcccccccc---hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCC
Q 016959          178 YMDGGSLEGAHIRQ---EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV  254 (380)
Q Consensus       178 ~~~~~~L~~~~~~~---~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (380)
                      |++||+|.+.....   |.++..|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+........+.+
T Consensus       351 ym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmV  430 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMV  430 (550)
T ss_pred             ecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccccc
Confidence            99999998776664   899999999999999999999999999999999999999999999999998887766678899


Q ss_pred             CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC--CCCCccccHHHHHH
Q 016959          255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP--PEAPEMASREFRDF  332 (380)
Q Consensus       255 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l  332 (380)
                      ||++|||||++..     +.|+++.||||||+++.||+-|..||-+   ++....++.+.....  ...++.++++++||
T Consensus       431 GTPYWMAPEVvtr-----k~YG~KVDIWSLGIMaIEMveGEPPYln---E~PlrAlyLIa~ng~P~lk~~~klS~~~kdF  502 (550)
T KOG0578|consen  431 GTPYWMAPEVVTR-----KPYGPKVDIWSLGIMAIEMVEGEPPYLN---ENPLRALYLIATNGTPKLKNPEKLSPELKDF  502 (550)
T ss_pred             CCCCccchhhhhh-----cccCccccchhhhhHHHHHhcCCCCccC---CChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence            9999999999964     6778899999999999999999999974   444455554444443  44667899999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          333 ISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       333 i~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      +.+||+.|+++|+++.|+|+||||+.+...
T Consensus       503 L~~cL~~dv~~RasA~eLL~HpFl~~a~p~  532 (550)
T KOG0578|consen  503 LDRCLVVDVEQRASAKELLEHPFLKMAKPE  532 (550)
T ss_pred             HHHHhhcchhcCCCHHHHhcChhhhhcCCH
Confidence            999999999999999999999999766443

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-54  Score=394.75  Aligned_cols=261  Identities=30%  Similarity=0.410  Sum_probs=219.0

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCC-eEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNG-EIE  173 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~-~~~  173 (380)
                      +.-++|.+.++||.|+||.||+|+.+.+|..||||.|++....-..-.=.+|+..|++|+ |||||++.+++.+.+ .+|
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            445789999999999999999999999999999999976543322222358999999998 999999999998877 999


Q ss_pred             EEEeccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          174 VLLEYMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       174 lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      +|||||+. +|++++     ...+..++.|++||++||+|+|.+|+.||||||+||||.....+||+|||+|+.+... .
T Consensus        87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-p  164 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK-P  164 (538)
T ss_pred             eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC-C
Confidence            99999986 454333     3368889999999999999999999999999999999999899999999999988654 4


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC--------
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--------  320 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------  320 (380)
                      ..+.++.|.+|+|||++..    ..+|+.+.|||++|||++|+++-+..|......|....++.+.......        
T Consensus       165 PYTeYVSTRWYRAPEvLLr----s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  165 PYTEYVSTRWYRAPEVLLR----SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             CcchhhhcccccchHHhhh----ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            5678899999999999864    5788999999999999999999999998766655555555444332211        


Q ss_pred             ------------------CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          321 ------------------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       321 ------------------~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                                        +...++.++.+||.+||..||++|||++|+|+||||+.....
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence                              222378899999999999999999999999999999976444

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-55  Score=375.45  Aligned_cols=244  Identities=32%  Similarity=0.489  Sum_probs=216.8

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEe-EEeeCCe-E
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHD-MYDRNGE-I  172 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~-~~~~~~~-~  172 (380)
                      -+.++|++.++||+|.||+||++....+|+.+|.|.+.-.. +...+..+..|+.+|+.|+|||||++++ .|.+++. +
T Consensus        16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl   95 (375)
T KOG0591|consen   16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL   95 (375)
T ss_pred             ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence            34678999999999999999999999999999999986433 4455677889999999999999999998 4555555 9


Q ss_pred             EEEEeccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHh--CC--ceecCCCCCcEEEcCCCcEEEeecccc
Q 016959          173 EVLLEYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHK--RK--IVHRDIKPSNLLINSSKNVKIADFGVS  240 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~--~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  240 (380)
                      +||||+|.+|+|...++        .+|..+|+++.|++.||..+|+  ..  |+||||||.||+++.+|.+||+|||++
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG  175 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence            99999999999965543        3688899999999999999999  45  999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC
Q 016959          241 RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE  320 (380)
Q Consensus       241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  320 (380)
                      +.+........+.+|||+||+||++..     ..|++++|||||||++|||+.-+.||...   ...++..++....-++
T Consensus       176 r~l~s~~tfA~S~VGTPyYMSPE~i~~-----~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI~qgd~~~  247 (375)
T KOG0591|consen  176 RFLSSKTTFAHSLVGTPYYMSPERIHE-----SGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKIEQGDYPP  247 (375)
T ss_pred             hHhcchhHHHHhhcCCCcccCHHHHhc-----CCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHHHcCCCCC
Confidence            999887777789999999999999964     67789999999999999999999999744   6778888888888777


Q ss_pred             CC-ccccHHHHHHHHHhcccCcCCCCCH
Q 016959          321 AP-EMASREFRDFISRCLQKDPHSRWPA  347 (380)
Q Consensus       321 ~~-~~~~~~~~~li~~~l~~dp~~R~t~  347 (380)
                      .| ...+.+++.||..|+..|++.||+.
T Consensus       248 ~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  248 LPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            88 7789999999999999999999986

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-53  Score=402.21  Aligned_cols=265  Identities=32%  Similarity=0.554  Sum_probs=231.4

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCC--CchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      .+-|++++.||.|+.|.|-+|++..||+.+|||++.+.  ..+.....+.+||.+|+.+.||||+++|++|+...++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            35689999999999999999999999999999999654  2344566789999999999999999999999999999999


Q ss_pred             EeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCC
Q 016959          176 LEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       176 ~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      +||+.||.|++++..    .+....++++||+.|+.|+|..+|+||||||+|+|+|..+++||+|||.|..... .....
T Consensus        91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-gklLe  169 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP-GKLLE  169 (786)
T ss_pred             EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC-Ccccc
Confidence            999999999877654    5778899999999999999999999999999999999999999999999975443 35567


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD  331 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (380)
                      +.||++.|.+||++.+    ..|++.++||||.|||||.||+|+.||+   .++...++.++..+ .-.+|..++.+++|
T Consensus       170 TSCGSPHYA~PEIV~G----~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV~~G-~f~MPs~Is~eaQd  241 (786)
T KOG0588|consen  170 TSCGSPHYAAPEIVSG----RPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKVQRG-VFEMPSNISSEAQD  241 (786)
T ss_pred             ccCCCcccCCchhhcC----CCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHHHcC-cccCCCcCCHHHHH
Confidence            8999999999999976    3677889999999999999999999997   33444444444433 35677999999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccccccCccccccccccc
Q 016959          332 FISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQI  371 (380)
Q Consensus       332 li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~~~~~~  371 (380)
                      ||.+||+.||++|+|.+||++|||+.+.......+.++..
T Consensus       242 LLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~  281 (786)
T KOG0588|consen  242 LLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPP  281 (786)
T ss_pred             HHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcCCC
Confidence            9999999999999999999999999999888777665443

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-53  Score=381.42  Aligned_cols=257  Identities=35%  Similarity=0.596  Sum_probs=215.0

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC--eEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG--EIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~  176 (380)
                      .++..++.||+|+||+||++.+..+|+.+|||.+....... .+.+.+|+.+|++++|||||+++|......  .++++|
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            46888999999999999999999889999999986553333 677899999999999999999999744433  699999


Q ss_pred             eccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCcEEEeeccccccccc---cC
Q 016959          177 EYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS-SKNVKIADFGVSRILAQ---TM  247 (380)
Q Consensus       177 e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~---~~  247 (380)
                      ||+.+|+|.+++.     .++..++.+++||++||+|||++||+|+||||+||||+. ++.+||+|||++.....   ..
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~  175 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS  175 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence            9999999976554     478889999999999999999999999999999999999 79999999999987763   12


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                      .......||+.|||||++..    +....+++|||||||++.||+||..||... ................+.++..++.
T Consensus       176 ~~~~~~~Gtp~~maPEvi~~----g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~~~~~P~ip~~ls~  250 (313)
T KOG0198|consen  176 DSELSVQGTPNYMAPEVIRN----GEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGREDSLPEIPDSLSD  250 (313)
T ss_pred             cccccccCCccccCchhhcC----CCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhccCCCCCCCcccCH
Confidence            23456789999999999964    233335899999999999999999999743 2222233333334445688899999


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      ++++||.+||..||++|||++++|+|||++....
T Consensus       251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  251 EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            9999999999999999999999999999988544

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.1e-53  Score=392.61  Aligned_cols=258  Identities=30%  Similarity=0.488  Sum_probs=226.9

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+.. .+...+.+.+|++++++++|||||.++++|+...++|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46888999999999999999999999999999996543 45556789999999999999999999999999999999999


Q ss_pred             ccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          178 YMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       178 ~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      ||.| +|+..+.    .+|+.++.++.|++.||.|||+++|+|||+||.|||++.+|.+|+||||+|+.+.......+.+
T Consensus        82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsi  160 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSI  160 (808)
T ss_pred             hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeec
Confidence            9998 7765543    4688899999999999999999999999999999999999999999999999887766666788


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHH
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI  333 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  333 (380)
                      .||+.|||||.+.     +..|+..+|+||||||+||++.|+.||.   ...+.. ..+.....+..+|..++.++++|+
T Consensus       161 kGtPlYmAPElv~-----e~pyd~~sDlWslGcilYE~~~G~PPF~---a~si~~-Lv~~I~~d~v~~p~~~S~~f~nfl  231 (808)
T KOG0597|consen  161 KGTPLYMAPELVE-----EQPYDHTSDLWSLGCILYELYVGQPPFY---ARSITQ-LVKSILKDPVKPPSTASSSFVNFL  231 (808)
T ss_pred             cCcccccCHHHHc-----CCCccchhhHHHHHHHHHHHhcCCCCch---HHHHHH-HHHHHhcCCCCCcccccHHHHHHH
Confidence            8999999999985     4777889999999999999999999996   233333 334445677788889999999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCccccccCcccccc
Q 016959          334 SRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQ  366 (380)
Q Consensus       334 ~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~  366 (380)
                      ..+|.+||.+|+|..+++.|||.++..+.....
T Consensus       232 ~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~  264 (808)
T KOG0597|consen  232 QGLLIKDPAQRLTWTDLLGHPFWKGKINIAELP  264 (808)
T ss_pred             HHHhhcChhhcccHHHHhcChHHhhhhhhhccc
Confidence            999999999999999999999999875544433

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-53  Score=367.24  Aligned_cols=276  Identities=26%  Similarity=0.448  Sum_probs=240.4

Q ss_pred             ccccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEee
Q 016959           91 NRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDR  168 (380)
Q Consensus        91 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  168 (380)
                      .....+.-++|..+++||+|.||+|.+|+.+.+++.||+|+++++-  .......-..|-.+|+..+||++..+...|..
T Consensus       160 ~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt  239 (516)
T KOG0690|consen  160 KRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT  239 (516)
T ss_pred             cccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence            4455678899999999999999999999999999999999997763  23334455678999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          169 NGEIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      .+++|+||||..||.|.-++.+    .+...+-+..+|+.||.|||+++||+||||.+|+|+|+||++||+|||+++.--
T Consensus       240 ~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  240 QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence            9999999999999998765544    456677789999999999999999999999999999999999999999998776


Q ss_pred             ccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc
Q 016959          245 QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM  324 (380)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (380)
                      .......++|||+.|+|||++..     ..|+..+|+|.+||++|||+||+.||.+.+.+..    ..+.......+|..
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleD-----nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL----FeLIl~ed~kFPr~  390 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLED-----NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL----FELILMEDLKFPRT  390 (516)
T ss_pred             cccceeccccCChhhcCchhhcc-----ccccceeehhhhhHHHHHHHhccCcccccchhHH----HHHHHhhhccCCcc
Confidence            66667789999999999999964     5667899999999999999999999975554433    33444556677888


Q ss_pred             ccHHHHHHHHHhcccCcCCCCC-----HHHHhcCccccccCcccccccccccCCCCCC
Q 016959          325 ASREFRDFISRCLQKDPHSRWP-----AAQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      ++++++.|+..+|.+||.+|+.     +.||.+|+||..++|...-+  +++.||+||
T Consensus       391 ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~--Kki~PPfKP  446 (516)
T KOG0690|consen  391 LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYR--KKIEPPFKP  446 (516)
T ss_pred             CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHH--hccCCCCCC
Confidence            9999999999999999999984     89999999999999988766  899999998

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-51  Score=375.03  Aligned_cols=263  Identities=35%  Similarity=0.561  Sum_probs=218.3

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-------------hHHHHHHHHHHHHHHhCCCCceeee
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-------------DSVRSQICREIEILRDVNHPNVVKC  162 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv~~  162 (380)
                      ....+|++.+.||+|.||+|-+|++..+++.||||++.+...             ....+++.+||.+|++|.|+|||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            345679999999999999999999999999999999954321             1123678999999999999999999


Q ss_pred             EeEEee--CCeEEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEee
Q 016959          163 HDMYDR--NGEIEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIAD  236 (380)
Q Consensus       163 ~~~~~~--~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~D  236 (380)
                      +++.++  .+.+|||+|||..|.+.....    ..+.+.++++++++.||+|||.+|||||||||.|+||+++|++||+|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD  253 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD  253 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence            999876  467999999999998764433    45678999999999999999999999999999999999999999999


Q ss_pred             cccccccccc-----CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHH
Q 016959          237 FGVSRILAQT-----MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMF  311 (380)
Q Consensus       237 fg~a~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~  311 (380)
                      ||.+......     .+.....+||+.|+|||.+..... ..+.+++.|||||||+||.|+.|++||.    .+......
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~-~~~~g~a~DiWalGVTLYCllfG~~PF~----~~~~~~l~  328 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNS-FSYSGFALDIWALGVTLYCLLFGQLPFF----DDFELELF  328 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCC-ccccchhhhhhhhhhhHHHhhhccCCcc----cchHHHHH
Confidence            9998766322     222345789999999999875322 4566789999999999999999999994    44444445


Q ss_pred             HHhhCCCCCCCcc--ccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          312 AICFAQPPEAPEM--ASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       312 ~~~~~~~~~~~~~--~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                      ......+..+|..  +..+++|||++||++||++|+++.+|..|||..+.....
T Consensus       329 ~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~  382 (576)
T KOG0585|consen  329 DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP  382 (576)
T ss_pred             HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence            5555566666654  689999999999999999999999999999999874443

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.4e-51  Score=377.15  Aligned_cols=270  Identities=26%  Similarity=0.365  Sum_probs=223.2

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      |+..+.||+|+||+||+|.+..+++.||+|++.....  ......+.+|+.+++.++|+||+++++++.+.+.+++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            6778899999999999999999999999999854331  22234577899999999999999999999999999999999


Q ss_pred             cCCCCccccc------ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          179 MDGGSLEGAH------IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       179 ~~~~~L~~~~------~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      +.+++|...+      ...+..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++...... .....
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~  160 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVRG  160 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-CeecC
Confidence            9999986443      2356678889999999999999999999999999999999999999999999865432 22345


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      ..||..|+|||++..     ..++.++|||||||++|+|++|+.||.......................+..++.++.+|
T Consensus       161 ~~g~~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  235 (285)
T cd05631         161 RVGTVGYMAPEVINN-----EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSI  235 (285)
T ss_pred             CCCCCCccCHhhhcC-----CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHH
Confidence            679999999999853     456788999999999999999999997544433333333333334445667789999999


Q ss_pred             HHHhcccCcCCCCC-----HHHHhcCccccccCcccccccccccCCCCCCC
Q 016959          333 ISRCLQKDPHSRWP-----AAQLLQHPFILRAGQSQVNQNLRQILPPPRPL  378 (380)
Q Consensus       333 i~~~l~~dp~~R~t-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  378 (380)
                      |.+||+.||++|++     ++|+++||||.+.++.....  ++.-||++|-
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~--~~~~~~~~~~  284 (285)
T cd05631         236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEA--NMLEPPFCPD  284 (285)
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHh--CcCCcCCCCC
Confidence            99999999999997     89999999999999888876  4566666663

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-54  Score=360.39  Aligned_cols=257  Identities=30%  Similarity=0.441  Sum_probs=225.2

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      .+.|++.+.||+|.|+.|+++.+..+|+.+|+|++.... .....+++.+|+.+-+.|+|||||++.+.+...+..|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            467999999999999999999999999999999984332 2224577899999999999999999999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---cEEEeeccccccccccCCC
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK---NVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~---~~kl~Dfg~a~~~~~~~~~  249 (380)
                      |++.|++|..-+-    .+|.....+++||+.||.|+|.+||||||+||+|+|+-...   -+||+|||+|..+. ....
T Consensus        90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g~~  168 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DGEA  168 (355)
T ss_pred             ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-Cccc
Confidence            9999999843222    25667788999999999999999999999999999996433   39999999999988 4456


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      ..+.+||+.|||||++..     ..++..+|||+-|+|||-|+.|..||.........+.+....+..+...++.+++++
T Consensus       169 ~~G~~GtP~fmaPEvvrk-----dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A  243 (355)
T KOG0033|consen  169 WHGFAGTPGYLSPEVLKK-----DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA  243 (355)
T ss_pred             cccccCCCcccCHHHhhc-----CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence            678899999999999964     566778999999999999999999998766667777777777888888999999999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      ++||++||..||.+|+|+.|+|+|||+.+-.
T Consensus       244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  244 KSLIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             HHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence            9999999999999999999999999998753

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.2e-51  Score=384.08  Aligned_cols=252  Identities=26%  Similarity=0.418  Sum_probs=211.7

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGG  182 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  182 (380)
                      +.||+|+||.||+|.+..+|+.||||++....  .......+.+|+.+++.++|+||+++++++...+.+++||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999986532  2233456778999999999999999999999999999999999999


Q ss_pred             Ccccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCCc
Q 016959          183 SLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIA  258 (380)
Q Consensus       183 ~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~  258 (380)
                      +|..++.    ..+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||+.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~  160 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence            9865543    356778889999999999999999999999999999999999999999998764433333455679999


Q ss_pred             cccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcc
Q 016959          259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ  338 (380)
Q Consensus       259 y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  338 (380)
                      |+|||++..     ..++.++|||||||++|||++|..||...   +....... ........+..++.++.+||.+||+
T Consensus       161 y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~Pf~~~---~~~~~~~~-~~~~~~~~p~~~~~~~~~li~~~L~  231 (323)
T cd05571         161 YLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHEKLFEL-ILMEEIRFPRTLSPEAKSLLAGLLK  231 (323)
T ss_pred             ccChhhhcC-----CCCCccccCcccchhhhhhhcCCCCCCCC---CHHHHHHH-HHcCCCCCCCCCCHHHHHHHHHHcc
Confidence            999999853     55678999999999999999999999643   22222222 2333456677889999999999999


Q ss_pred             cCcCCCC-----CHHHHhcCccccccCccccc
Q 016959          339 KDPHSRW-----PAAQLLQHPFILRAGQSQVN  365 (380)
Q Consensus       339 ~dp~~R~-----t~~eil~hp~~~~~~~~~~~  365 (380)
                      .||++|+     ++.|+++||||...++....
T Consensus       232 ~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~  263 (323)
T cd05571         232 KDPKQRLGGGPEDAKEIMEHRFFASINWQDVV  263 (323)
T ss_pred             CCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence            9999999     89999999999998776654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=9e-52  Score=362.36  Aligned_cols=266  Identities=28%  Similarity=0.367  Sum_probs=220.0

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchH-HHHHHHHHHHHHHhCCCCceeeeEeEEee--CCeE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNVVKCHDMYDR--NGEI  172 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~  172 (380)
                      -+.++|+++++|++|+||.||+|+++.|++.||+|+++-+.+.. .--.-.+||.+|.+++|||||.+-.+...  -+.+
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            45689999999999999999999999999999999997654322 22334689999999999999999988753  4579


Q ss_pred             EEEEeccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          173 EVLLEYMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      |+|||||+. +|..++     ......+.-++.|++.|++|||.+.|+|||||++|+|++..|.+||+|||+|+.+....
T Consensus       153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            999999986 443332     23456788899999999999999999999999999999999999999999999998887


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCc----
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE----  323 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----  323 (380)
                      ...+..+-|.+|+|||.+.+    ..-|+...||||+|||+.||+++...|......++...+...........|+    
T Consensus       232 k~~T~lVVTLWYRaPELLLG----~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLG----AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             ccCcceEEEeeecCHHHhcC----CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence            77788899999999999865    4567789999999999999999999998766666666665554332221111    


Q ss_pred             -----------------------c-ccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccccc
Q 016959          324 -----------------------M-ASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQ  366 (380)
Q Consensus       324 -----------------------~-~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~  366 (380)
                                             . ++....+|+..+|.+||++|.|+.|+|+|.||...+......
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~  374 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPS  374 (419)
T ss_pred             cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChh
Confidence                                   1 557889999999999999999999999999999965444433

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-51  Score=378.18  Aligned_cols=255  Identities=27%  Similarity=0.437  Sum_probs=214.9

Q ss_pred             ccccCCCcccccccceecccCCceEEEEEeCCCCcE-EEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEee
Q 016959           91 NRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRV-FALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDR  168 (380)
Q Consensus        91 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~-~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  168 (380)
                      ...+.++.+++.+.+.||+|+||+||++.+.  |.. ||||++.... .....+.|.+|+.+|.+++|||||+|+|++.+
T Consensus        33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS  110 (362)
T ss_pred             ccceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            3445677788888999999999999999995  555 9999996543 22236789999999999999999999999998


Q ss_pred             CC-eEEEEEeccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEEEcCCC-cEEEeeccc
Q 016959          169 NG-EIEVLLEYMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRK-IVHRDIKPSNLLINSSK-NVKIADFGV  239 (380)
Q Consensus       169 ~~-~~~lv~e~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~-ivH~Dlkp~Nil~~~~~-~~kl~Dfg~  239 (380)
                      .. .+++||||+.+|+|..++..      ....+..++.||++||+|||+++ |||||||++||||+.++ ++||||||+
T Consensus       111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence            77 79999999999999877644      45668899999999999999999 99999999999999997 999999999


Q ss_pred             cccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC
Q 016959          240 SRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP  319 (380)
Q Consensus       240 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  319 (380)
                      ++.............||..|||||++...   ...++.++||||||++||||+||..||.....  ............++
T Consensus       191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~---~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~~~~Rp  265 (362)
T KOG0192|consen  191 SREKVISKTSMTSVAGTYRWMAPEVLRGE---KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVVGGLRP  265 (362)
T ss_pred             ceeeccccccccCCCCCccccChhhhcCC---CCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhcCCCC
Confidence            98776543333457899999999999743   45678899999999999999999999974433  22233333466677


Q ss_pred             CCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       320 ~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..+..+++.+..||++||..||+.||++.||+.
T Consensus       266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            778889999999999999999999999999875

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-52  Score=358.54  Aligned_cols=266  Identities=30%  Similarity=0.477  Sum_probs=232.6

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCC-------CchHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCC
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN-------HEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNG  170 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~-------~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  170 (380)
                      +.|...+.||+|..+.|.+|.++.+|+.+|+|++...       ......+.-..|+.+|+++ .||+|+.+.++|+...
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            4577788999999999999999999999999998422       1234456677899999998 5999999999999999


Q ss_pred             eEEEEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      .+++|+|.|..|.|.+++..    ++...+.|++|++.|++|||.++||||||||+|||++++.++||+|||+|+.+..+
T Consensus        97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G  176 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG  176 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence            99999999999999888765    67888999999999999999999999999999999999999999999999998766


Q ss_pred             CCCCCCCCCCCccccccccccccC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          247 MDPCNSAVGTIAYMSPERINTDLN-HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                       ......|||++|.|||.+..+.. ....|+..+|+|++|+|||-|+.|..||...+..-+..++....+.+..+.|..+
T Consensus       177 -ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadi  255 (411)
T KOG0599|consen  177 -EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADI  255 (411)
T ss_pred             -hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhc
Confidence             45678899999999999965433 2345778999999999999999999999876666666777777788888899999


Q ss_pred             cHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccccc
Q 016959          326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN  365 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~  365 (380)
                      +...+|||.+||+.||.+|+|+.|+|.||||......+..
T Consensus       256 s~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r  295 (411)
T KOG0599|consen  256 SATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQAR  295 (411)
T ss_pred             cccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhccc
Confidence            9999999999999999999999999999999876544443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-51  Score=369.69  Aligned_cols=266  Identities=32%  Similarity=0.521  Sum_probs=222.5

Q ss_pred             cccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           92 RHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      ..+.++.++|++.++||.|..+.||+|+...++..||||++..+......+.+.+|+..|..++||||++++..|..+..
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~   98 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE   98 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence            34557789999999999999999999999999999999999766655557889999999999999999999999999999


Q ss_pred             EEEEEeccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      +|+||.||.+|++.+.+..      .|..+..|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+..
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            9999999999998765443      5777889999999999999999999999999999999999999999998776654


Q ss_pred             cCCCC----CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC--
Q 016959          246 TMDPC----NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP--  319 (380)
Q Consensus       246 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--  319 (380)
                      .....    .+.+||++|||||++..+   ...|++|+|||||||+..||.+|+.||..   -...+.+.......++  
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~---~~GYdfKaDIwSfGITA~ELA~G~aPf~k---~pPmkvLl~tLqn~pp~~  252 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQ---LHGYDFKADIWSFGITACELAHGHAPFSK---YPPMKVLLLTLQNDPPTL  252 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhc---ccCccchhhhhhhhHHHHHHhcCCCCccc---CChHHHHHHHhcCCCCCc
Confidence            43322    566899999999997542   35567899999999999999999999962   2222222222222222  


Q ss_pred             -------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          320 -------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       320 -------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                             +.....+..++.+|..||++||++|||+.++|+|+||+......
T Consensus       253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~  303 (516)
T KOG0582|consen  253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE  303 (516)
T ss_pred             ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence                   12234677899999999999999999999999999999875443

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-51  Score=375.94  Aligned_cols=255  Identities=27%  Similarity=0.394  Sum_probs=214.6

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36889999999999999999999999999999985432  2234566889999999999999999999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      ||+.+++|.+++.    ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...   ...
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---~~~  157 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---TWT  157 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---ccc
Confidence            9999999876643    356778889999999999999999999999999999999999999999999866432   235


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      .+|++.|+|||++..     ..++.++|||||||++|+|++|..||.....   ......+. ......+..++..+++|
T Consensus       158 ~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~~~~~~i~-~~~~~~~~~~~~~~~~l  228 (291)
T cd05612         158 LCGTPEYLAPEVIQS-----KGHNKAVDWWALGILIYEMLVGYPPFFDDNP---FGIYEKIL-AGKLEFPRHLDLYAKDL  228 (291)
T ss_pred             ccCChhhcCHHHHcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH-hCCcCCCccCCHHHHHH
Confidence            679999999999853     4567899999999999999999999974332   22222222 23345666778999999


Q ss_pred             HHHhcccCcCCCCC-----HHHHhcCccccccCccccc
Q 016959          333 ISRCLQKDPHSRWP-----AAQLLQHPFILRAGQSQVN  365 (380)
Q Consensus       333 i~~~l~~dp~~R~t-----~~eil~hp~~~~~~~~~~~  365 (380)
                      |++||+.||.+|++     ++|+++||||+..++....
T Consensus       229 i~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~  266 (291)
T cd05612         229 IKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVP  266 (291)
T ss_pred             HHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHh
Confidence            99999999999995     9999999999998877553

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-50  Score=379.23  Aligned_cols=253  Identities=25%  Similarity=0.431  Sum_probs=212.5

Q ss_pred             ccccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC
Q 016959           91 NRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN  169 (380)
Q Consensus        91 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  169 (380)
                      ...|.|..+++.++..||+|.||+||+|.|.+   .||||++.... .++..+.|++|+.++++-+|.||+-|.|++...
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            36678999999999999999999999999954   48999996543 566788999999999999999999999999887


Q ss_pred             CeEEEEEeccCCCCcccccccch-----HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHIRQE-----HILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      +. .||..+|+|.+|+.+++..+     ..+++|++||++||.|||.++|||||||..||++.+++.|||+|||+++.-.
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence            66 99999999999998888754     3477899999999999999999999999999999999999999999987543


Q ss_pred             c--cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC----CC
Q 016959          245 Q--TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA----QP  318 (380)
Q Consensus       245 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~----~~  318 (380)
                      .  .........|...|||||+++.+  ....+++.+|||||||++|||++|..||. .+..+  .++..+..+    ..
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmq--d~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~d--qIifmVGrG~l~pd~  614 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQ--DDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRD--QIIFMVGRGYLMPDL  614 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhc--ccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChh--heEEEecccccCccc
Confidence            2  22233455688999999999854  35677899999999999999999999998 33333  333333322    22


Q ss_pred             CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          319 PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       319 ~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ......+++++++|+..||..++++||.+.+||.
T Consensus       615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  615 SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            3345568889999999999999999999999987

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.5e-52  Score=347.45  Aligned_cols=255  Identities=30%  Similarity=0.493  Sum_probs=221.8

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      ..+..++|++++.||+|.||.||+|+.+.++..||+|++.+..  ......++.+|+++-..|+||||+++|++|.+...
T Consensus        17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r   96 (281)
T KOG0580|consen   17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR   96 (281)
T ss_pred             cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence            3467889999999999999999999999999999999996654  23445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      +|+++||..+|.|...+.      ..+.....++.|++.|+.|+|.++|+||||||+|+|++.+|.+||+|||.+.... 
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999999999876555      4567788999999999999999999999999999999999999999999987654 


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                       .....+.|||..|.+||...+     ..++..+|+|++|++.||++.|..||......+....+...    ....|..+
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~-----~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~----~~~~p~~i  245 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEG-----RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV----DLKFPSTI  245 (281)
T ss_pred             -CCCceeeecccccCCHhhcCC-----CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc----cccCCccc
Confidence             334578899999999998864     55667899999999999999999999855544444444333    44556889


Q ss_pred             cHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      +.+++|||.+||.++|.+|.+..|++.|||+...
T Consensus       246 s~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  246 SGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             ChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            9999999999999999999999999999999864

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-50  Score=379.02  Aligned_cols=257  Identities=27%  Similarity=0.432  Sum_probs=216.5

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+++.++
T Consensus        15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   94 (329)
T PTZ00263         15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY   94 (329)
T ss_pred             CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence            44578999999999999999999999999999999986432  2233467889999999999999999999999999999


Q ss_pred             EEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 016959          174 VLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  249 (380)
                      +||||+.+++|.+.+.    ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......   
T Consensus        95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---  171 (329)
T PTZ00263         95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---  171 (329)
T ss_pred             EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence            9999999999876543    356778889999999999999999999999999999999999999999999866432   


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      .....||+.|+|||++..     ..++.++|||||||++|+|++|..||....   .......+. ......+..++..+
T Consensus       172 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~-~~~~~~p~~~~~~~  242 (329)
T PTZ00263        172 TFTLCGTPEYLAPEVIQS-----KGHGKAVDWWTMGVLLYEFIAGYPPFFDDT---PFRIYEKIL-AGRLKFPNWFDGRA  242 (329)
T ss_pred             cceecCChhhcCHHHHcC-----CCCCCcceeechHHHHHHHHcCCCCCCCCC---HHHHHHHHh-cCCcCCCCCCCHHH
Confidence            235679999999999853     445779999999999999999999996332   223333322 23445666789999


Q ss_pred             HHHHHHhcccCcCCCCC-----HHHHhcCccccccCcccc
Q 016959          330 RDFISRCLQKDPHSRWP-----AAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t-----~~eil~hp~~~~~~~~~~  364 (380)
                      ++||.+||+.||++|++     ++|+++||||.+..+...
T Consensus       243 ~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~  282 (329)
T PTZ00263        243 RDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKL  282 (329)
T ss_pred             HHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHH
Confidence            99999999999999997     799999999998776654

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3e-50  Score=370.46  Aligned_cols=254  Identities=28%  Similarity=0.425  Sum_probs=205.8

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .++|++.++||.|+||+||+|.+..+++.||+|+++..........+.+|+.+++.++|+||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            46799999999999999999999999999999999655443344567789999999999999999999999999999999


Q ss_pred             ccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          178 YMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       178 ~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      |+.+ +|..++.     ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~  162 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN  162 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccC
Confidence            9986 6655432     245678889999999999999999999999999999999999999999999765443333445


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC-------------
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP-------------  319 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------  319 (380)
                      ..|+..|+|||++.+    +..++.++|||||||++|+|++|+.||......+....+.........             
T Consensus       163 ~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         163 EVVTLWYRPPDVLLG----STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             ceecccccChHHhcC----CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            678999999998753    245677999999999999999999999754333222222211110000             


Q ss_pred             -------------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          320 -------------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       320 -------------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                                   .....++.+++|||.+||+.||.+|+|++|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                         0112467899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.7e-50  Score=375.75  Aligned_cols=261  Identities=28%  Similarity=0.462  Sum_probs=213.6

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGG  182 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  182 (380)
                      +.||+|+||.||++.+..+|+.||+|++....  .......+.+|+.+++.++||||++++++|...+.+|+||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999999999999999986432  2233456778999999999999999999999999999999999999


Q ss_pred             Ccccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCCc
Q 016959          183 SLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIA  258 (380)
Q Consensus       183 ~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~  258 (380)
                      +|..++.    ..+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............||+.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~  160 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence            9865443    356778899999999999999999999999999999999999999999998764333333345679999


Q ss_pred             cccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcc
Q 016959          259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ  338 (380)
Q Consensus       259 y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  338 (380)
                      |+|||++..     ..++.++|||||||++|||++|..||.....   ....... .......+..+++++.+||.+||+
T Consensus       161 y~aPE~~~~-----~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~~-~~~~~~~p~~~~~~~~~li~~~L~  231 (323)
T cd05595         161 YLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELI-LMEEIRFPRTLSPEAKSLLAGLLK  231 (323)
T ss_pred             cCCcccccC-----CCCCchhchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHH-hcCCCCCCCCCCHHHHHHHHHHcc
Confidence            999999853     4567899999999999999999999964332   2222222 223345667789999999999999


Q ss_pred             cCcCCCC-----CHHHHhcCccccccCcccccccccccCCCCC
Q 016959          339 KDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPR  376 (380)
Q Consensus       339 ~dp~~R~-----t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~  376 (380)
                      .||++|+     ++.++++|+||....+....+  ....||++
T Consensus       232 ~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~--~~~~~~~~  272 (323)
T cd05595         232 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ--KKLLPPFK  272 (323)
T ss_pred             CCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHh--CCCCCCcC
Confidence            9999998     899999999999987766543  34444443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-52  Score=376.92  Aligned_cols=255  Identities=34%  Similarity=0.540  Sum_probs=227.4

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ...|...++||+|+||.||+|.+..+++.||+|++..+..+...+.+..|+.+|..++++||.++|+.|..+..++++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            45677889999999999999999999999999999888877778999999999999999999999999999999999999


Q ss_pred             ccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          178 YMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       178 ~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      ||.||++.+.+..    .+..+.-++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..+........++
T Consensus        92 y~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tf  171 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTF  171 (467)
T ss_pred             HhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccccc
Confidence            9999998776554    455677789999999999999999999999999999999999999999999988776666899


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHH
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI  333 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  333 (380)
                      +||+.|||||++.     +..|+.++||||||++.+||.+|..||.....   ...+..+-...++.+...+++.+++||
T Consensus       172 vGTPfwMAPEVI~-----~~~Y~~KADIWSLGITaiEla~GePP~s~~hP---mrvlflIpk~~PP~L~~~~S~~~kEFV  243 (467)
T KOG0201|consen  172 VGTPFWMAPEVIK-----QSGYDTKADIWSLGITAIELAKGEPPHSKLHP---MRVLFLIPKSAPPRLDGDFSPPFKEFV  243 (467)
T ss_pred             cccccccchhhhc-----cccccchhhhhhhhHHHHHHhcCCCCCcccCc---ceEEEeccCCCCCccccccCHHHHHHH
Confidence            9999999999996     35677899999999999999999999974333   334444555666777778999999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCccccccC
Q 016959          334 SRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       334 ~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      ..||++||+.||++.++|+|+|+++..
T Consensus       244 ~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  244 EACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             HHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence            999999999999999999999999954

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.7e-50  Score=378.86  Aligned_cols=261  Identities=23%  Similarity=0.352  Sum_probs=217.4

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCC-cEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTS-RVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN  169 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~-~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  169 (380)
                      ...+..++|.+.+.||+|+||.||+|.+..++ ..||+|++....  .......+.+|+.+++.++||||+++++++.+.
T Consensus        24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~  103 (340)
T PTZ00426         24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE  103 (340)
T ss_pred             CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence            34467789999999999999999999876554 689999985432  233456688999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      +.+++||||+.+++|..++..    .+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            999999999999998766543    5667888999999999999999999999999999999999999999999986643


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                      .   ....+||+.|+|||++.+     ..++.++|||||||++|||++|..||.....   ......+. ......+..+
T Consensus       184 ~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~~~~i~-~~~~~~p~~~  251 (340)
T PTZ00426        184 R---TYTLCGTPEYIAPEILLN-----VGHGKAADWWTLGIFIYEILVGCPPFYANEP---LLIYQKIL-EGIIYFPKFL  251 (340)
T ss_pred             C---cceecCChhhcCHHHHhC-----CCCCccccccchhhHHHHHhcCCCCCCCCCH---HHHHHHHh-cCCCCCCCCC
Confidence            2   245679999999999853     4567789999999999999999999974322   22222222 3334566778


Q ss_pred             cHHHHHHHHHhcccCcCCCC-----CHHHHhcCccccccCccccc
Q 016959          326 SREFRDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVN  365 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~-----t~~eil~hp~~~~~~~~~~~  365 (380)
                      +.++.++|++||+.||++|+     +++|+++||||.+.++....
T Consensus       252 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~  296 (340)
T PTZ00426        252 DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLL  296 (340)
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence            99999999999999999996     89999999999998876553

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.2e-49  Score=364.93  Aligned_cols=253  Identities=25%  Similarity=0.346  Sum_probs=209.8

Q ss_pred             ecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCCCc
Q 016959          107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL  184 (380)
Q Consensus       107 LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  184 (380)
                      ||+|+||+||+|.+..+++.||+|++.....  ....+.+..|+.+++.++|+||+++++++...+.+++||||+.+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            7999999999999999999999999864322  22335677899999999999999999999999999999999999998


Q ss_pred             cccc--------ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCC
Q 016959          185 EGAH--------IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT  256 (380)
Q Consensus       185 ~~~~--------~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  256 (380)
                      ...+        ...+..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+...........||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~  160 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT  160 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence            6443        23567788899999999999999999999999999999999999999999998765443334456799


Q ss_pred             CccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHh
Q 016959          257 IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC  336 (380)
Q Consensus       257 ~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  336 (380)
                      +.|+|||++..     ..++.++|||||||++|+|++|+.||.......................+..++.++.+|+.+|
T Consensus       161 ~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (280)
T cd05608         161 PGFMAPELLQG-----EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL  235 (280)
T ss_pred             cCccCHHHhcC-----CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHH
Confidence            99999999853     4556789999999999999999999975433222222223333344456677899999999999


Q ss_pred             cccCcCCCC-----CHHHHhcCccccccCcccc
Q 016959          337 LQKDPHSRW-----PAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       337 l~~dp~~R~-----t~~eil~hp~~~~~~~~~~  364 (380)
                      |+.||++|+     +++|+++||||++.++...
T Consensus       236 l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~  268 (280)
T cd05608         236 LAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL  268 (280)
T ss_pred             hcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHH
Confidence            999999999     8899999999999876654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.9e-50  Score=375.65  Aligned_cols=261  Identities=26%  Similarity=0.442  Sum_probs=214.2

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGG  182 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  182 (380)
                      +.||+|+||.||++.+..+++.||+|++....  .......+.+|+.+++.++||||+++++++...+.+++||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999996542  2233456788999999999999999999999999999999999999


Q ss_pred             Ccccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCCc
Q 016959          183 SLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIA  258 (380)
Q Consensus       183 ~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~  258 (380)
                      +|...+.    ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||+.
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~  160 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE  160 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence            9865543    356778889999999999999999999999999999999999999999998764333333345679999


Q ss_pred             cccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcc
Q 016959          259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ  338 (380)
Q Consensus       259 y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  338 (380)
                      |+|||++..     ..++.++|||||||++|+|++|..||.....   ...... ........+..++.++.+||.+||+
T Consensus       161 y~aPE~~~~-----~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~~~~-~~~~~~~~p~~~~~~~~~li~~~L~  231 (328)
T cd05593         161 YLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFEL-ILMEDIKFPRTLSADAKSLLSGLLI  231 (328)
T ss_pred             ccChhhhcC-----CCCCccCCccccchHHHHHhhCCCCCCCCCH---HHHHHH-hccCCccCCCCCCHHHHHHHHHHcC
Confidence            999999853     4567899999999999999999999964322   222222 2233445677789999999999999


Q ss_pred             cCcCCCC-----CHHHHhcCccccccCcccccccccccCCCCC
Q 016959          339 KDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPR  376 (380)
Q Consensus       339 ~dp~~R~-----t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~  376 (380)
                      .||++|+     ++.|+++||||.+.++.....  .+..|+++
T Consensus       232 ~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~--~~~~~~~~  272 (328)
T cd05593         232 KDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYD--KKLVPPFK  272 (328)
T ss_pred             CCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHh--CCCCCCcC
Confidence            9999997     899999999999987765543  33444433

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4e-50  Score=377.01  Aligned_cols=260  Identities=30%  Similarity=0.498  Sum_probs=228.5

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l  174 (380)
                      .+.|++++.||+|.||.||+|+.+.+|+.+|+|++.+...  ....+.+.+|+.+|+.+. |||||.++++|++...+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            4578999999999999999999999999999999966543  224578899999999998 9999999999999999999


Q ss_pred             EEeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC----CcEEEeeccccccccccC
Q 016959          175 LLEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS----KNVKIADFGVSRILAQTM  247 (380)
Q Consensus       175 v~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~----~~~kl~Dfg~a~~~~~~~  247 (380)
                      |||+|.||.|.+.+.   ..+.....++.||+.|+.|||+.||+||||||+|+|+...    +.+|++|||++..... .
T Consensus       114 vmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-~  192 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-G  192 (382)
T ss_pred             EEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-C
Confidence            999999999876544   4678888999999999999999999999999999999633    4799999999998877 4


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                      ......+||+.|+|||++..     ..|+..+||||+|+++|.|++|..||...........+.........+.++.++.
T Consensus       193 ~~~~~~~Gtp~y~APEvl~~-----~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~  267 (382)
T KOG0032|consen  193 ERLHTIVGTPEYVAPEVLGG-----RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE  267 (382)
T ss_pred             ceEeeecCCccccCchhhcC-----CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence            56678999999999999853     6678899999999999999999999987665555555666666677888999999


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                      .+++||.+||..||.+|+|+.++|+|||++......
T Consensus       268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~  303 (382)
T KOG0032|consen  268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEAT  303 (382)
T ss_pred             HHHHHHHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence            999999999999999999999999999999864443

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-50  Score=372.29  Aligned_cols=249  Identities=27%  Similarity=0.424  Sum_probs=209.0

Q ss_pred             ecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCCCc
Q 016959          107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL  184 (380)
Q Consensus       107 LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  184 (380)
                      ||+|+||+||+|.+..+++.||+|++....  .......+.+|+.+++.++|+||+++++++...+..++||||+.+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999999999999999986432  233446678899999999999999999999999999999999999999


Q ss_pred             ccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCCccc
Q 016959          185 EGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYM  260 (380)
Q Consensus       185 ~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~  260 (380)
                      ..++.    ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+.|+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~  160 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL  160 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence            76553    35677888999999999999999999999999999999999999999999976543333345567999999


Q ss_pred             cccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccC
Q 016959          261 SPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKD  340 (380)
Q Consensus       261 aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  340 (380)
                      |||++..     ..++.++|||||||++|+|++|..||...   ....... .........+..++.++.+||.+||..|
T Consensus       161 aPE~~~~-----~~~~~~~DvwslGvil~el~tg~~pf~~~---~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~d  231 (312)
T cd05585         161 APELLLG-----HGYTKAVDWWTLGVLLYEMLTGLPPFYDE---NVNEMYR-KILQEPLRFPDGFDRDAKDLLIGLLSRD  231 (312)
T ss_pred             CHHHHcC-----CCCCCccceechhHHHHHHHhCCCCcCCC---CHHHHHH-HHHcCCCCCCCcCCHHHHHHHHHHcCCC
Confidence            9999853     45677899999999999999999999643   2223222 2334455677788999999999999999


Q ss_pred             cCCCC---CHHHHhcCccccccCcccc
Q 016959          341 PHSRW---PAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       341 p~~R~---t~~eil~hp~~~~~~~~~~  364 (380)
                      |++|+   ++.|+|.||||...++...
T Consensus       232 p~~R~~~~~~~e~l~hp~~~~~~~~~~  258 (312)
T cd05585         232 PTRRLGYNGAQEIKNHPFFSQLSWKKL  258 (312)
T ss_pred             HHHcCCCCCHHHHHcCCCcCCCCHHHH
Confidence            99997   5899999999999865543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-50  Score=382.72  Aligned_cols=267  Identities=25%  Similarity=0.388  Sum_probs=215.7

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++|++.+.||+|+||+||+|++..+++.||||++....  .......+.+|+.+++.++|+||++++++|.+.+.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36889999999999999999999999999999996432  2234456788999999999999999999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC----
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD----  248 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~----  248 (380)
                      |||.+++|.+++.    ..+..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.....    
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            9999999876643    35777889999999999999999999999999999999999999999999875432110    


Q ss_pred             ----------------------------------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhC
Q 016959          249 ----------------------------------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLG  294 (380)
Q Consensus       249 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g  294 (380)
                                                        .....+||+.|+|||++..     ..++.++|||||||++|||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-----TGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-----CCCCCeeeeecchhHHHHhhcC
Confidence                                              0123469999999999853     4567899999999999999999


Q ss_pred             CCCCCCCCCCCHHHHHHHHhh-CCCCC--CCccccHHHHHHHHHhcccCcCCCCC---HHHHhcCccccccCcccccccc
Q 016959          295 RFPFAVGRQGDWASLMFAICF-AQPPE--APEMASREFRDFISRCLQKDPHSRWP---AAQLLQHPFILRAGQSQVNQNL  368 (380)
Q Consensus       295 ~~pf~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~li~~~l~~dp~~R~t---~~eil~hp~~~~~~~~~~~~~~  368 (380)
                      ..||.....   ......+.. .....  ....+++++++||.+||. +|.+|++   +.|+++||||++.++.......
T Consensus       236 ~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~~~~~~~  311 (364)
T cd05599         236 YPPFCSDNP---QETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRERP  311 (364)
T ss_pred             CCCCCCCCH---HHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHhhcC
Confidence            999974332   222222221 11112  223468899999999996 9999998   9999999999999887665545


Q ss_pred             cccCCC
Q 016959          369 RQILPP  374 (380)
Q Consensus       369 ~~~~~~  374 (380)
                      ++++|.
T Consensus       312 ~~~~~~  317 (364)
T cd05599         312 APIIPE  317 (364)
T ss_pred             CCCCCC
Confidence            555554

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.5e-50  Score=379.28  Aligned_cols=259  Identities=24%  Similarity=0.343  Sum_probs=209.5

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++|++.+.||+|+||+||+|.+..+++.||||++.+..  .......+.+|+.+++.++|+||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999999999999999996532  2334467888999999999999999999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC----
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD----  248 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~----  248 (380)
                      |||.|++|.+++.    ..+..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.+.....    
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            9999999876653    35677889999999999999999999999999999999999999999999875432100    


Q ss_pred             -------------------------------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 016959          249 -------------------------------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFP  297 (380)
Q Consensus       249 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~p  297 (380)
                                                     .....+||+.|+|||++..     ..++.++|||||||++|||++|..|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-----TGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-----CCCCCchhhhhhHHHHHHHHhCCCC
Confidence                                           0124579999999999853     4567799999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHhh-CCCCCCC--ccccHHHHHHHHHhcccCcCC---CCCHHHHhcCccccccCcccccc
Q 016959          298 FAVGRQGDWASLMFAICF-AQPPEAP--EMASREFRDFISRCLQKDPHS---RWPAAQLLQHPFILRAGQSQVNQ  366 (380)
Q Consensus       298 f~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~~l~~dp~~---R~t~~eil~hp~~~~~~~~~~~~  366 (380)
                      |......   .....+.. ......+  ..++.++++||.+|+. +|++   ||+++|+++||||++.++.....
T Consensus       236 f~~~~~~---~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~  306 (363)
T cd05628         236 FCSETPQ---ETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEHIRE  306 (363)
T ss_pred             CCCCCHH---HHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHHHHh
Confidence            9743332   22222221 1112222  2468899999999875 4544   58999999999999998877644

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-49  Score=364.19  Aligned_cols=270  Identities=26%  Similarity=0.378  Sum_probs=222.9

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .|++.++||+|+||+||++.+..+++.||+|++.....  ......+.+|+.+++.++|+||+.+++.+..++.+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            37788999999999999999998999999999864321  2223456789999999999999999999999999999999


Q ss_pred             ccCCCCccccc------ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCC
Q 016959          178 YMDGGSLEGAH------IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       178 ~~~~~~L~~~~------~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      |+.+++|..++      ...+..+..++.||+.||.|||++||+||||||+||++++++.++|+|||++...... ....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~  159 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIR  159 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-Cccc
Confidence            99999986543      2356678889999999999999999999999999999999999999999998765432 2224


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD  331 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (380)
                      ..+|+..|+|||++..     ..++.++|||||||++|||++|..||...........+...........+..++..+.+
T Consensus       160 ~~~~~~~y~aPE~~~~-----~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd05605         160 GRVGTVGYMAPEVVKN-----ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARS  234 (285)
T ss_pred             cccCCCCccCcHHhcC-----CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHH
Confidence            5578999999999853     45677899999999999999999999754433333333333333445566678999999


Q ss_pred             HHHHhcccCcCCCC-----CHHHHhcCccccccCcccccccccccCCCCCC
Q 016959          332 FISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       332 li~~~l~~dp~~R~-----t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      ||.+||..||++|+     +++++++||||...++...++  .+..||++|
T Consensus       235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~--~~~~~~~~~  283 (285)
T cd05605         235 ICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEA--GMLEPPFCP  283 (285)
T ss_pred             HHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhh--CCCCCCCCC
Confidence            99999999999999     899999999999988887765  556688777

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-50  Score=375.86  Aligned_cols=268  Identities=24%  Similarity=0.334  Sum_probs=218.3

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++|++.+.||+|+||.||+|++..+++.||||++....  .......+.+|+.+++.++|+||+++++++...+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999999999999999986442  1233456889999999999999999999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      ||+.+++|.+++.    ..+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....   ....
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~~  157 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANS  157 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccCC
Confidence            9999999987654    35677888999999999999999999999999999999999999999999976543   2356


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC-CCCCC---ccccHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ-PPEAP---EMASRE  328 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~  328 (380)
                      .+||+.|+|||++..     ..++.++|||||||++|||++|..||......+....+....... .+...   ..++.+
T Consensus       158 ~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~  232 (333)
T cd05600         158 VVGSPDYMAPEVLRG-----KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDE  232 (333)
T ss_pred             cccCccccChhHhcC-----CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHH
Confidence            679999999999853     456789999999999999999999997543333222222211111 11111   246889


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCccccccCcccccccccccCCC
Q 016959          329 FRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPP  374 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~  374 (380)
                      +.+||.+||..+|++|+++.|+++||||.+..+.......+.++|.
T Consensus       233 ~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~~~~~~~~~~~~  278 (333)
T cd05600         233 AWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELRELKPPFVPE  278 (333)
T ss_pred             HHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHHHhhCCCCCCCC
Confidence            9999999999999999999999999999998776665433434443

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.8e-49  Score=384.89  Aligned_cols=255  Identities=23%  Similarity=0.325  Sum_probs=194.3

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC------CCceeeeEeEEeeC
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN------HPNVVKCHDMYDRN  169 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~  169 (380)
                      +..++|++.++||+|+||+||+|.+..+++.||||+++...  .....+..|+.+++.+.      |.++++++++|...
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            34578999999999999999999999999999999985432  22344566777777764      45688999988754


Q ss_pred             -CeEEEEEeccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCC-------------
Q 016959          170 -GEIEVLLEYMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHK-RKIVHRDIKPSNLLINSSK-------------  230 (380)
Q Consensus       170 -~~~~lv~e~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~Nil~~~~~-------------  230 (380)
                       +.+++|||++ +++|.+++    ...+..+..|+.||+.||+|||+ .|||||||||+|||++.++             
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence             5789999988 45554433    34567788999999999999998 5999999999999998765             


Q ss_pred             ---cEEEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHH
Q 016959          231 ---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWA  307 (380)
Q Consensus       231 ---~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~  307 (380)
                         .+||+|||++.....   .....+||+.|+|||++.     +..++.++|||||||++|||++|+.||......+..
T Consensus       283 ~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~-----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~  354 (467)
T PTZ00284        283 DPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVL-----GLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL  354 (467)
T ss_pred             CCceEEECCCCccccCcc---ccccccCCccccCcHHhh-----cCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence               499999998864332   234678999999999985     355678999999999999999999999754433322


Q ss_pred             HHHHHHhhCCCC-----------------------C--------------C-CccccHHHHHHHHHhcccCcCCCCCHHH
Q 016959          308 SLMFAICFAQPP-----------------------E--------------A-PEMASREFRDFISRCLQKDPHSRWPAAQ  349 (380)
Q Consensus       308 ~~~~~~~~~~~~-----------------------~--------------~-~~~~~~~~~~li~~~l~~dp~~R~t~~e  349 (380)
                      ..+.......+.                       .              . ....+..+.|||.+||+.||++|+|++|
T Consensus       355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e  434 (467)
T PTZ00284        355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ  434 (467)
T ss_pred             HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence            222221110000                       0              0 0012456789999999999999999999


Q ss_pred             HhcCccccccCc
Q 016959          350 LLQHPFILRAGQ  361 (380)
Q Consensus       350 il~hp~~~~~~~  361 (380)
                      +|+||||.....
T Consensus       435 ~L~Hp~~~~~~~  446 (467)
T PTZ00284        435 MTTHPYVLKYYP  446 (467)
T ss_pred             HhcCccccccCC
Confidence            999999998644

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-50  Score=359.10  Aligned_cols=257  Identities=26%  Similarity=0.377  Sum_probs=210.6

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCC-CchHHHHHHHHHHHHHHhCCCCceeeeEeEEee-----CCe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN-HEDSVRSQICREIEILRDVNHPNVVKCHDMYDR-----NGE  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~  171 (380)
                      ...|...+.||+|+||.|+.+.++.+|+.||||.+... ...-..++..+|+++|+.++|+||+.+++++..     -+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            34556678999999999999999999999999998532 233445678899999999999999999999865     467


Q ss_pred             EEEEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc-
Q 016959          172 IEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT-  246 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  246 (380)
                      +|+|+|+|+ .+|...+..    .+..++-+++||++||.|+|+.||+||||||.|+|++.++.+||||||+|+..... 
T Consensus       101 vYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  101 VYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             eEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence            999999995 466554433    45678889999999999999999999999999999999999999999999987532 


Q ss_pred             -CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC------
Q 016959          247 -MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP------  319 (380)
Q Consensus       247 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------  319 (380)
                       ....+..+-|.+|+|||++..    ...|+...||||+||||.||++|+..|...+..++...+.........      
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~----~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i  255 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLN----SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI  255 (359)
T ss_pred             cccchhcceeeeeecCHHHHhc----cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence             223467788999999999854    466788999999999999999999999866555444444333322211      


Q ss_pred             ---------------------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          320 ---------------------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       320 ---------------------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                                           ...+.+++.+.||+++||..||.+|+|++|+|+||||...
T Consensus       256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~  316 (359)
T KOG0660|consen  256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY  316 (359)
T ss_pred             ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence                                 1223588899999999999999999999999999999886

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2e-49  Score=367.60  Aligned_cols=256  Identities=28%  Similarity=0.422  Sum_probs=204.0

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .++|++.+.||+|+||+||+|.+..+++.||||++...........+.+|+.+++.++|+||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            46899999999999999999999999999999998654433334567789999999999999999999999999999999


Q ss_pred             ccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          178 YMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       178 ~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      |+.+ +|...+     ...+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        84 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  162 (303)
T cd07869          84 YVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN  162 (303)
T ss_pred             CCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence            9975 443332     2356678889999999999999999999999999999999999999999998765433333345


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh--CCC------------
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF--AQP------------  318 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~------------  318 (380)
                      ..|++.|+|||++.+    ...++.++|||||||++|+|++|..||....  +..........  ..+            
T Consensus       163 ~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         163 EVVTLWYRPPDVLLG----STEYSTCLDMWGVGCIFVEMIQGVAAFPGMK--DIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             CcccCCCCChHHHcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc--cHHHHHHHHHHHhCCCChhhccchhhcc
Confidence            678999999999753    2346678999999999999999999997432  22222111110  000            


Q ss_pred             ---CC-----CC---------ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          319 ---PE-----AP---------EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       319 ---~~-----~~---------~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                         +.     .+         ...+.++.+||.+||+.||++|+|+.|+|+||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence               00     00         01346789999999999999999999999999998864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.7e-50  Score=356.64  Aligned_cols=262  Identities=30%  Similarity=0.455  Sum_probs=214.4

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCc-eeeeEeEEeeCC-----
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPN-VVKCHDMYDRNG-----  170 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~-----  170 (380)
                      .+.|+..++||+|+||+||+|+.+.+|+.||+|+++...+ +..-....+|+.+|+.++|+| ||.+++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            4568888999999999999999999999999999976654 344456679999999999999 999999998776     


Q ss_pred             -eEEEEEeccCCCCccccccc--------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          171 -EIEVLLEYMDGGSLEGAHIR--------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       171 -~~~lv~e~~~~~~L~~~~~~--------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                       .+++|+||++. +|..++..        ....++.+++||+.||+|||++||+||||||.||||+++|.+||+|||+|+
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence             89999999975 44333222        235789999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCC
Q 016959          242 ILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA  321 (380)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  321 (380)
                      ...-........++|..|+|||++.+    ...|+...||||+|||++||++++..|......+....+...........
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlG----s~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLG----STSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcC----CCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            77755555677889999999999864    34678899999999999999999999986555444333333332222111


Q ss_pred             C--------------------------ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          322 P--------------------------EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       322 ~--------------------------~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                      |                          +..+.+..+++.+||+.+|.+|.|+..+|.||||..+.....
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~  313 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSS  313 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchh
Confidence            1                          113348999999999999999999999999999999855443

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-50  Score=366.76  Aligned_cols=277  Identities=25%  Similarity=0.408  Sum_probs=238.2

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      +.++...|...++||+|+||+||-|+.+.||+.||.|.+.+..  .........+|-.+|.+++.++||.+-..|+..+.
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            4577788999999999999999999999999999999884332  11222345689999999999999999999999999


Q ss_pred             EEEEEeccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      +++||..|.||+|.-++..      .+...+-++.+|+.||++||+.+||+|||||+|||+|+.|+++|+|+|+|..+..
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            9999999999999654433      5677888999999999999999999999999999999999999999999998865


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                      . ....+.+||.+|||||++.+     ..|++..|+|||||+||||+.|+.||.......-.+.+.......+.++++.+
T Consensus       340 g-~~~~~rvGT~GYMAPEvl~n-----e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kF  413 (591)
T KOG0986|consen  340 G-KPIRGRVGTVGYMAPEVLQN-----EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKF  413 (591)
T ss_pred             C-CccccccCcccccCHHHHcC-----CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccccc
Confidence            5 45567799999999999964     44788999999999999999999999866655555566677777888899999


Q ss_pred             cHHHHHHHHHhcccCcCCCCC-----HHHHhcCccccccCccccc--ccccccCCCCC
Q 016959          326 SREFRDFISRCLQKDPHSRWP-----AAQLLQHPFILRAGQSQVN--QNLRQILPPPR  376 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~t-----~~eil~hp~~~~~~~~~~~--~~~~~~~~~~~  376 (380)
                      ++++++|.+.+|.+||++|+.     ++++.+||||++++|..+.  +.-++++|+|.
T Consensus       414 S~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~  471 (591)
T KOG0986|consen  414 SEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPG  471 (591)
T ss_pred             CHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCcc
Confidence            999999999999999999985     6799999999999998873  44466666654

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.2e-49  Score=371.40  Aligned_cols=267  Identities=27%  Similarity=0.464  Sum_probs=216.1

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      +.||+|+||+||+|.+..+++.||+|++.+..  .......+.+|+.++..+ +|+||+++++++...+.+++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999996542  233445677888888776 799999999999999999999999999


Q ss_pred             CCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCC
Q 016959          182 GSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI  257 (380)
Q Consensus       182 ~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  257 (380)
                      ++|..++    ...+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||.
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence            9986543    335677888999999999999999999999999999999999999999999876433333345677999


Q ss_pred             ccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CCCHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGR-----QGDWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      .|+|||++..     ..++.++|||||||++|+|++|..||....     ...................+..++.++.+|
T Consensus       161 ~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  235 (329)
T cd05618         161 NYIAPEILRG-----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV  235 (329)
T ss_pred             cccCHHHHcC-----CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence            9999999853     556778999999999999999999995211     111222233333444556777889999999


Q ss_pred             HHHhcccCcCCCCC------HHHHhcCccccccCcccccccccccCCCCCCC
Q 016959          333 ISRCLQKDPHSRWP------AAQLLQHPFILRAGQSQVNQNLRQILPPPRPL  378 (380)
Q Consensus       333 i~~~l~~dp~~R~t------~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  378 (380)
                      |.+||+.||++|++      +.++++||||+..++....+  ++..|+.+|.
T Consensus       236 l~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~--~~~~~~~~~~  285 (329)
T cd05618         236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQ--KQVVPPFKPN  285 (329)
T ss_pred             HHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHc--CCCCcCccCC
Confidence            99999999999998      58999999999987765543  4555555553

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.3e-49  Score=371.51  Aligned_cols=252  Identities=26%  Similarity=0.400  Sum_probs=208.3

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      +.||+|+||+||+|++..+++.||||++....  .....+.+..|..+++.+ +|+||+++++++...+.+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999986432  223345667888888876 699999999999999999999999999


Q ss_pred             CCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCC
Q 016959          182 GSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI  257 (380)
Q Consensus       182 ~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  257 (380)
                      ++|..++.    ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............||+
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP  160 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence            99865543    35677888999999999999999999999999999999999999999999876433333345567999


Q ss_pred             ccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhc
Q 016959          258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL  337 (380)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  337 (380)
                      .|+|||++..     ..++.++|||||||++|+|++|+.||.....   ......+ .......+..++.++.+||.+||
T Consensus       161 ~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i-~~~~~~~~~~~~~~~~~li~~~L  231 (320)
T cd05590         161 DYIAPEILQE-----MLYGPSVDWWAMGVLLYEMLCGHAPFEAENE---DDLFEAI-LNDEVVYPTWLSQDAVDILKAFM  231 (320)
T ss_pred             cccCHHHHcC-----CCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHHH-hcCCCCCCCCCCHHHHHHHHHHc
Confidence            9999999853     4567789999999999999999999974332   2222222 23344566678999999999999


Q ss_pred             ccCcCCCCCH------HHHhcCccccccCccccc
Q 016959          338 QKDPHSRWPA------AQLLQHPFILRAGQSQVN  365 (380)
Q Consensus       338 ~~dp~~R~t~------~eil~hp~~~~~~~~~~~  365 (380)
                      +.||++|+++      ++++.||||....+....
T Consensus       232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~  265 (320)
T cd05590         232 TKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLN  265 (320)
T ss_pred             ccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHH
Confidence            9999999998      999999999998776553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.9e-49  Score=372.42  Aligned_cols=261  Identities=28%  Similarity=0.445  Sum_probs=213.2

Q ss_pred             cccccceecccCCceEEEEEeC---CCCcEEEEEEecCCC---chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHP---PTSRVFALKVIYGNH---EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~---~~~~~~avK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  172 (380)
                      +|++.+.||+|+||+||+|++.   .+++.||+|++.+..   .....+.+.+|+.+++.+ +|+||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788999999999999998864   478999999986432   223345678899999999 599999999999999999


Q ss_pred             EEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-
Q 016959          173 EVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM-  247 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  247 (380)
                      ++||||+.+++|..++.    ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.... 
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~  160 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK  160 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence            99999999999876543    3567788899999999999999999999999999999999999999999998654322 


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                      ......+||..|+|||++..    ...++.++|||||||++|||++|..||...........+........+..+..++.
T Consensus       161 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd05614         161 ERTYSFCGTIEYMAPEIIRG----KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGP  236 (332)
T ss_pred             CccccccCCccccCHHHhcC----CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Confidence            22335679999999999853    23456789999999999999999999975433333333333333445566777899


Q ss_pred             HHHHHHHHhcccCcCCCC-----CHHHHhcCccccccCcccc
Q 016959          328 EFRDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~-----t~~eil~hp~~~~~~~~~~  364 (380)
                      .+.+||.+||+.||++|+     +++|+++||||++..+...
T Consensus       237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~  278 (332)
T cd05614         237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEAL  278 (332)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence            999999999999999999     8899999999998765443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.2e-49  Score=371.41  Aligned_cols=256  Identities=25%  Similarity=0.427  Sum_probs=211.1

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      +.||+|+||+||+|.+..+++.||||+++...  .......+.+|..+++.+ +||||++++++|.+.+.+|+||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999996542  233445678899999988 699999999999999999999999999


Q ss_pred             CCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCC
Q 016959          182 GSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI  257 (380)
Q Consensus       182 ~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  257 (380)
                      ++|..++    ...+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||.
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence            9986554    345778889999999999999999999999999999999999999999999875433333345678999


Q ss_pred             ccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-----CHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG-----DWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      .|+|||++..     ..++.++|+|||||++|+|++|+.||......     .................+..++.++.+|
T Consensus       161 ~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~l  235 (329)
T cd05588         161 NYIAPEILRG-----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSV  235 (329)
T ss_pred             cccCHHHHcC-----CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999853     45677899999999999999999999632111     1122233333344556677789999999


Q ss_pred             HHHhcccCcCCCCC------HHHHhcCccccccCccccc
Q 016959          333 ISRCLQKDPHSRWP------AAQLLQHPFILRAGQSQVN  365 (380)
Q Consensus       333 i~~~l~~dp~~R~t------~~eil~hp~~~~~~~~~~~  365 (380)
                      |.+||+.||++|++      ++|+++||||....+....
T Consensus       236 i~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~  274 (329)
T cd05588         236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLE  274 (329)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHH
Confidence            99999999999987      7899999999987766553

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.5e-49  Score=378.24  Aligned_cols=267  Identities=26%  Similarity=0.401  Sum_probs=217.1

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      ...+..++|++.+.||+|+||+||+|.+..+++.||+|++.+..  .......+.+|+.+++.++|+||+++++++.+++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~  116 (370)
T cd05596          37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK  116 (370)
T ss_pred             cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            34467789999999999999999999999999999999985432  2223345778999999999999999999999999


Q ss_pred             eEEEEEeccCCCCccccccc---chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          171 EIEVLLEYMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      .+++||||+.+|+|..++..   .+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence            99999999999999766533   466778899999999999999999999999999999999999999999998664332


Q ss_pred             C-CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC-CCCCCCc--
Q 016959          248 D-PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA-QPPEAPE--  323 (380)
Q Consensus       248 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~--  323 (380)
                      . .....+||+.|+|||++.... ....++.++|||||||++|||++|..||.....   ......+... .....+.  
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~  272 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQG-GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMDHKNSLTFPDDI  272 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCC-CCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH---HHHHHHHHcCCCcCCCCCcC
Confidence            1 234567999999999985421 134567899999999999999999999974332   2333333221 1222333  


Q ss_pred             cccHHHHHHHHHhcccCcCC--CCCHHHHhcCccccccCccc
Q 016959          324 MASREFRDFISRCLQKDPHS--RWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~--R~t~~eil~hp~~~~~~~~~  363 (380)
                      .++.++.+||.+||+.+|++  |+|++|+++||||+...+..
T Consensus       273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~~  314 (370)
T cd05596         273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTF  314 (370)
T ss_pred             CCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChhh
Confidence            57899999999999999988  99999999999999876553

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-50  Score=380.90  Aligned_cols=267  Identities=25%  Similarity=0.401  Sum_probs=211.6

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++|.+.++||+|+||+||+|.+..+++.||||++....  .......+.+|+++++.++|+||++++++|.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36889999999999999999999999999999985432  2334567889999999999999999999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC----
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD----  248 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~----  248 (380)
                      ||+.+++|..++.    ..+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.....    
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  160 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY  160 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            9999999976543    35677888999999999999999999999999999999999999999999864321000    


Q ss_pred             -------------------------------------------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHH
Q 016959          249 -------------------------------------------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLG  285 (380)
Q Consensus       249 -------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG  285 (380)
                                                                 .....+||+.|+|||++..     ..++.++||||||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG  235 (377)
T cd05629         161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-----QGYGQECDWWSLG  235 (377)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-----CCCCCceeeEecc
Confidence                                                       0013569999999999853     4567899999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCCHHHHHHHHhh-CCCCCCCc--cccHHHHHHHHHhcccCcCCC---CCHHHHhcCcccccc
Q 016959          286 VSILEFYLGRFPFAVGRQGDWASLMFAICF-AQPPEAPE--MASREFRDFISRCLQKDPHSR---WPAAQLLQHPFILRA  359 (380)
Q Consensus       286 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~li~~~l~~dp~~R---~t~~eil~hp~~~~~  359 (380)
                      |++|||++|..||......   .....+.. ......+.  .++.++.+||.+||. +|.+|   +++.|++.||||++.
T Consensus       236 vil~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         236 AIMFECLIGWPPFCSENSH---ETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHH---HHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9999999999999643322   22222211 11222232  478899999999997 77765   599999999999988


Q ss_pred             CcccccccccccCCC
Q 016959          360 GQSQVNQNLRQILPP  374 (380)
Q Consensus       360 ~~~~~~~~~~~~~~~  374 (380)
                      ++.........++|.
T Consensus       312 ~~~~~~~~~~~~~~~  326 (377)
T cd05629         312 DWDTIRQIRAPFIPQ  326 (377)
T ss_pred             CHHHHccCCCCcccC
Confidence            776655444444443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.6e-50  Score=375.26  Aligned_cols=275  Identities=26%  Similarity=0.369  Sum_probs=221.4

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++|.+.+.||+|+||+||+|.+..+++.||+|++....  .......+.+|+.+++.++|+||+++++++.+.+.+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36889999999999999999999999999999996542  2334566889999999999999999999999999999999


Q ss_pred             eccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-CC
Q 016959          177 EYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-PC  250 (380)
Q Consensus       177 e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~  250 (380)
                      ||+.+++|.+++.     ..+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... ..
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            9999999977653     35677888999999999999999999999999999999999999999999987653322 12


Q ss_pred             CCCCCCCccccccccccccCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh-CCCC--CCCcccc
Q 016959          251 NSAVGTIAYMSPERINTDLNH-GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF-AQPP--EAPEMAS  326 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~  326 (380)
                      ....||+.|+|||++...... +..++.++|||||||++|+|++|..||......   .....+.. ....  .....++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~  237 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA---KTYNNIMNFQRFLKFPEDPKVS  237 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH---HHHHHHHcCCCccCCCCCCCCC
Confidence            335689999999998642222 345678999999999999999999999643322   22222221 1111  2223578


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccccccccccCCCCCC
Q 016959          327 REFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      .++.+||.+||+ ||++|+|++++++||||...++.......++..|..++
T Consensus       238 ~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~  287 (330)
T cd05601         238 SDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTLKS  287 (330)
T ss_pred             HHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHHHhhCCCCccCcCCC
Confidence            899999999997 99999999999999999999888777655555555443

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.8e-49  Score=369.18  Aligned_cols=255  Identities=27%  Similarity=0.387  Sum_probs=209.6

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHH---HhCCCCceeeeEeEEeeCCeEEEE
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEIL---RDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      |++.+.||+|+||+||+|.+..+++.||||+++...  .....+.+.+|+.++   +.++||||+++++++...+.+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999999999999999996432  222345566776655   456799999999999999999999


Q ss_pred             EeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          176 LEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       176 ~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      |||+.+++|.....   ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus        81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (324)
T cd05589          81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST  160 (324)
T ss_pred             EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccc
Confidence            99999999865543   356778899999999999999999999999999999999999999999998754433333456


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      .+|++.|+|||++..     ..++.++|||||||++|+|++|..||.....   ......+. ......+..++.++.+|
T Consensus       161 ~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~G~~pf~~~~~---~~~~~~i~-~~~~~~p~~~~~~~~~l  231 (324)
T cd05589         161 FCGTPEFLAPEVLTE-----TSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---EEVFDSIV-NDEVRYPRFLSREAISI  231 (324)
T ss_pred             cccCccccCHhHhcC-----CCCCcccchhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHH-hCCCCCCCCCCHHHHHH
Confidence            779999999999853     4567789999999999999999999974332   22222222 22344666789999999


Q ss_pred             HHHhcccCcCCCC-----CHHHHhcCccccccCcccc
Q 016959          333 ISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       333 i~~~l~~dp~~R~-----t~~eil~hp~~~~~~~~~~  364 (380)
                      |.+||+.||++||     ++.++++||||++..+...
T Consensus       232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~  268 (324)
T cd05589         232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL  268 (324)
T ss_pred             HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHH
Confidence            9999999999999     7999999999999866554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.7e-49  Score=369.25  Aligned_cols=257  Identities=24%  Similarity=0.363  Sum_probs=212.6

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCC-CceeeeEeEEeeCCeEEEEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNH-PNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~  176 (380)
                      +|++.+.||+|+||.||+|.+..+++.||||++....  .....+.+..|+.++..+.| ++|+.+++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5788999999999999999999999999999986532  22344567789999999975 56888999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      ||+.+++|...+.    ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT  160 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence            9999999865543    356778889999999999999999999999999999999999999999998754333233345


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      .+||..|+|||++..     ..++.++|||||||++|+|++|+.||.....   ......+ .......+..++.++.+|
T Consensus       161 ~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i-~~~~~~~~~~~~~~~~~l  231 (324)
T cd05587         161 FCGTPDYIAPEIIAY-----QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQSI-MEHNVSYPKSLSKEAVSI  231 (324)
T ss_pred             ecCCccccChhhhcC-----CCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHH-HcCCCCCCCCCCHHHHHH
Confidence            679999999999853     4567789999999999999999999974332   2233222 233455667789999999


Q ss_pred             HHHhcccCcCCCCCH-----HHHhcCccccccCccccc
Q 016959          333 ISRCLQKDPHSRWPA-----AQLLQHPFILRAGQSQVN  365 (380)
Q Consensus       333 i~~~l~~dp~~R~t~-----~eil~hp~~~~~~~~~~~  365 (380)
                      +.+||..||++|++.     +++++||||.+.++....
T Consensus       232 i~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~  269 (324)
T cd05587         232 CKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLE  269 (324)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence            999999999999986     899999999998876553

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.4e-49  Score=372.26  Aligned_cols=252  Identities=27%  Similarity=0.431  Sum_probs=209.2

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGG  182 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  182 (380)
                      +.||+|+||+||+|.+..+++.||+|++....  .......+.+|+++++.++|+||+++++++...+.+++||||+.++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999996532  2233456778999999999999999999999999999999999999


Q ss_pred             Ccccccc----cchHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCC
Q 016959          183 SLEGAHI----RQEHILSDLARQVLSGLAYLHK-RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI  257 (380)
Q Consensus       183 ~L~~~~~----~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  257 (380)
                      +|..++.    ..+..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++.............||+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP  160 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence            9865443    3567788899999999999997 7999999999999999999999999999875443333334567999


Q ss_pred             ccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhc
Q 016959          258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL  337 (380)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  337 (380)
                      .|+|||++..     ..++.++|||||||++|+|++|..||.....   .... ..........+..++.++.+||.+||
T Consensus       161 ~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~-~~i~~~~~~~p~~~~~~~~~li~~~L  231 (325)
T cd05594         161 EYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLF-ELILMEEIRFPRTLSPEAKSLLSGLL  231 (325)
T ss_pred             ccCCHHHHcc-----CCCCCccccccccceeeeeccCCCCCCCCCH---HHHH-HHHhcCCCCCCCCCCHHHHHHHHHHh
Confidence            9999999853     4567899999999999999999999964332   2222 22233344566778999999999999


Q ss_pred             ccCcCCCC-----CHHHHhcCccccccCccccc
Q 016959          338 QKDPHSRW-----PAAQLLQHPFILRAGQSQVN  365 (380)
Q Consensus       338 ~~dp~~R~-----t~~eil~hp~~~~~~~~~~~  365 (380)
                      +.||++|+     ++.++++||||.+..+....
T Consensus       232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~  264 (325)
T cd05594         232 KKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVY  264 (325)
T ss_pred             hcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence            99999997     99999999999997766553

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.4e-49  Score=377.49  Aligned_cols=260  Identities=24%  Similarity=0.322  Sum_probs=206.9

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .|++.+.||+|+||+||+|++..+++.||||++....  .......+.+|+.+++.++|+||+++++++.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999999999999999996532  23345678899999999999999999999999999999999


Q ss_pred             ccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC------
Q 016959          178 YMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM------  247 (380)
Q Consensus       178 ~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~------  247 (380)
                      |+.+++|.+++.    ..+..++.++.||+.||+|||++||+||||||+||||+.++++||+|||++..+....      
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~  161 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ  161 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence            999999876543    3567788899999999999999999999999999999999999999999975431100      


Q ss_pred             -----------------------------------------CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHH
Q 016959          248 -----------------------------------------DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGV  286 (380)
Q Consensus       248 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~  286 (380)
                                                               ......+||+.|+|||++..     ..++.++|||||||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DiwSlG~  236 (381)
T cd05626         162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-----KGYTQLCDWWSVGV  236 (381)
T ss_pred             ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-----CCCCCccceeehhh
Confidence                                                     00124579999999999853     44677899999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcc--cCcCCCCCHHHHhcCccccccCcccc
Q 016959          287 SILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ--KDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       287 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~--~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                      ++|||++|..||......+....+..............++.++.+||.+|+.  .++..|+++.|+++||||....+...
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~~  316 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSD  316 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhHH
Confidence            9999999999997443222111111111111222233578999999999664  45555999999999999999877654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-50  Score=377.87  Aligned_cols=270  Identities=28%  Similarity=0.428  Sum_probs=218.8

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++|.+.+.||+|+||+||+|.+..+++.||||++....  .......+.+|+.+++.++|+||+++++++.+++.+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36889999999999999999999999999999986432  2234566889999999999999999999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-----
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM-----  247 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----  247 (380)
                      ||+.+++|..++.    ..+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....     
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY  160 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence            9999999876653    3567788899999999999999999999999999999999999999999998665432     


Q ss_pred             ------------------------CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 016959          248 ------------------------DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ  303 (380)
Q Consensus       248 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~  303 (380)
                                              .......||+.|+|||++..     ..++.++|||||||++|||++|+.||.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-----TPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcC-----CCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                    12345679999999999854     4567899999999999999999999975442


Q ss_pred             CCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCC-HHHHhcCccccccCcccccccccccCCC
Q 016959          304 GDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWP-AAQLLQHPFILRAGQSQVNQNLRQILPP  374 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-~~eil~hp~~~~~~~~~~~~~~~~~~~~  374 (380)
                      ......+..............++.++.+||.+||. ||++|++ +.|+|+||||++..+....+..+.++|.
T Consensus       236 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~~~~~~~~~~~~~  306 (350)
T cd05573         236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWENLRETKPPFVPE  306 (350)
T ss_pred             HHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHHHHhhCCCCcCCC
Confidence            22222221111111222223368999999999997 9999999 9999999999999887776544544444

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.3e-50  Score=358.97  Aligned_cols=253  Identities=28%  Similarity=0.463  Sum_probs=218.2

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      ..+|++.+.||+|+||+|-++.....|+.||||.++++.  .+...-.+.+||++|..|+||||+.+|.+|+..+.+.||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            468999999999999999999999999999999998765  334456788999999999999999999999999999999


Q ss_pred             EeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCC
Q 016959          176 LEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       176 ~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      |||..+|.|++++..    .+...+.+++||+.|+.|+|.++++|||||.+|||+|.++++||+|||++..+.+. ....
T Consensus       132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-kfLq  210 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-KFLQ  210 (668)
T ss_pred             EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc-cHHH
Confidence            999999999887644    67889999999999999999999999999999999999999999999999876544 4568


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD  331 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (380)
                      ++||++.|.+||++++.    .|-++.+|.|||||+||.|+.|.+||..   .|...++..+..+.-.  .+.-+.++.-
T Consensus       211 TFCGSPLYASPEIvNG~----PY~GPEVDsWsLGvLLYtLVyGtMPFDG---~Dhk~lvrQIs~GaYr--EP~~PSdA~g  281 (668)
T KOG0611|consen  211 TFCGSPLYASPEIVNGT----PYKGPEVDSWSLGVLLYTLVYGTMPFDG---RDHKRLVRQISRGAYR--EPETPSDASG  281 (668)
T ss_pred             HhcCCcccCCccccCCC----CCCCCccchhhHHHHHHHHhhcccccCC---chHHHHHHHhhccccc--CCCCCchHHH
Confidence            89999999999999763    4556789999999999999999999974   4444555554443322  2233558889


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          332 FISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       332 li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      ||++||..||++|.|+.+|..|=|+.--.
T Consensus       282 LIRwmLmVNP~RRATieDiAsHWWvNwgy  310 (668)
T KOG0611|consen  282 LIRWMLMVNPERRATIEDIASHWWVNWGY  310 (668)
T ss_pred             HHHHHHhcCcccchhHHHHhhhheeeccc
Confidence            99999999999999999999998876443

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.8e-49  Score=367.98  Aligned_cols=252  Identities=26%  Similarity=0.371  Sum_probs=208.2

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      +.||+|+||.||+|++..+++.||||++....  .......+..|..+++.+ +|+||++++++|...+.+|+||||+.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999986532  223345667888888866 799999999999999999999999999


Q ss_pred             CCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCC
Q 016959          182 GSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI  257 (380)
Q Consensus       182 ~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  257 (380)
                      ++|...+.    ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............||.
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP  160 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence            99865443    35667888999999999999999999999999999999999999999999876543333345567999


Q ss_pred             ccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhc
Q 016959          258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL  337 (380)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  337 (380)
                      .|+|||++..     ..++.++|||||||++|+|++|+.||......   .....+. ......+..++.++.+||.+||
T Consensus       161 ~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~~i~-~~~~~~p~~~~~~~~~ll~~~L  231 (321)
T cd05591         161 DYIAPEILQE-----LEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFESIL-HDDVLYPVWLSKEAVSILKAFM  231 (321)
T ss_pred             cccCHHHHcC-----CCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHHHHH-cCCCCCCCCCCHHHHHHHHHHh
Confidence            9999999853     45677899999999999999999999744322   2222222 2334456668899999999999


Q ss_pred             ccCcCCCC-------CHHHHhcCccccccCccccc
Q 016959          338 QKDPHSRW-------PAAQLLQHPFILRAGQSQVN  365 (380)
Q Consensus       338 ~~dp~~R~-------t~~eil~hp~~~~~~~~~~~  365 (380)
                      +.||++|+       ++.++++||||....+....
T Consensus       232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~  266 (321)
T cd05591         232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLE  266 (321)
T ss_pred             ccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHH
Confidence            99999999       99999999999998776653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.9e-49  Score=374.41  Aligned_cols=266  Identities=26%  Similarity=0.404  Sum_probs=214.1

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      ...+..++|++.+.||+|+||.||++++..+++.||+|++.+..  .......+.+|+.+++.++||||+++++++.+++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            34566789999999999999999999999999999999985422  2223455778999999999999999999999999


Q ss_pred             eEEEEEeccCCCCccccccc---chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          171 EIEVLLEYMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      .+|+|||||.+++|.+++..   .+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~  196 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG  196 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence            99999999999999766543   567788899999999999999999999999999999999999999999998764322


Q ss_pred             C-CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC-CCCCCC--c
Q 016959          248 D-PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA-QPPEAP--E  323 (380)
Q Consensus       248 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~--~  323 (380)
                      . .....+||+.|+|||++.... ...+++.++|||||||++|+|++|..||.....   ......+... .....+  .
T Consensus       197 ~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~~  272 (370)
T cd05621         197 MVRCDTAVGTPDYISPEVLKSQG-GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL---VGTYSKIMDHKNSLNFPEDV  272 (370)
T ss_pred             ceecccCCCCcccCCHHHHhccC-CCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCcccCCCCcc
Confidence            1 234667999999999986421 123467899999999999999999999974332   2222222221 122223  3


Q ss_pred             cccHHHHHHHHHhcccCcCC--CCCHHHHhcCccccccCcc
Q 016959          324 MASREFRDFISRCLQKDPHS--RWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~--R~t~~eil~hp~~~~~~~~  362 (380)
                      .++..+++++.+||..++.+  |+|+.|+++||||+...+.
T Consensus       273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~  313 (370)
T cd05621         273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWN  313 (370)
T ss_pred             cCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcC
Confidence            46889999999999865544  8999999999999986543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9e-49  Score=365.28  Aligned_cols=252  Identities=27%  Similarity=0.435  Sum_probs=206.2

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      +.||+|+||+||+|.+..+++.||||+++...  .....+.+..|..++..+ +|+||+++++++...+.+++||||+.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999986532  222334455666666654 799999999999999999999999999


Q ss_pred             CCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCC
Q 016959          182 GSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI  257 (380)
Q Consensus       182 ~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  257 (380)
                      ++|..++.    ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~  160 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence            99865543    35677888999999999999999999999999999999999999999999976543333445667999


Q ss_pred             ccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhc
Q 016959          258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL  337 (380)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  337 (380)
                      .|+|||++..     ..++.++|||||||++|||++|..||.....   ......+ ....+..+..++.++.+||.+||
T Consensus       161 ~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~i-~~~~~~~~~~~~~~~~~ll~~~l  231 (316)
T cd05592         161 DYIAPEILKG-----QKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDSI-LNDRPHFPRWISKEAKDCLSKLF  231 (316)
T ss_pred             cccCHHHHcC-----CCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHHH-HcCCCCCCCCCCHHHHHHHHHHc
Confidence            9999999853     4567789999999999999999999974332   2222222 33445567778999999999999


Q ss_pred             ccCcCCCCCH-HHHhcCccccccCccccc
Q 016959          338 QKDPHSRWPA-AQLLQHPFILRAGQSQVN  365 (380)
Q Consensus       338 ~~dp~~R~t~-~eil~hp~~~~~~~~~~~  365 (380)
                      +.||++|+++ .++++||||....+....
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~~~~~~~~  260 (316)
T cd05592         232 ERDPTKRLGVDGDIRQHPFFRGIDWERLE  260 (316)
T ss_pred             cCCHHHcCCChHHHHcCcccCCCCHHHHH
Confidence            9999999986 588899999998776553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2e-48  Score=365.39  Aligned_cols=262  Identities=37%  Similarity=0.665  Sum_probs=214.5

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      +..++|++.+.||+|+||.||++++..++..||+|++...........+.+|+++|+.++|+||+++++++..++.+++|
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            44678999999999999999999999999999999997665555667899999999999999999999999999999999


Q ss_pred             EeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          176 LEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKR-KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       176 ~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      |||+.+++|.+++..    .+..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..+....  .
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  159 (331)
T cd06649          82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--A  159 (331)
T ss_pred             eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc--c
Confidence            999999999776543    5677889999999999999986 69999999999999999999999999997664322  2


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHH--------------------
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLM--------------------  310 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--------------------  310 (380)
                      ....|+..|+|||++..     ..++.++|||||||++|||++|+.||......+.....                    
T Consensus       160 ~~~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         160 NSFVGTRSYMSPERLQG-----THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             ccCCCCcCcCCHhHhcC-----CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence            45679999999999853     45678999999999999999999999643222111110                    


Q ss_pred             -----------------------HHHhhCCCCCC-CccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          311 -----------------------FAICFAQPPEA-PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       311 -----------------------~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                                             ..+.....+.. ...++.++++||.+||+.||++|||+.|+|+||||+.......
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~~  312 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVEEV  312 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcccccc
Confidence                                   00111111111 1246789999999999999999999999999999998755433

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=9.4e-49  Score=365.18  Aligned_cols=251  Identities=23%  Similarity=0.379  Sum_probs=205.9

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      +.||+|+||.||+|++..+|+.||+|+++....  ......+..|..++..+ +|+||+++++++.+.+.+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            469999999999999999999999999865321  22334566777777754 899999999999999999999999999


Q ss_pred             CCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCC
Q 016959          182 GSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI  257 (380)
Q Consensus       182 ~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  257 (380)
                      ++|..++.    ..+..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++............+||.
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence            99865543    35667788999999999999999999999999999999999999999999875433333345677999


Q ss_pred             ccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhc
Q 016959          258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL  337 (380)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  337 (380)
                      .|+|||++..     ..++.++|||||||++|||++|..||....   .......+ ....+..+..++.++++||.+||
T Consensus       161 ~y~aPE~~~~-----~~~~~~~DiwslGvil~el~~g~~Pf~~~~---~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l  231 (316)
T cd05620         161 DYIAPEILQG-----LKYTFSVDWWSFGVLLYEMLIGQSPFHGDD---EDELFESI-RVDTPHYPRWITKESKDILEKLF  231 (316)
T ss_pred             CccCHHHHcC-----CCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHH-HhCCCCCCCCCCHHHHHHHHHHc
Confidence            9999999853     456778999999999999999999996433   22222222 23345566678999999999999


Q ss_pred             ccCcCCCCCH-HHHhcCccccccCcccc
Q 016959          338 QKDPHSRWPA-AQLLQHPFILRAGQSQV  364 (380)
Q Consensus       338 ~~dp~~R~t~-~eil~hp~~~~~~~~~~  364 (380)
                      +.||++|+++ +++++||||....+...
T Consensus       232 ~~dP~~R~~~~~~~~~h~~f~~~~~~~~  259 (316)
T cd05620         232 ERDPTRRLGVVGNIRGHPFFKTINWTAL  259 (316)
T ss_pred             cCCHHHcCCChHHHHcCCCcCCCCHHHH
Confidence            9999999997 58999999999876654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.2e-48  Score=366.29  Aligned_cols=266  Identities=25%  Similarity=0.443  Sum_probs=217.4

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      +.||+|+||+||+|.+..+++.||+|++....  .......+.+|+.++.++ +|+||+.+++++...+.+++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999996543  233455678899999888 599999999999999999999999999


Q ss_pred             CCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCC
Q 016959          182 GSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI  257 (380)
Q Consensus       182 ~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  257 (380)
                      ++|...+    ...+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP  160 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence            9986543    345778889999999999999999999999999999999999999999999875433333345677999


Q ss_pred             ccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---CCHHHHHHHHhhCCCCCCCccccHHHHHHHH
Q 016959          258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ---GDWASLMFAICFAQPPEAPEMASREFRDFIS  334 (380)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  334 (380)
                      .|+|||++.+     ..++.++|||||||++|+|++|..||.....   ..............+...+..++..+.++|.
T Consensus       161 ~y~aPE~~~~-----~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~  235 (327)
T cd05617         161 NYIAPEILRG-----EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLK  235 (327)
T ss_pred             ccCCHHHHCC-----CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999853     5567899999999999999999999963221   1222333334444555677788999999999


Q ss_pred             HhcccCcCCCCC------HHHHhcCccccccCcccccccccccCCCCCC
Q 016959          335 RCLQKDPHSRWP------AAQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       335 ~~l~~dp~~R~t------~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      +||+.||++|++      +.++++||||...++....+  .+..|+++|
T Consensus       236 ~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~--~~~~~~~~~  282 (327)
T cd05617         236 GFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEK--KQVTPPFKP  282 (327)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHh--CCCCCCccC
Confidence            999999999998      57999999999998776543  445555444

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2e-49  Score=378.63  Aligned_cols=261  Identities=25%  Similarity=0.356  Sum_probs=209.8

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++|++.+.||+|+||+||+|++..+++.||||++.+..  .......+.+|+.+|+.++|+||+++++.|.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999999999999999985432  1223456789999999999999999999999999999999


Q ss_pred             eccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-----
Q 016959          177 EYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM-----  247 (380)
Q Consensus       177 e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----  247 (380)
                      |||.+++|.+++..    .+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+....     
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~  160 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence            99999999776543    467778899999999999999999999999999999999999999999975331000     


Q ss_pred             --------------------------------------CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHH
Q 016959          248 --------------------------------------DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSIL  289 (380)
Q Consensus       248 --------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~  289 (380)
                                                            ......+||+.|||||++..     ..++.++|||||||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvily  235 (376)
T cd05598         161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-----TGYTQLCDWWSVGVILY  235 (376)
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-----CCCCcceeeeeccceee
Confidence                                                  00123579999999999853     45677999999999999


Q ss_pred             HHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCC---CHHHHhcCccccccCccccc
Q 016959          290 EFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRW---PAAQLLQHPFILRAGQSQVN  365 (380)
Q Consensus       290 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---t~~eil~hp~~~~~~~~~~~  365 (380)
                      ||++|..||......+....+..............++.++.+||.+|+ .+|++|+   |+.|+++||||+...+....
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~~~~~  313 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDFASLI  313 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCHHHHh
Confidence            999999999744332222222111111122233467899999999987 5999999   99999999999998776653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.2e-49  Score=377.10  Aligned_cols=256  Identities=24%  Similarity=0.360  Sum_probs=207.6

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .|++.++||+|+||+||+|++..+++.||+|++....  .......+.+|+.+++.++|+||+++++.|.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999999999999999986432  23345678899999999999999999999999999999999


Q ss_pred             ccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC------
Q 016959          178 YMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM------  247 (380)
Q Consensus       178 ~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~------  247 (380)
                      ||.+|+|..++.    ..+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....      
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~  161 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ  161 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence            999999876653    3567788899999999999999999999999999999999999999999975321000      


Q ss_pred             -----------------------------------------CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHH
Q 016959          248 -----------------------------------------DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGV  286 (380)
Q Consensus       248 -----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~  286 (380)
                                                               ....+.+||+.|+|||++..     ..++.++|||||||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DiwSlGv  236 (382)
T cd05625         162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-----TGYTQLCDWWSVGV  236 (382)
T ss_pred             cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-----CCCCCeeeEEechH
Confidence                                                     00123579999999999853     44677999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCHHHHHHHH-hhCC--CCCCCccccHHHHHHHHHhcccCcCCCCC---HHHHhcCccccccC
Q 016959          287 SILEFYLGRFPFAVGRQGDWASLMFAI-CFAQ--PPEAPEMASREFRDFISRCLQKDPHSRWP---AAQLLQHPFILRAG  360 (380)
Q Consensus       287 il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~t---~~eil~hp~~~~~~  360 (380)
                      ++|||++|+.||.....   ......+ ....  ..+....+++++.+||.+|+ .||++|++   ++|+++||||+...
T Consensus       237 il~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~  312 (382)
T cd05625         237 ILYEMLVGQPPFLAQTP---LETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID  312 (382)
T ss_pred             HHHHHHhCCCCCCCCCH---HHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence            99999999999974332   2222222 1111  22233467899999999986 59999997   99999999999987


Q ss_pred             cccc
Q 016959          361 QSQV  364 (380)
Q Consensus       361 ~~~~  364 (380)
                      +...
T Consensus       313 ~~~~  316 (382)
T cd05625         313 FSSD  316 (382)
T ss_pred             hHHH
Confidence            6653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1e-48  Score=366.07  Aligned_cols=258  Identities=24%  Similarity=0.350  Sum_probs=213.0

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      +|.+.+.||+|+||+||+|++..+++.||||++.+..  .......+..|..++..+ +|++|+.+++++...+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5788999999999999999999999999999986542  222344566788888777 5899999999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      ||+.+++|...+.    ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~  160 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT  160 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence            9999999865543    356778899999999999999999999999999999999999999999999754433333456


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      .+||+.|+|||++..     ..++.++|||||||++|||++|+.||.....   ......+. ......+..++.++.+|
T Consensus       161 ~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~-~~~~~~p~~~s~~~~~l  231 (323)
T cd05616         161 FCGTPDYIAPEIIAY-----QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIM-EHNVAYPKSMSKEAVAI  231 (323)
T ss_pred             CCCChhhcCHHHhcC-----CCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHHH-hCCCCCCCcCCHHHHHH
Confidence            679999999999853     4567899999999999999999999974332   22332222 33445667789999999


Q ss_pred             HHHhcccCcCCCCC-----HHHHhcCccccccCcccccc
Q 016959          333 ISRCLQKDPHSRWP-----AAQLLQHPFILRAGQSQVNQ  366 (380)
Q Consensus       333 i~~~l~~dp~~R~t-----~~eil~hp~~~~~~~~~~~~  366 (380)
                      +.+||+.||++|++     ..++++||||+..++.....
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~  270 (323)
T cd05616         232 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER  270 (323)
T ss_pred             HHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence            99999999999998     48999999999988776643

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.5e-49  Score=360.34  Aligned_cols=252  Identities=27%  Similarity=0.422  Sum_probs=203.9

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +|++.+.||+|+||+||+|++..+++.||+|++.... .....+.+.+|+.+++.++|+||+++++++...+.+++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            6889999999999999999999999999999986543 233456778999999999999999999999999999999999


Q ss_pred             cCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-CCCCC
Q 016959          179 MDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-PCNSA  253 (380)
Q Consensus       179 ~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~  253 (380)
                      +.++.+....    ...+..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+..... .....
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  161 (287)
T cd07848          82 VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEY  161 (287)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccccc
Confidence            9998765432    235667888999999999999999999999999999999999999999999987643222 22345


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC---------------
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP---------------  318 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------------  318 (380)
                      .|+..|+|||++.+     ..++.++|||||||++|||++|+.||......+....+.......+               
T Consensus       162 ~~~~~y~aPE~~~~-----~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07848         162 VATRWYRSPELLLG-----APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG  236 (287)
T ss_pred             ccccccCCcHHHcC-----CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence            78999999999853     4457799999999999999999999975332221111111110000               


Q ss_pred             ---C----------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          319 ---P----------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       319 ---~----------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                         +          .....++.++.+||.+||+.||++|+|++|+|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence               0          0112367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-48  Score=364.52  Aligned_cols=251  Identities=29%  Similarity=0.472  Sum_probs=207.1

Q ss_pred             ceecccCCceEEEEEeC---CCCcEEEEEEecCCC---chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          105 NRIGSGSGGTVWRVVHP---PTSRVFALKVIYGNH---EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~---~~~~~~avK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +.||+|+||.||+|++.   .+++.||||++....   .......+.+|+.+|+.++||||++++++|..++.+|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999863   468899999986432   222345677899999999999999999999999999999999


Q ss_pred             cCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCC
Q 016959          179 MDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV  254 (380)
Q Consensus       179 ~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (380)
                      +.+++|...+..    .+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  161 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC  161 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccC
Confidence            999998765532    4567788999999999999999999999999999999999999999999875443333345567


Q ss_pred             CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHH
Q 016959          255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS  334 (380)
Q Consensus       255 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  334 (380)
                      ||+.|+|||++..     ..++.++|||||||++|||++|..||.....   ......+. ......+..++.++.+||.
T Consensus       162 gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~G~~pf~~~~~---~~~~~~~~-~~~~~~~~~~~~~~~~li~  232 (323)
T cd05584         162 GTIEYMAPEILMR-----SGHGKAVDWWSLGALMYDMLTGAPPFTAENR---KKTIDKIL-KGKLNLPPYLTPEARDLLK  232 (323)
T ss_pred             CCccccChhhccC-----CCCCCcceecccHHHHHHHhcCCCCCCCCCH---HHHHHHHH-cCCCCCCCCCCHHHHHHHH
Confidence            9999999999853     4456789999999999999999999974332   22222222 2344567778999999999


Q ss_pred             HhcccCcCCCC-----CHHHHhcCccccccCcccc
Q 016959          335 RCLQKDPHSRW-----PAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       335 ~~l~~dp~~R~-----t~~eil~hp~~~~~~~~~~  364 (380)
                      +||+.||++|+     +++++++||||....+...
T Consensus       233 ~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~  267 (323)
T cd05584         233 KLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDL  267 (323)
T ss_pred             HHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence            99999999999     8999999999998766544

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.6e-48  Score=363.96  Aligned_cols=261  Identities=27%  Similarity=0.434  Sum_probs=212.0

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      +.||+|+||+||+|.+..+++.||||++++..  .......+.+|..+++.+ +|+||+++++++...+.+++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999996542  223345677888888887 699999999999999999999999999


Q ss_pred             CCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCC
Q 016959          182 GSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI  257 (380)
Q Consensus       182 ~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  257 (380)
                      ++|...+    ...+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+|+.
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~  160 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP  160 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence            9986544    345677888999999999999999999999999999999999999999999875433333334567999


Q ss_pred             ccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhc
Q 016959          258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL  337 (380)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  337 (380)
                      .|+|||++..     ..++.++|||||||++|+|++|..||.....   ......+ .......+..++.++.+||.+||
T Consensus       161 ~y~aPE~~~~-----~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~~~i-~~~~~~~~~~~~~~~~~li~~~l  231 (318)
T cd05570         161 DYIAPEILSY-----QPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELFQSI-LEDEVRYPRWLSKEAKSILKSFL  231 (318)
T ss_pred             cccCHHHhcC-----CCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHHHHH-HcCCCCCCCcCCHHHHHHHHHHc
Confidence            9999999853     4567799999999999999999999964332   2222222 23334556678999999999999


Q ss_pred             ccCcCCCCCH-----HHHhcCccccccCcccccccccccCCCCC
Q 016959          338 QKDPHSRWPA-----AQLLQHPFILRAGQSQVNQNLRQILPPPR  376 (380)
Q Consensus       338 ~~dp~~R~t~-----~eil~hp~~~~~~~~~~~~~~~~~~~~~~  376 (380)
                      +.||++|+++     .++++||||+...+.....  +++.|+.+
T Consensus       232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~--~~~~~~~~  273 (318)
T cd05570         232 TKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLER--KEIKPPFK  273 (318)
T ss_pred             cCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHh--CCCCCCcC
Confidence            9999999999     9999999999987654432  34444443

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.5e-48  Score=364.95  Aligned_cols=252  Identities=27%  Similarity=0.404  Sum_probs=204.9

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHH-HHHhCCCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIE-ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      +.||+|+||+||+|.+..+|+.||||++....  .......+.+|.. +++.++||||+++++++...+.+++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999999999999999986432  1122234445544 56789999999999999999999999999999


Q ss_pred             CCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCC
Q 016959          182 GSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI  257 (380)
Q Consensus       182 ~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  257 (380)
                      ++|..++.    ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP  160 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence            99865543    35667888999999999999999999999999999999999999999999876443333345567999


Q ss_pred             ccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhc
Q 016959          258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL  337 (380)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  337 (380)
                      .|+|||++..     ..++.++|||||||++|+|++|..||....   .......+ .......+..++.++.+||.+||
T Consensus       161 ~y~aPE~~~~-----~~~~~~~DvwslG~il~ell~g~~pf~~~~---~~~~~~~i-~~~~~~~~~~~~~~~~~li~~~l  231 (323)
T cd05575         161 EYLAPEVLRK-----QPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---TAEMYDNI-LNKPLRLKPNISVSARHLLEGLL  231 (323)
T ss_pred             hhcChhhhcC-----CCCCccccccccchhhhhhhcCCCCCCCCC---HHHHHHHH-HcCCCCCCCCCCHHHHHHHHHHh
Confidence            9999999853     456778999999999999999999997432   22333222 23344556677999999999999


Q ss_pred             ccCcCCCCCH----HHHhcCccccccCccccc
Q 016959          338 QKDPHSRWPA----AQLLQHPFILRAGQSQVN  365 (380)
Q Consensus       338 ~~dp~~R~t~----~eil~hp~~~~~~~~~~~  365 (380)
                      +.||++|+++    .|+++||||....+....
T Consensus       232 ~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~  263 (323)
T cd05575         232 QKDRTKRLGAKDDFLEIKNHVFFSSINWDDLV  263 (323)
T ss_pred             hcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHh
Confidence            9999999987    699999999988765553

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.4e-48  Score=362.39  Aligned_cols=252  Identities=26%  Similarity=0.395  Sum_probs=206.7

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      +.||+|+||+||+|++..+++.||||+++...  .......+..|..+++.+ +||||+++++++.+.+.+++||||+.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999986542  122234556677777764 899999999999999999999999999


Q ss_pred             CCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCC
Q 016959          182 GSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI  257 (380)
Q Consensus       182 ~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  257 (380)
                      ++|..++.    ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............||.
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence            99976543    35667788999999999999999999999999999999999999999999875433333334567999


Q ss_pred             ccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhc
Q 016959          258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL  337 (380)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  337 (380)
                      .|+|||++..     ..++.++|||||||++|||++|..||....   .......+.. ..+..+..++.++++||.+||
T Consensus       161 ~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~i~~-~~~~~~~~~~~~~~~li~~~l  231 (316)
T cd05619         161 DYIAPEILLG-----QKYNTSVDWWSFGVLLYEMLIGQSPFHGHD---EEELFQSIRM-DNPCYPRWLTREAKDILVKLF  231 (316)
T ss_pred             cccCHHHHcC-----CCCCchhhhhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHh-CCCCCCccCCHHHHHHHHHHh
Confidence            9999999853     456789999999999999999999996433   2333333332 234456678899999999999


Q ss_pred             ccCcCCCCCHH-HHhcCccccccCccccc
Q 016959          338 QKDPHSRWPAA-QLLQHPFILRAGQSQVN  365 (380)
Q Consensus       338 ~~dp~~R~t~~-eil~hp~~~~~~~~~~~  365 (380)
                      +.||++|+++. ++++||||+...+....
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~~~~~~~~  260 (316)
T cd05619         232 VREPERRLGVKGDIRQHPFFREIDWSALE  260 (316)
T ss_pred             ccCHhhcCCChHHHHcCcccCCCCHHHHH
Confidence            99999999996 89999999998876553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.2e-49  Score=373.01  Aligned_cols=259  Identities=25%  Similarity=0.387  Sum_probs=210.6

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++|++.+.||+|+||+||+|.+..+++.||||++....  .......+.+|+.++..++|+||+++++.+.+.+.+++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999999999999999986432  2334567888999999999999999999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-----
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM-----  247 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----  247 (380)
                      |||.+++|..++.    ..+..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+....     
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            9999999876643    3567788899999999999999999999999999999999999999999987543210     


Q ss_pred             ------------------------------CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 016959          248 ------------------------------DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFP  297 (380)
Q Consensus       248 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~p  297 (380)
                                                    ......+||+.|+|||++..     ..++.++|||||||++|||++|..|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-----TGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-----CCCCCcceeccccceeeecccCCCC
Confidence                                          01124579999999999853     4567799999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHhh-CCCCCCC--ccccHHHHHHHHHhcccCcCCCC---CHHHHhcCccccccCcccccc
Q 016959          298 FAVGRQGDWASLMFAICF-AQPPEAP--EMASREFRDFISRCLQKDPHSRW---PAAQLLQHPFILRAGQSQVNQ  366 (380)
Q Consensus       298 f~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~---t~~eil~hp~~~~~~~~~~~~  366 (380)
                      |......   .....+.. ......+  ..++.++++||.+|+ .||++|+   +++|+++||||++.++.....
T Consensus       236 f~~~~~~---~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~  306 (360)
T cd05627         236 FCSETPQ---ETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWGHIRE  306 (360)
T ss_pred             CCCCCHH---HHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHHHHhc
Confidence            9743332   22222221 1112222  236889999999987 5999998   489999999999998887754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2e-48  Score=361.91  Aligned_cols=260  Identities=28%  Similarity=0.444  Sum_probs=209.1

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .++|.+.++||+|+||+||+|.+..+++.||+|++...........+.+|+.++++++|+||+++++++..++..++|||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            46799999999999999999999999999999998755444444567789999999999999999999999999999999


Q ss_pred             ccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          178 YMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       178 ~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      |+.+ +|..++.     ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  163 (309)
T cd07872          85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN  163 (309)
T ss_pred             CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence            9986 5543332     245667889999999999999999999999999999999999999999999765443333345


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC---------------
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ---------------  317 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------------  317 (380)
                      ..++..|+|||++..    ...++.++|||||||++|+|++|+.||......+....+.......               
T Consensus       164 ~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         164 EVVTLWYRPPDVLLG----SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccCCHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence            568999999998753    2446779999999999999999999997544433322222211100               


Q ss_pred             ----CC-------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          318 ----PP-------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       318 ----~~-------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                          +.       .....++.++++||.+||+.||++|+|+.|+|+||||+.....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  295 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTR  295 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccc
Confidence                00       0112467899999999999999999999999999999987533

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.8e-48  Score=354.71  Aligned_cols=269  Identities=25%  Similarity=0.391  Sum_probs=217.1

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      |+..+.||+|+||+||++.+..+++.||+|.+....  .......+.+|+.+++.++|++|+.+++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677889999999999999999999999999985432  222335567899999999999999999999999999999999


Q ss_pred             cCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          179 MDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       179 ~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      +.+++|...+.      ..+..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....... ....
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~  160 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKG  160 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-cccC
Confidence            99999976542      3456788899999999999999999999999999999999999999999987654322 2234


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      ..|+..|+|||++..     ..++.++|||||||++|+|++|..||.......................+..++.++.+|
T Consensus       161 ~~g~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05630         161 RVGTVGYMAPEVVKN-----ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL  235 (285)
T ss_pred             CCCCccccChHHHcC-----CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHH
Confidence            579999999999853     456778999999999999999999997543322222222222222334556788899999


Q ss_pred             HHHhcccCcCCCCC-----HHHHhcCccccccCcccccccccccCCCCCC
Q 016959          333 ISRCLQKDPHSRWP-----AAQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       333 i~~~l~~dp~~R~t-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      +.+||+.||++|+|     ++|+++||||++..+..+..  .+.-||.+|
T Consensus       236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~--~~~~~~~~~  283 (285)
T cd05630         236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEA--GMLEPPFKP  283 (285)
T ss_pred             HHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhc--CCCCCCCCC
Confidence            99999999999999     99999999999987776543  333355554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.2e-48  Score=370.13  Aligned_cols=268  Identities=26%  Similarity=0.371  Sum_probs=214.6

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      ...+..++|++.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+++
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            34566789999999999999999999999999999999985422  2223455778999999999999999999999999


Q ss_pred             eEEEEEeccCCCCccccccc---chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          171 EIEVLLEYMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      .+++||||+.+++|..++..   .+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~  196 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  196 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence            99999999999999766543   466778899999999999999999999999999999999999999999998764322


Q ss_pred             -CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC---CCCCCCc
Q 016959          248 -DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA---QPPEAPE  323 (380)
Q Consensus       248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~  323 (380)
                       ......+||+.|+|||++.... ....++.++|||||||++|||++|..||.....   ......+...   .......
T Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~  272 (371)
T cd05622         197 MVRCDTAVGTPDYISPEVLKSQG-GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMNHKNSLTFPDDN  272 (371)
T ss_pred             cccccCcccCccccCHHHHhccC-CCccCCCccceeehhHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCcccCCCcC
Confidence             1234667999999999986421 123467899999999999999999999974332   2233332221   1122234


Q ss_pred             cccHHHHHHHHHhcccCcCC--CCCHHHHhcCccccccCcccc
Q 016959          324 MASREFRDFISRCLQKDPHS--RWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~--R~t~~eil~hp~~~~~~~~~~  364 (380)
                      .++.++++||.+||..++.+  |++++|+++|+||++..+...
T Consensus       273 ~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~~~~  315 (371)
T cd05622         273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWE  315 (371)
T ss_pred             CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCChhHH
Confidence            58899999999999844443  789999999999998765443

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.7e-48  Score=361.54  Aligned_cols=258  Identities=24%  Similarity=0.364  Sum_probs=212.1

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEEEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      +|+..+.||+|+||+||+|++..+++.||+|++.+..  .....+.+..|..+++.+. |++|+++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677899999999999999999999999999986532  2233456778888888886 578888999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      ||+.+++|..++.    ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~  160 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT  160 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence            9999999876543    357788899999999999999999999999999999999999999999998764433233345


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      ..||+.|+|||++..     ..++.++|||||||++|+|++|..||.....   ......+. ......+..++.++.++
T Consensus       161 ~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~-~~~~~~p~~~~~~~~~l  231 (323)
T cd05615         161 FCGTPDYIAPEIIAY-----QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSIM-EHNVSYPKSLSKEAVSI  231 (323)
T ss_pred             ccCCccccCHHHHcC-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHH-hCCCCCCccCCHHHHHH
Confidence            679999999999853     4467789999999999999999999964332   22222222 23345667789999999


Q ss_pred             HHHhcccCcCCCCC-----HHHHhcCccccccCcccccc
Q 016959          333 ISRCLQKDPHSRWP-----AAQLLQHPFILRAGQSQVNQ  366 (380)
Q Consensus       333 i~~~l~~dp~~R~t-----~~eil~hp~~~~~~~~~~~~  366 (380)
                      +.+||+.||.+|++     .+++++||||+..++.....
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~  270 (323)
T cd05615         232 CKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLEN  270 (323)
T ss_pred             HHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhc
Confidence            99999999999997     57999999999988776654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-48  Score=364.74  Aligned_cols=252  Identities=27%  Similarity=0.467  Sum_probs=208.3

Q ss_pred             ceecccCCceEEEEEe---CCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccC
Q 016959          105 NRIGSGSGGTVWRVVH---PPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMD  180 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~---~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  180 (380)
                      +.||+|+||+||++.+   ..+|+.||+|++..... ......+.+|++++++++|+||+++++++...+.+|+||||+.
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999876   35789999999965332 2234456789999999999999999999999999999999999


Q ss_pred             CCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCC
Q 016959          181 GGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT  256 (380)
Q Consensus       181 ~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  256 (380)
                      +++|.+.+.    ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............|+
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~  161 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGT  161 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCC
Confidence            999866543    3577788999999999999999999999999999999999999999999998665443344567799


Q ss_pred             CccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHh
Q 016959          257 IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC  336 (380)
Q Consensus       257 ~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  336 (380)
                      ..|+|||++..     ..++.++|||||||++|||++|+.||.....   ......+. ......+..++.++.+||.+|
T Consensus       162 ~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~~~i~-~~~~~~p~~~~~~~~~li~~~  232 (318)
T cd05582         162 VEYMAPEVVNR-----RGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETMTMIL-KAKLGMPQFLSPEAQSLLRAL  232 (318)
T ss_pred             hhhcCHHHHcC-----CCCCCccceeccceEeeeeccCCCCCCCCCH---HHHHHHHH-cCCCCCCCCCCHHHHHHHHHH
Confidence            99999999853     4456789999999999999999999964332   22222222 233455667899999999999


Q ss_pred             cccCcCCCCC-----HHHHhcCccccccCccccc
Q 016959          337 LQKDPHSRWP-----AAQLLQHPFILRAGQSQVN  365 (380)
Q Consensus       337 l~~dp~~R~t-----~~eil~hp~~~~~~~~~~~  365 (380)
                      |+.||++|++     +.+++.||||....+....
T Consensus       233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~  266 (318)
T cd05582         233 FKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLY  266 (318)
T ss_pred             hhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHH
Confidence            9999999999     7889999999988765543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-48  Score=362.77  Aligned_cols=273  Identities=24%  Similarity=0.340  Sum_probs=215.4

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++|++.+.||+|+||+||++.+..+++.||+|++.+..  .......+.+|+.+++.++|+||+.++++|.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999999999999999985422  2233456788999999999999999999999999999999


Q ss_pred             eccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC-C
Q 016959          177 EYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP-C  250 (380)
Q Consensus       177 e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-~  250 (380)
                      ||+.+++|..++.     ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...... .
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS  160 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence            9999999976653     256678889999999999999999999999999999999999999999998765433221 2


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC----CCCCCCcccc
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA----QPPEAPEMAS  326 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~~~~  326 (380)
                      ...+||+.|+|||++.........++.++|||||||++|+|++|+.||.....   ......+...    ..+.....++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~  237 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMNHKEHFQFPPDVTDVS  237 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH---HHHHHHHHcCCCcccCCCccCCCC
Confidence            23469999999999864222234567789999999999999999999964322   2222222111    1112223478


Q ss_pred             HHHHHHHHHhcccCcCC--CCCHHHHhcCccccccCcccccccccccCCC
Q 016959          327 REFRDFISRCLQKDPHS--RWPAAQLLQHPFILRAGQSQVNQNLRQILPP  374 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~--R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~  374 (380)
                      .++++||.+||+.++++  |+++.++++||||.+..+..+.....+.+|.
T Consensus       238 ~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~~~~~~~~  287 (331)
T cd05597         238 EEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPE  287 (331)
T ss_pred             HHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHHhhCCCCccCc
Confidence            89999999999765444  7899999999999998877766555444443

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.3e-47  Score=359.93  Aligned_cols=258  Identities=38%  Similarity=0.688  Sum_probs=211.3

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      +..++|++.++||+|+||.||++.+..++..+|+|++...........+.+|+++++.++|+||++++++|.+.+.+++|
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            45678999999999999999999999999999999987655555667899999999999999999999999999999999


Q ss_pred             EeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          176 LEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKR-KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       176 ~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      |||+.+++|.+++.    ..+..+..++.||+.||.|||++ +|+|+||||+|||++.++.+||+|||++..+....  .
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~  159 (333)
T cd06650          82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--A  159 (333)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--c
Confidence            99999999977653    34567788999999999999985 79999999999999999999999999987654322  2


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHH--------------------
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLM--------------------  310 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--------------------  310 (380)
                      ....|+..|+|||++..     ..++.++|||||||++|+|++|+.||............                    
T Consensus       160 ~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         160 NSFVGTRSYMSPERLQG-----THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             ccCCCCccccCHHHhcC-----CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence            44578999999999853     45677899999999999999999999643322211110                    


Q ss_pred             ---------------------HHHhhCCCCCCC-ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          311 ---------------------FAICFAQPPEAP-EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       311 ---------------------~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                                           ........+..+ ...+.++++||.+||+.||++|||+.|++.||||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                                 001111111111 13578899999999999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-48  Score=362.71  Aligned_cols=251  Identities=26%  Similarity=0.406  Sum_probs=214.1

Q ss_pred             ccccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           91 NRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        91 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      ...+.++.+.+...+.||+|-||+||+|.+..+ ..||+|.++....  ..+.|.+|+++|++|+|+|||++++++..++
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~  274 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGVCTKQE  274 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence            345668888999999999999999999999533 3689999865432  2356779999999999999999999999988


Q ss_pred             eEEEEEeccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      .+||||||+..|+|.++++.      ....+..++.|||+|++||+++++|||||..+||||+++..+||+|||+|+...
T Consensus       275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence            99999999999999888776      235688999999999999999999999999999999999999999999999544


Q ss_pred             ccCC-CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCC
Q 016959          245 QTMD-PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAP  322 (380)
Q Consensus       245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  322 (380)
                      +... ...+.--...|.|||.++-     ..++.+||||||||+||||+| |+.||.   .....+.+..+..+.+.+.|
T Consensus       355 d~~Y~~~~~~kfPIkWtAPEa~~~-----~~FS~kSDVWSFGVlL~E~fT~G~~py~---~msn~ev~~~le~GyRlp~P  426 (468)
T KOG0197|consen  355 DDEYTASEGGKFPIKWTAPEALNY-----GKFSSKSDVWSFGVLLWELFTYGRVPYP---GMSNEEVLELLERGYRLPRP  426 (468)
T ss_pred             CCceeecCCCCCCceecCHHHHhh-----CCcccccceeehhhhHHHHhccCCCCCC---CCCHHHHHHHHhccCcCCCC
Confidence            3321 2233334679999999863     456789999999999999987 999997   45556777778888899999


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      +.++.++.++|..||..+|++|||++.+..
T Consensus       427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  427 EGCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             CCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence            999999999999999999999999987654

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-48  Score=333.18  Aligned_cols=268  Identities=28%  Similarity=0.552  Sum_probs=218.8

Q ss_pred             cccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCC
Q 016959           92 RHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNG  170 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  170 (380)
                      .....+..+++.+..||.|+.|.|++++.+.+|...|||.++.....+..+++...+.++... ++|+||+++|+|..+.
T Consensus        85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~  164 (391)
T KOG0983|consen   85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT  164 (391)
T ss_pred             cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence            344566778888999999999999999999999999999998887777778888888887666 4999999999999999


Q ss_pred             eEEEEEeccCCC--Ccccc--cccchHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          171 EIEVLLEYMDGG--SLEGA--HIRQEHILSDLARQVLSGLAYLHKR-KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       171 ~~~lv~e~~~~~--~L~~~--~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      ..++.||.|..-  -|...  ...+|..+-++...++.||.||..+ ||+|||+||.|||+|+.|++||||||++.++.+
T Consensus       165 dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  165 DVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence            999999987521  11111  2235667778999999999999875 999999999999999999999999999998876


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCc--
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE--  323 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--  323 (380)
                      ... .....|.+.|||||.+...  ....|..++||||||++++||.||+.||...+ .++. .+..+....++.++.  
T Consensus       245 SkA-htrsAGC~~YMaPERidp~--~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~-tdFe-~ltkvln~ePP~L~~~~  319 (391)
T KOG0983|consen  245 SKA-HTRSAGCAAYMAPERIDPP--DKPKYDIRADVWSLGITLVELATGQYPYKGCK-TDFE-VLTKVLNEEPPLLPGHM  319 (391)
T ss_pred             ccc-cccccCCccccCccccCCC--CCCccchhhhhhhhccchhhhhcccCCCCCCC-ccHH-HHHHHHhcCCCCCCccc
Confidence            643 3455689999999999753  23456779999999999999999999997543 3433 333333355555443  


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                      .+++.+.+|+..||++|+.+||...++|+|||+.....++.
T Consensus       320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~  360 (391)
T KOG0983|consen  320 GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEV  360 (391)
T ss_pred             CcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhc
Confidence            37999999999999999999999999999999998766553

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-48  Score=364.98  Aligned_cols=252  Identities=28%  Similarity=0.431  Sum_probs=202.8

Q ss_pred             ecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhC---CCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDV---NHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       107 LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      ||+|+||+||+|.+..+++.||||++.+..  .......+..|..++..+   +||||+.+++++...+.+|+||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999999999999985432  112233445566666655   699999999999999999999999999


Q ss_pred             CCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCC
Q 016959          182 GSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI  257 (380)
Q Consensus       182 ~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  257 (380)
                      ++|...+.    ..+..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.............+||.
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  160 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT  160 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence            99865433    35677888999999999999999999999999999999999999999999876543333445677999


Q ss_pred             ccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhc
Q 016959          258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL  337 (380)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  337 (380)
                      .|+|||++..    ...++.++|||||||++|+|++|..||...   +.......+...........++.++.+||.+||
T Consensus       161 ~y~aPE~~~~----~~~~~~~~DvwslGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L  233 (330)
T cd05586         161 EYLAPEVLLD----EKGYTKHVDFWSLGVLVFEMCCGWSPFYAE---DTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLL  233 (330)
T ss_pred             cccCHHHHcC----CCCCCCccceeccccEEEEeccCCCCCCCC---CHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence            9999999853    234577899999999999999999999643   333333333333322223357899999999999


Q ss_pred             ccCcCCCC----CHHHHhcCccccccCccccc
Q 016959          338 QKDPHSRW----PAAQLLQHPFILRAGQSQVN  365 (380)
Q Consensus       338 ~~dp~~R~----t~~eil~hp~~~~~~~~~~~  365 (380)
                      +.||++|+    ++.|+++||||....+....
T Consensus       234 ~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~  265 (330)
T cd05586         234 NRNPQHRLGAHRDAVELKEHPFFADIDWDLLS  265 (330)
T ss_pred             CCCHHHCCCCCCCHHHHhcCccccCCCHHHHH
Confidence            99999998    79999999999987765553

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.4e-49  Score=349.58  Aligned_cols=252  Identities=28%  Similarity=0.382  Sum_probs=205.8

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC-----eEEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG-----EIEV  174 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~l  174 (380)
                      .|...+++|.|+||.||+|....+++.||||.+..+..-     -.+|+++|+.++|||||+++.+|....     ...+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            477788999999999999999999999999998554421     236999999999999999998885422     3557


Q ss_pred             EEeccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CcEEEeeccccccccc
Q 016959          175 LLEYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS-KNVKIADFGVSRILAQ  245 (380)
Q Consensus       175 v~e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~  245 (380)
                      ||||++. +|...+.        .+.-.++-+++||++||.|||+.||+||||||.|+|||.+ |.+||||||.|+.+..
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~  178 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK  178 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence            9999975 5544333        1233467799999999999999999999999999999955 8999999999998876


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC------
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP------  319 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------  319 (380)
                      ... ..+...|..|+|||.+.+    ...|+.+.||||.||++.||+.|+..|......++...+.++......      
T Consensus       179 ~ep-niSYicSRyYRaPELifg----a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  179 GEP-NISYICSRYYRAPELIFG----ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             CCC-ceeEEEeccccCHHHHcC----ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            643 467778999999999965    366788999999999999999999999876666666655554432211      


Q ss_pred             -------------------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          320 -------------------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       320 -------------------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                                         ......++++.||+.++|..+|.+|.++.|+|.||||..+...
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                               0233478899999999999999999999999999999998555

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-49  Score=371.47  Aligned_cols=261  Identities=33%  Similarity=0.546  Sum_probs=226.7

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .+.|.|+..||.|+||+||++..+.++-..|.|++.... +...+.+.-||++|..|+||+||++++.|..++.+|++.|
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            456889999999999999999999999999999985443 3446778889999999999999999999999999999999


Q ss_pred             ccCCCCcccc-----cccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          178 YMDGGSLEGA-----HIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       178 ~~~~~~L~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      ||.||-+...     ....+.++.-+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+...........+
T Consensus       110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs  189 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS  189 (1187)
T ss_pred             ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence            9999976543     23468889999999999999999999999999999999999999999999998766655556678


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC--CCccccHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--APEMASREFR  330 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  330 (380)
                      ++||++|||||++.........|.+++||||||++|.||.-+..|-.   .......+.++....++.  .|...+.++.
T Consensus       190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh---elnpMRVllKiaKSePPTLlqPS~Ws~~F~  266 (1187)
T KOG0579|consen  190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH---ELNPMRVLLKIAKSEPPTLLQPSHWSRSFS  266 (1187)
T ss_pred             ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc---ccchHHHHHHHhhcCCCcccCcchhhhHHH
Confidence            99999999999998888888889999999999999999999999874   334455556666666655  4566788999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      ||+++||.+||+.||++.++|+||||+.++..
T Consensus       267 DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  267 DFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             HHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence            99999999999999999999999999986544

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.4e-48  Score=361.05  Aligned_cols=251  Identities=27%  Similarity=0.417  Sum_probs=203.3

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHHHHHHH-HHHHhCCCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQICREI-EILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      +.||+|+||+||+|++..+++.||+|++.....  ......+..|. .+++.++|+||+++++++...+.+++||||+.+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            469999999999999999999999999864321  11223344444 457888999999999999999999999999999


Q ss_pred             CCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCC
Q 016959          182 GSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI  257 (380)
Q Consensus       182 ~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  257 (380)
                      ++|...+..    .+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  160 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP  160 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence            998765432    4667778999999999999999999999999999999999999999999976543333345667999


Q ss_pred             ccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhc
Q 016959          258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL  337 (380)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  337 (380)
                      .|+|||++..     ..++.++|||||||++|+|++|..||.....   ......+ .......+..++.++.++|.+||
T Consensus       161 ~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i-~~~~~~~~~~~~~~~~~li~~~l  231 (325)
T cd05602         161 EYLAPEVLHK-----QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDNI-LNKPLQLKPNITNSARHLLEGLL  231 (325)
T ss_pred             cccCHHHHcC-----CCCCCccccccccHHHHHHhcCCCCCCCCCH---HHHHHHH-HhCCcCCCCCCCHHHHHHHHHHc
Confidence            9999999853     4567789999999999999999999974332   2222222 22334455678999999999999


Q ss_pred             ccCcCCCCCHH----HHhcCccccccCcccc
Q 016959          338 QKDPHSRWPAA----QLLQHPFILRAGQSQV  364 (380)
Q Consensus       338 ~~dp~~R~t~~----eil~hp~~~~~~~~~~  364 (380)
                      +.||.+|+++.    ++++|+||....+...
T Consensus       232 ~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~  262 (325)
T cd05602         232 QKDRTKRLGAKDDFMEIKNHIFFSPINWDDL  262 (325)
T ss_pred             ccCHHHCCCCCCCHHHHhcCcccCCCCHHHH
Confidence            99999999865    8999999988776554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.3e-47  Score=347.20  Aligned_cols=259  Identities=37%  Similarity=0.646  Sum_probs=215.2

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+|++++++++|+||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            36888999999999999999999999999999987654445566788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCCc
Q 016959          179 MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIA  258 (380)
Q Consensus       179 ~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~  258 (380)
                      +.+++|..+....+..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++..+....  .....|+..
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~  158 (279)
T cd06619          81 MDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNA  158 (279)
T ss_pred             CCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--ccCCCCChh
Confidence            999999877777888889999999999999999999999999999999999999999999997654332  245679999


Q ss_pred             cccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC----HHHHHHHHhhCCCCC-CCccccHHHHHHH
Q 016959          259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD----WASLMFAICFAQPPE-APEMASREFRDFI  333 (380)
Q Consensus       259 y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~~~~~~~~-~~~~~~~~~~~li  333 (380)
                      |+|||++..     ..++.++|+|||||++|+|++|..||.......    ............... .....+.++.+||
T Consensus       159 y~aPE~~~~-----~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  233 (279)
T cd06619         159 YMAPERISG-----EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI  233 (279)
T ss_pred             hcCceeecC-----CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHH
Confidence            999999853     456779999999999999999999996322111    111111111112222 2334678999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          334 SRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       334 ~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                      .+||+.||++||+++|++.||||+..+....
T Consensus       234 ~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~  264 (279)
T cd06619         234 TQCMRKQPKERPAPENLMDHPFIVQYNDGNA  264 (279)
T ss_pred             HHHhhCChhhCCCHHHHhcCcccccccCccH
Confidence            9999999999999999999999998755544

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.6e-48  Score=361.39  Aligned_cols=252  Identities=27%  Similarity=0.398  Sum_probs=204.0

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHH-HHHhCCCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIE-ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      +.||+|+||+||+|.+..+|+.||+|++....  .......+..|.. +++.++||||+++++++...+.+++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999986432  1222344555554 57788999999999999999999999999999


Q ss_pred             CCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCC
Q 016959          182 GSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI  257 (380)
Q Consensus       182 ~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  257 (380)
                      ++|...+.    ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+||.
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP  160 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence            99865443    35677888999999999999999999999999999999999999999999876443333345667999


Q ss_pred             ccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhc
Q 016959          258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL  337 (380)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  337 (380)
                      .|+|||++..     ..++.++|||||||++|+|++|..||....   ......... ..........+..+.++|.+||
T Consensus       161 ~y~aPE~~~~-----~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~~~-~~~~~~~~~~~~~~~~ll~~ll  231 (325)
T cd05604         161 EYLAPEVIRK-----QPYDNTVDWWCLGAVLYEMLYGLPPFYCRD---VAEMYDNIL-HKPLVLRPGASLTAWSILEELL  231 (325)
T ss_pred             hhCCHHHHcC-----CCCCCcCccccccceehhhhcCCCCCCCCC---HHHHHHHHH-cCCccCCCCCCHHHHHHHHHHh
Confidence            9999999853     455678999999999999999999997433   223333322 2333445567889999999999


Q ss_pred             ccCcCCCCCH----HHHhcCccccccCccccc
Q 016959          338 QKDPHSRWPA----AQLLQHPFILRAGQSQVN  365 (380)
Q Consensus       338 ~~dp~~R~t~----~eil~hp~~~~~~~~~~~  365 (380)
                      +.||++|+++    .++++||||....+....
T Consensus       232 ~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~  263 (325)
T cd05604         232 EKDRQRRLGAKEDFLEIQEHPFFESLSWTDLE  263 (325)
T ss_pred             ccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence            9999999976    599999999988765543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-48  Score=361.71  Aligned_cols=255  Identities=29%  Similarity=0.500  Sum_probs=230.3

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe-EEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE-IEVL  175 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv  175 (380)
                      .++|..++.+|+|+||.+++++++..++.|++|.+.... .+..+.....|+.+++++.|||||.+.+.|..++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            367999999999999999999999999999999996544 34455678899999999999999999999998888 9999


Q ss_pred             EeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 016959          176 LEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       176 ~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  249 (380)
                      |+||+||+|.+.+.      +.++.+..++.||+.||.|||+++|+|||||+.||++++++.|||+|||+|+.+......
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~  162 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL  162 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence            99999999976544      357889999999999999999999999999999999999999999999999999877667


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      ..+.+||+.||.||++.     +..|..++|||||||++|||++-+.+|.   ..++...+.++....-.+.+...+.++
T Consensus       163 a~tvvGTp~YmcPEil~-----d~pYn~KSDiWsLGC~~yEm~~lk~aF~---a~~m~~Li~ki~~~~~~Plp~~ys~el  234 (426)
T KOG0589|consen  163 ASTVVGTPYYMCPEILS-----DIPYNEKSDIWSLGCCLYEMCTLKPAFK---ASNMSELILKINRGLYSPLPSMYSSEL  234 (426)
T ss_pred             hheecCCCcccCHHHhC-----CCCCCccCcchhhcchHHHHHhcccccC---ccchHHHHHHHhhccCCCCCccccHHH
Confidence            78899999999999986     4778889999999999999999999996   566777777777777788899999999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      +.+|+.||..+|+.||++.++|.+|.++..-
T Consensus       235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  235 RSLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             HHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence            9999999999999999999999999988653

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-47  Score=361.05  Aligned_cols=260  Identities=27%  Similarity=0.341  Sum_probs=202.0

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC-----CeEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN-----GEIE  173 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~  173 (380)
                      +|++.++||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...     ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788999999999999999999999999999986432 222345678999999999999999999987543     3589


Q ss_pred             EEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-
Q 016959          174 VLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-  248 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-  248 (380)
                      +|||||. ++|...+.    ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  159 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT  159 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence            9999996 46655433    35677888999999999999999999999999999999999999999999976432211 


Q ss_pred             --CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH-------------
Q 016959          249 --PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI-------------  313 (380)
Q Consensus       249 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-------------  313 (380)
                        .....+||..|+|||++..   ....++.++|||||||++|+|++|+.||...........+...             
T Consensus       160 ~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         160 AIFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             cccccCCCCCCCcCCHHHHhc---cccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence              2244679999999999743   1245677999999999999999999999643321111111110             


Q ss_pred             -----------hhCCCC---CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          314 -----------CFAQPP---EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       314 -----------~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                                 ....+.   .....++.++.++|.+||+.||++|||++|+|+||||++.....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~  300 (338)
T cd07859         237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE  300 (338)
T ss_pred             hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccc
Confidence                       000011   01124577899999999999999999999999999999876644

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=8.5e-48  Score=361.22  Aligned_cols=272  Identities=24%  Similarity=0.357  Sum_probs=215.0

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++|++.++||+|+||+||++++..+++.||+|++.+..  .......+.+|+.++..++|+||+++++++.+.+.+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47889999999999999999999999999999985422  2223445788999999999999999999999999999999


Q ss_pred             eccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-CC
Q 016959          177 EYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-PC  250 (380)
Q Consensus       177 e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~  250 (380)
                      ||+.+|+|.+++..     .+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..... ..
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            99999999776543     4567888999999999999999999999999999999999999999999876543222 22


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC----CCCCCcccc
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ----PPEAPEMAS  326 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~  326 (380)
                      ...+||+.|+|||++.........++.++|||||||++|||++|+.||...   +.......+....    .+.....++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~---~~~~~~~~i~~~~~~~~~p~~~~~~s  237 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIMNHKERFQFPAQVTDVS  237 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC---CHHHHHHHHhCCCccccCCCccccCC
Confidence            345799999999998532222345677999999999999999999999743   2333333322211    122234578


Q ss_pred             HHHHHHHHHhcccCcCC--CCCHHHHhcCccccccCcccccccccccCC
Q 016959          327 REFRDFISRCLQKDPHS--RWPAAQLLQHPFILRAGQSQVNQNLRQILP  373 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~--R~t~~eil~hp~~~~~~~~~~~~~~~~~~~  373 (380)
                      .++++||.+||+.++++  |++++|+++||||.++.+..........+|
T Consensus       238 ~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~~~~~~~~~~  286 (332)
T cd05623         238 EDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIP  286 (332)
T ss_pred             HHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHHhhCCCCccC
Confidence            99999999999765554  689999999999999887766544333333

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-48  Score=356.75  Aligned_cols=258  Identities=26%  Similarity=0.432  Sum_probs=225.0

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .=|.+.+.||+|.|+.|-++++.-+|..||||++.+... +.....+..|+..|+.++|||||++|++.+....+|+|+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            347888999999999999999999999999999976653 3345678899999999999999999999999999999999


Q ss_pred             ccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCcEEEeeccccccccccCCCCC
Q 016959          178 YMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN-SSKNVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       178 ~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      +-++|+|++++.+     .|...++++.||+.|+.|+|+..||||||||+||++. +-|-+||+|||++..+.+. ....
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-~kL~  176 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-KKLT  176 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc-chhh
Confidence            9999999998876     4667889999999999999999999999999998876 5677999999999877655 4567


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD  331 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (380)
                      +.||+..|-|||++.+    ..|+.+++||||||||||-|+||+.||...+..+...++..    -.-..|..++.+++|
T Consensus       177 TsCGSLAYSAPEILLG----DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD----CKYtvPshvS~eCrd  248 (864)
T KOG4717|consen  177 TSCGSLAYSAPEILLG----DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD----CKYTVPSHVSKECRD  248 (864)
T ss_pred             cccchhhccCchhhhc----CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc----ccccCchhhhHHHHH
Confidence            8999999999999875    47888999999999999999999999986555544433333    334678889999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccccccCccccc
Q 016959          332 FISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN  365 (380)
Q Consensus       332 li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~  365 (380)
                      ||..||..||++|.+++||..|+|++........
T Consensus       249 LI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT  282 (864)
T KOG4717|consen  249 LIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLST  282 (864)
T ss_pred             HHHHHHhcCchhhccHHHHhccccccCCCCCccc
Confidence            9999999999999999999999999998665543

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.6e-47  Score=357.69  Aligned_cols=251  Identities=26%  Similarity=0.402  Sum_probs=204.1

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHH-HHHHhCCCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREI-EILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      +.||+|+||.||+|++..+++.||+|++.+..  .......+..|. .+++.++|+||+++++++.+.+..|+||||+.+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999986432  122233444554 467889999999999999999999999999999


Q ss_pred             CCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCC
Q 016959          182 GSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI  257 (380)
Q Consensus       182 ~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  257 (380)
                      ++|...+.    ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP  160 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence            99865443    34667888999999999999999999999999999999999999999999875433333345567999


Q ss_pred             ccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhc
Q 016959          258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL  337 (380)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  337 (380)
                      .|+|||++..     ..++.++|||||||++|||++|..||...   +.......+ ...+...+...+.++.++|.+||
T Consensus       161 ~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~i-~~~~~~~~~~~~~~~~~li~~~l  231 (321)
T cd05603         161 EYLAPEVLRK-----EPYDRTVDWWCLGAVLYEMLYGLPPFYSR---DVSQMYDNI-LHKPLQLPGGKTVAACDLLVGLL  231 (321)
T ss_pred             ccCCHHHhcC-----CCCCCcCcccccchhhhhhhcCCCCCCCC---CHHHHHHHH-hcCCCCCCCCCCHHHHHHHHHHc
Confidence            9999999853     45677899999999999999999999643   233333222 33445666778899999999999


Q ss_pred             ccCcCCCCCH----HHHhcCccccccCcccc
Q 016959          338 QKDPHSRWPA----AQLLQHPFILRAGQSQV  364 (380)
Q Consensus       338 ~~dp~~R~t~----~eil~hp~~~~~~~~~~  364 (380)
                      +.||++|+++    .|+++|+||....+...
T Consensus       232 ~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~  262 (321)
T cd05603         232 HKDQRRRLGAKADFLEIKNHVFFSPINWDDL  262 (321)
T ss_pred             cCCHhhcCCCCCCHHHHhCCCCcCCCCHHHH
Confidence            9999999875    59999999998876654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.9e-47  Score=346.58  Aligned_cols=254  Identities=24%  Similarity=0.343  Sum_probs=202.7

Q ss_pred             ecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCCCc
Q 016959          107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL  184 (380)
Q Consensus       107 LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  184 (380)
                      ||+|+||+||++.+..+|+.||+|++.....  ......+..|+++++.++|+||+++++++..+..+++||||+.|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            7999999999999999999999999854321  12233456799999999999999999999999999999999999998


Q ss_pred             ccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCCc
Q 016959          185 EGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIA  258 (380)
Q Consensus       185 ~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~  258 (380)
                      .....      ..+..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... ......|+..
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~  159 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTNG  159 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCCC
Confidence            65442      2456677899999999999999999999999999999999999999999987664332 2234568999


Q ss_pred             cccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCH-HHHHHHHhhCCCCCCCccccHHHHHHHHHhc
Q 016959          259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDW-ASLMFAICFAQPPEAPEMASREFRDFISRCL  337 (380)
Q Consensus       259 y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  337 (380)
                      |+|||++..     ..++.++|||||||++|||++|..||........ ..................++.++++||.+||
T Consensus       160 y~aPE~~~~-----~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  234 (277)
T cd05607         160 YMAPEILKE-----EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFL  234 (277)
T ss_pred             ccCHHHHcc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHh
Confidence            999999853     3467899999999999999999999964332211 1222222211222223457889999999999


Q ss_pred             ccCcCCCCCH----HHHhcCccccccCcccccc
Q 016959          338 QKDPHSRWPA----AQLLQHPFILRAGQSQVNQ  366 (380)
Q Consensus       338 ~~dp~~R~t~----~eil~hp~~~~~~~~~~~~  366 (380)
                      +.||++|+++    ++++.|+||+..++.....
T Consensus       235 ~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~  267 (277)
T cd05607         235 AKKPEDRLGSREKNDDPRKHEFFKTINFPRLEA  267 (277)
T ss_pred             ccCHhhCCCCccchhhhhcChhhcCCCHHHHhc
Confidence            9999999999    7788999999987755544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-49  Score=389.84  Aligned_cols=279  Identities=25%  Similarity=0.365  Sum_probs=233.3

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      -....++|.+.++||+|+||.|.+++++.+++.||+|++.+..  .......|++|..+|..-+.+=|++++..|.++++
T Consensus        70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~  149 (1317)
T KOG0612|consen   70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY  149 (1317)
T ss_pred             HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence            3478899999999999999999999999999999999985422  12234568899999999899999999999999999


Q ss_pred             EEEEEeccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccc-cc
Q 016959          172 IEVLLEYMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA-QT  246 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~-~~  246 (380)
                      +|+||||+.||+|..++    ..++...+.++.+|+.||+-||+.|+|||||||+|||+|..|++||+|||.+-.+. ++
T Consensus       150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG  229 (1317)
T ss_pred             eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence            99999999999975443    45677888899999999999999999999999999999999999999999987776 44


Q ss_pred             CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH--hhCCCCCCCcc
Q 016959          247 MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI--CFAQPPEAPEM  324 (380)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~  324 (380)
                      .-.+...+|||.|++||++.........|+..+|+||+||++|||++|..||..+...+.+..+...  .+.+|  -...
T Consensus       230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP--~~~~  307 (1317)
T KOG0612|consen  230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP--DETD  307 (1317)
T ss_pred             cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC--cccc
Confidence            4456788999999999999775544477899999999999999999999999744333333333222  22222  1244


Q ss_pred             ccHHHHHHHHHhcccCcCCCCC---HHHHhcCccccccCcccccccccccCCCC
Q 016959          325 ASREFRDFISRCLQKDPHSRWP---AAQLLQHPFILRAGQSQVNQNLRQILPPP  375 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t---~~eil~hp~~~~~~~~~~~~~~~~~~~~~  375 (380)
                      ++.++++||.+++ -+|+.|..   ++++..||||.+++|..++..-++++|..
T Consensus       308 VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPev  360 (1317)
T KOG0612|consen  308 VSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEV  360 (1317)
T ss_pred             cCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcC
Confidence            8999999999999 68889998   99999999999999987777777777763

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.2e-47  Score=352.41  Aligned_cols=258  Identities=28%  Similarity=0.442  Sum_probs=207.4

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .++|.+.+.||.|+||.||+|.+..+++.||+|.+...........+.+|+.+++.++|+||+++++++...+..++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            46899999999999999999999999999999998655444444567789999999999999999999999999999999


Q ss_pred             ccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          178 YMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       178 ~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      |+.+ +|...+.     ..+..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++............
T Consensus        85 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  163 (301)
T cd07873          85 YLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN  163 (301)
T ss_pred             cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccc
Confidence            9985 6644332     246678889999999999999999999999999999999999999999999765433333344


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC--------------
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP--------------  318 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------------  318 (380)
                      ..++..|+|||++.+    ...++.++|||||||++|+|++|+.||......+....+........              
T Consensus       164 ~~~~~~y~~PE~~~~----~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         164 EVVTLWYRPPDILLG----STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             cceeecccCcHHHhC----CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence            567899999999753    23456789999999999999999999974433222221111110000              


Q ss_pred             ----C--------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          319 ----P--------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       319 ----~--------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                          +        .....++.++++||.+||+.||.+|||+.|+|+||||+.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence                0        01234678899999999999999999999999999998876

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.6e-47  Score=362.36  Aligned_cols=252  Identities=24%  Similarity=0.291  Sum_probs=199.4

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      .+....|++.++||+|+||.||+|.+..+++.||+|+..       ...+.+|+++++.++||||++++++|......++
T Consensus        88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence            356678999999999999999999999999999999752       2346789999999999999999999999999999


Q ss_pred             EEeccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc-CCC
Q 016959          175 LLEYMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT-MDP  249 (380)
Q Consensus       175 v~e~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~  249 (380)
                      |+|++.+ +|..++    ...+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... ...
T Consensus       161 v~e~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        161 ILPRYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             EEecCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence            9999964 554333    2356678899999999999999999999999999999999999999999999754322 122


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-------CHHHHHHHHhhC------
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG-------DWASLMFAICFA------  316 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------~~~~~~~~~~~~------  316 (380)
                      ....+||+.|+|||++..     ..++.++|||||||++|||++|..||......       .....+......      
T Consensus       240 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        240 YYGWAGTIATNAPELLAR-----DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             cccccCccCCCChhhhcC-----CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence            345679999999999853     45678999999999999999999887532110       000111000000      


Q ss_pred             --------------------CCCCC--C---ccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          317 --------------------QPPEA--P---EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       317 --------------------~~~~~--~---~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                                          .+...  +   ..++.++.+||.+||+.||++|||+.|+|+||||+.+
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                                00000  0   1246689999999999999999999999999999874

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.8e-47  Score=368.28  Aligned_cols=255  Identities=27%  Similarity=0.384  Sum_probs=198.4

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC------
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRN------  169 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------  169 (380)
                      ....+|.++++||+|+||.||+|.+..+++.||||++.....     ...+|+.+|+.++|+||++++++|...      
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            345689999999999999999999999999999999854321     234799999999999999999876432      


Q ss_pred             --CeEEEEEeccCCCCcccc--------cccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-cEEEeecc
Q 016959          170 --GEIEVLLEYMDGGSLEGA--------HIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFG  238 (380)
Q Consensus       170 --~~~~lv~e~~~~~~L~~~--------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg  238 (380)
                        ..+++||||+.++ |..+        ....+..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus       138 ~~~~l~lvmE~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        138 KNIFLNVVMEFIPQT-VHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             CceEEEEEEecCCcc-HHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence              2477899999864 4322        2234667888999999999999999999999999999999665 69999999


Q ss_pred             ccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC--
Q 016959          239 VSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA--  316 (380)
Q Consensus       239 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--  316 (380)
                      +|+.+... .......||+.|+|||++.+    ...++.++|||||||++|||++|..||......+....+......  
T Consensus       217 la~~~~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~  291 (440)
T PTZ00036        217 SAKNLLAG-QRSVSYICSRFYRAPELMLG----ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT  291 (440)
T ss_pred             cchhccCC-CCcccCCCCcCccCHHHhcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99876543 22345678999999999753    235678999999999999999999999754332222221111100  


Q ss_pred             ---------------CC--------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          317 ---------------QP--------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       317 ---------------~~--------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                                     .+        ..++...+.++++||.+||+.||++|+|+.|+|+||||..+..
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence                           00        0123346789999999999999999999999999999988754

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=7.6e-48  Score=365.78  Aligned_cols=250  Identities=30%  Similarity=0.469  Sum_probs=206.1

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-C-----CceeeeEeEEeeCCeEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-H-----PNVVKCHDMYDRNGEIE  173 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~iv~~~~~~~~~~~~~  173 (380)
                      +|++.+.||+|+||.|.+|.+..|++.||||+++..  .....+...|+.+|..|+ |     -|+|+++++|...+++|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~--k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK--KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC--hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            678899999999999999999999999999999544  345567778999999996 4     38999999999999999


Q ss_pred             EEEeccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC--cEEEeeccccccccc
Q 016959          174 VLLEYMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK--NVKIADFGVSRILAQ  245 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~  245 (380)
                      ||+|++.. +|.+++..      ....++.|+.||+.||.+||+.||||+||||||||+..-+  .|||+|||.|.....
T Consensus       265 iVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q  343 (586)
T KOG0667|consen  265 IVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ  343 (586)
T ss_pred             eeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence            99999964 66655544      3577899999999999999999999999999999997544  599999999987765


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC-----
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-----  320 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----  320 (380)
                      ..   .+.+.+..|+|||+|.     |..|+.+.||||||||++||++|...|...+..|+...+..+....+..     
T Consensus       344 ~v---ytYiQSRfYRAPEVIL-----GlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  344 RV---YTYIQSRFYRAPEVIL-----GLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             cc---eeeeeccccccchhhc-----cCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            43   3788999999999995     5778889999999999999999999897665555544444433221100     


Q ss_pred             -------------------------------------------CC-----------ccccHHHHHHHHHhcccCcCCCCC
Q 016959          321 -------------------------------------------AP-----------EMASREFRDFISRCLQKDPHSRWP  346 (380)
Q Consensus       321 -------------------------------------------~~-----------~~~~~~~~~li~~~l~~dp~~R~t  346 (380)
                                                                 .|           ..-...+.|||++||..||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence                                                       00           012336899999999999999999


Q ss_pred             HHHHhcCccccccC
Q 016959          347 AAQLLQHPFILRAG  360 (380)
Q Consensus       347 ~~eil~hp~~~~~~  360 (380)
                      ..|+|+||||.+..
T Consensus       496 p~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  496 PAQALNHPFLTGTS  509 (586)
T ss_pred             HHHHhcCccccccc
Confidence            99999999999653

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.9e-47  Score=346.51  Aligned_cols=268  Identities=25%  Similarity=0.368  Sum_probs=216.9

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      |+..+.||+|+||+||++.+..+++.||+|.+.....  ......+.+|+++++.++|+||+.+++.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            6677889999999999999999999999999854321  22334577899999999999999999999999999999999


Q ss_pred             cCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          179 MDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       179 ~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      +.+++|...+.      ..+..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... .....
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~  160 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRG  160 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-CcccC
Confidence            99999865442      356778899999999999999999999999999999999999999999998765432 22245


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      ..|+..|+|||++..     ..++.++|+|||||++|+|++|..||...........+...........+..++.++.+|
T Consensus       161 ~~g~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05632         161 RVGTVGYMAPEVLNN-----QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSI  235 (285)
T ss_pred             CCCCcCccChHHhcC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHH
Confidence            679999999999853     456778999999999999999999997443322222333322333344556788899999


Q ss_pred             HHHhcccCcCCCCC-----HHHHhcCccccccCcccccccccccCCCCC
Q 016959          333 ISRCLQKDPHSRWP-----AAQLLQHPFILRAGQSQVNQNLRQILPPPR  376 (380)
Q Consensus       333 i~~~l~~dp~~R~t-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~  376 (380)
                      +.+||+.||++|++     +.++++|+||...++....  ..+..|+..
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~~~~~~~  282 (285)
T cd05632         236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLE--AGMLDPPFV  282 (285)
T ss_pred             HHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHh--cCcCCCCCC
Confidence            99999999999999     8999999999999777553  344445443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6e-47  Score=356.38  Aligned_cols=252  Identities=27%  Similarity=0.387  Sum_probs=201.6

Q ss_pred             cCCCcccccccceecccCCceEEEEEeC-----CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEe
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHP-----PTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYD  167 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~  167 (380)
                      +.+..++|++.++||+|+||.||+|.+.     .+++.||||++...........+.+|+.+++.+ +|+||+++++++.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            4577889999999999999999999752     345789999997655445556788999999999 8999999999887


Q ss_pred             eC-CeEEEEEeccCCCCccccccc--------------------------------------------------------
Q 016959          168 RN-GEIEVLLEYMDGGSLEGAHIR--------------------------------------------------------  190 (380)
Q Consensus       168 ~~-~~~~lv~e~~~~~~L~~~~~~--------------------------------------------------------  190 (380)
                      .. +.+++||||+.+|+|.+++..                                                        
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            54 468999999999998655432                                                        


Q ss_pred             ----------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--CCCCCCCCCc
Q 016959          191 ----------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD--PCNSAVGTIA  258 (380)
Q Consensus       191 ----------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~  258 (380)
                                ....+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.....  ......++..
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                      2345677899999999999999999999999999999999999999999986543211  1223446788


Q ss_pred             cccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhc
Q 016959          259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL  337 (380)
Q Consensus       259 y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  337 (380)
                      |+|||++..     ..++.++|||||||++|||++ |..||.......  ..............+..++.++.+||.+||
T Consensus       242 y~aPE~~~~-----~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  314 (338)
T cd05102         242 WMAPESIFD-----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQRLKDGTRMRAPENATPEIYRIMLACW  314 (338)
T ss_pred             ccCcHHhhc-----CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence            999999853     456789999999999999996 999997433221  222223333344456678899999999999


Q ss_pred             ccCcCCCCCHHHHhc
Q 016959          338 QKDPHSRWPAAQLLQ  352 (380)
Q Consensus       338 ~~dp~~R~t~~eil~  352 (380)
                      +.||++|||+.|+++
T Consensus       315 ~~dp~~RPs~~el~~  329 (338)
T cd05102         315 QGDPKERPTFSALVE  329 (338)
T ss_pred             cCChhhCcCHHHHHH
Confidence            999999999999987

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.2e-47  Score=358.27  Aligned_cols=272  Identities=23%  Similarity=0.328  Sum_probs=214.0

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++|++.+.||+|+||+||++++..+++.||+|++.+..  .......+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999999999999999985422  2223455788999999999999999999999999999999


Q ss_pred             eccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-CC
Q 016959          177 EYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-PC  250 (380)
Q Consensus       177 e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~  250 (380)
                      ||+.||+|..++..     .+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            99999999776543     4567788999999999999999999999999999999999999999999976653322 12


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC-CC---CCCCcccc
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA-QP---PEAPEMAS  326 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~  326 (380)
                      ...+||+.|+|||++.........++.++|||||||++|+|++|+.||.....   ......+... ..   +.....++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~~~~~~  237 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMNHEERFQFPSHITDVS  237 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH---HHHHHHHHcCCCcccCCCccccCC
Confidence            33569999999999854221223456789999999999999999999964332   2222222221 11   12223468


Q ss_pred             HHHHHHHHHhcccCcCC--CCCHHHHhcCccccccCcccccccccccCC
Q 016959          327 REFRDFISRCLQKDPHS--RWPAAQLLQHPFILRAGQSQVNQNLRQILP  373 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~--R~t~~eil~hp~~~~~~~~~~~~~~~~~~~  373 (380)
                      .++++||.+||+.++++  |++++++++|+||+...+........+.+|
T Consensus       238 ~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~p  286 (331)
T cd05624         238 EEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIP  286 (331)
T ss_pred             HHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHHhhCCCCccC
Confidence            89999999999876655  579999999999999887766544433333

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.5e-47  Score=348.81  Aligned_cols=250  Identities=28%  Similarity=0.438  Sum_probs=194.3

Q ss_pred             cccccceecccCCceEEEEEeCC-CCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhC---CCCceeeeEeEEe-----eC
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPP-TSRVFALKVIYGNHE-DSVRSQICREIEILRDV---NHPNVVKCHDMYD-----RN  169 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~-----~~  169 (380)
                      +|++.+.||+|+||+||+|++.. +++.||+|++..... ......+.+|+.+++.+   +||||+++++++.     ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            68899999999999999999854 478899999864332 22234455677777665   6999999999875     34


Q ss_pred             CeEEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                      ..+++||||+.+ +|..++.      ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        82 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T cd07862          82 TKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  160 (290)
T ss_pred             CcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence            568999999975 6644432      356778899999999999999999999999999999999999999999999766


Q ss_pred             cccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC----
Q 016959          244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP----  319 (380)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----  319 (380)
                      ... .......||..|+|||++..     ..++.++|||||||++|||++|..||......+....+........+    
T Consensus       161 ~~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         161 SFQ-MALTSVVVTLWYRAPEVLLQ-----SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             cCC-cccccccccccccChHHHhC-----CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            433 23345678999999999853     45677899999999999999999999754433322222221110000    


Q ss_pred             -------------------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          320 -------------------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       320 -------------------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                                         .....++..+.+||.+||+.||++|||+.|+|+||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                               0112467789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.8e-47  Score=346.47  Aligned_cols=262  Identities=34%  Similarity=0.607  Sum_probs=219.7

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+...........+.+|+.++++++|+||+++++.+...+.+++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            47899999999999999999999999999999987655555567888999999999999999999999999999999999


Q ss_pred             cCCCCcccccc-------cchHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          179 MDGGSLEGAHI-------RQEHILSDLARQVLSGLAYLHK-RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       179 ~~~~~L~~~~~-------~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      +.+++|..++.       ..+..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++..+....  .
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~  158 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--A  158 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--c
Confidence            99999865533       3566788999999999999997 599999999999999999999999999987654322  2


Q ss_pred             CCCCCCCccccccccccccC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHH
Q 016959          251 NSAVGTIAYMSPERINTDLN-HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      ....++..|+|||++..... ....++.++|+|||||++|+|++|..||.......................+..++.++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd06622         159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA  238 (286)
T ss_pred             ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHH
Confidence            34568889999999854222 22345778999999999999999999997544444444444444555666777799999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      .+||.+||+.||++||++.++++||||......
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         239 QDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             HHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence            999999999999999999999999999887544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.2e-47  Score=359.18  Aligned_cols=255  Identities=27%  Similarity=0.371  Sum_probs=200.0

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC------C
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN------G  170 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~  170 (380)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++|+||+++++++...      .
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            468999999999999999999999999999999986542 333456678999999999999999999998644      3


Q ss_pred             eEEEEEeccCCCCcccc-cccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 016959          171 EIEVLLEYMDGGSLEGA-HIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~-~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  249 (380)
                      .+|+||||+.++.+... ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus       100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~  178 (359)
T cd07876         100 DVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN-FM  178 (359)
T ss_pred             eeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC-cc
Confidence            57999999987543321 12356678889999999999999999999999999999999999999999999765332 22


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHH-----------------
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFA-----------------  312 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~-----------------  312 (380)
                      .....||..|+|||++.+     ..++.++|||||||++|+|++|..||...+..+.......                 
T Consensus       179 ~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (359)
T cd07876         179 MTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV  253 (359)
T ss_pred             CCCCcccCCCCCchhccC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence            345678999999999853     4567789999999999999999999974432111110000                 


Q ss_pred             --HhhCCC-------------------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 016959          313 --ICFAQP-------------------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR  358 (380)
Q Consensus       313 --~~~~~~-------------------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~  358 (380)
                        .....+                   .......+.++++||.+||+.||++|||+.|+|+||||+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence              000000                   0011224678999999999999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=331.84  Aligned_cols=249  Identities=27%  Similarity=0.440  Sum_probs=210.7

Q ss_pred             cccccc-ceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEee----CCeE
Q 016959           99 AELQKG-NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDR----NGEI  172 (380)
Q Consensus        99 ~~~~~~-~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~~~  172 (380)
                      ++|.+. ++||-|-.|+|..|.++.|++.+|+|++...      .+..+|+++.... .|+|||.++++|+.    ...+
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            566654 5799999999999999999999999998433      3455788886666 59999999999863    4578


Q ss_pred             EEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCcEEEeeccccccc
Q 016959          173 EVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS---SKNVKIADFGVSRIL  243 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~---~~~~kl~Dfg~a~~~  243 (380)
                      .+|||.++||.|...+.      ..|.....|+.||+.|+.|||+.+|.||||||+|+|...   +..+||+|||+|+.-
T Consensus       135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t  214 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET  214 (400)
T ss_pred             EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence            89999999999976544      467788999999999999999999999999999999974   445999999999865


Q ss_pred             cccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC----CHHHHHHHHhhCCCC
Q 016959          244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG----DWASLMFAICFAQPP  319 (380)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----~~~~~~~~~~~~~~~  319 (380)
                      ... ....+.+-|++|.|||++..     ..|+..+|+||+||++|.|+||..||......    .+...+....+.++.
T Consensus       215 ~~~-~~L~TPc~TPyYvaPevlg~-----eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~  288 (400)
T KOG0604|consen  215 QEP-GDLMTPCFTPYYVAPEVLGP-----EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE  288 (400)
T ss_pred             CCC-ccccCCcccccccCHHHhCc-----hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence            432 34567889999999999864     44667899999999999999999999744332    455666667788888


Q ss_pred             CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       320 ~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      +-|..++++++|+|+++|..+|.+|+|++|+++|||+..-
T Consensus       289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            8999999999999999999999999999999999999764

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.6e-46  Score=366.03  Aligned_cols=252  Identities=23%  Similarity=0.350  Sum_probs=211.8

Q ss_pred             ccccccceecccCCceEEEEEeCCC-CcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPT-SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~-~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ..|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... ......+.+|+.+|+.++||||++++++|...+.+|+|||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E  145 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME  145 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence            3489999999999999999998777 7888999874433 3334567889999999999999999999999999999999


Q ss_pred             ccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-
Q 016959          178 YMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-  248 (380)
Q Consensus       178 ~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-  248 (380)
                      |+.+++|.+++.        ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..... 
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            999999965432        35667888999999999999999999999999999999999999999999987654321 


Q ss_pred             -CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          249 -PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       249 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                       .....+||+.|+|||++..     ..++.++|||||||++|+|++|..||...   .....+...........+..++.
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~Pf~~~---~~~~~~~~~~~~~~~~~~~~~s~  297 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWER-----KRYSKKADMWSLGVILYELLTLHRPFKGP---SQREIMQQVLYGKYDPFPCPVSS  297 (478)
T ss_pred             ccccccCCCccccCHhHhCC-----CCCCcHHhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCCCccCCH
Confidence             2345679999999999853     45678999999999999999999999633   33444444444445556667889


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ++.+||.+||..||++||++.+++.|+|++..
T Consensus       298 ~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        298 GMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            99999999999999999999999999999754

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.7e-46  Score=342.08  Aligned_cols=267  Identities=31%  Similarity=0.495  Sum_probs=217.4

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      ...+.|++.++||+|+||.||+|.+..+++.|++|++.... ......+.+|+.+++.++|+||+++++.+..++.+++|
T Consensus         9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644           9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            34467999999999999999999999999999999986543 33456788899999999999999999999999999999


Q ss_pred             EeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          176 LEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       176 ~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      |||+.+++|...+.     ..+..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..........
T Consensus        88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~  167 (292)
T cd06644          88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR  167 (292)
T ss_pred             EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccccc
Confidence            99999999865432     3567788999999999999999999999999999999999999999999987654433333


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC--CCCCccccHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP--PEAPEMASRE  328 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  328 (380)
                      ....++..|+|||++.........++.++|+|||||++|+|++|..||.....   ............  ...+..++.+
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  244 (292)
T cd06644         168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPPTLSQPSKWSME  244 (292)
T ss_pred             ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH---HHHHHHHhcCCCccCCCCcccCHH
Confidence            45668899999999854322234457789999999999999999999964322   222222222222  2234567789


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCccccccCcccccc
Q 016959          329 FRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQ  366 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~  366 (380)
                      +.++|.+||..||++||++.|+++||||..+......+
T Consensus       245 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~  282 (292)
T cd06644         245 FRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLR  282 (292)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhcCccccccccchhHH
Confidence            99999999999999999999999999999887666444

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-48  Score=336.08  Aligned_cols=257  Identities=27%  Similarity=0.443  Sum_probs=218.8

Q ss_pred             cceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEEEEeccCCC
Q 016959          104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEVLLEYMDGG  182 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~  182 (380)
                      .+.||+|+|+.|..|....+|..||||++.+. ....+.++.+|++++..++ |+||++++++|+++..+|+|||-+.||
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG  161 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence            45799999999999999999999999999665 3445778999999999996 999999999999999999999999999


Q ss_pred             Ccccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc---EEEeeccccccccccC-------C
Q 016959          183 SLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN---VKIADFGVSRILAQTM-------D  248 (380)
Q Consensus       183 ~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~---~kl~Dfg~a~~~~~~~-------~  248 (380)
                      .|..++.    ..+.....+..+|+.||+|||.+||.||||||+|||..+...   +|||||.++.-.....       .
T Consensus       162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP  241 (463)
T KOG0607|consen  162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP  241 (463)
T ss_pred             hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence            9865544    467888999999999999999999999999999999976554   9999999976432211       1


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC---------------CHHHHHHHH
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG---------------DWASLMFAI  313 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---------------~~~~~~~~~  313 (380)
                      ...+.+|+..|||||+..-......+|..++|.||||+|||.||.|..||...-..               ...+.+...
T Consensus       242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG  321 (463)
T KOG0607|consen  242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG  321 (463)
T ss_pred             cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc
Confidence            23567899999999998655555667888999999999999999999999632211               344556666


Q ss_pred             hhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          314 CFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      .+.++..-|..++.+.+|||..+|..|+.+|.++.++++|||+++...
T Consensus       322 kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~  369 (463)
T KOG0607|consen  322 KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP  369 (463)
T ss_pred             CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence            677788888889999999999999999999999999999999998644

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.8e-46  Score=357.68  Aligned_cols=256  Identities=30%  Similarity=0.424  Sum_probs=203.0

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC-----eEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG-----EIE  173 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~  173 (380)
                      +|++.+.||+|+||.||++.+..+++.||||++.... .......+.+|+.+++.++|+||+++++++...+     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788999999999999999998899999999986432 2233457889999999999999999999998766     789


Q ss_pred             EEEeccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-C
Q 016959          174 VLLEYMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM-D  248 (380)
Q Consensus       174 lv~e~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~  248 (380)
                      +||||+.+ +|...+    ...+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus        81 lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~  159 (372)
T cd07853          81 VVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK  159 (372)
T ss_pred             EEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence            99999975 454332    23567788999999999999999999999999999999999999999999997654322 1


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh-------------
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF-------------  315 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-------------  315 (380)
                      ......++..|+|||++.+    ...++.++||||||||+|||++|+.||......+....+.....             
T Consensus       160 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         160 HMTQEVVTQYYRAPEILMG----SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             cCCCCCcCCCcCCHHHHcC----CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence            2234568999999999853    23467789999999999999999999975433222222211100             


Q ss_pred             ------CCC---C------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          316 ------AQP---P------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       316 ------~~~---~------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                            ...   +      ......+.++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence                  000   0      12234578999999999999999999999999999999853

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.2e-46  Score=366.89  Aligned_cols=255  Identities=27%  Similarity=0.405  Sum_probs=212.6

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC-----
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG-----  170 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----  170 (380)
                      ..++|.+.+.||+|+||+||+|.+..+++.||||++.... .......+.+|+.++..++|+||+++++.+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            3468999999999999999999999999999999986543 3444567889999999999999999988765322     


Q ss_pred             ---eEEEEEeccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccc
Q 016959          171 ---EIEVLLEYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGV  239 (380)
Q Consensus       171 ---~~~lv~e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  239 (380)
                         .+++||||+.+|+|.+.+.        ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl  189 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF  189 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence               3789999999999976543        35667888999999999999999999999999999999999999999999


Q ss_pred             cccccccC--CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC
Q 016959          240 SRILAQTM--DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ  317 (380)
Q Consensus       240 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  317 (380)
                      ++.+....  ......+||+.|+|||++..     ..++.++|||||||++|||++|..||...   .............
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-----~~~s~k~DVwSlGvilyeLltG~~Pf~~~---~~~~~~~~~~~~~  261 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRR-----KPYSKKADMFSLGVLLYELLTLKRPFDGE---NMEEVMHKTLAGR  261 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCC-----CCCCcHHHHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHhcCC
Confidence            98654321  22345679999999999853     45678999999999999999999999633   3344444444444


Q ss_pred             CCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          318 PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       318 ~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ....+..++.++.+||.+||+.||++||++.++++|||++..
T Consensus       262 ~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        262 YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            556677889999999999999999999999999999998764

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-45  Score=356.54  Aligned_cols=248  Identities=24%  Similarity=0.315  Sum_probs=195.6

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ...|.+.+.||+|+||.||+|.+..+++.||||...       ...+.+|+++|++++|+|||++++++..++..++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            457999999999999999999999999999999642       2335689999999999999999999999999999999


Q ss_pred             ccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--CC
Q 016959          178 YMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD--PC  250 (380)
Q Consensus       178 ~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~  250 (380)
                      ++.+ +|..++     ...+..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.....  ..
T Consensus       241 ~~~~-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        241 KYRS-DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             ccCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence            9964 554433     235677889999999999999999999999999999999999999999999986643221  12


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC--------CHHHHHHHHhhCC-----
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG--------DWASLMFAICFAQ-----  317 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--------~~~~~~~~~~~~~-----  317 (380)
                      ....||..|+|||++.+     ..++.++||||||||||||++|..++......        .....+.......     
T Consensus       320 ~~~~GT~~Y~APE~~~~-----~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAG-----DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             cccCCCcCCcCHHHHcC-----CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            34679999999999853     45678999999999999999988765422111        1111111111100     


Q ss_pred             ------------------CC----CCC---ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 016959          318 ------------------PP----EAP---EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR  358 (380)
Q Consensus       318 ------------------~~----~~~---~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~  358 (380)
                                        .+    ..+   ..++.++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                              00    000   134568999999999999999999999999999974

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-46  Score=347.73  Aligned_cols=260  Identities=25%  Similarity=0.446  Sum_probs=206.1

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCe
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGE  171 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  171 (380)
                      ...+....|++.++||.||.++||++...+.+..++.|+.....+.....-+.+|+.+|.+|+ |.+||++++|-..++.
T Consensus       355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~  434 (677)
T KOG0596|consen  355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY  434 (677)
T ss_pred             eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence            455778899999999999999999999865555555555555567777888999999999996 9999999999988999


Q ss_pred             EEEEEeccCCCCcccccccc-----hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~~~-----~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      +|+|||+-+- +|...+...     .-.++.+..||++|+.++|..||||.||||.|+|+- .|.+||+|||+|..+...
T Consensus       435 lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  435 LYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             EEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence            9999998764 555444332     235778999999999999999999999999999997 789999999999877644


Q ss_pred             CC--CCCCCCCCCccccccccccccCC------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC
Q 016959          247 MD--PCNSAVGTIAYMSPERINTDLNH------GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP  318 (380)
Q Consensus       247 ~~--~~~~~~gt~~y~aPE~~~~~~~~------~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  318 (380)
                      ..  ...+.+||+-||+||.+......      ....++++||||||||||+|+.|+.||.     ++.+.+.++.....
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~-----~~~n~~aKl~aI~~  587 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG-----QIINQIAKLHAITD  587 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH-----HHHHHHHHHHhhcC
Confidence            32  33567899999999998543221      1124679999999999999999999995     22223333222222


Q ss_pred             ----CCCCccccHH-HHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          319 ----PEAPEMASRE-FRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       319 ----~~~~~~~~~~-~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                          .+++..-+.. +.++++.||..||++|||+.|+|+|||++..
T Consensus       588 P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  588 PNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             CCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence                2444443334 9999999999999999999999999999984

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.2e-46  Score=354.95  Aligned_cols=255  Identities=27%  Similarity=0.352  Sum_probs=200.1

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC------C
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN------G  170 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~  170 (380)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++|+||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            468999999999999999999999999999999986543 233456678899999999999999999987543      3


Q ss_pred             eEEEEEeccCCCCcccccc--cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          171 EIEVLLEYMDGGSLEGAHI--RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      .+|+||||+.++ |...+.  ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus       103 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-~  180 (364)
T cd07875         103 DVYIVMELMDAN-LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-F  180 (364)
T ss_pred             eEEEEEeCCCCC-HHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC-C
Confidence            579999999864 433322  346677889999999999999999999999999999999999999999999765432 2


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC------------
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA------------  316 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~------------  316 (380)
                      ......||..|+|||++.+     ..++.++|||||||++|+|++|+.||......+....+......            
T Consensus       181 ~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (364)
T cd07875         181 MMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  255 (364)
T ss_pred             cccCCcccCCcCCHHHHhC-----CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence            2345678999999999853     45677999999999999999999999744322211111110000            


Q ss_pred             ------CC--------------------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          317 ------QP--------------------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       317 ------~~--------------------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                            ..                    .......+.++++||.+||+.||++|||+.|+|+||||...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence                  00                    00111235678999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-46  Score=341.43  Aligned_cols=259  Identities=31%  Similarity=0.525  Sum_probs=214.8

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .++|++.+.||.|+||.||++.+..++..+|+|++.... ....+.+.+|++++++++|+||+++++.+..++..++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            467999999999999999999998899999999986543 3344678899999999999999999999999999999999


Q ss_pred             ccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          178 YMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       178 ~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      |+.+++|..++.     ..+..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++............
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  162 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT  162 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccce
Confidence            999999876643     356778899999999999999999999999999999999999999999998765544333345


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC--CCCCccccHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP--PEAPEMASREFR  330 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  330 (380)
                      ..|+..|++||++......+..++.++|+|||||++|+|++|..||...   +....+........  ...+..++.++.
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (280)
T cd06611         163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL---NPMRVLLKILKSEPPTLDQPSKWSSSFN  239 (280)
T ss_pred             eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC---CHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence            6789999999998543333455677899999999999999999999633   22233333332222  223456788999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      ++|.+||+.||++||++.++|+||||....
T Consensus       240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             HHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence            999999999999999999999999999873

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-45  Score=334.85  Aligned_cols=251  Identities=30%  Similarity=0.502  Sum_probs=208.7

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc----hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE----DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      +.|.+.+.||+|++|.||+|.+..+++.||+|.+.....    ......+.+|++++++++|+||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            468899999999999999999988999999999864321    2234568899999999999999999999999999999


Q ss_pred             EEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          175 LLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       175 v~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      |+||+.+++|.+.+.    ..+..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++..........
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            999999999876553    3566788899999999999999999999999999999999999999999987654321111


Q ss_pred             ---CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          251 ---NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       251 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                         ....|+..|+|||++.+     ..++.++|||||||++|+|++|+.||...  ..................+..++.
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  234 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISG-----EGYGRKADVWSVGCTVVEMLTEKPPWAEF--EAMAAIFKIATQPTNPQLPSHVSP  234 (263)
T ss_pred             ccccCCCcCccccCcceecc-----CCCCchhhhHHHHHHHHHHHhCCCCcccc--chHHHHHHHhccCCCCCCCccCCH
Confidence               34567889999999864     34677899999999999999999999632  222222233333344556777899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      ++.++|.+||..||++|||+.|+++|+||
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         235 DARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-45  Score=353.41  Aligned_cols=256  Identities=22%  Similarity=0.325  Sum_probs=200.8

Q ss_pred             CCcccccccceecccCCceEEEEEeC--CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHP--PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      +...+|.+.+.||+|+||.||+|...  .+++.||+|.+....      ...+|+.+|+.++|+||++++++|...+..+
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            34467999999999999999999764  356789999985432      3457999999999999999999999999999


Q ss_pred             EEEeccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-
Q 016959          174 VLLEYMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-  248 (380)
Q Consensus       174 lv~e~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-  248 (380)
                      +|||++.+ +|..++    ...+..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+..... 
T Consensus       163 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~  241 (392)
T PHA03207        163 MVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT  241 (392)
T ss_pred             EEehhcCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence            99999975 444333    235677889999999999999999999999999999999999999999999976653322 


Q ss_pred             -CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh---h---------
Q 016959          249 -PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC---F---------  315 (380)
Q Consensus       249 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~---------  315 (380)
                       ......||..|+|||++..     ..++.++|||||||++|||++|+.||...........+..+.   .         
T Consensus       242 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~  316 (392)
T PHA03207        242 PQCYGWSGTLETNSPELLAL-----DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN  316 (392)
T ss_pred             ccccccccccCccCHhHhcC-----CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence             2235679999999999853     456778999999999999999999997543322111111110   0         


Q ss_pred             --------------CCCCC--CC-----ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          316 --------------AQPPE--AP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       316 --------------~~~~~--~~-----~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                                    ...+.  .+     ..++.++.+||.+||..||++|||+.|+|.||||++.+...
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~  385 (392)
T PHA03207        317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINL  385 (392)
T ss_pred             cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhh
Confidence                          00000  00     12466889999999999999999999999999998865443

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-46  Score=340.10  Aligned_cols=252  Identities=36%  Similarity=0.600  Sum_probs=206.2

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHH-HHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEecc
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSV-RSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYM  179 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  179 (380)
                      |++++.||+|+||+||++.+..+++.||+|++........ .....+|+.++++++|+||+++++++.+....++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            6788999999999999999999999999999976654332 234456999999999999999999999999999999999


Q ss_pred             CCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCC
Q 016959          180 DGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG  255 (380)
Q Consensus       180 ~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  255 (380)
                      .+++|..++.    ..+..+..++.||+.||++||++||+|+||||+||+++.++.++|+|||++..............+
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  160 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVG  160 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999876554    467788999999999999999999999999999999999999999999999764333344456778


Q ss_pred             CCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC---CCCCCccccHHHHHH
Q 016959          256 TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ---PPEAPEMASREFRDF  332 (380)
Q Consensus       256 t~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l  332 (380)
                      +..|+|||++.    .+..++.++||||||+++|+|++|..||......+............   ..........++.++
T Consensus       161 ~~~y~aPE~~~----~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  236 (260)
T PF00069_consen  161 TPEYMAPEVLQ----QGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDL  236 (260)
T ss_dssp             SGGGSCHHHHT----TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred             ccccccccccc----ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHH
Confidence            99999999985    24666789999999999999999999997442222222222222111   111111224799999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccc
Q 016959          333 ISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       333 i~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      |.+||+.||++||++.|+++||||
T Consensus       237 i~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  237 IKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-46  Score=338.51  Aligned_cols=256  Identities=35%  Similarity=0.539  Sum_probs=216.5

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      ++|++.+.||.|+||.||+|.+..+++.||+|++...........+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888999999999999999999999999999986554444456788999999999999999999999999999999999


Q ss_pred             cCCCCccccccc---chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCC
Q 016959          179 MDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG  255 (380)
Q Consensus       179 ~~~~~L~~~~~~---~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  255 (380)
                      +.+++|.+++..   .+..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++.+...........+
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  160 (274)
T cd06609          81 CGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVG  160 (274)
T ss_pred             eCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccC
Confidence            999998766543   57778899999999999999999999999999999999999999999999877654334455678


Q ss_pred             CCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc-ccHHHHHHHH
Q 016959          256 TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM-ASREFRDFIS  334 (380)
Q Consensus       256 t~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~  334 (380)
                      +..|+|||++..     ..++.++|||||||++|+|++|..||.....   ............+..... ++.++.+++.
T Consensus       161 ~~~y~~PE~~~~-----~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  232 (274)
T cd06609         161 TPFWMAPEVIKQ-----SGYDEKADIWSLGITAIELAKGEPPLSDLHP---MRVLFLIPKNNPPSLEGNKFSKPFKDFVS  232 (274)
T ss_pred             CccccChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCcccCch---HHHHHHhhhcCCCCCcccccCHHHHHHHH
Confidence            999999999853     3477899999999999999999999964332   222233333334444444 7889999999


Q ss_pred             HhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          335 RCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       335 ~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      +||..||++|||++++++||||++....
T Consensus       233 ~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         233 LCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             HHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence            9999999999999999999999986554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-46  Score=354.08  Aligned_cols=255  Identities=25%  Similarity=0.368  Sum_probs=201.8

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC------C
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRN------G  170 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~  170 (380)
                      .++|++.+.||+|+||+||+|.+..+++.||||++..... ......+.+|+.+++.++|+||++++++|...      .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            4789999999999999999999999999999999865432 23345677899999999999999999987543      4


Q ss_pred             eEEEEEeccCCCCccccc---ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          171 EIEVLLEYMDGGSLEGAH---IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      .+|++++++ +++|....   ...+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        94 ~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-  171 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-  171 (343)
T ss_pred             cEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC-
Confidence            578999988 56665443   3467788899999999999999999999999999999999999999999999866432 


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC----------
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ----------  317 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----------  317 (380)
                        .....||..|+|||++.+    ...++.++|||||||++|+|++|..||......+....+.......          
T Consensus       172 --~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         172 --MTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             --cCCccccccccCchHhcC----CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence              345679999999999853    2456778999999999999999999996433222111111110000          


Q ss_pred             ---------CCC--------CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          318 ---------PPE--------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       318 ---------~~~--------~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                               .+.        .....++.+.+||.+||+.||++|||+.|+|+||||....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence                     000        1123456789999999999999999999999999998754

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.3e-46  Score=353.66  Aligned_cols=255  Identities=27%  Similarity=0.352  Sum_probs=200.1

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC------C
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN------G  170 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~  170 (380)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++|+||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            468999999999999999999999999999999986543 334456778899999999999999999988643      3


Q ss_pred             eEEEEEeccCCCCcccccc--cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          171 EIEVLLEYMDGGSLEGAHI--RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ..++||||+.++ |...+.  ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus        96 ~~~lv~e~~~~~-l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~-~  173 (355)
T cd07874          96 DVYLVMELMDAN-LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-F  173 (355)
T ss_pred             eeEEEhhhhccc-HHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc-c
Confidence            579999999875 333222  356667889999999999999999999999999999999999999999999865433 2


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh-------------
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF-------------  315 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-------------  315 (380)
                      ......||..|+|||++.+     ..++.++|||||||++|+|++|+.||......+..........             
T Consensus       174 ~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (355)
T cd07874         174 MMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_pred             ccCCccccCCccCHHHHcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence            2345678999999999853     4567789999999999999999999974332111111000000             


Q ss_pred             ------C-------------------CCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          316 ------A-------------------QPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       316 ------~-------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                            .                   .........+.++++||.+||+.||++|||+.|+|+||||...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                  0                   0001122245688999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.2e-45  Score=338.74  Aligned_cols=261  Identities=30%  Similarity=0.529  Sum_probs=213.9

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +-|++.+.||+|+||.||++.+..++..+++|.+.... ......+.+|+++++.++|+||+++++++..++..++|+||
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            34688899999999999999999999999999985443 33456688899999999999999999999999999999999


Q ss_pred             cCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          179 MDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       179 ~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      +.+++|...+.     ..+..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.............
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence            99999865432     3567788999999999999999999999999999999999999999999987664433334456


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC--CCCCCccccHHHHH
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ--PPEAPEMASREFRD  331 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  331 (380)
                      .++..|+|||++......+..++.++|||||||++|+|++|..||....   ............  ....+..++.++.+
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN---PMRVLLKIAKSEPPTLAQPSRWSSEFKD  240 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC---HHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence            7899999999985433345566789999999999999999999996432   222222222222  22345567889999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          332 FISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       332 li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                      ||.+||..||++||++.++++||||+......
T Consensus       241 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  272 (282)
T cd06643         241 FLKKCLEKNVDARWTTTQLLQHPFVTVNSNKP  272 (282)
T ss_pred             HHHHHccCChhhCcCHHHHhcCCCEeccCCCC
Confidence            99999999999999999999999999864433

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-47  Score=340.42  Aligned_cols=273  Identities=26%  Similarity=0.394  Sum_probs=230.5

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCe
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  171 (380)
                      .+...+|..+.+||+|+||+|.++..+++.+.||||+++++-  ++...+--..|-++|... +-|.+++++.+|..-++
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            356678999999999999999999999999999999997763  222234445677777665 47899999999999999


Q ss_pred             EEEEEeccCCCCcccc----cccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          172 IEVLLEYMDGGSLEGA----HIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      +|+||||+.||+|.-.    ....|....-++.+|+-||-|||++||++||||.+|||+|.+|++||+|||+++.-....
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~  504 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG  504 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence            9999999999998544    445788888899999999999999999999999999999999999999999998765555


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                      ....+.+||+.|+|||++.     -..|+.++|+||+||+||||+.|+.||...+.++.    ..........+|..++.
T Consensus       505 ~TTkTFCGTPdYiAPEIi~-----YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el----F~aI~ehnvsyPKslSk  575 (683)
T KOG0696|consen  505 VTTKTFCGTPDYIAPEIIA-----YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL----FQAIMEHNVSYPKSLSK  575 (683)
T ss_pred             cceeeecCCCcccccceEE-----ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHHHccCcCcccccH
Confidence            5668899999999999984     35667889999999999999999999974443333    33333445678889999


Q ss_pred             HHHHHHHHhcccCcCCCCC-----HHHHhcCccccccCcccccccccccCCCCCCC
Q 016959          328 EFRDFISRCLQKDPHSRWP-----AAQLLQHPFILRAGQSQVNQNLRQILPPPRPL  378 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  378 (380)
                      ++.++.+..|.+.|.+|+.     -.+|-+||||+.+.|.....  +++-||+||-
T Consensus       576 EAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~--~eiqPPfkPk  629 (683)
T KOG0696|consen  576 EAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLER--REIQPPFKPK  629 (683)
T ss_pred             HHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhh--ccCCCCCCCc
Confidence            9999999999999999986     47899999999999988765  7888888873

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.3e-46  Score=341.88  Aligned_cols=250  Identities=29%  Similarity=0.459  Sum_probs=194.1

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhC---CCCceeeeEeEEee-----CC
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDV---NHPNVVKCHDMYDR-----NG  170 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~-----~~  170 (380)
                      +|++.+.||+|+||+||+|.+..+++.||+|.+..... ......+.+|+.+++.+   +|+||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            47888999999999999999999999999999864322 12223455677776655   79999999998764     34


Q ss_pred             eEEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      .++++||++.+ +|..++.      ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            58999999986 5543322      3567788999999999999999999999999999999999999999999998664


Q ss_pred             ccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC-C-----
Q 016959          245 QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ-P-----  318 (380)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~-----  318 (380)
                      .. .......|+..|+|||++..     ..++.++|||||||++|+|++|..||......+....+....... .     
T Consensus       160 ~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         160 CQ-MALTPVVVTLWYRAPEVLLQ-----STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             Cc-ccCCCccccccccCchHhhC-----CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            33 22244568999999999853     456779999999999999999999996443322222222211000 0     


Q ss_pred             -----------------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          319 -----------------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       319 -----------------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                                       ......++..+.+||.+||+.||++|||+.|++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                             01123467789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.2e-46  Score=346.82  Aligned_cols=245  Identities=27%  Similarity=0.468  Sum_probs=186.2

Q ss_pred             cceecccCCceEEEEEeC--CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee--CCeEEEEEecc
Q 016959          104 GNRIGSGSGGTVWRVVHP--PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR--NGEIEVLLEYM  179 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~  179 (380)
                      +++||+|+||+||+|.+.  .+++.||+|.+.....   ...+.+|+.++++++|+||++++++|..  +..++++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            568999999999999965  4678999999854432   2346789999999999999999998854  45689999999


Q ss_pred             CCCCccccc-------------ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----cCCCcEEEeecccccc
Q 016959          180 DGGSLEGAH-------------IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI----NSSKNVKIADFGVSRI  242 (380)
Q Consensus       180 ~~~~L~~~~-------------~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~----~~~~~~kl~Dfg~a~~  242 (380)
                      .+ +|..++             ..++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||++..
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            75 442221             24566788999999999999999999999999999999    4567899999999987


Q ss_pred             ccccCC---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC---------HHHHH
Q 016959          243 LAQTMD---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD---------WASLM  310 (380)
Q Consensus       243 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---------~~~~~  310 (380)
                      +.....   ......||+.|+|||++.+    ...++.++|||||||++|+|++|+.||.......         ....+
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  237 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcC----CCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence            653321   2345678999999999853    2456778999999999999999999996432210         00001


Q ss_pred             HHHhhCCC----------C------------------------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          311 FAICFAQP----------P------------------------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       311 ~~~~~~~~----------~------------------------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      ........          +                        ......+.++.+||.+||+.||++|+|++|+|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            00000000          0                        0011235578999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1e-45  Score=343.53  Aligned_cols=257  Identities=40%  Similarity=0.711  Sum_probs=209.5

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      ++|++.++||+|+||.||++.+..++..+|+|.+...........+.+|++++++++|+||++++++|..++.+++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36899999999999999999999999999999987655555667788999999999999999999999999999999999


Q ss_pred             cCCCCccccccc----chHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          179 MDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHK-RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       179 ~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      +.+++|.+++..    .+..+..++.||+.||.|||+ .+++|+||||+|||++.++.+||+|||++.......  ....
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~  158 (308)
T cd06615          81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSF  158 (308)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc--cccC
Confidence            999999777543    566788999999999999998 599999999999999999999999999987654322  2456


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHH----------------------
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMF----------------------  311 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~----------------------  311 (380)
                      .|+..|+|||++.     +..++.++|+|||||++|+|++|..||.............                      
T Consensus       159 ~~~~~~~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         159 VGTRSYMSPERLQ-----GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             CCCcCccChhHhc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence            7899999999874     3446778999999999999999999996433222111110                      


Q ss_pred             -----------HHhhCCCCCCC-ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          312 -----------AICFAQPPEAP-EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       312 -----------~~~~~~~~~~~-~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                                 .......+..+ ..++.++++||.+||..||++|||+.|+++||||.+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  296 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE  296 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence                       00011111111 2367789999999999999999999999999999875433

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1e-45  Score=337.02  Aligned_cols=254  Identities=30%  Similarity=0.500  Sum_probs=205.0

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeC------Ce
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRN------GE  171 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~------~~  171 (380)
                      +.|++.+.||+|+||+||+|.+..+++.||+|++.....  ....+..|+.+++++ +|+||+++++++...      ..
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            568889999999999999999999999999999865432  235678899999998 699999999998652      46


Q ss_pred             EEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      ++++|||+.+++|.+++.      ..+..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+..
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~  163 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  163 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence            899999999999876533      24666788999999999999999999999999999999999999999999987654


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                      .........|+..|+|||++......+..++.++|||||||++|||++|..||.....  ...................+
T Consensus       164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06637         164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--MRALFLIPRNPAPRLKSKKW  241 (272)
T ss_pred             ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH--HHHHHHHhcCCCCCCCCCCc
Confidence            4334455678999999999854322344567799999999999999999999963221  11111111122222334457


Q ss_pred             cHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      +.++.+||.+||..||.+|||+.|++.||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         242 SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            8899999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-45  Score=344.20  Aligned_cols=267  Identities=30%  Similarity=0.438  Sum_probs=217.5

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCch--HHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED--SVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+......  .....+.+|+++++.++|+||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            3688899999999999999999989999999999655432  34567889999999999999999999999999999999


Q ss_pred             eccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--
Q 016959          177 EYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD--  248 (380)
Q Consensus       177 e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--  248 (380)
                      ||+.+++|.+++.      ..+..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            9999999976643      34567888999999999999999999999999999999999999999999875432111  


Q ss_pred             ---------------------------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 016959          249 ---------------------------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVG  301 (380)
Q Consensus       249 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  301 (380)
                                                 ......|+..|+|||++.+     ..++.++||||||+++|+|++|..||...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-----DGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-----CCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence                                       1123468899999999853     45677999999999999999999999643


Q ss_pred             CCCCHHHHHHHHhhCCCCCCC--ccccHHHHHHHHHhcccCcCCCCC----HHHHhcCccccccCcccccccccccCCC
Q 016959          302 RQGDWASLMFAICFAQPPEAP--EMASREFRDFISRCLQKDPHSRWP----AAQLLQHPFILRAGQSQVNQNLRQILPP  374 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~t----~~eil~hp~~~~~~~~~~~~~~~~~~~~  374 (380)
                      ...   ....... ......+  ..++.+++++|.+||..||++|||    ++|+|.||||+...+.......++.+|.
T Consensus       236 ~~~---~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~  310 (316)
T cd05574         236 NRD---ETFSNIL-KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPR  310 (316)
T ss_pred             chH---HHHHHHh-cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCCCCCC
Confidence            322   2222222 1122222  236889999999999999999999    9999999999999888887755555544

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.2e-45  Score=338.32  Aligned_cols=256  Identities=29%  Similarity=0.417  Sum_probs=215.7

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++|++.+.||+|+||.||++.+..+++.||+|++....  .....+.+.+|++++++++|+||+++++++.+++.+++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888999999999999999999999999999986432  2234567889999999999999999999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      ||+.+++|.+++.    ..+..+..++.||+.||.|||++||+|+||+|+|||++.++.+||+|||++......   ...
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~~  157 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TYT  157 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CCC
Confidence            9999999876643    356678889999999999999999999999999999999999999999999876543   345


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      ..|++.|+|||.+..     ..++.++||||||+++|+|++|..||....   ......... ......+..++..++++
T Consensus       158 ~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~-~~~~~~~~~~~~~l~~l  228 (290)
T cd05580         158 LCGTPEYLAPEIILS-----KGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYEKIL-EGKVRFPSFFSPDAKDL  228 (290)
T ss_pred             CCCCccccChhhhcC-----CCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHh-cCCccCCccCCHHHHHH
Confidence            578999999998853     345678999999999999999999996433   222222222 33445666778999999


Q ss_pred             HHHhcccCcCCCC-----CHHHHhcCccccccCcccccc
Q 016959          333 ISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQ  366 (380)
Q Consensus       333 i~~~l~~dp~~R~-----t~~eil~hp~~~~~~~~~~~~  366 (380)
                      |.+||..||++|+     +++|+++||||....+....+
T Consensus       229 i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~  267 (290)
T cd05580         229 IRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQ  267 (290)
T ss_pred             HHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhh
Confidence            9999999999999     999999999999998776643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.5e-45  Score=338.21  Aligned_cols=252  Identities=27%  Similarity=0.442  Sum_probs=199.9

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +|.+.+.||+|+||.||+|.+..++..||||++.... .......+.+|+.+++.++|+||+++++++.+++.+++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999999899999999986443 223345678899999999999999999999999999999999


Q ss_pred             cCCCCccccc-------ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCC
Q 016959          179 MDGGSLEGAH-------IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       179 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      +.+ +|..++       ...+..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...........
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  159 (285)
T cd07861          81 LSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT  159 (285)
T ss_pred             CCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence            984 554332       235677888999999999999999999999999999999999999999999876544333334


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh-----------------
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC-----------------  314 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-----------------  314 (380)
                      ...++..|+|||++.+    ...++.++|||||||++|+|++|+.||......+.........                 
T Consensus       160 ~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         160 HEVVTLWYRAPEVLLG----SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             CCcccccccChHHhcC----CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence            4567899999998753    2345678999999999999999999996432211111100000                 


Q ss_pred             -h-------CCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          315 -F-------AQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       315 -~-------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                       .       .........++.++.+||.+||+.||++|||+.|+++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence             0       00001123478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.2e-45  Score=335.47  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=203.0

Q ss_pred             eecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHHHHHHHHHHH---hCCCCceeeeEeEEeeCCeEEEEEeccC
Q 016959          106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQICREIEILR---DVNHPNVVKCHDMYDRNGEIEVLLEYMD  180 (380)
Q Consensus       106 ~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~E~~~l~---~l~h~~iv~~~~~~~~~~~~~lv~e~~~  180 (380)
                      .||+|+||.||++.+..+++.||+|.+.....  ........+|..+++   ..+|+||+.+++.+..++..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999999999999999999865431  111223334444433   3479999999999999999999999999


Q ss_pred             CCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCC
Q 016959          181 GGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT  256 (380)
Q Consensus       181 ~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  256 (380)
                      +++|..++.    ..+..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++.......  .....|+
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~  158 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGT  158 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--ccCcCCC
Confidence            999965543    3567788999999999999999999999999999999999999999999987554322  2345689


Q ss_pred             CccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHh
Q 016959          257 IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC  336 (380)
Q Consensus       257 ~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  336 (380)
                      ..|+|||.+..    +..++.++|+|||||++|+|++|..||......... .............+..++.++.++|.+|
T Consensus       159 ~~y~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~  233 (279)
T cd05633         159 HGYMAPEVLQK----GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTVNVELPDSFSPELKSLLEGL  233 (279)
T ss_pred             cCccCHHHhcC----CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcCCcCCccccCHHHHHHHHHH
Confidence            99999998742    345677899999999999999999999754433332 2333333445566777899999999999


Q ss_pred             cccCcCCCC-----CHHHHhcCccccccCcccc
Q 016959          337 LQKDPHSRW-----PAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       337 l~~dp~~R~-----t~~eil~hp~~~~~~~~~~  364 (380)
                      |+.||++|+     ++.|+++||||++.++.+.
T Consensus       234 l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~  266 (279)
T cd05633         234 LQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV  266 (279)
T ss_pred             hcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence            999999999     6999999999999887665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.2e-45  Score=329.47  Aligned_cols=249  Identities=27%  Similarity=0.497  Sum_probs=207.8

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEee-CCeEEEEEe
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDR-NGEIEVLLE  177 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e  177 (380)
                      .|++.+.||+|++|.||++.+..+++.||+|.+.... .....+.+.+|++++++++|+|++++++.+.. +..++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788999999999999999999899999999986433 33445678899999999999999999998764 456899999


Q ss_pred             ccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCC
Q 016959          178 YMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       178 ~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      |+.+++|.+++.      ..+..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++...........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  160 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS  160 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence            999999865542      35677889999999999999999999999999999999999999999999987654433344


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD  331 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (380)
                      ...|++.|+|||++..     ..++.++|+|||||++|+|++|+.||...   +.............+..+..++.++.+
T Consensus       161 ~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (257)
T cd08223         161 TLIGTPYYMSPELFSN-----KPYNYKSDVWALGCCVYEMATLKHAFNAK---DMNSLVYRIIEGKLPPMPKDYSPELGE  232 (257)
T ss_pred             cccCCcCccChhHhcC-----CCCCchhhhHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhcCCCCCccccCHHHHH
Confidence            5678999999999853     45667899999999999999999999633   233333333334444566778899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccc
Q 016959          332 FISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       332 li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      +|.+||+.||++|||+.|+++||||
T Consensus       233 li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         233 LIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.8e-45  Score=330.05  Aligned_cols=249  Identities=32%  Similarity=0.538  Sum_probs=210.6

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +|.+.+.||+|+||.||+|.+..+++.|++|.+.... .......+.+|+++++.++|+||+++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999999999999999986432 344567788999999999999999999999999999999999


Q ss_pred             cCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          179 MDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       179 ~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      +.+++|.+++..      .+..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+.........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~  160 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT  160 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence            999998766433      35667889999999999999999999999999999999999999999998876554333345


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      ..|+..|+|||++..     ..++.++|+|||||++|+|++|..||....   .............+..+..++.++.++
T Consensus       161 ~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (256)
T cd08529         161 IVGTPYYLSPELCED-----KPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKIIRGVFPPVSQMYSQQLAQL  232 (256)
T ss_pred             cccCccccCHHHhcC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCccccCHHHHHH
Confidence            578999999999853     445678999999999999999999997433   233333444444455555788999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccc
Q 016959          333 ISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       333 i~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      |.+||+.+|++||++.|+++|||+
T Consensus       233 i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         233 IDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.2e-45  Score=338.29  Aligned_cols=257  Identities=31%  Similarity=0.518  Sum_probs=211.9

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+....... .+.+.+|+.+++.++|+||+++++.|..+...++|||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch-HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            368999999999999999999999899999999986544333 4668899999999999999999999999999999999


Q ss_pred             ccCCCCccccccc---chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCC
Q 016959          178 YMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV  254 (380)
Q Consensus       178 ~~~~~~L~~~~~~---~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (380)
                      |+.+++|..++..   .+..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..............
T Consensus        98 ~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~  177 (296)
T cd06654          98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV  177 (296)
T ss_pred             ccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCccc
Confidence            9999999876543   4567888999999999999999999999999999999999999999999876544333334457


Q ss_pred             CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh-hCCCCCCCccccHHHHHHH
Q 016959          255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC-FAQPPEAPEMASREFRDFI  333 (380)
Q Consensus       255 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li  333 (380)
                      |+..|+|||.+..     ..++.++|||||||++|+|++|..||.......  ....... .......+..++..+.+||
T Consensus       178 ~~~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li  250 (296)
T cd06654         178 GTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLIATNGTPELQNPEKLSAIFRDFL  250 (296)
T ss_pred             CCccccCHHHHcC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHHHhcCCCCCCCCccccCHHHHHHH
Confidence            8999999998853     445679999999999999999999996433221  1111111 1112234556788999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          334 SRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       334 ~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      .+||..||++|||+.|+++||||......
T Consensus       251 ~~~l~~~p~~Rpt~~eil~~~~~~~~~~~  279 (296)
T cd06654         251 NRCLDMDVEKRGSAKELLQHQFLKIAKPL  279 (296)
T ss_pred             HHHCcCCcccCcCHHHHhhChhhhccCCc
Confidence            99999999999999999999999876443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-47  Score=357.22  Aligned_cols=250  Identities=35%  Similarity=0.530  Sum_probs=220.6

Q ss_pred             eecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCCCcc
Q 016959          106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLE  185 (380)
Q Consensus       106 ~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  185 (380)
                      +||+|+||+||.|++..+....|||.+..... ....-+.+||.+.+.|+|.|||+++|.+.+++.+-|.||.++||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            59999999999999999999999999854433 33456789999999999999999999999999999999999999997


Q ss_pred             ccccc-------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCcEEEeeccccccccccCCCCCCCCCCC
Q 016959          186 GAHIR-------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN-SSKNVKIADFGVSRILAQTMDPCNSAVGTI  257 (380)
Q Consensus       186 ~~~~~-------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  257 (380)
                      .++..       .|..+..+.+||++||.|||++.|||||||-+||||+ -.|.+||.|||.++++..-.....++.||.
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTL  740 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTL  740 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccch
Confidence            66543       4667788999999999999999999999999999997 578899999999999987777778899999


Q ss_pred             ccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhc
Q 016959          258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL  337 (380)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  337 (380)
                      .|||||+|..   ....|+.++|||||||++.||.||+.||-. -......+.+...+..-++.|..++.+++.||.+|+
T Consensus       741 QYMAPEvIDq---G~RGYG~aADIWS~GCT~vEMATGrPPF~E-lgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF  816 (1226)
T KOG4279|consen  741 QYMAPEVIDQ---GPRGYGKAADIWSFGCTMVEMATGRPPFVE-LGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF  816 (1226)
T ss_pred             hhhChHhhcc---CCcCCCchhhhhhccceeEeeccCCCCeee-cCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence            9999999964   245678899999999999999999999952 233455666667778889999999999999999999


Q ss_pred             ccCcCCCCCHHHHhcCccccccC
Q 016959          338 QKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       338 ~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      .+||.+||++.++|.+||++..+
T Consensus       817 epd~~~R~sA~~LL~DpFlq~~~  839 (1226)
T KOG4279|consen  817 EPDPCDRPSAKDLLQDPFLQHNN  839 (1226)
T ss_pred             CCCcccCccHHHhccCcccccCC
Confidence            99999999999999999999873

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.8e-45  Score=334.52  Aligned_cols=254  Identities=26%  Similarity=0.396  Sum_probs=209.6

Q ss_pred             ecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCCCc
Q 016959          107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL  184 (380)
Q Consensus       107 LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  184 (380)
                      ||+|+||+||+|.+..+|+.||+|++....  .......+.+|+++++.++|+||+++++++...+.+|+||||+.+++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999999999999999986432  122344567899999999999999999999999999999999999998


Q ss_pred             ccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCCc
Q 016959          185 EGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIA  258 (380)
Q Consensus       185 ~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~  258 (380)
                      ..++.      ..+..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++...... .......++..
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~  159 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPG  159 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCCCC
Confidence            65532      346677889999999999999999999999999999999999999999998765432 22344568889


Q ss_pred             cccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcc
Q 016959          259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ  338 (380)
Q Consensus       259 y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  338 (380)
                      |+|||++..     ..++.++|||||||++|+|++|+.||...........+...........+..++.++.++|.+||+
T Consensus       160 y~~PE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  234 (277)
T cd05577         160 YMAPEVLQG-----EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQ  234 (277)
T ss_pred             cCCHHHhcC-----CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHcc
Confidence            999999853     336778999999999999999999997544322222333333344555667789999999999999


Q ss_pred             cCcCCCC-----CHHHHhcCccccccCcccccc
Q 016959          339 KDPHSRW-----PAAQLLQHPFILRAGQSQVNQ  366 (380)
Q Consensus       339 ~dp~~R~-----t~~eil~hp~~~~~~~~~~~~  366 (380)
                      .||++|+     ++.++++||||.+.++.+...
T Consensus       235 ~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~  267 (277)
T cd05577         235 KDPEKRLGCRGGSADEVREHPLFKDLNWRRLEA  267 (277)
T ss_pred             CChhHccCCCcccHHHHHhChhhhcCChhhhhc
Confidence            9999999     889999999999999877754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.1e-45  Score=333.64  Aligned_cols=256  Identities=34%  Similarity=0.546  Sum_probs=215.7

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +.|+..+.||.|+||.||+|.+..++..||+|++...........+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45788899999999999999999899999999987655455567889999999999999999999999999999999999


Q ss_pred             cCCCCccccccc---chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCC
Q 016959          179 MDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG  255 (380)
Q Consensus       179 ~~~~~L~~~~~~---~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  255 (380)
                      +.+++|.+++..   .+..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++..+...........+
T Consensus        84 ~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  163 (277)
T cd06640          84 LGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVG  163 (277)
T ss_pred             CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccC
Confidence            999998766543   45677889999999999999999999999999999999999999999999776544333344568


Q ss_pred             CCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHH
Q 016959          256 TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISR  335 (380)
Q Consensus       256 t~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  335 (380)
                      +..|+|||++..     ...+.++|+|||||++|||++|..||.....   ............+..+..++..+.++|.+
T Consensus       164 ~~~y~apE~~~~-----~~~~~~~Dv~slG~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~  235 (277)
T cd06640         164 TPFWMAPEVIQQ-----SAYDSKADIWSLGITAIELAKGEPPNSDMHP---MRVLFLIPKNNPPTLTGEFSKPFKEFIDA  235 (277)
T ss_pred             cccccCHhHhcc-----CCCccHHHHHHHHHHHHHHHHCCCCCCCcCh---HhHhhhhhcCCCCCCchhhhHHHHHHHHH
Confidence            899999999853     4567799999999999999999999964322   22222233333455566678899999999


Q ss_pred             hcccCcCCCCCHHHHhcCccccccCcc
Q 016959          336 CLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       336 ~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      ||+.||++||++.+++.|+||......
T Consensus       236 ~l~~~p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06640         236 CLNKDPSFRPTAKELLKHKFIVKNAKK  262 (277)
T ss_pred             HcccCcccCcCHHHHHhChHhhhcchh
Confidence            999999999999999999999887654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.9e-45  Score=330.16  Aligned_cols=256  Identities=53%  Similarity=0.885  Sum_probs=222.1

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEecc
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYM  179 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  179 (380)
                      +|++.+.||+|++|.||+|.+..+++.||||++...........+.+|+..+++++|+||+++++++...+..++||||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            68889999999999999999999999999999876654455678999999999999999999999999999999999999


Q ss_pred             CCCCcccccc----cchHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCC
Q 016959          180 DGGSLEGAHI----RQEHILSDLARQVLSGLAYLHK-RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV  254 (380)
Q Consensus       180 ~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (380)
                      .+++|.+++.    ..+..+..++.||+.||.|||+ +|++|+||+|+||+++.++.++|+|||++..............
T Consensus        82 ~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~  161 (264)
T cd06623          82 DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV  161 (264)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccccee
Confidence            9999977654    3677788999999999999999 9999999999999999999999999999987755444334566


Q ss_pred             CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc-ccHHHHHHH
Q 016959          255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM-ASREFRDFI  333 (380)
Q Consensus       255 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li  333 (380)
                      ++..|+|||.+..     ..++.++|+||||+++|+|++|..||..............+........... ++..+.++|
T Consensus       162 ~~~~y~~pE~~~~-----~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  236 (264)
T cd06623         162 GTVTYMSPERIQG-----ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFI  236 (264)
T ss_pred             ecccccCHhhhCC-----CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence            8899999999853     4567799999999999999999999975544455666666665555566666 889999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCccccccC
Q 016959          334 SRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       334 ~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      .+||..+|++||++.|+++||||+..+
T Consensus       237 ~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         237 SACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             HHHccCChhhCCCHHHHHhCHHHHhcc
Confidence            999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3e-45  Score=333.16  Aligned_cols=255  Identities=31%  Similarity=0.457  Sum_probs=206.1

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|+++..... ....+.+|+.+++.++|+||+++++.+...+.+++||
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            346899999999999999999999999999999998655332 3356788999999999999999999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      ||+.+++|.+++.    ..+..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++............
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd06645          86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS  165 (267)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccccc
Confidence            9999999976543    357788899999999999999999999999999999999999999999998766544333345


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCC--CccccHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA--PEMASREFR  330 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  330 (380)
                      ..|+..|+|||++...  ....++.++|+|||||++|+|++|..||............... ....+..  ...++..+.
T Consensus       166 ~~~~~~y~aPE~~~~~--~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  242 (267)
T cd06645         166 FIGTPYWMAPEVAAVE--RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS-NFQPPKLKDKMKWSNSFH  242 (267)
T ss_pred             ccCcccccChhhhccc--cCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc-CCCCCcccccCCCCHHHH
Confidence            6799999999997421  1234567899999999999999999999643322111111111 1111111  123677899


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCcc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPF  355 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~  355 (380)
                      ++|.+||..||++|||++++++|||
T Consensus       243 ~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         243 HFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHccCCchhCcCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-45  Score=346.52  Aligned_cols=249  Identities=22%  Similarity=0.307  Sum_probs=193.8

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      +...+|.+.+.||+|+||.||+|.+..+++.||+|+....       ....|+.+++.++|+||+++++++...+..++|
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            3445799999999999999999999999999999985332       234689999999999999999999999999999


Q ss_pred             EeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          176 LEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       176 ~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      ||++.+ +|..++.     ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus       136 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~  213 (357)
T PHA03209        136 LPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAF  213 (357)
T ss_pred             EEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-ccc
Confidence            999975 5544332     356778899999999999999999999999999999999999999999998754322 222


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCH-----------HHHHHHHhhCCCC
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDW-----------ASLMFAICFAQPP  319 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-----------~~~~~~~~~~~~~  319 (380)
                      ....||..|+|||++..     ..++.++|||||||++|||+++..++........           ...+.... ..+.
T Consensus       214 ~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~~  287 (357)
T PHA03209        214 LGLAGTVETNAPEVLAR-----DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK-VHPE  287 (357)
T ss_pred             ccccccccccCCeecCC-----CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhc-cChh
Confidence            45679999999999853     4567899999999999999986555532211110           00010000 0011


Q ss_pred             CCC------------------------------ccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          320 EAP------------------------------EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       320 ~~~------------------------------~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      .++                              ..++.++.+||.+||+.||++|||+.|+|+||||+.+
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            111                              1345678889999999999999999999999999863

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2e-48  Score=337.03  Aligned_cols=257  Identities=35%  Similarity=0.544  Sum_probs=219.1

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +-|.++.+||+|+||.||++.++.+|..+|||.+..+.   ...++..|+.+++.++.+++|++||.|.....+|+||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            45888999999999999999999999999999985443   345677899999999999999999999888999999999


Q ss_pred             cCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          179 MDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       179 ~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      |..|++.+.++.     .+..+..+++..+.||+|||...-+|||||..|||++.+|+.||+|||.|..+.+.....++.
T Consensus       110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTV  189 (502)
T KOG0574|consen  110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTV  189 (502)
T ss_pred             cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCcc
Confidence            999998766443     577788899999999999999999999999999999999999999999999999888888899


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC--CCccccHHHHH
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--APEMASREFRD  331 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  331 (380)
                      .||+.|||||++..     -.|..++||||||++..||..|+.||.....   ...+..+--..++.  .|+..+.++-|
T Consensus       190 IGTPFWMAPEVI~E-----IGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---MRAIFMIPT~PPPTF~KPE~WS~~F~D  261 (502)
T KOG0574|consen  190 IGTPFWMAPEVIEE-----IGYDTKADIWSLGITAIEMAEGRPPYSDIHP---MRAIFMIPTKPPPTFKKPEEWSSEFND  261 (502)
T ss_pred             ccCcccccHHHHHH-----hccchhhhHhhhcchhhhhhcCCCCcccccc---cceeEeccCCCCCCCCChHhhhhHHHH
Confidence            99999999999964     4556789999999999999999999963222   11222222222222  34557889999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccccccCcccccc
Q 016959          332 FISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQ  366 (380)
Q Consensus       332 li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~  366 (380)
                      ||++||.++|++|.|+.++++|||++.+....+.+
T Consensus       262 Fi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~  296 (502)
T KOG0574|consen  262 FIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQ  296 (502)
T ss_pred             HHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHH
Confidence            99999999999999999999999999987665543

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.2e-45  Score=336.92  Aligned_cols=253  Identities=32%  Similarity=0.552  Sum_probs=211.2

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      ..|++.+.||.|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++|+||+++++++...+.+++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            5699999999999999999999999999999998654333 346788999999999999999999999999999999999


Q ss_pred             cCCCCccccccc---chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCC
Q 016959          179 MDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG  255 (380)
Q Consensus       179 ~~~~~L~~~~~~---~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  255 (380)
                      +.+++|..++..   .+..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++..............|
T Consensus        98 ~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  177 (296)
T cd06655          98 LAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVG  177 (296)
T ss_pred             cCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCC
Confidence            999998765443   56778899999999999999999999999999999999999999999998766544333344578


Q ss_pred             CCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh--hCCCCCCCccccHHHHHHH
Q 016959          256 TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC--FAQPPEAPEMASREFRDFI  333 (380)
Q Consensus       256 t~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li  333 (380)
                      +..|+|||.+..     ..++.++|+|||||++|+|++|..||.....   ........  .......+..++..+.+||
T Consensus       178 ~~~y~aPE~~~~-----~~~~~~~Dv~slGvil~~lltg~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li  249 (296)
T cd06655         178 TPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMVEGEPPYLNENP---LRALYLIATNGTPELQNPEKLSPIFRDFL  249 (296)
T ss_pred             CccccCcchhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCcccCCcccCCHHHHHHH
Confidence            999999998853     4456789999999999999999999964332   22222221  1122234566888999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCccccccC
Q 016959          334 SRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       334 ~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      .+||..||++|||+.+++.||||+...
T Consensus       250 ~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         250 NRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             HHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.6e-45  Score=348.50  Aligned_cols=253  Identities=23%  Similarity=0.346  Sum_probs=203.5

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCC-----CcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEE
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPT-----SRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMY  166 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~  166 (380)
                      .+.+..++|++.+.||+|+||.||+|++...     +..||||++...........+.+|+.+++.+ +|+||+++++++
T Consensus        32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            3456778999999999999999999986443     3579999997665555567788999999999 899999999999


Q ss_pred             eeCCeEEEEEeccCCCCcccccc---------------------------------------------------------
Q 016959          167 DRNGEIEVLLEYMDGGSLEGAHI---------------------------------------------------------  189 (380)
Q Consensus       167 ~~~~~~~lv~e~~~~~~L~~~~~---------------------------------------------------------  189 (380)
                      ...+..++|||||.+|+|.+++.                                                         
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            99999999999999999865542                                                         


Q ss_pred             -----------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--CC
Q 016959          190 -----------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD--PC  250 (380)
Q Consensus       190 -----------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~  250 (380)
                                       .....+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.....  ..
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                             23345778999999999999999999999999999999999999999999976543221  11


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      ....++..|||||++..     ..++.++|||||||++|+|++ |..||.......  ..............+..++.++
T Consensus       272 ~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l  344 (374)
T cd05106         272 GNARLPVKWMAPESIFD-----CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKMVKRGYQMSRPDFAPPEI  344 (374)
T ss_pred             cCCCCccceeCHHHhcC-----CCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHHHHcccCccCCCCCCHHH
Confidence            22335678999999853     456789999999999999997 999997433222  1122222233444556678999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhc
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .++|.+||+.||++|||+.|+++
T Consensus       345 ~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         345 YSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999986

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.3e-45  Score=334.65  Aligned_cols=254  Identities=28%  Similarity=0.484  Sum_probs=204.8

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++.++|+||+++++++.....+++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            368889999999999999999998999999999864432 2234567899999999999999999999999999999999


Q ss_pred             ccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          178 YMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       178 ~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      |+++++|.....    ..+..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.............
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  160 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY  160 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCc
Confidence            999988765432    3567788999999999999999999999999999999999999999999998765543333455


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC-----------------
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA-----------------  316 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-----------------  316 (380)
                      .++..|+|||++..    +..++.++|||||||++|+|++|..||......+....+......                 
T Consensus       161 ~~~~~~~aPE~~~~----~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         161 VATRWYRAPELLVG----DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             ccccccCCHHHHhC----CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence            68899999999753    234567899999999999999999999743332221111111000                 


Q ss_pred             --CCC--------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          317 --QPP--------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       317 --~~~--------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                        .+.        .....++..+.+||.+||+.||++|||+.|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence              000        0112457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.3e-45  Score=337.62  Aligned_cols=256  Identities=32%  Similarity=0.527  Sum_probs=211.1

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      .+|.+.+.||+|+||.||++.+..+++.||+|.+...... ..+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            6799999999999999999999889999999998654433 346688999999999999999999999999999999999


Q ss_pred             cCCCCccccccc---chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCC
Q 016959          179 MDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG  255 (380)
Q Consensus       179 ~~~~~L~~~~~~---~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  255 (380)
                      +++++|..+...   .+..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++..............+
T Consensus        98 ~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  177 (297)
T cd06656          98 LAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG  177 (297)
T ss_pred             cCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccC
Confidence            999999776543   45678889999999999999999999999999999999999999999998765543333345578


Q ss_pred             CCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHH
Q 016959          256 TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISR  335 (380)
Q Consensus       256 t~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  335 (380)
                      +..|+|||.+..     ..++.++|+|||||++|++++|..||............ ..........+..++..+.+||.+
T Consensus       178 ~~~y~aPE~~~~-----~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~  251 (297)
T cd06656         178 TPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTPELQNPERLSAVFRDFLNR  251 (297)
T ss_pred             CccccCHHHHcC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-ccCCCCCCCCccccCHHHHHHHHH
Confidence            999999999853     45577899999999999999999999643321111111 111111223455678899999999


Q ss_pred             hcccCcCCCCCHHHHhcCccccccCc
Q 016959          336 CLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       336 ~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      ||..||++||++.++++||||+....
T Consensus       252 ~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         252 CLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             HccCChhhCcCHHHHhcCchhccccc
Confidence            99999999999999999999987643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.6e-45  Score=336.89  Aligned_cols=254  Identities=33%  Similarity=0.548  Sum_probs=212.5

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +.|...+.||+|+||.||+|.+..+++.||+|.+...........+.+|+.++++++|+||+++++++...+..++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            45778889999999999999998899999999987655555567889999999999999999999999999999999999


Q ss_pred             cCCCCccccccc---chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCC
Q 016959          179 MDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG  255 (380)
Q Consensus       179 ~~~~~L~~~~~~---~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  255 (380)
                      +.+++|.+.+..   .+..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..+...........|
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  163 (277)
T cd06642          84 LGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVG  163 (277)
T ss_pred             cCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccC
Confidence            999998765433   56778889999999999999999999999999999999999999999999876543333334568


Q ss_pred             CCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHH
Q 016959          256 TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISR  335 (380)
Q Consensus       256 t~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  335 (380)
                      +..|+|||++..     ..++.++|+|||||++|||++|..||.......   ..........+.....++.++.++|.+
T Consensus       164 ~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~  235 (277)
T cd06642         164 TPFWMAPEVIKQ-----SAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLFLIPKNSPPTLEGQYSKPFKEFVEA  235 (277)
T ss_pred             cccccCHHHhCc-----CCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHhhhhcCCCCCCCcccCHHHHHHHHH
Confidence            899999999853     445778999999999999999999996332222   122222233344455678899999999


Q ss_pred             hcccCcCCCCCHHHHhcCccccccC
Q 016959          336 CLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       336 ~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      ||+.+|++||++.|+++||||....
T Consensus       236 ~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         236 CLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             HccCCcccCcCHHHHHHhHHHHHHh
Confidence            9999999999999999999998754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.2e-45  Score=337.18  Aligned_cols=252  Identities=23%  Similarity=0.314  Sum_probs=199.1

Q ss_pred             CCcccccccceecccCCceEEEEEeCC----------------CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCce
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPP----------------TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV  159 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~----------------~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  159 (380)
                      +..++|.+.++||+|+||.||+|.+..                ++..||+|++...........+.+|+.++++++|+||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence            456789999999999999999998532                3457999999766555566789999999999999999


Q ss_pred             eeeEeEEeeCCeEEEEEeccCCCCccccccc-----------------------chHHHHHHHHHHHHHHHHHHhCCcee
Q 016959          160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR-----------------------QEHILSDLARQVLSGLAYLHKRKIVH  216 (380)
Q Consensus       160 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----------------------~~~~~~~i~~qi~~al~~LH~~~ivH  216 (380)
                      +++++++.+.+..++||||+.+++|.+++..                       ....+..++.||+.||.|||++||+|
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH  161 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH  161 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            9999999999999999999999998665422                       23457789999999999999999999


Q ss_pred             cCCCCCcEEEcCCCcEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-
Q 016959          217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-  293 (380)
Q Consensus       217 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-  293 (380)
                      |||||+|||++.++.+||+|||+++.+.....  ......++..|+|||++..     ..++.++|||||||++|||++ 
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-----GKFTTASDVWAFGVTLWEILML  236 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-----CCCCchhhhHHHHHHHHHHHHc
Confidence            99999999999999999999999976543211  1233456789999999853     456779999999999999986 


Q ss_pred             -CCCCCCCCCCCCHHHHHHHHhh----CCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          294 -GRFPFAVGRQGDWASLMFAICF----AQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       294 -g~~pf~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                       +..||......+..........    ......+..++..+.+||.+||..||++|||+.||..
T Consensus       237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         237 CKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             cCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence             6677864333322222211111    1112234567889999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.2e-45  Score=338.79  Aligned_cols=252  Identities=29%  Similarity=0.466  Sum_probs=199.6

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++|+||+++++++.+.+.+++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778899999999999999999999999999986432 222335677899999999999999999999999999999999


Q ss_pred             cCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          179 MDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       179 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      +.+ +|...+     ...+..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.............
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE  159 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence            986 454332     23677788999999999999999999999999999999999999999999998665433333455


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-CHHHHHHHHhhC----------------
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG-DWASLMFAICFA----------------  316 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~----------------  316 (380)
                      .++..|+|||++.+    ...++.++|||||||++|+|++|..||...... .....+......                
T Consensus       160 ~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         160 VVTLWYRPPDVLFG----AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             ccccCCcChHHHhC----CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence            68899999999753    244577899999999999999999997532221 111111110000                


Q ss_pred             CCC---------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          317 QPP---------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       317 ~~~---------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      ...         .....++.++++||.+||+.||++|||++|+++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            000         1123467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.7e-45  Score=333.61  Aligned_cols=255  Identities=32%  Similarity=0.505  Sum_probs=204.8

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEe------eC
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYD------RN  169 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~------~~  169 (380)
                      ..+.|++.+.||.|+||.||+|.+..+++.||+|++....  .....+..|+.+++++ +|+||+++++++.      ..
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            3467899999999999999999999999999999985432  3345678899999998 6999999999984      34


Q ss_pred             CeEEEEEeccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                      ..++++|||+.+++|.+++..      .+..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++...
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~  171 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  171 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence            678999999999988665432      45567889999999999999999999999999999999999999999998766


Q ss_pred             cccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC-CCCCCC
Q 016959          244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA-QPPEAP  322 (380)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~  322 (380)
                      ...........|+..|+|||++......+..++.++|+|||||++|||++|..||.....   .......... ......
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~  248 (282)
T cd06636         172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP---MRALFLIPRNPPPKLKS  248 (282)
T ss_pred             hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH---HhhhhhHhhCCCCCCcc
Confidence            543333455678999999999854322234567789999999999999999999963221   1222222222 222233


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      ..++.++.+||.+||..||++|||+.|+|+||||
T Consensus       249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             cccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            4578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.9e-45  Score=347.24  Aligned_cols=254  Identities=24%  Similarity=0.360  Sum_probs=203.3

Q ss_pred             cccCCCcccccccceecccCCceEEEEEe-----CCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeE
Q 016959           92 RHQLINPAELQKGNRIGSGSGGTVWRVVH-----PPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDM  165 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~  165 (380)
                      ..+.+..++|++++.||+|+||+||+|++     ..++..||||+++........+.+.+|+.+|+.+ +||||++++++
T Consensus        28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~  107 (375)
T cd05104          28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGA  107 (375)
T ss_pred             cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence            34557778999999999999999999974     3457789999997554444556788999999999 89999999999


Q ss_pred             EeeCCeEEEEEeccCCCCcccccc--------------------------------------------------------
Q 016959          166 YDRNGEIEVLLEYMDGGSLEGAHI--------------------------------------------------------  189 (380)
Q Consensus       166 ~~~~~~~~lv~e~~~~~~L~~~~~--------------------------------------------------------  189 (380)
                      +...+..++|||||.+|+|.+++.                                                        
T Consensus       108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  187 (375)
T cd05104         108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR  187 (375)
T ss_pred             eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence            999999999999999999865442                                                        


Q ss_pred             -----------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          190 -----------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       190 -----------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                                             ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                                   123456789999999999999999999999999999999999999999999866433


Q ss_pred             CC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          247 MD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       247 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      ..  ......++..|+|||++..     ..++.++|||||||++|||++ |..||......  ...............+.
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~  340 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFN-----CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMIKEGYRMLSPE  340 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcC-----CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHHHhCccCCCCC
Confidence            21  1122335678999999853     456789999999999999997 89999643222  12222233333344456


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..+.++.+||.+||+.||++|||+.|+++
T Consensus       341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~  369 (375)
T cd05104         341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQ  369 (375)
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            67889999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.1e-45  Score=329.81  Aligned_cols=251  Identities=33%  Similarity=0.541  Sum_probs=207.8

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      ++|++.+.||.|+||+||+|.+..++..+|+|++...........+.+|+++++.++|+||+++++.+...+..++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            36889999999999999999998899999999987655444567889999999999999999999999999999999999


Q ss_pred             cCCCCccccccc-------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC--
Q 016959          179 MDGGSLEGAHIR-------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP--  249 (380)
Q Consensus       179 ~~~~~L~~~~~~-------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--  249 (380)
                      +.+++|.+.+..       .+..+..++.||+.||.|||++||+|+||+|+||++++++.++|+|||++..+......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  160 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR  160 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence            999998766532       45678889999999999999999999999999999999999999999998876543322  


Q ss_pred             --CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCC-----
Q 016959          250 --CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAP-----  322 (380)
Q Consensus       250 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----  322 (380)
                        .....|+..|+|||++..    ...++.++|+|||||++|+|++|..||......   ...............     
T Consensus       161 ~~~~~~~~~~~y~~Pe~~~~----~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~  233 (267)
T cd06610         161 KVRKTFVGTPCWMAPEVMEQ----VHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTLQNDPPSLETGADY  233 (267)
T ss_pred             cccccccCChhhcChHHHcc----ccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHhcCCCCCcCCcccc
Confidence              134468999999999854    235677899999999999999999999643322   122222222222221     


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      ..++.++.+++.+||..||++||++.|+++||||
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         234 KKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            2567899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.9e-45  Score=370.33  Aligned_cols=258  Identities=30%  Similarity=0.479  Sum_probs=208.2

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEee--CCeE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDR--NGEI  172 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~  172 (380)
                      +..++|.+.++||+|+||+||+|.+..+++.||+|++.... .......+..|+.+|+.|+|||||+++++|..  ...+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            44568999999999999999999999999999999986442 34456778899999999999999999998854  4579


Q ss_pred             EEEEeccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhC-------CceecCCCCCcEEEcCC--------
Q 016959          173 EVLLEYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKR-------KIVHRDIKPSNLLINSS--------  229 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~-------~ivH~Dlkp~Nil~~~~--------  229 (380)
                      ||||||+.+++|..++.        ..+..++.|+.||+.||.|||+.       +||||||||+||||+.+        
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            99999999999976543        45678899999999999999985       49999999999999642        


Q ss_pred             ---------CcEEEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 016959          230 ---------KNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAV  300 (380)
Q Consensus       230 ---------~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~  300 (380)
                               +.+||+|||++..+... ......+||+.|+|||++..   ....++.++||||||||||+|++|..||..
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~g---e~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLH---ETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhc---cCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                     34999999999866432 22345679999999999843   234567799999999999999999999964


Q ss_pred             CCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          301 GRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      ..  .....+..+... +.......+.++.+||.+||..+|++||++.|+|.|+||+...
T Consensus       246 ~~--~~~qli~~lk~~-p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        246 AN--NFSQLISELKRG-PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             CC--cHHHHHHHHhcC-CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            32  333333333222 2222244688999999999999999999999999999998653

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.2e-45  Score=327.80  Aligned_cols=249  Identities=27%  Similarity=0.513  Sum_probs=210.4

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +|++.+.||+|+||+||++.+..+++.||+|.+.... .......+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788999999999999999999999999999985432 333456788999999999999999999999999999999999


Q ss_pred             cCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          179 MDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       179 ~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      +.+++|.+.+.      ..+..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++............
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  160 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART  160 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence            99999865543      246678889999999999999999999999999999999999999999999766543333334


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      ..|+..|+|||++..     ...+.++|+|||||++|+|++|..||...   +................+..++.++.++
T Consensus       161 ~~~~~~~~~pe~~~~-----~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l  232 (256)
T cd08218         161 CIGTPYYLSPEICEN-----RPYNNKSDIWALGCVLYEMCTLKHAFEAG---NMKNLVLKIIRGSYPPVSSHYSYDLRNL  232 (256)
T ss_pred             ccCCccccCHHHhCC-----CCCCCccchhHHHHHHHHHHcCCCCccCC---CHHHHHHHHhcCCCCCCcccCCHHHHHH
Confidence            568899999999753     44567899999999999999999999743   3334444444445555667789999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccc
Q 016959          333 ISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       333 i~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      |.+||+.+|++||++.|+++||||
T Consensus       233 i~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         233 VSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=7.3e-45  Score=333.94  Aligned_cols=255  Identities=34%  Similarity=0.512  Sum_probs=204.1

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEe-----eCC
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYD-----RNG  170 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~-----~~~  170 (380)
                      ..++|++.+.||+|+||.||+|.+..+++.+|+|++....  .....+.+|+.+++.+ +|+||+++++++.     .++
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   93 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD   93 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence            3468999999999999999999999999999999975432  2235677899999999 6999999999873     446


Q ss_pred             eEEEEEeccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI  242 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  242 (380)
                      .+++||||+++++|.+.+.        ..+..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++..
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  173 (286)
T cd06638          94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ  173 (286)
T ss_pred             eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceee
Confidence            7999999999999865432        24566788999999999999999999999999999999999999999999987


Q ss_pred             ccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC--CCC
Q 016959          243 LAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ--PPE  320 (380)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~  320 (380)
                      +...........|+..|+|||++......+..++.++|||||||++|+|++|..||.....   ...........  ...
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~  250 (286)
T cd06638         174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP---MRALFKIPRNPPPTLH  250 (286)
T ss_pred             cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch---hHHHhhccccCCCccc
Confidence            6543333345679999999999854322234467799999999999999999999964322   11222211111  122


Q ss_pred             CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          321 APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       321 ~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      .+..++.++.+||.+||+.||++|||+.|+++|+||
T Consensus       251 ~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            344567899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-46  Score=349.77  Aligned_cols=253  Identities=34%  Similarity=0.534  Sum_probs=213.0

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      -|.-++.||+|+||.||-+++..+...||||.+....  ..+....+..|+.+|+.+.|||+|.+-|+|..+...|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            4667889999999999999999999999999995432  23345678899999999999999999999999999999999


Q ss_pred             ccCCC--Cccccccc--chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          178 YMDGG--SLEGAHIR--QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       178 ~~~~~--~L~~~~~~--~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      ||-|.  +|.+...+  .+..+..|+.+.+.||.|||+.+.||||||..|||+++.|.|||+|||.|....+    .+++
T Consensus       107 YClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----AnsF  182 (948)
T KOG0577|consen  107 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----ANSF  182 (948)
T ss_pred             HHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc----hhcc
Confidence            99874  23333333  4667888999999999999999999999999999999999999999999876544    4789


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc-ccHHHHHH
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM-ASREFRDF  332 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l  332 (380)
                      +|||+|||||+|.- ...|.| +-++|||||||+..||.-.+.|+.+   .+-...++.+.....+.+... .+..++.|
T Consensus       183 vGTPywMAPEVILA-MDEGqY-dgkvDvWSLGITCIELAERkPPlFn---MNAMSALYHIAQNesPtLqs~eWS~~F~~F  257 (948)
T KOG0577|consen  183 VGTPYWMAPEVILA-MDEGQY-DGKVDVWSLGITCIELAERKPPLFN---MNAMSALYHIAQNESPTLQSNEWSDYFRNF  257 (948)
T ss_pred             cCCccccchhHhee-cccccc-CCccceeeccchhhhhhhcCCCccC---chHHHHHHHHHhcCCCCCCCchhHHHHHHH
Confidence            99999999999963 333444 4589999999999999999999973   334556666666777766644 56789999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          333 ISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       333 i~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      |..||++-|++|||.+++|.|+|+.+-..
T Consensus       258 vd~CLqKipqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  258 VDSCLQKIPQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             HHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence            99999999999999999999999988543

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-44  Score=335.93  Aligned_cols=271  Identities=28%  Similarity=0.418  Sum_probs=217.8

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      +|++.+.||+|+||.||++.+..+++.||+|.+.....  ......+.+|+++++.++|+||+++++.+..++.+++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            68889999999999999999999999999999865432  2334577899999999999999999999999999999999


Q ss_pred             ccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC------
Q 016959          178 YMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM------  247 (380)
Q Consensus       178 ~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~------  247 (380)
                      |+.|++|..++..    .+..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++......      
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (305)
T cd05609          82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE  161 (305)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccc
Confidence            9999998766533    566778899999999999999999999999999999999999999999986321100      


Q ss_pred             ---------CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC
Q 016959          248 ---------DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP  318 (380)
Q Consensus       248 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  318 (380)
                               .......|+..|+|||.+..     ..++.++|+|||||++|||++|..||......+.......... ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~-~~  235 (305)
T cd05609         162 GHIEKDTREFLDKQVCGTPEYIAPEVILR-----QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI-EW  235 (305)
T ss_pred             cccccchhhccccCCccCccccCchhccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CC
Confidence                     00112457889999998753     4567889999999999999999999974333222222211111 11


Q ss_pred             CCCCccccHHHHHHHHHhcccCcCCCCC---HHHHhcCccccccCcccccccccccCCCCC
Q 016959          319 PEAPEMASREFRDFISRCLQKDPHSRWP---AAQLLQHPFILRAGQSQVNQNLRQILPPPR  376 (380)
Q Consensus       319 ~~~~~~~~~~~~~li~~~l~~dp~~R~t---~~eil~hp~~~~~~~~~~~~~~~~~~~~~~  376 (380)
                      +.....++.++.++|.+||+.||++||+   +.|+|+||||....++...+...+.+|.+.
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~  296 (305)
T cd05609         236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEFIPQLE  296 (305)
T ss_pred             CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhhcCCCCCCCCC
Confidence            2222357889999999999999999998   799999999999988888777777777654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=349.95  Aligned_cols=248  Identities=28%  Similarity=0.456  Sum_probs=211.4

Q ss_pred             cccccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC
Q 016959           90 QNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRN  169 (380)
Q Consensus        90 ~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  169 (380)
                      +...|.|..+.+..++-||.|+.|.||+|+.  .++.||||+++        +.-..+|+.|++|+|+||+.|.|+|...
T Consensus       115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~--------elkETdIKHLRkLkH~NII~FkGVCtqs  184 (904)
T KOG4721|consen  115 QEELWEIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVR--------ELKETDIKHLRKLKHPNIITFKGVCTQS  184 (904)
T ss_pred             hhhhccCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHh--------hhhhhhHHHHHhccCcceeeEeeeecCC
Confidence            3445667888888899999999999999998  68899999872        2233578899999999999999999999


Q ss_pred             CeEEEEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      ..+|||||||..|-|...+..    ....+.+|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++...+
T Consensus       185 PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~  264 (904)
T KOG4721|consen  185 PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD  264 (904)
T ss_pred             ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence            999999999999998776654    3566888999999999999999999999999999999999999999999987765


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh-CCCCCCCcc
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF-AQPPEAPEM  324 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~  324 (380)
                      . ....+++||..|||||+|.+     ...+.|+|||||||||||||||..||.   +.+...++..+.. ......|..
T Consensus       265 ~-STkMSFaGTVaWMAPEvIrn-----ePcsEKVDIwSfGVVLWEmLT~EiPYk---dVdssAIIwGVGsNsL~LpvPst  335 (904)
T KOG4721|consen  265 K-STKMSFAGTVAWMAPEVIRN-----EPCSEKVDIWSFGVVLWEMLTGEIPYK---DVDSSAIIWGVGSNSLHLPVPST  335 (904)
T ss_pred             h-hhhhhhhhhHhhhCHHHhhc-----CCcccccceehhHHHHHHHHhcCCCcc---ccchheeEEeccCCcccccCccc
Confidence            5 44468899999999999974     666789999999999999999999996   3343444443332 234567888


Q ss_pred             ccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          325 ASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      ++..++=||++||+-.|.+||++.+||.|-=+
T Consensus       336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             CchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            99999999999999999999999999998543

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.7e-45  Score=330.84  Aligned_cols=257  Identities=30%  Similarity=0.411  Sum_probs=205.3

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++...... ....+.+|+.+++.++|+||+++++++..++.+++|
T Consensus         6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc-hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            3456899999999999999999999989999999998644332 235678899999999999999999999999999999


Q ss_pred             EeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCC
Q 016959          176 LEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       176 ~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      |||+.+++|.+++.    ..+..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06646          85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK  164 (267)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence            99999999976543    35667888999999999999999999999999999999999999999999987654333334


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC-CCCCCccccHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ-PPEAPEMASREFR  330 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  330 (380)
                      ...|+..|+|||++...  ....++.++|+|||||++|||++|..||...........+....... .......++..+.
T Consensus       165 ~~~~~~~y~~PE~~~~~--~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06646         165 SFIGTPYWMAPEVAAVE--KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH  242 (267)
T ss_pred             ccccCccccCHhHcccc--cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence            56789999999987431  12334678999999999999999999996332211111111111110 0111234678999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCcc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPF  355 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~  355 (380)
                      +||.+||+.||++|||++++|+|+|
T Consensus       243 ~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         243 NFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHhhCChhhCcCHHHHhcCCC
Confidence            9999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.9e-44  Score=327.82  Aligned_cols=249  Identities=33%  Similarity=0.560  Sum_probs=206.6

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc--------hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--------DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      +|.+++.||+|+||.||+|.+..+++.||+|.+.....        ....+.+.+|+.++++++|+||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            36778899999999999999988899999998854321        1234568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          172 IEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      .+++|||+.+++|..++.    ..+..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||+++......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            999999999999876653    3466788899999999999999999999999999999999999999999988765221


Q ss_pred             C------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCC
Q 016959          248 D------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA  321 (380)
Q Consensus       248 ~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  321 (380)
                      .      ......|+..|+|||.+..     ..++.++|+|||||++|+|++|+.||....   ....+........+..
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~  232 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQ-----TSYTRKADIWSLGCLVVEMLTGKHPFPDCT---QLQAIFKIGENASPEI  232 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhcc-----CCCCchhhhHHHHHHHHHHhhCCCCCCCcc---HHHHHHHHhccCCCcC
Confidence            1      1123458899999999853     445678999999999999999999996432   2233333333445566


Q ss_pred             CccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      +..++.++.++|.+||+.||++||++.|+++||||
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            67789999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-45  Score=321.04  Aligned_cols=279  Identities=25%  Similarity=0.422  Sum_probs=237.6

Q ss_pred             cccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhC-CCCceeeeEeEEee
Q 016959           92 RHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDV-NHPNVVKCHDMYDR  168 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~  168 (380)
                      ..+.+...+|.+.++||+|+|++|.+++++.|.+.||+|+++++-  +++...-+..|-.+.... +||++|.++.+|..
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            445678889999999999999999999999999999999997652  333345566677666655 69999999999999


Q ss_pred             CCeEEEEEeccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          169 NGEIEVLLEYMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      +.++++|.||+.||+|.-++    ..+++..+.+..+|+.||.|||++|||+||||.+|||+|..|++||+|+|.++.--
T Consensus       323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence            99999999999999985443    34677788889999999999999999999999999999999999999999998766


Q ss_pred             ccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC----CCCCHHHHHHHHhhCCCCC
Q 016959          245 QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVG----RQGDWASLMFAICFAQPPE  320 (380)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~----~~~~~~~~~~~~~~~~~~~  320 (380)
                      ...+...++|||+.|+|||++.     |..|++.+|+|+||++++||+.|+.||..-    ...+....+..+.......
T Consensus       403 ~~gd~tstfcgtpnyiapeilr-----geeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir  477 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILR-----GEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR  477 (593)
T ss_pred             CCCcccccccCCCcccchhhhc-----ccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc
Confidence            6667778999999999999985     578889999999999999999999999721    1223344455555555667


Q ss_pred             CCccccHHHHHHHHHhcccCcCCCCC------HHHHhcCccccccCcccccccccccCCCCCC
Q 016959          321 APEMASREFRDFISRCLQKDPHSRWP------AAQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       321 ~~~~~~~~~~~li~~~l~~dp~~R~t------~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      .|..++-.+..+++.-|++||++|+.      +.++..|+||+.+.|....+  ++..||++|
T Consensus       478 iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leq--k~v~ppf~p  538 (593)
T KOG0695|consen  478 IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQ--KQVLPPFQP  538 (593)
T ss_pred             ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhh--cccCCCCCC
Confidence            77888889999999999999999974      78999999999998887766  899999887

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-46  Score=362.62  Aligned_cols=256  Identities=27%  Similarity=0.375  Sum_probs=208.8

Q ss_pred             ccccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeE-Eee
Q 016959           91 NRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDM-YDR  168 (380)
Q Consensus        91 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~-~~~  168 (380)
                      .....|....+++.+.|.+|||+.||+|.+...|..||+|++... ++...+.+.+|+++|+.|. |+|||.++|. ...
T Consensus        29 G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~  107 (738)
T KOG1989|consen   29 GQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN  107 (738)
T ss_pred             ceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence            344557778899999999999999999999988899999999877 5666788999999999997 9999999993 211


Q ss_pred             ------CCeEEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCcEEE
Q 016959          169 ------NGEIEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRK--IVHRDIKPSNLLINSSKNVKI  234 (380)
Q Consensus       169 ------~~~~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl  234 (380)
                            .-.+.|+||||.||.|-+++.      +.+.++++|++|+++||.+||.+.  |||||||-|||||+.+|+.||
T Consensus       108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL  187 (738)
T KOG1989|consen  108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL  187 (738)
T ss_pred             ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence                  135789999999888765544      368889999999999999999998  999999999999999999999


Q ss_pred             eeccccccccccCCCCC---------CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 016959          235 ADFGVSRILAQTMDPCN---------SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD  305 (380)
Q Consensus       235 ~Dfg~a~~~~~~~~~~~---------~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~  305 (380)
                      ||||.|+..........         ...-|+.|+|||.|.  ++.+...+.|+|||+|||+||-||+...||+..... 
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMID--lysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-  264 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMID--LYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-  264 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHh--hhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-
Confidence            99999875433321111         123699999999996  566778889999999999999999999999743221 


Q ss_pred             HHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcc
Q 016959          306 WASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPF  355 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~  355 (380)
                         .+....+..++  .+.++..+.+||+.||+.||++||++.|++++-+
T Consensus       265 ---aIlng~Y~~P~--~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  265 ---AILNGNYSFPP--FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             ---eEEeccccCCC--CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence               22222333322  2567889999999999999999999999987544

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.9e-45  Score=331.18  Aligned_cols=254  Identities=41%  Similarity=0.716  Sum_probs=213.1

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      ++|+..+.||.|+||.||+|.+..+++.+|+|++...........+.+|+++++.++|+||+++++++...+.+++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36888899999999999999999999999999997665556667888999999999999999999999999999999999


Q ss_pred             cCCCCccccccc-----chHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          179 MDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHK-RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       179 ~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      +.+++|.+++..     .+..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+........  ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~  158 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--KT  158 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--hc
Confidence            999998766542     456778899999999999999 9999999999999999999999999999876643322  22


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CCCHHHHHHHHhhCCCCCCCcc-ccHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGR--QGDWASLMFAICFAQPPEAPEM-ASREF  329 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~  329 (380)
                      ..++..|+|||.+.+     ..++.++|||||||++|+|++|..||....  ................+..+.. ++.++
T Consensus       159 ~~~~~~y~~PE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd06605         159 FVGTSSYMAPERIQG-----NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF  233 (265)
T ss_pred             ccCChhccCHHHHcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence            678899999999854     456778999999999999999999996432  1223333333333444444444 78899


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      +++|.+||..||++|||+.|++.||||++.
T Consensus       234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         234 QDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            999999999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-44  Score=326.70  Aligned_cols=246  Identities=28%  Similarity=0.485  Sum_probs=209.3

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEecc
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYM  179 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  179 (380)
                      +|++.+.||+|+||.||++.+..+++.||+|.++........+.+.+|+.+++.++|+||+++++.+..++.++++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            47888999999999999999999999999999865544455677889999999999999999999999999999999999


Q ss_pred             CCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          180 DGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       180 ~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      .+++|.++..      ..+..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.............
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  160 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY  160 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccc
Confidence            9998865432      3567788899999999999999999999999999999999999999999998765443334456


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHH
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI  333 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  333 (380)
                      .|+..|+|||++..     ..++.++|+||||+++|+|++|..||..   .+................+..++..+.+||
T Consensus       161 ~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~l~~g~~p~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  232 (255)
T cd08219         161 VGTPYYVPPEIWEN-----MPYNNKSDIWSLGCILYELCTLKHPFQA---NSWKNLILKVCQGSYKPLPSHYSYELRSLI  232 (255)
T ss_pred             cCCccccCHHHHcc-----CCcCchhhhhhhchhheehhhccCCCCC---CCHHHHHHHHhcCCCCCCCcccCHHHHHHH
Confidence            78999999999853     4467789999999999999999999963   333444444444445556677889999999


Q ss_pred             HHhcccCcCCCCCHHHHhcC
Q 016959          334 SRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       334 ~~~l~~dp~~R~t~~eil~h  353 (380)
                      .+||+.||++|||+.|++.-
T Consensus       233 ~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         233 KQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHhCCcccCCCHHHHhhc
Confidence            99999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.3e-44  Score=331.73  Aligned_cols=250  Identities=25%  Similarity=0.370  Sum_probs=207.4

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCC-----cEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTS-----RVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      +..++|++.+.||+|+||.||+|.+...+     +.||+|.+...........+.+|+.+++.++|+||+++++++...+
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence            45678999999999999999999876554     6899999876665666778999999999999999999999999989


Q ss_pred             eEEEEEeccCCCCccccccc--------------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC
Q 016959          171 EIEVLLEYMDGGSLEGAHIR--------------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK  230 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~~--------------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~  230 (380)
                      ..+++|||+.+++|.+++..                    .+..+..++.||+.||.|||++|++|+||||+||+++.++
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence            99999999999998655432                    3456778999999999999999999999999999999999


Q ss_pred             cEEEeeccccccccccC--CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHH
Q 016959          231 NVKIADFGVSRILAQTM--DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWA  307 (380)
Q Consensus       231 ~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~  307 (380)
                      .++|+|||++.......  .......++..|+|||.+..     ..++.++|||||||++|||++ |..||.....   .
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~  233 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-----GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---Q  233 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhcc-----CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---H
Confidence            99999999987653321  11234456889999998753     445778999999999999997 9999974333   3


Q ss_pred             HHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          308 SLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      .....+........+..++.++.+|+.+||+.||++||++.|++++
T Consensus       234 ~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         234 EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            3344444445556677889999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.2e-44  Score=331.31  Aligned_cols=260  Identities=20%  Similarity=0.313  Sum_probs=208.9

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCC-----CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPP-----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR  168 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  168 (380)
                      |.+..++|++.++||+|+||.||+|..+.     .+..||+|.+...........+.+|+.+++.++|+||+++++++.+
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK   80 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            34677899999999999999999997642     3568999998655444445567889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCccccccc--------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEE
Q 016959          169 NGEIEVLLEYMDGGSLEGAHIR--------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKI  234 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~~~--------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl  234 (380)
                      .+..++||||+.+++|.+++..              ....+..++.||+.||.|||++||+||||||+|||++.++.++|
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999777643              12456789999999999999999999999999999999999999


Q ss_pred             eeccccccccccCCC--CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHH
Q 016959          235 ADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMF  311 (380)
Q Consensus       235 ~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~  311 (380)
                      +|||+++........  .....++..|+|||.+..     ..++.++|+|||||++|||++ |..||....   ......
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-----~~~~~~~DvwslG~~l~el~~~~~~p~~~~~---~~~~~~  232 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-----GVFTTSSDMWSFGVVLWEITSLAEQPYQGLS---NEQVLK  232 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhcc-----CCCChHhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHH
Confidence            999998765332111  122345678999998753     445779999999999999998 788996433   233333


Q ss_pred             HHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc------CccccccCc
Q 016959          312 AICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ------HPFILRAGQ  361 (380)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~------hp~~~~~~~  361 (380)
                      ..........+..++..+.+++.+||+.||++|||+.|+++      ||||.++.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         233 FVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence            33333344455667889999999999999999999999987      999988754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=8.6e-45  Score=340.16  Aligned_cols=253  Identities=24%  Similarity=0.332  Sum_probs=198.5

Q ss_pred             ccceeccc--CCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEecc
Q 016959          103 KGNRIGSG--SGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYM  179 (380)
Q Consensus       103 ~~~~LG~G--~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  179 (380)
                      +.++||+|  +||+||++.++.+|+.||+|++.... .......+.+|+.+++.++||||++++++|..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  67899999999999999999996543 3344567888999999999999999999999999999999999


Q ss_pred             CCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-----
Q 016959          180 DGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-----  248 (380)
Q Consensus       180 ~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-----  248 (380)
                      .+++|.+++.      ..+..+..++.||+.||+|||++||+||||||+|||++.++.++++||+.+........     
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~  161 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV  161 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence            9999876542      34667889999999999999999999999999999999999999999987543321111     


Q ss_pred             --CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC--------
Q 016959          249 --PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP--------  318 (380)
Q Consensus       249 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------  318 (380)
                        ......++..|+|||++...   ...++.++|||||||++|||++|..||........  .........+        
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         162 HDFPKYSVKVLPWLSPEVLQQN---LQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             ccccccccceecccChHHhhcc---cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccccccccch
Confidence              11223567889999998531   13467899999999999999999999963221111  1111100000        


Q ss_pred             ------------------------------------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          319 ------------------------------------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       319 ------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                                                          ......++.++.+||.+||+.||++|||++|+++||||+.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                                                011123567899999999999999999999999999998754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-44  Score=330.30  Aligned_cols=254  Identities=36%  Similarity=0.591  Sum_probs=210.8

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC---CCceeeeEeEEeeCCeEEEEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN---HPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      .|++.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.+++.+.   |+|++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            47788899999999999999999999999999876554555667889999999986   999999999999999999999


Q ss_pred             eccCCCCccccccc---chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          177 EYMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       177 e~~~~~~L~~~~~~---~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      ||+.+++|.+++..   .+..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..+..........
T Consensus        82 e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06917          82 EYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF  161 (277)
T ss_pred             ecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccc
Confidence            99999998765433   467788899999999999999999999999999999999999999999998776544334456


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCc-cccHHHHHH
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE-MASREFRDF  332 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l  332 (380)
                      .|+..|+|||.+..    +..++.++|+|||||++|+|++|..||.....   ............+.... ..+.++.++
T Consensus       162 ~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (277)
T cd06917         162 VGTPYWMAPEVITE----GKYYDTKADIWSLGITIYEMATGNPPYSDVDA---FRAMMLIPKSKPPRLEDNGYSKLLREF  234 (277)
T ss_pred             cCCcceeCHHHhcc----CCccccchhHHHHHHHHHHHHhCCCCCCCCCh---hhhhhccccCCCCCCCcccCCHHHHHH
Confidence            78999999998753    34567789999999999999999999964322   22222222222233333 377899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          333 ISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       333 i~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      +.+||+.||++||++.|++.|+||+...
T Consensus       235 i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         235 VAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            9999999999999999999999998764

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.8e-44  Score=328.77  Aligned_cols=255  Identities=33%  Similarity=0.541  Sum_probs=213.3

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +-|++.+.||.|+||.||+|.+..+++.||||++...........+.+|+.+++.++|+||+++++++..++..++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            34778899999999999999998899999999986555455567788999999999999999999999999999999999


Q ss_pred             cCCCCccccccc---chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCC
Q 016959          179 MDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG  255 (380)
Q Consensus       179 ~~~~~L~~~~~~---~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  255 (380)
                      +.+++|..++..   .+..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++..+...........+
T Consensus        84 ~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  163 (277)
T cd06641          84 LGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVG  163 (277)
T ss_pred             CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccC
Confidence            999998766543   56778889999999999999999999999999999999999999999998766543323344568


Q ss_pred             CCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHH
Q 016959          256 TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISR  335 (380)
Q Consensus       256 t~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  335 (380)
                      +..|+|||.+..     ...+.++|+|||||++|+|++|..||.....   ............+.....++.++.+++.+
T Consensus       164 ~~~y~~PE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (277)
T cd06641         164 TPFWMAPEVIKQ-----SAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLFLIPKNNPPTLEGNYSKPLKEFVEA  235 (277)
T ss_pred             CccccChhhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence            899999998853     3456789999999999999999999963222   22222233334445566678999999999


Q ss_pred             hcccCcCCCCCHHHHhcCccccccCc
Q 016959          336 CLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       336 ~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      ||..+|++||++.++++||||.+...
T Consensus       236 ~l~~~p~~Rp~~~~~l~~~~~~~~~~  261 (277)
T cd06641         236 CLNKEPSFRPTAKELLKHKFIVRFAK  261 (277)
T ss_pred             HccCChhhCcCHHHHHhCHHHhhhhh
Confidence            99999999999999999999988643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.2e-44  Score=330.69  Aligned_cols=255  Identities=35%  Similarity=0.513  Sum_probs=204.6

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeC-----Ce
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRN-----GE  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-----~~  171 (380)
                      .++|.+.+.||+|+||.||+|.+..+++.+|+|++....  .....+.+|+.+++++ +|+|++++++++...     +.
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~   98 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ   98 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence            467999999999999999999999999999999985432  2345677899999998 799999999998643     46


Q ss_pred             EEEEEeccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                      .++||||+.+++|.+++.        ..+..++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++...
T Consensus        99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~  178 (291)
T cd06639          99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL  178 (291)
T ss_pred             eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence            899999999999865432        356778899999999999999999999999999999999999999999998866


Q ss_pred             cccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC--CC
Q 016959          244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP--EA  321 (380)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~  321 (380)
                      ...........|+..|+|||++......+..++.++|||||||++|+|++|+.||....   ..............  ..
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~  255 (291)
T cd06639         179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH---PVKTLFKIPRNPPPTLLH  255 (291)
T ss_pred             ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc---HHHHHHHHhcCCCCCCCc
Confidence            54332334456899999999985432223345779999999999999999999996332   22222222222222  22


Q ss_pred             CccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 016959          322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFIL  357 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~  357 (380)
                      +...+..+.+||.+||+.||++||++.|+++||||+
T Consensus       256 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            345677899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-45  Score=334.44  Aligned_cols=254  Identities=28%  Similarity=0.437  Sum_probs=198.9

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .++|++.+.||+|+||+||+|.+..+++.||||.+...........+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            46799999999999999999999989999999998654433333456789999999999999999999999999999999


Q ss_pred             ccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          178 YMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       178 ~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      |+.+ +|.+++.     ..+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN  162 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence            9986 6755432     256678889999999999999999999999999999999999999999998755332222233


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-CCHHHHHHHHhhCCC-------------
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ-GDWASLMFAICFAQP-------------  318 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~-------------  318 (380)
                      ..++..|+|||++.+    ...++.++|||||||++|+|++|..||..... .+....+........             
T Consensus       163 ~~~~~~~~aPE~~~~----~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         163 EVVTLWYRPPDVLLG----STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccCCcHHhhc----CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            457889999998753    23456789999999999999999999964331 111111111000000             


Q ss_pred             ----------C---CCCcccc--HHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          319 ----------P---EAPEMAS--REFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       319 ----------~---~~~~~~~--~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                                .   .....++  .++.++|.+||+.||++|||+.|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                      0   0001233  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=5.3e-45  Score=334.74  Aligned_cols=254  Identities=28%  Similarity=0.443  Sum_probs=204.7

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ++|++.++||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+++++.++|+||+++++++..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            368889999999999999999998999999999854432 2345667899999999999999999999999999999999


Q ss_pred             ccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          178 YMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       178 ~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      |+.+++|..+..    ..+..+..++.||+.||.|||+.|++|+||+|+||++++++.++|+|||++..+..........
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  160 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY  160 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcc
Confidence            999988765543    3567788999999999999999999999999999999999999999999998765544444456


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC-----------------
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA-----------------  316 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-----------------  316 (380)
                      .++..|+|||++..    ...++.++|||||||++|||++|..||......+....+......                 
T Consensus       161 ~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         161 VATRWYRAPELLVG----DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             cceeeccCcHHhcc----ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            78999999999753    234567899999999999999999999643321111111100000                 


Q ss_pred             -CCC---------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          317 -QPP---------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       317 -~~~---------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                       ..+         .....++..+.+|+.+||+.||++||++.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence             000         1123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.2e-44  Score=326.75  Aligned_cols=248  Identities=37%  Similarity=0.593  Sum_probs=206.6

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .++|++.+.||.|+||.||+|.+..+++.|++|.+.....   ...+.+|+++++.++|+||+++++++......|+++|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            3679999999999999999999998899999999854322   5788999999999999999999999999999999999


Q ss_pred             ccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          178 YMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       178 ~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      |+.+++|.+++.     ..+..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++............
T Consensus        79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (256)
T cd06612          79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT  158 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence            999999876643     256778899999999999999999999999999999999999999999999876554333344


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh--CCCCCCCccccHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF--AQPPEAPEMASREFR  330 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  330 (380)
                      ..|+..|+|||++.+     ..++.++||||||+++|+|++|+.||.......   .......  ......+..++.++.
T Consensus       159 ~~~~~~y~~PE~~~~-----~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd06612         159 VIGTPFWMAPEVIQE-----IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR---AIFMIPNKPPPTLSDPEKWSPEFN  230 (256)
T ss_pred             ccCCccccCHHHHhc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh---hhhhhccCCCCCCCchhhcCHHHH
Confidence            568899999999853     456778999999999999999999996432221   1111111  111223345678999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      ++|.+||+.||++|||+.|+|+||||
T Consensus       231 ~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         231 DFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-44  Score=331.56  Aligned_cols=258  Identities=39%  Similarity=0.641  Sum_probs=212.5

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      +..++|++.+.||+|+||+||++.+..+++.||+|++.........+.+.+|+++++.++|+||+++++++...+.+++|
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence            34578999999999999999999999899999999986655555667889999999999999999999999999999999


Q ss_pred             EeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          176 LEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHK-RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       176 ~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      |||+.+++|..++..    .+..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++.......  .
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--~  159 (284)
T cd06620          82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--A  159 (284)
T ss_pred             EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--c
Confidence            999999999765433    466788899999999999997 599999999999999999999999999987553322  2


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC--------CHHHHHHHHhhCCCCCCC
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG--------DWASLMFAICFAQPPEAP  322 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~  322 (380)
                      ....|+..|+|||++..     ..++.++|+|||||++|+|++|..||......        ..............+..+
T Consensus       160 ~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd06620         160 DTFVGTSTYMSPERIQG-----GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP  234 (284)
T ss_pred             CccccCcccCCHHHHcc-----CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC
Confidence            34578999999999853     45677899999999999999999999743321        111222222222233333


Q ss_pred             c-cccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          323 E-MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       323 ~-~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      . .++.++.+|+.+||+.||++|||+.|+++|+||....
T Consensus       235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            3 3778999999999999999999999999999997753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-44  Score=328.68  Aligned_cols=254  Identities=34%  Similarity=0.553  Sum_probs=206.0

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCC------
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNG------  170 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~------  170 (380)
                      .++|++.+.||+|+||.||+|.+..+++.+++|++.....  ....+.+|+.+++++ +|+||+++++++....      
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4689999999999999999999998999999999865443  346788999999999 6999999999986544      


Q ss_pred             eEEEEEeccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI  242 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  242 (380)
                      .+++||||+.+++|.++..        ..+..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~  162 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence            5899999999998865432        24567888999999999999999999999999999999999999999999876


Q ss_pred             ccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC--
Q 016959          243 LAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--  320 (380)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--  320 (380)
                      ............|+..|+|||++.........++.++|||||||++|+|++|..||.....   ..............  
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~  239 (275)
T cd06608         163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP---MRALFKIPRNPPPTLK  239 (275)
T ss_pred             cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch---HHHHHHhhccCCCCCC
Confidence            6544333445678999999999864333345567789999999999999999999963222   22222222222222  


Q ss_pred             CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          321 APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       321 ~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      .+...+.++++||.+||..||++|||+.|+++|||+
T Consensus       240 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            223367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=9.8e-45  Score=337.07  Aligned_cols=261  Identities=27%  Similarity=0.377  Sum_probs=204.2

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC--CeEE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRN--GEIE  173 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~  173 (380)
                      +.++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.++++++|+||+++++++...  +.++
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            46789999999999999999999999999999999864432 22233456799999999999999999998754  5689


Q ss_pred             EEEeccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          174 VLLEYMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       174 lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      +||||+.+ +|..++     ...+..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus        85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~  163 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK  163 (309)
T ss_pred             EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence            99999976 453332     235677889999999999999999999999999999999999999999999987654333


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC--------
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--------  320 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------  320 (380)
                      ......++..|+|||++.+    ...++.++|||||||++|+|++|..||......+....+..........        
T Consensus       164 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         164 PMTPKVVTLWYRAPELLLG----CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             CCCcccccccccChhhhcC----CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            3344456889999999753    2445678999999999999999999997443332222222211100000        


Q ss_pred             ------------------CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          321 ------------------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       321 ------------------~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                                        .....++++.+||.+||+.||++|||+.|+|.||||++.+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence                              012257889999999999999999999999999999875443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.5e-44  Score=327.19  Aligned_cols=249  Identities=20%  Similarity=0.294  Sum_probs=204.2

Q ss_pred             CCcccccccceecccCCceEEEEEeC---CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHP---PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      ++..+|++.+.||+|+||.||+|.+.   ..+..||+|+++..........+.+|+.+++.++||||+++++++...+..
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            45678999999999999999999764   356789999997665555567788999999999999999999999999999


Q ss_pred             EEEEeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          173 EVLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      ++||||+.+++|..++..     .+..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+.......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            999999999998765432     466788999999999999999999999999999999999999999999876542221


Q ss_pred             C-CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          248 D-PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       248 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                      . ......++..|+|||.+.     +..++.++|||||||++||++ +|..||.....   ......+........+..+
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~  233 (266)
T cd05064         162 IYTTMSGKSPVLWAAPEAIQ-----YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QDVIKAVEDGFRLPAPRNC  233 (266)
T ss_pred             hhcccCCCCceeecCHHHHh-----hCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHHCCCCCCCCCCC
Confidence            1 111234567899999884     355677999999999999977 49999974332   3333444444445567778


Q ss_pred             cHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          326 SREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      +..+.+++.+||+.+|++||+++||++
T Consensus       234 ~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         234 PNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.4e-44  Score=326.33  Aligned_cols=248  Identities=31%  Similarity=0.442  Sum_probs=207.8

Q ss_pred             ecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCCCc
Q 016959          107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL  184 (380)
Q Consensus       107 LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  184 (380)
                      ||.|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.++|+||+++++.+.++..+++++||+.+++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999999889999999986543  234456789999999999999999999999999999999999999999


Q ss_pred             cccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCCccc
Q 016959          185 EGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYM  260 (380)
Q Consensus       185 ~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~  260 (380)
                      .+++..    .+..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ......|+..|+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~  159 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYV  159 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCcc
Confidence            766533    566788899999999999999999999999999999999999999999998765432 223456899999


Q ss_pred             cccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh-hCCCCCCCccccHHHHHHHHHhccc
Q 016959          261 SPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC-FAQPPEAPEMASREFRDFISRCLQK  339 (380)
Q Consensus       261 aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~  339 (380)
                      +||.+..     ..++.++|+||||+++|+|++|..||.....+. ........ .......+...+.++.++|.+||..
T Consensus       160 ~PE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  233 (262)
T cd05572         160 APEIILN-----KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR  233 (262)
T ss_pred             ChhHhcC-----CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHHHHHhccCCCCCCCcccCHHHHHHHHHHccC
Confidence            9998743     445678999999999999999999997544322 22222222 2445566666789999999999999


Q ss_pred             CcCCCCC-----HHHHhcCccccccCc
Q 016959          340 DPHSRWP-----AAQLLQHPFILRAGQ  361 (380)
Q Consensus       340 dp~~R~t-----~~eil~hp~~~~~~~  361 (380)
                      ||++|++     +.|+++||||...++
T Consensus       234 ~p~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         234 NPEERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             ChhhCcCCcccCHHHHhcChhhhCCCC
Confidence            9999999     999999999998755

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=8.2e-45  Score=333.27  Aligned_cols=252  Identities=32%  Similarity=0.486  Sum_probs=200.0

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +|++.+.||.|+||.||+|.+..+++.||||++.... .......+.+|++++++++|+||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            3788899999999999999999999999999986443 222345688999999999999999999999999999999999


Q ss_pred             cCCCCccccc------ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          179 MDGGSLEGAH------IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       179 ~~~~~L~~~~------~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      +.+ +|..++      ...+..+..++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++..+.........
T Consensus        81 ~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (284)
T cd07860          81 LHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH  159 (284)
T ss_pred             ccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence            964 564433      2356778899999999999999999999999999999999999999999998766543333344


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC--------------
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP--------------  318 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------------  318 (380)
                      ..++..|+|||++.+    ...++.++|||||||++|+|+||..||......+.............              
T Consensus       160 ~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         160 EVVTLWYRAPEILLG----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             ccccccccCCeEEec----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence            567889999998753    23456789999999999999999999964332211111111000000              


Q ss_pred             -----------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          319 -----------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       319 -----------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                                 ......++.+++++|.+||+.||++|||++|+|+||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                       01123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.4e-44  Score=327.21  Aligned_cols=253  Identities=31%  Similarity=0.571  Sum_probs=209.7

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-----chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-----EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      +|+.++.||+|+||.||++.+..+++.||+|++....     .......+.+|+.++++++|+||+++++++.+.+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            3778899999999999999999999999999986433     12345778899999999999999999999999999999


Q ss_pred             EEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-cEEEeeccccccccccCC-
Q 016959          175 LLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMD-  248 (380)
Q Consensus       175 v~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~-  248 (380)
                      ||||+.+++|.+++.    ..+..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++........ 
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999876553    35677888999999999999999999999999999998776 599999999877653311 


Q ss_pred             ---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH-hhCCCCCCCcc
Q 016959          249 ---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI-CFAQPPEAPEM  324 (380)
Q Consensus       249 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~  324 (380)
                         ......|+..|+|||++..     ..++.++|+|||||++|+|++|..||...........+... .....+..+..
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~-----~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRG-----EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH  235 (268)
T ss_pred             CCccccccccccceeCHhHhcc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchh
Confidence               1223568899999999853     45567899999999999999999999754443333333222 22344566677


Q ss_pred             ccHHHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 016959          325 ASREFRDFISRCLQKDPHSRWPAAQLLQHPFIL  357 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~  357 (380)
                      ++.++.+++.+||..||++|||+.|+++||||+
T Consensus       236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         236 LSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             hCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            899999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3e-44  Score=329.64  Aligned_cols=248  Identities=19%  Similarity=0.262  Sum_probs=201.6

Q ss_pred             cCCCccccccc--ceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEee-
Q 016959           94 QLINPAELQKG--NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDR-  168 (380)
Q Consensus        94 ~~~~~~~~~~~--~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-  168 (380)
                      ..++.++++..  ..||+|++|.||+|..  +|+.||||++....  .....+.+.+|+.+|++++||||+++++++.+ 
T Consensus        13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~   90 (283)
T PHA02988         13 KCIESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI   90 (283)
T ss_pred             eecCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence            34566677666  7899999999999998  78999999986543  23335678899999999999999999999876 


Q ss_pred             ---CCeEEEEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEeecccc
Q 016959          169 ---NGEIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKR-KIVHRDIKPSNLLINSSKNVKIADFGVS  240 (380)
Q Consensus       169 ---~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  240 (380)
                         ...+++||||+.+|+|.+++..    .......++.|++.||.|||+. +++||||||+|||++.++.+||+|||++
T Consensus        91 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~  170 (283)
T PHA02988         91 VDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLE  170 (283)
T ss_pred             ccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchH
Confidence               4578999999999999776543    4556788999999999999984 9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH-hhCCCC
Q 016959          241 RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI-CFAQPP  319 (380)
Q Consensus       241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~~  319 (380)
                      ..+....   ....|+..|+|||++..   ....++.++|||||||++|||++|..||......+   ..... ......
T Consensus       171 ~~~~~~~---~~~~~~~~y~aPE~~~~---~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~~i~~~~~~~  241 (283)
T PHA02988        171 KILSSPP---FKNVNFMVYFSYKMLND---IFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYDLIINKNNSL  241 (283)
T ss_pred             hhhcccc---ccccCcccccCHHHhhh---ccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHhcCCCC
Confidence            8654322   34568999999999853   12456789999999999999999999997443322   22222 223344


Q ss_pred             CCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       320 ~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..+..++.++.+||.+||+.||++|||++|+++
T Consensus       242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            455568899999999999999999999999986

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5e-44  Score=325.38  Aligned_cols=252  Identities=35%  Similarity=0.528  Sum_probs=203.9

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEecc
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYM  179 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  179 (380)
                      .+.....||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++|+||+++++++..++..++|+||+
T Consensus         9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   87 (268)
T cd06624           9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV   87 (268)
T ss_pred             cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence            33444689999999999999988999999999865433 33467889999999999999999999999999999999999


Q ss_pred             CCCCccccccc-------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCcEEEeeccccccccccCCCCC
Q 016959          180 DGGSLEGAHIR-------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS-SKNVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       180 ~~~~L~~~~~~-------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      .+++|...+..       .+..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++...........
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  167 (268)
T cd06624          88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE  167 (268)
T ss_pred             CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccc
Confidence            99999765432       45567788999999999999999999999999999986 67899999999876644333334


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD  331 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (380)
                      ...|+..|+|||++..   ....++.++||||||+++|+|++|..||....... ............+..+..++.++.+
T Consensus       168 ~~~~~~~~~aPE~~~~---~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  243 (268)
T cd06624         168 TFTGTLQYMAPEVIDK---GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ-AAMFKVGMFKIHPEIPESLSAEAKN  243 (268)
T ss_pred             cCCCCccccChhhhcc---ccccCCchhhhHHHHHHHHHHHhCCCCCccccChh-hhHhhhhhhccCCCCCcccCHHHHH
Confidence            4568999999999743   12335678999999999999999999996432211 1111122223345566778899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccc
Q 016959          332 FISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       332 li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      |+.+||+.+|++|||+.|++.||||
T Consensus       244 li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         244 FILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHcCCCchhCCCHHHHHhCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.3e-44  Score=325.54  Aligned_cols=250  Identities=32%  Similarity=0.516  Sum_probs=202.7

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC----chHHHHHHHHHHHHHHhCCCCceeeeEeEEee--CCeEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH----EDSVRSQICREIEILRDVNHPNVVKCHDMYDR--NGEIE  173 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~  173 (380)
                      +|+..+.||+|+||.||+|.+..+++.||+|++....    .......+.+|+.+++.++|+||+++++++..  .+.++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            6888999999999999999999999999999985432    22345678899999999999999999998865  36788


Q ss_pred             EEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC--
Q 016959          174 VLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM--  247 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--  247 (380)
                      +++||+.+++|.+.+.    ..+..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..+....  
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS  162 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence            9999999999876543    3466778899999999999999999999999999999999999999999987654211  


Q ss_pred             -CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcccc
Q 016959          248 -DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS  326 (380)
Q Consensus       248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (380)
                       .......++..|+|||.+.+     ..++.++|||||||++|+|++|+.||....  ..............+..+..++
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~i~~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~  235 (266)
T cd06651         163 GTGIRSVTGTPYWMSPEVISG-----EGYGRKADVWSLGCTVVEMLTEKPPWAEYE--AMAAIFKIATQPTNPQLPSHIS  235 (266)
T ss_pred             CCccccCCccccccCHHHhCC-----CCCCchhhhHHHHHHHHHHHHCCCCccccc--hHHHHHHHhcCCCCCCCchhcC
Confidence             11233568899999999853     456778999999999999999999996332  1222222222233455566788


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 016959          327 REFRDFISRCLQKDPHSRWPAAQLLQHPFIL  357 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t~~eil~hp~~~  357 (380)
                      ..+++++ +||..+|++||+++|+++||||+
T Consensus       236 ~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         236 EHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            8999999 68889999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.7e-44  Score=336.55  Aligned_cols=245  Identities=27%  Similarity=0.455  Sum_probs=185.3

Q ss_pred             cceecccCCceEEEEEeCC--CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEe--eCCeEEEEEecc
Q 016959          104 GNRIGSGSGGTVWRVVHPP--TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYD--RNGEIEVLLEYM  179 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~  179 (380)
                      +.+||+|+||+||+|.+..  +++.||+|.+.....   ...+.+|+.+++.++|+||+++++++.  .+..+++||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            4689999999999999654  568899999854432   235678999999999999999999885  356789999999


Q ss_pred             CCCCccccc-------------ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----cCCCcEEEeecccccc
Q 016959          180 DGGSLEGAH-------------IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI----NSSKNVKIADFGVSRI  242 (380)
Q Consensus       180 ~~~~L~~~~-------------~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~----~~~~~~kl~Dfg~a~~  242 (380)
                      .++ |...+             ...+..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||+++.
T Consensus        83 ~~~-l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          83 EHD-LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CCc-HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            864 32221             23566788999999999999999999999999999999    4567899999999987


Q ss_pred             ccccCC---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC---------HHHHH
Q 016959          243 LAQTMD---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD---------WASLM  310 (380)
Q Consensus       243 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---------~~~~~  310 (380)
                      ......   ......||..|+|||++..    ...++.++|||||||++|||++|..||.......         ....+
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI  237 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcC----CCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence            653321   2234578999999999853    2446778999999999999999999996432110         00000


Q ss_pred             HHHhhCC----------------------------------CCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          311 FAICFAQ----------------------------------PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       311 ~~~~~~~----------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      .......                                  ........+..+++||.+||+.||++|||+.|+|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0000000                                  000111235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.1e-44  Score=330.64  Aligned_cols=253  Identities=30%  Similarity=0.445  Sum_probs=203.6

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++|+||+++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            47889999999999999999998999999999865442 34456788999999999999999999999999999999999


Q ss_pred             cCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-CCCC
Q 016959          179 MDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-PCNS  252 (380)
Q Consensus       179 ~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~~~  252 (380)
                      + +++|.+++.     ..+..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........ ....
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH  159 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence            9 899876543     35677889999999999999999999999999999999999999999999887654321 2334


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC----------------
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA----------------  316 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~----------------  316 (380)
                      ..|+..|+|||++..    ...++.++|||||||++|+|++|..+|...........+......                
T Consensus       160 ~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         160 QVATRWYRAPELLYG----ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             ccCcccccCceeeec----cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence            568999999998753    244577999999999999999998888543322111111110000                


Q ss_pred             ---CCC-------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 016959          317 ---QPP-------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFIL  357 (380)
Q Consensus       317 ---~~~-------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~  357 (380)
                         .+.       ......+.++.+||.+||+.||++|||++++|+||||.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence               000       01124568999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=329.54  Aligned_cols=256  Identities=29%  Similarity=0.415  Sum_probs=208.1

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-C-C----ceeeeEeEEe
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-H-P----NVVKCHDMYD  167 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----~iv~~~~~~~  167 (380)
                      ..+-..+|.+..+||+|+||.|..|.+..++..||||+++  .-..+++...-|+++|+++. + |    -+|.+.+||+
T Consensus        84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik--~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK--NVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHH--HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            3344678999999999999999999999999999999984  34566777888999999994 2 2    4778889999


Q ss_pred             eCCeEEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-------------
Q 016959          168 RNGEIEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS-------------  228 (380)
Q Consensus       168 ~~~~~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~-------------  228 (380)
                      ..+++|+|+|.+. .++.+++.      .+...++.|++|++.+|+|||+++++|.||||+|||+.+             
T Consensus       162 yrghiCivfellG-~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  162 YRGHICIVFELLG-LSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             ccCceEEEEeccC-hhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence            9999999999995 34444433      467789999999999999999999999999999999832             


Q ss_pred             -------CCcEEEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 016959          229 -------SKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVG  301 (380)
Q Consensus       229 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  301 (380)
                             .-.|+|+|||.|+.....   ..+.+.|..|+|||++.     |-.|+.++||||+||||+||++|...|...
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViL-----gLGwS~pCDvWSiGCIL~ElytG~~LFqtH  312 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVIL-----GLGWSQPCDVWSIGCILVELYTGETLFQTH  312 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchhee-----ccCcCCccCceeeeeEEEEeeccceecccC
Confidence                   224999999999866533   36788999999999995     467788999999999999999999999977


Q ss_pred             CCCCHHHHHHHHhhCCCCC-----------------CCc-------------------------cccHHHHHHHHHhccc
Q 016959          302 RQGDWASLMFAICFAQPPE-----------------APE-------------------------MASREFRDFISRCLQK  339 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~-----------------~~~-------------------------~~~~~~~~li~~~l~~  339 (380)
                      ++.+...++..+....+..                 ++.                         ....++.|||++||..
T Consensus       313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f  392 (415)
T KOG0671|consen  313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF  392 (415)
T ss_pred             CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence            7666555555544322211                 010                         0222689999999999


Q ss_pred             CcCCCCCHHHHhcCccccccC
Q 016959          340 DPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       340 dp~~R~t~~eil~hp~~~~~~  360 (380)
                      ||.+|+|+.|+|.||||+++.
T Consensus       393 DP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  393 DPARRITLREALSHPFFARLT  413 (415)
T ss_pred             CccccccHHHHhcCHHhhcCC
Confidence            999999999999999999864

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.1e-44  Score=325.30  Aligned_cols=249  Identities=31%  Similarity=0.536  Sum_probs=204.0

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-----chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-----EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      +|.+++.||+|+||+||+|... +++.+|+|.+....     .......+.+|+++++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            4788899999999999999874 78899999985432     22334568899999999999999999999999999999


Q ss_pred             EEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc----
Q 016959          175 LLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT----  246 (380)
Q Consensus       175 v~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  246 (380)
                      ++||+.+++|.+++..    .+..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++......    
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            9999999998776533    56778889999999999999999999999999999999999999999998765321    


Q ss_pred             --CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh-hCCCCCCCc
Q 016959          247 --MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC-FAQPPEAPE  323 (380)
Q Consensus       247 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~  323 (380)
                        ........|+..|+|||++..     ..++.++|||||||++|+|++|..||...+..  ........ ....+..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~  232 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINE-----SGYGRKSDIWSIGCTVFEMATGKPPLASMDRL--AAMFYIGAHRGLMPRLPD  232 (265)
T ss_pred             cccccccccCCCccccChhhhcC-----CCCcchhhHHHHHHHHHHHHhCCCccccCChH--HHHHHhhhccCCCCCCCC
Confidence              112234568999999999853     44567899999999999999999999643221  11111111 123345667


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      .++.++.++|.+||..||++||++.|+++||||
T Consensus       233 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         233 SFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            789999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.3e-44  Score=328.97  Aligned_cols=259  Identities=34%  Similarity=0.585  Sum_probs=203.3

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHH-HHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ++|++.+.||+|+||.||++.+..+|+.||+|++...........+..|+.. ++.++|+||+++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            3688999999999999999999999999999998765433333455556665 666789999999999999999999999


Q ss_pred             ccCCCCccccc--------ccchHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          178 YMDGGSLEGAH--------IRQEHILSDLARQVLSGLAYLHKR-KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       178 ~~~~~~L~~~~--------~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      |+++ +|.+.+        ...+..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||++....... 
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (283)
T cd06617          81 VMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-  158 (283)
T ss_pred             hhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence            9975 443222        235777889999999999999997 99999999999999999999999999987654321 


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCC-ccccH
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAP-EMASR  327 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  327 (380)
                      ......|+..|+|||++..... ...++.++|+|||||++|+|++|+.||..... .. ..............+ ..++.
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd06617         159 AKTIDAGCKPYMAPERINPELN-QKGYDVKSDVWSLGITMIELATGRFPYDSWKT-PF-QQLKQVVEEPSPQLPAEKFSP  235 (283)
T ss_pred             ccccccCCccccChhhcCCccc-ccccCccccchhhHHHHHHHHhCCCCCCcccc-CH-HHHHHHHhcCCCCCCccccCH
Confidence            1233568899999998853211 13456789999999999999999999963221 22 222222222223332 35788


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      ++.+||.+||..+|++||++.|+++||||+.....
T Consensus       236 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         236 EFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence            99999999999999999999999999999997644

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.6e-44  Score=329.78  Aligned_cols=252  Identities=29%  Similarity=0.486  Sum_probs=202.2

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEecc
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYM  179 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  179 (380)
                      +|++.++||.|++|.||+|++..+|+.||||++...........+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            47889999999999999999999999999999876544444466778999999999999999999999999999999999


Q ss_pred             CCCCccccc-------ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          180 DGGSLEGAH-------IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       180 ~~~~L~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      .+ +|.+++       ...+..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++............
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN  159 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence            86 554432       2356778899999999999999999999999999999999999999999999766443333344


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC--------------
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP--------------  318 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------------  318 (380)
                      ..++..|++||++..    ...++.++|||||||++|+|++|..||......+....+........              
T Consensus       160 ~~~~~~y~~PE~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07836         160 EVVTLWYRAPDVLLG----SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK  235 (284)
T ss_pred             ccccccccChHHhcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence            567899999998743    23456789999999999999999999975433222221111100000              


Q ss_pred             C-----------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          319 P-----------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       319 ~-----------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      .           ...+.++..++++|.+||+.||++||++.|+++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            0           0112357789999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-44  Score=339.86  Aligned_cols=272  Identities=28%  Similarity=0.398  Sum_probs=207.1

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC-----CeEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRN-----GEIE  173 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~  173 (380)
                      ++|++.++||+|+||.||+|.+..+|+.||||++...........+.+|+.+++.++|+||+++++++...     ...+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            57999999999999999999999999999999986544444556778899999999999999999986543     3589


Q ss_pred             EEEeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--
Q 016959          174 VLLEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD--  248 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--  248 (380)
                      +|+||+.+ +|.....   ..+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  
T Consensus        85 lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  163 (336)
T cd07849          85 IVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT  163 (336)
T ss_pred             EEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccccc
Confidence            99999976 5543332   35677889999999999999999999999999999999999999999999876543221  


Q ss_pred             -CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh------------
Q 016959          249 -PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF------------  315 (380)
Q Consensus       249 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~------------  315 (380)
                       ......|+..|+|||.+.+    ...++.++|||||||++|+|++|+.||...........+.....            
T Consensus       164 ~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
T cd07849         164 GFLTEYVATRWYRAPEIMLN----SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS  239 (336)
T ss_pred             CCcCCcCcCCCccChHHhhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence             1234568999999998743    24467789999999999999999999964322111111100000            


Q ss_pred             --------CC--CCC-----CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccccccccccCCCCCCCC
Q 016959          316 --------AQ--PPE-----APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPLS  379 (380)
Q Consensus       316 --------~~--~~~-----~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~  379 (380)
                              ..  ...     .....+.++.+||.+||+.||++|||+.|+++||||....-.    ..-...++|.||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~----~~~~~~~~~~~~~  314 (336)
T cd07849         240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP----SDEPVAEEPFPFD  314 (336)
T ss_pred             hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC----CCcccCCCCCChh
Confidence                    00  000     112357789999999999999999999999999999976322    1133444555654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.9e-44  Score=329.41  Aligned_cols=251  Identities=29%  Similarity=0.405  Sum_probs=197.7

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+|+.+++.++|+||+++++++..++..++||||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            57999999999999999999999899999999986554333344567899999999999999999999999999999999


Q ss_pred             cCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          179 MDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       179 ~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      +.+ +|...+.     ..+..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++............
T Consensus        85 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  163 (291)
T cd07870          85 MHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE  163 (291)
T ss_pred             ccC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCc
Confidence            974 5433322     2456677899999999999999999999999999999999999999999987654333333445


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh--CCC-------------
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF--AQP-------------  318 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~-------------  318 (380)
                      .++..|+|||++..    ...++.++|||||||++|+|++|..||.....  ..+.......  ..+             
T Consensus       164 ~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         164 VVTLWYRPPDVLLG----ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             cccccccCCceeec----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence            67899999999753    23456689999999999999999999963322  1111111100  000             


Q ss_pred             -----------CC---CC--ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          319 -----------PE---AP--EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       319 -----------~~---~~--~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                                 ..   .+  ...+.++.+++.+||..||++|||+.|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                       00   00  0125689999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-44  Score=352.94  Aligned_cols=259  Identities=22%  Similarity=0.258  Sum_probs=189.9

Q ss_pred             cccccccceecccCCceEEEEEeCCCC-cEEEEEE--------------ecC--CCchHHHHHHHHHHHHHHhCCCCcee
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTS-RVFALKV--------------IYG--NHEDSVRSQICREIEILRDVNHPNVV  160 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~-~~~avK~--------------~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv  160 (380)
                      .++|++.++||+|+||+||+|..+... ..+++|.              +.+  .........+.+|+.+|++++|+||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            468999999999999999998764332 2222221              100  11223345688999999999999999


Q ss_pred             eeEeEEeeCCeEEEEEeccCCCCcccccc---------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc
Q 016959          161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHI---------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN  231 (380)
Q Consensus       161 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~  231 (380)
                      ++++++...+..|+|++++.+. |..++.         .....++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYDFD-LYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEeccccC-HHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            9999999999999999998653 322211         123456779999999999999999999999999999999999


Q ss_pred             EEEeeccccccccccCC-CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHH
Q 016959          232 VKIADFGVSRILAQTMD-PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLM  310 (380)
Q Consensus       232 ~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~  310 (380)
                      +||+|||++..+..... .....+||..|+|||++..     ..++.++|||||||++|||++|..++...........+
T Consensus       306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-----DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             EEEEeCCCceecCcccccccccccCCcCCCCchhhcC-----CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            99999999987654322 2235679999999999853     45678999999999999999987654322222211111


Q ss_pred             HHHhhCC---CC-----------------------C-----CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          311 FAICFAQ---PP-----------------------E-----APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       311 ~~~~~~~---~~-----------------------~-----~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      .......   ..                       .     ....++.++.++|.+||+.||++|||+.|+|+||||...
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            1111000   00                       0     001245678889999999999999999999999999886


Q ss_pred             Ccc
Q 016959          360 GQS  362 (380)
Q Consensus       360 ~~~  362 (380)
                      ...
T Consensus       461 ~~~  463 (501)
T PHA03210        461 EEE  463 (501)
T ss_pred             Cch
Confidence            543

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=7.7e-44  Score=326.14  Aligned_cols=254  Identities=25%  Similarity=0.399  Sum_probs=204.0

Q ss_pred             eecccCCceEEEEEeCCCCcEEEEEEecCCCch--HHHHHHHHHH---HHHHhCCCCceeeeEeEEeeCCeEEEEEeccC
Q 016959          106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED--SVRSQICREI---EILRDVNHPNVVKCHDMYDRNGEIEVLLEYMD  180 (380)
Q Consensus       106 ~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~E~---~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  180 (380)
                      .||+|+||.||++.+..+++.||+|.+......  .....+..|.   .+++...|++|+.+++++...+.+++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999989999999998643211  1112233343   34445579999999999999999999999999


Q ss_pred             CCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCC
Q 016959          181 GGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT  256 (380)
Q Consensus       181 ~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  256 (380)
                      |++|..++.    ..+..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++..+....  .....|+
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~  158 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVGT  158 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--CcCcCCC
Confidence            999876543    3567788999999999999999999999999999999999999999999987654322  2345799


Q ss_pred             CccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHh
Q 016959          257 IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC  336 (380)
Q Consensus       257 ~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  336 (380)
                      ..|+|||++..    +..++.++||||+||++|+|++|..||........... ...........+..++.++.+++.+|
T Consensus       159 ~~y~aPE~~~~----~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~~li~~~  233 (278)
T cd05606         159 HGYMAPEVLQK----GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTLTMAVELPDSFSPELRSLLEGL  233 (278)
T ss_pred             cCCcCcHHhcC----CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-HHHhhccCCCCCCcCCHHHHHHHHHH
Confidence            99999999853    23466789999999999999999999975433333222 22233344566677899999999999


Q ss_pred             cccCcCCCC-----CHHHHhcCccccccCcccccc
Q 016959          337 LQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQ  366 (380)
Q Consensus       337 l~~dp~~R~-----t~~eil~hp~~~~~~~~~~~~  366 (380)
                      |..||.+|+     ++.|+++||||++..+.....
T Consensus       234 l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~  268 (278)
T cd05606         234 LQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFL  268 (278)
T ss_pred             hhcCHHhccCCCCCCHHHHHhCccccCCCchHhhh
Confidence            999999999     999999999999988777654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1e-43  Score=320.95  Aligned_cols=249  Identities=26%  Similarity=0.421  Sum_probs=210.1

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +|+..+.||.|+||.||.+++..+++.+++|.+.... .......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4788999999999999999999999999999985432 344556788999999999999999999999999999999999


Q ss_pred             cCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          179 MDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       179 ~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      +.+++|.+.+..      .+..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++............
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET  160 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence            999998765533      45678889999999999999999999999999999999999999999999876544333455


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      ..|+..|+|||.+.+     ..++.++||||||+++|+|++|..||....   .......+...........++.++.++
T Consensus       161 ~~~~~~y~ape~~~~-----~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (256)
T cd08221         161 VVGTPYYMSPELCQG-----VKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQGNYTPVVSVYSSELISL  232 (256)
T ss_pred             cCCCccccCHhhcCC-----CCCCCcchhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCCCccccCHHHHHH
Confidence            678999999998753     345678999999999999999999996432   333333333344444556678999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccc
Q 016959          333 ISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       333 i~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      |.+||..||++||++.|+|+|+|+
T Consensus       233 i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         233 VHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.2e-44  Score=326.92  Aligned_cols=251  Identities=21%  Similarity=0.340  Sum_probs=202.6

Q ss_pred             CCCcccccccceecccCCceEEEEEeCC-----CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPP-----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRN  169 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  169 (380)
                      .+..++|++.+.||+|+||.||+|.+..     ++..||+|++...........+.+|+.+++.++|+||+++++++...
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4567889999999999999999998642     45679999986544444456788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCccccccc--------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEe
Q 016959          170 GEIEVLLEYMDGGSLEGAHIR--------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIA  235 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~~--------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~  235 (380)
                      +..++||||+.+++|.+++..              ....+..++.|++.||.|||++|++|+||||+|||++.++.++|+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence            999999999999998766532              234577899999999999999999999999999999999999999


Q ss_pred             eccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHH
Q 016959          236 DFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFA  312 (380)
Q Consensus       236 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~  312 (380)
                      |||++..+.....  ......++..|+|||++..     ..++.++|||||||++|||++ |..||.....   ......
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~~~  233 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-----GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVLRF  233 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhhc-----CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence            9999876543221  1122345788999999853     556788999999999999998 7889864332   233333


Q ss_pred             HhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          313 ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      .........+..++..+.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         234 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            33333445566788899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.9e-44  Score=331.99  Aligned_cols=256  Identities=29%  Similarity=0.439  Sum_probs=204.5

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc----hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE----DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      +|.+.+.||+|+||.||+|.+..+++.||||.+.....    ......+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            37788899999999999999998999999999965432    22345677899999999999999999999999999999


Q ss_pred             EeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          176 LEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       176 ~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      |||+ +++|..++.     ..+..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..........
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 888865543     3566788999999999999999999999999999999999999999999998775543334


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC------------
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP------------  318 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------------  318 (380)
                      ....++..|+|||.+..    ...++.++|+|||||++|+|++|..+|......+....+........            
T Consensus       160 ~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         160 THQVVTRWYRAPELLFG----ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             cccccceeeeCHHHHhC----CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence            44567889999998743    24567789999999999999999777754332221111111100000            


Q ss_pred             ------------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          319 ------------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       319 ------------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                                  .......+.++.+||.+||..||++|||+.|+|+|+||++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence                        011234577899999999999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.2e-44  Score=324.88  Aligned_cols=248  Identities=31%  Similarity=0.486  Sum_probs=204.1

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCC--CchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++|++.+.||+|+||.||+|++..+++.||||.+...  ........+.+|+.+++.++|+||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5789999999999999999999999999999987542  23444567889999999999999999999999999999999


Q ss_pred             eccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          177 EYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       177 e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ||+.+++|..++.        ..+..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence            9999999865542        24567889999999999999999999999999999999999999999999887654333


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC-CCCCccccH
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP-PEAPEMASR  327 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  327 (380)
                      ......|+..|+|||.+..     ..++.++|+||||+++|+|++|+.||..... +............. +......+.
T Consensus       162 ~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08228         162 AAHSLVGTPYYMSPERIHE-----NGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQKIEQCDYPPLPTEHYSE  235 (267)
T ss_pred             HHhcCCCCccccChhhhcc-----CCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHHHHHhcCCCCCCChhhcCH
Confidence            2344568899999998853     3456789999999999999999999964332 22333333332222 223345778


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .+.++|.+||+.+|++||++.|+++
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHH
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-45  Score=344.79  Aligned_cols=256  Identities=29%  Similarity=0.457  Sum_probs=220.6

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ..-|.+.+.||+|.|++|.++++..++..||||++.+.. +......+.+|+++|+.|+|||||+++.+.+....+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            346889999999999999999999999999999997665 3334456889999999999999999999999999999999


Q ss_pred             eccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          177 EYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       177 e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      ||+.+|.+++++..    .+...+.++.|++.|++|||+++|||||||++|||++.+.++||+|||++..+.. .....+
T Consensus       135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-~~~lqt  213 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY-GLMLQT  213 (596)
T ss_pred             EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc-cccccc
Confidence            99999999877654    4566788999999999999999999999999999999999999999999998873 456689


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      .+|++.|.|||++.+.    .|.++++|+||+|++||.|+.|..||............    .......+-.++-++.+|
T Consensus       214 ~cgsppyAaPEl~~g~----~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv----l~gk~rIp~~ms~dce~l  285 (596)
T KOG0586|consen  214 FCGSPPYAAPELFNGK----KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV----LRGKYRIPFYMSCDCEDL  285 (596)
T ss_pred             cCCCCCccChHhhcCc----ccCCcceehhhhhhhheeeeecccccCCcccccccchh----eeeeecccceeechhHHH
Confidence            9999999999999763    57788999999999999999999999754433322222    122234456678899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          333 ISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       333 i~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      |+++|.++|.+|++.++++.|.|.-.....
T Consensus       286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  286 LRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             HHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            999999999999999999999999876555

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-44  Score=324.18  Aligned_cols=252  Identities=35%  Similarity=0.522  Sum_probs=206.3

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .++|++.+.||.|+||.||+|.+..+++.+++|++...... ....+.+|+.+++.++|+||+++++++...+.++++||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            36799999999999999999999989999999998655433 45778899999999999999999999999999999999


Q ss_pred             ccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          178 YMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       178 ~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      |+.+++|..++     ...+..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++..+.........
T Consensus        81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  160 (262)
T cd06613          81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS  160 (262)
T ss_pred             CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence            99999987643     2356778899999999999999999999999999999999999999999999876544333345


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC--C--CCCCCccccHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA--Q--PPEAPEMASRE  328 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~  328 (380)
                      ..++..|+|||.+....  ...++.++|+|||||++|+|++|..||.....   ..........  .  ........+.+
T Consensus       161 ~~~~~~y~~Pe~~~~~~--~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (262)
T cd06613         161 FIGTPYWMAPEVAAVER--KGGYDGKCDIWALGITAIELAELQPPMFDLHP---MRALFLISKSNFPPPKLKDKEKWSPV  235 (262)
T ss_pred             ccCCccccCchhhcccc--cCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCCCccccchhhhhHH
Confidence            67899999999985311  12456789999999999999999999964322   2222222111  1  11123345678


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcc
Q 016959          329 FRDFISRCLQKDPHSRWPAAQLLQHPF  355 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~eil~hp~  355 (380)
                      +.+||.+||..||++|||+.+++.|+|
T Consensus       236 ~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         236 FHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.2e-44  Score=332.08  Aligned_cols=256  Identities=32%  Similarity=0.494  Sum_probs=209.4

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +.|.....||+|+||.||++.+..+++.||||.+.... ....+.+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            34556778999999999999999899999999985433 33456688999999999999999999999999999999999


Q ss_pred             cCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCC
Q 016959          179 MDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG  255 (380)
Q Consensus       179 ~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  255 (380)
                      +.+++|..++.   ..+..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..............|
T Consensus       101 ~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~  180 (292)
T cd06658         101 LEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVG  180 (292)
T ss_pred             CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeec
Confidence            99999876543   356778899999999999999999999999999999999999999999998765444333345678


Q ss_pred             CCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC--CCCccccHHHHHHH
Q 016959          256 TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP--EAPEMASREFRDFI  333 (380)
Q Consensus       256 t~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li  333 (380)
                      +..|+|||.+..     ..++.++||||||+++|||++|..||.....   .............  .....++..+.++|
T Consensus       181 ~~~y~aPE~~~~-----~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li  252 (292)
T cd06658         181 TPYWMAPEVISR-----LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRRIRDNLPPRVKDSHKVSSVLRGFL  252 (292)
T ss_pred             CccccCHHHHcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCccccccccCHHHHHHH
Confidence            999999998853     4456789999999999999999999964322   2222222222222  22335688999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          334 SRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       334 ~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                      .+||..||++|||++|+++||||+..+.-+
T Consensus       253 ~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         253 DLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             HHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence            999999999999999999999999865443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-45  Score=344.33  Aligned_cols=279  Identities=24%  Similarity=0.358  Sum_probs=227.0

Q ss_pred             cccccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEe
Q 016959           90 QNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYD  167 (380)
Q Consensus        90 ~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  167 (380)
                      ..+..+.+..-|..++.||-|+||+|.++...+|...||+|.+++..  .......++.|..||...+.+-||+||..|.
T Consensus       620 RLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ  699 (1034)
T KOG0608|consen  620 RLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ  699 (1034)
T ss_pred             HHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence            34555678888999999999999999999999999999999996543  2334556788999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          168 RNGEIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       168 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                      +.+.+|+||||+.||++..++.+    .|...+.++.++.+|++++|..|+|||||||+|||||.+|+|||+||||++-+
T Consensus       700 DkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  700 DKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             cCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccc
Confidence            99999999999999998766544    56778889999999999999999999999999999999999999999999744


Q ss_pred             cccCC------------------------------------------CCCCCCCCCccccccccccccCCCCCCCcchhH
Q 016959          244 AQTMD------------------------------------------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDI  281 (380)
Q Consensus       244 ~~~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dv  281 (380)
                      ....+                                          .....+||+.|+|||++..     ..++..+|+
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-----~g~~q~cdw  854 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-----TGYTQLCDW  854 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-----cCccccchh
Confidence            21100                                          0124579999999999964     455678999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCC---HHHHhcCccccc
Q 016959          282 WSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWP---AAQLLQHPFILR  358 (380)
Q Consensus       282 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t---~~eil~hp~~~~  358 (380)
                      ||.|||||||+.|+.||-.....+.-..+............-++++++.++|.++. .+++.|+.   ++||..||||++
T Consensus       855 ws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg  933 (1034)
T KOG0608|consen  855 WSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG  933 (1034)
T ss_pred             hHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence            99999999999999999755544332222222233334455678999999998865 67888884   778999999999


Q ss_pred             cCcccccccccccCCC
Q 016959          359 AGQSQVNQNLRQILPP  374 (380)
Q Consensus       359 ~~~~~~~~~~~~~~~~  374 (380)
                      +.|...+++.-.-||.
T Consensus       934 IDfsslRkq~ApYIP~  949 (1034)
T KOG0608|consen  934 IDFSSLRKQRAPYIPR  949 (1034)
T ss_pred             cchHhhhhccCCcCcc
Confidence            9999987776556654

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-46  Score=341.90  Aligned_cols=249  Identities=34%  Similarity=0.507  Sum_probs=219.7

Q ss_pred             cceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCC
Q 016959          104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGG  182 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  182 (380)
                      .++||.|-||+||-|+++.+|+.||||++.+.. .......+.+|+.+|+.+.||.||.+-..|+..+.+++|||.+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            468999999999999999999999999996543 2333477899999999999999999999999999999999999876


Q ss_pred             Ccc-----cccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---cEEEeeccccccccccCCCCCCCC
Q 016959          183 SLE-----GAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK---NVKIADFGVSRILAQTMDPCNSAV  254 (380)
Q Consensus       183 ~L~-----~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~  254 (380)
                      -|+     ...+.++.....++.||+.||.|||-+||+|.||||+|||+....   ++||||||+|+.+... ....+.+
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRrsVV  727 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRRSVV  727 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-hhhhhhc
Confidence            553     233445666777889999999999999999999999999997554   5999999999988654 3346789


Q ss_pred             CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHH
Q 016959          255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS  334 (380)
Q Consensus       255 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  334 (380)
                      ||+.|+|||++.+     +.|...-||||+|+|+|--+.|..||.  +.+++...+....+..++..|..++.++.|||.
T Consensus       728 GTPAYLaPEVLrn-----kGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEdIndQIQNAaFMyPp~PW~eis~~AidlIn  800 (888)
T KOG4236|consen  728 GTPAYLAPEVLRN-----KGYNRSLDMWSVGVIIYVSLSGTFPFN--EDEDINDQIQNAAFMYPPNPWSEISPEAIDLIN  800 (888)
T ss_pred             CCccccCHHHHhh-----ccccccccceeeeEEEEEEecccccCC--CccchhHHhhccccccCCCchhhcCHHHHHHHH
Confidence            9999999999964     666778999999999999999999995  567888899999999999999999999999999


Q ss_pred             HhcccCcCCCCCHHHHhcCccccccC
Q 016959          335 RCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       335 ~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      .+|+..-.+|.++++.|.|||+++-.
T Consensus       801 ~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  801 NLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHHHHHHhcchHhhccchhhhcch
Confidence            99999999999999999999999864

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-43  Score=326.42  Aligned_cols=257  Identities=38%  Similarity=0.618  Sum_probs=206.3

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee--CCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR--NGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~  176 (380)
                      ++|+..++||.|++|.||+|.+..+++.+|+|++...........+.+|+++++.++|+||++++++|..  .+.+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            3678889999999999999999999999999999765555566788999999999999999999998854  34789999


Q ss_pred             eccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          177 EYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       177 e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ||+.+++|.+++.        ..+..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA  160 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence            9999999865432        24566888999999999999999999999999999999999999999999876543221


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--CCHHHHHHHHhhCCCCCCC----
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ--GDWASLMFAICFAQPPEAP----  322 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~----  322 (380)
                        ....++..|+|||.+..     ..++.++|||||||++|+|++|..||.....  ....+..........+...    
T Consensus       161 --~~~~~~~~y~~pE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         161 --GTFTGTSFYMAPERIQG-----KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             --ccccCCccccCHHHhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence              24457889999998853     4456789999999999999999999975422  1222222222221111111    


Q ss_pred             --ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          323 --EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       323 --~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                        ...++++.+||.+||..||++|||+.|++.||||+.....
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~  275 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK  275 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence              2245789999999999999999999999999999776444

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=8.3e-44  Score=322.49  Aligned_cols=249  Identities=32%  Similarity=0.487  Sum_probs=209.2

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEee--CCeEEEEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDR--NGEIEVLL  176 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~  176 (380)
                      +|++.+.||.|+||.||++.+..+++.||+|++.... .....+.+.+|+++++.++|+||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999999999999999986443 34455678899999999999999999997753  45689999


Q ss_pred             eccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHH-----hCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          177 EYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLH-----KRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       177 e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH-----~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                      ||+.+++|..++.        ..+..++.++.||+.||.|||     +.+++|+||||+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            9999999876543        245678899999999999999     899999999999999999999999999999877


Q ss_pred             cccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      ...........|+..|+|||++..     ..++.++|+||||+++|+|++|..||....   ................+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~pE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~  232 (265)
T cd08217         161 GHDSSFAKTYVGTPYYMSPEQLNH-----MSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIKEGKFRRIPY  232 (265)
T ss_pred             cCCcccccccccCCCccChhhhcC-----CCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHHhcCCCCCCcc
Confidence            654433445678999999999853     345678999999999999999999997443   333344444444456667


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      ..+.++.+++.+||..+|++|||+.||++|||+
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            788999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.1e-44  Score=330.41  Aligned_cols=254  Identities=25%  Similarity=0.370  Sum_probs=197.7

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCe-----
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGE-----  171 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~-----  171 (380)
                      ++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.+. |+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            368899999999999999999999999999999854432 223456788999999995 6999999999877655     


Q ss_pred             EEEEEeccCCCCccccc---------ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCcEEEeeccccc
Q 016959          172 IEVLLEYMDGGSLEGAH---------IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS-SKNVKIADFGVSR  241 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~---------~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~  241 (380)
                      .|+||||+.+ +|..++         ...+..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            8999999986 564432         2356778899999999999999999999999999999998 8899999999988


Q ss_pred             cccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC---
Q 016959          242 ILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP---  318 (380)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---  318 (380)
                      .+...........+++.|+|||++..    ...++.++|+||||+++|+|++|..||...........+........   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         160 AFSIPVKSYTHEIVTLWYRAPEVLLG----STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             ecCCCccccCCcccccCCCChHHhhC----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            65433333334457889999998743    24457789999999999999999999964322111111100000000   


Q ss_pred             ---------------------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 016959          319 ---------------------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFIL  357 (380)
Q Consensus       319 ---------------------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~  357 (380)
                                           ....+.++.++.+||.+||..||++||++.|+|.||||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                                 001134688999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=9.5e-44  Score=327.35  Aligned_cols=262  Identities=26%  Similarity=0.448  Sum_probs=211.6

Q ss_pred             cccccceecccCCceEEEEEeC---CCCcEEEEEEecCCC---chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHP---PTSRVFALKVIYGNH---EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~---~~~~~~avK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  172 (380)
                      .|++.+.||.|+||.||+|.+.   .+|+.||+|++....   .....+.+.+|+.+++.+ +|+||+.+++++..++.+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            3778899999999999999875   478999999986432   223346678899999999 599999999999999999


Q ss_pred             EEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-
Q 016959          173 EVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM-  247 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  247 (380)
                      ++||||+.+++|.+++.    ..+..+..++.||+.||.|||++|++||||+|+|||++.++.+||+|||++....... 
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  160 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV  160 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence            99999999999876543    3566788889999999999999999999999999999999999999999987654322 


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                      .......|+..|+|||.+...   ...++.++||||||+++|+|++|..||...........+...........+..++.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (290)
T cd05613         161 ERAYSFCGTIEYMAPDIVRGG---DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA  237 (290)
T ss_pred             cccccccCCcccCChhhccCC---CCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCH
Confidence            122345689999999998531   13456789999999999999999999974433322223333333334455667889


Q ss_pred             HHHHHHHHhcccCcCCCC-----CHHHHhcCccccccCcccc
Q 016959          328 EFRDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~-----t~~eil~hp~~~~~~~~~~  364 (380)
                      .+.+++.+||+.||++|+     ++.++++||||+..++...
T Consensus       238 ~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~  279 (290)
T cd05613         238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDL  279 (290)
T ss_pred             HHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHH
Confidence            999999999999999997     8999999999999987554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.2e-43  Score=325.43  Aligned_cols=250  Identities=21%  Similarity=0.330  Sum_probs=204.7

Q ss_pred             CCcccccccceecccCCceEEEEEeC----CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHP----PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      +..++|++.+.||+|+||+||+|.+.    .+++.+|+|.+...........+.+|+.+++.++|+||+++++++.....
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   81 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence            34578999999999999999999853    45678999999765555555778899999999999999999999999999


Q ss_pred             EEEEEeccCCCCcccccc---------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC
Q 016959          172 IEVLLEYMDGGSLEGAHI---------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK  230 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~---------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~  230 (380)
                      .|+||||+.+++|.+++.                     ..+..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence            999999999999876642                     23456778999999999999999999999999999999999


Q ss_pred             cEEEeeccccccccccC--CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHH
Q 016959          231 NVKIADFGVSRILAQTM--DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWA  307 (380)
Q Consensus       231 ~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~  307 (380)
                      .+||+|||+++.+....  .......++..|+|||++..     ..++.++|||||||++|||++ |..||....   ..
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~~~g~~p~~~~~---~~  233 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-----GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---NQ  233 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhcc-----CCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HH
Confidence            99999999997654321  11233446778999998853     446779999999999999998 999996432   23


Q ss_pred             HHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          308 SLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ..............+..++..+.+++.+||+.||++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         234 EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            3344444444455667789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.4e-44  Score=325.59  Aligned_cols=250  Identities=27%  Similarity=0.408  Sum_probs=210.8

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .|++.+.||.|+||.||+|.+..+++.||+|++....  .....+.+.+|++++++++||||+++++++......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            3788899999999999999999899999999986543  22345778899999999999999999999999999999999


Q ss_pred             ccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          178 YMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       178 ~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      |+.+++|...+.    ..+..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~  159 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTST  159 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-ccccc
Confidence            999999876543    3567788999999999999999999999999999999999999999999987665432 23456


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHH
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI  333 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  333 (380)
                      .|+..|+|||++..     ..++.++|+||||+++|+|++|..||.............. ........+..++.++.++|
T Consensus       160 ~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i  233 (258)
T cd05578         160 SGTPGYMAPEVLCR-----QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK-QETADVLYPATWSTEAIDAI  233 (258)
T ss_pred             CCChhhcCHHHHcc-----cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH-hccccccCcccCcHHHHHHH
Confidence            68899999999854     3366789999999999999999999975544322333222 22245566677889999999


Q ss_pred             HHhcccCcCCCCCH--HHHhcCccc
Q 016959          334 SRCLQKDPHSRWPA--AQLLQHPFI  356 (380)
Q Consensus       334 ~~~l~~dp~~R~t~--~eil~hp~~  356 (380)
                      .+||+.||++|+++  .|+++||||
T Consensus       234 ~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         234 NKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHccCChhHcCCccHHHHhcCCCC
Confidence            99999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9.3e-44  Score=325.49  Aligned_cols=249  Identities=25%  Similarity=0.391  Sum_probs=204.9

Q ss_pred             CCcccccccceecccCCceEEEEEeCC-----CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPP-----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      +..++|.+.+.||+|+||.||+|.+..     +++.||||++...........+.+|+++++.++|+||+++++++...+
T Consensus         2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            345679999999999999999998743     467899999976655556678999999999999999999999999999


Q ss_pred             eEEEEEeccCCCCcccccc------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcE
Q 016959          171 EIEVLLEYMDGGSLEGAHI------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNV  232 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~  232 (380)
                      ..++||||+.+++|.+++.                  ..+..+..++.||+.||.|||++|++||||||+||+++.++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence            9999999999999876543                  2345678899999999999999999999999999999999999


Q ss_pred             EEeeccccccccccC--CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHH
Q 016959          233 KIADFGVSRILAQTM--DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASL  309 (380)
Q Consensus       233 kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~  309 (380)
                      +|+|||++..+....  .......++..|+|||++..     ..++.++|||||||++|||++ |..||.....   ...
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~  233 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-----RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEV  233 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhcc-----CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHH
Confidence            999999987553221  11233446788999999853     456778999999999999998 9999964333   333


Q ss_pred             HHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          310 MFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ............+..++..+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         234 IECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3333334444555678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.6e-43  Score=321.61  Aligned_cols=251  Identities=30%  Similarity=0.470  Sum_probs=203.0

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC----chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC--CeE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH----EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN--GEI  172 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~  172 (380)
                      .+|.+++.||+|+||.||++.+..+++.||||.+....    .......+.+|+.++++++|+||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57899999999999999999999999999999985322    223456788999999999999999999988763  568


Q ss_pred             EEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-
Q 016959          173 EVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM-  247 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  247 (380)
                      +++|||+.+++|.+++.    ..+..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++..+.... 
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            89999999999976643    2456678899999999999999999999999999999999999999999987654211 


Q ss_pred             --CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          248 --DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       248 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                        .......|+..|+|||++.+     ..++.++|+|||||++|+|++|+.||...  ...............+..+..+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~  234 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISG-----EGYGRKADIWSVGCTVVEMLTEKPPWAEF--EAMAAIFKIATQPTNPVLPPHV  234 (265)
T ss_pred             cccccccCCCCccccChhhhcC-----CCCCcchhHHHHHHHHHHHhhCCCCCCcc--chHHHHHHHhcCCCCCCCchhh
Confidence              12234568899999999853     44567899999999999999999999632  1222222222222234456677


Q ss_pred             cHHHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 016959          326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFIL  357 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~  357 (380)
                      +..+.++|.+|| .+|++||+++|+++|||+.
T Consensus       235 ~~~~~~~i~~~l-~~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         235 SDHCRDFLKRIF-VEAKLRPSADELLRHTFVH  265 (265)
T ss_pred             CHHHHHHHHHHh-cChhhCCCHHHHhcCcccC
Confidence            889999999999 4999999999999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1e-43  Score=340.34  Aligned_cols=255  Identities=24%  Similarity=0.356  Sum_probs=205.2

Q ss_pred             ccccCCCcccccccceecccCCceEEEEEeCCC-----CcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEe
Q 016959           91 NRHQLINPAELQKGNRIGSGSGGTVWRVVHPPT-----SRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHD  164 (380)
Q Consensus        91 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~  164 (380)
                      ...+.++.++|.++++||+|+||.||+|.+...     +..||||++.........+.+.+|+.+|+++. ||||+++++
T Consensus        29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~  108 (400)
T cd05105          29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLG  108 (400)
T ss_pred             CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            355667889999999999999999999987433     34699999976555555678899999999996 999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCccccccc------------------------------------------------------
Q 016959          165 MYDRNGEIEVLLEYMDGGSLEGAHIR------------------------------------------------------  190 (380)
Q Consensus       165 ~~~~~~~~~lv~e~~~~~~L~~~~~~------------------------------------------------------  190 (380)
                      ++...+..++|||||.+|+|.+++..                                                      
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (400)
T cd05105         109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY  188 (400)
T ss_pred             EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence            99999999999999999998654321                                                      


Q ss_pred             ----------------------------------------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 016959          191 ----------------------------------------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNL  224 (380)
Q Consensus       191 ----------------------------------------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Ni  224 (380)
                                                                    .+..+..++.||+.||+|||++||+||||||+||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni  268 (400)
T cd05105         189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV  268 (400)
T ss_pred             chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence                                                          2334567999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 016959          225 LINSSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVG  301 (380)
Q Consensus       225 l~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~  301 (380)
                      |++.++.+||+|||+++.+.....  ......++..|+|||++..     ..++.++|||||||++|||++ |..||...
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwSlGvil~ellt~g~~P~~~~  343 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-----NLYTTLSDVWSYGILLWEIFSLGGTPYPGM  343 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-----CCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence            999999999999999986543221  1233456788999998853     456779999999999999996 99999643


Q ss_pred             CCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          302 RQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ...+  ..............+..++.++.++|.+||+.||++|||+.++.+
T Consensus       344 ~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         344 IVDS--TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             chhH--HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            2221  122223333344556678899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-43  Score=320.28  Aligned_cols=250  Identities=35%  Similarity=0.555  Sum_probs=207.6

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC----chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH----EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      +|+..+.||+|+||+||+|.+..+++.|++|.+....    .......+.+|+.+++.++|+||+++++++..++.++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3677889999999999999998889999999985432    233456788999999999999999999999999999999


Q ss_pred             EeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCC
Q 016959          176 LEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       176 ~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      +||+.+++|.+++.    ..+..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++....... ...
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~  159 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAK  159 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-ccc
Confidence            99999999876653    3566778899999999999999999999999999999999999999999987664432 234


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD  331 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (380)
                      ...|+..|++||.+...    ..++.++|+|||||++|+|++|+.||....  ..............+..+..++.++.+
T Consensus       160 ~~~~~~~y~~pe~~~~~----~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (258)
T cd06632         160 SFKGSPYWMAPEVIAQQ----GGYGLAADIWSLGCTVLEMATGKPPWSQLE--GVAAVFKIGRSKELPPIPDHLSDEAKD  233 (258)
T ss_pred             ccCCCcceeCHHHhcCC----CCCCchhhhHHHHHHHHHHHhCCCCcccCc--HHHHHHHHHhcccCCCcCCCcCHHHHH
Confidence            56689999999998531    236778999999999999999999996433  222222222223445566778899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccc
Q 016959          332 FISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       332 li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      ++.+||+.||++||++.|++.|||+
T Consensus       234 li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         234 FILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHHhhcCcccCcCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.9e-44  Score=329.39  Aligned_cols=258  Identities=28%  Similarity=0.440  Sum_probs=202.3

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ++|++.+.||+|++|+||+|.+..+++.||+|.+..... ......+.+|+++++.++|+||+++++++...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            478999999999999999999998999999999865432 2334567889999999999999999999999999999999


Q ss_pred             ccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCcEEEeeccccccccccCCCC
Q 016959          178 YMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS-SKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       178 ~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      |+.+ +|.....      ..+..+..++.||+.||+|||++|++|+||+|+||+++. ++.+||+|||++..........
T Consensus        82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~  160 (294)
T PLN00009         82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF  160 (294)
T ss_pred             cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence            9975 5533321      245667789999999999999999999999999999985 5579999999997654333333


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC-----------
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP-----------  319 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------  319 (380)
                      ....++..|+|||++..    ...++.++|||||||++|+|++|..||......+....+.........           
T Consensus       161 ~~~~~~~~y~~PE~~~~----~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        161 THEVVTLWYRAPEILLG----SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             ccCceeecccCHHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence            44567899999998753    245677899999999999999999999743222111111110000000           


Q ss_pred             --------------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          320 --------------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       320 --------------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                                    .....++.++.++|.+||+.||++||++.++++||||.+.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence                          012346788999999999999999999999999999998653

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-44  Score=328.59  Aligned_cols=253  Identities=28%  Similarity=0.481  Sum_probs=205.2

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+++++.++|+||+++++++..++..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            6889999999999999999999999999999986432 334457788999999999999999999999999999999999


Q ss_pred             cCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-CCCCC
Q 016959          179 MDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-PCNSA  253 (380)
Q Consensus       179 ~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~  253 (380)
                      +.++.+.....    ..+..+..++.||+.||.|||++|++|+||+|+||++++++.+||+|||++........ .....
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~  161 (288)
T cd07833          82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDY  161 (288)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCc
Confidence            99877654332    35677888999999999999999999999999999999999999999999987655432 33456


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC---------------
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP---------------  318 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------------  318 (380)
                      .++..|+|||++..    ...++.++||||||+++|+|++|..||......+.............               
T Consensus       162 ~~~~~~~~PE~~~~----~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         162 VATRWYRAPELLVG----DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             ccccCCcCCchhcC----CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence            78899999999854    22567799999999999999999999964332221111111110000               


Q ss_pred             -------------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          319 -------------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       319 -------------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                                   ...+..++.++++||++||..||++|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                         01223358899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-45  Score=295.31  Aligned_cols=255  Identities=28%  Similarity=0.459  Sum_probs=209.6

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +|...++||+|.||+||++++..+++.||+|.++.+. ++..-....+|+-+|+.++|.|||+++++...++.+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            5777889999999999999999999999999997654 344456678999999999999999999999999999999999


Q ss_pred             cCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          179 MDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       179 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      |+. +|..+.     .......+.++.|+++||.|+|++++.||||||.|+||+.+|.+||+|||+++.+.-...-....
T Consensus        83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysae  161 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE  161 (292)
T ss_pred             hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence            975 343322     22456678899999999999999999999999999999999999999999999887665555667


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCc---------
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPE---------  323 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------  323 (380)
                      +-|.+|++|.++.+    .+.|+...|+||-|||+.|+.. |+..|...+..+....+.........+.|+         
T Consensus       162 vvtlwyrppdvlfg----akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  162 VVTLWYRPPDVLFG----AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeeeeccCcceeee----eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            78999999999865    4677889999999999999986 666676555555555554443332222111         


Q ss_pred             ----------------cccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          324 ----------------MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       324 ----------------~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                                      .++..-+||+.++|..+|..|++++++|+||||.+.
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                            244467899999999999999999999999999874

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.4e-44  Score=326.50  Aligned_cols=249  Identities=21%  Similarity=0.321  Sum_probs=204.5

Q ss_pred             CCcccccccceecccCCceEEEEEeCCC-----CcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPT-----SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      ++..+|.+.+.||+|+||+||+|.+..+     ++.||||++.........+.+.+|+.++..++|+||+++++++...+
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            4567899999999999999999987543     57899999976555555677889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCcccccc--------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC
Q 016959          171 EIEVLLEYMDGGSLEGAHI--------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK  230 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~--------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~  230 (380)
                      ..++++||+.+++|..++.                    .....+..++.|++.||.|||++||+||||||+|||+++++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence            9999999999988765542                    23455778999999999999999999999999999999999


Q ss_pred             cEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHH
Q 016959          231 NVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWA  307 (380)
Q Consensus       231 ~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~  307 (380)
                      .+||+|||+++.+.....  ......+++.|+|||++..     ..++.++|||||||++|||++ |..||.....   .
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~  233 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-----GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---Q  233 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhc-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---H
Confidence            999999999876543221  1233456789999999853     445778999999999999998 8888864332   3


Q ss_pred             HHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          308 SLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .....+........+..++.++.+|+.+||+.||++||+++||+.
T Consensus       234 ~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         234 DVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            344444444445566778999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-43  Score=321.19  Aligned_cols=250  Identities=26%  Similarity=0.386  Sum_probs=205.5

Q ss_pred             CCcccccccceecccCCceEEEEEeCCC---CcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPT---SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      ++.++|.+.+.||+|+||+||+|.+..+   ...||||++...........+.+|+.+++.++|+||+++++++...+..
T Consensus         1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             CChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            3467899999999999999999998644   4579999987666555667788999999999999999999999999999


Q ss_pred             EEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          173 EVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      +++|||+.+++|.+++.     ..+..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++..+....
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            99999999999977653     3566788999999999999999999999999999999999999999999998775221


Q ss_pred             CC--CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc
Q 016959          248 DP--CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEM  324 (380)
Q Consensus       248 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (380)
                      ..  .....++..|+|||.+..     ..++.++||||||+++|+|++ |..||....   .......+........+..
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~-----~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~  232 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAY-----RKFTSASDVWSFGIVMWEVMSYGERPYWDMS---NQDVIKAVEDGYRLPPPMD  232 (266)
T ss_pred             cceeccCCCCCccccChhhhcc-----CCCccccchHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHHcCCCCCCCCC
Confidence            11  122335678999998853     445678999999999999997 999996332   2333334433334445567


Q ss_pred             ccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          325 ASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ++..+.+|+.+||+.||++||++.|++++
T Consensus       233 ~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         233 CPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            78999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.5e-43  Score=319.54  Aligned_cols=248  Identities=27%  Similarity=0.424  Sum_probs=207.1

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +|++.+.||+|+||.||+|.+..+++.+|||++.... .......+.+|+++++.++|+||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4788899999999999999999999999999986543 334467788999999999999999999999999999999999


Q ss_pred             cCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-cEEEeeccccccccccCCCCC
Q 016959          179 MDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       179 ~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      +.+++|.+++.      ..+..+..++.|++.||+|||++||+|+||+|+||+++.++ .++|+|||++....... ...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~  159 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAY  159 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-ccc
Confidence            99999876653      24567888999999999999999999999999999998554 58999999998765432 223


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD  331 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (380)
                      ...|+..|+|||.+..     ..++.++||||||+++|+|++|..||...+.   ...............+..++.++.+
T Consensus       160 ~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~  231 (256)
T cd08220         160 TVVGTPCYISPELCEG-----KPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKIMSGTFAPISDRYSPDLRQ  231 (256)
T ss_pred             ccccCCcccCchhccC-----CCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHHHHHhcCCCCCCCCcCHHHHH
Confidence            4568999999999853     4456789999999999999999999964332   2333333334444566678899999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccc
Q 016959          332 FISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       332 li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      ++.+||..||++|||+.|+++||||
T Consensus       232 li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         232 LILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHHHccCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.7e-43  Score=320.71  Aligned_cols=253  Identities=38%  Similarity=0.630  Sum_probs=208.7

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +|++.+.||+|+||.||+|.+..+++.||+|+++.... ......+.+|+.+++.++|+||+++++++...+.+++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            47888999999999999999988999999999876543 24567899999999999999999999999999999999999


Q ss_pred             cCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC----
Q 016959          179 MDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC----  250 (380)
Q Consensus       179 ~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~----  250 (380)
                      +.+++|.++...    .+..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++..........    
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~  160 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV  160 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence            999999776433    466788899999999999999999999999999999999999999999988765432221    


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc--ccHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM--ASRE  328 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  328 (380)
                      ....++..|+|||++....  ....+.++||||||+++|++++|+.||.....  .............+..+..  ++..
T Consensus       161 ~~~~~~~~~~~PE~~~~~~--~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  236 (264)
T cd06626         161 QSLAGTPAYMAPEVITGGK--GKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIMFHVGAGHKPPIPDSLQLSPE  236 (264)
T ss_pred             cCCcCCcCccChhhccCCC--CCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hHHHHHHHhcCCCCCCCcccccCHH
Confidence            2356789999999986421  12356789999999999999999999964322  2222222333444444444  4889


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          329 FRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      +.++|.+||+.||++|||+.|++.|||+
T Consensus       237 ~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         237 GKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=9.6e-44  Score=334.18  Aligned_cols=253  Identities=26%  Similarity=0.390  Sum_probs=201.1

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCC-----CCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEe
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPP-----TSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYD  167 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~  167 (380)
                      |.+..++|++.+.||+|+||.||+|.+..     +++.||+|++...........+..|+.+++++ +|+||+++++++.
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            45677899999999999999999997543     45789999987554444456778899999999 7999999999876


Q ss_pred             e-CCeEEEEEeccCCCCcccccc---------------------------------------------------------
Q 016959          168 R-NGEIEVLLEYMDGGSLEGAHI---------------------------------------------------------  189 (380)
Q Consensus       168 ~-~~~~~lv~e~~~~~~L~~~~~---------------------------------------------------------  189 (380)
                      . +..++++|||+.+++|.+++.                                                         
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            4 467889999999998865432                                                         


Q ss_pred             --------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--CCCCCCCCCcc
Q 016959          190 --------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD--PCNSAVGTIAY  259 (380)
Q Consensus       190 --------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y  259 (380)
                              ..+..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.....  ......++..|
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence                    23455778999999999999999999999999999999999999999999987643221  12234467789


Q ss_pred             ccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcc
Q 016959          260 MSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ  338 (380)
Q Consensus       260 ~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  338 (380)
                      +|||++..     ..++.++|||||||++|||++ |..||......+  .....+........+...+.++.+++.+||+
T Consensus       242 ~aPE~~~~-----~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~  314 (337)
T cd05054         242 MAPESIFD-----KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRRLKEGTRMRAPEYATPEIYSIMLDCWH  314 (337)
T ss_pred             cCcHHhcC-----CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHHHHhccCCCCCCccCCHHHHHHHHHHcc
Confidence            99998853     556779999999999999997 999996433222  1222222233344456678899999999999


Q ss_pred             cCcCCCCCHHHHhcC
Q 016959          339 KDPHSRWPAAQLLQH  353 (380)
Q Consensus       339 ~dp~~R~t~~eil~h  353 (380)
                      .+|++||++.|+++|
T Consensus       315 ~~p~~RPs~~ell~~  329 (337)
T cd05054         315 NNPEDRPTFSELVEI  329 (337)
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999984

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.1e-43  Score=331.15  Aligned_cols=249  Identities=22%  Similarity=0.381  Sum_probs=201.8

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcE----EEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRV----FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      +...+|++.+.||+|+||.||+|.+..++..    ||+|++...........+.+|+.+++.++|+||+++++++... .
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~   82 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   82 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence            4567899999999999999999998666553    8999987655555567788999999999999999999998764 5


Q ss_pred             EEEEEeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      .++++||+.+|+|.+.+..     ....+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            7899999999998766543     34567889999999999999999999999999999999999999999999876533


Q ss_pred             CCC--CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          247 MDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       247 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      ...  .....++..|+|||++..     ..++.++|||||||++|||++ |..||....   ................+.
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slGv~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~~  234 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILH-----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEISSILEKGERLPQPP  234 (316)
T ss_pred             CcceeccCCccceeecChHHhcc-----CCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHhCCCCCCCCC
Confidence            221  122334678999999853     456779999999999999987 999996432   222222333334444556


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      .++.++.+++.+||..||++||++.+++.+
T Consensus       235 ~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         235 ICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=8.5e-44  Score=325.96  Aligned_cols=249  Identities=28%  Similarity=0.384  Sum_probs=194.8

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeC--CeEEEEEe
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDRN--GEIEVLLE  177 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e  177 (380)
                      |.+.+.||+|+||.||+|.+..+++.||+|+++............+|+.+++++. |+||+++++++.+.  +.+++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            5678899999999999999999999999999865432222233457888888885 99999999999887  88999999


Q ss_pred             ccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          178 YMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       178 ~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      |+.+ +|...+     ...+..+..++.||+.||.|||++|++||||+|+||+++. +.+||+|||++..+.... ....
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-~~~~  157 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-PYTE  157 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC-CcCC
Confidence            9986 443332     2356778899999999999999999999999999999999 999999999998764332 2234


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC--------------C
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ--------------P  318 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------------~  318 (380)
                      ..++..|+|||++..    +..++.++|||||||++|||++|..||...+..+............              .
T Consensus       158 ~~~~~~y~aPE~~~~----~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         158 YISTRWYRAPECLLT----DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             CCCCcccCChhHhhc----CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence            568899999998643    3456778999999999999999999996433222111111110000              0


Q ss_pred             CC-----------CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          319 PE-----------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       319 ~~-----------~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      ..           ....++.++.+||.+||+.||++|||+.|+++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            00           112467899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.2e-43  Score=326.39  Aligned_cols=259  Identities=31%  Similarity=0.531  Sum_probs=206.3

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEEE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  175 (380)
                      +.++|+..+.||+|+||.||++.+..+++.||+|.+...........+.+|+.++.++. |+||+++++++..++..+++
T Consensus         2 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             cHHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            34678888999999999999999999999999999875544455667889999999996 99999999999988999999


Q ss_pred             EeccCCCCcccc---------cccchHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          176 LEYMDGGSLEGA---------HIRQEHILSDLARQVLSGLAYLHKR-KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       176 ~e~~~~~~L~~~---------~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      |||+.. ++.++         ....+..+..++.|++.||+|||+. ||+||||||+|||++.++.++|+|||++..+..
T Consensus        82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            999875 33221         2235677889999999999999975 999999999999999999999999999976644


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCC----
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA----  321 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----  321 (380)
                      ... .....|+..|+|||++....  +..++.++|||||||++|+|++|..||....  .....+........+..    
T Consensus       161 ~~~-~~~~~~~~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd06616         161 SIA-KTRDAGCRPYMAPERIDPSA--RDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPILSNSE  235 (288)
T ss_pred             CCc-cccccCccCccCHHHhcccc--ccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCcCCCcC
Confidence            322 23446889999999985321  2356779999999999999999999996432  22222222222222222    


Q ss_pred             CccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      +..++.++.+||.+||+.||++|||++|+++||||++...
T Consensus       236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~  275 (288)
T cd06616         236 EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE  275 (288)
T ss_pred             CCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence            2347889999999999999999999999999999988543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-43  Score=321.77  Aligned_cols=248  Identities=30%  Similarity=0.445  Sum_probs=197.8

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHHHHHHHHHH-HhCCCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQICREIEIL-RDVNHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      +.||+|+||.||+|.+..+++.||+|++.....  ......+..|..++ ...+|+|++++++++..++.+++|+||+.+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            569999999999999998999999999865431  12223344555444 445899999999999999999999999999


Q ss_pred             CCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCC
Q 016959          182 GSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI  257 (380)
Q Consensus       182 ~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  257 (380)
                      ++|..++.    ..+..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....    .....|+.
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~  157 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGTP  157 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCCc
Confidence            99876653    35677889999999999999999999999999999999999999999999875443    23456889


Q ss_pred             ccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhc
Q 016959          258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL  337 (380)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  337 (380)
                      .|++||.+.+     ..++.++||||||+++|+|++|..||...........+..............++.++.++|.+||
T Consensus       158 ~y~~pe~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  232 (260)
T cd05611         158 DYLAPETILG-----VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL  232 (260)
T ss_pred             CccChhhhcC-----CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence            9999999853     33677999999999999999999999744332222222222222233344467899999999999


Q ss_pred             ccCcCCCC---CHHHHhcCccccccCc
Q 016959          338 QKDPHSRW---PAAQLLQHPFILRAGQ  361 (380)
Q Consensus       338 ~~dp~~R~---t~~eil~hp~~~~~~~  361 (380)
                      +.||++||   ++.|+|.||||++.+|
T Consensus       233 ~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         233 CMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             cCCHHHccCCCcHHHHHcChHhhcCCC
Confidence            99999999   5589999999998765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-43  Score=323.02  Aligned_cols=250  Identities=21%  Similarity=0.334  Sum_probs=206.3

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCC-----CcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPT-----SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRN  169 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  169 (380)
                      .+..++|.+.+.||+|+||.||+|.+...     +..||+|.+...........+.+|+.+++.++|+||+++++++...
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            46678999999999999999999988643     4789999986655445556788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCccccccc--------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEe
Q 016959          170 GEIEVLLEYMDGGSLEGAHIR--------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIA  235 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~~--------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~  235 (380)
                      +..++||||+.+++|.+++..              .+..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence            999999999999998766532              345677899999999999999999999999999999999999999


Q ss_pred             eccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHH
Q 016959          236 DFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFA  312 (380)
Q Consensus       236 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~  312 (380)
                      |||+++.+.....  ......++..|+|||.+..     ..++.++|||||||++||+++ |..||....   .......
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~t~g~~p~~~~~---~~~~~~~  233 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-----GVFTTKSDVWSFGVVLWEMATLAEQPYQGLS---NEEVLKF  233 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhc-----CCCCcccchHHHHHHHHHhhccCCCCCccCC---HHHHHHH
Confidence            9999876543221  1233456789999998853     456778999999999999998 999996332   2333334


Q ss_pred             HhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          313 ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .........+..++.++.++|.+||+.+|++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         234 VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            4444455667778999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=7.6e-44  Score=328.48  Aligned_cols=254  Identities=31%  Similarity=0.435  Sum_probs=201.7

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC--CeEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRN--GEIEV  174 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l  174 (380)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|.++.... ......+.+|+.++++++|+||+++++++...  +..++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            3579999999999999999999998999999999864432 22334567899999999999999999998877  88999


Q ss_pred             EEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 016959          175 LLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       175 v~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  249 (380)
                      ||||+.+ +|...+.     ..+..+..++.||+.||+|||++|++|+||||+|||++.++.++|+|||++.........
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  162 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP  162 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence            9999985 6644332     356778899999999999999999999999999999999999999999999876554333


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC-------------
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA-------------  316 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-------------  316 (380)
                      .....++..|+|||.+..    ....+.++|+||||+++|+|++|..||......+....+......             
T Consensus       163 ~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         163 YTQLVVTLWYRAPELLLG----AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             cccccccccccCchhhcC----CccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            445568899999998753    233567899999999999999999999643322211111110000             


Q ss_pred             --------------CCCCCCcc-ccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          317 --------------QPPEAPEM-ASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       317 --------------~~~~~~~~-~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                                    .....+.. +++.+.+||.+||+.||++|||+.|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                          00112222 57889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.7e-44  Score=330.66  Aligned_cols=254  Identities=31%  Similarity=0.509  Sum_probs=209.0

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      ..|.....||+|+||.||++.+..+++.||+|++..... ...+.+.+|+.+++.++|+||+++++++..++..++|+||
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            456666789999999999999988999999999854432 2345688999999999999999999999999999999999


Q ss_pred             cCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCC
Q 016959          179 MDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG  255 (380)
Q Consensus       179 ~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  255 (380)
                      +++++|.....   ..+..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..............|
T Consensus       100 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~  179 (297)
T cd06659         100 LQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG  179 (297)
T ss_pred             CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceec
Confidence            99999876543   356778899999999999999999999999999999999999999999998765544333445678


Q ss_pred             CCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC--CCCCCccccHHHHHHH
Q 016959          256 TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ--PPEAPEMASREFRDFI  333 (380)
Q Consensus       256 t~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li  333 (380)
                      +..|+|||++..     ..++.++|||||||++|||++|..||.....   ...........  .......++..+.++|
T Consensus       180 ~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~~i  251 (297)
T cd06659         180 TPYWMAPEVISR-----TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLRDSPPPKLKNAHKISPVLRDFL  251 (297)
T ss_pred             CccccCHHHHcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhccCCCCccccCCCCHHHHHHH
Confidence            999999999853     4467789999999999999999999964322   22222222211  1223345788999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          334 SRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       334 ~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      .+||+.+|++||++.|+++||||.+...
T Consensus       252 ~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         252 ERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             HHHhcCCcccCcCHHHHhhChhhccCCC
Confidence            9999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.1e-43  Score=320.69  Aligned_cols=249  Identities=29%  Similarity=0.474  Sum_probs=206.8

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +|.+.+.||+|+||.||+|.+..+|..+|+|.+.... .....+.+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999999999999999985432 122345678999999999999999999999999999999999


Q ss_pred             cCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc-EEEeeccccccccccCCCCC
Q 016959          179 MDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN-VKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       179 ~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~-~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      +.+++|.+++.      ..+..+..++.||+.||.|||+++++|+||||+||++++++. +||+|||.+...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY  160 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence            99999876543      256778899999999999999999999999999999998765 69999999987755433334


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD  331 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (380)
                      ...|+..|+|||++..     ..++.++|+||||+++|+|++|..||....   ...................++.++.+
T Consensus       161 ~~~~~~~~~ape~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (257)
T cd08225         161 TCVGTPYYLSPEICQN-----RPYNNKTDIWSLGCVLYELCTLKHPFEGNN---LHQLVLKICQGYFAPISPNFSRDLRS  232 (257)
T ss_pred             ccCCCccccCHHHHcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHhcccCCCCCCCCCHHHHH
Confidence            4568999999998753     345678999999999999999999996432   23333333333344455567889999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccc
Q 016959          332 FISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       332 li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      +|.+||..+|++|||+.|++.||||
T Consensus       233 ~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         233 LISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHHhccChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.5e-43  Score=319.94  Aligned_cols=248  Identities=24%  Similarity=0.384  Sum_probs=205.3

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      .+...+|.+.+.||+|+||.||+|.+..+++.||+|++..+.  .....+.+|+++++.++|+||+++++++..++.+++
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (263)
T cd05052           2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   79 (263)
T ss_pred             CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence            456678999999999999999999999899999999986432  234568899999999999999999999999999999


Q ss_pred             EEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          175 LLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       175 v~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      +|||+.+++|.+++.      ..+..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            999999999876543      24566788999999999999999999999999999999999999999999976643321


Q ss_pred             C-CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCcccc
Q 016959          249 P-CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS  326 (380)
Q Consensus       249 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (380)
                      . .....++..|+|||.+.     +..++.++|||||||++|||++ |..||...   +................+..++
T Consensus       160 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~el~t~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~  231 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLA-----YNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELLEKGYRMERPEGCP  231 (263)
T ss_pred             eccCCCCCccccCCHHHhc-----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHHCCCCCCCCCCCC
Confidence            1 11223466899999874     3456778999999999999998 99999643   3333334444444556677789


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          327 REFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .++.++|.+||+.||++|||+.|+++
T Consensus       232 ~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         232 PKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHHH
Confidence            99999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.7e-43  Score=318.43  Aligned_cols=246  Identities=25%  Similarity=0.410  Sum_probs=200.4

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      ++.++|++.+.||+|+||.||++.+. .+..+|+|.+.....  ....+.+|+.++++++|+||+++++++...+..++|
T Consensus         1 ~~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           1 INPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             CCHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc--cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence            35678999999999999999999885 456799998754332  235688899999999999999999999999999999


Q ss_pred             EeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-C
Q 016959          176 LEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-P  249 (380)
Q Consensus       176 ~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~  249 (380)
                      |||+.+++|.+++.     ..+..+..++.||+.||+|||++||+|+||||+||+++.++.+||+|||+++....... .
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            99999999876553     24567888999999999999999999999999999999999999999999876543211 1


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE  328 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (380)
                      .....++..|+|||++..     ..++.++|+||||+++|+|++ |+.||....   .......+........+...+.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~---~~~~~~~i~~~~~~~~~~~~~~~  229 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNF-----SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS---NYEVVEMISRGFRLYRPKLASMT  229 (256)
T ss_pred             cCCCCCchhhCChhhccc-----CccchhhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHCCCCCCCCCCCCHH
Confidence            122335668999999853     456779999999999999999 999996433   33333444434444556667889


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc
Q 016959          329 FRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      +.+++.+||+.||++||++.|+++
T Consensus       230 ~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         230 VYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=9.9e-44  Score=327.88  Aligned_cols=256  Identities=32%  Similarity=0.527  Sum_probs=208.9

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .++|.+.+.||+|+||.||++.+..+++.||+|.+...... ..+.+.+|+.+++.++|+||+++++.+...+..|+|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP-KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch-HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            36789999999999999999999888999999998543322 34678899999999999999999999999999999999


Q ss_pred             ccCCCCccccccc---chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCC
Q 016959          178 YMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV  254 (380)
Q Consensus       178 ~~~~~~L~~~~~~---~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (380)
                      |+.+++|..++..   .+..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..............
T Consensus        97 ~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~  176 (293)
T cd06647          97 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV  176 (293)
T ss_pred             cCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccccc
Confidence            9999999776543   4667788999999999999999999999999999999999999999999876654433334456


Q ss_pred             CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHH
Q 016959          255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS  334 (380)
Q Consensus       255 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  334 (380)
                      |+..|++||.+..     ..++.++|+|||||++|++++|..||............. .........+..++..+.++|.
T Consensus       177 ~~~~y~~PE~~~~-----~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~  250 (293)
T cd06647         177 GTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLN  250 (293)
T ss_pred             CChhhcCchhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh-cCCCCCCCCccccCHHHHHHHH
Confidence            8899999998753     345678999999999999999999997433222111110 0111111233456788999999


Q ss_pred             HhcccCcCCCCCHHHHhcCccccccC
Q 016959          335 RCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       335 ~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      +||+.+|++||++.+++.|+||+...
T Consensus       251 ~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         251 RCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHccCChhhCcCHHHHhcCHHHhcCc
Confidence            99999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.4e-43  Score=316.87  Aligned_cols=240  Identities=23%  Similarity=0.385  Sum_probs=196.9

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCCCc
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL  184 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  184 (380)
                      +.||+|+||.||+|.+..+++.||+|.+...........+.+|+++++.++|+||+++++++...+..++||||+.+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999999899999999986655555667889999999999999999999999999999999999999998


Q ss_pred             ccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC--CCCCCCC
Q 016959          185 EGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC--NSAVGTI  257 (380)
Q Consensus       185 ~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~gt~  257 (380)
                      .+++.     ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........  ....++.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  160 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV  160 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCce
Confidence            76653     2466788899999999999999999999999999999999999999999987654321111  1112345


Q ss_pred             ccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHh
Q 016959          258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC  336 (380)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  336 (380)
                      .|+|||.+..     ..++.++|||||||++|+|++ |..||.....   ...............+..++..+.+|+.+|
T Consensus       161 ~y~aPE~~~~-----~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  232 (252)
T cd05084         161 KWTAPEALNY-----GRYSSESDVWSFGILLWEAFSLGAVPYANLSN---QQTREAIEQGVRLPCPELCPDAVYRLMERC  232 (252)
T ss_pred             eecCchhhcC-----CCCChHHHHHHHHHHHHHHHhCCCCCccccCH---HHHHHHHHcCCCCCCcccCCHHHHHHHHHH
Confidence            7999999853     446778999999999999997 9999963322   223333333444566677889999999999


Q ss_pred             cccCcCCCCCHHHHhc
Q 016959          337 LQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       337 l~~dp~~R~t~~eil~  352 (380)
                      |+.||++|||+.|+++
T Consensus       233 l~~~p~~Rps~~~~~~  248 (252)
T cd05084         233 WEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=339.20  Aligned_cols=272  Identities=24%  Similarity=0.353  Sum_probs=232.1

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .+..+++++...||-|+||.|-++........+|+|++++.+  +....+.+..|-++|..++.+.||++|..|.+...+
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv  495 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV  495 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence            356678888999999999999999887666679999997765  455567889999999999999999999999999999


Q ss_pred             EEEEeccCCCCcc----cccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          173 EVLLEYMDGGSLE----GAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       173 ~lv~e~~~~~~L~----~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      |++||-|-||.|-    +.....+...+.++..+++|++|||++|||+|||||+|+|++.+|-+||.|||+|+.+... .
T Consensus       496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-~  574 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-R  574 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC-C
Confidence            9999999999864    4445567778889999999999999999999999999999999999999999999998765 4


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHH
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE  328 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (380)
                      ...++|||+.|.|||++.+     +....++|+||||+++|||++|..||...+....++.+.+  ......+|..+...
T Consensus       575 KTwTFcGTpEYVAPEIILn-----KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk--Gid~i~~Pr~I~k~  647 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILN-----KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK--GIDKIEFPRRITKT  647 (732)
T ss_pred             ceeeecCCcccccchhhhc-----cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh--hhhhhhcccccchh
Confidence            4578999999999999964     5667789999999999999999999986555544444433  23345778889999


Q ss_pred             HHHHHHHhcccCcCCCCC-----HHHHhcCccccccCcccccccccccCCCCC
Q 016959          329 FRDFISRCLQKDPHSRWP-----AAQLLQHPFILRAGQSQVNQNLRQILPPPR  376 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~  376 (380)
                      +.+||+++...+|.+|+.     +.||-.|-||.+.+|.-.+.  +...||+.
T Consensus       648 a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~--~~L~pPi~  698 (732)
T KOG0614|consen  648 ATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRS--RTLPPPII  698 (732)
T ss_pred             HHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhh--ccCCCCcc
Confidence            999999999999999996     89999999999999987755  44444443

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.4e-43  Score=322.29  Aligned_cols=253  Identities=33%  Similarity=0.526  Sum_probs=207.8

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEecc
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYM  179 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  179 (380)
                      .|...+.||+|++|.||++.+..+++.+++|++..... ...+.+.+|+.+++.++|+||+++++++...+..++++||+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            46667899999999999999988999999999854332 23456889999999999999999999999999999999999


Q ss_pred             CCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCC
Q 016959          180 DGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT  256 (380)
Q Consensus       180 ~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  256 (380)
                      .+++|.+.+.   ..+..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++..............|+
T Consensus        99 ~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  178 (285)
T cd06648          99 EGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGT  178 (285)
T ss_pred             CCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCC
Confidence            9999976643   3556788899999999999999999999999999999999999999999987654433333445689


Q ss_pred             CccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCC--CccccHHHHHHHH
Q 016959          257 IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA--PEMASREFRDFIS  334 (380)
Q Consensus       257 ~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~  334 (380)
                      ..|+|||.+..     ..++.++|||||||++|+|++|..||.....   ............+..  +..++..+.+||.
T Consensus       179 ~~y~aPE~~~~-----~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (285)
T cd06648         179 PYWMAPEVISR-----LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAMKRIRDNLPPKLKNLHKVSPRLRSFLD  250 (285)
T ss_pred             ccccCHHHhcC-----CCCCCcccHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHHhcCCCCCcccccCCHHHHHHHH
Confidence            99999999853     3456789999999999999999999964332   222323322222222  2337789999999


Q ss_pred             HhcccCcCCCCCHHHHhcCccccccCc
Q 016959          335 RCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       335 ~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      +||+.||++|||+.++++||||+....
T Consensus       251 ~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         251 RMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HHcccChhhCcCHHHHccCcccccCCC
Confidence            999999999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.8e-43  Score=327.76  Aligned_cols=249  Identities=24%  Similarity=0.349  Sum_probs=200.5

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcE--EEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRV--FALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  172 (380)
                      +..++|++.+.||+|+||.||+|.+..++..  +|+|.+...........+.+|+.++.++ +|+||+++++++..++.+
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            4567899999999999999999998777754  5777765544445567788999999999 899999999999999999


Q ss_pred             EEEEeccCCCCcccccc--------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcE
Q 016959          173 EVLLEYMDGGSLEGAHI--------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNV  232 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~--------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~  232 (380)
                      ++||||+.+++|.+++.                    ..+..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence            99999999999876543                    2456788999999999999999999999999999999999999


Q ss_pred             EEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHH
Q 016959          233 KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMF  311 (380)
Q Consensus       233 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~  311 (380)
                      ||+|||++........ .....++..|+|||++..     ..++.++|||||||++|||++ |..||.....   .....
T Consensus       164 kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~  234 (303)
T cd05088         164 KIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNY-----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYE  234 (303)
T ss_pred             EeCccccCcccchhhh-cccCCCcccccCHHHHhc-----cCCcccccchhhhhHHHHHHhcCCCCcccCCh---HHHHH
Confidence            9999999864322111 112234668999998853     446778999999999999998 9999964332   22233


Q ss_pred             HHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          312 AICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ..........+..++.++.+||.+||+.||++||+++++|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         235 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            333333344555678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.1e-43  Score=321.06  Aligned_cols=250  Identities=24%  Similarity=0.324  Sum_probs=203.0

Q ss_pred             CCcccccccceecccCCceEEEEEeCC-----CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPP-----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      +..+.|.+.+.||+|+||.||+|.+..     ++..||+|.+...........+.+|+.+++.++|+||+++++++.+.+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            345679999999999999999999976     678899999865554555567889999999999999999999998888


Q ss_pred             eEEEEEeccCCCCcccccc-----------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---cEEEee
Q 016959          171 EIEVLLEYMDGGSLEGAHI-----------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK---NVKIAD  236 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~-----------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~---~~kl~D  236 (380)
                      ..++||||+.+++|.+++.           ..+..+..++.||+.||+|||++|++|+||||+|||++.++   .+||+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence            9999999999999976542           34566788999999999999999999999999999998655   599999


Q ss_pred             ccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHH
Q 016959          237 FGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAI  313 (380)
Q Consensus       237 fg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~  313 (380)
                      ||+++.+.....  ......++..|+|||++..     ..++.++|||||||++|||++ |..||......   ......
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~~  234 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-----GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEFV  234 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhc-----CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH
Confidence            999986632211  1112234568999999853     456789999999999999996 99999743332   233333


Q ss_pred             hhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          314 CFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ........+..++..+.+++.+||+.||++||++.++++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         235 TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            3334455567788999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.5e-43  Score=328.70  Aligned_cols=254  Identities=27%  Similarity=0.436  Sum_probs=197.4

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC------
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG------  170 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------  170 (380)
                      .++|++.++||+|+||.||+|.+..+++.||||.+.... .......+.+|+.++++++|+||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            467999999999999999999999999999999985433 2222345668999999999999999999886543      


Q ss_pred             --eEEEEEeccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          171 --EIEVLLEYMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       171 --~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                        ..++||||+.+ +|...+     ...+..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence              45999999976 554332     2357778999999999999999999999999999999999999999999999766


Q ss_pred             cccCC----CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC
Q 016959          244 AQTMD----PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP  319 (380)
Q Consensus       244 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  319 (380)
                      .....    ......++..|+|||++..    ...++.++||||||+++|+|++|+.||...........+.......+.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLG----ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcC----CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            43221    1234467889999998743    233467899999999999999999999754433222222222211111


Q ss_pred             CC----------------------------CccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          320 EA----------------------------PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       320 ~~----------------------------~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      ..                            ....+..+.+||.+||..||++|||++|+|+||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            10                            11135678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=8.8e-45  Score=353.69  Aligned_cols=253  Identities=25%  Similarity=0.394  Sum_probs=213.8

Q ss_pred             ccccCCCcccccccceecccCCceEEEEEeC-----CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeE
Q 016959           91 NRHQLINPAELQKGNRIGSGSGGTVWRVVHP-----PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM  165 (380)
Q Consensus        91 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~  165 (380)
                      .....+...+++..+.||+|.||+||+|+-.     .....||||.++...+...+.+|.+|+++|..++|||||+|+|+
T Consensus       478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGV  557 (774)
T KOG1026|consen  478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGV  557 (774)
T ss_pred             cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence            3444577888899999999999999999753     24567999999988888789999999999999999999999999


Q ss_pred             EeeCCeEEEEEeccCCCCccccccc------------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc
Q 016959          166 YDRNGEIEVLLEYMDGGSLEGAHIR------------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN  227 (380)
Q Consensus       166 ~~~~~~~~lv~e~~~~~~L~~~~~~------------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~  227 (380)
                      |..++.+++|+|||..|+|..++..                  ...+...|+.||+.||+||-++.+|||||..+|+||.
T Consensus       558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG  637 (774)
T ss_pred             EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec
Confidence            9999999999999999999655432                  2356788999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 016959          228 SSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQG  304 (380)
Q Consensus       228 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~  304 (380)
                      ++..|||+|||+++.......  ......-..+||+||-|.-     ..++.+|||||+||+|||+++ |..||..-.++
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-----~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~  712 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-----GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ  712 (774)
T ss_pred             cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-----CcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence            999999999999987643321  1112334679999999852     456779999999999999885 99999866655


Q ss_pred             CHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHh
Q 016959          305 DWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLL  351 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil  351 (380)
                      +..+.+   ........|+.++.++.+||..||+.+|++||++.||-
T Consensus       713 EVIe~i---~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  713 EVIECI---RAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             HHHHHH---HcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            554444   44455888999999999999999999999999999984

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3e-43  Score=324.48  Aligned_cols=252  Identities=23%  Similarity=0.389  Sum_probs=205.9

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCC-----CcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEe
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPT-----SRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYD  167 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~  167 (380)
                      ..+..++|++.+.||+|+||.||++.+...     ...+|+|++...........+.+|+.+++++ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            456778899999999999999999987643     3789999987655444556788999999999 7999999999999


Q ss_pred             eCCeEEEEEeccCCCCcccccc--------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc
Q 016959          168 RNGEIEVLLEYMDGGSLEGAHI--------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN  227 (380)
Q Consensus       168 ~~~~~~lv~e~~~~~~L~~~~~--------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~  227 (380)
                      ..+.++++|||+.+++|..++.                    ..+..+..++.||+.||.|||++||+||||||+|||++
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence            9999999999999999866542                    24556788999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 016959          228 SSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQG  304 (380)
Q Consensus       228 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~  304 (380)
                      .++.+||+|||+++.+.....  ......++..|+|||++.     +..++.++|||||||++|||++ |..||....  
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--  239 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF-----DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--  239 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhc-----cCCcCcccceeehhhHHHHHhcCCCCCCCCCC--
Confidence            999999999999986643211  122233567899999874     3556778999999999999997 999996433  


Q ss_pred             CHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          305 DWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                       ................+..++.++.+|+.+||..||++|||+.|++++
T Consensus       240 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         240 -VEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             -HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence             233333344444455666788999999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.4e-43  Score=335.45  Aligned_cols=255  Identities=27%  Similarity=0.371  Sum_probs=199.7

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC------C
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN------G  170 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~  170 (380)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++|+||++++++|...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            467999999999999999999999999999999986432 233445677899999999999999999988643      3


Q ss_pred             eEEEEEeccCCCCcccccc--cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          171 EIEVLLEYMDGGSLEGAHI--RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ..|+||||+.+ +|...+.  ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-  172 (353)
T cd07850          95 DVYLVMELMDA-NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-  172 (353)
T ss_pred             cEEEEEeccCC-CHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC-
Confidence            57999999976 5544332  4567788899999999999999999999999999999999999999999998664332 


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC------------
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA------------  316 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~------------  316 (380)
                      ......++..|+|||.+..     ..++.++|||||||++|+|++|..||...+..+....+......            
T Consensus       173 ~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
T cd07850         173 MMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT  247 (353)
T ss_pred             CCCCCcccccccCHHHHhC-----CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence            2234568899999999853     45678899999999999999999999744322111111000000            


Q ss_pred             ------CCC---------------------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          317 ------QPP---------------------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       317 ------~~~---------------------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                            ..+                     ..+...+..+++||.+||+.||++|||+.|+|+||||+.-
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~  317 (353)
T cd07850         248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW  317 (353)
T ss_pred             hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence                  000                     0012345678999999999999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.6e-43  Score=320.30  Aligned_cols=248  Identities=31%  Similarity=0.492  Sum_probs=203.2

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++|.+.+.||+|+||.||++.+..+++.+|||.+....  .......+.+|+.+++.++|+||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            47889999999999999999998899999999875432  2334567889999999999999999999999999999999


Q ss_pred             eccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          177 EYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       177 e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ||+.+++|.+++.        ..+..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence            9999999876543        25667888999999999999999999999999999999999999999999877654433


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC-CCCCCccccH
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ-PPEAPEMASR  327 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  327 (380)
                      ......|+..|+|||.+..     ..++.++|+||||+++|+|++|..||..... +............ ++..+..++.
T Consensus       162 ~~~~~~~~~~~~ape~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08229         162 AAHSLVGTPYYMSPERIHE-----NGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYPPLPSDHYSE  235 (267)
T ss_pred             ccccccCCcCccCHHHhcC-----CCccchhhHHHHHHHHHHHHhCCCCcccccc-hHHHHhhhhhcCCCCCCCcccccH
Confidence            3345678999999999853     4456789999999999999999999964322 2222222222222 2233345788


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .+.++|.+||+.||++|||+.+|++
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-46  Score=372.23  Aligned_cols=256  Identities=37%  Similarity=0.613  Sum_probs=221.1

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +++.+.+||.|.||.||.|.+..+|...|+|-++-.. .......+.+|..++..|+|||+|+++|+-.+.+..+|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            3556788999999999999999999999999985432 234456788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccc----hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC----CC
Q 016959          179 MDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD----PC  250 (380)
Q Consensus       179 ~~~~~L~~~~~~~----~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~----~~  250 (380)
                      |++|+|.+.....    +...+.+..|++.|+.|||+.|||||||||+||+++.+|-+|++|||.|..+.....    ..
T Consensus      1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred             hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence            9999998876653    555677889999999999999999999999999999999999999999988765432    23


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR  330 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (380)
                      ...+||+.|||||+|.+..  ++....+.|||||||++.||+||+.||..  .+.-..++..+..+..+..|..++.+.+
T Consensus      1396 ~~~~GT~~YMAPEvit~t~--~kG~~~A~DiWslGCVVlEM~tGkrPW~~--~dne~aIMy~V~~gh~Pq~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTK--GKGHGGAADIWSLGCVVLEMATGKRPWAE--LDNEWAIMYHVAAGHKPQIPERLSSEGR 1471 (1509)
T ss_pred             HhhcCCchhcCchhhcccc--cCCCCcchhhhcccceEEEeecCCCchhh--ccchhHHHhHHhccCCCCCchhhhHhHH
Confidence            4678999999999997543  34456789999999999999999999963  3334567778888888999999999999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      |||.+||..||++|+++.|+|+|-|-+.-
T Consensus      1472 dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             HHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence            99999999999999999999999987653

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-43  Score=323.54  Aligned_cols=249  Identities=30%  Similarity=0.461  Sum_probs=198.7

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEecc
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYM  179 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  179 (380)
                      |++.+.||.|++|+||+|.+..+|+.||+|++..... ......+.+|+.+++.++|+|++++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            5678899999999999999998999999999865432 223456788999999999999999999999999999999999


Q ss_pred             CCCCccccc------ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          180 DGGSLEGAH------IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       180 ~~~~L~~~~------~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      . ++|..++      ...+..+..++.||+.||+|||+++++||||+|+||+++.++.++|+|||++.............
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  159 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE  159 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence            6 4665443      23567788999999999999999999999999999999999999999999997654332223344


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh------------------
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF------------------  315 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~------------------  315 (380)
                      .++..|+|||++..    +..++.++||||||+++|+|++|..||......  .........                  
T Consensus       160 ~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         160 VVTLWYRAPEILLG----SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             ccccCCCCCceeec----CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhchhh
Confidence            57889999998753    234567899999999999999999999643221  111110000                  


Q ss_pred             ---------CCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          316 ---------AQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       316 ---------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                               .........++.++.++|.+||+.||++|||+.|+++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                     00011234467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.8e-43  Score=315.52  Aligned_cols=249  Identities=37%  Similarity=0.607  Sum_probs=211.6

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +|.+.+.||.|+||.||++.+..+++.||+|++.... .......+.+|+++++.++|+|++++++.+...+..++|+|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999999899999999986543 234566788999999999999999999999999999999999


Q ss_pred             cCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          179 MDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       179 ~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      +++++|...+.        ..+..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  160 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA  160 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence            99999865543        3456788999999999999999999999999999999999999999999998765543334


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR  330 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (380)
                      ....|+..|+|||.+..     ..++.++|+||||+++|+|++|..||....   ................+..++.++.
T Consensus       161 ~~~~~~~~y~~pe~~~~-----~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  232 (258)
T cd08215         161 KTVVGTPYYLSPELCQN-----KPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKILKGQYPPIPSQYSSELR  232 (258)
T ss_pred             cceeeeecccChhHhcc-----CCCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            45678999999998753     445678999999999999999999996433   3344444444445566667889999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      +++.+||..+|++|||+.|+|+||||
T Consensus       233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         233 NLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.3e-43  Score=321.26  Aligned_cols=254  Identities=25%  Similarity=0.418  Sum_probs=205.4

Q ss_pred             CCcccccccceecccCCceEEEEEe-----CCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVH-----PPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      |+..+|.+.+.||+|+||+||++..     ..++..+|+|.+.... ......+.+|+.++++++|+||+++++++...+
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            4567899999999999999999985     2345679999986543 334567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCcccccc-----------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEE
Q 016959          171 EIEVLLEYMDGGSLEGAHI-----------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVK  233 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~-----------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~k  233 (380)
                      .+++||||+.+++|.+++.                 .++..+..++.||+.||+|||++|++||||||+|||++.++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence            9999999999999866543                 35667889999999999999999999999999999999999999


Q ss_pred             EeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHH
Q 016959          234 IADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLM  310 (380)
Q Consensus       234 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~  310 (380)
                      |+|||++........  ......++..|+|||++.     +..++.++|||||||++|+|++ |..||.....   ....
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~~  232 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-----YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVI  232 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHH
Confidence            999999976533211  122334577899999885     3556779999999999999998 9999964332   3333


Q ss_pred             HHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          311 FAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      ...........+..++.++.+|+.+||+.||.+|||+.|++.  +++++.
T Consensus       233 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~--~l~~~~  280 (288)
T cd05093         233 ECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS--LLQNLA  280 (288)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH--HHHHHH
Confidence            334444444555668889999999999999999999999976  455543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.3e-43  Score=318.76  Aligned_cols=251  Identities=33%  Similarity=0.549  Sum_probs=201.3

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC---------chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH---------EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      +|.+.+.||.|+||.||+|.+..+++.||+|.+....         .....+.+.+|+.+++.++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4778889999999999999998899999999875321         1123456788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      .+++||||+.+++|.+++..    .+..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999998765433    45667889999999999999999999999999999999999999999998765432


Q ss_pred             CC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh-hCCC----C
Q 016959          247 MD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC-FAQP----P  319 (380)
Q Consensus       247 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~----~  319 (380)
                      ..  ......|+..|+|||.+...   ...++.++|+||||+++|++++|..||....   ......... ....    .
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~  235 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSY---SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE---AIAAMFKLGNKRSAPPIPP  235 (272)
T ss_pred             ccccccccccCCccccCHHHhccc---cCCCCccchhHHHHHHHHHHHhCCCCCcCcc---hHHHHHHhhccccCCcCCc
Confidence            11  12345688999999998542   1235778999999999999999999996322   222222211 1111    1


Q ss_pred             CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       320 ~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      .....++.++.++|.+||..||++|||++|+|+||||
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            2223468899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.3e-43  Score=317.79  Aligned_cols=246  Identities=22%  Similarity=0.378  Sum_probs=205.2

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ...+|.+.++||.|+||+||+|.+.. ++.+|+|++..... .....+.+|+.+++.++|+||+++++++...+..++||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT   81 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence            45689999999999999999999987 88999999865433 23456889999999999999999999999999999999


Q ss_pred             eccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          177 EYMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       177 e~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      ||+.+++|.+++..      ....+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~  161 (261)
T cd05148          82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS  161 (261)
T ss_pred             eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence            99999999776543      456678899999999999999999999999999999999999999999998765433323


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      ....++..|++||++..     ..++.++||||||+++|+|++ |+.||....   ................+..++..+
T Consensus       162 ~~~~~~~~~~~PE~~~~-----~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  233 (261)
T cd05148         162 SDKKIPYKWTAPEAASH-----GTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQITAGYRMPCPAKCPQEI  233 (261)
T ss_pred             cCCCCceEecCHHHHcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHHhCCcCCCCCCCCHHH
Confidence            34456778999999853     456778999999999999998 899996433   223333333444455667788999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhc
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .++|.+||+.||++|||+.++++
T Consensus       234 ~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         234 YKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.9e-43  Score=325.38  Aligned_cols=251  Identities=23%  Similarity=0.360  Sum_probs=203.6

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCC-------CCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeE
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPP-------TSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDM  165 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~  165 (380)
                      +.+..++|.+++.||+|+||.||++.+..       +...+|+|.+...........+.+|+.+++.+ +|+||++++++
T Consensus        13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            34556889999999999999999998643       23579999997654444456788899999999 79999999999


Q ss_pred             EeeCCeEEEEEeccCCCCccccccc--------------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 016959          166 YDRNGEIEVLLEYMDGGSLEGAHIR--------------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLL  225 (380)
Q Consensus       166 ~~~~~~~~lv~e~~~~~~L~~~~~~--------------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil  225 (380)
                      +...+..++||||+.+++|.+++..                    ....+..++.||+.||+|||++|++||||||+|||
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  172 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  172 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence            9999999999999999998766532                    34567889999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccccCCC--CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 016959          226 INSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGR  302 (380)
Q Consensus       226 ~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~  302 (380)
                      ++.++.+||+|||++.........  .....++..|+|||++..     ..++.++|||||||++|+|++ |..||... 
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~~~g~~p~~~~-  246 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-----RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-  246 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-----CCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-
Confidence            999999999999998765432111  112234578999998853     456789999999999999998 88898632 


Q ss_pred             CCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          303 QGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                        .................+..++.++.+|+.+||..+|++|||+.|+++
T Consensus       247 --~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~  294 (307)
T cd05098         247 --PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  294 (307)
T ss_pred             --CHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence              333344444444455666778899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.2e-42  Score=315.79  Aligned_cols=248  Identities=33%  Similarity=0.516  Sum_probs=204.7

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCC--CchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.++..  ........+.+|++++++++|+||+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            4789999999999999999999989999999988532  23334677889999999999999999999999999999999


Q ss_pred             eccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          177 EYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       177 e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ||+.+++|..++.        ..+..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++..+.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            9999999875542        24667889999999999999999999999999999999999999999999876654433


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCc-cccH
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE-MASR  327 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  327 (380)
                      ......++..|+|||.+..     ..++.++|+|||||++|+|++|..||.... ..................+. .++.
T Consensus       162 ~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHE-----NGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLYSLCKKIEKCDYPPLPADHYSE  235 (267)
T ss_pred             ccceecCCccccCHHHhcc-----CCCCchhcHHHHHHHHHHHHHCCCCcccCC-ccHHHHHhhhhcCCCCCCChhhcCH
Confidence            3345678999999998753     446778999999999999999999996433 22223333333233333333 6788


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ++.++|.+||..+|++|||+.++++
T Consensus       236 ~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         236 ELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.3e-44  Score=314.46  Aligned_cols=258  Identities=27%  Similarity=0.473  Sum_probs=200.5

Q ss_pred             cccccccceecccCCceEEEEEeCCCC----cEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEee-CCe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTS----RVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDR-NGE  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~----~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~  171 (380)
                      ...|+...+||+|+||.||+|..+.++    +.||||.++.+.+ ........+|+.+++.++|+|++.+..+|.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            467999999999999999999765543    3799999976532 2334456689999999999999999999876 788


Q ss_pred             EEEEEeccCCCCcc--------cccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC----CcEEEeeccc
Q 016959          172 IEVLLEYMDGGSLE--------GAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS----KNVKIADFGV  239 (380)
Q Consensus       172 ~~lv~e~~~~~~L~--------~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~----~~~kl~Dfg~  239 (380)
                      +++++||.+...+.        .....+...+..|+.||+.|+.|||++-|+||||||.||||..+    |.+||+|||+
T Consensus       103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence            99999999875431        11223566789999999999999999999999999999999877    8899999999


Q ss_pred             cccccccCCC---CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC---------CHH
Q 016959          240 SRILAQTMDP---CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG---------DWA  307 (380)
Q Consensus       240 a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---------~~~  307 (380)
                      ++.+......   ....+-|.+|+|||.+.+    ...|+.+.|||++|||+.||+|-...|...+..         +..
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLG----a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLG----ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcc----cccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            9988755432   345667999999999865    467888999999999999999988888532211         112


Q ss_pred             HHHHHHhhCCCCCCC---------------------------------ccccHHHHHHHHHhcccCcCCCCCHHHHhcCc
Q 016959          308 SLMFAICFAQPPEAP---------------------------------EMASREFRDFISRCLQKDPHSRWPAAQLLQHP  354 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp  354 (380)
                      ..+..+........|                                 ..-++...+|+.+||+.||.+|+|++|+|+|+
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            222222211111111                                 11234588999999999999999999999999


Q ss_pred             ccccc
Q 016959          355 FILRA  359 (380)
Q Consensus       355 ~~~~~  359 (380)
                      ||...
T Consensus       339 yF~~d  343 (438)
T KOG0666|consen  339 YFTED  343 (438)
T ss_pred             ccccC
Confidence            99986

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=315.42  Aligned_cols=250  Identities=30%  Similarity=0.486  Sum_probs=205.3

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCC----CchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC--CeE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN----HEDSVRSQICREIEILRDVNHPNVVKCHDMYDRN--GEI  172 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~  172 (380)
                      .+|.+.+.||+|+||.||+|.+..+++.||+|++...    ........+.+|+.+++.++|+||+++++++.+.  +.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5789999999999999999999999999999987432    1233456788999999999999999999998653  568


Q ss_pred             EEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-
Q 016959          173 EVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM-  247 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  247 (380)
                      ++++||+.+++|.+.+.    ..+..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... 
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            89999999999876543    3466788899999999999999999999999999999999999999999998654211 


Q ss_pred             --CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          248 --DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       248 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                        .......|+..|+|||++..     ..++.++|+|||||++|+|++|+.||...  ...............+..+..+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~p~~~  234 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISG-----EGYGRKADVWSVACTVVEMLTEKPPWAEY--EAMAAIFKIATQPTKPMLPDGV  234 (264)
T ss_pred             cCccccccCCcccccCHhhhcC-----CCCCccccHHHHHHHHHHHHhCCCCCCcc--CHHHHHHHHHcCCCCCCCCccc
Confidence              11234568999999999853     34567899999999999999999999632  2233333333334455678889


Q ss_pred             cHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      +..+.++|.+||+ ++..||++.+++.|||+
T Consensus       235 ~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         235 SDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             CHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            9999999999998 57999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=8.8e-43  Score=322.16  Aligned_cols=246  Identities=24%  Similarity=0.374  Sum_probs=198.4

Q ss_pred             ccccccceecccCCceEEEEEeCCCCc--EEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSR--VFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      ++|++.+.||+|+||.||+|.+..++.  .+++|.++..........+.+|+.+++++ +||||+++++++...+.++++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578999999999999999999876664  47888886544444556788999999999 799999999999999999999


Q ss_pred             EeccCCCCcccccc--------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEe
Q 016959          176 LEYMDGGSLEGAHI--------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIA  235 (380)
Q Consensus       176 ~e~~~~~~L~~~~~--------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~  235 (380)
                      |||+.+++|.+++.                    ..+..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~  161 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA  161 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence            99999999866543                    2345678899999999999999999999999999999999999999


Q ss_pred             eccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHh
Q 016959          236 DFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAIC  314 (380)
Q Consensus       236 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  314 (380)
                      |||++........ ......+..|+|||++..     ..++.++|||||||++|||++ |..||....   .........
T Consensus       162 dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlG~il~el~t~g~~pf~~~~---~~~~~~~~~  232 (297)
T cd05089         162 DFGLSRGEEVYVK-KTMGRLPVRWMAIESLNY-----SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT---CAELYEKLP  232 (297)
T ss_pred             CcCCCccccceec-cCCCCcCccccCchhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHh
Confidence            9999864322111 112223567999998853     456779999999999999997 999996433   233333333


Q ss_pred             hCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          315 FAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       315 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      .......+..++.++.+||.+||+.||.+|||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         233 QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            334445566788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.9e-43  Score=318.12  Aligned_cols=246  Identities=31%  Similarity=0.464  Sum_probs=202.0

Q ss_pred             ecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCCCc
Q 016959          107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL  184 (380)
Q Consensus       107 LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  184 (380)
                      ||.|+||.||++++..+++.|++|++.....  ......+.+|++++++++|+||+++++.+..++..++++||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999998899999999865432  24456788999999999999999999999999999999999999998


Q ss_pred             ccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--------CCCC
Q 016959          185 EGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD--------PCNS  252 (380)
Q Consensus       185 ~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~  252 (380)
                      .+++.    ..+..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........        ....
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  160 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR  160 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence            66543    36677889999999999999999999999999999999999999999999875433211        2234


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc--ccHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM--ASREFR  330 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  330 (380)
                      ..++..|++||.+..     ...+.++||||||+++|+|++|..||......   ........ .....+..  ++..+.
T Consensus       161 ~~~~~~~~~Pe~~~~-----~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~~~~  231 (265)
T cd05579         161 IVGTPDYIAPEVILG-----QGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQNILN-GKIEWPEDVEVSDEAI  231 (265)
T ss_pred             cccCccccCHHHhcC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhc-CCcCCCccccCCHHHH
Confidence            568889999999854     33567899999999999999999999644322   22222221 22233333  388999


Q ss_pred             HHHHHhcccCcCCCCCH---HHHhcCccccccCc
Q 016959          331 DFISRCLQKDPHSRWPA---AQLLQHPFILRAGQ  361 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~---~eil~hp~~~~~~~  361 (380)
                      +++.+||+.+|++|||+   .|+|+||||.+.+|
T Consensus       232 ~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         232 DLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             HHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence            99999999999999999   99999999998754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=9.9e-43  Score=315.51  Aligned_cols=247  Identities=24%  Similarity=0.382  Sum_probs=202.2

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      .+..++|++.++||+|+||.||+|.+. ++..||+|.+.....  ..+.+.+|+.+++.++|+||+++++++...+..++
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            467889999999999999999999875 566799999754332  35678899999999999999999999999999999


Q ss_pred             EEeccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          175 LLEYMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       175 v~e~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      +|||+.+++|.+++..      ....+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            9999999998766532      3456778999999999999999999999999999999999999999999987643221


Q ss_pred             -CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCcccc
Q 016959          249 -PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS  326 (380)
Q Consensus       249 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (380)
                       ......++..|+|||++..     ..++.++|||||||++|+|++ |..||.....   .............+....++
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~  230 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINF-----GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSALQRGYRMPRMENCP  230 (261)
T ss_pred             eccCCCccceecCCHHHhcc-----CCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCCCCCCCCCCC
Confidence             1123345678999998853     446778999999999999998 9999964332   23333333334444556678


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          327 REFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .++.+++.+||..||++||+++++++
T Consensus       231 ~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         231 DELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHH
Confidence            89999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.1e-42  Score=316.71  Aligned_cols=243  Identities=23%  Similarity=0.384  Sum_probs=193.9

Q ss_pred             ccccccee--cccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEEE
Q 016959          100 ELQKGNRI--GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus       100 ~~~~~~~L--G~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      +|.+.+.+  |+|+||.||++.+..+++.+|+|++.......      .|+.....+ +|+||+++++.|...+.+++||
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~   88 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIM   88 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEE
Confidence            45555555  99999999999999999999999985432111      122222222 6999999999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-cEEEeeccccccccccCCCCC
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      ||+.+++|.+++.    ..+..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......    .
T Consensus        89 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~----~  164 (267)
T PHA03390         89 DYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP----S  164 (267)
T ss_pred             EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC----c
Confidence            9999999976543    35778889999999999999999999999999999999888 9999999998765432    3


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD  331 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (380)
                      ...|+..|+|||++..     ..++.++|||||||++|+|++|..||......+................+..++..+.+
T Consensus       165 ~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T PHA03390        165 CYDGTLDYFSPEKIKG-----HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAND  239 (267)
T ss_pred             cCCCCCcccChhhhcC-----CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHH
Confidence            4568999999999853     44567899999999999999999999744333321111112223344556678999999


Q ss_pred             HHHHhcccCcCCCCC-HHHHhcCcccc
Q 016959          332 FISRCLQKDPHSRWP-AAQLLQHPFIL  357 (380)
Q Consensus       332 li~~~l~~dp~~R~t-~~eil~hp~~~  357 (380)
                      ||.+||+.||++|++ ++|+|+||||+
T Consensus       240 li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        240 FVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             HHHHHhccChhhCCchHHHHhcCCccc
Confidence            999999999999996 69999999996

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.1e-43  Score=322.46  Aligned_cols=252  Identities=32%  Similarity=0.501  Sum_probs=206.6

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccC
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMD  180 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  180 (380)
                      |....+||+|+||.||++....+++.||||++.... ......+.+|+.+++.++|+||+++++.+...+..++||||+.
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence            444568999999999999999999999999985433 2345678899999999999999999999999999999999999


Q ss_pred             CCCccccc---ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCC
Q 016959          181 GGSLEGAH---IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI  257 (380)
Q Consensus       181 ~~~L~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  257 (380)
                      +++|.+..   ...+..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++..............|+.
T Consensus       101 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  180 (292)
T cd06657         101 GGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTP  180 (292)
T ss_pred             CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCc
Confidence            99987654   235677888999999999999999999999999999999999999999999876654333334466899


Q ss_pred             ccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC--CCCccccHHHHHHHHH
Q 016959          258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP--EAPEMASREFRDFISR  335 (380)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~  335 (380)
                      .|++||++..     ..++.++|+||||+++|+|++|..||.....   ...........+.  .....++..+.+++.+
T Consensus       181 ~y~~pE~~~~-----~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  252 (292)
T cd06657         181 YWMAPELISR-----LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDNLPPKLKNLHKVSPSLKGFLDR  252 (292)
T ss_pred             cccCHHHhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhhCCcccCCcccCCHHHHHHHHH
Confidence            9999998753     3456789999999999999999999964322   2222222222222  2234578899999999


Q ss_pred             hcccCcCCCCCHHHHhcCccccccCc
Q 016959          336 CLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       336 ~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      ||+.||.+||++.|+++||||.+...
T Consensus       253 ~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         253 LLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             HHhCCcccCcCHHHHhcChHHhccCC
Confidence            99999999999999999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.6e-43  Score=320.68  Aligned_cols=243  Identities=28%  Similarity=0.486  Sum_probs=195.4

Q ss_pred             cccceecccCCceEEEEEeC----CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959          102 QKGNRIGSGSGGTVWRVVHP----PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus       102 ~~~~~LG~G~~g~V~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .+.+.||.|.||.||+|.+.    ..+..|+||++.........+.+.+|++.+++++|+||++++|++...+..++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            35678999999999999987    34678999999665555557889999999999999999999999998888999999


Q ss_pred             ccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC--CC
Q 016959          178 YMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM--DP  249 (380)
Q Consensus       178 ~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~  249 (380)
                      ||.+|+|.+++..      ....+..|+.||+.||.|||+++++|+||+++||+++.++.+||+|||++.......  ..
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~  161 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKN  161 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999765443      467788999999999999999999999999999999999999999999998763211  11


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE  328 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (380)
                      .....+...|+|||.+..     ..++.++||||||+++|||++ |+.||...   +.......+........+..++..
T Consensus       162 ~~~~~~~~~~~aPE~~~~-----~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  233 (259)
T PF07714_consen  162 DSSQQLPLRYLAPEVLKD-----GEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEIIEKLKQGQRLPIPDNCPKD  233 (259)
T ss_dssp             STTSESGGGGS-HHHHHH-----SEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHHHHHHHTTEETTSBTTSBHH
T ss_pred             cccccccccccccccccc-----cccccccccccccccccccccccccccccc---ccccccccccccccceeccchhHH
Confidence            233456789999999864     346789999999999999999 78998633   334444555555556667778999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc
Q 016959          329 FRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      +.++|.+||..||++|||+.|+++
T Consensus       234 ~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  234 IYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHh
Confidence            999999999999999999999985

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=356.15  Aligned_cols=249  Identities=23%  Similarity=0.398  Sum_probs=211.4

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCC-----cEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTS-----RVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      ++.+..+.++.||+|.||.||.|.-....     ..||||.+...........|.+|..+|++++|||||+++|++.+.+
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            45777888999999999999999865432     3499999988888888899999999999999999999999999999


Q ss_pred             eEEEEEeccCCCCcccccccc-----------hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccc
Q 016959          171 EIEVLLEYMDGGSLEGAHIRQ-----------EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGV  239 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~~~-----------~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  239 (380)
                      ..+|++|||.||+|..+++..           -..+..++.||++|+.||+++++|||||..+|+|++....+||+|||+
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999998877664           345788999999999999999999999999999999999999999999


Q ss_pred             cccccccCC-CCCC-CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhC
Q 016959          240 SRILAQTMD-PCNS-AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFA  316 (380)
Q Consensus       240 a~~~~~~~~-~~~~-~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  316 (380)
                      |+.+.+... .... ..-...|||||.+.+     ..++.++|||||||+|||+++ |..||....+   .+.+......
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-----~iFtskSDvWsFGVllWEifslG~~PY~~~~n---~~v~~~~~~g  920 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKD-----GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN---FEVLLDVLEG  920 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhh-----cccccccchhhhHHHHHHHHhCCCCCCCCcch---HHHHHHHHhC
Confidence            995433221 1111 234579999999864     667889999999999999886 9999974443   3344433444


Q ss_pred             CCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          317 QPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       317 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .+...|..++..+.++|.+||+.+|++||++..|++
T Consensus       921 gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  921 GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            488899999999999999999999999999999987

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.8e-42  Score=321.62  Aligned_cols=254  Identities=31%  Similarity=0.467  Sum_probs=204.8

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      .+.|.+.+.||+|+||+||+|.+..+++.||+|++....  .......+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356889999999999999999999899999999985432  233446788999999999999999999999999999999


Q ss_pred             EeccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          176 LEYMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       176 ~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      |||+.+. +.+..     ...+..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++......    
T Consensus        94 ~e~~~g~-l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----  168 (307)
T cd06607          94 MEYCLGS-ASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----  168 (307)
T ss_pred             HHhhCCC-HHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence            9999864 32221     2356778889999999999999999999999999999999999999999998755332    


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCC-CccccHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA-PEMASREF  329 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  329 (380)
                      ....++..|+|||++...  ....++.++||||||+++|||++|..||...   +.............+.. ...++..+
T Consensus       169 ~~~~~~~~y~aPE~~~~~--~~~~~~~~sDv~s~G~il~el~tg~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (307)
T cd06607         169 NSFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNDSPTLSSNDWSDYF  243 (307)
T ss_pred             CCccCCccccCceeeecc--CCCCCCcccchHHHHHHHHHHHcCCCCCCCc---cHHHHHHHHhcCCCCCCCchhhCHHH
Confidence            345688999999987421  1234567899999999999999999999632   22222222322222222 33467899


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      .++|.+||..||++||++.+++.||||.....
T Consensus       244 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  275 (307)
T cd06607         244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRERP  275 (307)
T ss_pred             HHHHHHHhcCChhhCcCHHHHhcChhhcccCC
Confidence            99999999999999999999999999988653

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6e-43  Score=325.71  Aligned_cols=252  Identities=25%  Similarity=0.424  Sum_probs=196.7

Q ss_pred             cccccceecccCCceEEEEEeCC--CCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC--CeEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPP--TSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN--GEIE  173 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~--~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~  173 (380)
                      .|.+.++||+|+||.||+|.+..  +++.||+|.+....  .......+.+|+.+++.++|+||+++++++.+.  +.++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            37788999999999999999988  89999999986532  123345677899999999999999999999887  8899


Q ss_pred             EEEeccCCCCccccc---------ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC----CCcEEEeecccc
Q 016959          174 VLLEYMDGGSLEGAH---------IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS----SKNVKIADFGVS  240 (380)
Q Consensus       174 lv~e~~~~~~L~~~~---------~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~----~~~~kl~Dfg~a  240 (380)
                      +||||+.+..+ +.+         ...+..++.++.||+.||.|||++||+||||||+|||++.    ++.+||+|||++
T Consensus        81 lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEHDLW-QIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCcCHH-HHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999986432 221         2356778899999999999999999999999999999999    899999999999


Q ss_pred             ccccccCC---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC------HHHHHH
Q 016959          241 RILAQTMD---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD------WASLMF  311 (380)
Q Consensus       241 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~~~  311 (380)
                      ..+.....   ......++..|+|||++..    ...++.++|||||||++|+|++|+.||.......      ....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhC----CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            86643322   2234567899999998753    2345678999999999999999999997443322      000000


Q ss_pred             HHh-------------------------hCCCCCCC-----------ccccHHHHHHHHHhcccCcCCCCCHHHHhcCcc
Q 016959          312 AIC-------------------------FAQPPEAP-----------EMASREFRDFISRCLQKDPHSRWPAAQLLQHPF  355 (380)
Q Consensus       312 ~~~-------------------------~~~~~~~~-----------~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~  355 (380)
                      ...                         .......+           ...+.++.++|.+||+.||++|||+.|+++|||
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            000                         00000011           145678999999999999999999999999999


Q ss_pred             c
Q 016959          356 I  356 (380)
Q Consensus       356 ~  356 (380)
                      |
T Consensus       316 f  316 (316)
T cd07842         316 F  316 (316)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-42  Score=311.67  Aligned_cols=249  Identities=37%  Similarity=0.580  Sum_probs=211.9

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +|++.+.||+|++|.||++.+..+++.|++|.+..... ......+.+|++++++++|+|++++++++...+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            47788999999999999999998999999999865542 24557889999999999999999999999999999999999


Q ss_pred             cCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCC
Q 016959          179 MDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV  254 (380)
Q Consensus       179 ~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (380)
                      +.+++|.+++.    ..+..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++..............
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~  160 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV  160 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccc
Confidence            99999876543    35677889999999999999999999999999999999999999999999987765443334567


Q ss_pred             CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHH
Q 016959          255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS  334 (380)
Q Consensus       255 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  334 (380)
                      ++..|+|||.+..     ...+.++|||+||+++|+|++|..||....   ................+..++..+.+++.
T Consensus       161 ~~~~y~~pe~~~~-----~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  232 (254)
T cd06627         161 GTPYWMAPEVIEM-----SGASTASDIWSLGCTVIELLTGNPPYYDLN---PMAALFRIVQDDHPPLPEGISPELKDFLM  232 (254)
T ss_pred             cchhhcCHhhhcC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence            8999999998753     335678999999999999999999996332   22333333344455667778999999999


Q ss_pred             HhcccCcCCCCCHHHHhcCccc
Q 016959          335 RCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       335 ~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      +||..+|++|||+.|++.||||
T Consensus       233 ~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         233 QCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.5e-42  Score=323.15  Aligned_cols=252  Identities=23%  Similarity=0.372  Sum_probs=203.2

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCC-------CCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEe
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPP-------TSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHD  164 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~  164 (380)
                      .+.+..++|.++++||+|+||.||+|++..       .+..+|+|.+...........+.+|+.+++.+ +|+||+++++
T Consensus         6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (314)
T cd05099           6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLG   85 (314)
T ss_pred             cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence            345677899999999999999999998632       34579999987655555566788999999999 5999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCccccccc--------------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 016959          165 MYDRNGEIEVLLEYMDGGSLEGAHIR--------------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNL  224 (380)
Q Consensus       165 ~~~~~~~~~lv~e~~~~~~L~~~~~~--------------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Ni  224 (380)
                      ++...+.++++|||+.+++|.+++..                    ....+..++.||+.||.|||++||+||||||+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  165 (314)
T cd05099          86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV  165 (314)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence            99999999999999999998765432                    3455778999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccccCCC--CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 016959          225 LINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVG  301 (380)
Q Consensus       225 l~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~  301 (380)
                      |++.++.+||+|||+++........  .....++..|+|||++..     ..++.++|||||||++|+|++ |..||...
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~~g~~p~~~~  240 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-----RVYTHQSDVWSFGILMWEIFTLGGSPYPGI  240 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-----CCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999866432111  112234568999999853     456778999999999999998 89999643


Q ss_pred             CCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          302 RQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..   ...............+..++.++.+|+.+||..||++|||+.|+++
T Consensus       241 ~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         241 PV---EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             CH---HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            32   3333333333444556678889999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.5e-42  Score=321.30  Aligned_cols=252  Identities=26%  Similarity=0.375  Sum_probs=204.6

Q ss_pred             cCCCcccccccceecccCCceEEEEEe-----CCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEe
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVH-----PPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYD  167 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~  167 (380)
                      +.+..++|.+.+.||+|+||.||++.+     ..++..||||+++........+.+.+|+.+++++ +|+||+++++++.
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            456778899999999999999999975     2345689999987665555567889999999999 7999999999999


Q ss_pred             eCCeEEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          168 RNGEIEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       168 ~~~~~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                      ..+..+++|||+.+++|.+++.      ..+..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999876653      3567788899999999999999999999999999999999999999999997


Q ss_pred             cccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCC
Q 016959          242 ILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQP  318 (380)
Q Consensus       242 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  318 (380)
                      .+.....  ......++..|+|||.+..     ..++.++|||||||++|+|++ |..||......  ............
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~~~~~~~~  262 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFN-----CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYKLIKEGYR  262 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhcc-----CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHHHHHcCCc
Confidence            6543221  1123346788999998853     446779999999999999998 99999643322  122222222333


Q ss_pred             CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          319 PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       319 ~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ...+...+.++.+|+.+||+.+|++|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         263 MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            3445567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=9.7e-43  Score=320.31  Aligned_cols=262  Identities=29%  Similarity=0.456  Sum_probs=209.1

Q ss_pred             cccccceecccCCceEEEEEeC---CCCcEEEEEEecCCC---chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHP---PTSRVFALKVIYGNH---EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~---~~~~~~avK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  172 (380)
                      +|++.+.||+|+||.||++.+.   .+++.||||+++...   .......+.+|+.+++++ +|+||+++++.+..++..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999999864   457889999986432   123345678999999999 599999999999999999


Q ss_pred             EEEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          173 EVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ++||||+.+++|...+..    .+..+..++.|++.||.|||+.|++||||+|.||+++.++.++|+|||++..+.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE  160 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence            999999999998765432    4567888999999999999999999999999999999999999999999876543322


Q ss_pred             -CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          249 -PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       249 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                       ......|+..|++||.+...   ....+.++|+||||+++|+|++|..||...........+...........+..++.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd05583         161 ERAYSFCGTIEYMAPEVIRGG---SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA  237 (288)
T ss_pred             cccccccCCccccCHHHhcCC---CCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCH
Confidence             12235689999999997531   12356789999999999999999999964333222222222233334456667889


Q ss_pred             HHHHHHHHhcccCcCCCCC---HHHHhcCccccccCcccc
Q 016959          328 EFRDFISRCLQKDPHSRWP---AAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t---~~eil~hp~~~~~~~~~~  364 (380)
                      ++.++|.+||+.||++|||   +.++|+||||+...+...
T Consensus       238 ~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~  277 (288)
T cd05583         238 EARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDL  277 (288)
T ss_pred             HHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHH
Confidence            9999999999999999998   577899999999887555

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-45  Score=312.36  Aligned_cols=267  Identities=29%  Similarity=0.467  Sum_probs=218.8

Q ss_pred             cccccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEee
Q 016959           90 QNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDR  168 (380)
Q Consensus        90 ~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~  168 (380)
                      ....+.++.++++-...||.|+||+|++..++.+|+..|||.++....+....++..|.+...+- ++||||++||....
T Consensus        55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~  134 (361)
T KOG1006|consen   55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS  134 (361)
T ss_pred             cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence            34556788888999999999999999999999999999999998877766677888888875544 79999999999988


Q ss_pred             CCeEEEEEeccCCCCcccc---------cccchHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEeecc
Q 016959          169 NGEIEVLLEYMDGGSLEGA---------HIRQEHILSDLARQVLSGLAYLHK-RKIVHRDIKPSNLLINSSKNVKIADFG  238 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~---------~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  238 (380)
                      ++..|+.||+|+- +|..+         ...+|+.+-.|....+.||+||.. ..|||||+||+|||++..|.+||||||
T Consensus       135 EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFG  213 (361)
T KOG1006|consen  135 EGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFG  213 (361)
T ss_pred             CCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeeccc
Confidence            8999999999974 44322         122567777888889999999986 599999999999999999999999999


Q ss_pred             ccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC
Q 016959          239 VSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP  318 (380)
Q Consensus       239 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  318 (380)
                      ++..+.++... +...|...|||||.+...   +..|..++||||||++|||+.||..||..  ..+..+.+..+..+.+
T Consensus       214 IcGqLv~SiAk-T~daGCrpYmAPERi~p~---~~gyDiRSDvWSLGITL~EvAtG~fPyr~--w~svfeql~~Vv~gdp  287 (361)
T KOG1006|consen  214 ICGQLVDSIAK-TVDAGCRPYMAPERIDPS---DKGYDIRSDVWSLGITLYEVATGNFPYRK--WDSVFEQLCQVVIGDP  287 (361)
T ss_pred             chHhHHHHHHh-hhccCCccccChhccCCc---cCCcchhhhhhhhcceEeeeecCCCCcch--HHHHHHHHHHHHcCCC
Confidence            99887655332 345688999999999653   44577899999999999999999999963  3345555555555555


Q ss_pred             CCCCc-----cccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          319 PEAPE-----MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       319 ~~~~~-----~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                      +.+..     ..+..++.+|.-||.+|-..||.+.+++++||++......
T Consensus       288 p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~  337 (361)
T KOG1006|consen  288 PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEG  337 (361)
T ss_pred             CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcC
Confidence            43321     2678999999999999999999999999999998765443

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.3e-43  Score=354.68  Aligned_cols=247  Identities=23%  Similarity=0.373  Sum_probs=198.1

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++|++.++||+|+||.||+|.+..+++.||||++....  ......++.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999999999999999996542  2345667899999999999999999999999999999999


Q ss_pred             eccCCCCccccccc---------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          177 EYMDGGSLEGAHIR---------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       177 e~~~~~~L~~~~~~---------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                      ||++|++|.+++..               ....+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence            99999998765432               123467889999999999999999999999999999999999999999998


Q ss_pred             cccccC------------------CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Q 016959          242 ILAQTM------------------DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ  303 (380)
Q Consensus       242 ~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~  303 (380)
                      ......                  ......+||+.|||||++.+     ..++.++|||||||++|||++|..||.....
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-----~~~S~kSDIWSLGVILyELLTG~~PF~~~~~  236 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-----VPASESTDIYALGVILYQMLTLSFPYRRKKG  236 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-----CCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence            652110                  11123579999999999853     5567899999999999999999999974322


Q ss_pred             CCHHHHHHHHhhCCCCC--CCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          304 GDWASLMFAICFAQPPE--APEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ..   .........+..  ....++..+.+++.+||..||++|++..+.+.+
T Consensus       237 ~k---i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        237 RK---ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hh---hhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            21   111111111111  123578899999999999999999887665543

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.6e-43  Score=331.52  Aligned_cols=259  Identities=26%  Similarity=0.359  Sum_probs=202.7

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC-----CeE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN-----GEI  172 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~  172 (380)
                      .+|.+.+.||+|+||+||+|.+..+++.||||.+.... .......+.+|+.+++.++|+||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            46899999999999999999999999999999986432 222345667899999999999999999987644     358


Q ss_pred             EEEEeccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          173 EVLLEYMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ++|+||+.+ +|..++    ...+..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus        85 ~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  163 (337)
T cd07858          85 YIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD  163 (337)
T ss_pred             EEEEeCCCC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence            999999974 554433    335777889999999999999999999999999999999999999999999987654333


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh--------------
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC--------------  314 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------------  314 (380)
                      ......++..|+|||.+..    +..++.++|||||||++|+|++|+.||...+.......+....              
T Consensus       164 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         164 FMTEYVVTRWYRAPELLLN----CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             cccccccccCccChHHHhc----CCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence            3345568999999998753    2346778999999999999999999996432111111111000              


Q ss_pred             ----------hCCC---CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          315 ----------FAQP---PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       315 ----------~~~~---~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                                ....   ......++.++.+||.+||+.||++|||+.|+|+||||..+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence                      0000   01224578899999999999999999999999999999886443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.4e-42  Score=332.41  Aligned_cols=255  Identities=25%  Similarity=0.379  Sum_probs=205.2

Q ss_pred             cccCCCcccccccceecccCCceEEEEEeC-----CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeE
Q 016959           92 RHQLINPAELQKGNRIGSGSGGTVWRVVHP-----PTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDM  165 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~  165 (380)
                      ..+.+..++|.++++||+|+||.||+|++.     .+++.||||++...........+.+|+.+|.++. |+||++++++
T Consensus        30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            346677889999999999999999999864     3457899999976554444567889999999997 9999999999


Q ss_pred             EeeCCeEEEEEeccCCCCccccccc-------------------------------------------------------
Q 016959          166 YDRNGEIEVLLEYMDGGSLEGAHIR-------------------------------------------------------  190 (380)
Q Consensus       166 ~~~~~~~~lv~e~~~~~~L~~~~~~-------------------------------------------------------  190 (380)
                      +...+..++|||||.+|+|.+++..                                                       
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            9999999999999999998655432                                                       


Q ss_pred             -----------------------------------------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 016959          191 -----------------------------------------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSN  223 (380)
Q Consensus       191 -----------------------------------------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~N  223 (380)
                                                                     ....+..++.||+.||+|||++||+||||||+|
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N  269 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN  269 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence                                                           122356788999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 016959          224 LLINSSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAV  300 (380)
Q Consensus       224 il~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~  300 (380)
                      ||++.++.+||+|||+++.......  ......++..|+|||.+..     ..++.++|||||||++|||++ |..||..
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGvil~e~l~~g~~P~~~  344 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-----NLYTTLSDVWSFGILLWEIFTLGGTPYPE  344 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-----CCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999976532211  1233457889999999853     446778999999999999998 8999964


Q ss_pred             CCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          301 GRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ....+  .....+........+..++.++.+|+.+||..+|++||++.||++.
T Consensus       345 ~~~~~--~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         345 LPMNE--QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CCchH--HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            33222  2222233334445566788999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.6e-42  Score=317.37  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=201.8

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCc----EEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSR----VFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      .+...+|++.++||+|+||+||+|.+..+++    .||+|++...........+.+|+.+++.++|+||+++++++.. .
T Consensus         3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~   81 (279)
T cd05109           3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S   81 (279)
T ss_pred             ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence            3567889999999999999999999876665    4899998766555556788899999999999999999998875 4


Q ss_pred             eEEEEEeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      ..++++||+.+|+|.+.+..     .+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            57899999999998766532     4567888999999999999999999999999999999999999999999987643


Q ss_pred             cCCC--CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCC
Q 016959          246 TMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAP  322 (380)
Q Consensus       246 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  322 (380)
                      ....  .....++..|+|||.+..     ..++.++|||||||++|||++ |..||......   ..............+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~~~~~~~~  233 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILH-----RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDLLEKGERLPQP  233 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhcc-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHCCCcCCCC
Confidence            2211  122334678999999853     446678999999999999998 99999643322   222223333444556


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..++.++.+++.+||..||++||++.|++.
T Consensus       234 ~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         234 PICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.4e-42  Score=318.97  Aligned_cols=256  Identities=38%  Similarity=0.612  Sum_probs=209.9

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .+.|+..+.||+|+||.||+|.+..+++.|++|++.....  ..+.+.+|+++++.++|+||+++++.+...+..++++|
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            3458888999999999999999988899999999865443  45678899999999999999999999999999999999


Q ss_pred             ccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          178 YMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       178 ~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      |+.+++|.+++..     ....+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++............
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  175 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS  175 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhcc
Confidence            9999999766443     45667889999999999999999999999999999999999999999998765543333344


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC--CCccccHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--APEMASREFR  330 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  330 (380)
                      ..++..|++||++..     ..++.++|+|||||++|+|++|..||.....   ..............  ....++.++.
T Consensus       176 ~~~~~~y~~PE~~~~-----~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~  247 (286)
T cd06614         176 VVGTPYWMAPEVIKR-----KDYGPKVDIWSLGIMCIEMAEGEPPYLREPP---LRALFLITTKGIPPLKNPEKWSPEFK  247 (286)
T ss_pred             ccCCcccCCHhHhcC-----CCCCCccccHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCCcchhhCCHHHH
Confidence            568899999998753     4456789999999999999999999963222   22222222222222  2233788999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                      ++|.+||+.+|.+|||+.++++|+||++..+.+
T Consensus       248 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  280 (286)
T cd06614         248 DFLNKCLVKDPEKRPSAEELLQHPFLKKACPKE  280 (286)
T ss_pred             HHHHHHhccChhhCcCHHHHhhChHhhccCchH
Confidence            999999999999999999999999999964443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.1e-42  Score=320.95  Aligned_cols=252  Identities=22%  Similarity=0.316  Sum_probs=200.3

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCC----------------cEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCce
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTS----------------RVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV  159 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~----------------~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  159 (380)
                      +..++|++.+.||+|+||.||+|.+..++                ..||+|++.........+.+.+|+++++.++|+||
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCE
Confidence            34578999999999999999999876543                56899999766655667789999999999999999


Q ss_pred             eeeEeEEeeCCeEEEEEeccCCCCccccc---------------ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 016959          160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAH---------------IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNL  224 (380)
Q Consensus       160 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~---------------~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Ni  224 (380)
                      +++++++..++..+++||++.+++|..++               ...+..+..++.|++.||.|||++||+|+||||+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni  161 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC  161 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence            99999999999999999999999886654               235667889999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccccC--CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh--CCCCCCC
Q 016959          225 LINSSKNVKIADFGVSRILAQTM--DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL--GRFPFAV  300 (380)
Q Consensus       225 l~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~--g~~pf~~  300 (380)
                      +++.++.++|+|||++..+....  .......++..|+|||++..     ..++.++|||||||++|||++  |..||..
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-----GKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-----CCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            99999999999999987654321  11234456789999998753     456789999999999999998  7788853


Q ss_pred             CCCCCHHHHHHHH----hhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          301 GRQGDWASLMFAI----CFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       301 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ....+........    ........+..++.++.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         237 LTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             cChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            3222221111111    011112234456789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1e-42  Score=328.27  Aligned_cols=253  Identities=25%  Similarity=0.388  Sum_probs=200.1

Q ss_pred             cCCCcccccccceecccCCceEEEEEeC-----CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEe
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHP-----PTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYD  167 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~  167 (380)
                      +.+..++|++.+.||+|+||+||+|.+.     .+++.||||+++..........+.+|+.+++++ +|+||+++++++.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            4567789999999999999999999853     467899999997655445556788999999999 6899999999876


Q ss_pred             e-CCeEEEEEeccCCCCccccccc--------------------------------------------------------
Q 016959          168 R-NGEIEVLLEYMDGGSLEGAHIR--------------------------------------------------------  190 (380)
Q Consensus       168 ~-~~~~~lv~e~~~~~~L~~~~~~--------------------------------------------------------  190 (380)
                      . +..++++||||.+|+|.+++..                                                        
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            4 4568899999999998655321                                                        


Q ss_pred             ---------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--CCCCC
Q 016959          191 ---------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD--PCNSA  253 (380)
Q Consensus       191 ---------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~  253 (380)
                                     ....+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....  .....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                           2334567899999999999999999999999999999999999999999876533211  11223


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      .++..|+|||++..     ..++.++|||||||++|+|++ |..||......  ...............+...+.++.++
T Consensus       242 ~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (343)
T cd05103         242 RLPLKWMAPETIFD-----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLKEGTRMRAPDYTTPEMYQT  314 (343)
T ss_pred             CCCcceECcHHhcC-----CCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHHHHhccCCCCCCCCCCHHHHHH
Confidence            45678999998753     456778999999999999996 99999643222  12222333333444556678899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcC
Q 016959          333 ISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       333 i~~~l~~dp~~R~t~~eil~h  353 (380)
                      +.+||+.||++|||+.|+++|
T Consensus       315 ~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         315 MLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.8e-43  Score=329.17  Aligned_cols=253  Identities=23%  Similarity=0.368  Sum_probs=195.9

Q ss_pred             ceeccc--CCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          105 NRIGSG--SGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       105 ~~LG~G--~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      ..||+|  +||+||++.+..+|+.||+|++.... .....+.+.+|+.+++.++|+||++++++|..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  99999999999999999999986543 344557889999999999999999999999999999999999999


Q ss_pred             CCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC------
Q 016959          182 GSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP------  249 (380)
Q Consensus       182 ~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~------  249 (380)
                      ++|.+++.      ..+..+..++.||+.||+|||++||+||||||+|||++.++.++++||+.+.........      
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD  163 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence            99876543      356677889999999999999999999999999999999999999999865433211110      


Q ss_pred             -CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC------------
Q 016959          250 -CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA------------  316 (380)
Q Consensus       250 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~------------  316 (380)
                       .....++..|+|||++...   ...++.++|||||||++|+|++|..||.......  .........            
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~---~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         164 FPQFSTSVLPWLSPELLRQD---LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             ccccccCccCccChhhhcCC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccch
Confidence             1112346679999998531   1235678999999999999999999996432211  111110000            


Q ss_pred             ---------------------------------CCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          317 ---------------------------------QPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       317 ---------------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                                                       ........++..+.+||.+||+.||++|||+.|+|+||||......
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence                                             0001122356789999999999999999999999999999987653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-44  Score=304.55  Aligned_cols=255  Identities=29%  Similarity=0.356  Sum_probs=202.1

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC----
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRN----  169 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----  169 (380)
                      ..|+.++|.+.++||+|||+.||+++...+++.||+|++.-.. .+..+...+|++..++++|||+++++++...+    
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            4478899999999999999999999999999999999986544 34467888999999999999999999875432    


Q ss_pred             -CeEEEEEeccCCCCccccccc--------chHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCcEEEeecc
Q 016959          170 -GEIEVLLEYMDGGSLEGAHIR--------QEHILSDLARQVLSGLAYLHKRK--IVHRDIKPSNLLINSSKNVKIADFG  238 (380)
Q Consensus       170 -~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg  238 (380)
                       ...|+++.|...|+|.+.+..        ++..+..|+.+|++||++||+..  ++||||||.|||+.+.+.++|.|||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence             359999999999998665443        57788999999999999999998  9999999999999999999999999


Q ss_pred             ccccccccCC---------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--CCHH
Q 016959          239 VSRILAQTMD---------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ--GDWA  307 (380)
Q Consensus       239 ~a~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~~~~  307 (380)
                      .++...-...         .......|..|+|||.++-  ..+.-.+.++|||||||+||+|+.|..||...-.  ....
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~v--k~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla  252 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNV--KSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA  252 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheec--ccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence            9876532211         1123457999999999974  2345557799999999999999999999962110  0000


Q ss_pred             HHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          308 SLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      -.+.......+..  ..++..+.+||+.||+.||.+||++.+++.+
T Consensus       253 LAv~n~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  253 LAVQNAQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EeeeccccccCCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            0111111111222  2278899999999999999999999999874

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=334.88  Aligned_cols=258  Identities=24%  Similarity=0.387  Sum_probs=211.2

Q ss_pred             cccCCCcccccccceecccCCceEEEEEeCCCCc---E-EEEEEecC--CCchHHHHHHHHHHHHHHhCCCCceeeeEeE
Q 016959           92 RHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSR---V-FALKVIYG--NHEDSVRSQICREIEILRDVNHPNVVKCHDM  165 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~---~-~avK~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~  165 (380)
                      ..|.+..++..+.++||+|+||+||+|..+..+.   . ||||..+.  ........++.+|.++|+.++|+|||++||+
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3455667778888999999999999998765422   3 89999875  3456677889999999999999999999999


Q ss_pred             EeeCCeEEEEEeccCCCCcccccccc-----hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccc
Q 016959          166 YDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS  240 (380)
Q Consensus       166 ~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  240 (380)
                      ......+++|||+|.||+|.+++...     ..+...++.+.+.||+|||+++++||||..+|+|++.++.+||+|||++
T Consensus       230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence            99999999999999999999888764     3456789999999999999999999999999999999999999999998


Q ss_pred             ccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHH-hhCCC
Q 016959          241 RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAI-CFAQP  318 (380)
Q Consensus       241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~-~~~~~  318 (380)
                      +.-..........--...|+|||.+..     ..++.++|||||||++||+++ |..||....   .......+ ....+
T Consensus       310 ~~~~~~~~~~~~~klPirWLAPEtl~~-----~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~---~~~v~~kI~~~~~r  381 (474)
T KOG0194|consen  310 RAGSQYVMKKFLKKLPIRWLAPETLNT-----GIFSFKTDVWSFGVLLWEIFENGAEPYPGMK---NYEVKAKIVKNGYR  381 (474)
T ss_pred             cCCcceeeccccccCcceecChhhhcc-----CccccccchhheeeeEEeeeccCCCCCCCCC---HHHHHHHHHhcCcc
Confidence            765422111111224679999999864     477889999999999999998 899997433   33444444 44566


Q ss_pred             CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          319 PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       319 ~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ...+...+.++..++.+||..||++|+|+.++.+  +++.+
T Consensus       382 ~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~--~l~~~  420 (474)
T KOG0194|consen  382 MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK--KLEAL  420 (474)
T ss_pred             CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH--HHHHH
Confidence            6677788889999999999999999999999876  55444

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.6e-42  Score=315.36  Aligned_cols=249  Identities=25%  Similarity=0.393  Sum_probs=202.3

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCC---cEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTS---RVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      ++.++|++.+.||+|+||.||+|.+..++   ..+|+|.++..........+.+|+.+++.++||||+++++++..++..
T Consensus         1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             CCHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            34678999999999999999999886444   379999987655555667889999999999999999999999999999


Q ss_pred             EEEEeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          173 EVLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      ++||||+.+++|.+++..     ....+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++..+....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            999999999998766543     456678899999999999999999999999999999999999999999998664332


Q ss_pred             CCC---CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          248 DPC---NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       248 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      ...   ....++..|++||.+..     ..++.++|+|||||++||+++ |..||......   .....+........+.
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~-----~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~  232 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAY-----RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIEEGYRLPAPM  232 (267)
T ss_pred             ceeeecCCCccceeecCHhHhcc-----CccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHhCCCcCCCCC
Confidence            211   12223568999999853     456789999999999999886 99999643322   2333333333344455


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .++..+.+++.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         233 DCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            67889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3e-42  Score=309.53  Aligned_cols=246  Identities=38%  Similarity=0.638  Sum_probs=204.8

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEecc
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYM  179 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  179 (380)
                      +|...+.||+|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++|+|++++++++...+..++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            47788999999999999999988899999999865544 34567889999999999999999999999999999999999


Q ss_pred             CCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCC
Q 016959          180 DGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV  254 (380)
Q Consensus       180 ~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (380)
                      .+++|.+.+.     ..+..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........ .....
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~  158 (253)
T cd05122          80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMV  158 (253)
T ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-cccee
Confidence            9999876542     35677889999999999999999999999999999999999999999999987654432 34566


Q ss_pred             CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc--ccHHHHHH
Q 016959          255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM--ASREFRDF  332 (380)
Q Consensus       255 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l  332 (380)
                      ++..|++||.+..     ...+.++||||||+++|+|++|..||.....   ..................  ++..+.++
T Consensus       159 ~~~~~~~PE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (253)
T cd05122         159 GTPYWMAPEVING-----KPYDYKADIWSLGITAIELAEGKPPYSELPP---MKALFKIATNGPPGLRNPEKWSDEFKDF  230 (253)
T ss_pred             cCCcccCHHHHcC-----CCCCccccHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHHhcCCCCcCcccccCHHHHHH
Confidence            8899999999853     3367789999999999999999999964322   222222222223333333  37899999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCcc
Q 016959          333 ISRCLQKDPHSRWPAAQLLQHPF  355 (380)
Q Consensus       333 i~~~l~~dp~~R~t~~eil~hp~  355 (380)
                      |.+||+.||++|||+.|+|+|||
T Consensus       231 i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         231 LKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHccCChhhCCCHHHHhcCCC
Confidence            99999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.2e-42  Score=326.61  Aligned_cols=258  Identities=26%  Similarity=0.378  Sum_probs=200.2

Q ss_pred             cccc-ccceecccCCceEEEEEeCCCCcEEEEEEecCCCchH-------------HHHHHHHHHHHHHhCCCCceeeeEe
Q 016959           99 AELQ-KGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-------------VRSQICREIEILRDVNHPNVVKCHD  164 (380)
Q Consensus        99 ~~~~-~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~~iv~~~~  164 (380)
                      ++|. +.+.||.|+||+||+|.+..+++.||||++.......             ....+.+|+++++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3454 5678999999999999999899999999985432211             0124678999999999999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccc
Q 016959          165 MYDRNGEIEVLLEYMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS  240 (380)
Q Consensus       165 ~~~~~~~~~lv~e~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  240 (380)
                      ++..++..++||||+.+ +|.+.+    ...+..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++
T Consensus        88 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         88 VYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             EEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence            99999999999999975 665443    2356778889999999999999999999999999999999999999999998


Q ss_pred             ccccc--------------cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCH
Q 016959          241 RILAQ--------------TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDW  306 (380)
Q Consensus       241 ~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~  306 (380)
                      .....              .........++..|+|||.+.+    ...++.++|+|||||++|+|++|..||...+..+.
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  242 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG----AEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ  242 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhccc----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            76541              1111223456889999999853    23457799999999999999999999975443322


Q ss_pred             HHHHHHHhhCCCC------------------------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          307 ASLMFAICFAQPP------------------------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       307 ~~~~~~~~~~~~~------------------------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      ...+.........                        ......+.++.++|.+||+.||++|||++|+|.||||+....
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~  321 (335)
T PTZ00024        243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL  321 (335)
T ss_pred             HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence            2222111110000                        011235778999999999999999999999999999987633

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-42  Score=311.36  Aligned_cols=242  Identities=26%  Similarity=0.396  Sum_probs=203.1

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      ++.++|++.+.||.|+||.||+|..  .|+.||+|.+.....  ...++.+|+.+++.++|+||+++++++.+.+..++|
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence            5678899999999999999999988  588999999965543  456788999999999999999999999988999999


Q ss_pred             EeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 016959          176 LEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       176 ~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  249 (380)
                      |||+.+++|.+++.      ..+..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......  
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--  156 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--  156 (256)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence            99999999876653      3567788999999999999999999999999999999999999999999998764322  


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE  328 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (380)
                       ....++..|+|||++..     ..++.++||||||+++|++++ |..||....   ................+..++.+
T Consensus       157 -~~~~~~~~~~ape~~~~-----~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  227 (256)
T cd05039         157 -DSGKLPVKWTAPEALRE-----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPHVEKGYRMEAPEGCPPE  227 (256)
T ss_pred             -ccCCCcccccCchhhcC-----CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHhcCCCCCCccCCCHH
Confidence             23345678999998853     445678999999999999997 999996432   33333333333444556678899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc
Q 016959          329 FRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      +.++|.+||..+|++|||+.|+++
T Consensus       228 ~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         228 VYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHHHHhccChhhCcCHHHHHH
Confidence            999999999999999999999987

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.7e-42  Score=313.37  Aligned_cols=247  Identities=23%  Similarity=0.364  Sum_probs=200.0

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      ++.++|.+.+.||+|+||+||++.+.. +..+|+|.+.....  ..+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           1 IDPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             CChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence            356789999999999999999998753 44699999864332  235688999999999999999999999988899999


Q ss_pred             EeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-C
Q 016959          176 LEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-P  249 (380)
Q Consensus       176 ~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~  249 (380)
                      |||+.+++|.+++.     ..+..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||+++....... .
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            99999998876543     35667889999999999999999999999999999999999999999999876543211 1


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE  328 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (380)
                      .....++..|++||.+..     ..++.++|||||||++|+|++ |..||.....   ...............+...+..
T Consensus       158 ~~~~~~~~~y~~pe~~~~-----~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLY-----SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKVSQGLRLYRPHLASEK  229 (256)
T ss_pred             cCCCccChhhCCHHHHhc-----CcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHhcCCCCCCCCCCCHH
Confidence            122335678999999853     446678999999999999998 9999964332   2233333334444455667899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          329 FRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      +.+++.+||+.||++|||+.+++++
T Consensus       230 ~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         230 VYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHHh
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.3e-42  Score=320.39  Aligned_cols=253  Identities=23%  Similarity=0.357  Sum_probs=205.4

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeC-------CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEe
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHP-------PTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHD  164 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~  164 (380)
                      .+.+..++|.+.+.||+|+||.||+|++.       ..+..||+|.+...........+.+|+.+++.+ +|+||+++++
T Consensus         9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101           9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            45677889999999999999999999752       234579999986554445567788999999999 7999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCccccccc--------------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 016959          165 MYDRNGEIEVLLEYMDGGSLEGAHIR--------------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNL  224 (380)
Q Consensus       165 ~~~~~~~~~lv~e~~~~~~L~~~~~~--------------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Ni  224 (380)
                      ++...+..++||||+.+++|..++..                    ....+..++.||+.||.|||++||+||||||+||
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  168 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV  168 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence            99999999999999999998765432                    2345778899999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccccCCC--CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 016959          225 LINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVG  301 (380)
Q Consensus       225 l~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~  301 (380)
                      |++.++.+||+|||+++.+......  .....++..|+|||++..     ..++.++||||||+++|+|++ |..||...
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~g~~p~~~~  243 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-----RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  243 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            9999999999999999876432211  223345678999998843     456778999999999999998 88888633


Q ss_pred             CCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          302 RQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                         .................+..++.++.+|+.+||..+|++|||+.|+++.
T Consensus       244 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         244 ---PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             ---CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence               3334444444444445566788999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.7e-42  Score=313.90  Aligned_cols=246  Identities=23%  Similarity=0.415  Sum_probs=200.8

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      .+..++|++.++||+|+||.||+|... +++.||+|.+......  ...+.+|+.++++++|+||+++++++.. +..++
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   77 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYI   77 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc--HHHHHHHHHHHHhcCCcCeeeEEEEEcc-CCcEE
Confidence            466789999999999999999999865 5678999998654432  3568899999999999999999998754 56899


Q ss_pred             EEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-
Q 016959          175 LLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM-  247 (380)
Q Consensus       175 v~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  247 (380)
                      +|||+.+++|.+++.      .....+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++....... 
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            999999999876543      2456678899999999999999999999999999999999999999999997665221 


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCcccc
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS  326 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (380)
                      .......++..|+|||++..     ..++.++||||||+++|||++ |..||.....   ...............+...+
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~-----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~  229 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNLERGYRMPRPDNCP  229 (260)
T ss_pred             ccccCCcccccccCHHHhcc-----CCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHcCCCCCCCCCCC
Confidence            11223446778999998853     445778999999999999998 9999964332   23333333444455667788


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          327 REFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .++.++|.+||+.||++|||++++++
T Consensus       230 ~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         230 EELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHH
Confidence            89999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3e-42  Score=315.72  Aligned_cols=248  Identities=23%  Similarity=0.334  Sum_probs=198.9

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCc----EEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSR----VFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      +..++|++.+.||+|+||+||+|.+..+++    .+++|.+...........+..|+..+++++|+||+++++++.. ..
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~   82 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS   82 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence            556789999999999999999999877766    4777777544334445677888989999999999999998764 56


Q ss_pred             EEEEEeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      .++++||+.+++|.+++..     .+..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.+...
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            7899999999999876543     45678889999999999999999999999999999999999999999999865432


Q ss_pred             CC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          247 MD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       247 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      ..  ......++..|+|||++..     ..++.++|||||||++|||++ |..||.....   ...............+.
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~-----~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~~~~~~~  234 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILF-----GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---HEVPDLLEKGERLAQPQ  234 (279)
T ss_pred             CcccccCCCCCcccccCHHHhcc-----CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCCcCCCCC
Confidence            21  1233456778999999853     446789999999999999998 9999964322   22222233334444555


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .++.++.+++.+||..||++|||+.|+++
T Consensus       235 ~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         235 ICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            67889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-42  Score=328.18  Aligned_cols=257  Identities=27%  Similarity=0.387  Sum_probs=203.5

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC------
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG------  170 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------  170 (380)
                      .++|++.+.||+|+||.||++.+..+++.||||++.... .......+.+|+.+++.++|+||+++++++....      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            467999999999999999999999999999999985433 3334567889999999999999999999987543      


Q ss_pred             eEEEEEeccCCCCccccc---ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          171 EIEVLLEYMDGGSLEGAH---IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      .+++||||+ +++|..+.   ...+..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++...... 
T Consensus        94 ~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-  171 (343)
T cd07880          94 DFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-  171 (343)
T ss_pred             eEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC-
Confidence            468999999 56775543   3457778899999999999999999999999999999999999999999999765432 


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC-----------
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA-----------  316 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-----------  316 (380)
                        .....++..|+|||.+..    ...++.++|+|||||++|+|++|..||...........+......           
T Consensus       172 --~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07880         172 --MTGYVVTRWYRAPEVILN----WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS  245 (343)
T ss_pred             --ccccccCCcccCHHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence              234567899999999853    234577899999999999999999999743321111111110000           


Q ss_pred             ---------CC-------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          317 ---------QP-------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       317 ---------~~-------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                               .+       ......++..+.++|.+||+.||++|||+.++++||||+.....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence                     00       01223567789999999999999999999999999999987443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8.9e-43  Score=322.59  Aligned_cols=256  Identities=29%  Similarity=0.464  Sum_probs=200.9

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC----
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRNG----  170 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----  170 (380)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++|+||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            345789999999999999999999999999999999864432 223356778999999999999999999887654    


Q ss_pred             ------eEEEEEeccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccc
Q 016959          171 ------EIEVLLEYMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGV  239 (380)
Q Consensus       171 ------~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  239 (380)
                            .+++|+||+.+. +...+     ...+..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||+
T Consensus        84 ~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~  162 (302)
T cd07864          84 FKKDKGAFYLVFEYMDHD-LMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL  162 (302)
T ss_pred             ccccCCcEEEEEcccCcc-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence                  799999999874 32222     235677889999999999999999999999999999999999999999999


Q ss_pred             cccccccCC-CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC
Q 016959          240 SRILAQTMD-PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP  318 (380)
Q Consensus       240 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  318 (380)
                      +..+..... ......++..|+|||++..    ...++.++|||||||++|+|++|+.||......+....+........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLG----EERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC  238 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            987654322 1223456788999998753    23356789999999999999999999974333222222222211111


Q ss_pred             C--------------------------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          319 P--------------------------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       319 ~--------------------------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      +                          .....++..+.++|.+||+.||++|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            1                          0122467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.1e-42  Score=321.25  Aligned_cols=266  Identities=30%  Similarity=0.545  Sum_probs=207.7

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCe
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGE  171 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  171 (380)
                      .+.+..++|++.+.||+|+||+||+|.+..+++.||||++...........+..|+.++.++. |+||+++++++.+...
T Consensus         9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618           9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            345677899999999999999999999998899999999976544444556667787776664 9999999999999999


Q ss_pred             EEEEEeccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHK-RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      .+++|||+.+ .|....     ...+..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++..+..
T Consensus        89 ~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          89 VFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             EEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            9999999865 443322     23566778899999999999997 5999999999999999999999999999876643


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCC--c
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAP--E  323 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~  323 (380)
                      ... .....++..|+|||.+..... ...++.++||||||+++|+|++|..||..... + ...............+  .
T Consensus       168 ~~~-~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~-~~~~~~~~~~~~~~~~~~~  243 (296)
T cd06618         168 SKA-KTRSAGCAAYMAPERIDPPDP-NPKYDIRADVWSLGISLVELATGQFPYKNCKT-E-FEVLTKILQEEPPSLPPNE  243 (296)
T ss_pred             CCc-ccCCCCCccccCHhhcCCCCC-ccccccchhHHHHHHHHHHHHhCCCCCCcchh-H-HHHHHHHhcCCCCCCCCCC
Confidence            322 233457889999999854221 23356789999999999999999999964221 1 2222222222222222  2


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                      .++.++.+||.+||..||++||++++++.||||+......
T Consensus       244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  283 (296)
T cd06618         244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE  283 (296)
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhH
Confidence            4688999999999999999999999999999999865443

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-42  Score=313.32  Aligned_cols=246  Identities=23%  Similarity=0.384  Sum_probs=200.3

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      +..+|++.+.||+|+||.||++.+. +++.+|+|++.....  ....+.+|+.+++.++|+||+++++++...+..++||
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            4568999999999999999999886 566899999854332  2345778999999999999999999999999999999


Q ss_pred             eccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC-C
Q 016959          177 EYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP-C  250 (380)
Q Consensus       177 e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-~  250 (380)
                      ||+.+++|.+++..     .+..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++........ .
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            99999998776532     46678899999999999999999999999999999999999999999998765432111 1


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      ....++..|+|||.+..     ..++.++|||||||++|+|++ |..||.....   ...............+..++.++
T Consensus       159 ~~~~~~~~y~~Pe~~~~-----~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd05059         159 QGTKFPVKWAPPEVFDY-----SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVESVSAGYRLYRPKLAPTEV  230 (256)
T ss_pred             CCCCCCccccCHHHhcc-----CCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHHHHcCCcCCCCCCCCHHH
Confidence            12223457999998853     456678999999999999998 8999964332   33334444444556666789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcC
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      .+++.+||..+|++|||+.|+++.
T Consensus       231 ~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         231 YTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHHhcCChhhCcCHHHHHHH
Confidence            999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.5e-42  Score=310.34  Aligned_cols=250  Identities=37%  Similarity=0.632  Sum_probs=210.2

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC--CeEEEEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRN--GEIEVLL  176 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~  176 (380)
                      +|.+.+.||+|++|.||+|.+..+++.|++|++..... ....+.+.+|+.++++++|+||+++++.+...  +.+++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            46778999999999999999998999999999865432 34467788999999999999999999999988  8899999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--CC
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD--PC  250 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~  250 (380)
                      ||+.+++|.+++.    ..+..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+........  ..
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  160 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT  160 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence            9999999876543    35677889999999999999999999999999999999999999999999987665432  13


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh-hCCCCCCCccccHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC-FAQPPEAPEMASREF  329 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  329 (380)
                      ....++..|++||.+..     ...+.++||||||+++|+|++|..||....  +......... .......+..++..+
T Consensus       161 ~~~~~~~~y~~pE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (260)
T cd06606         161 GSVRGTPYWMAPEVIRG-----EEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSSGEPPEIPEHLSEEA  233 (260)
T ss_pred             cCCCCCccccCHhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHhccccCCCcCCCcccCHHH
Confidence            45678999999998853     336778999999999999999999997443  2233333322 234455667778999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      .++|.+||..||++||++.|++.||||
T Consensus       234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         234 KDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.8e-42  Score=317.68  Aligned_cols=245  Identities=26%  Similarity=0.398  Sum_probs=199.0

Q ss_pred             cccccceecccCCceEEEEEeCC-----CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPP-----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+...........+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            47788999999999999998743     2367999998766555556778899999999999999999999999999999


Q ss_pred             EEeccCCCCcccccc----------------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 016959          175 LLEYMDGGSLEGAHI----------------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI  226 (380)
Q Consensus       175 v~e~~~~~~L~~~~~----------------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~  226 (380)
                      ++||+.+++|.+++.                            .....+..++.|++.||+|||++||+||||||+|||+
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill  160 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV  160 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence            999999999876532                            2345678899999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCC
Q 016959          227 NSSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQ  303 (380)
Q Consensus       227 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~  303 (380)
                      ++++.+||+|||++........  ......++..|+|||.+..     ..++.++||||||+++|+|++ |..||.....
T Consensus       161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  235 (290)
T cd05045         161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-----HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP  235 (290)
T ss_pred             cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-----CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            9999999999999976533221  1123345678999998743     456788999999999999998 9999964332


Q ss_pred             CCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          304 GDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                         ...............+..++.++.+++.+||+.||++||++.|+++
T Consensus       236 ---~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         236 ---ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             ---HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence               2333333333344556778899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.2e-42  Score=324.78  Aligned_cols=253  Identities=24%  Similarity=0.368  Sum_probs=205.1

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCC-------CcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEe
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPT-------SRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHD  164 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~-------~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~  164 (380)
                      .+.+...+|.+++.||+|+||.||+|.+...       +..||+|++...........+.+|+++++++ +|+||+++++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            4556677899999999999999999986432       2368999987655555567889999999999 7999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCccccccc--------------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 016959          165 MYDRNGEIEVLLEYMDGGSLEGAHIR--------------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNL  224 (380)
Q Consensus       165 ~~~~~~~~~lv~e~~~~~~L~~~~~~--------------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Ni  224 (380)
                      ++...+..+++|||+.+++|.+++..                    ....+..++.||+.||.|||++||+||||||+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  165 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV  165 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence            99999999999999999998766432                    2345678999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 016959          225 LINSSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVG  301 (380)
Q Consensus       225 l~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~  301 (380)
                      |++.++.+||+|||+++.......  ......++..|+|||++..     ..++.++|||||||++|||++ |..||...
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~~g~~p~~~~  240 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-----RVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-----CCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            999999999999999976543221  1122334568999999853     456778999999999999998 88999643


Q ss_pred             CCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          302 RQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                         +.......+........+..++.++.+|+.+||+.+|++|||+.|++++
T Consensus       241 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         241 ---PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             ---CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence               3334444444444555666788899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.7e-42  Score=317.91  Aligned_cols=248  Identities=25%  Similarity=0.415  Sum_probs=201.7

Q ss_pred             CCcccccccceecccCCceEEEEEeC-----CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHP-----PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      +...+|.+.+.||+|+||.||+|++.     .++..+++|.+..... .....+.+|+.++++++|+||+++++++...+
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            34567999999999999999999853     3456789998854332 33456889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCcccccc--------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC
Q 016959          171 EIEVLLEYMDGGSLEGAHI--------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK  230 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~--------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~  230 (380)
                      ..++||||+.+++|.+++.                    ..+..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence            9999999999999876653                    24566888999999999999999999999999999999999


Q ss_pred             cEEEeeccccccccccC--CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHH
Q 016959          231 NVKIADFGVSRILAQTM--DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWA  307 (380)
Q Consensus       231 ~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~  307 (380)
                      .++|+|||++.......  .......++..|+|||++..     ..++.++|||||||++|||++ |..||.....   .
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~  232 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-----RKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---T  232 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---H
Confidence            99999999997654321  11233456789999998853     556778999999999999998 9999964332   2


Q ss_pred             HHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          308 SLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..............+..++.++.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         233 EVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            333334444444556667889999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-42  Score=311.76  Aligned_cols=241  Identities=26%  Similarity=0.425  Sum_probs=203.5

Q ss_pred             ceecccCCceEEEEEeCCC---CcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          105 NRIGSGSGGTVWRVVHPPT---SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      +.||+|+||.||+|.+...   +..||+|++...........+.+|+.+++.++|+||+++++++.....+++||||+.+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4699999999999999865   8899999997665544567889999999999999999999999999999999999999


Q ss_pred             CCcccccc-------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-
Q 016959          182 GSLEGAHI-------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM-  247 (380)
Q Consensus       182 ~~L~~~~~-------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  247 (380)
                      ++|.+++.             .++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+....... 
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  160 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY  160 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence            99866543             2567789999999999999999999999999999999999999999999998765432 


Q ss_pred             -CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          248 -DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                       .......++..|+|||.+..     ..++.++|||||||++|+|++ |..||....   ................+..+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~  232 (262)
T cd00192         161 YRKKTGGKLPIRWMAPESLKD-----GIFTSKSDVWSFGVLLWEIFTLGATPYPGLS---NEEVLEYLRKGYRLPKPEYC  232 (262)
T ss_pred             cccccCCCcCccccCHHHhcc-----CCcchhhccHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCCCccC
Confidence             22344567889999998854     356778999999999999998 699997543   33334444445555667778


Q ss_pred             cHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          326 SREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      +.++.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         233 PDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            9999999999999999999999999974

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.4e-42  Score=317.74  Aligned_cols=249  Identities=26%  Similarity=0.397  Sum_probs=202.7

Q ss_pred             CCcccccccceecccCCceEEEEEeCC-----CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPP-----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      ++.++|++.+.||+|+||.||+|.+..     ++..||+|++...........+.+|+.++++++|+||+++++++.+++
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            456789999999999999999998743     678999999876655555677889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCcccccc--------------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 016959          171 EIEVLLEYMDGGSLEGAHI--------------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNL  224 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~--------------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Ni  224 (380)
                      ..+++|||+.+++|.+++.                          ..+..+..++.||+.||+|||++|++||||||+||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni  161 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC  161 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence            9999999999999866653                          23456788999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccccC--CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 016959          225 LINSSKNVKIADFGVSRILAQTM--DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVG  301 (380)
Q Consensus       225 l~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~  301 (380)
                      |++.++.++|+|||++..+....  .......++..|+|||.+..     ..++.++|||||||++|+|++ |..||...
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-----NRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999987553221  11123345678999998753     456779999999999999997 88898633


Q ss_pred             CCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          302 RQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .   ................+..++.++.+||.+||+.||++|||+.|+++
T Consensus       237 ~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         237 A---HEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             C---HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            2   23333333334344455677889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.9e-42  Score=312.22  Aligned_cols=247  Identities=30%  Similarity=0.515  Sum_probs=208.3

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +|++.++||+|+||.||++.+..+++.+|+|.+.... .......+.+|+.+++.++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778899999999999999999999999999986533 334456778899999999999999999999999999999999


Q ss_pred             cCCCCccccccc--------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          179 MDGGSLEGAHIR--------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       179 ~~~~~L~~~~~~--------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      +.+++|..++..        .+..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++......  ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~  158 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MA  158 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--Cc
Confidence            999998765433        45678899999999999999999999999999999999999999999999876544  22


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR  330 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (380)
                      ....++..|++||.+.+     ..++.++|+||||+++|+|++|+.||....   .............+..+...+.+++
T Consensus       159 ~~~~~~~~~~~Pe~~~~-----~~~~~~~D~~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd08530         159 KTQIGTPHYMAPEVWKG-----RPYSYKSDIWSLGCLLYEMATFAPPFEARS---MQDLRYKVQRGKYPPIPPIYSQDLQ  230 (256)
T ss_pred             ccccCCccccCHHHHCC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCCCCCchhhCHHHH
Confidence            34568899999999853     445678999999999999999999996433   2333333344444555567889999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      +++.+||..+|++|||+.|+++||++
T Consensus       231 ~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         231 NFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.9e-42  Score=311.21  Aligned_cols=238  Identities=25%  Similarity=0.400  Sum_probs=193.9

Q ss_pred             eecccCCceEEEEEeC--CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCCC
Q 016959          106 RIGSGSGGTVWRVVHP--PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGS  183 (380)
Q Consensus       106 ~LG~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  183 (380)
                      .||+|+||.||+|.+.  ..+..||+|++.........+.+.+|+.++++++|+||+++++++.. ...++||||+.+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999765  44567999998766555556779999999999999999999998864 57899999999999


Q ss_pred             cccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC---CCCCCC
Q 016959          184 LEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP---CNSAVG  255 (380)
Q Consensus       184 L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~g  255 (380)
                      |.+++.     .++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..+......   .....+
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  160 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW  160 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCC
Confidence            976553     356778899999999999999999999999999999999999999999999765433211   111223


Q ss_pred             CCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHH
Q 016959          256 TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS  334 (380)
Q Consensus       256 t~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  334 (380)
                      +..|+|||.+..     ..++.++|||||||++|++++ |..||.....   ......+........+..++.++.++|.
T Consensus       161 ~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~  232 (257)
T cd05115         161 PLKWYAPECINF-----RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG---PEVMSFIEQGKRLDCPAECPPEMYALMK  232 (257)
T ss_pred             CcccCCHHHHcc-----CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence            578999998753     446778999999999999996 9999964332   2334444445556677778999999999


Q ss_pred             HhcccCcCCCCCHHHHhc
Q 016959          335 RCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       335 ~~l~~dp~~R~t~~eil~  352 (380)
                      +||..||++||++.++++
T Consensus       233 ~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         233 DCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.7e-43  Score=329.38  Aligned_cols=260  Identities=28%  Similarity=0.409  Sum_probs=203.2

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEee----CCeEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDR----NGEIE  173 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~  173 (380)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+|+.++|+||+++++++..    ...++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            678999999999999999999999999999999865432 2345667789999999999999999998753    35689


Q ss_pred             EEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-
Q 016959          174 VLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-  248 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-  248 (380)
                      +||||+.+ +|..++.    ..+..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........ 
T Consensus        85 lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  163 (334)
T cd07855          85 VVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE  163 (334)
T ss_pred             EEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence            99999964 6654432    35677889999999999999999999999999999999999999999999976543221 


Q ss_pred             ---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh-----------
Q 016959          249 ---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC-----------  314 (380)
Q Consensus       249 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-----------  314 (380)
                         ......|+..|+|||.+..    ...++.++|||||||++|+|++|+.||...........+....           
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~  239 (334)
T cd07855         164 HKYFMTEYVATRWYRAPELLLS----LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI  239 (334)
T ss_pred             CCcccccccccccccChHHhcC----CcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence               1134578999999999753    2345778999999999999999999996433221111111100           


Q ss_pred             -----------hCCCCC-----CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          315 -----------FAQPPE-----APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       315 -----------~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                                 ......     .....+.++.++|.+||+.||++|||+.+++.||||.+.....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~  304 (334)
T cd07855         240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD  304 (334)
T ss_pred             chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence                       000111     1134688999999999999999999999999999998764433

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=9.7e-43  Score=318.37  Aligned_cols=249  Identities=30%  Similarity=0.489  Sum_probs=207.2

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  175 (380)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.++ |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36889999999999999999999999999999986432  2333467889999999998 99999999999999999999


Q ss_pred             EeccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC----
Q 016959          176 LEYMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM----  247 (380)
Q Consensus       176 ~e~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----  247 (380)
                      ||++.+++|.+.+    ...+..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......    
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            9999999987655    34567788999999999999999999999999999999999999999999987664322    


Q ss_pred             ----------------CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHH
Q 016959          248 ----------------DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMF  311 (380)
Q Consensus       248 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~  311 (380)
                                      .......++..|+|||++..     ...+.++|+||||++++++++|+.||.....   .....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~  232 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-----KPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTFQ  232 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCC-----CCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHHH
Confidence                            11233467899999998753     4467789999999999999999999974431   22222


Q ss_pred             HHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCH----HHHhcCccc
Q 016959          312 AICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPA----AQLLQHPFI  356 (380)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~----~eil~hp~~  356 (380)
                      .. .......+..+++.+.+||.+||+.||++||++    .|+|+||||
T Consensus       233 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         233 KI-LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HH-HhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            22 233345566778999999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-42  Score=313.17  Aligned_cols=245  Identities=22%  Similarity=0.333  Sum_probs=197.0

Q ss_pred             ccccceecccCCceEEEEEeCC---CCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe-----
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPP---TSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE-----  171 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~---~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----  171 (380)
                      |.+++.||+|+||.||+|.+..   ++..||+|+++... .......+.+|+.+++.++|+||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998754   34789999986543 23345678899999999999999999998765443     


Q ss_pred             -EEEEEeccCCCCccccc----------ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccc
Q 016959          172 -IEVLLEYMDGGSLEGAH----------IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS  240 (380)
Q Consensus       172 -~~lv~e~~~~~~L~~~~----------~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  240 (380)
                       .+++|||+.+++|...+          ..++..+..++.|++.||+|||++||+||||||+||++++++.+||+|||++
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence             79999999999986543          2355667889999999999999999999999999999999999999999999


Q ss_pred             ccccccCCC--CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCC
Q 016959          241 RILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQ  317 (380)
Q Consensus       241 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  317 (380)
                      +........  .....++..|+|||.+.     +..++.++|||||||++|||++ |..||.....   ...........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~  232 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLA-----DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYLRHGN  232 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCC
Confidence            866433211  11233567899999874     3556779999999999999998 8899964332   23333444445


Q ss_pred             CCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          318 PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       318 ~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ....+..++.++.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            556677789999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.1e-42  Score=314.96  Aligned_cols=248  Identities=25%  Similarity=0.386  Sum_probs=200.6

Q ss_pred             CCcccccccceecccCCceEEEEEe-----CCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVH-----PPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      +...+|...++||+|+||.||++..     ..++..+|+|.+.... ......+.+|+++++.++|+||+++++++...+
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR   80 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence            4567889999999999999999974     2356789999876443 344567899999999999999999999999999


Q ss_pred             eEEEEEeccCCCCcccccc-------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc
Q 016959          171 EIEVLLEYMDGGSLEGAHI-------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN  231 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~-------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~  231 (380)
                      ..+++|||+.+++|.+++.                   ..+..+..++.||+.||+|||++||+||||||+|||+++++.
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence            9999999999999865543                   245667889999999999999999999999999999999999


Q ss_pred             EEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHH
Q 016959          232 VKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWAS  308 (380)
Q Consensus       232 ~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~  308 (380)
                      +||+|||++........  ......++..|+|||.+..     ..++.++|||||||++|||++ |..||.....   ..
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~  232 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-----RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---TE  232 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-----CCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---HH
Confidence            99999999875532211  1123345788999998853     456778999999999999998 9999963322   22


Q ss_pred             HHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          309 LMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .............+..++..+.+||.+||+.||++||+++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         233 AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            33333344445556678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5e-42  Score=310.39  Aligned_cols=238  Identities=23%  Similarity=0.388  Sum_probs=193.6

Q ss_pred             eecccCCceEEEEEe--CCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCC
Q 016959          106 RIGSGSGGTVWRVVH--PPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGG  182 (380)
Q Consensus       106 ~LG~G~~g~V~~~~~--~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  182 (380)
                      .||+|+||+||+|.+  ..+++.+|+|++.... .....+.+.+|+.+++.++|+||+++++++.. +..++||||+.++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            599999999999965  4568899999986443 33456778899999999999999999998864 5678999999999


Q ss_pred             Ccccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC---CCCCCC
Q 016959          183 SLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP---CNSAVG  255 (380)
Q Consensus       183 ~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~g  255 (380)
                      +|.+++.    ..+..+..++.||+.||+|||++||+||||||.|||++.++.+||+|||++..+......   .....+
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  160 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW  160 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence            9876653    356778899999999999999999999999999999999999999999999866443221   122334


Q ss_pred             CCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHH
Q 016959          256 TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS  334 (380)
Q Consensus       256 t~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  334 (380)
                      +..|+|||.+..     ..++.++|+|||||++|||++ |..||.....   ......+........+..++.++.+||.
T Consensus       161 ~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i~~~~~~~~~~~~~~~l~~li~  232 (257)
T cd05116         161 PVKWYAPECMNY-----YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMIESGERMECPQRCPPEMYDLMK  232 (257)
T ss_pred             CccccCHhHhcc-----CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence            679999998753     446678999999999999997 9999974333   2333444444455677788999999999


Q ss_pred             HhcccCcCCCCCHHHHhc
Q 016959          335 RCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       335 ~~l~~dp~~R~t~~eil~  352 (380)
                      +||+.||++||++++|.+
T Consensus       233 ~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         233 LCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHhccCchhCcCHHHHHH
Confidence            999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.8e-42  Score=312.82  Aligned_cols=245  Identities=21%  Similarity=0.327  Sum_probs=194.4

Q ss_pred             ccccceecccCCceEEEEEeCCCCc--EEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEee------CCe
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSR--VFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDR------NGE  171 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~--~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~  171 (380)
                      |.++++||+|+||.||+|.+..++.  .+|+|.++... .....+.+.+|+.+++.++|+||+++++++..      ...
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999999877665  68999986542 33445778899999999999999999997642      235


Q ss_pred             EEEEEeccCCCCcccccc----------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          172 IEVLLEYMDGGSLEGAHI----------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~----------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                      .+++|||+.+++|..++.          .++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            789999999999865431          2466788899999999999999999999999999999999999999999998


Q ss_pred             cccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCC
Q 016959          242 ILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQP  318 (380)
Q Consensus       242 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  318 (380)
                      .......  ......++..|++||++..     ..++.++|||||||++|||++ |..||....   .............
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~~~~~~~  232 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLAD-----RVYTTKSDVWSFGVTMWEIATRGQTPYPGVE---NSEIYDYLRQGNR  232 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccC-----CCcChHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHcCCC
Confidence            7643221  1122346778999998853     456779999999999999998 889996432   2233333333344


Q ss_pred             CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          319 PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       319 ~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ...+..++..+.++|.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            44556788899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-42  Score=316.56  Aligned_cols=251  Identities=31%  Similarity=0.506  Sum_probs=199.2

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC--CeEEEEEe
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN--GEIEVLLE  177 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e  177 (380)
                      |++.+.||.|+||.||+|.+..+++.+|+|++.... .......+.+|+.+++.++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999999899999999997653 233445678899999999999999999999887  88999999


Q ss_pred             ccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-CCC
Q 016959          178 YMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-PCN  251 (380)
Q Consensus       178 ~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~~  251 (380)
                      |+.+ +|...+     ...+..+..++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++........ ...
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT  159 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence            9985 654443     335677889999999999999999999999999999999999999999999987654321 123


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC-----------
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-----------  320 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------  320 (380)
                      ...++..|+|||.+.+    ...++.++||||||+++|+|++|..||...........+..........           
T Consensus       160 ~~~~~~~y~~PE~~~~----~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         160 NRVITLWYRPPELLLG----ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             ccccccccCCceeeEc----cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence            4457889999998743    2345678999999999999999999997443322222221111100000           


Q ss_pred             ----------------CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          321 ----------------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       321 ----------------~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                                      ....++.++.++|.+||+.||++||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                            011137889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.8e-42  Score=322.55  Aligned_cols=245  Identities=25%  Similarity=0.347  Sum_probs=191.2

Q ss_pred             CCceEEEEEeCCCCcEEEEEEecCC-CchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCCCcccccc
Q 016959          111 SGGTVWRVVHPPTSRVFALKVIYGN-HEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHI  189 (380)
Q Consensus       111 ~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~  189 (380)
                      ++|.||.++...+++.||||++... ........+.+|+.+++.++|+||+++++++.+.+..+++|||+.+++|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            4455666666669999999999755 344456789999999999999999999999999999999999999999876543


Q ss_pred             ------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-------CCCCCCCC
Q 016959          190 ------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-------PCNSAVGT  256 (380)
Q Consensus       190 ------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~gt  256 (380)
                            ..+..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||.+..+.....       ......++
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN  171 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccccc
Confidence                  24667888999999999999999999999999999999999999999998875532211       12334577


Q ss_pred             CccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC--------------------
Q 016959          257 IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA--------------------  316 (380)
Q Consensus       257 ~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------------------  316 (380)
                      ..|+|||++...   ...++.++|||||||++|||++|..||.......  .........                    
T Consensus       172 ~~y~aPE~~~~~---~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (314)
T cd08216         172 LPWLSPEVLQQN---LQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQS  246 (314)
T ss_pred             ccccCHHHhcCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcc
Confidence            899999998531   1235678999999999999999999997432211  111111100                    


Q ss_pred             ------------CCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          317 ------------QPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       317 ------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                                  ........++.++.+||.+||+.||++|||++|+|+||||+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                        00111223456899999999999999999999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.8e-42  Score=325.78  Aligned_cols=262  Identities=27%  Similarity=0.436  Sum_probs=203.3

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeC--CeEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRN--GEIE  173 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~  173 (380)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|++.... .......+.+|+.+++.+ +|+||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            467999999999999999999998899999999885432 223345677899999999 999999999988643  4689


Q ss_pred             EEEeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--
Q 016959          174 VLLEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD--  248 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--  248 (380)
                      +||||+.+ +|..++.   ..+..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..+.....  
T Consensus        86 lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~  164 (337)
T cd07852          86 LVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP  164 (337)
T ss_pred             EEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccc
Confidence            99999985 6655443   35566778999999999999999999999999999999999999999999986643321  


Q ss_pred             ---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh----------
Q 016959          249 ---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF----------  315 (380)
Q Consensus       249 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~----------  315 (380)
                         ......|+..|+|||++..    ...++.++|||||||++|+|++|+.||......+....+.....          
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07852         165 ENPVLTDYVATRWYRAPEILLG----STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI  240 (337)
T ss_pred             cCcchhcccccccccCceeeec----cccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence               2234568999999998743    24456789999999999999999999964322211111100000          


Q ss_pred             -----------------CCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          316 -----------------AQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       316 -----------------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                                       .........++.++.++|.+||+.||++|||+.++++||||++......
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~  306 (337)
T cd07852         241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSD  306 (337)
T ss_pred             HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCC
Confidence                             0001112236789999999999999999999999999999999855443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-42  Score=318.73  Aligned_cols=251  Identities=23%  Similarity=0.329  Sum_probs=197.7

Q ss_pred             CcccccccceecccCCceEEEEEeCCC--------------CcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeee
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPT--------------SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKC  162 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~--------------~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~  162 (380)
                      ...+|++.++||+|+||.||+|.+..+              ...||+|++...........+.+|++++++++|+||+++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            456899999999999999999987543              235899998765555556779999999999999999999


Q ss_pred             EeEEeeCCeEEEEEeccCCCCccccccc----------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 016959          163 HDMYDRNGEIEVLLEYMDGGSLEGAHIR----------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI  226 (380)
Q Consensus       163 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~  226 (380)
                      ++++...+..++||||+.+++|.+++..                .+..+..++.|++.||.|||++|++|+||||+|||+
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill  162 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV  162 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence            9999999999999999999998665422                345677899999999999999999999999999999


Q ss_pred             cCCCcEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCC
Q 016959          227 NSSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL--GRFPFAVGR  302 (380)
Q Consensus       227 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~--g~~pf~~~~  302 (380)
                      +.++.+||+|||++..+.....  ......++..|+|||++..     ..++.++|||||||++|+|++  |..||....
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-----GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-----CCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            9999999999999876533211  1223345778999998753     446789999999999999987  677886433


Q ss_pred             CCCHHHHHHHHh----hCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          303 QGDWASLMFAIC----FAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       303 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..+.........    .......+..++..+.+|+.+||..||++||++++|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            322222111111    11112334557789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5e-42  Score=310.09  Aligned_cols=242  Identities=24%  Similarity=0.377  Sum_probs=199.5

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEE-eeCCeEE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY-DRNGEIE  173 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~  173 (380)
                      .++..+|++.+.||+|+||.||++..  .+..||+|.+....   ....+.+|+.+++.++|+|++++++++ ..++..+
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05082           2 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   76 (256)
T ss_pred             CccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence            35667899999999999999999987  57789999985432   345688999999999999999999975 4556789


Q ss_pred             EEEeccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          174 VLLEYMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      ++|||+.+++|.+++..      .+..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            99999999998766432      456778899999999999999999999999999999999999999999987554322


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCcccc
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS  326 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (380)
                         ....++..|+|||++..     ..++.++|||||||++|+|++ |+.||...   ........+........+..++
T Consensus       157 ---~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~  225 (256)
T cd05082         157 ---DTGKLPVKWTAPEALRE-----KKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKGYKMDAPDGCP  225 (256)
T ss_pred             ---CCCccceeecCHHHHcc-----CCCCchhhhHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHhcCCCCCCCCCCC
Confidence               23345678999998853     446678999999999999997 99999633   3334444444444556667789


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          327 REFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..+.++|.+||+.||++|||+.++++
T Consensus       226 ~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         226 PVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.5e-42  Score=311.66  Aligned_cols=246  Identities=24%  Similarity=0.380  Sum_probs=197.8

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      .+..++|.+.++||+|+||.||+|.+..+ ..||+|++.....  ..+.+.+|+++++.++|+||+++++++.. +..++
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l   77 (262)
T cd05071           2 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI   77 (262)
T ss_pred             CCChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence            35677899999999999999999988655 4599999865332  23568899999999999999999998754 56899


Q ss_pred             EEeccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          175 LLEYMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       175 v~e~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ||||+.+++|.+++..      .+..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++..+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            9999999998766543      4567788999999999999999999999999999999999999999999976643322


Q ss_pred             C-CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCcccc
Q 016959          249 P-CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS  326 (380)
Q Consensus       249 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (380)
                      . .....++..|+|||++.     +..++.++|||||||++|+|++ |..||......   .................++
T Consensus       158 ~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~  229 (262)
T cd05071         158 TARQGAKFPIKWTAPEAAL-----YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVERGYRMPCPPECP  229 (262)
T ss_pred             ccccCCcccceecCHhHhc-----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHHHHhcCCCCCCccccC
Confidence            1 12334667899999874     3456779999999999999999 88899643322   2233333333344456678


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          327 REFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..+.++|.+||+.||++||++.++++
T Consensus       230 ~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         230 ESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHHH
Confidence            89999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.5e-42  Score=312.69  Aligned_cols=248  Identities=24%  Similarity=0.387  Sum_probs=201.9

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCc---EEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSR---VFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      ...+|++.+.||+|+||.||+|.+..+++   .||||++...........+.+|+.+++.++|+||+++++++..++..+
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            45678999999999999999999876664   599999876555556678999999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          174 VLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      +||||+.+++|..++..     ....+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++........
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            99999999998765443     4566888999999999999999999999999999999999999999999876543221


Q ss_pred             C--CCC-C--CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCC
Q 016959          249 P--CNS-A--VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAP  322 (380)
Q Consensus       249 ~--~~~-~--~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  322 (380)
                      .  ... .  ..+..|+|||++..     ..++.++|||||||++||+++ |..||....   .......+........+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~---~~~~~~~i~~~~~~~~~  233 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAY-----RKFTSASDVWSYGIVMWEVMSYGERPYWDMS---NQDVINAIEQDYRLPPP  233 (269)
T ss_pred             ccccccccCCCcceeecCHhHhcc-----CcccchhhhhhhHHHHHHHhcCCCCCCCCCC---HHHHHHHHHcCCcCCCc
Confidence            1  011 1  12457999999853     445778999999999999886 999996433   23333333334444555


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..++.++.+++.+||..+|++||++++++.
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         234 MDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            677889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-42  Score=328.13  Aligned_cols=257  Identities=26%  Similarity=0.389  Sum_probs=201.1

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC------Ce
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN------GE  171 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~  171 (380)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||++.... .+.....+.+|+.+++.++|+||+++++++...      ..
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            57999999999999999999999899999999986532 233345678999999999999999999998654      35


Q ss_pred             EEEEEeccCCCCccccc--ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 016959          172 IEVLLEYMDGGSLEGAH--IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  249 (380)
                      +++|+||+.. +|....  ...+..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......   
T Consensus        95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~---  170 (342)
T cd07879          95 FYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE---  170 (342)
T ss_pred             EEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC---
Confidence            6999999964 554332  3466778889999999999999999999999999999999999999999998765322   


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh---------------
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC---------------  314 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---------------  314 (380)
                      .....++..|+|||++..    +..++.++|||||||++|||++|+.||...........+....               
T Consensus       171 ~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (342)
T cd07879         171 MTGYVVTRWYRAPEVILN----WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA  246 (342)
T ss_pred             CCCceeeecccChhhhcC----ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence            234567899999999753    2345778999999999999999999997433211111111100               


Q ss_pred             -----hCCCC-------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          315 -----FAQPP-------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       315 -----~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                           ...+.       ...+..+.++.+||.+||+.||++||++.|++.||||+......
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~  307 (342)
T cd07879         247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD  307 (342)
T ss_pred             hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence                 00000       01124677899999999999999999999999999999975433

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-42  Score=309.73  Aligned_cols=247  Identities=25%  Similarity=0.390  Sum_probs=200.4

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      .+..++|++.+.||+|+||.||+|.+. +++.||+|.++....  ....+.+|+.++++++|+||+++++++...+..++
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           2 EIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             ccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            356778999999999999999999875 457899999865432  24568899999999999999999999999999999


Q ss_pred             EEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          175 LLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       175 v~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      +|||+.+++|.+++.      .....+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999999876643      34567889999999999999999999999999999999999999999999987653211


Q ss_pred             C-CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCcccc
Q 016959          249 P-CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS  326 (380)
Q Consensus       249 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (380)
                      . .....++..|+|||++..     ..++.++||||||+++|+|++ |+.||....   .......+........+..++
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALY-----NRFSIKSDVWSFGILLTEIVTYGRMPYPGMT---NAEVLQQVDQGYRMPCPPGCP  230 (261)
T ss_pred             cccCCCcCceeccCcccccc-----CCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCcCC
Confidence            1 112223458999998753     456778999999999999999 999996432   223333333333344556678


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          327 REFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..+.+++.+||+.||++||++.++++
T Consensus       231 ~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         231 KELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            99999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-42  Score=309.03  Aligned_cols=239  Identities=26%  Similarity=0.388  Sum_probs=195.3

Q ss_pred             ceecccCCceEEEEEeCCCC---cEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTS---RVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      ++||+|+||.||+|....++   ..+|+|.+.........+.+.+|+.+++.++|+||+++++++. .+..++||||+.+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999876554   7899999976655455677889999999999999999999876 4568999999999


Q ss_pred             CCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC---CCCC
Q 016959          182 GSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAV  254 (380)
Q Consensus       182 ~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~  254 (380)
                      ++|.+++.    ..+..+..++.|++.||+|||++|++|+||||+|||++.++.+||+|||++..........   ....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05060          80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR  159 (257)
T ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcc
Confidence            99876654    3567788999999999999999999999999999999999999999999998664433221   1122


Q ss_pred             CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHH
Q 016959          255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI  333 (380)
Q Consensus       255 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  333 (380)
                      ++..|+|||.+..     ..++.++|||||||++|+|++ |..||.....   ...............+..++..+.++|
T Consensus       160 ~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li  231 (257)
T cd05060         160 WPLKWYAPECINY-----GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESGERLPRPEECPQEIYSIM  231 (257)
T ss_pred             ccccccCHHHhcC-----CCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCCcCCCCCCCCHHHHHHH
Confidence            3568999998853     446778999999999999997 9999964332   333333444445566677889999999


Q ss_pred             HHhcccCcCCCCCHHHHhc
Q 016959          334 SRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       334 ~~~l~~dp~~R~t~~eil~  352 (380)
                      .+||..||++||++.++++
T Consensus       232 ~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         232 LSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHhcCChhhCcCHHHHHH
Confidence            9999999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=7.8e-42  Score=310.85  Aligned_cols=249  Identities=25%  Similarity=0.411  Sum_probs=202.6

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCc---EEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSR---VFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      |...+|...+.||+|+||.||+|.+..++.   .+|+|.+...........+.+|+++++.++|+||+++++++...+..
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence            456688899999999999999999876554   79999987655555567788999999999999999999999999999


Q ss_pred             EEEEeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          173 EVLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      ++||||+.+++|..++..     .+..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            999999999999766532     456788899999999999999999999999999999999999999999987664322


Q ss_pred             CCC---CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          248 DPC---NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       248 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      ...   .....+..|+|||++..     ..++.++|||||||++|||++ |..||.....   ......+..........
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i~~~~~~~~~~  233 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIAY-----RKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAINDGFRLPAPM  233 (268)
T ss_pred             ccceeccCCCcCceecCHHHhhc-----CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhcCCCCCCCC
Confidence            211   11223457999998853     445778999999999999987 9999964333   23333333333444555


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .++.++.+++.+||..||++||++.++++
T Consensus       234 ~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         234 DCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            67889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-43  Score=331.45  Aligned_cols=246  Identities=33%  Similarity=0.489  Sum_probs=205.1

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      ..++|.+...+|.|+|+.|-.|.+..+++.+++|++.+..     ....+|+.++... +|+||+++.+.+.++.+.|+|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence            3567888888999999999999999999999999996552     2233567555555 699999999999999999999


Q ss_pred             EeccCCCCcccccccc-h--HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE-cCCCcEEEeeccccccccccCCCCC
Q 016959          176 LEYMDGGSLEGAHIRQ-E--HILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI-NSSKNVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       176 ~e~~~~~~L~~~~~~~-~--~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~-~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      ||++.|+.+.+.+... +  ..+..|+++|+.|+.|||++|||||||||+|||+ +..|+++|+|||.++.+...   +.
T Consensus       395 ~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~~  471 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---CD  471 (612)
T ss_pred             ehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---hc
Confidence            9999998875554432 2  3466799999999999999999999999999999 68999999999999887755   45


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD  331 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (380)
                      +.+-|..|.|||++.     ...++.++|+||||++||+||+|+.||......  .+++..+.   .+.....+|.+++|
T Consensus       472 tp~~t~~y~APEvl~-----~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~---~~~~s~~vS~~AKd  541 (612)
T KOG0603|consen  472 TPALTLQYVAPEVLA-----IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQ---MPKFSECVSDEAKD  541 (612)
T ss_pred             ccchhhcccChhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhc---CCccccccCHHHHH
Confidence            667899999999985     466788999999999999999999999855443  33333332   23334889999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          332 FISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       332 li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      ||.+||+.||.+|+++.|++.||||...+
T Consensus       542 Ll~~LL~~dP~~Rl~~~~i~~h~w~~~~~  570 (612)
T KOG0603|consen  542 LLQQLLQVDPALRLGADEIGAHPWFLSHP  570 (612)
T ss_pred             HHHHhccCChhhCcChhhhccCcchhcCC
Confidence            99999999999999999999999994333

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=324.35  Aligned_cols=247  Identities=30%  Similarity=0.446  Sum_probs=191.6

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC-eEEEEEe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG-EIEVLLE  177 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e  177 (380)
                      +.|...++||+|+||.||+|.... ++.||||++....... ..+|.+|+.++.+++|+|+|+|+|||.+.+ ..++|+|
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE  152 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE  152 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence            467777899999999999999864 4899999886554432 445999999999999999999999999888 5999999


Q ss_pred             ccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          178 YMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRK---IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       178 ~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      |+.+|+|.+++..      .+..+.+|+.++++||+|||...   |||||||+.|||+|++.+.||+|||+|+.......
T Consensus       153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~  232 (361)
T KOG1187|consen  153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDT  232 (361)
T ss_pred             ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcccc
Confidence            9999999766443      57788999999999999999854   99999999999999999999999999965543112


Q ss_pred             CCCCC-CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC---HHHH-HHH-----HhhCCC
Q 016959          249 PCNSA-VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD---WASL-MFA-----ICFAQP  318 (380)
Q Consensus       249 ~~~~~-~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~-~~~-----~~~~~~  318 (380)
                      ..... .||.+|+|||++..     ...+.++||||||++|.||++|+.+........   ...- ...     ......
T Consensus       233 ~~~~~~~gt~gY~~PEy~~~-----g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD  307 (361)
T KOG1187|consen  233 SVSTTVMGTFGYLAPEYAST-----GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD  307 (361)
T ss_pred             ceeeecCCCCccCChhhhcc-----CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence            22222 79999999999853     455779999999999999999998887433111   1110 011     111111


Q ss_pred             CCCC-ccc-----cHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          319 PEAP-EMA-----SREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       319 ~~~~-~~~-----~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      +.+. ...     -..+..+..+|++.+|++||+..|++.
T Consensus       308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            2221 111     223667889999999999999999854

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.1e-42  Score=313.27  Aligned_cols=248  Identities=32%  Similarity=0.505  Sum_probs=204.0

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC----chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH----EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      +|.+.+.||+|+||+||++.+..++..+++|+++...    .......+..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4788899999999999999998777777777765321    222334567899999999999999999999988999999


Q ss_pred             EeccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          176 LEYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       176 ~e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      +||+.+++|...+.        ..+..+..++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            99999999875442        356678889999999999999999999999999999974 669999999988765444


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                      .......|+..|+|||.+..     ..++.++|+||||+++|+|++|..||..   ...............+..+..++.
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~-----~~~~~~~Dv~slG~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  231 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKH-----QGYDSKSDIWSLGCILYEMCCLAHAFEG---QNFLSVVLRIVEGPTPSLPETYSR  231 (260)
T ss_pred             ccccCCCCCcCccCHHHHcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCC---ccHHHHHHHHHcCCCCCCcchhcH
Confidence            44445668899999998742     4456689999999999999999999953   233344444444555566677889


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      ++.++|.+||+.||++||++.|+++||||
T Consensus       232 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         232 QLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-42  Score=326.43  Aligned_cols=258  Identities=29%  Similarity=0.385  Sum_probs=205.5

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC-----eEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRNG-----EIE  173 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~  173 (380)
                      +|++.+.||.|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++|+||+++++++...+     .+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            47888999999999999999988899999999865432 344567889999999999999999999987765     789


Q ss_pred             EEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC--
Q 016959          174 VLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM--  247 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--  247 (380)
                      ++|||+.+ +|...+.    ..+..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++.......  
T Consensus        81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~  159 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE  159 (330)
T ss_pred             EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence            99999985 5654433    3567788899999999999999999999999999999999999999999998765543  


Q ss_pred             -CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC--------
Q 016959          248 -DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP--------  318 (380)
Q Consensus       248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------  318 (380)
                       .......++..|+|||++...    ...+.++|+||||+++|+|++|..||......+....+........        
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~----~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         160 KGFLTEYVVTRWYRAPELLLSS----SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             cccccccccccCcCCceeeecc----cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence             123455689999999998641    2567789999999999999999999964432222111111110000        


Q ss_pred             -------------------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          319 -------------------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       319 -------------------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                                         ......++.++.+||.+||+.||++|||+++++.||||++....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                               00122367889999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.2e-41  Score=306.34  Aligned_cols=239  Identities=22%  Similarity=0.371  Sum_probs=196.3

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCCCc
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL  184 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  184 (380)
                      +.||+|+||.||+|... +++.+|+|++...........+.+|+++++.++|+||+++++++...+..++||||+.+++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            36999999999999864 68899999987665555566788999999999999999999999999999999999999998


Q ss_pred             cccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC-CCCCCCCc
Q 016959          185 EGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIA  258 (380)
Q Consensus       185 ~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~gt~~  258 (380)
                      ..++..     .+..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......... ....++..
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK  159 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence            765432     456778899999999999999999999999999999999999999999987554322111 12234567


Q ss_pred             cccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhc
Q 016959          259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL  337 (380)
Q Consensus       259 y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  337 (380)
                      |+|||++..     ..++.++||||||+++|++++ |..||....   ................+..++..+.+++.+||
T Consensus       160 y~aPE~~~~-----~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  231 (250)
T cd05085         160 WTAPEALNY-----GRYSSESDVWSYGILLWETFSLGVCPYPGMT---NQQAREQVEKGYRMSCPQKCPDDVYKVMQRCW  231 (250)
T ss_pred             ccCHHHhcc-----CCCCchhHHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence            999999853     446778999999999999998 999996432   23333344444445556678899999999999


Q ss_pred             ccCcCCCCCHHHHhc
Q 016959          338 QKDPHSRWPAAQLLQ  352 (380)
Q Consensus       338 ~~dp~~R~t~~eil~  352 (380)
                      ..+|++||++.|+++
T Consensus       232 ~~~p~~Rp~~~~l~~  246 (250)
T cd05085         232 DYKPENRPKFSELQK  246 (250)
T ss_pred             ccCcccCCCHHHHHH
Confidence            999999999999986

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-42  Score=311.79  Aligned_cols=239  Identities=25%  Similarity=0.363  Sum_probs=192.8

Q ss_pred             ceecccCCceEEEEEeCCCCc--EEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSR--VFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~--~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      +.||+|+||.||+|.+..++.  .+++|.+...........+.+|+.+++++ +|+||+++++++...+..+++|||+.+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            369999999999999987775  46888886554455567788999999999 799999999999999999999999999


Q ss_pred             CCcccccc--------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          182 GSLEGAHI--------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       182 ~~L~~~~~--------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                      ++|.+++.                    ..+..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++.
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~  160 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR  160 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence            99876543                    2456778899999999999999999999999999999999999999999986


Q ss_pred             cccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCC
Q 016959          242 ILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPE  320 (380)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  320 (380)
                      ....... ......+..|+|||++..     ..++.++|||||||++|||++ |..||....   ...............
T Consensus       161 ~~~~~~~-~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~il~el~~~g~~pf~~~~---~~~~~~~~~~~~~~~  231 (270)
T cd05047         161 GQEVYVK-KTMGRLPVRWMAIESLNY-----SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKLPQGYRLE  231 (270)
T ss_pred             ccchhhh-ccCCCCccccCChHHHcc-----CCCCchhhHHHHHHHHHHHHcCCCCCccccC---HHHHHHHHhCCCCCC
Confidence            3322111 112234567999998843     456779999999999999996 999996432   223333333333445


Q ss_pred             CCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          321 APEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       321 ~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .+..++.++.+|+.+||..||.+|||+.|++.
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         232 KPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            56667889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.5e-41  Score=316.29  Aligned_cols=255  Identities=31%  Similarity=0.465  Sum_probs=202.9

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      -|...++||+|+||+||+|.+..+++.|++|++....  .......+.+|+.+++.++|+|++++++++.+....|+|||
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            3666788999999999999999899999999986432  23344568889999999999999999999999999999999


Q ss_pred             ccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          178 YMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       178 ~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      |+.+ ++...+     ...+..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++.....    ...
T Consensus       102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~~  176 (313)
T cd06633         102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----ANS  176 (313)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----CCC
Confidence            9975 443322     235667788999999999999999999999999999999999999999999864322    235


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC-CCCCCccccHHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ-PPEAPEMASREFRD  331 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  331 (380)
                      ..|+..|+|||++...  .+..++.++|||||||++|+|++|..||...+.   ........... +......++..+.+
T Consensus       177 ~~~~~~y~aPE~~~~~--~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~  251 (313)
T cd06633         177 FVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNDSPTLQSNEWTDSFRG  251 (313)
T ss_pred             ccccccccChhhcccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCCCccccCHHHHH
Confidence            6789999999997421  123456789999999999999999999964322   22222222222 22233456778999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          332 FISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       332 li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                      ||.+||+.+|++||++.+++.||||+.......
T Consensus       252 li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~  284 (313)
T cd06633         252 FVDYCLQKIPQERPASAELLRHDFVRRDRPARV  284 (313)
T ss_pred             HHHHHccCChhhCcCHHHHhcCcccCCCchhHH
Confidence            999999999999999999999999998654433

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.6e-42  Score=314.22  Aligned_cols=249  Identities=24%  Similarity=0.346  Sum_probs=198.8

Q ss_pred             ccccccceecccCCceEEEEEe----CCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC--CeE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVH----PPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRN--GEI  172 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~----~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~  172 (380)
                      .-|++.+.||+|+||.||+|..    ..+++.||+|.++..........+.+|+.+++.++|+||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578899999999999999974    4578899999987665555667899999999999999999999998765  568


Q ss_pred             EEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          173 EVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      ++||||+.+++|.+++.     ..+..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..+....
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~  163 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK  163 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence            99999999999977653     2456788899999999999999999999999999999999999999999998664332


Q ss_pred             C---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC------------CCCHHHHHHH
Q 016959          248 D---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGR------------QGDWASLMFA  312 (380)
Q Consensus       248 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~------------~~~~~~~~~~  312 (380)
                      .   ......++..|+|||++..     ..++.++|||||||++|+|++++.|+....            ..........
T Consensus       164 ~~~~~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         164 EYYTVKDDLDSPVFWYAPECLIQ-----SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cceeecCCCCCCccccCHHHhcc-----CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            1   1123456778999998753     446678999999999999999877653210            1111112222


Q ss_pred             HhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          313 ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .........+..++..+.+|+.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  278 (284)
T cd05079         239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE  278 (284)
T ss_pred             HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            2223334455668899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-43  Score=332.78  Aligned_cols=249  Identities=25%  Similarity=0.479  Sum_probs=209.6

Q ss_pred             cccceecccCCceEEEEEeCCCCcEEEEEEecC---CCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe--EEEEE
Q 016959          102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYG---NHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE--IEVLL  176 (380)
Q Consensus       102 ~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~lv~  176 (380)
                      +...+||+|+|-+||+|.+..+|..||.-.++.   ...+...++|..|+.+|+.|+|+|||++|+.|.+...  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            345679999999999999999999999766642   2345566899999999999999999999999987654  88999


Q ss_pred             eccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEc-CCCcEEEeeccccccccccCCC
Q 016959          177 EYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRK--IVHRDIKPSNLLIN-SSKNVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       177 e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~  249 (380)
                      |++..|+|..++.+    ....+..|++||+.||.|||++.  |||||||-+||+|+ ..|.|||+|+|+|+.+..... 
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a-  201 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA-  201 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc-
Confidence            99999999877654    45678899999999999999995  99999999999998 567899999999998876543 


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC-CCccccHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMASRE  328 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  328 (380)
                       ...+|||.|||||.+.      ..|...+||||||+.+.||+|+.+||.-..+  ..++++++..+..+. +...-+++
T Consensus       202 -ksvIGTPEFMAPEmYE------E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--~AQIYKKV~SGiKP~sl~kV~dPe  272 (632)
T KOG0584|consen  202 -KSVIGTPEFMAPEMYE------ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--PAQIYKKVTSGIKPAALSKVKDPE  272 (632)
T ss_pred             -ceeccCccccChHHHh------hhcchhhhhhhhhHHHHHHHhccCChhhhCC--HHHHHHHHHcCCCHHHhhccCCHH
Confidence             4588999999999874      5667789999999999999999999975443  345566665555443 33445789


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          329 FRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      +++||.+||.. ..+|+|+.|+|+||||...+.
T Consensus       273 vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g  304 (632)
T KOG0584|consen  273 VREFIEKCLAT-KSERLSAKELLKDPFFDEDGG  304 (632)
T ss_pred             HHHHHHHHhcC-chhccCHHHHhhChhhccccc
Confidence            99999999988 999999999999999998643

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=8e-42  Score=309.49  Aligned_cols=246  Identities=24%  Similarity=0.378  Sum_probs=199.4

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      .+..++|++.++||+|+||.||+|.+. ++..+|+|.+......  .+.+.+|+.++++++|+|++++++++.. ...++
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l   77 (260)
T cd05070           2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYI   77 (260)
T ss_pred             CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC--HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEE
Confidence            356788999999999999999999875 5567999998654332  3568899999999999999999998864 56899


Q ss_pred             EEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          175 LLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       175 v~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      +|||+.+++|.+++.      ..+..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++..+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            999999999876653      34567889999999999999999999999999999999999999999999976643221


Q ss_pred             -CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCcccc
Q 016959          249 -PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS  326 (380)
Q Consensus       249 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (380)
                       ......++..|+|||++..     ..++.++|+||||+++|+|++ |..||....   ................+...+
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~  229 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELVTKGRVPYPGMN---NREVLEQVERGYRMPCPQDCP  229 (260)
T ss_pred             ccccCCCCCccccChHHHhc-----CCCcchhhhHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCCCCcCC
Confidence             1122345668999998743     456778999999999999999 899996433   233333343344555667788


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          327 REFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..+.+|+.+||..||++|||++++++
T Consensus       230 ~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         230 ISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHHHHHcccCcccCcCHHHHHH
Confidence            99999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.2e-42  Score=313.19  Aligned_cols=249  Identities=22%  Similarity=0.291  Sum_probs=203.4

Q ss_pred             CCcccccccceecccCCceEEEEEeCC----CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee-CC
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR-NG  170 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~  170 (380)
                      ++.++|.+.+.||+|+||.||+|.+..    ++..|++|++...........+.+|+.++++++|+||+++++++.. ..
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            567899999999999999999999875    3688999998766566667788999999999999999999998665 56


Q ss_pred             eEEEEEeccCCCCcccccc------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecc
Q 016959          171 EIEVLLEYMDGGSLEGAHI------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFG  238 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  238 (380)
                      ..+++++|+.+++|..++.            ..+..+..++.||+.||+|||++|++|+||||+||++++++.+||+|||
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g  162 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA  162 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence            7899999999999866543            2466788899999999999999999999999999999999999999999


Q ss_pred             ccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhh
Q 016959          239 VSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICF  315 (380)
Q Consensus       239 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~  315 (380)
                      +++.+.....  ......++..|+|||++..     ..++.++|||||||++||+++ |..||....   ..........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~~  234 (280)
T cd05043         163 LSRDLFPMDYHCLGDNENRPVKWMALESLVN-----KEYSSASDVWSFGVLLWELMTLGQTPYVEID---PFEMAAYLKD  234 (280)
T ss_pred             CcccccCCceEEeCCCCCcchhccCHHHHhc-----CCCCchhhHHHhHHHHHHHhcCCCCCcCcCC---HHHHHHHHHc
Confidence            9986543211  1122345778999998853     456788999999999999998 999996432   2333333333


Q ss_pred             CCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          316 AQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       316 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ......+..++.++.+++.+||..||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         235 GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            4444455667889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-42  Score=315.82  Aligned_cols=251  Identities=33%  Similarity=0.493  Sum_probs=200.6

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEecc
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYM  179 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  179 (380)
                      |.+.+.||+|++|.||+|.+..+++.+++|.+..... ......+.+|+.+++.++|+||+++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            5677899999999999999998999999999865432 234567888999999999999999999999999999999999


Q ss_pred             CCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCC
Q 016959          180 DGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV  254 (380)
Q Consensus       180 ~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (380)
                      .+ +|...+     ...+..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+..............
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV  159 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence            86 554433     235667888999999999999999999999999999999999999999999987755432334456


Q ss_pred             CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC-----------------
Q 016959          255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ-----------------  317 (380)
Q Consensus       255 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-----------------  317 (380)
                      ++..|+|||.+..    ...++.++|+||||+++|+|++|+.||......+....+.......                 
T Consensus       160 ~~~~~~~PE~~~~----~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         160 VTRWYRAPELLLG----DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             CcccccCcHHHhc----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence            8889999999853    2356779999999999999999999996443322111111110000                 


Q ss_pred             ---------CCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          318 ---------PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       318 ---------~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                               .....+.++.++++||.+||+.||++||++.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                     001223467899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.9e-42  Score=313.11  Aligned_cols=247  Identities=23%  Similarity=0.345  Sum_probs=194.5

Q ss_pred             ccccceecccCCceEEEEE----eCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee--CCeEEE
Q 016959          101 LQKGNRIGSGSGGTVWRVV----HPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR--NGEIEV  174 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l  174 (380)
                      |++.+.||+|+||+||++.    ...+++.||+|++...........+.+|+++++.++|+||+++++++..  ...+++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            4888999999999998865    3456889999998765544456778899999999999999999998765  346899


Q ss_pred             EEeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC--
Q 016959          175 LLEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP--  249 (380)
Q Consensus       175 v~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--  249 (380)
                      +|||+.+++|.+++.   ..+..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.........  
T Consensus        86 v~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  165 (283)
T cd05080          86 IMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR  165 (283)
T ss_pred             EecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhc
Confidence            999999999976654   356778899999999999999999999999999999999999999999999866432211  


Q ss_pred             -CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC------------CHHHHHHHHhhC
Q 016959          250 -CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG------------DWASLMFAICFA  316 (380)
Q Consensus       250 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------------~~~~~~~~~~~~  316 (380)
                       .....++..|+|||.+..     ..++.++|||||||++|+|++|..||......            ............
T Consensus       166 ~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05080         166 VREDGDSPVFWYAVECLKE-----NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG  240 (283)
T ss_pred             cCCCCCCCceeeCHhHhcc-----cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence             122345678999998853     44567899999999999999999998632211            001111111112


Q ss_pred             CCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          317 QPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       317 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .....+..++.++.+++.+||..||++|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            223345567889999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.2e-42  Score=323.95  Aligned_cols=255  Identities=27%  Similarity=0.410  Sum_probs=197.7

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC---------
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRN---------  169 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---------  169 (380)
                      .+|.+.+.||.|+||.||+|.+..+++.||+|++..... ...+.+.+|+++++.++|+||+++++++...         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            679999999999999999999999999999999865443 3346688899999999999999999876543         


Q ss_pred             -----CeEEEEEeccCCCCccccc---ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCcEEEeecccc
Q 016959          170 -----GEIEVLLEYMDGGSLEGAH---IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS-SKNVKIADFGVS  240 (380)
Q Consensus       170 -----~~~~lv~e~~~~~~L~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a  240 (380)
                           ...++||||+.+ +|...+   ...+..++.++.||+.||.|||++||+||||||+||+++. ++.++|+|||++
T Consensus        84 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~  162 (342)
T cd07854          84 SLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA  162 (342)
T ss_pred             cccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccc
Confidence                 357899999975 665443   2457788899999999999999999999999999999984 557899999999


Q ss_pred             ccccccCC---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHH-----
Q 016959          241 RILAQTMD---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFA-----  312 (380)
Q Consensus       241 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~-----  312 (380)
                      ..+.....   ......++..|+|||++..    +..++.++|||||||++|+|++|+.||......+.......     
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLS----PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             eecCCccccccccccccccccccCHHHHhC----ccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            76543211   1123457889999998743    34567789999999999999999999964322111110000     


Q ss_pred             --------------Hhh--CCCC-----CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          313 --------------ICF--AQPP-----EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       313 --------------~~~--~~~~-----~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                                    ...  ....     .....++.++.+||.+||+.||++|||+.|+|.||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence                          000  0000     0123467899999999999999999999999999999865

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.4e-42  Score=315.42  Aligned_cols=251  Identities=23%  Similarity=0.329  Sum_probs=197.1

Q ss_pred             CcccccccceecccCCceEEEEEeCC----------------CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCcee
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPP----------------TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV  160 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~----------------~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv  160 (380)
                      ..++|++.+.||+|+||+||++.+..                ++..||+|++...........+.+|+.+++.++|+||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence            34679999999999999999986432                34579999987655555667889999999999999999


Q ss_pred             eeEeEEeeCCeEEEEEeccCCCCccccccc---------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 016959          161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIR---------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLL  225 (380)
Q Consensus       161 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil  225 (380)
                      ++++++...+..++||||+.+++|..++..               .+..+..++.||+.||+|||++|++|+||||+|||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            999999999999999999999998765432               23468889999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCC
Q 016959          226 INSSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL--GRFPFAVG  301 (380)
Q Consensus       226 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~--g~~pf~~~  301 (380)
                      ++.++.++|+|||++..+.....  ......++..|++||++..     ..++.++|||||||++|||++  |..||...
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-----GKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-----CCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            99999999999999976543211  1122334678999998643     456789999999999999998  77888643


Q ss_pred             CCCCHHHHHHHHh----hCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          302 RQGDWASLMFAIC----FAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       302 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ...+.........    .....+.+..++..+.+|+.+||+.||++||++.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3322221111110    11112334557789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-41  Score=307.77  Aligned_cols=245  Identities=23%  Similarity=0.388  Sum_probs=197.1

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      +..++|.+...||+|+||.||+|.+..+ ..+|+|.+....  ...+.+.+|+.+++.++|+|++++++++.. +..+++
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05069           3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIV   78 (260)
T ss_pred             CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEE
Confidence            5567899999999999999999988654 458999875433  234568889999999999999999998864 568899


Q ss_pred             EeccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-
Q 016959          176 LEYMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-  248 (380)
Q Consensus       176 ~e~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-  248 (380)
                      |||+.+++|.+++..      .+..+..++.||+.||.|||+.|++|+||||+||++++++.++|+|||++........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            999999998766532      4566788999999999999999999999999999999999999999999976543221 


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                      ......++..|+|||.+..     ...+.++|||||||++|+|++ |..||.....   ...............+...+.
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~-----~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQVERGYRMPCPQGCPE  230 (260)
T ss_pred             ccCCCccchhhCCHHHhcc-----CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCCcccCH
Confidence            1123346678999998753     446778999999999999999 9999964332   223333333334455667889


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .+.+++.+||..||++||+++++++
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         231 SLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-42  Score=327.20  Aligned_cols=257  Identities=27%  Similarity=0.396  Sum_probs=203.4

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe-----
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE-----  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----  171 (380)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++|+||+++++++...+.     
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            467999999999999999999999999999999986432 22344567789999999999999999998766554     


Q ss_pred             -EEEEEeccCCCCccccc---ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          172 -IEVLLEYMDGGSLEGAH---IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       172 -~~lv~e~~~~~~L~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                       .++|+||+ +++|.+++   ...+..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... 
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-  171 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-  171 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence             89999999 45776554   3366778899999999999999999999999999999999999999999999866433 


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC---------
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP---------  318 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------  318 (380)
                        .....++..|+|||.+..    ...++.++|||||||++|+|++|+.||...........+........         
T Consensus       172 --~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (343)
T cd07851         172 --MTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS  245 (343)
T ss_pred             --ccCCcccccccCHHHHhC----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence              245568899999999753    23557789999999999999999999964332221111111110000         


Q ss_pred             ---------------C---CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          319 ---------------P---EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       319 ---------------~---~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                                     .   ......+.++.+||.+||+.||++|||+.|+++||||+.....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence                           0   0112357899999999999999999999999999999976443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-41  Score=307.94  Aligned_cols=247  Identities=26%  Similarity=0.395  Sum_probs=202.3

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      .+..++|.+.+.||+|+||.||+|.+. +++.||||.+.....  ....+.+|+.++++++|+||+++++++......++
T Consensus         2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (261)
T cd05034           2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI   78 (261)
T ss_pred             ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence            367789999999999999999999975 557899999865432  23568899999999999999999999998899999


Q ss_pred             EEeccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          175 LLEYMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       175 v~e~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ||||+.+++|.+++..      ....+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..+.....
T Consensus        79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            9999999998766533      4567788999999999999999999999999999999999999999999876643211


Q ss_pred             -CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCcccc
Q 016959          249 -PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS  326 (380)
Q Consensus       249 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (380)
                       ......++..|+|||.+..     ...+.++|||||||++|+|++ |+.||....   ................+...+
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANY-----GRFTIKSDVWSFGILLTEIVTYGRVPYPGMT---NREVLEQVERGYRMPRPPNCP  230 (261)
T ss_pred             hhhhccCCCccccCHHHhcc-----CCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCCCCCCCCC
Confidence             1122334678999998853     456778999999999999998 999996432   233334444444445566678


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          327 REFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .++.+++.+||+.||++||+++++++
T Consensus       231 ~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         231 EELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHHH
Confidence            89999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3e-42  Score=320.14  Aligned_cols=255  Identities=31%  Similarity=0.421  Sum_probs=195.7

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC-------
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRN-------  169 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-------  169 (380)
                      .++|.+.++||.|+||.||+|.+..+++.+|||++..... ......+.+|+++++.++|+||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4789999999999999999999999999999999854322 22234567899999999999999999987443       


Q ss_pred             -CeEEEEEeccCCCCcccc----cccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          170 -GEIEVLLEYMDGGSLEGA----HIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       170 -~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                       ..+++|+||+.+..+...    ....+..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  166 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD  166 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence             357999999976432211    234677888999999999999999999999999999999999999999999997654


Q ss_pred             ccCC-----------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Q 016959          245 QTMD-----------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI  313 (380)
Q Consensus       245 ~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  313 (380)
                      ....           ......++..|+|||.+..    ...++.++|||||||++|||++|..||...........+...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG----ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             CCCcccccCCcccccccccceeccCcCChHHhhC----CCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            3211           1123457889999998753    234567899999999999999999999643332222222221


Q ss_pred             hhCCCC-------------------CC-------CccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          314 CFAQPP-------------------EA-------PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       314 ~~~~~~-------------------~~-------~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      .....+                   ..       ......++.+||.+||..||++|||+.|++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            111000                   00       12244688999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.3e-41  Score=305.37  Aligned_cols=244  Identities=26%  Similarity=0.425  Sum_probs=203.2

Q ss_pred             ccccceecccCCceEEEEEeCCCC----cEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTS----RVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      +++.+.||.|+||.||++.+...+    ..||+|++...........+..|+.+++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            356789999999999999998766    8999999976655545678899999999999999999999999999999999


Q ss_pred             eccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          177 EYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       177 e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      ||+.+++|.+++.      ..+..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..........
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK  160 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence            9999999876543      4566788999999999999999999999999999999999999999999997665431111


Q ss_pred             C-CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHH
Q 016959          251 N-SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE  328 (380)
Q Consensus       251 ~-~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (380)
                      . ...++..|+|||.+.     +..++.++|||||||++|+|++ |..||..   ..................+..++.+
T Consensus       161 ~~~~~~~~~y~~Pe~~~-----~~~~~~~~Di~slG~i~~~l~~~g~~p~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  232 (258)
T smart00219      161 KKGGKLPIRWMAPESLK-----DGKFTSKSDVWSFGVLLWEIFTLGESPYPG---MSNEEVLEYLKKGYRLPKPENCPPE  232 (258)
T ss_pred             cccCCCcccccChHHhc-----cCCCCcchhHHHHHHHHHHHHhCCCCCCCC---CCHHHHHHHHhcCCCCCCCCcCCHH
Confidence            1 233678999999874     3556789999999999999998 8888864   2333444444444555566678999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc
Q 016959          329 FRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      +.+++.+||+.||++|||+.|+++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      233 IYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHCcCChhhCcCHHHHHh
Confidence            999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-42  Score=315.02  Aligned_cols=251  Identities=31%  Similarity=0.483  Sum_probs=200.7

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEecc
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYM  179 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  179 (380)
                      |+..+.||+|+||.||+|+...+++.||+|++.... .......+.+|+.+++.++|+||+++++++...+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456788999999999999999999999999986543 2334466778999999999999999999999999999999999


Q ss_pred             CCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCC
Q 016959          180 DGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV  254 (380)
Q Consensus       180 ~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (380)
                      .+ +|.+++.     ..+..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++..............
T Consensus        81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (282)
T cd07829          81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV  159 (282)
T ss_pred             Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence            85 7765543     35677889999999999999999999999999999999999999999999987654433334456


Q ss_pred             CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC----------------
Q 016959          255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP----------------  318 (380)
Q Consensus       255 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----------------  318 (380)
                      ++..|+|||.+..    ...++.++|||||||++|||++|..||......+....+........                
T Consensus       160 ~~~~~~aPE~~~~----~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07829         160 VTLWYRAPEILLG----SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT  235 (282)
T ss_pred             cCcCcCChHHhcC----CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence            7889999999853    23567789999999999999999999964432221111111100000                


Q ss_pred             ---------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          319 ---------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       319 ---------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                               .......+.++.++|.+||..||++||++.|+++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                     01112347789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.8e-41  Score=315.03  Aligned_cols=253  Identities=32%  Similarity=0.469  Sum_probs=203.8

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      +.|...+.||+|+||.||++.+..++..||+|++....  .......+.+|+++++.++|+|++++++++.++...++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            45788899999999999999999899999999986432  2334567889999999999999999999999999999999


Q ss_pred             eccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCC
Q 016959          177 EYMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       177 e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      ||+.+ +|.+..     ...+..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++......    .
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----~  179 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----N  179 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----c
Confidence            99986 443332     2356678889999999999999999999999999999999999999999998654322    3


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh-CCCCCCCccccHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF-AQPPEAPEMASREFR  330 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  330 (380)
                      ...|+..|+|||++...  ....++.++|||||||++|+|++|..||....   .......... ..........+..++
T Consensus       180 ~~~~~~~y~aPE~~~~~--~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~  254 (317)
T cd06635         180 SFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQNESPTLQSNEWSDYFR  254 (317)
T ss_pred             cccCCccccChhhhhcC--CCCCCCccccHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHhccCCCCCCccccHHHH
Confidence            45688999999997421  12345678999999999999999999996432   2222222222 222333445788999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      +||.+||+.+|++||++.|+++|+|+.....
T Consensus       255 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         255 NFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             HHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence            9999999999999999999999999976533

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-42  Score=314.12  Aligned_cols=250  Identities=32%  Similarity=0.453  Sum_probs=196.9

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEEEEecc
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEVLLEYM  179 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~  179 (380)
                      |.+.+.||+|+||+||+|....+++.||||.+.............+|+..+++++ |+||+++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            5678899999999999999998999999999865433222334557899999998 999999999999999999999999


Q ss_pred             CCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          180 DGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       180 ~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                       +++|.+.+.      ..+..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++...... ......
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~-~~~~~~  158 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR-PPYTDY  158 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-CCcCCC
Confidence             667754432      256778899999999999999999999999999999999999999999999866433 223445


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC---------------
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP---------------  318 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------------  318 (380)
                      .++..|+|||++..    +..++.++|+||||+++|+|++|+.||......+....+........               
T Consensus       159 ~~~~~~~aPE~~~~----~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         159 VSTRWYRAPEILLR----STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             CCcccccCceeeec----CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            68899999998743    24456789999999999999999999964432222111111000000               


Q ss_pred             -----------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          319 -----------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       319 -----------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                                 .......+.++.++|.+||+.||++|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                       00111235789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-42  Score=323.18  Aligned_cols=254  Identities=28%  Similarity=0.386  Sum_probs=198.7

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC------C
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN------G  170 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~  170 (380)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.++++++|+||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            477999999999999999999998899999999986543 223345678899999999999999999988643      3


Q ss_pred             eEEEEEeccCCCCccccc---ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          171 EIEVLLEYMDGGSLEGAH---IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      ..+++++++ +++|....   ...+..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... 
T Consensus        96 ~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-  173 (345)
T cd07877          96 DVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-  173 (345)
T ss_pred             cEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc-
Confidence            467888877 56765443   2456778889999999999999999999999999999999999999999998765432 


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC-----------
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA-----------  316 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-----------  316 (380)
                        .....++..|+|||++.+    ...++.++|||||||++|+|++|..||...........+......           
T Consensus       174 --~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         174 --MTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             --ccccccCCCccCHHHHhC----ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence              244568899999998743    134567899999999999999999999643322111111110000           


Q ss_pred             -----------CCC-----CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          317 -----------QPP-----EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       317 -----------~~~-----~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                                 ..+     ......+.++.+||.+||+.||++|+++.++++||||++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~  306 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  306 (345)
T ss_pred             HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence                       000     0112357789999999999999999999999999999974

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-41  Score=309.81  Aligned_cols=253  Identities=24%  Similarity=0.391  Sum_probs=205.8

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCc----EEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSR----VFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      +...+|++.+.||+|+||.||+|.+..+++    .+|+|++...........+.+|+.++++++|+||+++++++.. ..
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence            556789999999999999999999876654    5899988766555556788899999999999999999999887 78


Q ss_pred             EEEEEeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      .++||||+.+++|.+++..     .+..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||+++.+...
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            9999999999998766543     46778899999999999999999999999999999999999999999999876533


Q ss_pred             CCCC--CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          247 MDPC--NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       247 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      ....  ....++..|+|||.+..     ..++.++|+|||||++||+++ |..||......   .....+........+.
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~  234 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILH-----RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDLLEKGERLPQPP  234 (279)
T ss_pred             ccceecCCCcccccccCHHHhhc-----CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHhCCCCCCCCC
Confidence            2211  12223568999998743     455678999999999999998 99999744332   3333333344455566


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ..+.++.+++.+||..||++||++.++++  .|..+
T Consensus       235 ~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~--~l~~~  268 (279)
T cd05057         235 ICTIDVYMVLVKCWMIDAESRPTFKELIN--EFSKM  268 (279)
T ss_pred             CCCHHHHHHHHHHcCCChhhCCCHHHHHH--HHHHH
Confidence            67889999999999999999999999987  45443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=8e-42  Score=346.68  Aligned_cols=144  Identities=26%  Similarity=0.436  Sum_probs=129.6

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      .++|.+.++||+|+||+||+|.+..+++.||||+++...  .......+.+|+.+++.++|+||+++++++...+.+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            467999999999999999999999999999999996532  334456788999999999999999999999999999999


Q ss_pred             EeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          176 LEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       176 ~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                      |||+.+++|..++.    ..+..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999976654    3567788999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.1e-41  Score=308.46  Aligned_cols=248  Identities=27%  Similarity=0.398  Sum_probs=201.5

Q ss_pred             CCcccccccceecccCCceEEEEEeCCC---CcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPT---SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      +..++|.+.++||+|+||.||+|.+...   ...||||...........+.+.+|+.+++.++|+||+++++++.+ +..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            4567899999999999999999987543   456899998665545566789999999999999999999998876 457


Q ss_pred             EEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          173 EVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      ++||||+.+++|.+++.     ..+..+..++.||+.||+|||++|++|+||||+|||++.++.++|+|||++.......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            89999999999977654     2566788899999999999999999999999999999999999999999987654332


Q ss_pred             C-CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          248 D-PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       248 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                      . ......++..|+|||.+..     ..++.++|||||||++||+++ |..||.....   ...............+..+
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~  233 (270)
T cd05056         162 YYKASKGKLPIKWMAPESINF-----RRFTSASDVWMFGVCMWEILMLGVKPFQGVKN---NDVIGRIENGERLPMPPNC  233 (270)
T ss_pred             ceecCCCCccccccChhhhcc-----CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCCcCCCCCCC
Confidence            1 1122234568999998743     456778999999999999885 9999964332   2333334444455666778


Q ss_pred             cHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          326 SREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      +.++.++|.+||..+|++|||+.+++.
T Consensus       234 ~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         234 PPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.1e-41  Score=310.17  Aligned_cols=244  Identities=22%  Similarity=0.336  Sum_probs=188.7

Q ss_pred             ceecccCCceEEEEEeCC--CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCC
Q 016959          105 NRIGSGSGGTVWRVVHPP--TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGG  182 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  182 (380)
                      +.||+|+||+||+|....  ....+|+|.+...........+.+|+.+++.++|+||+++++.+...+.+++||||+.++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999996532  345789998765554555667889999999999999999999999999999999999999


Q ss_pred             Cccccccc---------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC--CCCC
Q 016959          183 SLEGAHIR---------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM--DPCN  251 (380)
Q Consensus       183 ~L~~~~~~---------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~  251 (380)
                      +|.+++..         .+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......  ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~  160 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD  160 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence            99766433         245577899999999999999999999999999999999999999999986543211  1123


Q ss_pred             CCCCCCcccccccccccc--CCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCC-----CCCCCc
Q 016959          252 SAVGTIAYMSPERINTDL--NHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQ-----PPEAPE  323 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~--~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~-----~~~~~~  323 (380)
                      ...++..|+|||++....  ..+..++.++|||||||++|||++ |..||......+   .........     .+....
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05042         161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLKQVVREQDIKLPKPQLDL  237 (269)
T ss_pred             CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHhhccCccCCCCcccc
Confidence            344677899999975321  123456779999999999999998 788886433222   222211111     123344


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .++..+.+++..|| .||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         238 KYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             cCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            67889999999999 59999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=305.53  Aligned_cols=241  Identities=34%  Similarity=0.518  Sum_probs=203.6

Q ss_pred             ecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCCCc
Q 016959          107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL  184 (380)
Q Consensus       107 LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  184 (380)
                      ||+|+||.||++.+..+++.||+|++.....  ......+.+|+.+++.++|+||+++++.+..++..++||||+.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            7999999999999988899999999865432  23456788999999999999999999999999999999999999998


Q ss_pred             ccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCCccc
Q 016959          185 EGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYM  260 (380)
Q Consensus       185 ~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~  260 (380)
                      .+++.    ..+..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..............++..|+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  160 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL  160 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence            76543    35677888999999999999999999999999999999999999999999987654433345567899999


Q ss_pred             cccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccC
Q 016959          261 SPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKD  340 (380)
Q Consensus       261 aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  340 (380)
                      +||.+..     ...+.++|+||||+++|++++|..||.....   ........ ......+..++..+.++|.+||..|
T Consensus       161 ~Pe~~~~-----~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~-~~~~~~~~~~~~~l~~~i~~~l~~~  231 (250)
T cd05123         161 APEVLLG-----KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKIL-KDPLRFPEFLSPEARDLISGLLQKD  231 (250)
T ss_pred             ChHHhCC-----CCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHh-cCCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999853     3456789999999999999999999964332   22222222 2445667777899999999999999


Q ss_pred             cCCCCCH---HHHhcCccc
Q 016959          341 PHSRWPA---AQLLQHPFI  356 (380)
Q Consensus       341 p~~R~t~---~eil~hp~~  356 (380)
                      |++||++   .++++||||
T Consensus       232 p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         232 PTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HhhCCCcccHHHHHhCCCC
Confidence            9999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-41  Score=319.04  Aligned_cols=254  Identities=26%  Similarity=0.387  Sum_probs=199.9

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEee-CCeEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDR-NGEIEVL  175 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv  175 (380)
                      .++|++.+.||.|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||++++++|.. ....+++
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv   88 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV   88 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence            457999999999999999999999999999999875432 23345667789999999999999999998865 5678999


Q ss_pred             EeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          176 LEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       176 ~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      +||+. ++|...+.   ..+..+..++.||+.||.|||++||+||||+|.|||++.++.++|+|||++......   ...
T Consensus        89 ~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---~~~  164 (328)
T cd07856          89 TELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---MTG  164 (328)
T ss_pred             eehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC---cCC
Confidence            99995 46655433   245667789999999999999999999999999999999999999999998754322   244


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh------------------
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC------------------  314 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~------------------  314 (380)
                      ..++..|+|||++..    +..++.++|||||||++|+|++|..||...........+....                  
T Consensus       165 ~~~~~~y~aPE~~~~----~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd07856         165 YVSTRYYRAPEIMLT----WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR  240 (328)
T ss_pred             CcccccccCceeeec----cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence            567889999998743    2456789999999999999999999996433211111111000                  


Q ss_pred             ----hCCCCC-----CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          315 ----FAQPPE-----APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       315 ----~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                          ......     ....++.++.++|.+||+.+|++|||+.+++.||||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~  294 (328)
T cd07856         241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY  294 (328)
T ss_pred             HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence                000000     112467899999999999999999999999999999764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.9e-41  Score=314.88  Aligned_cols=252  Identities=31%  Similarity=0.473  Sum_probs=202.9

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCC--CchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      ...|...+.||+|+||.||+|++..++..+|+|.+...  ........+.+|+++++.++|+|++++++++......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            34578889999999999999999999999999998643  2233445678899999999999999999999999999999


Q ss_pred             EeccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          176 LEYMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       176 ~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      |||+.+ +|....     ...+..+..++.|++.||.|||++|++||||+|+|||++.++.++|+|||++......    
T Consensus        94 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----  168 (308)
T cd06634          94 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----  168 (308)
T ss_pred             EEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence            999975 553322     2356678889999999999999999999999999999999999999999998765432    


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC-CCCCCccccHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ-PPEAPEMASREF  329 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  329 (380)
                      ....|+..|+|||.+...  .....+.++|||||||++|+|++|..||.....   ........... +......++..+
T Consensus       169 ~~~~~~~~y~aPE~~~~~--~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  243 (308)
T cd06634         169 NXFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPALQSGHWSEYF  243 (308)
T ss_pred             ccccCCccccCHHHHhhc--ccCCCCcccchHHHHHHHHHHHcCCCCCccccH---HHHHHHHhhcCCCCcCcccccHHH
Confidence            345688999999997421  123356789999999999999999999963322   22222222222 222344678899


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      .+||.+||+.+|++||++.++++|||+...
T Consensus       244 ~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             HHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            999999999999999999999999999885

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-41  Score=303.47  Aligned_cols=239  Identities=24%  Similarity=0.392  Sum_probs=195.2

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCCCc
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL  184 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  184 (380)
                      ++||+|+||.||++.+.. ++.||+|.+...........+.+|+++++.++|+||+++++++......++||||+.+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            469999999999999977 9999999987655545567889999999999999999999999999999999999999998


Q ss_pred             cccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC--CCCCCCC
Q 016959          185 EGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC--NSAVGTI  257 (380)
Q Consensus       185 ~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~gt~  257 (380)
                      .+++..     ....+..++.|++.||+|||++|++||||||+|||++.++.++|+|||++..........  ....++.
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~  159 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI  159 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence            765432     456678899999999999999999999999999999999999999999987654221111  1223356


Q ss_pred             ccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHh
Q 016959          258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC  336 (380)
Q Consensus       258 ~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  336 (380)
                      .|+|||.+..     ..++.++|+|||||++|+|++ |..||......   ..............+..++.++.+++.+|
T Consensus       160 ~y~~PE~~~~-----~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~  231 (251)
T cd05041         160 KWTAPEALNY-----GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRERIESGYRMPAPQLCPEEIYRLMLQC  231 (251)
T ss_pred             ccCChHhhcc-----CCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHHHHHhcCCCCCCCccCCHHHHHHHHHH
Confidence            7999998753     456789999999999999998 88888643322   22222322334445667889999999999


Q ss_pred             cccCcCCCCCHHHHhc
Q 016959          337 LQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       337 l~~dp~~R~t~~eil~  352 (380)
                      |..+|++|||+.|+++
T Consensus       232 l~~~p~~Rp~~~ell~  247 (251)
T cd05041         232 WAYDPENRPSFSEIYN  247 (251)
T ss_pred             hccChhhCcCHHHHHH
Confidence            9999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.3e-41  Score=304.78  Aligned_cols=246  Identities=25%  Similarity=0.418  Sum_probs=199.6

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      .+..++|.+.++||+|+||.||++.+. .+..+|+|.+...  ......+.+|+.+++.++|+||+++++++.. ...++
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   77 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI   77 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence            466789999999999999999999865 4556899988543  2335678899999999999999999999887 77899


Q ss_pred             EEeccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          175 LLEYMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       175 v~e~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      +|||+.+++|.+++..      ....+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++..+.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            9999999998766543      3456778999999999999999999999999999999999999999999976643221


Q ss_pred             -CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCcccc
Q 016959          249 -PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS  326 (380)
Q Consensus       249 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (380)
                       ......++..|+|||++..     ..++.++|+|||||++|++++ |..||....   ................+...+
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~  229 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINF-----GSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIRALERGYRMPRPENCP  229 (260)
T ss_pred             ccccCCcccccccCHhHhcc-----CCcCccccchHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHhCCCCCCCcccCC
Confidence             1122345678999999853     456778999999999999998 999996432   233333334444445566788


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          327 REFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .++.+++.+||+.||++||++.++++
T Consensus       230 ~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         230 EELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHHcccCcccCcCHHHHHH
Confidence            89999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.6e-41  Score=304.34  Aligned_cols=246  Identities=24%  Similarity=0.429  Sum_probs=199.6

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      +..+|++.+.||+|+||.||++.+. .++.+|+|++......  ...+.+|+++++.++|+|++++++++......++||
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            4578999999999999999999885 4678999998644322  346788999999999999999999999999999999


Q ss_pred             eccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-CC
Q 016959          177 EYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-PC  250 (380)
Q Consensus       177 e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~  250 (380)
                      ||+.+++|.+++.     ..+..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........ ..
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence            9999999876543     24567888999999999999999999999999999999999999999999876533211 11


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      ....++..|+|||.+..     ..++.++||||||+++|||++ |..||....   ................+...+..+
T Consensus       159 ~~~~~~~~~~aPe~~~~-----~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd05112         159 TGTKFPVKWSSPEVFSF-----SKYSSKSDVWSFGVLMWEVFSEGKTPYENRS---NSEVVETINAGFRLYKPRLASQSV  230 (256)
T ss_pred             CCCccchhhcCHhHhcc-----CCcChHHHHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHhCCCCCCCCCCCCHHH
Confidence            22335678999998853     456778999999999999998 999996332   233333433333444455678999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcC
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      .+|+.+||..+|++|||+.|++++
T Consensus       231 ~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         231 YELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHHHcccChhhCCCHHHHHHh
Confidence            999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.4e-41  Score=304.78  Aligned_cols=240  Identities=25%  Similarity=0.344  Sum_probs=189.4

Q ss_pred             ceecccCCceEEEEEeCC---CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEe-eCCeEEEEEeccC
Q 016959          105 NRIGSGSGGTVWRVVHPP---TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYD-RNGEIEVLLEYMD  180 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~  180 (380)
                      +.||+|+||.||+|.+..   .+..+|+|.+...........+.+|+.+++.++|+||+++++++. .++..+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            469999999999998643   346799999865444445677889999999999999999999765 4566899999999


Q ss_pred             CCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC----CCCC
Q 016959          181 GGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM----DPCN  251 (380)
Q Consensus       181 ~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~~~~  251 (380)
                      +++|.+++..     ....+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..+....    ....
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  160 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT  160 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccc
Confidence            9999776543     345567889999999999999999999999999999999999999999987553321    1112


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLG-RFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR  330 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (380)
                      ...++..|+|||.+..     ..++.++|||||||++|||++| ..||...   +................+..++..+.
T Consensus       161 ~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (262)
T cd05058         161 GAKLPVKWMALESLQT-----QKFTTKSDVWSFGVLLWELMTRGAPPYPDV---DSFDITVYLLQGRRLLQPEYCPDPLY  232 (262)
T ss_pred             cCcCCccccChhHhcc-----CccchHHHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHhcCCCCCCCCcCCHHHH
Confidence            3446778999998753     4567799999999999999995 5566432   23333333434444445566788999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~  352 (380)
                      +++.+||..+|++||++.|+++
T Consensus       233 ~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         233 EVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHHH
Confidence            9999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.3e-41  Score=312.59  Aligned_cols=249  Identities=24%  Similarity=0.393  Sum_probs=199.9

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCc----EEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSR----VFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      +..++|+..+.||+|+||.||+|.+..++.    .+|+|++...........+.+|+.+++.++|+||+++++++... .
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~   82 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence            556789999999999999999999877765    47888886555445455788999999999999999999998754 5


Q ss_pred             EEEEEeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      .++++||+.+|+|.+++..     .+..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++.+...
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence            6799999999998766543     45678889999999999999999999999999999999999999999999866433


Q ss_pred             CC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          247 MD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       247 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      ..  ......++..|+|||.+.     +..++.++|||||||++|||++ |..||.....   ...............+.
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~~~~~~  234 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIH-----YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDLLEKGERLPQPP  234 (303)
T ss_pred             ccccccCCCccccccCCHHHhc-----cCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHCCCCCCCCC
Confidence            22  122334577899999874     3556788999999999999987 9999964322   22222223333344455


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      .++..+.+++.+||..||++||++.++++.
T Consensus       235 ~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         235 ICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            678899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.1e-41  Score=306.47  Aligned_cols=247  Identities=20%  Similarity=0.276  Sum_probs=188.2

Q ss_pred             ceecccCCceEEEEEeC--CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCC
Q 016959          105 NRIGSGSGGTVWRVVHP--PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGG  182 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  182 (380)
                      +.||+|+||.||+|.+.  .++..+|+|.+...........+.+|+.+++.++|+||+++++++.+....++||||+.++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36999999999999864  3457899999866554444567889999999999999999999999888999999999999


Q ss_pred             Cccccccc---------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--CCC
Q 016959          183 SLEGAHIR---------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD--PCN  251 (380)
Q Consensus       183 ~L~~~~~~---------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~  251 (380)
                      +|.+++..         .+..+..++.|++.||+|||++|++|+||||+||+++.++++||+|||++........  ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~  160 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD  160 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence            99766532         2345678899999999999999999999999999999999999999999875432211  122


Q ss_pred             CCCCCCccccccccccccC--CCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHH-hh-CCCCCCCcccc
Q 016959          252 SAVGTIAYMSPERINTDLN--HGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAI-CF-AQPPEAPEMAS  326 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~  326 (380)
                      ...++..|+|||++.....  ....++.++|||||||++|||++ |..||......+........ .. ...+......+
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd05087         161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS  240 (269)
T ss_pred             CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCC
Confidence            3457889999999853211  01234678999999999999996 99999644332221111110 01 11122223467


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          327 REFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..+.++|.+|| .+|++|||++||+.
T Consensus       241 ~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         241 DRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             hHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            88999999999 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.2e-41  Score=304.47  Aligned_cols=240  Identities=24%  Similarity=0.387  Sum_probs=196.1

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      ++.++|++.+.||+|+||.||++..  +++.||+|.+....   ....+.+|+.+++.++|+||+++++++... ..+++
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v   76 (254)
T cd05083           3 LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV   76 (254)
T ss_pred             ccHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence            4567899999999999999999875  78889999985432   245688999999999999999999998765 47999


Q ss_pred             EeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 016959          176 LEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       176 ~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  249 (380)
                      |||+.+++|.+++.      ..+..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......  
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--  154 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--  154 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence            99999999876543      2456678899999999999999999999999999999999999999999987644321  


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE  328 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (380)
                       .....+..|+|||.+..     ..++.++|+|||||++|+|++ |..||.....   ...............+..++..
T Consensus       155 -~~~~~~~~y~~pe~~~~-----~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  225 (254)
T cd05083         155 -DNSKLPVKWTAPEALKH-----KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL---KEVKECVEKGYRMEPPEGCPAD  225 (254)
T ss_pred             -CCCCCCceecCHHHhcc-----CCcCchhhHHHHHHHHHHHHhCCCCCCccCCH---HHHHHHHhCCCCCCCCCcCCHH
Confidence             23334678999998753     456778999999999999997 9999964333   2333333334444455678899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc
Q 016959          329 FRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      +.+++.+||+.+|++||+++++++
T Consensus       226 ~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         226 VYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.2e-42  Score=290.55  Aligned_cols=266  Identities=21%  Similarity=0.377  Sum_probs=211.4

Q ss_pred             cccccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEee
Q 016959           90 QNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDR  168 (380)
Q Consensus        90 ~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~  168 (380)
                      ......-+.++|++.+++|+|.|++||.|....+++.++||+++    .-..+.+.+|+.+|+.|. |+||++++++..+
T Consensus        29 ~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~D  104 (338)
T KOG0668|consen   29 SLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKD  104 (338)
T ss_pred             heeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence            33334456789999999999999999999999899999999984    334577899999999997 9999999999875


Q ss_pred             C--CeEEEEEeccCCCCcccccc-cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CcEEEeecccccccc
Q 016959          169 N--GEIEVLLEYMDGGSLEGAHI-RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS-KNVKIADFGVSRILA  244 (380)
Q Consensus       169 ~--~~~~lv~e~~~~~~L~~~~~-~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~  244 (380)
                      .  ....+|+||+.+.++..+.. .....++.++.|++.||+|+|+.||.|||+||.|++||.. ..++|+|+|+|.+..
T Consensus       105 p~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  105 PESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             ccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            4  46789999999988765443 3566788899999999999999999999999999999954 569999999998877


Q ss_pred             ccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-CHHHHH-------------
Q 016959          245 QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG-DWASLM-------------  310 (380)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~~-------------  310 (380)
                      ...+ .+-.+.+..|--||.+-+    -..|..+-|+|||||+|..|++.+.||..+..+ ++.-.+             
T Consensus       185 p~~e-YnVRVASRyfKGPELLVd----y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  185 PGKE-YNVRVASRYFKGPELLVD----YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             CCce-eeeeeehhhcCCchheee----chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            6533 345667899999999854    245567899999999999999999999755433 111111             


Q ss_pred             HHHhhCCCCC--------------------CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          311 FAICFAQPPE--------------------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       311 ~~~~~~~~~~--------------------~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                      .+......+.                    -...+++++.||+.++|..|.++|+|+.|++.||||.....++.
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~  333 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAES  333 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhh
Confidence            1111111111                    11226789999999999999999999999999999998755443

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-44  Score=302.03  Aligned_cols=264  Identities=25%  Similarity=0.380  Sum_probs=214.9

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCC-CchHHHHHHHHHHHHHHhCCCCceeeeEeEEe------
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN-HEDSVRSQICREIEILRDVNHPNVVKCHDMYD------  167 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------  167 (380)
                      ....+.|+...+||+|.||+||+|+.+.+|+.||+|++.-+ ..+..-....+|+++|..|+|+|++.++++|.      
T Consensus        13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~   92 (376)
T KOG0669|consen   13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT   92 (376)
T ss_pred             eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence            34567788999999999999999999999999999886432 23333445678999999999999999998764      


Q ss_pred             --eCCeEEEEEeccCC---CCcccc-cccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          168 --RNGEIEVLLEYMDG---GSLEGA-HIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       168 --~~~~~~lv~e~~~~---~~L~~~-~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                        +...+|+||.+|+.   |.|.+. ...+...+.+++.++..||.|+|.+.|+|||+|++|+||+.+|.+||+|||+++
T Consensus        93 ~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   93 NRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence              23459999999985   334444 445677899999999999999999999999999999999999999999999997


Q ss_pred             cccccCC----CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC
Q 016959          242 ILAQTMD----PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ  317 (380)
Q Consensus       242 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  317 (380)
                      .+.....    ..+..+-|..|++||.+.+    ...++.+.|||+-|||+.||.++..-+..+........+..++...
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG----~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~  248 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLG----DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI  248 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhc----ccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence            6643221    2345567999999999875    3556778999999999999999999998766666667777777666


Q ss_pred             CCCCCcc-------------------------------ccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          318 PPEAPEM-------------------------------ASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       318 ~~~~~~~-------------------------------~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      .++.|++                               -++++.||+.+||..||.+|++++++|+|.||.+.+-.
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence            6554443                               23378899999999999999999999999999887544

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=317.45  Aligned_cols=258  Identities=25%  Similarity=0.355  Sum_probs=214.4

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      ..++..+.+.++++||+|-||+|.+|+.. .+..||||+++.......+..|..|+++|.+|+|||||+++|+|..++.+
T Consensus       532 l~EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi  610 (807)
T KOG1094|consen  532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL  610 (807)
T ss_pred             hhhcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence            34577888999999999999999999984 36899999999888888889999999999999999999999999999999


Q ss_pred             EEEEeccCCCCcccccccch------HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          173 EVLLEYMDGGSLEGAHIRQE------HILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~~~~------~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      ++|+||+++|+|.+++...+      .....|+.||+.||+||.+.++|||||.+.|||++.++++||+|||.++.+...
T Consensus       611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence            99999999999987765532      234569999999999999999999999999999999999999999999866433


Q ss_pred             CC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHH--hCCCCCCCCCCCCHHHHHHHHhhCCC----
Q 016959          247 MD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY--LGRFPFAVGRQGDWASLMFAICFAQP----  318 (380)
Q Consensus       247 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell--~g~~pf~~~~~~~~~~~~~~~~~~~~----  318 (380)
                      ..  .....+-..+|||+|.|..     ..++.++|+|+||+++||++  |...||.....++..+..........    
T Consensus       691 ~yy~vqgr~vlpiRwmawEsill-----gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~  765 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILL-----GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV  765 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHh-----ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee
Confidence            21  2233456789999999853     44567999999999999964  78999975555544444444333332    


Q ss_pred             CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 016959          319 PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR  358 (380)
Q Consensus       319 ~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~  358 (380)
                      ...|..++..+.+||.+||..|-++||+++++..  +|+.
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~--~lq~  803 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL--FLQE  803 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH--HHHH
Confidence            3467779999999999999999999999999954  5554

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-41  Score=309.40  Aligned_cols=249  Identities=31%  Similarity=0.479  Sum_probs=194.2

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhC---CCCceeeeEeEEeeCCe-----
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDV---NHPNVVKCHDMYDRNGE-----  171 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~-----  171 (380)
                      |++.+.||+|+||.||+|++..+++.||+|++..... ......+.+|+.+++++   +|+||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5678899999999999999988899999999964332 23344566788777666   59999999999987776     


Q ss_pred             EEEEEeccCCCCccccc------ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAH------IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      ++++|||+.+ +|.+++      ...+..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~  159 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF  159 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence            9999999975 564432      235677889999999999999999999999999999999999999999999977643


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC-C-------
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA-Q-------  317 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~-------  317 (380)
                      .. ......++..|+|||++..     ..++.++|+|||||++|+|++|..||......+....+...... .       
T Consensus       160 ~~-~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07838         160 EM-ALTSVVVTLWYRAPEVLLQ-----SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN  233 (287)
T ss_pred             Cc-ccccccccccccChHHhcc-----CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence            32 2234457889999999853     45677899999999999999999999743332222222111000 0       


Q ss_pred             --------C-------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          318 --------P-------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       318 --------~-------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                              .       ......++..+.++|.+||+.||++||++.|++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                    0       00112346788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.6e-42  Score=345.01  Aligned_cols=253  Identities=30%  Similarity=0.469  Sum_probs=198.3

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC--------
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG--------  170 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------  170 (380)
                      .+|+....||+||||.||+|+++-+|+.||||+|..........++.+|+.+|.+|+|||||+++..|.+..        
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            578889999999999999999999999999999977766777888999999999999999999887542100        


Q ss_pred             --------------------------------------------------------------------------------
Q 016959          171 --------------------------------------------------------------------------------  170 (380)
Q Consensus       171 --------------------------------------------------------------------------------  170 (380)
                                                                                                      
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             -------------------------------eEEEEEeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCc
Q 016959          171 -------------------------------EIEVLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKI  214 (380)
Q Consensus       171 -------------------------------~~~lv~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~i  214 (380)
                                                     .+||-||||+..+|.+.+..     .....+++++||++||.|+|++||
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi  718 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI  718 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence                                           13444555555444333222     234578899999999999999999


Q ss_pred             eecCCCCCcEEEcCCCcEEEeecccccccc-----------------ccCC-CCCCCCCCCccccccccccccCCCCCCC
Q 016959          215 VHRDIKPSNLLINSSKNVKIADFGVSRILA-----------------QTMD-PCNSAVGTIAYMSPERINTDLNHGKYDG  276 (380)
Q Consensus       215 vH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~-----------------~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~  276 (380)
                      |||||||.||++++++.|||+|||+|+.+.                 .... ..++.+||..|+|||++.+...  ..|+
T Consensus       719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~--~~Yn  796 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS--NKYN  796 (1351)
T ss_pred             eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc--cccc
Confidence            999999999999999999999999998721                 0111 3456789999999999965321  3577


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCC---CccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA---PEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       277 ~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      .|+|||||||||+||+.   ||.  ...+....+..++.+..+..   +..--+.-..+|.+||+.||.+|||+.|+|++
T Consensus       797 ~KiDmYSLGIVlFEM~y---PF~--TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEMLY---PFG--TSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             chhhhHHHHHHHHHHhc---cCC--chHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence            89999999999999984   564  34455555666654444433   44444567789999999999999999999999


Q ss_pred             ccccc
Q 016959          354 PFILR  358 (380)
Q Consensus       354 p~~~~  358 (380)
                      .||-.
T Consensus       872 ~llpp  876 (1351)
T KOG1035|consen  872 ELLPP  876 (1351)
T ss_pred             cCCCc
Confidence            99983

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.9e-41  Score=307.21  Aligned_cols=240  Identities=24%  Similarity=0.392  Sum_probs=194.1

Q ss_pred             ceecccCCceEEEEEeCCCC------cEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          105 NRIGSGSGGTVWRVVHPPTS------RVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~------~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +.||+|+||.||+|++....      +.+|+|.+...........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36999999999999876433      789999986554444567788999999999999999999999999999999999


Q ss_pred             cCCCCccccccc-----------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-----cEEEeecccccc
Q 016959          179 MDGGSLEGAHIR-----------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK-----NVKIADFGVSRI  242 (380)
Q Consensus       179 ~~~~~L~~~~~~-----------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~-----~~kl~Dfg~a~~  242 (380)
                      +.+++|.+++..           ....+..++.||+.||.|||+++++|+||||+||+++.++     .++|+|||++..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~  160 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD  160 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence            999998766532           3466778999999999999999999999999999999877     899999999876


Q ss_pred             ccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCC
Q 016959          243 LAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPP  319 (380)
Q Consensus       243 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  319 (380)
                      +.....  ......++..|+|||++..     ..++.++|||||||++|+|++ |..||.....   .............
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~~~~  232 (269)
T cd05044         161 IYKSDYYRKEGEGLLPVRWMAPESLLD-----GKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVTAGGRL  232 (269)
T ss_pred             cccccccccCcccCCCccccCHHHHcc-----CCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHhcCCcc
Confidence            533211  1123345788999999853     446789999999999999998 9999963322   2333333333444


Q ss_pred             CCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       320 ~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..+..++..+.+||.+||..+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         233 QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            556678899999999999999999999999976

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6e-41  Score=306.19  Aligned_cols=250  Identities=22%  Similarity=0.370  Sum_probs=200.9

Q ss_pred             CCcccccccceecccCCceEEEEEeCC-----CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPP-----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      +..++|++.+.||+|+||+||+|+.+.     +.+.|++|.+...........+.+|+.++++++|+||+++++++.+.+
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            455789999999999999999999753     356899999865555546678899999999999999999999999989


Q ss_pred             eEEEEEeccCCCCcccccc-------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeec
Q 016959          171 EIEVLLEYMDGGSLEGAHI-------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADF  237 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~-------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  237 (380)
                      ..++||||+.+++|.+++.             ..+..+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999976543             346678889999999999999999999999999999999999999999


Q ss_pred             ccccccccc-CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHh-
Q 016959          238 GVSRILAQT-MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAIC-  314 (380)
Q Consensus       238 g~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~-  314 (380)
                      |++...... ........++..|+|||.+..     ...+.++||||||+++|+|++ |..||.......   ...... 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~~~  233 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-----DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRLQA  233 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHHHc
Confidence            998654321 112234456788999998753     345678999999999999998 888996333222   222222 


Q ss_pred             hCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          315 FAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       315 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      .......+..++..+.+++.+||..||++|||+.|++.+
T Consensus       234 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         234 GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            111223345678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.9e-41  Score=303.61  Aligned_cols=239  Identities=26%  Similarity=0.402  Sum_probs=193.5

Q ss_pred             ceecccCCceEEEEEeCC-CC--cEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          105 NRIGSGSGGTVWRVVHPP-TS--RVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~-~~--~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      +.||+|+||.||+|.+.. .+  ..||||.+...........+.+|+.++++++|+||+++++++.. ...++||||+.+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999865 33  36999999766554566789999999999999999999999988 889999999999


Q ss_pred             CCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC---CCCC
Q 016959          182 GSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD---PCNS  252 (380)
Q Consensus       182 ~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~  252 (380)
                      ++|.+.+.      ..+..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++..+.....   ....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  159 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH  159 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence            99876543      34567888999999999999999999999999999999999999999999987643211   1123


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHh-hCCCCCCCccccHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAIC-FAQPPEAPEMASREFR  330 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  330 (380)
                      ..++..|+|||++..     ..++.++|||||||++|+|++ |..||......+   ...... .......+..++..+.
T Consensus       160 ~~~~~~y~~pE~~~~-----~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  231 (257)
T cd05040         160 LKVPFAWCAPESLRT-----RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKIDKEGERLERPEACPQDIY  231 (257)
T ss_pred             CCCCceecCHHHhcc-----cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHhcCCcCCCCccCCHHHH
Confidence            456789999998853     446778999999999999998 999996433322   222222 2223334556788999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~  352 (380)
                      +++.+||+.+|++||++.|+++
T Consensus       232 ~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         232 NVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHCCCCcccCCCHHHHHH
Confidence            9999999999999999999986

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-40  Score=305.76  Aligned_cols=249  Identities=26%  Similarity=0.368  Sum_probs=193.8

Q ss_pred             cccccccceecccCCceEEEEEe----CCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee--CCe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVH----PPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR--NGE  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~----~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~  171 (380)
                      ..+|++.+.||+|+||.||+|..    ..+++.||+|.+.... ......+.+|+++++.++|+||+++++++..  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            45789999999999999999973    4578899999986543 3345678899999999999999999998643  356


Q ss_pred             EEEEEeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      +++||||+.+++|.+++..     .+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  161 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD  161 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence            8999999999999876532     45677889999999999999999999999999999999999999999999876433


Q ss_pred             CCC---CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC-------------HHHHH
Q 016959          247 MDP---CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD-------------WASLM  310 (380)
Q Consensus       247 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------------~~~~~  310 (380)
                      ...   .....++..|+|||++..     ..++.++|||||||++|||++|..++.......             .....
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTE-----SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhcc-----CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            221   112224456999998853     456779999999999999999887764221100             00111


Q ss_pred             HHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          311 FAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ...........+..++.++.+||.+||..+|++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            112222233445567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6e-41  Score=307.28  Aligned_cols=250  Identities=27%  Similarity=0.410  Sum_probs=200.2

Q ss_pred             cccccccceecccCCceEEEEEeC----CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee--CCe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHP----PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR--NGE  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~----~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~  171 (380)
                      .++|++.+.||+|+||.||+|...    .+++.||||++...........+.+|+++++.++|+||+++++++..  ...
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            467888999999999999999864    34789999999765554456789999999999999999999999877  557


Q ss_pred             EEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      .+++|||+.+++|.+++.     ..+..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED  162 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence            999999999999977664     345667889999999999999999999999999999999999999999999876532


Q ss_pred             CCC---CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC------------HHHHHH
Q 016959          247 MDP---CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD------------WASLMF  311 (380)
Q Consensus       247 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------------~~~~~~  311 (380)
                      ...   .....++..|++||.+..     ..++.++|||||||++|||++|..||.......            ......
T Consensus       163 ~~~~~~~~~~~~~~~~~~Pe~~~~-----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         163 KDYYYVKEPGESPIFWYAPECLRT-----SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             CcceeccCCCCCcccccCcHHHcc-----CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            211   112345667999998853     356678999999999999999999986332211            112222


Q ss_pred             HHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          312 AICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..........+..++.++.+|+.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            22233333445567789999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.8e-41  Score=314.92  Aligned_cols=273  Identities=23%  Similarity=0.306  Sum_probs=202.3

Q ss_pred             cccccceecccCCceEEEEEeCCC--CcEEEEEEecCCC-chHHHHHHHHHHHHHHhC-CCCceeeeEeEEee----CCe
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPT--SRVFALKVIYGNH-EDSVRSQICREIEILRDV-NHPNVVKCHDMYDR----NGE  171 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~--~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~~  171 (380)
                      +|.+.+.||+|+||.||++.+..+  +..||+|++.... .......+.+|+.+++++ +|+||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            377889999999999999999887  8899999986432 222345677899999999 59999999987532    245


Q ss_pred             EEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          172 IEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      +++++|++.+ +|...+.    ..+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus        81 ~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  159 (332)
T cd07857          81 LYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP  159 (332)
T ss_pred             EEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence            7888999864 6654432    3567788899999999999999999999999999999999999999999998654321


Q ss_pred             C----CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh---------
Q 016959          248 D----PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC---------  314 (380)
Q Consensus       248 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---------  314 (380)
                      .    ......|+..|+|||++..    +..++.++|||||||++|+|++|..||...........+....         
T Consensus       160 ~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         160 GENAGFMTEYVATRWYRAPEIMLS----FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccCcccCccccCcHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            1    1234578999999998743    2345678999999999999999999996433211111100000         


Q ss_pred             ---------------hCCC---CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccccccccccCCCCC
Q 016959          315 ---------------FAQP---PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPR  376 (380)
Q Consensus       315 ---------------~~~~---~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~  376 (380)
                                     ....   ......++..+.+|+.+||+.||++|||+.|++.||||+.... ...... --+|++-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~-~~~~~~-~~~~~~~  313 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD-PDDEPV-CQKPFDF  313 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC-cccccc-ccccccC
Confidence                           0000   0112235789999999999999999999999999999976533 112222 3445555


Q ss_pred             CCC
Q 016959          377 PLS  379 (380)
Q Consensus       377 ~~~  379 (380)
                      +|.
T Consensus       314 ~~~  316 (332)
T cd07857         314 SFE  316 (332)
T ss_pred             Ccc
Confidence            553

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-42  Score=332.49  Aligned_cols=258  Identities=33%  Similarity=0.527  Sum_probs=219.3

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEe-----eCCe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYD-----RNGE  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~-----~~~~  171 (380)
                      .+.|++.+.||.|.+|.||+++++.+++.+|+|++....+  ..+++..|+++|+.+ .|||++.++|+|.     .++.
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d--~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED--EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc--ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            3568899999999999999999999999999999854443  346677899999988 5999999999985     3578


Q ss_pred             EEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      +|||||||.||+.-++..      ..|..+.-|++.++.|+.+||.+.++|||+|-.|||++.++.|||+|||.+..+..
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS  175 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence            999999999998654433      35677888999999999999999999999999999999999999999999999988


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC--CCc
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--APE  323 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~  323 (380)
                      +.....+.+||+.|||||++.........|+.++|+||||++..||--|..|+..   .-....+..+....++.  .|.
T Consensus       176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D---mHPmraLF~IpRNPPPkLkrp~  252 (953)
T KOG0587|consen  176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD---MHPMRALFLIPRNPPPKLKRPK  252 (953)
T ss_pred             ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC---cchhhhhccCCCCCCccccchh
Confidence            8888889999999999999976666666778899999999999999999999962   22233444444444433  345


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      .-++++.|||..||.+|-++||+..++|.|||++...
T Consensus       253 kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~  289 (953)
T KOG0587|consen  253 KWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP  289 (953)
T ss_pred             hHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence            6788999999999999999999999999999999654

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.7e-41  Score=307.09  Aligned_cols=235  Identities=18%  Similarity=0.340  Sum_probs=186.1

Q ss_pred             ceecccCCceEEEEEeCCCCc-------EEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959          105 NRIGSGSGGTVWRVVHPPTSR-------VFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~-------~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      +.||+|+||.||+|.+...+.       .+|+|.+.... ....+.+.+|+.+++.++|+||+++++++..++..++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            369999999999999865543       38888874332 3345678889999999999999999999999889999999


Q ss_pred             ccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc--------EEEeecccccccc
Q 016959          178 YMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN--------VKIADFGVSRILA  244 (380)
Q Consensus       178 ~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~--------~kl~Dfg~a~~~~  244 (380)
                      |+.+++|..++..     .+..+..++.||+.||+|||++||+||||||+|||++.++.        ++++|||++....
T Consensus        80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~  159 (258)
T cd05078          80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL  159 (258)
T ss_pred             cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence            9999999766543     45667789999999999999999999999999999987765        6999999986554


Q ss_pred             ccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          245 QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR-FPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      ..    ....++..|+|||++..    +..++.++|||||||++|+|++|. .||.....   .....  ........+.
T Consensus       160 ~~----~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~---~~~~~--~~~~~~~~~~  226 (258)
T cd05078         160 PK----EILLERIPWVPPECIEN----PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS---QKKLQ--FYEDRHQLPA  226 (258)
T ss_pred             Cc----hhccccCCccCchhccC----CCCCCchhhHHHHHHHHHHHHcCCCCChhhccH---HHHHH--HHHccccCCC
Confidence            32    34568889999999853    234577899999999999999985 55542221   11111  1122344555


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ..+.++.+||.+||+.||++|||++|+++.
T Consensus       227 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         227 PKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             CCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            667899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.8e-41  Score=304.44  Aligned_cols=235  Identities=20%  Similarity=0.341  Sum_probs=183.6

Q ss_pred             ceecccCCceEEEEEeCCC------------CcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959          105 NRIGSGSGGTVWRVVHPPT------------SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~------------~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      +.||+|+||.||+|+....            ...+++|++.... ......+.+|+.+++.++||||+++++++......
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            3699999999999985422            2358888875433 33455788899999999999999999999988899


Q ss_pred             EEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc-------EEEeecccc
Q 016959          173 EVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN-------VKIADFGVS  240 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~-------~kl~Dfg~a  240 (380)
                      ++||||+.+++|..++.     ..+..+..++.||+.||+|||++||+||||||+|||++.++.       ++++|||++
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~  159 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP  159 (262)
T ss_pred             EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence            99999999998865543     355678889999999999999999999999999999986664       899999998


Q ss_pred             ccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCCHHHHHHHHhhCCCC
Q 016959          241 RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFAICFAQPP  319 (380)
Q Consensus       241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~~~~  319 (380)
                      ......    ....++..|+|||++..    +..++.++|||||||++|||+ +|..||......+....   .  ....
T Consensus       160 ~~~~~~----~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~---~--~~~~  226 (262)
T cd05077         160 ITVLSR----QECVERIPWIAPECVED----SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF---Y--EGQC  226 (262)
T ss_pred             ccccCc----ccccccccccChhhhcC----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH---H--hcCc
Confidence            655322    34567889999998742    355677899999999999997 58888864322221111   1  1111


Q ss_pred             CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       320 ~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ......+.++.+||.+||+.||++||++.+|+++
T Consensus       227 ~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         227 MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            2222345789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.4e-41  Score=305.41  Aligned_cols=234  Identities=23%  Similarity=0.380  Sum_probs=183.0

Q ss_pred             eecccCCceEEEEEeCC------------------------CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceee
Q 016959          106 RIGSGSGGTVWRVVHPP------------------------TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK  161 (380)
Q Consensus       106 ~LG~G~~g~V~~~~~~~------------------------~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~  161 (380)
                      +||+|+||.||+|....                        ....||+|++..... .....+.+|+.+++.++|+||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence            69999999999987532                        124588998854332 33456788999999999999999


Q ss_pred             eEeEEeeCCeEEEEEeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC------
Q 016959          162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK------  230 (380)
Q Consensus       162 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~------  230 (380)
                      +++++......++||||+.+++|..++..     .+..+..++.||+.||+|||++||+||||||+|||++.++      
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~  160 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS  160 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence            99999999999999999999998765432     4567788999999999999999999999999999998654      


Q ss_pred             -cEEEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCCHHH
Q 016959          231 -NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWAS  308 (380)
Q Consensus       231 -~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell-~g~~pf~~~~~~~~~~  308 (380)
                       .+|++|||++......    ....++..|+|||.+..    +..++.++|||||||++|||+ +|..||..........
T Consensus       161 ~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~----~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  232 (274)
T cd05076         161 PFIKLSDPGVSFTALSR----EERVERIPWIAPECVPG----GNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER  232 (274)
T ss_pred             ceeeecCCccccccccc----cccccCCcccCchhhcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence             3899999987644322    23457888999998753    245678999999999999985 7999996443322211


Q ss_pred             HHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          309 LMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ..     ......+.....++.++|.+||+.+|++|||+.++|++
T Consensus       233 ~~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         233 FY-----EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HH-----HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            11     11222334456789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=8.1e-41  Score=298.96  Aligned_cols=225  Identities=25%  Similarity=0.355  Sum_probs=184.1

Q ss_pred             cCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCCCcccccc
Q 016959          110 GSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHI  189 (380)
Q Consensus       110 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~  189 (380)
                      |.||+||+|.+..+++.||+|++....      ...+|...+....|+||+++++++...+..++||||+.+++|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            899999999999999999999986542      12344455555679999999999999999999999999999866543


Q ss_pred             ----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCCcccccccc
Q 016959          190 ----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERI  265 (380)
Q Consensus       190 ----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~  265 (380)
                          ..+..+..++.|++.||+|||++||+||||||+||+++.++.++++|||.+..+....   ....++..|+|||.+
T Consensus        78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y~aPE~~  154 (237)
T cd05576          78 KFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMYCAPEVG  154 (237)
T ss_pred             HhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccccCCccc
Confidence                3567788999999999999999999999999999999999999999999886654332   344567889999987


Q ss_pred             ccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCC
Q 016959          266 NTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRW  345 (380)
Q Consensus       266 ~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  345 (380)
                      ..     ..++.++|+||+||++|||++|..||......        .........+..++..+++||.+||+.||++|+
T Consensus       155 ~~-----~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  221 (237)
T cd05576         155 GI-----SEETEACDWWSLGAILFELLTGKTLVECHPSG--------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERL  221 (237)
T ss_pred             CC-----CCCCchhhHHHHHHHHHHHHHCcchhhcCchh--------cccccccCCcccCCHHHHHHHHHHccCCHHHhc
Confidence            43     44567899999999999999999888532111        111122345566889999999999999999999


Q ss_pred             CH-----HHHhcCccc
Q 016959          346 PA-----AQLLQHPFI  356 (380)
Q Consensus       346 t~-----~eil~hp~~  356 (380)
                      ++     +|+++||||
T Consensus       222 ~~~~~~~~~~~~h~~~  237 (237)
T cd05576         222 GAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCCccchHHHHcCCCC
Confidence            85     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.5e-40  Score=299.44  Aligned_cols=245  Identities=28%  Similarity=0.459  Sum_probs=196.4

Q ss_pred             cccccceecccCCceEEEEEeCC-CCcEEEEEEecCCC---------chHHHHHHHHHHHHHHh-CCCCceeeeEeEEee
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPP-TSRVFALKVIYGNH---------EDSVRSQICREIEILRD-VNHPNVVKCHDMYDR  168 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~-~~~~~avK~~~~~~---------~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~  168 (380)
                      +|++.+.||+|+||.||+|.+.. +++.+|+|.+....         ......++.+|+.++.+ ++|+||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999987 68899999885321         22334567788888765 789999999999999


Q ss_pred             CCeEEEEEeccCCCCccccc--------ccchHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEeeccc
Q 016959          169 NGEIEVLLEYMDGGSLEGAH--------IRQEHILSDLARQVLSGLAYLHK-RKIVHRDIKPSNLLINSSKNVKIADFGV  239 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  239 (380)
                      ++..+++|||+.+++|.+++        ...+..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            99999999999999886543        23456788999999999999996 7899999999999999999999999999


Q ss_pred             cccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC
Q 016959          240 SRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP  319 (380)
Q Consensus       240 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  319 (380)
                      +....... ......|+..|++||.+..     ..++.++|+||||+++|+|++|..||....   ..............
T Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~-----~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~---~~~~~~~~~~~~~~  231 (269)
T cd08528         161 AKQKQPES-KLTSVVGTILYSCPEIVKN-----EPYGEKADVWAFGCILYQMCTLQPPFYSTN---MLSLATKIVEAVYE  231 (269)
T ss_pred             eeeccccc-ccccccCcccCcChhhhcC-----CCCchHHHHHHHHHHHHHHHhCCCcccccC---HHHHHHHHhhccCC
Confidence            98665432 3345668999999999853     445779999999999999999999996332   22222222222222


Q ss_pred             C-CCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          320 E-APEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       320 ~-~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      . ....++.++.++|.+||+.||++||++.|+.++
T Consensus       232 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         232 PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            2 223578899999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.7e-40  Score=300.07  Aligned_cols=246  Identities=18%  Similarity=0.297  Sum_probs=185.8

Q ss_pred             eecccCCceEEEEEeCCC--CcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCCC
Q 016959          106 RIGSGSGGTVWRVVHPPT--SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGS  183 (380)
Q Consensus       106 ~LG~G~~g~V~~~~~~~~--~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  183 (380)
                      .||+|+||+||++.....  ...+++|.+.........+.+.+|+.+++.++||||+++++.+......++||||+.+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999975433  345677777655444456788999999999999999999999999999999999999999


Q ss_pred             ccccccc--------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc--CCCCCCC
Q 016959          184 LEGAHIR--------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT--MDPCNSA  253 (380)
Q Consensus       184 L~~~~~~--------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~  253 (380)
                      |..++..        ....+..++.||+.||+|||+++++||||||+|||++.++.++|+|||++......  .......
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  161 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDK  161 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCC
Confidence            9766542        23456789999999999999999999999999999999999999999998643211  1122345


Q ss_pred             CCCCccccccccccccC--CCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHH-h-hCCCCCCCccccHH
Q 016959          254 VGTIAYMSPERINTDLN--HGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAI-C-FAQPPEAPEMASRE  328 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~--~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~  328 (380)
                      .++..|+|||++.....  ....++.++|||||||++|||++ |..||......+........ . ....+.....++..
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (268)
T cd05086         162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSER  241 (268)
T ss_pred             cCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHH
Confidence            68899999999843111  12234678999999999999986 57788533222211111111 1 11123344457889


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhc
Q 016959          329 FRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      +.+++..|| .+|++||+++|+++
T Consensus       242 ~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         242 WYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             HHHHHHHHh-hCcccCCCHHHHHH
Confidence            999999999 78999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.5e-40  Score=299.09  Aligned_cols=233  Identities=24%  Similarity=0.369  Sum_probs=184.6

Q ss_pred             ceecccCCceEEEEEeCCCC----------cEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959          105 NRIGSGSGGTVWRVVHPPTS----------RVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~----------~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      +.||+|+||.||+|.+..++          ..+++|++......  ...+.+|+.+++.++|+||+++++++.. +..++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            46999999999999998766          35788876544322  5778899999999999999999999887 77899


Q ss_pred             EEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-------cEEEeecccccc
Q 016959          175 LLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK-------NVKIADFGVSRI  242 (380)
Q Consensus       175 v~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~-------~~kl~Dfg~a~~  242 (380)
                      ||||+.+++|..++.     .....+..++.||+.||+|||++||+||||||+|||++.++       .+||+|||++..
T Consensus        78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~  157 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT  157 (259)
T ss_pred             EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence            999999999976654     34566788999999999999999999999999999999887       799999999986


Q ss_pred             ccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCC
Q 016959          243 LAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEA  321 (380)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  321 (380)
                      ....    ....++..|+|||++...   ...++.++|||||||++|+|++ |..||...........   ..  .....
T Consensus       158 ~~~~----~~~~~~~~y~aPE~~~~~---~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~---~~--~~~~~  225 (259)
T cd05037         158 VLSR----EERVERIPWIAPECIRNG---QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF---YQ--DQHRL  225 (259)
T ss_pred             cccc----cccccCCCccChhhhcCC---CCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH---Hh--cCCCC
Confidence            5431    334577889999998531   1356789999999999999998 5778864432222111   11  11122


Q ss_pred             CccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      +......+.++|.+||..||++|||+.|+++
T Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         226 PMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2223479999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.8e-40  Score=302.45  Aligned_cols=252  Identities=18%  Similarity=0.243  Sum_probs=181.9

Q ss_pred             CCcccccccceecccCCceEEEEEeCCC---CcEEEEEEecCCCchHHHH----------HHHHHHHHHHhCCCCceeee
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPT---SRVFALKVIYGNHEDSVRS----------QICREIEILRDVNHPNVVKC  162 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~----------~~~~E~~~l~~l~h~~iv~~  162 (380)
                      +...+|++.++||+|+||+||+|.+..+   ++.+|+|+..........+          ....++..+..++|+|++++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            5567899999999999999999998877   6778888753322211111          11233344556789999999


Q ss_pred             EeEEeeCC----eEEEEEeccCCCC--c-ccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEe
Q 016959          163 HDMYDRNG----EIEVLLEYMDGGS--L-EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIA  235 (380)
Q Consensus       163 ~~~~~~~~----~~~lv~e~~~~~~--L-~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~  235 (380)
                      ++++....    ..+++++++....  + .......+..+..++.||+.||+|||++||+||||||+|||++.++.++|+
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~  168 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII  168 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence            98765433    3466777764321  1 111224567788999999999999999999999999999999999999999


Q ss_pred             eccccccccccC-------CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC-HH
Q 016959          236 DFGVSRILAQTM-------DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD-WA  307 (380)
Q Consensus       236 Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~  307 (380)
                      |||+|+.+....       .......||+.|+|||++.     +..++.++|||||||++|||++|..||....... ..
T Consensus       169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~-----~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN-----GACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             EcCCceeeccCCcccccccccccccCCCccccCHHHhC-----CCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            999998664221       1112346999999999875     3556889999999999999999999997543221 11


Q ss_pred             HHH-HHH-h-hCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          308 SLM-FAI-C-FAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       308 ~~~-~~~-~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ... ... . ..........+++++.+++..||..+|++||+++++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        244 HAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            111 110 0 01111123456789999999999999999999999986

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=324.18  Aligned_cols=240  Identities=32%  Similarity=0.514  Sum_probs=193.7

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC------CeEEE
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRN------GEIEV  174 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~l  174 (380)
                      +...+.||+|+||.||+++++.+|+.||||.+.........+...+|+++|++++|+|||+++++-+..      ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            455678999999999999999999999999997766666678899999999999999999999976543      35678


Q ss_pred             EEeccCCCCcccccccc-------hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc--CCCc--EEEeeccccccc
Q 016959          175 LLEYMDGGSLEGAHIRQ-------EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN--SSKN--VKIADFGVSRIL  243 (380)
Q Consensus       175 v~e~~~~~~L~~~~~~~-------~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~--~~~~--~kl~Dfg~a~~~  243 (380)
                      |||||.||+|...+..+       +..++.++.+++.||.|||++||+||||||.||++.  .+|+  .||+|||.|+.+
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            99999999998777664       567899999999999999999999999999999985  3343  899999999988


Q ss_pred             cccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC-HHHHHHHHhhCCCC---
Q 016959          244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD-WASLMFAICFAQPP---  319 (380)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~---  319 (380)
                      .+.. ...+.+||..|.+||.+.+    .++|+..+|.|||||++|++.||..||....... ..+.+.......+.   
T Consensus       175 ~d~s-~~~S~vGT~~YLhPel~E~----q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  175 DDNS-LFTSLVGTEEYLHPELYER----QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA  249 (732)
T ss_pred             CCCC-eeeeecCchhhcChHHHhh----ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence            7664 6789999999999999854    4778889999999999999999999997443331 22233322222211   


Q ss_pred             -----------------CCCccccH----HHHHHHHHhcccCcCCCC
Q 016959          320 -----------------EAPEMASR----EFRDFISRCLQKDPHSRW  345 (380)
Q Consensus       320 -----------------~~~~~~~~----~~~~li~~~l~~dp~~R~  345 (380)
                                       +.+..++.    .+-..+..+|..|+++|.
T Consensus       250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                             12333333    345667778899999999

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7.4e-40  Score=298.57  Aligned_cols=244  Identities=21%  Similarity=0.354  Sum_probs=191.6

Q ss_pred             ccccceecccCCceEEEEEeC---CCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC------
Q 016959          101 LQKGNRIGSGSGGTVWRVVHP---PTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG------  170 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~---~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------  170 (380)
                      |.+.+.||+|+||.||+|.+.   .+++.||||++.... .....+.+.+|+++++.++|+||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999864   357899999986543 3344567889999999999999999999876432      


Q ss_pred             eEEEEEeccCCCCccccc----------ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccc
Q 016959          171 EIEVLLEYMDGGSLEGAH----------IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS  240 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~----------~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  240 (380)
                      ..+++++|+.+++|..++          ......+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            247889999999885443          2345668899999999999999999999999999999999999999999999


Q ss_pred             ccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCC
Q 016959          241 RILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQ  317 (380)
Q Consensus       241 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  317 (380)
                      +.......  ......++..|++||.+..     ..++.++|||||||++|+|++ |..||.....   ...........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~  232 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLAD-----NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLIKGN  232 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhc-----CccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHHcCC
Confidence            86543211  1123345678999998753     455678999999999999998 8899863322   22333333333


Q ss_pred             CCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          318 PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       318 ~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ....+...+..+.+++.+||..+|++||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         233 RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            33444567789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.2e-40  Score=328.69  Aligned_cols=260  Identities=19%  Similarity=0.234  Sum_probs=179.3

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCC----CcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeE----
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPT----SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM----  165 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~----~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~----  165 (380)
                      ..+..++|++.+.||+|+||.||+|.+..+    +..||||++......   +...+|  .++...+.++..++..    
T Consensus       127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~---e~~~~e--~l~~~~~~~~~~~~~~~~~~  201 (566)
T PLN03225        127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV---EIWMNE--RVRRACPNSCADFVYGFLEP  201 (566)
T ss_pred             CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh---HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence            345678999999999999999999999888    899999997543211   111111  1122222222222221    


Q ss_pred             --EeeCCeEEEEEeccCCCCcccccccc------------------------hHHHHHHHHHHHHHHHHHHhCCceecCC
Q 016959          166 --YDRNGEIEVLLEYMDGGSLEGAHIRQ------------------------EHILSDLARQVLSGLAYLHKRKIVHRDI  219 (380)
Q Consensus       166 --~~~~~~~~lv~e~~~~~~L~~~~~~~------------------------~~~~~~i~~qi~~al~~LH~~~ivH~Dl  219 (380)
                        ...+..+++|+||+.+++|.+++...                        +..+..++.||+.||+|||++||+||||
T Consensus       202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL  281 (566)
T PLN03225        202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV  281 (566)
T ss_pred             cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence              24566899999999999886554321                        2335679999999999999999999999


Q ss_pred             CCCcEEEcC-CCcEEEeeccccccccccC-CCCCCCCCCCccccccccccccCC-----------------CCCCCcchh
Q 016959          220 KPSNLLINS-SKNVKIADFGVSRILAQTM-DPCNSAVGTIAYMSPERINTDLNH-----------------GKYDGYAGD  280 (380)
Q Consensus       220 kp~Nil~~~-~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-----------------~~~~~~~~D  280 (380)
                      ||+|||++. ++.+||+|||+|+.+.... ......++++.|||||.+......                 ...+..++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999985 5789999999998654322 223456789999999976321111                 012334679


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC----------CCC----------CCCccccHHHHHHHHHhcccC
Q 016959          281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA----------QPP----------EAPEMASREFRDFISRCLQKD  340 (380)
Q Consensus       281 vwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~----------~~~----------~~~~~~~~~~~~li~~~l~~d  340 (380)
                      |||||||||||+++..++..    +.......+...          ...          ...+.......|||.+||+.|
T Consensus       362 VwSlGviL~el~~~~~~~~~----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDS----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCch----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            99999999999998776531    111111111000          000          011122345669999999999


Q ss_pred             cCCCCCHHHHhcCccccccCcc
Q 016959          341 PHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       341 p~~R~t~~eil~hp~~~~~~~~  362 (380)
                      |++|||+.|+|+||||++....
T Consensus       438 P~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        438 GRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             cccCCCHHHHhCCcCcCCCCcc
Confidence            9999999999999999987664

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=297.89  Aligned_cols=254  Identities=29%  Similarity=0.445  Sum_probs=198.1

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-----C---CceeeeEeEEe
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-----H---PNVVKCHDMYD  167 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~iv~~~~~~~  167 (380)
                      +...+|.+.++||.|.|++||+|.+..+.+.||+|+++.  .+.+.+....||++|+.++     |   .+||+|++.|.
T Consensus        75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS--AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk  152 (590)
T KOG1290|consen   75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS--AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK  152 (590)
T ss_pred             ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh--hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence            555899999999999999999999999999999999853  3456677889999999983     2   37999999997


Q ss_pred             e----CCeEEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCC-------
Q 016959          168 R----NGEIEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHK-RKIVHRDIKPSNLLINSS-------  229 (380)
Q Consensus       168 ~----~~~~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~Nil~~~~-------  229 (380)
                      .    +.++|+|+|++.. .|..++.      .+-..+++|++||+.||+|||. +||||.||||+|||+..+       
T Consensus       153 hsGpNG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~  231 (590)
T KOG1290|consen  153 HSGPNGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKD  231 (590)
T ss_pred             ecCCCCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhh
Confidence            5    4589999999954 4433333      3567799999999999999997 599999999999998210       


Q ss_pred             --------------------------------------------------------------------------------
Q 016959          230 --------------------------------------------------------------------------------  229 (380)
Q Consensus       230 --------------------------------------------------------------------------------  229 (380)
                                                                                                      
T Consensus       232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~  311 (590)
T KOG1290|consen  232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING  311 (590)
T ss_pred             hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence                                                                                            


Q ss_pred             -------------------------------------------------------------------------------C
Q 016959          230 -------------------------------------------------------------------------------K  230 (380)
Q Consensus       230 -------------------------------------------------------------------------------~  230 (380)
                                                                                                     -
T Consensus       312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di  391 (590)
T KOG1290|consen  312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI  391 (590)
T ss_pred             cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence                                                                                           0


Q ss_pred             cEEEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC------CC
Q 016959          231 NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGR------QG  304 (380)
Q Consensus       231 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~------~~  304 (380)
                      .+||+|||-|.++...   .+..+.|..|+|||++.     |..|+..+||||++|++|||+||.+.|....      .+
T Consensus       392 ~vKIaDlGNACW~~kh---FT~DIQTRQYRapEVll-----GsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE  463 (590)
T KOG1290|consen  392 RVKIADLGNACWVHKH---FTEDIQTRQYRAPEVLL-----GSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDE  463 (590)
T ss_pred             eEEEeeccchhhhhhh---hchhhhhhhccCcceee-----cCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence            2667777777665432   24556899999999995     5778889999999999999999999997433      22


Q ss_pred             CHHHHHHHHhhCCCC--------------------------------------CCCccccHHHHHHHHHhcccCcCCCCC
Q 016959          305 DWASLMFAICFAQPP--------------------------------------EAPEMASREFRDFISRCLQKDPHSRWP  346 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~li~~~l~~dp~~R~t  346 (380)
                      +....+..+....+.                                      .++..-..++.||+.-||+.+|++|+|
T Consensus       464 DHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t  543 (590)
T KOG1290|consen  464 DHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT  543 (590)
T ss_pred             HHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence            333333333322221                                      122234457899999999999999999


Q ss_pred             HHHHhcCccccccC
Q 016959          347 AAQLLQHPFILRAG  360 (380)
Q Consensus       347 ~~eil~hp~~~~~~  360 (380)
                      +.++|+|||+....
T Consensus       544 A~~cl~hPwLn~~~  557 (590)
T KOG1290|consen  544 AAQCLKHPWLNPVA  557 (590)
T ss_pred             HHHHhcCccccCCC
Confidence            99999999998654

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-41  Score=305.71  Aligned_cols=263  Identities=26%  Similarity=0.404  Sum_probs=207.8

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCC------CchHHHHHHHHHHHHHHhCCCCceeeeEeEEe-e
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN------HEDSVRSQICREIEILRDVNHPNVVKCHDMYD-R  168 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~  168 (380)
                      .-.++|.++++||+|||++||++.+....+.||||+-..+      ..+.+.+...+|..+.+.|+||.||++|++|. +
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            3456788999999999999999999999999999986322      23455666789999999999999999999986 5


Q ss_pred             CCeEEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhC--CceecCCCCCcEEEcC---CCcEEEeeccc
Q 016959          169 NGEIEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKR--KIVHRDIKPSNLLINS---SKNVKIADFGV  239 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~--~ivH~Dlkp~Nil~~~---~~~~kl~Dfg~  239 (380)
                      .+.+|-|+|||+|.+|.-++.    ..+...+.|+.||+.||.||...  -|||-||||.|||+..   -|.+||+|||+
T Consensus       540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            567899999999999864443    36788999999999999999987  5999999999999963   35699999999


Q ss_pred             cccccccCC-------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Q 016959          240 SRILAQTMD-------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFA  312 (380)
Q Consensus       240 a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  312 (380)
                      ++.+.+...       ......||.+|++||.+.-.. .....+.++||||+|||+|.++.|+.||..+......-....
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgk-ePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT  698 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGK-EPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT  698 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCC-CCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence            998765433       234567999999999985311 123456799999999999999999999975433211111111


Q ss_pred             HhhCCCC--CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          313 ICFAQPP--EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       313 ~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      +......  +..+.++.++.+||++||.+--++|..+.|+..||||..-
T Consensus       699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence            1111111  2234579999999999999999999999999999999863

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-40  Score=308.98  Aligned_cols=256  Identities=25%  Similarity=0.362  Sum_probs=215.2

Q ss_pred             hccccccCCCcccccccceecccCCceEEEEEeCC----CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeE
Q 016959           88 NHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH  163 (380)
Q Consensus        88 ~~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~  163 (380)
                      ....+...+..+.+...++||.|-||.||.|....    ..--||||+.+.+.+.+..+.|..|..+|+.++|||||+++
T Consensus       378 ~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLI  457 (974)
T KOG4257|consen  378 TPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLI  457 (974)
T ss_pred             CCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhhee
Confidence            34455667788888999999999999999997532    23459999998877777789999999999999999999999


Q ss_pred             eEEeeCCeEEEEEeccCCCCcccccccc-----hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecc
Q 016959          164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFG  238 (380)
Q Consensus       164 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  238 (380)
                      |++.+. ..|+|||++.-|.|..+++..     -..+..++.||+.||.|||++++|||||..+||||.....+||+|||
T Consensus       458 Gv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFG  536 (974)
T KOG4257|consen  458 GVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFG  536 (974)
T ss_pred             eeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccc
Confidence            999875 689999999999998877653     34567799999999999999999999999999999999999999999


Q ss_pred             ccccccccCCCCCC-CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCCHHHHHHHHhhC
Q 016959          239 VSRILAQTMDPCNS-AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFAICFA  316 (380)
Q Consensus       239 ~a~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~  316 (380)
                      +++.+.+......+ ..-...|||||-++     -..++.++|||-|||.+||++ .|..||..-++.|.   +-.+..+
T Consensus       537 LSR~~ed~~yYkaS~~kLPIKWmaPESIN-----fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV---I~~iEnG  608 (974)
T KOG4257|consen  537 LSRYLEDDAYYKASRGKLPIKWMAPESIN-----FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV---IGHIENG  608 (974)
T ss_pred             hhhhccccchhhccccccceeecCccccc-----hhcccchhhHHHHHHHHHHHHHhcCCccccccccce---EEEecCC
Confidence            99988765433222 22357999999985     255678999999999999966 69999987666654   3445567


Q ss_pred             CCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          317 QPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       317 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .+.+.|++|++.+..|+.+||.+||.+||++.|+.+
T Consensus       609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence            788999999999999999999999999999887653

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=310.36  Aligned_cols=250  Identities=22%  Similarity=0.363  Sum_probs=212.9

Q ss_pred             cccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           92 RHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      ..|.....++...++||-|-||.||.|.|+.-.-.||||.++.+.  ...++|..|..+|+.++|||+|+++|+|..+..
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            345567778888899999999999999999999999999996554  346889999999999999999999999999999


Q ss_pred             EEEEEeccCCCCcccccccch------HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHIRQE------HILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~~~~------~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      +|||.|||..|+|.+++....      -.+..++.||..|++||..+++|||||...|+||.++..+||+|||+++.+..
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence            999999999999988877643      23668899999999999999999999999999999999999999999998764


Q ss_pred             cC-CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          246 TM-DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       246 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      .. ....+.--...|.|||-+-     -..++.++|||+|||+|||+.| |-.||..   .+..+....+....+-+.|.
T Consensus       418 DTYTAHAGAKFPIKWTAPEsLA-----yNtFSiKSDVWAFGVLLWEIATYGMsPYPG---idlSqVY~LLEkgyRM~~Pe  489 (1157)
T KOG4278|consen  418 DTYTAHAGAKFPIKWTAPESLA-----YNTFSIKSDVWAFGVLLWEIATYGMSPYPG---IDLSQVYGLLEKGYRMDGPE  489 (1157)
T ss_pred             CceecccCccCcccccCccccc-----ccccccchhhHHHHHHHHHHHhcCCCCCCC---ccHHHHHHHHhccccccCCC
Confidence            32 2333444578999999872     1234679999999999999986 8999974   34455555556667778889


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHh
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLL  351 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil  351 (380)
                      .|++.+.+||..||+.+|.+||+++||-
T Consensus       490 GCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  490 GCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             CCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence            9999999999999999999999999984

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=314.30  Aligned_cols=261  Identities=23%  Similarity=0.364  Sum_probs=220.3

Q ss_pred             cccccCCCcccccccceecccCCceEEEEEeCCC-C--cEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEE
Q 016959           90 QNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPT-S--RVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY  166 (380)
Q Consensus        90 ~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~-~--~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  166 (380)
                      ...+..|..+++.+.++||+|.||.|++|.|... |  -.||||.++..........|.+|+.+|.+|+|+|+++|||+.
T Consensus       101 ~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvV  180 (1039)
T KOG0199|consen  101 IDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVV  180 (1039)
T ss_pred             CCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeee
Confidence            3455668889999999999999999999999743 3  359999998777666788999999999999999999999999


Q ss_pred             eeCCeEEEEEeccCCCCcccccccc------hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccc
Q 016959          167 DRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS  240 (380)
Q Consensus       167 ~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  240 (380)
                      .+ ..+.+|||++..|+|.+.+...      -..+..++.||+.||.||.++++|||||...|||+-....|||||||+.
T Consensus       181 l~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLm  259 (1039)
T KOG0199|consen  181 LD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLM  259 (1039)
T ss_pred             cc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccce
Confidence            87 6789999999999997776652      2457789999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCC---CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhC
Q 016959          241 RILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFA  316 (380)
Q Consensus       241 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  316 (380)
                      +.+....+..   ...--...|.|||.++.     ..++.++|||++||+||||++ |..||....   -..++..+...
T Consensus       260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-----~kFShaSDvWmyGVTiWEMFtyGEePW~G~~---g~qIL~~iD~~  331 (1039)
T KOG0199|consen  260 RALGENEDMYVMAPQRKVPFAWCAPESLRH-----RKFSHASDVWMYGVTIWEMFTYGEEPWVGCR---GIQILKNIDAG  331 (1039)
T ss_pred             eccCCCCcceEecCCCcCcccccCHhHhcc-----ccccccchhhhhhhhHHhhhccCCCCCCCCC---HHHHHHhcccc
Confidence            9887554432   11123468999999863     556778999999999999986 899997443   35566666678


Q ss_pred             CCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          317 QPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       317 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ++.+.++.+++++.+++++||..+|++|||+.+|.+.-+++..
T Consensus       332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea  374 (1039)
T KOG0199|consen  332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA  374 (1039)
T ss_pred             ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence            8889999999999999999999999999999999876666554

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-41  Score=320.39  Aligned_cols=250  Identities=26%  Similarity=0.437  Sum_probs=216.8

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCc---EEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSR---VFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      .|+...+.|.++||.|-||+|++|+.+..|+   .||||.++....+..+..|..|..||-+++||||++|.|+......
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P  704 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP  704 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence            3666677788999999999999999987664   6999999999888899999999999999999999999999999999


Q ss_pred             EEEEEeccCCCCcccccccch-----HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHIRQE-----HILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~~~~-----~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      +.||.|||++|.|..+++..+     .++..+++.|+.|+.||-+.|+|||||...||||+.+..+||+|||+++.+.+.
T Consensus       705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence            999999999999998877654     347789999999999999999999999999999999999999999999988665


Q ss_pred             CCCCCCCC-C--CCccccccccccccCCCCCCCcchhHHHHHHHHHHH-HhCCCCCCCCCCCCHHHHHHHHhhCCCCCCC
Q 016959          247 MDPCNSAV-G--TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF-YLGRFPFAVGRQGDWASLMFAICFAQPPEAP  322 (380)
Q Consensus       247 ~~~~~~~~-g--t~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~el-l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  322 (380)
                      .....+.. |  ..+|.|||.|.     ...++.++||||+||+|||. -.|..||....+.+   .++.+....+.+.|
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa-----~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd---VIkaIe~gyRLPpP  856 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIA-----YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VIKAIEQGYRLPPP  856 (996)
T ss_pred             CCccccccCCccceeecChhHhh-----hcccCchhhccccceEEEEecccCCCcccccchHH---HHHHHHhccCCCCC
Confidence            43332222 2  47999999984     24557799999999999994 57999998555544   55566667777888


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      -.++..+..||..||++|-.+||.+.||+.
T Consensus       857 mDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  857 MDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence            889999999999999999999999999986

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4e-38  Score=305.52  Aligned_cols=264  Identities=20%  Similarity=0.239  Sum_probs=184.8

Q ss_pred             CCCcccccccceecccCCceEEEEEeC----------------CCCcEEEEEEecCCCchHH-------------HHHHH
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHP----------------PTSRVFALKVIYGNHEDSV-------------RSQIC  145 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~----------------~~~~~~avK~~~~~~~~~~-------------~~~~~  145 (380)
                      .+..++|.+.++||+|+||+||+|.+.                ..++.||||.+........             .+...
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence            357889999999999999999999752                2356799999854322111             11233


Q ss_pred             HHHHHHHhCCCCce-----eeeEeEEee--------CCeEEEEEeccCCCCccccccc----------------------
Q 016959          146 REIEILRDVNHPNV-----VKCHDMYDR--------NGEIEVLLEYMDGGSLEGAHIR----------------------  190 (380)
Q Consensus       146 ~E~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~----------------------  190 (380)
                      .|+.++.+++|.++     ++++++|..        .+..++||||+.+++|.+++..                      
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            46667777766544     667777643        3568999999999998655431                      


Q ss_pred             ------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-CCCCCCCCCcccccc
Q 016959          191 ------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-PCNSAVGTIAYMSPE  263 (380)
Q Consensus       191 ------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE  263 (380)
                            ....++.++.||+.+|.|||+++|+||||||+|||++.++.+||+|||++........ ......+++.|+|||
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence                  1234677899999999999999999999999999999999999999999976543221 111233578999999


Q ss_pred             ccccccCCC-----------------CCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCC--------CHHHHHHHH-hhC
Q 016959          264 RINTDLNHG-----------------KYDGYAGDIWSLGVSILEFYLGRF-PFAVGRQG--------DWASLMFAI-CFA  316 (380)
Q Consensus       264 ~~~~~~~~~-----------------~~~~~~~DvwslG~il~ell~g~~-pf~~~~~~--------~~~~~~~~~-~~~  316 (380)
                      .+.......                 .....+.||||+|||+|+|++|.. ||......        ......... ...
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            985321110                 011234799999999999999886 66421100        000000000 011


Q ss_pred             CCCCCCccccHHHHHHHHHhcccCc---CCCCCHHHHhcCccccc
Q 016959          317 QPPEAPEMASREFRDFISRCLQKDP---HSRWPAAQLLQHPFILR  358 (380)
Q Consensus       317 ~~~~~~~~~~~~~~~li~~~l~~dp---~~R~t~~eil~hp~~~~  358 (380)
                      ......+..+...+||+.+||..+|   .+|+|++|+|+||||..
T Consensus       461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            1223345678899999999999876   68999999999999953

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.9e-40  Score=304.44  Aligned_cols=255  Identities=25%  Similarity=0.418  Sum_probs=204.9

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC------CCceeeeEeEEe
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN------HPNVVKCHDMYD  167 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~------h~~iv~~~~~~~  167 (380)
                      ..+-..+|.+....|+|-|++|.+|.+..-|..||||+|..+  +-..+.=..|+++|++|+      --|+++|+..|.
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~  504 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK  504 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence            334456788888999999999999999988999999999544  334455568999999995      248999999999


Q ss_pred             eCCeEEEEEeccCCCCccccccc-------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc-EEEeeccc
Q 016959          168 RNGEIEVLLEYMDGGSLEGAHIR-------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN-VKIADFGV  239 (380)
Q Consensus       168 ~~~~~~lv~e~~~~~~L~~~~~~-------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~-~kl~Dfg~  239 (380)
                      ..+++|||+|-+.. +|...+..       ....++.++.||+.||..|..+||+|.||||+||||++..+ +||||||.
T Consensus       505 hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  505 HKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             hcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence            99999999998753 44433322       23457889999999999999999999999999999996654 99999999


Q ss_pred             cccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC
Q 016959          240 SRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP  319 (380)
Q Consensus       240 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  319 (380)
                      |.......  .+.+.-+..|+|||+|.     |..|....|+||+||+||||+||+..|....++.+..+.......++.
T Consensus       584 A~~~~ene--itPYLVSRFYRaPEIiL-----G~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~  656 (752)
T KOG0670|consen  584 ASFASENE--ITPYLVSRFYRAPEIIL-----GLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN  656 (752)
T ss_pred             cccccccc--ccHHHHHHhccCcceee-----cCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence            97665432  34455678999999995     577788899999999999999999999987777776666555544431


Q ss_pred             C-----------------------------------------------------CCc---cccHHHHHHHHHhcccCcCC
Q 016959          320 E-----------------------------------------------------APE---MASREFRDFISRCLQKDPHS  343 (380)
Q Consensus       320 ~-----------------------------------------------------~~~---~~~~~~~~li~~~l~~dp~~  343 (380)
                      .                                                     ++.   ..-..+++|+.+||..||++
T Consensus       657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K  736 (752)
T KOG0670|consen  657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK  736 (752)
T ss_pred             HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence            1                                                     000   02226899999999999999


Q ss_pred             CCCHHHHhcCccccc
Q 016959          344 RWPAAQLLQHPFILR  358 (380)
Q Consensus       344 R~t~~eil~hp~~~~  358 (380)
                      |.|+.|+|.||||+.
T Consensus       737 Rit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  737 RITVNQALKHPFITE  751 (752)
T ss_pred             cCCHHHHhcCCcccC
Confidence            999999999999975

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.1e-37  Score=277.84  Aligned_cols=238  Identities=39%  Similarity=0.615  Sum_probs=196.2

Q ss_pred             CCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCCCccccccc
Q 016959          111 SGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR  190 (380)
Q Consensus       111 ~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~  190 (380)
                      +||.||+|.+..+++.+|+|++...........+.+|++.+++++|+||+++++++......++++|++.+++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999999889999999986554433367889999999999999999999999998999999999999998766543


Q ss_pred             ----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCCccccccccc
Q 016959          191 ----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN  266 (380)
Q Consensus       191 ----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~  266 (380)
                          ....+..++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||.+....... ......++..|++||.+.
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~  159 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVLL  159 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHHc
Confidence                556788899999999999999999999999999999999999999999998765432 334566889999999885


Q ss_pred             cccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc--ccHHHHHHHHHhcccCcCCC
Q 016959          267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM--ASREFRDFISRCLQKDPHSR  344 (380)
Q Consensus       267 ~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~dp~~R  344 (380)
                           +...+.++|+|+||+++|+|++|..||...  .+...................  ++.++.+++.+||..||++|
T Consensus       160 -----~~~~~~~~Di~slG~~l~~l~~~~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R  232 (244)
T smart00220      160 -----GKGYGKAVDVWSLGVILYELLTGKPPFPGD--DQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR  232 (244)
T ss_pred             -----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence                 244566999999999999999999999642  222233333222222222222  78899999999999999999


Q ss_pred             CCHHHHhcCccc
Q 016959          345 WPAAQLLQHPFI  356 (380)
Q Consensus       345 ~t~~eil~hp~~  356 (380)
                      |++.++++||||
T Consensus       233 p~~~~~~~~~~~  244 (244)
T smart00220      233 LTAEEALQHPFF  244 (244)
T ss_pred             cCHHHHhhCCCC
Confidence            999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=279.54  Aligned_cols=256  Identities=30%  Similarity=0.453  Sum_probs=199.9

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC-----CeEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN-----GEIE  173 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~  173 (380)
                      +++..+-||.|+||.||.+.+..+|+.||+|++..-. .-...+++.+|+++|+-++|.|++..+++....     ..+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            4566678999999999999999999999999984322 222346788999999999999999999876543     2467


Q ss_pred             EEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-C
Q 016959          174 VLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM-D  248 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~  248 (380)
                      ++.|++.. +|...+..    ....+.-+++||++||+|||+.||.||||||.|+|++.+..+||||||+|+...... .
T Consensus       134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence            78888864 55554433    334567789999999999999999999999999999999999999999998765432 2


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC----------
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP----------  318 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----------  318 (380)
                      ..+..+-|.+|+|||++.+    ...|+...||||+|||+.||+..+..|.........+++.++.....          
T Consensus       213 hMTqEVVTQYYRAPEiLMG----aRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  213 NMTHEVVTQYYRAPELLMG----ARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhHHHHHHHHhccHHHhhc----chhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            2344567899999999875    36678899999999999999999999986555544444443322111          


Q ss_pred             ------------CC--------CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          319 ------------PE--------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       319 ------------~~--------~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                                  +.        .+..-..+..+++.++|..||++|.+.++++.|+++.+..
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence                        00        1112334788999999999999999999999999998753

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=260.17  Aligned_cols=205  Identities=31%  Similarity=0.543  Sum_probs=175.7

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeE
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  172 (380)
                      ..+..+++..+..||+|+||.|-+.++..+|...|+|.+...-......++.+|+.+..+. .+|++|.|||.+.+++..
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            5567788888999999999999999999999999999998777667778888999886665 699999999999999999


Q ss_pred             EEEEeccCCCCcccc--------cccchHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          173 EVLLEYMDGGSLEGA--------HIRQEHILSDLARQVLSGLAYLHKR-KIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~--------~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                      ++.||.|+. +|..+        ..-+|..+-+|+..++.||.|||++ .|+|||+||.||||+.+|++|+||||++..+
T Consensus       121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence            999999974 44322        2336777889999999999999987 8999999999999999999999999999887


Q ss_pred             cccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 016959          244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVG  301 (380)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  301 (380)
                      .++... +-..|...|||||.++.+... ..|+.++||||||+++.||.+++.||...
T Consensus       200 ~dSiAk-t~daGCkpYmaPEri~~e~n~-~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  200 VDSIAK-TMDAGCKPYMAPERINPELNQ-KGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             hhhhHH-HHhcCCCccCChhhcCcccCc-ccceeehhhhhhhhhhhhhhhcccccccc
Confidence            665432 224588999999999876554 36788999999999999999999999743

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-39  Score=281.92  Aligned_cols=253  Identities=28%  Similarity=0.389  Sum_probs=198.0

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC------
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN------  169 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------  169 (380)
                      ...+|.-.+-+|.|.- .|..+-+..+++.||+|.+.... .....++..+|..+++.++|+||++++.+|...      
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            3457888888999999 88888898899999999985432 233346677999999999999999999998643      


Q ss_pred             CeEEEEEeccCCCCcccc--cccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          170 GEIEVLLEYMDGGSLEGA--HIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      ...|+|||++.. +|...  +...-..+..|..|+++|+.|||+.||+||||||+||++..++.+||+|||+|+..... 
T Consensus        94 ~e~y~v~e~m~~-nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-  171 (369)
T KOG0665|consen   94 QEVYLVMELMDA-NLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-  171 (369)
T ss_pred             HhHHHHHHhhhh-HHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc-
Confidence            358999999975 44433  33345668889999999999999999999999999999999999999999999876544 


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC--------
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP--------  319 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--------  319 (380)
                      -..+..+.|..|+|||++.+     ..+...+||||+||++.||++|...|.....-+....+........+        
T Consensus       172 ~~mtpyVvtRyyrapevil~-----~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  172 FMMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             cccCchhheeeccCchheec-----cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence            24467789999999999964     33678899999999999999999999743333222221111110000        


Q ss_pred             ------------------------------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 016959          320 ------------------------------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFIL  357 (380)
Q Consensus       320 ------------------------------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~  357 (380)
                                                    +....-...++||+.+||..||++|.+++++|.||||+
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                                          01112234689999999999999999999999999998

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-39  Score=309.99  Aligned_cols=242  Identities=32%  Similarity=0.435  Sum_probs=187.4

Q ss_pred             ccccceecccCCce-EEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEEEEec
Q 016959          101 LQKGNRIGSGSGGT-VWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       101 ~~~~~~LG~G~~g~-V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      |.-.+.+|.|+-|+ ||+|..  .||.||||++-    .+......+|+..|+..+ |||||++++.-.+....||..|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLL----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHh----hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            34456799999995 799998  89999999973    233456779999999995 99999999998999999999999


Q ss_pred             cCCCCcccccccc--h------HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CC--cEEEeeccccccccc
Q 016959          179 MDGGSLEGAHIRQ--E------HILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS---SK--NVKIADFGVSRILAQ  245 (380)
Q Consensus       179 ~~~~~L~~~~~~~--~------~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~---~~--~~kl~Dfg~a~~~~~  245 (380)
                      |.. +|.+++...  +      ...+.++.|++.||++||+.+||||||||.||||+.   ++  .++|+|||+++.+..
T Consensus       585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~  663 (903)
T KOG1027|consen  585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG  663 (903)
T ss_pred             hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence            975 666555542  1      234678999999999999999999999999999985   33  599999999998865


Q ss_pred             cCC---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCHHHHHHHHhhCCCC--
Q 016959          246 TMD---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLG-RFPFAVGRQGDWASLMFAICFAQPP--  319 (380)
Q Consensus       246 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~--  319 (380)
                      ...   ...+..||-+|+|||++...     ....++||||||||+|+.++| ..||....     +...++......  
T Consensus       664 ~~sS~~r~s~~sGt~GW~APE~L~~~-----~~~~avDiFslGCvfyYvltgG~HpFGd~~-----~R~~NIl~~~~~L~  733 (903)
T KOG1027|consen  664 GKSSFSRLSGGSGTSGWQAPEQLRED-----RKTQAVDIFSLGCVFYYVLTGGSHPFGDSL-----ERQANILTGNYTLV  733 (903)
T ss_pred             CcchhhcccCCCCcccccCHHHHhcc-----ccCcccchhhcCceEEEEecCCccCCCchH-----HhhhhhhcCcccee
Confidence            432   34567799999999999753     234479999999999998875 99996322     222222211111  


Q ss_pred             CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       320 ~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      .+.+....++.|||.+|++.||..||++.++|.||||=..
T Consensus       734 ~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  734 HLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             eeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            1111112289999999999999999999999999999543

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-37  Score=308.24  Aligned_cols=257  Identities=26%  Similarity=0.413  Sum_probs=213.8

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCC-------CCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEe
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPP-------TSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHD  164 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~  164 (380)
                      .+.+..+.+.+.+.||.|.||.|++|....       ....||||.++........+.+..|+++|+.+ .|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            667788888888999999999999997431       14579999998777777788999999999999 5999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCccccccc--------------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 016959          165 MYDRNGEIEVLLEYMDGGSLEGAHIR--------------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNL  224 (380)
Q Consensus       165 ~~~~~~~~~lv~e~~~~~~L~~~~~~--------------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Ni  224 (380)
                      ++...+.+++|+|||..|+|..++..                    ....+..++.||+.|++||++..+|||||..+||
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV  449 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV  449 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence            99999999999999999998655433                    2345788999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccccCCCC-CCCC--CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 016959          225 LINSSKNVKIADFGVSRILAQTMDPC-NSAV--GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAV  300 (380)
Q Consensus       225 l~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~--gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~  300 (380)
                      |+..+..+||+|||+|+......... ....  -...|||||.+..     ..++.++||||+||+||||++ |..||..
T Consensus       450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-----~~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-----RVFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-----CcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            99999999999999998654432221 1122  2457999999853     567889999999999999886 9999964


Q ss_pred             CCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 016959          301 GRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR  358 (380)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~  358 (380)
                      ..  ........+..+.+...|..++.++.++|+.||+.+|++||++.|+.+  +|..
T Consensus       525 ~~--~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~--~~~~  578 (609)
T KOG0200|consen  525 IP--PTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE--FFEK  578 (609)
T ss_pred             CC--cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH--HHHH
Confidence            22  133445567777888999999999999999999999999999999987  6666

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.9e-36  Score=320.42  Aligned_cols=239  Identities=20%  Similarity=0.294  Sum_probs=184.2

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEecc
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYM  179 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  179 (380)
                      .+...+.||+|+||.||+|++..+++.||||++......     ...|++.+++++|||||++++++.+.+..++||||+
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            355667899999999999999889999999998543321     124688899999999999999999999999999999


Q ss_pred             CCCCccccccc-chHHHHHHHHHHHHHHHHHH---hCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCC
Q 016959          180 DGGSLEGAHIR-QEHILSDLARQVLSGLAYLH---KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG  255 (380)
Q Consensus       180 ~~~~L~~~~~~-~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~g  255 (380)
                      ++++|.+++.. .+..+..++.||+.||+|||   +.+|+||||||+||+++.++..++. ||.+......    ....|
T Consensus       766 ~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~  840 (968)
T PLN00113        766 EGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFI  840 (968)
T ss_pred             CCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----CCccc
Confidence            99999877654 56778899999999999999   6799999999999999988888775 6655433221    23468


Q ss_pred             CCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--CCHHHHHHHHhh------CCCC------CC
Q 016959          256 TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ--GDWASLMFAICF------AQPP------EA  321 (380)
Q Consensus       256 t~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~------~~~~------~~  321 (380)
                      |..|||||++.     +..++.++|||||||++|||++|+.||.....  ............      ...+      ..
T Consensus       841 t~~y~aPE~~~-----~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  915 (968)
T PLN00113        841 SSAYVAPETRE-----TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV  915 (968)
T ss_pred             cccccCccccc-----CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence            89999999975     35567899999999999999999999953221  111111110000      0001      11


Q ss_pred             CccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ......++.+++.+||+.||++|||+.|+++.
T Consensus       916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        916 NQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            11223467899999999999999999999973

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-37  Score=279.02  Aligned_cols=248  Identities=25%  Similarity=0.347  Sum_probs=190.5

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC--CCCceeeeEeEEeeCC---
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV--NHPNVVKCHDMYDRNG---  170 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~~---  170 (380)
                      .+...+++.+.||+|.||.||+|..  +++.||||++.    ...+..+.+|.++....  +|+||++|++.-+...   
T Consensus       207 ~~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  207 LELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFP----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR  280 (534)
T ss_pred             ccCCchhhHHHhhcCccceeehhhc--cCceeEEEecC----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence            3455677888999999999999998  67999999983    33456678888887764  7999999999866554   


Q ss_pred             -eEEEEEeccCCCCccccccc---chHHHHHHHHHHHHHHHHHHh---------CCceecCCCCCcEEEcCCCcEEEeec
Q 016959          171 -EIEVLLEYMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHK---------RKIVHRDIKPSNLLINSSKNVKIADF  237 (380)
Q Consensus       171 -~~~lv~e~~~~~~L~~~~~~---~~~~~~~i~~qi~~al~~LH~---------~~ivH~Dlkp~Nil~~~~~~~kl~Df  237 (380)
                       .+++|++|.+.|+|.+++..   +.....+|+..|++||+|||+         -.|+|||||..||||..|+++.|+||
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence             89999999999999988776   577788999999999999996         25999999999999999999999999


Q ss_pred             cccccccccCC--CCCCCCCCCccccccccccccCCCCCC-CcchhHHHHHHHHHHHHhCCCCC------------C--C
Q 016959          238 GVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYD-GYAGDIWSLGVSILEFYLGRFPF------------A--V  300 (380)
Q Consensus       238 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DvwslG~il~ell~g~~pf------------~--~  300 (380)
                      |+|..+.....  .....+||.+|||||++.+..+..... -.+.||||+|.|||||++...-+            .  .
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV  440 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence            99998864432  234578999999999997655444222 23789999999999998654333            2  1


Q ss_pred             CCCCCHHHHHHH-HhhCCCCCCCcc-----ccHHHHHHHHHhcccCcCCCCCHHH
Q 016959          301 GRQGDWASLMFA-ICFAQPPEAPEM-----ASREFRDFISRCLQKDPHSRWPAAQ  349 (380)
Q Consensus       301 ~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~li~~~l~~dp~~R~t~~e  349 (380)
                      +....+.++... .....++.+++.     .-.-+++.++.||+.|++-|+|+.=
T Consensus       441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C  495 (534)
T KOG3653|consen  441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC  495 (534)
T ss_pred             cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence            222223333222 223334444332     2346889999999999999999753

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=293.93  Aligned_cols=263  Identities=32%  Similarity=0.479  Sum_probs=216.4

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ..++|+...++|.|+||.||+++++.+++..|+|+++....+. ..-+..|+-+++.++|+|||.++|-|.....+|++|
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            4578999999999999999999999999999999998776554 356778999999999999999999999999999999


Q ss_pred             eccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          177 EYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       177 e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      |||.||+|++....    .+.++..++++.++|++|||+.|-+|||||-.|||+++.|.+|++|||.+..+........+
T Consensus        92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks  171 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS  171 (829)
T ss_pred             EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence            99999999877554    56678888999999999999999999999999999999999999999999888776666788


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh-CCCCCC--CccccHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF-AQPPEA--PEMASREF  329 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~  329 (380)
                      +.||++|||||+-.-  .....|...+|+|++|++..|+---+.|-..  ...+......-.. ..++.+  +..-++.+
T Consensus       172 fiGtpywmapEvaav--erkggynqlcdiwa~gitAiel~eLqpplfd--lhpmr~l~LmTkS~~qpp~lkDk~kws~~f  247 (829)
T KOG0576|consen  172 FIGTPYWMAPEVAAV--ERKGGYNQLCDIWALGITAIELGELQPPLFD--LHPMRALFLMTKSGFQPPTLKDKTKWSEFF  247 (829)
T ss_pred             ccCCccccchhHHHH--HhcccccccccccccccchhhhhhcCCcccc--cchHHHHHHhhccCCCCCcccCCccchHHH
Confidence            999999999999753  2334567789999999999999876766531  2222222211111 122222  23356788


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                      -+|++.+|.++|++|||++.+|.|||+..--....
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~l~~rl  282 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRL  282 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccchhhHH
Confidence            99999999999999999999999999987644333

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-36  Score=270.60  Aligned_cols=249  Identities=26%  Similarity=0.443  Sum_probs=190.5

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHh--CCCCceeeeEeEEeeC----Ce
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRD--VNHPNVVKCHDMYDRN----GE  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~----~~  171 (380)
                      ..++.+.+.||+|.||+||+|.+  -|..||||++....+.    .+.+|.++.+.  |+|+||+.|++.-..+    .+
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~----SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDER----SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hheeEEEEEecCccccceeeccc--cCCceEEEEecccchh----hhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            45678889999999999999999  6789999999655433    35577777775  4899999999764322    26


Q ss_pred             EEEEEeccCCCCcccccccc---hHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEcCCCcEEEeecccc
Q 016959          172 IEVLLEYMDGGSLEGAHIRQ---EHILSDLARQVLSGLAYLHKR--------KIVHRDIKPSNLLINSSKNVKIADFGVS  240 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~~~---~~~~~~i~~qi~~al~~LH~~--------~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  240 (380)
                      +|+|.+|.+.|+|++++...   -+...+++..++.||++||..        .|.|||||..||||.++|.+-|+|+|+|
T Consensus       284 LwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             EEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            99999999999999998763   455678999999999999952        4999999999999999999999999999


Q ss_pred             ccccccCC----CCCCCCCCCccccccccccccCCCCCCCc-chhHHHHHHHHHHHHh----------CCCCCCC--CCC
Q 016959          241 RILAQTMD----PCNSAVGTIAYMSPERINTDLNHGKYDGY-AGDIWSLGVSILEFYL----------GRFPFAV--GRQ  303 (380)
Q Consensus       241 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~DvwslG~il~ell~----------g~~pf~~--~~~  303 (380)
                      .......+    ..+..+||.+|||||++.......-+.++ .+||||||.|+||++.          -+.||..  ...
T Consensus       364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D  443 (513)
T KOG2052|consen  364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD  443 (513)
T ss_pred             EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence            87654322    34678899999999999876655555554 5899999999999974          2567752  233


Q ss_pred             CCHHHHHHHHhhCCC-CC---CCcc--ccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          304 GDWASLMFAICFAQP-PE---APEM--ASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       304 ~~~~~~~~~~~~~~~-~~---~~~~--~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..+.++...++.... +.   .|..  +=..+..+|+.||..||.-|.|+--|.+
T Consensus       444 Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  444 PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            334444444443222 22   2221  1225678999999999999999877754

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-36  Score=289.48  Aligned_cols=244  Identities=24%  Similarity=0.388  Sum_probs=204.6

Q ss_pred             cccccceecccCCceEEEEEeCCCCc----EEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSR----VFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      +....++||.|+||+||+|.+...|+    .||+|++..........++.+|+-+|.+++|||++++++++.... +.||
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            45567889999999999999876554    589999877666666778999999999999999999999987654 7899


Q ss_pred             EeccCCCCcccccccc-----hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          176 LEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       176 ~e~~~~~~L~~~~~~~-----~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      ++|+++|.|.++.+..     ......|..||++||.|||.++++||||..+||||..-.++||.|||+|+.+.......
T Consensus       776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence            9999999998776652     34577899999999999999999999999999999999999999999999887655433


Q ss_pred             CCCC--CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          251 NSAV--GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       251 ~~~~--gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                      ....  -.+.|||-|.+..     ..++.++|||||||++||++| |..||......   ++-..+..+.+...|+.++-
T Consensus       856 ~~~~gK~pikwmale~i~~-----~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~---eI~dlle~geRLsqPpiCti  927 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRI-----RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE---EIPDLLEKGERLSQPPICTI  927 (1177)
T ss_pred             cccccccCcHHHHHHHhhc-----cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH---HhhHHHhccccCCCCCCccH
Confidence            3332  3578999999853     566789999999999999886 99999754443   44444555677888999999


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ++.-+|.+||..|++.||+++++.+
T Consensus       928 DVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  928 DVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHHHhccCcccCccHHHHHH
Confidence            9999999999999999999998764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.7e-35  Score=267.74  Aligned_cols=259  Identities=27%  Similarity=0.452  Sum_probs=199.1

Q ss_pred             cccccccceecccCCceEEEEEeCC---CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPP---TSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  173 (380)
                      ...|...++||.|+|++||++.+..   .++.||+|.+.....   ..++.+|+++|..+. +.||+++.+++..++...
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS---PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC---chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            4568889999999999999999887   788999999865443   345889999999995 999999999999999999


Q ss_pred             EEEeccCCCCccccccc-chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCcEEEeeccccccccccC----
Q 016959          174 VLLEYMDGGSLEGAHIR-QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN-SSKNVKIADFGVSRILAQTM----  247 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~~-~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~----  247 (380)
                      +|+||++.....++... .-..++.+++.++.||.++|.+|||||||||.|+|.+ ..+.-.|+|||+|.......    
T Consensus       112 ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~  191 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEH  191 (418)
T ss_pred             EEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhh
Confidence            99999998776554333 4677889999999999999999999999999999998 56779999999997221000    


Q ss_pred             ---------C-------------------------------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHH
Q 016959          248 ---------D-------------------------------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVS  287 (380)
Q Consensus       248 ---------~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~i  287 (380)
                               .                               ......||++|+|||++..    ....+.++||||.|+|
T Consensus       192 s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k----~~~QttaiDiws~GVI  267 (418)
T KOG1167|consen  192 SRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR----CPRQTTAIDIWSAGVI  267 (418)
T ss_pred             hhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh----ccCcCCccceeeccce
Confidence                     0                               0112469999999999853    2345668999999999


Q ss_pred             HHHHHhCCCCCCCCCCC--CHHHH---------------------------------HHH-------HhhC------CCC
Q 016959          288 ILEFYLGRFPFAVGRQG--DWASL---------------------------------MFA-------ICFA------QPP  319 (380)
Q Consensus       288 l~ell~g~~pf~~~~~~--~~~~~---------------------------------~~~-------~~~~------~~~  319 (380)
                      +..++++++||.....+  ...++                                 ...       .+..      ...
T Consensus       268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~  347 (418)
T KOG1167|consen  268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE  347 (418)
T ss_pred             eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence            99999999999632211  00000                                 000       0000      001


Q ss_pred             CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       320 ~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                      ...+..+..+.||+.+||..||.+|.|++|+|.||||.......
T Consensus       348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~~  391 (418)
T KOG1167|consen  348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRTE  391 (418)
T ss_pred             cccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhhh
Confidence            11223455889999999999999999999999999999765433

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=276.59  Aligned_cols=196  Identities=29%  Similarity=0.451  Sum_probs=168.2

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHH-----HHHHHHHHHHHHhCC---CCceeeeEeEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSV-----RSQICREIEILRDVN---HPNVVKCHDMYD  167 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~-----~~~~~~E~~~l~~l~---h~~iv~~~~~~~  167 (380)
                      ..+|...+.||.|+||.|++|.++.+...|+||.+.++.  .+.+     .-.+..||++|..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            356888999999999999999999999999999997653  1111     224667999999997   999999999999


Q ss_pred             eCCeEEEEEeccC-CCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 016959          168 RNGEIEVLLEYMD-GGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI  242 (380)
Q Consensus       168 ~~~~~~lv~e~~~-~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  242 (380)
                      +++.+|++||-.. |.+|++++.+    .|....-|++||+.|+++||+.||||||||-+||.++.+|.+||+|||.|..
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~  719 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY  719 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence            9999999999764 5678877665    4677888999999999999999999999999999999999999999999875


Q ss_pred             ccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 016959          243 LAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFA  299 (380)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~  299 (380)
                      ...  .....++||..|.|||++.+.    +|.+..-|||+||++||.++....||.
T Consensus       720 ~ks--gpfd~f~gtv~~aapevl~g~----~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  720 TKS--GPFDVFVGTVDYAAPEVLGGE----KYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hcC--CCcceeeeeccccchhhhCCC----ccCCCcchhhhhhheeeEEEeccCCCc
Confidence            543  334678999999999999765    444556899999999999999999985

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-34  Score=254.55  Aligned_cols=251  Identities=20%  Similarity=0.265  Sum_probs=207.8

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCC-----cEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEe-
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTS-----RVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYD-  167 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-  167 (380)
                      ..+...+++...++.+|.||.||+|.+++.+     +.|-+|.++....+-....+..|--++..+.|||+..+.++.. 
T Consensus       279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie  358 (563)
T KOG1024|consen  279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE  358 (563)
T ss_pred             hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence            3466778888999999999999999886543     4477788876666666778888998899999999999999864 


Q ss_pred             eCCeEEEEEeccCCCCccccccc------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEe
Q 016959          168 RNGEIEVLLEYMDGGSLEGAHIR------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIA  235 (380)
Q Consensus       168 ~~~~~~lv~e~~~~~~L~~~~~~------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~  235 (380)
                      +....++++.+..-|+|..++..            ...++..++.|++.|++|||+.||||.||..+|++||+..++||+
T Consensus       359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt  438 (563)
T KOG1024|consen  359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT  438 (563)
T ss_pred             ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence            45567788888888888776652            234577899999999999999999999999999999999999999


Q ss_pred             eccccccccccCCCC--CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHH
Q 016959          236 DFGVSRILAQTMDPC--NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFA  312 (380)
Q Consensus       236 Dfg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~  312 (380)
                      |=.+++.+-+....+  ........||++|.+.+     ..++..+|+||||++||||+| |+.||.   .-|..++..-
T Consensus       439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-----~~yssasDvWsfGVllWELmtlg~~Pya---eIDPfEm~~y  510 (563)
T KOG1024|consen  439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-----SHYSSASDVWSFGVLLWELMTLGKLPYA---EIDPFEMEHY  510 (563)
T ss_pred             cchhccccCcccccccCCCCCCcccccCHHHHhh-----hhhcchhhhHHHHHHHHHHHhcCCCCcc---ccCHHHHHHH
Confidence            999998775543322  22335679999999854     667889999999999999886 999997   4556666666


Q ss_pred             HhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          313 ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      +..+.+...|-+++.++..+|.-||..+|++||+++|+..
T Consensus       511 lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  511 LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            7777888899999999999999999999999999999763

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=8.7e-33  Score=240.42  Aligned_cols=209  Identities=39%  Similarity=0.672  Sum_probs=181.6

Q ss_pred             ecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCCCccc
Q 016959          107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG  186 (380)
Q Consensus       107 LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  186 (380)
                      ||.|.+|.||++....+++.+++|++...........+.+|+..++.+.|++|+++++++......++++|++.+++|..
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999888999999999665543345678899999999999999999999999899999999999999876


Q ss_pred             ccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCcEEEeeccccccccccCCCCCCCCCCCccc
Q 016959          187 AHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS-SKNVKIADFGVSRILAQTMDPCNSAVGTIAYM  260 (380)
Q Consensus       187 ~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~  260 (380)
                      ++.     .....+..++.+++.++.+||++|++|+||+|.||+++. ++.++|+|||.+..............+...|+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  160 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYM  160 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCcc
Confidence            653     356678899999999999999999999999999999998 89999999999987654432234456889999


Q ss_pred             cccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccC
Q 016959          261 SPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKD  340 (380)
Q Consensus       261 aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  340 (380)
                      +||.+...    ...+.++|+|+||+++++|                                   ..+.+++.+||+.|
T Consensus       161 ~pe~~~~~----~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~~  201 (215)
T cd00180         161 APEVLLGK----GYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQKD  201 (215)
T ss_pred             ChhHhccc----CCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhCC
Confidence            99998531    2556789999999999998                                   58899999999999


Q ss_pred             cCCCCCHHHHhcCc
Q 016959          341 PHSRWPAAQLLQHP  354 (380)
Q Consensus       341 p~~R~t~~eil~hp  354 (380)
                      |++||++.++++|+
T Consensus       202 p~~R~~~~~l~~~~  215 (215)
T cd00180         202 PEKRPSAKEILEHL  215 (215)
T ss_pred             cccCcCHHHHhhCC
Confidence            99999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-35  Score=248.84  Aligned_cols=256  Identities=20%  Similarity=0.317  Sum_probs=195.5

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeE-EeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDM-YDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~-~~~~~~~~lv~  176 (380)
                      +.|.+.+.||+|.||++.+|+++.++..+++|.+....  .....|.+|...--.|. |.||+.-|++ |+..+.+.+++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            56899999999999999999999999999999985543  34577888887655564 8999998875 77888999999


Q ss_pred             eccCCCCccccccc---chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc--CCCcEEEeeccccccccccCCCCC
Q 016959          177 EYMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN--SSKNVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       177 e~~~~~~L~~~~~~---~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~--~~~~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      ||++.|+|......   .|..-..++.|+++|++|+|++++||||||.+||||-  +.-++||||||+.+..+....   
T Consensus       102 E~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~---  178 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK---  178 (378)
T ss_pred             ccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh---
Confidence            99999999766554   3556678999999999999999999999999999995  334699999999876554332   


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC--HHHHHHHHhhC--CCCCCCccccH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD--WASLMFAICFA--QPPEAPEMASR  327 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~  327 (380)
                      ...-+..|-+||.............+.+|+|.||+|+|.++||..||..+...+  ..+.+......  ..+.....+++
T Consensus       179 ~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~  258 (378)
T KOG1345|consen  179 YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSE  258 (378)
T ss_pred             hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCH
Confidence            222456788999886533222233567999999999999999999998443332  12222221111  12233345788


Q ss_pred             HHHHHHHHhcccCcCCC---CCHHHHhcCcccccc
Q 016959          328 EFRDFISRCLQKDPHSR---WPAAQLLQHPFILRA  359 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R---~t~~eil~hp~~~~~  359 (380)
                      .+..+.++-|..++++|   .++......-|....
T Consensus       259 ~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~  293 (378)
T KOG1345|consen  259 KALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL  293 (378)
T ss_pred             HHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence            99999999999999999   777777777776554

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.2e-30  Score=230.21  Aligned_cols=195  Identities=35%  Similarity=0.588  Sum_probs=166.3

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccC
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMD  180 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  180 (380)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+...........+.+|++.+++++|+|++++++++......++++|++.
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            45678899999999999999888999999998655433346788899999999999999999999998899999999999


Q ss_pred             CCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-CCCCCCC
Q 016959          181 GGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM-DPCNSAV  254 (380)
Q Consensus       181 ~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~  254 (380)
                      +++|.+++.     ..+..+..++.+++.++.+||+++++|+||++.||+++.++.++|+|||++....... .......
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  160 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK  160 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence            989876643     3556688899999999999999999999999999999999999999999988765432 1223456


Q ss_pred             CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 016959          255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFA  299 (380)
Q Consensus       255 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~  299 (380)
                      ++..|++||.+.    ....++.++|+|+||+++++|++|+.||.
T Consensus       161 ~~~~~~~pe~~~----~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      161 GTPFYLAPEVLL----GGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             ccCCcCCHhHhc----CCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            788999999873    23445568999999999999999999995

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=6.5e-32  Score=280.43  Aligned_cols=196  Identities=21%  Similarity=0.175  Sum_probs=138.1

Q ss_pred             hCCC-CceeeeEeEE-------eeCCeEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCC
Q 016959          153 DVNH-PNVVKCHDMY-------DRNGEIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDI  219 (380)
Q Consensus       153 ~l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dl  219 (380)
                      .+.| .||++++++|       ...+.+++++|++ +++|.+++.     ..+..+..++.||+.||+|||++||+||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            3344 5777777766       2234577788887 458876664     345678899999999999999999999999


Q ss_pred             CCCcEEEcCC-------------------CcEEEeeccccccccccC----------------CCCCCCCCCCccccccc
Q 016959          220 KPSNLLINSS-------------------KNVKIADFGVSRILAQTM----------------DPCNSAVGTIAYMSPER  264 (380)
Q Consensus       220 kp~Nil~~~~-------------------~~~kl~Dfg~a~~~~~~~----------------~~~~~~~gt~~y~aPE~  264 (380)
                      ||+||||+..                   +.+|++|||+++......                ......+||+.|||||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            9999999654                   445666666665321100                00112468999999999


Q ss_pred             cccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCC
Q 016959          265 INTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR  344 (380)
Q Consensus       265 ~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  344 (380)
                      +..     ..++.++||||||||||||++|..|+...     ...+........+...........+++.+||+.||.+|
T Consensus       187 ~~~-----~~~~~~sDVwSlGviL~ELl~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~R  256 (793)
T PLN00181        187 DNG-----SSSNCASDVYRLGVLLFELFCPVSSREEK-----SRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCR  256 (793)
T ss_pred             hcc-----CCCCchhhhhhHHHHHHHHhhCCCchhhH-----HHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhC
Confidence            853     45678999999999999999998887421     11111111111111111224567799999999999999


Q ss_pred             CCHHHHhcCcccccc
Q 016959          345 WPAAQLLQHPFILRA  359 (380)
Q Consensus       345 ~t~~eil~hp~~~~~  359 (380)
                      |++.|+|+||||...
T Consensus       257 ps~~eil~h~~~~~~  271 (793)
T PLN00181        257 PSMSELLQSEFINEP  271 (793)
T ss_pred             cChHHHhhchhhhhh
Confidence            999999999999874

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=4.4e-31  Score=261.68  Aligned_cols=257  Identities=28%  Similarity=0.415  Sum_probs=199.7

Q ss_pred             cccceecccCCceEEEEEeCCCCcEEEEEEec----C-CCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959          102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIY----G-NHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus       102 ~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~----~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      .....+|.|.+|.|+.+......+.++.|..+    . .........+..|+-+-..+.|+|++..+..+.+...+.-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            35678999999988888877666666666543    2 222233333777888888899999998888777766666679


Q ss_pred             eccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC----C
Q 016959          177 EYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM----D  248 (380)
Q Consensus       177 e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~  248 (380)
                      |||++ +|...+..    ....+..++.|++.||.|||+.||.|||||++|++++.+|.+||+|||.+..+.-..    .
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~  479 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH  479 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence            99999 88766554    344567899999999999999999999999999999999999999999988664332    2


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHH-HHH----HHhhCCCCCCCc
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWAS-LMF----AICFAQPPEAPE  323 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~----~~~~~~~~~~~~  323 (380)
                      ...+.+|+..|+|||++..    ..|+.+..||||.|++++.|++|+.||......+... ...    ......+.....
T Consensus       480 ~~~g~~gS~pY~apE~~~~----~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~  555 (601)
T KOG0590|consen  480 ESSGIVGSDPYLAPEVLTG----KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS  555 (601)
T ss_pred             hhcCcccCCcCcCcccccc----cccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence            3467889999999999865    4677788999999999999999999998766554321 100    011111223445


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                      .++.+.+.+|.+||+.||.+|.|+++|++.+||+...-..
T Consensus       556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~  595 (601)
T KOG0590|consen  556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCH  595 (601)
T ss_pred             hchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEE
Confidence            5788999999999999999999999999999999876543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.3e-31  Score=249.12  Aligned_cols=253  Identities=28%  Similarity=0.422  Sum_probs=205.8

Q ss_pred             eecccCCceEEEEEe---CCCCcEEEEEEecCCCchH-HHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEEEEeccC
Q 016959          106 RIGSGSGGTVWRVVH---PPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEVLLEYMD  180 (380)
Q Consensus       106 ~LG~G~~g~V~~~~~---~~~~~~~avK~~~~~~~~~-~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~  180 (380)
                      .+|+|+||.|+++..   ...|..||+|+.++..... .+..-..|..++..++ |+.+|++...|+.+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998753   3467889999986553211 1114456778888886 9999999999999999999999999


Q ss_pred             CCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCC
Q 016959          181 GGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT  256 (380)
Q Consensus       181 ~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  256 (380)
                      ||+|......    .+.....+...++.+++++|+.||+|||+|++||+++.+|++++.|||+.+........    |||
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----cgt  156 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----CGT  156 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----ccc
Confidence            9988655444    35556778899999999999999999999999999999999999999999876544322    899


Q ss_pred             CccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHh
Q 016959          257 IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC  336 (380)
Q Consensus       257 ~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  336 (380)
                      ..|||||+++       ......|.||+|++++||++|..||..    +....+    .......+..++.++++++..+
T Consensus       157 ~eymApEI~~-------gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I----l~~~~~~p~~l~~~a~~~~~~l  221 (612)
T KOG0603|consen  157 YEYRAPEIIN-------GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI----LKAELEMPRELSAEARSLFRQL  221 (612)
T ss_pred             hhhhhhHhhh-------ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH----hhhccCCchhhhHHHHHHHHHH
Confidence            9999999985       234579999999999999999999963    222222    2334566778889999999999


Q ss_pred             cccCcCCCCC-----HHHHhcCccccccCcccccccccccCCCCCCCC
Q 016959          337 LQKDPHSRWP-----AAQLLQHPFILRAGQSQVNQNLRQILPPPRPLS  379 (380)
Q Consensus       337 l~~dp~~R~t-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~  379 (380)
                      +..+|.+|..     +.|+++|+||+.+.+.....  +++-|++||-+
T Consensus       222 ~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~--r~~~~~fkp~~  267 (612)
T KOG0603|consen  222 FKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEA--RSRPPPFKPGS  267 (612)
T ss_pred             HhhCHHHHhccCcchhHHHhccchheeeeHhhHhh--cCCCCCCCCcc
Confidence            9999999985     58999999999998887766  77778877743

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=7.1e-29  Score=231.48  Aligned_cols=164  Identities=19%  Similarity=0.206  Sum_probs=131.2

Q ss_pred             cccccccceecccCCceEEEEEeCC-CCcEEEEEEecCC----CchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPP-TSRVFALKVIYGN----HEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~-~~~~~avK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .+.|.+.+.||+|+||+||+|.+.. +++.||||++...    ........+.+|+++|+.++|+|++..+..   .+..
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~   93 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKD   93 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCc
Confidence            4679999999999999999999876 6788899987533    123346678999999999999999853322   2467


Q ss_pred             EEEEeccCCCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEEcCCCcEEEeeccccccccccCC---
Q 016959          173 EVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDI-KPSNLLINSSKNVKIADFGVSRILAQTMD---  248 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dl-kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---  248 (380)
                      |+||||+.|++|.......   ...++.|++++|.|||++||+|||| ||+|||++.++.+||+|||+|+.+.....   
T Consensus        94 ~LVmE~~~G~~L~~~~~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~  170 (365)
T PRK09188         94 GLVRGWTEGVPLHLARPHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYR  170 (365)
T ss_pred             EEEEEccCCCCHHHhCccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhh
Confidence            9999999999986322111   2568899999999999999999999 99999999999999999999987654321   


Q ss_pred             -----CCCCCCCCCcccccccccc
Q 016959          249 -----PCNSAVGTIAYMSPERINT  267 (380)
Q Consensus       249 -----~~~~~~gt~~y~aPE~~~~  267 (380)
                           .....+++..|+|||.+..
T Consensus       171 ~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        171 IAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             hhhhhhhhhhhccCccCCcccCCh
Confidence                 1235678889999999854

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.6e-28  Score=209.04  Aligned_cols=150  Identities=25%  Similarity=0.324  Sum_probs=116.7

Q ss_pred             cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCCcccccccccccc
Q 016959          190 RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL  269 (380)
Q Consensus       190 ~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  269 (380)
                      .++..++.++.||+.||.|||+++      ||+|||++.++.+|+  ||++......     ...||+.|||||++..  
T Consensus        14 l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g~~~y~aPE~~~~--   78 (176)
T smart00750       14 LNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRVDPYFMAPEVIQG--   78 (176)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCCcccccChHHhcC--
Confidence            467889999999999999999999      999999999999999  9998765432     2368999999999853  


Q ss_pred             CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC------CCccccH--HHHHHHHHhcccCc
Q 016959          270 NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE------APEMASR--EFRDFISRCLQKDP  341 (380)
Q Consensus       270 ~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~--~~~~li~~~l~~dp  341 (380)
                         ..++.++|||||||++|||++|..||......  ..............      .+..++.  ++.++|.+||..||
T Consensus        79 ---~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p  153 (176)
T smart00750       79 ---QSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLP  153 (176)
T ss_pred             ---CCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhccc
Confidence               45677999999999999999999999643221  11122221111111      1222333  69999999999999


Q ss_pred             CCCCCHHHHhcCcccccc
Q 016959          342 HSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       342 ~~R~t~~eil~hp~~~~~  359 (380)
                      ++||++.|+++|+|+...
T Consensus       154 ~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      154 QRREAANHYLAHCRALFA  171 (176)
T ss_pred             ccccCHHHHHHHHHHHHH
Confidence            999999999999998753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-27  Score=209.51  Aligned_cols=207  Identities=21%  Similarity=0.291  Sum_probs=166.7

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEEE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  175 (380)
                      ..-.|.++++||+|+||.+++|++.-+++.||||.-....   ..-++..|+...+.|. .++|...|.+-..+.+-.+|
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            3447999999999999999999999999999999843222   2345778999888885 78999998877778888899


Q ss_pred             EeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-----cEEEeeccccccccc
Q 016959          176 LEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK-----NVKIADFGVSRILAQ  245 (380)
Q Consensus       176 ~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~-----~~kl~Dfg~a~~~~~  245 (380)
                      +|++ |.+|+++..     .+-.++..+|.||+.-++|+|++.+|+|||||+|+||..-+     .|-|+|||+|+...+
T Consensus       103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            9998 567766543     35677889999999999999999999999999999997443     399999999998765


Q ss_pred             cCC-------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Q 016959          246 TMD-------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFA  312 (380)
Q Consensus       246 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  312 (380)
                      ...       ...+..||.+||+-.-.     .|...+.+.|+-|||-+++++|.|..||..-+.....+...+
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTH-----lGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK  250 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTH-----LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK  250 (449)
T ss_pred             ccccccCccccccccccceeeeEeecc-----ccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH
Confidence            422       23567799999997754     467788999999999999999999999985444433333333

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=5.3e-27  Score=218.85  Aligned_cols=247  Identities=23%  Similarity=0.279  Sum_probs=188.6

Q ss_pred             cccccceecccCCceEEEEEeCCCC-cEEEEEEecCCCchHHHHHHHHHHHHHHhCCC----CceeeeEeEE-eeCCeEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTS-RVFALKVIYGNHEDSVRSQICREIEILRDVNH----PNVVKCHDMY-DRNGEIE  173 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h----~~iv~~~~~~-~~~~~~~  173 (380)
                      .|.+.++||+|+||.||+|.+..++ +.+|+|+.......... .+..|+.++..+..    .++..+++.. ..+...+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            7999999999999999999987664 68999987554333222 67788998888862    5889999888 4777889


Q ss_pred             EEEeccCCCCccccc------ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-----CcEEEeeccccc-
Q 016959          174 VLLEYMDGGSLEGAH------IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS-----KNVKIADFGVSR-  241 (380)
Q Consensus       174 lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~-----~~~kl~Dfg~a~-  241 (380)
                      +||+.+ |.+|.++.      ..+..++..|+.|++.+|++||+.|++||||||+|+++...     ..+.|.|||+++ 
T Consensus        98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence            999998 45665543      23566788999999999999999999999999999999855     359999999998 


Q ss_pred             -cccccCC-------C-CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Q 016959          242 -ILAQTMD-------P-CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFA  312 (380)
Q Consensus       242 -~~~~~~~-------~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~  312 (380)
                       .......       . .....||..|.+++...     +...+.+.|+||++.++.+|+.|..||..............
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~-----~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~  251 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHL-----GIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK  251 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhC-----CCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence             3211110       1 23455999999999875     46677899999999999999999999975544333333333


Q ss_pred             HhhCCCCC-CCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          313 ICFAQPPE-APEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       313 ~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ........ .....+.++.+++..+-..+..++|....+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  252 DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            33322222 334456788888888888999999998887663

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=2.2e-26  Score=213.43  Aligned_cols=257  Identities=32%  Similarity=0.517  Sum_probs=199.9

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchH--HHHHHHHHHHHHHhCCCC-ceeeeEeEEeeCCeEEEEEe
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP-NVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e  177 (380)
                      |.+.+.||.|+||.||++.+.   ..+++|.+.......  ....+.+|+.++..+.|+ +++++++.+...+..+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            667889999999999999996   788999986654433  467889999999999988 79999999987777899999


Q ss_pred             ccCCCCcccccc-------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-cEEEeeccccccccccCC-
Q 016959          178 YMDGGSLEGAHI-------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMD-  248 (380)
Q Consensus       178 ~~~~~~L~~~~~-------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~-  248 (380)
                      ++.++++.....       ..+.....++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++..+..... 
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999999864333       44567888999999999999999999999999999999888 799999999986554332 


Q ss_pred             -----CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-CHHHHHHHHhhCCCC---
Q 016959          249 -----PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG-DWASLMFAICFAQPP---  319 (380)
Q Consensus       249 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~---  319 (380)
                           ......|+..|++||.+....  ........|+|++|++++++++|..||...... ...............   
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~--~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLS--LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA  236 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCC--CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence                 236778999999999985310  145677899999999999999999998644321 112222222222211   


Q ss_pred             -CCCccc----cHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          320 -EAPEMA----SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       320 -~~~~~~----~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                       ......    ...+.+++.+|+..+|..|.+..+...++|.......
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~  284 (384)
T COG0515         237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLK  284 (384)
T ss_pred             cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccc
Confidence             111111    2578999999999999999999999988766665433

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=6.1e-27  Score=197.80  Aligned_cols=202  Identities=23%  Similarity=0.335  Sum_probs=163.0

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeE
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  172 (380)
                      ..+....|.+.++||.|+||.+|+|....+|..||||+-...   ....++..|..+.+.|+ ...|..+..++.+...-
T Consensus        10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~---a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn   86 (341)
T KOG1163|consen   10 ELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK---AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN   86 (341)
T ss_pred             hheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc---CCCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence            346677899999999999999999999999999999995332   22345677888888887 46777777777788888


Q ss_pred             EEEEeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---cEEEeecccccccc
Q 016959          173 EVLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK---NVKIADFGVSRILA  244 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~---~~kl~Dfg~a~~~~  244 (380)
                      .+|||+. |.+|+++...     +..++.-++-||+.-++|+|.++++||||||+|+|..-+.   .+.|+|||+|+.+.
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9999998 5688766554     3456778899999999999999999999999999997443   49999999999775


Q ss_pred             ccCC-------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 016959          245 QTMD-------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG  304 (380)
Q Consensus       245 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~  304 (380)
                      +...       ......||..|.+-...     .|...+.+.|+-|+|.+|.++..|..||..-...
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh-----~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~  227 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAH-----LGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA  227 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhh-----hhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence            4322       23456799999987755     3456678899999999999999999999854433

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.94  E-value=2.5e-27  Score=235.53  Aligned_cols=237  Identities=28%  Similarity=0.434  Sum_probs=171.6

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ..+|..++.|-.|+||.||.++++.+.+.+|+|+=   .+.-    +.+-  ++.....|++|                 
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiN---kq~l----ilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN---KQNL----ILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccc---ccch----hhhc--cccccCCccee-----------------
Confidence            35789999999999999999999999999999652   1111    1111  23333344444                 


Q ss_pred             ccCCCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC---------
Q 016959          178 YMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD---------  248 (380)
Q Consensus       178 ~~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---------  248 (380)
                          |+-...+......    -.+++.+++|||+.||+|||+||+|++|+.-|++|++|||+.+.-.....         
T Consensus       136 ----gDc~tllk~~g~l----Pvdmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~  207 (1205)
T KOG0606|consen  136 ----GDCATLLKNIGPL----PVDMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIE  207 (1205)
T ss_pred             ----chhhhhcccCCCC----cchhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchH
Confidence                2222222221111    12237899999999999999999999999999999999999864211000         


Q ss_pred             ------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCC
Q 016959          249 ------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAP  322 (380)
Q Consensus       249 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  322 (380)
                            .....+||+.|+|||++..     ..|+..+|+|+||+|+||++-|..||..+..++............ ++-.
T Consensus       208 k~t~Ef~dKqvcgTPeyiaPeVilr-----qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w-pE~d  281 (1205)
T KOG0606|consen  208 KDTHEFQDKQVCGTPEYIAPEVILR-----QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW-PEED  281 (1205)
T ss_pred             HHHHHhhhccccCCccccChhhhhh-----hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc-cccC
Confidence                  1245689999999999964     556778999999999999999999998665554443333322222 2224


Q ss_pred             ccccHHHHHHHHHhcccCcCCCC---CHHHHhcCccccccCcccccccccccCCC
Q 016959          323 EMASREFRDFISRCLQKDPHSRW---PAAQLLQHPFILRAGQSQVNQNLRQILPP  374 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~---t~~eil~hp~~~~~~~~~~~~~~~~~~~~  374 (380)
                      ..+++++++++.++|+.+|..|.   .+-++.+|+||+.+.|..+-++.-+++|-
T Consensus       282 ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefvpq  336 (1205)
T KOG0606|consen  282 EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFVPQ  336 (1205)
T ss_pred             cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhcccccc
Confidence            55788999999999999999997   57889999999999999776666666664

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=1.1e-24  Score=195.24  Aligned_cols=233  Identities=22%  Similarity=0.288  Sum_probs=146.5

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCC----------CceeeeEeEEe
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNH----------PNVVKCHDMYD  167 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h----------~~iv~~~~~~~  167 (380)
                      .+..++.||.|+++.||.+++..||+.+|||+.....  .....+.+.+|.-....+.+          -.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4667889999999999999999999999999985332  33456667777655544322          12232333221


Q ss_pred             ---------eC---C-----eEEEEEeccCCCCccccccc---------ch--HHHHHHHHHHHHHHHHHHhCCceecCC
Q 016959          168 ---------RN---G-----EIEVLLEYMDGGSLEGAHIR---------QE--HILSDLARQVLSGLAYLHKRKIVHRDI  219 (380)
Q Consensus       168 ---------~~---~-----~~~lv~e~~~~~~L~~~~~~---------~~--~~~~~i~~qi~~al~~LH~~~ivH~Dl  219 (380)
                               ..   .     +.+++|+.+. ++|......         ..  .....+..|+++.+++||..|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                     11   1     2355666664 345333221         11  112345689999999999999999999


Q ss_pred             CCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCCccccccccccccC---CCCCCCcchhHHHHHHHHHHHHhCCC
Q 016959          220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN---HGKYDGYAGDIWSLGVSILEFYLGRF  296 (380)
Q Consensus       220 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DvwslG~il~ell~g~~  296 (380)
                      +|+|++++.+|.++|+||+..........   ....+..|.+||.......   ....++.+.|.|+||+++|.|.||..
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR---CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEEE---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCceee---ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999999999999998776554321   1335688999998743211   12245778999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCC
Q 016959          297 PFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR  344 (380)
Q Consensus       297 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  344 (380)
                      ||...........    .   -.... .+++.+++||.++|+.||++|
T Consensus       249 Pf~~~~~~~~~~~----~---f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEW----D---FSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGG----G---GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccc----c---chhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9974332211111    1   11233 678899999999999999988

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1e-24  Score=196.49  Aligned_cols=253  Identities=19%  Similarity=0.260  Sum_probs=171.0

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCC-----------------------------------cEEEEEEecCC--
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTS-----------------------------------RVFALKVIYGN--  135 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~-----------------------------------~~~avK~~~~~--  135 (380)
                      ...+..++|+++..||+|+-..||.+.....|                                   -..|||.|..-  
T Consensus       151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~  230 (598)
T KOG4158|consen  151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH  230 (598)
T ss_pred             hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence            34578899999999999999999998643211                                   02566665321  


Q ss_pred             --CchHHHHHHHHHHH------H--------HHh-------C-CCCceeeeEeEEee-----------------------
Q 016959          136 --HEDSVRSQICREIE------I--------LRD-------V-NHPNVVKCHDMYDR-----------------------  168 (380)
Q Consensus       136 --~~~~~~~~~~~E~~------~--------l~~-------l-~h~~iv~~~~~~~~-----------------------  168 (380)
                        ......+.+.+|+.      .        .+.       | .|||||++.++|.+                       
T Consensus       231 ~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~  310 (598)
T KOG4158|consen  231 DSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS  310 (598)
T ss_pred             CCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence              12222233333321      0        111       1 59999999987733                       


Q ss_pred             ----CCeEEEEEeccCCCCccccccc---chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc--CCCc--EEEeec
Q 016959          169 ----NGEIEVLLEYMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN--SSKN--VKIADF  237 (380)
Q Consensus       169 ----~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~--~~~~--~kl~Df  237 (380)
                          ...+|+||...+. +|..++..   .-....-|+.|+++|+.|||.+||.|||||.+||||.  +|+.  +.|+||
T Consensus       311 g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDF  389 (598)
T KOG4158|consen  311 GAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADF  389 (598)
T ss_pred             ccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccc
Confidence                2246777766643 44444322   2334556889999999999999999999999999995  4443  889999


Q ss_pred             cccccccc------cCCCCCCCCCCCccccccccccccCCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHH
Q 016959          238 GVSRILAQ------TMDPCNSAVGTIAYMSPERINTDLNHGK-YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLM  310 (380)
Q Consensus       238 g~a~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~  310 (380)
                      |++-....      ........-|...-||||+......-.. ..-.++|.|+.|.+.||+++...||......  .-..
T Consensus       390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem--~L~~  467 (598)
T KOG4158|consen  390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM--LLDT  467 (598)
T ss_pred             ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh--eech
Confidence            98743221      1111223457889999999854221111 1123899999999999999999999742222  1122


Q ss_pred             HHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHH
Q 016959          311 FAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAA  348 (380)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~  348 (380)
                      ......+.+.+++.+++.+++|+..+|+.||.+|++..
T Consensus       468 r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  468 RTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             hhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence            22455677889999999999999999999999999853

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=2.2e-24  Score=185.30  Aligned_cols=136  Identities=18%  Similarity=0.195  Sum_probs=104.8

Q ss_pred             cceecccCCceEEEEEeCCCCcEEEEEEecCCCchH-------------------------HHHHHHHHHHHHHhCCCCc
Q 016959          104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-------------------------VRSQICREIEILRDVNHPN  158 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-------------------------~~~~~~~E~~~l~~l~h~~  158 (380)
                      ...||+|+||.||+|.+. +|+.||||+++......                         .......|+.+++++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999997 89999999996542110                         0122345999999998776


Q ss_pred             eeeeEeEEeeCCeEEEEEeccCCCCcccc----cccchHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEEEcCCCcEE
Q 016959          159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGA----HIRQEHILSDLARQVLSGLAYL-HKRKIVHRDIKPSNLLINSSKNVK  233 (380)
Q Consensus       159 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~al~~L-H~~~ivH~Dlkp~Nil~~~~~~~k  233 (380)
                      +.....+.. . ..++||||+.|+++...    ...+...+..++.||+.+|.|| |+.||+||||||+|||++ ++.++
T Consensus        81 v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPILL-K-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEEe-c-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            643332222 2 23899999998766432    2335667889999999999999 799999999999999998 57899


Q ss_pred             Eeeccccccc
Q 016959          234 IADFGVSRIL  243 (380)
Q Consensus       234 l~Dfg~a~~~  243 (380)
                      |+|||+|...
T Consensus       158 LiDFG~a~~~  167 (190)
T cd05147         158 IIDVSQSVEH  167 (190)
T ss_pred             EEEccccccC
Confidence            9999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=4.7e-24  Score=181.86  Aligned_cols=189  Identities=15%  Similarity=0.109  Sum_probs=141.0

Q ss_pred             cccceecccCCceEEEEEeCCCCcEEEEEEecCCCc---hHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEEEEe
Q 016959          102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE---DSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus       102 ~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .+...|++|+||+||.+..  .+..++.+.+.....   .-....+.+|+++|++|. |+++++++++    +..+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3567899999999997776  677778777644332   111225789999999995 5889999886    34699999


Q ss_pred             ccCCCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEEcCCCcEEEeeccccccccccCCC----C--
Q 016959          178 YMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDI-KPSNLLINSSKNVKIADFGVSRILAQTMDP----C--  250 (380)
Q Consensus       178 ~~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dl-kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~----~--  250 (380)
                      |+.|.+|.......   ...++.|++.+|+++|++||+|||| ||+|||++.++.++|+|||+|.........    .  
T Consensus        79 yI~G~~L~~~~~~~---~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~r  155 (218)
T PRK12274         79 YLAGAAMYQRPPRG---DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLARE  155 (218)
T ss_pred             eecCccHHhhhhhh---hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHH
Confidence            99999987543322   2357889999999999999999999 799999999999999999999854432210    0  


Q ss_pred             -------CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 016959          251 -------NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGR  302 (380)
Q Consensus       251 -------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  302 (380)
                             .-...++.|++|+...-.   ....-.+.+.++.|+-+|.++|+..++..++
T Consensus       156 Dl~~llk~~~~y~~~~l~~~~~~~l---~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        156 DLRHLLKHKRMYCPAALTPVERRVL---KRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHhcCCCCCCHHHHhhh---ccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                   011257888888875321   1111146799999999999999999986443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=1.1e-24  Score=189.63  Aligned_cols=173  Identities=17%  Similarity=0.195  Sum_probs=131.1

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHH------HHHHHHHHHhCCCCceeeeEeEEe
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQ------ICREIEILRDVNHPNVVKCHDMYD  167 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~  167 (380)
                      +-..+|.+.+.||.|+||.||++..  +++.+|||++.....  +.....      +.+|+..+.++.|++|..+.+++.
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            3457899999999999999999766  466899999964432  222222      578999999999999999998865


Q ss_pred             eC--------CeEEEEEeccCCCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccc
Q 016959          168 RN--------GEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGV  239 (380)
Q Consensus       168 ~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  239 (380)
                      ..        +..+++|||++|.+|.+.....+    ....+|+.+|..||+.|++|||+||.||+++.+| ++|+|||.
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~  180 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPEISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSG  180 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhhccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCC
Confidence            43        35789999999999977644333    3566999999999999999999999999999888 99999998


Q ss_pred             cccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHH
Q 016959          240 SRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY  292 (380)
Q Consensus       240 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell  292 (380)
                      .........  ..          .++.     ...+..++|+|+||+++..+.
T Consensus       181 ~~~~~e~~a--~d----------~~vl-----er~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        181 KRCTAQRKA--KD----------RIDL-----ERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             cccccchhh--HH----------HHHH-----HhHhcccccccceeEeehHHH
Confidence            765432110  00          0111     122336899999999887653

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=8e-25  Score=218.16  Aligned_cols=243  Identities=24%  Similarity=0.275  Sum_probs=173.1

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchH---HHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS---VRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++...+.||.+.|=+|.+|++. .| .|+||++.+....-   ...+-.+|++ ...+++||++.+..+.+.+...|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            6788899999999999999985 34 48999985543221   1222234444 55568999999998888888888999


Q ss_pred             eccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC---
Q 016959          177 EYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP---  249 (380)
Q Consensus       177 e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~---  249 (380)
                      +|... +|++.+..    ..-+.+.|+.||+.||..+|..||+|||||.+||||+...-+.|+||.-.+-..-..+.   
T Consensus       101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad  179 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD  179 (1431)
T ss_pred             HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence            99875 45544333    34456779999999999999999999999999999999999999999866432111111   


Q ss_pred             ----CCCCCCCCcccccccccccc------CCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCC
Q 016959          250 ----CNSAVGTIAYMSPERINTDL------NHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQP  318 (380)
Q Consensus       250 ----~~~~~gt~~y~aPE~~~~~~------~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  318 (380)
                          ..+...-.+|+|||.+....      ......+++.||||+||+++||++ |+.+|.       ...+...+.+..
T Consensus       180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-------LSQL~aYr~~~~  252 (1431)
T KOG1240|consen  180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-------LSQLLAYRSGNA  252 (1431)
T ss_pred             ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-------HHHHHhHhccCc
Confidence                12223446899999996522      011114678999999999999876 688885       111112211110


Q ss_pred             CC----CCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          319 PE----APEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       319 ~~----~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ..    +...-+..++.+|..|++.||.+|.++++.|+.
T Consensus       253 ~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  253 DDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             cCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            00    111124489999999999999999999999974

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=3.2e-23  Score=178.63  Aligned_cols=137  Identities=17%  Similarity=0.190  Sum_probs=107.5

Q ss_pred             cceecccCCceEEEEEeCCCCcEEEEEEecCCCch-------------------------HHHHHHHHHHHHHHhCCCCc
Q 016959          104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED-------------------------SVRSQICREIEILRDVNHPN  158 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------------------------~~~~~~~~E~~~l~~l~h~~  158 (380)
                      ...||+|+||.||+|.+. +|+.||||++......                         .....+..|+..+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            568999999999999987 8999999998654210                         01223467899999999888


Q ss_pred             eeeeEeEEeeCCeEEEEEeccCCCCcccc----cccchHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEE
Q 016959          159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGA----HIRQEHILSDLARQVLSGLAYLHK-RKIVHRDIKPSNLLINSSKNVK  233 (380)
Q Consensus       159 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~Nil~~~~~~~k  233 (380)
                      +.....+....  .++||||+.|+++...    ..........++.|++.+|.+||. +||+||||||+|||++ ++.++
T Consensus        81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~  157 (190)
T cd05145          81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY  157 (190)
T ss_pred             CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence            75544433332  4899999998754322    123455678899999999999999 9999999999999999 89999


Q ss_pred             Eeecccccccc
Q 016959          234 IADFGVSRILA  244 (380)
Q Consensus       234 l~Dfg~a~~~~  244 (380)
                      |+|||++..+.
T Consensus       158 liDFG~a~~~~  168 (190)
T cd05145         158 IIDVSQAVELD  168 (190)
T ss_pred             EEEcccceecC
Confidence            99999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2.2e-24  Score=185.48  Aligned_cols=248  Identities=20%  Similarity=0.289  Sum_probs=193.3

Q ss_pred             ccccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC
Q 016959           91 NRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN  169 (380)
Q Consensus        91 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  169 (380)
                      .+...|+..++.+..+|.+...|+.|+|++.  |..+++|++.... .......|.+|.-.|+-+.||||+.+++.|...
T Consensus       182 sr~~gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp  259 (448)
T KOG0195|consen  182 SRYTGIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP  259 (448)
T ss_pred             ccccCcchhhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC
Confidence            3445577778888899999999999999995  4456778774332 344556788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCcccccccc------hHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCcEEEe--eccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLSGLAYLHKRK--IVHRDIKPSNLLINSSKNVKIA--DFGV  239 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~~~------~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~--Dfg~  239 (380)
                      .++.++..|++.|+|++.+...      ..+..+++.+|++|++|||+..  |----|....|+||++.+.+|.  |--+
T Consensus       260 pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kf  339 (448)
T KOG0195|consen  260 PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKF  339 (448)
T ss_pred             CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheeccccee
Confidence            9999999999999998877653      3567789999999999999974  4445688899999999887764  3222


Q ss_pred             cccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC
Q 016959          240 SRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP  319 (380)
Q Consensus       240 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  319 (380)
                      +-.       ..+..-.+.||+||.+.......  .-..+|+|||++++|||.|...||..  ...+.--++....+.+.
T Consensus       340 sfq-------e~gr~y~pawmspealqrkped~--n~raadmwsfaillwel~trevpfad--lspmecgmkialeglrv  408 (448)
T KOG0195|consen  340 SFQ-------EVGRAYSPAWMSPEALQRKPEDL--NIRAADMWSFAILLWELNTREVPFAD--LSPMECGMKIALEGLRV  408 (448)
T ss_pred             eee-------ccccccCcccCCHHHHhcCchhc--chhhhhHHHHHHHHHHhhcccccccc--CCchhhhhhhhhccccc
Confidence            211       12334578999999986432111  12479999999999999999999963  22333334444556778


Q ss_pred             CCCccccHHHHHHHHHhcccCcCCCCCHHHHh
Q 016959          320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLL  351 (380)
Q Consensus       320 ~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil  351 (380)
                      ..|+.++..+..||.-|++.||.+||.++.|+
T Consensus       409 ~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             cCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            89999999999999999999999999998775

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=6.5e-22  Score=171.69  Aligned_cols=134  Identities=19%  Similarity=0.300  Sum_probs=103.3

Q ss_pred             cccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-----CCCceeeeEeEEeeCC---e-E
Q 016959          102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-----NHPNVVKCHDMYDRNG---E-I  172 (380)
Q Consensus       102 ~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~---~-~  172 (380)
                      .-.+.||+|+||.||.  +..++.. +||++...... ..+.+.+|+.+++.+     +||||++++|+++.+.   . +
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            3456899999999995  6556555 79998654322 346789999999999     5799999999998763   4 3


Q ss_pred             EEEEec--cCCCCcccccccc--hHHHHHHHHHHHHHH-HHHHhCCceecCCCCCcEEEcCC----CcEEEeecccc
Q 016959          173 EVLLEY--MDGGSLEGAHIRQ--EHILSDLARQVLSGL-AYLHKRKIVHRDIKPSNLLINSS----KNVKIADFGVS  240 (380)
Q Consensus       173 ~lv~e~--~~~~~L~~~~~~~--~~~~~~i~~qi~~al-~~LH~~~ivH~Dlkp~Nil~~~~----~~~kl~Dfg~a  240 (380)
                      .+|+||  +.+++|.+++...  +.. ..++.|++.++ +|||+++|+||||||+|||++..    +.++|+||+.+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~~~~e~-~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQCRYEED-VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcccccHh-HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            378999  5578998776542  122 35678888777 99999999999999999999743    37999995544

>smart00090 RIO RIO-like kinase

Probab=99.86  E-value=3.1e-21  Score=171.37  Aligned_cols=140  Identities=21%  Similarity=0.268  Sum_probs=108.6

Q ss_pred             cccccceecccCCceEEEEE-eCCCCcEEEEEEecCCCch-----------------------HHHHHHHHHHHHHHhCC
Q 016959          100 ELQKGNRIGSGSGGTVWRVV-HPPTSRVFALKVIYGNHED-----------------------SVRSQICREIEILRDVN  155 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~-~~~~~~~~avK~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~  155 (380)
                      .|.+.+.||+|+||.||+|. +..+|+.||||+++.....                       .....+.+|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998 6678999999998643210                       01234678999999997


Q ss_pred             CC--ceeeeEeEEeeCCeEEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEEEcC
Q 016959          156 HP--NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRK-IVHRDIKPSNLLINS  228 (380)
Q Consensus       156 h~--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~-ivH~Dlkp~Nil~~~  228 (380)
                      +.  .+.++++   .. ..++||||+.|.+|.....    ........++.||+.+|.+||++| |+||||||+||+++ 
T Consensus       109 ~~~i~~p~~~~---~~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIA---WR-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeE---ec-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            53  2334443   22 3589999999988754431    123446789999999999999999 99999999999999 


Q ss_pred             CCcEEEeecccccccc
Q 016959          229 SKNVKIADFGVSRILA  244 (380)
Q Consensus       229 ~~~~kl~Dfg~a~~~~  244 (380)
                      ++.++|+|||.+....
T Consensus       184 ~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CCCEEEEEChhhhccC
Confidence            8899999999986543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=6e-22  Score=200.83  Aligned_cols=195  Identities=22%  Similarity=0.273  Sum_probs=149.4

Q ss_pred             cccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC---CCceeeeEeEEee
Q 016959           92 RHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN---HPNVVKCHDMYDR  168 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~  168 (380)
                      ....+..+.|.|.+.||+|+||+||+|.... |+.||||+=+...    ..+|.--.+++.+|+   -+.|..+..++.-
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~----~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPN----PWEFYICLQVMERLKPQMLPSIMHISSAHVF  765 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCC----ceeeeehHHHHHhhchhhhcchHHHHHHHcc
Confidence            3444667889999999999999999999986 9999999953322    111112233344443   2345555555555


Q ss_pred             CCeEEEEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-------CCcEEEeec
Q 016959          169 NGEIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS-------SKNVKIADF  237 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~-------~~~~kl~Df  237 (380)
                      .+..++|+||...|+|.++...    .+..+..+..||+..|++||..+|||+||||+|+||..       ...++|+||
T Consensus       766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence            6777999999999999877654    45667889999999999999999999999999999942       234999999


Q ss_pred             ccccccccc--CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCC
Q 016959          238 GVSRILAQT--MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRF  296 (380)
Q Consensus       238 g~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~  296 (380)
                      |.+-.+.--  .......++|-.+-.+|...     |+.|+++.|.|.|+.+++-||+|++
T Consensus       846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~-----grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMRE-----GRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ccceeeeEcCCCcEEeeeeccccchhHHHhc-----CCCCchhhhhHHHHHHHHHHHHHHH
Confidence            998755322  22345677899999999774     6889999999999999999999874

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=1.6e-20  Score=164.59  Aligned_cols=135  Identities=18%  Similarity=0.256  Sum_probs=112.6

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCCc-------hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-------DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      +.||+|++|.||+|.+  .|..+++|+......       ......+.+|+.++..+.|+++.....++...+..+++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999988  677899998643221       1123467889999999999988877777767778899999


Q ss_pred             ccCCCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 016959          178 YMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI  242 (380)
Q Consensus       178 ~~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  242 (380)
                      |++|++|.+.+.........++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus        80 ~~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNGMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999998776543336778999999999999999999999999999999 88899999998864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.84  E-value=3.1e-20  Score=161.17  Aligned_cols=137  Identities=23%  Similarity=0.302  Sum_probs=108.7

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCch---------------------HHHHHHHHHHHHHHhCCCC--
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED---------------------SVRSQICREIEILRDVNHP--  157 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---------------------~~~~~~~~E~~~l~~l~h~--  157 (380)
                      |.+.+.||+|+||.||++.+. +|+.||||++......                     ........|+.++..+.|.  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            777899999999999999885 7999999987543210                     0112356789899988776  


Q ss_pred             ceeeeEeEEeeCCeEEEEEeccCCCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeec
Q 016959          158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADF  237 (380)
Q Consensus       158 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  237 (380)
                      .+...++    ....++||||+.|++|......  .....++.+++.++.++|+.||+||||||+||+++.++.++|+||
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDf  169 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL--EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDW  169 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc--ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEEC
Confidence            3444443    2455899999999988765432  335678899999999999999999999999999999999999999


Q ss_pred             ccccccc
Q 016959          238 GVSRILA  244 (380)
Q Consensus       238 g~a~~~~  244 (380)
                      |++..+.
T Consensus       170 g~~~~~~  176 (198)
T cd05144         170 PQMVSTD  176 (198)
T ss_pred             CccccCC
Confidence            9996554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.83  E-value=3.2e-20  Score=161.25  Aligned_cols=131  Identities=20%  Similarity=0.282  Sum_probs=105.2

Q ss_pred             eecccCCceEEEEEeCCCCcEEEEEEecCCC----c---hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNH----E---DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       106 ~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      .||+|+||.||++.+  +++.+++|+.....    .   .....++.+|+++++.+.|+++.....++...+..++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999996  67789999864321    1   11235678899999999887655444445556667899999


Q ss_pred             cCCCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 016959          179 MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI  242 (380)
Q Consensus       179 ~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  242 (380)
                      ++|++|.+.......   .++.|++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~~---~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND---ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH---HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999998776543322   7899999999999999999999999999999 88999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.83  E-value=4.3e-21  Score=179.55  Aligned_cols=174  Identities=25%  Similarity=0.385  Sum_probs=133.3

Q ss_pred             CeEEEEEeccCCCCcccccccc-------hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHIRQ-------EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI  242 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  242 (380)
                      ..+||.|++|...+|.+++...       ......++.|+..|++|   +|.+|+|+||.||++..++.+||.|||+.+.
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            3588999999999999998642       34577899999999999   9999999999999999999999999999887


Q ss_pred             ccccC------CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhh
Q 016959          243 LAQTM------DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICF  315 (380)
Q Consensus       243 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~  315 (380)
                      .....      ......+||..||+||.|.     |..|+.++||||||+||+||+. =...|.      -......+..
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~-----g~~y~~kvdIyaLGlil~EL~~~f~T~~e------r~~t~~d~r~  474 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIR-----GQQYSEKVDIYALGLILAELLIQFSTQFE------RIATLTDIRD  474 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHh-----hhhhhhhcchhhHHHHHHHHHHHhccHHH------HHHhhhhhhc
Confidence            65433      2345678999999999996     4677889999999999999986 222221      2222333333


Q ss_pred             CCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 016959          316 AQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFIL  357 (380)
Q Consensus       316 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~  357 (380)
                      ...++....-.++-.+|+.+||...|.+||++.+.--|+|.+
T Consensus       475 g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  475 GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             CCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence            332211112234566899999999999999888888887753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=5.6e-22  Score=196.94  Aligned_cols=255  Identities=25%  Similarity=0.343  Sum_probs=204.0

Q ss_pred             cccccceecccCCceEEEEEeCC-CCcEEEEEEecCC-CchHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEEEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPP-TSRVFALKVIYGN-HEDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~-~~~~~avK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      .|.+.+.||+|+|+.|-.+.... ....+|+|.+... ......+.+..|..+-+.+. |.|++.+++...+.+..++++
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            36666779999999999887743 3456777776433 23445566777888888887 999999999999999999999


Q ss_pred             eccCCCCccccc-c-----cchHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEcCCC-cEEEeeccccccccc-cC
Q 016959          177 EYMDGGSLEGAH-I-----RQEHILSDLARQVLSGLAYLH-KRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQ-TM  247 (380)
Q Consensus       177 e~~~~~~L~~~~-~-----~~~~~~~~i~~qi~~al~~LH-~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~-~~  247 (380)
                      ++..|+++.... .     ........++.|+..++.|+| ..++.|+|+||+|.+++..+ .+++.|||+|+.+.. ..
T Consensus       101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g  180 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNG  180 (601)
T ss_pred             CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCC
Confidence            999999988776 2     234557789999999999999 99999999999999999999 999999999998765 21


Q ss_pred             --CCCCCCCC-CCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHH-HHHHhhCCCCCCCc
Q 016959          248 --DPCNSAVG-TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASL-MFAICFAQPPEAPE  323 (380)
Q Consensus       248 --~~~~~~~g-t~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~  323 (380)
                        ......+| ++.|+|||...+.    .+.....|+||.|+++..+++|..|+......+.... ............+.
T Consensus       181 ~~~~~~~~~g~s~~y~a~E~~~~~----~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (601)
T KOG0590|consen  181 AERSLKDRCGSSPPYGAPEHLSGK----AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN  256 (601)
T ss_pred             cceeeecccCCCCCCCCcccccch----hhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence              23345678 9999999998542    4667789999999999999999999975544432211 11111222355677


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR  358 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~  358 (380)
                      .++....+++.+++..+|..|.+.+++..++|+..
T Consensus       257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cCChhhhhcccccccCCchhccccccccccccccc
Confidence            78889999999999999999999999999999999

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=4.8e-20  Score=175.52  Aligned_cols=202  Identities=25%  Similarity=0.387  Sum_probs=151.9

Q ss_pred             HHhCCCCceeeeEeEEeeCCeEEEEEeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCc-eecCCCCCcE
Q 016959          151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKI-VHRDIKPSNL  224 (380)
Q Consensus       151 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~i-vH~Dlkp~Ni  224 (380)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+..     .......++++|+.||.|||+-.| .|+.|+..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            4578899999999999999999999999999999877665     233455688999999999998765 9999999999


Q ss_pred             EEcCCCcEEEeecccccccccc--CCCCCCCCCCCccccccccccccCCCC--CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 016959          225 LINSSKNVKIADFGVSRILAQT--MDPCNSAVGTIAYMSPERINTDLNHGK--YDGYAGDIWSLGVSILEFYLGRFPFAV  300 (380)
Q Consensus       225 l~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~  300 (380)
                      ++|..-.+||+|||+.......  ........-...|.|||.+........  .-+.+.|+||+|++++|+++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            9999999999999998766421  111122224568999999976422222  135679999999999999999999985


Q ss_pred             CCCCC-HHHHHHHHhh-CC---CCCCC--ccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          301 GRQGD-WASLMFAICF-AQ---PPEAP--EMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       301 ~~~~~-~~~~~~~~~~-~~---~~~~~--~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..... ..+.+..+.. ..   .+..+  ....+++..++.+||..+|++||+++++-.
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            33222 2333333333 22   22222  134557999999999999999999998764

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.81  E-value=1.5e-19  Score=179.74  Aligned_cols=136  Identities=22%  Similarity=0.250  Sum_probs=109.3

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCC--C-----chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN--H-----EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~--~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      |...+.||+|+||+||++.+..  +.+++|+....  .     .....+.+.+|+++++.++|++++....++......+
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             cCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            4567899999999999998843  34444443111  1     1122456889999999999999988777777767789


Q ss_pred             EEEeccCCCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          174 VLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                      +||||++|++|.+.+.    ....++.|++.+|.|||+.||+||||||+|||+ .++.++|+|||+++..
T Consensus       413 lv~E~~~g~~L~~~l~----~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE----GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEecCCCcHHHHHH----HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            9999999999987654    346789999999999999999999999999999 5788999999998653

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.79  E-value=7.6e-19  Score=150.99  Aligned_cols=133  Identities=20%  Similarity=0.308  Sum_probs=98.3

Q ss_pred             cceecccCCceEEEEEeCCCCcEEEEEEecCCCch--HHHH---------------------HHHHHHHHHHhCCCC--c
Q 016959          104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED--SVRS---------------------QICREIEILRDVNHP--N  158 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~---------------------~~~~E~~~l~~l~h~--~  158 (380)
                      .+.||+|+||+||+|.+. +++.||||++......  ....                     ....|...+..+.+.  .
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            567999999999999986 7899999998643211  1011                     113566666666433  3


Q ss_pred             eeeeEeEEeeCCeEEEEEeccCCCCc-----ccccccchHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcE
Q 016959          159 VVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHK-RKIVHRDIKPSNLLINSSKNV  232 (380)
Q Consensus       159 iv~~~~~~~~~~~~~lv~e~~~~~~L-----~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~Nil~~~~~~~  232 (380)
                      +.+.+++    ...++||||+.++.+     ......  .....++.+++.++.++|. .||+|+||||+||+++ ++.+
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~--~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL--EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhhhc--ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence            4444443    245899999999543     322211  4567899999999999999 9999999999999999 8999


Q ss_pred             EEeecccccccc
Q 016959          233 KIADFGVSRILA  244 (380)
Q Consensus       233 kl~Dfg~a~~~~  244 (380)
                      +|+|||.+....
T Consensus       154 ~liDfg~a~~~~  165 (187)
T cd05119         154 YIIDVPQAVEID  165 (187)
T ss_pred             EEEECccccccc
Confidence            999999986554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.77  E-value=5.5e-18  Score=139.72  Aligned_cols=132  Identities=23%  Similarity=0.330  Sum_probs=112.3

Q ss_pred             ccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCC--CceeeeEeEEeeCCeEEEEEeccC
Q 016959          103 KGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH--PNVVKCHDMYDRNGEIEVLLEYMD  180 (380)
Q Consensus       103 ~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~  180 (380)
                      +.+.||+|.++.||++...  ++.+++|.+.....   ...+.+|+.+++.+.+  .++.++++++...+..+++|||+.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence            4577999999999999984  47899999855433   4568889999999976  589999998888888999999999


Q ss_pred             CCCcccccccchHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEEcCCCcEEEeecccccc
Q 016959          181 GGSLEGAHIRQEHILSDLARQVLSGLAYLHKR---KIVHRDIKPSNLLINSSKNVKIADFGVSRI  242 (380)
Q Consensus       181 ~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  242 (380)
                      +..+...   .......++.+++.++.+||..   +++|+|++|+|||++.++.++++|||.+..
T Consensus        77 g~~~~~~---~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV---SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC---CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            9888765   4455667899999999999985   799999999999999989999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=1.3e-18  Score=165.86  Aligned_cols=252  Identities=28%  Similarity=0.375  Sum_probs=196.0

Q ss_pred             cccccccceecc--cCCceEEEEEe--CCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCe
Q 016959           98 PAELQKGNRIGS--GSGGTVWRVVH--PPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGE  171 (380)
Q Consensus        98 ~~~~~~~~~LG~--G~~g~V~~~~~--~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  171 (380)
                      ...+.+.+.+|.  |.+|.||.+..  ..++..+|+|.=+... .......=.+|+...+.++ |+|.++.+..|+..+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            345667788999  99999999888  7889999999832221 1112222346777777775 9999999999999999


Q ss_pred             EEEEEeccCCCCcccccc-----cchHHHHHHHHHHHH----HHHHHHhCCceecCCCCCcEEEcCC-CcEEEeeccccc
Q 016959          172 IEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLS----GLAYLHKRKIVHRDIKPSNLLINSS-KNVKIADFGVSR  241 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~----al~~LH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~  241 (380)
                      .++-+|+|. .+|..+-.     ..+..++....+..+    ||.++|+.+++|-|+||+||+...+ ..++++|||+..
T Consensus       193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~  271 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS  271 (524)
T ss_pred             ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence            999999997 45543322     356778888888888    9999999999999999999999998 889999999998


Q ss_pred             cccccCCCC-----CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC
Q 016959          242 ILAQTMDPC-----NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA  316 (380)
Q Consensus       242 ~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  316 (380)
                      .+....-..     ....|...|++||..+      ..++..+|+|+||.++.+..+|......+....|.......   
T Consensus       272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~------~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~---  342 (524)
T KOG0601|consen  272 KISDGNFSSVFKVSKRPEGDCIYAAKELLN------GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY---  342 (524)
T ss_pred             EccCCccccceeeeecCCCCceEeChhhhc------cccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---
Confidence            776543211     2226888999999985      55677899999999999999998888766555554443322   


Q ss_pred             CCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          317 QPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       317 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      .+.++-...+.++...+..|++.++-.|++++++++|+++...
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            3444445567788889999999999999999999999998843

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.76  E-value=4.6e-18  Score=151.32  Aligned_cols=136  Identities=16%  Similarity=0.268  Sum_probs=102.6

Q ss_pred             cceec-ccCCceEEEEEeCCCCcEEEEEEecCCC------------chHHHHHHHHHHHHHHhCCCCce--eeeEeEEee
Q 016959          104 GNRIG-SGSGGTVWRVVHPPTSRVFALKVIYGNH------------EDSVRSQICREIEILRDVNHPNV--VKCHDMYDR  168 (380)
Q Consensus       104 ~~~LG-~G~~g~V~~~~~~~~~~~~avK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~  168 (380)
                      ...|| .|+.|+||.+..  .+..++||.+....            ......++.+|+.++..|+|++|  +..+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            35688 999999999988  47789999874311            11234567889999999988774  666766433


Q ss_pred             C-Ce---EEEEEeccCC-CCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 016959          169 N-GE---IEVLLEYMDG-GSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI  242 (380)
Q Consensus       169 ~-~~---~~lv~e~~~~-~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  242 (380)
                      . +.   .++|||+++| .+|..++... ..-...+.||+.+|.+||++||+||||||+|||++.++.++|+|||.+..
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEA-PLSEEQWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            2 22   3599999997 5776554332 11123467899999999999999999999999999989999999998754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.65  E-value=4.5e-17  Score=163.18  Aligned_cols=275  Identities=24%  Similarity=0.335  Sum_probs=204.3

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCch--HHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED--SVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      ...+.+.+.+-+-.|.++.++.+.-..+|...++|+.......  ...+.+..+-.++-...+|.++...--+......+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            4567778888899999999999998888877777776433211  11222333333333345677776655555667899


Q ss_pred             EEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc----
Q 016959          174 VLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ----  245 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----  245 (380)
                      ++++|..+++|...++.    .....+.....+.++++|||...+.|+|++|.|+|+..+++.++.|||......-    
T Consensus       881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~  960 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT  960 (1205)
T ss_pred             hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence            99999999988766554    3344566788899999999999999999999999999999999999984432110    


Q ss_pred             --c-------------------------CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 016959          246 --T-------------------------MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF  298 (380)
Q Consensus       246 --~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf  298 (380)
                        .                         ........||+.|.+||.+.     +......+|+|++|++++|.++|..||
T Consensus       961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l-----g~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL-----GRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccc-----cccCCCcchhhhhhhhhhhhhcCCCCC
Confidence              0                         00123456999999999874     455566899999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHH---HHhcCccccccCcccccccccccCCCC
Q 016959          299 AVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAA---QLLQHPFILRAGQSQVNQNLRQILPPP  375 (380)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~---eil~hp~~~~~~~~~~~~~~~~~~~~~  375 (380)
                      ..........-+... ....+..+...+.++.+++.++|..++.+|..+.   ++-.|+||+..+|..+.....+++|-+
T Consensus      1036 na~tpq~~f~ni~~~-~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~ 1114 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNR-DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQKAEFVPQP 1114 (1205)
T ss_pred             CCcchhhhhhccccC-CCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccccccCccCCCC
Confidence            644333322111111 1112345566888999999999999999999987   999999999999999999999999876


Q ss_pred             C
Q 016959          376 R  376 (380)
Q Consensus       376 ~  376 (380)
                      -
T Consensus      1115 ~ 1115 (1205)
T KOG0606|consen 1115 E 1115 (1205)
T ss_pred             C
Confidence            4

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.64  E-value=6.8e-15  Score=142.08  Aligned_cols=139  Identities=21%  Similarity=0.294  Sum_probs=96.9

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHH---------------------------------H------HHH
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR---------------------------------S------QIC  145 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~---------------------------------~------~~~  145 (380)
                      +-||.|++|.||+|+.. +|+.||||+.+....+...                                 .      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            56999999999999975 7899999998644211110                                 0      133


Q ss_pred             HHHHHHHhC----CCCceeeeEeEE-eeCCeEEEEEeccCCCCcccccccc--hHHHHHHHHHHHH-HHHHHHhCCceec
Q 016959          146 REIEILRDV----NHPNVVKCHDMY-DRNGEIEVLLEYMDGGSLEGAHIRQ--EHILSDLARQVLS-GLAYLHKRKIVHR  217 (380)
Q Consensus       146 ~E~~~l~~l----~h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~i~~qi~~-al~~LH~~~ivH~  217 (380)
                      +|...+.++    ++.+-+.+-.++ +.....++||||++|++|.+.....  ......++.+++. .+..+|..|++|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~g~~H~  281 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRDGFFHA  281 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhCCceeC
Confidence            455444444    222223322222 2234568999999999987764321  1123456666666 5788999999999


Q ss_pred             CCCCCcEEEcCCCcEEEeecccccccc
Q 016959          218 DIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       218 Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      |+||.||+++.++.++++|||++..+.
T Consensus       282 D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       282 DLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.62  E-value=3.9e-15  Score=145.55  Aligned_cols=144  Identities=16%  Similarity=0.240  Sum_probs=92.0

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCch---------------------------------HHHHHHHH
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED---------------------------------SVRSQICR  146 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---------------------------------~~~~~~~~  146 (380)
                      +|+. +-||.|++|.||+|+.+.+|+.||||+++....+                                 +..+.+.+
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4555 6799999999999999888999999999644211                                 11222334


Q ss_pred             HHHHHHh------C----CCCceeeeEeEEe-eCCeEEEEEeccCCCCccccccc--chHHHHHHHHHHH-HHHHHHHhC
Q 016959          147 EIEILRD------V----NHPNVVKCHDMYD-RNGEIEVLLEYMDGGSLEGAHIR--QEHILSDLARQVL-SGLAYLHKR  212 (380)
Q Consensus       147 E~~~l~~------l----~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~i~~qi~-~al~~LH~~  212 (380)
                      |+.+++.      +    .+.+.+.+-.+|. -....++||||+.|+.+.+....  .......++...+ .-+..+...
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~~  279 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFRD  279 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHhC
Confidence            4443333      2    1222233223222 23456799999999988653211  1111112222222 223345579


Q ss_pred             CceecCCCCCcEEEcCCC----cEEEeecccccccc
Q 016959          213 KIVHRDIKPSNLLINSSK----NVKIADFGVSRILA  244 (380)
Q Consensus       213 ~ivH~Dlkp~Nil~~~~~----~~kl~Dfg~a~~~~  244 (380)
                      |++|+|+||.||+++.+|    .++++|||++..+.
T Consensus       280 GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        280 GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            999999999999999888    89999999987664

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.61  E-value=1e-14  Score=140.72  Aligned_cols=168  Identities=18%  Similarity=0.272  Sum_probs=129.7

Q ss_pred             EEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCCCccccc-ccchHHH
Q 016959          117 RVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAH-IRQEHIL  195 (380)
Q Consensus       117 ~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-~~~~~~~  195 (380)
                      .|..+.++..|.|.+++.... .....+.+-++.|+.++||||+++++.++.++.+|+|+|.+.-..  ..+ ......+
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~--~~lk~l~~~~v  106 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLE--TVLKELGKEEV  106 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHH--HHHHHhHHHHH
Confidence            466677888899998866655 555667788999999999999999999999999999999997533  111 1224556


Q ss_pred             HHHHHHHHHHHHHHH-hCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCCccccccccccccCCCCC
Q 016959          196 SDLARQVLSGLAYLH-KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY  274 (380)
Q Consensus       196 ~~i~~qi~~al~~LH-~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  274 (380)
                      ...+.||+.||.||| +++++|++|....|+|+..|..||++|.++...............-..|..|+.+...      
T Consensus       107 ~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s------  180 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS------  180 (690)
T ss_pred             HHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc------
Confidence            677899999999997 5789999999999999999999999999886554333222223333456777765321      


Q ss_pred             CCcchhHHHHHHHHHHHHhC
Q 016959          275 DGYAGDIWSLGVSILEFYLG  294 (380)
Q Consensus       275 ~~~~~DvwslG~il~ell~g  294 (380)
                       .-..|.|.|||++++++.|
T Consensus       181 -~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 -EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -ccchhhhhHHHHHHHHhCc
Confidence             0237999999999999998

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.59  E-value=9.1e-15  Score=123.42  Aligned_cols=126  Identities=15%  Similarity=0.219  Sum_probs=95.7

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCce-eeeEeEEeeCCeEEEEEeccCCCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV-VKCHDMYDRNGEIEVLLEYMDGGS  183 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~  183 (380)
                      +.|+.|.++.||++..  .++.|++|+......  ....+..|+.+++.+.+.++ .+++.+..  ...++||||++|.+
T Consensus         4 ~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           4 SPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eecCCcccCceEEEEE--CCeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            5689999999999987  478899999754432  12345688999988865443 34554433  23479999999988


Q ss_pred             cccccccchHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          184 LEGAHIRQEHILSDLARQVLSGLAYLHKRKI-----VHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       184 L~~~~~~~~~~~~~i~~qi~~al~~LH~~~i-----vH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                      +.....    ....++.+++.+|..||..++     +|+|++|.||+++ ++.++++|||.+.
T Consensus        78 l~~~~~----~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          78 LLTEDF----SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccccc----cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            875411    123467899999999999985     9999999999999 6789999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.56  E-value=9.5e-14  Score=118.54  Aligned_cols=135  Identities=18%  Similarity=0.192  Sum_probs=98.8

Q ss_pred             cceecccCCceEEEEEeCC------CCcEEEEEEecCCC------------c---------hHHHHHH----HHHHHHHH
Q 016959          104 GNRIGSGSGGTVWRVVHPP------TSRVFALKVIYGNH------------E---------DSVRSQI----CREIEILR  152 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~------~~~~~avK~~~~~~------------~---------~~~~~~~----~~E~~~l~  152 (380)
                      ...||.|.-+.||.|....      .+..+|||+.+...            +         ...+..+    .+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3569999999999998653      35789999974210            0         1112233    38999999


Q ss_pred             hCC--CCceeeeEeEEeeCCeEEEEEeccCCCCc-----ccccccchHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcE
Q 016959          153 DVN--HPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYL-HKRKIVHRDIKPSNL  224 (380)
Q Consensus       153 ~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~~L-----~~~~~~~~~~~~~i~~qi~~al~~L-H~~~ivH~Dlkp~Ni  224 (380)
                      ++.  .-++...+++    ...++||||+.+..+     .+. ...+.....+..+++.+|..| |..||||+||++.||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            984  3456666654    456899999987533     222 223345667889999999999 899999999999999


Q ss_pred             EEcCCCcEEEeecccccccc
Q 016959          225 LINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       225 l~~~~~~~kl~Dfg~a~~~~  244 (380)
                      |++ ++.+.|+|||.+....
T Consensus       157 L~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         157 LWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEE-CCcEEEEECCCceeCC
Confidence            997 5789999999887554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.47  E-value=3.1e-14  Score=136.11  Aligned_cols=246  Identities=21%  Similarity=0.204  Sum_probs=176.5

Q ss_pred             ccccccceecccCCceEEEEEeC-CCCcEEEEEEecCCCchHH-HHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHP-PTSRVFALKVIYGNHEDSV-RSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  175 (380)
                      .+|..+..||.|.|+.|+.+..+ .++..|++|.+........ ...-..|+.+...+. |.+++.....|...+..|+-
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            45667788999999999998766 6788999998865432222 122245676666664 89999988888887888899


Q ss_pred             EeccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CcEEEeeccccccccccCCCC
Q 016959          176 LEYMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS-KNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       176 ~e~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      .|||.++++....    ...+..++.+..|++.++.++|+..++|+|+||.||++..+ +..++.|||+.+.+....   
T Consensus       345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~---  421 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS---  421 (524)
T ss_pred             hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec---
Confidence            9999998865432    22455678899999999999999999999999999999875 789999999987543221   


Q ss_pred             CCCCCCCccc-cccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHH
Q 016959          251 NSAVGTIAYM-SPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       251 ~~~~gt~~y~-aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      ....+..+++ ..|++..    ...+..+.|+++||..+.+.++|...-....  .+..    +.... .........++
T Consensus       422 ~~~~~~~r~~p~~~~~~e----~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--~~~~----i~~~~-~p~~~~~~~~~  490 (524)
T KOG0601|consen  422 GVFHHIDRLYPIAEILLE----DYPHLSKADIFSLGLSVDEAITGSPLSESGV--QSLT----IRSGD-TPNLPGLKLQL  490 (524)
T ss_pred             ccccccccccccchhhcc----ccccccccccccccccccccccCcccCcccc--ccee----eeccc-ccCCCchHHhh
Confidence            1222334444 3565543    2445668999999999999998765443111  1111    11111 22222333788


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccccc
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQHPFILR  358 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~hp~~~~  358 (380)
                      ..+.+.++..++..|+.+.++..|.=|..
T Consensus       491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  491 QVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             hhhhhhhcCCccccchhhhhhcccchhhh
Confidence            89999999999999999999988876654

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.42  E-value=1.8e-12  Score=107.13  Aligned_cols=132  Identities=23%  Similarity=0.280  Sum_probs=96.9

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEe-cCCC------chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVI-YGNH------EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~-~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ..+++|+-+.+|.+.+  -|..+++|.= .+..      ..-..++..+|..++.++.--.|..-+=++.+.+...|+||
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            4588999999999977  4555677753 2211      12234567789999988853333332323444566789999


Q ss_pred             ccCCCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 016959          178 YMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI  242 (380)
Q Consensus       178 ~~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  242 (380)
                      |++|..|.+.+...   ...++..+-.-+.-||..||+|+||.+.||++..++ +.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~---~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA---RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc---chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99998887666554   245788888899999999999999999999998554 99999999863

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.40  E-value=2.9e-12  Score=112.81  Aligned_cols=136  Identities=21%  Similarity=0.282  Sum_probs=103.2

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCC--CceeeeEeEEeeC---CeEEEEEecc
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH--PNVVKCHDMYDRN---GEIEVLLEYM  179 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~---~~~~lv~e~~  179 (380)
                      +.||.|.++.||++... +|+.|++|+............+..|+.+++.+.+  .++.+++.+....   +..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            56899999999999874 3578999997544322234567899999999965  3456677766553   3678999999


Q ss_pred             CCCCcccccc---cchHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 016959          180 DGGSLEGAHI---RQEHILSDLARQVLSGLAYLHK---------------------------------------------  211 (380)
Q Consensus       180 ~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~---------------------------------------------  211 (380)
                      .|.++.....   ........++.+++.+|..||+                                             
T Consensus        83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (223)
T cd05154          83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR  162 (223)
T ss_pred             CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence            9998877653   3445566677788888887773                                             


Q ss_pred             -----------CCceecCCCCCcEEEcC--CCcEEEeeccccc
Q 016959          212 -----------RKIVHRDIKPSNLLINS--SKNVKIADFGVSR  241 (380)
Q Consensus       212 -----------~~ivH~Dlkp~Nil~~~--~~~~kl~Dfg~a~  241 (380)
                                 ..++|+|+++.|||++.  ++.+.|+||+.+.
T Consensus       163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                       23699999999999998  5668999999875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=5.3e-13  Score=118.62  Aligned_cols=198  Identities=22%  Similarity=0.347  Sum_probs=134.6

Q ss_pred             HhCCCCceeeeEeEEeeC-----CeEEEEEeccCCCCcccccccc--------hHHHHHHHHHHHHHHHHHHhCC--cee
Q 016959          152 RDVNHPNVVKCHDMYDRN-----GEIEVLLEYMDGGSLEGAHIRQ--------EHILSDLARQVLSGLAYLHKRK--IVH  216 (380)
Q Consensus       152 ~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~i~~qi~~al~~LH~~~--ivH  216 (380)
                      -.+.|-|||+++.+|.+.     .+..++.||+..|++..+++..        .....+|+.||+.||.|||+..  |+|
T Consensus       122 lqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiih  201 (458)
T KOG1266|consen  122 LQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIH  201 (458)
T ss_pred             HHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcccc
Confidence            344699999999998653     4588999999999998776653        2345689999999999999985  999


Q ss_pred             cCCCCCcEEEcCCCcEEEeeccccccccccCC-----CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHH
Q 016959          217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMD-----PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF  291 (380)
Q Consensus       217 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~el  291 (380)
                      +++..+-|++..+|-+|+.--... .......     ......+-++|.+||.=..     ...+-.+|||++|+-..+|
T Consensus       202 gnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-----tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  202 GNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTT-----TNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcc-----cccccchhhhhhhHHHHHH
Confidence            999999999998888887521111 1111000     1122346788999996321     2223479999999999998


Q ss_pred             HhCCCCCCCCC-CCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          292 YLGRFPFAVGR-QGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       292 l~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      ..+..--.... .......+.......       -+.--++++.+||+..|..||++.++|-||.+-...-.
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~i~~l-------en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhsl  340 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANVIIGL-------ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSL  340 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhheeec-------cCccccCcCcccccCCCCCCcchhhhhcCceeeecchH
Confidence            77654322111 111122222221111       12234578999999999999999999999988766443

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.33  E-value=6.8e-11  Score=108.88  Aligned_cols=242  Identities=17%  Similarity=0.190  Sum_probs=156.3

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeE-----E--eeCCe
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDM-----Y--DRNGE  171 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~-----~--~~~~~  171 (380)
                      -+..++-||+|+-+.+|..-..  +.. +.|++....... ..+.   +..|... .||-+-.-+.|     +  ..+..
T Consensus        12 ~i~~gr~LgqGgea~ly~l~e~--~d~-VAKIYh~Pppa~-~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          12 PIPPGRPLGQGGEADLYTLGEV--RDQ-VAKIYHAPPPAA-QAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             ccCCCccccCCccceeeecchh--hch-hheeecCCCchH-HHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            3456788999999999976442  223 447765433222 2222   2223333 46533321211     1  12234


Q ss_pred             EEEEEeccCCCCc-----------ccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccc
Q 016959          172 IEVLLEYMDGGSL-----------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS  240 (380)
Q Consensus       172 ~~lv~e~~~~~~L-----------~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  240 (380)
                      +.++|..+.|..-           ..+.......+...++.|+.+.+.||..|.+-+|+.++|+||.+++.+.|.|=...
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence            7788888876521           11222245668889999999999999999999999999999999999999975533


Q ss_pred             ccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCC-----CCCCHHHHHHHHh
Q 016959          241 RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLG-RFPFAVG-----RQGDWASLMFAIC  314 (380)
Q Consensus       241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g-~~pf~~~-----~~~~~~~~~~~~~  314 (380)
                      ... .........+|...|.+||.-+-....+..-+...|.|.||+++++++.| +.||...     ..+..+..+....
T Consensus       165 qi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         165 QIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             eec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            222 22233456789999999998764445555566789999999999998876 9999732     2222222222222


Q ss_pred             hCC-----------CC-CCCccccHHHHHHHHHhccc--CcCCCCCHHH
Q 016959          315 FAQ-----------PP-EAPEMASREFRDFISRCLQK--DPHSRWPAAQ  349 (380)
Q Consensus       315 ~~~-----------~~-~~~~~~~~~~~~li~~~l~~--dp~~R~t~~e  349 (380)
                      +..           +. ..+..+++++..|..+|+..  ++.-|||++.
T Consensus       244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            111           11 12345788999999999975  3668999754

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.33  E-value=1.3e-11  Score=101.74  Aligned_cols=138  Identities=22%  Similarity=0.339  Sum_probs=99.8

Q ss_pred             ccceecccCCceEEEEEeCCCCcEEEEEEec-CC--C----chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959          103 KGNRIGSGSGGTVWRVVHPPTSRVFALKVIY-GN--H----EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus       103 ~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~-~~--~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      ....|-+|+-+.|+++.+  .|+.++||.-. +.  +    ..-.+.+..+|+++|.++.--.|.--.=+|.+...-.++
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            456789999999999998  78888888632 11  1    223456778899999888533333222234455556899


Q ss_pred             EeccCCC-Cccccccc-----c-hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc---EEEeecccccc
Q 016959          176 LEYMDGG-SLEGAHIR-----Q-EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN---VKIADFGVSRI  242 (380)
Q Consensus       176 ~e~~~~~-~L~~~~~~-----~-~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~---~kl~Dfg~a~~  242 (380)
                      |||++|- ++.+++..     . +.....++.+|-+.+.-||.++|||+||..+||++..++.   +.++|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9999883 34444332     1 2234678999999999999999999999999999986664   58999999753

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=1.2e-12  Score=127.17  Aligned_cols=156  Identities=25%  Similarity=0.319  Sum_probs=115.3

Q ss_pred             HHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEeeccccccccccCCC---------CCCCCCCCcccccccccccc
Q 016959          200 RQVLSGLAYLHKR-KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP---------CNSAVGTIAYMSPERINTDL  269 (380)
Q Consensus       200 ~qi~~al~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~  269 (380)
                      .+++.|+.|+|.. ++||++|.|++|.++..+..||+.|+++.........         ..-..-...|.|||++..  
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~--  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG--  183 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc--
Confidence            3445899999975 9999999999999999999999999998654432111         011124568999999864  


Q ss_pred             CCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHH
Q 016959          270 NHGKYDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAA  348 (380)
Q Consensus       270 ~~~~~~~~~~DvwslG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~  348 (380)
                         ..-+.++|+|||||++|.++ .|+.-+..........................++.++++=|.+++..|..-||++.
T Consensus       184 ---~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~  260 (700)
T KOG2137|consen  184 ---TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLD  260 (700)
T ss_pred             ---ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchh
Confidence               33456899999999999998 55555543333333333222222223344567899999999999999999999999


Q ss_pred             HHhcCccccccC
Q 016959          349 QLLQHPFILRAG  360 (380)
Q Consensus       349 eil~hp~~~~~~  360 (380)
                      +++..|||.+..
T Consensus       261 ~l~~~~ff~D~~  272 (700)
T KOG2137|consen  261 LLLSIPFFSDPG  272 (700)
T ss_pred             hhhcccccCCch
Confidence            999999998863

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.28  E-value=8.3e-11  Score=100.10  Aligned_cols=125  Identities=24%  Similarity=0.336  Sum_probs=83.2

Q ss_pred             eEEEEEeCCCCcEEEEEEecCC-------------------------CchHHHHHHHHHHHHHHhCCCC--ceeeeEeEE
Q 016959          114 TVWRVVHPPTSRVFALKVIYGN-------------------------HEDSVRSQICREIEILRDVNHP--NVVKCHDMY  166 (380)
Q Consensus       114 ~V~~~~~~~~~~~~avK~~~~~-------------------------~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~~  166 (380)
                      .||.|... .|..+|||+.+..                         ..........+|.+.|+++..-  ++.+.+++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            48888873 6779999997421                         0111234577899999999744  566666542


Q ss_pred             eeCCeEEEEEeccC--CCCcccccccc--hHHHHHHHHHHHHHHHH-HHhCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          167 DRNGEIEVLLEYMD--GGSLEGAHIRQ--EHILSDLARQVLSGLAY-LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       167 ~~~~~~~lv~e~~~--~~~L~~~~~~~--~~~~~~i~~qi~~al~~-LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                          ..++||||++  |..+..+....  ......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|||.+.
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav  154 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAV  154 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEE
T ss_pred             ----CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcce
Confidence                2379999999  65554433322  34566788888885555 579999999999999999976 89999999886


Q ss_pred             ccc
Q 016959          242 ILA  244 (380)
Q Consensus       242 ~~~  244 (380)
                      ...
T Consensus       155 ~~~  157 (188)
T PF01163_consen  155 DSS  157 (188)
T ss_dssp             ETT
T ss_pred             ecC
Confidence            543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.26  E-value=2.3e-10  Score=107.92  Aligned_cols=210  Identities=15%  Similarity=0.243  Sum_probs=149.2

Q ss_pred             CCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEe----eCCeEEEEEeccCCC-Ccc
Q 016959          111 SGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYD----RNGEIEVLLEYMDGG-SLE  185 (380)
Q Consensus       111 ~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~~-~L~  185 (380)
                      --.+.|++....+|..|++|++........ .....-++.++++.|.|||.+.++|.    .+..+++|++|.++- +|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQST-NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCc-ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            345789999999999999999944332221 12223477899999999999999876    345689999998763 332


Q ss_pred             c-------------------ccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          186 G-------------------AHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       186 ~-------------------~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      +                   -....|..+|.++.|+..||.++|+.|+.-+-|.+.+||++.+.+++|...|+...+...
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            1                   122246789999999999999999999999999999999998888999888876554432


Q ss_pred             CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcccc
Q 016959          247 MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS  326 (380)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (380)
                      .       +       |-+..        ..+-|.-.||.+++.|.||..--.   ..+.......      .......+
T Consensus       447 ~-------~-------~~le~--------~Qq~D~~~lG~ll~aLAt~~~ns~---~~d~~~~s~~------~~I~~~yS  495 (655)
T KOG3741|consen  447 P-------T-------EPLES--------QQQNDLRDLGLLLLALATGTENSN---RTDSTQSSHL------TRITTTYS  495 (655)
T ss_pred             C-------C-------cchhH--------HhhhhHHHHHHHHHHHhhcccccc---cccchHHHHH------HHhhhhhh
Confidence            1       0       11111        125799999999999999964211   1121111100      11234567


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          327 REFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      .+++++|.-+...++++ -++.++|.+
T Consensus       496 ~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  496 TDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            89999999999888887 777777754

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.25  E-value=1.7e-10  Score=103.92  Aligned_cols=135  Identities=16%  Similarity=0.154  Sum_probs=94.2

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHH----------HHHHHHHHHHhCC--CCceeeeEeEEee----
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS----------QICREIEILRDVN--HPNVVKCHDMYDR----  168 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~----------~~~~E~~~l~~l~--h~~iv~~~~~~~~----  168 (380)
                      +.+-......|+++..  .|+.|.||...........+          .+.+|...+.+|.  .-.+...+.+.+.    
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            4454445556777776  67889999764332111111          3678998888874  2223344444432    


Q ss_pred             -CCeEEEEEeccCCC-Ccccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-------CCcEE
Q 016959          169 -NGEIEVLLEYMDGG-SLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS-------SKNVK  233 (380)
Q Consensus       169 -~~~~~lv~e~~~~~-~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~-------~~~~k  233 (380)
                       ....++|+|++++. +|.++..      ..+.....++.+++..+.-||..||+|+||++.|||++.       +..+.
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~  185 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLS  185 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEE
Confidence             23578999999885 6655532      123456689999999999999999999999999999985       45799


Q ss_pred             Eeeccccc
Q 016959          234 IADFGVSR  241 (380)
Q Consensus       234 l~Dfg~a~  241 (380)
                      |+||+.+.
T Consensus       186 LIDl~r~~  193 (268)
T PRK15123        186 VIDLHRAQ  193 (268)
T ss_pred             EEECCccc
Confidence            99999874

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.20  E-value=2.7e-10  Score=99.93  Aligned_cols=136  Identities=22%  Similarity=0.324  Sum_probs=101.7

Q ss_pred             cccceecccCCceEEEEEeCCCCcEEEEEEecCCCc---------------------hHHHHHHHHHHHHHHhCCCC--c
Q 016959          102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE---------------------DSVRSQICREIEILRDVNHP--N  158 (380)
Q Consensus       102 ~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---------------------~~~~~~~~~E~~~l~~l~h~--~  158 (380)
                      .++..||-|.-+.||.|.+. .|..+|||.-+....                     .-.+....+|.++|++|...  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            45788999999999999986 688999997532110                     11234467899999999633  5


Q ss_pred             eeeeEeEEeeCCeEEEEEeccCCCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecc
Q 016959          159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFG  238 (380)
Q Consensus       159 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  238 (380)
                      +.+-+++    +...+|||+++|..|..... .......++..|++-+.-+-..||||+|+.+-||++++||.+.++||-
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~-~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwP  247 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLRL-DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWP  247 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecccC-cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCc
Confidence            6666553    56789999999988876653 223344456666666666669999999999999999999999999998


Q ss_pred             ccccc
Q 016959          239 VSRIL  243 (380)
Q Consensus       239 ~a~~~  243 (380)
                      -+...
T Consensus       248 Q~v~~  252 (304)
T COG0478         248 QAVPI  252 (304)
T ss_pred             ccccC
Confidence            76543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.04  E-value=1.8e-09  Score=94.12  Aligned_cols=102  Identities=23%  Similarity=0.272  Sum_probs=78.1

Q ss_pred             HHHHHHHHHHHHhCC--CCceeeeEeEEeeC----CeEEEEEeccCCC-Cccccccc----chHHHHHHHHHHHHHHHHH
Q 016959          141 RSQICREIEILRDVN--HPNVVKCHDMYDRN----GEIEVLLEYMDGG-SLEGAHIR----QEHILSDLARQVLSGLAYL  209 (380)
Q Consensus       141 ~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~----~~~~lv~e~~~~~-~L~~~~~~----~~~~~~~i~~qi~~al~~L  209 (380)
                      ..+..+|...+..|.  .-.+.+.+++.+..    ...++|+|++++. +|.++...    .......++.+++..+.-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            345778888877774  23344455554432    2468999999874 67666554    4556778999999999999


Q ss_pred             HhCCceecCCCCCcEEEcCCC---cEEEeecccccc
Q 016959          210 HKRKIVHRDIKPSNLLINSSK---NVKIADFGVSRI  242 (380)
Q Consensus       210 H~~~ivH~Dlkp~Nil~~~~~---~~kl~Dfg~a~~  242 (380)
                      |.+||+|+|+++.|||++.++   .+.|+||+-+..
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999999999999999887   799999997754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.96  E-value=1.8e-08  Score=86.81  Aligned_cols=137  Identities=19%  Similarity=0.224  Sum_probs=88.6

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHH--H------HHHHHHHHHHHhCC---CCceeeeEeEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSV--R------SQICREIEILRDVN---HPNVVKCHDMY  166 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~--~------~~~~~E~~~l~~l~---h~~iv~~~~~~  166 (380)
                      ..+|.+.+++-......|.+..-  +|+.+++|..+.......  .      ....+++..+.++.   ...+..++-+.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            44566666776666666776666  678899998754321111  0      01223333333332   22333322222


Q ss_pred             -----eeCCeEEEEEeccCCCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          167 -----DRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       167 -----~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                           ......+++|||++|..|.+.....+    .++..|.+++.-||..|++|+|.+|.|++++.+ .++++||+..+
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~  182 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIEDIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR  182 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchhcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence                 22345678999999998877654443    245667788999999999999999999999954 49999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.95  E-value=1.2e-08  Score=90.19  Aligned_cols=129  Identities=18%  Similarity=0.275  Sum_probs=84.1

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCC--ceeeeEeEEeeCCeEEEEEeccCCC
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHP--NVVKCHDMYDRNGEIEVLLEYMDGG  182 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~  182 (380)
                      ..||+|..+.||+.    .+..+++|......   ....+.+|.++++.+..-  .+.+.+++.+..+...+|||+++|.
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            46899999999984    24467889875433   234568899999888533  3567777777778889999999996


Q ss_pred             C-cccccccchHHHHHHHHHHHHHH---------------------------------------HHHHh----CCceecC
Q 016959          183 S-LEGAHIRQEHILSDLARQVLSGL---------------------------------------AYLHK----RKIVHRD  218 (380)
Q Consensus       183 ~-L~~~~~~~~~~~~~i~~qi~~al---------------------------------------~~LH~----~~ivH~D  218 (380)
                      . +.............++.+++..+                                       .+|..    ..++|+|
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            3 22111111111111111111111                                       22221    2468999


Q ss_pred             CCCCcEEEcCCCcEEEeeccccc
Q 016959          219 IKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       219 lkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                      +.|.||++++++ +.|+||+.+.
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcC
Confidence            999999999888 9999999774

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.81  E-value=1.1e-07  Score=82.94  Aligned_cols=132  Identities=18%  Similarity=0.224  Sum_probs=94.0

Q ss_pred             eecccCCceEEEEEeCCCCcEEEEEEecCCCch-----------------------HHHHHHHHHHHHHHhCC--CCcee
Q 016959          106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED-----------------------SVRSQICREIEILRDVN--HPNVV  160 (380)
Q Consensus       106 ~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~--h~~iv  160 (380)
                      .|..|.-++||+|.. .+++.+|||+++.....                       ........|+.-|+++.  +-.+.
T Consensus        55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            577888889999886 46889999998532111                       01112346777787773  44455


Q ss_pred             eeEeEEeeCCeEEEEEeccCCC-----CcccccccchHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEE
Q 016959          161 KCHDMYDRNGEIEVLLEYMDGG-----SLEGAHIRQEHILSDLARQVLSGLAYLHK-RKIVHRDIKPSNLLINSSKNVKI  234 (380)
Q Consensus       161 ~~~~~~~~~~~~~lv~e~~~~~-----~L~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~Nil~~~~~~~kl  234 (380)
                      +-+.+.    .-.+||||+...     .|.+.....+ ....+..++++.+.-|-. .|+||+||+.-|||+. ++.+.+
T Consensus       134 ~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~-e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i  207 (268)
T COG1718         134 EPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELE-EAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI  207 (268)
T ss_pred             Cceeec----CCeEEEEeccCCCCCCCCcccCCcCch-hHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence            555543    347999999754     2333333333 566778889999888866 8999999999999999 889999


Q ss_pred             eecccccccc
Q 016959          235 ADFGVSRILA  244 (380)
Q Consensus       235 ~Dfg~a~~~~  244 (380)
                      +|||-|....
T Consensus       208 ID~~QaV~~~  217 (268)
T COG1718         208 IDVSQAVTID  217 (268)
T ss_pred             EECccccccC
Confidence            9999987654

>PRK09902 hypothetical protein; Provisional

Probab=98.81  E-value=4.6e-08  Score=83.98  Aligned_cols=132  Identities=14%  Similarity=0.135  Sum_probs=93.8

Q ss_pred             ecccCCceEEEEEeCCCCcEEEEEEecCCC----c-hHHHHHHHHHHHHHHhCC--CCceeeeEeEEee-----CCeEEE
Q 016959          107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH----E-DSVRSQICREIEILRDVN--HPNVVKCHDMYDR-----NGEIEV  174 (380)
Q Consensus       107 LG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~-~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~-----~~~~~l  174 (380)
                      -|+||.+.|++...  .|+.|-+|.-....    - +.-...|.+|+..|+.|.  .-.+.+.. ++..     .-..+|
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            57789999999887  45578888753110    0 224567889999999884  22244444 3321     124678


Q ss_pred             EEeccCC-CCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc--EEEeeccccc
Q 016959          175 LLEYMDG-GSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN--VKIADFGVSR  241 (380)
Q Consensus       175 v~e~~~~-~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~  241 (380)
                      |+|-+.| .+|.+++..      .......++.+++.++.-||+.|+.|+|+.+.||+++.+|.  ++++||.-++
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            8997764 456544322      34455689999999999999999999999999999987777  9999998654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.77  E-value=4.9e-08  Score=95.36  Aligned_cols=140  Identities=21%  Similarity=0.276  Sum_probs=91.0

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCCch---------------------------------HHHHH------HH
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED---------------------------------SVRSQ------IC  145 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---------------------------------~~~~~------~~  145 (380)
                      +-|+.++-|.||+|+.. +|+.||||+.+.+-.+                                 +..+.      +.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            45889999999999996 5999999997433111                                 11112      23


Q ss_pred             HHHHHHHhCC-----CCceeeeEeEEeeCCeEEEEEeccCCCCcccccccc--hHHHHHHHHHHHHH-HHHHHhCCceec
Q 016959          146 REIEILRDVN-----HPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ--EHILSDLARQVLSG-LAYLHKRKIVHR  217 (380)
Q Consensus       146 ~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~i~~qi~~a-l~~LH~~~ivH~  217 (380)
                      +|...+.++.     .+++.--.=+++-.+.-.++|||++|..+.+.....  ......++..++++ +..+=..|++|.
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~dgffHa  289 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRDGFFHA  289 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhcCcccc
Confidence            3444444431     333332222344456678999999998877663322  12233344443332 334445899999


Q ss_pred             CCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          218 DIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       218 Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      |.+|.||+++.+|++.+.|||+...+..
T Consensus       290 DpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         290 DPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CCCccceEEecCCcEEEEcCcceecCCH
Confidence            9999999999999999999999876643

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.74  E-value=5.8e-08  Score=80.04  Aligned_cols=132  Identities=25%  Similarity=0.308  Sum_probs=94.7

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEecc
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYM  179 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  179 (380)
                      .....+.||+|++|.||+|.+  .|..+|+|+-+.   +..+..+..|.++|..++-.++..=+-.+.   ...+.|||.
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~---ds~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i   94 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRR---DSPRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYI   94 (201)
T ss_pred             hhhhhhhhhcccccEEEEeec--cCceEEEEEecC---CcchhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhh
Confidence            345567899999999999999  677899998543   344677889999999998665554332222   224559999


Q ss_pred             CCCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCC-CCcEEEcCCCcEEEeecccccc
Q 016959          180 DGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIK-PSNLLINSSKNVKIADFGVSRI  242 (380)
Q Consensus       180 ~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlk-p~Nil~~~~~~~kl~Dfg~a~~  242 (380)
                      .|..|..+....+   .+-...++++---|-..||-|+.|. |..++|..++.+.|+||.-|+.
T Consensus        95 ~G~~L~~~~~~~~---rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          95 DGRPLGKLEIGGD---RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             cCcchhhhhhccc---HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            9988766544311   2234556666666778899999997 6656666677999999998873

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.70  E-value=1.8e-09  Score=104.35  Aligned_cols=236  Identities=24%  Similarity=0.194  Sum_probs=164.3

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCc-eeeeEeEEeeCCeEEEEEecc
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN-VVKCHDMYDRNGEIEVLLEYM  179 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~  179 (380)
                      +...+.+++|+++++++.+...+...+ .+++...      ....-++++|.+++||| .+..++-++.+...+++++++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            344567999999999999887665554 7776332      33445788999999999 777777777788899999999


Q ss_pred             CCC-Ccccccccch-----HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          180 DGG-SLEGAHIRQE-----HILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       180 ~~~-~L~~~~~~~~-----~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      .++ +........+     -++..+.+.-++++++||+.--+|+|    ||+.. .+..+..||+....+.... ..++.
T Consensus       317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~-~~~t~  390 (829)
T KOG0576|consen  317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTM-KPRTA  390 (829)
T ss_pred             cCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCccc-ccccC
Confidence            987 3332322222     23445667778899999998878998    77776 4779999999998887664 34677


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc-----c-H
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA-----S-R  327 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~-~  327 (380)
                      .+++.++|||++..     ..+....|.|++|.-..++.-|..|-.......       ......+..+...     + .
T Consensus       391 ~~~~~~~~pev~~~-----~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~-------~~~g~~p~s~~L~~~~aw~~~  458 (829)
T KOG0576|consen  391 IGTPEPLAPEVIQE-----NTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAVL-------PMIGNGPNSPMLTDKSAWSPV  458 (829)
T ss_pred             CCCCCCCCchhhcc-----cccccCCCccCCCcchhhcCCCCCCCCCCcccc-------CCCCCCCCccccchhhhcCcc
Confidence            89999999998754     233346899999986666776766654210000       0000000000000     0 1


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      .-+++...|+..-|..|++.-.++-|.+|.+-+.
T Consensus       459 ~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl  492 (829)
T KOG0576|consen  459 FHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL  492 (829)
T ss_pred             cccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence            1225778899999999999999999999987544

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.66  E-value=3.1e-07  Score=82.24  Aligned_cols=129  Identities=19%  Similarity=0.166  Sum_probs=81.2

Q ss_pred             ecccCC-ceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEEEEeccCCCCc
Q 016959          107 IGSGSG-GTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEVLLEYMDGGSL  184 (380)
Q Consensus       107 LG~G~~-g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  184 (380)
                      |-.|.+ ..||++...  +..++||+.....    ...+.+|+.+++.+. +--+.+++++....+..++|||+++|..|
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            444555 689999763  4678889874332    234667888888884 44466777777766678999999999776


Q ss_pred             ccccc-cchHH-------------------------HHHHHHH-----------------------HHHHHHHHH-----
Q 016959          185 EGAHI-RQEHI-------------------------LSDLARQ-----------------------VLSGLAYLH-----  210 (380)
Q Consensus       185 ~~~~~-~~~~~-------------------------~~~i~~q-----------------------i~~al~~LH-----  210 (380)
                      ..... .....                         ......+                       +...+..|-     
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            53321 00000                         0000000                       111112221     


Q ss_pred             --hCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          211 --KRKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       211 --~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                        ...++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence              1248999999999999987778899999763

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.65  E-value=3.5e-07  Score=77.95  Aligned_cols=126  Identities=27%  Similarity=0.380  Sum_probs=92.0

Q ss_pred             ccccccceecccCC-ceEEEEEeCCCCcEEEEEEecC---C-----------Cch------HHHHHHHHHHHHHHhC---
Q 016959           99 AELQKGNRIGSGSG-GTVWRVVHPPTSRVFALKVIYG---N-----------HED------SVRSQICREIEILRDV---  154 (380)
Q Consensus        99 ~~~~~~~~LG~G~~-g~V~~~~~~~~~~~~avK~~~~---~-----------~~~------~~~~~~~~E~~~l~~l---  154 (380)
                      ++++..+.||.|.- |.||+++.  .|+.||+|+++.   .           ...      ....-|..|.+...+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            57889999999999 99999999  788999999321   0           010      2234577788776666   


Q ss_pred             CCCce--eeeEeEEeeC------------------CeEEEEEeccCCCCcccccccchHHHHHHHHHHHHHHHHHHhCCc
Q 016959          155 NHPNV--VKCHDMYDRN------------------GEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKI  214 (380)
Q Consensus       155 ~h~~i--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~i  214 (380)
                      .+.++  |+++||..-.                  ....||.||+....         .....-+.+|.+-|..+|..||
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~~~~~~~dl~~~~k~gI  185 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRDIPQMLRDLKILHKLGI  185 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhHHHHHHHHHHHHHHCCe
Confidence            45566  9999987311                  12457778776543         1122346778889999999999


Q ss_pred             eecCCCCCcEEEcCCCcEEEeecccc
Q 016959          215 VHRDIKPSNLLINSSKNVKIADFGVS  240 (380)
Q Consensus       215 vH~Dlkp~Nil~~~~~~~kl~Dfg~a  240 (380)
                      +-+|+++.|..     .-||+|||.+
T Consensus       186 ~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  186 VPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             eeccCcccccc-----CCEEEecccC
Confidence            99999999988     3588999864

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.65  E-value=3.7e-07  Score=80.79  Aligned_cols=133  Identities=23%  Similarity=0.330  Sum_probs=80.1

Q ss_pred             cceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCC--ceeeeEeEE---eeCCeEEEEEec
Q 016959          104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHP--NVVKCHDMY---DRNGEIEVLLEY  178 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~~---~~~~~~~lv~e~  178 (380)
                      .+.|+.|..+.||++....  +.+++|+....   .....+.+|..+++.+...  .+.+++.+.   ......+++|++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~   76 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY   76 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence            3579999999999999854  58899996333   4456778899888888422  355666543   233457899999


Q ss_pred             cCCCCcccccc--------------------c-------c--h-H------HHHHH------------HHHHHH-HHHHH
Q 016959          179 MDGGSLEGAHI--------------------R-------Q--E-H------ILSDL------------ARQVLS-GLAYL  209 (380)
Q Consensus       179 ~~~~~L~~~~~--------------------~-------~--~-~------~~~~i------------~~qi~~-al~~L  209 (380)
                      ++|..+.....                    .       .  . .      .....            ...+.. .+..+
T Consensus        77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (239)
T PF01636_consen   77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL  156 (239)
T ss_dssp             ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred             eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence            99876544000                    0       0  0 0      00000            111222 33344


Q ss_pred             Hh-------CCceecCCCCCcEEEc-CCCcEEEeeccccc
Q 016959          210 HK-------RKIVHRDIKPSNLLIN-SSKNVKIADFGVSR  241 (380)
Q Consensus       210 H~-------~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~  241 (380)
                      +.       ..++|+|+.+.|||++ .++.+-|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            32       4699999999999999 66667899999764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=98.64  E-value=5.2e-07  Score=94.57  Aligned_cols=81  Identities=17%  Similarity=0.283  Sum_probs=58.2

Q ss_pred             cceecccCCceEEEEEeCCCC--cEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCce--eeeEeEEeeC---CeEEEE
Q 016959          104 GNRIGSGSGGTVWRVVHPPTS--RVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNV--VKCHDMYDRN---GEIEVL  175 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~~~--~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~---~~~~lv  175 (380)
                      .+.|+.|.+..+|+......+  ..+++|+............+.+|+.+|+.+. |.++  .+++.++.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            567899999999998875432  4678887643322222346789999999995 6654  7777777654   467899


Q ss_pred             EeccCCCCc
Q 016959          176 LEYMDGGSL  184 (380)
Q Consensus       176 ~e~~~~~~L  184 (380)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.54  E-value=1e-06  Score=91.06  Aligned_cols=204  Identities=23%  Similarity=0.266  Sum_probs=135.2

Q ss_pred             HHHHHHHHHhCCCCceeeeEeEEeeCCeEE----EEEeccCCCCcccc----cccchHHHHHHHHHHHHHHHHHHhCCce
Q 016959          144 ICREIEILRDVNHPNVVKCHDMYDRNGEIE----VLLEYMDGGSLEGA----HIRQEHILSDLARQVLSGLAYLHKRKIV  215 (380)
Q Consensus       144 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~----lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~al~~LH~~~iv  215 (380)
                      ..-|+..+.++.|+|++.++.|-.......    +..++|...++...    ....-.+++.+..++++|+.|+|+....
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~  308 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE  308 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence            345667788889999999988765433222    33467766655433    3335567788999999999999999666


Q ss_pred             ecCCCCC---cEEEcCCCcEEEe--eccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHH
Q 016959          216 HRDIKPS---NLLINSSKNVKIA--DFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE  290 (380)
Q Consensus       216 H~Dlkp~---Nil~~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~e  290 (380)
                      |.-|...   +..++.++.+.+.  ||+....+..... .........+.++|.....   ........|+|.+|.++..
T Consensus       309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-~~~~~~~~~~~~~e~~~~~---~~~~~r~~dL~~lgll~~~  384 (1351)
T KOG1035|consen  309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-SFSDLLAEIRNADEDLKEN---TAKKSRLTDLWCLGLLLLQ  384 (1351)
T ss_pred             eeEEecccccccccCccceeecchhhhcccccCCCccc-chhhcCccccccccccccc---cchhhhhhHHHHHHHHHhh
Confidence            6655544   4444556666666  8888776654322 2334456677788876421   1222345799999999999


Q ss_pred             HHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          291 FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       291 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                      +..|..+-....      ....       ...........+++.+|+..+.++|+++.+++.|+|..--....+
T Consensus       385 ~~~~~~i~~~~~------~~~~-------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~  445 (1351)
T KOG1035|consen  385 LSQGEDISEKSA------VPVS-------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNES  445 (1351)
T ss_pred             hhhcCccccccc------chhh-------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccccccc
Confidence            988765442111      0000       111112227889999999999999999999999999987655444

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.50  E-value=1.4e-06  Score=77.50  Aligned_cols=74  Identities=11%  Similarity=0.121  Sum_probs=46.2

Q ss_pred             ceecccCCce-EEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCC---ceeeeEeEEeeC---CeEEEEEe
Q 016959          105 NRIGSGSGGT-VWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHP---NVVKCHDMYDRN---GEIEVLLE  177 (380)
Q Consensus       105 ~~LG~G~~g~-V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~~~---~~~~lv~e  177 (380)
                      +.|+.|+... ||++.     ..+++|+....   .....+.+|.++++.+...   .+.++++.....   +..+++|+
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~---~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~   74 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA---GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR   74 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCcc---chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence            4577777775 89762     25778875432   1245688899999877521   334444433321   24588999


Q ss_pred             ccCCCCccc
Q 016959          178 YMDGGSLEG  186 (380)
Q Consensus       178 ~~~~~~L~~  186 (380)
                      +++|.++..
T Consensus        75 ~i~G~~l~~   83 (235)
T cd05155          75 WLEGETATA   83 (235)
T ss_pred             eecCCCCCc
Confidence            999987743

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.40  E-value=4.7e-06  Score=71.63  Aligned_cols=129  Identities=17%  Similarity=0.276  Sum_probs=89.8

Q ss_pred             cceecccCCceEEEEEeCCCCcEEEEEEecCCC---------------chHHHHHHHHHHHHHHhCC------CCceeee
Q 016959          104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH---------------EDSVRSQICREIEILRDVN------HPNVVKC  162 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~---------------~~~~~~~~~~E~~~l~~l~------h~~iv~~  162 (380)
                      ...||+|+.=.||.--   .+...+||++....               ......+..+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            4579999999999533   34456899986554               0112345556666555554      7899999


Q ss_pred             EeEEeeCCeEEEEEeccCCC------CcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----cE
Q 016959          163 HDMYDRNGEIEVLLEYMDGG------SLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK----NV  232 (380)
Q Consensus       163 ~~~~~~~~~~~lv~e~~~~~------~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~----~~  232 (380)
                      +|+.+.+....+|+|.+.+.      +|.+++....- ...+...+-+-.+||-+.+|+.+||+|.||++....    .+
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~-~~~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~l  161 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGL-TEELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRL  161 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCc-cHHHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEE
Confidence            99999998899999988643      23444322211 124556666777899999999999999999996332    47


Q ss_pred             EEee
Q 016959          233 KIAD  236 (380)
Q Consensus       233 kl~D  236 (380)
                      .|+|
T Consensus       162 vlID  165 (199)
T PF10707_consen  162 VLID  165 (199)
T ss_pred             EEEe
Confidence            7777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.35  E-value=2.3e-06  Score=73.14  Aligned_cols=96  Identities=21%  Similarity=0.174  Sum_probs=81.0

Q ss_pred             HHHHHHHHhCCC-CceeeeEeEEeeCCeEEEEEeccCCCC-------cccccccchHHHHHHHHHHHHHHHHHHh---CC
Q 016959          145 CREIEILRDVNH-PNVVKCHDMYDRNGEIEVLLEYMDGGS-------LEGAHIRQEHILSDLARQVLSGLAYLHK---RK  213 (380)
Q Consensus       145 ~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~-------L~~~~~~~~~~~~~i~~qi~~al~~LH~---~~  213 (380)
                      .+|.-+++.+++ +++.+++|.|..    .++.||...+.       |..+....+..+.+|+.++++.+++|+.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            468889999975 699999999832    67899998663       4566777889999999999999999998   45


Q ss_pred             ceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          214 IVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       214 ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      +.-.|++++|+-+++++++|++|.+.+....
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            8889999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.27  E-value=6.1e-06  Score=80.66  Aligned_cols=138  Identities=19%  Similarity=0.292  Sum_probs=86.4

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCCc------------------------------hHHHHHHHHHHHHH---
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE------------------------------DSVRSQICREIEIL---  151 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------------------------------~~~~~~~~~E~~~l---  151 (380)
                      +-||.-+.|.||+|+.+. |+.||||+-+..-.                              ++..+.+..|+..+   
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            458999999999999975 99999999643211                              11122222333222   


Q ss_pred             ---Hh----CCCCc------eeeeEeEEeeCCeEEEEEeccCCCCcccccccc--hHHHHHHHHHHHHHHH-HHHhCCce
Q 016959          152 ---RD----VNHPN------VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ--EHILSDLARQVLSGLA-YLHKRKIV  215 (380)
Q Consensus       152 ---~~----l~h~~------iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~i~~qi~~al~-~LH~~~iv  215 (380)
                         .+    +.|-+      |.+++  ++-...-.++||||+|.-+.+.....  .-....++..+.++.. .|=..|++
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~Gff  323 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKTGFF  323 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhcCCc
Confidence               22    23444      33333  22334568999999998776553221  1112244444444433 23356899


Q ss_pred             ecCCCCCcEEEcC----CCcEEEeeccccccccc
Q 016959          216 HRDIKPSNLLINS----SKNVKIADFGVSRILAQ  245 (380)
Q Consensus       216 H~Dlkp~Nil~~~----~~~~kl~Dfg~a~~~~~  245 (380)
                      |+|-+|.||+++.    ++.+.+.|||+...+..
T Consensus       324 HaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  324 HADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            9999999999994    56799999999876643

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.25  E-value=2.2e-06  Score=77.48  Aligned_cols=135  Identities=19%  Similarity=0.287  Sum_probs=98.1

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-----------------chHH----HHHHHHHHHHHHhCC-CC-
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-----------------EDSV----RSQICREIEILRDVN-HP-  157 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----------------~~~~----~~~~~~E~~~l~~l~-h~-  157 (380)
                      +.+++.||-|.-+.||.+.+. .|+..++|.-+...                 ...+    +-...+|+..|+.|. |- 
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            346788999999999999884 57888998642111                 1111    123457888888884 33 


Q ss_pred             ceeeeEeEEeeCCeEEEEEeccCCCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeec
Q 016959          158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADF  237 (380)
Q Consensus       158 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  237 (380)
                      -+.+.++    .++.++|||++.|..|........  ...+...+..-+--|..+|+||+|..--||+|++++.++++||
T Consensus       173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v~d--~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDF  246 (465)
T KOG2268|consen  173 PVPKPID----HNRHCVVMELVDGYPLRQVRHVED--PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDF  246 (465)
T ss_pred             CCCCccc----ccceeeHHHhhcccceeeeeecCC--hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeec
Confidence            3344444    356799999999988876654332  2335666777778899999999999999999999999999999


Q ss_pred             ccccc
Q 016959          238 GVSRI  242 (380)
Q Consensus       238 g~a~~  242 (380)
                      --...
T Consensus       247 PQmvS  251 (465)
T KOG2268|consen  247 PQMVS  251 (465)
T ss_pred             hHhhc
Confidence            86543

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.25  E-value=1e-05  Score=72.96  Aligned_cols=129  Identities=16%  Similarity=0.205  Sum_probs=75.8

Q ss_pred             eecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCce-eeeEeEEeeCCeEEEEEeccCCCCc
Q 016959          106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV-VKCHDMYDRNGEIEVLLEYMDGGSL  184 (380)
Q Consensus       106 ~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L  184 (380)
                      .+..|-.+.+|++..  +++.+++|+........ .-...+|..+++.+..-.+ .+++...  .  -++||||++|..+
T Consensus         3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~   75 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVI   75 (256)
T ss_pred             cCCCcCcCCeEEEEe--CCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccc
Confidence            356788889999874  57788899754322111 0124678888888853322 3344333  2  2689999998765


Q ss_pred             ccccccc--------------------------hHHHHHHHHH---------HHHHHHHHHh--------CCceecCCCC
Q 016959          185 EGAHIRQ--------------------------EHILSDLARQ---------VLSGLAYLHK--------RKIVHRDIKP  221 (380)
Q Consensus       185 ~~~~~~~--------------------------~~~~~~i~~q---------i~~al~~LH~--------~~ivH~Dlkp  221 (380)
                      .......                          ...+..+..+         +...+..+-.        ..++|+|+.+
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            4210000                          0001111111         1111222221        2489999999


Q ss_pred             CcEEEcCCCcEEEeecccccc
Q 016959          222 SNLLINSSKNVKIADFGVSRI  242 (380)
Q Consensus       222 ~Nil~~~~~~~kl~Dfg~a~~  242 (380)
                      .||++++++ +.|+||+.|..
T Consensus       156 ~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       156 YNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcEEEeCCC-CEEEeccccCc
Confidence            999999877 78999998753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.23  E-value=1.8e-05  Score=72.93  Aligned_cols=135  Identities=17%  Similarity=0.192  Sum_probs=83.8

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCC--ceeeeEe------EEeeCCeE
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHP--NVVKCHD------MYDRNGEI  172 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~------~~~~~~~~  172 (380)
                      ..-.+.|..|....+|++..  .+..+++|+... .   ....+..|+.+++.+.+.  .+.+++.      +....+..
T Consensus        16 ~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~   89 (296)
T cd05153          16 LLSFEGISAGIENTNYFVTT--DSGRYVLTLFEK-V---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP   89 (296)
T ss_pred             hhheecccCccccceEEEEe--CCCcEEEEEcCC-C---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence            33356788888889999875  345789998753 1   134566788887777422  2444433      22335567


Q ss_pred             EEEEeccCCCCccccccc---------------------c------hH---H-HH--------HHHHHHHHHHHHHHh--
Q 016959          173 EVLLEYMDGGSLEGAHIR---------------------Q------EH---I-LS--------DLARQVLSGLAYLHK--  211 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~~---------------------~------~~---~-~~--------~i~~qi~~al~~LH~--  211 (380)
                      ++|+++++|..+......                     .      ..   . ..        .....+..++.++..  
T Consensus        90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~  169 (296)
T cd05153          90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD  169 (296)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence            899999998765321000                     0      00   0 00        011122334445443  


Q ss_pred             -----CCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          212 -----RKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       212 -----~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                           .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence                 479999999999999987777899999764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK10593 hypothetical protein; Provisional

Probab=98.21  E-value=4.7e-05  Score=70.18  Aligned_cols=79  Identities=14%  Similarity=0.084  Sum_probs=56.3

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCC---CceeeeEeEEee---CCeEEE
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH---PNVVKCHDMYDR---NGEIEV  174 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h---~~iv~~~~~~~~---~~~~~l  174 (380)
                      ..-.+.||.|..+.||+....  +..+++|..+...   ....+.+|...|+.|.-   -.+.++++++..   .+..++
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDS--QGNPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             hheeeecCCccceeEEEEEcC--CCCEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence            344567999999999998763  3356778753211   12467789999988852   367788877654   366899


Q ss_pred             EEeccCCCCc
Q 016959          175 LLEYMDGGSL  184 (380)
Q Consensus       175 v~e~~~~~~L  184 (380)
                      |||+++|.++
T Consensus        91 VmE~i~G~~~  100 (297)
T PRK10593         91 LLERLRGVSV  100 (297)
T ss_pred             EEeccCCEec
Confidence            9999998765

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.18  E-value=2.1e-05  Score=74.86  Aligned_cols=78  Identities=18%  Similarity=0.126  Sum_probs=53.9

Q ss_pred             ccceecccCCceEEEEEeCCCCcEEEEEEecCC----Cc--hHHHHHHHHHHHHHHhCC---CCceeeeEeEEeeCCeEE
Q 016959          103 KGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN----HE--DSVRSQICREIEILRDVN---HPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus       103 ~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~--~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~  173 (380)
                      ..+.||.|.+..||++.....++.++||.-...    .+  ....++...|.+.|+.+.   ..++.+++.+  +.+..+
T Consensus        30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~  107 (401)
T PRK09550         30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV  107 (401)
T ss_pred             eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence            346799999999999998644468999984211    01  223456777888888763   2456667665  335578


Q ss_pred             EEEeccCCC
Q 016959          174 VLLEYMDGG  182 (380)
Q Consensus       174 lv~e~~~~~  182 (380)
                      +|||++++.
T Consensus       108 lVME~L~~~  116 (401)
T PRK09550        108 TVMEDLSDH  116 (401)
T ss_pred             EEEecCCCc
Confidence            999999763

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.16  E-value=2e-05  Score=69.99  Aligned_cols=74  Identities=18%  Similarity=0.244  Sum_probs=47.4

Q ss_pred             ceecccCCceEEEEEeCC-CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEEEEeccCCC
Q 016959          105 NRIGSGSGGTVWRVVHPP-TSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEVLLEYMDGG  182 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~  182 (380)
                      +.|..|-...+|++.... .++.|++|+.......  .....+|+.+++.+. +.-..++++.+.  +  .++|||++|.
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~   77 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGR   77 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCC
Confidence            457888888999997643 3568899976433211  122346888888884 333445554433  2  3799999987


Q ss_pred             Cc
Q 016959          183 SL  184 (380)
Q Consensus       183 ~L  184 (380)
                      ++
T Consensus        78 ~l   79 (235)
T cd05157          78 TL   79 (235)
T ss_pred             cC
Confidence            65

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=98.15  E-value=4.2e-05  Score=70.95  Aligned_cols=137  Identities=19%  Similarity=0.250  Sum_probs=82.7

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCC--CceeeeEeE------EeeCCe
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH--PNVVKCHDM------YDRNGE  171 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~------~~~~~~  171 (380)
                      .....+.++.|....+|++..  ++..+++|+......   ...+..|++++..|..  -.+.+++..      ....+.
T Consensus        23 ~~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~   97 (307)
T TIGR00938        23 ELLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK   97 (307)
T ss_pred             CceeccccCCccccceEEEEe--CCCcEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence            344566788888889999875  344688898744221   2334566777766632  123444331      223567


Q ss_pred             EEEEEeccCCCCccccc----------------------c--------cchHH-HH-----------HHHHHHHHHHHHH
Q 016959          172 IEVLLEYMDGGSLEGAH----------------------I--------RQEHI-LS-----------DLARQVLSGLAYL  209 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~----------------------~--------~~~~~-~~-----------~i~~qi~~al~~L  209 (380)
                      .+++++|++|..+....                      .        ..... ..           .....+...++++
T Consensus        98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l  177 (307)
T TIGR00938        98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL  177 (307)
T ss_pred             EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence            88999999986542100                      0        00000 00           0111233455555


Q ss_pred             Hh-------CCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          210 HK-------RKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       210 H~-------~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                      ..       .++||+|+++.||+++.++...|+||+.+.
T Consensus       178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            42       689999999999999988777899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=98.04  E-value=0.00014  Score=67.81  Aligned_cols=134  Identities=13%  Similarity=0.229  Sum_probs=75.5

Q ss_pred             cccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-----CCceeeeE---eEEeeCCeEE
Q 016959          102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-----HPNVVKCH---DMYDRNGEIE  173 (380)
Q Consensus       102 ~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~---~~~~~~~~~~  173 (380)
                      ...+.|+.|....+|++...  +..+++|++. ...   .+.+..|+.+++.|.     .|.++...   .+....+..+
T Consensus        25 ~~~~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~   98 (319)
T PRK05231         25 LSLKGIAEGIENSNFFLTTT--QGEYVLTLFE-RLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA   98 (319)
T ss_pred             hccchhccccccceEEEEeC--CCcEEEEEec-cCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence            33456788888899998763  3368999874 211   223344555555552     23333211   0123356789


Q ss_pred             EEEeccCCCCccccc------------------c----c-----c----hHHHHH-----------HHHH-HHHHHHHHH
Q 016959          174 VLLEYMDGGSLEGAH------------------I----R-----Q----EHILSD-----------LARQ-VLSGLAYLH  210 (380)
Q Consensus       174 lv~e~~~~~~L~~~~------------------~----~-----~----~~~~~~-----------i~~q-i~~al~~LH  210 (380)
                      ++++|++|..+....                  .    .     .    ......           .+.+ +...++.+.
T Consensus        99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  178 (319)
T PRK05231         99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA  178 (319)
T ss_pred             EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence            999999987542100                  0    0     0    000000           1111 111222332


Q ss_pred             -------hCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          211 -------KRKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       211 -------~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                             ..|+||+|+++.|||++.+...-|+||+.+.
T Consensus       179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence                   2489999999999999966556899999874

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.99  E-value=5e-05  Score=70.22  Aligned_cols=74  Identities=20%  Similarity=0.286  Sum_probs=47.0

Q ss_pred             ceecccCCceEEEEEeCC------CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCC-ceeeeEeEEeeCCeEEEEEe
Q 016959          105 NRIGSGSGGTVWRVVHPP------TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHP-NVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e  177 (380)
                      +.|..|-...||++....      .++.|++|+......  ......+|+.+++.+... -..++++++. +   .+|+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e   77 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEE   77 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhh
Confidence            346667777899987643      257899999744322  223456788888887532 2345555553 2   35899


Q ss_pred             ccCCCCc
Q 016959          178 YMDGGSL  184 (380)
Q Consensus       178 ~~~~~~L  184 (380)
                      |++|..+
T Consensus        78 ~i~G~~l   84 (302)
T cd05156          78 FIPSRTL   84 (302)
T ss_pred             eeCCCcC
Confidence            9888655

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.88  E-value=0.0002  Score=65.29  Aligned_cols=30  Identities=23%  Similarity=0.595  Sum_probs=25.0

Q ss_pred             CceecCCCCCcEEEcCCCc-EEEeecccccc
Q 016959          213 KIVHRDIKPSNLLINSSKN-VKIADFGVSRI  242 (380)
Q Consensus       213 ~ivH~Dlkp~Nil~~~~~~-~kl~Dfg~a~~  242 (380)
                      .++|+|+++.|||+++++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            3799999999999997555 56999998753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.87  E-value=0.00029  Score=65.15  Aligned_cols=137  Identities=20%  Similarity=0.285  Sum_probs=89.5

Q ss_pred             ccceecccCCceEEEEEeCCCCcEEEEEEecCC-----------------------Cch--HHHHHHHHHHHHHHhCCCC
Q 016959          103 KGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN-----------------------HED--SVRSQICREIEILRDVNHP  157 (380)
Q Consensus       103 ~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~-----------------------~~~--~~~~~~~~E~~~l~~l~h~  157 (380)
                      +...|..|.-+.||.|... +|..+|||+++..                       +.+  ...-....|+.-|++|+.-
T Consensus       148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            4456888999999999874 6778999997421                       111  1122234677778888543


Q ss_pred             ceeeeEeEEeeCCeEEEEEeccCCCC-----cccccccchHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEEEcCCCc
Q 016959          158 NVVKCHDMYDRNGEIEVLLEYMDGGS-----LEGAHIRQEHILSDLARQVLSGLAYL-HKRKIVHRDIKPSNLLINSSKN  231 (380)
Q Consensus       158 ~iv~~~~~~~~~~~~~lv~e~~~~~~-----L~~~~~~~~~~~~~i~~qi~~al~~L-H~~~ivH~Dlkp~Nil~~~~~~  231 (380)
                      .|..---+..  ....|||+++....     |.+... ....+..+-.|++.-+.-| |.+++||.||.--|+|+. +|.
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~l-s~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~  302 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASL-STSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGK  302 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcCcccccccC-ChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCE
Confidence            3322111111  24579999997543     222222 2334556666777777666 567999999999999997 788


Q ss_pred             EEEeecccccccc
Q 016959          232 VKIADFGVSRILA  244 (380)
Q Consensus       232 ~kl~Dfg~a~~~~  244 (380)
                      +.|+|.+-+....
T Consensus       303 lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  303 LYIIDVSQSVEHD  315 (520)
T ss_pred             EEEEEccccccCC
Confidence            9999998776443

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.83  E-value=1.8e-06  Score=91.24  Aligned_cols=206  Identities=13%  Similarity=-0.013  Sum_probs=137.0

Q ss_pred             HHHHHHHHHHHHhCCCCceeeeEeEEee--CCeEEEEEeccCCCCcccccccc--------hHHHHHHHHHHHHHHHHHH
Q 016959          141 RSQICREIEILRDVNHPNVVKCHDMYDR--NGEIEVLLEYMDGGSLEGAHIRQ--------EHILSDLARQVLSGLAYLH  210 (380)
Q Consensus       141 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~i~~qi~~al~~LH  210 (380)
                      ++....|...++...|+++.....-...  ...-+..+++|.+|.+...+.+.        +..+.....+.+.+..-+|
T Consensus      1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred             HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence            4445556666677789988876554432  33567889999999876554432        1222223334367777766


Q ss_pred             hC-----CceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHH
Q 016959          211 KR-----KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLG  285 (380)
Q Consensus       211 ~~-----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG  285 (380)
                      +.     -.+|++||+.|.+|..+-++++.++|+.+...+........++++.|+.+++.+.     -.++.++|+|..|
T Consensus      1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-----ik~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-----IKFTKRSDILRRS 1427 (2724)
T ss_pred             hcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-----HhhhhHHHHHHHH
Confidence            54     2789999999999999999999999999855544444566778999999999864     3445569999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC-----CCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          286 VSILEFYLGRFPFAVGRQGDWASLMFAICFA-----QPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       286 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      +.+|+...|..+|.        .........     .....+...+.+.-.....+|-..-.+||.-..++.-+.|...
T Consensus      1428 ~~ly~rs~~n~~fi--------~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~ 1498 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYFI--------FFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVG 1498 (2724)
T ss_pred             HHHHHHhcccHHHH--------HHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccccc
Confidence            99999998887773        111111111     1111222223344445555555666789999999887777654

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.79  E-value=0.00036  Score=64.23  Aligned_cols=138  Identities=17%  Similarity=0.227  Sum_probs=83.9

Q ss_pred             cccceecccCCceEEEEEeCCCCcEEEEEEecC-CCchHHHHHHHHHHHHHHhCCC--CceeeeEeEEeeCC--eEEEEE
Q 016959          102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYG-NHEDSVRSQICREIEILRDVNH--PNVVKCHDMYDRNG--EIEVLL  176 (380)
Q Consensus       102 ~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~-~~~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~--~~~lv~  176 (380)
                      .+.+.+-.|..-.+|....  +++.+++. ... ...........+|+.+++.+.-  --+...++++.++.  ..+.||
T Consensus        28 ~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~  104 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM  104 (321)
T ss_pred             ceeeeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence            3444453444445666655  37888888 431 2333345667788998888742  23444556665544  779999


Q ss_pred             eccCCCCcccccccchHHHHHHHH-HHHHHHH------------------------------------------------
Q 016959          177 EYMDGGSLEGAHIRQEHILSDLAR-QVLSGLA------------------------------------------------  207 (380)
Q Consensus       177 e~~~~~~L~~~~~~~~~~~~~i~~-qi~~al~------------------------------------------------  207 (380)
                      +|++|..+.......... .+++. .+...|.                                                
T Consensus       105 ~~veGe~~~~~~~~~~~~-~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~  183 (321)
T COG3173         105 EWVEGEVVWSALPPESLG-RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL  183 (321)
T ss_pred             EEecceeccCcCCcccch-HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence            999986543222111000 11222 3333333                                                


Q ss_pred             --HHHhC--------CceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          208 --YLHKR--------KIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       208 --~LH~~--------~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                        ||+.+        .++|+|+++.||+++.++-+=|+||+.+..-
T Consensus       184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence              44332        3799999999999998888999999998643

>PLN02236 choline kinase

Probab=97.66  E-value=0.0006  Score=64.23  Aligned_cols=136  Identities=15%  Similarity=0.253  Sum_probs=78.7

Q ss_pred             ccccccceecccCCceEEEEEeCC----CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCC-ceeeeEeEEeeCCeEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHP-NVVKCHDMYDRNGEIE  173 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~----~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~  173 (380)
                      +.+.+. .|-.|-.-.+|++....    .++.|++|+...... .... -.+|..+++.+..- --.++++.+.. +   
T Consensus        37 ~~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---  109 (344)
T PLN02236         37 EALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---  109 (344)
T ss_pred             CcEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---
Confidence            344443 45558888999987532    246899998754432 2222 25788888888532 23345565533 2   


Q ss_pred             EEEeccCCCCcccccccc---------------------------hHHHHHHHH-----------------HHHHHHHHH
Q 016959          174 VLLEYMDGGSLEGAHIRQ---------------------------EHILSDLAR-----------------QVLSGLAYL  209 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~~~---------------------------~~~~~~i~~-----------------qi~~al~~L  209 (380)
                      .|.+|+.+.+|.......                           ...+..+..                 .+...+..|
T Consensus       110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L  189 (344)
T PLN02236        110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL  189 (344)
T ss_pred             eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence            578998876653110000                           011112211                 111122222


Q ss_pred             H--------hCCceecCCCCCcEEEcC-CCcEEEeeccccc
Q 016959          210 H--------KRKIVHRDIKPSNLLINS-SKNVKIADFGVSR  241 (380)
Q Consensus       210 H--------~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~  241 (380)
                      .        ...++|+|+++.|||+++ ++.+.|+||..|.
T Consensus       190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            2        235899999999999986 4679999999875

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.58  E-value=0.00059  Score=63.93  Aligned_cols=80  Identities=14%  Similarity=0.281  Sum_probs=47.6

Q ss_pred             cccccccceecccCCceEEEEEeCCC---CcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCce-eeeEeEEeeCCeEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPT---SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV-VKCHDMYDRNGEIE  173 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~  173 (380)
                      .+++.+.. |..|-...+|++.....   +..|++|+...... .. -.-.+|..+++.+..-++ .++++++. .+   
T Consensus        14 ~~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---   86 (330)
T PLN02421         14 DSDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---   86 (330)
T ss_pred             cCceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence            34455444 44477778999875432   34789998754332 11 122468888888853333 35565553 33   


Q ss_pred             EEEeccCCCCc
Q 016959          174 VLLEYMDGGSL  184 (380)
Q Consensus       174 lv~e~~~~~~L  184 (380)
                      +|.+|+.|..|
T Consensus        87 ~i~~fi~g~~l   97 (330)
T PLN02421         87 MIQSFINARTL   97 (330)
T ss_pred             EeehhhcCCCC
Confidence            58899887665

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.53  E-value=0.0027  Score=58.84  Aligned_cols=29  Identities=28%  Similarity=0.495  Sum_probs=25.5

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          212 RKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       212 ~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57899999999999987 678999999663

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.45  E-value=0.00045  Score=64.52  Aligned_cols=74  Identities=15%  Similarity=0.117  Sum_probs=47.8

Q ss_pred             eecccCCceEEEEEeCCCCcEEEEEEec----C--CCchHHHHHHHHHHHHHHhCC--CC-ceeeeEeEEeeCCeEEEEE
Q 016959          106 RIGSGSGGTVWRVVHPPTSRVFALKVIY----G--NHEDSVRSQICREIEILRDVN--HP-NVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus       106 ~LG~G~~g~V~~~~~~~~~~~~avK~~~----~--~~~~~~~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~lv~  176 (380)
                      .||.|....||++.....++.++||.-.    .  ..-+-..++..-|...|+...  .| .+.+++. | +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~-D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-F-DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-E-ccccceehH
Confidence            5899999999999986444789999742    1  111223445566778887763  34 3444443 3 344567999


Q ss_pred             eccCC
Q 016959          177 EYMDG  181 (380)
Q Consensus       177 e~~~~  181 (380)
                      |++..
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.35  E-value=0.0028  Score=57.95  Aligned_cols=76  Identities=20%  Similarity=0.233  Sum_probs=47.5

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC---CCceeeeEeEEeeCCeEEEEEe
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN---HPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ++..+.|+.|....+|+..  .+++.+.||+-.    ......+..|..-|+.|.   .-.+.+.+++....+..++|||
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~----~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle   92 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS----ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLE   92 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE----GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecC----hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEE
Confidence            4445679999999999988  478889999864    222345677888888773   4467788888776667799999


Q ss_pred             ccCCC
Q 016959          178 YMDGG  182 (380)
Q Consensus       178 ~~~~~  182 (380)
                      |++.+
T Consensus        93 ~l~~~   97 (288)
T PF03881_consen   93 FLEMG   97 (288)
T ss_dssp             -----
T ss_pred             eecCC
Confidence            99876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.32  E-value=0.0039  Score=57.83  Aligned_cols=29  Identities=17%  Similarity=0.331  Sum_probs=27.1

Q ss_pred             CceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          213 KIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       213 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                      ++||+|+.+.|||++.++.+.|+||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            79999999999999999999999999875

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.24  E-value=0.00096  Score=58.23  Aligned_cols=30  Identities=37%  Similarity=0.650  Sum_probs=21.4

Q ss_pred             CceecCCCCCcEEE-cCCCcEEEeecccccc
Q 016959          213 KIVHRDIKPSNLLI-NSSKNVKIADFGVSRI  242 (380)
Q Consensus       213 ~ivH~Dlkp~Nil~-~~~~~~kl~Dfg~a~~  242 (380)
                      .++|+||.+.|||+ +.++.++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            58999999999999 7899999999998753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.21  E-value=0.00032  Score=67.38  Aligned_cols=165  Identities=22%  Similarity=0.317  Sum_probs=98.7

Q ss_pred             HHHHHHHHHHHhCCCCceeeeEeEEee-CCeEEEEEeccCCCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 016959          142 SQICREIEILRDVNHPNVVKCHDMYDR-NGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIK  220 (380)
Q Consensus       142 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlk  220 (380)
                      .++.....+++.+.|+|...++++-.. ..+..+|||++. .+|++........    ..+++       .+|+.|-   
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~l~----~~s~~-------~~~~~~~---   91 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGNLK----DESLL-------AHGVLHL---   91 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcccc----hhhhc-------cccccee---
Confidence            456667888999999999999987653 345788999995 4565544332211    11111       1222221   


Q ss_pred             CCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 016959          221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAV  300 (380)
Q Consensus       221 p~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~  300 (380)
                               +.++.+| -++    ..            |  |-.+          .+++|||++|.++.+++.|...+..
T Consensus        92 ---------~~~~~td-~~~----t~------------~--~~~~----------~pKsdVwsl~~i~~el~L~~~l~~~  133 (725)
T KOG1093|consen   92 ---------NIIYITD-HFL----TK------------Y--PSPI----------GPKSDVWSLGFIILELYLGISLEAE  133 (725)
T ss_pred             ---------hhhhccc-ccc----cc------------C--CCCC----------CcchhhhhHHHHHHHHHHhhHHHHH
Confidence                     1223333 000    00            0  1111          1389999999999999999877752


Q ss_pred             CCCCCHHHHHHHHhhCCCC--------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          301 GRQGDWASLMFAICFAQPP--------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      -...+....+.+.......        .....++..+.++..+|+-..|..||...++++++-|...
T Consensus       134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            2222222222222111110        1222366678899999999999999999999999988765

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=97.17  E-value=0.005  Score=57.33  Aligned_cols=129  Identities=23%  Similarity=0.354  Sum_probs=78.1

Q ss_pred             ecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-C--Cc---eeeeEeE--EeeCC--eEEEEE
Q 016959          107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-H--PN---VVKCHDM--YDRNG--EIEVLL  176 (380)
Q Consensus       107 LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h--~~---iv~~~~~--~~~~~--~~~lv~  176 (380)
                      |.. .-..||++...  +..+++|+....   .....+..|+..|+.|. +  +-   +..+-|-  ..-.+  ..+-++
T Consensus        34 l~s-~eN~~f~~~~~--~g~~iLki~~~~---~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf  107 (331)
T COG2334          34 LNS-EENSNFRVQTE--DGRYILKIYRPG---WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF  107 (331)
T ss_pred             ccc-ccCceEEEEec--CCCeEEEEecCC---CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence            444 44578988873  344499998654   22455667888888773 2  11   2222221  11233  778899


Q ss_pred             eccCCCCccc-cccc------------------------------chH----H---------HHHHHHHHHHHHHHHHh-
Q 016959          177 EYMDGGSLEG-AHIR------------------------------QEH----I---------LSDLARQVLSGLAYLHK-  211 (380)
Q Consensus       177 e~~~~~~L~~-~~~~------------------------------~~~----~---------~~~i~~qi~~al~~LH~-  211 (380)
                      +|++|..+.. ....                              ...    .         -.....++...++.+.+ 
T Consensus       108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~  187 (331)
T COG2334         108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR  187 (331)
T ss_pred             EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence            9999887762 1000                              000    0         00123345555555553 


Q ss_pred             -------CC--ceecCCCCCcEEEcCCCc-EEEeeccccc
Q 016959          212 -------RK--IVHRDIKPSNLLINSSKN-VKIADFGVSR  241 (380)
Q Consensus       212 -------~~--ivH~Dlkp~Nil~~~~~~-~kl~Dfg~a~  241 (380)
                             .+  +||+|+.+.||+++.+.. +.++|||.+.
T Consensus       188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                   24  999999999999998875 8999999764

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.99  E-value=0.0016  Score=61.62  Aligned_cols=76  Identities=18%  Similarity=0.129  Sum_probs=50.1

Q ss_pred             cceecccCCceEEEEEeCCCCcEEEEEEe----cC-CCchHHHHHHHHHHHHHHhCC--CC-ceeeeEeEEeeCCeEEEE
Q 016959          104 GNRIGSGSGGTVWRVVHPPTSRVFALKVI----YG-NHEDSVRSQICREIEILRDVN--HP-NVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~~~~~~avK~~----~~-~~~~~~~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~lv  175 (380)
                      .+.||.|.-.-||++.+...++.++||.-    +. ..-.-..++..-|.+.|+...  .| .+.+++. | +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~-D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-F-DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-E-CcHHhhHH
Confidence            56799999999999998434678999974    21 111233456667888888764  34 4445543 3 34456788


Q ss_pred             EeccCC
Q 016959          176 LEYMDG  181 (380)
Q Consensus       176 ~e~~~~  181 (380)
                      ||++..
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888854

>PTZ00384 choline kinase; Provisional

Probab=96.96  E-value=0.0075  Score=57.53  Aligned_cols=81  Identities=12%  Similarity=0.153  Sum_probs=46.4

Q ss_pred             CcccccccceecccCCceEEEEEeCCCC-cE-----EEEEEecCCCchHHHHHHHHHHHHHHhCCC-CceeeeEeEEeeC
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTS-RV-----FALKVIYGNHEDSVRSQICREIEILRDVNH-PNVVKCHDMYDRN  169 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~-~~-----~avK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~  169 (380)
                      ..+++.+. .|..|-...+|++...... ..     |.+++. ........ .-.+|+.+++.+.. ..-.++++.+.. 
T Consensus        49 ~~~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~-g~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~-  124 (383)
T PTZ00384         49 NPEFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS-STYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD-  124 (383)
T ss_pred             CcccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEec-cCCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC-
Confidence            33444444 4555888899999754321 22     444432 22211111 22468888888864 444456666542 


Q ss_pred             CeEEEEEeccCCCCc
Q 016959          170 GEIEVLLEYMDGGSL  184 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L  184 (380)
                         ++|.||++|..|
T Consensus       125 ---g~l~efIeGr~l  136 (383)
T PTZ00384        125 ---FTIQEWVEGNTM  136 (383)
T ss_pred             ---EEEEEEeccccC
Confidence               589999998765

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.91  E-value=0.018  Score=55.00  Aligned_cols=75  Identities=20%  Similarity=0.224  Sum_probs=49.6

Q ss_pred             ccceecccCCceEEEEEeCCCCcEEEEEEecCC----Cc--hHHHHHHHHHHHHHHhCC---CCceeeeEeEEeeCCeEE
Q 016959          103 KGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN----HE--DSVRSQICREIEILRDVN---HPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus       103 ~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~----~~--~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~  173 (380)
                      ..+.||.|....||++.+  .++.++||.-...    ..  .....+...|...|+.+.   ..++.+++.++.  +..+
T Consensus        36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            356799999999999987  3456899985311    00  012333445566676653   247778887776  3457


Q ss_pred             EEEeccCC
Q 016959          174 VLLEYMDG  181 (380)
Q Consensus       174 lv~e~~~~  181 (380)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999977

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.80  E-value=0.023  Score=53.17  Aligned_cols=70  Identities=16%  Similarity=0.121  Sum_probs=41.0

Q ss_pred             CCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCC--Cceee---eEe--EEeeCCeEEEEEeccCCCC
Q 016959          111 SGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH--PNVVK---CHD--MYDRNGEIEVLLEYMDGGS  183 (380)
Q Consensus       111 ~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~---~~~--~~~~~~~~~lv~e~~~~~~  183 (380)
                      .-..||++... ++..+++|+.....  .....+..|+..+..|..  -.++.   .-|  +...++..+.+++++.|..
T Consensus        37 ~eN~vy~v~~~-~~~~~vlKv~r~~~--~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         37 YENRVYQFGDE-DGRRVVAKFYRPER--WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             ccceEEEEecC-CCCEEEEEEcCccc--CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            34568988763 46678999874322  123456677777776631  11222   111  2334567788999988764

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.76  E-value=0.0088  Score=55.53  Aligned_cols=71  Identities=23%  Similarity=0.293  Sum_probs=54.4

Q ss_pred             CeEEEEEeccCCCCcccccccchHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEeecccccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKR-KIVHRDIKPSNLLINSSKNVKIADFGVSRI  242 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  242 (380)
                      ...|++|++. |+.+...-.....++..++.+.+..++-+..+ ..-||||...||||+ +|+|.|+||-+++.
T Consensus       299 ~y~yl~~kdh-gt~is~ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         299 LYLYLHFKDH-GTPISIIKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             eEEEEEEecC-CceeeeeecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            3455666665 44555444445566777888877777777765 789999999999999 99999999999984

>PRK06148 hypothetical protein; Provisional

Probab=96.75  E-value=0.037  Score=59.60  Aligned_cols=30  Identities=23%  Similarity=0.595  Sum_probs=25.7

Q ss_pred             CCceecCCCCCcEEEcCCC--cEE-Eeeccccc
Q 016959          212 RKIVHRDIKPSNLLINSSK--NVK-IADFGVSR  241 (380)
Q Consensus       212 ~~ivH~Dlkp~Nil~~~~~--~~k-l~Dfg~a~  241 (380)
                      .++||+|+.+.|||++.++  ++. |+|||.+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            4799999999999999775  555 99999875

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.70  E-value=0.0084  Score=51.85  Aligned_cols=101  Identities=16%  Similarity=0.176  Sum_probs=66.1

Q ss_pred             EEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCCCCcccccccchHHHHHHHHHHHHHH
Q 016959          127 FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGL  206 (380)
Q Consensus       127 ~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~al  206 (380)
                      ..+|++....-.-....+.+++.++.++.  .|+++..-  ..-.+.+++|+|-....         ....++..=+.+|
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------~~~N~i~agi~~L  154 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------NFSNFITAGIKDL  154 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------chhHHHHHhHHHH
Confidence            35555543322212344578888888763  46776632  44567899999963211         1112222225677


Q ss_pred             HHHHh--CCceecCCCCCcEEEcCCCcEEEeecccc
Q 016959          207 AYLHK--RKIVHRDIKPSNLLINSSKNVKIADFGVS  240 (380)
Q Consensus       207 ~~LH~--~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  240 (380)
                      .-.|+  .+.+|+|-.|+|||-|+.|.+||.|-+..
T Consensus       155 ~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  155 MDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             HHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence            78884  47999999999999999999999998754

The function of this family is unknown.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.47  E-value=0.056  Score=47.17  Aligned_cols=79  Identities=22%  Similarity=0.301  Sum_probs=55.3

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC---CCCceeeeEeEEeeCCeEEEEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV---NHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      +++..+.+--|.--..|.+.+  ....|.||+=    .......+..|+.-|..|   +.-.+.+.+.+-...++.|+||
T Consensus        17 ~i~er~~v~gG~inea~~v~d--g~~~~FvK~n----~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVl   90 (286)
T COG3001          17 EIKEREEVSGGDINEAWRLRD--GTDPFFVKCN----QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVL   90 (286)
T ss_pred             hhhcccccCCccccceeEeec--CCcceEEEec----chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEE
Confidence            444555676666667777766  5567888872    333345666777666665   3456778888888889999999


Q ss_pred             eccCCCCc
Q 016959          177 EYMDGGSL  184 (380)
Q Consensus       177 e~~~~~~L  184 (380)
                      ||++.+.+
T Consensus        91 e~L~~~~~   98 (286)
T COG3001          91 EYLPTGPL   98 (286)
T ss_pred             eeccCCCC
Confidence            99987655

>PTZ00296 choline kinase; Provisional

Probab=96.47  E-value=0.038  Score=53.78  Aligned_cols=82  Identities=13%  Similarity=0.252  Sum_probs=48.5

Q ss_pred             CCcccccccceecccCCceEEEEEeCCC--------CcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCcee-eeEeEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPT--------SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV-KCHDMY  166 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~--------~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~  166 (380)
                      +..+++ -.+.|..|-.-.+|++.....        ++.|.+++.-...+.- . .-..|..+++.+..-+|- ++++.+
T Consensus       103 ~~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l-I-dR~~E~~v~~~ls~~gi~P~l~~~f  179 (442)
T PTZ00296        103 FTEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL-Y-NPISEFEVYKTMSKYRIAPQLLNTF  179 (442)
T ss_pred             CCcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce-e-CHHHHHHHHHHHHHCCCCCceEEEe
Confidence            344555 456677787888999875421        5678999874433221 1 234577777776432222 455555


Q ss_pred             eeCCeEEEEEeccCCCCc
Q 016959          167 DRNGEIEVLLEYMDGGSL  184 (380)
Q Consensus       167 ~~~~~~~lv~e~~~~~~L  184 (380)
                      . +   +.|.||++|..|
T Consensus       180 ~-g---g~I~efi~g~~l  193 (442)
T PTZ00296        180 S-G---GRIEEWLYGDPL  193 (442)
T ss_pred             C-C---CEEEEeeCCccC
Confidence            3 2   457888887644

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	380
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-49
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-47
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-47
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-46
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-45
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-45
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-45
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-45
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-45
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-40
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-38
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-37
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-37
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-36
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-36
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		9e-36
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-35
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-35
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-35
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-35
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-35
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-35
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-34
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-32
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-32
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-32
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-31
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-31
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-31
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-31
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-29
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-29
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-29
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-29
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-29
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-29
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-29
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-29
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-29
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		9e-29
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-29
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-29
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-28
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-28
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-28
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-28
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-28
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-28
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-28
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-28
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-28
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-28
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-28
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-28
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-28
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-28
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-28
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-28
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-28
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-28
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-28
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-28
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-28
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-28
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-28
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-28
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-28
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-28
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-28
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-28
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-28
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-28
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-28
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-28
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-28
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-28
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-28
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-28
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-28
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-28
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-28
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-28
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		9e-28
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-27
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-27
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-27
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-27
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-27
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-27
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-27
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-27
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-27
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-27
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-27
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-27
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-27
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-27
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-27
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-27
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-27
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-27
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-27
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-27
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-27
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-27
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-27
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-27
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-27
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-27
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-27
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-27
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-27
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-27
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-27
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-27
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-27
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-27
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-27
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-27
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-27
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-27
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-27
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		9e-27
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-27
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-27
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-26
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-26
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-26
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-26
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-26
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-26
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-26
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-26
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-26
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-26
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-26
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-26
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-26
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-26
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-26
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-26
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-26
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-26
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-26
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-26
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-26
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-26
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-26
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-26
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-26
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-26
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-26
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-26
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-26
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-26
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-26
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-26
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-26
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-26
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-25
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-25
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-25
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-25
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-25
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-25
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-25
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-25
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-25
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-25
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-25
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-25
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-25
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-25
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-25
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-25
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-25
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-25
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-25
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-25
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-25
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-25
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-25
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		8e-25
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		8e-25
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-25
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-25
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-24
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-24
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-24
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-24
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-24
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-24
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-24
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-24
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-24
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-24
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-24
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-24
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-24
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-24
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-24
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-24
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-24
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-24
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-24
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-24
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-24
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-24
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-24
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-24
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-24
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-24
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-24
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-24
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-24
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-24
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-24
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-23
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-23
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-23
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-23
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-23
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-23
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-23
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-23
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-23
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-23
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-23
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-23
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-23
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-23
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-23
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-23
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-23
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-23
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-23
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-23
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-23
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-23
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-23
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-23
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-23
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		8e-23
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-23
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-23
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-23
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-23
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-22
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-22
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-22
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-22
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-22
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-22
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-22
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-22
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-22
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-22
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-22
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-22
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-22
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-22
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-22
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-22
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-22
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-22
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-22
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-22
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		9e-22
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-21
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-21
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-21
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-21
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-21
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-21
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-21
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-21
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-21
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-21
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-21
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-21
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-21
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-21
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-21
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-21
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-21
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-21
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-21
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-21
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-21
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-21
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-21
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-21
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-21
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-21
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-21
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-21
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-20
3soa_A	444	Full-Length Human Camkii Length = 444		1e-20
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-20
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-20
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-20
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-20
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-20
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-20
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-20
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-20
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-20
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-20
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-20
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-20
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-20
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-20
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-20
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-20
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-20
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-20
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-19
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-19
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-19
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-19
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-19
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-19
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-19
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-19
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-19
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-19
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-19
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-19
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-19
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-19
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-19
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-19
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-19
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-19
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-19
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-19
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-19
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-19
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-19
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-19
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-19
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-19
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-19
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-19
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-19
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-19
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-19
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-19
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-19
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-19
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-19
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-19
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-19
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-19
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-19
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-19
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-19
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-19
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-19
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-19
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-19
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-19
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-19
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-19
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-19
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-19
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-19
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-19
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-19
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-19
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-19
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-19
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-19
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-19
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-19
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-19
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-19
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		9e-19
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		9e-19
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-18
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-18
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-18
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-18
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-18
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-18
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-18
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-18
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-18
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-18
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-18
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-18
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-18
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-18
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-18
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-18
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-18
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-18
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-18
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-18
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-18
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-18
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-18
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-18
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-18
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-18
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-18
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-18
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		8e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-18
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-18
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-17
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-17
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-17
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-17
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-17
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-17
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-17
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-17
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-17
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-17
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-17
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-17
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-17
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-17
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-17
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-17
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-17
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-17
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-17
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-17
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-17
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-17
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-17
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-17
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-17
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-17
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-17
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-17
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-17
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-17
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-17
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-17
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-17
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-17
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-17
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-17
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-17
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-17
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-17
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-17
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-17
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-17
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-17
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-17
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-17
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-17
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-17
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-17
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-17
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-17
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-17
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-17
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-17
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-17
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-17
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-17
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-17
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-17
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-17
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-17
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-17
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-17
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-17
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-17
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-17
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-17
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-17
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-17
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-17
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-17
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-17
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-17
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-17
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		8e-17
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		8e-17
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-17
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		8e-17
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-17
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-17
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-17
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-17
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-17
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		9e-17
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		9e-17
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-17
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-16
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-16
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-16
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-16
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-16
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-16
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-16
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-16
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-16
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-16
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-16
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-16
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-16
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-16
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-16
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-16
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-16
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-16
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-16
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-16
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-16
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-16
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-16
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-16
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-16
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-16
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-16
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-16
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-16
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-16
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-16
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-16
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-16
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-16
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-16
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-16
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-16
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-16
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-16
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-16
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-16
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-16
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-16
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-16
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-16
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-16
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-16
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-16
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-16
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-16
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-16
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-16
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-16
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-16
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-16
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-16
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-16
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-16
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-16
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		6e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-16
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-16
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-16
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-16
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-16
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-16
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		6e-16
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-16
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-16
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-16
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		8e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		8e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-16
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		9e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		9e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		9e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-16
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-15
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-15
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-15
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-15
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-15
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-15
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-15
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-15
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-15
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-15
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-15
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-15
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-15
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-15
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-15
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-15
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-15
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-15
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-15
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-15
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-15
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-15
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		7e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		8e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		9e-15
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-14
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-14
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-14
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-14
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-14
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-14
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-14
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-14
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-14
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-14
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-14
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-14
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		7e-14
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		9e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-13
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-13
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		6e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-13
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-12
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-12
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		3e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-12
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-12
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-12
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-12
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-12
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-12
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		6e-12
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-12
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-12
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-12
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-12
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-12
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-12
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-12
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-12
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		7e-12
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-12
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-12
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-12
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		7e-12
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-12
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		7e-12
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-12
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-12
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-12
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		8e-12
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		8e-12
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-12
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		8e-12
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		9e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		9e-12
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		9e-12
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-11
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-11
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-11
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-11
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		5e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-11
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		7e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		8e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-10
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-10
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		3e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-10
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		3e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-10
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-10
3gni_B	389	Structure Of Strad And Mo25 Length = 389		6e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-10
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-09
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-09

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  191 bits (485), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 108/274 (39%), Positives = 167/274 (60%), Gaps = 16/274 (5%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV 159
           + +K + +G+G+GG V++V H P+  V A K+I+   + ++R+QI RE+++L + N P +
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 85
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYL-HKRKI 214
           V  +  +  +GEI + +E+MDGGSL+    +     E IL  ++  V+ GL YL  K KI
Sbjct: 86  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 145
Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           +HRD+KPSN+L+NS   +K+ DFGVS  L  +M   NS VGT +YMSPER+      G +
Sbjct: 146 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERL-----QGTH 198
Query: 275 DGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWA--SLMFAICFAQPPEAPE-MASREFRD 331
                DIWS+G+S++E  +GR+P   G  G  A   L+  I    PP+ P  + S EF+D
Sbjct: 199 YSVQSDIWSMGLSLVEMAVGRYPIGSG-SGSMAIFELLDYIVNEPPPKLPSGVFSLEFQD 257
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN 365
           F+++CL K+P  R    QL+ H FI R+   +V+
Sbjct: 258 FVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVD 291

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  184 bits (468), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 105/279 (37%), Positives = 166/279 (59%), Gaps = 20/279 (7%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV 159
           + +K + +G+G+GG V++V H P+  V A K+I+   + ++R+QI RE+++L + N P +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYL-HKRKI 214
           V  +  +  +GEI + +E+MDGGSL+    +     E IL  ++  V+ GL YL  K KI
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           +HRD+KPSN+L+NS   +K+ DFGVS  L  +M   NS VGT +YMSPER+      G +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERL-----QGTH 179
Query: 275 DGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWA-------SLMFAICFAQPPEAPE-MAS 326
                DIWS+G+S++E  +GR+P       + +        L+  I    PP+ P  + S
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFS 239
Query: 327 REFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN 365
            EF+DF+++CL K+P  R    QL+ H FI R+   +V+
Sbjct: 240 LEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVD 278

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  184 bits (466), Expect = 9e-47,   Method: Compositional matrix adjust.
 Identities = 105/275 (38%), Positives = 164/275 (59%), Gaps = 22/275 (8%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV 159
           + +K + +G+G+GG V++V H P+  V A K+I+   + ++R+QI RE+++L + N P +
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 69
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYL-HKRKI 214
           V  +  +  +GEI + +E+MDGGSL+    +     E IL  ++  V+ GL YL  K KI
Sbjct: 70  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 129
Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           +HRD+KPSN+L+NS   +K+ DFGVS  L   M   N  VGT +YMSPER+      G +
Sbjct: 130 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEM--ANEFVGTRSYMSPERL-----QGTH 182
Query: 275 DGYAGDIWSLGVSILEFYLGRF---PFAVGRQGDWASLMFAICFAQPPEAPE-MASREFR 330
                DIWS+G+S++E  +GR+   P A+    D+      I    PP+ P  + S EF+
Sbjct: 183 YSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDY------IVNEPPPKLPSAVFSLEFQ 236
Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN 365
           DF+++CL K+P  R    QL+ H FI R+   +V+
Sbjct: 237 DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVD 271

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  181 bits (458), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 109/311 (35%), Positives = 168/311 (54%), Gaps = 52/311 (16%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV 159
           + +K + +G+G+GG V++V H P+  V A K+I+   + ++R+QI RE+++L + N P +
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 128
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYL-HKRKI 214
           V  +  +  +GEI + +E+MDGGSL+    +     E IL  ++  V+ GL YL  K KI
Sbjct: 129 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 188
Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           +HRD+KPSN+L+NS   +K+ DFGVS  L  +M   NS VGT +YMSPER+      G +
Sbjct: 189 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERL-----QGTH 241
Query: 275 DGYAGDIWSLGVSILEFYLGRFP------------FAVGRQGDWA--------------- 307
                DIWS+G+S++E  +GR+P            F    +GD A               
Sbjct: 242 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 301
Query: 308 ------------SLMFAICFAQPPEAPEMA-SREFRDFISRCLQKDPHSRWPAAQLLQHP 354
                        L+  I    PP+ P    S EF+DF+++CL K+P  R    QL+ H 
Sbjct: 302 YGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 361
Query: 355 FILRAGQSQVN 365
           FI R+   +V+
Sbjct: 362 FIKRSDAEEVD 372

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 109/311 (35%), Positives = 169/311 (54%), Gaps = 52/311 (16%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV 159
           + +K + +G+G+GG V++V H P+  V A K+I+   + ++R+QI RE+++L + N P +
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYL-HKRKI 214
           V  +  +  +GEI + +E+MDGGSL+    +     E IL  ++  V+ GL YL  K KI
Sbjct: 94  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 153
Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           +HRD+KPSN+L+NS   +K+ DFGVS  L  +M   NS VGT +YMSPER+      G +
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERL-----QGTH 206
Query: 275 DGYAGDIWSLGVSILEFYLGRFP------------FAVGRQGDWA--------------- 307
                DIWS+G+S++E  +GR+P            F    +GD A               
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266
Query: 308 ------------SLMFAICFAQPPEAPE-MASREFRDFISRCLQKDPHSRWPAAQLLQHP 354
                        L+  I    PP+ P  + S EF+DF+++CL K+P  R    QL+ H 
Sbjct: 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326
Query: 355 FILRAGQSQVN 365
           FI R+   +V+
Sbjct: 327 FIKRSDAEEVD 337

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 109/311 (35%), Positives = 169/311 (54%), Gaps = 52/311 (16%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV 159
           + +K + +G+G+GG V++V H P+  V A K+I+   + ++R+QI RE+++L + N P +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYL-HKRKI 214
           V  +  +  +GEI + +E+MDGGSL+    +     E IL  ++  V+ GL YL  K KI
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           +HRD+KPSN+L+NS   +K+ DFGVS  L  +M   NS VGT +YMSPER+      G +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERL-----QGTH 179
Query: 275 DGYAGDIWSLGVSILEFYLGRFP------------FAVGRQGDWA--------------- 307
                DIWS+G+S++E  +GR+P            F    +GD A               
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 308 ------------SLMFAICFAQPPEAPE-MASREFRDFISRCLQKDPHSRWPAAQLLQHP 354
                        L+  I    PP+ P  + S EF+DF+++CL K+P  R    QL+ H 
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 355 FILRAGQSQVN 365
           FI R+   +V+
Sbjct: 300 FIKRSDAEEVD 310

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 109/311 (35%), Positives = 169/311 (54%), Gaps = 52/311 (16%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV 159
           + +K + +G+G+GG V++V H P+  V A K+I+   + ++R+QI RE+++L + N P +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYL-HKRKI 214
           V  +  +  +GEI + +E+MDGGSL+    +     E IL  ++  V+ GL YL  K KI
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           +HRD+KPSN+L+NS   +K+ DFGVS  L  +M   NS VGT +YMSPER+      G +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERL-----QGTH 179
Query: 275 DGYAGDIWSLGVSILEFYLGRFP------------FAVGRQGDWA--------------- 307
                DIWS+G+S++E  +GR+P            F    +GD A               
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 308 ------------SLMFAICFAQPPEAPE-MASREFRDFISRCLQKDPHSRWPAAQLLQHP 354
                        L+  I    PP+ P  + S EF+DF+++CL K+P  R    QL+ H 
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 355 FILRAGQSQVN 365
           FI R+   +V+
Sbjct: 300 FIKRSDAEEVD 310

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 109/311 (35%), Positives = 169/311 (54%), Gaps = 52/311 (16%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV 159
           + +K + +G+G+GG V++V H P+  V A K+I+   + ++R+QI RE+++L + N P +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYL-HKRKI 214
           V  +  +  +GEI + +E+MDGGSL+    +     E IL  ++  V+ GL YL  K KI
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           +HRD+KPSN+L+NS   +K+ DFGVS  L  +M   NS VGT +YMSPER+      G +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERL-----QGTH 179
Query: 275 DGYAGDIWSLGVSILEFYLGRFP------------FAVGRQGDWA--------------- 307
                DIWS+G+S++E  +GR+P            F    +GD A               
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 308 ------------SLMFAICFAQPPEAPE-MASREFRDFISRCLQKDPHSRWPAAQLLQHP 354
                        L+  I    PP+ P  + S EF+DF+++CL K+P  R    QL+ H 
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 355 FILRAGQSQVN 365
           FI R+   +V+
Sbjct: 300 FIKRSDAEEVD 310

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 109/311 (35%), Positives = 169/311 (54%), Gaps = 52/311 (16%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV 159
           + +K + +G+G+GG V++V H P+  V A K+I+   + ++R+QI RE+++L + N P +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYL-HKRKI 214
           V  +  +  +GEI + +E+MDGGSL+    +     E IL  ++  V+ GL YL  K KI
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 126
Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           +HRD+KPSN+L+NS   +K+ DFGVS  L  +M   NS VGT +YMSPER+      G +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERL-----QGTH 179
Query: 275 DGYAGDIWSLGVSILEFYLGRFP------------FAVGRQGDWA--------------- 307
                DIWS+G+S++E  +GR+P            F    +GD A               
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 308 ------------SLMFAICFAQPPEAPE-MASREFRDFISRCLQKDPHSRWPAAQLLQHP 354
                        L+  I    PP+ P  + S EF+DF+++CL K+P  R    QL+ H 
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 355 FILRAGQSQVN 365
           FI R+   +V+
Sbjct: 300 FIKRSDAEEVD 310

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 104/316 (32%), Positives = 168/316 (53%), Gaps = 58/316 (18%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV 159
           + ++ + +G+G+GG V +V H P+  + A K+I+   + ++R+QI RE+++L + N P +
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 76
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYL-HKRK 213
           V  +  +  +GEI + +E+MDGGSL     E   I +E IL  ++  VL GLAYL  K +
Sbjct: 77  VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEE-ILGKVSIAVLRGLAYLREKHQ 135
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           I+HRD+KPSN+L+NS   +K+ DFGVS  L  +M   NS VGT +YM+PER+      G 
Sbjct: 136 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMAPERL-----QGT 188
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPF----------------AVGRQGDWAS--------- 308
           +     DIWS+G+S++E  +GR+P                   G +G+  S         
Sbjct: 189 HYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG 248
Query: 309 ------------------LMFAICFAQPPEAPE-MASREFRDFISRCLQKDPHSRWPAAQ 349
                             L+  I    PP+ P  + + +F++F+++CL K+P  R     
Sbjct: 249 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKM 308
Query: 350 LLQHPFILRAGQSQVN 365
           L  H FI R+   +V+
Sbjct: 309 LTNHTFIKRSEVEEVD 324

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 83/258 (32%), Positives = 143/258 (55%), Gaps = 11/258 (4%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
            +G G+ G V++  +  TS + A KVI    E+ +   +  EI+IL   +HPN+VK  D 
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV-EIDILASCDHPNIVKLLDA 102
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRDIK 220
           +     + +L+E+  GG+++   +  E  L++     + +Q L  L YLH  KI+HRD+K
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
             N+L     ++K+ADFGVS    +T+   +S +GT  +M+PE +  + +  +   Y  D
Sbjct: 163 AGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKAD 222
Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--APEMASREFRDFISRCLQ 338
           +WSLG++++E      P     + +   ++  I  ++PP    P   S  F+DF+ +CL+
Sbjct: 223 VWSLGITLIEMAEIEPPH---HELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLE 279
Query: 339 KDPHSRWPAAQLLQHPFI 356
           K+  +RW  +QLLQHPF+
Sbjct: 280 KNVDARWTTSQLLQHPFV 297

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 82/258 (31%), Positives = 142/258 (55%), Gaps = 11/258 (4%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
            +G G+ G V++  +  TS + A KVI    E+ +   +  EI+IL   +HPN+VK  D 
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV-EIDILASCDHPNIVKLLDA 102
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRDIK 220
           +     + +L+E+  GG+++   +  E  L++     + +Q L  L YLH  KI+HRD+K
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
             N+L     ++K+ADFGVS    + +   +S +GT  +M+PE +  + +  +   Y  D
Sbjct: 163 AGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKAD 222
Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--APEMASREFRDFISRCLQ 338
           +WSLG++++E      P     + +   ++  I  ++PP    P   S  F+DF+ +CL+
Sbjct: 223 VWSLGITLIEMAEIEPPH---HELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLE 279
Query: 339 KDPHSRWPAAQLLQHPFI 356
           K+  +RW  +QLLQHPF+
Sbjct: 280 KNVDARWTTSQLLQHPFV 297

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 93/275 (33%), Positives = 148/275 (53%), Gaps = 26/275 (9%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
            ++G GS G+V++ +H  T ++ A+K +     +S   +I +EI I++  + P+VVK + 
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESDLQEIIKEISIMQQCDSPHVVKYYG 91
Query: 165 MYDRNGEIEVLLEYMDGGSLEGA-HIRQEHILSD----LARQVLSGLAYLHKRKIVHRDI 219
            Y +N ++ +++EY   GS+     +R + +  D    + +  L GL YLH  + +HRDI
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDI 151
Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY-- 277
           K  N+L+N+  + K+ADFGV+  L   M   N  +GT  +M+PE I          GY  
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQE-------IGYNC 204
Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASL--MFAICFAQPPE--APEMASREFRDFI 333
             DIWSLG++ +E   G+ P+A     D   +  +F I    PP    PE+ S  F DF+
Sbjct: 205 VADIWSLGITAIEMAEGKPPYA-----DIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFV 259
Query: 334 SRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNL 368
            +CL K P  R  A QLLQHPF+  A    + ++L
Sbjct: 260 KQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDL 294

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 81/258 (31%), Positives = 141/258 (54%), Gaps = 11/258 (4%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
            +G G+ G V++  +  TS + A KVI    E+ +   +  EI+IL   +HPN+VK  D 
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV-EIDILASCDHPNIVKLLDA 102
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRDIK 220
           +     + +L+E+  GG+++   +  E  L++     + +Q L  L YLH  KI+HRD+K
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
             N+L     ++K+ADFGVS    + +   +  +GT  +M+PE +  + +  +   Y  D
Sbjct: 163 AGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKAD 222
Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--APEMASREFRDFISRCLQ 338
           +WSLG++++E      P     + +   ++  I  ++PP    P   S  F+DF+ +CL+
Sbjct: 223 VWSLGITLIEMAEIEPPH---HELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLE 279
Query: 339 KDPHSRWPAAQLLQHPFI 356
           K+  +RW  +QLLQHPF+
Sbjct: 280 KNVDARWTTSQLLQHPFV 297

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  147 bits (371), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 152/275 (55%), Gaps = 16/275 (5%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
            +G G+ G V++  +  T  + A KVI    E+ +   I  EIEIL   +HP +VK    
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV-EIEILATCDHPYIVKLLGA 76
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRDIK 220
           Y  +G++ +++E+  GG+++   +  +  L++     + RQ+L  L +LH ++I+HRD+K
Sbjct: 77  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 136
Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD-LNHGKYDGYAG 279
             N+L+    ++++ADFGVS    +T+   +S +GT  +M+PE +  + +    YD Y  
Sbjct: 137 AGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD-YKA 195
Query: 280 DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--APEMASREFRDFISRCL 337
           DIWSLG++++E      P     + +   ++  I  + PP    P   S EFRDF+   L
Sbjct: 196 DIWSLGITLIEMAQIEPPH---HELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIAL 252
Query: 338 QKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQIL 372
            K+P +R  AAQLL+HPF+        N+ LR+++
Sbjct: 253 DKNPETRPSAAQLLEHPFV---SSITSNKALRELV 284

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  147 bits (371), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 152/275 (55%), Gaps = 16/275 (5%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
            +G G+ G V++  +  T  + A KVI    E+ +   I  EIEIL   +HP +VK    
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV-EIEILATCDHPYIVKLLGA 84
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRDIK 220
           Y  +G++ +++E+  GG+++   +  +  L++     + RQ+L  L +LH ++I+HRD+K
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 144
Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD-LNHGKYDGYAG 279
             N+L+    ++++ADFGVS    +T+   +S +GT  +M+PE +  + +    YD Y  
Sbjct: 145 AGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD-YKA 203
Query: 280 DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--APEMASREFRDFISRCL 337
           DIWSLG++++E      P     + +   ++  I  + PP    P   S EFRDF+   L
Sbjct: 204 DIWSLGITLIEMAQIEPPH---HELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIAL 260
Query: 338 QKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQIL 372
            K+P +R  AAQLL+HPF+        N+ LR+++
Sbjct: 261 DKNPETRPSAAQLLEHPFV---SSITSNKALRELV 292

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 95/271 (35%), Positives = 147/271 (54%), Gaps = 14/271 (5%)
Query: 96  INPAEL-QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV 154
           ++P EL  K  +IG GS G V++ +   T +V A+K+I     +     I +EI +L   
Sbjct: 3   LDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 62
Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLH 210
           + P V K +  Y ++ ++ +++EY+ GGS    LE   + +  I + L R++L GL YLH
Sbjct: 63  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL-REILKGLDYLH 121
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
             K +HRDIK +N+L++    VK+ADFGV+  L  T    N+ VGT  +M+PE I     
Sbjct: 122 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI----K 177
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
              YD  A DIWSLG++ +E   G  P +   +     ++F I    PP      S+  +
Sbjct: 178 QSAYDSKA-DIWSLGITAIELARGEPPHS---ELHPMKVLFLIPKNNPPTLEGNYSKPLK 233
Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
           +F+  CL K+P  R  A +LL+H FILR  +
Sbjct: 234 EFVEACLNKEPSFRPTAKELLKHKFILRNAK 264

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 95/271 (35%), Positives = 147/271 (54%), Gaps = 14/271 (5%)
Query: 96  INPAEL-QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV 154
           ++P EL  K  +IG GS G V++ +   T +V A+K+I     +     I +EI +L   
Sbjct: 23  MDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 82
Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLH 210
           + P V K +  Y ++ ++ +++EY+ GGS    LE   + +  I + L R++L GL YLH
Sbjct: 83  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL-REILKGLDYLH 141
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
             K +HRDIK +N+L++    VK+ADFGV+  L  T    N+ VGT  +M+PE I     
Sbjct: 142 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI----K 197
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
              YD  A DIWSLG++ +E   G  P +   +     ++F I    PP      S+  +
Sbjct: 198 QSAYDSKA-DIWSLGITAIELARGEPPHS---ELHPMKVLFLIPKNNPPTLEGNYSKPLK 253
Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
           +F+  CL K+P  R  A +LL+H FILR  +
Sbjct: 254 EFVEACLNKEPSFRPTAKELLKHKFILRNAK 284

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 95/271 (35%), Positives = 146/271 (53%), Gaps = 14/271 (5%)
Query: 96  INPAEL-QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV 154
           ++P EL  K  +IG GS G V++ +   T +V A+K+I     +     I +EI +L   
Sbjct: 3   LDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 62
Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLH 210
           + P V K +  Y ++ ++ +++EY+ GGS    LE   + +  I + L R++L GL YLH
Sbjct: 63  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL-REILKGLDYLH 121
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
             K +HRDIK +N+L++    VK+ADFGV+  L  T    N  VGT  +M+PE I     
Sbjct: 122 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI----K 177
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
              YD  A DIWSLG++ +E   G  P +   +     ++F I    PP      S+  +
Sbjct: 178 QSAYDSKA-DIWSLGITAIELARGEPPHS---ELHPMKVLFLIPKNNPPTLEGNYSKPLK 233
Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
           +F+  CL K+P  R  A +LL+H FILR  +
Sbjct: 234 EFVEACLNKEPSFRPTAKELLKHKFILRNAK 264

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 95/270 (35%), Positives = 145/270 (53%), Gaps = 14/270 (5%)
Query: 97  NPAEL-QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           +P EL  K  +IG GS G V++ +   T +V A+K+I     +     I +EI +L   +
Sbjct: 19  DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 78
Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHK 211
            P V K +  Y ++ ++ +++EY+ GGS    LE   + +  I + L R++L GL YLH 
Sbjct: 79  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL-REILKGLDYLHS 137
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            K +HRDIK +N+L++    VK+ADFGV+  L  T    N  VGT  +M+PE I      
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI----KQ 193
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
             YD  A DIWSLG++ +E   G  P +   +     ++F I    PP      S+  ++
Sbjct: 194 SAYDSKA-DIWSLGITAIELARGEPPHS---ELHPMKVLFLIPKNNPPTLEGNYSKPLKE 249
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
           F+  CL K+P  R  A +LL+H FILR  +
Sbjct: 250 FVEACLNKEPSFRPTAKELLKHKFILRNAK 279

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  144 bits (364), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 143/269 (53%), Gaps = 16/269 (5%)
Query: 96  INPAEL-QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV 154
           ++P EL  K +RIG GS G V++ +   T  V A+K+I     +     I +EI +L   
Sbjct: 15  VDPEELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC 74
Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHK 211
           + P + +    Y ++ ++ +++EY+ GGS   L      +E  ++ + R++L GL YLH 
Sbjct: 75  DSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHS 134
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            + +HRDIK +N+L++   +VK+ADFGV+  L  T    N  VGT  +M+PE I      
Sbjct: 135 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI----KQ 190
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDW--ASLMFAICFAQPPEAPEMASREF 329
             YD +  DIWSLG++ +E   G  P       D     ++F I    PP      S+ F
Sbjct: 191 SAYD-FKADIWSLGITAIELAKGEPP-----NSDLHPMRVLFLIPKNSPPTLEGQHSKPF 244
Query: 330 RDFISRCLQKDPHSRWPAAQLLQHPFILR 358
           ++F+  CL KDP  R  A +LL+H FI R
Sbjct: 245 KEFVEACLNKDPRFRPTAKELLKHKFITR 273

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/268 (34%), Positives = 143/268 (53%), Gaps = 12/268 (4%)
Query: 95  LINPAEL-QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRD 153
           + +P EL  K  RIG GS G V++ +   T +V A+K+I     +     I +EI +L  
Sbjct: 18  IADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ 77
Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLH 210
            +   V K +  Y +  ++ +++EY+ GGS   L  A    E  ++ + +++L GL YLH
Sbjct: 78  CDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLH 137
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
             K +HRDIK +N+L++   +VK+ADFGV+  L  T    N+ VGT  +M+PE I     
Sbjct: 138 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI----Q 193
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
              YD  A DIWSLG++ +E   G  P           ++F I    PP      ++ F+
Sbjct: 194 QSAYDSKA-DIWSLGITAIELAKGEPP---NSDMHPMRVLFLIPKNNPPTLVGDFTKSFK 249
Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFILR 358
           +FI  CL KDP  R  A +LL+H FI++
Sbjct: 250 EFIDACLNKDPSFRPTAKELLKHKFIVK 277

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 85/271 (31%), Positives = 141/271 (52%), Gaps = 14/271 (5%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDV 154
           +   +L+    +G G+ G V ++ H P+ ++ A+K I        + ++  +++I +R V
Sbjct: 48  VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV 107
Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGG-------SLEGAHIRQEHILSDLARQVLSGLA 207
           + P  V  +    R G++ + +E MD          ++      E IL  +A  ++  L 
Sbjct: 108 DCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 167
Query: 208 YLH-KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN 266
           +LH K  ++HRD+KPSN+LIN+   VK+ DFG+S  L  ++     A G   YM+PERIN
Sbjct: 168 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDA-GCKPYMAPERIN 226
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAP-EMA 325
            +LN   Y     DIWSLG++++E  + RFP+     G     +  +     P+ P +  
Sbjct: 227 PELNQKGY-SVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLKQVVEEPSPQLPADKF 283
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           S EF DF S+CL+K+   R    +L+QHPF 
Sbjct: 284 SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 99/279 (35%), Positives = 143/279 (51%), Gaps = 23/279 (8%)
Query: 102 QKGNRI--GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPN 158
           + G+R+  G G+ G V+           A+K I     DS  SQ +  EI + + + H N
Sbjct: 23  ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKN 80
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLE-------GAHIRQEHILSDLARQVLSGLAYLHK 211
           +V+    +  NG I++ +E + GGSL        G     E  +    +Q+L GL YLH 
Sbjct: 81  IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140
Query: 212 RKIVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSA-VGTIAYMSPERINTD- 268
            +IVHRDIK  N+LIN+   V KI+DFG S+ LA  ++PC     GT+ YM+PE I+   
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKGP 199
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI-CFAQPPEAPEMASR 327
             +GK    A DIWSLG +I+E   G+ PF     G+  + MF +  F   PE PE  S 
Sbjct: 200 RGYGK----AADIWSLGCTIIEMATGKPPFY--ELGEPQAAMFKVGMFKVHPEIPESMSA 253
Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQ 366
           E + FI +C + DP  R  A  LL   F+  + + +  Q
Sbjct: 254 EAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQ 292

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  134 bits (338), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 98/269 (36%), Positives = 139/269 (51%), Gaps = 23/269 (8%)
Query: 102 QKGNRI--GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPN 158
           + G+R+  G G+ G V+           A+K I     DS  SQ +  EI + + + H N
Sbjct: 9   ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLHEEIALHKHLKHKN 66
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLE-------GAHIRQEHILSDLARQVLSGLAYLHK 211
           +V+    +  NG I++ +E + GGSL        G     E  +    +Q+L GL YLH 
Sbjct: 67  IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 126
Query: 212 RKIVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSA-VGTIAYMSPERINTD- 268
            +IVHRDIK  N+LIN+   V KI+DFG S+ LA  ++PC     GT+ YM+PE I+   
Sbjct: 127 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKGP 185
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI-CFAQPPEAPEMASR 327
             +GK    A DIWSLG +I+E   G+ PF     G+  + MF +  F   PE PE  S 
Sbjct: 186 RGYGK----AADIWSLGCTIIEMATGKPPFY--ELGEPQAAMFKVGMFKVHPEIPESMSA 239
Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           E + FI +C + DP  R  A  LL   F+
Sbjct: 240 EAKAFILKCFEPDPDKRACANDLLVDEFL 268

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/271 (31%), Positives = 140/271 (51%), Gaps = 14/271 (5%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDV 154
           +   +L+    +G G+ G V ++ H P+ ++ A+K I        + ++  +++I +R V
Sbjct: 4   VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV 63
Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGG-------SLEGAHIRQEHILSDLARQVLSGLA 207
           + P  V  +    R G++ + +E MD          ++      E IL  +A  ++  L 
Sbjct: 64  DCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 208 YLH-KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN 266
           +LH K  ++HRD+KPSN+LIN+   VK+ DFG+S  L   +     A G   YM+PERIN
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-GCKPYMAPERIN 182
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAP-EMA 325
            +LN   Y     DIWSLG++++E  + RFP+     G     +  +     P+ P +  
Sbjct: 183 PELNQKGY-SVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLKQVVEEPSPQLPADKF 239
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           S EF DF S+CL+K+   R    +L+QHPF 
Sbjct: 240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 85/276 (30%), Positives = 144/276 (52%), Gaps = 26/276 (9%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDVNHPN 158
           +L+    IG G+ G+V ++VH P+ ++ A+K I    ++  + Q+  ++++ +R  + P 
Sbjct: 23  DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY 82
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAH---------IRQEHILSDLARQVLSGLAYL 209
           +V+ +    R G+  + +E M   S +  +         +  E IL  +    +  L +L
Sbjct: 83  IVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 210 HKR-KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
            +  KI+HRDIKPSN+L++ S N+K+ DFG+S  L  ++     A G   YM+PERI+  
Sbjct: 142 KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA-GCRPYMAPERIDPS 200
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASL---MFAICFAQPPEAPEMA 325
            +   YD    D+WSLG+++ E   GRFP+       W S+   +  +    PP+     
Sbjct: 201 ASRQGYD-VRSDVWSLGITLYELATGRFPYP-----KWNSVFDQLTQVVKGDPPQLSNSE 254
Query: 326 SREFR----DFISRCLQKDPHSRWPAAQLLQHPFIL 357
            REF     +F++ CL KD   R    +LL+HPFIL
Sbjct: 255 EREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 91/298 (30%), Positives = 141/298 (47%), Gaps = 33/298 (11%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           IN  + +    IGSG+   V      P     A+K I      +   ++ +EI+ +   +
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL---------EGAH---IRQEHILSDLARQVL 203
           HPN+V  +  +    E+ ++++ + GGS+         +G H   +  E  ++ + R+VL
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-----NSAVGTIA 258
            GL YLHK   +HRD+K  N+L+    +V+IADFGVS  LA   D        + VGT  
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF---------AVGRQGDWASL 309
           +M+PE +        YD +  DIWS G++ +E   G  P+          +  Q D  SL
Sbjct: 192 WMAPEVMEQVRG---YD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247
Query: 310 MFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQN 367
              +   Q  E  +   + FR  IS CLQKDP  R  AA+LL+H F  +A   +  Q 
Sbjct: 248 ETGV---QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQE 302

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  131 bits (330), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 90/290 (31%), Positives = 139/290 (47%), Gaps = 33/290 (11%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           IN  + +    IGSG+   V      P     A+K I      +   ++ +EI+ +   +
Sbjct: 7   INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 66
Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL---------EGAH---IRQEHILSDLARQVL 203
           HPN+V  +  +    E+ ++++ + GGS+         +G H   +  E  ++ + R+VL
Sbjct: 67  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 126
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-----NSAVGTIA 258
            GL YLHK   +HRD+K  N+L+    +V+IADFGVS  LA   D        + VGT  
Sbjct: 127 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF---------AVGRQGDWASL 309
           +M+PE +        YD +  DIWS G++ +E   G  P+          +  Q D  SL
Sbjct: 187 WMAPEVMEQVRG---YD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 242
Query: 310 MFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA 359
              +   Q  E  +   + FR  IS CLQKDP  R  AA+LL+H F  +A
Sbjct: 243 ETGV---QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 289

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/256 (31%), Positives = 128/256 (50%), Gaps = 14/256 (5%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +IG G+ GTV+  +   T +  A++ +    +   +  I  EI ++R+  +PN+V   D 
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDS 85
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           Y    E+ V++EY+ GGSL          E  ++ + R+ L  L +LH  +++HRDIK  
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145
Query: 223 NLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           N+L+    +VK+ DFG    +       +  VGT  +M+PE +       K  G   DIW
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR-----KAYGPKVDIW 200
Query: 283 SLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA--PEMASREFRDFISRCLQKD 340
           SLG+  +E   G  P+      +    ++ I     PE   PE  S  FRDF++RCL+ D
Sbjct: 201 SLGIMAIEMIEGEPPYL---NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 257
Query: 341 PHSRWPAAQLLQHPFI 356
              R  A +LLQH F+
Sbjct: 258 VEKRGSAKELLQHQFL 273

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 81/256 (31%), Positives = 128/256 (50%), Gaps = 14/256 (5%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +IG G+ GTV+  +   T +  A++ +    +   +  I  EI ++R+  +PN+V   D 
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDS 85
Query: 166 YDRNGEIEVLLEYMDGGSLEGA---HIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           Y    E+ V++EY+ GGSL          E  ++ + R+ L  L +LH  +++HRDIK  
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145
Query: 223 NLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           N+L+    +VK+ DFG    +       ++ VGT  +M+PE +       K  G   DIW
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-----KAYGPKVDIW 200
Query: 283 SLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA--PEMASREFRDFISRCLQKD 340
           SLG+  +E   G  P+      +    ++ I     PE   PE  S  FRDF++RCL  D
Sbjct: 201 SLGIMAIEMIEGEPPYL---NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257
Query: 341 PHSRWPAAQLLQHPFI 356
              R  A +LLQH F+
Sbjct: 258 VEKRGSAKELLQHQFL 273

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 81/256 (31%), Positives = 127/256 (49%), Gaps = 14/256 (5%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +IG G+ GTV+  +   T +  A++ +    +   +  I  EI ++R+  +PN+V   D 
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDS 85
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           Y    E+ V++EY+ GGSL          E  ++ + R+ L  L +LH  +++HRDIK  
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145
Query: 223 NLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           N+L+    +VK+ DFG    +       +  VGT  +M+PE +       K  G   DIW
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTR-----KAYGPKVDIW 200
Query: 283 SLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA--PEMASREFRDFISRCLQKD 340
           SLG+  +E   G  P+      +    ++ I     PE   PE  S  FRDF++RCL  D
Sbjct: 201 SLGIMAIEMIEGEPPYL---NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257
Query: 341 PHSRWPAAQLLQHPFI 356
              R  A +LLQH F+
Sbjct: 258 VEKRGSAKELLQHQFL 273

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 80/256 (31%), Positives = 128/256 (50%), Gaps = 14/256 (5%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +IG G+ GTV+  +   T +  A++ +    +   +  I  EI ++R+  +PN+V   D 
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDS 86
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           Y    E+ V++EY+ GGSL          E  ++ + R+ L  L +LH  +++HRDIK  
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 146
Query: 223 NLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           N+L+    +VK+ DFG    +       +  VGT  +M+PE +       K  G   DIW
Sbjct: 147 NILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR-----KAYGPKVDIW 201
Query: 283 SLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA--PEMASREFRDFISRCLQKD 340
           SLG+  +E   G  P+      +    ++ I     PE   PE  S  FRDF++RCL+ D
Sbjct: 202 SLGIMAIEMIEGEPPYL---NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 258
Query: 341 PHSRWPAAQLLQHPFI 356
              R  A +L+QH F+
Sbjct: 259 VEKRGSAKELIQHQFL 274

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 142/296 (47%), Gaps = 41/296 (13%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRD 153
           L++    QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L++
Sbjct: 3   LVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSG 205
           +NHPN+VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L G
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQG 119
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERI 265
           LA+ H  +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE  
Sbjct: 120 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI- 178
Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAIC 314
              L   KY   A DIWSLG    E    R  FP        F + R  G    +++   
Sbjct: 179 ---LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 235
Query: 315 FAQP---PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            + P   P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 236 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 144/277 (51%), Gaps = 17/277 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI--YGNHEDSVRSQICREIEILRDVNHP 157
           +L+    +GSG+ G VW++    T  V A+K +   GN E++ R  +  ++ +L+  + P
Sbjct: 26  DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV-VLKSHDCP 84
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYL-HK 211
            +V+C   +  N ++ + +E M G   E    R      E IL  +   ++  L YL  K
Sbjct: 85  YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN-TDLN 270
             ++HRD+KPSN+L++    +K+ DFG+S  L        SA G  AYM+PERI+  D  
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA-GCAAYMAPERIDPPDPT 202
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA--SRE 328
              YD  A D+WSLG+S++E   G+FP+   +  D+  L   +   +PP  P     S +
Sbjct: 203 KPDYDIRA-DVWSLGISLVELATGQFPYKNCKT-DFEVLT-KVLQEEPPLLPGHMGFSGD 259
Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN 365
           F+ F+  CL KD   R    +LL+H FI R    +V+
Sbjct: 260 FQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 129/256 (50%), Gaps = 14/256 (5%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +IG G+ GTV+  +   T +  A++ +    +   +  I  EI ++R+  +PN+V   D 
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDS 86
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIRQ---EHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           Y    E+ V++EY+ GGSL          E  ++ + R+ L  L +LH  +++HR+IK  
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSD 146
Query: 223 NLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           N+L+    +VK+ DFG    +       ++ VGT  +M+PE +       K  G   DIW
Sbjct: 147 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-----KAYGPKVDIW 201
Query: 283 SLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA--PEMASREFRDFISRCLQKD 340
           SLG+  +E   G  P+      +    ++ I     PE   PE  S  FRDF++RCL+ D
Sbjct: 202 SLGIMAIEMIEGEPPYL---NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 258
Query: 341 PHSRWPAAQLLQHPFI 356
              R  A +L+QH F+
Sbjct: 259 VEKRGSAKELIQHQFL 274

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 87/275 (31%), Positives = 135/275 (49%), Gaps = 22/275 (8%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIY--GNHEDSVRSQICREIEILRDVNHPNVVKCH 163
            IG GS G V+       S V A+K +   G   +     I +E+  L+ + HPN ++  
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDI 219
             Y R     +++EY  G + +   +     QE  ++ +    L GLAYLH   ++HRD+
Sbjct: 121 GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDV 180
Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           K  N+L++    VK+ DFG + I+A    P N  VGT  +M+PE I   ++ G+YDG   
Sbjct: 181 KAGNILLSEPGLVKLGDFGSASIMA----PANXFVGTPYWMAPEVI-LAMDEGQYDGKV- 234
Query: 280 DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA----SREFRDFISR 335
           D+WSLG++ +E    + P          + M A+      E+P +     S  FR+F+  
Sbjct: 235 DVWSLGITCIELAERKPPLFN------MNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 288
Query: 336 CLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQ 370
           CLQK P  R  +  LL+H F+LR     V  +L Q
Sbjct: 289 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQ 323

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 121
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI----LLG 177
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 128
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI----LLG 184
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 244
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 245 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 121
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI----LLG 177
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 120
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI----LLG 176
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 120
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI----LLG 176
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 122
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI----LLG 178
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 87/275 (31%), Positives = 135/275 (49%), Gaps = 22/275 (8%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIY--GNHEDSVRSQICREIEILRDVNHPNVVKCH 163
            IG GS G V+       S V A+K +   G   +     I +E+  L+ + HPN ++  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDI 219
             Y R     +++EY  G + +   +     QE  ++ +    L GLAYLH   ++HRD+
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDV 141
Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           K  N+L++    VK+ DFG + I+A    P N  VGT  +M+PE I   ++ G+YDG   
Sbjct: 142 KAGNILLSEPGLVKLGDFGSASIMA----PANXFVGTPYWMAPEVI-LAMDEGQYDGKV- 195
Query: 280 DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA----SREFRDFISR 335
           D+WSLG++ +E    + P          + M A+      E+P +     S  FR+F+  
Sbjct: 196 DVWSLGITCIELAERKPPLFN------MNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249
Query: 336 CLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQ 370
           CLQK P  R  +  LL+H F+LR     V  +L Q
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQ 284

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 121
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI----LLG 177
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 128
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 129 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI----LLG 184
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 244
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 245 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 160 VKCHDMYDRNGEIEVLLE--------YMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E        +MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 64  VKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 120
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI----LLG 176
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 134/267 (50%), Gaps = 28/267 (10%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +IG GS G V       + R  A+K++    +   R  +  E+ I+RD  H NVV+ +  
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR-RELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 166 YDRNGEIEVLLEYMDGGSLEG--AHIR-QEHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           Y    E+ VL+E++ GG+L    + +R  E  ++ +   VL  LAYLH + ++HRDIK  
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSD 170
Query: 223 NLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           ++L+     VK++DFG    +++ +      VGT  +M+PE I+  L   +      DIW
Sbjct: 171 SILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEV-----DIW 225
Query: 283 SLGVSILEFYLGRFPF-------AVGRQGDWASLMFAICFAQPPEA--PEMASREFRDFI 333
           SLG+ ++E   G  P+       A+ R  D          + PP+       S   RDF+
Sbjct: 226 SLGIMVIEMVDGEPPYFSDSPVQAMKRLRD----------SPPPKLKNSHKVSPVLRDFL 275
Query: 334 SRCLQKDPHSRWPAAQLLQHPFILRAG 360
            R L +DP  R  A +LL HPF+L+ G
Sbjct: 276 ERMLVRDPQERATAQELLDHPFLLQTG 302

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 124
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 180
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 120
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 176
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 121
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 177
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 124
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 180
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 123
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 179
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 124
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 125 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 180
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 120
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 176
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 121
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 177
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 125
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 126 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 181
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 242 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 123
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 124 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 179
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 121
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 177
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 122
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 178
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 123
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 179
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 122
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 178
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 121
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 122 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 177
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 124
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 180
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 124
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 180
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 122
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 123 HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 178
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 122
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 123 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 178
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 160 VKCHDMYDRNGEIEVLLE--------YMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E        +MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 68  VKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 124
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 180
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 123
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 179
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 92/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 121
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI----LLG 177
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 126/261 (48%), Gaps = 25/261 (9%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKV--IYGNHEDSVRSQICREIEILRDVNH 156
           A  +   +IG G    V+R          ALK   I+   +   R+   +EI++L+ +NH
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 157 PNVVKCHDMYDRNGEIEVLLEYMDGGSLEG--AHIRQ------EHILSDLARQVLSGLAY 208
           PNV+K +  +  + E+ ++LE  D G L     H ++      E  +     Q+ S L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
           +H R+++HRDIKP+N+ I ++  VK+ D G+ R  +      +S VGT  YMSPERI   
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI--- 208
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC-----FAQPPEAPE 323
             H     +  DIWSLG  + E    + PF     GD  +L +++C        PP   +
Sbjct: 209 --HENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNL-YSLCKKIEQCDYPPLPSD 261
Query: 324 MASREFRDFISRCLQKDPHSR 344
             S E R  ++ C+  DP  R
Sbjct: 262 HYSEELRQLVNMCINPDPEKR 282

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/290 (31%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V ALK I  + E + V S   REI +L+++NHPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GL++ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLSFCHS 121
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI----LLG 177
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 90/290 (31%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFAL-KVIYGNHEDSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V AL K+      + V S   REI +L+++NHPN+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 121
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 122 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI----LLG 177
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 90/290 (31%), Positives = 137/290 (47%), Gaps = 41/290 (14%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFAL-KVIYGNHEDSVRSQICREIEILRDVNHPNV 159
            QK  +IG G+ G V++  +  T  V AL K+      + V S   REI +L+++NHPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 160 VKCHDMYDRNGEIEVLLEY--------MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           VK  D+     ++ ++ E+        MD  +L G  +    ++     Q+L GLA+ H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP---LIKSYLFQLLQGLAFCHS 120
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L  
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI----LLG 176
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP--------FAVGRQ-GDWASLMFAICFAQP-- 318
            KY   A DIWSLG    E    R  FP        F + R  G    +++    + P  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 319 -PEAPEMASREF-----------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P+ A ++F           R  +S+ L  DP+ R  A   L HPF 
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 134/271 (49%), Gaps = 25/271 (9%)
Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNH 156
           + G  +GSG    V +     T + +A K I      S R      +I RE+ ILR++ H
Sbjct: 8   EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 157 PNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLA----RQVLSGLAYLHKR 212
           PN++  HD+++   ++ ++LE + GG L      +E +  D A    +Q+L G+ YLH +
Sbjct: 68  PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK 127
Query: 213 KIVHRDIKPSNLLINSSKNV-----KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           +I H D+KP N+++   KNV     K+ DFG++  + +  +   +  GT  +++PE +N 
Sbjct: 128 RIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKI-EAGNEFKNIFGTPEFVAPEIVN- 184
Query: 268 DLNHGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                 Y+  G   D+WS+GV       G  PF    + +  + + A+ +    E     
Sbjct: 185 ------YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           S   +DFI R L KDP  R   AQ L+H +I
Sbjct: 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 97/283 (34%), Positives = 135/283 (47%), Gaps = 30/283 (10%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEIL-RDVNHPNVVKCHDM 165
           IG GS     R +H  T+  FA+K+I     D  +     EIEIL R   HPN++   D+
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKII-----DKSKRDPTEEIEILLRYGQHPNIITLKDV 84
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLA----YLHKRKIVHRDIKP 221
           YD    + V+ E M GG L    +RQ+      A  VL  +     YLH + +VHRD+KP
Sbjct: 85  YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKP 144
Query: 222 SNLL-INSSKN---VKIADFGVSRIL----AQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           SN+L ++ S N   ++I DFG ++ L       M PC +A     +++PE     L    
Sbjct: 145 SNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA----NFVAPEV----LERQG 196
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC---FAQPPEAPEMASREFR 330
           YD  A DIWSLGV +     G  PFA G       ++  I    F+         S   +
Sbjct: 197 YDA-ACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAK 255
Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILP 373
           D +S+ L  DPH R  AA +L+HP+I+   Q    Q  RQ  P
Sbjct: 256 DLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAP 298

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 131/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +  +  + ++LEY   G+    L+      E   +    ++ + L+Y H +K
Sbjct: 69  NILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKK 128
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S  +        +  GT+ Y+ PE I   ++  K
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEMIEGRMHDEK 186
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      D    +  + F  P    E A    RD I
Sbjct: 187 V-----DLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGA----RDLI 237
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 150/271 (55%), Gaps = 33/271 (12%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKV--IYGNHEDSVRSQICREIEILRDVNHP-NVVKCH 163
           +G+G+ G V++  H  T ++ A+KV  + G+ E+ ++    +EI +L+  +H  N+   +
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK----QEINMLKKYSHHRNIATYY 87
Query: 164 DMYDR------NGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLH 210
             + +      + ++ +++E+   GS+       +G  +++E I + + R++L GL++LH
Sbjct: 88  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI-AYICREILRGLSHLH 146
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
           + K++HRDIK  N+L+  +  VK+ DFGVS  L +T+   N+ +GT  +M+PE I  D N
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 206
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA----S 326
                 +  D+WSLG++ +E   G  P       D   +       + P AP +     S
Sbjct: 207 PDATYDFKSDLWSLGITAIEMAEGAPPLC-----DMHPMRALFLIPRNP-APRLKSKKWS 260
Query: 327 REFRDFISRCLQKDPHSRWPAA-QLLQHPFI 356
           ++F+ FI  CL K+ HS+ PA  QL++HPFI
Sbjct: 261 KKFQSFIESCLVKN-HSQRPATEQLMKHPFI 290

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 134/271 (49%), Gaps = 25/271 (9%)
Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNH 156
           + G  +GSG    V +     T + +A K I      S R      +I RE+ ILR++ H
Sbjct: 15  EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 74
Query: 157 PNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLA----RQVLSGLAYLHKR 212
           PN++  HD+++   ++ ++LE + GG L      +E +  D A    +Q+L G+ YLH +
Sbjct: 75  PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK 134
Query: 213 KIVHRDIKPSNLLINSSKNV-----KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           +I H D+KP N+++   KNV     K+ DFG++  + +  +   +  GT  +++PE +N 
Sbjct: 135 RIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKI-EAGNEFKNIFGTPEFVAPEIVN- 191
Query: 268 DLNHGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                 Y+  G   D+WS+GV       G  PF    + +  + + A+ +    E     
Sbjct: 192 ------YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 245
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           S   +DFI R L KDP  R   AQ L+H +I
Sbjct: 246 SELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 134/271 (49%), Gaps = 25/271 (9%)
Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNH 156
           + G  +GSG    V +     T + +A K I      S R      +I RE+ ILR++ H
Sbjct: 29  EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRH 88
Query: 157 PNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLA----RQVLSGLAYLHKR 212
           PN++  HD+++   ++ ++LE + GG L      +E +  D A    +Q+L G+ YLH +
Sbjct: 89  PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK 148
Query: 213 KIVHRDIKPSNLLINSSKNV-----KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           +I H D+KP N+++   KNV     K+ DFG++  + +  +   +  GT  +++PE +N 
Sbjct: 149 RIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKI-EAGNEFKNIFGTPEFVAPEIVN- 205
Query: 268 DLNHGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                 Y+  G   D+WS+GV       G  PF    + +  + + A+ +    E     
Sbjct: 206 ------YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 259
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           S   +DFI R L KDP  R   AQ L+H +I
Sbjct: 260 SELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 290

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 81/258 (31%), Positives = 130/258 (50%), Gaps = 15/258 (5%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +G GS G V +     T + +A+KVI   + ++   S I RE+E+L+ ++HPN++K  ++
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            + +    ++ E   GG L    I++    EH  + + +QV SG+ Y+HK  IVHRD+KP
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKP 149
Query: 222 SNLLINSSK---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
            N+L+ S +   ++KI DFG+S    Q        +GT  Y++PE +      G YD   
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEVL-----RGTYDEKC 203
Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ 338
            D+WS GV +     G  PF    + D    +    +A         S + +D I + L 
Sbjct: 204 -DVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLT 262
Query: 339 KDPHSRWPAAQLLQHPFI 356
             P  R  A Q L+HP+I
Sbjct: 263 FHPSLRITATQCLEHPWI 280

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 132/271 (48%), Gaps = 14/271 (5%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDV 154
           +   +L+    +G G+ G V +  H P+ ++ A+K I        + ++  +++I  R V
Sbjct: 31  VKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTV 90
Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGG-------SLEGAHIRQEHILSDLARQVLSGLA 207
           + P  V  +    R G++ +  E  D          ++      E IL  +A  ++  L 
Sbjct: 91  DCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 150
Query: 208 YLH-KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN 266
           +LH K  ++HRD+KPSN+LIN+   VK  DFG+S  L   +     A G   Y +PERIN
Sbjct: 151 HLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA-GCKPYXAPERIN 209
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAP-EMA 325
            +LN   Y     DIWSLG++ +E  + RFP+     G     +  +     P+ P +  
Sbjct: 210 PELNQKGY-SVKSDIWSLGITXIELAILRFPY--DSWGTPFQQLKQVVEEPSPQLPADKF 266
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           S EF DF S+CL+K+   R    +L QHPF 
Sbjct: 267 SAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 132/265 (49%), Gaps = 21/265 (7%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 214 IVHRDIKPSNLLINSSKNVKIADFG--VSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
           ++HRDIKP NLL+ S+  +KIADFG  V    ++  D C    GT+ Y+ PE I   ++ 
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGRMHD 185
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
            K      D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD
Sbjct: 186 EKV-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RD 236
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFI 356
            ISR L+ +P  R    ++L+HP+I
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 132/265 (49%), Gaps = 21/265 (7%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 214 IVHRDIKPSNLLINSSKNVKIADFG--VSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
           ++HRDIKP NLL+ S+  +KIADFG  V    ++  D C    GT+ Y+ PE I   ++ 
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGRMHD 184
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
            K      D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD
Sbjct: 185 EKV-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RD 235
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFI 356
            ISR L+ +P  R    ++L+HP+I
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 132/265 (49%), Gaps = 21/265 (7%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 214 IVHRDIKPSNLLINSSKNVKIADFG--VSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
           ++HRDIKP NLL+ S+  +KIADFG  V    ++  D C    GT+ Y+ PE I   ++ 
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGRMHD 184
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
            K      D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD
Sbjct: 185 EKV-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RD 235
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFI 356
            ISR L+ +P  R    ++L+HP+I
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 132/265 (49%), Gaps = 21/265 (7%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 214 IVHRDIKPSNLLINSSKNVKIADFG--VSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
           ++HRDIKP NLL+ S+  +KIADFG  V    ++  D C    GT+ Y+ PE I   ++ 
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGRMHD 189
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
            K      D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD
Sbjct: 190 EKV-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RD 240
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFI 356
            ISR L+ +P  R    ++L+HP+I
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 130/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 35  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 94
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 95  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 154
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S  +        +  GT+ Y+ PE I   ++  K
Sbjct: 155 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 212
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 213 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 263
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 264 SRLLKHNPSQRPMLREVLEHPWI 286

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 132/265 (49%), Gaps = 21/265 (7%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 35  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 94
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 95  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 154
Query: 214 IVHRDIKPSNLLINSSKNVKIADFG--VSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
           ++HRDIKP NLL+ S+  +KIADFG  V    ++  D C    GT+ Y+ PE I   ++ 
Sbjct: 155 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDYLPPEMIEGRMHD 210
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
            K      D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD
Sbjct: 211 EKV-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RD 261
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFI 356
            ISR L+ +P  R    ++L+HP+I
Sbjct: 262 LISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 128/261 (49%), Gaps = 17/261 (6%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSV-RSQICREIEILRDVNHPNVVKCHD 164
           +IG GS G    V      R + +K I  +   S  R +  RE+ +L ++ HPN+V+  +
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 165 MYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
            ++ NG + ++++Y +GG L       +G   +++ IL D   Q+   L ++H RKI+HR
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL-DWFVQICLALKHVHDRKILHR 149
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           DIK  N+ +     V++ DFG++R+L  T++   + +GT  Y+SPE       + K    
Sbjct: 150 DIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNK---- 205
Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL 337
             DIW+LG  + E    +  F     G   +L+  I     P      S + R  +S+  
Sbjct: 206 -SDIWALGCVLYELCTLKHAFEA---GSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLF 261
Query: 338 QKDPHSRWPAAQLLQHPFILR 358
           +++P  R     +L+  FI +
Sbjct: 262 KRNPRDRPSVNSILEKGFIAK 282

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 131/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S  +       ++  GT+ Y+ PE I   ++  K
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEK 187
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 188 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 238
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 132/265 (49%), Gaps = 15/265 (5%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +G GS G V +     T + +A+KVI   + ++   S I RE+E+L+ ++HPN++K  ++
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            + +    ++ E   GG L    I++    EH  + + +QV SG+ Y+HK  IVHRD+KP
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKP 149
Query: 222 SNLLINSSK---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
            N+L+ S +   ++KI DFG+S    Q        +GT  Y++PE +      G YD   
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEVL-----RGTYDE-K 202
Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ 338
            D+WS GV +     G  PF    + D    +    +A         S + +D I + L 
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLT 262
Query: 339 KDPHSRWPAAQLLQHPFILRAGQSQ 363
             P  R  A Q L+HP+I +    +
Sbjct: 263 FHPSLRITATQCLEHPWIQKYSSEE 287

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 129/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S  +        +  GT+ Y+ PE I      G+
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEXIE-----GR 186
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 187 XHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 242
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 243 SRLLKHNPSQRPXLREVLEHPWI 265

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 94/287 (32%), Positives = 137/287 (47%), Gaps = 37/287 (12%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEIL-RDVNHPNVVKCHDM 165
           IG GS     R VH  T+  +A+KVI     D  +     EIEIL R   HPN++   D+
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVI-----DKSKRDPSEEIEILLRYGQHPNIITLKDV 89
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLA----YLHKRKIVHRDIKP 221
           YD    + ++ E M GG L    +RQ+      A  VL  +     YLH + +VHRD+KP
Sbjct: 90  YDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKP 149
Query: 222 SNLL-INSSKN---VKIADFGVSRIL----AQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           SN+L ++ S N   ++I DFG ++ L       M PC +A     +++PE +       K
Sbjct: 150 SNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTA----NFVAPEVL-------K 198
Query: 274 YDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC---FAQPPEAPEMASRE 328
             GY    DIWSLG+ +     G  PFA G       ++  I    F          S  
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSET 258
Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFILRAG---QSQVNQNLRQIL 372
            +D +S+ L  DPH R  A Q+LQHP++ +     QSQ++    Q++
Sbjct: 259 AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLV 305

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 130/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 13  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 132
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S  +        +  GT+ Y+ PE I   ++  K
Sbjct: 133 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 190
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 191 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 241
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 242 SRLLKHNPSQRPMLREVLEHPWI 264

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 130/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S  +        +  GT+ Y+ PE I   ++  K
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 186
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 187 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 237
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 75/223 (33%), Positives = 126/223 (56%), Gaps = 11/223 (4%)
Query: 142 SQICREIEILRDVNHPNVVKCHDMYDRNGE--IEVLLEYMDGGSLEGAHIRQEHILSDLA 199
            Q+ +EI IL+ ++HPNVVK  ++ D   E  + ++ E ++ G +      +  +  D A
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-LSEDQA 139
Query: 200 R----QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG 255
           R     ++ G+ YLH +KI+HRDIKPSNLL+    ++KIADFGVS     +    ++ VG
Sbjct: 140 RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVG 199
Query: 256 TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF 315
           T A+M+PE ++       + G A D+W++GV++  F  G+ PF   R     S + +   
Sbjct: 200 TPAFMAPESLSE--TRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQAL 257
Query: 316 AQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR 358
            + P+ P++A  + +D I+R L K+P SR    ++  HP++ R
Sbjct: 258 -EFPDQPDIA-EDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 81/258 (31%), Positives = 130/258 (50%), Gaps = 15/258 (5%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +G GS G V +     T + +A+KVI   + ++   S I RE+E+L+ ++HPN++K  ++
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            + +    ++ E   GG L    I++    EH  + + +QV SG+ Y+HK  IVHRD+KP
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKP 149
Query: 222 SNLLINSSK---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
            N+L+ S +   ++KI DFG+S    Q        +GT  Y++PE +      G YD   
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEVL-----RGTYDE-K 202
Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ 338
            D+WS GV +     G  PF    + D    +    +A         S + +D I + L 
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLT 262
Query: 339 KDPHSRWPAAQLLQHPFI 356
             P  R  A Q L+HP+I
Sbjct: 263 FHPSLRITATQCLEHPWI 280

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 94/287 (32%), Positives = 137/287 (47%), Gaps = 37/287 (12%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEIL-RDVNHPNVVKCHDM 165
           IG GS     R VH  T+  +A+KVI     D  +     EIEIL R   HPN++   D+
Sbjct: 35  IGVGSYSECKRCVHKATNMEYAVKVI-----DKSKRDPSEEIEILLRYGQHPNIITLKDV 89
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLA----YLHKRKIVHRDIKP 221
           YD    + ++ E M GG L    +RQ+      A  VL  +     YLH + +VHRD+KP
Sbjct: 90  YDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKP 149
Query: 222 SNLL-INSSKN---VKIADFGVSRIL----AQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           SN+L ++ S N   ++I DFG ++ L       M PC +A     +++PE +       K
Sbjct: 150 SNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTA----NFVAPEVL-------K 198
Query: 274 YDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC---FAQPPEAPEMASRE 328
             GY    DIWSLG+ +     G  PFA G       ++  I    F          S  
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSET 258
Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFILRAG---QSQVNQNLRQIL 372
            +D +S+ L  DPH R  A Q+LQHP++ +     QSQ++    Q++
Sbjct: 259 AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLV 305

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 130/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S  +        +  GT+ Y+ PE I   ++  K
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 190 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 240
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 130/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 8   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 67
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 68  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 127
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S  +        +  GT+ Y+ PE I   ++  K
Sbjct: 128 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 185
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 186 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 236
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 237 SRLLKHNPSQRPMLREVLEHPWI 259

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 130/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 26  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 85
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 86  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 145
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S  +        +  GT+ Y+ PE I   ++  K
Sbjct: 146 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 203
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 204 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 254
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 255 SRLLKHNPSQRPMLREVLEHPWI 277

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 130/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S  +        +  GT+ Y+ PE I   ++  K
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 191
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 192 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 242
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 130/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S  +        +  GT+ Y+ PE I   ++  K
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 190 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 240
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 132/265 (49%), Gaps = 21/265 (7%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 214 IVHRDIKPSNLLINSSKNVKIADFG--VSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
           ++HRDIKP NLL+ S+  +KIADFG  V    ++  D C    GT+ Y+ PE I   ++ 
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDYLPPEMIEGRMHD 187
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
            K      D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD
Sbjct: 188 EKV-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RD 238
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFI 356
            ISR L+ +P  R    ++L+HP+I
Sbjct: 239 LISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 135/267 (50%), Gaps = 24/267 (8%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNVVKCHD- 164
           IG+GS G   ++      ++   K + YG+  ++ +  +  E+ +LR++ HPN+V+ +D 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 165 MYDR-NGEIEVLLEYMDGGSL-----EGAHIRQ---EHILSDLARQVLSGLAYLHKRK-- 213
           + DR N  + +++EY +GG L     +G   RQ   E  +  +  Q+   L   H+R   
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 214 ---IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
              ++HRD+KP+N+ ++  +NVK+ DFG++RIL    D     VGT  YMSPE++N    
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMSY 193
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
           + K      DIWSLG  + E      PF    Q + A  +    F +    P   S E  
Sbjct: 194 NEK-----SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYRYSDELN 245
Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFIL 357
           + I+R L    + R    ++L++P IL
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLIL 272

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 129/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G     L+      E   +    ++ + L+Y H ++
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S  +        +  GT+ Y+ PE I   ++  K
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 191
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 192 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 242
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 131/271 (48%), Gaps = 29/271 (10%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I      S R       I RE+ IL+++ HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL----SDLARQVLSGLAYLHKRKI 214
           V+  H++Y+   ++ ++LE + GG L      +E +     ++  +Q+L+G+ YLH  +I
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 135
Query: 215 VHRDIKPSNLLI---NSSK-NVKIADFGVSRILAQTMDPCN---SAVGTIAYMSPERINT 267
            H D+KP N+++   N  K  +KI DFG    LA  +D  N   +  GT A+++PE +N 
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEFKNIFGTPAFVAPEIVN- 190
Query: 268 DLNHGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                 Y+  G   D+WS+GV       G  PF    + +  + + A+ +    E     
Sbjct: 191 ------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 244
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           S   +DFI R L KDP  R      LQHP+I
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 129/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S  +           GT+ Y+ PE I   ++  K
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTELCGTLDYLPPEMIEGRMHDEK 186
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 187 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 237
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 130/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 70  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S     +     S  GT+ Y+ PE I   ++  K
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS--GTLDYLPPEMIEGRMHDEK 187
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 188 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 238
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWI 261

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 130/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S  +        +  GT+ Y+ PE I   ++  K
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEMIEGRMHDEK 186
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 187 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 237
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 129/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S  +           GT+ Y+ PE I   ++  K
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTXLCGTLDYLPPEMIEGRMHDEK 186
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 187 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 237
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 129/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+         + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 6   DFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 65
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 66  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 125
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S  +        +  GT+ Y+ PE I   ++  K
Sbjct: 126 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 183
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 184 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 234
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 235 SRLLKHNPSQRPMLREVLEHPWI 257

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 130/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S     +     +  GT+ Y+ PE I   ++  K
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRA--ALCGTLDYLPPEMIEGRMHDEK 189
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 190 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 240
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 145/297 (48%), Gaps = 30/297 (10%)
Query: 97  NPAELQKGNRIGSGSGGTVW---RVVHPPTSRVFALKVIYGNH---EDSVRSQICREIEI 150
           +P+  +    +G GS G V+   +V  P +  ++A+KV+        D VR+++ R+I  
Sbjct: 26  DPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI-- 83
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSG 205
           L DVNHP VVK H  +   G++ ++L+++ GG L     +     +E +   LA   L G
Sbjct: 84  LADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL-G 142
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERI 265
           L +LH   I++RD+KP N+L++   ++K+ DFG+S+          S  GT+ YM+PE +
Sbjct: 143 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVV 202
Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
           N   +      ++ D WS GV + E   G  PF    QG        +        P+  
Sbjct: 203 NRQGH-----SHSADWWSYGVLMFEMLTGSLPF----QGKDRKETMTLILKAKLGMPQFL 253
Query: 326 SREFRDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           S E +  +    +++P +R       A ++ +H F      +++ +  R+I PP +P
Sbjct: 254 STEAQSLLRALFKRNPANRLGSGPDGAEEIKRHVFYSTIDWNKLYR--REIKPPFKP 308

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 129/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 11  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 70
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 130
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S  +           GT+ Y+ PE I   ++  K
Sbjct: 131 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEK 188
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 189 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 239
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 240 SRLLKHNPSQRPMLREVLEHPWI 262

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 129/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 9   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 68
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 69  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 128
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S  +           GT+ Y+ PE I   ++  K
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEK 186
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 187 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 237
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 132/269 (49%), Gaps = 25/269 (9%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHE-DSVRSQICREIEILRDVN-HP 157
           +G G    V R +H PT + +A+K+I       +   E   +R    +E++ILR V+ HP
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKR 212
           N+++  D Y+ N    ++ + M  G L   ++ ++  LS+     + R +L  +  LHK 
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGEL-FDYLTEKVTLSEKETRKIMRALLEVICALHKL 143
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP---CNSAVGTIAYMSPERINTDL 269
            IVHRD+KP N+L++   N+K+ DFG S      +DP     S  GT +Y++PE I   +
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFS----CQLDPGEKLRSVCGTPSYLAPEIIECSM 199
Query: 270 --NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR 327
             NH  Y G   D+WS GV +     G  PF   +Q     ++ +  +       +  S 
Sbjct: 200 NDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 258
Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +D +SR L   P  R+ A + L HPF 
Sbjct: 259 TVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 129/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S  +           GT+ Y+ PE I   ++  K
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEK 189
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 190 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 240
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 135/267 (50%), Gaps = 24/267 (8%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNVVKCHD- 164
           IG+GS G   ++      ++   K + YG+  ++ +  +  E+ +LR++ HPN+V+ +D 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 165 MYDR-NGEIEVLLEYMDGGSL-----EGAHIRQ---EHILSDLARQVLSGLAYLHKRK-- 213
           + DR N  + +++EY +GG L     +G   RQ   E  +  +  Q+   L   H+R   
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 214 ---IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
              ++HRD+KP+N+ ++  +NVK+ DFG++RIL        + VGT  YMSPE++N    
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSY 193
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
           + K      DIWSLG  + E      PF    Q + A  +    F +    P   S E  
Sbjct: 194 NEK-----SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYRYSDELN 245
Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFIL 357
           + I+R L    + R    ++L++P IL
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLIL 272

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 130/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 12  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 71
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 72  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 131
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIA+FG S  +        +  GT+ Y+ PE I   ++  K
Sbjct: 132 VIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 190 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 240
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 78/263 (29%), Positives = 128/263 (48%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 14  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 73
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G     L+      E   +    ++ + L+Y H ++
Sbjct: 74  NILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR 133
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S  +           GT+ Y+ PE I   ++  K
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLXGTLDYLPPEMIEGRMHDEK 191
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 192 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 242
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 135/267 (50%), Gaps = 24/267 (8%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNVVKCHD- 164
           IG+GS G   ++      ++   K + YG+  ++ +  +  E+ +LR++ HPN+V+ +D 
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 165 MYDR-NGEIEVLLEYMDGGSL-----EGAHIRQ---EHILSDLARQVLSGLAYLHKRK-- 213
           + DR N  + +++EY +GG L     +G   RQ   E  +  +  Q+   L   H+R   
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 214 ---IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
              ++HRD+KP+N+ ++  +NVK+ DFG++RIL        + VGT  YMSPE++N    
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSY 193
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
           + K      DIWSLG  + E      PF    Q + A  +    F +    P   S E  
Sbjct: 194 NEK-----SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYRYSDELN 245
Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFIL 357
           + I+R L    + R    ++L++P IL
Sbjct: 246 EIITRMLNLKDYHRPSVEEILENPLIL 272

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 130/263 (49%), Gaps = 17/263 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HP
Sbjct: 11  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 70
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++
Sbjct: 71  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 130
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIA+FG S  +        +  GT+ Y+ PE I   ++  K
Sbjct: 131 VIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 188
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF      +    +  + F  P    E A    RD I
Sbjct: 189 V-----DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA----RDLI 239
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 240 SRLLKHNPSQRPMLREVLEHPWI 262

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 128/259 (49%), Gaps = 17/259 (6%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHPNVVK 161
           G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HPN+++
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILR 76
Query: 162 CHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
            +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++++HR
Sbjct: 77  LYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHR 136
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           DIKP NLL+ S+  +KIADFG S  +       ++  GT+ Y+ PE I   ++  K    
Sbjct: 137 DIKPENLLLGSNGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKV--- 191
Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL 337
             D+WSLGV   EF +G  PF      +    +  + F  P    E A    RD ISR L
Sbjct: 192 --DLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGA----RDLISRLL 245
Query: 338 QKDPHSRWPAAQLLQHPFI 356
           + +   R   A++L+HP+I
Sbjct: 246 KHNASQRLTLAEVLEHPWI 264

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 130/267 (48%), Gaps = 18/267 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-------DSVRSQICREIEILRDV-NHPN 158
           IG G    V R VH  T   FA+K++    E       + VR    RE  ILR V  HP+
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRK 213
           ++   D Y+ +  + ++ + M  G L   ++ ++  LS+     + R +L  +++LH   
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGEL-FDYLTEKVALSEKETRSIMRSLLEAVSFLHANN 220
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPE--RINTDLNH 271
           IVHRD+KP N+L++ +  ++++DFG S  L +  +      GT  Y++PE  + + D  H
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHL-EPGEKLRELCGTPGYLAPEILKCSMDETH 279
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
             Y G   D+W+ GV +     G  PF   RQ     ++    +       +  S   +D
Sbjct: 280 PGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKD 338
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFILR 358
            ISR LQ DP +R  A Q LQHPF  R
Sbjct: 339 LISRLLQVDPEARLTAEQALQHPFFER 365

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 93/279 (33%), Positives = 131/279 (46%), Gaps = 22/279 (7%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEIL-RDVNHPNVVKCHDM 165
           IG GS     R +H  T+  FA+K+I     D  +     EIEIL R   HPN++   D+
Sbjct: 30  IGVGSYSVCKRCIHKATNXEFAVKII-----DKSKRDPTEEIEILLRYGQHPNIITLKDV 84
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVL----SGLAYLHKRKIVHRDIKP 221
           YD    + V+ E   GG L    +RQ+      A  VL      + YLH + +VHRD+KP
Sbjct: 85  YDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKP 144
Query: 222 SNLL-INSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           SN+L ++ S N   ++I DFG ++ L        +   T  +++PE     L    YD  
Sbjct: 145 SNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEV----LERQGYDA- 199
Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC---FAQPPEAPEMASREFRDFIS 334
           A DIWSLGV +     G  PFA G       ++  I    F+         S   +D +S
Sbjct: 200 ACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVS 259
Query: 335 RCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILP 373
           + L  DPH R  AA +L+HP+I+   Q    Q  RQ  P
Sbjct: 260 KXLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAP 298

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 86/265 (32%), Positives = 132/265 (49%), Gaps = 19/265 (7%)
Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVV 160
           Q+  ++GSG+ G V       T    A+K+I       S  S++  E+ +L+ ++HPN++
Sbjct: 40  QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKIVH 216
           K +D ++      +++E   GG L    I +    E   + + +QVLSG+ YLHK  IVH
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVH 159
Query: 217 RDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           RD+KP NLL+ S +    +KI DFG+S +  +        +GT  Y++PE +       K
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKERLGTAYYIAPEVLRK-----K 213
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM--ASREFRD 331
           YD    D+WS+GV +     G  PF  G Q D   L          ++PE    S   +D
Sbjct: 214 YDEKC-DVWSIGVILFILLAGYPPF--GGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFI 356
            I + LQ D   R  A Q L+HP+I
Sbjct: 271 LIKQMLQFDSQRRISAQQALEHPWI 295

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 127/259 (49%), Gaps = 17/259 (6%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHPNVVK 161
           G  +G G  G V+      +  + ALKV++    +   V  Q+ RE+EI   + HPN+++
Sbjct: 17  GRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILR 76
Query: 162 CHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
            +  +     + ++LEY   G+    L+      E   +    ++ + L+Y H ++++HR
Sbjct: 77  LYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHR 136
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           DIKP NLL+ S+  +KIADFG S  +        +  GT+ Y+ PE I   ++  K    
Sbjct: 137 DIKPENLLLGSNGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV--- 191
Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL 337
             D+WSLGV   EF +G  PF      +    +  + F  P    E A    RD ISR L
Sbjct: 192 --DLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGA----RDLISRLL 245
Query: 338 QKDPHSRWPAAQLLQHPFI 356
           + +   R   A++L+HP+I
Sbjct: 246 KHNASQRLTLAEVLEHPWI 264

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 130/268 (48%), Gaps = 23/268 (8%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICRE-----IEILRDVNHPN 158
           G  +GSG    V +     T   +A K I      + R  +CRE     + ILR V HPN
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLA----RQVLSGLAYLHKRKI 214
           ++  HD+Y+   ++ ++LE + GG L     ++E +  + A    +Q+L G+ YLH +KI
Sbjct: 77  IITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 215 VHRDIKPSNLLINSSK----NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
            H D+KP N+++        ++K+ DFG++  +   ++  N   GT  +++PE +N    
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-IFGTPEFVAPEIVN---- 191
Query: 271 HGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
              Y+  G   D+WS+GV       G  PF    + +  + + A+ +    E     S  
Sbjct: 192 ---YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +DFI + L K+   R    + L+HP+I
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 131/272 (48%), Gaps = 31/272 (11%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I      S R       I RE+ IL+++ HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           V+  H++Y+   ++ ++LE + GG L     E   + +E   ++  +Q+L+G+ YLH  +
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA-TEFLKQILNGVYYLHSLQ 134
Query: 214 IVHRDIKPSNLLI---NSSK-NVKIADFGVSRILAQTMDPCN---SAVGTIAYMSPERIN 266
           I H D+KP N+++   N  K  +KI DFG    LA  +D  N   +  GT  +++PE +N
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEFKNIFGTPEFVAPEIVN 190
Query: 267 TDLNHGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM 324
                  Y+  G   D+WS+GV       G  PF    + +  + + A+ +    E    
Sbjct: 191 -------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 325 ASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            S   +DFI R L KDP  R      LQHP+I
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 130/271 (47%), Gaps = 29/271 (10%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I      S R       I RE+ IL+++ HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL----SDLARQVLSGLAYLHKRKI 214
           V+  H++Y+   ++ ++LE + GG L      +E +     ++  +Q+L+G+ YLH  +I
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 135
Query: 215 VHRDIKPSNLLI---NSSK-NVKIADFGVSRILAQTMDPCN---SAVGTIAYMSPERINT 267
            H D+KP N+++   N  K  +KI DFG    LA  +D  N   +  GT  +++PE +N 
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 268 DLNHGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                 Y+  G   D+WS+GV       G  PF    + +  + + A+ +    E     
Sbjct: 191 ------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 244
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           S   +DFI R L KDP  R      LQHP+I
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 131/269 (48%), Gaps = 25/269 (9%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHE-DSVRSQICREIEILRDVN-HP 157
           +G G    V R +H PT + +A+K+I       +   E   +R    +E++ILR V+ HP
Sbjct: 12  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 71
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKR 212
           N+++  D Y+ N    ++ + M  G L   ++ ++  LS+     + R +L  +  LHK 
Sbjct: 72  NIIQLKDTYETNTFFFLVFDLMKKGEL-FDYLTEKVTLSEKETRKIMRALLEVICALHKL 130
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP---CNSAVGTIAYMSPERINTDL 269
            IVHRD+KP N+L++   N+K+ DFG S      +DP        GT +Y++PE I   +
Sbjct: 131 NIVHRDLKPENILLDDDMNIKLTDFGFS----CQLDPGEKLREVCGTPSYLAPEIIECSM 186
Query: 270 --NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR 327
             NH  Y G   D+WS GV +     G  PF   +Q     ++ +  +       +  S 
Sbjct: 187 NDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 245
Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +D +SR L   P  R+ A + L HPF 
Sbjct: 246 TVKDLVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 130/271 (47%), Gaps = 29/271 (10%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I      S R       I RE+ IL+++ HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL----SDLARQVLSGLAYLHKRKI 214
           V+  H++Y+   ++ ++LE + GG L      +E +     ++  +Q+L+G+ YLH  +I
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 135
Query: 215 VHRDIKPSNLLI---NSSK-NVKIADFGVSRILAQTMDPCN---SAVGTIAYMSPERINT 267
            H D+KP N+++   N  K  +KI DFG    LA  +D  N   +  GT  +++PE +N 
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 268 DLNHGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                 Y+  G   D+WS+GV       G  PF    + +  + + A+ +    E     
Sbjct: 191 ------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 244
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           S   +DFI R L KDP  R      LQHP+I
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 130/271 (47%), Gaps = 29/271 (10%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I      S R       I RE+ IL+++ HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL----SDLARQVLSGLAYLHKRKI 214
           V+  H++Y+   ++ ++LE + GG L      +E +     ++  +Q+L+G+ YLH  +I
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 135
Query: 215 VHRDIKPSNLLI---NSSK-NVKIADFGVSRILAQTMDPCN---SAVGTIAYMSPERINT 267
            H D+KP N+++   N  K  +KI DFG    LA  +D  N   +  GT  +++PE +N 
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 268 DLNHGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                 Y+  G   D+WS+GV       G  PF    + +  + + A+ +    E     
Sbjct: 191 ------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 244
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           S   +DFI R L KDP  R      LQHP+I
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 131/269 (48%), Gaps = 25/269 (9%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHE-DSVRSQICREIEILRDVN-HP 157
           +G G    V R +H PT + +A+K+I       +   E   +R    +E++ILR V+ HP
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKR 212
           N+++  D Y+ N    ++ + M  G L   ++ ++  LS+     + R +L  +  LHK 
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGEL-FDYLTEKVTLSEKETRKIMRALLEVICALHKL 143
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP---CNSAVGTIAYMSPERINTDL 269
            IVHRD+KP N+L++   N+K+ DFG S      +DP        GT +Y++PE I   +
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFS----CQLDPGEKLREVCGTPSYLAPEIIECSM 199
Query: 270 --NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR 327
             NH  Y G   D+WS GV +     G  PF   +Q     ++ +  +       +  S 
Sbjct: 200 NDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 258
Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +D +SR L   P  R+ A + L HPF 
Sbjct: 259 TVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 130/271 (47%), Gaps = 29/271 (10%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I      S R       I RE+ IL+++ HPN
Sbjct: 15  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL----SDLARQVLSGLAYLHKRKI 214
           V+  H++Y+   ++ ++LE + GG L      +E +     ++  +Q+L+G+ YLH  +I
Sbjct: 75  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 134
Query: 215 VHRDIKPSNLLI---NSSK-NVKIADFGVSRILAQTMDPCN---SAVGTIAYMSPERINT 267
            H D+KP N+++   N  K  +KI DFG    LA  +D  N   +  GT  +++PE +N 
Sbjct: 135 AHFDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEFKNIFGTPEFVAPEIVN- 189
Query: 268 DLNHGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                 Y+  G   D+WS+GV       G  PF    + +  + + A+ +    E     
Sbjct: 190 ------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           S   +DFI R L KDP  R      LQHP+I
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 130/271 (47%), Gaps = 29/271 (10%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I      S R       I RE+ IL+++ HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL----SDLARQVLSGLAYLHKRKI 214
           V+  H++Y+   ++ ++LE + GG L      +E +     ++  +Q+L+G+ YLH  +I
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 135
Query: 215 VHRDIKPSNLLI---NSSK-NVKIADFGVSRILAQTMDPCN---SAVGTIAYMSPERINT 267
            H D+KP N+++   N  K  +KI DFG    LA  +D  N   +  GT  +++PE +N 
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 268 DLNHGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                 Y+  G   D+WS+GV       G  PF    + +  + + A+ +    E     
Sbjct: 191 ------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 244
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           S   +DFI R L KDP  R      LQHP+I
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 130/271 (47%), Gaps = 29/271 (10%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I      S R       I RE+ IL+++ HPN
Sbjct: 16  GEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL----SDLARQVLSGLAYLHKRKI 214
           V+  H++Y+   ++ ++LE + GG L      +E +     ++  +Q+L+G+ YLH  +I
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 135
Query: 215 VHRDIKPSNLLI---NSSK-NVKIADFGVSRILAQTMDPCN---SAVGTIAYMSPERINT 267
            H D+KP N+++   N  K  +KI DFG    LA  +D  N   +  GT  +++PE +N 
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 268 DLNHGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                 Y+  G   D+WS+GV       G  PF    + +  + + A+ +    E     
Sbjct: 191 ------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 244
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           S   +DFI R L KDP  R      LQHP+I
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 130/271 (47%), Gaps = 29/271 (10%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I      S R       I RE+ IL+++ HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL----SDLARQVLSGLAYLHKRKI 214
           V+  H++Y+   ++ ++LE + GG L      +E +     ++  +Q+L+G+ YLH  +I
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 135
Query: 215 VHRDIKPSNLLI---NSSK-NVKIADFGVSRILAQTMDPCN---SAVGTIAYMSPERINT 267
            H D+KP N+++   N  K  +KI DFG    LA  +D  N   +  GT  +++PE +N 
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 268 DLNHGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                 Y+  G   D+WS+GV       G  PF    + +  + + A+ +    E     
Sbjct: 191 ------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 244
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           S   +DFI R L KDP  R      LQHP+I
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 130/271 (47%), Gaps = 29/271 (10%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I      S R       I RE+ IL+++ HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL----SDLARQVLSGLAYLHKRKI 214
           V+  H++Y+   ++ ++LE + GG L      +E +     ++  +Q+L+G+ YLH  +I
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 135
Query: 215 VHRDIKPSNLLI---NSSK-NVKIADFGVSRILAQTMDPCN---SAVGTIAYMSPERINT 267
            H D+KP N+++   N  K  +KI DFG    LA  +D  N   +  GT  +++PE +N 
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 268 DLNHGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                 Y+  G   D+WS+GV       G  PF    + +  + + A+ +    E     
Sbjct: 191 ------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 244
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           S   +DFI R L KDP  R      LQHP+I
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 130/271 (47%), Gaps = 29/271 (10%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I      S R       I RE+ IL+++ HPN
Sbjct: 15  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL----SDLARQVLSGLAYLHKRKI 214
           V+  H++Y+   ++ ++LE + GG L      +E +     ++  +Q+L+G+ YLH  +I
Sbjct: 75  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 134
Query: 215 VHRDIKPSNLLI---NSSK-NVKIADFGVSRILAQTMDPCN---SAVGTIAYMSPERINT 267
            H D+KP N+++   N  K  +KI DFG    LA  +D  N   +  GT  +++PE +N 
Sbjct: 135 AHFDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEFKNIFGTPEFVAPEIVN- 189
Query: 268 DLNHGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                 Y+  G   D+WS+GV       G  PF    + +  + + A+ +    E     
Sbjct: 190 ------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           S   +DFI R L KDP  R      LQHP+I
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 133/260 (51%), Gaps = 14/260 (5%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +IG GS G V       + ++ A+K +    +   R  +  E+ I+RD  H NVV+ ++ 
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMYNS 216
Query: 166 YDRNGEIEVLLEYMDGGSLEG--AHIR-QEHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           Y    E+ V++E+++GG+L     H R  E  ++ +   VL  L+ LH + ++HRDIK  
Sbjct: 217 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 276
Query: 223 NLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           ++L+     VK++DFG    +++ +      VGT  +M+PE I + L +G       DIW
Sbjct: 277 SILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP----EVDIW 331
Query: 283 SLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM--ASREFRDFISRCLQKD 340
           SLG+ ++E   G  P+           M  I    PP    +   S   + F+ R L +D
Sbjct: 332 SLGIMVIEMVDGEPPYF---NEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 388
Query: 341 PHSRWPAAQLLQHPFILRAG 360
           P  R  AA+LL+HPF+ +AG
Sbjct: 389 PAQRATAAELLKHPFLAKAG 408

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 130/277 (46%), Gaps = 25/277 (9%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVK 161
           G  +G G  G V+         + ALKV++ +   ++ V  Q+ REIEI   + HPN+++
Sbjct: 20  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 79
Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEG---AHIR-QEHILSDLARQVLSGLAYLHKRKIVHR 217
            ++ +     I ++LE+   G L      H R  E   +    ++   L Y H+RK++HR
Sbjct: 80  MYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHR 139
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           DIKP NLL+     +KIADFG S + A ++       GT+ Y+ PE I      GK    
Sbjct: 140 DIKPENLLMGYKGELKIADFGWS-VHAPSLRR-RXMCGTLDYLPPEMIE-----GKTHDE 192
Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL 337
             D+W  GV   EF +G  PF      +    +  +    PP      S   +D IS+ L
Sbjct: 193 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSKDLISKLL 248
Query: 338 QKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPP 374
           +  P  R P   +++HP+        V  N R++LPP
Sbjct: 249 RYHPPQRLPLKGVMEHPW--------VKANSRRVLPP 277

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 133/260 (51%), Gaps = 14/260 (5%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +IG GS G V       + ++ A+K +    +   R  +  E+ I+RD  H NVV+ ++ 
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMYNS 139
Query: 166 YDRNGEIEVLLEYMDGGSLEG--AHIR-QEHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           Y    E+ V++E+++GG+L     H R  E  ++ +   VL  L+ LH + ++HRDIK  
Sbjct: 140 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 199
Query: 223 NLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           ++L+     VK++DFG    +++ +      VGT  +M+PE I + L +G       DIW
Sbjct: 200 SILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP----EVDIW 254
Query: 283 SLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM--ASREFRDFISRCLQKD 340
           SLG+ ++E   G  P+           M  I    PP    +   S   + F+ R L +D
Sbjct: 255 SLGIMVIEMVDGEPPYF---NEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 311
Query: 341 PHSRWPAAQLLQHPFILRAG 360
           P  R  AA+LL+HPF+ +AG
Sbjct: 312 PAQRATAAELLKHPFLAKAG 331

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 133/260 (51%), Gaps = 14/260 (5%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +IG GS G V       + ++ A+K +    +   R  +  E+ I+RD  H NVV+ ++ 
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMYNS 94
Query: 166 YDRNGEIEVLLEYMDGGSLEG--AHIR-QEHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           Y    E+ V++E+++GG+L     H R  E  ++ +   VL  L+ LH + ++HRDIK  
Sbjct: 95  YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 154
Query: 223 NLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           ++L+     VK++DFG    +++ +      VGT  +M+PE I + L +G       DIW
Sbjct: 155 SILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP----EVDIW 209
Query: 283 SLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM--ASREFRDFISRCLQKD 340
           SLG+ ++E   G  P+           M  I    PP    +   S   + F+ R L +D
Sbjct: 210 SLGIMVIEMVDGEPPYF---NEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 266
Query: 341 PHSRWPAAQLLQHPFILRAG 360
           P  R  AA+LL+HPF+ +AG
Sbjct: 267 PAQRATAAELLKHPFLAKAG 286

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 130/271 (47%), Gaps = 15/271 (5%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G+G+   V       T ++FA+K I         S I  EI +LR + H N+V   D+Y
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIY 89
Query: 167 DRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           +    + ++++ + GG L    + +    E   S L RQVL  + YLH+  IVHRD+KP 
Sbjct: 90  ESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPE 149
Query: 223 NLLINS---SKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           NLL  S      + I+DFG+S++  +  D  ++A GT  Y++PE +       K    A 
Sbjct: 150 NLLYYSQDEESKIMISDFGLSKMEGKG-DVMSTACGTPGYVAPEVLAQ-----KPYSKAV 203
Query: 280 DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQK 339
           D WS+GV       G  PF           +    +       +  S   +DFI   ++K
Sbjct: 204 DCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEK 263
Query: 340 DPHSRWPAAQLLQHPFILRAGQSQVNQNLRQ 370
           DP+ R+   Q  +HP+I  AG + +N+N+ +
Sbjct: 264 DPNKRYTCEQAARHPWI--AGDTALNKNIHE 292

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 133/260 (51%), Gaps = 14/260 (5%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +IG GS G V       + ++ A+K +    +   R  +  E+ I+RD  H NVV+ ++ 
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMYNS 96
Query: 166 YDRNGEIEVLLEYMDGGSLEG--AHIR-QEHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           Y    E+ V++E+++GG+L     H R  E  ++ +   VL  L+ LH + ++HRDIK  
Sbjct: 97  YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 156
Query: 223 NLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           ++L+     VK++DFG    +++ +      VGT  +M+PE I + L +G       DIW
Sbjct: 157 SILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP----EVDIW 211
Query: 283 SLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM--ASREFRDFISRCLQKD 340
           SLG+ ++E   G  P+           M  I    PP    +   S   + F+ R L +D
Sbjct: 212 SLGIMVIEMVDGEPPYF---NEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 268
Query: 341 PHSRWPAAQLLQHPFILRAG 360
           P  R  AA+LL+HPF+ +AG
Sbjct: 269 PAQRATAAELLKHPFLAKAG 288

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 130/271 (47%), Gaps = 29/271 (10%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I      S R       I RE+ IL+++ HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLA----RQVLSGLAYLHKRKI 214
           V+  H++Y+   ++ ++LE + GG L      +E +  + A    +Q+L+G+ YLH  +I
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 135
Query: 215 VHRDIKPSNLLI---NSSK-NVKIADFGVSRILAQTMDPCN---SAVGTIAYMSPERINT 267
            H D+KP N+++   N  K  +KI DFG    LA  +D  N   +  GT  +++PE +N 
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 268 DLNHGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                 Y+  G   D+WS+GV       G  PF    + +  + + A+ +    E     
Sbjct: 191 ------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 244
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           S   +DFI R L KDP  R      LQHP+I
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 130/271 (47%), Gaps = 29/271 (10%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I      S R       I RE+ IL+++ HPN
Sbjct: 16  GEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL----SDLARQVLSGLAYLHKRKI 214
           V+  H++Y+   ++ ++LE + GG L      +E +     ++  +Q+L+G+ YLH  +I
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 135
Query: 215 VHRDIKPSNLLI---NSSK-NVKIADFGVSRILAQTMDPCN---SAVGTIAYMSPERINT 267
            H D+KP N+++   N  K  +KI DFG    LA  +D  N   +  GT  +++PE +N 
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 268 DLNHGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                 Y+  G   D+WS+GV       G  PF    + +  + + A+ +    E     
Sbjct: 191 ------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 244
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           S   +DFI R L KDP  R      LQHP+I
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 126/261 (48%), Gaps = 22/261 (8%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G+G+ G V RV    T   FA K +   HE S +  + +EI+ +  + HP +V  HD +
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAF 117
Query: 167 DRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYLHKRKIVHRDIKP 221
           + + E+ ++ E+M GG L      + + +S     +  RQV  GL ++H+   VH D+KP
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP 177
Query: 222 SNLLINS--SKNVKIADFGVSRILAQTMDPCNS---AVGTIAYMSPERINTDLNHGKYDG 276
            N++  +  S  +K+ DFG    L   +DP  S     GT  + +PE     +  GK  G
Sbjct: 178 ENIMFTTKRSNELKLIDFG----LTAHLDPKQSVKVTTGTAEFAAPE-----VAEGKPVG 228
Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC-FAQPPEAPEMASREFRDFISR 335
           Y  D+WS+GV       G  PF  G   D        C +     A    S + +DFI +
Sbjct: 229 YYTDMWSVGVLSYILLSGLSPFG-GENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 287
Query: 336 CLQKDPHSRWPAAQLLQHPFI 356
            L  DP++R    Q L+HP++
Sbjct: 288 LLLADPNTRMTIHQALEHPWL 308

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 126/262 (48%), Gaps = 22/262 (8%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
            +G+G+ G V RV    T   FA K +   HE S +  + +EI+ +  + HP +V  HD 
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYLHKRKIVHRDIK 220
           ++ + E+ ++ E+M GG L      + + +S     +  RQV  GL ++H+   VH D+K
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 282
Query: 221 PSNLLINS--SKNVKIADFGVSRILAQTMDPCNS---AVGTIAYMSPERINTDLNHGKYD 275
           P N++  +  S  +K+ DFG    L   +DP  S     GT  + +PE     +  GK  
Sbjct: 283 PENIMFTTKRSNELKLIDFG----LTAHLDPKQSVKVTTGTAEFAAPE-----VAEGKPV 333
Query: 276 GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC-FAQPPEAPEMASREFRDFIS 334
           GY  D+WS+GV       G  PF  G   D        C +     A    S + +DFI 
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPFG-GENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 392
Query: 335 RCLQKDPHSRWPAAQLLQHPFI 356
           + L  DP++R    Q L+HP++
Sbjct: 393 KLLLADPNTRMTIHQALEHPWL 414

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 133/260 (51%), Gaps = 14/260 (5%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +IG GS G V       + ++ A+K +    +   R  +  E+ I+RD  H NVV+ ++ 
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMYNS 85
Query: 166 YDRNGEIEVLLEYMDGGSLEG--AHIRQ-EHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           Y    E+ V++E+++GG+L     H R  E  ++ +   VL  L+ LH + ++HRDIK  
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 145
Query: 223 NLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           ++L+     VK++DFG    +++ +      VGT  +M+PE I + L +G       DIW
Sbjct: 146 SILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP----EVDIW 200
Query: 283 SLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM--ASREFRDFISRCLQKD 340
           SLG+ ++E   G  P+           M  I    PP    +   S   + F+ R L +D
Sbjct: 201 SLGIMVIEMVDGEPPYF---NEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 257
Query: 341 PHSRWPAAQLLQHPFILRAG 360
           P  R  AA+LL+HPF+ +AG
Sbjct: 258 PAQRATAAELLKHPFLAKAG 277

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 133/260 (51%), Gaps = 14/260 (5%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +IG GS G V       + ++ A+K +    +   R  +  E+ I+RD  H NVV+ ++ 
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMYNS 89
Query: 166 YDRNGEIEVLLEYMDGGSLEG--AHIR-QEHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           Y    E+ V++E+++GG+L     H R  E  ++ +   VL  L+ LH + ++HRDIK  
Sbjct: 90  YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 149
Query: 223 NLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           ++L+     VK++DFG    +++ +      VGT  +M+PE I + L +G       DIW
Sbjct: 150 SILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELI-SRLPYGP----EVDIW 204
Query: 283 SLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM--ASREFRDFISRCLQKD 340
           SLG+ ++E   G  P+           M  I    PP    +   S   + F+ R L +D
Sbjct: 205 SLGIMVIEMVDGEPPYF---NEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 261
Query: 341 PHSRWPAAQLLQHPFILRAG 360
           P  R  AA+LL+HPF+ +AG
Sbjct: 262 PAQRATAAELLKHPFLAKAG 281

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 132/272 (48%), Gaps = 33/272 (12%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++GSG+ G V  V    +     +K I  +       QI  EIE+L+ ++HPN++K  ++
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 166 YDRNGEIEVLLEYMDGGSL----EGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHR 217
           ++    + +++E  +GG L      A  R     E  +++L +Q+++ LAY H + +VH+
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK 148
Query: 218 DIKPSNLLINSS---KNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           D+KP N+L   +     +KI DFG++ +        N+A GT  YM+PE    D+     
Sbjct: 149 DLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA-GTALYMAPEVFKRDVT---- 203
Query: 275 DGYAGDIWSLGVSILEFYLGRFPFA------VGRQGDWASLMFAI-CFAQPPEAPEMASR 327
             +  DIWS GV +     G  PF       V ++  +    +A+ C    P+A      
Sbjct: 204 --FKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV----- 256
Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRA 359
              D + + L KDP  R  AAQ+L H +  +A
Sbjct: 257 ---DLLKQMLTKDPERRPSAAQVLHHEWFKQA 285

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 129/274 (47%), Gaps = 25/274 (9%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHD 164
           +G G  G V+         + ALKV++ +   ++ V  Q+ REIEI   + HPN+++ ++
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 165 MYDRNGEIEVLLEYMDGGSLEG---AHIR-QEHILSDLARQVLSGLAYLHKRKIVHRDIK 220
            +     I ++LE+   G L      H R  E   +    ++   L Y H+RK++HRDIK
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIK 141
Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
           P NLL+     +KIADFG S + A ++       GT+ Y+ PE I      GK      D
Sbjct: 142 PENLLMGYKGELKIADFGWS-VHAPSLRR-RXMCGTLDYLPPEMIE-----GKTHDEKVD 194
Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKD 340
           +W  GV   EF +G  PF      +    +  +    PP      S   +D IS+ L+  
Sbjct: 195 LWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSKDLISKLLRYH 250
Query: 341 PHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPP 374
           P  R P   +++HP+        V  N R++LPP
Sbjct: 251 PPQRLPLKGVMEHPW--------VKANSRRVLPP 276

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 138/281 (49%), Gaps = 25/281 (8%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++ +   ++ V  Q+ REIEI   ++HP
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           N+++ ++ +     I ++LEY   G L    + +    E   + +  ++   L Y H +K
Sbjct: 84  NILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKK 143
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+     +KIADFG S + A ++    +  GT+ Y+ PE I   +++ K
Sbjct: 144 VIHRDIKPENLLLGLKGELKIADFGWS-VHAPSLRR-KTMCGTLDYLPPEMIEGRMHNEK 201
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+W +GV   E  +G  PF      +    +  +    P   P  A    +D I
Sbjct: 202 V-----DLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGA----QDLI 252
Query: 334 SRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPP 374
           S+ L+ +P  R P AQ+  HP+        V  N R++LPP
Sbjct: 253 SKLLRHNPSERLPLAQVSAHPW--------VRANSRRVLPP 285

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 128/256 (50%), Gaps = 16/256 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDVNHPNVVKCHD 164
           +G GS G V    H  T +  ALK I      +  +  ++ REI  L+ + HP+++K +D
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIK 220
           +     +I +++EY  GG L    + ++ +  D  R    Q++  + Y H+ KIVHRD+K
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLK 135
Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
           P NLL++ + NVKIADFG+S I+    +   ++ G+  Y +PE IN  L    Y G   D
Sbjct: 136 PENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVINGKL----YAGPEVD 190
Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKD 340
           +WS G+ +    +GR PF      ++   +F    +     P+  S   +  I R +  D
Sbjct: 191 VWSCGIVLYVMLVGRLPF----DDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVAD 246
Query: 341 PHSRWPAAQLLQHPFI 356
           P  R    ++ + P+ 
Sbjct: 247 PMQRITIQEIRRDPWF 262

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 29/290 (10%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  ++HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKR 212
             VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH +
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLN 270
            I+HRD+KP N+L+N   +++I DFG +++L+        N  VGT  Y+SPE +     
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE--- 208
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
             K    + D+W+LG  I +   G  PF  G +G    L+FA       + PE    + R
Sbjct: 209 --KSAXKSSDLWALGCIIYQLVAGLPPFRAGNEG----LIFAKIIKLEYDFPEKFFPKAR 262
Query: 331 DFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
           D + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 308

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 131/260 (50%), Gaps = 14/260 (5%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           +IG GS G V       T +  A+K +    +   R  +  E+ I+RD +H NVV  +  
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR-RELLFNEVVIMRDYHHDNVVDMYSS 110
Query: 166 YDRNGEIEVLLEYMDGGSLEG--AHIRQ-EHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           Y    E+ V++E+++GG+L     H R  E  ++ +   VL  L+YLH + ++HRDIK  
Sbjct: 111 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSD 170
Query: 223 NLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIW 282
           ++L+ S   +K++DFG    +++ +      VGT  +M+PE I+  L +G       DIW
Sbjct: 171 SILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISR-LPYGT----EVDIW 225
Query: 283 SLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM--ASREFRDFISRCLQKD 340
           SLG+ ++E   G  P+           M  I  + PP   ++   S   R F+   L ++
Sbjct: 226 SLGIMVIEMIDGEPPYF---NEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVRE 282
Query: 341 PHSRWPAAQLLQHPFILRAG 360
           P  R  A +LL HPF+  AG
Sbjct: 283 PSQRATAQELLGHPFLKLAG 302

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 29/290 (10%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  ++HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKR 212
             VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH +
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLN 270
            I+HRD+KP N+L+N   +++I DFG +++L+        N  VGT  Y+SPE +     
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE--- 208
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
             K    + D+W+LG  I +   G  PF  G +G    L+FA       + PE    + R
Sbjct: 209 --KSACKSSDLWALGCIIYQLVAGLPPFRAGNEG----LIFAKIIKLEYDFPEKFFPKAR 262
Query: 331 DFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
           D + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 308

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 134/292 (45%), Gaps = 40/292 (13%)
Query: 103 KGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKC 162
           K +++G G+  TV++     T  + ALK I   HE+       RE+ +L+D+ H N+V  
Sbjct: 6   KLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 65
Query: 163 HDMYDRNGEIEVLLEYMDGGSLE----GAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
           HD+      + ++ EY+D    +      +I   H +     Q+L GLAY H++K++HRD
Sbjct: 66  HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRD 125
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           +KP NLLIN    +K+ADFG++R  +      ++ V T+ Y  P     D+  G  D Y+
Sbjct: 126 LKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPP-----DILLGSTD-YS 179
Query: 279 G--DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE---MASREFR--- 330
              D+W +G    E   GR  F      +    +F I    P E      +++ EF+   
Sbjct: 180 TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI-LGTPTEETWPGILSNEEFKTYN 238
Query: 331 ---------------------DFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
                                D +++ LQ +  +R  A   ++HPF L  G+
Sbjct: 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 82/276 (29%), Positives = 133/276 (48%), Gaps = 17/276 (6%)
Query: 103 KGNRI-GSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNV 159
           KG R+ G GS G V       T +  A+KVI      + + +  + RE+++L+ ++HPN+
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI----LSDLARQVLSGLAYLHKRKIV 215
           +K ++ ++  G   ++ E   GG L    I ++       + + RQVLSG+ Y+HK KIV
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIV 148
Query: 216 HRDIKPSNLLINSSK---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL+ S     N++I DFG+S    +        +GT  Y++PE +     HG
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKIGTAYYIAPEVL-----HG 202
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
            YD    D+WS GV +     G  PF    + D    +    +       +  S   +D 
Sbjct: 203 TYDEKC-DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 333 ISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNL 368
           I + L   P  R  A   L H +I    + Q++ ++
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDV 297

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/276 (29%), Positives = 133/276 (48%), Gaps = 17/276 (6%)
Query: 103 KGNRI-GSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNV 159
           KG R+ G GS G V       T +  A+KVI      + + +  + RE+++L+ ++HPN+
Sbjct: 53  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 112
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI----LSDLARQVLSGLAYLHKRKIV 215
           +K ++ ++  G   ++ E   GG L    I ++       + + RQVLSG+ Y+HK KIV
Sbjct: 113 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIV 172
Query: 216 HRDIKPSNLLINSSK---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL+ S     N++I DFG+S    +        +GT  Y++PE +     HG
Sbjct: 173 HRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKIGTAYYIAPEVL-----HG 226
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
            YD    D+WS GV +     G  PF    + D    +    +       +  S   +D 
Sbjct: 227 TYDEKC-DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 285
Query: 333 ISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNL 368
           I + L   P  R  A   L H +I    + Q++ ++
Sbjct: 286 IRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDV 321

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/276 (29%), Positives = 133/276 (48%), Gaps = 17/276 (6%)
Query: 103 KGNRI-GSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNV 159
           KG R+ G GS G V       T +  A+KVI      + + +  + RE+++L+ ++HPN+
Sbjct: 52  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 111
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI----LSDLARQVLSGLAYLHKRKIV 215
           +K ++ ++  G   ++ E   GG L    I ++       + + RQVLSG+ Y+HK KIV
Sbjct: 112 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIV 171
Query: 216 HRDIKPSNLLINSSK---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL+ S     N++I DFG+S    +        +GT  Y++PE +     HG
Sbjct: 172 HRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKIGTAYYIAPEVL-----HG 225
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
            YD    D+WS GV +     G  PF    + D    +    +       +  S   +D 
Sbjct: 226 TYDEKC-DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 284
Query: 333 ISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNL 368
           I + L   P  R  A   L H +I    + Q++ ++
Sbjct: 285 IRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDV 320

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 129/271 (47%), Gaps = 29/271 (10%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I      S R       I RE+ IL+++ HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL----SDLARQVLSGLAYLHKRKI 214
           V+  H++Y+   ++ ++ E + GG L      +E +     ++  +Q+L+G+ YLH  +I
Sbjct: 76  VITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 135
Query: 215 VHRDIKPSNLLI---NSSK-NVKIADFGVSRILAQTMDPCN---SAVGTIAYMSPERINT 267
            H D+KP N+++   N  K  +KI DFG    LA  +D  N   +  GT  +++PE +N 
Sbjct: 136 AHFDLKPENIMLLDRNVPKPRIKIIDFG----LAHKIDFGNEFKNIFGTPEFVAPEIVN- 190
Query: 268 DLNHGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                 Y+  G   D+WS+GV       G  PF    + +  + + A+ +    E     
Sbjct: 191 ------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 244
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           S   +DFI R L KDP  R      LQHP+I
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 129/274 (47%), Gaps = 21/274 (7%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G+G+   V       T ++ A+K I     +     +  EI +L  + HPN+V   D+Y
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 167 DRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           +  G + ++++ + GG L    + +    E   S L  QVL  + YLH   IVHRD+KP 
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPE 145
Query: 223 NLL---INSSKNVKIADFGVSRILAQTMDP---CNSAVGTIAYMSPERINTDLNHGKYDG 276
           NLL   ++    + I+DFG+S++     DP    ++A GT  Y++PE +       K   
Sbjct: 146 NLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQ-----KPYS 196
Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
            A D WS+GV       G  PF           +    +       +  S   +DFI   
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 256
Query: 337 LQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQ 370
           ++KDP  R+   Q LQHP+I  AG + +++N+ Q
Sbjct: 257 MEKDPEKRFTCEQALQHPWI--AGDTALDKNIHQ 288

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 129/274 (47%), Gaps = 21/274 (7%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G+G+   V       T ++ A+K I     +     +  EI +L  + HPN+V   D+Y
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 167 DRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           +  G + ++++ + GG L    + +    E   S L  QVL  + YLH   IVHRD+KP 
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPE 145
Query: 223 NLL---INSSKNVKIADFGVSRILAQTMDP---CNSAVGTIAYMSPERINTDLNHGKYDG 276
           NLL   ++    + I+DFG+S++     DP    ++A GT  Y++PE +       K   
Sbjct: 146 NLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQ-----KPYS 196
Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
            A D WS+GV       G  PF           +    +       +  S   +DFI   
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 256
Query: 337 LQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQ 370
           ++KDP  R+   Q LQHP+I  AG + +++N+ Q
Sbjct: 257 MEKDPEKRFTCEQALQHPWI--AGDTALDKNIHQ 288

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 129/274 (47%), Gaps = 21/274 (7%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G+G+   V       T ++ A+K I     +     +  EI +L  + HPN+V   D+Y
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 167 DRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           +  G + ++++ + GG L    + +    E   S L  QVL  + YLH   IVHRD+KP 
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPE 145
Query: 223 NLL---INSSKNVKIADFGVSRILAQTMDP---CNSAVGTIAYMSPERINTDLNHGKYDG 276
           NLL   ++    + I+DFG+S++     DP    ++A GT  Y++PE +       K   
Sbjct: 146 NLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQ-----KPYS 196
Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
            A D WS+GV       G  PF           +    +       +  S   +DFI   
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 256
Query: 337 LQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQ 370
           ++KDP  R+   Q LQHP+I  AG + +++N+ Q
Sbjct: 257 MEKDPEKRFTCEQALQHPWI--AGDTALDKNIHQ 288

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 129/274 (47%), Gaps = 21/274 (7%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G+G+   V       T ++ A+K I     +     +  EI +L  + HPN+V   D+Y
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 167 DRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKIVHRDIKPS 222
           +  G + ++++ + GG L    + +    E   S L  QVL  + YLH   IVHRD+KP 
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPE 145
Query: 223 NLL---INSSKNVKIADFGVSRILAQTMDP---CNSAVGTIAYMSPERINTDLNHGKYDG 276
           NLL   ++    + I+DFG+S++     DP    ++A GT  Y++PE +       K   
Sbjct: 146 NLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQ-----KPYS 196
Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
            A D WS+GV       G  PF           +    +       +  S   +DFI   
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 256
Query: 337 LQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQ 370
           ++KDP  R+   Q LQHP+I  AG + +++N+ Q
Sbjct: 257 MEKDPEKRFTCEQALQHPWI--AGDTALDKNIHQ 288

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 129/271 (47%), Gaps = 17/271 (6%)
Query: 103 KGNRI-GSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNV 159
           KG R+ G GS G V       T +  A+KVI      + + +  + RE+++L+ ++HPN+
Sbjct: 35  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 94
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI----LSDLARQVLSGLAYLHKRKIV 215
           +K ++ ++  G   ++ E   GG L    I ++       + + RQVLSG+ Y+HK KIV
Sbjct: 95  MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIV 154
Query: 216 HRDIKPSNLLINSSK---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL+ S     N++I DFG+S    +        +GT  Y++PE +     HG
Sbjct: 155 HRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKIGTAYYIAPEVL-----HG 208
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
            YD    D+WS GV +     G  PF    + D    +    +       +  S   +D 
Sbjct: 209 TYDEKC-DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 267
Query: 333 ISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ 363
           I + L   P  R  A   L H +I    + Q
Sbjct: 268 IRKMLTYVPSMRISARDALDHEWIQTYTKEQ 298

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 130/302 (43%), Gaps = 45/302 (14%)
Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQIC-REIEILRDVNHPNVV 160
           +K  +IG GS G V++  +  T ++ A+K    + +D V  +I  REI +L+ + HPN+V
Sbjct: 6   EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLV 65
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKIVH 216
              +++ R   + ++ EY D   L      Q    EH++  +  Q L  + + HK   +H
Sbjct: 66  NLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIH 125
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KP N+LI     +K+ DFG +R+L    D  +  V T  Y SPE +  D  +G    
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGP--- 182
Query: 277 YAGDIWSLGVSILE----------------FYLGRFPFA--VGRQGDWASLMFAICFAQP 318
              D+W++G    E                 YL R      + R     S        + 
Sbjct: 183 -PVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241
Query: 319 PEAPEMASREFR---------DFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLR 369
           P+  +M   E +           +  CL  DP  R    QLL HP+          +N+R
Sbjct: 242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF---------ENIR 292
Query: 370 QI 371
           +I
Sbjct: 293 EI 294

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 82/276 (29%), Positives = 138/276 (50%), Gaps = 21/276 (7%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR-EIEILRDVNHPNVVKCH 163
           + +G G+   V+R     T + +ALKV+    + +V  +I R EI +L  ++HPN++K  
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVL----KKTVDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKIVHRDI 219
           ++++   EI ++LE + GG L    + +    E   +D  +Q+L  +AYLH+  IVHRD+
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDL 174
Query: 220 KPSNLLINS---SKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           KP NLL  +      +KIADFG+S+I+   +    +  GT  Y +PE +      G   G
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLSKIVEHQV-LMKTVCGTPGYCAPEIL-----RGCAYG 228
Query: 277 YAGDIWSLGVSILEFYLGRFPF--AVGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS 334
              D+WS+G+       G  PF    G Q  +  ++    +   P   E+ S   +D + 
Sbjct: 229 PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV-SLNAKDLVR 287
Query: 335 RCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQ 370
           + +  DP  R    Q LQHP++     + V+ +  Q
Sbjct: 288 KLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQ 323

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 129/268 (48%), Gaps = 23/268 (8%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I      + R      +I RE+ ILR V H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLA----RQVLSGLAYLHKRKI 214
           V+  HD+Y+   ++ ++LE + GG L     ++E +  + A    +Q+L G+ YLH +KI
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 215 VHRDIKPSNLLINSSK----NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
            H D+KP N+++        ++K+ DFG++  +   ++  N   GT  +++PE +N    
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-IFGTPEFVAPEIVN---- 191
Query: 271 HGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
              Y+  G   D+WS+GV       G  PF    + +  + + A+ +    E     S  
Sbjct: 192 ---YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +DFI + L K+   R    + L+HP+I
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 129/268 (48%), Gaps = 23/268 (8%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I      + R      +I RE+ ILR V H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLA----RQVLSGLAYLHKRKI 214
           V+  HD+Y+   ++ ++LE + GG L     ++E +  + A    +Q+L G+ YLH +KI
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 215 VHRDIKPSNLLINSSK----NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
            H D+KP N+++        ++K+ DFG++  +   ++  N   GT  +++PE +N    
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-IFGTPEFVAPEIVN---- 191
Query: 271 HGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
              Y+  G   D+WS+GV       G  PF    + +  + + A+ +    E     S  
Sbjct: 192 ---YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +DFI + L K+   R    + L+HP+I
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 135/292 (46%), Gaps = 29/292 (9%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVN 155
           P + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  ++
Sbjct: 8   PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 67
Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLH 210
           HP  VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH
Sbjct: 68  HPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTAEIVSALEYLH 126
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTD 268
            + I+HRD+KP N+L+N   +++I DFG +++L+        N  VGT  Y+SPE +   
Sbjct: 127 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE- 185
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
               K    + D+W+LG  I +   G  PF  G +     L+F        + PE    +
Sbjct: 186 ----KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPEKFFPK 237
Query: 329 FRDFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
            RD + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 238 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 285

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 135/292 (46%), Gaps = 29/292 (9%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVN 155
           P + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  ++
Sbjct: 9   PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 68
Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLH 210
           HP  VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH
Sbjct: 69  HPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTAEIVSALEYLH 127
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTD 268
            + I+HRD+KP N+L+N   +++I DFG +++L+        N  VGT  Y+SPE +   
Sbjct: 128 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE- 186
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
               K    + D+W+LG  I +   G  PF  G +     L+F        + PE    +
Sbjct: 187 ----KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPEKFFPK 238
Query: 329 FRDFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
            RD + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 239 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 286

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 135/292 (46%), Gaps = 29/292 (9%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVN 155
           P + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  ++
Sbjct: 7   PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 66
Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLH 210
           HP  VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH
Sbjct: 67  HPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTAEIVSALEYLH 125
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTD 268
            + I+HRD+KP N+L+N   +++I DFG +++L+        N  VGT  Y+SPE +   
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE- 184
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
               K    + D+W+LG  I +   G  PF  G +     L+F        + PE    +
Sbjct: 185 ----KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPEKFFPK 236
Query: 329 FRDFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
            RD + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 284

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 135/292 (46%), Gaps = 29/292 (9%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVN 155
           P + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  ++
Sbjct: 6   PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 65
Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLH 210
           HP  VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH
Sbjct: 66  HPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTAEIVSALEYLH 124
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTD 268
            + I+HRD+KP N+L+N   +++I DFG +++L+        N  VGT  Y+SPE +   
Sbjct: 125 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE- 183
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
               K    + D+W+LG  I +   G  PF  G +     L+F        + PE    +
Sbjct: 184 ----KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPEKFFPK 235
Query: 329 FRDFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
            RD + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 236 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 283

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 135/290 (46%), Gaps = 29/290 (10%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  ++HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKR 212
             VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH +
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLN 270
            I+HRD+KP N+L+N   +++I DFG +++L+        NS VGT  Y+SPE +     
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE--- 208
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
             K    + D+W+LG  I +   G  PF  G +     L+F        + PE    + R
Sbjct: 209 --KSASKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPEKFFPKAR 262
Query: 331 DFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
           D + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 308

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 82/276 (29%), Positives = 131/276 (47%), Gaps = 17/276 (6%)
Query: 103 KGNRI-GSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNV 159
           KG R+ G GS G V       T +  A+KVI      + + +  + RE+++L+ ++HPN+
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI----LSDLARQVLSGLAYLHKRKIV 215
            K ++ ++  G   ++ E   GG L    I ++       + + RQVLSG+ Y HK KIV
Sbjct: 89  XKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIV 148
Query: 216 HRDIKPSNLLINSSK---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL+ S     N++I DFG+S    +        +GT  Y++PE +     HG
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKXKDKIGTAYYIAPEVL-----HG 202
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
            YD    D+WS GV +     G  PF    + D    +    +       +  S   +D 
Sbjct: 203 TYDEKC-DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 333 ISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNL 368
           I + L   P  R  A   L H +I    + Q++ ++
Sbjct: 262 IRKXLTYVPSXRISARDALDHEWIQTYTKEQISVDV 297

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 136/284 (47%), Gaps = 26/284 (9%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G G+ G V  V    T R +A+K++       +D V +    E  +L++  HP +    
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALK 74
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRD 218
             +  +  +  ++EY +GG L   H+ +E + ++        +++S L YLH R +V+RD
Sbjct: 75  YAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 133
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           IK  NL+++   ++KI DFG+ +          +  GT  Y++PE +  D ++G+    A
Sbjct: 134 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE-DNDYGR----A 188
Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ 338
            D W LGV + E   GR PF      D   L F +   +    P   S E +  ++  L+
Sbjct: 189 VDWWGLGVVMYEMMCGRLPFY---NQDHERL-FELILMEEIRFPRTLSPEAKSLLAGLLK 244
Query: 339 KDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           KDP  R       A ++++H F L      V Q  +++LPP +P
Sbjct: 245 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ--KKLLPPFKP 286

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 136/284 (47%), Gaps = 26/284 (9%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G G+ G V  V    T R +A+K++       +D V +    E  +L++  HP +    
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALK 71
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRD 218
             +  +  +  ++EY +GG L   H+ +E + ++        +++S L YLH R +V+RD
Sbjct: 72  YAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           IK  NL+++   ++KI DFG+ +          +  GT  Y++PE +  D ++G+    A
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE-DNDYGR----A 185
Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ 338
            D W LGV + E   GR PF      D   L F +   +    P   S E +  ++  L+
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFY---NQDHERL-FELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 339 KDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           KDP  R       A ++++H F L      V Q  +++LPP +P
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ--KKLLPPFKP 283

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 136/284 (47%), Gaps = 26/284 (9%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G G+ G V  V    T R +A+K++       +D V +    E  +L++  HP +    
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALK 71
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRD 218
             +  +  +  ++EY +GG L   H+ +E + ++        +++S L YLH R +V+RD
Sbjct: 72  YAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           IK  NL+++   ++KI DFG+ +          +  GT  Y++PE +  D ++G+    A
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE-DNDYGR----A 185
Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ 338
            D W LGV + E   GR PF      D   L F +   +    P   S E +  ++  L+
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFY---NQDHERL-FELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 339 KDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           KDP  R       A ++++H F L      V Q  +++LPP +P
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ--KKLLPPFKP 283

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 132/290 (45%), Gaps = 38/290 (13%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQIC-REIEILRDVNHPNVVKCHDM 165
           +G GS G V +  +  T R+ A+K    + +D +  +I  REI++L+ + H N+V   ++
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
             +     ++ E++D   L+   +        ++     Q+++G+ + H   I+HRDIKP
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKP 152
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDI 281
            N+L++ S  VK+ DFG +R LA   +  +  V T  Y +PE +  D+ +GK    A D+
Sbjct: 153 ENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGK----AVDV 208
Query: 282 WSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC-----------FAQPP-----EAPEMA 325
           W++G  + E ++G  P   G           +C           F + P       PE+ 
Sbjct: 209 WAIGCLVTEMFMGE-PLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIK 267
Query: 326 SRE------------FRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ 363
            RE              D   +CL  DP  R   A+LL H F    G ++
Sbjct: 268 EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAE 317

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 135/290 (46%), Gaps = 29/290 (10%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  ++HP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKR 212
             VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH +
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLN 270
            I+HRD+KP N+L+N   +++I DFG +++L+        NS VGT  Y+SPE +     
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE--- 209
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
             K    + D+W+LG  I +   G  PF  G +     L+F        + PE    + R
Sbjct: 210 --KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPEKFFPKAR 263
Query: 331 DFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
           D + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 264 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 309

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 135/300 (45%), Gaps = 49/300 (16%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
           ++ ++  ++G+G+  TV++ ++  T    ALK +  + E+   S   REI +++++ H N
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHEN 64
Query: 159 VVKCHDMYDRNGEIEVLLEYMD------------GGSLEGAHIRQEHILSDLARQVLSGL 206
           +V+ +D+     ++ ++ E+MD            G +  G  +   +++     Q+L GL
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLEL---NLVKYFQWQLLQGL 121
Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN 266
           A+ H+ KI+HRD+KP NLLIN    +K+ DFG++R     ++  +S V T+ Y +P+ + 
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLM 181
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI-----------CF 315
               +      + DIWS G  + E   G+  F      +   L+F I             
Sbjct: 182 GSRTYST----SIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237
Query: 316 AQPPEAPEMASR-------------------EFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             P   P +  R                      DF+   LQ +P  R  A Q L HP+ 
Sbjct: 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 132/278 (47%), Gaps = 29/278 (10%)
Query: 98  PAELQKGN---------RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREI 148
           P E+++G+          +GSG+ G V R V   T RVF  K I   +    +  +  EI
Sbjct: 41  PVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEI 99
Query: 149 EILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVL 203
            I+  ++HP ++  HD ++   E+ ++LE++ GG L      +++ +S+       RQ  
Sbjct: 100 SIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 159
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSK--NVKIADFGVSRILAQTMDP---CNSAVGTIA 258
            GL ++H+  IVH DIKP N++  + K  +VKI DFG    LA  ++P         T  
Sbjct: 160 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG----LATKLNPDEIVKVTTATAE 215
Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP 318
           + +PE ++ +       G+  D+W++GV       G  PFA     +    +    +   
Sbjct: 216 FAAPEIVDREPV-----GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 270
Query: 319 PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +A    S E +DFI   LQK+P  R      L+HP++
Sbjct: 271 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 308

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 134/284 (47%), Gaps = 26/284 (9%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G G+ G V  V    T R +A+K++       +D V +    E  +L++  HP +    
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALK 71
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRD 218
             +  +  +  ++EY +GG L   H+ +E + ++        +++S L YLH R +V+RD
Sbjct: 72  YAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           IK  NL+++   ++KI DFG+ +             GT  Y++PE +  D ++G+    A
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE-DNDYGR----A 185
Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ 338
            D W LGV + E   GR PF           +F +   +    P   S E +  ++  L+
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 339 KDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           KDP  R       A ++++H F L      V Q  +++LPP +P
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ--KKLLPPFKP 283

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 134/284 (47%), Gaps = 26/284 (9%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G G+ G V  V    T R +A+K++       +D V +    E  +L++  HP +    
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALK 71
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRD 218
             +  +  +  ++EY +GG L   H+ +E + ++        +++S L YLH R +V+RD
Sbjct: 72  YAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           IK  NL+++   ++KI DFG+ +             GT  Y++PE +  D ++G+    A
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE-DNDYGR----A 185
Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ 338
            D W LGV + E   GR PF           +F +   +    P   S E +  ++  L+
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 339 KDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           KDP  R       A ++++H F L      V Q  +++LPP +P
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ--KKLLPPFKP 283

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 134/284 (47%), Gaps = 26/284 (9%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G G+ G V  V    T R +A+K++       +D V +    E  +L++  HP +    
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALK 76
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRD 218
             +  +  +  ++EY +GG L   H+ +E + ++        +++S L YLH R +V+RD
Sbjct: 77  YAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 135
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           IK  NL+++   ++KI DFG+ +             GT  Y++PE +  D ++G+    A
Sbjct: 136 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE-DNDYGR----A 190
Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ 338
            D W LGV + E   GR PF           +F +   +    P   S E +  ++  L+
Sbjct: 191 VDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILMEEIRFPRTLSPEAKSLLAGLLK 246
Query: 339 KDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           KDP  R       A ++++H F L      V Q  +++LPP +P
Sbjct: 247 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ--KKLLPPFKP 288

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 135/290 (46%), Gaps = 29/290 (10%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  ++HP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKR 212
             VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH +
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLN 270
            I+HRD+KP N+L+N   +++I DFG +++L+        NS VGT  Y+SPE +     
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE--- 205
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
             K    + D+W+LG  I +   G  PF  G +     L+F        + PE    + R
Sbjct: 206 --KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPEKFFPKAR 259
Query: 331 DFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
           D + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 260 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 305

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 129/268 (48%), Gaps = 23/268 (8%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I      + R      +I RE+ ILR V H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLA----RQVLSGLAYLHKRKI 214
           V+  HD+Y+   ++ ++LE + GG L     ++E +  + A    +Q+L G+ YLH +KI
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 215 VHRDIKPSNLLINSSK----NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
            H D+KP N+++        ++K+ DFG++  +   ++  N   GT  +++PE +N    
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-IFGTPEFVAPEIVN---- 191
Query: 271 HGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
              Y+  G   D+WS+GV       G  PF    + +  + + ++ +    E     S  
Sbjct: 192 ---YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +DFI + L K+   R    + L+HP+I
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 134/284 (47%), Gaps = 26/284 (9%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G G+ G V  V    T R +A+K++       +D V +    E  +L++  HP +    
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTALK 71
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRD 218
             +  +  +  ++EY +GG L   H+ +E + ++        +++S L YLH R +V+RD
Sbjct: 72  YAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           IK  NL+++   ++KI DFG+ +             GT  Y++PE +  D ++G+    A
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLE-DNDYGR----A 185
Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ 338
            D W LGV + E   GR PF           +F +   +    P   S E +  ++  L+
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 339 KDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           KDP  R       A ++++H F L      V Q  +++LPP +P
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ--KKLLPPFKP 283

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 131/272 (48%), Gaps = 18/272 (6%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI--YGNHEDSVRSQICREIEILRDVNHP 157
           + + GN +G GS   V+R     T    A+K+I     ++  +  ++  E++I   + HP
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLSGLAYLHK 211
           ++++ ++ ++ +  + ++LE    G +   +++       E+       Q+++G+ YLH 
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEM-NRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
             I+HRD+  SNLL+  + N+KIADFG++  L    +   +  GT  Y+SPE I T   H
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE-IATRSAH 189
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
               G   D+WSLG       +GR PF      D              E P   S E +D
Sbjct: 190 ----GLESDVWSLGCMFYTLLIGRPPF----DTDTVKNTLNKVVLADYEMPSFLSIEAKD 241
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ 363
            I + L+++P  R   + +L HPF+ R   ++
Sbjct: 242 LIHQLLRRNPADRLSLSSVLDHPFMSRNSSTK 273

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 129/268 (48%), Gaps = 23/268 (8%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I      + R      +I RE+ ILR V H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLA----RQVLSGLAYLHKRKI 214
           V+  HD+Y+   ++ ++LE + GG L     ++E +  + A    +Q+L G+ YLH +KI
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 215 VHRDIKPSNLLINSSK----NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
            H D+KP N+++        ++K+ DFG++  +   ++  N   GT  +++PE +N    
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-IFGTPEFVAPEIVN---- 191
Query: 271 HGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
              Y+  G   D+WS+GV       G  PF    + +  + + ++ +    E     S  
Sbjct: 192 ---YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +DFI + L K+   R    + L+HP+I
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 129/268 (48%), Gaps = 23/268 (8%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-----SQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I      + R      +I RE+ ILR V H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLA----RQVLSGLAYLHKRKI 214
           V+  HD+Y+   ++ ++LE + GG L     ++E +  + A    +Q+L G+ YLH +KI
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKI 136
Query: 215 VHRDIKPSNLLINSSK----NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
            H D+KP N+++        ++K+ DFG++  +   ++  N   GT  +++PE +N    
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-IFGTPEFVAPEIVN---- 191
Query: 271 HGKYD--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
              Y+  G   D+WS+GV       G  PF    + +  + + ++ +    E     S  
Sbjct: 192 ---YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +DFI + L K+   R    + L+HP+I
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 124/265 (46%), Gaps = 21/265 (7%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI----YGNHEDSVRSQICREIEILRDVNHPNVVKC 162
           IG G+   V R ++  T + FA+K++    + +        + RE  I   + HP++V+ 
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 163 HDMYDRNGEIEVLLEYMDGGSL--------EGAHIRQEHILSDLARQVLSGLAYLHKRKI 214
            + Y  +G + ++ E+MDG  L        +   +  E + S   RQ+L  L Y H   I
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI 151
Query: 215 VHRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
           +HRD+KP N+L+ S +N   VK+ DFGV+  L ++       VGT  +M+PE +  +  +
Sbjct: 152 IHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PY 210
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
           GK      D+W  GV +     G  PF   ++  +  ++    +   P      S   +D
Sbjct: 211 GK----PVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGK-YKMNPRQWSHISESAKD 265
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFI 356
            + R L  DP  R    + L HP++
Sbjct: 266 LVRRMLMLDPAERITVYEALNHPWL 290

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 135/290 (46%), Gaps = 29/290 (10%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  ++HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKR 212
             VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH +
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLN 270
            I+HRD+KP N+L+N   +++I DFG +++L+        N+ VGT  Y+SPE +     
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTE--- 206
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
             K    + D+W+LG  I +   G  PF  G +     L+F        + PE    + R
Sbjct: 207 --KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPEKFFPKAR 260
Query: 331 DFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
           D + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 306

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 79/252 (31%), Positives = 126/252 (50%), Gaps = 16/252 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDVNHPNVVKCHD 164
           +G GS G V    H  T +  ALK+I      +  ++ +I REI  LR + HP+++K +D
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIK 220
           +     EI +++EY  G  L    ++++ +    AR    Q++S + Y H+ KIVHRD+K
Sbjct: 72  VIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLK 130
Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
           P NLL++   NVKIADFG+S I+    +   ++ G+  Y +PE I+  L    Y G   D
Sbjct: 131 PENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKL----YAGPEVD 185
Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKD 340
           +WS GV +      R PF      +   ++F          P+  S      I R L  +
Sbjct: 186 VWSCGVILYVMLCRRLPF----DDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN 241
Query: 341 PHSRWPAAQLLQ 352
           P +R    +++Q
Sbjct: 242 PLNRISIHEIMQ 253

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 134/290 (46%), Gaps = 29/290 (10%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  ++HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKR 212
             VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH +
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLN 270
            I+HRD+KP N+L+N   +++I DFG +++L+        N  VGT  Y+SPE +     
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE--- 208
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
             K    + D+W+LG  I +   G  PF  G +     L+F        + PE    + R
Sbjct: 209 --KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPEKFFPKAR 262
Query: 331 DFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
           D + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 308

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 134/290 (46%), Gaps = 29/290 (10%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  ++HP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKR 212
             VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH +
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLN 270
            I+HRD+KP N+L+N   +++I DFG +++L+        N  VGT  Y+SPE +     
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE--- 209
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
             K    + D+W+LG  I +   G  PF  G +     L+F        + PE    + R
Sbjct: 210 --KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPEKFFPKAR 263
Query: 331 DFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
           D + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 264 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 309

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 134/290 (46%), Gaps = 29/290 (10%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  ++HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKR 212
             VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH +
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLN 270
            I+HRD+KP N+L+N   +++I DFG +++L+        N  VGT  Y+SPE +     
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE--- 206
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
             K    + D+W+LG  I +   G  PF  G +     L+F        + PE    + R
Sbjct: 207 --KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPEKFFPKAR 260
Query: 331 DFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
           D + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 306

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 79/252 (31%), Positives = 126/252 (50%), Gaps = 16/252 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDVNHPNVVKCHD 164
           +G GS G V    H  T +  ALK+I      +  ++ +I REI  LR + HP+++K +D
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIK 220
           +     EI +++EY  G  L    ++++ +    AR    Q++S + Y H+ KIVHRD+K
Sbjct: 81  VIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLK 139
Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
           P NLL++   NVKIADFG+S I+    +   ++ G+  Y +PE I+  L    Y G   D
Sbjct: 140 PENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKL----YAGPEVD 194
Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKD 340
           +WS GV +      R PF      +   ++F          P+  S      I R L  +
Sbjct: 195 VWSCGVILYVMLCRRLPF----DDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN 250
Query: 341 PHSRWPAAQLLQ 352
           P +R    +++Q
Sbjct: 251 PLNRISIHEIMQ 262

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 134/290 (46%), Gaps = 29/290 (10%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  ++HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKR 212
             VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH +
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLN 270
            I+HRD+KP N+L+N   +++I DFG +++L+        N  VGT  Y+SPE +     
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE--- 208
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
             K    + D+W+LG  I +   G  PF  G +     L+F        + PE    + R
Sbjct: 209 --KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPEKFFPKAR 262
Query: 331 DFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
           D + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 308

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 134/290 (46%), Gaps = 29/290 (10%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  ++HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKR 212
             VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH +
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLN 270
            I+HRD+KP N+L+N   +++I DFG +++L+        N  VGT  Y+SPE +     
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE--- 208
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
             K    + D+W+LG  I +   G  PF  G +     L+F        + PE    + R
Sbjct: 209 --KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPEKFFPKAR 262
Query: 331 DFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
           D + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 308

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 134/290 (46%), Gaps = 29/290 (10%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  ++HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKR 212
             VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH +
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLN 270
            I+HRD+KP N+L+N   +++I DFG +++L+        N  VGT  Y+SPE +     
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE--- 206
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
             K    + D+W+LG  I +   G  PF  G +     L+F        + PE    + R
Sbjct: 207 --KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPEKFFPKAR 260
Query: 331 DFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
           D + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 306

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 79/252 (31%), Positives = 126/252 (50%), Gaps = 16/252 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDVNHPNVVKCHD 164
           +G GS G V    H  T +  ALK+I      +  ++ +I REI  LR + HP+++K +D
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIK 220
           +     EI +++EY  G  L    ++++ +    AR    Q++S + Y H+ KIVHRD+K
Sbjct: 76  VIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLK 134
Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
           P NLL++   NVKIADFG+S I+    +   ++ G+  Y +PE I+  L    Y G   D
Sbjct: 135 PENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKL----YAGPEVD 189
Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKD 340
           +WS GV +      R PF      +   ++F          P+  S      I R L  +
Sbjct: 190 VWSCGVILYVMLCRRLPF----DDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN 245
Query: 341 PHSRWPAAQLLQ 352
           P +R    +++Q
Sbjct: 246 PLNRISIHEIMQ 257

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 134/290 (46%), Gaps = 29/290 (10%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  ++HP
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKR 212
             VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH +
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLN 270
            I+HRD+KP N+L+N   +++I DFG +++L+        N  VGT  Y+SPE +     
Sbjct: 134 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE--- 190
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
             K    + D+W+LG  I +   G  PF  G +     L+F        + PE    + R
Sbjct: 191 --KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPEKFFPKAR 244
Query: 331 DFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
           D + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 245 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 290

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 79/252 (31%), Positives = 126/252 (50%), Gaps = 16/252 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDVNHPNVVKCHD 164
           +G GS G V    H  T +  ALK+I      +  ++ +I REI  LR + HP+++K +D
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIK 220
           +     EI +++EY  G  L    ++++ +    AR    Q++S + Y H+ KIVHRD+K
Sbjct: 82  VIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLK 140
Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
           P NLL++   NVKIADFG+S I+    +   ++ G+  Y +PE I+  L    Y G   D
Sbjct: 141 PENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKL----YAGPEVD 195
Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKD 340
           +WS GV +      R PF      +   ++F          P+  S      I R L  +
Sbjct: 196 VWSCGVILYVMLCRRLPF----DDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN 251
Query: 341 PHSRWPAAQLLQ 352
           P +R    +++Q
Sbjct: 252 PLNRISIHEIMQ 263

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 134/290 (46%), Gaps = 29/290 (10%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  ++HP
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKR 212
             VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH +
Sbjct: 98  FFVKLYFCFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLN 270
            I+HRD+KP N+L+N   +++I DFG +++L+        N  VGT  Y+SPE +     
Sbjct: 157 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE--- 213
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
             K    + D+W+LG  I +   G  PF  G +     L+F        + PE    + R
Sbjct: 214 --KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPEKFFPKAR 267
Query: 331 DFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
           D + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 268 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 313

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 145/297 (48%), Gaps = 30/297 (10%)
Query: 97  NPAELQKGNRIGSGSGGTVWRVVHPPTS---RVFALKVIYGNH---EDSVRSQICREIEI 150
           +P++ +    +G GS G V+ V     S   +++A+KV+        D VR+++ R+I  
Sbjct: 23  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI-- 80
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSG 205
           L +VNHP +VK H  +   G++ ++L+++ GG L     +     +E +   LA   L+ 
Sbjct: 81  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA- 139
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERI 265
           L +LH   I++RD+KP N+L++   ++K+ DFG+S+          S  GT+ YM+PE +
Sbjct: 140 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 199
Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
           N    H +    + D WS GV + E   G  PF    QG        +        P+  
Sbjct: 200 NRR-GHTQ----SADWWSFGVLMFEMLTGTLPF----QGKDRKETMTMILKAKLGMPQFL 250
Query: 326 SREFRDFISRCLQKDPHSRWPAA-----QLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           S E +  +    +++P +R  A      ++ +H F      +++ +  R+I PP +P
Sbjct: 251 SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYR--REIHPPFKP 305

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 145/297 (48%), Gaps = 30/297 (10%)
Query: 97  NPAELQKGNRIGSGSGGTVWRVVHPPTS---RVFALKVIYGNH---EDSVRSQICREIEI 150
           +P++ +    +G GS G V+ V     S   +++A+KV+        D VR+++ R+I  
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI-- 79
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSG 205
           L +VNHP +VK H  +   G++ ++L+++ GG L     +     +E +   LA   L+ 
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA- 138
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERI 265
           L +LH   I++RD+KP N+L++   ++K+ DFG+S+          S  GT+ YM+PE +
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
           N    H +    + D WS GV + E   G  PF    QG        +        P+  
Sbjct: 199 NRR-GHTQ----SADWWSFGVLMFEMLTGTLPF----QGKDRKETMTMILKAKLGMPQFL 249
Query: 326 SREFRDFISRCLQKDPHSRWPAA-----QLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           S E +  +    +++P +R  A      ++ +H F      +++ +  R+I PP +P
Sbjct: 250 SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYR--REIHPPFKP 304

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 146/299 (48%), Gaps = 30/299 (10%)
Query: 97  NPAELQKGNRIGSGSGGTVWRVVHPPTS---RVFALKVIYGNH---EDSVRSQICREIEI 150
           +P++ +    +G GS G V+ V     S   +++A+KV+        D VR+++ R+I  
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI-- 79
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSG 205
           L +VNHP +VK H  +   G++ ++L+++ GG L     +     +E +   LA   L+ 
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA- 138
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERI 265
           L +LH   I++RD+KP N+L++   ++K+ DFG+S+          S  GT+ YM+PE +
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
           N    H +    + D WS GV + E   G  PF    QG        +        P+  
Sbjct: 199 NRR-GHTQ----SADWWSFGVLMFEMLTGTLPF----QGKDRKETMTMILKAKLGMPQFL 249
Query: 326 SREFRDFISRCLQKDPHSRWPAA-----QLLQHPFILRAGQSQVNQNLRQILPPPRPLS 379
           S E +  +    +++P +R  A      ++ +H F      +++ +  R+I PP +P +
Sbjct: 250 SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYR--REIHPPFKPAT 306

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 134/290 (46%), Gaps = 29/290 (10%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  ++HP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKR 212
             VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH +
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLN 270
            I+HRD+KP N+L+N   +++I DFG +++L+        N  VGT  Y+SPE +     
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE--- 205
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
             K    + D+W+LG  I +   G  PF  G +     L+F        + PE    + R
Sbjct: 206 --KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPEKFFPKAR 259
Query: 331 DFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
           D + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 260 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 305

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 132/263 (50%), Gaps = 14/263 (5%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           + K   +G G  G V +     T    A K+I        + ++  EI ++  ++H N++
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD-KEEVKNEISVMNQLDHANLI 149
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDL-----ARQVLSGLAYLHKRKIV 215
           + +D ++   +I +++EY+DGG L    I + + L++L      +Q+  G+ ++H+  I+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYIL 209
Query: 216 HRDIKPSNLLI--NSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           H D+KP N+L     +K +KI DFG++R   +  +      GT  +++PE +N D     
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLAR-RYKPREKLKVNFGTPEFLAPEVVNYD----- 263
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
           +  +  D+WS+GV       G  PF      +  + + A  +    E  +  S E ++FI
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI 323
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           S+ L K+   R  A++ L+HP++
Sbjct: 324 SKLLIKEKSWRISASEALKHPWL 346

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 133/290 (45%), Gaps = 29/290 (10%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           + + G  +G GS  T        TSR +A+K++   H  +++    + RE +++  ++HP
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKR 212
             VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH +
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLN 270
            I+HRD+KP N+L+N   +++I DFG +++L+        N  VGT  Y+SPE +     
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE--- 206
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
             K    + D+W+LG  I +   G  PF  G +     L+F        + PE    + R
Sbjct: 207 --KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPEKFFPKAR 260
Query: 331 DFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
           D + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 306

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/197 (34%), Positives = 103/197 (52%), Gaps = 10/197 (5%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVKCHDM 165
           IG G+   V    H  T R  A+K+I     +    Q + RE+ I++ +NHPN+VK  ++
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 166 YDRNGEIEVLLEYMDGGSLEG---AHIR-QEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            +    + +++EY  GG +     AH R +E       RQ++S + Y H+++IVHRD+K 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKA 139
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDI 281
            NLL+++  N+KIADFG S          ++  G+  Y +PE         KYDG   D+
Sbjct: 140 ENLLLDADMNIKIADFGFSNEFT-VGGKLDTFCGSPPYAAPELFQGK----KYDGPEVDV 194
Query: 282 WSLGVSILEFYLGRFPF 298
           WSLGV +     G  PF
Sbjct: 195 WSLGVILYTLVSGSLPF 211

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 137/289 (47%), Gaps = 30/289 (10%)
Query: 107 IGSGSGGTVW---RVVHPPTSRVFALKV-----IYGNHEDSVRSQICREIEILRDVNHPN 158
           +G G  G V+   +V    T ++FA+KV     I  N +D+  ++  R I  L +V HP 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI--LEEVKHPF 82
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLA----RQVLSGLAYLHKRKI 214
           +V     +   G++ ++LEY+ GG L     R+   + D A     ++   L +LH++ I
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           ++RD+KP N+++N   +VK+ DFG+ +         ++  GTI YM+PE I     H + 
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE-ILMRSGHNR- 200
Query: 275 DGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS 334
              A D WSLG  + +   G  PF    +      +       PP      ++E RD + 
Sbjct: 201 ---AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQEARDLLK 253
Query: 335 RCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRPL 378
           + L+++  SR       A ++  HPF       ++    R++ PP +PL
Sbjct: 254 KLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLA--RKVEPPFKPL 300

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 132/289 (45%), Gaps = 25/289 (8%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDV-NHPNVVKCH 163
           IG GS   V  V    T R++A+KV+     ++D     +  E  +     NHP +V  H
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDI 219
             +     +  ++EY++GG L     RQ  +  + AR    ++   L YLH+R I++RD+
Sbjct: 88  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 147
Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           K  N+L++S  ++K+ D+G+ +   +  D  +   GT  Y++PE +      G+  G++ 
Sbjct: 148 KLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL-----RGEDYGFSV 202
Query: 280 DIWSLGVSILEFYLGRFPFAVGRQGD-----WASLMFAICFAQPPEAPEMASREFRDFIS 334
           D W+LGV + E   GR PF +    D         +F +   +    P   S +    + 
Sbjct: 203 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMSVKAASVLK 262
Query: 335 RCLQKDPHSRWPA------AQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
             L KDP  R         A +  HPF        + Q  +Q++PP +P
Sbjct: 263 SFLNKDPKERLGCLPQTGFADIQGHPFFRNVDWDMMEQ--KQVVPPFKP 309

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 133/290 (45%), Gaps = 29/290 (10%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  ++HP
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKR 212
             VK +  +  + ++   L Y   G L   +IR+     E        +++S L YLH +
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELL-KYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLN 270
            I+HRD+KP N+L+N   +++I DFG +++L+        N  VGT  Y+SPE +     
Sbjct: 155 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE--- 211
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
             K    + D+W+LG  I +   G  PF  G +     L+F        + P     + R
Sbjct: 212 --KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPAAFFPKAR 265
Query: 331 DFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPP 374
           D + + L  D   R    +      L  HPF     +S   +NL Q  PP
Sbjct: 266 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPP 311

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 132/289 (45%), Gaps = 25/289 (8%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDV-NHPNVVKCH 163
           IG GS   V  V    T R++A+KV+     ++D     +  E  +     NHP +V  H
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDI 219
             +     +  ++EY++GG L     RQ  +  + AR    ++   L YLH+R I++RD+
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 136
Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           K  N+L++S  ++K+ D+G+ +   +  D  +   GT  Y++PE +      G+  G++ 
Sbjct: 137 KLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL-----RGEDYGFSV 191
Query: 280 DIWSLGVSILEFYLGRFPFAVGRQGD-----WASLMFAICFAQPPEAPEMASREFRDFIS 334
           D W+LGV + E   GR PF +    D         +F +   +    P   S +    + 
Sbjct: 192 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 251
Query: 335 RCLQKDPHSRWPA------AQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
             L KDP  R         A +  HPF        + Q  +Q++PP +P
Sbjct: 252 SFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQ--KQVVPPFKP 298

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 132/289 (45%), Gaps = 25/289 (8%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDV-NHPNVVKCH 163
           IG GS   V  V    T R++A+KV+     ++D     +  E  +     NHP +V  H
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDI 219
             +     +  ++EY++GG L     RQ  +  + AR    ++   L YLH+R I++RD+
Sbjct: 73  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 132
Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           K  N+L++S  ++K+ D+G+ +   +  D  +   GT  Y++PE +      G+  G++ 
Sbjct: 133 KLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEIL-----RGEDYGFSV 187
Query: 280 DIWSLGVSILEFYLGRFPFAVGRQGD-----WASLMFAICFAQPPEAPEMASREFRDFIS 334
           D W+LGV + E   GR PF +    D         +F +   +    P   S +    + 
Sbjct: 188 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 247
Query: 335 RCLQKDPHSRWPA------AQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
             L KDP  R         A +  HPF        + Q  +Q++PP +P
Sbjct: 248 SFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQ--KQVVPPFKP 294

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/197 (34%), Positives = 102/197 (51%), Gaps = 10/197 (5%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVKCHDM 165
           IG G+   V    H  T R  A+K+I     +    Q + RE+ I++ +NHPN+VK  ++
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 166 YDRNGEIEVLLEYMDGGSLEG---AHIR-QEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            +    + +++EY  GG +     AH R +E       RQ++S + Y H+++IVHRD+K 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKA 142
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDI 281
            NLL+++  N+KIADFG S          ++  G   Y +PE         KYDG   D+
Sbjct: 143 ENLLLDADMNIKIADFGFSNEFT-VGGKLDAFCGAPPYAAPELFQGK----KYDGPEVDV 197
Query: 282 WSLGVSILEFYLGRFPF 298
           WSLGV +     G  PF
Sbjct: 198 WSLGVILYTLVSGSLPF 214

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 134/277 (48%), Gaps = 19/277 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIY-------GNHEDSVRSQICREIEILRDVNHPNV 159
           +GSG+ G V       T +  A+K+I           E      +  EIEIL+ +NHP +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIV 215
           +K  + +D   +  ++LE M+GG L    +  + +     +    Q+L  + YLH+  I+
Sbjct: 78  IKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 136
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP N+L++S +    +KI DFG S+IL +T     +  GT  Y++PE +   +   
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPE-VLVSVGTA 194
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGR-QGDWASLMFAICFAQPPEAPEMASREFRD 331
            Y+  A D WSLGV +     G  PF+  R Q      + +  +   PE     S +  D
Sbjct: 195 GYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALD 253
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNL 368
            + + L  DP +R+   + L+HP++      +  Q+L
Sbjct: 254 LVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 290

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 134/277 (48%), Gaps = 19/277 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIY-------GNHEDSVRSQICREIEILRDVNHPNV 159
           +GSG+ G V       T +  A+K+I           E      +  EIEIL+ +NHP +
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIV 215
           +K  + +D   +  ++LE M+GG L    +  + +     +    Q+L  + YLH+  I+
Sbjct: 84  IKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 142
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP N+L++S +    +KI DFG S+IL +T     +  GT  Y++PE +   +   
Sbjct: 143 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPE-VLVSVGTA 200
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGR-QGDWASLMFAICFAQPPEAPEMASREFRD 331
            Y+  A D WSLGV +     G  PF+  R Q      + +  +   PE     S +  D
Sbjct: 201 GYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALD 259
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNL 368
            + + L  DP +R+   + L+HP++      +  Q+L
Sbjct: 260 LVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 296

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 133/289 (46%), Gaps = 25/289 (8%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDV-NHPNVVKCH 163
           IG GS   V  V    T R++A++V+     ++D     +  E  +     NHP +V  H
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDI 219
             +     +  ++EY++GG L     RQ  +  + AR    ++   L YLH+R I++RD+
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 179
Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           K  N+L++S  ++K+ D+G+ +   +  D  ++  GT  Y++PE +      G+  G++ 
Sbjct: 180 KLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL-----RGEDYGFSV 234
Query: 280 DIWSLGVSILEFYLGRFPFAVGRQGD-----WASLMFAICFAQPPEAPEMASREFRDFIS 334
           D W+LGV + E   GR PF +    D         +F +   +    P   S +    + 
Sbjct: 235 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 294
Query: 335 RCLQKDPHSRWPA------AQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
             L KDP  R         A +  HPF        + Q  +Q++PP +P
Sbjct: 295 SFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQ--KQVVPPFKP 341

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 134/277 (48%), Gaps = 19/277 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIY-------GNHEDSVRSQICREIEILRDVNHPNV 159
           +GSG+ G V       T +  A+K+I           E      +  EIEIL+ +NHP +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIV 215
           +K  + +D   +  ++LE M+GG L    +  + +     +    Q+L  + YLH+  I+
Sbjct: 78  IKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 136
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP N+L++S +    +KI DFG S+IL +T     +  GT  Y++PE +   +   
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPE-VLVSVGTA 194
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGR-QGDWASLMFAICFAQPPEAPEMASREFRD 331
            Y+  A D WSLGV +     G  PF+  R Q      + +  +   PE     S +  D
Sbjct: 195 GYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALD 253
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNL 368
            + + L  DP +R+   + L+HP++      +  Q+L
Sbjct: 254 LVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 290

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 134/277 (48%), Gaps = 19/277 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIY-------GNHEDSVRSQICREIEILRDVNHPNV 159
           +GSG+ G V       T +  A+K+I           E      +  EIEIL+ +NHP +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIV 215
           +K  + +D   +  ++LE M+GG L    +  + +     +    Q+L  + YLH+  I+
Sbjct: 78  IKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 136
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP N+L++S +    +KI DFG S+IL +T     +  GT  Y++PE +   +   
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPE-VLVSVGTA 194
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGR-QGDWASLMFAICFAQPPEAPEMASREFRD 331
            Y+  A D WSLGV +     G  PF+  R Q      + +  +   PE     S +  D
Sbjct: 195 GYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALD 253
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNL 368
            + + L  DP +R+   + L+HP++      +  Q+L
Sbjct: 254 LVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 290

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 134/277 (48%), Gaps = 19/277 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIY-------GNHEDSVRSQICREIEILRDVNHPNV 159
           +GSG+ G V       T +  A+K+I           E      +  EIEIL+ +NHP +
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIV 215
           +K  + +D   +  ++LE M+GG L    +  + +     +    Q+L  + YLH+  I+
Sbjct: 77  IKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 135
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP N+L++S +    +KI DFG S+IL +T     +  GT  Y++PE +   +   
Sbjct: 136 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPE-VLVSVGTA 193
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGR-QGDWASLMFAICFAQPPEAPEMASREFRD 331
            Y+  A D WSLGV +     G  PF+  R Q      + +  +   PE     S +  D
Sbjct: 194 GYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALD 252
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNL 368
            + + L  DP +R+   + L+HP++      +  Q+L
Sbjct: 253 LVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 289

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 136/289 (47%), Gaps = 30/289 (10%)
Query: 107 IGSGSGGTVW---RVVHPPTSRVFALKV-----IYGNHEDSVRSQICREIEILRDVNHPN 158
           +G G  G V+   +V    T ++FA+KV     I  N +D+  ++  R I  L +V HP 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI--LEEVKHPF 82
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLA----RQVLSGLAYLHKRKI 214
           +V     +   G++ ++LEY+ GG L     R+   + D A     ++   L +LH++ I
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           ++RD+KP N+++N   +VK+ DFG+ +         +   GTI YM+PE I     H + 
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPE-ILMRSGHNR- 200
Query: 275 DGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS 334
              A D WSLG  + +   G  PF    +      +       PP      ++E RD + 
Sbjct: 201 ---AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQEARDLLK 253
Query: 335 RCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRPL 378
           + L+++  SR       A ++  HPF       ++    R++ PP +PL
Sbjct: 254 KLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLA--RKVEPPFKPL 300

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 130/268 (48%), Gaps = 20/268 (7%)
Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ--ICREIEILRDVNHPNV 159
           Q+  ++GSG+ G V       T    A+K+I  +   +  +   +  E+ +L+ ++HPN+
Sbjct: 24  QRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNI 83
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHILSDLA---RQVLSGLAYLHKRKIV 215
           +K ++ ++      +++E   GG L +   +RQ+    D A   +QVLSG  YLHK  IV
Sbjct: 84  MKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIV 143
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL+ S      +KI DFG+S    +        +GT  Y++PE +       
Sbjct: 144 HRDLKPENLLLESKSRDALIKIVDFGLSAHF-EVGGKMKERLGTAYYIAPEVLRK----- 197
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASL--MFAICFAQPPEAPEMASREFR 330
           KYD    D+WS GV +     G  PF  G Q D   L  +    F+  P      S E +
Sbjct: 198 KYDEKC-DVWSCGVILYILLCGYPPF--GGQTDQEILKRVEKGKFSFDPPDWTQVSDEAK 254
Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFILR 358
             +   L  +P  R  A + L HP+I++
Sbjct: 255 QLVKLMLTYEPSKRISAEEALNHPWIVK 282

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 67/197 (34%), Positives = 104/197 (52%), Gaps = 10/197 (5%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVKCHDM 165
           IG G+   V    H  T +  A+K+I     +S   Q + RE+ I++ +NHPN+VK  ++
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 166 YDRNGEIEVLLEYMDGGSLEG---AHIR-QEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            +    + +++EY  GG +     AH R +E       RQ++S + Y H++ IVHRD+K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKA 141
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDI 281
            NLL+++  N+KIADFG S       +  ++  G+  Y +PE         KYDG   D+
Sbjct: 142 ENLLLDADMNIKIADFGFSNEFTFG-NKLDTFCGSPPYAAPELFQGK----KYDGPEVDV 196
Query: 282 WSLGVSILEFYLGRFPF 298
           WSLGV +     G  PF
Sbjct: 197 WSLGVILYTLVSGSLPF 213

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 78/260 (30%), Positives = 125/260 (48%), Gaps = 21/260 (8%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCHDM 165
           +GSG+   V+ V    T ++FALK I      + R S +  EI +L+ + H N+V   D+
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCI--KKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 166 YDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDI 219
           Y+      ++++ + GG L       G +  ++  L  + +QVLS + YLH+  IVHRD+
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL--VIQQVLSAVKYLHENGIVHRDL 132
Query: 220 KPSNLLI---NSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           KP NLL      +  + I DFG+S++    +   ++A GT  Y++PE     L    Y  
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAPEV----LAQKPYSK 186
Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
            A D WS+GV       G  PF    +      +    +       +  S   +DFI   
Sbjct: 187 -AVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHL 245
Query: 337 LQKDPHSRWPAAQLLQHPFI 356
           L+KDP+ R+   + L HP+I
Sbjct: 246 LEKDPNERYTCEKALSHPWI 265

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 105/203 (51%), Gaps = 12/203 (5%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNV 159
           LQK   IG G+   V    H  T R  A+K+I     +    Q + RE+ I++ +NHPN+
Sbjct: 19  LQK--TIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEG---AHIR-QEHILSDLARQVLSGLAYLHKRKIV 215
           VK  ++ +    + +++EY  GG +     AH R +E       RQ++S + Y H++ IV
Sbjct: 77  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIV 136
Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           HRD+K  NLL++   N+KIADFG S       +  ++  G+  Y +PE         KYD
Sbjct: 137 HRDLKAENLLLDGDMNIKIADFGFSNEFT-VGNKLDTFCGSPPYAAPELFQGK----KYD 191
Query: 276 GYAGDIWSLGVSILEFYLGRFPF 298
           G   D+WSLGV +     G  PF
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPF 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 67/197 (34%), Positives = 104/197 (52%), Gaps = 10/197 (5%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVKCHDM 165
           IG G+   V    H  T +  A+K+I     +S   Q + RE+ I++ +NHPN+VK  ++
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 166 YDRNGEIEVLLEYMDGGSLEG---AHIR-QEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            +    + +++EY  GG +     AH R +E       RQ++S + Y H++ IVHRD+K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKA 141
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDI 281
            NLL+++  N+KIADFG S       +  ++  G+  Y +PE         KYDG   D+
Sbjct: 142 ENLLLDADMNIKIADFGFSNEFTFG-NKLDTFCGSPPYAAPELFQGK----KYDGPEVDV 196
Query: 282 WSLGVSILEFYLGRFPF 298
           WSLGV +     G  PF
Sbjct: 197 WSLGVILYTLVSGSLPF 213

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 133/278 (47%), Gaps = 24/278 (8%)
Query: 103 KGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVK 161
           K   +G GS     + VH  +++ FA+K+I    E + +    +EI  L+    HPN+VK
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ----KEITALKLCEGHPNIVK 70
Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI----LSDLARQVLSGLAYLHKRKIVHR 217
            H+++       +++E ++GG L     +++H      S + R+++S ++++H   +VHR
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 218 DIKPSNLLI---NSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           D+KP NLL    N +  +KI DFG +R+      P  +   T+ Y +PE     LN   Y
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL----LNQNGY 186
Query: 275 DGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC-------FAQPPEAPEMASR 327
           D  + D+WSLGV +     G+ PF    +    +    I        F+   EA +  S+
Sbjct: 187 DE-SCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 245
Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN 365
           E +D I   L  DP+ R   + L  + ++    Q   N
Sbjct: 246 EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSN 283

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 130/268 (48%), Gaps = 20/268 (7%)
Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ--ICREIEILRDVNHPNV 159
           Q+  ++GSG+ G V       T    A+K+I  +   +  +   +  E+ +L+ ++HPN+
Sbjct: 7   QRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNI 66
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHILSDLA---RQVLSGLAYLHKRKIV 215
           +K ++ ++      +++E   GG L +   +RQ+    D A   +QVLSG  YLHK  IV
Sbjct: 67  MKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIV 126
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL+ S      +KI DFG+S    +        +GT  Y++PE +       
Sbjct: 127 HRDLKPENLLLESKSRDALIKIVDFGLSAHF-EVGGKMKERLGTAYYIAPEVLRK----- 180
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASL--MFAICFAQPPEAPEMASREFR 330
           KYD    D+WS GV +     G  PF  G Q D   L  +    F+  P      S E +
Sbjct: 181 KYDEKC-DVWSCGVILYILLCGYPPF--GGQTDQEILKRVEKGKFSFDPPDWTQVSDEAK 237
Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFILR 358
             +   L  +P  R  A + L HP+I++
Sbjct: 238 QLVKLMLTYEPSKRISAEEALNHPWIVK 265

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 67/197 (34%), Positives = 103/197 (52%), Gaps = 10/197 (5%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVKCHDM 165
           IG G+   V    H  T +  A+K+I     +S   Q + RE+ I++ +NHPN+VK  ++
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 166 YDRNGEIEVLLEYMDGGSLEG---AHIR-QEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            +    + +++EY  GG +     AH R +E       RQ++S + Y H++ IVHRD+K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKA 141
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDI 281
            NLL+++  N+KIADFG S       +  ++  G   Y +PE         KYDG   D+
Sbjct: 142 ENLLLDADMNIKIADFGFSNEFTFG-NKLDAFCGAPPYAAPELFQGK----KYDGPEVDV 196
Query: 282 WSLGVSILEFYLGRFPF 298
           WSLGV +     G  PF
Sbjct: 197 WSLGVILYTLVSGSLPF 213

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 128/292 (43%), Gaps = 47/292 (16%)
Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNVV 160
           +K  +IG G+ GTV++  +  T  + ALK +  + +D  V S   REI +L+++ H N+V
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 161 KCHDMYDRNGEIEVLLEYMD----------GGSLEGAHIRQEHILSDLARQVLSGLAYLH 210
           + HD+   + ++ ++ E+ D           G L+        I+     Q+L GL + H
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD------PEIVKSFLFQLLKGLGFCH 118
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
            R ++HRD+KP NLLIN +  +K+ADFG++R     +   ++ V T+ Y  P+     L 
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDV----LF 174
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD-----------------WASLMFAI 313
             K    + D+WS G    E      P   G   D                 W S+    
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 314 CFAQPPEAPEMAS---------REFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +   P  P   S            RD +   L+ +P  R  A + LQHP+ 
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 135/270 (50%), Gaps = 26/270 (9%)
Query: 107 IGSGSGGTVW---RVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNH-PNV 159
           +G+G+ G V+   ++    T +++A+KV+       +         E ++L  +   P +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKRKI 214
           V  H  +    ++ ++L+Y++GG L   H+ Q     EH +     +++  L +LHK  I
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGEL-FTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 180
Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAVGTIAYMSPERI-NTDLNHG 272
           ++RDIK  N+L++S+ +V + DFG+S+  +A   +      GTI YM+P+ +   D  H 
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHD 240
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAV-GRQGDWASLMFAICFAQPPEAPEMASREFRD 331
           K    A D WSLGV + E   G  PF V G +   A +   I  ++PP   EM++   +D
Sbjct: 241 K----AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA-KD 295
Query: 332 FISRCLQKDPHSRW-----PAAQLLQHPFI 356
            I R L KDP  R       A ++ +H F 
Sbjct: 296 LIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 107/210 (50%), Gaps = 15/210 (7%)
Query: 99  AELQKGN-----RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILR 152
           A+L  GN      IG G+   V    H  T +  A+K+I     +S   Q + RE+ I++
Sbjct: 2   ADLHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMK 61
Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAY 208
            +NHPN+VK  ++ +    + +++EY  GG +    +    +    AR    Q++S + Y
Sbjct: 62  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQY 121
Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
            H++ IVHRD+K  NLL+++  N+KIADFG S       +  ++  G+  Y +PE     
Sbjct: 122 CHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDTFCGSPPYAAPELFQGK 180
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPF 298
               KYDG   D+WSLGV +     G  PF
Sbjct: 181 ----KYDGPEVDVWSLGVILYTLVSGSLPF 206

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNVVKCHD 164
           +IG G+ G V++         FALK I    ED  + S   REI IL+++ H N+VK +D
Sbjct: 9   KIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIK 220
           +      + ++ E++D    +   + +  + S  A+    Q+L+G+AY H R+++HRD+K
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
           P NLLIN    +KIADFG++R     +      V T+ Y +P+ +   +   KY     D
Sbjct: 128 PQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL---MGSKKYSTTI-D 183
Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI-----------CFAQPPEAPEMASRE- 328
           IWS+G    E   G   F    + D    +F I               P   P     E 
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 329 -----FR--------DFISRCLQKDPHSRWPAAQLLQHPFI 356
                F         D +S+ L+ DP+ R  A Q L+H + 
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 131/286 (45%), Gaps = 36/286 (12%)
Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNVV 160
           QK  ++G G+ G V++       R+ ALK I  + ED  + S   REI +L++++HPN+V
Sbjct: 24  QKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVH 216
              D+      + ++ E+M+        E     Q+  +     Q+L G+A+ H+ +I+H
Sbjct: 83  SLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILH 142
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KP NLLINS   +K+ADFG++R     +      V T+ Y +P+ +   +   KY  
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL---MGSKKYST 199
Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC-------FAQPPEAPEMASREF 329
            + DIWS+G    E   G+  F      D    +F+I        + Q  E P    R F
Sbjct: 200 -SVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258
Query: 330 R-------------------DFISRCLQKDPHSRWPAAQLLQHPFI 356
           +                   D +S  L  DP+ R  A   + HP+ 
Sbjct: 259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 131/286 (45%), Gaps = 36/286 (12%)
Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNVV 160
           QK  ++G G+ G V++       R+ ALK I  + ED  + S   REI +L++++HPN+V
Sbjct: 24  QKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVH 216
              D+      + ++ E+M+        E     Q+  +     Q+L G+A+ H+ +I+H
Sbjct: 83  SLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILH 142
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KP NLLINS   +K+ADFG++R     +      V T+ Y +P+ +   +   KY  
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL---MGSKKYST 199
Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC-------FAQPPEAPEMASREF 329
            + DIWS+G    E   G+  F      D    +F+I        + Q  E P    R F
Sbjct: 200 -SVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258
Query: 330 R-------------------DFISRCLQKDPHSRWPAAQLLQHPFI 356
           +                   D +S  L  DP+ R  A   + HP+ 
Sbjct: 259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 66/197 (33%), Positives = 104/197 (52%), Gaps = 10/197 (5%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVKCHDM 165
           IG G+   V    H  T +  A+++I     +S   Q + RE+ I++ +NHPN+VK  ++
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 166 YDRNGEIEVLLEYMDGGSLEG---AHIR-QEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            +    + +++EY  GG +     AH R +E       RQ++S + Y H++ IVHRD+K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKA 141
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDI 281
            NLL+++  N+KIADFG S       +  ++  G+  Y +PE         KYDG   D+
Sbjct: 142 ENLLLDADMNIKIADFGFSNEFTFG-NKLDTFCGSPPYAAPELFQGK----KYDGPEVDV 196
Query: 282 WSLGVSILEFYLGRFPF 298
           WSLGV +     G  PF
Sbjct: 197 WSLGVILYTLVSGSLPF 213

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNVVKCHD 164
           +IG G+ G V++         FALK I    ED  + S   REI IL+++ H N+VK +D
Sbjct: 9   KIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIK 220
           +      + ++ E++D    +   + +  + S  A+    Q+L+G+AY H R+++HRD+K
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
           P NLLIN    +KIADFG++R     +      V T+ Y +P+ +   +   KY     D
Sbjct: 128 PQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL---MGSKKYSTTI-D 183
Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI-----------CFAQPPEAPEMASRE- 328
           IWS+G    E   G   F    + D    +F I               P   P     E 
Sbjct: 184 IWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 329 -----FR--------DFISRCLQKDPHSRWPAAQLLQHPFI 356
                F         D +S+ L+ DP+ R  A Q L+H + 
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 133/277 (48%), Gaps = 19/277 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIY-------GNHEDSVRSQICREIEILRDVNHPNV 159
           +GSG+ G V       T +  A+++I           E      +  EIEIL+ +NHP +
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           +K  + +D   +  ++LE M+GG L     G    +E        Q+L  + YLH+  I+
Sbjct: 217 IKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 275
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP N+L++S +    +KI DFG S+IL +T     +  GT  Y++PE +   +   
Sbjct: 276 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPE-VLVSVGTA 333
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGR-QGDWASLMFAICFAQPPEAPEMASREFRD 331
            Y+  A D WSLGV +     G  PF+  R Q      + +  +   PE     S +  D
Sbjct: 334 GYNR-AVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALD 392
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNL 368
            + + L  DP +R+   + L+HP++      +  Q+L
Sbjct: 393 LVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 429

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 133/277 (48%), Gaps = 19/277 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIY-------GNHEDSVRSQICREIEILRDVNHPNV 159
           +GSG+ G V       T +  A+++I           E      +  EIEIL+ +NHP +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           +K  + +D   +  ++LE M+GG L     G    +E        Q+L  + YLH+  I+
Sbjct: 203 IKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 261
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP N+L++S +    +KI DFG S+IL +T     +  GT  Y++PE +   +   
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPE-VLVSVGTA 319
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGR-QGDWASLMFAICFAQPPEAPEMASREFRD 331
            Y+  A D WSLGV +     G  PF+  R Q      + +  +   PE     S +  D
Sbjct: 320 GYNR-AVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALD 378
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNL 368
            + + L  DP +R+   + L+HP++      +  Q+L
Sbjct: 379 LVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 415

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNVVKCHD 164
           +IG G+ G V++         FALK I    ED  + S   REI IL+++ H N+VK +D
Sbjct: 9   KIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIK 220
           +      + ++ E++D    +   + +  + S  A+    Q+L+G+AY H R+++HRD+K
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127
Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
           P NLLIN    +KIADFG++R     +      + T+ Y +P+ +   +   KY     D
Sbjct: 128 PQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL---MGSKKYSTTI-D 183
Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI-----------CFAQPPEAPEMASRE- 328
           IWS+G    E   G   F    + D    +F I               P   P     E 
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243
Query: 329 -----FR--------DFISRCLQKDPHSRWPAAQLLQHPFI 356
                F         D +S+ L+ DP+ R  A Q L+H + 
Sbjct: 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 66/197 (33%), Positives = 103/197 (52%), Gaps = 10/197 (5%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVKCHDM 165
           IG G+   V    H  T +  A+++I     +S   Q + RE+ I++ +NHPN+VK  ++
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 166 YDRNGEIEVLLEYMDGGSLEG---AHIR-QEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            +    + +++EY  GG +     AH R +E       RQ++S + Y H++ IVHRD+K 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKA 141
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDI 281
            NLL+++  N+KIADFG S       +  +   G+  Y +PE         KYDG   D+
Sbjct: 142 ENLLLDADMNIKIADFGFSNEFTFG-NKLDEFCGSPPYAAPELFQGK----KYDGPEVDV 196
Query: 282 WSLGVSILEFYLGRFPF 298
           WSLGV +     G  PF
Sbjct: 197 WSLGVILYTLVSGSLPF 213

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 128/268 (47%), Gaps = 15/268 (5%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS--QICREIEILRDVNHP 157
           E Q    +G G+   V R +  PT + +A K+I    + S R   ++ RE  I R + HP
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKII-NTKKLSARDHQKLEREARICRLLKHP 63
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI----LSDLARQVLSGLAYLHKRK 213
           N+V+ HD     G   ++ + + GG L    + +E+      S   +Q+L  + + H   
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 214 IVHRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
           IVHRD+KP NLL+ S      VK+ADFG++  +           GT  Y+SPE +  D  
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKD-P 182
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
           +GK      D+W+ GV +    +G  PF    Q      + A  +  P    +  + E +
Sbjct: 183 YGK----PVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFILR 358
           D I++ L  +P  R  A++ L+HP+I +
Sbjct: 239 DLINKMLTINPAKRITASEALKHPWICQ 266

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 131/286 (45%), Gaps = 27/286 (9%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR------------SQICREIEILRD 153
           ++GSG+ G V            A+KVI  +  D  R             +I  EI +L+ 
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLE----GAHIRQEHILSDLARQVLSGLAYL 209
           ++HPN++K  D+++      ++ E+ +GG L       H   E   +++ +Q+LSG+ YL
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYL 162
Query: 210 HKRKIVHRDIKPSNLLI---NSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN 266
           HK  IVHRDIKP N+L+   NS  N+KI DFG+S   ++        +GT  Y++PE + 
Sbjct: 163 HKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLK 221
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS 326
              N         D+WS GV +     G  PF      D    +    +       +  S
Sbjct: 222 KKYNE------KCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNIS 275
Query: 327 REFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQIL 372
            E ++ I   L  D + R  A + L   +I +   + +N++ ++ L
Sbjct: 276 DEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA-NNINKSDQKTL 320

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 142/286 (49%), Gaps = 18/286 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI--YGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
           IG G+ G V  V H  + +V+A+K++  +   + S  +    E +I+   N P VV+   
Sbjct: 83  IGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 142
Query: 165 MYDRNGEIEVLLEYMDGG---SLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            +  +  + +++EYM GG   +L   +   E        +V+  L  +H   ++HRD+KP
Sbjct: 143 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKP 202
Query: 222 SNLLINSSKNVKIADFGVSRILAQT-MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
            N+L++   ++K+ADFG    + +T M  C++AVGT  Y+SPE + +    G Y G   D
Sbjct: 203 DNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYY-GRECD 261
Query: 281 IWSLGVSILEFYLGRFPF-AVGRQGDWASLM---FAICFAQPPEAPEMASREFRDFISRC 336
            WS+GV + E  +G  PF A    G ++ +M    ++CF +  E  + A      F++  
Sbjct: 262 WWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTD- 320
Query: 337 LQKDPHSRWPAAQLLQHPFILRAGQSQVN-QNLRQILPPPRP-LSS 380
            ++    R    ++ QHPF       Q N  N+R+   P  P LSS
Sbjct: 321 -REVRLGRNGVEEIKQHPFF---KNDQWNWDNIRETAAPVVPELSS 362

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 127/262 (48%), Gaps = 21/262 (8%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS-----QICREIEILRDVNHPN 158
           G+ +G G+ G V    H  T    A+K++   +   +RS     +I REI+ L+   HP+
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKIL---NRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHILSD-LARQVLSGLAYLHKRKI 214
           ++K + +     +  +++EY+ GG L      H R E + +  L +Q+LS + Y H+  +
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           VHRD+KP N+L+++  N KIADFG+S +++   +   ++ G+  Y +PE I+  L    Y
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRL----Y 187
Query: 275 DGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS 334
            G   DIWS GV +     G  PF      +    +F          PE  +R     + 
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPF----DDEHVPTLFKKIRGGVFYIPEYLNRSVATLLM 243
Query: 335 RCLQKDPHSRWPAAQLLQHPFI 356
             LQ DP  R     + +H + 
Sbjct: 244 HMLQVDPLKRATIKDIREHEWF 265

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 128/268 (47%), Gaps = 15/268 (5%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS--QICREIEILRDVNHP 157
           E Q    +G G+   V R +  PT + +A K+I    + S R   ++ RE  I R + HP
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKII-NTKKLSARDHQKLEREARICRLLKHP 63
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI----LSDLARQVLSGLAYLHKRK 213
           N+V+ HD     G   ++ + + GG L    + +E+      S   +Q+L  + + H   
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 214 IVHRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
           IVHRD+KP NLL+ S      VK+ADFG++  +           GT  Y+SPE +  D  
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKD-P 182
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
           +GK      D+W+ GV +    +G  PF    Q      + A  +  P    +  + E +
Sbjct: 183 YGK----PVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFILR 358
           D I++ L  +P  R  A++ L+HP+I +
Sbjct: 239 DLINKMLTINPAKRITASEALKHPWICQ 266

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 121/265 (45%), Gaps = 21/265 (7%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI----YGNHEDSVRSQICREIEILRDVNHPNVVKC 162
           IG G    V R ++  T + FA+K++    + +        + RE  I   + HP++V+ 
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 163 HDMYDRNGEIEVLLEYMDGGSL--------EGAHIRQEHILSDLARQVLSGLAYLHKRKI 214
            + Y  +G + ++ E+MDG  L        +   +  E + S   RQ+L  L Y H   I
Sbjct: 94  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI 153
Query: 215 VHRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
           +HRD+KP  +L+ S +N   VK+  FGV+  L ++       VGT  +M+PE +  +  +
Sbjct: 154 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PY 212
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
           GK      D+W  GV +     G  PF   ++  +  ++    +   P      S   +D
Sbjct: 213 GK----PVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGK-YKMNPRQWSHISESAKD 267
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFI 356
            + R L  DP  R    + L HP++
Sbjct: 268 LVRRMLMLDPAERITVYEALNHPWL 292

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 130/283 (45%), Gaps = 23/283 (8%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHPNVVK 161
           G+ +G G+ G V    H  T    A+K++      S  V  +I REI+ L+   HP+++K
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKIVHR 217
            + +     +I +++EY+ GG L     +     E     L +Q+LSG+ Y H+  +VHR
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHR 140
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           D+KP N+L+++  N KIADFG+S +++   +    + G+  Y +PE I+  L    Y G 
Sbjct: 141 DLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRXSCGSPNYAAPEVISGRL----YAGP 195
Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL 337
             DIWS GV +     G  PF      D    +F          P+  +      +   L
Sbjct: 196 EVDIWSSGVILYALLCGTLPF----DDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHML 251
Query: 338 QKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPLSS 380
           Q DP  R     + +H +          Q+L + L P  P  S
Sbjct: 252 QVDPMKRATIKDIREHEWF--------KQDLPKYLFPEDPSYS 286

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 128/292 (43%), Gaps = 47/292 (16%)
Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNVV 160
           +K  +IG G+ GTV++  +  T  + ALK +  + +D  V S   REI +L+++ H N+V
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 161 KCHDMYDRNGEIEVLLEYMD----------GGSLEGAHIRQEHILSDLARQVLSGLAYLH 210
           + HD+   + ++ ++ E+ D           G L+        I+     Q+L GL + H
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD------PEIVKSFLFQLLKGLGFCH 118
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
            R ++HRD+KP NLLIN +  +K+A+FG++R     +   ++ V T+ Y  P+     L 
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV----LF 174
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD-----------------WASLMFAI 313
             K    + D+WS G    E      P   G   D                 W S+    
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 314 CFAQPPEAPEMAS---------REFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +   P  P   S            RD +   L+ +P  R  A + LQHP+ 
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 126/262 (48%), Gaps = 21/262 (8%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS-----QICREIEILRDVNHPN 158
           G+ +G G+ G V    H  T    A+K++   +   +RS     +I REI+ L+   HP+
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKIL---NRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHILSD-LARQVLSGLAYLHKRKI 214
           ++K + +     +  +++EY+ GG L      H R E + +  L +Q+LS + Y H+  +
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           VHRD+KP N+L+++  N KIADFG+S +++   +    + G+  Y +PE I+  L    Y
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRDSCGSPNYAAPEVISGRL----Y 187
Query: 275 DGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS 334
            G   DIWS GV +     G  PF      +    +F          PE  +R     + 
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPF----DDEHVPTLFKKIRGGVFYIPEYLNRSVATLLM 243
Query: 335 RCLQKDPHSRWPAAQLLQHPFI 356
             LQ DP  R     + +H + 
Sbjct: 244 HMLQVDPLKRATIKDIREHEWF 265

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 134/285 (47%), Gaps = 41/285 (14%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV 154
           +  P++L  G  +G G  G   +V H  T  V  +K +    E++ R+ + +E++++R +
Sbjct: 6   IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFL-KEVKVMRCL 64
Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG--AHIRQEHILS---DLARQVLSGLAYL 209
            HPNV+K   +  ++  +  + EY+ GG+L G    +  ++  S     A+ + SG+AYL
Sbjct: 65  EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA-QTMDPCN-------------SAVG 255
           H   I+HRD+   N L+  +KNV +ADFG++R++  +   P               + VG
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 256 TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRF---PFAVGRQGDWA----S 308
              +M+PE IN     G+      D++S G+ + E  +GR    P  + R  D+      
Sbjct: 185 NPYWMAPEMIN-----GRSYDEKVDVFSFGIVLCEI-IGRVNADPDYLPRTMDFGLNVRG 238
Query: 309 LMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
            +   C   PP  P      F     RC   DP  R P+   L+H
Sbjct: 239 FLDRYC---PPNCPP----SFFPITVRCCDLDPEKR-PSFVKLEH 275

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 121/265 (45%), Gaps = 21/265 (7%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI----YGNHEDSVRSQICREIEILRDVNHPNVVKC 162
           IG G    V R ++  T + FA+K++    + +        + RE  I   + HP++V+ 
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 163 HDMYDRNGEIEVLLEYMDGGSL--------EGAHIRQEHILSDLARQVLSGLAYLHKRKI 214
            + Y  +G + ++ E+MDG  L        +   +  E + S   RQ+L  L Y H   I
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI 151
Query: 215 VHRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
           +HRD+KP  +L+ S +N   VK+  FGV+  L ++       VGT  +M+PE +  +  +
Sbjct: 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PY 210
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
           GK      D+W  GV +     G  PF   ++  +  ++    +   P      S   +D
Sbjct: 211 GK----PVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGK-YKMNPRQWSHISESAKD 265
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFI 356
            + R L  DP  R    + L HP++
Sbjct: 266 LVRRMLMLDPAERITVYEALNHPWL 290

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 67/197 (34%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVKCHDM 165
           IG G+   V    H  T +  A+K+I     +S   Q + RE+ I + +NHPN+VK  ++
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 166 YDRNGEIEVLLEYMDGGSLEG---AHIR-QEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            +    + ++ EY  GG +     AH R +E       RQ++S + Y H++ IVHRD+K 
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLKA 141
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDI 281
            NLL+++  N+KIADFG S       +  ++  G   Y +PE         KYDG   D+
Sbjct: 142 ENLLLDADXNIKIADFGFSNEFT-FGNKLDAFCGAPPYAAPELFQGK----KYDGPEVDV 196
Query: 282 WSLGVSILEFYLGRFPF 298
           WSLGV +     G  PF
Sbjct: 197 WSLGVILYTLVSGSLPF 213

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 143/283 (50%), Gaps = 29/283 (10%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIY---GNHEDSVRSQICREIEILRDVNHPNVVK 161
           +++G G   TV+       +   A+K I+      E++++ +  RE+     ++H N+V 
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLK-RFEREVHNSSQLSHQNIVS 75
Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYLHKRKIVH 216
             D+ + +    +++EY++G +L   +I     LS     +   Q+L G+ + H  +IVH
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVH 134
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQT-MDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           RDIKP N+LI+S+K +KI DFG+++ L++T +   N  +GT+ Y SPE+       G+  
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK-----GEAT 189
Query: 276 GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF--- 332
               DI+S+G+ + E  +G  PF     G+ A +  AI   Q    P + +   +D    
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPF----NGETA-VSIAIKHIQDS-VPNVTTDVRKDIPQS 243
Query: 333 ----ISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQI 371
               I R  +KD  +R+   Q ++        +++ N+++ ++
Sbjct: 244 LSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYEL 286

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 139/292 (47%), Gaps = 27/292 (9%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNH 156
           E +    +G G+ G V  V    T R +A+K++       +D V +    E  +L++  H
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEV-AHTLTENRVLQNSRH 207
Query: 157 PNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHK 211
           P +      +  +  +  ++EY +GG L   H+ +E + S D AR    +++S L YLH 
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAEIVSALDYLHS 266
Query: 212 RK-IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
            K +V+RD+K  NL+++   ++KI DFG+ +   +      +  GT  Y++PE +  D +
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE-DND 325
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
           +G+    A D W LGV + E   GR PF      D   L F +   +    P     E +
Sbjct: 326 YGR----AVDWWGLGVVMYEMMCGRLPFY---NQDHEKL-FELILMEEIRFPRTLGPEAK 377
Query: 331 DFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
             +S  L+KDP  R       A +++QH F   AG    +   +++ PP +P
Sbjct: 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF--AGIVWQHVYEKKLSPPFKP 427

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 139/292 (47%), Gaps = 27/292 (9%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNH 156
           E +    +G G+ G V  V    T R +A+K++       +D V +    E  +L++  H
Sbjct: 152 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEV-AHTLTENRVLQNSRH 210
Query: 157 PNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHK 211
           P +      +  +  +  ++EY +GG L   H+ +E + S D AR    +++S L YLH 
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAEIVSALDYLHS 269
Query: 212 RK-IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
            K +V+RD+K  NL+++   ++KI DFG+ +   +      +  GT  Y++PE +  D +
Sbjct: 270 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE-DND 328
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
           +G+    A D W LGV + E   GR PF      D   L F +   +    P     E +
Sbjct: 329 YGR----AVDWWGLGVVMYEMMCGRLPFY---NQDHEKL-FELILMEEIRFPRTLGPEAK 380
Query: 331 DFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
             +S  L+KDP  R       A +++QH F   AG    +   +++ PP +P
Sbjct: 381 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF--AGIVWQHVYEKKLSPPFKP 430

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 139/296 (46%), Gaps = 27/296 (9%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILR 152
           +   E +    +G G+ G V  V    T R +A+K++       +D V +    E  +L+
Sbjct: 6   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEV-AHTLTENRVLQ 64
Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLA 207
           +  HP +      +  +  +  ++EY +GG L   H+ +E + S D AR    +++S L 
Sbjct: 65  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAEIVSALD 123
Query: 208 YLHKRK-IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN 266
           YLH  K +V+RD+K  NL+++   ++KI DFG+ +   +         GT  Y++PE + 
Sbjct: 124 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLE 183
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS 326
            D ++G+    A D W LGV + E   GR PF      D   L F +   +    P    
Sbjct: 184 -DNDYGR----AVDWWGLGVVMYEMMCGRLPFY---NQDHEKL-FELILMEEIRFPRTLG 234
Query: 327 REFRDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
            E +  +S  L+KDP  R       A +++QH F   AG    +   +++ PP +P
Sbjct: 235 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF--AGIVWQHVYEKKLSPPFKP 288

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 124/262 (47%), Gaps = 20/262 (7%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS--QICREIEILRDVNHPNVVKCH 163
            +G G+   V R VH  T   FA K+I    + S R   ++ RE  I R + HPN+V+ H
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 164 DMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHILSDLA---RQVLSGLAYLHKRKIVHRDI 219
           D         ++ + + GG L E    R+ +  +D +   +Q+L  +AY H   IVHR++
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNL 154
Query: 220 KPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           KP NLL+ S      VK+ADFG++ I     +  +   GT  Y+SPE +       K D 
Sbjct: 155 KPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSPEVL-------KKDP 206
Query: 277 YAG--DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS 334
           Y+   DIW+ GV +    +G  PF    Q    + + A  +  P    +  + E +  I 
Sbjct: 207 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 266
Query: 335 RCLQKDPHSRWPAAQLLQHPFI 356
             L  +P  R  A Q L+ P+I
Sbjct: 267 SMLTVNPKKRITADQALKVPWI 288

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 139/296 (46%), Gaps = 27/296 (9%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILR 152
           +   E +    +G G+ G V  V    T R +A+K++       +D V +    E  +L+
Sbjct: 5   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEV-AHTLTENRVLQ 63
Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLA 207
           +  HP +      +  +  +  ++EY +GG L   H+ +E + S D AR    +++S L 
Sbjct: 64  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAEIVSALD 122
Query: 208 YLHKRK-IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN 266
           YLH  K +V+RD+K  NL+++   ++KI DFG+ +   +         GT  Y++PE + 
Sbjct: 123 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLE 182
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS 326
            D ++G+    A D W LGV + E   GR PF      D   L F +   +    P    
Sbjct: 183 -DNDYGR----AVDWWGLGVVMYEMMCGRLPFY---NQDHEKL-FELILMEEIRFPRTLG 233
Query: 327 REFRDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
            E +  +S  L+KDP  R       A +++QH F   AG    +   +++ PP +P
Sbjct: 234 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF--AGIVWQHVYEKKLSPPFKP 287

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 138/292 (47%), Gaps = 27/292 (9%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNH 156
           E +    +G G+ G V  V    T R +A+K++       +D V +    E  +L++  H
Sbjct: 11  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEV-AHTLTENRVLQNSRH 69
Query: 157 PNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHK 211
           P +      +  +  +  ++EY +GG L   H+ +E + S D AR    +++S L YLH 
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAEIVSALDYLHS 128
Query: 212 RK-IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
            K +V+RD+K  NL+++   ++KI DFG+ +   +         GT  Y++PE +  D +
Sbjct: 129 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLE-DND 187
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
           +G+    A D W LGV + E   GR PF      D   L F +   +    P     E +
Sbjct: 188 YGR----AVDWWGLGVVMYEMMCGRLPFY---NQDHEKL-FELILMEEIRFPRTLGPEAK 239
Query: 331 DFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
             +S  L+KDP  R       A +++QH F   AG    +   +++ PP +P
Sbjct: 240 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF--AGIVWQHVYEKKLSPPFKP 289

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/317 (26%), Positives = 141/317 (44%), Gaps = 65/317 (20%)
Query: 100 ELQKG----NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIEIL 151
           ELQK       IG GS G V   +   T  + A+K++  N    +      +I  E+ ++
Sbjct: 23  ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLM 82
Query: 152 RDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL--------------------------- 184
           + ++HPN+ + +++Y+    I +++E   GG L                           
Sbjct: 83  KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 185 ----EGA-------------HIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN 227
               E A              +++E ++S++ RQ+ S L YLH + I HRDIKP N L +
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS 202
Query: 228 SSKN--VKIADFGVSRILAQTMD----PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDI 281
           ++K+  +K+ DFG+S+   +  +       +  GT  +++PE +NT     +  G   D 
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT---NESYGPKCDA 259
Query: 282 WSLGVSILEFYLGRFPFAVGRQGDWASLMF--AICFAQPPEAPEMASREFRDFISRCLQK 339
           WS GV +    +G  PF      D  S +    +CF  P     + S   RD +S  L +
Sbjct: 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNY--NVLSPLARDLLSNLLNR 317
Query: 340 DPHSRWPAAQLLQHPFI 356
           +   R+ A + LQHP+I
Sbjct: 318 NVDERFDAMRALQHPWI 334

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 125/264 (47%), Gaps = 15/264 (5%)
Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS--QICREIEILRDVNHPNV 159
           Q    +G G+   V R V     + +A K+I    + S R   ++ RE  I R + HPN+
Sbjct: 25  QLFEELGKGAFSVVRRCVKVLAGQEYAAKII-NTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI----LSDLARQVLSGLAYLHKRKIV 215
           V+ HD     G   ++ + + GG L    + +E+      S   +Q+L  + + H+  +V
Sbjct: 84  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVV 143
Query: 216 HRDIKPSNLLINSS---KNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL+ S      VK+ADFG++  +           GT  Y+SPE +  D  +G
Sbjct: 144 HRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYG 202
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
           K      D+W+ GV +    +G  PF    Q      + A  +  P    +  + E +D 
Sbjct: 203 K----PVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 258
Query: 333 ISRCLQKDPHSRWPAAQLLQHPFI 356
           I++ L  +P  R  AA+ L+HP+I
Sbjct: 259 INKMLTINPSKRITAAEALKHPWI 282

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 124/261 (47%), Gaps = 17/261 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG+G+ G    +     + + A+K  Y    + +   + REI   R + HPN+V+  ++ 
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVK--YIERGEKIDENVKREIINHRSLRHPNIVRFKEVI 84
Query: 167 DRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIKPS 222
                + +++EY  GG L            D AR    Q++SG++Y H  ++ HRD+K  
Sbjct: 85  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDLKLE 144
Query: 223 NLLINSS--KNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
           N L++ S    +KIADFG S+       P  SAVGT AY++PE     L   +YDG   D
Sbjct: 145 NTLLDGSPAPRLKIADFGYSKASVLHSQP-KSAVGTPAYIAPEV----LLKKEYDGKVAD 199
Query: 281 IWSLGVSILEFYLGRFPFAVGRQ-GDWASLMFAICFAQPPEAPEMA--SREFRDFISRCL 337
           +WS GV++    +G +PF    +  ++   +  I   Q    P+    S E R  ISR  
Sbjct: 200 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYA-IPDYVHISPECRHLISRIF 258
Query: 338 QKDPHSRWPAAQLLQHPFILR 358
             DP  R    ++  H + L+
Sbjct: 259 VADPAKRISIPEIRNHEWFLK 279

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 124/263 (47%), Gaps = 20/263 (7%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS--QICREIEILRDVNHPNVVKC 162
             +G G+   V R VH  T   FA K+I    + S R   ++ RE  I R + HPN+V+ 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 163 HDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHILSDLA---RQVLSGLAYLHKRKIVHRD 218
           HD         ++ + + GG L E    R+ +  +D +   +Q+L  +AY H   IVHR+
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 130
Query: 219 IKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           +KP NLL+ S      VK+ADFG++ I     +  +   GT  Y+SPE +       K D
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSPEVL-------KKD 182
Query: 276 GYAG--DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
            Y+   DIW+ GV +    +G  PF    Q    + + A  +  P    +  + E +  I
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
              L  +P  R  A Q L+ P+I
Sbjct: 243 DSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 124/263 (47%), Gaps = 20/263 (7%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS--QICREIEILRDVNHPNVVKC 162
             +G G+   V R VH  T   FA K+I    + S R   ++ RE  I R + HPN+V+ 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 163 HDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHILSDLA---RQVLSGLAYLHKRKIVHRD 218
           HD         ++ + + GG L E    R+ +  +D +   +Q+L  +AY H   IVHR+
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 130
Query: 219 IKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           +KP NLL+ S      VK+ADFG++ I     +  +   GT  Y+SPE +       K D
Sbjct: 131 LKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSPEVL-------KKD 182
Query: 276 GYAG--DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
            Y+   DIW+ GV +    +G  PF    Q    + + A  +  P    +  + E +  I
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
              L  +P  R  A Q L+ P+I
Sbjct: 243 DSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/263 (30%), Positives = 124/263 (47%), Gaps = 20/263 (7%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS--QICREIEILRDVNHPNVVKC 162
             +G G+   V R VH  T   FA K+I    + S R   ++ RE  I R + HPN+V+ 
Sbjct: 11  EELGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICRKLQHPNIVRL 69
Query: 163 HDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHILSDLA---RQVLSGLAYLHKRKIVHRD 218
           HD         ++ + + GG L E    R+ +  +D +   +Q+L  +AY H   IVHR+
Sbjct: 70  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRN 129
Query: 219 IKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           +KP NLL+ S      VK+ADFG++ I     +  +   GT  Y+SPE +       K D
Sbjct: 130 LKPENLLLASKAKGAAVKLADFGLA-IEVNDSEAWHGFAGTPGYLSPEVL-------KKD 181
Query: 276 GYAG--DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
            Y+   DIW+ GV +    +G  PF    Q    + + A  +  P    +  + E +  I
Sbjct: 182 PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 241
Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
              L  +P  R  A Q L+ P+I
Sbjct: 242 DSMLTVNPKKRITADQALKVPWI 264

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 132/287 (45%), Gaps = 22/287 (7%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IGSG+ G    +    T  + A+K  Y     ++   + REI   R + HPN+V+  ++ 
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVK--YIERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 167 DRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIKPS 222
                + +++EY  GG L            D AR    Q+LSG++Y H  +I HRD+K  
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLE 145
Query: 223 NLLINSS--KNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
           N L++ S    +KI DFG S+       P  S VGT AY++PE     L   +YDG   D
Sbjct: 146 NTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV----LLRQEYDGKIAD 200
Query: 281 IWSLGVSILEFYLGRFPFAVGRQ-GDWASL---MFAICFAQPPEAPEMASREFRDFISRC 336
           +WS GV++    +G +PF    +  D+      + ++ ++ P +     S E    ISR 
Sbjct: 201 VWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDI--RISPECCHLISRI 258
Query: 337 LQKDPHSRWPAAQLLQHPFILR---AGQSQVNQNLRQILPPPRPLSS 380
              DP +R    ++  H + L+   A     +    Q   P +P+ S
Sbjct: 259 FVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQS 305

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 133/304 (43%), Gaps = 51/304 (16%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
           ++ Q  + +G G+ G V    H PT  + A+K I    +     +  REI+IL+   H N
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHEN 70
Query: 159 VVKCH-----DMYDRNGEIEVLLEYM--DGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           ++        D ++   E+ ++ E M  D   +    +  +  +     Q L  +  LH 
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHG 130
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRIL----AQTMDPCNSAVGTIA------YMS 261
             ++HRD+KPSNLLINS+ ++K+ DFG++RI+    A   +P     G +       Y +
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRA 190
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG-DWASLMFAI------- 313
           PE + T   + +    A D+WS G  + E +L R P   GR       L+F I       
Sbjct: 191 PEVMLTSAKYSR----AMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFGIIGTPHSD 245
Query: 314 ----CFAQP------------PEAP--EMASR---EFRDFISRCLQKDPHSRWPAAQLLQ 352
               C   P            P AP  +M  R   +  D + R L  DP  R  A + L+
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
Query: 353 HPFI 356
           HP++
Sbjct: 306 HPYL 309

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/265 (29%), Positives = 123/265 (46%), Gaps = 23/265 (8%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNH-PNVVKCH 163
            +G G    V + +   T + +A K +         R++I  EI +L      P V+  H
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 164 DMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
           ++Y+   EI ++LEY  GG +      E A +  E+ +  L +Q+L G+ YLH+  IVH 
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL 155
Query: 218 DIKPSNLLINSSK---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           D+KP N+L++S     ++KI DFG+SR +    +     +GT  Y++PE +N       Y
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYLAPEILN-------Y 207
Query: 275 D--GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFA-ICFAQPPEAPEMASREFRD 331
           D    A D+W++G+          PF VG       L  + +      E     S+   D
Sbjct: 208 DPITTATDMWNIGIIAYMLLTHTSPF-VGEDNQETYLNISQVNVDYSEETFSSVSQLATD 266
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFI 356
           FI   L K+P  R  A   L H ++
Sbjct: 267 FIQSLLVKNPEKRPTAEICLSHSWL 291

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 135/306 (44%), Gaps = 55/306 (17%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
           ++ Q  + +G G+ G V    H PT  + A+K I    +     +  REI+IL+   H N
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHEN 70
Query: 159 VVKCH-----DMYDRNGEIEVLLEYM--DGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           ++        D ++   E+ ++ E M  D   +    +  +  +     Q L  +  LH 
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHG 130
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRIL----AQTMDPC------NSAVGTIAYMS 261
             ++HRD+KPSNLLINS+ ++K+ DFG++RI+    A   +P          V T  Y +
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRA 190
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWAS---LMFAI----- 313
           PE + T   + +    A D+WS G  + E +L R P   GR  D+     L+F I     
Sbjct: 191 PEVMLTSAKYSR----AMDVWSCGCILAELFLRR-PIFPGR--DYRHQLLLIFGIIGTPH 243
Query: 314 ------CFAQP------------PEAP--EMASR---EFRDFISRCLQKDPHSRWPAAQL 350
                 C   P            P AP  +M  R   +  D + R L  DP  R  A + 
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 351 LQHPFI 356
           L+HP++
Sbjct: 304 LEHPYL 309

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 127/268 (47%), Gaps = 15/268 (5%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS--QICREIEILRDVNHP 157
           + Q    +G G+   V R V    ++ +A K+I    + S R   ++ RE  I R + HP
Sbjct: 32  DYQLFEELGKGAFSVVRRCVKKTPTQEYAAKII-NTKKLSARDHQKLEREARICRLLKHP 90
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI----LSDLARQVLSGLAYLHKRK 213
           N+V+ HD     G   ++ + + GG L    + +E+      S    Q+L  + ++H+  
Sbjct: 91  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHD 150
Query: 214 IVHRDIKPSNLLINSS---KNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
           IVHRD+KP NLL+ S      VK+ADFG++  +           GT  Y+SPE +  D  
Sbjct: 151 IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKD-P 209
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
           +GK      DIW+ GV +    +G  PF    Q      + A  +  P    +  + E +
Sbjct: 210 YGK----PVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAK 265
Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFILR 358
           + I++ L  +P  R  A Q L+HP++ +
Sbjct: 266 NLINQMLTINPAKRITADQALKHPWVCQ 293

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 131/303 (43%), Gaps = 49/303 (16%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
           ++ Q  + +G G+ G V    H PT  + A+K I    +     +  REI+IL+   H N
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHEN 70
Query: 159 VVKCH-----DMYDRNGEIEVLLEYM--DGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           ++        D ++   E+ ++ E M  D   +    +  +  +     Q L  +  LH 
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHG 130
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRIL----AQTMDPCNSAVGTIAYM------S 261
             ++HRD+KPSNLLINS+ ++K+ DFG++RI+    A   +P     G   Y+      +
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRA 190
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI-------- 313
           PE + T   + +    A D+WS G  + E +L R  F          L+F I        
Sbjct: 191 PEVMLTSAKYSR----AMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 314 ---CFAQP------------PEAP--EMASR---EFRDFISRCLQKDPHSRWPAAQLLQH 353
              C   P            P AP  +M  R   +  D + R L  DP  R  A + L+H
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 354 PFI 356
           P++
Sbjct: 307 PYL 309

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 134/291 (46%), Gaps = 19/291 (6%)
Query: 95  LINPAELQK---GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIE 149
           L++P  +++   G  +G G     + +    T  VFA KV+  +   +   + ++  EI 
Sbjct: 35  LVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIA 94
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSG 205
           I + +++P+VV  H  ++ +  + V+LE     SL   H R++ +    AR    Q + G
Sbjct: 95  IHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 154
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERI 265
           + YLH  +++HRD+K  NL +N   +VKI DFG++  +    +   +  GT  Y++PE +
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVL 214
Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                  K   +  DIWSLG  +    +G+ PF      +    +    ++ P     +A
Sbjct: 215 CK-----KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVA 269
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPR 376
           S      I R L  DP  R   A+LL   F   +G + +      +  PPR
Sbjct: 270 SA----LIRRMLHADPTLRPSVAELLTDEF-FTSGYAPMRLPTSCLTVPPR 315

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 124/261 (47%), Gaps = 17/261 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IGSG+ G    +    ++ + A+K  Y    + + + + REI   R + HPN+V+  ++ 
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVK--YIERGEKIAANVKREIINHRSLRHPNIVRFKEVI 84
Query: 167 DRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIKPS 222
                + +++EY  GG L            D AR    Q++SG++Y H  ++ HRD+K  
Sbjct: 85  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 144
Query: 223 NLLINSS--KNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
           N L++ S    +KI DFG S+       P  S VGT AY++PE     L   +YDG   D
Sbjct: 145 NTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV----LLKKEYDGKVAD 199
Query: 281 IWSLGVSILEFYLGRFPFAVGRQ-GDWASLMFAICFAQPPEAPEMA--SREFRDFISRCL 337
           +WS GV++    +G +PF    +  ++   +  I   Q    P+    S E R  ISR  
Sbjct: 200 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYA-IPDYVHISPECRHLISRIF 258
Query: 338 QKDPHSRWPAAQLLQHPFILR 358
             DP  R    ++  H + L+
Sbjct: 259 VADPAKRISIPEIRNHEWFLK 279

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 133/291 (45%), Gaps = 19/291 (6%)
Query: 95  LINPAELQK---GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIE 149
           L++P  +++   G  +G G     + +    T  VFA KV+  +   +   + ++  EI 
Sbjct: 19  LVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIA 78
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSG 205
           I + +++P+VV  H  ++ +  + V+LE     SL   H R++ +    AR    Q + G
Sbjct: 79  IHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 138
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERI 265
           + YLH  +++HRD+K  NL +N   +VKI DFG++  +    +      GT  Y++PE +
Sbjct: 139 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVL 198
Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                  K   +  DIWSLG  +    +G+ PF      +    +    ++ P     +A
Sbjct: 199 CK-----KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVA 253
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPR 376
           S      I R L  DP  R   A+LL   F   +G + +      +  PPR
Sbjct: 254 SA----LIRRMLHADPTLRPSVAELLTDEF-FTSGYAPMRLPTSCLTVPPR 299

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 133/292 (45%), Gaps = 25/292 (8%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILR 152
           I   EL K   +G GS G V+      T++ FA+K +  +    +D V   +  +  +  
Sbjct: 17  IEDFELHK--MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 74
Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR------QVLSGL 206
              HP +      +     +  ++EY++GG L   HI+  H   DL+R      +++ GL
Sbjct: 75  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL-MYHIQSCHKF-DLSRATFYAAEIILGL 132
Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN 266
            +LH + IV+RD+K  N+L++   ++KIADFG+ +         N   GT  Y++PE + 
Sbjct: 133 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEIL- 191
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS 326
                G+   ++ D WS GV + E  +G+ PF     G     +F       P  P    
Sbjct: 192 ----LGQKYNHSVDWWSFGVLLYEMLIGQSPF----HGQDEEELFHSIRMDNPFYPRWLE 243
Query: 327 REFRDFISRCLQKDPHSRWPA-AQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           +E +D + +   ++P  R      + QHP        ++ +  ++I PP RP
Sbjct: 244 KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELER--KEIDPPFRP 293

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 133/282 (47%), Gaps = 35/282 (12%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDM 165
           +G G+   V   V     + +A+K+I      S RS++ RE+E L     + N+++  + 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHS-RSRVFREVETLYQCQGNKNILELIEF 79
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHI-RQEHI----LSDLARQVLSGLAYLHKRKIVHRDIK 220
           ++ +    ++ E + GGS+  AHI +Q+H      S + R V + L +LH + I HRD+K
Sbjct: 80  FEDDTRFYLVFEKLQGGSIL-AHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLK 138
Query: 221 PSNLLINSSKN---VKIADF--GVSRILAQTMDP-----CNSAVGTIAYMSPERINTDLN 270
           P N+L  S +    VKI DF  G    L  +  P       +  G+  YM+PE +    +
Sbjct: 139 PENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTD 198
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG---DWA-SLMFAICFAQPPEAPEMAS 326
              +     D+WSLGV +L   L  +P  VG  G    W    +  +C  +  E+ +   
Sbjct: 199 QATFYDKRCDLWSLGV-VLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 257
Query: 327 REF------------RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            EF            +D IS+ L +D   R  AAQ+LQHP++
Sbjct: 258 YEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 133/291 (45%), Gaps = 19/291 (6%)
Query: 95  LINPAELQK---GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIE 149
           L++P  +++   G  +G G     + +    T  VFA KV+  +   +   + ++  EI 
Sbjct: 35  LVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIA 94
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSG 205
           I + +++P+VV  H  ++ +  + V+LE     SL   H R++ +    AR    Q + G
Sbjct: 95  IHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 154
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERI 265
           + YLH  +++HRD+K  NL +N   +VKI DFG++  +    +      GT  Y++PE +
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVL 214
Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                  K   +  DIWSLG  +    +G+ PF      +    +    ++ P     +A
Sbjct: 215 CK-----KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVA 269
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPR 376
           S      I R L  DP  R   A+LL   F   +G + +      +  PPR
Sbjct: 270 SA----LIRRMLHADPTLRPSVAELLTDEF-FTSGYAPMRLPTSCLTVPPR 315

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 127/292 (43%), Gaps = 53/292 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVN---HPNVVKC 162
           IG G+ GTV++   P +    ALK +   N E+ +     RE+ +LR +    HPNVV+ 
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 163 HDM-----YDRNGEIEVLLE--------YMDGGSLEGAHIRQEHILSDLARQVLSGLAYL 209
            D+      DR  ++ ++ E        Y+D     G        + DL RQ L GL +L
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGL---PAETIKDLMRQFLRGLDFL 128
Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
           H   IVHRD+KP N+L+ S   VK+ADFG++RI +  M   +  V T+ Y +PE     L
Sbjct: 129 HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALDPVVVTLWYRAPEV----L 183
Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--------- 320
               Y     D+WS+G    E +  +  F    + D    +F +    PPE         
Sbjct: 184 LQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL-IGLPPEDDWPRDVSL 241
Query: 321 ----------------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                            PEM     +  +   L  +PH R  A + LQH ++
Sbjct: 242 PRGAFPPRGPRPVQSVVPEMEESGAQ-LLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 123/261 (47%), Gaps = 17/261 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IGSG+ G    +    ++ + A+K  Y    + +   + REI   R + HPN+V+  ++ 
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVK--YIERGEKIDENVKREIINHRSLRHPNIVRFKEVI 83
Query: 167 DRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIKPS 222
                + +++EY  GG L            D AR    Q++SG++Y H  ++ HRD+K  
Sbjct: 84  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 143
Query: 223 NLLINSS--KNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
           N L++ S    +KI DFG S+       P  S VGT AY++PE     L   +YDG   D
Sbjct: 144 NTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV----LLKKEYDGKVAD 198
Query: 281 IWSLGVSILEFYLGRFPFAVGRQ-GDWASLMFAICFAQPPEAPEMA--SREFRDFISRCL 337
           +WS GV++    +G +PF    +  ++   +  I   Q    P+    S E R  ISR  
Sbjct: 199 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYA-IPDYVHISPECRHLISRIF 257
Query: 338 QKDPHSRWPAAQLLQHPFILR 358
             DP  R    ++  H + L+
Sbjct: 258 VADPAKRISIPEIRNHEWFLK 278

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 91/313 (29%), Positives = 138/313 (44%), Gaps = 50/313 (15%)
Query: 107 IGSGSGGTVWRVVHPPTS-RVFALK-VIYGNHEDSVRSQICREIEILRDVN---HPNVVK 161
           IG G+ G V++        R  ALK V     E+ +     RE+ +LR +    HPNVV+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 162 CHDM-----YDRNGEIEVLLEYMDGGSLEGAHIRQE-----HILSDLARQVLSGLAYLHK 211
             D+      DR  ++ ++ E++D           E       + D+  Q+L GL +LH 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            ++VHRD+KP N+L+ SS  +K+ADFG++RI +  M    S V T+ Y +PE +      
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVVTLWYRAPEVL------ 191
Query: 272 GKYDGYAG--DIWSLGVSILEFY--------------LGRFPFAVGRQG--DWASLM--- 310
                YA   D+WS+G    E +              LG+    +G  G  DW   +   
Sbjct: 192 -LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 250
Query: 311 ---FAICFAQPPEAPEMASREF-RDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQ 366
              F    AQP E       E  +D + +CL  +P  R  A   L HP+       +  +
Sbjct: 251 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF--QDLERCKE 308
Query: 367 NLRQILPPPRPLS 379
           NL   LPP +  S
Sbjct: 309 NLDSHLPPSQNTS 321

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 81/264 (30%), Positives = 125/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 36  NTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EYM GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +K+ADFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 133/291 (45%), Gaps = 19/291 (6%)
Query: 95  LINPAELQK---GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIE 149
           L++P  +++   G  +G G     + +    T  VFA KV+  +   +   + ++  EI 
Sbjct: 35  LVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIA 94
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSG 205
           I + +++P+VV  H  ++ +  + V+LE     SL   H R++ +    AR    Q + G
Sbjct: 95  IHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQG 154
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERI 265
           + YLH  +++HRD+K  NL +N   +VKI DFG++  +    +      GT  Y++PE +
Sbjct: 155 VQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVL 214
Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
                  K   +  DIWSLG  +    +G+ PF      +    +    ++ P     +A
Sbjct: 215 CK-----KGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVA 269
Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPR 376
           S      I R L  DP  R   A+LL   F   +G + +      +  PPR
Sbjct: 270 SA----LIRRMLHADPTLRPSVAELLTDEF-FTSGYAPMRLPTSCLTVPPR 315

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 81/264 (30%), Positives = 125/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 36  NTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EYM GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +K+ADFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 129/281 (45%), Gaps = 23/281 (8%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G GS G V+      T++ FA+K +  +    +D V   +  +  +     HP +    
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR------QVLSGLAYLHKRKIVHR 217
             +     +  ++EY++GG L   HI+  H   DL+R      +++ GL +LH + IV+R
Sbjct: 85  CTFQTKENLFFVMEYLNGGDL-MYHIQSCHKF-DLSRATFYAAEIILGLQFLHSKGIVYR 142
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           D+K  N+L++   ++KIADFG+ +         N   GT  Y++PE +      G+   +
Sbjct: 143 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEIL-----LGQKYNH 197
Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL 337
           + D WS GV + E  +G+ PF     G     +F       P  P    +E +D + +  
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPF----HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 253
Query: 338 QKDPHSRWPA-AQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
            ++P  R      + QHP        ++ +  ++I PP RP
Sbjct: 254 VREPEKRLGVRGDIRQHPLFREINWEELER--KEIDPPFRP 292

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 125/266 (46%), Gaps = 15/266 (5%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR--SQICREIEILRDVNHP 157
           E Q    +G G+   V R V     + +A  +I    + S R   ++ RE  I R + HP
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMII-NTKKLSARDHQKLEREARICRLLKHP 70
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI----LSDLARQVLSGLAYLHKRK 213
           N+V+ HD     G   ++ + + GG L    + +E+      S   +Q+L  + + H+  
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 214 IVHRDIKPSNLLINSS---KNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
           +VHR++KP NLL+ S      VK+ADFG++  +           GT  Y+SPE +  D  
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD-P 189
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
           +GK      D+W+ GV +    +G  PF    Q      + A  +  P    +  + E +
Sbjct: 190 YGK----PVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245
Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFI 356
           D I++ L  +P  R  AA+ L+HP+I
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWI 271

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 126/292 (43%), Gaps = 53/292 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVN---HPNVVKC 162
           IG G+ GTV++   P +    ALK +   N E+ +     RE+ +LR +    HPNVV+ 
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 163 HDM-----YDRNGEIEVLLE--------YMDGGSLEGAHIRQEHILSDLARQVLSGLAYL 209
            D+      DR  ++ ++ E        Y+D     G        + DL RQ L GL +L
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGL---PAETIKDLMRQFLRGLDFL 128
Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
           H   IVHRD+KP N+L+ S   VK+ADFG++RI +  M      V T+ Y +PE     L
Sbjct: 129 HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALAPVVVTLWYRAPEV----L 183
Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--------- 320
               Y     D+WS+G    E +  +  F    + D    +F +    PPE         
Sbjct: 184 LQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL-IGLPPEDDWPRDVSL 241
Query: 321 ----------------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                            PEM     +  +   L  +PH R  A + LQH ++
Sbjct: 242 PRGAFPPRGPRPVQSVVPEMEESGAQ-LLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 118/262 (45%), Gaps = 27/262 (10%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH-------EDSVRSQICREIEILRDVNHPNV 159
           +GSG+ G VW  V    ++   +K I           ED    ++  EI IL  V H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKRKI 214
           +K  D+++  G  ++++E    G    A I +     E + S + RQ++S + YL  + I
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDI 151
Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           +HRDIK  N++I     +K+ DFG +  L +      +  GTI Y +PE     L    Y
Sbjct: 152 IHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEV----LMGNPY 206
Query: 275 DGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS 334
            G   ++WSLGV++        PF    +   A++            P + S+E    +S
Sbjct: 207 RGPELEMWSLGVTLYTLVFEENPFCELEETVEAAI----------HPPYLVSKELMSLVS 256
Query: 335 RCLQKDPHSRWPAAQLLQHPFI 356
             LQ  P  R    +L+  P++
Sbjct: 257 GLLQPVPERRTTLEKLVTDPWV 278

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 126/292 (43%), Gaps = 53/292 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVN---HPNVVKC 162
           IG G+ GTV++   P +    ALK +   N E+ +     RE+ +LR +    HPNVV+ 
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 163 HDM-----YDRNGEIEVLLE--------YMDGGSLEGAHIRQEHILSDLARQVLSGLAYL 209
            D+      DR  ++ ++ E        Y+D     G        + DL RQ L GL +L
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGL---PAETIKDLMRQFLRGLDFL 128
Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
           H   IVHRD+KP N+L+ S   VK+ADFG++RI +  M      V T+ Y +PE     L
Sbjct: 129 HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALFPVVVTLWYRAPEV----L 183
Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--------- 320
               Y     D+WS+G    E +  +  F    + D    +F +    PPE         
Sbjct: 184 LQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL-IGLPPEDDWPRDVSL 241
Query: 321 ----------------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                            PEM     +  +   L  +PH R  A + LQH ++
Sbjct: 242 PRGAFPPRGPRPVQSVVPEMEESGAQ-LLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 125/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 36  NTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +K+ADFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 85/286 (29%), Positives = 133/286 (46%), Gaps = 43/286 (15%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDM 165
           +G G+   V   ++  TS+ +A+K+I       +RS++ RE+E+L     H NV++  + 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDL-----ARQVLSGLAYLHKRKIVHRDIK 220
           ++      ++ E M GGS+  +HI +    ++L      + V S L +LH + I HRD+K
Sbjct: 80  FEEEDRFYLVFEKMRGGSIL-SHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLK 138
Query: 221 PSNLLI---NSSKNVKIADFGVSRILA-----------QTMDPCNSAVGTIAYMSPERIN 266
           P N+L    N    VKI DFG+   +            + + PC SA     YM+PE + 
Sbjct: 139 PENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSA----EYMAPEVVE 194
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD---W---------ASLMFAIC 314
                        D+WSLGV IL   L  +P  VGR G    W          +++F   
Sbjct: 195 AFSEEASIYDKRCDLWSLGV-ILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI 253
Query: 315 FAQPPEAPEM----ASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                E P+      S   +D IS+ L +D   R  AAQ+LQHP++
Sbjct: 254 QEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 112/212 (52%), Gaps = 10/212 (4%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI--YGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
           IG G+ G V  V H  T +V+A+K++  +   + S  +    E +I+   N P VV+   
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIK 220
            +  +  + +++EYM GG L    +    +    AR    +V+  L  +H    +HRD+K
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNL-MSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 195
Query: 221 PSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           P N+L++ S ++K+ADFG   ++  + M  C++AVGT  Y+SPE + +    G Y G   
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY-GREC 254
Query: 280 DIWSLGVSILEFYLGRFPF-AVGRQGDWASLM 310
           D WS+GV + E  +G  PF A    G ++ +M
Sbjct: 255 DWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 112/212 (52%), Gaps = 10/212 (4%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI--YGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
           IG G+ G V  V H  T +V+A+K++  +   + S  +    E +I+   N P VV+   
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIK 220
            +  +  + +++EYM GG L    +    +    AR    +V+  L  +H    +HRD+K
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLVNL-MSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 200
Query: 221 PSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           P N+L++ S ++K+ADFG   ++  + M  C++AVGT  Y+SPE + +    G Y G   
Sbjct: 201 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY-GREC 259
Query: 280 DIWSLGVSILEFYLGRFPF-AVGRQGDWASLM 310
           D WS+GV + E  +G  PF A    G ++ +M
Sbjct: 260 DWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 112/212 (52%), Gaps = 10/212 (4%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI--YGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
           IG G+ G V  V H  T +V+A+K++  +   + S  +    E +I+   N P VV+   
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIK 220
            +  +  + +++EYM GG L    +    +    AR    +V+  L  +H    +HRD+K
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLVNL-MSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 200
Query: 221 PSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           P N+L++ S ++K+ADFG   ++  + M  C++AVGT  Y+SPE + +    G Y G   
Sbjct: 201 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY-GREC 259
Query: 280 DIWSLGVSILEFYLGRFPF-AVGRQGDWASLM 310
           D WS+GV + E  +G  PF A    G ++ +M
Sbjct: 260 DWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 122/261 (46%), Gaps = 17/261 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IGSG+ G    +    ++ + A+K  Y    + +   + REI   R + HPN+V+  ++ 
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVK--YIERGEKIDENVKREIINHRSLRHPNIVRFKEVI 84
Query: 167 DRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIKPS 222
                + +++EY  GG L            D AR    Q++SG++Y H  ++ HRD+K  
Sbjct: 85  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 144
Query: 223 NLLINSS--KNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
           N L++ S    +KI  FG S+       P  S VGT AY++PE     L   +YDG   D
Sbjct: 145 NTLLDGSPAPRLKICAFGYSKSSVLHSQP-KSTVGTPAYIAPEV----LLKKEYDGKVAD 199
Query: 281 IWSLGVSILEFYLGRFPFAVGRQ-GDWASLMFAICFAQPPEAPEMA--SREFRDFISRCL 337
           +WS GV++    +G +PF    +  ++   +  I   Q    P+    S E R  ISR  
Sbjct: 200 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYA-IPDYVHISPECRHLISRIF 258
Query: 338 QKDPHSRWPAAQLLQHPFILR 358
             DP  R    ++  H + L+
Sbjct: 259 VADPAKRISIPEIRNHEWFLK 279

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   FA+K++  + +  V+         E  
Sbjct: 36  NTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   FA+K++  + +  V+         E  
Sbjct: 36  NTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   FA+K++  + +  V+         E  
Sbjct: 36  NTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHP 157
           P E+++  R+G+G  G V R +H  T    A+K          R + C EI+I++ +NHP
Sbjct: 16  PWEMKE--RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 73
Query: 158 NVVKCHDMYDRNGEIE------VLLEYMDGGSL-------EGAHIRQEHILSDLARQVLS 204
           NVV   ++ D   ++       + +EY +GG L       E     +E  +  L   + S
Sbjct: 74  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 133
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNV---KIADFGVSRILAQTMDPCNSAVGTIAYMS 261
            L YLH+ +I+HRD+KP N+++         KI D G ++ L Q  + C   VGT+ Y++
Sbjct: 134 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLA 192
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF 298
           PE     L   KY     D WS G    E   G  PF
Sbjct: 193 PEL----LEQKKYT-VTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHP 157
           P E+++  R+G+G  G V R +H  T    A+K          R + C EI+I++ +NHP
Sbjct: 15  PWEMKE--RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 158 NVVKCHDMYDRNGEIE------VLLEYMDGGSL-------EGAHIRQEHILSDLARQVLS 204
           NVV   ++ D   ++       + +EY +GG L       E     +E  +  L   + S
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNV---KIADFGVSRILAQTMDPCNSAVGTIAYMS 261
            L YLH+ +I+HRD+KP N+++         KI D G ++ L Q  + C   VGT+ Y++
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLA 191
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF 298
           PE     L   KY     D WS G    E   G  PF
Sbjct: 192 PEL----LEQKKYT-VTVDYWSFGTLAFECITGFRPF 223

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 39/267 (14%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIE---- 149
           N A L +  RI   G+GS G V  V H  T   +A+K++     D  +    +EIE    
Sbjct: 36  NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-----DKQKVVKLKEIEHTLN 90
Query: 150 ---ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQ 201
              IL+ VN P +VK    +  N  + +++EY  GG +  +H+R+    S+      A Q
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM-FSHLRRIGRFSEPHARFYAAQ 149
Query: 202 VLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYM 260
           ++    YLH   +++RD+KP NL+I+    +K+ DFG++ R+  +T   C    GT  Y+
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC----GTPEYL 205
Query: 261 SPERINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP 318
           +PE I +        GY  A D W+LGV I E   G  PF      D    ++    +  
Sbjct: 206 APEIILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGK 254
Query: 319 PEAPEMASREFRDFISRCLQKDPHSRW 345
              P   S + +D +   LQ D   R+
Sbjct: 255 VRFPSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 128/278 (46%), Gaps = 25/278 (8%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
           N IG GS G V   V   T    A K I     + V  +  +EIEI++ ++HPN+++ ++
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV-DRFKQEIEIMKSLDHPNIIRLYE 73
Query: 165 MYDRNGEIEVLLEYMDGGSL--EGAHIR--QEHILSDLARQVLSGLAYLHKRKIVHRDIK 220
            ++ N +I +++E   GG L     H R  +E   + + + VLS +AY HK  + HRD+K
Sbjct: 74  TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLK 133
Query: 221 PSNLLI---NSSKNVKIADFGVSRILAQTMDP---CNSAVGTIAYMSPERINTDLNHGKY 274
           P N L    +    +K+ DFG    LA    P     + VGT  Y+SP+ +      G Y
Sbjct: 134 PENFLFLTDSPDSPLKLIDFG----LAARFKPGKMMRTKVGTPYYVSPQVL-----EGLY 184
Query: 275 DGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS 334
            G   D WS GV +     G  PF+     +    +    F  P +     S +    I 
Sbjct: 185 -GPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIR 243
Query: 335 RCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQIL 372
           R L K P  R  + Q L+H +     + Q++ + R +L
Sbjct: 244 RLLTKSPKQRITSLQALEHEWF----EKQLSSSPRNLL 277

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 129/290 (44%), Gaps = 48/290 (16%)
Query: 107 IGSGSGGTVWRVVHPPTS-RVFALK-VIYGNHEDSVRSQICREIEILRDVN---HPNVVK 161
           IG G+ G V++        R  ALK V     E+ +     RE+ +LR +    HPNVV+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 162 CHDM-----YDRNGEIEVLLEYMDGGSLEGAHIRQE-----HILSDLARQVLSGLAYLHK 211
             D+      DR  ++ ++ E++D           E       + D+  Q+L GL +LH 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            ++VHRD+KP N+L+ SS  +K+ADFG++RI +  M    S V T+ Y +PE +      
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQ---- 193
Query: 272 GKYDGYAG--DIWSLGVSILEFY--------------LGRFPFAVGRQG--DWASLM--- 310
                YA   D+WS+G    E +              LG+    +G  G  DW   +   
Sbjct: 194 ---SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 250
Query: 311 ---FAICFAQPPEAPEMASREF-RDFISRCLQKDPHSRWPAAQLLQHPFI 356
              F    AQP E       E  +D + +CL  +P  R  A   L HP+ 
Sbjct: 251 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 129/290 (44%), Gaps = 48/290 (16%)
Query: 107 IGSGSGGTVWRVVHPPTS-RVFALK-VIYGNHEDSVRSQICREIEILRDVN---HPNVVK 161
           IG G+ G V++        R  ALK V     E+ +     RE+ +LR +    HPNVV+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 162 CHDM-----YDRNGEIEVLLEYMDGGSLEGAHIRQE-----HILSDLARQVLSGLAYLHK 211
             D+      DR  ++ ++ E++D           E       + D+  Q+L GL +LH 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 138
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            ++VHRD+KP N+L+ SS  +K+ADFG++RI +  M    S V T+ Y +PE +      
Sbjct: 139 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVVTLWYRAPEVLLQ---- 193
Query: 272 GKYDGYAG--DIWSLGVSILEFY--------------LGRFPFAVGRQG--DWASLM--- 310
                YA   D+WS+G    E +              LG+    +G  G  DW   +   
Sbjct: 194 ---SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 250
Query: 311 ---FAICFAQPPEAPEMASREF-RDFISRCLQKDPHSRWPAAQLLQHPFI 356
              F    AQP E       E  +D + +CL  +P  R  A   L HP+ 
Sbjct: 251 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 108/214 (50%), Gaps = 25/214 (11%)
Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH----EDSVRSQICREIEILRDVNHP 157
           +K + +G G   TV++     T+++ A+K I   H    +D +     REI++L++++HP
Sbjct: 13  EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 72
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGG----------SLEGAHIRQEHILSDLARQVLSGLA 207
           N++   D +     I ++ ++M+             L  +HI+   +++      L GL 
Sbjct: 73  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT------LQGLE 126
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           YLH+  I+HRD+KP+NLL++ +  +K+ADFG+++            V T  Y +PE    
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPEL--- 183
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVG 301
            L   +  G   D+W++G  + E  L R PF  G
Sbjct: 184 -LFGARMYGVGVDMWAVGCILAELLL-RVPFLPG 215

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 128/278 (46%), Gaps = 25/278 (8%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
           N IG GS G V   V   T    A K I     + V  +  +EIEI++ ++HPN+++ ++
Sbjct: 32  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV-DRFKQEIEIMKSLDHPNIIRLYE 90
Query: 165 MYDRNGEIEVLLEYMDGGSL--EGAHIR--QEHILSDLARQVLSGLAYLHKRKIVHRDIK 220
            ++ N +I +++E   GG L     H R  +E   + + + VLS +AY HK  + HRD+K
Sbjct: 91  TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLK 150
Query: 221 PSNLLI---NSSKNVKIADFGVSRILAQTMDP---CNSAVGTIAYMSPERINTDLNHGKY 274
           P N L    +    +K+ DFG    LA    P     + VGT  Y+SP+ +      G Y
Sbjct: 151 PENFLFLTDSPDSPLKLIDFG----LAARFKPGKMMRTKVGTPYYVSPQVL-----EGLY 201
Query: 275 DGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS 334
            G   D WS GV +     G  PF+     +    +    F  P +     S +    I 
Sbjct: 202 -GPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIR 260
Query: 335 RCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQIL 372
           R L K P  R  + Q L+H +     + Q++ + R +L
Sbjct: 261 RLLTKSPKQRITSLQALEHEWF----EKQLSSSPRNLL 294

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 126/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A+L + +RI   G+GS G V  V H  +   +A+K++  + +  V+         E  
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 137/292 (46%), Gaps = 44/292 (15%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V +  +   SR +A+K I   H +   S I  E+ +L  +NH  VV+ +  +
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 167 -------------DRNGEIEVLLEYMDGGSLEGAHIRQEHILSD------LARQVLSGLA 207
                         +   + + +EY + G+L    I  E++         L RQ+L  L+
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDL-IHSENLNQQRDEYWRLFRQILEALS 130
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM--------------DPCNSA 253
           Y+H + I+HRD+KP N+ I+ S+NVKI DFG+++ + +++              D   SA
Sbjct: 131 YIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190
Query: 254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG-DWASLMFA 312
           +GT  Y++ E ++     G Y+    D++SLG+   E     +PF+ G +  +    + +
Sbjct: 191 IGTAMYVATEVLD---GTGHYNEKI-DMYSLGIIFFEMI---YPFSTGMERVNILKKLRS 243
Query: 313 ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV 364
           +    PP+  +   +  +  I   +  DP+ R  A  LL   ++    Q +V
Sbjct: 244 VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEV 295

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 123/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 37  NTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 94
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           I + VN P +VK    +  N  + ++LEY  GG +  +H+R+    S+      A Q++ 
Sbjct: 95  IQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 153
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +K+ADFG + R+  +T   C    GT  Y++PE
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC----GTPEYLAPE 209
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 210 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 258
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKRF 282

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 126/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A+L + +RI   G+GS G V  V H  +   +A+K++  + +  V+         E  
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 126/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A+L + +RI   G+GS G V  V H  +   +A+K++  + +  V+         E  
Sbjct: 23  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 80
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 81  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARFYAAQIVL 139
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 140 TFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 195
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 196 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 244
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 245 PSHFSSDLKDLLRNLLQVDLTKRF 268

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 126/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A+L + +RI   G+GS G V  V H  +   +A+K++  + +  V+         E  
Sbjct: 37  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 94
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARFYAAQIVL 153
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 209
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 210 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 258
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKRF 282

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 118/256 (46%), Gaps = 15/256 (5%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHD 164
           +G G     + +    T  VFA K++  +   +   R ++  EI I R + H +VV  H 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIK 220
            ++ N  + V+LE     SL   H R++ +    AR    Q++ G  YLH+ +++HRD+K
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
             NL +N    VKI DFG++  +    +   +  GT  Y++PE ++      K   +  D
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSK-----KGHSFEVD 199
Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKD 340
           +WS+G  +    +G+ PF      +    +    ++ P     +A+      I + LQ D
Sbjct: 200 VWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA----SLIQKMLQTD 255
Query: 341 PHSRWPAAQLLQHPFI 356
           P +R    +LL   F 
Sbjct: 256 PTARPTINELLNDEFF 271

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 118/256 (46%), Gaps = 15/256 (5%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHD 164
           +G G     + +    T  VFA K++  +   +   R ++  EI I R + H +VV  H 
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIK 220
            ++ N  + V+LE     SL   H R++ +    AR    Q++ G  YLH+ +++HRD+K
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
             NL +N    VKI DFG++  +    +   +  GT  Y++PE ++      K   +  D
Sbjct: 149 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSK-----KGHSFEVD 203
Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKD 340
           +WS+G  +    +G+ PF      +    +    ++ P     +A+      I + LQ D
Sbjct: 204 VWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA----SLIQKMLQTD 259
Query: 341 PHSRWPAAQLLQHPFI 356
           P +R    +LL   F 
Sbjct: 260 PTARPTINELLNDEFF 275

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 118/256 (46%), Gaps = 15/256 (5%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHD 164
           +G G     + +    T  VFA K++  +   +   R ++  EI I R + H +VV  H 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIK 220
            ++ N  + V+LE     SL   H R++ +    AR    Q++ G  YLH+ +++HRD+K
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
             NL +N    VKI DFG++  +    +   +  GT  Y++PE ++      K   +  D
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSK-----KGHSFEVD 199
Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKD 340
           +WS+G  +    +G+ PF      +    +    ++ P     +A+      I + LQ D
Sbjct: 200 VWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA----SLIQKMLQTD 255
Query: 341 PHSRWPAAQLLQHPFI 356
           P +R    +LL   F 
Sbjct: 256 PTARPTINELLNDEFF 271

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 123/268 (45%), Gaps = 15/268 (5%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS--QICREIEILRDVNHP 157
           E Q    IG G+   V R V   T   +A K+I    + S R   ++ RE  I R + H 
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKII-NTKKLSARDHQKLEREARICRLLKHS 63
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI----LSDLARQVLSGLAYLHKRK 213
           N+V+ HD     G   ++ + + GG L    + +E+      S   +Q+L  + + H+  
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 123
Query: 214 IVHRDIKPSNLLINSS---KNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
           +VHRD+KP NLL+ S      VK+ADFG++  +           GT  Y+SPE +  +  
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAY 183
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
                G   DIW+ GV +    +G  PF    Q      + A  +  P    +  + E +
Sbjct: 184 -----GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAK 238
Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFILR 358
           + I++ L  +P  R  A + L+HP++ +
Sbjct: 239 NLINQMLTINPAKRITAHEALKHPWVCQ 266

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 132/301 (43%), Gaps = 61/301 (20%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G  G V+  V     +  A+K I      SV+  + REI+I+R ++H N+VK  ++ 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKVFEIL 77
Query: 167 DRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR-----------------QVLSGLAYL 209
             +G  ++  +      L   +I QE++ +DLA                  Q+L GL Y+
Sbjct: 78  GPSGS-QLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYI 136
Query: 210 HKRKIVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIA-------YMS 261
           H   ++HRD+KP+NL IN+   V KI DFG++RI    MDP  S  G ++       Y S
Sbjct: 137 HSANVLHRDLKPANLFINTEDLVLKIGDFGLARI----MDPHYSHKGHLSEGLVTKWYRS 192
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMF-AICFAQPPE 320
           P  + +  N+ K    A D+W+ G    E   G+  FA   + +   L+  +I      +
Sbjct: 193 PRLLLSPNNYTK----AIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248
Query: 321 APEM-------------------------ASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
             E+                          SRE  DF+ + L   P  R  A + L HP+
Sbjct: 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308
Query: 356 I 356
           +
Sbjct: 309 M 309

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 126/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A+L + +RI   G+GS G V  V H  +   +A+K++  + +  V+         E  
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 126/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A+L + +RI   G+GS G V  V H  +   +A+K++  + +  V+         E  
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADEPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 29  NTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 86
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 87  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 145
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 146 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 201
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 202 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 250
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 251 PSHFSSDLKDLLRNLLQVDLTKRF 274

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 37  NTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 94
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 153
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 209
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 210 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 258
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKRF 282

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 125/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A+L + +RI   G+GS G V  V H  +   +A+K++  + +  V+         E  
Sbjct: 57  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 114
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 115 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARFYAAQIVL 173
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+   T   C    GT  Y++PE
Sbjct: 174 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLC----GTPEYLAPE 229
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 230 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 278
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 279 PSHFSSDLKDLLRNLLQVDLTKRF 302

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 129/276 (46%), Gaps = 22/276 (7%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR-EIEILRDV 154
           I  +E+    RIGSGS GTV++        V  LKV+    E   + Q  R E+ +LR  
Sbjct: 33  IEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPE---QFQAFRNEVAVLRKT 89
Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHI----LSDLARQVLSGLAYL 209
            H N++     Y     + ++ ++ +G SL +  H+++       L D+ARQ   G+ YL
Sbjct: 90  RHVNILLFMG-YMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYL 148
Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ--TMDPCNSAVGTIAYMSPERINT 267
           H + I+HRD+K +N+ ++    VKI DFG++ + ++           G++ +M+PE I  
Sbjct: 149 HAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRM 208
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP--PEAPEMA 325
             N+     +  D++S G+ + E   G  P++     D    M    +A P   +  +  
Sbjct: 209 QDNNPF--SFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC 266
Query: 326 SREFRDFISRCLQKDPHSR------WPAAQLLQHPF 355
            +  +  ++ C++K    R        + +LLQH  
Sbjct: 267 PKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 37  NTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 94
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 153
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 209
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 210 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 258
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKRF 282

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 37  NTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 94
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 153
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 209
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 210 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 258
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKRF 282

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 122/250 (48%), Gaps = 20/250 (8%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ----ICREIEILRDVNHPNVVKC 162
           IG GS G V  V    T +++A+K  Y N +  V       + +E++I++ + HP +V  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMK--YMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 163 HDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
              +    ++ ++++ + GG L     +  H ++E +   +   V++ L YL  ++I+HR
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA-LDYLQNQRIIHR 139
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           D+KP N+L++   +V I DF ++ +L +      +  GT  YM+PE  ++    G    +
Sbjct: 140 DMKPDNILLDEHGHVHITDFNIAAMLPRETQ-ITTMAGTKPYMAPEMFSSRKGAGY--SF 196
Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLM--FAICFAQPPEAPEMASREFRDFISR 335
           A D WSLGV+  E   GR P+ +        ++  F       P A    S+E    + +
Sbjct: 197 AVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSA---WSQEMVSLLKK 253
Query: 336 CLQKDPHSRW 345
            L+ +P  R+
Sbjct: 254 LLEPNPDQRF 263

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 57  NTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 114
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 115 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 173
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 174 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 229
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 230 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 278
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 279 PSHFSSDLKDLLRNLLQVDLTKRF 302

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 123/261 (47%), Gaps = 17/261 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IGSG+ G    +    ++ + A+K  Y    + +   + REI   R + HPN+V+  ++ 
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVK--YIERGEKIDENVKREIINHRSLRHPNIVRFKEVI 84
Query: 167 DRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIKPS 222
                + +++EY  GG L            D AR    Q++SG++Y H  ++ HRD+K  
Sbjct: 85  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 144
Query: 223 NLLINSS--KNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
           N L++ S    +KI  FG S+       P ++ VGT AY++PE     L   +YDG   D
Sbjct: 145 NTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT-VGTPAYIAPEV----LLKKEYDGKVAD 199
Query: 281 IWSLGVSILEFYLGRFPFAVGRQ-GDWASLMFAICFAQPPEAPEMA--SREFRDFISRCL 337
           +WS GV++    +G +PF    +  ++   +  I   Q    P+    S E R  ISR  
Sbjct: 200 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYA-IPDYVHISPECRHLISRIF 258
Query: 338 QKDPHSRWPAAQLLQHPFILR 358
             DP  R    ++  H + L+
Sbjct: 259 VADPAKRISIPEIRNHEWFLK 279

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 123/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 37  NTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 94
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY  GG +  +H+R+    S+      A Q++ 
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 153
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NL+I+    +K+ DFG + R+  +T   C    GT  Y++PE
Sbjct: 154 TFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPE 209
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 210 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 258
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKRF 282

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 37  NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 94
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 153
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEYLAPE 209
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 210 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 258
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKRF 282

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 36  NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 125/267 (46%), Gaps = 39/267 (14%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIE---- 149
           N A L +  RI   G+GS G V  V H  T   +A+K++     D  +    +EIE    
Sbjct: 36  NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-----DKQKVVKLKEIEHTLN 90
Query: 150 ---ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQ 201
              IL+ VN P +VK    +  N  + +++EY  GG +  +H+R+    S+      A Q
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM-FSHLRRIGRFSEPHARFYAAQ 149
Query: 202 VLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYM 260
           ++    YLH   +++RD+KP NL+I+    +++ DFG++ R+  +T   C    GT  Y+
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC----GTPEYL 205
Query: 261 SPERINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP 318
           +PE I +        GY  A D W+LGV I E   G  PF      D    ++    +  
Sbjct: 206 APEIILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGK 254
Query: 319 PEAPEMASREFRDFISRCLQKDPHSRW 345
              P   S + +D +   LQ D   R+
Sbjct: 255 VRFPSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 22  NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 79
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 80  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 138
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 139 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEYLAPE 194
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 195 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 243
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 244 PSHFSSDLKDLLRNLLQVDLTKRF 267

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 37  NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 94
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 153
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 209
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 210 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 258
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKRF 282

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 36  NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 124/259 (47%), Gaps = 33/259 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A+L + +RI   G+GS G V  V H  +   +A+K++  + +  V+         E  
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKD 340
           P   S + +D +   LQ D
Sbjct: 258 PSHFSSDLKDLLRNLLQVD 276

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 36  NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 126/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A+L + +RI   G+GS G V  V H  +   +A+K++  + +  V+         E  
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    ++      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFAEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 124/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 36  NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 132/286 (46%), Gaps = 43/286 (15%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDM 165
           +G G+   V   ++  TS+ +A+K+I       +RS++ RE+E+L     H NV++  + 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDL-----ARQVLSGLAYLHKRKIVHRDIK 220
           ++      ++ E M GGS+  +HI +    ++L      + V S L +LH + I HRD+K
Sbjct: 80  FEEEDRFYLVFEKMRGGSIL-SHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLK 138
Query: 221 PSNLLI---NSSKNVKIADFGVSRILA-----------QTMDPCNSAVGTIAYMSPERIN 266
           P N+L    N    VKI DF +   +            + + PC SA     YM+PE + 
Sbjct: 139 PENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA----EYMAPEVVE 194
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD---W---------ASLMFAIC 314
                        D+WSLGV IL   L  +P  VGR G    W          +++F   
Sbjct: 195 AFSEEASIYDKRCDLWSLGV-ILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI 253
Query: 315 FAQPPEAPEM----ASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                E P+      S   +D IS+ L +D   R  AAQ+LQHP++
Sbjct: 254 QEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 126/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A+L + +RI   G+GS G V  V H  +   +A+K++  + +  V+         E  
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NL+I+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IIIS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 15/256 (5%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHD 164
           +G G     + +    T  VFA K++  +   +   R ++  EI I R + H +VV  H 
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIK 220
            ++ N  + V+LE     SL   H R++ +    AR    Q++ G  YLH+ +++HRD+K
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
             NL +N    VKI DFG++  +    +      GT  Y++PE ++      K   +  D
Sbjct: 167 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK-----KGHSFEVD 221
Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKD 340
           +WS+G  +    +G+ PF      +    +    ++ P     +A+      I + LQ D
Sbjct: 222 VWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA----SLIQKMLQTD 277
Query: 341 PHSRWPAAQLLQHPFI 356
           P +R    +LL   F 
Sbjct: 278 PTARPTINELLNDEFF 293

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 15/256 (5%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHD 164
           +G G     + +    T  VFA K++  +   +   R ++  EI I R + H +VV  H 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIK 220
            ++ N  + V+LE     SL   H R++ +    AR    Q++ G  YLH+ +++HRD+K
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
             NL +N    VKI DFG++  +    +      GT  Y++PE ++      K   +  D
Sbjct: 169 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK-----KGHSFEVD 223
Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKD 340
           +WS+G  +    +G+ PF      +    +    ++ P     +A+      I + LQ D
Sbjct: 224 VWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA----SLIQKMLQTD 279
Query: 341 PHSRWPAAQLLQHPFI 356
           P +R    +LL   F 
Sbjct: 280 PTARPTINELLNDEFF 295

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 126/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A+L + +RI   G+GS G V  V H  +   +A+K++  + +  V+         E  
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I +   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYQMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 123/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 36  NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY  GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NL+I+    +K+ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +  +
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 72
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL----LKRREFHAEPV 188
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 125/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A+L + +RI   G+GS G V  V H  +   +A+K++  + +  V+         E  
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+     +      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFXEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 125/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A+L + +RI   G+GS G V  V H  +   +A+K++  + +  V+         E  
Sbjct: 57  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 114
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+     +      A Q++ 
Sbjct: 115 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFXEPHARFYAAQIVL 173
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 174 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 229
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 230 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 278
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 279 PSHFSSDLKDLLRNLLQVDLTKRF 302

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 125/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A+L + +RI   G+GS G V  V H  +   +A+K++  + +  V+         E  
Sbjct: 31  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 88
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+     +      A Q++ 
Sbjct: 89  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFXEPHARFYAAQIVL 147
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 148 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 203
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 204 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 252
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 253 PSHFSSDLKDLLRNLLQVDLTKRF 276

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 125/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A+L + +RI   G+GS G V  V H  +   +A+K++  + +  V+         E  
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+     +      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFXEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 15/256 (5%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHD 164
           +G G     + +    T  VFA K++  +   +   R ++  EI I R + H +VV  H 
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIK 220
            ++ N  + V+LE     SL   H R++ +    AR    Q++ G  YLH+ +++HRD+K
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
             NL +N    VKI DFG++  +    +      GT  Y++PE ++      K   +  D
Sbjct: 143 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK-----KGHSFEVD 197
Query: 281 IWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKD 340
           +WS+G  +    +G+ PF      +    +    ++ P     +A+      I + LQ D
Sbjct: 198 VWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA----SLIQKMLQTD 253
Query: 341 PHSRWPAAQLLQHPFI 356
           P +R    +LL   F 
Sbjct: 254 PTARPTINELLNDEFF 269

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +  +
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG-H 72
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL----LKRREFHAEPV 188
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 123/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 29  NTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 86
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+     +      A Q++ 
Sbjct: 87  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGRFXEPHARFYAAQIVL 145
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 146 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 201
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 202 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 250
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 251 PSHFSSDLKDLLRNLLQVDLTKRF 274

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 125/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A+L + +RI   G+GS G V  V H  +   +A+K++  + +  V+         E  
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+     +      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFXEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +  +
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG-H 72
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL----LKRREFHAEPV 188
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 125/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A+L + +RI   G+GS G V  V H  +   +A+K++  + +  V+         E  
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++P 
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPA 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +  +
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG-H 73
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL----LKRREFHAEPV 189
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 190 DVWSCGIVLTAMLAGELPW 208

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 124/295 (42%), Gaps = 56/295 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQI----CREIEILRDVN---HPNV 159
           IG G+ GTV++   P +    ALK +   +       +     RE+ +LR +    HPNV
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 160 VKCHDM-----YDRNGEIEVLLE--------YMDGGSLEGAHIRQEHILSDLARQVLSGL 206
           V+  D+      DR  ++ ++ E        Y+D     G        + DL RQ L GL
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGL---PAETIKDLMRQFLRGL 133
Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN 266
            +LH   IVHRD+KP N+L+ S   VK+ADFG++RI +  M      V T+ Y +PE   
Sbjct: 134 DFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPVVVTLWYRAPEV-- 190
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE------ 320
             L    Y     D+WS+G    E +  +  F    + D    +F +    PPE      
Sbjct: 191 --LLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL-IGLPPEDDWPRD 246
Query: 321 -------------------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                               PEM     +  +   L  +PH R  A + LQH ++
Sbjct: 247 VSLPRGAFPPRGPRPVQSVVPEMEESGAQ-LLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 123/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 36  NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY  GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NL+I+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 122/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 37  NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 94
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P + K    +  N  + +++EY  GG +  +H+R+    S+      A Q++ 
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 153
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NL+I+    +K+ DFG + R+  +T   C    GT  Y++PE
Sbjct: 154 TFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPE 209
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 210 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 258
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKRF 282

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 123/257 (47%), Gaps = 21/257 (8%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
            +L    +IG+GS GTV R     +     + +    H + V ++  RE+ I++ + HPN
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERV-NEFLREVAIMKRLRHPN 95
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSL------EGA--HIRQEHILSDLARQVLSGLAYLH 210
           +V       +   + ++ EY+  GSL       GA   + +   LS +A  V  G+ YLH
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS-MAYDVAKGMNYLH 154
Query: 211 KRK--IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
            R   IVHR++K  NLL++    VK+ DFG+SR+ A T     SA GT  +M+PE +  +
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF-AQPPEAPEMASR 327
            ++ K      D++S GV + E    + P+      + A ++ A+ F  +  E P   + 
Sbjct: 215 PSNEK-----SDVYSFGVILWELATLQQPWG---NLNPAQVVAAVGFKCKRLEIPRNLNP 266
Query: 328 EFRDFISRCLQKDPHSR 344
           +    I  C   +P  R
Sbjct: 267 QVAAIIEGCWTNEPWKR 283

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 122/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 37  NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 94
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P + K    +  N  + +++EY  GG +  +H+R+    S+      A Q++ 
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM-FSHLRRIGRFSEPHARFYAAQIVL 153
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NL+I+    +K+ DFG + R+  +T   C    GT  Y++PE
Sbjct: 154 TFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPE 209
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 210 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 258
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKRF 282

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 123/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 36  NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+     +      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGRFXEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +  +
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 71
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 131
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 132 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL----LKRREFHAEPV 187
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 188 DVWSCGIVLTAMLAGELPW 206

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 123/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 36  NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+     +      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGRFXEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 123/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 37  NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 94
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+     +      A Q++ 
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGRFXEPHARFYAAQIVL 153
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT  Y++PE
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEYLAPE 209
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 210 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 258
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKRF 282

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +  +
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL----LKRREFHAEPV 189
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 190 DVWSCGIVLTAMLAGELPW 208

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +  +
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 72
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL----LKRREFHAEPV 188
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 122/264 (46%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 36  NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY  GG +  +H+R+     +      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM-FSHLRRIGRFXEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NL+I+    +K+ DFG + R+  +T   C    GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +  +
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 72
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL----LKRREFHAEPV 188
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 136/292 (46%), Gaps = 44/292 (15%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V +  +   SR +A+K I   H +   S I  E+ +L  +NH  VV+ +  +
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 167 -------------DRNGEIEVLLEYMDGGSLEGAHIRQEHILSD------LARQVLSGLA 207
                         +   + + +EY +  +L    I  E++         L RQ+L  L+
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDL-IHSENLNQQRDEYWRLFRQILEALS 130
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM--------------DPCNSA 253
           Y+H + I+HRD+KP N+ I+ S+NVKI DFG+++ + +++              D   SA
Sbjct: 131 YIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190
Query: 254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG-DWASLMFA 312
           +GT  Y++ E ++     G Y+    D++SLG+   E     +PF+ G +  +    + +
Sbjct: 191 IGTAMYVATEVLD---GTGHYNEKI-DMYSLGIIFFEMI---YPFSTGMERVNILKKLRS 243
Query: 313 ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV 364
           +    PP+  +   +  +  I   +  DP+ R  A  LL   ++    Q +V
Sbjct: 244 VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEV 295

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +  +
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 72
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL----LKRREFHAEPV 188
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +  +
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 72
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL----LKRREFHAEPV 188
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +  +
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 72
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL----LKRREFHAEPV 188
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +  +
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL----LKRREFHAEPV 189
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 190 DVWSCGIVLTAMLAGELPW 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +  +
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 72
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL----LKRREFHAEPV 188
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +  +
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL----LKRREFHAEPV 189
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 190 DVWSCGIVLTAMLAGELPW 208

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 125/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A+L + +RI   G+GS G V  V H  +   +A+K++  + +  V+         E  
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T        GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLAGTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +  +
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL----LKRREFHAEPV 189
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 190 DVWSCGIVLTAMLAGELPW 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +  +
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL----LKRREFHAEPV 189
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 190 DVWSCGIVLTAMLAGELPW 208

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +  +
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL----LKRREFHAEPV 189
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 190 DVWSCGIVLTAMLAGELPW 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +  +
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 72
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL----LKRREFHAEPV 188
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +  +
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 72
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL----LKRREFHAEPV 188
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 125/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A+L + +RI   G+GS G V  V H  +   +A+K++  + +  V+         E  
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T   C    GT   ++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC----GTPEALAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +  +
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 72
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 132
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 133 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL----LKRREFHAEPV 188
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 189 DVWSCGIVLTAMLAGELPW 207

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 125/264 (47%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A+L + +RI   G+GS G V  V H  +   +A+K++  + +  V+         E  
Sbjct: 36  NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 93
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P +VK    +  N  + +++EY+ GG +  +H+R+    S+      A Q++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARFYAAQIVL 152
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NLLI+    +++ DFG + R+  +T        GT  Y++PE
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----XLXGTPEYLAPE 208
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 209 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 257
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRF 281

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 129/285 (45%), Gaps = 26/285 (9%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G GS G V       T  ++A+KV+  +    +D V   +  +  +    NHP + +  
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRD 218
             +     +  ++E+++GG L   HI++     +      A +++S L +LH + I++RD
Sbjct: 91  CCFQTPDRLFFVMEFVNGGDLM-FHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRD 149
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           +K  N+L++   + K+ADFG+ +          +  GT  Y++PE +   L      G A
Sbjct: 150 LKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY-----GPA 204
Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ 338
            D W++GV + E   G  PF    + D    +       P    E A+   + F++    
Sbjct: 205 VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMT---- 260
Query: 339 KDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPPPRP 377
           K+P  R  +        +L+HPF      +Q+N   RQI PP RP
Sbjct: 261 KNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNH--RQIEPPFRP 303

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 120/268 (44%), Gaps = 25/268 (9%)
Query: 104 GNRIGSGSGGTVWRVVHPPT---SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           G+ +G GS G V  V+   T     V  LK        +  + + +EI++LR + H NV+
Sbjct: 10  GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 161 KCHDMY--DRNGEIEVLLEYMDGGSLEGAH--------IRQEHILSDLARQVLSGLAYLH 210
           +  D+   +   ++ +++EY   G  E           + Q H       Q++ GL YLH
Sbjct: 70  QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAH---GYFCQLIDGLEYLH 126
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL--AQTMDPCNSAVGTIAYMSPERINTD 268
            + IVH+DIKP NLL+ +   +KI+  GV+  L      D C ++ G+ A+  PE  N  
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN-- 184
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
                + G+  DIWS GV++     G +PF    +GD    +F          P      
Sbjct: 185 -GLDTFSGFKVDIWSAGVTLYNITTGLYPF----EGDNIYKLFENIGKGSYAIPGDCGPP 239
Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             D +   L+ +P  R+   Q+ QH + 
Sbjct: 240 LSDLLKGMLEYEPAKRFSIRQIRQHSWF 267

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 121/264 (45%), Gaps = 33/264 (12%)
Query: 97  NPAELQKGNRI---GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIE 149
           N A L +  RI   G+GS G V  V H  T   +A+K++  + +  V+         E  
Sbjct: 37  NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL--DKQKVVKLKQIEHTLNEKR 94
Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLS 204
           IL+ VN P + K    +  N  + +++EY  GG +  +H+R+     +      A Q++ 
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM-FSHLRRIGRFXEPHARFYAAQIVL 153
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE 263
              YLH   +++RD+KP NL+I+    +K+ DFG + R+  +T   C    GT  Y++PE
Sbjct: 154 TFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC----GTPEYLAPE 209
Query: 264 RINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
            I +        GY  A D W+LGV I E   G  PF      D    ++    +     
Sbjct: 210 IILS-------KGYNKAVDWWALGVLIYEMAAGYPPFF----ADQPIQIYEKIVSGKVRF 258
Query: 322 PEMASREFRDFISRCLQKDPHSRW 345
           P   S + +D +   LQ D   R+
Sbjct: 259 PSHFSSDLKDLLRNLLQVDLTKRF 282

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I   +NH NVVK +  +
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG-H 73
Query: 167 DRNGEIEVL-LEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
            R G I+ L LEY  GG L    E      E        Q+++G+ YLH   I HRDIKP
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133
Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE     L   ++     
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL----LKRREFHAEPV 189
Query: 280 DIWSLGVSILEFYLGRFPF 298
           D+WS G+ +     G  P+
Sbjct: 190 DVWSCGIVLTAMLAGELPW 208

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 113/257 (43%), Gaps = 15/257 (5%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G  G V R V   + + +  K +     D V   + +EI IL    H N++  H+ +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIARHRNILHLHESF 70
Query: 167 DRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
           +   E+ ++ E++ G  +       A    E  +     QV   L +LH   I H DI+P
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRP 130
Query: 222 SNLLINS--SKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            N++  +  S  +KI +FG +R     + P ++    + + +PE    +++       A 
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQAR----QLKPGDNF--RLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 280 DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQK 339
           D+WSLG  +     G  PF           +    +    EA +  S E  DF+ R L K
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK 244
Query: 340 DPHSRWPAAQLLQHPFI 356
           +  SR  A++ LQHP++
Sbjct: 245 ERKSRMTASEALQHPWL 261

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 92/310 (29%), Positives = 135/310 (43%), Gaps = 56/310 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG+GS G V++     +  V   KV+      +      RE++I+R V HPNVV     +
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN------RELQIMRIVKHPNVVDLKAFF 101
Query: 167 DRNGE------IEVLLEYMDG----GSLEGAHIRQEH---ILSDLARQVLSGLAYLHKRK 213
             NG+      + ++LEY+       S   A ++Q     ++     Q+L  LAY+H   
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG 161
Query: 214 IVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           I HRDIKP NLL++    V K+ DFG ++IL    +P  S + +  Y +PE I    N+ 
Sbjct: 162 ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-EPNVSXICSRYYRAPELIFGATNYT 220
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA----------- 321
                  DIWS G  + E   G+ P   G  G    +        P              
Sbjct: 221 T----NIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYME 275
Query: 322 -------PEMASREFR--------DFISRCLQKDPHSRWPAAQLLQHPFI--LRAGQSQV 364
                  P   S+ FR        D ISR L+  P +R  A + L HPF   LR G++++
Sbjct: 276 HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARM 335
Query: 365 NQNLRQILPP 374
             N R+ LPP
Sbjct: 336 -PNGRE-LPP 343

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 121/257 (47%), Gaps = 21/257 (8%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
            +L    +IG+GS GTV R     +     + +    H + V ++  RE+ I++ + HPN
Sbjct: 37  CDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERV-NEFLREVAIMKRLRHPN 95
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSL------EGA--HIRQEHILSDLARQVLSGLAYLH 210
           +V       +   + ++ EY+  GSL       GA   + +   LS +A  V  G+ YLH
Sbjct: 96  IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS-MAYDVAKGMNYLH 154
Query: 211 KRK--IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
            R   IVHRD+K  NLL++    VK+ DFG+SR+ A        A GT  +M+PE +  +
Sbjct: 155 NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF-AQPPEAPEMASR 327
            ++ K      D++S GV + E    + P+      + A ++ A+ F  +  E P   + 
Sbjct: 215 PSNEK-----SDVYSFGVILWELATLQQPWG---NLNPAQVVAAVGFKCKRLEIPRNLNP 266
Query: 328 EFRDFISRCLQKDPHSR 344
           +    I  C   +P  R
Sbjct: 267 QVAAIIEGCWTNEPWKR 283

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 124/260 (47%), Gaps = 31/260 (11%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T+RV    +  G        Q   E ++++ + H  +V+ + +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 81
Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I +++EYM  GSL        G ++R   ++ D+A Q+ SG+AY+ +   VHRD
Sbjct: 82  VSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV-DMAAQIASGMAYVERMNYVHRD 139
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L+  +   K+ADFG++R++          A   I + +PE       +G++   
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAA----LYGRFT-I 194
Query: 278 AGDIWSLGVSILEFYL-GRFPF--AVGRQG-DWASLMFAI-CFAQPPEAPEMASREFRDF 332
             D+WS G+ + E    GR P+   V R+  D     + + C   PPE PE       D 
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPE----SLHDL 247
Query: 333 ISRCLQKDPHSRWPAAQLLQ 352
           + +C +KDP  R P  + LQ
Sbjct: 248 MCQCWRKDPEER-PTFEYLQ 266

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKXQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLTQ 264

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEG----AHIRQEHILSDLARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L      A +  +H+   L  Q+L GL 
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHV-QFLIYQILRGLK 135
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 190
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 191 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 249 ESARNYIQSLAQ 260

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 118/261 (45%), Gaps = 24/261 (9%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN------HEDSVRSQICREIEIL 151
           P++      IG GS G V    H      +A+KV+          E  + S+  R + +L
Sbjct: 37  PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE--RNV-LL 93
Query: 152 RDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGL 206
           ++V HP +V  H  +    ++  +L+Y++GG L   H+++E    +      A ++ S L
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL-FYHLQRERCFLEPRARFYAAEIASAL 152
Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN 266
            YLH   IV+RD+KP N+L++S  ++ + DFG+ +   +     ++  GT  Y++PE   
Sbjct: 153 GYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV-- 210
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS 326
             L+   YD    D W LG  + E   G  PF      +    M+     +P +     +
Sbjct: 211 --LHKQPYDRTV-DWWCLGAVLYEMLYGLPPFYSRNTAE----MYDNILNKPLQLKPNIT 263
Query: 327 REFRDFISRCLQKDPHSRWPA 347
              R  +   LQKD   R  A
Sbjct: 264 NSARHLLEGLLQKDRTKRLGA 284

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + IGSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 26  PERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 144
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 145 YIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 199
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 200 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 257
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 258 ESARNYIQSLTQ 269

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 123/260 (47%), Gaps = 31/260 (11%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T+RV    +  GN          +E ++++ + H  +V+ + +
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA---FLQEAQVMKKLRHEKLVQLYAV 248
Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I ++ EYM  GSL        G ++R   ++ D+A Q+ SG+AY+ +   VHRD
Sbjct: 249 VSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV-DMAAQIASGMAYVERMNYVHRD 306
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L+  +   K+ADFG+ R++          A   I + +PE       +G++   
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAA----LYGRFT-I 361
Query: 278 AGDIWSLGVSILEFYL-GRFPF--AVGRQG-DWASLMFAI-CFAQPPEAPEMASREFRDF 332
             D+WS G+ + E    GR P+   V R+  D     + + C   PPE PE       D 
Sbjct: 362 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPE----SLHDL 414
Query: 333 ISRCLQKDPHSRWPAAQLLQ 352
           + +C +KDP  R P  + LQ
Sbjct: 415 MCQCWRKDPEER-PTFEYLQ 433

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 115/252 (45%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKSQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG+ R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDSELKILDFGLCR---HTDDEMTGYVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLTQ 264

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 123/288 (42%), Gaps = 47/288 (16%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVKCHDM 165
           +GSG+ G V   V   T    A+K +Y   +  + ++   RE+ +L+ + H NV+   D+
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 166 Y------DRNGEIEVLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLAYLHKRKIV 215
           +      D   +  +++ +M  G+  G  ++ E +  D    L  Q+L GL Y+H   I+
Sbjct: 93  FTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII 150
Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           HRD+KP NL +N    +KI DFG++R   Q        V T  Y +PE I   LN  +Y 
Sbjct: 151 HRDLKPGNLAVNEDCELKILDFGLAR---QADSEMXGXVVTRWYRAPEVI---LNWMRYT 204
Query: 276 GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--------------- 320
               DIWS+G  + E   G+  F      D    +  +    P E               
Sbjct: 205 QTV-DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 263
Query: 321 -APEMASREFR-----------DFISRCLQKDPHSRWPAAQLLQHPFI 356
             PE+  ++F            + + + L  D   R  A + L HP+ 
Sbjct: 264 GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 105/203 (51%), Gaps = 24/203 (11%)
Query: 106 RIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           ++G G+ G+V    + P    T  V A+K +  + E+ +R    REIEIL+ + H N+VK
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 78
Query: 162 ----CHDMYDRNGEIEVLLEYMDGGSLEG---AHI-RQEHI-LSDLARQVLSGLAYLHKR 212
               C+    RN  +++++EY+  GSL     AH  R +HI L     Q+  G+ YL  +
Sbjct: 79  YKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTK 136
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS---AVGTIAYMSPERINTDL 269
           + +HRD+   N+L+ +   VKI DFG++++L Q  +           I + +PE     L
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE----SL 192
Query: 270 NHGKYDGYAGDIWSLGVSILEFY 292
              K+   A D+WS GV + E +
Sbjct: 193 TESKF-SVASDVWSFGVVLYELF 214

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 119/257 (46%), Gaps = 22/257 (8%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
            R+G+G  G VW   +  +++V    +  G    SV++    E  +++ + H  +V+ + 
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQA-FLEEANLMKTLQHDKLVRLYA 75
Query: 165 MYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
           +  R   I ++ EYM  GSL       EG  +    ++ D + Q+  G+AY+ ++  +HR
Sbjct: 76  VVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI-DFSAQIAEGMAYIERKNYIHR 134
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDG 276
           D++ +N+L++ S   KIADFG++R++          A   I + +PE IN      K   
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK--- 191
Query: 277 YAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISR 335
              D+WS G+ + E    G+ P+  GR    A +M A+         E    E  D +  
Sbjct: 192 --SDVWSFGILLYEIVTYGKIPYP-GRTN--ADVMTALSQGYRMPRVENCPDELYDIMKM 246
Query: 336 CLQKDPHSRWPAAQLLQ 352
           C ++    R P    LQ
Sbjct: 247 CWKEKAEER-PTFDYLQ 262

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 124/260 (47%), Gaps = 31/260 (11%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T+RV    +  G        Q   E ++++ + H  +V+ + +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 81
Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I +++EYM  GSL        G ++R   ++ D+A Q+ SG+AY+ +   VHRD
Sbjct: 82  VSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLV-DMAAQIASGMAYVERMNYVHRD 139
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L+  +   K+ADFG++R++          A   I + +PE       +G++   
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA----LYGRFT-I 194
Query: 278 AGDIWSLGVSILEFYL-GRFPF--AVGRQG-DWASLMFAI-CFAQPPEAPEMASREFRDF 332
             D+WS G+ + E    GR P+   V R+  D     + + C   PPE PE       D 
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPE----SLHDL 247
Query: 333 ISRCLQKDPHSRWPAAQLLQ 352
           + +C +KDP  R P  + LQ
Sbjct: 248 MCQCWRKDPEER-PTFEYLQ 266

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 134/292 (45%), Gaps = 44/292 (15%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V +  +   SR +A+K I   H +   S I  E+ +L  +NH  VV+ +  +
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLSTILSEVXLLASLNHQYVVRYYAAW 71
Query: 167 -------------DRNGEIEVLLEYMDGGSLEGAHIRQEHILSD------LARQVLSGLA 207
                         +   + +  EY +  +L    I  E++         L RQ+L  L+
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDL-IHSENLNQQRDEYWRLFRQILEALS 130
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM--------------DPCNSA 253
           Y+H + I+HR++KP N+ I+ S+NVKI DFG+++ + +++              D   SA
Sbjct: 131 YIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSA 190
Query: 254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG-DWASLMFA 312
           +GT  Y++ E ++     G Y+    D +SLG+   E     +PF+ G +  +    + +
Sbjct: 191 IGTAXYVATEVLD---GTGHYNEKI-DXYSLGIIFFEXI---YPFSTGXERVNILKKLRS 243
Query: 313 ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV 364
           +    PP+  +   +  +  I   +  DP+ R  A  LL   ++    Q +V
Sbjct: 244 VSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEV 295

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 123/260 (47%), Gaps = 31/260 (11%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T+RV    +  G        Q   E ++++ + H  +V+ + +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKIRHEKLVQLYAV 81
Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I ++ EYM  GSL        G ++R   ++ D+A Q+ SG+AY+ +   VHRD
Sbjct: 82  VSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV-DMAAQIASGMAYVERMNYVHRD 139
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L+  +   K+ADFG++R++          A   I + +PE       +G++   
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA----LYGRFT-I 194
Query: 278 AGDIWSLGVSILEFYL-GRFPF--AVGRQG-DWASLMFAI-CFAQPPEAPEMASREFRDF 332
             D+WS G+ + E    GR P+   V R+  D     + + C   PPE PE       D 
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPE----SLHDL 247
Query: 333 ISRCLQKDPHSRWPAAQLLQ 352
           + +C +KDP  R P  + LQ
Sbjct: 248 MCQCWRKDPEER-PTFEYLQ 266

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 26  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 144
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 145 YIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 199
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 200 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 257
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 258 ESARNYIQSLTQ 269

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 23  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 82
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 141
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 142 YIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 196
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 197 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 254
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 255 ESARNYIQSLTQ 266

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKXQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLTQ 264

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 146
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAPEIM-- 201
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 202 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 260 ESARNYIQSLTQ 271

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 146
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAPEIM-- 201
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 202 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 260 ESARNYIQSLTQ 271

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 27  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 86
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 145
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 146 YIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 200
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 201 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 258
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 259 ESARNYIQSLTQ 270

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 146
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAPEIM-- 201
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 202 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 260 ESARNYIQSLTQ 271

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 32  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 91
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 150
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 151 YIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 205
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 206 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 263
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 264 ESARNYIQSLTQ 275

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 123/260 (47%), Gaps = 31/260 (11%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T+RV    +  G        Q   E ++++ + H  +V+ + +
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 70
Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I ++ EYM  GSL        G ++R   ++ D+A Q+ SG+AY+ +   VHRD
Sbjct: 71  VSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV-DMAAQIASGMAYVERMNYVHRD 128
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L+  +   K+ADFG++R++          A   I + +PE       +G++   
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA----LYGRFT-I 183
Query: 278 AGDIWSLGVSILEFYL-GRFPF--AVGRQG-DWASLMFAI-CFAQPPEAPEMASREFRDF 332
             D+WS G+ + E    GR P+   V R+  D     + + C   PPE PE       D 
Sbjct: 184 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPE----SLHDL 236
Query: 333 ISRCLQKDPHSRWPAAQLLQ 352
           + +C +KDP  R P  + LQ
Sbjct: 237 MCQCWRKDPEER-PTFEYLQ 255

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 33  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKH 92
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 151
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 152 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 206
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 207 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 264
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 265 ESARNYIQSLTQ 276

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 123/260 (47%), Gaps = 31/260 (11%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T+RV    +  G        Q   E ++++ + H  +V+ + +
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 71
Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I ++ EYM  GSL        G ++R   ++ D+A Q+ SG+AY+ +   VHRD
Sbjct: 72  VSEE-PIXIVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAYVERMNYVHRD 129
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L+  +   K+ADFG++R++          A   I + +PE       +G++   
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAA----LYGRFT-I 184
Query: 278 AGDIWSLGVSILEFYL-GRFPF--AVGRQG-DWASLMFAI-CFAQPPEAPEMASREFRDF 332
             D+WS G+ + E    GR P+   V R+  D     + + C   PPE PE       D 
Sbjct: 185 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPE----SLHDL 237
Query: 333 ISRCLQKDPHSRWPAAQLLQ 352
           + +C +K+P  R P  + LQ
Sbjct: 238 MCQCWRKEPEER-PTFEYLQ 256

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 18/202 (8%)
Query: 104 GNRIGSGSGGTVWR-VVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKC 162
           GN++G G  G V++  V+  T  V  L  +     + ++ Q  +EI+++    H N+V+ 
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 163 HDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
                   ++ ++  YM  GSL       +G      H+   +A+   +G+ +LH+   +
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155
Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRI---LAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRDIK +N+L++ +   KI+DFG++R     AQT+   +  VGT AYM+PE +  ++   
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTV-MXSRIVGTTAYMAPEALRGEITP- 213
Query: 273 KYDGYAGDIWSLGVSILEFYLG 294
                  DI+S GV +LE   G
Sbjct: 214 -----KSDIYSFGVVLLEIITG 230

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 35/208 (16%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK---CH 163
           IGSG  G V++  H    + + +K +  N+E + R     E++ L  ++H N+V    C 
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER-----EVKALAKLDHVNIVHYNGCW 73
Query: 164 DMYDRNGEIE-------------VLLEYMDGGSLE-------GAHIRQEHILSDLARQVL 203
           D +D + E               + +E+ D G+LE       G  + +   L +L  Q+ 
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL-ELFEQIT 132
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPE 263
            G+ Y+H +K+++RD+KPSN+ +  +K VKI DFG+   L        S  GT+ YMSPE
Sbjct: 133 KGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK-GTLRYMSPE 191
Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILEF 291
           +I++  ++GK      D+++LG+ + E 
Sbjct: 192 QISSQ-DYGK----EVDLYALGLILAEL 214

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 40  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 99
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 158
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 159 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 213
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 214 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 271
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 272 ESARNYIQSLAQ 283

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 41  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 100
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 159
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 160 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 214
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 215 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 272
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 273 ESARNYIQSLAQ 284

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 106 RIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           ++G G+ G+V    + P    T  V A+K +  + E+ +R    REIEIL+ + H N+VK
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 106
Query: 162 ----CHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHI-LSDLARQVLSGLAYLHKR 212
               C+    RN  +++++EY+  GSL    +    R +HI L     Q+  G+ YL  +
Sbjct: 107 YKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS---AVGTIAYMSPERINTDL 269
           + +HRD+   N+L+ +   VKI DFG++++L Q  +           I + +PE     L
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE----SL 220
Query: 270 NHGKYDGYAGDIWSLGVSILEFY 292
              K+   A D+WS GV + E +
Sbjct: 221 TESKF-SVASDVWSFGVVLYELF 242

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNAMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLTQ 264

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 123/260 (47%), Gaps = 31/260 (11%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T+RV    +  G        Q   E ++++ + H  +V+ + +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 81
Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I ++ EYM  GSL        G ++R   ++ D+A Q+ SG+AY+ +   VHRD
Sbjct: 82  VSEE-PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLV-DMAAQIASGMAYVERMNYVHRD 139
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L+  +   K+ADFG++R++          A   I + +PE       +G++   
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA----LYGRFT-I 194
Query: 278 AGDIWSLGVSILEFYL-GRFPF--AVGRQG-DWASLMFAI-CFAQPPEAPEMASREFRDF 332
             D+WS G+ + E    GR P+   V R+  D     + + C   PPE PE       D 
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPE----SLHDL 247
Query: 333 ISRCLQKDPHSRWPAAQLLQ 352
           + +C +KDP  R P  + LQ
Sbjct: 248 MCQCWRKDPEER-PTFEYLQ 266

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 41  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 100
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 159
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 160 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMXGXVATRWYRAPEIM-- 214
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 215 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 272
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 273 ESARNYIQSLAQ 284

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 135
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 190
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 191 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 249 ESARNYIQSLAQ 260

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 106 RIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           ++G G+ G+V    + P    T  V A+K +  + E+ +R    REIEIL+ + H N+VK
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 79
Query: 162 ----CHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHI-LSDLARQVLSGLAYLHKR 212
               C+    RN  +++++EY+  GSL    +    R +HI L     Q+  G+ YL  +
Sbjct: 80  YKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 137
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS---AVGTIAYMSPERINTDL 269
           + +HRD+   N+L+ +   VKI DFG++++L Q  +           I + +PE     L
Sbjct: 138 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE----SL 193
Query: 270 NHGKYDGYAGDIWSLGVSILEFY 292
              K+   A D+WS GV + E +
Sbjct: 194 TESKF-SVASDVWSFGVVLYELF 215

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGXVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLTQ 264

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 27  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 86
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 145
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 146 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 200
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 201 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 258
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 259 ESARNYIQSLAQ 270

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLTQ 264

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 106 RIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           ++G G+ G+V    + P    T  V A+K +  + E+ +R    REIEIL+ + H N+VK
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 73
Query: 162 ----CHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHI-LSDLARQVLSGLAYLHKR 212
               C+    RN  +++++EY+  GSL    +    R +HI L     Q+  G+ YL  +
Sbjct: 74  YKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 131
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS---AVGTIAYMSPERINTDL 269
           + +HRD+   N+L+ +   VKI DFG++++L Q  +           I + +PE     L
Sbjct: 132 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE----SL 187
Query: 270 NHGKYDGYAGDIWSLGVSILEFY 292
              K+   A D+WS GV + E +
Sbjct: 188 TESKF-SVASDVWSFGVVLYELF 209

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLAQ 264

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 123/260 (47%), Gaps = 31/260 (11%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T+RV    +  G        Q   E ++++ + H  +V+ + +
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 72
Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I ++ EYM  GSL        G ++R   ++ D+A Q+ SG+AY+ +   VHRD
Sbjct: 73  VSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV-DMAAQIASGMAYVERMNYVHRD 130
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L+  +   K+ADFG++R++          A   I + +PE       +G++   
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA----LYGRFT-I 185
Query: 278 AGDIWSLGVSILEFYL-GRFPF--AVGRQG-DWASLMFAI-CFAQPPEAPEMASREFRDF 332
             D+WS G+ + E    GR P+   V R+  D     + + C   PPE PE       D 
Sbjct: 186 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPE----SLHDL 238
Query: 333 ISRCLQKDPHSRWPAAQLLQ 352
           + +C +KDP  R P  + LQ
Sbjct: 239 MCQCWRKDPEER-PTFEYLQ 257

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLTQ 264

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLTQ 264

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 123/260 (47%), Gaps = 31/260 (11%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T+RV    +  G        Q   E ++++ + H  +V+ + +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 81
Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I ++ EYM  GSL        G ++R   ++ D+A Q+ SG+AY+ +   VHRD
Sbjct: 82  VSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV-DMAAQIASGMAYVERMNYVHRD 139
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L+  +   K+ADFG++R++          A   I + +PE       +G++   
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA----LYGRFT-I 194
Query: 278 AGDIWSLGVSILEFYL-GRFPF--AVGRQG-DWASLMFAI-CFAQPPEAPEMASREFRDF 332
             D+WS G+ + E    GR P+   V R+  D     + + C   PPE PE       D 
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPE----SLHDL 247
Query: 333 ISRCLQKDPHSRWPAAQLLQ 352
           + +C +KDP  R P  + LQ
Sbjct: 248 MCQCWRKDPEER-PTFEYLQ 266

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 106 RIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           ++G G+ G+V    + P    T  V A+K +  + E+ +R    REIEIL+ + H N+VK
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 81
Query: 162 ----CHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHI-LSDLARQVLSGLAYLHKR 212
               C+    RN  +++++EY+  GSL    +    R +HI L     Q+  G+ YL  +
Sbjct: 82  YKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 139
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS---AVGTIAYMSPERINTDL 269
           + +HRD+   N+L+ +   VKI DFG++++L Q  +           I + +PE     L
Sbjct: 140 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE----SL 195
Query: 270 NHGKYDGYAGDIWSLGVSILEFY 292
              K+   A D+WS GV + E +
Sbjct: 196 TESKF-SVASDVWSFGVVLYELF 217

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 44  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 103
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 162
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 163 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 217
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 218 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 275
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 276 ESARNYIQSLTQ 287

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 106 RIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           ++G G+ G+V    + P    T  V A+K +  + E+ +R    REIEIL+ + H N+VK
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 80
Query: 162 ----CHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHI-LSDLARQVLSGLAYLHKR 212
               C+    RN  +++++EY+  GSL    +    R +HI L     Q+  G+ YL  +
Sbjct: 81  YKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 138
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS---AVGTIAYMSPERINTDL 269
           + +HRD+   N+L+ +   VKI DFG++++L Q  +           I + +PE     L
Sbjct: 139 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE----SL 194
Query: 270 NHGKYDGYAGDIWSLGVSILEFY 292
              K+   A D+WS GV + E +
Sbjct: 195 TESKF-SVASDVWSFGVVLYELF 216

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 106 RIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           ++G G+ G+V    + P    T  V A+K +  + E+ +R    REIEIL+ + H N+VK
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 74
Query: 162 ----CHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHI-LSDLARQVLSGLAYLHKR 212
               C+    RN  +++++EY+  GSL    +    R +HI L     Q+  G+ YL  +
Sbjct: 75  YKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 132
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS---AVGTIAYMSPERINTDL 269
           + +HRD+   N+L+ +   VKI DFG++++L Q  +           I + +PE     L
Sbjct: 133 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE----SL 188
Query: 270 NHGKYDGYAGDIWSLGVSILEFY 292
              K+   A D+WS GV + E +
Sbjct: 189 TESKF-SVASDVWSFGVVLYELF 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 106 RIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           ++G G+ G+V    + P    T  V A+K +  + E+ +R    REIEIL+ + H N+VK
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 75
Query: 162 ----CHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHI-LSDLARQVLSGLAYLHKR 212
               C+    RN  +++++EY+  GSL    +    R +HI L     Q+  G+ YL  +
Sbjct: 76  YKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS---AVGTIAYMSPERINTDL 269
           + +HRD+   N+L+ +   VKI DFG++++L Q  +           I + +PE     L
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE----SL 189
Query: 270 NHGKYDGYAGDIWSLGVSILEFY 292
              K+   A D+WS GV + E +
Sbjct: 190 TESKF-SVASDVWSFGVVLYELF 211

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 146
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 201
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 202 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 260 ESARNYIQSLTQ 271

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 123/260 (47%), Gaps = 31/260 (11%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T+RV    +  G        Q   E ++++ + H  +V+ + +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 81
Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I +++EYM  G L        G ++R   ++ D+A Q+ SG+AY+ +   VHRD
Sbjct: 82  VSEE-PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLV-DMAAQIASGMAYVERMNYVHRD 139
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L+  +   K+ADFG++R++          A   I + +PE       +G++   
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA----LYGRFT-I 194
Query: 278 AGDIWSLGVSILEFYL-GRFPF--AVGRQG-DWASLMFAI-CFAQPPEAPEMASREFRDF 332
             D+WS G+ + E    GR P+   V R+  D     + + C   PPE PE       D 
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPE----SLHDL 247
Query: 333 ISRCLQKDPHSRWPAAQLLQ 352
           + +C +KDP  R P  + LQ
Sbjct: 248 MCQCWRKDPEER-PTFEYLQ 266

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLTQ 264

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 106 RIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           ++G G+ G+V    + P    T  V A+K +  + E+ +R    REIEIL+ + H N+VK
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 82
Query: 162 ----CHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHI-LSDLARQVLSGLAYLHKR 212
               C+    RN  +++++EY+  GSL    +    R +HI L     Q+  G+ YL  +
Sbjct: 83  YKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 140
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS---AVGTIAYMSPERINTDL 269
           + +HRD+   N+L+ +   VKI DFG++++L Q  +           I + +PE     L
Sbjct: 141 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE----SL 196
Query: 270 NHGKYDGYAGDIWSLGVSILEFY 292
              K+   A D+WS GV + E +
Sbjct: 197 TESKF-SVASDVWSFGVVLYELF 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 135
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 190
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 191 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 249 ESARNYIQSLTQ 260

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 32  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 91
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 150
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 151 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 205
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 206 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 263
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 264 ESARNYIQSLTQ 275

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 18  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 77
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 136
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 137 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 191
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 192 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 249
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 250 ESARNYIQSLTQ 261

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 106 RIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           ++G G+ G+V    + P    T  V A+K +  + E+ +R    REIEIL+ + H N+VK
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 78
Query: 162 ----CHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHI-LSDLARQVLSGLAYLHKR 212
               C+    RN  +++++EY+  GSL    +    R +HI L     Q+  G+ YL  +
Sbjct: 79  YKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 136
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS---AVGTIAYMSPERINTDL 269
           + +HRD+   N+L+ +   VKI DFG++++L Q  +           I + +PE     L
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE----SL 192
Query: 270 NHGKYDGYAGDIWSLGVSILEFY 292
              K+   A D+WS GV + E +
Sbjct: 193 TESKF-SVASDVWSFGVVLYELF 214

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 18  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 77
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 136
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 137 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 191
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 192 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 249
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 250 ESARNYIQSLTQ 261

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLTQ 264

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 118/269 (43%), Gaps = 34/269 (12%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQIC---REIEILR 152
           I+ AEL     IG G  G V+R          A+K    + ++ +   I    +E ++  
Sbjct: 4   IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGG----SLEGAHIRQEHILSDLARQVLSGLAY 208
            + HPN++    +  +   + +++E+  GG     L G  I  + IL + A Q+  G+ Y
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPD-ILVNWAVQIARGMNY 120
Query: 209 LHKRKIV---HRDIKPSNLLI--------NSSKNVKIADFGVSRILAQTMDPCNSAVGTI 257
           LH   IV   HRD+K SN+LI         S+K +KI DFG++R   +T     SA G  
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGAY 178
Query: 258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF--AVGRQGDWASLMFAICF 315
           A+M+PE I   +          D+WS GV + E   G  PF    G    +   M  +  
Sbjct: 179 AWMAPEVIRASMF-----SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233
Query: 316 AQPPEAPEMASREFRDFISRCLQKDPHSR 344
             P   PE     F   +  C   DPHSR
Sbjct: 234 PIPSTCPE----PFAKLMEDCWNPDPHSR 258

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 26  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 144
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 145 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 199
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 200 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 257
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 258 ESARNYIQSLTQ 269

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLTQ 264

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 20  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 79
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 80  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 138
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 139 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 193
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 194 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 251
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 252 ESARNYIQSLTQ 263

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 23  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 82
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 141
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 142 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 196
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 197 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 254
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 255 ESARNYIQSLTQ 266

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 26  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 144
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 145 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 199
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 200 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 257
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 258 ESARNYIQSLTQ 269

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLTQ 264

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 41  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 100
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 159
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 160 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 214
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 215 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 272
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 273 ESARNYIQSLTQ 284

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 27  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 86
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 145
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 146 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 200
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 201 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 258
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 259 ESARNYIQSLTQ 270

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 19  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 78
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 79  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 137
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 138 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 192
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 193 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 250
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 251 ESARNYIQSLTQ 262

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 106 RIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           ++G G+ G+V    + P    T  V A+K +  + E+ +R    REIEIL+ + H N+VK
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 75
Query: 162 ----CHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHI-LSDLARQVLSGLAYLHKR 212
               C+    RN  +++++EY+  GSL    +    R +HI L     Q+  G+ YL  +
Sbjct: 76  YKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS---AVGTIAYMSPERINTDL 269
           + +HRD+   N+L+ +   VKI DFG++++L Q  +           I + +PE     L
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE----SL 189
Query: 270 NHGKYDGYAGDIWSLGVSILEFY 292
              K+   A D+WS GV + E +
Sbjct: 190 TESKF-SVASDVWSFGVVLYELF 211

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 40  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 99
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 158
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 159 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 213
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 214 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 271
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 272 ESARNYIQSLTQ 283

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 33  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 92
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 151
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 152 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 206
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 207 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 264
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 265 ESARNYIQSLTQ 276

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 33  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 92
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 151
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 152 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 206
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 207 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 264
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 265 ESARNYIQSLTQ 276

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 104 GNRIGSGSGGTVWR-VVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKC 162
           GN++G G  G V++  V+  T  V  L  +     + ++ Q  +EI+++    H N+V+ 
Sbjct: 36  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 163 HDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
                   ++ ++  YM  GSL       +G      H+   +A+   +G+ +LH+   +
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155
Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRI---LAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRDIK +N+L++ +   KI+DFG++R     AQT+      VGT AYM+PE +  ++   
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTV-MXXRIVGTTAYMAPEALRGEITP- 213
Query: 273 KYDGYAGDIWSLGVSILEFYLG 294
                  DI+S GV +LE   G
Sbjct: 214 -----KSDIYSFGVVLLEIITG 230

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 23  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 82
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 141
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 142 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 196
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 197 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 254
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 255 ESARNYIQSLTQ 266

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 30/206 (14%)
Query: 106 RIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           ++G G+ G+V    + P    T  V A+K +  + E+ +R    REIEIL+ + H N+VK
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 75
Query: 162 ----CHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHI-LSDLARQVLSGLAYLHKR 212
               C+    RN  +++++EY+  GSL    +    R +HI L     Q+  G+ YL  +
Sbjct: 76  YKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ------TMDPCNSAVGTIAYMSPERIN 266
           + +HRD+   N+L+ +   VKI DFG++++L Q        +P  S    I + +PE   
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP---IFWYAPE--- 187
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFY 292
             L   K+   A D+WS GV + E +
Sbjct: 188 -SLTESKF-SVASDVWSFGVVLYELF 211

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 23  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 82
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 141
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 142 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 196
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 197 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 254
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 255 ESARNYIQSLTQ 266

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 27  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 86
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 145
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 146 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 200
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 201 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 258
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 259 ESARNYIQSLTQ 270

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 106 RIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           ++G G+ G+V    + P    T  V A+K +  + E+ +R    REIEIL+ + H N+VK
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 93
Query: 162 ----CHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHI-LSDLARQVLSGLAYLHKR 212
               C+    RN  +++++EY+  GSL    +    R +HI L     Q+  G+ YL  +
Sbjct: 94  YKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 151
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS---AVGTIAYMSPERINTDL 269
           + +HRD+   N+L+ +   VKI DFG++++L Q  +           I + +PE     L
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE----SL 207
Query: 270 NHGKYDGYAGDIWSLGVSILEFY 292
              K+   A D+WS GV + E +
Sbjct: 208 TESKF-SVASDVWSFGVVLYELF 229

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 130/303 (42%), Gaps = 56/303 (18%)
Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPN 158
           Q+   IGSG+ G V            A+K +   + N   + R+   RE+ +L+ VNH N
Sbjct: 25  QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY--RELVLLKCVNHKN 82
Query: 159 VVKCHDMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHK 211
           ++   +++     +E      +++E MD    +  H+  +H  +S L  Q+L G+ +LH 
Sbjct: 83  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS 142
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
             I+HRD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  
Sbjct: 143 AGIIHRDLKPSNIVVKSDCTLKILDFGLART-ASTNFMMTPYVVTRYYRAPEVI---LGM 198
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD-W-----------ASLMFAI------ 313
           G  +    DIWS+G  + E   G   F      D W           A  M A+      
Sbjct: 199 GYKENV--DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRN 256
Query: 314 --------------------CFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
                                F    E  ++ + + RD +S+ L  DP  R    + L+H
Sbjct: 257 YVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRH 316
Query: 354 PFI 356
           P+I
Sbjct: 317 PYI 319

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKXVNHKNIISLL 89
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 149
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 150 RDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 205
Query: 277 YAGDIWSLGVSILEF-----------YLGRFPFAVGRQG--------------------- 304
              DIWS+G  + E            Y+ ++   + + G                     
Sbjct: 206 V--DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263
Query: 305 -DWASLMFAICFAQP-----PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A L F   F         E  ++ + + RD +S+ L  DP  R      LQHP+I
Sbjct: 264 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 109/227 (48%), Gaps = 26/227 (11%)
Query: 146 REIEILRDVNHPNVVKCHDMYDRNGEIE--------VLLEYMDGGSLEGAHIRQEHILSD 197
           RE +    +NHP +V  +D     GE E        +++EY+DG +L      +  +   
Sbjct: 61  REAQNAAALNHPAIVAVYD----TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 116
Query: 198 LARQVLS----GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN-- 251
            A +V++     L + H+  I+HRD+KP+N++I+++  VK+ DFG++R +A + +     
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 252 -SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLM 310
            + +GT  Y+SPE+   D    +      D++SLG  + E   G  PF  G   D  +  
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDAR-----SDVYSLGCVLYEVLTGEPPF-TGDSPDSVAYQ 230
Query: 311 FAICFAQPPEA-PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                  PP A  E  S +    + + L K+P +R+  A  ++   +
Sbjct: 231 HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 106 RIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           ++G G+ G+V    + P    T  V A+K +  + E+ +R    REIEIL+ + H N+VK
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 93
Query: 162 ----CHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHI-LSDLARQVLSGLAYLHKR 212
               C+    RN  +++++EY+  GSL    +    R +HI L     Q+  G+ YL  +
Sbjct: 94  YKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 151
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS---AVGTIAYMSPERINTDL 269
           + +HRD+   N+L+ +   VKI DFG++++L Q  +           I + +PE     L
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE----SL 207
Query: 270 NHGKYDGYAGDIWSLGVSILEFY 292
              K+   A D+WS GV + E +
Sbjct: 208 TESKF-SVASDVWSFGVVLYELF 229

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--YRELVLMKXVNHKNIISLL 89
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIH 149
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 150 RDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 205
Query: 277 YAGDIWSLGVSILEF-----------YLGRFPFAVGRQG--------------------- 304
              DIWS+G  + E            Y+ ++   + + G                     
Sbjct: 206 V--DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263
Query: 305 -DWASLMFAICFAQP-----PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A L F   F         E  ++ + + RD +S+ L  DP  R      LQHP+I
Sbjct: 264 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGFVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLTQ 264

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 123/260 (47%), Gaps = 31/260 (11%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T+RV    +  G        Q   E ++++ + H  +V+ + +
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 74
Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I ++ EYM  GSL        G ++R   ++ D+A Q+ SG+AY+ +   VHRD
Sbjct: 75  VSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAYVERMNYVHRD 132
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L+  +   K+ADFG++R++          A   I + +PE       +G++   
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA----LYGRFT-I 187
Query: 278 AGDIWSLGVSILEFYL-GRFPF--AVGRQG-DWASLMFAI-CFAQPPEAPEMASREFRDF 332
             D+WS G+ + E    GR P+   V R+  D     + + C   PPE PE       D 
Sbjct: 188 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPE----SLHDL 240
Query: 333 ISRCLQKDPHSRWPAAQLLQ 352
           + +C +K+P  R P  + LQ
Sbjct: 241 MCQCWRKEPEER-PTFEYLQ 259

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 115/252 (45%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q    +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 31  PERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 90
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 91  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 149
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 150 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 204
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 205 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 262
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 263 ESARNYIQSLAQ 274

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKXVNHKNIISLL 89
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 149
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 150 RDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 205
Query: 277 YAGDIWSLGVSILEF-----------YLGRFPFAVGRQG--------------------- 304
              DIWS+G  + E            Y+ ++   + + G                     
Sbjct: 206 V--DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263
Query: 305 -DWASLMFAICFAQP-----PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A L F   F         E  ++ + + RD +S+ L  DP  R      LQHP+I
Sbjct: 264 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 135
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGFVATRWYRAPEIM-- 190
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 191 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 249 ESARNYIQSLAQ 260

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 21/216 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV 154
           ++N  +L  G +IG G+ G V+       + + A+K         ++++  +E  IL+  
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY 169
Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAY 208
           +HPN+V+   +  +   I +++E + GG        EGA +R + +L  +     +G+ Y
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLL-QMVGDAAAGMEY 228
Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT-----IAYMSPE 263
           L  +  +HRD+   N L+     +KI+DFG+SR   +  D   +A G      + + +PE
Sbjct: 229 LESKCCIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVXAASGGLRQVPVKWTAPE 285
Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
                LN+G+Y   + D+WS G+ + E F LG  P+
Sbjct: 286 ----ALNYGRYSSES-DVWSFGILLWETFSLGASPY 316

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMAGFVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLAQ 264

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 122/260 (46%), Gaps = 31/260 (11%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T+RV    +  G        Q   E ++++ + H  +V+ + +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 81
Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I ++ EYM  GSL        G ++R   ++ D+A Q+ SG+AY+ +   VHRD
Sbjct: 82  VSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV-DMAAQIASGMAYVERMNYVHRD 139
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDGY 277
           +  +N+L+  +   K+ADFG++R++          A   I + +PE       +G++   
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA----LYGRFT-I 194
Query: 278 AGDIWSLGVSILEFYL-GRFPF--AVGRQG-DWASLMFAI-CFAQPPEAPEMASREFRDF 332
             D+WS G+ + E    GR P+   V R+  D     + + C   PPE PE       D 
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPE----SLHDL 247
Query: 333 ISRCLQKDPHSRWPAAQLLQ 352
           + +C +KDP  R P  + LQ
Sbjct: 248 MCQCWRKDPEER-PTFEYLQ 266

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 129/280 (46%), Gaps = 35/280 (12%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T+RV    +  G           +E ++++ + H  +V+ + +
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 330
Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I ++ EYM  GSL        G ++R   ++ D+A Q+ SG+AY+ +   VHRD
Sbjct: 331 VSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAYVERMNYVHRD 388
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L+  +   K+ADFG++R++          A   I + +PE       +G++   
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA----LYGRFT-I 443
Query: 278 AGDIWSLGVSILEFYL-GRFPF--AVGRQG-DWASLMFAI-CFAQPPEAPEMASREFRDF 332
             D+WS G+ + E    GR P+   V R+  D     + + C   PPE PE       D 
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPE----SLHDL 496
Query: 333 ISRCLQKDPHSRWPAAQLLQ----HPFILRAGQSQVNQNL 368
           + +C +K+P  R P  + LQ      F     Q Q  +NL
Sbjct: 497 MCQCWRKEPEER-PTFEYLQAFLEDYFTSTEPQXQPGENL 535

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 153
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 154 LKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT 210
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 211 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 269
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 270 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P  LQ    +GSG+ G+V         +  A+K +    +  + ++   RE+ +L+ + H
Sbjct: 27  PQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKH 86
Query: 157 PNVVKCHDMYDRNGEIEVLLEYMDGGSLEGA---HIRQEHILSD-----LARQVLSGLAY 208
            NV+   D++     IE   E     +L GA   +I +   LSD     L  Q+L GL Y
Sbjct: 87  ENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKY 146
Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
           +H   I+HRD+KPSN+ +N    ++I DFG++R   Q  +     V T  Y +PE +   
Sbjct: 147 IHSAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMTGYVATRWYRAPEIM--- 200
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
           LN   Y+    DIWS+G  + E   G+  F      D    +  +     PE     S E
Sbjct: 201 LNWMHYNQTV-DIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSE 259
Query: 329 --------------------FR-------DFISRCLQKDPHSRWPAAQLLQHPFI 356
                               FR       D + R L  D   R  AA+ L H + 
Sbjct: 260 HARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 314

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 44  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 103
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 162
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 163 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMXGYVATRWYRAPEIM-- 217
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 218 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 275
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 276 ESARNYIQSLTQ 287

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 108/216 (50%), Gaps = 21/216 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV 154
           ++N  +L  G +IG G+ G V+       + + A+K         ++++  +E  IL+  
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY 169
Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAY 208
           +HPN+V+   +  +   I +++E + GG        EGA +R + +L  +     +G+ Y
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLL-QMVGDAAAGMEY 228
Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT-----IAYMSPE 263
           L  +  +HRD+   N L+     +KI+DFG+SR   +  D   +A G      + + +PE
Sbjct: 229 LESKCCIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVYAASGGLRQVPVKWTAPE 285
Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
                LN+G+Y   + D+WS G+ + E F LG  P+
Sbjct: 286 ----ALNYGRYSSES-DVWSFGILLWETFSLGASPY 316

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 106 RIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           ++G G+ G+V    + P    T  V A+K +  + E+ +R    REIEIL+ + H N+VK
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 78
Query: 162 ----CHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHI-LSDLARQVLSGLAYLHKR 212
               C+    RN  +++++E++  GSL    +    R +HI L     Q+  G+ YL  +
Sbjct: 79  YKGVCYSAGRRN--LKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 136
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS---AVGTIAYMSPERINTDL 269
           + +HRD+   N+L+ +   VKI DFG++++L Q  +           I + +PE     L
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE----SL 192
Query: 270 NHGKYDGYAGDIWSLGVSILEFY 292
              K+   A D+WS GV + E +
Sbjct: 193 TESKF-SVASDVWSFGVVLYELF 214

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVNHKNIISLL 89
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIH 149
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 150 RDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 205
Query: 277 YAGDIWSLGVSILEF-----------YLGRFPFAVGRQG--------------------- 304
              DIWS+G  + E            Y+ ++   + + G                     
Sbjct: 206 V--DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263
Query: 305 -DWASLMFAICFAQP-----PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A L F   F         E  ++ + + RD +S+ L  DP  R      LQHP+I
Sbjct: 264 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI D+G++R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDYGLAR---HTDDEMTGYVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLTQ 264

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 125/289 (43%), Gaps = 45/289 (15%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 167 DRNGEIE-----VLLEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
            R   IE      L+ ++ G  L    +  H+  +HI   L  Q+L GL Y+H   ++HR
Sbjct: 111 -RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHR 168
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKY 274
           D+KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y
Sbjct: 169 DLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGY 225
Query: 275 DGYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FA 312
              + DIWS+G  + E            YL +    +G      Q D   ++      + 
Sbjct: 226 TK-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 284
Query: 313 ICFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           +      + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 285 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 333

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 31/260 (11%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T+RV A+K +             +E ++++ + H  +V+ + +
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I ++ EYM+ GSL        G ++R   ++ D++ Q+ SG+AY+ +   VHRD
Sbjct: 79  VSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLV-DMSAQIASGMAYVERMNYVHRD 136
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L+  +   K+ADFG++R++          A   I + +PE       +G++   
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA----LYGRFT-I 191
Query: 278 AGDIWSLGVSILEFYL-GRFPF--AVGRQG-DWASLMFAI-CFAQPPEAPEMASREFRDF 332
             D+WS G+ + E    GR P+   V R+  D     + + C   PPE PE       D 
Sbjct: 192 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPE----SLHDL 244
Query: 333 ISRCLQKDPHSRWPAAQLLQ 352
           + +C +K+P  R P  + LQ
Sbjct: 245 MCQCWRKEPEER-PTFEYLQ 263

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 123/260 (47%), Gaps = 31/260 (11%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T+RV    +  G           +E ++++ + H  +V+ + +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 247
Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I ++ EYM  GSL        G ++R   ++ D+A Q+ SG+AY+ +   VHRD
Sbjct: 248 VSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAYVERMNYVHRD 305
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L+  +   K+ADFG++R++          A   I + +PE       +G++   
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA----LYGRFT-I 360
Query: 278 AGDIWSLGVSILEFYL-GRFPF--AVGRQG-DWASLMFAI-CFAQPPEAPEMASREFRDF 332
             D+WS G+ + E    GR P+   V R+  D     + + C   PPE PE       D 
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPE----SLHDL 413
Query: 333 ISRCLQKDPHSRWPAAQLLQ 352
           + +C +K+P  R P  + LQ
Sbjct: 414 MCQCWRKEPEER-PTFEYLQ 432

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 123/260 (47%), Gaps = 31/260 (11%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T+RV    +  G           +E ++++ + H  +V+ + +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 247
Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I ++ EYM  GSL        G ++R   ++ D+A Q+ SG+AY+ +   VHRD
Sbjct: 248 VSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAYVERMNYVHRD 305
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L+  +   K+ADFG++R++          A   I + +PE       +G++   
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA----LYGRFT-I 360
Query: 278 AGDIWSLGVSILEFYL-GRFPF--AVGRQG-DWASLMFAI-CFAQPPEAPEMASREFRDF 332
             D+WS G+ + E    GR P+   V R+  D     + + C   PPE PE       D 
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPE----SLHDL 413
Query: 333 ISRCLQKDPHSRWPAAQLLQ 352
           + +C +K+P  R P  + LQ
Sbjct: 414 MCQCWRKEPEER-PTFEYLQ 432

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 122/260 (46%), Gaps = 31/260 (11%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T+RV    +  G        Q   E ++++ + H  +V+ + +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 81
Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I ++ EYM  G L        G ++R   ++ D+A Q+ SG+AY+ +   VHRD
Sbjct: 82  VSEE-PIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLV-DMAAQIASGMAYVERMNYVHRD 139
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L+  +   K+ADFG++R++          A   I + +PE       +G++   
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA----LYGRFT-I 194
Query: 278 AGDIWSLGVSILEFYL-GRFPF--AVGRQG-DWASLMFAI-CFAQPPEAPEMASREFRDF 332
             D+WS G+ + E    GR P+   V R+  D     + + C   PPE PE       D 
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPE----SLHDL 247
Query: 333 ISRCLQKDPHSRWPAAQLLQ 352
           + +C +KDP  R P  + LQ
Sbjct: 248 MCQCWRKDPEER-PTFEYLQ 266

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 128/298 (42%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKVVNHKNIIGLL 89
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIH 149
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 150 RDLKPSNIVVKSDATLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 205
Query: 277 YAGDIWSLGVSILEFYLGRFPF---------------------------------AVGRQ 303
              DIWS+GV + E   G   F                                  V  +
Sbjct: 206 V--DIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263
Query: 304 GDWASLMFA-----ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A   F      + F    E  ++ + + RD +S+ L  D   R    + LQHP+I
Sbjct: 264 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 118/258 (45%), Gaps = 14/258 (5%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           I   ++  G RIGSGS GTV++        V  L V     +         E+ +LR   
Sbjct: 32  IPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTR 89
Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHI----LSDLARQVLSGLAYLH 210
           H N++     Y    ++ ++ ++ +G SL    HI +       L D+ARQ   G+ YLH
Sbjct: 90  HVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 148
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTD 268
            + I+HRD+K +N+ ++    VKI DFG++ + ++           G+I +M+PE I   
Sbjct: 149 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS-- 326
            +   Y  +  D+++ G+ + E   G+ P++     D    M    +  P  +   ++  
Sbjct: 209 -DKNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 266
Query: 327 REFRDFISRCLQKDPHSR 344
           +  +  ++ CL+K    R
Sbjct: 267 KAMKRLMAECLKKKRDER 284

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 134/295 (45%), Gaps = 49/295 (16%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS--QICREIEILRDVNHPNVVKCHD 164
           IG+G+ G V       T +  A+K I  N  D V +  +  RE++IL+   H N++   D
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 120
Query: 165 M------YDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKI 214
           +      Y     + V+L+ M+    +  H  Q    EH+   L  Q+L GL Y+H  ++
Sbjct: 121 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFL-YQLLRGLKYMHSAQV 179
Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRIL----AQTMDPCNSAVGTIAYMSPERINTDLN 270
           +HRD+KPSNLL+N +  +KI DFG++R L    A+        V T  Y +PE +   L+
Sbjct: 180 IHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM---LS 236
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGR--FP------------FAVGR------QGDWASLM 310
             +Y   A D+WS+G    E    R  FP              +G       Q   A  +
Sbjct: 237 LHEYTQ-AIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERV 295
Query: 311 FAICFAQPPEAP-------EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR 358
            A   + PP  P         A R+    + R L+ +P +R  AA  L+HPF+ +
Sbjct: 296 RAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 118/258 (45%), Gaps = 14/258 (5%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           I   ++  G RIGSGS GTV++        V  L V     +         E+ +LR   
Sbjct: 33  IPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTR 90
Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHI----LSDLARQVLSGLAYLH 210
           H N++     Y    ++ ++ ++ +G SL    HI +       L D+ARQ   G+ YLH
Sbjct: 91  HVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 149
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTD 268
            + I+HRD+K +N+ ++    VKI DFG++ + ++           G+I +M+PE I   
Sbjct: 150 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS-- 326
            +   Y  +  D+++ G+ + E   G+ P++     D    M    +  P  +   ++  
Sbjct: 210 -DKNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 267
Query: 327 REFRDFISRCLQKDPHSR 344
           +  +  ++ CL+K    R
Sbjct: 268 KAMKRLMAECLKKKRDER 285

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIISLL 82
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAGIIH 142
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 143 RDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 198
Query: 277 YAGDIWSLGVSILEF-----------YLGRFPFAVGRQG--------------------- 304
              DIWS+G  + E            Y+ ++   + + G                     
Sbjct: 199 V--DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256
Query: 305 -DWASLMFAICFAQP-----PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A L F   F         E  ++ + + RD +S+ L  DP  R      LQHP+I
Sbjct: 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 149
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 150 LKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT 206
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 207 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLL 265
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 266 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 117/255 (45%), Gaps = 14/255 (5%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
            ++  G RIGSGS GTV++        V  L V     +         E+ +LR   H N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVN 65
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHI----LSDLARQVLSGLAYLHKRK 213
           ++     Y    ++ ++ ++ +G SL    HI +       L D+ARQ   G+ YLH + 
Sbjct: 66  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNH 271
           I+HRD+K +N+ ++    VKI DFG++ + ++           G+I +M+PE I    + 
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ-DK 183
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS--REF 329
             Y  +  D+++ G+ + E   G+ P++     D    M    +  P  +   ++  +  
Sbjct: 184 NPYS-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 330 RDFISRCLQKDPHSR 344
           +  ++ CL+K    R
Sbjct: 243 KRLMAECLKKKRDER 257

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 149
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 150 LKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT 206
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 207 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 265
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 266 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 130/305 (42%), Gaps = 60/305 (19%)
Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPN 158
           Q+   IGSG+ G V            A+K +   + N   + R+   RE+ +L+ VNH N
Sbjct: 27  QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY--RELVLLKCVNHKN 84
Query: 159 VVKCHDMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHK 211
           ++   +++     +E      +++E MD    +  H+  +H  +S L  Q+L G+ +LH 
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS 144
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
             I+HRD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I      
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLART-ACTNFMMTPYVVTRYYRAPEVILG---- 199
Query: 272 GKYDGYAG--DIWSLGVSILEFYLGRFPFAVGRQGD-W-----------ASLMFAI---- 313
               GYA   DIWS+G  + E   G   F      D W           A  M A+    
Sbjct: 200 ---MGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 256
Query: 314 ----------------------CFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLL 351
                                  F    E  ++ + + RD +S+ L  DP  R    + L
Sbjct: 257 RNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEAL 316
Query: 352 QHPFI 356
           +HP+I
Sbjct: 317 RHPYI 321

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 117/255 (45%), Gaps = 14/255 (5%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
            ++  G RIGSGS GTV++        V  L V     +         E+ +LR   H N
Sbjct: 10  GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVN 67
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHI----LSDLARQVLSGLAYLHKRK 213
           ++     Y    ++ ++ ++ +G SL    HI +       L D+ARQ   G+ YLH + 
Sbjct: 68  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 126
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNH 271
           I+HRD+K +N+ ++    VKI DFG++ + ++           G+I +M+PE I    + 
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ-DK 185
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS--REF 329
             Y  +  D+++ G+ + E   G+ P++     D    M    +  P  +   ++  +  
Sbjct: 186 NPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 244
Query: 330 RDFISRCLQKDPHSR 344
           +  ++ CL+K    R
Sbjct: 245 KRLMAECLKKKRDER 259

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 118/258 (45%), Gaps = 14/258 (5%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           I   ++  G RIGSGS GTV++        V  L V     +         E+ +LR   
Sbjct: 10  IPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTR 67
Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHI----LSDLARQVLSGLAYLH 210
           H N++     Y    ++ ++ ++ +G SL    HI +       L D+ARQ   G+ YLH
Sbjct: 68  HVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 126
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTD 268
            + I+HRD+K +N+ ++    VKI DFG++ + ++           G+I +M+PE I   
Sbjct: 127 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS-- 326
            +   Y  +  D+++ G+ + E   G+ P++     D    M    +  P  +   ++  
Sbjct: 187 -DKNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 244
Query: 327 REFRDFISRCLQKDPHSR 344
           +  +  ++ CL+K    R
Sbjct: 245 KAMKRLMAECLKKKRDER 262

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 124/260 (47%), Gaps = 31/260 (11%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T+RV    +  G        Q   E ++++ + H  +V+ + +
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYAV 78
Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I ++ EYM+ GSL        G ++R   ++ D++ Q+ SG+AY+ +   VHRD
Sbjct: 79  VSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLV-DMSAQIASGMAYVERMNYVHRD 136
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQT-MDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L+  +   K+ADFG++R++          A   I + +PE       +G++   
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAA----LYGRFT-I 191
Query: 278 AGDIWSLGVSILEFYL-GRFPF--AVGRQG-DWASLMFAI-CFAQPPEAPEMASREFRDF 332
             D+WS G+ + E    GR P+   V R+  D     + + C   PPE PE       D 
Sbjct: 192 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPE----SLHDL 244
Query: 333 ISRCLQKDPHSRWPAAQLLQ 352
           + +C +K+P  R P  + LQ
Sbjct: 245 MCQCWRKEPEER-PTFEYLQ 263

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 149
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 150 LKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT 206
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 207 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLL 265
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 266 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 128/298 (42%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKVVNHKNIIGLL 89
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIH 149
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 150 RDLKPSNIVVKSDATLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 205
Query: 277 YAGDIWSLGVSILEFYLGRFPF---------------------------------AVGRQ 303
              DIWS+GV + E   G   F                                  V  +
Sbjct: 206 V--DIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263
Query: 304 GDWASLMFA-----ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A   F      + F    E  ++ + + RD +S+ L  D   R    + LQHP+I
Sbjct: 264 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 153
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 154 LKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT 210
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 211 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 269
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 270 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 116/253 (45%), Gaps = 22/253 (8%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIEILRDVN 155
           + Q    +G+GS G V  +      R +A+KV+    E  VR         E  +L  V 
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL--KKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHK 211
           HP +++    +    +I ++++Y++GG L     + +   + +A+    +V   L YLH 
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
           + I++RD+KP N+L++ + ++KI DFG ++ +    D      GT  Y++PE ++T    
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYXLCGTPDYIAPEVVST---- 177
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
            K    + D WS G+ I E   G  PF           +       PP      + + +D
Sbjct: 178 -KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP----FFNEDVKD 232
Query: 332 FISRCLQKDPHSR 344
            +SR + +D   R
Sbjct: 233 LLSRLITRDLSQR 245

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 117/255 (45%), Gaps = 14/255 (5%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
            ++  G RIGSGS GTV++        V  L V     +         E+ +LR   H N
Sbjct: 13  GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVN 70
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHI----LSDLARQVLSGLAYLHKRK 213
           ++     Y    ++ ++ ++ +G SL    HI +       L D+ARQ   G+ YLH + 
Sbjct: 71  ILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 129
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNH 271
           I+HRD+K +N+ ++    VKI DFG++ + ++           G+I +M+PE I    + 
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ-DK 188
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS--REF 329
             Y  +  D+++ G+ + E   G+ P++     D    M    +  P  +   ++  +  
Sbjct: 189 NPYS-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 247
Query: 330 RDFISRCLQKDPHSR 344
           +  ++ CL+K    R
Sbjct: 248 KRLMAECLKKKRDER 262

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 31  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIISLL 88
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 89  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 148
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 149 RDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 204
Query: 277 YAGDIWSLGVSILEF-----------YLGRFPFAVGRQG--------------------- 304
              DIWS+G  + E            Y+ ++   + + G                     
Sbjct: 205 V--DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 262
Query: 305 -DWASLMFAICFAQP-----PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A L F   F         E  ++ + + RD +S+ L  DP  R      LQHP+I
Sbjct: 263 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 320

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIISLL 90
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 150
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 151 RDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 206
Query: 277 YAGDIWSLGVSILEF-----------YLGRFPFAVGRQG--------------------- 304
              DIWS+G  + E            Y+ ++   + + G                     
Sbjct: 207 V--DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 264
Query: 305 -DWASLMFAICFAQP-----PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A L F   F         E  ++ + + RD +S+ L  DP  R      LQHP+I
Sbjct: 265 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIISLL 90
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 150
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 151 RDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 206
Query: 277 YAGDIWSLGVSILEF-----------YLGRFPFAVGRQG--------------------- 304
              DIWS+G  + E            Y+ ++   + + G                     
Sbjct: 207 V--DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 264
Query: 305 -DWASLMFAICFAQP-----PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A L F   F         E  ++ + + RD +S+ L  DP  R      LQHP+I
Sbjct: 265 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIISLL 127
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 187
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 188 RDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 243
Query: 277 YAGDIWSLGVSILEF-----------YLGRFPFAVGRQG--------------------- 304
              DIWS+G  + E            Y+ ++   + + G                     
Sbjct: 244 V--DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 301
Query: 305 -DWASLMFAICFAQP-----PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A L F   F         E  ++ + + RD +S+ L  DP  R      LQHP+I
Sbjct: 302 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVKCH 163
             +GSG+ G+V   +   +    A+K +    +  + ++   RE+ +L+ + H NV+   
Sbjct: 48  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 164 DMYD-----RNG-EIEVLLEYM--DGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           D++      RN  +  +++ +M  D   + G    +E I   L  Q+L GL Y+H   +V
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKI-QYLVYQMLKGLKYIHSAGVV 166
Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           HRD+KP NL +N    +KI DFG++R     M      V T  Y +PE I + +++ +  
Sbjct: 167 HRDLKPGNLAVNEDCELKILDFGLARHADAEM---TGYVVTRWYRAPEVILSWMHYNQ-- 221
Query: 276 GYAGDIWSLGVSILEFYLGRFPFA----------------------VGRQGDWASLMFAI 313
               DIWS+G  + E   G+  F                       V +  D A+  +  
Sbjct: 222 --TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQ 279
Query: 314 CFAQPPEAPEM-----ASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
              Q P          AS +  D + + L+ D   R  AAQ L HPF 
Sbjct: 280 SLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIISLL 89
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 149
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 150 RDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 205
Query: 277 YAGDIWSLGVSILEF-----------YLGRFPFAVGRQG--------------------- 304
              DIWS+G  + E            Y+ ++   + + G                     
Sbjct: 206 V--DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263
Query: 305 -DWASLMFAICFAQP-----PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A L F   F         E  ++ + + RD +S+ L  DP  R      LQHP+I
Sbjct: 264 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 126/297 (42%), Gaps = 47/297 (15%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       +    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 50  PERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 109
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 110 ENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 168
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D     V T  Y +PE +  
Sbjct: 169 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIM-- 223
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA------ 321
            LN   Y+    DIWS+G  + E   GR  F      +    +  +    PP +      
Sbjct: 224 -LNWMHYN-MTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLT-GTPPASVISRMP 280
Query: 322 -----------PEMASREFR-----------DFISRCLQKDPHSRWPAAQLLQHPFI 356
                      P+M  R F            D + + L  D   R  A++ L HP+ 
Sbjct: 281 SHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYF 337

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 134/295 (45%), Gaps = 49/295 (16%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS--QICREIEILRDVNHPNVVKCHD 164
           IG+G+ G V       T +  A+K I  N  D V +  +  RE++IL+   H N++   D
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 165 M------YDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKI 214
           +      Y     + V+L+ M+    +  H  Q    EH+   L  Q+L GL Y+H  ++
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFL-YQLLRGLKYMHSAQV 180
Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRIL----AQTMDPCNSAVGTIAYMSPERINTDLN 270
           +HRD+KPSNLL+N +  +KI DFG++R L    A+        V T  Y +PE +   L+
Sbjct: 181 IHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM---LS 237
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGR--FP------------FAVGR------QGDWASLM 310
             +Y   A D+WS+G    E    R  FP              +G       Q   A  +
Sbjct: 238 LHEYTQ-AIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERV 296
Query: 311 FAICFAQPPEAP-------EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR 358
            A   + PP  P         A R+    + R L+ +P +R  AA  L+HPF+ +
Sbjct: 297 RAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 351

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIISLL 89
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 149
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 150 RDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 205
Query: 277 YAGDIWSLGVSILEF-----------YLGRFPFAVGRQG--------------------- 304
              DIWS+G  + E            Y+ ++   + + G                     
Sbjct: 206 V--DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 263
Query: 305 -DWASLMFAICFAQP-----PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A L F   F         E  ++ + + RD +S+ L  DP  R      LQHP+I
Sbjct: 264 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 117/255 (45%), Gaps = 14/255 (5%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
            ++  G RIGSGS GTV++        V  L V     +         E+ +LR   H N
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVN 65
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHI----LSDLARQVLSGLAYLHKRK 213
           ++     Y    ++ ++ ++ +G SL    HI +       L D+ARQ   G+ YLH + 
Sbjct: 66  ILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNH 271
           I+HRD+K +N+ ++    VKI DFG++ + ++           G+I +M+PE I    + 
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ-DK 183
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS--REF 329
             Y  +  D+++ G+ + E   G+ P++     D    M    +  P  +   ++  +  
Sbjct: 184 NPYS-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 330 RDFISRCLQKDPHSR 344
           +  ++ CL+K    R
Sbjct: 243 KRLMAECLKKKRDER 257

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIISLL 82
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 142
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 143 RDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 198
Query: 277 YAGDIWSLGVSILEF-----------YLGRFPFAVGRQG--------------------- 304
              DIWS+G  + E            Y+ ++   + + G                     
Sbjct: 199 V--DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256
Query: 305 -DWASLMFAICFAQP-----PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A L F   F         E  ++ + + RD +S+ L  DP  R      LQHP+I
Sbjct: 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P  LQ    +GSG+ G+V         +  A+K +    +  + ++   RE+ +L+ + H
Sbjct: 27  PQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKH 86
Query: 157 PNVVKCHDMYDRNGEIEVLLEYMDGGSLEGA---HIRQEHILSD-----LARQVLSGLAY 208
            NV+   D++     IE   E     +L GA   +I +   LSD     L  Q+L GL Y
Sbjct: 87  ENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKY 146
Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
           +H   I+HRD+KPSN+ +N    ++I DFG++R   Q  +     V T  Y +PE +   
Sbjct: 147 IHSAGIIHRDLKPSNVAVNEDSELRILDFGLAR---QADEEMTGYVATRWYRAPEIM--- 200
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
           LN   Y+    DIWS+G  + E   G+  F      D    +  +     PE     S E
Sbjct: 201 LNWMHYNQTV-DIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSE 259
Query: 329 --------------------FR-------DFISRCLQKDPHSRWPAAQLLQHPFI 356
                               FR       D + R L  D   R  AA+ L H + 
Sbjct: 260 HARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 314

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIISLL 83
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 143
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 144 RDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 199
Query: 277 YAGDIWSLGVSILEF-----------YLGRFPFAVGRQG--------------------- 304
              DIWS+G  + E            Y+ ++   + + G                     
Sbjct: 200 V--DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 257
Query: 305 -DWASLMFAICFAQP-----PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A L F   F         E  ++ + + RD +S+ L  DP  R      LQHP+I
Sbjct: 258 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/261 (22%), Positives = 115/261 (44%), Gaps = 34/261 (13%)
Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEH--------I 194
           E++I+ D+ +   + C  +     E+ ++ EYM+  S+    E   +  ++        +
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 195 LSDLARQVLSGLAYLHKRK-IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA 253
           +  + + VL+  +Y+H  K I HRD+KPSN+L++ +  VK++DFG S  +         +
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--KIKGS 210
Query: 254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFA-------------- 299
            GT  +M PE  +   N   Y+G   DIWSLG+ +   +    PF+              
Sbjct: 211 RGTYEFMPPEFFS---NESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267
Query: 300 --VGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFIL 357
             +    D    ++ +   +   +    S E  DF+   L+K+P  R  +   L+H ++ 
Sbjct: 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA 327
Query: 358 RAGQSQVNQNLRQILPPPRPL 378
                 + +  +++    + L
Sbjct: 328 DTNIEDLREFSKELYKKRKKL 348

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIISLL 83
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 143
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 144 RDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 199
Query: 277 YAGDIWSLGVSILEF-----------YLGRFPFAVGRQG--------------------- 304
              DIWS+G  + E            Y+ ++   + + G                     
Sbjct: 200 V--DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 257
Query: 305 -DWASLMFAICFAQP-----PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A L F   F         E  ++ + + RD +S+ L  DP  R      LQHP+I
Sbjct: 258 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 151
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 152 LKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT 208
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVGRQG-----------DWASLMFAI 313
             + DIWS+G  + E            YL +    +G  G           +  +  + +
Sbjct: 209 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNYLL 267
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 268 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIISLL 127
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 187
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 188 RDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 243
Query: 277 YAGDIWSLGVSILEF-----------YLGRFPFAVGRQG--------------------- 304
              DIWS+G  + E            Y+ ++   + + G                     
Sbjct: 244 V--DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 301
Query: 305 -DWASLMFAICFAQP-----PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A L F   F         E  ++ + + RD +S+ L  DP  R      LQHP+I
Sbjct: 302 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 147
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 148 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT 204
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 205 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNYLL 263
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 264 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 311

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 30/206 (14%)
Query: 106 RIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           ++G G+ G+V    + P    T  V A+K +  + E+ +R    REIEIL+ + H N+VK
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVK 76
Query: 162 ----CHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHI-LSDLARQVLSGLAYLHKR 212
               C+    RN  +++++EY+  GSL    +    R +HI L     Q+  G+ YL  +
Sbjct: 77  YKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 134
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ------TMDPCNSAVGTIAYMSPERIN 266
           + +HR++   N+L+ +   VKI DFG++++L Q        +P  S    I + +PE   
Sbjct: 135 RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP---IFWYAPE--- 188
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFY 292
             L   K+   A D+WS GV + E +
Sbjct: 189 -SLTESKF-SVASDVWSFGVVLYELF 212

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 149
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 150 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT 206
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 207 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 265
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 266 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 169
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 170 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT 226
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 227 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 285
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 286 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 333

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 151
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 152 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT 208
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 209 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 267
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 268 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 18/202 (8%)
Query: 104 GNRIGSGSGGTVWR-VVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKC 162
           GN++G G  G V++  V+  T  V  L  +     + ++ Q  +EI+++    H N+V+ 
Sbjct: 30  GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 89
Query: 163 HDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
                   ++ ++  YM  GSL       +G      H+   +A+   +G+ +LH+   +
Sbjct: 90  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 149
Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRI---LAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRDIK +N+L++ +   KI+DFG++R     AQ +      VGT AYM+PE +  ++   
Sbjct: 150 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXV-MXXRIVGTTAYMAPEALRGEITP- 207
Query: 273 KYDGYAGDIWSLGVSILEFYLG 294
                  DI+S GV +LE   G
Sbjct: 208 -----KSDIYSFGVVLLEIITG 224

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 151
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 152 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT 208
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 209 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 267
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 268 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 154
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 155 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT 211
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 212 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 270
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 271 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 318

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 155
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 156 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT 212
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 213 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 271
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 272 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 319

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 146
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 147 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT 203
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 204 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 262
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 263 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 310

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 153
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 154 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT 210
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 211 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 269
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 270 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 157
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 158 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT 214
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 215 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 273
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 274 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 321

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 149
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 150 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT 206
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 207 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 265
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 266 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 153
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCN---SAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 154 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM---LNSKGYT 210
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 211 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 269
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 270 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 154
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCN---SAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 155 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM---LNSKGYT 211
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 212 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 270
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 271 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 318

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 147
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 148 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT 204
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 205 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 263
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 264 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 311

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 123/261 (47%), Gaps = 23/261 (8%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           L+   ++G+G  G VW   +   ++V    +  G+   SV + +  E  +++ + H  +V
Sbjct: 17  LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLA-EANVMKTLQHDKLV 73
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           K H +  +   I ++ E+M  GSL       EG+      ++ D + Q+  G+A++ +R 
Sbjct: 74  KLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI-DFSAQIAEGMAFIEQRN 131
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHG 272
            +HRD++ +N+L+++S   KIADFG++R++          A   I + +PE I    N G
Sbjct: 132 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI----NFG 187
Query: 273 KYDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
            +     D+WS G+ ++E    GR P+  G             +  P   PE    E  +
Sbjct: 188 SFT-IKSDVWSFGILLMEIVTYGRIPYP-GMSNPEVIRALERGYRMP--RPENCPEELYN 243
Query: 332 FISRCLQKDPHSRWPAAQLLQ 352
            + RC +  P  R P  + +Q
Sbjct: 244 IMMRCWKNRPEER-PTFEYIQ 263

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 123/260 (47%), Gaps = 31/260 (11%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           ++G G  G VW      T+RV    +  G           +E ++++ + H  +V+ + +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 247
Query: 166 YDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                 I ++ EYM  GSL        G ++R   ++ D+A Q+ SG+AY+ +   VHRD
Sbjct: 248 VSEE-PIYIVGEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAYVERMNYVHRD 305
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDGY 277
           ++ +N+L+  +   K+ADFG++R++          A   I + +PE       +G++   
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA----LYGRFT-I 360
Query: 278 AGDIWSLGVSILEFYL-GRFPF--AVGRQG-DWASLMFAI-CFAQPPEAPEMASREFRDF 332
             D+WS G+ + E    GR P+   V R+  D     + + C   PPE PE       D 
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPE----SLHDL 413
Query: 333 ISRCLQKDPHSRWPAAQLLQ 352
           + +C +K+P  R P  + LQ
Sbjct: 414 MCQCWRKEPEER-PTFEYLQ 432

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 126/288 (43%), Gaps = 44/288 (15%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVKCH 163
             +GSG+ G+V   +   +    A+K +    +  + ++   RE+ +L+ + H NV+   
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 164 DMYD-----RNG-EIEVLLEYM--DGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           D++      RN  +  +++ +M  D   + G    +E I   L  Q+L GL Y+H   +V
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKI-QYLVYQMLKGLKYIHSAGVV 148
Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           HRD+KP NL +N    +KI DFG++R     M      V T  Y +PE I + +++ +  
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLARHADAEM---TGYVVTRWYRAPEVILSWMHYNQ-- 203
Query: 276 GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC------FAQP----------- 318
               DIWS+G  + E   G+  F      D  + +  +       F Q            
Sbjct: 204 --TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQ 261
Query: 319 --PEAPEM--------ASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             P+ P          AS +  D + + L+ D   R  AAQ L HPF 
Sbjct: 262 SLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 127/268 (47%), Gaps = 33/268 (12%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHED-----SVRSQICREIEILRDVNHPNVVK 161
           IG GS  TV++ +   T+    ++V +   +D     S R +   E E L+ + HPN+V+
Sbjct: 34  IGRGSFKTVYKGLDTETT----VEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVR 89
Query: 162 CHDMYDRNGE----IEVLLEYMDGGSLEGA----HIRQEHILSDLARQVLSGLAYLHKRK 213
            +D ++   +    I ++ E    G+L+       + +  +L    RQ+L GL +LH R 
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRT 149
Query: 214 --IVHRDIKPSNLLINS-SKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
             I+HRD+K  N+ I   + +VKI D G++ +   +     + +GT  + +PE       
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFXAPEXYEE--- 204
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMF--AICFAQPPEAPEMASRE 328
             KYD  + D+++ G   LE     +P++  +    A+ ++       +P    ++A  E
Sbjct: 205 --KYDE-SVDVYAFGXCXLEXATSEYPYSECQN---AAQIYRRVTSGVKPASFDKVAIPE 258
Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            ++ I  C++++   R+    LL H F 
Sbjct: 259 VKEIIEGCIRQNKDERYSIKDLLNHAFF 286

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A+K I      +   +  REI+IL    H N++  +D+ 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 153
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 154 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT 210
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 211 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 269
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 270 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 48/221 (21%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK---CH 163
           IGSG  G V++  H    + + ++ +  N+E + R     E++ L  ++H N+V    C 
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER-----EVKALAKLDHVNIVHYNGCW 74
Query: 164 DMYDRNGEIE--------------------------VLLEYMDGGSLE-------GAHIR 190
           D +D + E                            + +E+ D G+LE       G  + 
Sbjct: 75  DGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 134
Query: 191 QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
           +   L +L  Q+  G+ Y+H +K++HRD+KPSN+ +  +K VKI DFG+   L       
Sbjct: 135 KVLAL-ELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 193
Query: 251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
            S  GT+ YMSPE+I++  ++GK      D+++LG+ + E 
Sbjct: 194 RSK-GTLRYMSPEQISSQ-DYGK----EVDLYALGLILAEL 228

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 84/327 (25%), Positives = 140/327 (42%), Gaps = 86/327 (26%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVN-HPNVVKCH 163
           ++G G+ G VW+ +   T  V A+K I+   ++S  +Q   REI IL +++ H N+V   
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 164 DMY--DRNGEIEVLLEYM--DGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDI 219
           ++   D + ++ ++ +YM  D  ++  A+I +      +  Q++  + YLH   ++HRD+
Sbjct: 76  NVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDM 135
Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA---------------------VGTIA 258
           KPSN+L+N+  +VK+ADFG+SR         N+                      V T  
Sbjct: 136 KPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRW 195
Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR----------------------- 295
           Y +PE +   L   KY     D+WSLG  + E   G+                       
Sbjct: 196 YRAPEIL---LGSTKYTK-GIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPS 251
Query: 296 --------FPFAVG-----------RQGD-------WASLMFAICFAQPPEAPEMASREF 329
                    PFA             RQ +       W +L+  I     P+A    + E 
Sbjct: 252 NEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKI----NPKAD--CNEEA 305
Query: 330 RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            D + + LQ +P+ R  A   L+HPF+
Sbjct: 306 LDLLDKLLQFNPNKRISANDALKHPFV 332

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 115/252 (45%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI DF ++R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDFYLAR---HTDDEMTGYVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLTQ 264

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P  LQ    +GSG+ G+V         +  A+K +    +  + ++   RE+ +L+ + H
Sbjct: 19  PQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKH 78
Query: 157 PNVVKCHDMYDRNGEIEVLLEYMDGGSLEGA---HIRQEHILSD-----LARQVLSGLAY 208
            NV+   D++     IE   E     +L GA   +I +   LSD     L  Q+L GL Y
Sbjct: 79  ENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKY 138
Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
           +H   I+HRD+KPSN+ +N    ++I DFG++R   Q  +     V T  Y +PE +   
Sbjct: 139 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADEEMTGYVATRWYRAPEIM--- 192
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
           LN   Y+    DIWS+G  + E   G+  F      D    +  +     PE     S E
Sbjct: 193 LNWMHYNQTV-DIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSE 251
Query: 329 --------------------FR-------DFISRCLQKDPHSRWPAAQLLQHPFI 356
                               FR       D + R L  D   R  AA+ L H + 
Sbjct: 252 HARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF 306

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 129/300 (43%), Gaps = 60/300 (20%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIGLL 89
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 149
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQT--MDPCNSAVGTIAYMSPERINTDLNHGKY 274
           RD+KPSN+++ S   +KI DFG++R    +  M+P    V T  Y +PE I   L  G  
Sbjct: 150 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEP---EVVTRYYRAPEVI---LGMGYK 203
Query: 275 DGYAGDIWSLGVSILEFYLGRFPF---------------------------------AVG 301
           +    DIWS+G  + E    +  F                                  V 
Sbjct: 204 ENV--DIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYVE 261
Query: 302 RQGDWASLMFA-----ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +  +A   F      + F    E  ++ + + RD +S+ L  D   R    + LQHP+I
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 115/252 (45%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI  FG++R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILGFGLAR---HTDDEMTGYVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLTQ 264

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 110/233 (47%), Gaps = 38/233 (16%)
Query: 146 REIEILRDVNHPNVVKCHDMYDRNGEIE--------VLLEYMDGGSLEGAHIRQEHILSD 197
           RE +    +NHP +V  +D     GE E        +++EY+DG +L      +  +   
Sbjct: 61  REAQNAAALNHPAIVAVYD----TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 116
Query: 198 LARQVLS----GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA---QTMDPC 250
            A +V++     L + H+  I+HRD+KP+N+LI+++  VK+ DFG++R +A    ++   
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT 176
Query: 251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLM 310
            + +GT  Y+SPE+   D    +      D++SLG  + E   G  PF     GD     
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDAR-----SDVYSLGCVLYEVLTGEPPF----TGDSP--- 224
Query: 311 FAICFAQPPEAP-------EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            ++ +    E P       E  S +    + + L K+P +R+  A  ++   +
Sbjct: 225 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKVVNHKNIIGLL 89
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 149
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 150 RDLKPSNIVVKSDATLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 205
Query: 277 YAGDIWSLGVSILEFYLGRFPF---------------------------------AVGRQ 303
              DIWS+G  + E   G   F                                  V  +
Sbjct: 206 V--DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263
Query: 304 GDWASLMFA-----ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A   F      + F    E  ++ + + RD +S+ L  D   R    + LQHP+I
Sbjct: 264 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIGLL 89
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 149
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 150 RDLKPSNIVVKSDATLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 205
Query: 277 YAGDIWSLGVSILEFYLGRFPF---------------------------------AVGRQ 303
              DIWS+G  + E   G   F                                  V  +
Sbjct: 206 V--DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263
Query: 304 GDWASLMFA-----ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A   F      + F    E  ++ + + RD +S+ L  D   R    + LQHP+I
Sbjct: 264 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 128/277 (46%), Gaps = 33/277 (11%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           L+   ++G+G  G VW   +   ++V    +  G+   SV + +  E  +++ + H  +V
Sbjct: 184 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLA-EANVMKTLQHDKLV 240
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           K H +  +   I ++ E+M  GSL       EG+      ++ D + Q+  G+A++ +R 
Sbjct: 241 KLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI-DFSAQIAEGMAFIEQRN 298
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
            +HRD++ +N+L+++S   KIADFG++R+ A+           I + +PE I    N G 
Sbjct: 299 YIHRDLRAANILVSASLVCKIADFGLARVGAKF---------PIKWTAPEAI----NFGS 345
Query: 274 YDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
           +     D+WS G+ ++E    GR P+  G             +  P   PE    E  + 
Sbjct: 346 FT-IKSDVWSFGILLMEIVTYGRIPYP-GMSNPEVIRALERGYRMP--RPENCPEELYNI 401
Query: 333 ISRCLQKDPHSRWPAAQLLQHPF--ILRAGQSQVNQN 367
           + RC +  P  R P  + +Q        A +SQ  Q 
Sbjct: 402 MMRCWKNRPEER-PTFEYIQSVLDDFYTATESQXQQQ 437

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 127/286 (44%), Gaps = 29/286 (10%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G GS G V       T  ++A+K++  +    +D V   +  +  +      P + + H
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRD 218
             +     +  ++EY++GG L   HI+Q     +      A ++  GL +LHKR I++RD
Sbjct: 87  SCFQTVDRLYFVMEYVNGGDLM-YHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRD 145
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS--AVGTIAYMSPERINTDLNHGKYDG 276
           +K  N++++S  ++KIADFG+ +     MD   +    GT  Y++PE I     +  Y G
Sbjct: 146 LKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPDYIAPEII----AYQPY-G 198
Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
            + D W+ GV + E   G+ PF     G+    +F          P+  S+E        
Sbjct: 199 KSVDWWAYGVLLYEMLAGQPPF----DGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGL 254
Query: 337 LQKDPHSRWPAA-----QLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           + K P  R          + +H F  R    ++    R+I PP +P
Sbjct: 255 MTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLEN--REIQPPFKP 298

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 88/334 (26%), Positives = 149/334 (44%), Gaps = 63/334 (18%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALK-VIYGNHEDSVRSQICREIEILRDVNHP 157
           ++ +K  +IG G+ G V++  H  T +  ALK V+  N ++       REI+IL+ + H 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 158 NVVKCHDM-------YDR-NGEIEVLLEYMD---GGSLEGAHIRQEHILSDLAR---QVL 203
           NVV   ++       Y+R  G I ++ ++ +    G L    ++    LS++ R    +L
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLL 134
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI--LAQTMDP--CNSAVGTIAY 259
           +GL Y+H+ KI+HRD+K +N+LI     +K+ADFG++R   LA+   P    + V T+ Y
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 194
Query: 260 MSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGR-QGDWASLMFAICFAQP 318
             PE +  + ++G       D+W  G  + E +  R P   G  +    +L+  +C +  
Sbjct: 195 RPPELLLGERDYGP----PIDLWGAGCIMAEMW-TRSPIMQGNTEQHQLALISQLCGSIT 249
Query: 319 PEA-PEMASREFR---------------------------DFISRCLQKDPHSRWPAAQL 350
           PE  P + + E                             D I + L  DP  R  +   
Sbjct: 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 309
Query: 351 LQHPFI--------LRAGQSQVNQNLRQILPPPR 376
           L H F         L+   S    ++ + L PPR
Sbjct: 310 LNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPR 343

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 115/252 (45%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI D G++R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDAGLAR---HTDDEMTGYVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLTQ 264

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIGLL 89
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 149
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 150 RDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 205
Query: 277 YAGDIWSLGVSILEFYLGRFPF---------------------------------AVGRQ 303
              DIWS+G  + E   G   F                                  V  +
Sbjct: 206 V--DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 263
Query: 304 GDWASLMFA-----ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A   F      + F    E  ++ + + RD +S+ L  D   R    + LQHP+I
Sbjct: 264 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 88/334 (26%), Positives = 149/334 (44%), Gaps = 63/334 (18%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALK-VIYGNHEDSVRSQICREIEILRDVNHP 157
           ++ +K  +IG G+ G V++  H  T +  ALK V+  N ++       REI+IL+ + H 
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 77
Query: 158 NVVKCHDM-------YDR-NGEIEVLLEYMD---GGSLEGAHIRQEHILSDLAR---QVL 203
           NVV   ++       Y+R  G I ++ ++ +    G L    ++    LS++ R    +L
Sbjct: 78  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLL 135
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI--LAQTMDP--CNSAVGTIAY 259
           +GL Y+H+ KI+HRD+K +N+LI     +K+ADFG++R   LA+   P    + V T+ Y
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 260 MSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGR-QGDWASLMFAICFAQP 318
             PE +  + ++G       D+W  G  + E +  R P   G  +    +L+  +C +  
Sbjct: 196 RPPELLLGERDYGP----PIDLWGAGCIMAEMW-TRSPIMQGNTEQHQLALISQLCGSIT 250
Query: 319 PEA-PEMASREFR---------------------------DFISRCLQKDPHSRWPAAQL 350
           PE  P + + E                             D I + L  DP  R  +   
Sbjct: 251 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 310
Query: 351 LQHPFI--------LRAGQSQVNQNLRQILPPPR 376
           L H F         L+   S    ++ + L PPR
Sbjct: 311 LNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPR 344

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIGLL 89
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 149
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 150 RDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 205
Query: 277 YAGDIWSLGVSILEFYLGRFPF---------------------------------AVGRQ 303
              DIWS+G  + E   G   F                                  V  +
Sbjct: 206 V--DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263
Query: 304 GDWASLMFA-----ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A   F      + F    E  ++ + + RD +S+ L  D   R    + LQHP+I
Sbjct: 264 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           L+   R+G+G  G VW   +   ++V    +  G+           E  +++ + H  +V
Sbjct: 15  LKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 71
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           + + +  +   I ++ EYM+ GSL        G  +    +L D+A Q+  G+A++ +R 
Sbjct: 72  RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLL-DMAAQIAEGMAFIEERN 129
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHG 272
            +HRD++ +N+L++ + + KIADFG++R++          A   I + +PE I    N+G
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAI----NYG 185
Query: 273 KYDGYAGDIWSLGVSILEFYL-GRFPF 298
            +     D+WS G+ + E    GR P+
Sbjct: 186 TFT-IKSDVWSFGILLTEIVTHGRIPY 211

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 43/288 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG G+ G V            A++ I      +   +  REI+IL    H N++  +D+ 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 167 -----DRNGEIEVLLEYMDGGS---LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRD 218
                ++  ++ ++ + M+      L+  H+  +HI   L  Q+L GL Y+H   ++HRD
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-QILRGLKYIHSANVLHRD 153
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGKYD 275
           +KPSNLL+N++ ++KI DFG++R+     D        V T  Y +PE +   LN   Y 
Sbjct: 154 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT 210
Query: 276 GYAGDIWSLGVSILEF-----------YLGRFPFAVG-----RQGDWASLM------FAI 313
             + DIWS+G  + E            YL +    +G      Q D   ++      + +
Sbjct: 211 K-SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 269
Query: 314 CFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                 + P       A  +  D + + L  +PH R    Q L HP++
Sbjct: 270 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIGLL 90
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 91  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 150
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 151 RDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 206
Query: 277 YAGDIWSLGVSILEFYLGRFPF---------------------------------AVGRQ 303
              DIWS+G  + E   G   F                                  V  +
Sbjct: 207 V--DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 264
Query: 304 GDWASLMFA-----ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A   F      + F    E  ++ + + RD +S+ L  D   R    + LQHP+I
Sbjct: 265 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 123/261 (47%), Gaps = 23/261 (8%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           L+   ++G+G  G VW   +   ++V    +  G+   SV + +  E  +++ + H  +V
Sbjct: 190 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLA-EANVMKTLQHDKLV 246
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           K H +  +   I ++ E+M  GSL       EG+      ++ D + Q+  G+A++ +R 
Sbjct: 247 KLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI-DFSAQIAEGMAFIEQRN 304
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHG 272
            +HRD++ +N+L+++S   KIADFG++R++          A   I + +PE I    N G
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI----NFG 360
Query: 273 KYDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
            +     D+WS G+ ++E    GR P+  G             +  P   PE    E  +
Sbjct: 361 SFT-IKSDVWSFGILLMEIVTYGRIPYP-GMSNPEVIRALERGYRMP--RPENCPEELYN 416
Query: 332 FISRCLQKDPHSRWPAAQLLQ 352
            + RC +  P  R P  + +Q
Sbjct: 417 IMMRCWKNRPEER-PTFEYIQ 436

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 126/298 (42%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIGLL 89
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 149
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 150 RDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPEVVTRYYRAPEVI---LGMGYKEN 205
Query: 277 YAGDIWSLGVSILEFYLGRFPF---------------------------------AVGRQ 303
              DIWS+G  + E   G   F                                  V  +
Sbjct: 206 V--DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 263
Query: 304 GDWASLMFA-----ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A   F      + F    E   + + + RD +S+ L  D   R    + LQHP+I
Sbjct: 264 PKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA--YRELVLMKVVNHKNIIGLL 89
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIH 149
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 150 RDLKPSNIVVKSDATLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 205
Query: 277 YAGDIWSLGVSILEFYLGRFPF---------------------------------AVGRQ 303
              DIWS+G  + E   G   F                                  V  +
Sbjct: 206 V--DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263
Query: 304 GDWASLMFA-----ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A   F      + F    E  ++ + + RD +S+ L  D   R    + LQHP+I
Sbjct: 264 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 110/233 (47%), Gaps = 38/233 (16%)
Query: 146 REIEILRDVNHPNVVKCHDMYDRNGEIE--------VLLEYMDGGSLEGAHIRQEHILSD 197
           RE +    +NHP +V  +D     GE E        +++EY+DG +L      +  +   
Sbjct: 61  REAQNAAALNHPAIVAVYD----TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 116
Query: 198 LARQVLS----GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN-- 251
            A +V++     L + H+  I+HRD+KP+N++I+++  VK+ DFG++R +A + +     
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 252 -SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLM 310
            + +GT  Y+SPE+   D    +      D++SLG  + E   G  PF     GD     
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDAR-----SDVYSLGCVLYEVLTGEPPF----TGDSP--- 224
Query: 311 FAICFAQPPEAP-------EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            ++ +    E P       E  S +    + + L K+P +R+  A  ++   +
Sbjct: 225 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 110/233 (47%), Gaps = 38/233 (16%)
Query: 146 REIEILRDVNHPNVVKCHDMYDRNGEIE--------VLLEYMDGGSLEGAHIRQEHILSD 197
           RE +    +NHP +V  +D     GE E        +++EY+DG +L      +  +   
Sbjct: 61  REAQNAAALNHPAIVAVYD----TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 116
Query: 198 LARQVLS----GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN-- 251
            A +V++     L + H+  I+HRD+KP+N++I+++  VK+ DFG++R +A + +     
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 252 -SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLM 310
            + +GT  Y+SPE+   D    +      D++SLG  + E   G  PF     GD     
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDAR-----SDVYSLGCVLYEVLTGEPPF----TGDSP--- 224
Query: 311 FAICFAQPPEAP-------EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            ++ +    E P       E  S +    + + L K+P +R+  A  ++   +
Sbjct: 225 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 117/258 (45%), Gaps = 14/258 (5%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           I   ++  G RIGSGS GTV++        V  L V     +         E+ +LR   
Sbjct: 25  IPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTR 82
Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHI----LSDLARQVLSGLAYLH 210
           H N++     Y    ++ ++ ++ +G SL    HI +       L D+ARQ   G+ YLH
Sbjct: 83  HVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 141
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTD 268
            + I+HRD+K +N+ ++    VKI DFG++   ++           G+I +M+PE I   
Sbjct: 142 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS-- 326
            +   Y  +  D+++ G+ + E   G+ P++     D    M    +  P  +   ++  
Sbjct: 202 -DKNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 259
Query: 327 REFRDFISRCLQKDPHSR 344
           +  +  ++ CL+K    R
Sbjct: 260 KAMKRLMAECLKKKRDER 277

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 17/203 (8%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTS----RVFALKVIYGNHEDSVRSQICREIEILRDVNH 156
           L+K   +G G  G V    + PT+     + A+K +       +RS   REIEILR + H
Sbjct: 10  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYH 69
Query: 157 PNVVKCHDMYDRNGE--IEVLLEYMDGGSLEGAHIRQEHILSDL---ARQVLSGLAYLHK 211
            ++VK     +  GE  +++++EY+  GSL     R    L+ L   A+Q+  G+AYLH 
Sbjct: 70  EHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHA 129
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTD 268
           +  +HR +   N+L+++ + VKI DFG+++ + +  +           + + +PE     
Sbjct: 130 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE----C 185
Query: 269 LNHGKYDGYAGDIWSLGVSILEF 291
           L   K+  YA D+WS GV++ E 
Sbjct: 186 LKECKF-YYASDVWSFGVTLYEL 207

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 117/258 (45%), Gaps = 14/258 (5%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           I   ++  G RIGSGS GTV++        V  L V     +         E+ +LR   
Sbjct: 5   IPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTR 62
Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHI----LSDLARQVLSGLAYLH 210
           H N++     Y    ++ ++ ++ +G SL    HI +       L D+ARQ   G+ YLH
Sbjct: 63  HVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTD 268
            + I+HRD+K +N+ ++    VKI DFG++   ++           G+I +M+PE I   
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS-- 326
            +   Y  +  D+++ G+ + E   G+ P++     D    M    +  P  +   ++  
Sbjct: 182 -DKNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 327 REFRDFISRCLQKDPHSR 344
           +  +  ++ CL+K    R
Sbjct: 240 KAMKRLMAECLKKKRDER 257

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 110/233 (47%), Gaps = 38/233 (16%)
Query: 146 REIEILRDVNHPNVVKCHDMYDRNGEIE--------VLLEYMDGGSLEGAHIRQEHILSD 197
           RE +    +NHP +V  +D     GE E        +++EY+DG +L      +  +   
Sbjct: 78  REAQNAAALNHPAIVAVYD----TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 133
Query: 198 LARQVLS----GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN-- 251
            A +V++     L + H+  I+HRD+KP+N++I+++  VK+ DFG++R +A + +     
Sbjct: 134 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 193
Query: 252 -SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLM 310
            + +GT  Y+SPE+   D    +      D++SLG  + E   G  PF     GD     
Sbjct: 194 AAVIGTAQYLSPEQARGDSVDAR-----SDVYSLGCVLYEVLTGEPPF----TGDSP--- 241
Query: 311 FAICFAQPPEAP-------EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            ++ +    E P       E  S +    + + L K+P +R+  A  ++   +
Sbjct: 242 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 294

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 115/252 (45%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI D G++R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDRGLAR---HTDDEMTGYVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLTQ 264

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 100/198 (50%), Gaps = 20/198 (10%)
Query: 107 IGSGSGGTVW--RVVHPPTSRVF-ALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IG+G  G V    +  P    +F A+K +   + +  R     E  I+   +HPNV+   
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH------ILSDLARQVLSGLAYLHKRKIVHR 217
            +  ++  + ++ E+M+ GSL+ + +RQ         L  + R + +G+ YL     VHR
Sbjct: 101 GVVTKSTPVMIITEFMENGSLD-SFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHR 159
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILA-QTMDPC-NSAVGT---IAYMSPERINTDLNHG 272
           D+   N+L+NS+   K++DFG+SR L   T DP   SA+G    I + +PE I     + 
Sbjct: 160 DLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI----QYR 215
Query: 273 KYDGYAGDIWSLGVSILE 290
           K+   A D+WS G+ + E
Sbjct: 216 KFTS-ASDVWSYGIVMWE 232

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 17/203 (8%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTS----RVFALKVIYGNHEDSVRSQICREIEILRDVNH 156
           L+K   +G G  G V    + PT+     + A+K +       +RS   REIEILR + H
Sbjct: 11  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYH 70
Query: 157 PNVVKCHDMYDRNGE--IEVLLEYMDGGSLEGAHIRQEHILSDL---ARQVLSGLAYLHK 211
            ++VK     +  GE  +++++EY+  GSL     R    L+ L   A+Q+  G+AYLH 
Sbjct: 71  EHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHA 130
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTD 268
           +  +HR +   N+L+++ + VKI DFG+++ + +  +           + + +PE     
Sbjct: 131 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE----C 186
Query: 269 LNHGKYDGYAGDIWSLGVSILEF 291
           L   K+  YA D+WS GV++ E 
Sbjct: 187 LKECKF-YYASDVWSFGVTLYEL 208

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 60/300 (20%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIGLL 89
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 149
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQT--MDPCNSAVGTIAYMSPERINTDLNHGKY 274
           RD+KPSN+++ S   +KI DFG++R    +  M+P    V T  Y +PE I   L  G  
Sbjct: 150 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEP---EVVTRYYRAPEVI---LGMGYK 203
Query: 275 DGYAGDIWSLGVSILEFYLGRFPF---------------------------------AVG 301
           +    D+WS+G  + E    +  F                                  V 
Sbjct: 204 ENV--DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
Query: 302 RQGDWASLMFA-----ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +  +A   F      + F    E  ++ + + RD +S+ L  D   R    + LQHP+I
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 123/259 (47%), Gaps = 26/259 (10%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
            ++G+G  G VW   +  +++V    +  G    SV++    E  +++ + H  +V+ + 
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQA-FLEEANLMKTLQHDKLVRLYA 74
Query: 165 MYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
           +  +   I ++ E+M  GSL       EG  +    ++ D + Q+  G+AY+ ++  +HR
Sbjct: 75  VVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLI-DFSAQIAEGMAYIERKNYIHR 133
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDG 276
           D++ +N+L++ S   KIADFG++R++          A   I + +PE IN      K   
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK--- 190
Query: 277 YAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS--REFRDFI 333
              ++WS G+ + E    G+ P+  GR    A +M A+  +Q    P M +   E  D +
Sbjct: 191 --SNVWSFGILLYEIVTYGKIPYP-GRTN--ADVMSAL--SQGYRMPRMENCPDELYDIM 243
Query: 334 SRCLQKDPHSRWPAAQLLQ 352
             C ++    R P    LQ
Sbjct: 244 KMCWKEKAEER-PTFDYLQ 261

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 117/258 (45%), Gaps = 14/258 (5%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           I   ++  G RIGSGS GTV++        V  L V     +         E+ +LR   
Sbjct: 33  IPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTR 90
Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHI----LSDLARQVLSGLAYLH 210
           H N++     Y    ++ ++ ++ +G SL    HI +       L D+ARQ   G+ YLH
Sbjct: 91  HVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 149
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTD 268
            + I+HRD+K +N+ ++    VKI DFG++   ++           G+I +M+PE I   
Sbjct: 150 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS-- 326
            +   Y  +  D+++ G+ + E   G+ P++     D    M    +  P  +   ++  
Sbjct: 210 -DKNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 267
Query: 327 REFRDFISRCLQKDPHSR 344
           +  +  ++ CL+K    R
Sbjct: 268 KAMKRLMAECLKKKRDER 285

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 115/252 (45%), Gaps = 19/252 (7%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   Q  + +GSG+ G+V       T    A+K +    +  + ++   RE+ +L+ + H
Sbjct: 21  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 157 PNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLA 207
            NV+   D++     +E      L+ ++ G  L    ++ + +  D    L  Q+L GL 
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 139
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           Y+H   I+HRD+KPSNL +N    +KI D G++R    T D     V T  Y +PE +  
Sbjct: 140 YIHSADIIHRDLKPSNLAVNEDCELKILDGGLAR---HTDDEMTGYVATRWYRAPEIM-- 194
Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE-APEMAS 326
            LN   Y+    DIWS+G  + E   GR  F      D   L+  +      E   +++S
Sbjct: 195 -LNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 327 REFRDFISRCLQ 338
              R++I    Q
Sbjct: 253 ESARNYIQSLTQ 264

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 27/243 (11%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALK-VIYGNHEDSVRSQICREIEILRDVNHP 157
           ++ +K  +IG G+ G V++  H  T +  ALK V+  N ++       REI+IL+ + H 
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 77
Query: 158 NVVKCHDM-------YDR-NGEIEVLLEYMD---GGSLEGAHIRQEHILSDLAR---QVL 203
           NVV   ++       Y+R  G I ++ ++ +    G L    ++    LS++ R    +L
Sbjct: 78  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLL 135
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI--LAQTMDP--CNSAVGTIAY 259
           +GL Y+H+ KI+HRD+K +N+LI     +K+ADFG++R   LA+   P    + V T+ Y
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 260 MSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGR-QGDWASLMFAICFAQP 318
             PE +  + ++G       D+W  G  + E +  R P   G  +    +L+  +C +  
Sbjct: 196 RPPELLLGERDYGP----PIDLWGAGCIMAEMW-TRSPIMQGNTEQHQLALISQLCGSIT 250
Query: 319 PEA 321
           PE 
Sbjct: 251 PEV 253

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 104/203 (51%), Gaps = 22/203 (10%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHP 157
            ++   +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HP
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHP 74
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLH 210
           N+V+   +  R     +++E+M  G+L   ++R+ +       +L  +A Q+ S + YL 
Sbjct: 75  NLVQLLGVCTREPPFYIIIEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINT 267
           K+  +HRD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE    
Sbjct: 134 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE---- 187
Query: 268 DLNHGKYDGYAGDIWSLGVSILE 290
            L + K+     D+W+ GV + E
Sbjct: 188 SLAYNKF-SIKSDVWAFGVLLWE 209

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIGLL 89
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 149
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 150 RDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 205
Query: 277 YAGDIWSLGVSILEFYLGRFPF---------------------------------AVGRQ 303
              DIWS+G  + E   G   F                                  V  +
Sbjct: 206 V--DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENR 263
Query: 304 GDWASLMFA-----ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A   F      + F    E  ++ + + RD +S+ L  D   R    + LQHP+I
Sbjct: 264 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 117/244 (47%), Gaps = 23/244 (9%)
Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG--AHIRQ----EHILSDLAR 200
           E +IL  VN   VV     Y+    + ++L  M+GG L+    H+ Q    E      A 
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL--AQTMDPCNSAVGTIA 258
           ++  GL  LH+ +IV+RD+KP N+L++   +++I+D G++  +   QT+      VGT+ 
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI---KGRVGTVG 350
Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP 318
           YM+PE +  +    +Y  ++ D W+LG  + E   G+ PF   ++      +  +    P
Sbjct: 351 YMAPEVVKNE----RYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP 405
Query: 319 PEAPEMASREFRDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILP 373
            E  E  S + R   S+ L KDP  R       A ++ +HP   +    ++   +  + P
Sbjct: 406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGM--LEP 463
Query: 374 PPRP 377
           P +P
Sbjct: 464 PFKP 467

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 34/275 (12%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDVNHPNVVKCHDM 165
           +G G  G V ++ +  T   FALK++    +D  +++  RE+E+  R    P++V+  D+
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKML----QDCPKAR--REVELHWRASQCPHIVRIVDV 123
Query: 166 YDR----NGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           Y+        + +++E +DGG L       G     E   S++ + +   + YLH   I 
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 183
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL  S +    +K+ DFG ++    + +   +   T  Y++PE +  +    
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE---- 238
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPF------AVGRQGDWASLMFAICFAQPPEAPEMAS 326
           KYD  + D+WSLGV +     G  PF      A+         M    F  P  +    S
Sbjct: 239 KYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE--VS 295
Query: 327 REFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
            E +  I   L+ +P  R    + + HP+I+++ +
Sbjct: 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 117/244 (47%), Gaps = 23/244 (9%)
Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG--AHIRQ----EHILSDLAR 200
           E +IL  VN   VV     Y+    + ++L  M+GG L+    H+ Q    E      A 
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL--AQTMDPCNSAVGTIA 258
           ++  GL  LH+ +IV+RD+KP N+L++   +++I+D G++  +   QT+      VGT+ 
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI---KGRVGTVG 350
Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP 318
           YM+PE +  +    +Y  ++ D W+LG  + E   G+ PF   ++      +  +    P
Sbjct: 351 YMAPEVVKNE----RYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP 405
Query: 319 PEAPEMASREFRDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILP 373
            E  E  S + R   S+ L KDP  R       A ++ +HP   +    ++   +  + P
Sbjct: 406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGM--LEP 463
Query: 374 PPRP 377
           P +P
Sbjct: 464 PFKP 467

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 102/197 (51%), Gaps = 22/197 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     +++E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE----SLAYNK 188
Query: 274 YDGYAGDIWSLGVSILE 290
           +     D+W+ GV + E
Sbjct: 189 F-SIKSDVWAFGVLLWE 204

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 127/298 (42%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 37  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIGLL 94
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 95  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 154
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 155 RDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 210
Query: 277 YAGDIWSLGVSILEFYLGRFPF---------------------------------AVGRQ 303
              D+WS+G  + E    +  F                                  V  +
Sbjct: 211 V--DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 268
Query: 304 GDWASLMFA-----ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A   F      + F    E  ++ + + RD +S+ L  D   R    + LQHP+I
Sbjct: 269 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 326

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 129/275 (46%), Gaps = 34/275 (12%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDVNHPNVVKCHDM 165
           +G G  G V ++ +  T   FALK++    +D  +++  RE+E+  R    P++V+  D+
Sbjct: 31  LGLGINGKVLQIFNKRTQEKFALKML----QDCPKAR--REVELHWRASQCPHIVRIVDV 84
Query: 166 YDR----NGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           Y+        + +++E +DGG L       G     E   S++ + +   + YLH   I 
Sbjct: 85  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 144
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL  S +    +K+ DFG ++    + +   +   T  Y++PE +  +    
Sbjct: 145 HRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE---- 199
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPF------AVGRQGDWASLMFAICFAQPPEAPEMAS 326
           KYD  + D+WSLGV +     G  PF      A+         M    F   PE  E+ S
Sbjct: 200 KYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN-PEWSEV-S 256
Query: 327 REFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
            E +  I   L+ +P  R    + + HP+I+++ +
Sbjct: 257 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 291

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 102/197 (51%), Gaps = 22/197 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     +++E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 74  GVCTREPPFYIIIEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTXTAHAGAKFPIKWTAPE----SLAYNK 186
Query: 274 YDGYAGDIWSLGVSILE 290
           +     D+W+ GV + E
Sbjct: 187 F-SIKSDVWAFGVLLWE 202

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 34/275 (12%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDVNHPNVVKCHDM 165
           +G G  G V ++ +  T   FALK++    +D  +++  RE+E+  R    P++V+  D+
Sbjct: 30  LGLGINGKVLQIFNKRTQEKFALKML----QDCPKAR--REVELHWRASQCPHIVRIVDV 83
Query: 166 YDR----NGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           Y+        + +++E +DGG L       G     E   S++ + +   + YLH   I 
Sbjct: 84  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 143
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL  S +    +K+ DFG ++    + +   +   T  Y++PE +  +    
Sbjct: 144 HRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE---- 198
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPF------AVGRQGDWASLMFAICFAQPPEAPEMAS 326
           KYD  + D+WSLGV +     G  PF      A+         M    F  P  +    S
Sbjct: 199 KYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE--VS 255
Query: 327 REFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
            E +  I   L+ +P  R    + + HP+I+++ +
Sbjct: 256 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 290

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 34/275 (12%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDVNHPNVVKCHDM 165
           +G G  G V ++ +  T   FALK++    +D  +++  RE+E+  R    P++V+  D+
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKML----QDCPKAR--REVELHWRASQCPHIVRIVDV 77
Query: 166 YDR----NGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           Y+        + +++E +DGG L       G     E   S++ + +   + YLH   I 
Sbjct: 78  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 137
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL  S +    +K+ DFG ++    + +   +   T  Y++PE +  +    
Sbjct: 138 HRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE---- 192
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPF------AVGRQGDWASLMFAICFAQPPEAPEMAS 326
           KYD  + D+WSLGV +     G  PF      A+         M    F  P  +    S
Sbjct: 193 KYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE--VS 249
Query: 327 REFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
            E +  I   L+ +P  R    + + HP+I+++ +
Sbjct: 250 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 284

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 17/208 (8%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   EL++   +GSG+ GTV++ +  P         A+K++          +   E  I
Sbjct: 11  ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI 70
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHILSDL----ARQVLSG 205
           +  ++HP++V+   +   +  I+++ + M  G L E  H  +++I S L      Q+  G
Sbjct: 71  MASMDHPHLVRLLGVC-LSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKG 129
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSPE 263
           + YL +R++VHRD+   N+L+ S  +VKI DFG++R+L       N+  G   I +M+ E
Sbjct: 130 MMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 189
Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILEF 291
            I     H +   +  D+WS GV+I E 
Sbjct: 190 CI-----HYRKFTHQSDVWSYGVTIWEL 212

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 16/195 (8%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G+G  G V   R+  P    +  A+K +   + +  R     E  I+   +HPN+++  
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 164 DMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHI--LSDLARQVLSGLAYLHKRKIVHRD 218
            +  ++  + ++ EYM+ GSL+     H  Q  +  L  + R + SG+ YL     VHRD
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRD 172
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYD 275
           +   N+LINS+   K++DFG+SR+L    +   +  G    I + SPE I     + K+ 
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI----AYRKFT 228
Query: 276 GYAGDIWSLGVSILE 290
             A D+WS G+ + E
Sbjct: 229 S-ASDVWSYGIVLWE 242

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 34  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIGLL 91
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 92  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 151
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 152 RDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMVPFVVTRYYRAPEVI---LGMGYKEN 207
Query: 277 YAGDIWSLGVSILEFYLGRFPF---------------------------------AVGRQ 303
              DIWS+G  + E   G   F                                  V  +
Sbjct: 208 V--DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 265
Query: 304 GDWASLMFA-----ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A   F      + F    E  ++ + + RD +S+ L  D   R    + LQHP+I
Sbjct: 266 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 323

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 102/197 (51%), Gaps = 22/197 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     +++E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 77  GVCTREPPFYIIIEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTXTAHAGAKFPIKWTAPE----SLAYNK 189
Query: 274 YDGYAGDIWSLGVSILE 290
           +     D+W+ GV + E
Sbjct: 190 F-SIKSDVWAFGVLLWE 205

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 34/275 (12%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDVNHPNVVKCHDM 165
           +G G  G V ++ +  T   FALK++    +D  +++  RE+E+  R    P++V+  D+
Sbjct: 32  LGLGINGKVLQIFNKRTQEKFALKML----QDCPKAR--REVELHWRASQCPHIVRIVDV 85
Query: 166 YDR----NGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           Y+        + +++E +DGG L       G     E   S++ + +   + YLH   I 
Sbjct: 86  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 145
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL  S +    +K+ DFG ++    + +   +   T  Y++PE +  +    
Sbjct: 146 HRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE---- 200
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPF------AVGRQGDWASLMFAICFAQPPEAPEMAS 326
           KYD  + D+WSLGV +     G  PF      A+         M    F  P  +    S
Sbjct: 201 KYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE--VS 257
Query: 327 REFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
            E +  I   L+ +P  R    + + HP+I+++ +
Sbjct: 258 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 292

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 102/197 (51%), Gaps = 22/197 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     +++E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE----SLAYNK 188
Query: 274 YDGYAGDIWSLGVSILE 290
           +     D+W+ GV + E
Sbjct: 189 F-SIKSDVWAFGVLLWE 204

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 131/275 (47%), Gaps = 34/275 (12%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDVNHPNVVKCHDM 165
           +G G  G V ++ +  T   FALK++    +D  +++  RE+E+  R    P++V+  D+
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKML----QDCPKAR--REVELHWRASQCPHIVRIVDV 79
Query: 166 YDR----NGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           Y+        + +++E +DGG L       G     E   S++ + +   + YLH   I 
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 139
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL  S +    +K+ DFG ++    + +   +   T  Y++PE +  +    
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE---- 194
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWAS--LMFAICFAQ----PPEAPEMAS 326
           KYD  + D+WSLGV I+   L  +P      G   S  +   I   Q     PE  E+ S
Sbjct: 195 KYDK-SCDMWSLGV-IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV-S 251
Query: 327 REFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
            E +  I   L+ +P  R    + + HP+I+++ +
Sbjct: 252 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 286

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 17/208 (8%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   EL++   +GSG+ GTV++ +  P         A+K++          +   E  I
Sbjct: 34  ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI 93
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHILSDL----ARQVLSG 205
           +  ++HP++V+   +   +  I+++ + M  G L E  H  +++I S L      Q+  G
Sbjct: 94  MASMDHPHLVRLLGVC-LSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKG 152
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSPE 263
           + YL +R++VHRD+   N+L+ S  +VKI DFG++R+L       N+  G   I +M+ E
Sbjct: 153 MMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 212
Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILEF 291
            I     H +   +  D+WS GV+I E 
Sbjct: 213 CI-----HYRKFTHQSDVWSYGVTIWEL 235

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 131/275 (47%), Gaps = 34/275 (12%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDVNHPNVVKCHDM 165
           +G G  G V ++ +  T   FALK++    +D  +++  RE+E+  R    P++V+  D+
Sbjct: 76  LGLGINGKVLQIFNKRTQEKFALKML----QDCPKAR--REVELHWRASQCPHIVRIVDV 129
Query: 166 YDR----NGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           Y+        + +++E +DGG L       G     E   S++ + +   + YLH   I 
Sbjct: 130 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 189
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL  S +    +K+ DFG ++    + +   +   T  Y++PE +  +    
Sbjct: 190 HRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE---- 244
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWAS--LMFAICFAQ----PPEAPEMAS 326
           KYD  + D+WSLGV I+   L  +P      G   S  +   I   Q     PE  E+ S
Sbjct: 245 KYDK-SCDMWSLGV-IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV-S 301
Query: 327 REFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
            E +  I   L+ +P  R    + + HP+I+++ +
Sbjct: 302 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 336

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           L+   R+G+G  G VW   +   ++V    +  G+           E  +++ + H  +V
Sbjct: 21  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 77
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           + + +  +   I ++ EYM+ GSL        G  +    +L D+A Q+  G+A++ +R 
Sbjct: 78  RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLL-DMAAQIAEGMAFIEERN 135
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHG 272
            +HRD++ +N+L++ + + KIADFG++R++          A   I + +PE I    N+G
Sbjct: 136 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI----NYG 191
Query: 273 KYDGYAGDIWSLGVSILEFYL-GRFPF 298
            +     D+WS G+ + E    GR P+
Sbjct: 192 TFT-IKSDVWSFGILLTEIVTHGRIPY 217

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 127/278 (45%), Gaps = 40/278 (14%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDVNHPNVVKCHDM 165
           +G G  G V ++ +  T   FALK++    +D  +++  RE+E+  R    P++V+  D+
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKML----QDCPKAR--REVELHWRASQCPHIVRIVDV 77
Query: 166 YDR----NGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           Y+        + +++E +DGG L       G     E   S++ + +   + YLH   I 
Sbjct: 78  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 137
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILA---QTMDPCNSAVGTIAYMSPERINTDL 269
           HRD+KP NLL  S +    +K+ DFG ++         +PC     T  Y++PE +  + 
Sbjct: 138 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCY----TPYYVAPEVLGPE- 192
Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGRFPF------AVGRQGDWASLMFAICFAQPPEAPE 323
              KYD  + D+WSLGV +     G  PF      A+         M    F  P  +  
Sbjct: 193 ---KYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE- 247
Query: 324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
             S E +  I   L+ +P  R    + + HP+I+++ +
Sbjct: 248 -VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 284

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR---------QEHILSD 197
           E +IL  V+   +V     ++   ++ +++  M+GG +   HI          QE     
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR-YHIYNVDEDNPGFQEPRAIF 293
Query: 198 LARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI 257
              Q++SGL +LH+R I++RD+KP N+L++   NV+I+D G++  L           GT 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF-AVGRQGDWASLMFAICFA 316
            +M+PE +  +    +YD ++ D ++LGV++ E    R PF A G + +   L   +   
Sbjct: 354 GFMAPELLLGE----EYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-LE 407
Query: 317 QPPEAPEMASREFRDFISRCLQKDPHSR 344
           Q    P+  S   +DF    LQKDP  R
Sbjct: 408 QAVTYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
            R+G+G  G VW   +   ++V    +  G+           E  +++ + H  +V+ + 
Sbjct: 27  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYA 83
Query: 165 MYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
           +  +   I ++ EYM+ GSL        G  +    +L D+A Q+  G+A++ +R  +HR
Sbjct: 84  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLL-DMAAQIAEGMAFIEERNYIHR 141
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDG 276
           D++ +N+L++ + + KIADFG++R++          A   I + +PE I    N+G +  
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI----NYGTFT- 196
Query: 277 YAGDIWSLGVSILEFYL-GRFPF 298
              D+WS G+ + E    GR P+
Sbjct: 197 IKSDVWSFGILLTEIVTHGRIPY 219

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR---------QEHILSD 197
           E +IL  V+   +V     ++   ++ +++  M+GG +   HI          QE     
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR-YHIYNVDEDNPGFQEPRAIF 293
Query: 198 LARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI 257
              Q++SGL +LH+R I++RD+KP N+L++   NV+I+D G++  L           GT 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF-AVGRQGDWASLMFAICFA 316
            +M+PE +  +    +YD ++ D ++LGV++ E    R PF A G + +   L   +   
Sbjct: 354 GFMAPELLLGE----EYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-LE 407
Query: 317 QPPEAPEMASREFRDFISRCLQKDPHSR 344
           Q    P+  S   +DF    LQKDP  R
Sbjct: 408 QAVTYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 34/275 (12%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDVNHPNVVKCHDM 165
           +G G  G V ++ +  T   FALK++    +D  +++  RE+E+  R    P++V+  D+
Sbjct: 25  LGLGINGKVLQIFNKRTQEKFALKML----QDCPKAR--REVELHWRASQCPHIVRIVDV 78
Query: 166 YDR----NGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           Y+        + +++E +DGG L       G     E   S++ + +   + YLH   I 
Sbjct: 79  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 138
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL  S +    +K+ DFG ++    + +   +   T  Y++PE +  +    
Sbjct: 139 HRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE---- 193
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPF------AVGRQGDWASLMFAICFAQPPEAPEMAS 326
           KYD  + D+WSLGV +     G  PF      A+         M    F  P  +    S
Sbjct: 194 KYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE--VS 250
Query: 327 REFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
            E +  I   L+ +P  R    + + HP+I+++ +
Sbjct: 251 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 285

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR---------QEHILSD 197
           E +IL  V+   +V     ++   ++ +++  M+GG +   HI          QE     
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR-YHIYNVDEDNPGFQEPRAIF 293
Query: 198 LARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI 257
              Q++SGL +LH+R I++RD+KP N+L++   NV+I+D G++  L           GT 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF-AVGRQGDWASLMFAICFA 316
            +M+PE +  +    +YD ++ D ++LGV++ E    R PF A G + +   L   +   
Sbjct: 354 GFMAPELLLGE----EYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-LE 407
Query: 317 QPPEAPEMASREFRDFISRCLQKDPHSR 344
           Q    P+  S   +DF    LQKDP  R
Sbjct: 408 QAVTYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 127/274 (46%), Gaps = 32/274 (11%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDVNHPNVVKCHDM 165
           +G G  G V ++ +  T   FALK++    +D  +++  RE+E+  R    P++V+  D+
Sbjct: 40  LGLGINGKVLQIFNKRTQEKFALKML----QDCPKAR--REVELHWRASQCPHIVRIVDV 93
Query: 166 YDR----NGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           Y+        + +++E +DGG L       G     E   S++ + +   + YLH   I 
Sbjct: 94  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 153
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL  S +    +K+ DFG ++    + +   +   T  Y++PE +  +    
Sbjct: 154 HRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE---- 208
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ-----GDWASLMFAICFAQPPEAPEMASR 327
           KYD  + D+WSLGV +     G  PF          G    +         PE  E+ S 
Sbjct: 209 KYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV-SE 266
Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
           E +  I   L+ +P  R    + + HP+I+++ +
Sbjct: 267 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 300

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 34/275 (12%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDVNHPNVVKCHDM 165
           +G G  G V ++ +  T   FALK++    +D  +++  RE+E+  R    P++V+  D+
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKML----QDCPKAR--REVELHWRASQCPHIVRIVDV 79
Query: 166 YDR----NGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           Y+        + +++E +DGG L       G     E   S++ + +   + YLH   I 
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 139
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL  S +    +K+ DFG ++    + +   +   T  Y++PE +  +    
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE---- 194
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPF------AVGRQGDWASLMFAICFAQPPEAPEMAS 326
           KYD  + D+WSLGV +     G  PF      A+         M    F  P  +    S
Sbjct: 195 KYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE--VS 251
Query: 327 REFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
            E +  I   L+ +P  R    + + HP+I+++ +
Sbjct: 252 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 286

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           L+   R+G+G  G VW   +   ++V    +  G+           E  +++ + H  +V
Sbjct: 24  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 80
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           + + +  +   I ++ EYM+ GSL        G  +    +L D+A Q+  G+A++ +R 
Sbjct: 81  RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLL-DMAAQIAEGMAFIEERN 138
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHG 272
            +HRD++ +N+L++ + + KIADFG++R++          A   I + +PE I    N+G
Sbjct: 139 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI----NYG 194
Query: 273 KYDGYAGDIWSLGVSILEFYL-GRFPF 298
            +     D+WS G+ + E    GR P+
Sbjct: 195 TFT-IKSDVWSFGILLTEIVTHGRIPY 220

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 127/298 (42%), Gaps = 56/298 (18%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG+ G V         R  A+K +   + N   + R+   RE+ +++ VNH N++   
Sbjct: 26  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIGLL 83
Query: 164 DMYDRNGEIE------VLLEYMDGGSLEGAHIRQEHI-LSDLARQVLSGLAYLHKRKIVH 216
           +++     +E      +++E MD    +   +  +H  +S L  Q+L G+ +LH   I+H
Sbjct: 84  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIH 143
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KPSN+++ S   +KI DFG++R  A T       V T  Y +PE I   L  G  + 
Sbjct: 144 RDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVI---LGMGYKEN 199
Query: 277 YAGDIWSLGVSILEFYLGRFPF---------------------------------AVGRQ 303
              D+WS+G  + E    +  F                                  V  +
Sbjct: 200 V--DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 257
Query: 304 GDWASLMFA-----ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +A   F      + F    E  ++ + + RD +S+ L  D   R    + LQHP+I
Sbjct: 258 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 315

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR---------QEHILSD 197
           E +IL  V+   +V     ++   ++ +++  M+GG +   HI          QE     
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR-YHIYNVDEDNPGFQEPRAIF 293
Query: 198 LARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTI 257
              Q++SGL +LH+R I++RD+KP N+L++   NV+I+D G++  L           GT 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF-AVGRQGDWASLMFAICFA 316
            +M+PE +  +    +YD ++ D ++LGV++ E    R PF A G + +   L   +   
Sbjct: 354 GFMAPELLLGE----EYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-LE 407
Query: 317 QPPEAPEMASREFRDFISRCLQKDPHSR 344
           Q    P+  S   +DF    LQKDP  R
Sbjct: 408 QAVTYPDKFSPASKDFCEALLQKDPEKR 435

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 116/267 (43%), Gaps = 35/267 (13%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPT---SRVFALKVIYGNHEDSVRSQICREIEILR 152
           I    ++ G  IG G  G V + ++      +   A+K       DSVR +  +E   +R
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 66
Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVL------SGL 206
             +HP++VK   +   N  + +++E    G L  + ++      DLA  +L      + L
Sbjct: 67  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELR-SFLQVRKFSLDLASLILYAYQLSTAL 124
Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA-QTMDPCNSAVGTIAYMSPERI 265
           AYL  ++ VHRDI   N+L++S+  VK+ DFG+SR +   T    +     I +M+PE I
Sbjct: 125 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESI 184
Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPF-------AVGRQGDWASLMFAICFAQ 317
           N      +    A D+W  GV + E  + G  PF        +GR  +   L        
Sbjct: 185 NF-----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------PM 233
Query: 318 PPEAPEMASREFRDFISRCLQKDPHSR 344
           PP  P          +++C   DP  R
Sbjct: 234 PPNCPPT----LYSLMTKCWAYDPSRR 256

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 22/197 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     ++ E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE----SLAYNK 188
Query: 274 YDGYAGDIWSLGVSILE 290
           +     D+W+ GV + E
Sbjct: 189 F-SIKSDVWAFGVLLWE 204

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 22/197 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     ++ E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 77  GVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 135
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAPAGAKFPIKWTAPE----SLAYNK 189
Query: 274 YDGYAGDIWSLGVSILE 290
           +     D+W+ GV + E
Sbjct: 190 F-SIKSDVWAFGVLLWE 205

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 22/197 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     ++ E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE----SLAYNK 193
Query: 274 YDGYAGDIWSLGVSILE 290
           +     D+W+ GV + E
Sbjct: 194 F-SIKSDVWAFGVLLWE 209

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           L+   R+G+G  G VW   +   ++V    +  G+           E  +++ + H  +V
Sbjct: 17  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 73
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           + + +  +   I ++ EYM+ GSL        G  +    +L D+A Q+  G+A++ +R 
Sbjct: 74  RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLL-DMAAQIAEGMAFIEERN 131
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHG 272
            +HRD++ +N+L++ + + KIADFG++R++          A   I + +PE I    N+G
Sbjct: 132 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI----NYG 187
Query: 273 KYDGYAGDIWSLGVSILEFYL-GRFPF 298
            +     D+WS G+ + E    GR P+
Sbjct: 188 TFT-IKSDVWSFGILLTEIVTHGRIPY 213

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 22/197 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 79
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     ++ E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 138
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE----SLAYNK 192
Query: 274 YDGYAGDIWSLGVSILE 290
           +     D+W+ GV + E
Sbjct: 193 F-SIKSDVWAFGVLLWE 208

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           L+   R+G+G  G VW   +   ++V    +  G+           E  +++ + H  +V
Sbjct: 15  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 71
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           + + +  +   I ++ EYM+ GSL        G  +    +L D+A Q+  G+A++ +R 
Sbjct: 72  RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLL-DMAAQIAEGMAFIEERN 129
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHG 272
            +HRD++ +N+L++ + + KIADFG++R++          A   I + +PE I    N+G
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI----NYG 185
Query: 273 KYDGYAGDIWSLGVSILEFYL-GRFPF 298
            +     D+WS G+ + E    GR P+
Sbjct: 186 TFT-IKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 16/195 (8%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G+G  G V   R+  P    +  A+K +   + +  R     E  I+   +HPN+++  
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 100
Query: 164 DMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHI--LSDLARQVLSGLAYLHKRKIVHRD 218
            +  ++  + ++ EYM+ GSL+     H  Q  +  L  + R + SG+ YL     VHRD
Sbjct: 101 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 160
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYD 275
           +   N+LINS+   K++DFG+SR+L    +   +  G    I + SPE I     + K+ 
Sbjct: 161 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI----AYRKFT 216
Query: 276 GYAGDIWSLGVSILE 290
             A D+WS G+ + E
Sbjct: 217 S-ASDVWSYGIVLWE 230

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 22/197 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     ++ E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTXTAHAGAKFPIKWTAPE----SLAYNK 193
Query: 274 YDGYAGDIWSLGVSILE 290
           +     D+W+ GV + E
Sbjct: 194 F-SIKSDVWAFGVLLWE 209

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 12/211 (5%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           I   ++  G RIGSGS GTV++        V  L V     +         E+ +LR   
Sbjct: 9   IPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTR 66
Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHI----LSDLARQVLSGLAYLH 210
           H N++     Y    ++ ++ ++ +G SL    H  +       L D+ARQ   G+ YLH
Sbjct: 67  HVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 125
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTD 268
            + I+HRD+K +N+ ++    VKI DFG++ + ++           G+I +M+PE I   
Sbjct: 126 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR-- 183
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFA 299
           +       +  D+++ G+ + E   G+ P++
Sbjct: 184 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 214

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 16/195 (8%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G+G  G V   R+  P    +  A+K +   + +  R     E  I+   +HPN+++  
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 164 DMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHI--LSDLARQVLSGLAYLHKRKIVHRD 218
            +  ++  + ++ EYM+ GSL+     H  Q  +  L  + R + SG+ YL     VHRD
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 172
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYD 275
           +   N+LINS+   K++DFG+SR+L    +   +  G    I + SPE I     + K+ 
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI----AYRKFT 228
Query: 276 GYAGDIWSLGVSILE 290
             A D+WS G+ + E
Sbjct: 229 S-ASDVWSYGIVLWE 242

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 16/195 (8%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G+G  G V   R+  P    +  A+K +   + +  R     E  I+   +HPN+++  
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 164 DMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHI--LSDLARQVLSGLAYLHKRKIVHRD 218
            +  ++  + ++ EYM+ GSL+     H  Q  +  L  + R + SG+ YL     VHRD
Sbjct: 84  GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 143
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYD 275
           +   N+LINS+   K++DFG+SR+L    +   +  G    I + SPE I     + K+ 
Sbjct: 144 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI----AYRKFT 199
Query: 276 GYAGDIWSLGVSILE 290
             A D+WS G+ + E
Sbjct: 200 S-ASDVWSYGIVLWE 213

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 103/203 (50%), Gaps = 22/203 (10%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHP 157
            ++   +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HP
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHP 69
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLH 210
           N+V+   +  R     ++ E+M  G+L   ++R+ +       +L  +A Q+ S + YL 
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLE 128
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINT 267
           K+  +HRD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE    
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE---- 182
Query: 268 DLNHGKYDGYAGDIWSLGVSILE 290
            L + K+     D+W+ GV + E
Sbjct: 183 SLAYNKF-SIKSDVWAFGVLLWE 204

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 93/195 (47%), Gaps = 16/195 (8%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG  G V   R+  P    V  A+K +   + +  R     E  I+   +HPN+++  
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 164 DMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHI--LSDLARQVLSGLAYLHKRKIVHRD 218
            +  R     ++ EYM+ GSL+     H  Q  I  L  + R V +G+ YL     VHRD
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRD 176
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYD 275
           +   N+L++S+   K++DFG+SR+L    D   +  G    I + +PE I       +  
Sbjct: 177 LAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAF-----RTF 231
Query: 276 GYAGDIWSLGVSILE 290
             A D+WS GV + E
Sbjct: 232 SSASDVWSFGVVMWE 246

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           L+   R+G+G  G VW   +   ++V    +  G+           E  +++ + H  +V
Sbjct: 16  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 72
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           + + +  +   I ++ EYM+ GSL        G  +    +L D+A Q+  G+A++ +R 
Sbjct: 73  RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLL-DMAAQIAEGMAFIEERN 130
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHG 272
            +HRD++ +N+L++ + + KIADFG++R++          A   I + +PE I    N+G
Sbjct: 131 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI----NYG 186
Query: 273 KYDGYAGDIWSLGVSILEFYL-GRFPF 298
            +     D+WS G+ + E    GR P+
Sbjct: 187 TFT-IKSDVWSFGILLTEIVTHGRIPY 212

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 22/197 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     ++ E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTXTAHAGAKFPIKWTAPE----SLAYNK 186
Query: 274 YDGYAGDIWSLGVSILE 290
           +     D+W+ GV + E
Sbjct: 187 F-SIKSDVWAFGVLLWE 202

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 22/197 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     ++ E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAPAGAKFPIKWTAPE----SLAYNK 190
Query: 274 YDGYAGDIWSLGVSILE 290
           +     D+W+ GV + E
Sbjct: 191 F-SIKSDVWAFGVLLWE 206

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           L+   R+G+G  G VW   +   ++V    +  G+           E  +++ + H  +V
Sbjct: 15  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 71
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           + + +  +   I ++ EYM+ GSL        G  +    +L D+A Q+  G+A++ +R 
Sbjct: 72  RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLL-DMAAQIAEGMAFIEERN 129
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHG 272
            +HRD++ +N+L++ + + KIADFG++R++          A   I + +PE I    N+G
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI----NYG 185
Query: 273 KYDGYAGDIWSLGVSILEFYL-GRFPF 298
            +     D+WS G+ + E    GR P+
Sbjct: 186 TFT-IKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 105/227 (46%), Gaps = 33/227 (14%)
Query: 103 KGNRIGSGSGGTVWRVVHPPTSRV--FALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           +G ++G G+ G V++           +ALK I G     +    CREI +LR++ HPNV+
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVI 81
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEH---------------ILSDLARQVLSG 205
               ++  + + +V L + D    +  HI + H               ++  L  Q+L G
Sbjct: 82  SLQKVFLSHADRKVWLLF-DYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 206 LAYLHKRKIVHRDIKPSNLLINSS----KNVKIADFGVSRILAQTMDP---CNSAVGTIA 258
           + YLH   ++HRD+KP+N+L+         VKIAD G +R+    + P    +  V T  
Sbjct: 141 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 200
Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD 305
           Y +PE +    ++ K    A DIW++G    E  L   P    RQ D
Sbjct: 201 YRAPELLLGARHYTK----AIDIWAIGCIFAEL-LTSEPIFHCRQED 242

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 22/197 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 32  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 88
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     ++ E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 89  GVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 147
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE----SLAYNK 201
Query: 274 YDGYAGDIWSLGVSILE 290
           +     D+W+ GV + E
Sbjct: 202 F-SIKSDVWAFGVLLWE 217

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 16/195 (8%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G+G  G V   R+  P    +  A+K +   + +  R     E  I+   +HPN+++  
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 164 DMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHI--LSDLARQVLSGLAYLHKRKIVHRD 218
            +  ++  + ++ EYM+ GSL+     H  Q  +  L  + R + SG+ YL     VHRD
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 172
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYD 275
           +   N+LINS+   K++DFG+SR+L    +   +  G    I + SPE I     + K+ 
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI----AYRKFT 228
Query: 276 GYAGDIWSLGVSILE 290
             A D+WS G+ + E
Sbjct: 229 S-ASDVWSYGIVLWE 242

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 16/195 (8%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G+G  G V   R+  P    +  A+K +   + +  R     E  I+   +HPN+++  
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 164 DMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHI--LSDLARQVLSGLAYLHKRKIVHRD 218
            +  ++  + ++ EYM+ GSL+     H  Q  +  L  + R + SG+ YL     VHRD
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 172
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYD 275
           +   N+LINS+   K++DFG+SR+L    +   +  G    I + SPE I     + K+ 
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI----AYRKFT 228
Query: 276 GYAGDIWSLGVSILE 290
             A D+WS G+ + E
Sbjct: 229 S-ASDVWSYGIVLWE 242

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 22/197 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     ++ E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 132
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTFTAHAGAKFPIKWTAPE----SLAYNK 186
Query: 274 YDGYAGDIWSLGVSILE 290
           +     D+W+ GV + E
Sbjct: 187 F-SIKSDVWAFGVLLWE 202

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 16/195 (8%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G+G  G V   R+  P    +  A+K +   + +  R     E  I+   +HPN+++  
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 110
Query: 164 DMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHI--LSDLARQVLSGLAYLHKRKIVHRD 218
            +  ++  + ++ EYM+ GSL+     H  Q  +  L  + R + SG+ YL     VHRD
Sbjct: 111 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 170
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYD 275
           +   N+LINS+   K++DFG+SR+L    +   +  G    I + SPE I     + K+ 
Sbjct: 171 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI----AYRKFT 226
Query: 276 GYAGDIWSLGVSILE 290
             A D+WS G+ + E
Sbjct: 227 S-ASDVWSYGIVLWE 240

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 128/276 (46%), Gaps = 47/276 (17%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH-------PNV 159
           +G G  G V    H  T +  ALK++Y    DS +++        ++V+H       P++
Sbjct: 18  LGLGVNGKVLECFHRRTGQKCALKLLY----DSPKAR--------QEVDHHWQASGGPHI 65
Query: 160 VKCHDMYD--RNGE--IEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYL 209
           V   D+Y+   +G+  + +++E M+GG L       G     E   +++ R + + + +L
Sbjct: 66  VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 125
Query: 210 HKRKIVHRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN 266
           H   I HRD+KP NLL  S +    +K+ DFG ++    T +   +   T  Y++PE + 
Sbjct: 126 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEVLG 183
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWAS--LMFAICFAQ----PPE 320
            +    KYD  + D+WSLGV I+   L  FP      G   S  +   I   Q     PE
Sbjct: 184 PE----KYDK-SCDMWSLGV-IMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 237
Query: 321 APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             E+ S + +  I   L+ DP  R    Q + HP+I
Sbjct: 238 WSEV-SEDAKQLIRLLLKTDPTERLTITQFMNHPWI 272

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 128/276 (46%), Gaps = 47/276 (17%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH-------PNV 159
           +G G  G V    H  T +  ALK++Y    DS +++        ++V+H       P++
Sbjct: 37  LGLGVNGKVLECFHRRTGQKCALKLLY----DSPKAR--------QEVDHHWQASGGPHI 84
Query: 160 VKCHDMYD--RNGE--IEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYL 209
           V   D+Y+   +G+  + +++E M+GG L       G     E   +++ R + + + +L
Sbjct: 85  VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 210 HKRKIVHRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN 266
           H   I HRD+KP NLL  S +    +K+ DFG ++    T +   +   T  Y++PE + 
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEVLG 202
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWAS--LMFAICFAQ----PPE 320
            +    KYD  + D+WSLGV I+   L  FP      G   S  +   I   Q     PE
Sbjct: 203 PE----KYDK-SCDMWSLGV-IMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256
Query: 321 APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             E+ S + +  I   L+ DP  R    Q + HP+I
Sbjct: 257 WSEV-SEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 16/195 (8%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G+G  G V   R+  P    +  A+K +   + +  R     E  I+   +HPN+++  
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 164 DMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHI--LSDLARQVLSGLAYLHKRKIVHRD 218
            +  ++  + ++ EYM+ GSL+     H  Q  +  L  + R + SG+ YL     VHRD
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 172
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYD 275
           +   N+LINS+   K++DFG+SR+L    +   +  G    I + SPE I     + K+ 
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI----AYRKFT 228
Query: 276 GYAGDIWSLGVSILE 290
             A D+WS G+ + E
Sbjct: 229 S-ASDVWSYGIVLWE 242

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 22/197 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     ++ E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE----SLAYNK 188
Query: 274 YDGYAGDIWSLGVSILE 290
           +     D+W+ GV + E
Sbjct: 189 F-SIKSDVWAFGVLLWE 204

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 22/197 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     ++ E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE----SLAYNK 193
Query: 274 YDGYAGDIWSLGVSILE 290
           +     D+W+ GV + E
Sbjct: 194 F-SIKSDVWAFGVLLWE 209

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
            R+G+G  G VW   +   ++V    +  G+           E  +++ + H  +V+ + 
Sbjct: 29  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYA 85
Query: 165 MYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
           +  +   I ++ EYM+ GSL        G  +    +L D+A Q+  G+A++ +R  +HR
Sbjct: 86  VVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLL-DMAAQIAEGMAFIEERNYIHR 143
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHGKYDG 276
           D++ +N+L++ + + KIADFG++R++          A   I + +PE I    N+G +  
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI----NYGTFT- 198
Query: 277 YAGDIWSLGVSILEFYL-GRFPF 298
              D+WS G+ + E    GR P+
Sbjct: 199 IKSDVWSFGILLTEIVTHGRIPY 221

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 118/266 (44%), Gaps = 33/266 (12%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPT---SRVFALKVIYGNHEDSVRSQICREIEILR 152
           I    ++ G  IG G  G V + ++      +   A+K       DSVR +  +E   +R
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 66
Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG-AHIRQEHI-LSDL---ARQVLSGLA 207
             +HP++VK   +   N  + +++E    G L     +R+  + L+ L   A Q+ + LA
Sbjct: 67  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 125
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA-QTMDPCNSAVGTIAYMSPERIN 266
           YL  ++ VHRDI   N+L++S+  VK+ DFG+SR +   T    +     I +M+PE IN
Sbjct: 126 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPF-------AVGRQGDWASLMFAICFAQP 318
                 +    A D+W  GV + E  + G  PF        +GR  +   L        P
Sbjct: 186 F-----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------PMP 234
Query: 319 PEAPEMASREFRDFISRCLQKDPHSR 344
           P  P          +++C   DP  R
Sbjct: 235 PNCPPT----LYSLMTKCWAYDPSRR 256

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 22/197 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     ++ E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE----SLAYNK 190
Query: 274 YDGYAGDIWSLGVSILE 290
           +     D+W+ GV + E
Sbjct: 191 F-SIKSDVWAFGVLLWE 206

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 22/197 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     ++ E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 139
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE----SLAYNK 193
Query: 274 YDGYAGDIWSLGVSILE 290
           +     D+W+ GV + E
Sbjct: 194 F-SIKSDVWAFGVLLWE 209

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 117/266 (43%), Gaps = 33/266 (12%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSR---VFALKVIYGNHEDSVRSQICREIEILR 152
           I    ++ G  IG G  G V + ++          A+K       DSVR +  +E   +R
Sbjct: 35  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 94
Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG-AHIRQEHI-LSDL---ARQVLSGLA 207
             +HP++VK   +   N  + +++E    G L     +R+  + L+ L   A Q+ + LA
Sbjct: 95  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 153
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA-QTMDPCNSAVGTIAYMSPERIN 266
           YL  ++ VHRDI   N+L++S+  VK+ DFG+SR +   T    +     I +M+PE IN
Sbjct: 154 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 213
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPF-------AVGRQGDWASLMFAICFAQP 318
                 +    A D+W  GV + E  + G  PF        +GR  +   L        P
Sbjct: 214 F-----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------PMP 262
Query: 319 PEAPEMASREFRDFISRCLQKDPHSR 344
           P  P          +++C   DP  R
Sbjct: 263 PNCPPT----LYSLMTKCWAYDPSRR 284

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 107 IGSGSGGTVWRVV-HPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           IG G+ G V     H   +RV A+K I      +   +  REI+IL    H NV+   D+
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRV-AIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDI 109
Query: 166 YDRNGEIEV---------LLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVH 216
             R   +E          L+E      L+   +  +HI   L  Q+L GL Y+H   ++H
Sbjct: 110 L-RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLY-QILRGLKYIHSANVLH 167
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTDLNHGK 273
           RD+KPSNLLIN++ ++KI DFG++RI     D        V T  Y +PE +   LN   
Sbjct: 168 RDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIM---LNSKG 224
Query: 274 YDGYAGDIWSLGVSILEFYLGR--FP 297
           Y   + DIWS+G  + E    R  FP
Sbjct: 225 YTK-SIDIWSVGCILAEMLSNRPIFP 249

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 22/197 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     ++ E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 136
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE----SLAYNK 190
Query: 274 YDGYAGDIWSLGVSILE 290
           +     D+W+ GV + E
Sbjct: 191 F-SIKSDVWAFGVLLWE 206

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 22/197 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     ++ E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE----SLAYNK 188
Query: 274 YDGYAGDIWSLGVSILE 290
           +     D+W+ GV + E
Sbjct: 189 F-SIKSDVWAFGVLLWE 204

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           L+   R+G+G  G VW   +   ++V    +  G+           E  +++ + H  +V
Sbjct: 21  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 77
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           + + +  +   I ++ EYM+ GSL        G  +    +L D+A Q+  G+A++ +R 
Sbjct: 78  RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLL-DMAAQIAEGMAFIEERN 135
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHG 272
            +HRD++ +N+L++ + + KIADFG++R++          A   I + +PE I    N+G
Sbjct: 136 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI----NYG 191
Query: 273 KYDGYAGDIWSLGVSILEFYL-GRFPF 298
            +     D+WS G+ + E    GR P+
Sbjct: 192 TFT-IKSDVWSFGILLTEIVTHGRIPY 217

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 117/266 (43%), Gaps = 33/266 (12%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSR---VFALKVIYGNHEDSVRSQICREIEILR 152
           I    ++ G  IG G  G V + ++          A+K       DSVR +  +E   +R
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 66
Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG-AHIRQEHI-LSDL---ARQVLSGLA 207
             +HP++VK   +   N  + +++E    G L     +R+  + L+ L   A Q+ + LA
Sbjct: 67  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 125
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA-QTMDPCNSAVGTIAYMSPERIN 266
           YL  ++ VHRDI   N+L++S+  VK+ DFG+SR +   T    +     I +M+PE IN
Sbjct: 126 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPF-------AVGRQGDWASLMFAICFAQP 318
                 +    A D+W  GV + E  + G  PF        +GR  +   L        P
Sbjct: 186 F-----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------PMP 234
Query: 319 PEAPEMASREFRDFISRCLQKDPHSR 344
           P  P          +++C   DP  R
Sbjct: 235 PNCPPT----LYSLMTKCWAYDPSRR 256

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 93/195 (47%), Gaps = 16/195 (8%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IGSG  G V   R+  P    V  A+K +   + +  R     E  I+   +HPN+++  
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 164 DMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHI--LSDLARQVLSGLAYLHKRKIVHRD 218
            +  R     ++ EYM+ GSL+     H  Q  I  L  + R V +G+ YL     VHRD
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRD 176
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYD 275
           +   N+L++S+   K++DFG+SR+L    D   +  G    I + +PE I       +  
Sbjct: 177 LAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF-----RTF 231
Query: 276 GYAGDIWSLGVSILE 290
             A D+WS GV + E
Sbjct: 232 SSASDVWSFGVVMWE 246

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           L+   R+G+G  G VW   +   ++V    +  G+           E  +++ + H  +V
Sbjct: 20  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 76
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           + + +  +   I ++ EYM+ GSL        G  +    +L D+A Q+  G+A++ +R 
Sbjct: 77  RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLL-DMAAQIAEGMAFIEERN 134
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHG 272
            +HRD++ +N+L++ + + KIADFG++R++          A   I + +PE I    N+G
Sbjct: 135 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI----NYG 190
Query: 273 KYDGYAGDIWSLGVSILEFYL-GRFPF 298
            +     D+WS G+ + E    GR P+
Sbjct: 191 TFT-IKSDVWSFGILLTEIVTHGRIPY 216

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 103/203 (50%), Gaps = 17/203 (8%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTS----RVFALKVIYGNHEDSVRSQICREIEILRDVNH 156
           L+K   +G G  G V    + PT+     + A+K +  +     RS   +EI+ILR + H
Sbjct: 33  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH 92
Query: 157 PNVVKCHDMYDRNG--EIEVLLEYMDGGSLEGAHIRQEHILSDL---ARQVLSGLAYLHK 211
            +++K     +  G   +++++EY+  GSL     R    L+ L   A+Q+  G+AYLH 
Sbjct: 93  EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTD 268
           +  +HRD+   N+L+++ + VKI DFG+++ + +  +           + + +PE +   
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEY 212
Query: 269 LNHGKYDGYAGDIWSLGVSILEF 291
             +     YA D+WS GV++ E 
Sbjct: 213 KFY-----YASDVWSFGVTLYEL 230

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 117/266 (43%), Gaps = 33/266 (12%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSR---VFALKVIYGNHEDSVRSQICREIEILR 152
           I    ++ G  IG G  G V + ++          A+K       DSVR +  +E   +R
Sbjct: 12  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 71
Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG-AHIRQEHI-LSDL---ARQVLSGLA 207
             +HP++VK   +   N  + +++E    G L     +R+  + L+ L   A Q+ + LA
Sbjct: 72  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA-QTMDPCNSAVGTIAYMSPERIN 266
           YL  ++ VHRDI   N+L++S+  VK+ DFG+SR +   T    +     I +M+PE IN
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 190
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPF-------AVGRQGDWASLMFAICFAQP 318
                 +    A D+W  GV + E  + G  PF        +GR  +   L        P
Sbjct: 191 F-----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------PMP 239
Query: 319 PEAPEMASREFRDFISRCLQKDPHSR 344
           P  P          +++C   DP  R
Sbjct: 240 PNCPPT----LYSLMTKCWAYDPSRR 261

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 117/266 (43%), Gaps = 33/266 (12%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSR---VFALKVIYGNHEDSVRSQICREIEILR 152
           I    ++ G  IG G  G V + ++          A+K       DSVR +  +E   +R
Sbjct: 4   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63
Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG-AHIRQEHI-LSDL---ARQVLSGLA 207
             +HP++VK   +   N  + +++E    G L     +R+  + L+ L   A Q+ + LA
Sbjct: 64  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA-QTMDPCNSAVGTIAYMSPERIN 266
           YL  ++ VHRDI   N+L++S+  VK+ DFG+SR +   T    +     I +M+PE IN
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPF-------AVGRQGDWASLMFAICFAQP 318
                 +    A D+W  GV + E  + G  PF        +GR  +   L        P
Sbjct: 183 F-----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------PMP 231
Query: 319 PEAPEMASREFRDFISRCLQKDPHSR 344
           P  P          +++C   DP  R
Sbjct: 232 PNCPPT----LYSLMTKCWAYDPSRR 253

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 104/203 (51%), Gaps = 17/203 (8%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTS----RVFALKVIYGNHEDSVRSQICREIEILRDVNH 156
           L+K   +G G  G V    + PT+     + A+K +  +     RS   +EI+ILR + H
Sbjct: 16  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYH 75
Query: 157 PNVVKCHDMYDRNGE--IEVLLEYMDGGSLEGAHIRQEHILSDL---ARQVLSGLAYLHK 211
            +++K     +  GE  +++++EY+  GSL     R    L+ L   A+Q+  G+AYLH 
Sbjct: 76  EHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHS 135
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTD 268
           +  +HR++   N+L+++ + VKI DFG+++ + +  +           + + +PE +   
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 269 LNHGKYDGYAGDIWSLGVSILEF 291
             +     YA D+WS GV++ E 
Sbjct: 196 KFY-----YASDVWSFGVTLYEL 213

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 117/266 (43%), Gaps = 33/266 (12%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSR---VFALKVIYGNHEDSVRSQICREIEILR 152
           I    ++ G  IG G  G V + ++          A+K       DSVR +  +E   +R
Sbjct: 10  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 69
Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG-AHIRQEHI-LSDL---ARQVLSGLA 207
             +HP++VK   +   N  + +++E    G L     +R+  + L+ L   A Q+ + LA
Sbjct: 70  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 128
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA-QTMDPCNSAVGTIAYMSPERIN 266
           YL  ++ VHRDI   N+L++S+  VK+ DFG+SR +   T    +     I +M+PE IN
Sbjct: 129 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 188
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPF-------AVGRQGDWASLMFAICFAQP 318
                 +    A D+W  GV + E  + G  PF        +GR  +   L        P
Sbjct: 189 F-----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------PMP 237
Query: 319 PEAPEMASREFRDFISRCLQKDPHSR 344
           P  P          +++C   DP  R
Sbjct: 238 PNCPPT----LYSLMTKCWAYDPSRR 259

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 104/203 (51%), Gaps = 17/203 (8%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTS----RVFALKVIYGNHEDSVRSQICREIEILRDVNH 156
           L+K   +G G  G V    + PT+     + A+K +  +     RS   +EI+ILR + H
Sbjct: 16  LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYH 75
Query: 157 PNVVKCHDMYDRNGE--IEVLLEYMDGGSLEGAHIRQEHILSDL---ARQVLSGLAYLHK 211
            +++K     +  GE  +++++EY+  GSL     R    L+ L   A+Q+  G+AYLH 
Sbjct: 76  EHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHA 135
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERINTD 268
           +  +HR++   N+L+++ + VKI DFG+++ + +  +           + + +PE +   
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 269 LNHGKYDGYAGDIWSLGVSILEF 291
             +     YA D+WS GV++ E 
Sbjct: 196 KFY-----YASDVWSFGVTLYEL 213

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           L+   R+G+G  G VW   +   ++V    +  G+           E  +++ + H  +V
Sbjct: 15  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 71
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           + + +  +   I ++ EYM+ GSL        G  +    +L D+A Q+  G+A++ +R 
Sbjct: 72  RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLL-DMAAQIAEGMAFIEERN 129
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHG 272
            +HRD++ +N+L++ + + KIADFG++R++          A   I + +PE I    N+G
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI----NYG 185
Query: 273 KYDGYAGDIWSLGVSILEFYL-GRFPF 298
            +     D+WS G+ + E    GR P+
Sbjct: 186 TFT-IKSDVWSFGILLTEIVTHGRIPY 211

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           L+   R+G+G  G VW   +   ++V    +  G+           E  +++ + H  +V
Sbjct: 10  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 66
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           + + +  +   I ++ EYM+ GSL        G  +    +L D+A Q+  G+A++ +R 
Sbjct: 67  RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLL-DMAAQIAEGMAFIEERN 124
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHG 272
            +HRD++ +N+L++ + + KIADFG++R++          A   I + +PE I    N+G
Sbjct: 125 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI----NYG 180
Query: 273 KYDGYAGDIWSLGVSILEFYL-GRFPF 298
            +     D+WS G+ + E    GR P+
Sbjct: 181 TFT-IKSDVWSFGILLTEIVTHGRIPY 206

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 116/267 (43%), Gaps = 35/267 (13%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPT---SRVFALKVIYGNHEDSVRSQICREIEILR 152
           I    ++ G  IG G  G V + ++      +   A+K       DSVR +  +E   +R
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 66
Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVL------SGL 206
             +HP++VK   +   N  + +++E    G L  + ++      DLA  +L      + L
Sbjct: 67  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELR-SFLQVRKFSLDLASLILYAYQLSTAL 124
Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA-QTMDPCNSAVGTIAYMSPERI 265
           AYL  ++ VHRDI   N+L++++  VK+ DFG+SR +   T    +     I +M+PE I
Sbjct: 125 AYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 184
Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPF-------AVGRQGDWASLMFAICFAQ 317
           N      +    A D+W  GV + E  + G  PF        +GR  +   L        
Sbjct: 185 NF-----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------PM 233
Query: 318 PPEAPEMASREFRDFISRCLQKDPHSR 344
           PP  P          +++C   DP  R
Sbjct: 234 PPNCPPT----LYSLMTKCWAYDPSRR 256

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 117/266 (43%), Gaps = 33/266 (12%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSR---VFALKVIYGNHEDSVRSQICREIEILR 152
           I    ++ G  IG G  G V + ++          A+K       DSVR +  +E   +R
Sbjct: 9   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 68
Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG-AHIRQEHI-LSDL---ARQVLSGLA 207
             +HP++VK   +   N  + +++E    G L     +R+  + L+ L   A Q+ + LA
Sbjct: 69  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 127
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA-QTMDPCNSAVGTIAYMSPERIN 266
           YL  ++ VHRDI   N+L++S+  VK+ DFG+SR +   T    +     I +M+PE IN
Sbjct: 128 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 187
Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPF-------AVGRQGDWASLMFAICFAQP 318
                 +    A D+W  GV + E  + G  PF        +GR  +   L        P
Sbjct: 188 F-----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------PMP 236
Query: 319 PEAPEMASREFRDFISRCLQKDPHSR 344
           P  P          +++C   DP  R
Sbjct: 237 PNCPPT----LYSLMTKCWAYDPSRR 258

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 123/243 (50%), Gaps = 27/243 (11%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALK-VIYGNHEDSVRSQICREIEILRDVNHP 157
           ++ +K  +IG G+ G V++  H  T +  ALK V+  N ++       REI+IL+ + H 
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 77
Query: 158 NVVKCHDM-------YDR-NGEIEVLLEYMD---GGSLEGAHIRQEHILSDLAR---QVL 203
           NVV   ++       Y+R    I ++ ++ +    G L    ++    LS++ R    +L
Sbjct: 78  NVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQMLL 135
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI--LAQTMDP--CNSAVGTIAY 259
           +GL Y+H+ KI+HRD+K +N+LI     +K+ADFG++R   LA+   P    + V T+ Y
Sbjct: 136 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 260 MSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGR-QGDWASLMFAICFAQP 318
             PE +  + ++G       D+W  G  + E +  R P   G  +    +L+  +C +  
Sbjct: 196 RPPELLLGERDYGP----PIDLWGAGCIMAEMW-TRSPIMQGNTEQHQLALISQLCGSIT 250
Query: 319 PEA 321
           PE 
Sbjct: 251 PEV 253

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 97/195 (49%), Gaps = 16/195 (8%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G+G  G V   R+  P    +  A+K +   + +  R     E  I+   +HPN+++  
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 164 DMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHI--LSDLARQVLSGLAYLHKRKIVHRD 218
            +  ++  + ++ EYM+ GSL+     H  Q  +  L  + R + SG+ YL     VHRD
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 172
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYD 275
           +   N+LINS+   K++DFG++R+L    +   +  G    I + SPE I     + K+ 
Sbjct: 173 LAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAI----AYRKFT 228
Query: 276 GYAGDIWSLGVSILE 290
             A D+WS G+ + E
Sbjct: 229 S-ASDVWSYGIVLWE 242

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 108/235 (45%), Gaps = 42/235 (17%)
Query: 146 REIEILRDVNHPNVVKCHDMYDRNGEIE--------VLLEYMDGGSL------EGAHIRQ 191
           RE +    +NHP +V  +      GE E        +++EY+DG +L      EG    +
Sbjct: 61  REAQNAAALNHPAIVAVY----ATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 116
Query: 192 EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN 251
             I  ++       L + H+  I+HRD+KP+N++I+++  VK+ DFG++R +A + +   
Sbjct: 117 RAI--EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 252 ---SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWAS 308
              + +GT  Y+SPE+   D    +      D++SLG  + E   G  PF     GD   
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDAR-----SDVYSLGCVLYEVLTGEPPF----TGDSP- 224
Query: 309 LMFAICFAQPPEAP-------EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
              ++ +    E P       E  S +    + + L K+P +R+  A  ++   +
Sbjct: 225 --VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 125/270 (46%), Gaps = 26/270 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRD 153
           +I+P+EL     IGSG  G V         +V A+K I    E ++  +    E E++  
Sbjct: 3   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTI---REGAMSEEDFIEEAEVMMK 58
Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQE------HILSDLARQVLSGLA 207
           ++HP +V+ + +      I ++ E+M+ G L   ++R +        L  +   V  G+A
Sbjct: 59  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGMA 117
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPER 264
           YL +  ++HRD+   N L+  ++ +K++DFG++R +    D   S+ GT   + + SPE 
Sbjct: 118 YLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPEV 175
Query: 265 INTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE 323
            +      K      D+WS GV + E F  G+ P+      +   ++  I        P 
Sbjct: 176 FSFSRYSSK-----SDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTGFRLYKPR 227
Query: 324 MASREFRDFISRCLQKDPHSRWPAAQLLQH 353
           +AS      ++ C ++ P  R   ++LL+ 
Sbjct: 228 LASTHVYQIMNHCWKERPEDRPAFSRLLRQ 257

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 123/267 (46%), Gaps = 39/267 (14%)
Query: 95  LINPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI 150
           +I+  E++    +G G+ G V    WR      ++  A+K I     +S R     E+  
Sbjct: 5   MIDYKEIEVEEVVGRGAFGVVCKAKWR------AKDVAIKQI---ESESERKAFIVELRQ 55
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL----EGA----HIRQEHILSDLARQV 202
           L  VNHPN+VK +        + +++EY +GGSL     GA    +    H +S    Q 
Sbjct: 56  LSRVNHPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS-WCLQC 112
Query: 203 LSGLAYLHK---RKIVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIA 258
             G+AYLH    + ++HRD+KP NLL+ +   V KI DFG +  +   M    +  G+ A
Sbjct: 113 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---TNNKGSAA 169
Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF-AVGRQGDWASLMFAICFAQ 317
           +M+PE     +  G       D++S G+ + E    R PF  +G  G    +M+A+    
Sbjct: 170 WMAPE-----VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG--GPAFRIMWAVHNGT 222
Query: 318 PPEAPEMASREFRDFISRCLQKDPHSR 344
            P   +   +     ++RC  KDP  R
Sbjct: 223 RPPLIKNLPKPIESLMTRCWSKDPSQR 249

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 29/217 (13%)
Query: 96  INPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNHEDSV-RSQICREIEI 150
           I+P +L     +G+G  G V    WR  +       A+K+I    E S+   +   E ++
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYD-----VAIKMI---KEGSMSEDEFIEEAKV 52
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSG 205
           + +++H  +V+ + +  +   I ++ EYM  G L     E  H  Q   L ++ + V   
Sbjct: 53  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 112
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSP 262
           + YL  ++ +HRD+   N L+N    VK++DFG+SR +    D   S+VG+   + +  P
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPP 170
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E     L + K+     DIW+ GV + E Y LG+ P+
Sbjct: 171 EV----LMYSKFSS-KSDIWAFGVLMWEIYSLGKMPY 202

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 29/217 (13%)
Query: 96  INPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNHEDSV-RSQICREIEI 150
           I+P +L     +G+G  G V    WR  +       A+K+I    E S+   +   E ++
Sbjct: 5   IDPKDLTFLKELGTGQFGVVKYGKWRGQYD-----VAIKMI---KEGSMSEDEFIEEAKV 56
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSG 205
           + +++H  +V+ + +  +   I ++ EYM  G L     E  H  Q   L ++ + V   
Sbjct: 57  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 116
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSP 262
           + YL  ++ +HRD+   N L+N    VK++DFG+SR +    D   S+VG+   + +  P
Sbjct: 117 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPP 174
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E     L + K+     DIW+ GV + E Y LG+ P+
Sbjct: 175 EV----LMYSKFSS-KSDIWAFGVLMWEIYSLGKMPY 206

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 123/267 (46%), Gaps = 39/267 (14%)
Query: 95  LINPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI 150
           +I+  E++    +G G+ G V    WR      ++  A+K I     +S R     E+  
Sbjct: 4   MIDYKEIEVEEVVGRGAFGVVCKAKWR------AKDVAIKQI---ESESERKAFIVELRQ 54
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL----EGA----HIRQEHILSDLARQV 202
           L  VNHPN+VK +        + +++EY +GGSL     GA    +    H +S    Q 
Sbjct: 55  LSRVNHPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS-WCLQC 111
Query: 203 LSGLAYLHK---RKIVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIA 258
             G+AYLH    + ++HRD+KP NLL+ +   V KI DFG +  +   M    +  G+ A
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---TNNKGSAA 168
Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF-AVGRQGDWASLMFAICFAQ 317
           +M+PE     +  G       D++S G+ + E    R PF  +G  G    +M+A+    
Sbjct: 169 WMAPE-----VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG--GPAFRIMWAVHNGT 221
Query: 318 PPEAPEMASREFRDFISRCLQKDPHSR 344
            P   +   +     ++RC  KDP  R
Sbjct: 222 RPPLIKNLPKPIESLMTRCWSKDPSQR 248

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 29/217 (13%)
Query: 96  INPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNHEDSV-RSQICREIEI 150
           I+P +L     +G+G  G V    WR  +       A+K+I    E S+   +   E ++
Sbjct: 6   IDPKDLTFLKELGTGQFGVVKYGKWRGQYD-----VAIKMI---KEGSMSEDEFIEEAKV 57
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSG 205
           + +++H  +V+ + +  +   I ++ EYM  G L     E  H  Q   L ++ + V   
Sbjct: 58  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 117
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSP 262
           + YL  ++ +HRD+   N L+N    VK++DFG+SR +    D   S+VG+   + +  P
Sbjct: 118 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPP 175
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E     L + K+     DIW+ GV + E Y LG+ P+
Sbjct: 176 EV----LMYSKFSS-KSDIWAFGVLMWEIYSLGKMPY 207

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 120/254 (47%), Gaps = 26/254 (10%)
Query: 107 IGSGSGGTVWR-VVHPPTSR--VFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IG+G  G V R  +  P  +    A+K + G + +  R +   E  I+    HPN+++  
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH------ILSDLARQVLSGLAYLHKRKIVHR 217
            +   +  + +L E+M+ G+L+ + +R          L  + R + SG+ YL +   VHR
Sbjct: 84  GVVTNSMPVMILTEFMENGALD-SFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHR 142
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQ-TMDPC-NSAVGT---IAYMSPERINTDLNHG 272
           D+   N+L+NS+   K++DFG+SR L + + DP   S++G    I + +PE I       
Sbjct: 143 DLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI----AFR 198
Query: 273 KYDGYAGDIWSLGVSILEFY-LGRFPF-AVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
           K+   A D WS G+ + E    G  P+  +  Q    ++        PP+ P    +   
Sbjct: 199 KFTS-ASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLML 257
Query: 331 DFISRCLQKDPHSR 344
           D    C QKD ++R
Sbjct: 258 D----CWQKDRNAR 267

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 16/195 (8%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G+G  G V   R+  P    +  A+K +   + +  R     E  I+   +HPN+++  
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 164 DMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHI--LSDLARQVLSGLAYLHKRKIVHRD 218
            +  ++  + ++ EYM+ GSL+     H  Q  +  L  + R + SG+ YL     VHRD
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 172
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYD 275
           +   N+LINS+   K++DFG+ R+L    +   +  G    I + SPE I     + K+ 
Sbjct: 173 LAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI----AYRKFT 228
Query: 276 GYAGDIWSLGVSILE 290
             A D+WS G+ + E
Sbjct: 229 S-ASDVWSYGIVLWE 242

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 18/196 (9%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IG G  G V   R+  P    +  A+K +   + D  R     E  I+   +HPN++   
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH------ILSDLARQVLSGLAYLHKRKIVHR 217
            +  +   + ++ EYM+ GSL+ A +R+         L  + R + SG+ YL     VHR
Sbjct: 97  GVVTKCKPVMIITEYMENGSLD-AFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAVHR 155
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKY 274
           D+   N+L+NS+   K++DFG+SR+L    +   +  G    I + +PE I     + K+
Sbjct: 156 DLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI----AYRKF 211
Query: 275 DGYAGDIWSLGVSILE 290
              A D+WS G+ + E
Sbjct: 212 TS-ASDVWSYGIVMWE 226

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 29/217 (13%)
Query: 96  INPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNHEDSV-RSQICREIEI 150
           I+P +L     +G+G  G V    WR  +       A+K+I    E S+   +   E ++
Sbjct: 21  IDPKDLTFLKELGTGQFGVVKYGKWRGQYD-----VAIKMI---KEGSMSEDEFIEEAKV 72
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSG 205
           + +++H  +V+ + +  +   I ++ EYM  G L     E  H  Q   L ++ + V   
Sbjct: 73  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 132
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSP 262
           + YL  ++ +HRD+   N L+N    VK++DFG+SR +    D   S+VG+   + +  P
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPP 190
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E     L + K+     DIW+ GV + E Y LG+ P+
Sbjct: 191 EV----LMYSKFSS-KSDIWAFGVLMWEIYSLGKMPY 222

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 120/254 (47%), Gaps = 26/254 (10%)
Query: 107 IGSGSGGTVWR-VVHPPTSR--VFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IG+G  G V R  +  P  +    A+K + G + +  R +   E  I+    HPN+++  
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH------ILSDLARQVLSGLAYLHKRKIVHR 217
            +   +  + +L E+M+ G+L+ + +R          L  + R + SG+ YL +   VHR
Sbjct: 82  GVVTNSMPVMILTEFMENGALD-SFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHR 140
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQ-TMDPC-NSAVGT---IAYMSPERINTDLNHG 272
           D+   N+L+NS+   K++DFG+SR L + + DP   S++G    I + +PE I       
Sbjct: 141 DLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI----AFR 196
Query: 273 KYDGYAGDIWSLGVSILEFY-LGRFPF-AVGRQGDWASLMFAICFAQPPEAPEMASREFR 330
           K+   A D WS G+ + E    G  P+  +  Q    ++        PP+ P    +   
Sbjct: 197 KFTS-ASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLPPPPDCPTSLHQLML 255
Query: 331 DFISRCLQKDPHSR 344
           D    C QKD ++R
Sbjct: 256 D----CWQKDRNAR 265

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 116/267 (43%), Gaps = 35/267 (13%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVH---PPTSRVFALKVIYGNHEDSVRSQICREIEILR 152
           I    ++ G  IG G  G V + ++      +   A+K       DSVR +  +E   +R
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 446
Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVL------SGL 206
             +HP++VK   +   N  + +++E    G L  + ++      DLA  +L      + L
Sbjct: 447 QFDHPHIVKLIGVITEN-PVWIIMELCTLGELR-SFLQVRKFSLDLASLILYAYQLSTAL 504
Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA-QTMDPCNSAVGTIAYMSPERI 265
           AYL  ++ VHRDI   N+L++S+  VK+ DFG+SR +   T    +     I +M+PE I
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 564
Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPF-------AVGRQGDWASLMFAICFAQ 317
           N      +    A D+W  GV + E  + G  PF        +GR  +   L        
Sbjct: 565 NF-----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------PM 613
Query: 318 PPEAPEMASREFRDFISRCLQKDPHSR 344
           PP  P          +++C   DP  R
Sbjct: 614 PPNCPPT----LYSLMTKCWAYDPSRR 636

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 29/217 (13%)
Query: 96  INPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNHEDSV-RSQICREIEI 150
           I+P +L     +G+G  G V    WR  +       A+K+I    E S+   +   E ++
Sbjct: 12  IDPKDLTFLKELGTGQFGVVKYGKWRGQYD-----VAIKMI---KEGSMSEDEFIEEAKV 63
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSG 205
           + +++H  +V+ + +  +   I ++ EYM  G L     E  H  Q   L ++ + V   
Sbjct: 64  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 123
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSP 262
           + YL  ++ +HRD+   N L+N    VK++DFG+SR +    D   S+VG+   + +  P
Sbjct: 124 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPP 181
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E     L + K+     DIW+ GV + E Y LG+ P+
Sbjct: 182 EV----LMYSKFSS-KSDIWAFGVLMWEIYSLGKMPY 213

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 116/264 (43%), Gaps = 22/264 (8%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED-SVRSQICREIEILRDVN-HPN 158
            Q+ +R+G GS G V++V      R++A+K           R++   E+     V  HP 
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLE------GAHIRQEHILSDLARQVLSGLAYLHKR 212
            V+    ++  G I  L   + G SL+      GA + +  +   L R  L  LA+LH +
Sbjct: 119 CVRLEQAWEEGG-ILYLQTELCGPSLQQHCEAWGASLPEAQVWGYL-RDTLLALAHLHSQ 176
Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
            +VH D+KP+N+ +      K+ DFG+       ++   +  G +    P  +  +L  G
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGL------LVELGTAGAGEVQEGDPRYMAPELLQG 230
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
            Y G A D++SLG++ILE          G +G W  L        PPE     S E R  
Sbjct: 231 SY-GTAADVFSLGLTILEVAC-NMELPHGGEG-WQQLRQGYL---PPEFTAGLSSELRSV 284
Query: 333 ISRCLQKDPHSRWPAAQLLQHPFI 356
           +   L+ DP  R  A  LL  P +
Sbjct: 285 LVMMLEPDPKLRATAEALLALPVL 308

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 124/270 (45%), Gaps = 26/270 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSV-RSQICREIEILRD 153
           +I+P+EL     IGSG  G V         +V A+K I    E S+       E E++  
Sbjct: 23  VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTI---KEGSMSEDDFIEEAEVMMK 78
Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQE------HILSDLARQVLSGLA 207
           ++HP +V+ + +      I ++ E+M+ G L   ++R +        L  +   V  G+A
Sbjct: 79  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGMA 137
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPER 264
           YL +  ++HRD+   N L+  ++ +K++DFG++R +    D   S+ GT   + + SPE 
Sbjct: 138 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPEV 195
Query: 265 INTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE 323
            +      K      D+WS GV + E F  G+ P+      +   ++  I        P 
Sbjct: 196 FSFSRYSSK-----SDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTGFRLYKPR 247
Query: 324 MASREFRDFISRCLQKDPHSRWPAAQLLQH 353
           +AS      ++ C ++ P  R   ++LL+ 
Sbjct: 248 LASTHVYQIMNHCWKERPEDRPAFSRLLRQ 277

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 131/268 (48%), Gaps = 23/268 (8%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR-EIEILRDVNHPNVVKCHD 164
           +IGSG    V++V++    +++A+K +     D+      R EI  L  +   +  K   
Sbjct: 19  QIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-HSDKIIR 76
Query: 165 MYDRNGEIEVLLEYMDGGSLE-GAHIRQEHILSDLARQ-----VLSGLAYLHKRKIVHRD 218
           +YD     + +   M+ G+++  + ++++  +    R+     +L  +  +H+  IVH D
Sbjct: 77  LYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 136
Query: 219 IKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           +KP+N LI     +K+ DFG++  +    T    +S VGT+ YM PE I  D++  + +G
Sbjct: 137 LKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK-DMSSSRENG 194
Query: 277 YAG-------DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF-AQPPEAPEMASRE 328
            +        D+WSLG  +     G+ PF   +  +  S + AI       E P++  ++
Sbjct: 195 KSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPNHEIEFPDIPEKD 252
Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +D +  CL++DP  R    +LL HP++
Sbjct: 253 LQDVLKCCLKRDPKQRISIPELLAHPYV 280

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 129/284 (45%), Gaps = 26/284 (9%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR-----EIEILRDVNHPNVVK 161
           IG G  G V+      T +++A+K +        + +         + ++   + P +V 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVH 216
               +    ++  +L+ M+GG L   H+ Q  + S+      A +++ GL ++H R +V+
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLH-YHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KP+N+L++   +V+I+D G++   ++     +++VGT  YM+PE +   +    YD 
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGV---AYDS 370
Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
            A D +SLG  + +   G  PF   +  D   +   +      E P+  S E R  +   
Sbjct: 371 SA-DWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELPDSFSPELRSLLEGL 428
Query: 337 LQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPP 375
           LQ+D + R       A ++ + PF        V     Q  PPP
Sbjct: 429 LQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV---FLQKYPPP 469

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 125/270 (46%), Gaps = 26/270 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRD 153
           +I+P+EL     IGSG  G V         +V A+K I    E ++  +    E E++  
Sbjct: 1   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTI---REGAMSEEDFIEEAEVMMK 56
Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQE------HILSDLARQVLSGLA 207
           ++HP +V+ + +      I ++ E+M+ G L   ++R +        L  +   V  G+A
Sbjct: 57  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPER 264
           YL +  ++HRD+   N L+  ++ +K++DFG++R +    D   S+ GT   + + SPE 
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPEV 173
Query: 265 INTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE 323
            +      K      D+WS GV + E F  G+ P+      +   ++  I        P 
Sbjct: 174 FSFSRYSSK-----SDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTGFRLYKPR 225
Query: 324 MASREFRDFISRCLQKDPHSRWPAAQLLQH 353
           +AS      ++ C ++ P  R   ++LL+ 
Sbjct: 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 18/196 (9%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IG G  G V   R+  P    +  A+K +   + D  R     E  I+   +HPN++   
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH------ILSDLARQVLSGLAYLHKRKIVHR 217
            +  +   + ++ EYM+ GSL+ A +R+         L  + R + SG+ YL     VHR
Sbjct: 82  GVVTKCKPVMIITEYMENGSLD-AFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHR 140
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKY 274
           D+   N+L+NS+   K++DFG+SR+L    +   +  G    I + +PE I     + K+
Sbjct: 141 DLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI----AYRKF 196
Query: 275 DGYAGDIWSLGVSILE 290
              A D+WS G+ + E
Sbjct: 197 TS-ASDVWSYGIVMWE 211

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 129/284 (45%), Gaps = 26/284 (9%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR-----EIEILRDVNHPNVVK 161
           IG G  G V+      T +++A+K +        + +         + ++   + P +V 
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 255
Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVH 216
               +    ++  +L+ M+GG L   H+ Q  + S+      A +++ GL ++H R +V+
Sbjct: 256 MSYAFHTPDKLSFILDLMNGGDLH-YHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 314
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KP+N+L++   +V+I+D G++   ++     +++VGT  YM+PE +   +    YD 
Sbjct: 315 RDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGV---AYDS 369
Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
            A D +SLG  + +   G  PF   +  D   +   +      E P+  S E R  +   
Sbjct: 370 SA-DWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELPDSFSPELRSLLEGL 427
Query: 337 LQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPP 375
           LQ+D + R       A ++ + PF        V     Q  PPP
Sbjct: 428 LQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV---FLQKYPPP 468

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 99/198 (50%), Gaps = 20/198 (10%)
Query: 107 IGSGSGGTVW--RVVHPPTSRVF-ALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IG+G  G V    +  P    +F A+K +   + +  R     E  I+   +HPNV+   
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH------ILSDLARQVLSGLAYLHKRKIVHR 217
            +  ++  + ++ E+M+ GSL+ + +RQ         L  + R + +G+ YL     VHR
Sbjct: 75  GVVTKSTPVMIITEFMENGSLD-SFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHR 133
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILA-QTMDPC-NSAVGT---IAYMSPERINTDLNHG 272
            +   N+L+NS+   K++DFG+SR L   T DP   SA+G    I + +PE I     + 
Sbjct: 134 ALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI----QYR 189
Query: 273 KYDGYAGDIWSLGVSILE 290
           K+   A D+WS G+ + E
Sbjct: 190 KFTS-ASDVWSYGIVMWE 206

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRV----FALKVIYGNHEDSVRSQICREIEIL 151
           I+P+ + +   IG+G  G V++ +   +S       A+K +   + +  R     E  I+
Sbjct: 41  IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 100
Query: 152 RDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEH------ILSDLARQVLSG 205
              +H N+++   +  +   + ++ EYM+ G+L+   +R++        L  + R + +G
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALD-KFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSP 262
           + YL     VHRD+   N+L+NS+   K++DFG+SR+L    +   +  G    I + +P
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILE 290
           E I    ++ K+   A D+WS G+ + E
Sbjct: 220 EAI----SYRKFTS-ASDVWSFGIVMWE 242

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 18/196 (9%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IG G  G V   R+  P    +  A+K +   + D  R     E  I+   +HPN++   
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH------ILSDLARQVLSGLAYLHKRKIVHR 217
            +  +   + ++ EYM+ GSL+ A +R+         L  + R + SG+ YL     VHR
Sbjct: 76  GVVTKCKPVMIITEYMENGSLD-AFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHR 134
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKY 274
           D+   N+L+NS+   K++DFG+SR+L    +   +  G    I + +PE I     + K+
Sbjct: 135 DLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI----AYRKF 190
Query: 275 DGYAGDIWSLGVSILE 290
              A D+WS G+ + E
Sbjct: 191 TS-ASDVWSYGIVMWE 205

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 130/280 (46%), Gaps = 27/280 (9%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     ++ E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 341
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           R++   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE----SLAYNK 395
Query: 274 YDGYAGDIWSLGVSILEF-YLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
           +     D+W+ GV + E    G  P+      D + +   +      E PE    +  + 
Sbjct: 396 FS-IKSDVWAFGVLLWEIATYGMSPYP---GIDLSQVYELLEKDYRMERPEGCPEKVYEL 451
Query: 333 ISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQIL 372
           +  C Q +P  R P+   +   F     +S ++  + + L
Sbjct: 452 MRACWQWNPSDR-PSFAEIHQAFETMFQESSISDEVEKEL 490

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 132/269 (49%), Gaps = 25/269 (9%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR-EIEILRDVN-HPNVVKCH 163
           +IGSG    V++V++    +++A+K +     D+      R EI  L  +  H +  K  
Sbjct: 15  QIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD--KII 71
Query: 164 DMYDRNGEIEVLLEYMDGGSLE-GAHIRQEHILSDLARQ-----VLSGLAYLHKRKIVHR 217
            +YD     + +   M+ G+++  + ++++  +    R+     +L  +  +H+  IVH 
Sbjct: 72  RLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHS 131
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           D+KP+N LI     +K+ DFG++  +    T    +S VGT+ YM PE I  D++  + +
Sbjct: 132 DLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK-DMSSSREN 189
Query: 276 GYAG-------DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF-AQPPEAPEMASR 327
           G +        D+WSLG  +     G+ PF   +  +  S + AI       E P++  +
Sbjct: 190 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPNHEIEFPDIPEK 247
Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           + +D +  CL++DP  R    +LL HP++
Sbjct: 248 DLQDVLKCCLKRDPKQRISIPELLAHPYV 276

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 125/270 (46%), Gaps = 26/270 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRD 153
           +I+P+EL     IGSG  G V         +V A+K I    E ++  +    E E++  
Sbjct: 3   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTI---REGAMSEEDFIEEAEVMMK 58
Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQE------HILSDLARQVLSGLA 207
           ++HP +V+ + +      I ++ E+M+ G L   ++R +        L  +   V  G+A
Sbjct: 59  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGMA 117
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPER 264
           YL +  ++HRD+   N L+  ++ +K++DFG++R +    D   S+ GT   + + SPE 
Sbjct: 118 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPEV 175
Query: 265 INTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE 323
            +      K      D+WS GV + E F  G+ P+      +   ++  I        P 
Sbjct: 176 FSFSRYSSK-----SDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTGFRLYKPR 227
Query: 324 MASREFRDFISRCLQKDPHSRWPAAQLLQH 353
           +AS      ++ C ++ P  R   ++LL+ 
Sbjct: 228 LASTHVYQIMNHCWKERPEDRPAFSRLLRQ 257

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 12/211 (5%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           I   ++  G RIGSGS GTV++        V  L V     +         E+ +LR   
Sbjct: 21  IPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTR 78
Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHI----LSDLARQVLSGLAYLH 210
           H N++     Y    ++ ++ ++ +G SL    H  +       L D+ARQ   G+ YLH
Sbjct: 79  HVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTD 268
            + I+HRD+K +N+ ++    VKI DFG++   ++           G+I +M+PE I   
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR-- 195
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFA 299
           +       +  D+++ G+ + E   G+ P++
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 119/261 (45%), Gaps = 23/261 (8%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           LQ   R+G+G  G VW       ++V A+K +              E +I++ + H  +V
Sbjct: 11  LQLIKRLGNGQFGEVWMGTWNGNTKV-AIKTLKPGTMSP--ESFLEEAQIMKKLKHDKLV 67
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           + + +      I ++ EYM+ GSL       EG  ++  + L D+A QV +G+AY+ +  
Sbjct: 68  QLYAVVSEE-PIYIVTEYMNKGSLLDFLKDGEGRALKLPN-LVDMAAQVAAGMAYIERMN 125
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHG 272
            +HRD++ +N+L+ +    KIADFG++R++          A   I + +PE       +G
Sbjct: 126 YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAA----LYG 181
Query: 273 KYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
           ++     D+WS G+ + E    GR P+  G             +  P   P+       +
Sbjct: 182 RFT-IKSDVWSFGILLTELVTKGRVPYP-GMNNREVLEQVERGYRMP--CPQDCPISLHE 237
Query: 332 FISRCLQKDPHSRWPAAQLLQ 352
            +  C +KDP  R P  + LQ
Sbjct: 238 LMIHCWKKDPEER-PTFEYLQ 257

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 129/284 (45%), Gaps = 26/284 (9%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR-----EIEILRDVNHPNVVK 161
           IG G  G V+      T +++A+K +        + +         + ++   + P +V 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVH 216
               +    ++  +L+ M+GG L   H+ Q  + S+      A +++ GL ++H R +V+
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLH-YHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KP+N+L++   +V+I+D G++   ++     +++VGT  YM+PE +   +    YD 
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGV---AYDS 370
Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
            A D +SLG  + +   G  PF   +  D   +   +      E P+  S E R  +   
Sbjct: 371 SA-DWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELPDSFSPELRSLLEGL 428
Query: 337 LQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPP 375
           LQ+D + R       A ++ + PF        V     Q  PPP
Sbjct: 429 LQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV---FLQKYPPP 469

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 129/284 (45%), Gaps = 26/284 (9%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR-----EIEILRDVNHPNVVK 161
           IG G  G V+      T +++A+K +        + +         + ++   + P +V 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVH 216
               +    ++  +L+ M+GG L   H+ Q  + S+      A +++ GL ++H R +V+
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLH-YHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KP+N+L++   +V+I+D G++   ++     +++VGT  YM+PE +   +    YD 
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGV---AYDS 370
Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
            A D +SLG  + +   G  PF   +  D   +   +      E P+  S E R  +   
Sbjct: 371 SA-DWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELPDSFSPELRSLLEGL 428
Query: 337 LQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPP 375
           LQ+D + R       A ++ + PF        V     Q  PPP
Sbjct: 429 LQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV---FLQKYPPP 469

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 29/217 (13%)
Query: 96  INPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNHEDSV-RSQICREIEI 150
           I+P +L     +G+G  G V    WR  +       A+K+I    E S+   +   E ++
Sbjct: 21  IDPKDLTFLKELGTGQFGVVKYGKWRGQYD-----VAIKMI---KEGSMSEDEFIEEAKV 72
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSG 205
           + +++H  +V+ + +  +   I ++ EYM  G L     E  H  Q   L ++ + V   
Sbjct: 73  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 132
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSP 262
           + YL  ++ +HRD+   N L+N    VK++DFG+SR +    D   S+VG+   + +  P
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEETSSVGSKFPVRWSPP 190
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E     L + K+     DIW+ GV + E Y LG+ P+
Sbjct: 191 EV----LMYSKFSS-KSDIWAFGVLMWEIYSLGKMPY 222

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 116/267 (43%), Gaps = 35/267 (13%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVH---PPTSRVFALKVIYGNHEDSVRSQICREIEILR 152
           I    ++ G  IG G  G V + ++      +   A+K       DSVR +  +E   +R
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 446
Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVL------SGL 206
             +HP++VK   +   N  + +++E    G L  + ++      DLA  +L      + L
Sbjct: 447 QFDHPHIVKLIGVITEN-PVWIIMELCTLGELR-SFLQVRKFSLDLASLILYAYQLSTAL 504
Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA-QTMDPCNSAVGTIAYMSPERI 265
           AYL  ++ VHRDI   N+L++++  VK+ DFG+SR +   T    +     I +M+PE I
Sbjct: 505 AYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 564
Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPF-------AVGRQGDWASLMFAICFAQ 317
           N      +    A D+W  GV + E  + G  PF        +GR  +   L        
Sbjct: 565 NF-----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------PM 613
Query: 318 PPEAPEMASREFRDFISRCLQKDPHSR 344
           PP  P          +++C   DP  R
Sbjct: 614 PPNCPPT----LYSLMTKCWAYDPSRR 636

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 130/280 (46%), Gaps = 27/280 (9%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 321
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +  R     ++ E+M  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 322 GVCTREPPFYIITEFMTYGNLLD-YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 380
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           R++   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE     L + K
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPE----SLAYNK 434
Query: 274 YDGYAGDIWSLGVSILEF-YLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
           +     D+W+ GV + E    G  P+      D + +   +      E PE    +  + 
Sbjct: 435 FS-IKSDVWAFGVLLWEIATYGMSPYP---GIDLSQVYELLEKDYRMERPEGCPEKVYEL 490
Query: 333 ISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQIL 372
           +  C Q +P  R P+   +   F     +S ++  + + L
Sbjct: 491 MRACWQWNPSDR-PSFAEIHQAFETMFQESSISDEVEKEL 529

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 132/269 (49%), Gaps = 25/269 (9%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR-EIEILRDVN-HPNVVKCH 163
           +IGSG    V++V++    +++A+K +     D+      R EI  L  +  H +  K  
Sbjct: 35  QIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD--KII 91
Query: 164 DMYDRNGEIEVLLEYMDGGSLE-GAHIRQEHILSDLARQ-----VLSGLAYLHKRKIVHR 217
            +YD     + +   M+ G+++  + ++++  +    R+     +L  +  +H+  IVH 
Sbjct: 92  RLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHS 151
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           D+KP+N LI     +K+ DFG++  +    T    +S VGT+ YM PE I  D++  + +
Sbjct: 152 DLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK-DMSSSREN 209
Query: 276 GYAG-------DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF-AQPPEAPEMASR 327
           G +        D+WSLG  +     G+ PF   +  +  S + AI       E P++  +
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPNHEIEFPDIPEK 267
Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           + +D +  CL++DP  R    +LL HP++
Sbjct: 268 DLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 131/268 (48%), Gaps = 23/268 (8%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR-EIEILRDVNHPNVVKCHD 164
           +IGSG    V++V++    +++A+K +     D+      R EI  L  +   +  K   
Sbjct: 16  QIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-HSDKIIR 73
Query: 165 MYDRNGEIEVLLEYMDGGSLE-GAHIRQEHILSDLARQ-----VLSGLAYLHKRKIVHRD 218
           +YD     + +   M+ G+++  + ++++  +    R+     +L  +  +H+  IVH D
Sbjct: 74  LYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 133
Query: 219 IKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           +KP+N LI     +K+ DFG++  +    T    +S VGT+ YM PE I  D++  + +G
Sbjct: 134 LKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK-DMSSSRENG 191
Query: 277 YAG-------DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF-AQPPEAPEMASRE 328
            +        D+WSLG  +     G+ PF   +  +  S + AI       E P++  ++
Sbjct: 192 KSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPNHEIEFPDIPEKD 249
Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +D +  CL++DP  R    +LL HP++
Sbjct: 250 LQDVLKCCLKRDPKQRISIPELLAHPYV 277

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 125/270 (46%), Gaps = 26/270 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRD 153
           +I+P+EL     IGSG  G V         +V A+K I    E ++  +    E E++  
Sbjct: 6   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTI---REGAMSEEDFIEEAEVMMK 61
Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQE------HILSDLARQVLSGLA 207
           ++HP +V+ + +      I ++ E+M+ G L   ++R +        L  +   V  G+A
Sbjct: 62  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGMA 120
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPER 264
           YL +  ++HRD+   N L+  ++ +K++DFG++R +    D   S+ GT   + + SPE 
Sbjct: 121 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPEV 178
Query: 265 INTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE 323
            +      K      D+WS GV + E F  G+ P+      +   ++  I        P 
Sbjct: 179 FSFSRYSSK-----SDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTGFRLYKPR 230
Query: 324 MASREFRDFISRCLQKDPHSRWPAAQLLQH 353
           +AS      ++ C ++ P  R   ++LL+ 
Sbjct: 231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 131/268 (48%), Gaps = 23/268 (8%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR-EIEILRDVNHPNVVKCHD 164
           +IGSG    V++V++    +++A+K +     D+      R EI  L  +   +  K   
Sbjct: 63  QIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-HSDKIIR 120
Query: 165 MYDRNGEIEVLLEYMDGGSLE-GAHIRQEHILSDLARQ-----VLSGLAYLHKRKIVHRD 218
           +YD     + +   M+ G+++  + ++++  +    R+     +L  +  +H+  IVH D
Sbjct: 121 LYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 180
Query: 219 IKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           +KP+N LI     +K+ DFG++  +    T    +S VGT+ YM PE I  D++  + +G
Sbjct: 181 LKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK-DMSSSRENG 238
Query: 277 YAG-------DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF-AQPPEAPEMASRE 328
            +        D+WSLG  +     G+ PF   +  +  S + AI       E P++  ++
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPNHEIEFPDIPEKD 296
Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +D +  CL++DP  R    +LL HP++
Sbjct: 297 LQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           L+   R+G+G  G VW   +   ++V    +  G+           E  +++ + H  +V
Sbjct: 11  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLV 67
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           + + +  +   I ++ EYM+ GSL        G  +    +L D+A Q+  G+A++ +R 
Sbjct: 68  RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLL-DMAAQIAEGMAFIEERN 125
Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-NSAVGTIAYMSPERINTDLNHG 272
            +HR+++ +N+L++ + + KIADFG++R++          A   I + +PE I    N+G
Sbjct: 126 YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI----NYG 181
Query: 273 KYDGYAGDIWSLGVSILEFYL-GRFPF 298
            +     D+WS G+ + E    GR P+
Sbjct: 182 TFT-IKSDVWSFGILLTEIVTHGRIPY 207

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/235 (31%), Positives = 118/235 (50%), Gaps = 37/235 (15%)
Query: 146 REIEILRDVN-HPNVVK--CHDMYDRNGE---IEV----LLEYMDGGSLEGAHIRQEHIL 195
           RE+++LR+ + HPNV++  C +  DR  +   IE+    L EY++      AH+  E I 
Sbjct: 66  REVQLLRESDEHPNVIRYFCTEK-DRQFQYIAIELCAATLQEYVEQKDF--AHLGLEPIT 122
Query: 196 SDLARQVLSGLAYLHKRKIVHRDIKPSNLLI---NSSKNVK--IADFGVSRILA---QTM 247
             L +Q  SGLA+LH   IVHRD+KP N+LI   N+   +K  I+DFG+ + LA    + 
Sbjct: 123 --LLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180
Query: 248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL---GRFPFAVGRQG 304
              +   GT  +++PE ++ D        Y  DI+S G     +Y+   G  PF    Q 
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENP--TYTVDIFSAGCVF--YYVISEGSHPFGKSLQR 236
Query: 305 DWASLMFAIC---FAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             A+++   C      P +  ++ +RE    I + +  DP  R  A  +L+HPF 
Sbjct: 237 Q-ANILLGACSLDCLHPEKHEDVIARE---LIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 132/273 (48%), Gaps = 33/273 (12%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR-EIEILRDVN-HPNVVKCH 163
           +IGSG    V++V++    +++A+K +     D+      R EI  L  +  H +  K  
Sbjct: 35  QIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD--KII 91
Query: 164 DMYDRNGEIEVLLEYMDGGSLE-GAHIRQEHILSDLARQ-----VLSGLAYLHKRKIVHR 217
            +YD     + +   M+ G+++  + ++++  +    R+     +L  +  +H+  IVH 
Sbjct: 92  RLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHS 151
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDP------CNSAVGTIAYMSPERINTDLNH 271
           D+KP+N LI     +K+ DFG+    A  M P       +S VGT+ YM PE I  D++ 
Sbjct: 152 DLKPANFLIVDGM-LKLIDFGI----ANQMQPDXXXVVKDSQVGTVNYMPPEAIK-DMSS 205
Query: 272 GKYDGYAG-------DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF-AQPPEAPE 323
            + +G +        D+WSLG  +     G+ PF   +  +  S + AI       E P+
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPNHEIEFPD 263
Query: 324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           +  ++ +D +  CL++DP  R    +LL HP++
Sbjct: 264 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 12/211 (5%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           I   ++  G RIGSGS GTV++        V  L V     +         E+ +LR   
Sbjct: 21  IPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQ--LQAFKNEVGVLRKTR 78
Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHI----LSDLARQVLSGLAYLH 210
           H N++     Y    ++ ++ ++ +G SL    H  +       L D+ARQ   G+ YLH
Sbjct: 79  HVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTD 268
            + I+HRD+K +N+ ++    VKI DFG++   ++           G+I +M+PE I   
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR-- 195
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFA 299
           +       +  D+++ G+ + E   G+ P++
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 131/268 (48%), Gaps = 23/268 (8%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR-EIEILRDVNHPNVVKCHD 164
           +IGSG    V++V++    +++A+K +     D+      R EI  L  +   +  K   
Sbjct: 63  QIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-HSDKIIR 120
Query: 165 MYDRNGEIEVLLEYMDGGSLE-GAHIRQEHILSDLARQ-----VLSGLAYLHKRKIVHRD 218
           +YD     + +   M+ G+++  + ++++  +    R+     +L  +  +H+  IVH D
Sbjct: 121 LYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 180
Query: 219 IKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           +KP+N LI     +K+ DFG++  +    T    +S VGT+ YM PE I  D++  + +G
Sbjct: 181 LKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK-DMSSSRENG 238
Query: 277 YAG-------DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF-AQPPEAPEMASRE 328
            +        D+WSLG  +     G+ PF   +  +  S + AI       E P++  ++
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPNHEIEFPDIPEKD 296
Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +D +  CL++DP  R    +LL HP++
Sbjct: 297 LQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 16/195 (8%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G+G  G V   R+  P    +  A+K +   + +  R     E  I+   +HPN+++  
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 164 DMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHI--LSDLARQVLSGLAYLHKRKIVHRD 218
            +  ++  + ++ E M+ GSL+     H  Q  +  L  + R + SG+ YL     VHRD
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRD 172
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYD 275
           +   N+LINS+   K++DFG+SR+L    +   +  G    I + SPE I     + K+ 
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI----AYRKFT 228
Query: 276 GYAGDIWSLGVSILE 290
             A D+WS G+ + E
Sbjct: 229 S-ASDVWSYGIVLWE 242

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 16/195 (8%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G+G  G V   R+  P    +  A+K +   + +  R     E  I+   +HPN+++  
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 164 DMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHI--LSDLARQVLSGLAYLHKRKIVHRD 218
            +  ++  + ++ E M+ GSL+     H  Q  +  L  + R + SG+ YL     VHRD
Sbjct: 84  GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 143
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYD 275
           +   N+LINS+   K++DFG+SR+L    +   +  G    I + SPE I     + K+ 
Sbjct: 144 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI----AYRKFT 199
Query: 276 GYAGDIWSLGVSILE 290
             A D+WS G+ + E
Sbjct: 200 S-ASDVWSYGIVLWE 213

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 125/270 (46%), Gaps = 26/270 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRD 153
           +I+P+EL     IGSG  G V         +V A+K I    E ++  +    E E++  
Sbjct: 4   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTI---REGAMSEEDFIEEAEVMMK 59
Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQE------HILSDLARQVLSGLA 207
           ++HP +V+ + +      I ++ E+M+ G L   ++R +        L  +   V  G+A
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGMA 118
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPER 264
           YL +  ++HRD+   N L+  ++ +K++DFG++R +    D   S+ GT   + + SPE 
Sbjct: 119 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPEV 176
Query: 265 INTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE 323
            +      K      D+WS GV + E F  G+ P+      +   ++  I        P 
Sbjct: 177 FSFSRYSSK-----SDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTGFRLYKPR 228
Query: 324 MASREFRDFISRCLQKDPHSRWPAAQLLQH 353
           +AS      ++ C ++ P  R   ++LL+ 
Sbjct: 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 16/195 (8%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G+G  G V   R+  P    +  A+K +   + +  R     E  I+   +HPN+++  
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 164 DMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHI--LSDLARQVLSGLAYLHKRKIVHRD 218
            +  ++  + ++ E M+ GSL+     H  Q  +  L  + R + SG+ YL     VHRD
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD 172
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYD 275
           +   N+LINS+   K++DFG+SR+L    +   +  G    I + SPE I     + K+ 
Sbjct: 173 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI----AYRKFT 228
Query: 276 GYAGDIWSLGVSILE 290
             A D+WS G+ + E
Sbjct: 229 S-ASDVWSYGIVLWE 242

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 93/190 (48%), Gaps = 13/190 (6%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNVVKCH 163
            ++G G+ G V++ +   T+   A+K I   HE+  V     RE+ +L+++ H N+++  
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 164 DMYDRNGEIEVLLEYMDGG---SLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIK 220
            +   N  + ++ EY +      ++        ++     Q+++G+ + H R+ +HRD+K
Sbjct: 100 SVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLK 159
Query: 221 PSNLLINSSKN-----VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           P NLL++ S       +KI DFG++R     +      + T+ Y  PE     L   ++ 
Sbjct: 160 PQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEI----LLGSRHY 215
Query: 276 GYAGDIWSLG 285
             + DIWS+ 
Sbjct: 216 STSVDIWSIA 225

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 22/197 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR-SQICREIEILRDVNHPNVVKCH 163
           +++G G  G V+  V    S   A+K +    ED++   +  +E  +++++ HPN+V+  
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 94
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
            +        ++ EYM  G+L   ++R+ +       +L  +A Q+ S + YL K+  +H
Sbjct: 95  GVCTLEPPFYIVTEYMPYGNLLD-YLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIH 153
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGK 273
           RD+   N L+  +  VK+ADFG+SR++  T D   +  G    I + +PE +  +    K
Sbjct: 154 RDLAARNCLVGENHVVKVADFGLSRLM--TGDTYTAHAGAKFPIKWTAPESLAYNTFSIK 211
Query: 274 YDGYAGDIWSLGVSILE 290
                 D+W+ GV + E
Sbjct: 212 -----SDVWAFGVLLWE 223

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 117/271 (43%), Gaps = 48/271 (17%)
Query: 106 RIGSGSGGTVWRV----VHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
            +G G+ G V+      + P   ++        +  D+ R    RE E+L ++ H ++VK
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 79
Query: 162 CHDMYDRNGEIEVLLEYMDGGSL---------------EG---AHIRQEHILSDLARQVL 203
            + +      + ++ EYM  G L               EG     + Q  +L  +A+Q+ 
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH-IAQQIA 138
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS---------RILAQTMDPCNSAV 254
           +G+ YL  +  VHRD+   N L+  +  VKI DFG+S         R+   TM P     
Sbjct: 139 AGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP----- 193
Query: 255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAI 313
             I +M PE I     + K+     D+WSLGV + E F  G+ P+    Q     ++  I
Sbjct: 194 --IRWMPPESI----MYRKFTT-ESDVWSLGVVLWEIFTYGKQPW---YQLSNNEVIECI 243
Query: 314 CFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
              +  + P    +E  + +  C Q++PH R
Sbjct: 244 TQGRVLQRPRTCPQEVYELMLGCWQREPHMR 274

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 96/195 (49%), Gaps = 16/195 (8%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IG+G  G V   R+  P    V  A+K +   + +  R     E  I+   +HPNVV   
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 164 DMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHI--LSDLARQVLSGLAYLHKRKIVHRD 218
            +  R   + +++E+M+ G+L+     H  Q  +  L  + R + +G+ YL     VHRD
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRD 170
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYD 275
           +   N+L+NS+   K++DFG+SR++    +   +  G    + + +PE I     + K+ 
Sbjct: 171 LAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAI----QYRKFT 226
Query: 276 GYAGDIWSLGVSILE 290
             A D+WS G+ + E
Sbjct: 227 S-ASDVWSYGIVMWE 240

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 125/286 (43%), Gaps = 21/286 (7%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR----SQICREIEILRDVNHPNVVKC 162
           IG G+   V  V    T +V+A+K++  N  D ++    S    E ++L + +   + + 
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIM--NKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 163 HDMYDRNGEIEVLLEYMDGGSLEGAHIR-QEHILSDLAR----QVLSGLAYLHKRKIVHR 217
           H  +     + +++EY  GG L     +  E I +++AR    +++  +  +H+   VHR
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHR 186
Query: 218 DIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           DIKP N+L++   ++++ADFG   ++ A        AVGT  Y+SPE +           
Sbjct: 187 DIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGS 246
Query: 277 YA--GDIWSLGVSILEFYLGRFPFAVGRQGD-WASLMFAICFAQPPEAPEMASREFRDFI 333
           Y    D W+LGV   E + G+ PF      + +  ++        P   E    E RDFI
Sbjct: 247 YGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFI 306
Query: 334 SR--CLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
            R  C  +    R  A     HPF            LR  +PP  P
Sbjct: 307 QRLLCPPETRLGRGGAGDFRTHPFFFGLDWD----GLRDSVPPFTP 348

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/147 (35%), Positives = 80/147 (54%), Gaps = 11/147 (7%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVKCHDM 165
           IG+GS G V         RV A+K I    ED +  + I REI IL  +NH +VVK  D+
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 166 Y-----DRNGEIEVLLEYMDGGSLE----GAHIRQEHILSDLARQVLSGLAYLHKRKIVH 216
                 ++  E+ V+LE  D    +      ++ + HI + L   +L G+ Y+H   I+H
Sbjct: 121 VIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVHSAGILH 179
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRIL 243
           RD+KP+N L+N   +VK+ DFG++R +
Sbjct: 180 RDLKPANCLVNQDCSVKVCDFGLARTV 206

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 96  INPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNHEDSV-RSQICREIEI 150
           I+P +L     +G+G  G V    WR  +       A+K+I    E S+   +   E ++
Sbjct: 6   IDPKDLTFLKELGTGQFGVVKYGKWRGQYD-----VAIKMI---KEGSMSEDEFIEEAKV 57
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSG 205
           + +++H  +V+ + +  +   I ++ EYM  G L     E  H  Q   L ++ + V   
Sbjct: 58  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 117
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSP 262
           + YL  ++ +HRD+   N L+N    VK++DFG+SR +    D   S+ G+   + +  P
Sbjct: 118 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSRGSKFPVRWSPP 175
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E     L + K+     DIW+ GV + E Y LG+ P+
Sbjct: 176 EV----LMYSKFSS-KSDIWAFGVLMWEIYSLGKMPY 207

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR--SQICREIEILRDVNHPNVVKCHD 164
           +G G+   V+R  H  T  +FA+KV   N+   +R      RE E+L+ +NH N+VK   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 165 MYDRNGEIE--VLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           + +        +++E+   GSL         A+   E     + R V+ G+ +L +  IV
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIV 134
Query: 216 HRDIKPSNLL----INSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSP---ERINTD 268
           HR+IKP N++     +     K+ DFG +R L    +   S  GT  Y+ P   ER    
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLR 193
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPF 298
            +H K  G   D+WS+GV+      G  PF
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 104 GNRIGSGSGGTVWR-VVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKC 162
           GN+ G G  G V++  V+  T  V  L  +     + ++ Q  +EI++     H N+V+ 
Sbjct: 27  GNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL 86
Query: 163 HDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
                   ++ ++  Y   GSL       +G      H    +A+   +G+ +LH+   +
Sbjct: 87  LGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHI 146
Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRI---LAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRDIK +N+L++ +   KI+DFG++R     AQ +   +  VGT AY +PE +  ++   
Sbjct: 147 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXX-SRIVGTTAYXAPEALRGEITP- 204
Query: 273 KYDGYAGDIWSLGVSILEFYLG 294
                  DI+S GV +LE   G
Sbjct: 205 -----KSDIYSFGVVLLEIITG 221

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 130/268 (48%), Gaps = 23/268 (8%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR-EIEILRDVNHPNVVKCHD 164
           +IGSG    V++V++    +++A+K +     D+      R EI  L  +   +  K   
Sbjct: 63  QIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-HSDKIIR 120
Query: 165 MYDRNGEIEVLLEYMDGGSLE-GAHIRQEHILSDLARQ-----VLSGLAYLHKRKIVHRD 218
           +YD     + +   M+ G+++  + ++++  +    R+     +L  +  +H+  IVH D
Sbjct: 121 LYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 180
Query: 219 IKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           +KP+N LI     +K+ DFG++  +    T    +S VG + YM PE I  D++  + +G
Sbjct: 181 LKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK-DMSSSRENG 238
Query: 277 YAG-------DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF-AQPPEAPEMASRE 328
            +        D+WSLG  +     G+ PF   +  +  S + AI       E P++  ++
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPNHEIEFPDIPEKD 296
Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +D +  CL++DP  R    +LL HP++
Sbjct: 297 LQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 125/287 (43%), Gaps = 25/287 (8%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G GS G V       T  ++A+K++  +    +D V   +  +  +      P + + H
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRD 218
             +     +  ++EY++GG L   HI+Q     +      A ++  GL +L  + I++RD
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLM-YHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRD 467
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           +K  N++++S  ++KIADFG+ +             GT  Y++PE I     +  Y G +
Sbjct: 468 LKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII----AYQPY-GKS 522
Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ 338
            D W+ GV + E   G+ PF    +G+    +F          P+  S+E        + 
Sbjct: 523 VDWWAFGVLLYEMLAGQAPF----EGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 578
Query: 339 KDPHSRWPAA-----QLLQHPFILRAGQSQVNQNLRQILPPPRPLSS 380
           K P  R          + +H F       ++ +  ++I PP +P +S
Sbjct: 579 KHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER--KEIQPPYKPKAS 623

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 121/274 (44%), Gaps = 32/274 (11%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDVNHPNVVKCHDM 165
           +G G  G V ++ +  T   FALK +    +D  +++  RE+E+  R    P++V+  D+
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKXL----QDCPKAR--REVELHWRASQCPHIVRIVDV 123
Query: 166 YDR----NGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           Y+        + ++ E +DGG L       G     E   S++ + +   + YLH   I 
Sbjct: 124 YENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIA 183
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL  S +    +K+ DFG ++    + +   +   T  Y++PE +  +    
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSLTTPCYTPYYVAPEVLGPE---- 238
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ-----GDWASLMFAICFAQPPEAPEMASR 327
           KYD  + D WSLGV       G  PF          G    +         PE  E+ S 
Sbjct: 239 KYDK-SCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEV-SE 296
Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
           E +  I   L+ +P  R    +   HP+I ++ +
Sbjct: 297 EVKXLIRNLLKTEPTQRXTITEFXNHPWIXQSTK 330

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 112/241 (46%), Gaps = 11/241 (4%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQIC--REIEILRDVNHPNVVKCHD 164
           IG G+ G V  V    T R++A+K++            C   E ++L + +   +   H 
Sbjct: 82  IGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHY 141
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL-SDLAR----QVLSGLAYLHKRKIVHRDI 219
            +     + ++++Y  GG L     + E  L  D+AR    +++  +  +H+   VHRDI
Sbjct: 142 AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDI 201
Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNS-AVGTIAYMSPERINT-DLNHGKYDGY 277
           KP N+L++ + ++++ADFG    +       +S AVGT  Y+SPE +   +   GKY G 
Sbjct: 202 KPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKY-GP 260
Query: 278 AGDIWSLGVSILEFYLGRFPF-AVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
             D WSLGV + E   G  PF A      +  +M      Q P      S E +D I R 
Sbjct: 261 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRL 320
Query: 337 L 337
           +
Sbjct: 321 I 321

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 112/241 (46%), Gaps = 11/241 (4%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQIC--REIEILRDVNHPNVVKCHD 164
           IG G+ G V  V    T R++A+K++            C   E ++L + +   +   H 
Sbjct: 98  IGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHY 157
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL-SDLAR----QVLSGLAYLHKRKIVHRDI 219
            +     + ++++Y  GG L     + E  L  D+AR    +++  +  +H+   VHRDI
Sbjct: 158 AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDI 217
Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNS-AVGTIAYMSPERINT-DLNHGKYDGY 277
           KP N+L++ + ++++ADFG    +       +S AVGT  Y+SPE +   +   GKY G 
Sbjct: 218 KPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKY-GP 276
Query: 278 AGDIWSLGVSILEFYLGRFPF-AVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
             D WSLGV + E   G  PF A      +  +M      Q P      S E +D I R 
Sbjct: 277 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRL 336
Query: 337 L 337
           +
Sbjct: 337 I 337

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 123/284 (43%), Gaps = 25/284 (8%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGN---HEDSVRSQICREIEILRDVNHPNVVKCH 163
           +G GS G V       T  ++A+K++  +    +D V   +  +  +      P + + H
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRD 218
             +     +  ++EY++GG L   HI+Q     +      A ++  GL +L  + I++RD
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLM-YHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRD 146
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           +K  N++++S  ++KIADFG+ +             GT  Y++PE I     +  Y G +
Sbjct: 147 LKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII----AYQPY-GKS 201
Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ 338
            D W+ GV + E   G+ PF    +G+    +F          P+  S+E        + 
Sbjct: 202 VDWWAFGVLLYEMLAGQAPF----EGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 257
Query: 339 KDPHSRWPAA-----QLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           K P  R          + +H F       ++ +  ++I PP +P
Sbjct: 258 KHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER--KEIQPPYKP 299

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 10/201 (4%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQIC--REIEILRDVNHPNVVKCHD 164
           IG G+ G V  V      +VFA+K++            C   E ++L + +   +   H 
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL-SDLARQVLSGLAY----LHKRKIVHRDI 219
            +  +  + ++++Y  GG L     + E  L  ++AR  L+ +      +H+   VHRDI
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDI 201
Query: 220 KPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPERINT-DLNHGKYDGY 277
           KP N+L++ + ++++ADFG   +++       + AVGT  Y+SPE +   +   G+Y G 
Sbjct: 202 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY-GP 260
Query: 278 AGDIWSLGVSILEFYLGRFPF 298
             D WSLGV + E   G  PF
Sbjct: 261 ECDWWSLGVCMYEMLYGETPF 281

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVR--SQICREIEILRDVNHPNVVKCHD 164
           +G G+   V+R  H  T  +FA+KV   N+   +R      RE E+L+ +NH N+VK   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 165 MYDRNGEIE--VLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           + +        +++E+   GSL         A+   E     + R V+ G+ +L +  IV
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIV 134
Query: 216 HRDIKPSNLL----INSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSP---ERINTD 268
           HR+IKP N++     +     K+ DFG +R L    +      GT  Y+ P   ER    
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVXLYGTEEYLHPDMYERAVLR 193
Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPF 298
            +H K  G   D+WS+GV+      G  PF
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 119/276 (43%), Gaps = 37/276 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRV-FALKVIYGNH-------EDSVRSQICREIEI 150
           AE + G  +G G  GTV+   H  T R+  A+KVI  N         DSV   +  E+ +
Sbjct: 31  AEYRLGPLLGKGGFGTVF-AGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL--EVAL 87
Query: 151 LRDVN----HPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQ 201
           L  V     HP V++  D ++      ++LE          +I ++  L +        Q
Sbjct: 88  LWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQ 147
Query: 202 VLSGLAYLHKRKIVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYM 260
           V++ + + H R +VHRDIK  N+LI+  +   K+ DFG   +L    +P     GT  Y 
Sbjct: 148 VVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTDFDGTRVYS 205
Query: 261 SPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE 320
            PE I+      +Y      +WSLG+ + +   G  PF   ++   A L F         
Sbjct: 206 PPEWISRH----QYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHF--------- 252
Query: 321 APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P   S +    I RCL   P SR    ++L  P++
Sbjct: 253 -PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 102/236 (43%), Gaps = 45/236 (19%)
Query: 139 SVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHIL 195
           + R    RE E+L ++ H ++VK + +      + ++ EYM  G L     AH     IL
Sbjct: 59  AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 118
Query: 196 SD-----------------LARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFG 238
            D                 +A Q+ SG+ YL  +  VHRD+   N L+ ++  VKI DFG
Sbjct: 119 VDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFG 178
Query: 239 VS---------RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSIL 289
           +S         R+   TM P       I +M PE I     + K+     D+WS GV + 
Sbjct: 179 MSRDVYSTDYYRVGGHTMLP-------IRWMPPESI----MYRKFTT-ESDVWSFGVILW 226
Query: 290 E-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
           E F  G+ P+    Q     ++  I   +  E P +  +E  D +  C Q++P  R
Sbjct: 227 EIFTYGKQPWF---QLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQR 279

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 16/195 (8%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IG+G  G V   R+  P    +  A+K +   + +  R     E  I+   +HPN++   
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYLHKRKIVHRD 218
            +  ++  + ++ EYM+ GSL+    + +   +      + R + +G+ YL     VHRD
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRD 149
Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYD 275
           +   N+LINS+   K++DFG+SR+L    +   +  G    I + +PE I       K+ 
Sbjct: 150 LAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI----AFRKFT 205
Query: 276 GYAGDIWSLGVSILE 290
             A D+WS G+ + E
Sbjct: 206 S-ASDVWSYGIVMWE 219

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 115/278 (41%), Gaps = 46/278 (16%)
Query: 104 GNRIGSGSGG-----TVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
           G  +G G  G     T + +         A+K++  N   S    +  E  +L+ VNHP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI------------------------ 194
           V+K +    ++G + +++EY   GSL G       +                        
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 195 ----LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
               L   A Q+  G+ YL + K+VHRD+   N+L+   + +KI+DFG+SR + +     
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 251 NSAVGTI--AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWA 307
             + G I   +M+ E +   +   +      D+WS GV + E   LG  P+     G   
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQ-----SDVWSFGVLLWEIVTLGGNPYP----GIPP 258
Query: 308 SLMFAIC-FAQPPEAPEMASREFRDFISRCLQKDPHSR 344
             +F +       E P+  S E    + +C +++P  R
Sbjct: 259 ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 115/278 (41%), Gaps = 46/278 (16%)
Query: 104 GNRIGSGSGG-----TVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
           G  +G G  G     T + +         A+K++  N   S    +  E  +L+ VNHP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI------------------------ 194
           V+K +    ++G + +++EY   GSL G       +                        
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 195 ----LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
               L   A Q+  G+ YL + K+VHRD+   N+L+   + +KI+DFG+SR + +     
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 251 NSAVGTI--AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWA 307
             + G I   +M+ E +   +   +      D+WS GV + E   LG  P+     G   
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQ-----SDVWSFGVLLWEIVTLGGNPYP----GIPP 258
Query: 308 SLMFAIC-FAQPPEAPEMASREFRDFISRCLQKDPHSR 344
             +F +       E P+  S E    + +C +++P  R
Sbjct: 259 ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 102/219 (46%), Gaps = 21/219 (9%)
Query: 143 QICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILS 196
           +  +E + +  ++HP +VK + +  +   I ++ EY+  G L       G  +    +L 
Sbjct: 49  EFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL- 107
Query: 197 DLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT 256
           ++   V  G+A+L   + +HRD+   N L++    VK++DFG++R +    D   S+VGT
Sbjct: 108 EMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD--DQYVSSVGT 165
Query: 257 ---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFA 312
              + + +PE      ++ KY     D+W+ G+ + E F LG+ P+ +    +   ++  
Sbjct: 166 KFPVKWSAPEV----FHYFKYSS-KSDVWAFGILMWEVFSLGKMPYDLYTNSE---VVLK 217
Query: 313 ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLL 351
           +        P +AS      +  C  + P  R    QLL
Sbjct: 218 VSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLL 256

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 22/207 (10%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNH 156
           L+  +++G G+ G+V    + P    T  + A+K +  +  D  R    REI+IL+ ++ 
Sbjct: 9   LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-FQREIQILKALHS 67
Query: 157 PNVVKCHDMYDRNG--EIEVLLEYMDGGSLEGAHIRQEHILSDLAR------QVLSGLAY 208
             +VK   +    G  E+ +++EY+  G L     R    L D +R      Q+  G+ Y
Sbjct: 68  DFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARL-DASRLLLYSSQICKGMEY 126
Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERI 265
           L  R+ VHRD+   N+L+ S  +VKIADFG++++L    D           I + +PE +
Sbjct: 127 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESL 186
Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFY 292
           + ++   +      D+WS GV + E +
Sbjct: 187 SDNIFSRQ-----SDVWSFGVVLYELF 208

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 93/207 (44%), Gaps = 28/207 (13%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV--NHPNVVK--C 162
           +G G  G VWR +    S   A+K+     E S      RE EI   V   H N++    
Sbjct: 16  VGKGRYGEVWRGLWHGES--VAVKIFSSRDEQS----WFRETEIYNTVLLRHDNILGFIA 69
Query: 163 HDMYDRNGEIEVLL--EYMDGGSLEGAHIRQE---HILSDLARQVLSGLAYLH------- 210
            DM  RN   ++ L   Y + GSL     RQ    H+   LA     GLA+LH       
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 211 -KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC----NSAVGTIAYMSPERI 265
            K  I HRD K  N+L+ S+    IAD G++ + +Q  D      N  VGT  YM+PE +
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 266 NTDLNHGKYDGYA-GDIWSLGVSILEF 291
           +  +    ++ Y   DIW+ G+ + E 
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 103/249 (41%), Gaps = 48/249 (19%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G  G V+   +      +A+K I   + +  R ++ RE++ L  + HP +V+  + +
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 167 DRNGEIEVLL---------------------EYMDGGSLEGAHIRQEHILSDLARQVLSG 205
                 E L                      ++M+G        R+  +   +  Q+   
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIAEA 130
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ------TMDPC------NSA 253
           + +LH + ++HRD+KPSN+       VK+ DFG+   + Q       + P          
Sbjct: 131 VEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQ 190
Query: 254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ-----GDWAS 308
           VGT  YMSPE+I     HG    +  DI+SLG+ + E     +PF+   +      D  +
Sbjct: 191 VGTKLYMSPEQI-----HGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTDVRN 242
Query: 309 LMFAICFAQ 317
           L F   F Q
Sbjct: 243 LKFPPLFTQ 251

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 27/213 (12%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALK-VIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           IG+GS G V++     +  + A+K V+ G    +      RE++I+R ++H N+V+    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNIVRLRYF 81
Query: 166 YDRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKR 212
           +  +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 213 KIVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I    ++
Sbjct: 142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDY 200
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG 304
                 + D+WS G  + E  LG+ P   G  G
Sbjct: 201 TS----SIDVWSAGCVLAELLLGQ-PIFPGDSG 228

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 46/278 (16%)
Query: 104 GNRIGSGSGG-----TVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
           G  +G G  G     T + +         A+K++  N   S    +  E  +L+ VNHP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI------------------------ 194
           V+K +    ++G + +++EY   GSL G       +                        
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 195 ----LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
               L   A Q+  G+ YL +  +VHRD+   N+L+   + +KI+DFG+SR + +     
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 251 NSAVGTI--AYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWA 307
             + G I   +M+ E +   +   +      D+WS GV + E   LG  P+     G   
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQ-----SDVWSFGVLLWEIVTLGGNPYP----GIPP 258
Query: 308 SLMFAIC-FAQPPEAPEMASREFRDFISRCLQKDPHSR 344
             +F +       E P+  S E    + +C +++P  R
Sbjct: 259 ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 121/275 (44%), Gaps = 55/275 (20%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDVNHPNVVKCHDM 165
           +G G  G V ++ +  T   FALK++    +D  +++  RE+E+  R    P++V+  D+
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKML----QDCPKAR--REVELHWRASQCPHIVRIVDV 79
Query: 166 YDR----NGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           Y+        + +++E +DGG L       G     E   S++ + +   + YLH   I 
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 139
Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL  S +    +K+ DFG ++                          +    
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGFAK--------------------------ETTGE 173
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWAS--LMFAICFAQ----PPEAPEMAS 326
           KYD  + D+WSLGV I+   L  +P      G   S  +   I   Q     PE  E+ S
Sbjct: 174 KYDK-SCDMWSLGV-IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV-S 230
Query: 327 REFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
            E +  I   L+ +P  R    + + HP+I+++ +
Sbjct: 231 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 115/278 (41%), Gaps = 52/278 (18%)
Query: 107 IGSGSGGTVWRVVHP------PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           IG G+ G V++   P      P + V A+K++       +++   RE  ++ + ++PN+V
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMV-AVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHILSDL--------------------- 198
           K   +      + +L EYM  G L E       H +  L                     
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 199 ------ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL--AQTMDPC 250
                 ARQV +G+AYL +RK VHRD+   N L+  +  VKIADFG+SR +  A      
Sbjct: 174 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAD 233
Query: 251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWA--- 307
            +    I +M PE I     + +Y     D+W+ GV + E       F+ G Q  +    
Sbjct: 234 GNDAIPIRWMPPESI----FYNRYTT-ESDVWAYGVVLWEI------FSYGLQPYYGMAH 282
Query: 308 -SLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
             +++ +        PE    E  + +  C  K P  R
Sbjct: 283 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADR 320

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 116/265 (43%), Gaps = 38/265 (14%)
Query: 106 RIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHP 157
            +G GS G V+       V   P +RV A+K +  N   S+R +I    E  ++++ N  
Sbjct: 17  ELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTV--NEAASMRERIEFLNEASVMKEFNCH 73
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGA------HIRQEHILS--------DLARQVL 203
           +VV+   +  +     V++E M  G L+         +    +L+         +A ++ 
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 133
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMS 261
            G+AYL+  K VHRD+   N ++     VKI DFG++R + +T        G   + +MS
Sbjct: 134 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 193
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEF-YLGRFPF-AVGRQGDWASLMFAICFAQPP 319
           PE     L  G +  Y+ D+WS GV + E   L   P+  +  +     +M      +P 
Sbjct: 194 PE----SLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 248
Query: 320 EAPEMASREFRDFISRCLQKDPHSR 344
             P+M      + +  C Q +P  R
Sbjct: 249 NCPDM----LLELMRMCWQYNPKMR 269

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPP----TSRVFALKVIY----GNHEDSVRSQICREIEILR 152
           L++   +G G  G V    + P    T    A+K +     GNH   ++    +EIEILR
Sbjct: 23  LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK----KEIEILR 78
Query: 153 DVNHPNVVKCHDMYDRNGE--IEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSG 205
           ++ H N+VK   +   +G   I++++E++  GSL+    + ++ ++       A Q+  G
Sbjct: 79  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSP 262
           + YL  R+ VHRD+   N+L+ S   VKI DFG+++ +    +     +     + + +P
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 198
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           E     L   K+   A D+WS GV++ E 
Sbjct: 199 EC----LMQSKF-YIASDVWSFGVTLHEL 222

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG+GS G V++     +  + A+K +  +          RE++I+R ++H N+V+    +
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYFF 116
Query: 167 DRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKRK 213
             +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H   
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 214 IVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I      G
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELI-----FG 230
Query: 273 KYDGYAG-DIWSLGVSILEFYLGR--FP 297
             D  +  D+WS G  + E  LG+  FP
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIFP 258

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPP----TSRVFALKVIY----GNHEDSVRSQICREIEILR 152
           L++   +G G  G V    + P    T    A+K +     GNH   ++    +EIEILR
Sbjct: 11  LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK----KEIEILR 66
Query: 153 DVNHPNVVKCHDMYDRNGE--IEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSG 205
           ++ H N+VK   +   +G   I++++E++  GSL+    + ++ ++       A Q+  G
Sbjct: 67  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 126
Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSP 262
           + YL  R+ VHRD+   N+L+ S   VKI DFG+++ +    +     +     + + +P
Sbjct: 127 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 186
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           E     L   K+   A D+WS GV++ E 
Sbjct: 187 EC----LMQSKF-YIASDVWSFGVTLHEL 210

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 28/208 (13%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALK-VIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           IG+GS G V++     +  + A+K V+ G    +      RE++I+R ++H N+V+    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNIVRLRYF 81
Query: 166 YDRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKR 212
           +  +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 213 KIVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I    ++
Sbjct: 142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDY 200
Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP 297
                 + D+WS G  + E  LG+  FP
Sbjct: 201 TS----SIDVWSAGCVLAELLLGQPIFP 224

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG+GS G V++     +  + A+K +  +          RE++I+R ++H N+V+    +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYFF 82
Query: 167 DRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKRK 213
             +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H   
Sbjct: 83  YSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 214 IVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I    ++ 
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDYT 201
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG 304
                + D+WS G  + E  LG+ P   G  G
Sbjct: 202 S----SIDVWSAGCVLAELLLGQ-PIFPGDSG 228

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG+GS G V++     +  + A+K +  +          RE++I+R ++H N+V+    +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYFF 82
Query: 167 DRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKRK 213
             +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 214 IVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I    ++ 
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDYT 201
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG 304
                + D+WS G  + E  LG+ P   G  G
Sbjct: 202 S----SIDVWSAGCVLAELLLGQ-PIFPGDSG 228

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG+GS G V++     +  + A+K +  +          RE++I+R ++H N+V+    +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYFF 82
Query: 167 DRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKRK 213
             +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 214 IVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I    ++ 
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDYT 201
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG 304
                + D+WS G  + E  LG+ P   G  G
Sbjct: 202 S----SIDVWSAGCVLAELLLGQ-PIFPGDSG 228

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG+GS G V++     +  + A+K +  +          RE++I+R ++H N+V+    +
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYFF 83
Query: 167 DRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKRK 213
             +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H   
Sbjct: 84  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 143
Query: 214 IVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I    ++ 
Sbjct: 144 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDYT 202
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG 304
                + D+WS G  + E  LG+ P   G  G
Sbjct: 203 S----SIDVWSAGCVLAELLLGQ-PIFPGDSG 229

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 27/213 (12%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALK-VIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
           IG+GS G V++     +  + A+K V+ G    +      RE++I+R ++H N+V+    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN------RELQIMRKLDHCNIVRLRYF 81
Query: 166 YDRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKR 212
           +  +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 213 KIVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I    ++
Sbjct: 142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDY 200
Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG 304
                 + D+WS G  + E  LG+ P   G  G
Sbjct: 201 TS----SIDVWSAGCVLAELLLGQ-PIFPGDSG 228

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG+GS G V++     +  + A+K +  +          RE++I+R ++H N+V+    +
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYFF 94
Query: 167 DRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKRK 213
             +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H   
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 154
Query: 214 IVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I    ++ 
Sbjct: 155 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDYT 213
Query: 273 KYDGYAGDIWSLGVSILEFYLGR--FP 297
                + D+WS G  + E  LG+  FP
Sbjct: 214 S----SIDVWSAGCVLAELLLGQPIFP 236

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 116/265 (43%), Gaps = 38/265 (14%)
Query: 106 RIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHP 157
            +G GS G V+       V   P +RV A+K +  N   S+R +I    E  ++++ N  
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTV--NEAASMRERIEFLNEASVMKEFNCH 82
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGA------HIRQEHILS--------DLARQVL 203
           +VV+   +  +     V++E M  G L+         +    +L+         +A ++ 
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMS 261
            G+AYL+  K VHRD+   N ++     VKI DFG++R + +T        G   + +MS
Sbjct: 143 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 202
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEF-YLGRFPF-AVGRQGDWASLMFAICFAQPP 319
           PE     L  G +  Y+ D+WS GV + E   L   P+  +  +     +M      +P 
Sbjct: 203 PE----SLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 257
Query: 320 EAPEMASREFRDFISRCLQKDPHSR 344
             P+M      + +  C Q +P  R
Sbjct: 258 NCPDM----LFELMRMCWQYNPKMR 278

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG+GS G V++     +  + A+K +  +          RE++I+R ++H N+V+    +
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYFF 101
Query: 167 DRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKRK 213
             +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H   
Sbjct: 102 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 161
Query: 214 IVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I    ++ 
Sbjct: 162 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDYT 220
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG 304
                + D+WS G  + E  LG+ P   G  G
Sbjct: 221 S----SIDVWSAGCVLAELLLGQ-PIFPGDSG 247

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG+GS G V++     +  + A+K +  +          RE++I+R ++H N+V+    +
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYFF 90
Query: 167 DRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKRK 213
             +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H   
Sbjct: 91  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 150
Query: 214 IVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I    ++ 
Sbjct: 151 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDYT 209
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG 304
                + D+WS G  + E  LG+ P   G  G
Sbjct: 210 S----SIDVWSAGCVLAELLLGQ-PIFPGDSG 236

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG+GS G V++     +  + A+K +  +          RE++I+R ++H N+V+    +
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYFF 86
Query: 167 DRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKRK 213
             +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H   
Sbjct: 87  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 146
Query: 214 IVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I    ++ 
Sbjct: 147 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDYT 205
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG 304
                + D+WS G  + E  LG+ P   G  G
Sbjct: 206 S----SIDVWSAGCVLAELLLGQ-PIFPGDSG 232

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG+GS G V++     +  + A+K +  +          RE++I+R ++H N+V+    +
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYFF 94
Query: 167 DRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKRK 213
             +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H   
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 154
Query: 214 IVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I    ++ 
Sbjct: 155 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRYYRAPELIFGATDYT 213
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG 304
                + D+WS G  + E  LG+ P   G  G
Sbjct: 214 S----SIDVWSAGCVLAELLLGQ-PIFPGDSG 240

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   EL+K   +GSG+ GTV++ +  P         A+KV+  N       +I  E  +
Sbjct: 13  ILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYV 72
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V  P V +   +      ++++ + M  G L   H+R+         L +   Q+  
Sbjct: 73  MAGVGSPYVSRLLGIC-LTSTVQLVTQLMPYGCLLD-HVRENRGRLGSQDLLNWCMQIAK 130
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL--AQTMDPCNSAVGTIAYMSP 262
           G++YL   ++VHRD+   N+L+ S  +VKI DFG++R+L   +T    +     I +M+ 
Sbjct: 131 GMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 190
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I       +   +  D+WS GV++ E    G  P+
Sbjct: 191 ESILR-----RRFTHQSDVWSYGVTVWELMTFGAKPY 222

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG+GS G V++     +  + A+K +  +          RE++I+R ++H N+V+    +
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYFF 82
Query: 167 DRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKRK 213
             +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H   
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 214 IVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I    ++ 
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYT 201
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG 304
                + D+WS G  + E  LG+ P   G  G
Sbjct: 202 S----SIDVWSAGCVLAELLLGQ-PIFPGDSG 228

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG+GS G V++     +  + A+K +  +          RE++I+R ++H N+V+    +
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYFF 95
Query: 167 DRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKRK 213
             +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H   
Sbjct: 96  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 155
Query: 214 IVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I    ++ 
Sbjct: 156 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYT 214
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG 304
                + D+WS G  + E  LG+ P   G  G
Sbjct: 215 S----SIDVWSAGCVLAELLLGQ-PIFPGDSG 241

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG+GS G V++     +  + A+K +  +          RE++I+R ++H N+V+    +
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYFF 87
Query: 167 DRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKRK 213
             +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H   
Sbjct: 88  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 147
Query: 214 IVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I    ++ 
Sbjct: 148 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYT 206
Query: 273 KYDGYAGDIWSLGVSILEFYLGR--FP 297
                + D+WS G  + E  LG+  FP
Sbjct: 207 S----SIDVWSAGCVLAELLLGQPIFP 229

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG+GS G V++     +  + A+K +  +          RE++I+R ++H N+V+    +
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYFF 116
Query: 167 DRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKRK 213
             +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H   
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 214 IVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I      G
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI-----FG 230
Query: 273 KYDGYAG-DIWSLGVSILEFYLGR--FP 297
             D  +  D+WS G  + E  LG+  FP
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIFP 258

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG+GS G V++     +  + A+K +  +          RE++I+R ++H N+V+    +
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYFF 110
Query: 167 DRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKRK 213
             +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H   
Sbjct: 111 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 170
Query: 214 IVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I      G
Sbjct: 171 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI-----FG 224
Query: 273 KYDGYAG-DIWSLGVSILEFYLGR--FP 297
             D  +  D+WS G  + E  LG+  FP
Sbjct: 225 ATDYTSSIDVWSAGCVLAELLLGQPIFP 252

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG+GS G V++     +  + A+K +  +          RE++I+R ++H N+V+    +
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYFF 118
Query: 167 DRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKRK 213
             +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H   
Sbjct: 119 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 178
Query: 214 IVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I      G
Sbjct: 179 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI-----FG 232
Query: 273 KYDGYAG-DIWSLGVSILEFYLGR--FP 297
             D  +  D+WS G  + E  LG+  FP
Sbjct: 233 ATDYTSSIDVWSAGCVLAELLLGQPIFP 260

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG+GS G V++     +  + A+K +  +          RE++I+R ++H N+V+    +
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYFF 120
Query: 167 DRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKRK 213
             +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H   
Sbjct: 121 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 180
Query: 214 IVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I      G
Sbjct: 181 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI-----FG 234
Query: 273 KYDGYAG-DIWSLGVSILEFYLGR--FP 297
             D  +  D+WS G  + E  LG+  FP
Sbjct: 235 ATDYTSSIDVWSAGCVLAELLLGQPIFP 262

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++++ M  G L   ++R+         L +   Q+  
Sbjct: 71  MASVDNPHVCRLLGIC-LTSTVQLIMQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 128
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 189 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 220

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           IG+GS G V++     +  + A+K +  +          RE++I+R ++H N+V+    +
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYFF 161
Query: 167 DRNGE------IEVLLEYMDGGSLEGA--HIRQEHILSDL-----ARQVLSGLAYLHKRK 213
             +GE      + ++L+Y+       A  + R +  L  +       Q+   LAY+H   
Sbjct: 162 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 221
Query: 214 IVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I      G
Sbjct: 222 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI-----FG 275
Query: 273 KYDGYAG-DIWSLGVSILEFYLGR--FP 297
             D  +  D+WS G  + E  LG+  FP
Sbjct: 276 ATDYTSSIDVWSAGCVLAELLLGQPIFP 303

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 12  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 71
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++++ M  G L   ++R+         L +   Q+  
Sbjct: 72  MASVDNPHVCRLLGIC-LTSTVQLIMQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 129
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 130 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 190 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 221

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 15  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 74
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++++ M  G L   ++R+         L +   Q+  
Sbjct: 75  MASVDNPHVCRLLGIC-LTSTVQLIMQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 132
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 133 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 193 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 224

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++++ M  G L   ++R+         L +   Q+  
Sbjct: 73  MASVDNPHVCRLLGIC-LTSTVQLIMQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 130
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 191 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 12  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 71
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++++ M  G L   ++R+         L +   Q+  
Sbjct: 72  MASVDNPHVCRLLGIC-LTSTVQLIMQLMPFGXLLD-YVREHKDNIGSQYLLNWCVQIAK 129
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 130 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 190 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 221

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 73
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++++ M  G L   ++R+         L +   Q+  
Sbjct: 74  MASVDNPHVCRLLGIC-LTSTVQLIMQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 131
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 192 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 223

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNH 156
           L+  +++G G+ G+V    + P    T  + A+K +  +  D  R    REI+IL+ ++ 
Sbjct: 25  LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-FQREIQILKALHS 83
Query: 157 PNVVKCHDMYDRNG--EIEVLLEYMDGGSLEGAHIRQEHILSDLAR------QVLSGLAY 208
             +VK   +    G   + +++EY+  G L     R    L D +R      Q+  G+ Y
Sbjct: 84  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL-DASRLLLYSSQICKGMEY 142
Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERI 265
           L  R+ VHRD+   N+L+ S  +VKIADFG++++L    D           I + +PE +
Sbjct: 143 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFY 292
           + ++   +      D+WS GV + E +
Sbjct: 203 SDNIFSRQ-----SDVWSFGVVLYELF 224

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNH 156
           L+  +++G G+ G+V    + P    T  + A+K +  +  D  R    REI+IL+ ++ 
Sbjct: 13  LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-FQREIQILKALHS 71
Query: 157 PNVVKCHDMYDRNG--EIEVLLEYMDGGSLEGAHIRQEHILSDLAR------QVLSGLAY 208
             +VK   +    G   + +++EY+  G L     R    L D +R      Q+  G+ Y
Sbjct: 72  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL-DASRLLLYSSQICKGMEY 130
Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERI 265
           L  R+ VHRD+   N+L+ S  +VKIADFG++++L    D           I + +PE +
Sbjct: 131 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 190
Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFY 292
           + ++   +      D+WS GV + E +
Sbjct: 191 SDNIFSRQ-----SDVWSFGVVLYELF 212

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNH 156
           L+  +++G G+ G+V    + P    T  + A+K +  +  D  R    REI+IL+ ++ 
Sbjct: 12  LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-FQREIQILKALHS 70
Query: 157 PNVVKCHDMYDRNG--EIEVLLEYMDGGSLEGAHIRQEHILSDLAR------QVLSGLAY 208
             +VK   +    G   + +++EY+  G L     R    L D +R      Q+  G+ Y
Sbjct: 71  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL-DASRLLLYSSQICKGMEY 129
Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYMSPERI 265
           L  R+ VHRD+   N+L+ S  +VKIADFG++++L    D           I + +PE +
Sbjct: 130 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 189
Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFY 292
           + ++   +      D+WS GV + E +
Sbjct: 190 SDNIFSRQ-----SDVWSFGVVLYELF 211

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 57/299 (19%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV---- 154
            E  +  +IGSG  G+V++ V      ++A+K        SV  Q       LR+V    
Sbjct: 7   TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ-----NALREVYAHA 61
Query: 155 ---NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS--------DLARQVL 203
               H +VV+    +  +  + +  EY +GGSL  A      I+S        DL  QV 
Sbjct: 62  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 121
Query: 204 SGLAYLHKRKIVHRDIKPSNLLIN-----------------SSKNV--KIADFG-VSRIL 243
            GL Y+H   +VH DIKPSN+ I+                 +S  V  KI D G V+RI 
Sbjct: 122 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 181
Query: 244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ 303
           +  ++  +S      +++ E +  +  H        DI++L ++++    G  P    R 
Sbjct: 182 SPQVEEGDS-----RFLANEVLQENYTHLP----KADIFALALTVVX-AAGAEPLP--RN 229
Query: 304 GD-WASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
           GD W      I   + P  P++ S+EF + +   +  DP  R  A  L++H  +L A +
Sbjct: 230 GDQW----HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 284

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 116/265 (43%), Gaps = 38/265 (14%)
Query: 106 RIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHP 157
            +G GS G V+       V   P +RV A+K +  N   S+R +I    E  ++++ N  
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTV--NEAASMRERIEFLNEASVMKEFNCH 81
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGA------HIRQEHILS--------DLARQVL 203
           +VV+   +  +     V++E M  G L+         +    +L+         +A ++ 
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMS 261
            G+AYL+  K VHRD+   N ++     VKI DFG++R + +T        G   + +MS
Sbjct: 142 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 201
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEF-YLGRFPF-AVGRQGDWASLMFAICFAQPP 319
           PE     L  G +  Y+ D+WS GV + E   L   P+  +  +     +M      +P 
Sbjct: 202 PE----SLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 256
Query: 320 EAPEMASREFRDFISRCLQKDPHSR 344
             P+M      + +  C Q +P  R
Sbjct: 257 NCPDM----LFELMRMCWQYNPKMR 277

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 105/220 (47%), Gaps = 24/220 (10%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ----ICREIEI 150
           +    EL+K   +GSG  GTV + V  P      + V     ED    Q    +   +  
Sbjct: 9   IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQE------HILSDLARQVLS 204
           +  ++H ++V+   +      ++++ +Y+  GSL   H+RQ        +L +   Q+  
Sbjct: 69  IGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLD-HVRQHRGALGPQLLLNWGVQIAK 126
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL----AQTMDPCNSAVGTIAYM 260
           G+ YL +  +VHR++   N+L+ S   V++ADFGV+ +L     Q +   + A   I +M
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL--YSEAKTPIKWM 184
Query: 261 SPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFA 299
           + E I    + GKY  +  D+WS GV++ E    G  P+A
Sbjct: 185 ALESI----HFGKYT-HQSDVWSYGVTVWELMTFGAEPYA 219

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 116/265 (43%), Gaps = 38/265 (14%)
Query: 106 RIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHP 157
            +G GS G V+       V   P +RV A+K +  N   S+R +I    E  ++++ N  
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTV--NEAASMRERIEFLNEASVMKEFNCH 75
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGA------HIRQEHILS--------DLARQVL 203
           +VV+   +  +     V++E M  G L+         +    +L+         +A ++ 
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMS 261
            G+AYL+  K VHRD+   N ++     VKI DFG++R + +T        G   + +MS
Sbjct: 136 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 195
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEF-YLGRFPF-AVGRQGDWASLMFAICFAQPP 319
           PE     L  G +  Y+ D+WS GV + E   L   P+  +  +     +M      +P 
Sbjct: 196 PE----SLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 250
Query: 320 EAPEMASREFRDFISRCLQKDPHSR 344
             P+M      + +  C Q +P  R
Sbjct: 251 NCPDM----LFELMRMCWQYNPKMR 271

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 116/265 (43%), Gaps = 38/265 (14%)
Query: 106 RIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHP 157
            +G GS G V+       V   P +RV A+K +  N   S+R +I    E  ++++ N  
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTV--NEAASMRERIEFLNEASVMKEFNCH 88
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGA------HIRQEHILS--------DLARQVL 203
           +VV+   +  +     V++E M  G L+         +    +L+         +A ++ 
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 148
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMS 261
            G+AYL+  K VHRD+   N ++     VKI DFG++R + +T        G   + +MS
Sbjct: 149 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 208
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEF-YLGRFPF-AVGRQGDWASLMFAICFAQPP 319
           PE     L  G +  Y+ D+WS GV + E   L   P+  +  +     +M      +P 
Sbjct: 209 PE----SLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 263
Query: 320 EAPEMASREFRDFISRCLQKDPHSR 344
             P+M      + +  C Q +P  R
Sbjct: 264 NCPDM----LFELMRMCWQYNPKMR 284

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 116/265 (43%), Gaps = 38/265 (14%)
Query: 106 RIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHP 157
            +G GS G V+       V   P +RV A+K +  N   S+R +I    E  ++++ N  
Sbjct: 26  ELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTV--NEAASMRERIEFLNEASVMKEFNCH 82
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGA------HIRQEHILS--------DLARQVL 203
           +VV+   +  +     V++E M  G L+         +    +L+         +A ++ 
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMS 261
            G+AYL+  K VHRD+   N ++     VKI DFG++R + +T        G   + +MS
Sbjct: 143 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 202
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEF-YLGRFPF-AVGRQGDWASLMFAICFAQPP 319
           PE     L  G +  Y+ D+WS GV + E   L   P+  +  +     +M      +P 
Sbjct: 203 PE----SLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 257
Query: 320 EAPEMASREFRDFISRCLQKDPHSR 344
             P+M      + +  C Q +P  R
Sbjct: 258 NCPDM----LFELMRMCWQYNPKMR 278

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 57/299 (19%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV---- 154
            E  +  +IGSG  G+V++ V      ++A+K        SV  Q       LR+V    
Sbjct: 11  TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ-----NALREVYAHA 65
Query: 155 ---NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS--------DLARQVL 203
               H +VV+    +  +  + +  EY +GGSL  A      I+S        DL  QV 
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 204 SGLAYLHKRKIVHRDIKPSNLLIN-----------------SSKNV--KIADFG-VSRIL 243
            GL Y+H   +VH DIKPSN+ I+                 +S  V  KI D G V+RI 
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ 303
           +  ++  +S      +++ E +  +  H        DI++L ++++    G  P    R 
Sbjct: 186 SPQVEEGDS-----RFLANEVLQENYTHLP----KADIFALALTVV-CAAGAEPLP--RN 233
Query: 304 GD-WASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
           GD W      I   + P  P++ S+EF + +   +  DP  R  A  L++H  +L A +
Sbjct: 234 GDQW----HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 20/218 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ----ICREIEI 150
           +    EL+K   +GSG  GTV + V  P      + V     ED    Q    +   +  
Sbjct: 27  IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 86
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQE------HILSDLARQVLS 204
           +  ++H ++V+   +      ++++ +Y+  GSL   H+RQ        +L +   Q+  
Sbjct: 87  IGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLD-HVRQHRGALGPQLLLNWGVQIAK 144
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC--NSAVGTIAYMSP 262
           G+ YL +  +VHR++   N+L+ S   V++ADFGV+ +L         + A   I +M+ 
Sbjct: 145 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFA 299
           E I    + GKY  +  D+WS GV++ E    G  P+A
Sbjct: 205 ESI----HFGKYT-HQSDVWSYGVTVWELMTFGAEPYA 237

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 57/299 (19%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV---- 154
            E  +  +IGSG  G+V++ V      ++A+K        SV  Q       LR+V    
Sbjct: 9   TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ-----NALREVYAHA 63
Query: 155 ---NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS--------DLARQVL 203
               H +VV+    +  +  + +  EY +GGSL  A      I+S        DL  QV 
Sbjct: 64  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 204 SGLAYLHKRKIVHRDIKPSNLLIN-----------------SSKNV--KIADFG-VSRIL 243
            GL Y+H   +VH DIKPSN+ I+                 +S  V  KI D G V+RI 
Sbjct: 124 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 183
Query: 244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ 303
           +  ++  +S      +++ E +  +  H        DI++L ++++    G  P    R 
Sbjct: 184 SPQVEEGDS-----RFLANEVLQENYTHLP----KADIFALALTVV-CAAGAEPLP--RN 231
Query: 304 GD-WASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
           GD W      I   + P  P++ S+EF + +   +  DP  R  A  L++H  +L A +
Sbjct: 232 GDQW----HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 286

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 116/265 (43%), Gaps = 38/265 (14%)
Query: 106 RIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHP 157
            +G GS G V+       V   P +RV A+K +  N   S+R +I    E  ++++ N  
Sbjct: 23  ELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTV--NEAASMRERIEFLNEASVMKEFNCH 79
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGA------HIRQEHILS--------DLARQVL 203
           +VV+   +  +     V++E M  G L+         +    +L+         +A ++ 
Sbjct: 80  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 139
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMS 261
            G+AYL+  K VHRD+   N ++     VKI DFG++R + +T        G   + +MS
Sbjct: 140 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 199
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEF-YLGRFPF-AVGRQGDWASLMFAICFAQPP 319
           PE     L  G +  Y+ D+WS GV + E   L   P+  +  +     +M      +P 
Sbjct: 200 PE----SLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 254
Query: 320 EAPEMASREFRDFISRCLQKDPHSR 344
             P+M      + +  C Q +P  R
Sbjct: 255 NCPDM----LFELMRMCWQYNPKMR 275

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 129/299 (43%), Gaps = 57/299 (19%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV---- 154
            E  +  +IGSG  G+V++ V      ++A+K        SV  Q       LR+V    
Sbjct: 9   TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ-----NALREVYAHA 63
Query: 155 ---NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS--------DLARQVL 203
               H +VV+    +  +  + +  EY +GGSL  A      I+S        DL  QV 
Sbjct: 64  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 204 SGLAYLHKRKIVHRDIKPSNLLIN-----------------SSKNV--KIADFG-VSRIL 243
            GL Y+H   +VH DIKPSN+ I+                 +S  V  KI D G V+RI 
Sbjct: 124 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 183
Query: 244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ 303
           +  ++  +S      +++ E +  +  H        DI++L ++++    G  P    R 
Sbjct: 184 SPQVEEGDS-----RFLANEVLQENYTHLP----KADIFALALTVV-CAAGAEPLP--RN 231
Query: 304 GD-WASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
           GD W      I   + P  P++ S+EF + +   +  DP  R  A  L++H  +L A +
Sbjct: 232 GDQW----HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 286

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 116/265 (43%), Gaps = 38/265 (14%)
Query: 106 RIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHP 157
            +G GS G V+       V   P +RV A+K +  N   S+R +I    E  ++++ N  
Sbjct: 25  ELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTV--NEAASMRERIEFLNEASVMKEFNCH 81
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGA------HIRQEHILS--------DLARQVL 203
           +VV+   +  +     V++E M  G L+         +    +L+         +A ++ 
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMS 261
            G+AYL+  K VHRD+   N ++     VKI DFG++R + +T        G   + +MS
Sbjct: 142 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 201
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEF-YLGRFPF-AVGRQGDWASLMFAICFAQPP 319
           PE     L  G +  Y+ D+WS GV + E   L   P+  +  +     +M      +P 
Sbjct: 202 PE----SLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 256
Query: 320 EAPEMASREFRDFISRCLQKDPHSR 344
             P+M      + +  C Q +P  R
Sbjct: 257 NCPDM----LFELMRMCWQYNPKMR 277

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 121/275 (44%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 65
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLEYM-------DGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE M       D  +  GA   QE +      QV
Sbjct: 66  KKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGA--LQEELARSFFWQV 123
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 124 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 181
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    + D   +   + F Q    
Sbjct: 182 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFFRQ---- 229
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
               S E +  I  CL   P  R    ++  HP++
Sbjct: 230 --RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 21  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 80
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++ + M  G L   ++R+         L +   Q+  
Sbjct: 81  MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 138
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 139 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 198
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 199 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 230

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 116/264 (43%), Gaps = 38/264 (14%)
Query: 107 IGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHPN 158
           +G GS G V+       V   P +RV A+K +  N   S+R +I    E  ++++ N  +
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRV-AIKTV--NEAASMRERIEFLNEASVMKEFNCHH 111
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGA------HIRQEHILS--------DLARQVLS 204
           VV+   +  +     V++E M  G L+         +    +L+         +A ++  
Sbjct: 112 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 171
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+AYL+  K VHRD+   N ++     VKI DFG++R + +T        G   + +MSP
Sbjct: 172 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 231
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEF-YLGRFPF-AVGRQGDWASLMFAICFAQPPE 320
           E     L  G +  Y+ D+WS GV + E   L   P+  +  +     +M      +P  
Sbjct: 232 E----SLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN 286
Query: 321 APEMASREFRDFISRCLQKDPHSR 344
            P+M      + +  C Q +P  R
Sbjct: 287 CPDM----LFELMRMCWQYNPKMR 306

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 73
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++ + M  G L   ++R+         L +   Q+  
Sbjct: 74  MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 131
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 192 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 223

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 73
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++ + M  G L   ++R+         L +   Q+  
Sbjct: 74  MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 131
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 192 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 223

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++ + M  G L   ++R+         L +   Q+  
Sbjct: 71  MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 128
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 189 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 220

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++ + M  G L   ++R+         L +   Q+  
Sbjct: 73  MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 130
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 191 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 222

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 73
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++ + M  G L   ++R+         L +   Q+  
Sbjct: 74  MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 131
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 192 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 223

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 36  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 95
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++ + M  G L   ++R+         L +   Q+  
Sbjct: 96  MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 153
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 154 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 213
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 214 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 245

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 18  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 77
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++ + M  G L   ++R+         L +   Q+  
Sbjct: 78  MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 135
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 196 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 227

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++ + M  G L   ++R+         L +   Q+  
Sbjct: 71  MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGXLLD-YVREHKDNIGSQYLLNWCVQIAK 128
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 189 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 220

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 8   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 67
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++ + M  G L   ++R+         L +   Q+  
Sbjct: 68  MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAE 125
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 126 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 185
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 186 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 217

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++++ M  G L   ++R+         L +   Q+  
Sbjct: 73  MASVDNPHVCRLLGIC-LTSTVQLIMQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 130
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG +++L       ++  G   I +M+ 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 191 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 120/246 (48%), Gaps = 40/246 (16%)
Query: 147 EIEILRDVN-HPNVVK--CHDMYDR---------NGEIEVLLEYMDGGSLEGAHIRQEHI 194
           EI++L + + HPNV++  C +  DR         N  ++ L+E  +    E   +++E+ 
Sbjct: 58  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSD-ENLKLQKEYN 116
Query: 195 LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK-------------NVKIADFGVSR 241
              L RQ+ SG+A+LH  KI+HRD+KP N+L+++S               + I+DFG+ +
Sbjct: 117 PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 242 IL----AQTMDPCNSAVGTIAYMSPERI--NTDLNHGKYDGYAGDIWSLGVSILEFYL-- 293
            L    +      N+  GT  + +PE +  + +L   +    + DI+S+G     +Y+  
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF--YYILS 234
Query: 294 -GRFPFA--VGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQL 350
            G+ PF     R+ +    +F++   +      + + E  D IS+ +  DP  R  A ++
Sbjct: 235 KGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIA-EATDLISQMIDHDPLKRPTAMKV 293
Query: 351 LQHPFI 356
           L+HP  
Sbjct: 294 LRHPLF 299

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 17  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 76
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++ + M  G L   ++R+         L +   Q+  
Sbjct: 77  MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 134
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 135 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 194
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 195 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 226

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++ + M  G L   ++R+         L +   Q+  
Sbjct: 71  MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 128
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 189 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 79/160 (49%), Gaps = 15/160 (9%)
Query: 142 SQICREIEILRDVNHPNVVKCHDMYDRN-GEIEVLLEYMDGGSLEGAHIRQEH--ILSDL 198
           SQ   E  I++D +HPNV+    +  R+ G   V+L YM  G L      + H   + DL
Sbjct: 77  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 136
Query: 199 ---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAV 254
                QV  G+ +L  +K VHRD+   N +++    VK+ADFG++R +L +  D  ++  
Sbjct: 137 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKT 196
Query: 255 GT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           G    + +M+ E + T     K      D+WS GV + E 
Sbjct: 197 GAKLPVKWMALESLQTQKFTTK-----SDVWSFGVLLWEL 231

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 5   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 64
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++ + M  G L   ++R+         L +   Q+  
Sbjct: 65  MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 122
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 183 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 214

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 100
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 158
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 216
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    + D   +   + F Q    
Sbjct: 217 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFFRQ---- 264
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
               S E +  I  CL   P  R    ++  HP++
Sbjct: 265 --RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSV----RSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P      + V      ++       +I  E  +
Sbjct: 45  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYV 104
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++ + M  G L   ++R+         L +   Q+  
Sbjct: 105 MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 162
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 163 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 222
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 223 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 254

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 40/266 (15%)
Query: 106 RIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHP 157
            +G GS G V+       V   P +RV A+K +  N   S+R +I    E  ++++ N  
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTV--NEAASMRERIEFLNEASVMKEFNCH 88
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR-------QEHILS--------DLARQV 202
           +VV+   +  +     V++E M  G L+ +++R          +L+         +A ++
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLK-SYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYM 260
             G+AYL+  K VHRD+   N ++     VKI DFG++R + +T        G   + +M
Sbjct: 148 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 261 SPERINTDLNHGKYDGYAGDIWSLGVSILEF-YLGRFPF-AVGRQGDWASLMFAICFAQP 318
           SPE     L  G +  Y+ D+WS GV + E   L   P+  +  +     +M      +P
Sbjct: 208 SPE----SLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 262
Query: 319 PEAPEMASREFRDFISRCLQKDPHSR 344
              P+M      + +  C Q +P  R
Sbjct: 263 DNCPDM----LFELMRMCWQYNPKMR 284

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 15  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 74
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++++ M  G L   ++R+         L +   Q+  
Sbjct: 75  MASVDNPHVCRLLGIC-LTSTVQLIMQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 132
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG +++L       ++  G   I +M+ 
Sbjct: 133 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 193 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 224

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 61
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 119
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 120 LEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 177
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    + D   +   + F Q    
Sbjct: 178 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFFRQ---- 225
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
               S E +  I  CL   P  R    ++  HP++
Sbjct: 226 --RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 56  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 113
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 114 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 171
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 172 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 229
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    + D   +   + F Q    
Sbjct: 230 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFFRQ---- 277
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
               S E +  I  CL   P  R    ++  HP++
Sbjct: 278 --RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 310

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 80
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 81  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 138
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 139 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 196
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    + D   +   + F Q    
Sbjct: 197 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFFRQ---- 244
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
               S E +  I  CL   P  R    ++  HP++
Sbjct: 245 --RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++++ M  G L   ++R+         L +   Q+  
Sbjct: 73  MASVDNPHVCRLLGIC-LTSTVQLIMQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 130
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG +++L       ++  G   I +M+ 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 191 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 222

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 80
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 81  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 138
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 139 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 196
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    + D   +   + F Q    
Sbjct: 197 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFFRQ---- 244
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
               S E +  I  CL   P  R    ++  HP++
Sbjct: 245 --RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 81
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 82  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 139
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 197
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    + D   +   + F Q    
Sbjct: 198 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFFRQ---- 245
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
               S E +  I  CL   P  R    ++  HP++
Sbjct: 246 --RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVKCHDM 165
           IG GS G V+      T +  A+K +    ED +  + I REI IL  +    +++ +D+
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 166 YD-----RNGEIEVLLEYMDGGSLE----GAHIRQEHILSDLARQVLSGLAYLHKRKIVH 216
                  +  E+ ++LE  D    +       + +EHI + L   +L G  ++H+  I+H
Sbjct: 94  IIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY-NLLLGENFIHESGIIH 152
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMD--------------PCN--------SAV 254
           RD+KP+N L+N   +VK+ DFG++R +    D              P N        S V
Sbjct: 153 RDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHV 212
Query: 255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
            T  Y +PE I    N+ K    + DIWS G    E 
Sbjct: 213 VTRWYRAPELILLQENYTK----SIDIWSTGCIFAEL 245

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 40/266 (15%)
Query: 106 RIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHP 157
            +G GS G V+       V   P +RV A+K +  N   S+R +I    E  ++++ N  
Sbjct: 22  ELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTV--NEAASMRERIEFLNEASVMKEFNCH 78
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-------ILS--------DLARQV 202
           +VV+   +  +     V++E M  G L+ +++R          +L+         +A ++
Sbjct: 79  HVVRLLGVVSQGQPTLVIMELMTRGDLK-SYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 137
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYM 260
             G+AYL+  K VHRD+   N ++     VKI DFG++R + +T        G   + +M
Sbjct: 138 ADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 197
Query: 261 SPERINTDLNHGKYDGYAGDIWSLGVSILEF-YLGRFPF-AVGRQGDWASLMFAICFAQP 318
           SPE     L  G +  Y+ D+WS GV + E   L   P+  +  +     +M      +P
Sbjct: 198 SPE----SLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 252
Query: 319 PEAPEMASREFRDFISRCLQKDPHSR 344
              P+M      + +  C Q +P  R
Sbjct: 253 DNCPDM----LFELMRMCWQYNPKMR 274

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 51  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 108
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 109 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 166
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 167 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 224
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    + D   +   + F Q    
Sbjct: 225 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFFRQ---- 272
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
               S E +  I  CL   P  R    ++  HP++
Sbjct: 273 --RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 93
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 151
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 209
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    + D   +   + F Q    
Sbjct: 210 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFFRQ---- 257
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
               S E +  I  CL   P  R    ++  HP++
Sbjct: 258 --RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 81
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 82  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 139
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 197
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    + D   +   + F Q    
Sbjct: 198 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFFRQ---- 245
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
               S E +  I  CL   P  R    ++  HP++
Sbjct: 246 --RVSXECQHLIRWCLALRPXDRPTFEEIQNHPWM 278

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 118/275 (42%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 94
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 152
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 210
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    +     + F          
Sbjct: 211 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR--------- 257
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +  S E +  I  CL   P  R    ++  HP++
Sbjct: 258 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 118/275 (42%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 93
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 151
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 209
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    +     + F          
Sbjct: 210 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR--------- 256
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +  S E +  I  CL   P  R    ++  HP++
Sbjct: 257 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 81
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 82  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 139
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 140 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 197
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    + D   +   + F Q    
Sbjct: 198 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFFRQ---- 245
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
               S E +  I  CL   P  R    ++  HP++
Sbjct: 246 --RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 118/275 (42%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 94
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 152
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 210
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    +     + F          
Sbjct: 211 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR--------- 257
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +  S E +  I  CL   P  R    ++  HP++
Sbjct: 258 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 118/275 (42%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 94
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 152
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 210
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    +     + F          
Sbjct: 211 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR--------- 257
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +  S E +  I  CL   P  R    ++  HP++
Sbjct: 258 -QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 118/275 (42%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 93
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 151
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 209
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    +     + F          
Sbjct: 210 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR--------- 256
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +  S E +  I  CL   P  R    ++  HP++
Sbjct: 257 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 66
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 124
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 182
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    + D   +   + F Q    
Sbjct: 183 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFFRQ---- 230
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
               S E +  I  CL   P  R    ++  HP++
Sbjct: 231 --RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 118/275 (42%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 93
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 151
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 152 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 209
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    +     + F          
Sbjct: 210 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR--------- 256
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +  S E +  I  CL   P  R    ++  HP++
Sbjct: 257 -QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 51  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 108
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 109 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 166
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 167 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 224
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    + D   +   + F Q    
Sbjct: 225 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFFRQ---- 272
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
               S E +  I  CL   P  R    ++  HP++
Sbjct: 273 --RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 118/275 (42%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 94
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 152
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 153 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 210
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    +     + F          
Sbjct: 211 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR--------- 257
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +  S E +  I  CL   P  R    ++  HP++
Sbjct: 258 -QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 65
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 66  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 123
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 124 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 181
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    + D   +   + F Q    
Sbjct: 182 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFFRQ---- 229
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
               S E +  I  CL   P  R    ++  HP++
Sbjct: 230 --RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 115/265 (43%), Gaps = 38/265 (14%)
Query: 106 RIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHP 157
            +G GS G V+       V   P +RV A+K +  N   S+R +I    E  ++++ N  
Sbjct: 19  ELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTV--NEAASMRERIEFLNEASVMKEFNCH 75
Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGA------HIRQEHILS--------DLARQVL 203
           +VV+   +  +     V++E M  G L+         +    +L+         +A ++ 
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMS 261
            G+AYL+  K VHRD+   N  +     VKI DFG++R + +T        G   + +MS
Sbjct: 136 DGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 195
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEF-YLGRFPF-AVGRQGDWASLMFAICFAQPP 319
           PE     L  G +  Y+ D+WS GV + E   L   P+  +  +     +M      +P 
Sbjct: 196 PE----SLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 250
Query: 320 EAPEMASREFRDFISRCLQKDPHSR 344
             P+M      + +  C Q +P  R
Sbjct: 251 NCPDM----LLELMRMCWQYNPKMR 271

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/263 (24%), Positives = 113/263 (42%), Gaps = 26/263 (9%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALK-VIYGNHEDSVR-----SQICREIEILRD 153
           E++   +IG G  G V +        V A+K +I G+ E          +  RE+ I+ +
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEYMDGGS-----LEGAHIRQEHILSDLARQVLSGLAY 208
           +NHPN+VK + +   +    +++E++  G      L+ AH  +  +   L   +  G+ Y
Sbjct: 80  LNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 209 LHKRK--IVHRDIKPSNLLI-----NSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           +  +   IVHRD++  N+ +     N+    K+ADFG+S+   Q++   +  +G   +M+
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---QSVHSVSGLLGNFQWMA 194
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I  +     Y   A D +S  + +     G  PF     G    +         P  
Sbjct: 195 PETIGAE--EESYTEKA-DTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251
Query: 322 PEMASREFRDFISRCLQKDPHSR 344
           PE      R+ I  C   DP  R
Sbjct: 252 PEDCPPRLRNVIELCWSGDPKKR 274

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 66
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 124
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 182
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    + D   +   + F Q    
Sbjct: 183 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFFRQ---- 230
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
               S E +  I  CL   P  R    ++  HP++
Sbjct: 231 --RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 31  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 88
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 89  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 146
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 147 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 204
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    + D   +   + F Q    
Sbjct: 205 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFFRQ---- 252
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
               S E +  I  CL   P  R    ++  HP++
Sbjct: 253 --RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 285

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 66
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 124
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 125 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 182
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    + D   +   + F Q    
Sbjct: 183 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFFRQ---- 230
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
               S E +  I  CL   P  R    ++  HP++
Sbjct: 231 --RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 119/246 (48%), Gaps = 40/246 (16%)
Query: 147 EIEILRDVN-HPNVVK--CHDMYDR---------NGEIEVLLEYMDGGSLEGAHIRQEHI 194
           EI++L + + HPNV++  C +  DR         N  ++ L+E  +    E   +++E+ 
Sbjct: 58  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSD-ENLKLQKEYN 116
Query: 195 LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK-------------NVKIADFGVSR 241
              L RQ+ SG+A+LH  KI+HRD+KP N+L+++S               + I+DFG+ +
Sbjct: 117 PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 242 ILAQTMDP----CNSAVGTIAYMSPERI--NTDLNHGKYDGYAGDIWSLGVSILEFYL-- 293
            L           N+  GT  + +PE +  + +L   +    + DI+S+G     +Y+  
Sbjct: 177 KLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF--YYILS 234
Query: 294 -GRFPFA--VGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQL 350
            G+ PF     R+ +    +F++   +      + + E  D IS+ +  DP  R  A ++
Sbjct: 235 KGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIA-EATDLISQMIDHDPLKRPTAMKV 293
Query: 351 LQHPFI 356
           L+HP  
Sbjct: 294 LRHPLF 299

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 7   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 64
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 65  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 122
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 123 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 180
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    + D   +   + F Q    
Sbjct: 181 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFFRQ---- 228
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
               S E +  I  CL   P  R    ++  HP++
Sbjct: 229 --RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 261

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/263 (24%), Positives = 112/263 (42%), Gaps = 26/263 (9%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALK-VIYGNHEDSVR-----SQICREIEILRD 153
           E++   +IG G  G V +        V A+K +I G+ E          +  RE+ I+ +
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEYMDGGS-----LEGAHIRQEHILSDLARQVLSGLAY 208
           +NHPN+VK + +   +    +++E++  G      L+ AH  +  +   L   +  G+ Y
Sbjct: 80  LNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 209 LHKRK--IVHRDIKPSNLLI-----NSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           +  +   IVHRD++  N+ +     N+    K+ADFG S+   Q++   +  +G   +M+
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ---QSVHSVSGLLGNFQWMA 194
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I  +     Y   A D +S  + +     G  PF     G    +         P  
Sbjct: 195 PETIGAE--EESYTEKA-DTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251
Query: 322 PEMASREFRDFISRCLQKDPHSR 344
           PE      R+ I  C   DP  R
Sbjct: 252 PEDCPPRLRNVIELCWSGDPKKR 274

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   + SG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 18  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 77
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++++ M  G L   ++R+         L +   Q+  
Sbjct: 78  MASVDNPHVCRLLGIC-LTSTVQLIMQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 135
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 196 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 227

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 61
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 119
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 177
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    + D   +   + F Q    
Sbjct: 178 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFFRQ---- 225
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
               S E +  I  CL   P  R    ++  HP++
Sbjct: 226 --RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 118/275 (42%), Gaps = 37/275 (13%)
Query: 99  AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEIL 151
           ++ Q G  +GSG  G+V+  +    +   A+K +       +G   +  R  +  E+ +L
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR--VPMEVVLL 61
Query: 152 RDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQEHILSDLARQV 202
           + V+     V++  D ++R     ++LE         D  +  GA   QE +      QV
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQV 119
Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           L  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSP 177
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I     + +Y G +  +WSLG+ + +   G  PF    +     + F          
Sbjct: 178 PEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR--------- 224
Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +  S E +  I  CL   P  R    ++  HP++
Sbjct: 225 -QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 103/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++ + M  G L   ++R+         L +   Q+  
Sbjct: 73  MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 130
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG +++L       ++  G   I +M+ 
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 191 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 103/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 18  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 77
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++ + M  G L   ++R+         L +   Q+  
Sbjct: 78  MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 135
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG +++L       ++  G   I +M+ 
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 196 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 227

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 103/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   +GSG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++ + M  G L   ++R+         L +   Q+  
Sbjct: 71  MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 128
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG +++L       ++  G   I +M+ 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 189 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 220

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 122/281 (43%), Gaps = 42/281 (14%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILR--DVNHPNVVKCH 163
           R+G GS G V R+    T    A+K         VR ++ R  E++    +  P +V  +
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVK--------KVRLEVFRAEELMACAGLTSPRIVPLY 151
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRD 218
                   + + +E ++GGSL G  ++++  L +        Q L GL YLH R+I+H D
Sbjct: 152 GAVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGD 210
Query: 219 IKPSNLLINS-SKNVKIADFGVSRI-----LAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           +K  N+L++S   +  + DFG +       L +++   +   GT  +M+PE +      G
Sbjct: 211 VKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVL-----G 265
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP--EAPEMASREFR 330
           +      D+WS    +L    G  P+    +G    L   I    PP  E P   +    
Sbjct: 266 RSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRG---PLCLKIASEPPPVREIPPSCAPLTA 322
Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQI 371
             I   L+K+P  R  AA+L            +VN+ L+Q+
Sbjct: 323 QAIQEGLRKEPIHRVSAAEL----------GGKVNRALQQV 353

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 142 SQICREIEILRDVNHPNVVKCHDMYDRN-GEIEVLLEYMDGGSLEGAHIRQEH--ILSDL 198
           SQ   E  I++D +HPNV+    +  R+ G   V+L YM  G L      + H   + DL
Sbjct: 135 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 194
Query: 199 ---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAV 254
                QV  G+ +L  +K VHRD+   N +++    VK+ADFG++R +  +  D  ++  
Sbjct: 195 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 254
Query: 255 GT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           G    + +M+ E + T     K      D+WS GV + E 
Sbjct: 255 GAKLPVKWMALESLQTQKFTTK-----SDVWSFGVLLWEL 289

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 142 SQICREIEILRDVNHPNVVKCHDMYDRN-GEIEVLLEYMDGGSLEGAHIRQEH--ILSDL 198
           SQ   E  I++D +HPNV+    +  R+ G   V+L YM  G L      + H   + DL
Sbjct: 76  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 135
Query: 199 ---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAV 254
                QV  G+ +L  +K VHRD+   N +++    VK+ADFG++R +  +  D  ++  
Sbjct: 136 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 195
Query: 255 GT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           G    + +M+ E + T     K      D+WS GV + E 
Sbjct: 196 GAKLPVKWMALESLQTQKFTTK-----SDVWSFGVLLWEL 230

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 142 SQICREIEILRDVNHPNVVKCHDMYDRN-GEIEVLLEYMDGGSLEGAHIRQEH--ILSDL 198
           SQ   E  I++D +HPNV+    +  R+ G   V+L YM  G L      + H   + DL
Sbjct: 81  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 140
Query: 199 ---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAV 254
                QV  G+ +L  +K VHRD+   N +++    VK+ADFG++R +  +  D  ++  
Sbjct: 141 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 200
Query: 255 GT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           G    + +M+ E + T     K      D+WS GV + E 
Sbjct: 201 GAKLPVKWMALESLQTQKFTTK-----SDVWSFGVLLWEL 235

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 142 SQICREIEILRDVNHPNVVKCHDMYDRN-GEIEVLLEYMDGGSLEGAHIRQEH--ILSDL 198
           SQ   E  I++D +HPNV+    +  R+ G   V+L YM  G L      + H   + DL
Sbjct: 76  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 135
Query: 199 ---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAV 254
                QV  G+ +L  +K VHRD+   N +++    VK+ADFG++R +  +  D  ++  
Sbjct: 136 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 195
Query: 255 GT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           G    + +M+ E + T     K      D+WS GV + E 
Sbjct: 196 GAKLPVKWMALESLQTQKFTTK-----SDVWSFGVLLWEL 230

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 142 SQICREIEILRDVNHPNVVKCHDMYDRN-GEIEVLLEYMDGGSLEGAHIRQEH--ILSDL 198
           SQ   E  I++D +HPNV+    +  R+ G   V+L YM  G L      + H   + DL
Sbjct: 74  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 133
Query: 199 ---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAV 254
                QV  G+ +L  +K VHRD+   N +++    VK+ADFG++R +  +  D  ++  
Sbjct: 134 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 193
Query: 255 GT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           G    + +M+ E + T     K      D+WS GV + E 
Sbjct: 194 GAKLPVKWMALESLQTQKFTTK-----SDVWSFGVLLWEL 228

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 142 SQICREIEILRDVNHPNVVKCHDMYDRN-GEIEVLLEYMDGGSLEGAHIRQEH--ILSDL 198
           SQ   E  I++D +HPNV+    +  R+ G   V+L YM  G L      + H   + DL
Sbjct: 77  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 136
Query: 199 ---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAV 254
                QV  G+ +L  +K VHRD+   N +++    VK+ADFG++R +  +  D  ++  
Sbjct: 137 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 196
Query: 255 GT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           G    + +M+ E + T     K      D+WS GV + E 
Sbjct: 197 GAKLPVKWMALESLQTQKFTTK-----SDVWSFGVLLWEL 231

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 21/232 (9%)
Query: 125 RVFALKVIYGN-HEDSV-RSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGG 182
           R+ ALK+       D V R++  RE      +  P+VV  HD  + +G++ V    ++G 
Sbjct: 60  RIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGV 119
Query: 183 SLEGAHIRQEHILS-----DLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADF 237
            L  A +R++  L+      + RQ+ S L   H     HRD+KP N+L+++     + DF
Sbjct: 120 DL-AAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDF 178
Query: 238 GV-SRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRF 296
           G+ S    + +    + VGT+ Y +PER +   +H     Y  DI++L   + E   G  
Sbjct: 179 GIASATTDEKLTQLGNTVGTLYYXAPERFSE--SHAT---YRADIYALTCVLYECLTGSP 233
Query: 297 PFAVGRQGDWASLMFA---ICFAQPPEAPEMASREFRDFISRCLQKDPHSRW 345
           P+    QGD  S+  A       +P          F   I+R   K+P  R+
Sbjct: 234 PY----QGDQLSVXGAHINQAIPRPSTVRPGIPVAFDAVIARGXAKNPEDRY 281

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 103/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   + SG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 11  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++ + M  G L   ++R+         L +   Q+  
Sbjct: 71  MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 128
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 189 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 118/244 (48%), Gaps = 40/244 (16%)
Query: 147 EIEILRDVN-HPNVVK--CHDMYDR---------NGEIEVLLEYMDGGSLEGAHIRQEHI 194
           EI++L + + HPNV++  C +  DR         N  ++ L+E  +  S E   +++E+ 
Sbjct: 76  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNV-SDENLKLQKEYN 134
Query: 195 LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK-------------NVKIADFGVSR 241
              L RQ+ SG+A+LH  KI+HRD+KP N+L+++S               + I+DFG+ +
Sbjct: 135 PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 194
Query: 242 ILAQTMDP----CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL---G 294
            L           N+  GT  + +PE +    +  +    + DI+S+G     +Y+   G
Sbjct: 195 KLDSGQXXFRXNLNNPSGTSGWRAPELLEE--STKRRLTRSIDIFSMGCVF--YYILSKG 250
Query: 295 RFPFA--VGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
           + PF     R+ +    +F++   +      + + E  D IS+ +  DP  R  A ++L+
Sbjct: 251 KHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIA-EATDLISQMIDHDPLKRPTAMKVLR 309
Query: 353 HPFI 356
           HP  
Sbjct: 310 HPLF 313

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 103/217 (47%), Gaps = 20/217 (9%)
Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEI 150
           ++   E +K   + SG+ GTV++ +  P         A+K +          +I  E  +
Sbjct: 18  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 77
Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLS 204
           +  V++P+V +   +      ++++ + M  G L   ++R+         L +   Q+  
Sbjct: 78  MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 135
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++  G   I +M+ 
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 195
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
           E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 196 ESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 227

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 118/244 (48%), Gaps = 40/244 (16%)
Query: 147 EIEILRDVN-HPNVVK--CHDMYDR---------NGEIEVLLEYMDGGSLEGAHIRQEHI 194
           EI++L + + HPNV++  C +  DR         N  ++ L+E  +  S E   +++E+ 
Sbjct: 76  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNV-SDENLKLQKEYN 134
Query: 195 LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK-------------NVKIADFGVSR 241
              L RQ+ SG+A+LH  KI+HRD+KP N+L+++S               + I+DFG+ +
Sbjct: 135 PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 194
Query: 242 ILAQTMDP----CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL---G 294
            L           N+  GT  + +PE +    +  +    + DI+S+G     +Y+   G
Sbjct: 195 KLDSGQXXFRXNLNNPSGTSGWRAPELLEE--STKRRLTRSIDIFSMGCVF--YYILSKG 250
Query: 295 RFPFA--VGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
           + PF     R+ +    +F++   +      + + E  D IS+ +  DP  R  A ++L+
Sbjct: 251 KHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIA-EATDLISQMIDHDPLKRPTAMKVLR 309
Query: 353 HPFI 356
           HP  
Sbjct: 310 HPLF 313

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 121/281 (43%), Gaps = 42/281 (14%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILR--DVNHPNVVKCH 163
           R+G GS G V R+    T    A+K         VR ++ R  E++    +  P +V  +
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVK--------KVRLEVFRAEELMACAGLTSPRIVPLY 132
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRD 218
                   + + +E ++GGSL G  ++++  L +        Q L GL YLH R+I+H D
Sbjct: 133 GAVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGD 191
Query: 219 IKPSNLLINS-SKNVKIADFGVSRI-----LAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           +K  N+L++S   +  + DFG +       L + +   +   GT  +M+PE +      G
Sbjct: 192 VKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVL-----G 246
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP--EAPEMASREFR 330
           +      D+WS    +L    G  P+    +G    L   I    PP  E P   +    
Sbjct: 247 RSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRG---PLCLKIASEPPPVREIPPSCAPLTA 303
Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQI 371
             I   L+K+P  R  AA+L            +VN+ L+Q+
Sbjct: 304 QAIQEGLRKEPIHRVSAAEL----------GGKVNRALQQV 334

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 29/195 (14%)
Query: 128 ALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG 186
           A+K++  +  +   S +  E+E+++ +  H N++       ++G + V++EY   G+L  
Sbjct: 64  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 123
Query: 187 ----------------AHIRQEHI----LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI 226
                           +H  +E +    L   A QV  G+ YL  +K +HRD+   N+L+
Sbjct: 124 YLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 183
Query: 227 NSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSL 284
                +KIADFG++R +        +  G   + +M+PE +       +   +  D+WS 
Sbjct: 184 TEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEAL-----FDRIYTHQSDVWSF 238
Query: 285 GVSILE-FYLGRFPF 298
           GV + E F LG  P+
Sbjct: 239 GVLLWEIFTLGGSPY 253

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 112/263 (42%), Gaps = 26/263 (9%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALK-VIYGNHEDSVR-----SQICREIEILRD 153
           E++   +IG G  G V +        V A+K +I G+ E          +  RE+ I+ +
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEYMDGGS-----LEGAHIRQEHILSDLARQVLSGLAY 208
           +NHPN+VK + +   +    +++E++  G      L+ AH  +  +   L   +  G+ Y
Sbjct: 80  LNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 209 LHKRK--IVHRDIKPSNLLI-----NSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           +  +   IVHRD++  N+ +     N+    K+ADF +S+   Q++   +  +G   +M+
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ---QSVHSVSGLLGNFQWMA 194
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE I  +     Y   A D +S  + +     G  PF     G    +         P  
Sbjct: 195 PETIGAE--EESYTEKA-DTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251
Query: 322 PEMASREFRDFISRCLQKDPHSR 344
           PE      R+ I  C   DP  R
Sbjct: 252 PEDCPPRLRNVIELCWSGDPKKR 274

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           +N  EL+    IG G  G V  ++        A+K I     D+       E  ++  + 
Sbjct: 3   LNMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCI---KNDATAQAFLAEASVMTQLR 57
Query: 156 HPNVVKCHD-MYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAY 208
           H N+V+    + +  G + ++ EYM  GSL       G  +     L   +  V   + Y
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
           L     VHRD+   N+L++     K++DFG+++  + T D     V    + +PE +   
Sbjct: 118 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALRE- 173
Query: 269 LNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
               K      D+WS G+ + E Y  GR P+
Sbjct: 174 ----KKFSTKSDVWSFGILLWEIYSFGRVPY 200

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           +N  EL+    IG G  G V  ++        A+K I     D+       E  ++  + 
Sbjct: 9   LNMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCI---KNDATAQAFLAEASVMTQLR 63
Query: 156 HPNVVKCHD-MYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAY 208
           H N+V+    + +  G + ++ EYM  GSL       G  +     L   +  V   + Y
Sbjct: 64  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 123
Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
           L     VHRD+   N+L++     K++DFG+++  + T D     V    + +PE +   
Sbjct: 124 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREA 180
Query: 269 LNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
               K      D+WS G+ + E Y  GR P+
Sbjct: 181 AFSTK-----SDVWSFGILLWEIYSFGRVPY 206

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           +N  EL+    IG G  G V  ++        A+K I     D+       E  ++  + 
Sbjct: 18  LNMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCI---KNDATAQAFLAEASVMTQLR 72
Query: 156 HPNVVKCHD-MYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAY 208
           H N+V+    + +  G + ++ EYM  GSL       G  +     L   +  V   + Y
Sbjct: 73  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
           L     VHRD+   N+L++     K++DFG+++  + T D     V    + +PE +   
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREK 189
Query: 269 LNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
               K      D+WS G+ + E Y  GR P+
Sbjct: 190 KFSTK-----SDVWSFGILLWEIYSFGRVPY 215

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           +N  EL+    IG G  G V  ++        A+K I     D+       E  ++  + 
Sbjct: 190 LNMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCI---KNDATAQAFLAEASVMTQLR 244
Query: 156 HPNVVKCHD-MYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAY 208
           H N+V+    + +  G + ++ EYM  GSL       G  +     L   +  V   + Y
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
           L     VHRD+   N+L++     K++DFG+++  + T D     V    + +PE +   
Sbjct: 305 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREK 361
Query: 269 LNHGKYDGYAGDIWSLGVSILEFY-LGRFPF 298
               K      D+WS G+ + E Y  GR P+
Sbjct: 362 KFSTK-----SDVWSFGILLWEIYSFGRVPY 387

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 104/231 (45%), Gaps = 38/231 (16%)
Query: 100 ELQKGNRIGSGSGGTVWRVV-------HPPTSRVFALKVIYGNHEDSVRSQICREIEILR 152
           +L  G  +G G+ G V            P  +   A+K++  +  +   S +  E+E+++
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 153 DV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR------------------QEH 193
            +  H N++       ++G + V++EY   G+L   ++R                  ++ 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR-EYLRARRPPGMEYSYDINRVPEEQM 154
Query: 194 ILSDLAR---QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
              DL     Q+  G+ YL  +K +HRD+   N+L+  +  +KIADFG++R +       
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 251 NSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
           N+  G   + +M+PE +       +   +  D+WS GV + E F LG  P+
Sbjct: 215 NTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 79/343 (23%), Positives = 139/343 (40%), Gaps = 94/343 (27%)
Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVI-----YGNHEDSVRSQICREIEILRDVNHPN 158
           G  +G+GS G V  V    + + FALK +     Y N          RE++I++ ++H N
Sbjct: 12  GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN----------RELDIMKVLDHVN 61
Query: 159 VVKCHDMYDRNGEIE--------------------------------------VLLEYMD 180
           ++K  D +   G+ E                                      V++EY+ 
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 181 GG--SLEGAHIRQ-----EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN-V 232
                +  + IR       +++S    Q+   + ++H   I HRDIKP NLL+NS  N +
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181
Query: 233 KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY 292
           K+ DFG ++ L  + +P  + + +  Y +PE +   L   +Y   + D+WS+G    E  
Sbjct: 182 KLCDFGSAKKLIPS-EPSVAXICSRFYRAPELM---LGATEYTP-SIDLWSIGCVFGELI 236
Query: 293 LGRFPFAVGRQGDWASLMFAICFAQPPEA-------------PEMASREFR--------- 330
           LG+  F+     D    +  I      E              P + ++++R         
Sbjct: 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPS 296
Query: 331 ---DFISRCLQKDPHSRWPAAQLLQHPFI--LR-AGQSQVNQN 367
              D + + L+ +P  R    + + HPF   LR + +S+V  N
Sbjct: 297 LAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNN 339

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 23/225 (10%)
Query: 95  LINPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGN--HEDSVRSQICREI 148
           LI   +L+   ++G GS G V    W      T  V A+K +  +   +        RE+
Sbjct: 14  LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREV 72
Query: 149 EILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHIL----SDLARQVL 203
             +  ++H N+++ + +      ++++ E    GSL +     Q H L    S  A QV 
Sbjct: 73  NAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYM 260
            G+ YL  ++ +HRD+   NLL+ +   VKI DFG+ R L Q  D            A+ 
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 191
Query: 261 SPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQG 304
           +PE + T     +   +A D W  GV++ E F  G+ P+ +G  G
Sbjct: 192 APESLKT-----RTFSHASDTWMFGVTLWEMFTYGQEPW-IGLNG 230

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 120/281 (42%), Gaps = 35/281 (12%)
Query: 101 LQKGNRIGSGSGGTV-----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV- 154
           L+ G  +G G+ G V     + +    T R  A+K++      S    +  E++IL  + 
Sbjct: 31  LKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIG 90
Query: 155 NHPNVVKCHDMYDR-NGEIEVLLEYMDGGSL---------EGAHIRQEHILSDL------ 198
           +H NVV       +  G + V++E+   G+L         E    + E +  D       
Sbjct: 91  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHL 150
Query: 199 ---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC--NSA 253
              + QV  G+ +L  RK +HRD+   N+L++    VKI DFG++R + +  D      A
Sbjct: 151 IXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFA 312
              + +M+PE I       +      D+WS GV + E F LG  P+  G + D       
Sbjct: 211 RLPLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKID-EEFCRR 263
Query: 313 ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
           +       AP+  + E    +  C   +P  R   ++L++H
Sbjct: 264 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 142 SQICREIEILRDVNHPNVVKCHDMYDRN-GEIEVLLEYMDGGSLEGAHIRQEH--ILSDL 198
           SQ   E  I++D +HPNV+    +  R+ G   V+L YM  G L      + H   + DL
Sbjct: 75  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 134
Query: 199 ---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAV 254
                QV  G+ YL  +K VHRD+   N +++    VK+ADFG++R +  +     ++  
Sbjct: 135 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKT 194
Query: 255 GT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           G    + +M+ E + T     K      D+WS GV + E 
Sbjct: 195 GAKLPVKWMALESLQTQKFTTK-----SDVWSFGVLLWEL 229

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 115/267 (43%), Gaps = 42/267 (15%)
Query: 106 RIGSGSGGTVWR-----VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHPN 158
            +G GS G V+      ++        A+K +  N   S+R +I    E  +++     +
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHH 81
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR-----------------QEHILSDLARQ 201
           VV+   +  +     V++E M  G L+ +++R                 QE I   +A +
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLK-SYLRSLRPEAENNPGRPPPTLQEMI--QMAAE 138
Query: 202 VLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAY 259
           +  G+AYL+ +K VHRD+   N ++     VKI DFG++R + +T        G   + +
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 260 MSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF-AVGRQGDWASLMFAICFAQ 317
           M+PE     L  G +   + D+WS GV + E   L   P+  +  +     +M      Q
Sbjct: 199 MAPE----SLKDGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ 253
Query: 318 PPEAPEMASREFRDFISRCLQKDPHSR 344
           P   PE  +    D +  C Q +P+ R
Sbjct: 254 PDNCPERVT----DLMRMCWQFNPNMR 276

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 23/225 (10%)
Query: 95  LINPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGN--HEDSVRSQICREI 148
           LI   +L+   ++G GS G V    W      T  V A+K +  +   +        RE+
Sbjct: 4   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREV 62
Query: 149 EILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHIL----SDLARQVL 203
             +  ++H N+++ + +      ++++ E    GSL +     Q H L    S  A QV 
Sbjct: 63  NAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYM 260
            G+ YL  ++ +HRD+   NLL+ +   VKI DFG+ R L Q  D            A+ 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 181
Query: 261 SPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQG 304
           +PE + T     +   +A D W  GV++ E F  G+ P+ +G  G
Sbjct: 182 APESLKT-----RTFSHASDTWMFGVTLWEMFTYGQEPW-IGLNG 220

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 30/214 (14%)
Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV--NHP 157
           ++Q   +IG G  G VW  +        A+KV +   E S      RE EI + V   H 
Sbjct: 38  QIQMVKQIGKGRYGEVW--MGKWRGEKVAVKVFFTTEEAS----WFRETEIYQTVLMRHE 91
Query: 158 NVVK--CHDMYDRNG--EIEVLLEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYL 209
           N++     D+       ++ ++ +Y + GSL    +   +  + +L  LA   +SGL +L
Sbjct: 92  NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLK-LAYSSVSGLCHL 150
Query: 210 H--------KRKIVHRDIKPSNLLINSSKNVKIADFGVS-RILAQTMD---PCNSAVGTI 257
           H        K  I HRD+K  N+L+  +    IAD G++ + ++ T +   P N+ VGT 
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 258 AYMSPERINTDLNHGKYDGY-AGDIWSLGVSILE 290
            YM PE ++  LN   +  Y   D++S G+ + E
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWE 244

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 23/225 (10%)
Query: 95  LINPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGN--HEDSVRSQICREI 148
           LI   +L+   ++G GS G V    W      T  V A+K +  +   +        RE+
Sbjct: 14  LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREV 72
Query: 149 EILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHIL----SDLARQVL 203
             +  ++H N+++ + +      ++++ E    GSL +     Q H L    S  A QV 
Sbjct: 73  NAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYM 260
            G+ YL  ++ +HRD+   NLL+ +   VKI DFG+ R L Q  D            A+ 
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 261 SPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQG 304
           +PE + T     +   +A D W  GV++ E F  G+ P+ +G  G
Sbjct: 192 APESLKT-----RTFSHASDTWMFGVTLWEMFTYGQEPW-IGLNG 230

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 142 SQICREIEILRDVNHPNVVKCHDMYDRN-GEIEVLLEYMDGGSLEGAHIRQEH--ILSDL 198
           SQ   E  I++D +HPNV+    +  R+ G   V+L YM  G L      + H   + DL
Sbjct: 68  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 127
Query: 199 ---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAV 254
                QV  G+ YL  +K VHRD+   N +++    VK+ADFG++R +  +     ++  
Sbjct: 128 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 187
Query: 255 GT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           G    + +M+ E + T     K      D+WS GV + E 
Sbjct: 188 GAKLPVKWMALESLQTQKFTTK-----SDVWSFGVLLWEL 222

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 23/225 (10%)
Query: 95  LINPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGN--HEDSVRSQICREI 148
           LI   +L+   ++G GS G V    W      T  V A+K +  +   +        RE+
Sbjct: 4   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREV 62
Query: 149 EILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHIL----SDLARQVL 203
             +  ++H N+++ + +      ++++ E    GSL +     Q H L    S  A QV 
Sbjct: 63  NAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYM 260
            G+ YL  ++ +HRD+   NLL+ +   VKI DFG+ R L Q  D            A+ 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 261 SPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQG 304
           +PE + T     +   +A D W  GV++ E F  G+ P+ +G  G
Sbjct: 182 APESLKT-----RTFSHASDTWMFGVTLWEMFTYGQEPW-IGLNG 220

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 114/267 (42%), Gaps = 42/267 (15%)
Query: 106 RIGSGSGGTVWR-----VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHPN 158
            +G GS G V+      ++        A+K +  N   S+R +I    E  +++     +
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHH 78
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR-----------------QEHILSDLARQ 201
           VV+   +  +     V++E M  G L+ +++R                 QE I   +A +
Sbjct: 79  VVRLLGVVSKGQPTLVVMELMAHGDLK-SYLRSLRPEAENNPGRPPPTLQEMI--QMAAE 135
Query: 202 VLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAY 259
           +  G+AYL+ +K VHRD+   N ++     VKI DFG++R + +T        G   + +
Sbjct: 136 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 195
Query: 260 MSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF-AVGRQGDWASLMFAICFAQ 317
           M+PE     L  G +   + D+WS GV + E   L   P+  +  +     +M      Q
Sbjct: 196 MAPE----SLKDGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ 250
Query: 318 PPEAPEMASREFRDFISRCLQKDPHSR 344
           P   PE  +    D +  C Q +P  R
Sbjct: 251 PDNCPERVT----DLMRMCWQFNPKMR 273

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 108/252 (42%), Gaps = 22/252 (8%)
Query: 105 NRI-GSGSGGTVWRVV---HPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           NRI G G  G V+  V   H       A+K    +     + +   E  I+++++HP++V
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDL-----ARQVLSGLAYLHKRKIV 215
           K   + +      +++E    G L     R ++ L  L     + Q+   +AYL     V
Sbjct: 89  KLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCV 147
Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSPERINTDLNHGK 273
           HRDI   N+L+ S + VK+ DFG+SR + +  D   ++V    I +MSPE IN      +
Sbjct: 148 HRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINF-----R 201
Query: 274 YDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
               A D+W   V + E    G+ PF      D   ++           P++        
Sbjct: 202 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK---GDRLPKPDLCPPVLYTL 258
Query: 333 ISRCLQKDPHSR 344
           ++RC   DP  R
Sbjct: 259 MTRCWDYDPSDR 270

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 40/229 (17%)
Query: 98  PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNH 156
           P   +  + IG GS G V+       ++  A+K +    ED +  + I REI IL  +  
Sbjct: 27  PDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 86
Query: 157 PNVVKCHDMYD-----RNGEIEVLLEYMDGGSLE----GAHIRQEHILSDLARQVLSGLA 207
             +++ HD+       +  E+ ++LE  D    +       + ++H+ + L   +L G  
Sbjct: 87  DYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILY-NLLLGEK 145
Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-----------------PC 250
           ++H+  I+HRD+KP+N L+N   +VKI DFG++R +    D                 P 
Sbjct: 146 FIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPH 205
Query: 251 N--------SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           N        S V T  Y +PE I    N+      + DIWS G    E 
Sbjct: 206 NKNLKKQLTSHVVTRWYRAPELILLQENYTN----SIDIWSTGCIFAEL 250

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 100 ELQKGNRIGSGSGGTVWRVV-------HPPTSRVFALKVIYGNHEDSVRSQICREIEILR 152
           +L  G  +G G+ G V            P  +   A+K++  +  +   S +  E+E+++
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 153 DV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR------------------QEH 193
            +  H N++       ++G + V++EY   G+L   ++R                  ++ 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR-EYLRARRPPGMEXSYDINRVPEEQM 154
Query: 194 ILSDLAR---QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
              DL     Q+  G+ YL  +K +HRD+   N+L+  +  +KIADFG++R +       
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXK 214
Query: 251 NSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
            +  G   + +M+PE +       +   +  D+WS GV + E F LG  P+
Sbjct: 215 KTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 100 ELQKGNRIGSGSGGTVWRVV-------HPPTSRVFALKVIYGNHEDSVRSQICREIEILR 152
           +L  G  +G G+ G V            P  +   A+K++  +  +   S +  E+E+++
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 153 DV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR------------------QEH 193
            +  H N++       ++G + V++EY   G+L   ++R                  ++ 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR-EYLRARRPPGMEYSYDINRVPEEQM 154
Query: 194 ILSDLAR---QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
              DL     Q+  G+ YL  +K +HRD+   N+L+  +  +KIADFG++R +       
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXK 214
Query: 251 NSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
            +  G   + +M+PE +       +   +  D+WS GV + E F LG  P+
Sbjct: 215 KTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 81/168 (48%), Gaps = 13/168 (7%)
Query: 189 IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD 248
           I  E ++S  + QV  G+ +L  RK +HRD+   N+L++ +  VKI DFG++R + +  D
Sbjct: 196 ITMEDLIS-YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPD 254
Query: 249 PCNSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF-AVGRQG 304
                     + +M+PE I   +   K      D+WS GV + E F LG  P+  V    
Sbjct: 255 YVRKGDTRLPLKWMAPESIFDKIYSTK-----SDVWSYGVLLWEIFSLGGSPYPGVQMDE 309
Query: 305 DWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
           D+ S +          APE ++ E    +  C  +DP  R   A+L++
Sbjct: 310 DFCSRLRE---GMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVE 354

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 114/267 (42%), Gaps = 42/267 (15%)
Query: 106 RIGSGSGGTVWR-----VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHPN 158
            +G GS G V+      ++        A+K +  N   S+R +I    E  +++     +
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHH 81
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR-----------------QEHILSDLARQ 201
           VV+   +  +     V++E M  G L+ +++R                 QE I   +A +
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLK-SYLRSLRPEAENNPGRPPPTLQEMI--QMAAE 138
Query: 202 VLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAY 259
           +  G+AYL+ +K VHRD+   N ++     VKI DFG++R + +T        G   + +
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 260 MSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF-AVGRQGDWASLMFAICFAQ 317
           M+PE     L  G +   + D+WS GV + E   L   P+  +  +     +M      Q
Sbjct: 199 MAPE----SLKDGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ 253
Query: 318 PPEAPEMASREFRDFISRCLQKDPHSR 344
           P   PE  +    D +  C Q +P  R
Sbjct: 254 PDNCPERVT----DLMRMCWQFNPKMR 276

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 29/195 (14%)
Query: 128 ALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG 186
           A+K++  +  +   S +  E+E+++ +  H N++       ++G + V++EY   G+L  
Sbjct: 49  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 108
Query: 187 ----------------AHIRQEHI----LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI 226
                           +H  +E +    L   A QV  G+ YL  +K +HRD+   N+L+
Sbjct: 109 YLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168
Query: 227 NSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSL 284
                +KIADFG++R +        +  G   + +M+PE +       +   +  D+WS 
Sbjct: 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-----FDRIYTHQSDVWSF 223
Query: 285 GVSILE-FYLGRFPF 298
           GV + E F LG  P+
Sbjct: 224 GVLLWEIFTLGGSPY 238

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 29/195 (14%)
Query: 128 ALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG 186
           A+K++  +  +   S +  E+E+++ +  H N++       ++G + V++EY   G+L  
Sbjct: 57  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 116
Query: 187 ----------------AHIRQEHI----LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI 226
                           +H  +E +    L   A QV  G+ YL  +K +HRD+   N+L+
Sbjct: 117 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 176
Query: 227 NSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSL 284
                +KIADFG++R +        +  G   + +M+PE +       +   +  D+WS 
Sbjct: 177 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-----FDRIYTHQSDVWSF 231
Query: 285 GVSILE-FYLGRFPF 298
           GV + E F LG  P+
Sbjct: 232 GVLLWEIFTLGGSPY 246

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 142 SQICREIEILRDVNHPNVVKCHDMYDRN-GEIEVLLEYMDGGSLEGAHIRQEH--ILSDL 198
           SQ   E  I++D +HPNV+    +  R+ G   V+L YM  G L      + H   + DL
Sbjct: 95  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 154
Query: 199 ---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAV 254
                QV  G+ YL  +K VHRD+   N +++    VK+ADFG++R +  +     ++  
Sbjct: 155 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 214
Query: 255 GT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           G    + +M+ E + T     K      D+WS GV + E 
Sbjct: 215 GAKLPVKWMALESLQTQKFTTK-----SDVWSFGVLLWEL 249

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 29/195 (14%)
Query: 128 ALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG 186
           A+K++  +  +   S +  E+E+++ +  H N++       ++G + V++EY   G+L  
Sbjct: 53  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 112
Query: 187 ----------------AHIRQEHI----LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI 226
                           +H  +E +    L   A QV  G+ YL  +K +HRD+   N+L+
Sbjct: 113 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 172
Query: 227 NSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSL 284
                +KIADFG++R +        +  G   + +M+PE +       +   +  D+WS 
Sbjct: 173 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-----FDRIYTHQSDVWSF 227
Query: 285 GVSILE-FYLGRFPF 298
           GV + E F LG  P+
Sbjct: 228 GVLLWEIFTLGGSPY 242

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 23/225 (10%)
Query: 95  LINPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGN--HEDSVRSQICREI 148
           LI   +L+   ++G GS G V    W      T  V A+K +  +   +        RE+
Sbjct: 8   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREV 66
Query: 149 EILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHIL----SDLARQVL 203
             +  ++H N+++ + +      ++++ E    GSL +     Q H L    S  A QV 
Sbjct: 67  NAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 125
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYM 260
            G+ YL  ++ +HRD+   NLL+ +   VKI DFG+ R L Q  D            A+ 
Sbjct: 126 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 261 SPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQG 304
           +PE + T     +   +A D W  GV++ E F  G+ P+ +G  G
Sbjct: 186 APESLKT-----RTFSHASDTWMFGVTLWEMFTYGQEPW-IGLNG 224

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 23/225 (10%)
Query: 95  LINPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGN--HEDSVRSQICREI 148
           LI   +L+   ++G GS G V    W      T  V A+K +  +   +        RE+
Sbjct: 4   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREV 62
Query: 149 EILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHIL----SDLARQVL 203
             +  ++H N+++ + +      ++++ E    GSL +     Q H L    S  A QV 
Sbjct: 63  NAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYM 260
            G+ YL  ++ +HRD+   NLL+ +   VKI DFG+ R L Q  D            A+ 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 261 SPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQG 304
           +PE + T     +   +A D W  GV++ E F  G+ P+ +G  G
Sbjct: 182 APESLKT-----RTFSHASDTWMFGVTLWEMFTYGQEPW-IGLNG 220

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 142 SQICREIEILRDVNHPNVVKCHDMYDRN-GEIEVLLEYMDGGSLEGAHIRQEH--ILSDL 198
           SQ   E  I++D +HPNV+    +  R+ G   V+L YM  G L      + H   + DL
Sbjct: 76  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 135
Query: 199 ---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAV 254
                QV  G+ YL  +K VHRD+   N +++    VK+ADFG++R +  +     ++  
Sbjct: 136 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 195
Query: 255 GT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           G    + +M+ E + T     K      D+WS GV + E 
Sbjct: 196 GAKLPVKWMALESLQTQKFTTK-----SDVWSFGVLLWEL 230

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 29/195 (14%)
Query: 128 ALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG 186
           A+K++  +  +   S +  E+E+++ +  H N++       ++G + V++EY   G+L  
Sbjct: 64  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 123
Query: 187 ----------------AHIRQEHI----LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI 226
                           +H  +E +    L   A QV  G+ YL  +K +HRD+   N+L+
Sbjct: 124 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 183
Query: 227 NSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSL 284
                +KIADFG++R +        +  G   + +M+PE +       +   +  D+WS 
Sbjct: 184 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-----FDRIYTHQSDVWSF 238
Query: 285 GVSILE-FYLGRFPF 298
           GV + E F LG  P+
Sbjct: 239 GVLLWEIFTLGGSPY 253

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 142 SQICREIEILRDVNHPNVVKCHDMYDRN-GEIEVLLEYMDGGSLEGAHIRQEH--ILSDL 198
           SQ   E  I++D +HPNV+    +  R+ G   V+L YM  G L      + H   + DL
Sbjct: 73  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 132
Query: 199 ---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAV 254
                QV  G+ YL  +K VHRD+   N +++    VK+ADFG++R +  +     ++  
Sbjct: 133 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 192
Query: 255 GT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           G    + +M+ E + T     K      D+WS GV + E 
Sbjct: 193 GAKLPVKWMALESLQTQKFTTK-----SDVWSFGVLLWEL 227

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 142 SQICREIEILRDVNHPNVVKCHDMYDRN-GEIEVLLEYMDGGSLEGAHIRQEH--ILSDL 198
           SQ   E  I++D +HPNV+    +  R+ G   V+L YM  G L      + H   + DL
Sbjct: 71  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 130
Query: 199 ---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAV 254
                QV  G+ YL  +K VHRD+   N +++    VK+ADFG++R +  +     ++  
Sbjct: 131 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 190
Query: 255 GT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           G    + +M+ E + T     K      D+WS GV + E 
Sbjct: 191 GAKLPVKWMALESLQTQKFTTK-----SDVWSFGVLLWEL 225

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 29/195 (14%)
Query: 128 ALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG 186
           A+K++  +  +   S +  E+E+++ +  H N++       ++G + V++EY   G+L  
Sbjct: 56  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 115
Query: 187 ----------------AHIRQEHI----LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI 226
                           +H  +E +    L   A QV  G+ YL  +K +HRD+   N+L+
Sbjct: 116 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 175
Query: 227 NSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSL 284
                +KIADFG++R +        +  G   + +M+PE +       +   +  D+WS 
Sbjct: 176 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-----FDRIYTHQSDVWSF 230
Query: 285 GVSILE-FYLGRFPF 298
           GV + E F LG  P+
Sbjct: 231 GVLLWEIFTLGGSPY 245

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 108/252 (42%), Gaps = 22/252 (8%)
Query: 105 NRI-GSGSGGTVWRVV---HPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           NRI G G  G V+  V   H       A+K    +     + +   E  I+++++HP++V
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDL-----ARQVLSGLAYLHKRKIV 215
           K   + +      +++E    G L     R ++ L  L     + Q+   +AYL     V
Sbjct: 73  KLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCV 131
Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSPERINTDLNHGK 273
           HRDI   N+L+ S + VK+ DFG+SR + +  D   ++V    I +MSPE IN      +
Sbjct: 132 HRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINF-----R 185
Query: 274 YDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
               A D+W   V + E    G+ PF      D   ++           P++        
Sbjct: 186 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK---GDRLPKPDLCPPVLYTL 242
Query: 333 ISRCLQKDPHSR 344
           ++RC   DP  R
Sbjct: 243 MTRCWDYDPSDR 254

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 142 SQICREIEILRDVNHPNVVKCHDMYDRN-GEIEVLLEYMDGGSLEGAHIRQEH--ILSDL 198
           SQ   E  I++D +HPNV+    +  R+ G   V+L YM  G L      + H   + DL
Sbjct: 74  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 133
Query: 199 ---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAV 254
                QV  G+ YL  +K VHRD+   N +++    VK+ADFG++R +  +     ++  
Sbjct: 134 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 193
Query: 255 GT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           G    + +M+ E + T     K      D+WS GV + E 
Sbjct: 194 GAKLPVKWMALESLQTQKFTTK-----SDVWSFGVLLWEL 228

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 29/195 (14%)
Query: 128 ALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG 186
           A+K++  +  +   S +  E+E+++ +  H N++       ++G + V++EY   G+L  
Sbjct: 64  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 123
Query: 187 ----------------AHIRQEHI----LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI 226
                           +H  +E +    L   A QV  G+ YL  +K +HRD+   N+L+
Sbjct: 124 YLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 183
Query: 227 NSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSL 284
                +KIADFG++R +        +  G   + +M+PE +       +   +  D+WS 
Sbjct: 184 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-----FDRIYTHQSDVWSF 238
Query: 285 GVSILE-FYLGRFPF 298
           GV + E F LG  P+
Sbjct: 239 GVLLWEIFTLGGSPY 253

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 108/252 (42%), Gaps = 22/252 (8%)
Query: 105 NRI-GSGSGGTVWRVV---HPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           NRI G G  G V+  V   H       A+K    +     + +   E  I+++++HP++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDL-----ARQVLSGLAYLHKRKIV 215
           K   + +      +++E    G L     R ++ L  L     + Q+   +AYL     V
Sbjct: 77  KLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCV 135
Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSPERINTDLNHGK 273
           HRDI   N+L+ S + VK+ DFG+SR + +  D   ++V    I +MSPE IN      +
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINF-----R 189
Query: 274 YDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
               A D+W   V + E    G+ PF      D   ++           P++        
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK---GDRLPKPDLCPPVLYTL 246
Query: 333 ISRCLQKDPHSR 344
           ++RC   DP  R
Sbjct: 247 MTRCWDYDPSDR 258

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 23/225 (10%)
Query: 95  LINPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGN--HEDSVRSQICREI 148
           LI   +L+   ++G GS G V    W      T  V A+K +  +   +        RE+
Sbjct: 8   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREV 66
Query: 149 EILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQEHIL----SDLARQVL 203
             +  ++H N+++ + +      ++++ E    GSL +     Q H L    S  A QV 
Sbjct: 67  NAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 125
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC---NSAVGTIAYM 260
            G+ YL  ++ +HRD+   NLL+ +   VKI DFG+ R L Q  D            A+ 
Sbjct: 126 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 261 SPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQG 304
           +PE + T     +   +A D W  GV++ E F  G+ P+ +G  G
Sbjct: 186 APESLKT-----RTFSHASDTWMFGVTLWEMFTYGQEPW-IGLNG 224

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 29/195 (14%)
Query: 128 ALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG 186
           A+K++  +  +   S +  E+E+++ +  H N++       ++G + V++EY   G+L  
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164
Query: 187 ----------------AHIRQEHI----LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI 226
                           +H  +E +    L   A QV  G+ YL  +K +HRD+   N+L+
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224
Query: 227 NSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSL 284
                +KIADFG++R +        +  G   + +M+PE +       +   +  D+WS 
Sbjct: 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-----FDRIYTHQSDVWSF 279
Query: 285 GVSILE-FYLGRFPF 298
           GV + E F LG  P+
Sbjct: 280 GVLLWEIFTLGGSPY 294

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 29/195 (14%)
Query: 128 ALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG 186
           A+K++  +  +   S +  E+E+++ +  H N++       ++G + V++EY   G+L  
Sbjct: 64  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 123
Query: 187 ----------------AHIRQEHI----LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI 226
                           +H  +E +    L   A QV  G+ YL  +K +HRD+   N+L+
Sbjct: 124 YLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 183
Query: 227 NSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSL 284
                +KIADFG++R +        +  G   + +M+PE +       +   +  D+WS 
Sbjct: 184 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-----FDRIYTHQSDVWSF 238
Query: 285 GVSILE-FYLGRFPF 298
           GV + E F LG  P+
Sbjct: 239 GVLLWEIFTLGGSPY 253

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 142 SQICREIEILRDVNHPNVVKCHDMYDRN-GEIEVLLEYMDGGSLEGAHIRQEH--ILSDL 198
           SQ   E  I++D +HPNV+    +  R+ G   V+L YM  G L      + H   + DL
Sbjct: 94  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 153
Query: 199 ---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAV 254
                QV  G+ YL  +K VHRD+   N +++    VK+ADFG++R +  +     ++  
Sbjct: 154 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 213
Query: 255 GT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           G    + +M+ E + T     K      D+WS GV + E 
Sbjct: 214 GAKLPVKWMALESLQTQKFTTK-----SDVWSFGVLLWEL 248

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 142 SQICREIEILRDVNHPNVVKCHDMYDRN-GEIEVLLEYMDGGSLEGAHIRQEH--ILSDL 198
           SQ   E  I++D +HPNV+    +  R+ G   V+L YM  G L      + H   + DL
Sbjct: 75  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 134
Query: 199 ---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAV 254
                QV  G+ YL  +K VHRD+   N +++    VK+ADFG++R +  +     ++  
Sbjct: 135 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 194
Query: 255 GT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           G    + +M+ E + T     K      D+WS GV + E 
Sbjct: 195 GAKLPVKWMALESLQTQKFTTK-----SDVWSFGVLLWEL 229

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 142 SQICREIEILRDVNHPNVVKCHDMYDRN-GEIEVLLEYMDGGSLEGAHIRQEH--ILSDL 198
           SQ   E  I++D +HPNV+    +  R+ G   V+L YM  G L      + H   + DL
Sbjct: 76  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 135
Query: 199 ---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAV 254
                QV  G+ YL  +K VHRD+   N +++    VK+ADFG++R +  +     ++  
Sbjct: 136 IGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 195
Query: 255 GT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           G    + +M+ E + T     K      D+WS GV + E 
Sbjct: 196 GAKLPVKWMALESLQTQKFTTK-----SDVWSFGVLLWEL 230

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 116/263 (44%), Gaps = 29/263 (11%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK--C 162
            ++G G    V  V        +ALK I   HE   R +  RE ++ R  NHPN+++   
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRIL-CHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 163 HDMYDRNGEIE--VLLEYMDGGSL---------EGAHIRQEHILSDLARQVLSGLAYLHK 211
           + + +R  + E  +LL +   G+L         +G  + ++ IL  L   +  GL  +H 
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW-LLLGICRGLEAIHA 152
Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRIL---------AQTMDPCNSAVGTIAYMSP 262
           +   HRD+KP+N+L+       + D G              A T+    +   TI+Y +P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF-AVGRQGDWASLMFAICFAQPPEA 321
           E  +   +H   D    D+WSLG  +     G  P+  V ++GD  +L      +  P++
Sbjct: 213 ELFSVQ-SHCVIDERT-DVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS-IPQS 269
Query: 322 PEMASREFRDFISRCLQKDPHSR 344
           P  +S  ++  ++  +  DPH R
Sbjct: 270 PRHSSALWQ-LLNSMMTVDPHQR 291

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 114/267 (42%), Gaps = 42/267 (15%)
Query: 106 RIGSGSGGTVWR-----VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHPN 158
            +G GS G V+      ++        A+K +  N   S+R +I    E  +++     +
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHH 81
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR-----------------QEHILSDLARQ 201
           VV+   +  +     V++E M  G L+ +++R                 QE I   +A +
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLK-SYLRSLRPEAENNPGRPPPTLQEMI--QMAAE 138
Query: 202 VLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAY 259
           +  G+AYL+ +K VHRD+   N ++     VKI DFG++R + +T        G   + +
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRW 198
Query: 260 MSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF-AVGRQGDWASLMFAICFAQ 317
           M+PE     L  G +   + D+WS GV + E   L   P+  +  +     +M      Q
Sbjct: 199 MAPE----SLKDGVFTT-SSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ 253
Query: 318 PPEAPEMASREFRDFISRCLQKDPHSR 344
           P   PE  +    D +  C Q +P  R
Sbjct: 254 PDNCPERVT----DLMRMCWQFNPKMR 276

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 28/225 (12%)
Query: 142 SQICREIEILRDVN--HPNVVKCHDMYDRNGEIEVLLE-------YMDGGSLEGAHIRQE 192
           +++  E+ +L+ V+     V++  D ++R     ++LE         D  +  GA   QE
Sbjct: 99  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQE 156
Query: 193 HILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCN 251
            +      QVL  + + H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+    
Sbjct: 157 ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YT 214
Query: 252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMF 311
              GT  Y  PE I     + +Y G +  +WSLG+ + +   G  PF    + D   +  
Sbjct: 215 DFDGTRVYSPPEWI----RYHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRG 266
Query: 312 AICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            + F Q        S E +  I  CL   P  R    ++  HP++
Sbjct: 267 QVFFRQ------RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 41/285 (14%)
Query: 101 LQKGNRIGSGSGGTV-----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV- 154
           L+ G  +G G+ G V     + +    T R  A+K++      S    +  E++IL  + 
Sbjct: 29  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 155 NHPNVVKCHDMYDR-NGEIEVLLEYMDGGSLEGAHIRQ---------------------- 191
           +H NVV       +  G + V++E+   G+L   ++R                       
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 192 EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC- 250
           EH++   + QV  G+ +L  RK +HRD+   N+L++    VKI DFG++R + +  D   
Sbjct: 148 EHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 251 -NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWAS 308
              A   + +M+PE I       +      D+WS GV + E F LG  P+  G + D   
Sbjct: 207 KGDARLPLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKID-EE 259
Query: 309 LMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
               +       AP+  + E    +  C   +P  R   ++L++H
Sbjct: 260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 115/283 (40%), Gaps = 38/283 (13%)
Query: 101 LQKGNRIGSGSGG-----TVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV- 154
           L  G  +G+G+ G     T + ++    +   A+K++  +   + R  +  E+++L  + 
Sbjct: 41  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 100
Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGA--HIRQEHILS---------------- 196
           NH N+V         G   V+ EY   G L       R   I S                
Sbjct: 101 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 160
Query: 197 ----DLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-- 250
                 + QV  G+A+L  +  +HRD+   N+L+   +  KI DFG++R +    +    
Sbjct: 161 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 220
Query: 251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASL 309
            +A   + +M+PE I   +       +  D+WS G+ + E F LG  P+  G   D +  
Sbjct: 221 GNARLPVKWMAPESIFNCVY-----TFESDVWSYGIFLWELFSLGSSPYP-GMPVD-SKF 273
Query: 310 MFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
              I       +PE A  E  D +  C   DP  R    Q++Q
Sbjct: 274 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 316

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 117/251 (46%), Gaps = 22/251 (8%)
Query: 106 RIGSGSGGTVWRVVHP-PTSRVFALKVIYGNHED--SVRSQICREIEILRDVNHPNVVKC 162
            +GSG+ GTV +  +            I  N  +  +++ ++  E  +++ +++P +V+ 
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 163 HDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
             + +    + +++E  + G L     +  H++ ++I+ +L  QV  G+ YL +   VHR
Sbjct: 78  IGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNII-ELVHQVSMGMKYLEESNFVHR 135
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKY 274
           D+   N+L+ +    KI+DFG+S+ L    +   +       + + +PE I    N+ K+
Sbjct: 136 DLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECI----NYYKF 191
Query: 275 DGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                D+WS GV + E F  G+ P+  G +G   + M      +    P    RE  D +
Sbjct: 192 SS-KSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEK--GERMGCPAGCPREMYDLM 247
Query: 334 SRCLQKDPHSR 344
           + C   D  +R
Sbjct: 248 NLCWTYDVENR 258

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 115/283 (40%), Gaps = 38/283 (13%)
Query: 101 LQKGNRIGSGSGG-----TVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV- 154
           L  G  +G+G+ G     T + ++    +   A+K++  +   + R  +  E+++L  + 
Sbjct: 48  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 107
Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGA--HIRQEHILS---------------- 196
           NH N+V         G   V+ EY   G L       R   I S                
Sbjct: 108 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 197 ----DLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-- 250
                 + QV  G+A+L  +  +HRD+   N+L+   +  KI DFG++R +    +    
Sbjct: 168 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVK 227
Query: 251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASL 309
            +A   + +M+PE I   +       +  D+WS G+ + E F LG  P+  G   D +  
Sbjct: 228 GNARLPVKWMAPESIFNCVY-----TFESDVWSYGIFLWELFSLGSSPYP-GMPVD-SKF 280
Query: 310 MFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
              I       +PE A  E  D +  C   DP  R    Q++Q
Sbjct: 281 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 115/283 (40%), Gaps = 38/283 (13%)
Query: 101 LQKGNRIGSGSGG-----TVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV- 154
           L  G  +G+G+ G     T + ++    +   A+K++  +   + R  +  E+++L  + 
Sbjct: 48  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 107
Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGA--HIRQEHILS---------------- 196
           NH N+V         G   V+ EY   G L       R   I S                
Sbjct: 108 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 197 ----DLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-- 250
                 + QV  G+A+L  +  +HRD+   N+L+   +  KI DFG++R +    +    
Sbjct: 168 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 227
Query: 251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASL 309
            +A   + +M+PE I   +       +  D+WS G+ + E F LG  P+  G   D +  
Sbjct: 228 GNARLPVKWMAPESIFNCVY-----TFESDVWSYGIFLWELFSLGSSPYP-GMPVD-SKF 280
Query: 310 MFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
              I       +PE A  E  D +  C   DP  R    Q++Q
Sbjct: 281 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 41/285 (14%)
Query: 101 LQKGNRIGSGSGGTV-----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV- 154
           L+ G  +G G+ G V     + +    T R  A+K++      S    +  E++IL  + 
Sbjct: 20  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 79
Query: 155 NHPNVVKCHDMYDR-NGEIEVLLEYMDGGSLEGAHIRQ---------------------- 191
           +H NVV       +  G + V++E+   G+L   ++R                       
Sbjct: 80  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 192 EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC- 250
           EH++   + QV  G+ +L  RK +HRD+   N+L++    VKI DFG++R + +  D   
Sbjct: 139 EHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 251 -NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWAS 308
              A   + +M+PE I       +      D+WS GV + E F LG  P+  G + D   
Sbjct: 198 KGDARLPLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKID-EE 250
Query: 309 LMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
               +       AP+  + E    +  C   +P  R   ++L++H
Sbjct: 251 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 98/195 (50%), Gaps = 18/195 (9%)
Query: 107 IGSGSGGTVWRVVHPPTSRVF--ALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
           +G G+ G+V + V+    +    A+KV+    E +   ++ RE +I+  +++P +V+   
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHI-RQEHI----LSDLARQVLSGLAYLHKRKIVHRDI 219
           +      + +++E   GG L    + ++E I    +++L  QV  G+ YL ++  VHRD+
Sbjct: 78  VCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 136
Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT----IAYMSPERINTDLNHGKYD 275
              N+L+ +    KI+DFG+S+ L    D   +A       + + +PE IN      +  
Sbjct: 137 AARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPECINFRKFSSR-- 193
Query: 276 GYAGDIWSLGVSILE 290
               D+WS GV++ E
Sbjct: 194 ---SDVWSYGVTMWE 205

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 41/285 (14%)
Query: 101 LQKGNRIGSGSGGTV-----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV- 154
           L+ G  +G G+ G V     + +    T R  A+K++      S    +  E++IL  + 
Sbjct: 29  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 155 NHPNVVKCHDMYDR-NGEIEVLLEYMDGGSLEGAHIRQ---------------------- 191
           +H NVV       +  G + V++E+   G+L   ++R                       
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 192 EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC- 250
           EH++   + QV  G+ +L  RK +HRD+   N+L++    VKI DFG++R + +  D   
Sbjct: 148 EHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVR 206
Query: 251 -NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWAS 308
              A   + +M+PE I       +      D+WS GV + E F LG  P+  G + D   
Sbjct: 207 KGDARLPLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKID-EE 259
Query: 309 LMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
               +       AP+  + E    +  C   +P  R   ++L++H
Sbjct: 260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 117/251 (46%), Gaps = 22/251 (8%)
Query: 106 RIGSGSGGTVWRVVHP-PTSRVFALKVIYGNHED--SVRSQICREIEILRDVNHPNVVKC 162
            +GSG+ GTV +  +            I  N  +  +++ ++  E  +++ +++P +V+ 
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 163 HDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
             + +    + +++E  + G L     +  H++ ++I+ +L  QV  G+ YL +   VHR
Sbjct: 92  IGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNII-ELVHQVSMGMKYLEESNFVHR 149
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKY 274
           D+   N+L+ +    KI+DFG+S+ L    +   +       + + +PE I    N+ K+
Sbjct: 150 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI----NYYKF 205
Query: 275 DGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                D+WS GV + E F  G+ P+  G +G   + M      +    P    RE  D +
Sbjct: 206 SS-KSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEK--GERMGCPAGCPREMYDLM 261
Query: 334 SRCLQKDPHSR 344
           + C   D  +R
Sbjct: 262 NLCWTYDVENR 272

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 121/284 (42%), Gaps = 40/284 (14%)
Query: 101 LQKGNRIGSGSGGTV-----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV- 154
           L  G  +G G+ G V     + +    T R  A+K++      S    +  E++IL  + 
Sbjct: 30  LNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 89
Query: 155 NHPNVVKCHDMYDR-NGEIEVLLEYMDGGSLEGAHIRQ---------------------E 192
           +H NVV       +  G + V++E+   G+L   ++R                      E
Sbjct: 90  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKTPEDLYKDFLTLE 148
Query: 193 HILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-- 250
           H++   + QV  G+ +L  RK +HRD+   N+L++    VKI DFG++R + +  D    
Sbjct: 149 HLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASL 309
             A   + +M+PE I       +      D+WS GV + E F LG  P+  G + D    
Sbjct: 208 GDARLPLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKID-EEF 260
Query: 310 MFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
              +       AP+  + E    +  C   +P  R   ++L++H
Sbjct: 261 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 115/283 (40%), Gaps = 38/283 (13%)
Query: 101 LQKGNRIGSGSGG-----TVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV- 154
           L  G  +G+G+ G     T + ++    +   A+K++  +   + R  +  E+++L  + 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGA--HIRQEHILS---------------- 196
           NH N+V         G   V+ EY   G L       R   I S                
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 197 ----DLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-- 250
                 + QV  G+A+L  +  +HRD+   N+L+   +  KI DFG++R +    +    
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASL 309
            +A   + +M+PE I   +       +  D+WS G+ + E F LG  P+  G   D +  
Sbjct: 205 GNARLPVKWMAPESIFNCVY-----TFESDVWSYGIFLWELFSLGSSPYP-GMPVD-SKF 257
Query: 310 MFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
              I       +PE A  E  D +  C   DP  R    Q++Q
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 115/283 (40%), Gaps = 38/283 (13%)
Query: 101 LQKGNRIGSGSGG-----TVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV- 154
           L  G  +G+G+ G     T + ++    +   A+K++  +   + R  +  E+++L  + 
Sbjct: 43  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 102
Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGA--HIRQEHILS---------------- 196
           NH N+V         G   V+ EY   G L       R   I S                
Sbjct: 103 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 162
Query: 197 ----DLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-- 250
                 + QV  G+A+L  +  +HRD+   N+L+   +  KI DFG++R +    +    
Sbjct: 163 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 222
Query: 251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASL 309
            +A   + +M+PE I   +       +  D+WS G+ + E F LG  P+  G   D +  
Sbjct: 223 GNARLPVKWMAPESIFNCVY-----TFESDVWSYGIFLWELFSLGSSPYP-GMPVD-SKF 275
Query: 310 MFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
              I       +PE A  E  D +  C   DP  R    Q++Q
Sbjct: 276 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 318

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 117/251 (46%), Gaps = 22/251 (8%)
Query: 106 RIGSGSGGTVWRVVHP-PTSRVFALKVIYGNHED--SVRSQICREIEILRDVNHPNVVKC 162
            +GSG+ GTV +  +            I  N  +  +++ ++  E  +++ +++P +V+ 
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 163 HDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
             + +    + +++E  + G L     +  H++ ++I+ +L  QV  G+ YL +   VHR
Sbjct: 94  IGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNII-ELVHQVSMGMKYLEESNFVHR 151
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV---GTIAYMSPERINTDLNHGKY 274
           D+   N+L+ +    KI+DFG+S+ L    +   +       + + +PE I    N+ K+
Sbjct: 152 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI----NYYKF 207
Query: 275 DGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                D+WS GV + E F  G+ P+  G +G   + M      +    P    RE  D +
Sbjct: 208 SS-KSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEK--GERMGCPAGCPREMYDLM 263
Query: 334 SRCLQKDPHSR 344
           + C   D  +R
Sbjct: 264 NLCWTYDVENR 274

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 117/251 (46%), Gaps = 22/251 (8%)
Query: 106 RIGSGSGGTVWRVVHP-PTSRVFALKVIYGNHED--SVRSQICREIEILRDVNHPNVVKC 162
            +GSG+ GTV +  +            I  N  +  +++ ++  E  +++ +++P +V+ 
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 163 HDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
             + +    + +++E  + G L     +  H++ ++I+ +L  QV  G+ YL +   VHR
Sbjct: 94  IGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNII-ELVHQVSMGMKYLEESNFVHR 151
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV---GTIAYMSPERINTDLNHGKY 274
           D+   N+L+ +    KI+DFG+S+ L    +   +       + + +PE I    N+ K+
Sbjct: 152 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI----NYYKF 207
Query: 275 DGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                D+WS GV + E F  G+ P+  G +G   + M      +    P    RE  D +
Sbjct: 208 SS-KSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEK--GERMGCPAGCPREMYDLM 263
Query: 334 SRCLQKDPHSR 344
           + C   D  +R
Sbjct: 264 NLCWTYDVENR 274

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 117/251 (46%), Gaps = 22/251 (8%)
Query: 106 RIGSGSGGTVWRVVHP-PTSRVFALKVIYGNHED--SVRSQICREIEILRDVNHPNVVKC 162
            +GSG+ GTV +  +            I  N  +  +++ ++  E  +++ +++P +V+ 
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 163 HDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
             + +    + +++E  + G L     +  H++ ++I+ +L  QV  G+ YL +   VHR
Sbjct: 437 IGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNII-ELVHQVSMGMKYLEESNFVHR 494
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKY 274
           D+   N+L+ +    KI+DFG+S+ L    +   +       + + +PE I    N+ K+
Sbjct: 495 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI----NYYKF 550
Query: 275 DGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                D+WS GV + E F  G+ P+  G +G   + M      +    P    RE  D +
Sbjct: 551 SS-KSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEK--GERMGCPAGCPREMYDLM 606
Query: 334 SRCLQKDPHSR 344
           + C   D  +R
Sbjct: 607 NLCWTYDVENR 617

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 117/251 (46%), Gaps = 22/251 (8%)
Query: 106 RIGSGSGGTVWRVVHP-PTSRVFALKVIYGNHED--SVRSQICREIEILRDVNHPNVVKC 162
            +GSG+ GTV +  +            I  N  +  +++ ++  E  +++ +++P +V+ 
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 163 HDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
             + +    + +++E  + G L     +  H++ ++I+ +L  QV  G+ YL +   VHR
Sbjct: 436 IGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNII-ELVHQVSMGMKYLEESNFVHR 493
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKY 274
           D+   N+L+ +    KI+DFG+S+ L    +   +       + + +PE I    N+ K+
Sbjct: 494 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI----NYYKF 549
Query: 275 DGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                D+WS GV + E F  G+ P+  G +G   + M      +    P    RE  D +
Sbjct: 550 SS-KSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEK--GERMGCPAGCPREMYDLM 605
Query: 334 SRCLQKDPHSR 344
           + C   D  +R
Sbjct: 606 NLCWTYDVENR 616

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 117/251 (46%), Gaps = 22/251 (8%)
Query: 106 RIGSGSGGTVWRVVHP-PTSRVFALKVIYGNHED--SVRSQICREIEILRDVNHPNVVKC 162
            +GSG+ GTV +  +            I  N  +  +++ ++  E  +++ +++P +V+ 
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 163 HDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
             + +    + +++E  + G L     +  H++ ++I+ +L  QV  G+ YL +   VHR
Sbjct: 78  IGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNII-ELVHQVSMGMKYLEESNFVHR 135
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKY 274
           D+   N+L+ +    KI+DFG+S+ L    +   +       + + +PE I    N+ K+
Sbjct: 136 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI----NYYKF 191
Query: 275 DGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                D+WS GV + E F  G+ P+  G +G   + M      +    P    RE  D +
Sbjct: 192 SS-KSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEK--GERMGCPAGCPREMYDLM 247
Query: 334 SRCLQKDPHSR 344
           + C   D  +R
Sbjct: 248 NLCWTYDVENR 258

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 121/281 (43%), Gaps = 37/281 (13%)
Query: 101 LQKGNRIGSGSGGTV-----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV- 154
           L  G  +G G+ G V     + +    T R  A+K++      S    +  E++IL  + 
Sbjct: 29  LNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 155 NHPNVVKCHDMYDR-NGEIEVLLEYMDGGSLEGAHIRQ------------------EHIL 195
           +H NVV       +  G + V++E+   G+L   ++R                   EH++
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 196 SDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC--NSA 253
              + QV  G+ +L  RK +HRD+   N+L++    VKI DFG++R + +  D      A
Sbjct: 148 C-YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 206
Query: 254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFA 312
              + +M+PE I       +      D+WS GV + E F LG  P+  G + D       
Sbjct: 207 RLPLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKID-EEFCRR 259
Query: 313 ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
           +       AP+  + E    +  C   +P  R   ++L++H
Sbjct: 260 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 117/251 (46%), Gaps = 22/251 (8%)
Query: 106 RIGSGSGGTVWRVVHP-PTSRVFALKVIYGNHED--SVRSQICREIEILRDVNHPNVVKC 162
            +GSG+ GTV +  +            I  N  +  +++ ++  E  +++ +++P +V+ 
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 163 HDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
             + +    + +++E  + G L     +  H++ ++I+ +L  QV  G+ YL +   VHR
Sbjct: 84  IGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNII-ELVHQVSMGMKYLEESNFVHR 141
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKY 274
           D+   N+L+ +    KI+DFG+S+ L    +   +       + + +PE I    N+ K+
Sbjct: 142 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI----NYYKF 197
Query: 275 DGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                D+WS GV + E F  G+ P+  G +G   + M      +    P    RE  D +
Sbjct: 198 SS-KSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEK--GERMGCPAGCPREMYDLM 253
Query: 334 SRCLQKDPHSR 344
           + C   D  +R
Sbjct: 254 NLCWTYDVENR 264

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 117/251 (46%), Gaps = 22/251 (8%)
Query: 106 RIGSGSGGTVWRVVHP-PTSRVFALKVIYGNHED--SVRSQICREIEILRDVNHPNVVKC 162
            +GSG+ GTV +  +            I  N  +  +++ ++  E  +++ +++P +V+ 
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 163 HDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
             + +    + +++E  + G L     +  H++ ++I+ +L  QV  G+ YL +   VHR
Sbjct: 72  IGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNII-ELVHQVSMGMKYLEESNFVHR 129
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKY 274
           D+   N+L+ +    KI+DFG+S+ L    +   +       + + +PE I    N+ K+
Sbjct: 130 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI----NYYKF 185
Query: 275 DGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                D+WS GV + E F  G+ P+  G +G   + M      +    P    RE  D +
Sbjct: 186 SS-KSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEK--GERMGCPAGCPREMYDLM 241
Query: 334 SRCLQKDPHSR 344
           + C   D  +R
Sbjct: 242 NLCWTYDVENR 252

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 114/267 (42%), Gaps = 42/267 (15%)
Query: 106 RIGSGSGGTVWR-----VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHPN 158
            +G GS G V+      ++        A+K +  N   S+R +I    E  +++     +
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHH 80
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR-----------------QEHILSDLARQ 201
           VV+   +  +     V++E M  G L+ +++R                 QE I   +A +
Sbjct: 81  VVRLLGVVSKGQPTLVVMELMAHGDLK-SYLRSLRPEAENNPGRPPPTLQEMI--QMAAE 137
Query: 202 VLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAY 259
           +  G+AYL+ +K VHRD+   N ++     VKI DFG++R + +T        G   + +
Sbjct: 138 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 197
Query: 260 MSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF-AVGRQGDWASLMFAICFAQ 317
           M+PE     L  G +   + D+WS GV + E   L   P+  +  +     +M      Q
Sbjct: 198 MAPE----SLKDGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ 252
Query: 318 PPEAPEMASREFRDFISRCLQKDPHSR 344
           P   PE  +    D +  C Q +P  R
Sbjct: 253 PDNCPERVT----DLMRMCWQFNPKMR 275

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 121/281 (43%), Gaps = 37/281 (13%)
Query: 101 LQKGNRIGSGSGGTV-----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV- 154
           L  G  +G G+ G V     + +    T R  A+K++      S    +  E++IL  + 
Sbjct: 29  LNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 155 NHPNVVKCHDMYDR-NGEIEVLLEYMDGGSLEGAHIRQ------------------EHIL 195
           +H NVV       +  G + V++E+   G+L   ++R                   EH++
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 196 SDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC--NSA 253
              + QV  G+ +L  RK +HRD+   N+L++    VKI DFG++R + +  D      A
Sbjct: 148 X-YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFA 312
              + +M+PE I       +      D+WS GV + E F LG  P+  G + D       
Sbjct: 207 RLPLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKID-EEFXRR 259
Query: 313 ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
           +       AP+  + E    +  C   +P  R   ++L++H
Sbjct: 260 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/251 (23%), Positives = 117/251 (46%), Gaps = 22/251 (8%)
Query: 106 RIGSGSGGTVWRVVHP-PTSRVFALKVIYGNHED--SVRSQICREIEILRDVNHPNVVKC 162
            +GSG+ GTV +  +            I  N  +  +++ ++  E  +++ +++P +V+ 
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 163 HDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
             + +    + +++E  + G L     +  H++ ++I+ +L  QV  G+ YL +   VHR
Sbjct: 74  IGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNII-ELVHQVSMGMKYLEESNFVHR 131
Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKY 274
           D+   N+L+ +    KI+DFG+S+ L    +   +       + + +PE I    N+ K+
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI----NYYKF 187
Query: 275 DGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                D+WS GV + E F  G+ P+  G +G   + M      +    P    RE  D +
Sbjct: 188 SS-KSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEK--GERMGCPAGCPREMYDLM 243
Query: 334 SRCLQKDPHSR 344
           + C   D  +R
Sbjct: 244 NLCWTYDVENR 254

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 114/267 (42%), Gaps = 42/267 (15%)
Query: 106 RIGSGSGGTVWR-----VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHPN 158
            +G GS G V+      ++        A+K +  N   S+R +I    E  +++     +
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHH 81
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR-----------------QEHILSDLARQ 201
           VV+   +  +     V++E M  G L+ +++R                 QE I   +A +
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLK-SYLRSLRPEAENNPGRPPPTLQEMI--QMAAE 138
Query: 202 VLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAY 259
           +  G+AYL+ +K VHRD+   N ++     VKI DFG++R + +T        G   + +
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
Query: 260 MSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF-AVGRQGDWASLMFAICFAQ 317
           M+PE     L  G +   + D+WS GV + E   L   P+  +  +     +M      Q
Sbjct: 199 MAPE----SLKDGVFTT-SSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ 253
Query: 318 PPEAPEMASREFRDFISRCLQKDPHSR 344
           P   PE  +    D +  C Q +P  R
Sbjct: 254 PDNCPERVT----DLMRMCWQFNPKMR 276

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 41/285 (14%)
Query: 101 LQKGNRIGSGSGGTV-----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV- 154
           L+ G  +G G+ G V     + +    T R  A+K++      S    +  E++IL  + 
Sbjct: 29  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 155 NHPNVVKCHDMYDR-NGEIEVLLEYMDGGSLEGAHIRQ---------------------- 191
           +H NVV       +  G + V++E+   G+L   ++R                       
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 192 EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC- 250
           EH++   + QV  G+ +L  RK +HRD+   N+L++    VKI DFG++R + +  D   
Sbjct: 148 EHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 251 -NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWAS 308
              A   + +M+PE I       +      D+WS GV + E F LG  P+  G + D   
Sbjct: 207 KGDARLPLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKID-EE 259
Query: 309 LMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
               +       AP+  + E    +  C   +P  R   ++L++H
Sbjct: 260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 41/285 (14%)
Query: 101 LQKGNRIGSGSGGTV-----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV- 154
           L+ G  +G G+ G V     + +    T R  A+K++      S    +  E++IL  + 
Sbjct: 31  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 90
Query: 155 NHPNVVKCHDMYDR-NGEIEVLLEYMDGGSLEGAHIRQ---------------------- 191
           +H NVV       +  G + V++E+   G+L   ++R                       
Sbjct: 91  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKEAPEDLYKDFLTL 149
Query: 192 EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC- 250
           EH++   + QV  G+ +L  RK +HRD+   N+L++    VKI DFG++R + +  D   
Sbjct: 150 EHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 208
Query: 251 -NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWAS 308
              A   + +M+PE I       +      D+WS GV + E F LG  P+  G + D   
Sbjct: 209 KGDARLPLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKID-EE 261
Query: 309 LMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
               +       AP+  + E    +  C   +P  R   ++L++H
Sbjct: 262 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 306

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 41/285 (14%)
Query: 101 LQKGNRIGSGSGGTV-----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV- 154
           L+ G  +G G+ G V     + +    T R  A+K++      S    +  E++IL  + 
Sbjct: 66  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 125
Query: 155 NHPNVVKCHDMYDR-NGEIEVLLEYMDGGSLEGAHIRQ---------------------- 191
           +H NVV       +  G + V++E+   G+L   ++R                       
Sbjct: 126 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKVAPEDLYKDFLTL 184
Query: 192 EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC- 250
           EH++   + QV  G+ +L  RK +HRD+   N+L++    VKI DFG++R + +  D   
Sbjct: 185 EHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 243
Query: 251 -NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWAS 308
              A   + +M+PE I       +      D+WS GV + E F LG  P+  G + D   
Sbjct: 244 KGDARLPLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKID-EE 296
Query: 309 LMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
               +       AP+  + E    +  C   +P  R   ++L++H
Sbjct: 297 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 100 ELQKGNRIGSGSGGTVWRVV-------HPPTSRVFALKVIYGNHEDSVRSQICREIEILR 152
           +L  G  +G G+ G V            P  +   A+K++  +  +   S +  E+E+++
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 153 DV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR------------------QEH 193
            +  H N++       ++G + V++EY   G+L   ++R                  ++ 
Sbjct: 96  MIGKHKNIITLLGACTQDGPLYVIVEYASKGNLR-EYLRARRPPGMEYSYDINRVPEEQM 154
Query: 194 ILSDLAR---QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
              DL     Q+  G+ YL  +K +HRD+   N+L+  +  +KIADFG++R +       
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 251 NSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
            +  G   + +M+PE +       +   +  D+WS GV + E F LG  P+
Sbjct: 215 KTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 121/285 (42%), Gaps = 41/285 (14%)
Query: 101 LQKGNRIGSGSGGTV-----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV- 154
           L+ G  +G G+ G V     + +    T R  A+K++      S    +  E++IL  + 
Sbjct: 20  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 79
Query: 155 NHPNVVKCHDMYDR-NGEIEVLLEYMDGGSLEGAHIRQ---------------------- 191
           +H NVV       +  G + V+ E+   G+L   ++R                       
Sbjct: 80  HHLNVVNLLGACTKPGGPLMVITEFCKFGNL-STYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 192 EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC- 250
           EH++   + QV  G+ +L  RK +HRD+   N+L++    VKI DFG++R + +  D   
Sbjct: 139 EHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 251 -NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWAS 308
              A   + +M+PE I       +      D+WS GV + E F LG  P+  G + D   
Sbjct: 198 KGDARLPLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKID-EE 250
Query: 309 LMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
               +       AP+  + E    +  C   +P  R   ++L++H
Sbjct: 251 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 102/231 (44%), Gaps = 38/231 (16%)
Query: 100 ELQKGNRIGSGSGGTVWRVV-------HPPTSRVFALKVIYGNHEDSVRSQICREIEILR 152
           +L  G  +G G  G V            P  +   A+K++  +  +   S +  E+E+++
Sbjct: 82  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 141
Query: 153 DV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR------------------QEH 193
            +  H N++       ++G + V++EY   G+L   ++R                  ++ 
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR-EYLRARRPPGMEYSYDINRVPEEQM 200
Query: 194 ILSDLAR---QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
              DL     Q+  G+ YL  +K +HRD+   N+L+  +  +KIADFG++R +       
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 251 NSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
            +  G   + +M+PE +       +   +  D+WS GV + E F LG  P+
Sbjct: 261 KTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 100 ELQKGNRIGSGSGGTVWRVV-------HPPTSRVFALKVIYGNHEDSVRSQICREIEILR 152
           +L  G  +G G+ G V            P  +   A+K++  +  +   S +  E+E+++
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMK 95
Query: 153 DV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR------------------QEH 193
            +  H N++       ++G + V++EY   G+L   ++R                  ++ 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR-EYLRARRPPGMEYSYDINRVPEEQM 154
Query: 194 ILSDLAR---QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
              DL     Q+  G+ YL  +K +HRD+   N+L+  +  +KIADFG++R +       
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 251 NSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
            +  G   + +M+PE +       +   +  D+WS GV + E F LG  P+
Sbjct: 215 KTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 119/286 (41%), Gaps = 50/286 (17%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV--NHPNVVK--C 162
           +G G  G VWR          A+K+     E S      RE E+   V   H N++    
Sbjct: 16  VGKGRYGEVWR--GSWQGENVAVKIFSSRDEKS----WFRETELYNTVMLRHENILGFIA 69
Query: 163 HDMYDRNGEIEVLL--EYMDGGSL-EGAHIRQEHILSDL--ARQVLSGLAYLH------- 210
            DM  R+   ++ L   Y + GSL +   +     +S L     + SGLA+LH       
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 211 -KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC----NSAVGTIAYMSPERI 265
            K  I HRD+K  N+L+  +    IAD G++ + +Q+ +      N  VGT  YM+PE +
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 266 NTDLNHGKYDGYAG-DIWSLGV------------SILEFYLGRFPFAVGRQGDWASLMFA 312
           +  +    +D Y   DIW+ G+             I+E Y   F   V     +  +   
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 249
Query: 313 ICFAQPPEAPEMASREFRD--------FISRCLQKDPHSRWPAAQL 350
           +C  Q  + P + +R F D         +  C  ++P +R  A ++
Sbjct: 250 VCVDQ--QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 78/325 (24%), Positives = 125/325 (38%), Gaps = 87/325 (26%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR-EIEILRDVNHPNVVKCHD 164
           ++G G   TVW       +   A+K++ G   D V ++    EI++L+ VN  +  K   
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHI----------------RQEH------ILSDLARQV 202
           M      I  LL++ +     G H+                + EH       +  +++Q+
Sbjct: 83  M--GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 203 LSGLAYLHKR-KIVHRDIKPSNLL---INSSKN---VKIADFGVSRILAQTMDPCNSAVG 255
           L GL Y+H+R  I+H DIKP N+L   ++S +N   +KIAD G +       +   +++ 
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSIQ 197
Query: 256 TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF------------------------ 291
           T  Y SPE +      G   G   DIWS    I E                         
Sbjct: 198 TREYRSPEVL-----LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252
Query: 292 ---YLGRFPFAVGRQGDWASLMF-----------------AICFAQPPEAPEMASREFRD 331
               LG  P  + R G +    F                      +  +  +  ++E  D
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFI 356
           F+S  LQ DP  R  A  L+ HP++
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWL 337

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 119/286 (41%), Gaps = 50/286 (17%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV--NHPNVVK--C 162
           +G G  G VWR          A+K+     E S      RE E+   V   H N++    
Sbjct: 16  VGKGRYGEVWR--GSWQGENVAVKIFSSRDEKS----WFRETELYNTVMLRHENILGFIA 69
Query: 163 HDMYDRNGEIEVLL--EYMDGGSL-EGAHIRQEHILSDL--ARQVLSGLAYLH------- 210
            DM  R+   ++ L   Y + GSL +   +     +S L     + SGLA+LH       
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 211 -KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC----NSAVGTIAYMSPERI 265
            K  I HRD+K  N+L+  +    IAD G++ + +Q+ +      N  VGT  YM+PE +
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 266 NTDLNHGKYDGYAG-DIWSLGV------------SILEFYLGRFPFAVGRQGDWASLMFA 312
           +  +    +D Y   DIW+ G+             I+E Y   F   V     +  +   
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 249
Query: 313 ICFAQPPEAPEMASREFRD--------FISRCLQKDPHSRWPAAQL 350
           +C  Q  + P + +R F D         +  C  ++P +R  A ++
Sbjct: 250 VCVDQ--QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 78/325 (24%), Positives = 125/325 (38%), Gaps = 87/325 (26%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR-EIEILRDVNHPNVVKCHD 164
           ++G G   TVW       +   A+K++ G   D V ++    EI++L+ VN  +  K   
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHI----------------RQEH------ILSDLARQV 202
           M      I  LL++ +     G H+                + EH       +  +++Q+
Sbjct: 83  M--GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 203 LSGLAYLHKR-KIVHRDIKPSNLL---INSSKN---VKIADFGVSRILAQTMDPCNSAVG 255
           L GL Y+H+R  I+H DIKP N+L   ++S +N   +KIAD G +       +   +++ 
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSIQ 197
Query: 256 TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF------------------------ 291
           T  Y SPE +      G   G   DIWS    I E                         
Sbjct: 198 TREYRSPEVL-----LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252
Query: 292 ---YLGRFPFAVGRQGDWASLMF-----------------AICFAQPPEAPEMASREFRD 331
               LG  P  + R G +    F                      +  +  +  ++E  D
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312
Query: 332 FISRCLQKDPHSRWPAAQLLQHPFI 356
           F+S  LQ DP  R  A  L+ HP++
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWL 337

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 102/231 (44%), Gaps = 38/231 (16%)
Query: 100 ELQKGNRIGSGSGGTVWRVV-------HPPTSRVFALKVIYGNHEDSVRSQICREIEILR 152
           +L  G  +G G  G V            P  +   A+K++  +  +   S +  E+E+++
Sbjct: 23  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 82
Query: 153 DV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR------------------QEH 193
            +  H N++       ++G + V++EY   G+L   ++R                  ++ 
Sbjct: 83  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR-EYLRARRPPGMEYSYDINRVPEEQM 141
Query: 194 ILSDLAR---QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
              DL     Q+  G+ YL  +K +HRD+   N+L+  +  +KIADFG++R +       
Sbjct: 142 TFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYK 201
Query: 251 NSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
            +  G   + +M+PE +       +   +  D+WS GV + E F LG  P+
Sbjct: 202 KTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 247

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 98/195 (50%), Gaps = 18/195 (9%)
Query: 107 IGSGSGGTVWRVVHPPTSRVF--ALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
           +G G+ G+V + V+    +    A+KV+    E +   ++ RE +I+  +++P +V+   
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHI-RQEHI----LSDLARQVLSGLAYLHKRKIVHRDI 219
           +      + +++E   GG L    + ++E I    +++L  QV  G+ YL ++  VHR++
Sbjct: 404 VCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNL 462
Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT----IAYMSPERINTDLNHGKYD 275
              N+L+ +    KI+DFG+S+ L    D   +A       + + +PE IN      +  
Sbjct: 463 AARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPECINFRKFSSR-- 519
Query: 276 GYAGDIWSLGVSILE 290
               D+WS GV++ E
Sbjct: 520 ---SDVWSYGVTMWE 531

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 100 ELQKGNRIGSGSGGTVWRVV-------HPPTSRVFALKVIYGNHEDSVRSQICREIEILR 152
           +L  G  +G G+ G V            P  +   A+K++  +  +   S +  E+E+++
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 153 DV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR------------------QEH 193
            +  H N++       ++G + V++EY   G+L   ++R                  ++ 
Sbjct: 96  MIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLR-EYLRARRPPGMEYSYDINRVPEEQM 154
Query: 194 ILSDLAR---QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
              DL     Q+  G+ YL  +K +HRD+   N+L+  +  +KIADFG++R +       
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 251 NSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
            +  G   + +M+PE +       +   +  D+WS GV + E F LG  P+
Sbjct: 215 KTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 119/286 (41%), Gaps = 50/286 (17%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV--NHPNVVK--C 162
           +G G  G VWR          A+K+     E S      RE E+   V   H N++    
Sbjct: 45  VGKGRYGEVWR--GSWQGENVAVKIFSSRDEKS----WFRETELYNTVMLRHENILGFIA 98
Query: 163 HDMYDRNGEIEVLL--EYMDGGSL-EGAHIRQEHILSDL--ARQVLSGLAYLH------- 210
            DM  R+   ++ L   Y + GSL +   +     +S L     + SGLA+LH       
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 211 -KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC----NSAVGTIAYMSPERI 265
            K  I HRD+K  N+L+  +    IAD G++ + +Q+ +      N  VGT  YM+PE +
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 218
Query: 266 NTDLNHGKYDGYAG-DIWSLGV------------SILEFYLGRFPFAVGRQGDWASLMFA 312
           +  +    +D Y   DIW+ G+             I+E Y   F   V     +  +   
Sbjct: 219 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 278
Query: 313 ICFAQPPEAPEMASREFRD--------FISRCLQKDPHSRWPAAQL 350
           +C  Q  + P + +R F D         +  C  ++P +R  A ++
Sbjct: 279 VCVDQ--QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 322

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 102/231 (44%), Gaps = 38/231 (16%)
Query: 100 ELQKGNRIGSGSGGTVWRVV-------HPPTSRVFALKVIYGNHEDSVRSQICREIEILR 152
           +L  G  +G G  G V            P  +   A+K++  +  +   S +  E+E+++
Sbjct: 25  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 84
Query: 153 DV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR------------------QEH 193
            +  H N++       ++G + V++EY   G+L   ++R                  ++ 
Sbjct: 85  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR-EYLRARRPPGMEYSYDINRVPEEQM 143
Query: 194 ILSDLAR---QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
              DL     Q+  G+ YL  +K +HRD+   N+L+  +  +KIADFG++R +       
Sbjct: 144 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 203
Query: 251 NSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
            +  G   + +M+PE +       +   +  D+WS GV + E F LG  P+
Sbjct: 204 KTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 249

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 102/231 (44%), Gaps = 38/231 (16%)
Query: 100 ELQKGNRIGSGSGGTVWRVV-------HPPTSRVFALKVIYGNHEDSVRSQICREIEILR 152
           +L  G  +G G  G V            P  +   A+K++  +  +   S +  E+E+++
Sbjct: 28  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 87
Query: 153 DV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR------------------QEH 193
            +  H N++       ++G + V++EY   G+L   ++R                  ++ 
Sbjct: 88  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR-EYLRARRPPGMEYSYDINRVPEEQM 146
Query: 194 ILSDLAR---QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
              DL     Q+  G+ YL  +K +HRD+   N+L+  +  +KIADFG++R +       
Sbjct: 147 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 206
Query: 251 NSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
            +  G   + +M+PE +       +   +  D+WS GV + E F LG  P+
Sbjct: 207 KTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 252

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 121/285 (42%), Gaps = 41/285 (14%)
Query: 101 LQKGNRIGSGSGGTV-----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV- 154
           L+ G  +G G+ G V     + +    T R  A+K++      S    +  E++IL  + 
Sbjct: 20  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 79
Query: 155 NHPNVVKCHDMYDR-NGEIEVLLEYMDGGSLEGAHIRQ---------------------- 191
           +H NVV       +  G + V+ E+   G+L   ++R                       
Sbjct: 80  HHLNVVNLLGACTKPGGPLMVITEFCKFGNL-STYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 192 EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC- 250
           EH++   + QV  G+ +L  RK +HRD+   N+L++    VKI DFG++R + +  D   
Sbjct: 139 EHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 251 -NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWAS 308
              A   + +M+PE I       +      D+WS GV + E F LG  P+  G + D   
Sbjct: 198 KGDARLPLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKID-EE 250
Query: 309 LMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
               +       AP+  + E    +  C   +P  R   ++L++H
Sbjct: 251 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 115/267 (43%), Gaps = 42/267 (15%)
Query: 106 RIGSGSGGTVWR-----VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHPN 158
            +G GS G V+      ++        A+K +  N   S+R +I    E  +++     +
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHH 81
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR-----------------QEHILSDLARQ 201
           VV+   +  +     V++E M  G L+ +++R                 QE I   +A +
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLK-SYLRSLRPEAENNPGRPPPTLQEMI--QMAAE 138
Query: 202 VLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAY 259
           +  G+AYL+ +K VHR++   N ++     VKI DFG++R + +T        G   + +
Sbjct: 139 IADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
Query: 260 MSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF-AVGRQGDWASLMFAICFAQ 317
           M+PE     L  G +   + D+WS GV + E   L   P+  +  +     +M      Q
Sbjct: 199 MAPE----SLKDGVFTT-SSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ 253
Query: 318 PPEAPEMASREFRDFISRCLQKDPHSR 344
           P   PE  +    D +  C Q +P+ R
Sbjct: 254 PDNCPERVT----DLMRMCWQFNPNMR 276

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/285 (24%), Positives = 121/285 (42%), Gaps = 41/285 (14%)
Query: 101 LQKGNRIGSGSGGTV-----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV- 154
           L+ G  +G G+ G V     + +    T R  A+K++      S    +  E++IL  + 
Sbjct: 20  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 79
Query: 155 NHPNVVKCHDMYDR-NGEIEVLLEYMDGGSLEGAHIRQ---------------------- 191
           +H NVV       +  G + V+ E+   G+L   ++R                       
Sbjct: 80  HHLNVVNLLGACTKPGGPLMVITEFCKFGNL-STYLRSKRNEFVPYKVAPEDLYKDFLTL 138
Query: 192 EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC- 250
           EH++   + QV  G+ +L  RK +HRD+   N+L++    VKI DFG++R + +  D   
Sbjct: 139 EHLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 251 -NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWAS 308
              A   + +M+PE I       +      D+WS GV + E F LG  P+  G + D   
Sbjct: 198 KGDARLPLKWMAPETI-----FDRVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKID-EE 250
Query: 309 LMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
               +       AP+  + E    +  C   +P  R   ++L++H
Sbjct: 251 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 111/270 (41%), Gaps = 34/270 (12%)
Query: 107 IGSGSGGTVWR-----VVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           +G G+ G V+      + + P+    A+K +   + +        E  I+   NH N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEH------------ILSDLARQVLSGLAYL 209
           C  +  ++    +LLE M GG L+ + +R+               L  +AR +  G  YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLK-SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 210 HKRKIVHRDIKPSNLLINS---SKNVKIADFGVSRIL--AQTMDPCNSAVGTIAYMSPER 264
            +   +HRDI   N L+      +  KI DFG++R +  A        A+  + +M PE 
Sbjct: 172 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 231
Query: 265 INTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPE-AP 322
               +   K      D WS GV + E F LG  P+      +    + +     PP+  P
Sbjct: 232 FMEGIFTSK-----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCP 286
Query: 323 EMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
               R     +++C Q  P  R   A +L+
Sbjct: 287 GPVYR----IMTQCWQHQPEDRPNFAIILE 312

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 115/267 (43%), Gaps = 42/267 (15%)
Query: 106 RIGSGSGGTVWR-----VVHPPTSRVFALKVIYGNHEDSVRSQI--CREIEILRDVNHPN 158
            +G GS G V+      ++        A+K +  N   S+R +I    E  +++     +
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHH 82
Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR-----------------QEHILSDLARQ 201
           VV+   +  +     V++E M  G L+ +++R                 QE I   +A +
Sbjct: 83  VVRLLGVVSKGQPTLVVMELMAHGDLK-SYLRSLRPEAENNPGRPPPTLQEMI--QMAAE 139
Query: 202 VLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT--IAY 259
           +  G+AYL+ +K VHR++   N ++     VKI DFG++R + +T        G   + +
Sbjct: 140 IADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 199
Query: 260 MSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPF-AVGRQGDWASLMFAICFAQ 317
           M+PE     L  G +   + D+WS GV + E   L   P+  +  +     +M      Q
Sbjct: 200 MAPE----SLKDGVFTT-SSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ 254
Query: 318 PPEAPEMASREFRDFISRCLQKDPHSR 344
           P   PE  +    D +  C Q +P+ R
Sbjct: 255 PDNCPERVT----DLMRMCWQFNPNMR 277

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 100 ELQKGNRIGSGSGGTVWRVV-------HPPTSRVFALKVIYGNHEDSVRSQICREIEILR 152
           +L  G  +G G+ G V            P  +   A+K++  +  +   S +  E+E+++
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 153 DV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR------------------QEH 193
            +  H N++       ++G + V++EY   G+L   ++R                  ++ 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR-EYLRARRPPGMEYSYDINRVPEEQM 154
Query: 194 ILSDLAR---QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
              DL     Q+  G+ YL  +K +HRD+   N+L+  +  ++IADFG++R +       
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYK 214
Query: 251 NSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
            +  G   + +M+PE +       +   +  D+WS GV + E F LG  P+
Sbjct: 215 KTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 63/291 (21%)
Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGS---LEGAHIR---QEHILSDLAR 200
           E+ + +  NHPN+V     +  + E+ V+  +M  GS   L   H      E  ++ + +
Sbjct: 60  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 119
Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ---------TMDPCN 251
            VL  L Y+H    VHR +K S++LI+    V ++  G+   L+            D   
Sbjct: 120 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMISHGQRQRVVHDFPK 177
Query: 252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF------------- 298
            +V  + ++SPE +  +L    YD    DI+S+G++  E   G  PF             
Sbjct: 178 YSVKVLPWLSPEVLQQNLQ--GYDA-KSDIYSVGITACELANGHVPFKDMPATQMLLEKL 234
Query: 299 ------------------------AVGRQGDWASLMFAICFAQPPEAPE-----MASREF 329
                                   +V   G   SL  +       ++P        S  F
Sbjct: 235 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 294
Query: 330 RDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPLSS 380
             F+ +CLQ++P +R  A+ LL H F  +  + + ++ L ++L P  P+++
Sbjct: 295 HHFVEQCLQRNPDARPSASTLLNHSF-FKQIKRRASEALPELLRPVTPITN 344

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 27/207 (13%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR--EIEILRDVNHPNVVKCH 163
           R+G GS G V R+    T    A+K         VR ++ R  E+     ++ P +V  +
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLY 132
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRD 218
                   + + +E ++GGSL G  I+Q   L +        Q L GL YLH R+I+H D
Sbjct: 133 GAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 191
Query: 219 IKPSNLLINSSKN-VKIADFGVSRI-----LAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           +K  N+L++S  +   + DFG +       L +++   +   GT  +M+PE +      G
Sbjct: 192 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM-----G 246
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFA 299
           K      DIWS    +L    G  P+ 
Sbjct: 247 KPCDAKVDIWSSCCMMLHMLNGCHPWT 273

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/291 (23%), Positives = 119/291 (40%), Gaps = 63/291 (21%)
Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGS---LEGAHIR---QEHILSDLAR 200
           E+ + +  NHPN+V     +  + E+ V+  +M  GS   L   H      E  ++ + +
Sbjct: 76  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135
Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ---------TMDPCN 251
            VL  L Y+H    VHR +K S++LI+    V ++  G+   L+            D   
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMISHGQRQRVVHDFPK 193
Query: 252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF------------- 298
            +V  + ++SPE +  +L    YD    DI+S+G++  E   G  PF             
Sbjct: 194 YSVKVLPWLSPEVLQQNLQ--GYDA-KSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250
Query: 299 ------------------------AVGRQGDWASLMFAICFAQPPEAPE-----MASREF 329
                                   +V   G   SL  +       ++P        S  F
Sbjct: 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 310
Query: 330 RDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPLSS 380
             F+ +CLQ++P +R  A+ LL H F  +  + + ++ L ++L P  P+++
Sbjct: 311 HHFVEQCLQRNPDARPSASTLLNHSF-FKQIKRRASEALPELLRPVTPITN 360

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 27/207 (13%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR--EIEILRDVNHPNVVKCH 163
           R+G GS G V R+    T    A+K         VR ++ R  E+     ++ P +V  +
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLY 116
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRD 218
                   + + +E ++GGSL G  I+Q   L +        Q L GL YLH R+I+H D
Sbjct: 117 GAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 175
Query: 219 IKPSNLLINSSKN-VKIADFGVSRI-----LAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           +K  N+L++S  +   + DFG +       L +++   +   GT  +M+PE +      G
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV-----MG 230
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFA 299
           K      DIWS    +L    G  P+ 
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPWT 257

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 106/253 (41%), Gaps = 24/253 (9%)
Query: 107 IGSGSGGTVW--RVVHPPTSRV-FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
           IG G  G V+    +    +R+  A+K +    E        RE  ++R +NHPNV+   
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 164 D-MYDRNGEIEVLLEYMDGGSLEGAHIRQEH---ILSDL---ARQVLSGLAYLHKRKIVH 216
             M    G   VLL YM  G L    IR       + DL     QV  G+ YL ++K VH
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLL-QFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVH 147
Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQ----TMDPCNSAVGTIAYMSPERINTDLNHG 272
           RD+   N +++ S  VK+ADFG++R +      ++     A   + + + E + T     
Sbjct: 148 RDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTT 207
Query: 273 KYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
           K      D+WS GV + E    G  P+   R  D   L   +   +    PE        
Sbjct: 208 K-----SDVWSFGVLLWELLTRGAPPY---RHIDPFDLTHFLAQGRRLPQPEYCPDSLYQ 259
Query: 332 FISRCLQKDPHSR 344
            + +C + DP  R
Sbjct: 260 VMQQCWEADPAVR 272

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 22/221 (9%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
           N +G G  G V++      + V A+K +          Q   E+E++    H N+++   
Sbjct: 44  NILGRGGFGKVYKGRLADGTLV-AVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRG 102
Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD----------LARQVLSGLAYLHKR-- 212
                 E  ++  YM  GS+  A   +E   S           +A     GLAYLH    
Sbjct: 103 FCMTPTERLLVYPYMANGSV--ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 160
Query: 213 -KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV-GTIAYMSPERINTDLN 270
            KI+HRD+K +N+L++      + DFG+++++         AV GTI +++PE ++T  +
Sbjct: 161 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKS 220
Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMF 311
             K      D++  GV +LE   G+  F + R  +   +M 
Sbjct: 221 SEKT-----DVFGYGVMLLELITGQRAFDLARLANDDDVML 256

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 27/207 (13%)
Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICR--EIEILRDVNHPNVVKCH 163
           R+G GS G V R+    T    A+K         VR ++ R  E+     ++ P +V  +
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLY 130
Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRD 218
                   + + +E ++GGSL G  I+Q   L +        Q L GL YLH R+I+H D
Sbjct: 131 GAVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 189
Query: 219 IKPSNLLINSSKN-VKIADFGVSRI-----LAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           +K  N+L++S  +   + DFG +       L +++   +   GT  +M+PE +      G
Sbjct: 190 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV-----MG 244
Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFA 299
           K      DIWS    +L    G  P+ 
Sbjct: 245 KPCDAKVDIWSSCCMMLHMLNGCHPWT 271

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 63/132 (47%), Gaps = 21/132 (15%)
Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD--------PCNS 252
           Q+   + +LH + ++HRD+KPSN+       VK+ DFG+   + Q  +        P  +
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 253 A----VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ---GD 305
                VGT  YMSPE+I     HG    +  DI+SLG+ + E  L  F   + R     D
Sbjct: 232 THXGQVGTKLYMSPEQI-----HGNNYSHKVDIFSLGLILFEL-LYSFSTQMERVRIITD 285
Query: 306 WASLMFAICFAQ 317
             +L F + F Q
Sbjct: 286 VRNLKFPLLFTQ 297

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 111/270 (41%), Gaps = 34/270 (12%)
Query: 107 IGSGSGGTVWR-----VVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           +G G+ G V+      + + P+    A+K +     +        E  I+  +NH N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEH------------ILSDLARQVLSGLAYL 209
           C  +  ++    +LLE M GG L+ + +R+               L  +AR +  G  YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLK-SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 210 HKRKIVHRDIKPSNLLINS---SKNVKIADFGVSRIL--AQTMDPCNSAVGTIAYMSPER 264
            +   +HRDI   N L+      +  KI DFG++R +  A        A+  + +M PE 
Sbjct: 172 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 231
Query: 265 INTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPE-AP 322
               +   K      D WS GV + E F LG  P+      +    + +     PP+  P
Sbjct: 232 FMEGIFTSK-----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCP 286
Query: 323 EMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
               R     +++C Q  P  R   A +L+
Sbjct: 287 GPVYR----IMTQCWQHQPEDRPNFAIILE 312

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 97/237 (40%), Gaps = 47/237 (19%)
Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRV-----FALKVIYGNHEDSVRSQICREIEILRDV- 154
           L+ G  +GSG+ G V        S+       A+K++    + S R  +  E++++  + 
Sbjct: 47  LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 106
Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSL---------------------------EGA 187
           +H N+V        +G I ++ EY   G L                           E  
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 188 HIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM 247
           ++     L   A QV  G+ +L  +  VHRD+   N+L+   K VKI DFG++R     M
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR---DIM 223
Query: 248 DPCNSAVGT-----IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
              N  V       + +M+PE     L  G Y     D+WS G+ + E F LG  P+
Sbjct: 224 SDSNYVVRGNARLPVKWMAPE----SLFEGIYT-IKSDVWSYGILLWEIFSLGVNPY 275

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 28/218 (12%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
           +R G    G ++       ++  A+K +    E  +R +   E  +   + HPNVV    
Sbjct: 37  DRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLG 96
Query: 165 MYDRNGEIEVLLEYMDGGSL-EGAHIRQEHI-------------------LSDLARQVLS 204
           +  ++  + ++  Y   G L E   +R  H                       L  Q+ +
Sbjct: 97  VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAA 156
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL--AQTMDPCNSAVGTIAYMSP 262
           G+ YL    +VH+D+   N+L+    NVKI+D G+ R +  A       +++  I +M+P
Sbjct: 157 GMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAP 216
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFA 299
           E I     +GK+     DIWS GV + E F  G  P+ 
Sbjct: 217 EAI----MYGKF-SIDSDIWSYGVVLWEVFSYGLQPYC 249

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 105/268 (39%), Gaps = 42/268 (15%)
Query: 107 IGSGSGGTVWRV----VHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKC 162
           +G G+ G V+      + P   ++           +S R    RE E+L  + H ++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 163 HDMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHILSD----------------LARQVL 203
             +      + ++ EYM  G L     +H     +L+                 +A QV 
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT--MDPCNSAVGTIAYMS 261
           +G+ YL     VHRD+   N L+     VKI DFG+SR +  T         +  I +M 
Sbjct: 146 AGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP 205
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASL-----MFAICFA 316
           PE I     + K+   + D+WS GV + E       F  G+Q  W  L     +  I   
Sbjct: 206 PESI----LYRKFTTES-DVWSFGVVLWEI------FTYGKQ-PWYQLSNTEAIDCITQG 253
Query: 317 QPPEAPEMASREFRDFISRCLQKDPHSR 344
           +  E P     E    +  C Q++P  R
Sbjct: 254 RELERPRACPPEVYAIMRGCWQREPQQR 281

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 111/270 (41%), Gaps = 34/270 (12%)
Query: 107 IGSGSGGTVWR-----VVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           +G G+ G V+      + + P+    A+K +     +        E  I+  +NH N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEH------------ILSDLARQVLSGLAYL 209
           C  +  ++    +LLE M GG L+ + +R+               L  +AR +  G  YL
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLK-SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 210 HKRKIVHRDIKPSNLLINS---SKNVKIADFGVSRIL--AQTMDPCNSAVGTIAYMSPER 264
            +   +HRDI   N L+      +  KI DFG++R +  A        A+  + +M PE 
Sbjct: 158 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 217
Query: 265 INTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPE-AP 322
               +   K      D WS GV + E F LG  P+      +    + +     PP+  P
Sbjct: 218 FMEGIFTSK-----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCP 272
Query: 323 EMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
               R     +++C Q  P  R   A +L+
Sbjct: 273 GPVYR----IMTQCWQHQPEDRPNFAIILE 298

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 102/231 (44%), Gaps = 38/231 (16%)
Query: 100 ELQKGNRIGSGSGGTVWRVV-------HPPTSRVFALKVIYGNHEDSVRSQICREIEILR 152
           +L  G  +G G+ G V            P  +   A+K++  +  +   S +  E+E+++
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 153 DV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR------------------QEH 193
            +  H N++       ++G + V++ Y   G+L   ++R                  ++ 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVAYASKGNLR-EYLRARRPPGMEYSYDINRVPEEQM 154
Query: 194 ILSDLAR---QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
              DL     Q+  G+ YL  +K +HRD+   N+L+  +  +KIADFG++R +       
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 251 NSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
            +  G   + +M+PE +       +   +  D+WS GV + E F LG  P+
Sbjct: 215 KTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 107/275 (38%), Gaps = 56/275 (20%)
Query: 107 IGSGSGGTVWRV----VHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKC 162
           +G G+ G V+      + P   ++           +S R    RE E+L  + H ++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 163 HDMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHILSD----------------LARQVL 203
             +      + ++ EYM  G L     +H     +L+                 +A QV 
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS---------RILAQTMDPCNSAV 254
           +G+ YL     VHRD+   N L+     VKI DFG+S         R+  +TM P     
Sbjct: 169 AGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP----- 223
Query: 255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASL----- 309
             I +M PE I     + K+   + D+WS GV + E       F  G+Q  W  L     
Sbjct: 224 --IRWMPPESI----LYRKFTTES-DVWSFGVVLWEI------FTYGKQ-PWYQLSNTEA 269
Query: 310 MFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
           +  I   +  E P     E    +  C Q++P  R
Sbjct: 270 IDCITQGRELERPRACPPEVYAIMRGCWQREPQQR 304

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 105/268 (39%), Gaps = 42/268 (15%)
Query: 107 IGSGSGGTVWRV----VHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKC 162
           +G G+ G V+      + P   ++           +S R    RE E+L  + H ++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 163 HDMYDRNGEIEVLLEYMDGGSLEG---AHIRQEHILSD----------------LARQVL 203
             +      + ++ EYM  G L     +H     +L+                 +A QV 
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT--MDPCNSAVGTIAYMS 261
           +G+ YL     VHRD+   N L+     VKI DFG+SR +  T         +  I +M 
Sbjct: 140 AGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP 199
Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASL-----MFAICFA 316
           PE I     + K+   + D+WS GV + E       F  G+Q  W  L     +  I   
Sbjct: 200 PESI----LYRKFTTES-DVWSFGVVLWEI------FTYGKQ-PWYQLSNTEAIDCITQG 247
Query: 317 QPPEAPEMASREFRDFISRCLQKDPHSR 344
           +  E P     E    +  C Q++P  R
Sbjct: 248 RELERPRACPPEVYAIMRGCWQREPQQR 275

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 110/270 (40%), Gaps = 34/270 (12%)
Query: 107 IGSGSGGTVWR-----VVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           +G G+ G V+      + + P+    A+K +     +        E  I+   NH N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI------------LSDLARQVLSGLAYL 209
           C  +  ++    +LLE M GG L+ + +R+               L  +AR +  G  YL
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLK-SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 148
Query: 210 HKRKIVHRDIKPSNLLINS---SKNVKIADFGVSRIL--AQTMDPCNSAVGTIAYMSPER 264
            +   +HRDI   N L+      +  KI DFG++R +  A        A+  + +M PE 
Sbjct: 149 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 208
Query: 265 INTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPE-AP 322
               +   K      D WS GV + E F LG  P+      +    + +     PP+  P
Sbjct: 209 FMEGIFTSK-----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCP 263
Query: 323 EMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
               R     +++C Q  P  R   A +L+
Sbjct: 264 GPVYR----IMTQCWQHQPEDRPNFAIILE 289

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 110/270 (40%), Gaps = 34/270 (12%)
Query: 107 IGSGSGGTVWR-----VVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           +G G+ G V+      + + P+    A+K +     +        E  I+   NH N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEH------------ILSDLARQVLSGLAYL 209
           C  +  ++    +LLE M GG L+ + +R+               L  +AR +  G  YL
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLK-SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 210 HKRKIVHRDIKPSNLLINS---SKNVKIADFGVSRIL--AQTMDPCNSAVGTIAYMSPER 264
            +   +HRDI   N L+      +  KI DFG++R +  A        A+  + +M PE 
Sbjct: 184 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 243
Query: 265 INTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPE-AP 322
               +   K      D WS GV + E F LG  P+      +    + +     PP+  P
Sbjct: 244 FMEGIFTSK-----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCP 298
Query: 323 EMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
               R     +++C Q  P  R   A +L+
Sbjct: 299 GPVYR----IMTQCWQHQPEDRPNFAIILE 324

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 28/218 (12%)
Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
           +R G    G ++       ++  A+K +    E  +R +   E  +   + HPNVV    
Sbjct: 20  DRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLG 79
Query: 165 MYDRNGEIEVLLEYMDGGSL-EGAHIRQEHI-------------------LSDLARQVLS 204
           +  ++  + ++  Y   G L E   +R  H                       L  Q+ +
Sbjct: 80  VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAA 139
Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL--AQTMDPCNSAVGTIAYMSP 262
           G+ YL    +VH+D+   N+L+    NVKI+D G+ R +  A       +++  I +M+P
Sbjct: 140 GMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAP 199
Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFA 299
           E I     +GK+     DIWS GV + E F  G  P+ 
Sbjct: 200 EAI----MYGKF-SIDSDIWSYGVVLWEVFSYGLQPYC 232

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 110/270 (40%), Gaps = 34/270 (12%)
Query: 107 IGSGSGGTVWR-----VVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           +G G+ G V+      + + P+    A+K +     +        E  I+   NH N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEH------------ILSDLARQVLSGLAYL 209
           C  +  ++    +LLE M GG L+ + +R+               L  +AR +  G  YL
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLK-SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 210 HKRKIVHRDIKPSNLLINS---SKNVKIADFGVSRIL--AQTMDPCNSAVGTIAYMSPER 264
            +   +HRDI   N L+      +  KI DFG++R +  A        A+  + +M PE 
Sbjct: 158 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 217
Query: 265 INTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPE-AP 322
               +   K      D WS GV + E F LG  P+      +    + +     PP+  P
Sbjct: 218 FMEGIFTSK-----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCP 272
Query: 323 EMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
               R     +++C Q  P  R   A +L+
Sbjct: 273 GPVYR----IMTQCWQHQPEDRPNFAIILE 298

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 110/270 (40%), Gaps = 34/270 (12%)
Query: 107 IGSGSGGTVWR-----VVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           +G G+ G V+      + + P+    A+K +     +        E  I+   NH N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEH------------ILSDLARQVLSGLAYL 209
           C  +  ++    +LLE M GG L+ + +R+               L  +AR +  G  YL
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLK-SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 163
Query: 210 HKRKIVHRDIKPSNLLINS---SKNVKIADFGVSRIL--AQTMDPCNSAVGTIAYMSPER 264
            +   +HRDI   N L+      +  KI DFG++R +  A        A+  + +M PE 
Sbjct: 164 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 223
Query: 265 INTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPE-AP 322
               +   K      D WS GV + E F LG  P+      +    + +     PP+  P
Sbjct: 224 FMEGIFTSK-----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCP 278
Query: 323 EMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
               R     +++C Q  P  R   A +L+
Sbjct: 279 GPVYR----IMTQCWQHQPEDRPNFAIILE 304

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 110/270 (40%), Gaps = 34/270 (12%)
Query: 107 IGSGSGGTVWR-----VVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           +G G+ G V+      + + P+    A+K +     +        E  I+   NH N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI------------LSDLARQVLSGLAYL 209
           C  +  ++    +LLE M GG L+ + +R+               L  +AR +  G  YL
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLK-SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 210 HKRKIVHRDIKPSNLLINS---SKNVKIADFGVSRIL--AQTMDPCNSAVGTIAYMSPER 264
            +   +HRDI   N L+      +  KI DFG++R +  A        A+  + +M PE 
Sbjct: 157 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 216
Query: 265 INTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPE-AP 322
               +   K      D WS GV + E F LG  P+      +    + +     PP+  P
Sbjct: 217 FMEGIFTSK-----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCP 271
Query: 323 EMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
               R     +++C Q  P  R   A +L+
Sbjct: 272 GPVYR----IMTQCWQHQPEDRPNFAIILE 297

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 110/270 (40%), Gaps = 34/270 (12%)
Query: 107 IGSGSGGTVWR-----VVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           +G G+ G V+      + + P+    A+K +     +        E  I+   NH N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEH------------ILSDLARQVLSGLAYL 209
           C  +  ++    +LLE M GG L+ + +R+               L  +AR +  G  YL
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLK-SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 210 HKRKIVHRDIKPSNLLINS---SKNVKIADFGVSRIL--AQTMDPCNSAVGTIAYMSPER 264
            +   +HRDI   N L+      +  KI DFG++R +  A        A+  + +M PE 
Sbjct: 174 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 233
Query: 265 INTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPE-AP 322
               +   K      D WS GV + E F LG  P+      +    + +     PP+  P
Sbjct: 234 FMEGIFTSK-----TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCP 288
Query: 323 EMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
               R     +++C Q  P  R   A +L+
Sbjct: 289 GPVYR----IMTQCWQHQPEDRPNFAIILE 314

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 102/231 (44%), Gaps = 38/231 (16%)
Query: 100 ELQKGNRIGSGSGGTVWRVV-------HPPTSRVFALKVIYGNHEDSVRSQICREIEILR 152
           +L  G  +G G+ G V            P  +   A+K++  +  +   S +  E+E+++
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 153 DV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIR------------------QEH 193
            +  H N++       ++G + V++ Y   G+L   ++R                  ++ 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVGYASKGNLR-EYLRARRPPGMEYSYDINRVPEEQM 154
Query: 194 ILSDLAR---QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
              DL     Q+  G+ YL  +K +HRD+   N+L+  +  +KIADFG++R +       
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 251 NSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
            +  G   + +M+PE +       +   +  D+WS GV + E F LG  P+
Sbjct: 215 KTTNGRLPVKWMAPEAL-----FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 101/242 (41%), Gaps = 26/242 (10%)
Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV------NHPNVV 160
           IG GS G V +       +  ALK++   +E     Q   EI IL  +      N  NV+
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV--RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEH-----ILSDLARQVLSGLAYLHKRKIV 215
              + +     I +  E +     E     +       ++   A  +L  L  LHK +I+
Sbjct: 163 HMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRII 222
Query: 216 HRDIKPSNLLINSS--KNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           H D+KP N+L+       +K+ DFG S    Q +    + + +  Y +PE I      G 
Sbjct: 223 HCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV---YTXIQSRFYRAPEVI-----LGA 274
Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGR-QGDWASLMFAICFAQPPEAPEMASREFRDF 332
             G   D+WSLG  + E   G +P   G  +GD  + M  +    P +    AS+  ++F
Sbjct: 275 RYGMPIDMWSLGCILAELLTG-YPLLPGEDEGDQLACMIEL-LGMPSQKLLDASKRAKNF 332
Query: 333 IS 334
           +S
Sbjct: 333 VS 334
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	380
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-117
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-111
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-106
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-103
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-102
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-85
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-82
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-78
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-77
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-77
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-77
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-77
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-77
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-76
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-75
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-75
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-75
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-73
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-73
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	7e-73
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-72
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-72
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-72
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-70
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-70
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-69
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-67
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-66
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-65
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-65
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-64
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-62
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-61
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-61
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-61
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-61
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-61
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-61
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-61
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-61
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-61
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-61
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-60
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-60
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-60
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-60
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-60
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-59
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-59
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-59
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-59
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-59
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-59
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-59
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-59
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-58
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-58
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-58
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-58
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-58
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-58
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-58
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-58
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-58
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-57
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-57
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-57
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-56
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-56
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-56
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-56
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	9e-56
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-55
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-54
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-54
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-53
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-53
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-53
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-53
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-53
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-53
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-53
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-52
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-52
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-52
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-52
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-52
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-52
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-51
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-51
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-50
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-50
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-50
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-50
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-50
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-50
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-48
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-48
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-48
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-48
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-48
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-47
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-46
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-46
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-46
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-46
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-45
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-45
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-45
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-45
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-44
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-44
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-44
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-43
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-43
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-43
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-42
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-42
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-42
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-42
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-41
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-41
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-41
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-41
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-41
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-41
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-40
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-40
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-40
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-40
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-39
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-39
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-39
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-39
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-39
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-39
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-38
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-38
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-38
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-38
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-38
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-38
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-38
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-37
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-37
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-37
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-36
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-36
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-36
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-36
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-36
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-36
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-36
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-35
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-35
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-35
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-35
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-35
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-35
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-35
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-35
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-35
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-34
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-34
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-34
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-34
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-33
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-32
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-32
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-32
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-32
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-32
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-32
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-32
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-31
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-31
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-31
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-31
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-31
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-31
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-30
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-30
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-30
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-30
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-30
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-30
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-30
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-30
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-30
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-29
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-29
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-29
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-29
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-29
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-28
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-28
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-28
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-28
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-27
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-27
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-27
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-27
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-26
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-26
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-26
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-26
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-26
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-26
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-25
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-25
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-25
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-25
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-25
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-25
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-25
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-24
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-24
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-24
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-23
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-23
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-23
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-23
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-23
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-23
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-23
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-22
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-22
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-22
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-22
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-21
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-20
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-18
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-17
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-13
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-06
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	8e-04

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  327 bits (840), Expect = e-111
 Identities = 84/283 (29%), Positives = 142/283 (50%), Gaps = 20/283 (7%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDV 154
           +   +L+    +G G+ G V ++ H P+ ++ A+K I        + ++  +++I +R V
Sbjct: 4   VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV 63

Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGS-------LEGAHIRQEHILSDLARQVLSGLA 207
           + P  V  +    R G++ + +E MD          ++      E IL  +A  ++  L 
Sbjct: 64  DCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123

Query: 208 YLH-KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN 266
           +LH K  ++HRD+KPSN+LIN+   VK+ DFG+S  L   +   +   G   YM+PERIN
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA-KDIDAGCKPYMAPERIN 182

Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWAS---LMFAICFAQPPEAP- 322
            +LN   Y     DIWSLG++++E  + RFP+       W +    +  +     P+ P 
Sbjct: 183 PELNQKGYS-VKSDIWSLGITMIELAILRFPYD-----SWGTPFQQLKQVVEEPSPQLPA 236

Query: 323 EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN 365
           +  S EF DF S+CL+K+   R    +L+QHPF         +
Sbjct: 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTD 279

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  315 bits (808), Expect = e-106
 Identities = 109/358 (30%), Positives = 178/358 (49%), Gaps = 54/358 (15%)

Query: 67  GQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRV 126
           G+          Q+++ +     + +   +   + +K + +G+G+GG V++V H P+  V
Sbjct: 1   GKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV 60

Query: 127 FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEG 186
            A K+I+   + ++R+QI RE+++L + N P +V  +  +  +GEI + +E+MDGGSL+ 
Sbjct: 61  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120

Query: 187 AHIRQ----EHILSDLARQVLSGLAYLH-KRKIVHRDIKPSNLLINSSKNVKIADFGVSR 241
              +     E IL  ++  V+ GL YL  K KI+HRD+KPSN+L+NS   +K+ DFGVS 
Sbjct: 121 VLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180

Query: 242 ILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVG 301
            L  +M   NS VGT +YMSPER+      G +     DIWS+G+S++E  +GR+P    
Sbjct: 181 QLIDSM--ANSFVGTRSYMSPERLQ-----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233

Query: 302 RQGDWAS---------------------------------------LMFAICFAQPPEAP 322
              +                                          L+  I    PP+ P
Sbjct: 234 DAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP 293

Query: 323 EMA-SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN--QNLRQILPPPRP 377
               S EF+DF+++CL K+P  R    QL+ H FI R+   +V+    L   +   +P
Sbjct: 294 SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQP 351

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  307 bits (788), Expect = e-103
 Identities = 84/288 (29%), Positives = 139/288 (48%), Gaps = 26/288 (9%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI-LRDV 154
               +L+    IG G+ G+V ++VH P+ ++ A+K I    ++  + Q+  ++++ +R  
Sbjct: 19  FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS 78

Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSL---------EGAHIRQEHILSDLARQVLSG 205
           + P +V+ +    R G+  + +E M                  I  E IL  +    +  
Sbjct: 79  DCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIP-EEILGKITLATVKA 137

Query: 206 LAYLH-KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPER 264
           L +L    KI+HRDIKPSN+L++ S N+K+ DFG+S  L  ++       G   YM+PER
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPER 196

Query: 265 INTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWAS---LMFAICFAQPPEA 321
           I+   +   YD    D+WSLG+++ E   GRFP+       W S    +  +    PP+ 
Sbjct: 197 IDPSASRQGYD-VRSDVWSLGITLYELATGRFPYP-----KWNSVFDQLTQVVKGDPPQL 250

Query: 322 PEMA----SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN 365
                   S  F +F++ CL KD   R    +LL+HPFIL   +  V 
Sbjct: 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVE 298

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  303 bits (777), Expect = e-102
 Identities = 76/281 (27%), Positives = 137/281 (48%), Gaps = 17/281 (6%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEIL-RDV 154
               +L+    +GSG+ G VW++    T  V A+K +  +       +I  +++++ +  
Sbjct: 22  AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH 81

Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLH 210
           + P +V+C   +  N ++ + +E M   + +     Q    E IL  +   ++  L YL 
Sbjct: 82  DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK 141

Query: 211 -KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
            K  ++HRD+KPSN+L++    +K+ DFG+S  L       + + G  AYM+PERI+   
Sbjct: 142 EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA-KDRSAGCAAYMAPERIDPPD 200

Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWAS---LMFAICFAQPPEAPEMA- 325
                     D+WSLG+S++E   G+FP+      +  +   ++  +   +PP  P    
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQFPYK-----NCKTDFEVLTKVLQEEPPLLPGHMG 255

Query: 326 -SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN 365
            S +F+ F+  CL KD   R    +LL+H FI R    +V+
Sbjct: 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  260 bits (667), Expect = 2e-85
 Identities = 90/276 (32%), Positives = 132/276 (47%), Gaps = 19/276 (6%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
                +G G+ G V+           A+K I        +  +  EI + + + H N+V+
Sbjct: 25  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQ 83

Query: 162 CHDMYDRNGEIEVLLEYMDGGSLE-------GAHIRQEHILSDLARQVLSGLAYLHKRKI 214
               +  NG I++ +E + GGSL        G     E  +    +Q+L GL YLH  +I
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143

Query: 215 VHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           VHRDIK  N+LIN+    +KI+DFG S+ LA       +  GT+ YM+PE I+       
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIID-----KG 198

Query: 274 YDGY--AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI-CFAQPPEAPEMASREFR 330
             GY  A DIWSLG +I+E   G+ PF     G+  + MF +  F   PE PE  S E +
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPPFY--ELGEPQAAMFKVGMFKVHPEIPESMSAEAK 256

Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQ 366
            FI +C + DP  R  A  LL   F+  + + +  Q
Sbjct: 257 AFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQ 292

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  253 bits (647), Expect = 6e-82
 Identities = 76/294 (25%), Positives = 135/294 (45%), Gaps = 24/294 (8%)

Query: 76  HPHQQQQNQTQNNHQNRHQLINPAELQK---GNRIGSGSGGTVWRVVHPPTSRVFALKVI 132
           H H    +      +N +       ++K     +IG GS G    V      R + +K I
Sbjct: 2   HHHHHHSSGVDLGTENLY----FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI 57

Query: 133 -YGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLE------ 185
                    R +  RE+ +L ++ HPN+V+  + ++ NG + ++++Y +GG L       
Sbjct: 58  NISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ 117

Query: 186 -GAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA 244
            G   +++ IL D   Q+   L ++H RKI+HRDIK  N+ +     V++ DFG++R+L 
Sbjct: 118 KGVLFQEDQIL-DWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176

Query: 245 QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG 304
            T++   + +GT  Y+SPE       +  Y+    DIW+LG  + E    +  F     G
Sbjct: 177 STVELARACIGTPYYLSPEIC----ENKPYN-NKSDIWALGCVLYELCTLKHAF---EAG 228

Query: 305 DWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR 358
              +L+  I     P      S + R  +S+  +++P  R     +L+  FI +
Sbjct: 229 SMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  243 bits (622), Expect = 1e-78
 Identities = 83/316 (26%), Positives = 138/316 (43%), Gaps = 21/316 (6%)

Query: 67  GQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRV 126
            + +      P  Q Q Q        +  +     +   +IG G    V+R         
Sbjct: 2   DEQSQGMQGPPVPQFQPQKALRPDMGYNTLA--NFRIEKKIGRGQFSEVYRAACLLDGVP 59

Query: 127 FALKVI-YGNHEDSV-RSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL 184
            ALK +   +  D+  R+   +EI++L+ +NHPNV+K +  +  + E+ ++LE  D G L
Sbjct: 60  VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL 119

Query: 185 ---------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIA 235
                    +   I +  +      Q+ S L ++H R+++HRDIKP+N+ I ++  VK+ 
Sbjct: 120 SRMIKHFKKQKRLIPERTVW-KYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLG 178

Query: 236 DFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR 295
           D G+ R  +      +S VGT  YMSPERI    +   Y+ +  DIWSLG  + E    +
Sbjct: 179 DLGLGRFFSSKTTAAHSLVGTPYYMSPERI----HENGYN-FKSDIWSLGCLLYEMAALQ 233

Query: 296 FPFAVGRQGDWASLMFAICFAQPPEAPEMA-SREFRDFISRCLQKDPHSRWPAAQLLQHP 354
            PF  G + +  SL   I     P  P    S E R  ++ C+  DP  R     +    
Sbjct: 234 SPFY-GDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVA 292

Query: 355 FILRAGQSQVNQNLRQ 370
             + A  +   ++   
Sbjct: 293 KRMHACTASSLEHHHH 308

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  240 bits (615), Expect = 1e-77
 Identities = 88/291 (30%), Positives = 154/291 (52%), Gaps = 18/291 (6%)

Query: 89  HQNRHQLINPAEL-QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICRE 147
           +++  + ++P E+ +    +G G+ G V++  +  T  + A KVI    E+ +      E
Sbjct: 8   YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL-EDYIVE 66

Query: 148 IEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQV 202
           IEIL   +HP +VK    Y  +G++ +++E+  GG++     E      E  +  + RQ+
Sbjct: 67  IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQM 126

Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSP 262
           L  L +LH ++I+HRD+K  N+L+    ++++ADFGVS    +T+   +S +GT  +M+P
Sbjct: 127 LEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAP 186

Query: 263 ERINTD-LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASL--MFAICFAQPP 319
           E +  + +    YD  A DIWSLG++++E      P       +   +  +  I  + PP
Sbjct: 187 EVVMCETMKDTPYDYKA-DIWSLGITLIEMAQIEPPHH-----ELNPMRVLLKIAKSDPP 240

Query: 320 --EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNL 368
               P   S EFRDF+   L K+P +R  AAQLL+HPF+     ++  + L
Sbjct: 241 TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALREL 291

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  239 bits (613), Expect = 2e-77
 Identities = 99/291 (34%), Positives = 150/291 (51%), Gaps = 20/291 (6%)

Query: 74  NHHPHQQQQNQTQNNHQNRHQLINPAEL-QKGNRIGSGSGGTVWRVVHPPTSRVFALKVI 132
            H P Q      QN   +      P EL  K  +IG GS G V++ +   T +V A+K+I
Sbjct: 2   AHSPVQSGLPGMQNLKAD------PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII 55

Query: 133 YGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGS----LEGAH 188
                +     I +EI +L   + P V K +  Y ++ ++ +++EY+ GGS    LE   
Sbjct: 56  DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP 115

Query: 189 IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD 248
           + +  I + + R++L GL YLH  K +HRDIK +N+L++    VK+ADFGV+  L  T  
Sbjct: 116 LDETQI-ATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174

Query: 249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWAS 308
             N+ VGT  +M+PE I        YD  A DIWSLG++ +E   G  P +   +     
Sbjct: 175 KRNTFVGTPFWMAPEVI----KQSAYDSKA-DIWSLGITAIELARGEPPHS---ELHPMK 226

Query: 309 LMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA 359
           ++F I    PP      S+  ++F+  CL K+P  R  A +LL+H FILR 
Sbjct: 227 VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  240 bits (615), Expect = 3e-77
 Identities = 76/340 (22%), Positives = 126/340 (37%), Gaps = 37/340 (10%)

Query: 59  TSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAEL---------QKGNRIGS 109
            ++S +S  ++ S  +    +       N      + + P +              R+G 
Sbjct: 9   QAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGR 68

Query: 110 GSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRN 169
           GS G V R+    T    A+K +       +      E+     ++ P +V  +      
Sbjct: 69  GSFGEVHRMKDKQTGFQCAVKKV------RLEVFRVEELVACAGLSSPRIVPLYGAVREG 122

Query: 170 GEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNL 224
             + + +E ++GGSL G  I+Q     E        Q L GL YLH R+I+H D+K  N+
Sbjct: 123 PWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181

Query: 225 LINSS-KNVKIADFGVSRILA-----QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           L++S      + DFG +  L      +++   +   GT  +M+PE +      GK     
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM-----GKPCDAK 236

Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP--EAPEMASREFRDFISRC 336
            DIWS    +L    G  P+    Q     L   I    PP  E P   +      I   
Sbjct: 237 VDIWSSCCMMLHMLNGCHPWT---QYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG 293

Query: 337 LQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPR 376
           L+K+P  R  A +L +           +    +     PR
Sbjct: 294 LRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR 333

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  239 bits (613), Expect = 3e-77
 Identities = 66/300 (22%), Positives = 128/300 (42%), Gaps = 21/300 (7%)

Query: 73  QNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI 132
            +HH H    +    N   +   +         +IGSG    V++V++    +++A+K +
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYV 60

Query: 133 -YGNHEDSVRSQICREIEILRDVNHPN--VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHI 189
                ++        EI  L  +   +  +++ +D    +  I +++E      L  + +
Sbjct: 61  NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLN-SWL 118

Query: 190 RQEHILS-DLAR----QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA 244
           +++  +     +     +L  +  +H+  IVH D+KP+N LI     +K+ DFG++  + 
Sbjct: 119 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQ 177

Query: 245 --QTMDPCNSAVGTIAYMSPERI------NTDLNHGKYDGYAGDIWSLGVSILEFYLGRF 296
              T    +S VGT+ YM PE I        +           D+WSLG  +     G+ 
Sbjct: 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237

Query: 297 PFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           PF        + L   I      E P++  ++ +D +  CL++DP  R    +LL HP++
Sbjct: 238 PFQ-QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  237 bits (607), Expect = 8e-77
 Identities = 76/274 (27%), Positives = 131/274 (47%), Gaps = 26/274 (9%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNVV 160
           +    IG+GS G   ++      ++   K + YG+  ++ +  +  E+ +LR++ HPN+V
Sbjct: 9   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 68

Query: 161 KCHDMY--DRNGEIEVLLEYMDGGSL---------EGAHIRQEHILSDLARQVLSGLAYL 209
           + +D      N  + +++EY +GG L         E  ++ +E +L  +  Q+   L   
Sbjct: 69  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL-RVMTQLTLALKEC 127

Query: 210 HKRK-----IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPER 264
           H+R      ++HRD+KP+N+ ++  +NVK+ DFG++RIL        + VGT  YMSPE+
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQ 187

Query: 265 INTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM 324
               +N   Y+    DIWSLG  + E      PF          L   I   +    P  
Sbjct: 188 ----MNRMSYN-EKSDIWSLGCLLYELCALMPPF---TAFSQKELAGKIREGKFRRIPYR 239

Query: 325 ASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR 358
            S E  + I+R L    + R    ++L++P IL 
Sbjct: 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  238 bits (610), Expect = 8e-76
 Identities = 64/320 (20%), Positives = 130/320 (40%), Gaps = 21/320 (6%)

Query: 53  PLPLPPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSG 112
            +P       ++++     H +        +   ++  N    +         +IGSG  
Sbjct: 10  LVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGS 69

Query: 113 GTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPN--VVKCHDMYDRN 169
             V++V++    +++A+K +     ++        EI  L  +   +  +++ +D    +
Sbjct: 70  SKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 128

Query: 170 GEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNL 224
             I +++E      L  + +++             + +L  +  +H+  IVH D+KP+N 
Sbjct: 129 QYIYMVMEC-GNIDLN-SWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 186

Query: 225 LINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERI------NTDLNHGKYDG 276
           LI     +K+ DFG++  +    T    +S VG + YM PE I        +        
Sbjct: 187 LI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKIS 245

Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
              D+WSLG  +     G+ PF        + L   I      E P++  ++ +D +  C
Sbjct: 246 PKSDVWSLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCC 304

Query: 337 LQKDPHSRWPAAQLLQHPFI 356
           L++DP  R    +LL HP++
Sbjct: 305 LKRDPKQRISIPELLAHPYV 324

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  235 bits (601), Expect = 1e-75
 Identities = 82/277 (29%), Positives = 133/277 (48%), Gaps = 29/277 (10%)

Query: 97  NPAEL-QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           +P +   +  +IG G+ GTV+  +   T +  A++ +    +   +  I  EI ++R+  
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENK 75

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHK 211
           +PN+V   D Y    E+ V++EY+ GGSL        + +  I + + R+ L  L +LH 
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-AAVCRECLQALEFLHS 134

Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            +++HRDIK  N+L+    +VK+ DFG    +       ++ VGT  +M+PE +      
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV----TR 190

Query: 272 GKYDGYAGDIWSLGVSILEF------YLGRFPFAVGRQGDWASLMFAICFAQPP--EAPE 323
             Y     DIWSLG+  +E       YL   P            ++ I     P  + PE
Sbjct: 191 KAYGPKV-DIWSLGIMAIEMIEGEPPYLNENPLRA---------LYLIATNGTPELQNPE 240

Query: 324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG 360
             S  FRDF++RCL+ D   R  A +LLQH F+  A 
Sbjct: 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  236 bits (603), Expect = 1e-75
 Identities = 90/313 (28%), Positives = 141/313 (45%), Gaps = 29/313 (9%)

Query: 61  NSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAEL-QKGNRIGSGSGGTVWRVV 119
           + SS     T +           Q +   +      +P  L     +IG GS G V    
Sbjct: 6   HHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR 65

Query: 120 HPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYM 179
              + R  A+K++    +   R  +  E+ I+RD  H NVV+ +  Y    E+ VL+E++
Sbjct: 66  EKHSGRQVAVKMMDLRKQQR-RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124

Query: 180 DGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIA 235
            GG+L        + +E I + +   VL  LAYLH + ++HRDIK  ++L+     VK++
Sbjct: 125 QGGALTDIVSQVRLNEEQI-ATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLS 183

Query: 236 DFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF---- 291
           DFG    +++ +    S VGT  +M+PE I    +   Y     DIWSLG+ ++E     
Sbjct: 184 DFGFCAQISKDVPKRKSLVGTPYWMAPEVI----SRSLYATEV-DIWSLGIMVIEMVDGE 238

Query: 292 --YLGRFPFAVGRQGDWASLMFAICFAQPP--EAPEMASREFRDFISRCLQKDPHSRWPA 347
             Y    P            M  +  + PP  +     S   RDF+ R L +DP  R  A
Sbjct: 239 PPYFSDSPVQA---------MKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATA 289

Query: 348 AQLLQHPFILRAG 360
            +LL HPF+L+ G
Sbjct: 290 QELLDHPFLLQTG 302

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  235 bits (602), Expect = 2e-75
 Identities = 95/283 (33%), Positives = 154/283 (54%), Gaps = 25/283 (8%)

Query: 97  NPAEL-QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
            P E+     ++G GS G+V++ +H  T ++ A+K +    E  +  +I +EI I++  +
Sbjct: 26  QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDL-QEIIKEISIMQQCD 82

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYL 209
            P+VVK +  Y +N ++ +++EY   GS+          + ++ I + + +  L GL YL
Sbjct: 83  SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEI-ATILQSTLKGLEYL 141

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
           H  + +HRDIK  N+L+N+  + K+ADFGV+  L  TM   N+ +GT  +M+PE I    
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI---- 197

Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASL--MFAICFAQPP--EAPEMA 325
               Y+  A DIWSLG++ +E   G+ P+A     D   +  +F I    PP    PE+ 
Sbjct: 198 QEIGYNCVA-DIWSLGITAIEMAEGKPPYA-----DIHPMRAIFMIPTNPPPTFRKPELW 251

Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNL 368
           S  F DF+ +CL K P  R  A QLLQHPF+  A    + ++L
Sbjct: 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDL 294

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  230 bits (588), Expect = 2e-73
 Identities = 78/315 (24%), Positives = 120/315 (38%), Gaps = 27/315 (8%)

Query: 55  PLPPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAEL-----QKGNRIGS 109
                  + +   QS           +   ++      +    P        Q+ +R+G 
Sbjct: 8   SSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGH 67

Query: 110 GSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYD 167
           GS G V++V      R++A+K           R++   E+     V  HP  V+    ++
Sbjct: 68  GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127

Query: 168 RNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKP 221
             G + +  E   G SL       GA + +  +     R  L  LA+LH + +VH D+KP
Sbjct: 128 EGGILYLQTELC-GPSLQQHCEAWGASLPEAQVW-GYLRDTLLALAHLHSQGLVHLDVKP 185

Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDI 281
           +N+ +      K+ DFG+   L  T        G   YM+PE     L  G Y   A D+
Sbjct: 186 ANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQEGDPRYMAPE-----LLQGSYG-TAADV 238

Query: 282 WSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDP 341
           +SLG++ILE          G    W  L        PPE     S E R  +   L+ DP
Sbjct: 239 FSLGLTILEVACNMELPHGGE--GWQQLRQGYL---PPEFTAGLSSELRSVLVMMLEPDP 293

Query: 342 HSRWPAAQLLQHPFI 356
             R  A  LL  P +
Sbjct: 294 KLRATAEALLALPVL 308

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  229 bits (587), Expect = 2e-73
 Identities = 73/308 (23%), Positives = 133/308 (43%), Gaps = 50/308 (16%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           ++   +G G+ G V +  +   SR +A+K I   H +   S I  E+ +L  +NH  VV+
Sbjct: 9   EEIAVLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLSTILSEVMLLASLNHQYVVR 66

Query: 162 CHDMYDRNGEIEVL-------------LEYMDGGSL------EGAHIRQEHILSDLARQV 202
            +  +                      +EY + G+L      E  + +++     L RQ+
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW-RLFRQI 125

Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC------------ 250
           L  L+Y+H + I+HRD+KP N+ I+ S+NVKI DFG+++ + +++D              
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185

Query: 251 --NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWAS 308
              SA+GT  Y++ E ++     G Y+    D++SLG+   E             G    
Sbjct: 186 NLTSAIGTAMYVATEVLD---GTGHYN-EKIDMYSLGIIFFEMIYPFST------GMERV 235

Query: 309 LMFAICFAQ----PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV 364
            +     +     PP+  +   +  +  I   +  DP+ R  A  LL   ++    Q +V
Sbjct: 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEV 295

Query: 365 NQNLRQIL 372
            +   + L
Sbjct: 296 IKEALKSL 303

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  229 bits (586), Expect = 7e-73
 Identities = 65/288 (22%), Positives = 123/288 (42%), Gaps = 22/288 (7%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPN-- 158
               +IGSG    V++V++    +++A+K +     ++        EI  L  +   +  
Sbjct: 12  SILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKRK 213
           +++ +D    +  I +++E      L  + +++             + +L  +  +H+  
Sbjct: 71  IIRLYDYEITDQYIYMVMEC-GNIDLN-SWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERI------ 265
           IVH D+KP+N LI     +K+ DFG++  +    T    +S VGT+ YM PE I      
Sbjct: 129 IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187

Query: 266 NTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA 325
             +           D+WSLG  +     G+ PF        + L   I      E P++ 
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEFPDIP 246

Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILP 373
            ++ +D +  CL++DP  R    +LL HP++ +     VNQ  +    
Sbjct: 247 EKDLQDVLKCCLKRDPKQRISIPELLAHPYV-QIQTHPVNQMAKGTTE 293

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  226 bits (577), Expect = 4e-72
 Identities = 65/290 (22%), Positives = 112/290 (38%), Gaps = 45/290 (15%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDV-NHPNV 159
            +  +IGSG  G+V++ V      ++A+K                RE+     +  H +V
Sbjct: 14  HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73

Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ---------EHILSDLARQVLSGLAYLH 210
           V+    +  +  + +  EY +GGSL    I +         E  L DL  QV  GL Y+H
Sbjct: 74  VRYFSAWAEDDHMLIQNEYCNGGSLA-DAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 211 KRKIVHRDIKPSNLLIN-------------------SSKNVKIADFGVSRILAQTMDPCN 251
              +VH DIKPSN+ I+                   +    KI D G    ++       
Sbjct: 133 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----Q 188

Query: 252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMF 311
              G   +++ E +  +  H        DI++L ++++           G          
Sbjct: 189 VEEGDSRFLANEVLQENYTHL----PKADIFALALTVVCAAGAEPLPRNG------DQWH 238

Query: 312 AICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
            I   + P  P++ S+EF + +   +  DP  R  A  L++H  +L A +
Sbjct: 239 EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  226 bits (577), Expect = 7e-72
 Identities = 87/292 (29%), Positives = 134/292 (45%), Gaps = 37/292 (12%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           IN  + +    IGSG+   V      P     A+K I      +   ++ +EI+ +   +
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL---------EGAHIRQ---EHILSDLARQVL 203
           HPN+V  +  +    E+ ++++ + GGS+         +G H      E  ++ + R+VL
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC-----NSAVGTIA 258
            GL YLHK   +HRD+K  N+L+    +V+IADFGVS  LA   D        + VGT  
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASL--MFAICFA 316
           +M+PE +        YD  A DIWS G++ +E   G  P+       +  +  +      
Sbjct: 192 WMAPEVME---QVRGYDFKA-DIWSFGITAIELATGAAPYH-----KYPPMKVLMLTLQN 242

Query: 317 QPPEAPEMA---------SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA 359
            PP                + FR  IS CLQKDP  R  AA+LL+H F  +A
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  226 bits (578), Expect = 7e-72
 Identities = 83/284 (29%), Positives = 147/284 (51%), Gaps = 24/284 (8%)

Query: 97  NPAEL-QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV- 154
           +PA + +    +G+G+ G V++  H  T ++ A+KV+  +       +I +EI +L+   
Sbjct: 21  DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQEINMLKKYS 78

Query: 155 NHPNVVKCHDMYDRNGEIE------VLLEYMDGGSL-------EGAHIRQEHILSDLARQ 201
           +H N+   +  + +           +++E+   GS+       +G  +++E I + + R+
Sbjct: 79  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI-AYICRE 137

Query: 202 VLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           +L GL++LH+ K++HRDIK  N+L+  +  VK+ DFGVS  L +T+   N+ +GT  +M+
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197

Query: 262 PERINTDLNHGK-YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE 320
           PE I  D N    YD  + D+WSLG++ +E   G  P         A  +F I     P 
Sbjct: 198 PEVIACDENPDATYDFKS-DLWSLGITAIEMAEGAPPLC-DMHPMRA--LFLIPRNPAPR 253

Query: 321 -APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ 363
              +  S++F+ FI  CL K+   R    QL++HPFI      +
Sbjct: 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNER 297

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  224 bits (572), Expect = 1e-70
 Identities = 87/323 (26%), Positives = 144/323 (44%), Gaps = 26/323 (8%)

Query: 57  PPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAEL-QKGNRIGSGSGGTV 115
            PT+ +    G              ++        +    +P +L      IG GS G V
Sbjct: 14  IPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKD---DPEKLFSDLREIGHGSFGAV 70

Query: 116 WRVVHPPTSRVFALKVI--YGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE 173
           +       S V A+K +   G   +     I +E+  L+ + HPN ++    Y R     
Sbjct: 71  YFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130

Query: 174 VLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS 229
           +++EY  G + +   + +    E  ++ +    L GLAYLH   ++HRD+K  N+L++  
Sbjct: 131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 190

Query: 230 KNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSIL 289
             VK+ DFG +   +  M P NS VGT  +M+PE I        YDG   D+WSLG++ +
Sbjct: 191 GLVKLGDFGSA---SI-MAPANSFVGTPYWMAPEVILAMDEGQ-YDGKV-DVWSLGITCI 244

Query: 290 EFYLGRFPFAVGRQGDWASL--MFAICFAQPP--EAPEMASREFRDFISRCLQKDPHSRW 345
           E    + P       +  ++  ++ I   + P  ++    S  FR+F+  CLQK P  R 
Sbjct: 245 ELAERKPPLF-----NMNAMSALYHIAQNESPALQSGHW-SEYFRNFVDSCLQKIPQDRP 298

Query: 346 PAAQLLQHPFILRAGQSQVNQNL 368
            +  LL+H F+LR     V  +L
Sbjct: 299 TSEVLLKHRFVLRERPPTVIMDL 321

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  221 bits (566), Expect = 1e-70
 Identities = 60/290 (20%), Positives = 128/290 (44%), Gaps = 45/290 (15%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           ++   IGSG  G V++  H    + + +K +          +  RE++ L  ++H N+V 
Sbjct: 14  KEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKAEREVKALAKLDHVNIVH 68

Query: 162 CHDMY----------------DRNGEIEVLLEYMDGGSLE-------GAHIRQEHILSDL 198
            +  +                 +   + + +E+ D G+LE       G  + +   L +L
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL-EL 127

Query: 199 ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIA 258
             Q+  G+ Y+H +K+++RD+KPSN+ +  +K VKI DFG+   L         + GT+ 
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK-RTRSKGTLR 186

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQ 317
           YMSPE+I    +   Y     D+++LG+ + E  ++    F      + +     +   +
Sbjct: 187 YMSPEQI----SSQDYG-KEVDLYALGLILAELLHVCDTAF------ETSKFFTDL---R 232

Query: 318 PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQN 367
                ++  ++ +  + + L K P  R   +++L+   + +    +  ++
Sbjct: 233 DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERH 282

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  217 bits (555), Expect = 8e-69
 Identities = 69/272 (25%), Positives = 125/272 (45%), Gaps = 29/272 (10%)

Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNV 159
           L+    IG GS  TV++ +   T+   A   +       S R +   E E+L+ + HPN+
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87

Query: 160 VKCHDMY----DRNGEIEVLLEYMDGGSLEGAHIRQEH------ILSDLARQVLSGLAYL 209
           V+ +D +         I ++ E M  G+L      +        +L    RQ+L GL +L
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTL--KTYLKRFKVMKIKVLRSWCRQILKGLQFL 145

Query: 210 HKRK--IVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN 266
           H R   I+HRD+K  N+ I     +VKI D G++ +   +     + +GT  +M+PE   
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYE 203

Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ--PPEAPEM 324
                 KYD  + D+++ G+ +LE     +P++   +   A+ ++    +   P    ++
Sbjct: 204 -----EKYD-ESVDVYAFGMCMLEMATSEYPYS---ECQNAAQIYRRVTSGVKPASFDKV 254

Query: 325 ASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           A  E ++ I  C++++   R+    LL H F 
Sbjct: 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  216 bits (551), Expect = 4e-67
 Identities = 69/364 (18%), Positives = 133/364 (36%), Gaps = 67/364 (18%)

Query: 78  HQQQQNQTQNNHQNRHQLINPAEL-QKGNRIGSGSG--GTVWRVVHPPTSRVFALKVI-Y 133
           H    +      Q     +      +    IG G     TV    + PT     ++ I  
Sbjct: 3   HHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL 62

Query: 134 GNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEH 193
               + + + +  E+ + +  NHPN+V     +  + E+ V+  +M  GS     +   H
Sbjct: 63  EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA--KDLICTH 120

Query: 194 ILSDLA--------RQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ 245
            +  +         + VL  L Y+H    VHR +K S++LI+    V ++    +  +  
Sbjct: 121 FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180

Query: 246 TM-------DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF 298
                    D    +V  + ++SPE +  +L  G YD  + DI+S+G++  E   G  PF
Sbjct: 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL-QG-YDAKS-DIYSVGITACELANGHVPF 237

Query: 299 A------------------------------------------VGRQGDWASLMFAICFA 316
                                                      +      ++   +   +
Sbjct: 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDS 297

Query: 317 QPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPR 376
                    S  F  F+ +CLQ++P +R  A+ LL H F  +  + + ++ L ++L P  
Sbjct: 298 PSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR-RASEALPELLRPVT 356

Query: 377 PLSS 380
           P+++
Sbjct: 357 PITN 360

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  212 bits (542), Expect = 2e-66
 Identities = 70/314 (22%), Positives = 118/314 (37%), Gaps = 33/314 (10%)

Query: 68  QSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF 127
            S+ H +HH   ++        Q    +I+        ++G G    V  V        +
Sbjct: 2   GSSHHHHHHSSGRENL----YFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFY 57

Query: 128 ALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY----DRNGEIEVLLEYMDGGS 183
           ALK I  + +   R +  RE ++ R  NHPN+++             E  +LL +   G+
Sbjct: 58  ALKRILCHEQQD-REEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGT 116

Query: 184 L---------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKI 234
           L         +G  + ++ IL  L   +  GL  +H +   HRD+KP+N+L+       +
Sbjct: 117 LWNEIERLKDKGNFLTEDQIL-WLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVL 175

Query: 235 ADFGVSRIL---------AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLG 285
            D G              A T+    +   TI+Y +PE     +          D+WSLG
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELF--SVQSHCVIDERTDVWSLG 233

Query: 286 VSILEFYLGRFPF-AVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
             +     G  P+  V ++GD  S+  A+            S      ++  +  DPH R
Sbjct: 234 CVLYAMMFGEGPYDMVFQKGD--SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQR 291

Query: 345 WPAAQLLQHPFILR 358
                LL     L+
Sbjct: 292 PHIPLLLSQLEALQ 305

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  209 bits (534), Expect = 3e-65
 Identities = 71/296 (23%), Positives = 110/296 (37%), Gaps = 43/296 (14%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
            + +G G+   V+R  H  T  +FA+KV              RE E+L+ +NH N+VK  
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 164 DMYDRNGEIEVLL--EYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKI 214
            + +       +L  E+   GSL         A+   E     + R V+ G+ +L +  I
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI 133

Query: 215 VHRDIKPSNLLINSSK----NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPE---RINT 267
           VHR+IKP N++    +      K+ DFG +R L    +   S  GT  Y+ P+   R   
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVL 192

Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD-WASLMFAICFAQPPEA----- 321
             +H K  G   D+WS+GV+      G  PF           +M+ I   +P  A     
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ 252

Query: 322 -------------------PEMASREFRDFISRCLQKDPHSRWPAAQLLQHP-FIL 357
                                         ++  L+ D    W   Q       IL
Sbjct: 253 KAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  208 bits (532), Expect = 3e-65
 Identities = 55/286 (19%), Positives = 109/286 (38%), Gaps = 41/286 (14%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           +    +G G  G V+   +      +A+K I   + +  R ++ RE++ L  + HP +V+
Sbjct: 8   EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR 67

Query: 162 CHDMY------------DRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQV 202
             + +                 + + ++     +L            R+  +   +  Q+
Sbjct: 68  YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127

Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN----------- 251
              + +LH + ++HRD+KPSN+       VK+ DFG+   + Q  +              
Sbjct: 128 AEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187

Query: 252 -SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLM 310
              VGT  YMSPE+    ++   Y  +  DI+SLG+ + E     +PF    Q +    +
Sbjct: 188 TGQVGTKLYMSPEQ----IHGNSYS-HKVDIFSLGLILFELL---YPF--STQMERVRTL 237

Query: 311 FAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +   + P             +   L   P  R  A  ++++   
Sbjct: 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  210 bits (537), Expect = 2e-64
 Identities = 70/291 (24%), Positives = 119/291 (40%), Gaps = 28/291 (9%)

Query: 83  NQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS 142
            Q   + +    ++        + +G G+ GT+        +R  A+K I          
Sbjct: 8   EQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFAD- 65

Query: 143 QICREIEILRDVN-HPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILS 196
              RE+++LR+ + HPNV++            + +E     +L     +           
Sbjct: 66  ---REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPI 121

Query: 197 DLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN-----VKIADFGVSRILAQ---TMD 248
            L +Q  SGLA+LH   IVHRD+KP N+LI+           I+DFG+ + LA    +  
Sbjct: 122 TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS 181

Query: 249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL---GRFPFAVGRQGD 305
             +   GT  +++PE ++ D        Y  DI+S G  +  +Y+   G  PF    Q  
Sbjct: 182 RRSGVPGTEGWIAPEMLSEDCKENP--TYTVDIFSAGC-VF-YYVISEGSHPFGKSLQRQ 237

Query: 306 WASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            A+++   C        +      R+ I + +  DP  R  A  +L+HPF 
Sbjct: 238 -ANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  203 bits (518), Expect = 2e-62
 Identities = 79/289 (27%), Positives = 126/289 (43%), Gaps = 31/289 (10%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVI----YGNHEDSVRSQICREIEILRDVNHPNV 159
              IG G    V R ++  T + FA+K++    + +        + RE  I   + HP++
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQ---EHILSDLARQVLSGLAYLHK 211
           V+  + Y  +G + ++ E+MDG  L     + A       E + S   RQ+L  L Y H 
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148

Query: 212 RKIVHRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
             I+HRD+KP  +L+ S +N   VK+  FGV+  L ++       VGT  +M+PE     
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV---- 204

Query: 269 LNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQ----PPEAPE 323
           +    Y G   D+W  GV IL   L G  PF     G    L   I   +    P +   
Sbjct: 205 VKREPY-GKPVDVWGCGV-ILFILLSGCLPF----YGTKERLFEGIIKGKYKMNPRQWSH 258

Query: 324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQIL 372
           + S   +D + R L  DP  R    + L HP++    +     +L + +
Sbjct: 259 I-SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETV 306

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  201 bits (513), Expect = 1e-61
 Identities = 104/373 (27%), Positives = 156/373 (41%), Gaps = 43/373 (11%)

Query: 15  SSSSSSSSPSSSLANRRGQRRRPDLTLPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQN 74
                SS   +     R + RR    LP   R+   A    L    + S++        N
Sbjct: 3   HHHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLN 62

Query: 75  HHPHQQQQNQTQNNHQNRHQLINPAELQK-------GNRIGSGSGGTVWRVVHPPTSRVF 127
               +  +N    +     +L + A  ++        + IG G    V R VH  T   F
Sbjct: 63  DAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEF 122

Query: 128 ALKVI-------YGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYM 179
           A+K++            + VR    RE  ILR V  HP+++   D Y+ +  + ++ + M
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLM 182

Query: 180 DGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKI 234
             G L     E   +  E     + R +L  +++LH   IVHRD+KP N+L++ +  +++
Sbjct: 183 RKGELFDYLTEKVAL-SEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRL 241

Query: 235 ADFGVSRILAQTMDPCNSAVGTIAYMSPE--RINTDLNHGKYDGYAGDIWSLGVSILEFY 292
           +DFG S  L    +      GT  Y++PE  + + D  H  Y G   D+W+ GV IL   
Sbjct: 242 SDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWACGV-ILFTL 298

Query: 293 L-GRFPFAVGRQGDWA---SLMF-AICFAQP----PEAPEMASREFRDFISRCLQKDPHS 343
           L G  PF       W     LM   I   Q     PE  +  S   +D ISR LQ DP +
Sbjct: 299 LAGSPPF-------WHRRQILMLRMIMEGQYQFSSPEWDDR-SSTVKDLISRLLQVDPEA 350

Query: 344 RWPAAQLLQHPFI 356
           R  A Q LQHPF 
Sbjct: 351 RLTAEQALQHPFF 363

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  201 bits (512), Expect = 1e-61
 Identities = 66/361 (18%), Positives = 133/361 (36%), Gaps = 62/361 (17%)

Query: 67  GQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRV 126
           G   S ++   +           + + + IN   + +   +  G    +        ++ 
Sbjct: 1   GPLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIR--TLNQGKFNKIILCEK--DNKF 56

Query: 127 FALKVIY----------------GNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG 170
           +ALK                        S       E++I+ D+ +   + C  +     
Sbjct: 57  YALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYD 116

Query: 171 EIEVLLEYMDGGSL------------EGAHIRQEHILSDLARQVLSGLAYLHKRK-IVHR 217
           E+ ++ EYM+  S+                     ++  + + VL+  +Y+H  K I HR
Sbjct: 117 EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR 176

Query: 218 DIKPSNLLINSSKNVKIADFGVSRI----LAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           D+KPSN+L++ +  VK++DFG S        +         GT  +M PE  +   N   
Sbjct: 177 DVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS--R----GTYEFMPPEFFS---NESS 227

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVG----------RQGD------WASLMFAICFAQ 317
           Y+G   DIWSLG+ +   +    PF++           R  +          ++ +   +
Sbjct: 228 YNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKK 287

Query: 318 PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
              +    S E  DF+   L+K+P  R  +   L+H ++       + +  +++    + 
Sbjct: 288 STCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYKKRKK 347

Query: 378 L 378
           L
Sbjct: 348 L 348

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  198 bits (506), Expect = 1e-61
 Identities = 83/286 (29%), Positives = 131/286 (45%), Gaps = 37/286 (12%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVK 161
           G  +G G  G V+         + ALKV++ +   ++ V  Q+ REIEI   + HPN+++
Sbjct: 19  GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78

Query: 162 CHD-MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIV 215
            ++  +DR   I ++LE+   G L    +++        +     ++   L Y H+RK++
Sbjct: 79  MYNYFHDRK-RIYLMLEFAPRGELY-KELQKHGRFDEQRSATFMEELADALHYCHERKVI 136

Query: 216 HRDIKPSNLLINSSKNVKIADFGVS----RILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
           HRDIKP NLL+     +KIADFG S     +  +TM  C    GT+ Y+ PE I      
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM--C----GTLDYLPPEMIE----- 185

Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
           GK      D+W  GV   EF +G  PF         +           + P   S   +D
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPF----DSPSHTETHRRIVNVDLKFPPFLSDGSKD 241

Query: 332 FISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
            IS+ L+  P  R P   +++HP++          N R++LPP   
Sbjct: 242 LISKLLRYHPPQRLPLKGVMEHPWVK--------ANSRRVLPPVYQ 279

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  202 bits (516), Expect = 2e-61
 Identities = 70/288 (24%), Positives = 121/288 (42%), Gaps = 43/288 (14%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKC 162
              +G GS GTV         R  A+K +  +  D        EI++L +  +HPNV++ 
Sbjct: 20  EKILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFCDIAL----MEIKLLTESDDHPNVIRY 74

Query: 163 HDMYDRNGEIEVLLEYMDGGSL-----------EGAHIRQEHILSDLARQVLSGLAYLHK 211
           +     +  + + LE     +L           E   +++E+    L RQ+ SG+A+LH 
Sbjct: 75  YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133

Query: 212 RKIVHRDIKPSNLLINSSK-------------NVKIADFGVSRILAQTMDPC----NSAV 254
            KI+HRD+KP N+L+++S               + I+DFG+ + L           N+  
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193

Query: 255 GTIAYMSPERINTDLNHGKYDGY--AGDIWSLGVSILEFYL---GRFPFAVGRQGDWASL 309
           GT  + +PE +    N         + DI+S+G  +  +Y+   G+ PF      +   +
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC-VF-YYILSKGKHPFGDKYSRESNII 251

Query: 310 MFAICFAQPPEAP-EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                  +           E  D IS+ +  DP  R  A ++L+HP  
Sbjct: 252 RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  198 bits (505), Expect = 3e-61
 Identities = 83/281 (29%), Positives = 129/281 (45%), Gaps = 27/281 (9%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVI--------YGNHEDSVRSQICREIEILRDVN 155
              +G G    V R +H PT + +A+K+I               +R    +E++ILR V+
Sbjct: 22  KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81

Query: 156 -HPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLH 210
            HPN+++  D Y+ N    ++ + M  G L      +    E     + R +L  +  LH
Sbjct: 82  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 141

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPE--RINTD 268
           K  IVHRD+KP N+L++   N+K+ DFG S  L    +      GT +Y++PE    + +
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMN 200

Query: 269 LNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQ----PPEAPE 323
            NH  Y G   D+WS GV I+   L G  PF   +Q     ++  I         PE  +
Sbjct: 201 DNHPGY-GKEVDMWSTGV-IMYTLLAGSPPFWHRKQ---MLMLRMIMSGNYQFGSPEWDD 255

Query: 324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV 364
             S   +D +SR L   P  R+ A + L HPF  +    +V
Sbjct: 256 Y-SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  203 bits (519), Expect = 3e-61
 Identities = 86/326 (26%), Positives = 142/326 (43%), Gaps = 40/326 (12%)

Query: 72  HQNHHPHQQQQNQTQNNHQNRHQLINPAELQK-------GNRIGSGSGGTVWRVVHPPTS 124
           H +HH   ++    Q + Q    +   ++            ++GSG+ G V       T 
Sbjct: 3   HHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTH 62

Query: 125 RVFALKVI-----YGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYM 179
              A+K+I       +    +      E+ +L+ ++HPN++K +D ++      +++E  
Sbjct: 63  VERAIKIIRKTSVSTSSNSKLL----EEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY 118

Query: 180 DGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK---N 231
            GG L            E   + + +QVLSG+ YLHK  IVHRD+KP NLL+ S +    
Sbjct: 119 KGGELFDEIIHRMKF-NEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDAL 177

Query: 232 VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEF 291
           +KI DFG+S +           +GT  Y++PE +       KY     D+WS+GV IL  
Sbjct: 178 IKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVL-----RKKY-DEKCDVWSIGV-ILFI 229

Query: 292 YL-GRFPFAVGRQGDWASLMFAICFAQPP-EAPEMA--SREFRDFISRCLQKDPHSRWPA 347
            L G  PF      +   ++  +   +   ++PE    S   +D I + LQ D   R  A
Sbjct: 230 LLAGYPPFGGQTDQE---ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISA 286

Query: 348 AQLLQHPFILRAGQSQVNQNLRQILP 373
            Q L+HP+I      + +      L 
Sbjct: 287 QQALEHPWIKEMCSKKESGIELPSLA 312

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  198 bits (505), Expect = 6e-61
 Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 37/286 (12%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
              +G G  G V R V   + + +  K +     D  +  + +EI IL    H N++  H
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLH 67

Query: 164 DMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
           + ++   E+ ++ E++ G  +          +  E  +     QV   L +LH   I H 
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTSAFEL-NEREIVSYVHQVCEALQFLHSHNIGHF 126

Query: 218 DIKPSNLLINSSKN--VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           DI+P N++  + ++  +KI +FG +R L    D          Y +PE +     H    
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPE-V---HQHDVV- 180

Query: 276 GYAGDIWSLGVSILEFYL---GRFPFAVGRQGDWA----SLMFAICFAQ---PPEAPEMA 325
             A D+WSLG  ++  Y+   G  PF        A     ++  I  A+     EA +  
Sbjct: 181 STATDMWSLGT-LV--YVLLSGINPF-------LAETNQQIIENIMNAEYTFDEEAFKEI 230

Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQI 371
           S E  DF+ R L K+  SR  A++ LQHP++ +  +    + +R +
Sbjct: 231 SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTL 276

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  199 bits (508), Expect = 8e-61
 Identities = 76/368 (20%), Positives = 155/368 (42%), Gaps = 27/368 (7%)

Query: 17  SSSSSSPSSSLANRRGQRRRPDLTLPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHH 76
             SS     +        +           + +  V      T      S ++++     
Sbjct: 7   HHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDI 66

Query: 77  PHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH 136
           P        +     +  + +   + K   +G G  G V +     T    A K+I    
Sbjct: 67  PAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG 126

Query: 137 EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS 196
               + ++  EI ++  ++H N+++ +D ++   +I +++EY+DGG L    I + + L+
Sbjct: 127 MKD-KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT 185

Query: 197 -----DLARQVLSGLAYLHKRKIVHRDIKPSNLLINS--SKNVKIADFGVSRILAQTMDP 249
                   +Q+  G+ ++H+  I+H D+KP N+L  +  +K +KI DFG++R      + 
Sbjct: 186 ELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EK 244

Query: 250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL---GRFPFAVGRQGDW 306
                GT  +++PE +N       +  +  D+WS+GV I   Y+   G  PF      + 
Sbjct: 245 LKVNFGTPEFLAPEVVN-----YDFVSFPTDMWSVGV-IA--YMLLSGLSPFLGDNDAE- 295

Query: 307 ASLMFAICFAQ---PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFIL-RAGQS 362
              +  I   +     E  +  S E ++FIS+ L K+   R  A++ L+HP++      S
Sbjct: 296 --TLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHS 353

Query: 363 QVNQNLRQ 370
           +++   ++
Sbjct: 354 RLSAQKKK 361

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  203 bits (517), Expect = 8e-61
 Identities = 81/337 (24%), Positives = 143/337 (42%), Gaps = 52/337 (15%)

Query: 72  HQNHHPHQQQQNQTQNNHQNRHQLINPAELQK-------GNRIGSGSGGTVWRVVHPPTS 124
           H +HH    ++N           +    +  K         ++GSG+ G V         
Sbjct: 2   HHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61

Query: 125 RVFALKVI------------YGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI 172
              A+KVI               + +    +I  EI +L+ ++HPN++K  D+++     
Sbjct: 62  SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121

Query: 173 EVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN 227
            ++ E+ +GG L            E   +++ +Q+LSG+ YLHK  IVHRDIKP N+L+ 
Sbjct: 122 YLVTEFYEGGELFEQIINRHKF-DECDAANIMKQILSGICYLHKHNIVHRDIKPENILLE 180

Query: 228 SSK---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSL 284
           +     N+KI DFG+S   ++        +GT  Y++PE +       KY     D+WS 
Sbjct: 181 NKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVL-----KKKY-NEKCDVWSC 233

Query: 285 GVSILEFYL-GRFPFAVGRQGDWAS----LMFAICFAQPP-EAPEMA--SREFRDFISRC 336
           GV I+   L G  PF              ++  +   +   +  +    S E ++ I   
Sbjct: 234 GV-IMYILLCGYPPF-------GGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLM 285

Query: 337 LQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILP 373
           L  D + R  A + L   +I +   + +N++ ++ L 
Sbjct: 286 LTYDYNKRCTAEEALNSRWI-KKYANNINKSDQKTLC 321

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  196 bits (500), Expect = 9e-61
 Identities = 75/267 (28%), Positives = 127/267 (47%), Gaps = 29/267 (10%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVK 161
           G  +G G  G V+      +  + ALKV++     +  V  Q+ RE+EI   + HPN+++
Sbjct: 14  GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73

Query: 162 CHD-MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIV 215
            +   +D    + ++LEY   G++    +++              ++ + L+Y H ++++
Sbjct: 74  LYGYFHDAT-RVYLILEYAPLGTVY-RELQKLSKFDEQRTATYITELANALSYCHSKRVI 131

Query: 216 HRDIKPSNLLINSSKNVKIADFGVS----RILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
           HRDIKP NLL+ S+  +KIADFG S          +  C    GT+ Y+ PE I      
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL--C----GTLDYLPPEMIE----- 180

Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
           G+      D+WSLGV   EF +G+ PF    + +     +          P+  +   RD
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFVTEGARD 236

Query: 332 FISRCLQKDPHSRWPAAQLLQHPFILR 358
            ISR L+ +P  R    ++L+HP+I  
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITA 263

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  196 bits (501), Expect = 2e-60
 Identities = 80/279 (28%), Positives = 132/279 (47%), Gaps = 32/279 (11%)

Query: 103 KGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVK 161
           K   +G GS     + VH  +++ FA+K+I    E + +    +EI  L+    HPN+VK
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ----KEITALKLCEGHPNIVK 70

Query: 162 CHDMYDRNGEIEVLLEYMDGGSL-EGAHIRQ-----EHILSDLARQVLSGLAYLHKRKIV 215
            H+++       +++E ++GG L E   I++     E   S + R+++S ++++H   +V
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFE--RIKKKKHFSETEASYIMRKLVSAVSHMHDVGVV 128

Query: 216 HRDIKPSNLLINSSK---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL         +KI DFG +R+      P  +   T+ Y +PE     LN  
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL----LNQN 184

Query: 273 KYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQ--------PPEAPE 323
            YD  + D+WSLGV IL   L G+ PF    +    +    I   +          EA +
Sbjct: 185 GYD-ESCDLWSLGV-ILYTMLSGQVPFQSHDRSLTCTSAVEI-MKKIKKGDFSFEGEAWK 241

Query: 324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS 362
             S+E +D I   L  DP+ R   + L  + ++    Q 
Sbjct: 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  195 bits (498), Expect = 3e-60
 Identities = 85/305 (27%), Positives = 141/305 (46%), Gaps = 48/305 (15%)

Query: 90  QNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI----------------- 132
                 +N   L   + IG GS G V    +   +  +A+KV+                 
Sbjct: 6   SGDCVQLNQYTL--KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63

Query: 133 --------YGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR--NGEIEVLLEYMDGG 182
                             Q+ +EI IL+ ++HPNVVK  ++ D      + ++ E ++ G
Sbjct: 64  RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123

Query: 183 SLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADF 237
            +    +     LS D AR     ++ G+ YLH +KI+HRDIKPSNLL+    ++KIADF
Sbjct: 124 PV--MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADF 181

Query: 238 GVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL--GR 295
           GVS     +    ++ VGT A+M+PE ++       + G A D+W++GV  L +    G+
Sbjct: 182 GVSNEFKGSDALLSNTVGTPAFMAPESLSE--TRKIFSGKALDVWAMGV-TL-YCFVFGQ 237

Query: 296 FPFAVGRQGDWASLMFAICFAQPPEAPEMA--SREFRDFISRCLQKDPHSRWPAAQLLQH 353
            PF      +    + +   +Q  E P+    + + +D I+R L K+P SR    ++  H
Sbjct: 238 CPF----MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293

Query: 354 PFILR 358
           P++ R
Sbjct: 294 PWVTR 298

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  194 bits (495), Expect = 5e-60
 Identities = 77/271 (28%), Positives = 125/271 (46%), Gaps = 30/271 (11%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDVNHPNV 159
           + GN +G GS   V+R     T    A+K+I     ++  +  ++  E++I   + HP++
Sbjct: 14  KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSI 73

Query: 160 VKCHD-MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRK 213
           ++ ++   D N  + ++LE    G +      +    S + AR    Q+++G+ YLH   
Sbjct: 74  LELYNYFEDSN-YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG 132

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQ------TMDPCNSAVGTIAYMSPERINT 267
           I+HRD+  SNLL+  + N+KIADFG++  L        T+  C    GT  Y+SPE    
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--C----GTPNYISPEIAT- 185

Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR 327
                   G   D+WSLG       +GR PF      D              E P   S 
Sbjct: 186 ----RSAHGLESDVWSLGCMFYTLLIGRPPF----DTDTVKNTLNKVVLADYEMPSFLSI 237

Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILR 358
           E +D I + L+++P  R   + +L HPF+ R
Sbjct: 238 EAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  197 bits (503), Expect = 6e-60
 Identities = 69/291 (23%), Positives = 108/291 (37%), Gaps = 42/291 (14%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
            + +G G+   V+R  H  T  +FA+KV              RE E+L+ +NH N+VK  
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 164 DMYDRNGEIEVLL--EYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRKI 214
            + +       +L  E+   GSL         A+   E     + R V+ G+ +L +  I
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI 133

Query: 215 VHRDIKPSNLLINSSK----NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPE---RINT 267
           VHR+IKP N++    +      K+ DFG +R L    +   S  GT  Y+ P+   R   
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVL 192

Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD-WASLMFAICFAQPPEA----- 321
             +H K  G   D+WS+GV+      G  PF           +M+ I   +P  A     
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ 252

Query: 322 -------------------PEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
                                         ++  L+ D    W   Q    
Sbjct: 253 KAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  195 bits (498), Expect = 6e-60
 Identities = 85/272 (31%), Positives = 131/272 (48%), Gaps = 27/272 (9%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSVRSQICREIEILRDVNH 156
              +GSG+ G V       T +  A+K+I           E      +  EIEIL+ +NH
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 157 PNVVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHK 211
           P ++K  + +D   +  ++LE M+GG L         + +E        Q+L  + YLH+
Sbjct: 75  PCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRL-KEATCKLYFYQMLLAVQYLHE 132

Query: 212 RKIVHRDIKPSNLLINSSK---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
             I+HRD+KP N+L++S +    +KI DFG S+IL +T     +  GT  Y++PE + + 
Sbjct: 133 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSV 191

Query: 269 LNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQ---PPEAPEM 324
              G Y   A D WSLGV IL   L G  PF+  R     SL   I   +    PE    
Sbjct: 192 GTAG-Y-NRAVDCWSLGV-ILFICLSGYPPFSEHR--TQVSLKDQITSGKYNFIPEVWAE 246

Query: 325 ASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            S +  D + + L  DP +R+   + L+HP++
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  199 bits (507), Expect = 2e-59
 Identities = 85/325 (26%), Positives = 143/325 (44%), Gaps = 51/325 (15%)

Query: 71  SHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALK 130
            H +HH   ++    Q     R+ +           +G GS G V +     T + +A+K
Sbjct: 2   HHHHHHSSGRENLYFQGTFAERYNI--------VCMLGKGSFGEVLKCKDRITQQEYAVK 53

Query: 131 VI-----YGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL- 184
           VI           ++     RE+E+L+ ++HPN++K  ++ + +    ++ E   GG L 
Sbjct: 54  VINKASAKNKDTSTIL----REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF 109

Query: 185 ----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK---NVKIADF 237
               +      EH  + + +QV SG+ Y+HK  IVHRD+KP N+L+ S +   ++KI DF
Sbjct: 110 DEIIKRKRF-SEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168

Query: 238 GVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL--GR 295
           G+S    Q        +GT  Y++PE +      G Y     D+WS GV IL + L  G 
Sbjct: 169 GLSTCFQQN-TKMKDRIGTAYYIAPEVL-----RGTY-DEKCDVWSAGV-IL-YILLSGT 219

Query: 296 FPFAVGRQGDWAS----LMFAICFAQPP-EAPEMA--SREFRDFISRCLQKDPHSRWPAA 348
            PF       +      ++  +   +   + P+    S + +D I + L   P  R  A 
Sbjct: 220 PPF-------YGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITAT 272

Query: 349 QLLQHPFILRAGQSQVNQNLRQILP 373
           Q L+HP+I +        +    L 
Sbjct: 273 QCLEHPWIQKYSSETPTISDLPSLE 297

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  199 bits (507), Expect = 2e-59
 Identities = 84/281 (29%), Positives = 132/281 (46%), Gaps = 30/281 (10%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVI----YGNHEDSVRSQICREIEILRDVNHPNV 159
              +G GS G V       T +  A+KVI         D  +  + RE+++L+ ++HPN+
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD--KESLLREVQLLKQLDHPNI 88

Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRKI 214
           +K ++ ++  G   ++ E   GG L            E   + + RQVLSG+ Y+HK KI
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF-SEVDAARIIRQVLSGITYMHKNKI 147

Query: 215 VHRDIKPSNLLINSSK---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
           VHRD+KP NLL+ S     N++I DFG+S     +       +GT  Y++PE +     H
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVL-----H 201

Query: 272 GKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPP-EAPEMA--SR 327
           G Y     D+WS GV IL   L G  PF    + D   ++  +   +   E P+    S 
Sbjct: 202 GTY-DEKCDVWSTGV-ILYILLSGCPPFNGANEYD---ILKKVEKGKYTFELPQWKKVSE 256

Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNL 368
             +D I + L   P  R  A   L H +I    + Q++ ++
Sbjct: 257 SAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDV 297

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  192 bits (491), Expect = 2e-59
 Identities = 83/314 (26%), Positives = 138/314 (43%), Gaps = 49/314 (15%)

Query: 71  SHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALK 130
            H +HH   ++    Q     R+ +           +G GS G V +     T + +A+K
Sbjct: 2   HHHHHHSSGRENLYFQGTFAERYNI--------VCMLGKGSFGEVLKCKDRITQQEYAVK 53

Query: 131 VI-----YGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL- 184
           VI           ++     RE+E+L+ ++HPN++K  ++ + +    ++ E   GG L 
Sbjct: 54  VINKASAKNKDTSTIL----REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELF 109

Query: 185 ----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK---NVKIADF 237
               +      EH  + + +QV SG+ Y+HK  IVHRD+KP N+L+ S +   ++KI DF
Sbjct: 110 DEIIKRKRF-SEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168

Query: 238 GVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRF 296
           G+S    Q        +GT  Y++PE +      G Y     D+WS GV IL   L G  
Sbjct: 169 GLSTCFQQN-TKMKDRIGTAYYIAPEVL-----RGTY-DEKCDVWSAGV-ILYILLSGTP 220

Query: 297 PFAVGRQGDWA----SLMFAICFAQP--PEAP-EMASREFRDFISRCLQKDPHSRWPAAQ 349
           PF       +      ++  +   +           S + +D I + L   P  R  A Q
Sbjct: 221 PF-------YGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQ 273

Query: 350 LLQHPFILRAGQSQ 363
            L+HP+I +    +
Sbjct: 274 CLEHPWIQKYSSEE 287

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  192 bits (491), Expect = 3e-59
 Identities = 81/291 (27%), Positives = 117/291 (40%), Gaps = 42/291 (14%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVI-----YGNHEDSVRSQICREIEILRDVNHPN 158
              +G G+   V R VH  T   FA K+I            +     RE  I R + HPN
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE----REARICRKLQHPN 66

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           +V+ HD         ++ + + GG L            E   S   +Q+L  +AY H   
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY-SEADASHCIQQILESIAYCHSNG 125

Query: 214 IVHRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
           IVHR++KP NLL+ S      VK+ADFG++  +    +  +   GT  Y+SPE +   L 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFAGTPGYLSPE-V---LK 180

Query: 271 HGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWA----SLMFAICFAQ----PPEA 321
              Y     DIW+ GV IL   L G  PF       W      L   I         PE 
Sbjct: 181 KDPY-SKPVDIWACGV-ILYILLVGYPPF-------WDEDQHRLYAQIKAGAYDYPSPEW 231

Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQIL 372
             + + E +  I   L  +P  R  A Q L+ P+I    +     + +  +
Sbjct: 232 DTV-TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTV 281

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  196 bits (501), Expect = 3e-59
 Identities = 88/301 (29%), Positives = 140/301 (46%), Gaps = 33/301 (10%)

Query: 92  RHQLINPAELQK----GNRIGSGSGGTVWRVVHPPTSRVFALKVI-------YGNHEDSV 140
             Q + P  L+        +GSG+ G V       T +  A+++I           E   
Sbjct: 124 DDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADP 183

Query: 141 RSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHIL 195
              +  EIEIL+ +NHP ++K  + +D   +  ++LE M+GG L         + +E   
Sbjct: 184 ALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRL-KEATC 241

Query: 196 SDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK---NVKIADFGVSRILAQTMDPCNS 252
                Q+L  + YLH+  I+HRD+KP N+L++S +    +KI DFG S+IL +T     +
Sbjct: 242 KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRT 300

Query: 253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMF 311
             GT  Y++PE +   +    Y   A D WSLGV IL   L G  PF+  R     SL  
Sbjct: 301 LCGTPTYLAPE-VLVSVGTAGY-NRAVDCWSLGV-ILFICLSGYPPFSEHR--TQVSLKD 355

Query: 312 AICFAQ----PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQN 367
            I   +    P    E+ S +  D + + L  DP +R+   + L+HP++      +  Q+
Sbjct: 356 QITSGKYNFIPEVWAEV-SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 414

Query: 368 L 368
           L
Sbjct: 415 L 415

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  194 bits (494), Expect = 3e-59
 Identities = 79/287 (27%), Positives = 128/287 (44%), Gaps = 33/287 (11%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVI-----YGNHEDSVRSQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I       +     R  I RE+ IL+++ HPN
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           V+  H++Y+   ++ ++LE + GG L     E   +  E   ++  +Q+L+G+ YLH  +
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESL-TEEEATEFLKQILNGVYYLHSLQ 134

Query: 214 IVHRDIKPSNLLINS----SKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
           I H D+KP N+++         +KI DFG++  +    +   +  GT  +++PE I   +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPE-I---V 189

Query: 270 NHGKYDGYAGDIWSLGVSILEFYL---GRFPFAVGRQGDWASLMFAICFAQ---PPEAPE 323
           N+    G   D+WS+GV I   Y+   G  PF    + +    +  +         E   
Sbjct: 190 NYEPL-GLEADMWSIGV-IT--YILLSGASPFLGDTKQE---TLANVSAVNYEFEDEYFS 242

Query: 324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQ 370
             S   +DFI R L KDP  R      LQHP+I      Q       
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKAS 289

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  191 bits (488), Expect = 6e-59
 Identities = 81/284 (28%), Positives = 124/284 (43%), Gaps = 40/284 (14%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVV 160
            N IG GS G V   V   T    A K I   +    D  +    +EIEI++ ++HPN++
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK----QEIEIMKSLDHPNII 69

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           + ++ ++ N +I +++E   GG L           +E   + + + VLS +AY HK  + 
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVF-RESDAARIMKDVLSAVAYCHKLNVA 128

Query: 216 HRDIKPSNLLINSSK---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP N L  +      +K+ DFG++           + VGT  Y+SP+ +      G
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVL-----EG 182

Query: 273 KYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWAS----LMFAICFAQP--PEAP-EM 324
            Y G   D WS GV ++   L G  PF        A     +M  I       PE     
Sbjct: 183 LY-GPECDEWSAGV-MMYVLLCGYPPF-------SAPTDSEVMLKIREGTFTFPEKDWLN 233

Query: 325 ASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNL 368
            S +    I R L K P  R  + Q L+H +  +   S   +NL
Sbjct: 234 VSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS-PRNL 276

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  192 bits (491), Expect = 8e-59
 Identities = 77/289 (26%), Positives = 128/289 (44%), Gaps = 33/289 (11%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVI-----YGNHEDSVRSQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I       +     R +I RE+ ILR V H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           V+  HD+Y+   ++ ++LE + GG L     +   +  E   +   +Q+L G+ YLH +K
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS-EEEATSFIKQILDGVNYLHTKK 135

Query: 214 IVHRDIKPSNLLINS----SKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
           I H D+KP N+++        ++K+ DFG++  +        +  GT  +++PE I   +
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPE-I---V 190

Query: 270 NHGKYDGYAGDIWSLGVSILEFYL---GRFPFAVGRQGDWASLMFAICFAQ---PPEAPE 323
           N+    G   D+WS+GV I   Y+   G  PF    + +    +  I         E   
Sbjct: 191 NYEPL-GLEADMWSIGV-IT--YILLSGASPFLGDTKQE---TLANITSVSYDFDEEFFS 243

Query: 324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQIL 372
             S   +DFI + L K+   R    + L+HP+I      Q       ++
Sbjct: 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVV 292

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  190 bits (486), Expect = 1e-58
 Identities = 75/303 (24%), Positives = 133/303 (43%), Gaps = 41/303 (13%)

Query: 72  HQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKV 131
           H +HH   ++    Q    +              ++GSG+ G V  V    +     +K 
Sbjct: 3   HHHHHSSGRENLYFQGTIDDLFIF--------KRKLGSGAFGDVHLVEERSSGLERVIKT 54

Query: 132 IYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------- 184
           I  +       QI  EIE+L+ ++HPN++K  ++++    + +++E  +GG L       
Sbjct: 55  INKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSA 114

Query: 185 -EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK---NVKIADFGVS 240
                   E  +++L +Q+++ LAY H + +VH+D+KP N+L   +     +KI DFG++
Sbjct: 115 QARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174

Query: 241 RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFA 299
            +     +   +A GT  YM+PE             +  DIWS GV ++ F L G  PF 
Sbjct: 175 ELFKSD-EHSTNAAGTALYMAPEVFK-----RDV-TFKCDIWSAGV-VMYFLLTGCLPF- 225

Query: 300 VGRQGDWAS----LMFAICFAQP--PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
                   +    +     + +P         + +  D + + L KDP  R  AAQ+L H
Sbjct: 226 ------TGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279

Query: 354 PFI 356
            + 
Sbjct: 280 EWF 282

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  192 bits (491), Expect = 2e-58
 Identities = 77/289 (26%), Positives = 129/289 (44%), Gaps = 33/289 (11%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVI-----YGNHEDSVRSQICREIEILRDVNHPN 158
           G  +GSG    V +     T   +A K I       +     R +I RE+ ILR V HPN
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           ++  HD+Y+   ++ ++LE + GG L     +   +  E   +   +Q+L G+ YLH +K
Sbjct: 77  IITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS-EEEATSFIKQILDGVNYLHTKK 135

Query: 214 IVHRDIKPSNLLINS----SKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
           I H D+KP N+++        ++K+ DFG++  +        +  GT  +++PE I   +
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPE-I---V 190

Query: 270 NHGKYDGYAGDIWSLGVSILEFYL---GRFPFAVGRQGDWASLMFAICFAQ---PPEAPE 323
           N+    G   D+WS+GV I   Y+   G  PF    + +    +  I         E   
Sbjct: 191 NYEPL-GLEADMWSIGV-IT--YILLSGASPFLGDTKQE---TLANITAVSYDFDEEFFS 243

Query: 324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQIL 372
             S   +DFI + L K+   R    + L+HP+I      Q       ++
Sbjct: 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVV 292

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  191 bits (488), Expect = 3e-58
 Identities = 88/271 (32%), Positives = 128/271 (47%), Gaps = 24/271 (8%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEIL-RDVNHPNVVKC 162
              IG GS     R +H  T+  FA+K+I  +  D        EIEIL R   HPN++  
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-PT----EEIEILLRYGQHPNIITL 81

Query: 163 HDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKIVHRD 218
            D+YD    + V+ E M GG L    +RQ    E   S +   +   + YLH + +VHRD
Sbjct: 82  KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRD 141

Query: 219 IKPSNLLINS----SKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           +KPSN+L        ++++I DFG ++ L        +   T  +++PE +   L    Y
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V---LERQGY 197

Query: 275 DGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQ---PPEAPEMASREFR 330
           D  A DIWSLGV +L   L G  PFA G       ++  I   +           S   +
Sbjct: 198 D-AACDIWSLGV-LLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAK 255

Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
           D +S+ L  DPH R  AA +L+HP+I+   Q
Sbjct: 256 DLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  190 bits (484), Expect = 4e-58
 Identities = 70/269 (26%), Positives = 118/269 (43%), Gaps = 31/269 (11%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNV 159
            +G  +G G     + +    T  VFA K++  +   +   R ++  EI I R + H +V
Sbjct: 18  VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 77

Query: 160 VKCHD-MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKI 214
           V  H    D +  + V+LE     SL   H R++ +    AR    Q++ G  YLH+ ++
Sbjct: 78  VGFHGFFEDND-FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRV 136

Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQ------TMDPCNSAVGTIAYMSPERINTD 268
           +HRD+K  NL +N    VKI DFG++  +         +  C    GT  Y++PE ++  
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--C----GTPNYIAPEVLS-- 188

Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFA-ICFAQPPEAPEMASR 327
               K   +  D+WS+G  +    +G+ PF    +       +  I   +    P+  + 
Sbjct: 189 ---KKGHSFEVDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNEYSI-PKHINP 240

Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                I + LQ DP +R    +LL   F 
Sbjct: 241 VAASLIQKMLQTDPTARPTINELLNDEFF 269

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  191 bits (487), Expect = 4e-58
 Identities = 74/312 (23%), Positives = 126/312 (40%), Gaps = 26/312 (8%)

Query: 53  PLPLPPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSG 112
           P P  P            +     P ++      +    R          +G  +G G  
Sbjct: 2   PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRR-------YVRGRFLGKGGF 54

Query: 113 GTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHD-MYDRN 169
              + +    T  VFA K++  +   +   R ++  EI I R + H +VV  H    D +
Sbjct: 55  AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 114

Query: 170 GEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIKPSNLL 225
             + V+LE     SL   H R++ +    AR    Q++ G  YLH+ +++HRD+K  NL 
Sbjct: 115 -FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 173

Query: 226 INSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLG 285
           +N    VKI DFG++  +    +      GT  Y++PE ++      K   +  D+WS+G
Sbjct: 174 LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS-----KKGHSFEVDVWSIG 228

Query: 286 VSILEFYLGRFPFAVGRQGDWASLMFA-ICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
             +    +G+ PF    +       +  I   +    P+  +      I + LQ DP +R
Sbjct: 229 CIMYTLLVGKPPF----ETSCLKETYLRIKKNEYSI-PKHINPVAASLIQKMLQTDPTAR 283

Query: 345 WPAAQLLQHPFI 356
               +LL   F 
Sbjct: 284 PTINELLNDEFF 295

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  194 bits (494), Expect = 5e-58
 Identities = 78/295 (26%), Positives = 123/295 (41%), Gaps = 46/295 (15%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVI-----YGNHEDSVRSQICREIEILRDVNHPN 158
              +G G+   V R V     + +A  +I            +     RE  I R + HPN
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE----REARICRLLKHPN 71

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL----SDLARQVLSGLAYLHKRKI 214
           +V+ HD     G   ++ + + GG L    + +E+      S   +Q+L  + + H+  +
Sbjct: 72  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 131

Query: 215 VHRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
           VHR++KP NLL+ S      VK+ADFG++  +           GT  Y+SPE +   L  
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE-V---LRK 187

Query: 272 GKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWAS----LMFAICFAQ----PPEAP 322
             Y G   D+W+ GV IL   L G  PF       W      L   I         PE  
Sbjct: 188 DPY-GKPVDLWACGV-ILYILLVGYPPF-------WDEDQHRLYQQIKAGAYDFPSPEWD 238

Query: 323 EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ-------SQVNQNLRQ 370
            + + E +D I++ L  +P  R  AA+ L+HP+I             +    L++
Sbjct: 239 TV-TPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKK 292

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  189 bits (483), Expect = 7e-58
 Identities = 82/280 (29%), Positives = 134/280 (47%), Gaps = 33/280 (11%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVV 160
              +GSG+   V+ V    T ++FALK I       + S+      EI +L+ + H N+V
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE----NEIAVLKKIKHENIV 69

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL----SDLARQVLSGLAYLHKRKIVH 216
              D+Y+      ++++ + GG L    + +        S + +QVLS + YLH+  IVH
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVH 129

Query: 217 RDIKPSNLLINSSK---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           RD+KP NLL  + +    + I DFG+S++        ++A GT  Y++PE     L    
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAPEV----LAQKP 183

Query: 274 YDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQ----PPEAPEMASRE 328
           Y   A D WS+GV I    L G  PF    +   + L   I         P   ++ S  
Sbjct: 184 Y-SKAVDCWSIGV-ITYILLCGYPPF---YEETESKLFEKIKEGYYEFESPFWDDI-SES 237

Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNL 368
            +DFI   L+KDP+ R+   + L HP+I   G + +++++
Sbjct: 238 AKDFICHLLEKDPNERYTCEKALSHPWI--DGNTALHRDI 275

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  192 bits (489), Expect = 7e-58
 Identities = 75/274 (27%), Positives = 128/274 (46%), Gaps = 22/274 (8%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
              +GSG+ G V R V   T RVF  K I   +    +  +  EI I+  ++HP ++  H
Sbjct: 56  LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPKLINLH 114

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYLHKRKIVHRD 218
           D ++   E+ ++LE++ GG L      +++ +S     +  RQ   GL ++H+  IVH D
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLD 174

Query: 219 IKPSNLLINSSKN--VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           IKP N++  + K   VKI DFG++  L    +       T  + +PE ++      +  G
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVD-----REPVG 228

Query: 277 YAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQ---PPEAPEMASREFRDF 332
           +  D+W++GV +    L G  PFA     +    +  +         +A    S E +DF
Sbjct: 229 FYTDMWAIGV-LGYVLLSGLSPFAGEDDLE---TLQNVKRCDWEFDEDAFSSVSPEAKDF 284

Query: 333 ISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQ 366
           I   LQK+P  R      L+HP++     +  ++
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 318

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  191 bits (487), Expect = 7e-58
 Identities = 82/296 (27%), Positives = 118/296 (39%), Gaps = 49/296 (16%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVI-----YGNHEDSVRSQICREIEILRDVNHPN 158
              +G G+   V R VH  T   FA K+I            +     RE  I R + HPN
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE----REARICRKLQHPN 89

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           +V+ HD         ++ + + GG L            E   S   +Q+L  +AY H   
Sbjct: 90  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY-SEADASHCIQQILESIAYCHSNG 148

Query: 214 IVHRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
           IVHR++KP NLL+ S      VK+ADFG++  +  + +  +   GT  Y+SPE +   L 
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPE-V---LK 203

Query: 271 HGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWA----SLMFAICFAQ----PPEA 321
              Y     DIW+ GV IL   L G  PF       W      L   I         PE 
Sbjct: 204 KDPY-SKPVDIWACGV-ILYILLVGYPPF-------WDEDQHRLYAQIKAGAYDYPSPEW 254

Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ-------SQVNQNLRQ 370
             + + E +  I   L  +P  R  A Q L+ P+I    +             L++
Sbjct: 255 DTV-TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKK 309

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  188 bits (480), Expect = 1e-57
 Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 35/274 (12%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVI-----YGNHEDSVRSQICREIEILRDVNHPN 158
           G  +GSG    V +     T + +A K I       +     R +I RE+ ILR++ HPN
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYLHKRK 213
           ++  HD+++   ++ ++LE + GG L     E   +  E   +   +Q+L G+ YLH ++
Sbjct: 70  IITLHDIFENKTDVVLILELVSGGELFDFLAEKESL-TEDEATQFLKQILDGVHYLHSKR 128

Query: 214 IVHRDIKPSNLLINS----SKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
           I H D+KP N+++      +  +K+ DFG++  +    +   +  GT  +++PE I   +
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAPE-I---V 183

Query: 270 NHGKYDGYAGDIWSLGVSILEFYL---GRFPFAVGRQGDWASLMF-AICFAQ---PPEAP 322
           N+    G   D+WS+GV I   Y+   G  PF     G+        I         E  
Sbjct: 184 NYEPL-GLEADMWSIGV-IT--YILLSGASPF----LGETKQETLTNISAVNYDFDEEYF 235

Query: 323 EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
              S   +DFI R L KDP  R   AQ L+H +I
Sbjct: 236 SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  190 bits (484), Expect = 1e-57
 Identities = 78/351 (22%), Positives = 139/351 (39%), Gaps = 76/351 (21%)

Query: 74  NHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI- 132
           +HH H     +           +   +      IG GS G V   +   T  + A+K++ 
Sbjct: 2   HHHHHHSSGRENLYFQGGSLLELQ-KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60

Query: 133 ---YGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL----- 184
                        +I  E+ +++ ++HPN+ + +++Y+    I +++E   GG L     
Sbjct: 61  KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120

Query: 185 ---------------------------------------EGAHIRQEHILSDLARQVLSG 205
                                                      +++E ++S++ RQ+ S 
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180

Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKN--VKIADFGVSRILAQT----MDPCNSAVGTIAY 259
           L YLH + I HRDIKP N L +++K+  +K+ DFG+S+   +          +  GT  +
Sbjct: 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240

Query: 260 MSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWAS----LMFAIC 314
           ++PE +NT   +  Y G   D WS GV +L   L G  PF               +  + 
Sbjct: 241 VAPEVLNT--TNESY-GPKCDAWSAGV-LLHLLLMGAVPF-------PGVNDADTISQVL 289

Query: 315 FAQ----PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
             +     P    + S   RD +S  L ++   R+ A + LQHP+I +   
Sbjct: 290 NKKLCFENPNYNVL-SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  195 bits (496), Expect = 3e-57
 Identities = 81/356 (22%), Positives = 144/356 (40%), Gaps = 31/356 (8%)

Query: 29  NRRGQRRRPDLTLPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNN 88
           N+ GQ +  + T P+                       G+ T   N+  +     +    
Sbjct: 86  NKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYP 145

Query: 89  HQNRHQLINPAEL-QKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICR 146
                +  +  +       +G+G+ G V RV    T   FA K +   +  D  +  + +
Sbjct: 146 QPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRK 203

Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLAR 200
           EI+ +  + HP +V  HD ++ + E+ ++ E+M GG L      E   +  E    +  R
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM-SEDEAVEYMR 262

Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSK--NVKIADFGVSRILAQTMDPCNSAVGTIA 258
           QV  GL ++H+   VH D+KP N++  + +   +K+ DFG++  L           GT  
Sbjct: 263 QVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAE 321

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL---GRFPFAVGRQGDWASLMFAICF 315
           + +PE        GK  GY  D+WS+GV +   Y+   G  PF      +    +  +  
Sbjct: 322 FAAPEVAE-----GKPVGYYTDMWSVGV-LS--YILLSGLSPFGGENDDE---TLRNVKS 370

Query: 316 AQ---PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNL 368
                   A    S + +DFI + L  DP++R    Q L+HP++        +  +
Sbjct: 371 CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 426

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  186 bits (474), Expect = 1e-56
 Identities = 78/298 (26%), Positives = 133/298 (44%), Gaps = 29/298 (9%)

Query: 94  QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH---EDSVRSQICREIEI 150
           +LI    +  G+ +G GS G V  V+   T    A+K++         +  + + +EI++
Sbjct: 2   KLIGKYLM--GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQL 59

Query: 151 LRDVNHPNVVKCHDMYDR--NGEIEVLLEYMDGGSLEG-AHIRQEHILSDLAR----QVL 203
           LR + H NV++  D+       ++ +++EY   G  E    + ++      A     Q++
Sbjct: 60  LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLI 119

Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM--DPCNSAVGTIAYMS 261
            GL YLH + IVH+DIKP NLL+ +   +KI+  GV+  L      D C ++ G+ A+  
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179

Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYL--GRFPFAVGRQGDWASLMFAICFAQPP 319
           PE  N       + G+  DIWS GV  L + +  G +PF    +GD    +F        
Sbjct: 180 PEIAN---GLDTFSGFKVDIWSAGV-TL-YNITTGLYPF----EGDNIYKLFENIGKGSY 230

Query: 320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
             P        D +   L+ +P  R+   Q+ QH +     + +       +  PP P
Sbjct: 231 AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF----RKKHPPAEAPVPIPPSP 284

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  186 bits (475), Expect = 2e-56
 Identities = 72/353 (20%), Positives = 126/353 (35%), Gaps = 66/353 (18%)

Query: 60  SNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVV 119
           +   S  G S   Q+    Q  +             +    L+    +  G    V+   
Sbjct: 2   AGPGSLGGASGRDQSDFVGQTVE-------------LGELRLRVRRVLAEGGFAFVYEAQ 48

Query: 120 HPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHD--------MYDRNG 170
              + R +ALK +  N E+  R  I +E+  ++ +  HPN+V+                 
Sbjct: 49  DVGSGREYALKRLLSNEEEKNR-AIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107

Query: 171 EIEVLLEYMDGGSLE-------GAHIRQEHILSDLARQVLSGLAYLHKRK--IVHRDIKP 221
           E  +L E   G  +E          +  + +L  +  Q    + ++H++K  I+HRD+K 
Sbjct: 108 EFLLLTELCKGQLVEFLKKMESRGPLSCDTVL-KIFYQTCRAVQHMHRQKPPIIHRDLKV 166

Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDPCNSA------------VGTIAYMSPERINTDL 269
            NLL+++   +K+ DFG +  ++   D   SA              T  Y +PE I  DL
Sbjct: 167 ENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII--DL 224

Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ--PPEAPEMASR 327
                 G   DIW+LG  +      + PF              I   +   P        
Sbjct: 225 YSNFPIGEKQDIWALGCILYLLCFRQHPFE-------DGAKLRIVNGKYSIPPHDTQ-YT 276

Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPLSS 380
            F   I   LQ +P  R   A+++     + A ++         + P  P++ 
Sbjct: 277 VFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN---------VNPKSPITE 320

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  186 bits (474), Expect = 5e-56
 Identities = 85/320 (26%), Positives = 140/320 (43%), Gaps = 38/320 (11%)

Query: 61  NSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQK-----------GNRIGS 109
           +   SSG     +N +                  + +                  + +G 
Sbjct: 4   HHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGR 63

Query: 110 GSGGTVWRVVHPPTSRVFALKVIY-GNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR 168
           G+   V+R     T + +ALKV+     +  VR     EI +L  ++HPN++K  ++++ 
Sbjct: 64  GATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR----TEIGVLLRLSHPNIIKLKEIFET 119

Query: 169 NGEIEVLLEYMDGGSLEGAHIRQEHIL----SDLARQVLSGLAYLHKRKIVHRDIKPSNL 224
             EI ++LE + GG L    + + +      +D  +Q+L  +AYLH+  IVHRD+KP NL
Sbjct: 120 PTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENL 179

Query: 225 LINSSK---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDI 281
           L  +      +KIADFG+S+I+        +  GT  Y +PE I     +G       D+
Sbjct: 180 LYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPE-ILRGCAYGP----EVDM 233

Query: 282 WSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQ----PPEAPEMASREFRDFISRC 336
           WS+G+ I    L G  PF    +GD   +   I   +     P   E+ S   +D + + 
Sbjct: 234 WSVGI-ITYILLCGFEPF-YDERGD-QFMFRRILNCEYYFISPWWDEV-SLNAKDLVRKL 289

Query: 337 LQKDPHSRWPAAQLLQHPFI 356
           +  DP  R    Q LQHP++
Sbjct: 290 IVLDPKKRLTTFQALQHPWV 309

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  185 bits (472), Expect = 6e-56
 Identities = 77/286 (26%), Positives = 125/286 (43%), Gaps = 33/286 (11%)

Query: 103 KGNRIGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNH-PN 158
               +G G    V + +   T + +A K +       +   R++I  EI +L      P 
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC--RAEILHEIAVLELAKSCPR 90

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKR 212
           V+  H++Y+   EI ++LEY  GG +      E A +  E+ +  L +Q+L G+ YLH+ 
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN 150

Query: 213 KIVHRDIKPSNLLINSSK---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
            IVH D+KP N+L++S     ++KI DFG+SR +          +GT  Y++PE I   L
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIMGTPEYLAPE-I---L 205

Query: 270 NHGKYDGYAGDIWSLGVSILEFYL---GRFPFAVGRQGDWASLMFAICFAQ---PPEAPE 323
           N+      A D+W++G+ I   Y+      PF      +       I         E   
Sbjct: 206 NYDPI-TTATDMWNIGI-IA--YMLLTHTSPFVGEDNQE---TYLNISQVNVDYSEETFS 258

Query: 324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLR 369
             S+   DFI   L K+P  R  A   L H ++ +     +     
Sbjct: 259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEE 304

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  186 bits (473), Expect = 9e-56
 Identities = 57/405 (14%), Positives = 109/405 (26%), Gaps = 81/405 (20%)

Query: 20  SSSPSSSLANRR-GQRRRPDLTLPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPH 78
            SS   +L  +  G     +L   IPQ             +    S++    S    +  
Sbjct: 7   HSSGRENLYFQGPGDVVIEELFNRIPQ-------ANVRTTSEYMQSAADSLVSTSLWNTG 59

Query: 79  QQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED 138
           Q  + +++   + R        L +G  +G              T   F + V Y     
Sbjct: 60  QPFRVESELGERPRT-------LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP 112

Query: 139 SVRSQ---------------------------ICREIEILRDVNHPNVVKCHDMYDRNGE 171
              +                                 ++++D     +++          
Sbjct: 113 PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWV 172

Query: 172 IEVLLEYM-------DGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRDI 219
           +     Y          G +  +H      L       L  QV+  LA LH   +VH  +
Sbjct: 173 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 232

Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN------TDLNHGK 273
           +P +++++    V +  F         +        +  +  PE            +   
Sbjct: 233 RPVDIVLDQRGGVFLTGFEHLVRDGARVVSS----VSRGFEPPELEARRATISYHRDRRT 288

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
              ++ D W+LG+ I   +    P         +  +F  C   P           R  +
Sbjct: 289 LMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPV--------RALL 340

Query: 334 SRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPL 378
              L+     R    Q ++ P           + LR  L    PL
Sbjct: 341 EGFLRYPKEDRLLPLQAMETPEY---------EQLRTELSAALPL 376

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  184 bits (470), Expect = 1e-55
 Identities = 82/310 (26%), Positives = 138/310 (44%), Gaps = 34/310 (10%)

Query: 71  SHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALK 130
           +H +HH     +   Q     ++ + +  +L K   +G G  G V    H  T +  ALK
Sbjct: 2   AHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSK-QVLGLGVNGKVLECFHRRTGQKCALK 60

Query: 131 VIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYD--RNGEIEVLL--EYMDGGSL- 184
           ++     DS +++  +E++        P++V   D+Y+   +G+  +L+  E M+GG L 
Sbjct: 61  LL----YDSPKAR--QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELF 114

Query: 185 -----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK---NVKIAD 236
                 G     E   +++ R + + + +LH   I HRD+KP NLL  S +    +K+ D
Sbjct: 115 SRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD 174

Query: 237 FGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GR 295
           FG ++   Q  +   +   T  Y++PE     L   KYD  + D+WSLGV I+   L G 
Sbjct: 175 FGFAKETTQ--NALQTPCYTPYYVAPEV----LGPEKYD-KSCDMWSLGV-IMYILLCGF 226

Query: 296 FPF-AVGRQGDWASLMFAICFAQP--PEAP-EMASREFRDFISRCLQKDPHSRWPAAQLL 351
            PF +   Q     +   I   Q   P       S + +  I   L+ DP  R    Q +
Sbjct: 227 PPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFM 286

Query: 352 QHPFILRAGQ 361
            HP+I ++  
Sbjct: 287 NHPWINQSMV 296

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  179 bits (456), Expect = 4e-54
 Identities = 68/279 (24%), Positives = 117/279 (41%), Gaps = 27/279 (9%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 167 DRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIVHRDIKP 221
                  + LEY  GG L    I  +  +    A+    Q+++G+ YLH   I HRDIKP
Sbjct: 75  REGNIQYLFLEYCSGGELF-DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133

Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDPC--NSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE +       ++     
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL----KRREFHAEPV 189

Query: 280 DIWSLGVSILEFYL--GRFPFAVGRQGDWASLMFAICFAQPPEAPEMA-SREFRDFISRC 336
           D+WS G+ +L   +  G  P+   +  D           +    P           + + 
Sbjct: 190 DVWSCGI-VL-TAMLAGELPWD--QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245

Query: 337 LQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPP 375
           L ++P +R     + +  +         N+ L++    P
Sbjct: 246 LVENPSARITIPDIKKDRWY--------NKPLKKGAKRP 276

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  180 bits (458), Expect = 4e-54
 Identities = 79/285 (27%), Positives = 121/285 (42%), Gaps = 41/285 (14%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDV-NHPNVVKC 162
           +G G+   V   ++  TS+ +A+K+I    G+    V     RE+E+L     H NV++ 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF----REVEMLYQCQGHRNVLEL 76

Query: 163 HDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYLHKRKIVHR 217
            + ++      ++ E M GGS+  +HI +     E   S + + V S L +LH + I HR
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSIL-SHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135

Query: 218 DIKPSNLLINSSKN---VKIADFGVSRIL-------AQTMDPCNSAVGTIAYMSPERINT 267
           D+KP N+L         VKI DF +   +         +     +  G+  YM+PE +  
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195

Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPE------ 320
                       D+WSLGV IL   L G  PF      D        C A          
Sbjct: 196 FSEEASIYDKRCDLWSLGV-ILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ 254

Query: 321 -------APEMA--SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                    + A  S   +D IS+ L +D   R  AAQ+LQHP++
Sbjct: 255 EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  181 bits (461), Expect = 1e-53
 Identities = 84/333 (25%), Positives = 138/333 (41%), Gaps = 37/333 (11%)

Query: 53  PLPLPPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQK-----GNRI 107
           P+P P  +        +  H    P      Q    H      I    +          +
Sbjct: 11  PVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVL 70

Query: 108 GSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMY 166
           G G  G V ++ +  T   FALK++    +D  +++  RE+E+       P++V+  D+Y
Sbjct: 71  GLGINGKVLQIFNKRTQEKFALKML----QDCPKAR--REVELHWRASQCPHIVRIVDVY 124

Query: 167 D--RNGEIEVLL--EYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVH 216
           +    G   +L+  E +DGG L       G     E   S++ + +   + YLH   I H
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAH 184

Query: 217 RDIKPSNLLINSSK---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           RD+KP NLL  S +    +K+ DFG ++    + +   +   T  Y++PE     L   K
Sbjct: 185 RDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPYYVAPEV----LGPEK 239

Query: 274 YDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMF-AICFAQP--PEAP-EMASRE 328
           YD  + D+WSLGV I+   L G  PF        +  M   I   Q   P       S E
Sbjct: 240 YD-KSCDMWSLGV-IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 297

Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
            +  I   L+ +P  R    + + HP+I+++ +
Sbjct: 298 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  180 bits (457), Expect = 2e-53
 Identities = 47/348 (13%), Positives = 88/348 (25%), Gaps = 56/348 (16%)

Query: 57  PPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVW 116
                  ++  ++ +      + +    +  +   R        L+    +  G    V+
Sbjct: 27  EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERK-------LKLVEPLRVGDRSVVF 79

Query: 117 RVVHPPTSRVFALKVIYGNHEDS--VRSQICREIEILRDVNHPNVVKCHDMY-------- 166
            V        FALKV     E+S     ++         +   +  +  D          
Sbjct: 80  LVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139

Query: 167 ------------------DRNGEIEVLLEYMDG-----GSLEGAHIRQEHILSDLAR--- 200
                                    +L+           S              LA    
Sbjct: 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHIL 199

Query: 201 --QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIA 258
             Q++   A L  + +VH    P NL I     + + D      +             + 
Sbjct: 200 TAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPAS---SVPVT 256

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP 318
           Y   E +N          +A + W LG+SI   +    PF +   G   S          
Sbjct: 257 YAPREFLN---ASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPG 313

Query: 319 PEAPEMA-----SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
            ++             +  I R L  D   R    + ++ P  L+   
Sbjct: 314 TDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  177 bits (451), Expect = 3e-53
 Identities = 62/278 (22%), Positives = 110/278 (39%), Gaps = 36/278 (12%)

Query: 90  QNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS------VRSQ 143
           ++R   +   E++   +IG G  G V +        V A+K +     +          +
Sbjct: 10  KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQE 69

Query: 144 ICREIEILRDVNHPNVVK----CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS--- 196
             RE+ I+ ++NHPN+VK     H+         +++E++  G L    + + H +    
Sbjct: 70  FQREVFIMSNLNHPNIVKLYGLMHN------PPRMVMEFVPCGDLYHRLLDKAHPIKWSV 123

Query: 197 --DLARQVLSGLAYLHKRK--IVHRDIKPSNLLI-----NSSKNVKIADFGVSRILAQTM 247
              L   +  G+ Y+  +   IVHRD++  N+ +     N+    K+ADFG+S+    ++
Sbjct: 124 KLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV 183

Query: 248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWA 307
              +  +G   +M+PE I        Y   A D +S  + +     G  PF         
Sbjct: 184 ---SGLLGNFQWMAPETIGA--EEESYTEKA-DTYSFAMILYTILTGEGPFD-EYSYGKI 236

Query: 308 SLMFAICFAQP-PEAPEMASREFRDFISRCLQKDPHSR 344
             +  I      P  PE      R+ I  C   DP  R
Sbjct: 237 KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKR 274

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  177 bits (452), Expect = 3e-53
 Identities = 69/275 (25%), Positives = 116/275 (42%), Gaps = 32/275 (11%)

Query: 92  RHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEIL 151
            H++  P++L  G  +G G  G   +V H  T  V  +K +    E++ R    +E++++
Sbjct: 3   PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR-TFLKEVKVM 61

Query: 152 RDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI------LSDLARQVLSG 205
           R + HPNV+K   +  ++  +  + EY+ GG+L    I+              A+ + SG
Sbjct: 62  RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLR-GIIKSMDSQYPWSQRVSFAKDIASG 120

Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN-------------- 251
           +AYLH   I+HRD+   N L+  +KNV +ADFG++R++                      
Sbjct: 121 MAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180

Query: 252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMF 311
           + VG   +M+PE I    N   YD    D++S G+ + E                 ++ F
Sbjct: 181 TVVGNPYWMAPEMI----NGRSYD-EKVDVFSFGIVLCEIIGRVNAD---PDYLPRTMDF 232

Query: 312 AICFAQ--PPEAPEMASREFRDFISRCLQKDPHSR 344
            +          P      F     RC   DP  R
Sbjct: 233 GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  181 bits (459), Expect = 3e-53
 Identities = 46/317 (14%), Positives = 89/317 (28%), Gaps = 49/317 (15%)

Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--------------------- 139
           L +G  +G              T   F + V Y                           
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 140 ------VRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYM-------DGGSLEG 186
                 V  +     ++++D     +++          +     Y          G +  
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 187 AHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR 241
           +H      L       L  QV+  LA LH   +VH  ++P +++++    V +  F    
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 242 IL-AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAV 300
              A  + P           +   +    +H     +A D W+LG++I   +    P   
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN-- 317

Query: 301 GRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG 360
               D A       F      P+      R  +   L+     R    Q ++ P      
Sbjct: 318 --TDDAALGGSEWIFRSCKNIPQ----PVRALLEGFLRYPKEDRLLPLQAMETPE-YEQL 370

Query: 361 QSQVNQNLRQILPPPRP 377
           +++++  L        P
Sbjct: 371 RTELSAALPLYQTDGEP 387

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  177 bits (452), Expect = 4e-53
 Identities = 75/336 (22%), Positives = 133/336 (39%), Gaps = 41/336 (12%)

Query: 60  SNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVV 119
            +   SSG      +  P            + +  L +  ++  G  +GSG  G+V+  +
Sbjct: 6   HHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQV--GPLLGSGGFGSVYSGI 63

Query: 120 HPPTSRVFALKVI-----YGNHEDSVRSQICREIEILRDVNH--PNVVKCHDMYDRNGEI 172
               +   A+K +         E    +++  E+ +L+ V+     V++  D ++R    
Sbjct: 64  RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123

Query: 173 EVLLEYMDG-GSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIVHRDIKPSNLLI 226
            ++LE  +    L    I +   L  +LAR    QVL  + + H   ++HRDIK  N+LI
Sbjct: 124 VLILERPEPVQDLF-DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 182

Query: 227 NSSK-NVKIADFGVSRILAQTM--DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWS 283
           + ++  +K+ DFG   +L  T+  D      GT  Y  PE I     + +Y G +  +WS
Sbjct: 183 DLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWI----RYHRYHGRSAAVWS 234

Query: 284 LGVSILEFYL--GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDP 341
           LG+ +L + +  G  PF      +                 +  S E +  I  CL   P
Sbjct: 235 LGI-LL-YDMVCGDIPFE--HDEEIIRGQVFF--------RQRVSSECQHLIRWCLALRP 282

Query: 342 HSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
             R    ++  HP++      Q    +      P P
Sbjct: 283 SDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGP 318

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  177 bits (452), Expect = 4e-53
 Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 30/284 (10%)

Query: 85  TQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQ 143
           +  +  +    I    L K   IG G+   V    H  T R  A+K+I       +   +
Sbjct: 3   SIASCADEQPHIGNYRLLK--TIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK 60

Query: 144 ICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR-- 200
           + RE+ I++ +NHPN+VK  ++ +    + +++EY  GG +   ++     +    AR  
Sbjct: 61  LFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEV-FDYLVAHGRMKEKEARSK 119

Query: 201 --QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP---CNSAVG 255
             Q++S + Y H+++IVHRD+K  NLL+++  N+KIADFG     +         ++  G
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFG----FSNEFTVGGKLDAFCG 175

Query: 256 TIAYMSPERINTDLNHGK-YDGYAGDIWSLGVSILEFYL--GRFPFAVGRQGDWASLMFA 312
              Y +PE        GK YDG   D+WSLGV IL + L  G  PF     G     +  
Sbjct: 176 APPYAAPELFQ-----GKKYDGPEVDVWSLGV-IL-YTLVSGSLPF----DGQNLKELRE 224

Query: 313 ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                    P   S +  + + R L  +P  R    Q+++  +I
Sbjct: 225 RVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  174 bits (444), Expect = 2e-52
 Identities = 83/295 (28%), Positives = 135/295 (45%), Gaps = 33/295 (11%)

Query: 90  QNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICRE 147
            +    I    L  G+ +G G+ G V    H  T    A+K++         V  +I RE
Sbjct: 4   HDGRVKIGHYVL--GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61

Query: 148 IEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QV 202
           I+ L+   HP+++K + +     +  +++EY+ GG L   +I +   +    AR    Q+
Sbjct: 62  IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGEL-FDYICKHGRVEEMEARRLFQQI 120

Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSP 262
           LS + Y H+  +VHRD+KP N+L+++  N KIADFG+S +++   +   ++ G+  Y +P
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAP 179

Query: 263 ERINTDLNHGK-YDGYAGDIWSLGVSILEFYL--GRFPFAVGRQGDWASLMFAICFAQPP 319
           E I+     G+ Y G   DIWS GV IL + L  G  PF      +    +F        
Sbjct: 180 EVIS-----GRLYAGPEVDIWSCGV-IL-YALLCGTLPF----DDEHVPTLFKKIRGGVF 228

Query: 320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPP 374
             PE  +R     +   LQ DP  R     + +H +          Q+L   L P
Sbjct: 229 YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF--------KQDLPSYLFP 275

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  175 bits (447), Expect = 3e-52
 Identities = 70/284 (24%), Positives = 119/284 (41%), Gaps = 27/284 (9%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK +   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 167 DRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIVHRDIKP 221
                  + LEY  GG L    I  +  +    A+    Q+++G+ YLH   I HRDIKP
Sbjct: 75  REGNIQYLFLEYCSGGELF-DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKP 133

Query: 222 SNLLINSSKNVKIADFGVSRILAQTMDPC--NSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            NLL++   N+KI+DFG++ +          N   GT+ Y++PE +       ++     
Sbjct: 134 ENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL----KRREFHAEPV 189

Query: 280 DIWSLGVSILEFYL--GRFPFAVGRQGDWASLMFAICFAQPPEAPEMA-SREFRDFISRC 336
           D+WS G+ +L   +  G  P+   +  D           +    P           + + 
Sbjct: 190 DVWSCGI-VL-TAMLAGELPWD--QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245

Query: 337 LQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPLSS 380
           L ++P +R     + +  +         N+ L++    PR  S 
Sbjct: 246 LVENPSARITIPDIKKDRWY--------NKPLKKGAKRPRVTSG 281

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  182 bits (464), Expect = 5e-52
 Identities = 71/292 (24%), Positives = 110/292 (37%), Gaps = 31/292 (10%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
             R+G+G  G V R +H  T    A+K          R + C EI+I++ +NHPNVV   
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78

Query: 164 DMYDRNGEIEVL------LEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLH 210
           ++ D   ++         +EY +GG L       E     +E  +  L   + S L YLH
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138

Query: 211 KRKIVHRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           + +I+HRD+KP N+++         KI D G ++ L Q  + C   VGT+ Y++PE +  
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPELLEQ 197

Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR 327
                KY     D WS G    E   G  PF    Q             +  E   +   
Sbjct: 198 K----KYTVTV-DYWSFGTLAFECITGFRPFLPNWQ---PVQWHGKVREKSNEHIVVYDD 249

Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLR----QILPPP 375
                    +   P+            ++        +Q  R    Q     
Sbjct: 250 LTGAVKFSSVLPTPNHLSGILAGKLERWL--QCMLMWHQRQRGTDPQNPNVG 299

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  174 bits (443), Expect = 6e-52
 Identities = 81/329 (24%), Positives = 125/329 (37%), Gaps = 40/329 (12%)

Query: 69  STSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFA 128
            T      P            ++R        L     +G G  GTV+           A
Sbjct: 3   LTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGP--LLGKGGFGTVFAGHRLTDRLQVA 60

Query: 129 LKVI-----YGNHEDSVRSQICREIEILRDVN----HPNVVKCHDMYDRNGEIEVLLEY- 178
           +KVI      G    S       E+ +L  V     HP V++  D ++      ++LE  
Sbjct: 61  IKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERP 120

Query: 179 MDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIVHRDIKPSNLLINSSK-NV 232
           +    L   +I ++  L    +R    QV++ + + H R +VHRDIK  N+LI+  +   
Sbjct: 121 LPAQDLF-DYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA 179

Query: 233 KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY 292
           K+ DFG   +L     P     GT  Y  PE I    +  +Y      +WSLG+ +L + 
Sbjct: 180 KLIDFGSGALLHDE--PYTDFDGTRVYSPPEWI----SRHQYHALPATVWSLGI-LL-YD 231

Query: 293 L--GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQL 350
           +  G  PF   ++   A L F          P   S +    I RCL   P SR    ++
Sbjct: 232 MVCGDIPFERDQEILEAELHF----------PAHVSPDCCALIRRCLAPKPSSRPSLEEI 281

Query: 351 LQHPFILRAGQSQVNQNLRQILPPPRPLS 379
           L  P+ ++     V  N  +  P P   S
Sbjct: 282 LLDPW-MQTPAEDVPLNPSKGGPAPLAWS 309

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  174 bits (443), Expect = 7e-52
 Identities = 78/297 (26%), Positives = 126/297 (42%), Gaps = 41/297 (13%)

Query: 72  HQNHHPHQQQQNQTQNNHQNRHQL------INPAELQKGNRIGSGSGGTVWR------VV 119
           H +HHP       T  N   +  +      I   +L    +IG+GS GTV R       V
Sbjct: 4   HHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDV 63

Query: 120 HPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY 178
                   A+K++      +   ++  RE+ I++ + HPN+V       +   + ++ EY
Sbjct: 64  --------AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115

Query: 179 MDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHKRK--IVHRDIKPSNLLINSS 229
           +  GSL              E     +A  V  G+ YLH R   IVHR++K  NLL++  
Sbjct: 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK 175

Query: 230 KNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSIL 289
             VK+ DFG+SR+ A T     SA GT  +M+PE +         +  + D++S GV + 
Sbjct: 176 YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL----RDEPSNEKS-DVYSFGVILW 230

Query: 290 EFYLGRFPFAVGRQG-DWASLMFAICFAQP-PEAPEMASREFRDFISRCLQKDPHSR 344
           E    + P+       + A ++ A+ F     E P   + +    I  C   +P  R
Sbjct: 231 ELATLQQPWG----NLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKR 283

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  174 bits (444), Expect = 8e-52
 Identities = 75/320 (23%), Positives = 127/320 (39%), Gaps = 44/320 (13%)

Query: 77  PHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI---- 132
               +  + +       +            +GSG+ G VW  V    ++   +K I    
Sbjct: 4   EEPPKAVELEGLAACEGEYSQKYSTMS--PLGSGAFGFVWTAVDKEKNKEVVVKFIKKEK 61

Query: 133 ---YGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE-YMDGGSLEGAH 188
                  ED    ++  EI IL  V H N++K  D+++  G  ++++E +  G  L  A 
Sbjct: 62  VLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLF-AF 120

Query: 189 IRQEHILS-DLAR----QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL 243
           I +   L   LA     Q++S + YL  + I+HRDIK  N++I     +K+ DFG +  L
Sbjct: 121 IDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180

Query: 244 AQTMDPCNSAVGTIAYMSPERINTDLNHGK-YDGYAGDIWSLGVSILEFYL--GRFPFAV 300
            +      +  GTI Y +PE +      G  Y G   ++WSLGV  L + L     PF  
Sbjct: 181 ERG-KLFYTFCGTIEYCAPEVLM-----GNPYRGPELEMWSLGV-TL-YTLVFEENPFCE 232

Query: 301 GRQ---GDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFIL 357
             +                     P + S+E    +S  LQ  P  R    +L+  P+ +
Sbjct: 233 LEETVEAA-----IHP--------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW-V 278

Query: 358 RAGQSQVNQNLRQILPPPRP 377
               +  +    ++    +P
Sbjct: 279 TQPVNLADYTWEEVFRVNKP 298

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  172 bits (438), Expect = 4e-51
 Identities = 72/263 (27%), Positives = 117/263 (44%), Gaps = 29/263 (11%)

Query: 94  QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRD 153
            +I+  E++    +G G+ G V +      ++  A+K I     +S R     E+  L  
Sbjct: 3   HMIDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQI---ESESERKAFIVELRQLSR 57

Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL--------EGAHIRQEHILSDLARQVLSG 205
           VNHPN+VK +        + +++EY +GGSL           +    H +S    Q   G
Sbjct: 58  VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS-WCLQCSQG 114

Query: 206 LAYLHKRK---IVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMS 261
           +AYLH  +   ++HRD+KP NLL+ +   V KI DFG +  +   M    +  G+ A+M+
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---TNNKGSAAWMA 171

Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           PE          Y     D++S G+ + E    R PF     G    +M+A+     P  
Sbjct: 172 PEVF----EGSNYSEKC-DVFSWGIILWEVITRRKPFD-EIGGPAFRIMWAVHNGTRPPL 225

Query: 322 PEMASREFRDFISRCLQKDPHSR 344
            +   +     ++RC  KDP  R
Sbjct: 226 IKNLPKPIESLMTRCWSKDPSQR 248

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  175 bits (445), Expect = 1e-50
 Identities = 83/305 (27%), Positives = 136/305 (44%), Gaps = 31/305 (10%)

Query: 85  TQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRS 142
            +    +    I    L     +G G+ G V    H  T    A+K++         V  
Sbjct: 4   AEKQKHDGRVKIGHYILGD--TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVG 61

Query: 143 QICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR-- 200
           +I REI+ L+   HP+++K + +     +I +++EY+ GG L     +   +    +R  
Sbjct: 62  KIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRL 121

Query: 201 --QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIA 258
             Q+LSG+ Y H+  +VHRD+KP N+L+++  N KIADFG+S +++   +   ++ G+  
Sbjct: 122 FQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPN 180

Query: 259 YMSPERINTDLNHGK-YDGYAGDIWSLGVSILEFYL--GRFPFAVGRQGDWASLMFAICF 315
           Y +PE I+     G+ Y G   DIWS GV IL + L  G  PF      D    +F    
Sbjct: 181 YAAPEVIS-----GRLYAGPEVDIWSSGV-IL-YALLCGTLPF----DDDHVPTLFKKIC 229

Query: 316 AQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPP 375
                 P+  +      +   LQ DP  R     + +H +          Q+L + L P 
Sbjct: 230 DGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWF--------KQDLPKYLFPE 281

Query: 376 RPLSS 380
            P  S
Sbjct: 282 DPSYS 286

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  170 bits (432), Expect = 1e-50
 Identities = 64/279 (22%), Positives = 115/279 (41%), Gaps = 56/279 (20%)

Query: 96  INPAELQKGNRIGSGSGGTVWR------VVHPPTSRVFALKVI-YGNHEDSVRSQICREI 148
           I   ++  G RIGSGS GTV++      V         A+K++               E+
Sbjct: 21  IPDGQITVGQRIGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFKNEV 71

Query: 149 EILRDVNHPNVVK----CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI------LSDL 198
            +LR   H N++              ++ ++ ++ +G SL   H+           L D+
Sbjct: 72  GVLRKTRHVNILLFMGYS-----TAPQLAIVTQWCEGSSLY-HHLHASETKFEMKKLIDI 125

Query: 199 ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM--DPCNSAVGT 256
           ARQ   G+ YLH + I+HRD+K +N+ ++    VKI DFG++   ++           G+
Sbjct: 126 ARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185

Query: 257 IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF-----------AVGRQGD 305
           I +M+PE I    +   Y   + D+++ G+ + E   G+ P+            VGR   
Sbjct: 186 ILWMAPEVIRMQ-DSNPYSFQS-DVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS- 242

Query: 306 WASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
              L   +      +      +  +  ++ CL+K    R
Sbjct: 243 ---LSPDL-----SKVRSNCPKRMKRLMAECLKKKRDER 273

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  171 bits (435), Expect = 2e-50
 Identities = 84/280 (30%), Positives = 136/280 (48%), Gaps = 30/280 (10%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHD 164
           +G GS G V    H  T +  ALK I      +  +  ++ REI  L+ + HP+++K +D
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRDIK 220
           +     +I +++EY  GG L    + ++ +  D  R    Q++  + Y H+ KIVHRD+K
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLK 135

Query: 221 PSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK-YDGYAG 279
           P NLL++ + NVKIADFG+S I+    +   ++ G+  Y +PE IN     GK Y G   
Sbjct: 136 PENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVIN-----GKLYAGPEV 189

Query: 280 DIWSLGVSILEFYL--GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL 337
           D+WS G+ +L + +  GR PF      ++   +F    +     P+  S   +  I R +
Sbjct: 190 DVWSCGI-VL-YVMLVGRLPF----DDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMI 243

Query: 338 QKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
             DP  R    ++ + P+         N NL   L P   
Sbjct: 244 VADPMQRITIQEIRRDPWF--------NVNLPDYLRPMEE 275

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  168 bits (429), Expect = 2e-50
 Identities = 50/278 (17%), Positives = 92/278 (33%), Gaps = 48/278 (17%)

Query: 91  NRHQLINPAELQKGNRIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDS-VRSQ 143
           N+H  I+  +L    ++     G +W+       +         +KV+      +     
Sbjct: 2   NKHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDI--------VVKVLKVRDWSTRKSRD 53

Query: 144 ICREIEILRDVNHPNVVK----CHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQE 192
              E   LR  +HPNV+     C      +    ++  +M  GSL           + Q 
Sbjct: 54  FNEECPRLRIFSHPNVLPVLGACQSPPAPH--PTLITHWMPYGSLYNVLHEGTNFVVDQS 111

Query: 193 HILSDLARQVLSGLAYLHKRK--IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
             +   A  +  G+A+LH  +  I    +   +++I+     +I+   V           
Sbjct: 112 QAVK-FALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP---- 166

Query: 251 NSAVGTIAYMSPERINTDLNHGKYDGY--AGDIWSLGVSILEFYLGRFPFAVGRQG-DWA 307
              +   A+++PE     L     D    + D+WS  V + E      PFA         
Sbjct: 167 -GRMYAPAWVAPEA----LQKKPEDTNRRSADMWSFAVLLWELVTREVPFA----DLSNM 217

Query: 308 SLMFAICFAQP-PEAPEMASREFRDFISRCLQKDPHSR 344
            +   +      P  P   S      +  C+ +DP  R
Sbjct: 218 EIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKR 255

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  171 bits (435), Expect = 3e-50
 Identities = 86/322 (26%), Positives = 136/322 (42%), Gaps = 38/322 (11%)

Query: 79  QQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED 138
            +    T           +  +  K   IGSG+ G    +    T  + A+K I      
Sbjct: 2   DRAPVTTGPLDMPIMHDSDRYDFVK--DIGSGNFGVARLMRDKLTKELVAVKYI--ERGA 57

Query: 139 SVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-D 197
           ++   + REI   R + HPN+V+  ++      + +++EY  GG L    I      S D
Sbjct: 58  AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELY-ERICNAGRFSED 116

Query: 198 LAR----QVLSGLAYLHKRKIVHRDIKPSNLLI--NSSKNVKIADFGVSRILAQTMDPCN 251
            AR    Q+LSG++Y H  +I HRD+K  N L+  + +  +KI DFG S+       P  
Sbjct: 117 EARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-K 175

Query: 252 SAVGTIAYMSPERINTDLNHGK-YDGYAGDIWSLGVSILEFYL--GRFPFAVGRQGDWAS 308
           S VGT AY++PE +       + YDG   D+WS GV  L + +  G +PF    +     
Sbjct: 176 STVGTPAYIAPEVLL-----RQEYDGKIADVWSCGV-TL-YVMLVGAYPF----EDPEEP 224

Query: 309 LMF-----AICFAQ--PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR--- 358
             +      I   +   P+   + S E    ISR    DP +R    ++  H + L+   
Sbjct: 225 RDYRKTIQRILSVKYSIPDDIRI-SPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283

Query: 359 AGQSQVNQNLRQILPPPRPLSS 380
           A     +    Q   P +P+ S
Sbjct: 284 ADLMNESNTGSQFQEPEQPMQS 305

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  165 bits (421), Expect = 1e-48
 Identities = 72/316 (22%), Positives = 125/316 (39%), Gaps = 57/316 (18%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNVV 160
           +K  +IG GS G V++  +  T ++ A+K    + +D  ++    REI +L+ + HPN+V
Sbjct: 6   EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLV 65

Query: 161 KCHDMYDRNGEIEVLLEYMD----------GGSLEGAHIRQEHILSDLARQVLSGLAYLH 210
              +++ R   + ++ EY D             +    ++       +  Q L  + + H
Sbjct: 66  NLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKS------ITWQTLQAVNFCH 119

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
           K   +HRD+KP N+LI     +K+ DFG +R+L    D  +  V T  Y SPE +   + 
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELL---VG 176

Query: 271 HGKYDGYAGDIWSLGVSILEFYLGR--FP-----------FAV------GRQGDWASLMF 311
             +Y G   D+W++G    E   G   +P                      Q  +++  +
Sbjct: 177 DTQY-GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235

Query: 312 AICFAQPPEAPE--------MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ 363
                 P               S      +  CL  DP  R    QLL HP+        
Sbjct: 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF------- 288

Query: 364 VNQNLRQILPPPRPLS 379
             +N+R+I    +   
Sbjct: 289 --ENIREIEDLAKEHD 302

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  165 bits (421), Expect = 1e-48
 Identities = 87/326 (26%), Positives = 141/326 (43%), Gaps = 38/326 (11%)

Query: 67  GQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRV 126
           G +   +      Q         +       P + + G  +G GS  TV       TSR 
Sbjct: 3   GTAAEPRPGAGSLQHAQPPPQPRK-----KRPEDFKFGKILGEGSFSTVVLARELATSRE 57

Query: 127 FALKVIYGNH---EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGS 183
           +A+K++   H   E+ V   + RE +++  ++HP  VK +  +  + ++   L Y   G 
Sbjct: 58  YAIKILEKRHIIKENKVP-YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 116

Query: 184 LEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFG 238
           L   +IR+         R    +++S L YLH + I+HRD+KP N+L+N   +++I DFG
Sbjct: 117 LLK-YIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFG 175

Query: 239 VSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRF 296
            +++L+        NS VGT  Y+SPE + T+ +  K    + D+W+LG  I +   G  
Sbjct: 176 TAKVLSPESKQARANSFVGTAQYVSPE-LLTEKSACK----SSDLWALGCIIYQLVAGLP 230

Query: 297 PFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRW------PAAQL 350
           PF    +     L+F        + PE    + RD + + L  D   R           L
Sbjct: 231 PF----RAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 286

Query: 351 LQHPFILRAGQSQVN-QNLRQILPPP 375
             HPF        V  +NL Q  PP 
Sbjct: 287 KAHPFF-----ESVTWENLHQQTPPK 307

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  166 bits (422), Expect = 1e-48
 Identities = 72/292 (24%), Positives = 125/292 (42%), Gaps = 48/292 (16%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNVV 160
           +    +G GS G V +  +  T R+ A+K    + +D  V+    REI++L+ + H N+V
Sbjct: 28  ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLV 87

Query: 161 KCHDMYDRNGEIEVLLEYMD----------GGSLEGAHIRQEHILSDLARQVLSGLAYLH 210
              ++  +     ++ E++D             L+   +++         Q+++G+ + H
Sbjct: 88  NLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQK------YLFQIINGIGFCH 141

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
              I+HRDIKP N+L++ S  VK+ DFG +R LA   +  +  V T  Y +PE +   + 
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL---VG 198

Query: 271 HGKYDGYAGDIWSLGVSILEFYLGR--FP-----------FA------------VGRQGD 305
             KY G A D+W++G  + E ++G   FP                           +   
Sbjct: 199 DVKY-GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257

Query: 306 WASLMFAICFAQPPEAPE--MASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
           +A +       + P        S    D   +CL  DP  R   A+LL H F
Sbjct: 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  163 bits (416), Expect = 2e-48
 Identities = 75/276 (27%), Positives = 122/276 (44%), Gaps = 48/276 (17%)

Query: 96  INPAELQKGNRIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHED---SVRSQICR 146
           I+ AEL     IG G  G V+R       V        A+K    + ++        + +
Sbjct: 4   IDFAELTLEEIIGIGGFGKVYRAFWIGDEV--------AVKAARHDPDEDISQTIENVRQ 55

Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLE----GAHIRQEHILSDLARQV 202
           E ++   + HPN++    +  +   + +++E+  GG L     G  I  + ++ + A Q+
Sbjct: 56  EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILV-NWAVQI 114

Query: 203 LSGLAYLHKRK---IVHRDIKPSNLLIN--------SSKNVKIADFGVSRILAQTMDPCN 251
             G+ YLH      I+HRD+K SN+LI         S+K +KI DFG++R   +T     
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--M 172

Query: 252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSIL-EFYLGRFPFAVGRQG-DWASL 309
           SA G  A+M+PE I        +   + D+WS GV +L E   G  PF    +G D  ++
Sbjct: 173 SAAGAYAWMAPEVI----RASMFSKGS-DVWSYGV-LLWELLTGEVPF----RGIDGLAV 222

Query: 310 MFAICFAQ-PPEAPEMASREFRDFISRCLQKDPHSR 344
            + +   +     P      F   +  C   DPHSR
Sbjct: 223 AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSR 258

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  165 bits (420), Expect = 9e-48
 Identities = 69/290 (23%), Positives = 135/290 (46%), Gaps = 37/290 (12%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH---EDSVRSQICREIEILRDVNHPNVVKCH 163
           IG GS G V  V    T +++A+K +        + VR+ + +E++I++ + HP +V   
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRN-VFKELQIMQGLEHPFLVNLW 81

Query: 164 -------DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHK 211
                  DM+       ++++ + GG L   H++Q      +  +    +++  L YL  
Sbjct: 82  YSFQDEEDMF-------MVVDLLLGGDL-RYHLQQNVHFKEETVKLFICELVMALDYLQN 133

Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
           ++I+HRD+KP N+L++   +V I DF ++ +L +      +  GT  YM+PE  ++    
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSSRKGA 192

Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
           G Y  +A D WSLGV+  E   GR P+ +        ++           P   S+E   
Sbjct: 193 G-Y-SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-VVTYPSAWSQEMVS 249

Query: 332 FISRCLQKDPHSRWPAAQ-LLQHPFILRAGQSQVN-QNL--RQILPPPRP 377
            + + L+ +P  R+     +   P++     + +N   +  ++++P   P
Sbjct: 250 LLKKLLEPNPDQRFSQLSDVQNFPYM-----NDINWDAVFQKRLIPGFIP 294

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  163 bits (415), Expect = 1e-47
 Identities = 61/310 (19%), Positives = 113/310 (36%), Gaps = 47/310 (15%)

Query: 58  PTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWR 117
           P  N S  S +S   +        Q             I   +L+ G  IG G  G V+ 
Sbjct: 2   PEMNLSLLSARSFPRKASQTSIFLQEWD----------IPFEQLEIGELIGKGRFGQVYH 51

Query: 118 ------VVHPPTSRVFALKVIYGNHED-SVRSQICREIEILRDVNHPNVVKCHDMYDRNG 170
                 V         A+++I    ++        RE+   R   H NVV          
Sbjct: 52  GRWHGEV---------AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102

Query: 171 EIEVLLEYMDGGSLEGAHIRQEHI------LSDLARQVLSGLAYLHKRKIVHRDIKPSNL 224
            + ++     G +L  + +R   I         +A++++ G+ YLH + I+H+D+K  N+
Sbjct: 103 HLAIITSLCKGRTLY-SVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNV 161

Query: 225 LINSSKNVKIADFGVSRILAQTM-----DPCNSAVGTIAYMSPERINTDLNHGKYDGY-- 277
             + +  V I DFG+  I          D      G + +++PE I       + D    
Sbjct: 162 FYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPF 220

Query: 278 --AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF-AQPPEAPEMASREFRDFIS 334
               D+++LG    E +   +PF   +     ++++ +    +P  +     +E  D + 
Sbjct: 221 SKHSDVFALGTIWYELHAREWPF---KTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILL 277

Query: 335 RCLQKDPHSR 344
            C   +   R
Sbjct: 278 FCWAFEQEER 287

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  160 bits (406), Expect = 2e-46
 Identities = 43/238 (18%), Positives = 87/238 (36%), Gaps = 29/238 (12%)

Query: 138 DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS- 196
            S       +I  +   +  N V           + + ++     +L+    R+  +   
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161

Query: 197 ------DLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
                  +  Q+   + +LH + ++HRD+KPSN+       VK+ DFG+   + Q  +  
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221

Query: 251 N------------SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF 298
                          VGT  YMSPE+    ++   Y  +  DI+SLG+ + E     + F
Sbjct: 222 TVLTPMPAYATHTGQVGTKLYMSPEQ----IHGNNYS-HKVDIFSLGLILFELL---YSF 273

Query: 299 AVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           +   +     ++  +   + P        +    +   L   P  R  A  ++++   
Sbjct: 274 STQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 55.7 bits (134), Expect = 6e-09
 Identities = 14/64 (21%), Positives = 30/64 (46%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
            +G G  G V+   +      +A+K I   + +  R ++ RE++ L  + HP +V+  + 
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 166 YDRN 169
           +   
Sbjct: 73  WLET 76

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  158 bits (403), Expect = 4e-46
 Identities = 73/278 (26%), Positives = 116/278 (41%), Gaps = 53/278 (19%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKC 162
              +G G  G V ++ +  T   FALK++    +D  +++  RE+E+       P++V+ 
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKML----QDCPKAR--REVELHWRASQCPHIVRI 76

Query: 163 HDMYD--RNGEIEVLL--EYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKR 212
            D+Y+    G   +L+  E +DGG L       G     E   S++ + +   + YLH  
Sbjct: 77  VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 136

Query: 213 KIVHRDIKPSNLLINSSK---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
            I HRD+KP NLL  S +    +K+ DFG     A                  E      
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFG----FA-----------------KE-----T 170

Query: 270 NHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMF-AICFAQP--PEAP-EM 324
              KYD  + D+WSLGV I+   L G  PF        +  M   I   Q   P      
Sbjct: 171 TGEKYD-KSCDMWSLGV-IMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 228

Query: 325 ASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS 362
            S E +  I   L+ +P  R    + + HP+I+++ + 
Sbjct: 229 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  159 bits (405), Expect = 4e-46
 Identities = 72/300 (24%), Positives = 117/300 (39%), Gaps = 48/300 (16%)

Query: 94  QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRD 153
           Q     ++Q   +IG G  G VW           A+KV +   E S   +   EI     
Sbjct: 32  QRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRE--TEIYQTVL 87

Query: 154 VNHPNVVKC--HDMYDRNGEIEVLL--EYMDGGSLEGAHIRQEHILS-----DLARQVLS 204
           + H N++     D+       ++ L  +Y + GSL      +   L       LA   +S
Sbjct: 88  MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLY--DYLKSTTLDAKSMLKLAYSSVS 145

Query: 205 GLAYLH--------KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD----PCNS 252
           GL +LH        K  I HRD+K  N+L+  +    IAD G++       +    P N+
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205

Query: 253 AVGTIAYMSPERIN--TDLNHGKYDGYAGDIWSLGV------------SILEFYLGRFPF 298
            VGT  YM PE ++   + NH +    A D++S G+             I+E Y   +  
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMA-DMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264

Query: 299 AVGRQGDWASLMFAICFAQP-PEAPEMAS-----REFRDFISRCLQKDPHSRWPAAQLLQ 352
            V     +  +   +C  +  P  P   S     R+    ++ C   +P SR  A ++ +
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  158 bits (402), Expect = 7e-46
 Identities = 68/259 (26%), Positives = 112/259 (43%), Gaps = 29/259 (11%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDVNHPNVVKCH 163
            +G G  G V+        R+ ALK++      +   R+++ RE      +  P+VV  H
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 164 DMYDRNGEIEVLL----EYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYLHKRKI 214
           D     GEI+  L      ++G  L  A +R++  L+      + RQ+ S L   H    
Sbjct: 101 DF----GEIDGQLYVDMRLINGVDL-AAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155

Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQ-TMDPCNSAVGTIAYMSPERINTDLNHGK 273
            HRD+KP N+L+++     + DFG++       +    + VGT+ YM+PER +       
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS-----ES 210

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA---SREFR 330
           +  Y  DI++L   + E   G  P+    QGD  S+M A      P    +       F 
Sbjct: 211 HATYRADIYALTCVLYECLTGSPPY----QGDQLSVMGAHINQAIPRPSTVRPGIPVAFD 266

Query: 331 DFISRCLQKDPHSRWPAAQ 349
             I+R + K+P  R+    
Sbjct: 267 AVIARGMAKNPEDRYVTCG 285

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  157 bits (400), Expect = 1e-45
 Identities = 71/301 (23%), Positives = 117/301 (38%), Gaps = 50/301 (16%)

Query: 94  QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRD 153
           Q     ++     +G G  G VWR          A+K+     E S   +   E+     
Sbjct: 3   QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRE--TELYNTVM 58

Query: 154 VNHPNVVKC--HDMYDRNGEIEVLL--EYMDGGSLEGAHIRQEHILS-----DLARQVLS 204
           + H N++     DM  R+   ++ L   Y + GSL      Q   L       +   + S
Sbjct: 59  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLY--DYLQLTTLDTVSCLRIVLSIAS 116

Query: 205 GLAYLH--------KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD----PCNS 252
           GLA+LH        K  I HRD+K  N+L+  +    IAD G++ + +Q+ +      N 
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176

Query: 253 AVGTIAYMSPERINTDLNHGKYDGY-AGDIWSLGV------------SILEFYLGRFPFA 299
            VGT  YM+PE ++  +    +D Y   DIW+ G+             I+E Y  + PF 
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY--KPPFY 234

Query: 300 --VGRQGDWASLMFAICFAQP-PEAPE-----MASREFRDFISRCLQKDPHSRWPAAQLL 351
             V     +  +   +C  Q  P  P               +  C  ++P +R  A ++ 
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294

Query: 352 Q 352
           +
Sbjct: 295 K 295

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  157 bits (399), Expect = 2e-45
 Identities = 56/297 (18%), Positives = 112/297 (37%), Gaps = 46/297 (15%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
                LQ       G  G VW+      +   A+K+     + S +++   E+  L  + 
Sbjct: 21  FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNE--YEVYSLPGMK 76

Query: 156 HPNVVKC--HDMYDRNGEIEVLL--EYMDGGSLEGAHIRQEHILS-----DLARQVLSGL 206
           H N+++    +    + ++++ L   + + GSL      + +++S      +A  +  GL
Sbjct: 77  HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLS--DFLKANVVSWNELCHIAETMARGL 134

Query: 207 AYLH----------KRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL--AQTMDPCNSAV 254
           AYLH          K  I HRDIK  N+L+ ++    IADFG++      ++    +  V
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194

Query: 255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF-------------AVG 301
           GT  YM+PE +   +N  +      D++++G+ + E                      +G
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254

Query: 302 RQGDWASLMFAICFAQ----PPEA--PEMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
           +      +   +   +      +            + I  C   D  +R  A  + +
Sbjct: 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  157 bits (398), Expect = 5e-45
 Identities = 69/300 (23%), Positives = 108/300 (36%), Gaps = 48/300 (16%)

Query: 94  QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRD 153
           Q      +     IG G  G VWR          A+K+     E S   +   EI     
Sbjct: 37  QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE--AEIYQTVM 92

Query: 154 VNHPNVVKC--HDMYDRNGEIEVLL--EYMDGGSLEGAHIRQEHILS-----DLARQVLS 204
           + H N++     D  D     ++ L  +Y + GSL        + ++      LA    S
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLF--DYLNRYTVTVEGMIKLALSTAS 150

Query: 205 GLAYLH--------KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD----PCNS 252
           GLA+LH        K  I HRD+K  N+L+  +    IAD G++       D      N 
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210

Query: 253 AVGTIAYMSPE--RINTDLNHGKYDGYAGDIWSLGV------------SILEFYLGRFPF 298
            VGT  YM+PE    + ++ H +    A DI+++G+             I E Y   +  
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRA-DIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269

Query: 299 AVGRQGDWASLMFAICFA-QPPEAPEM-----ASREFRDFISRCLQKDPHSRWPAAQLLQ 352
            V        +   +C     P  P       A R     +  C   +  +R  A ++ +
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  156 bits (395), Expect = 2e-44
 Identities = 47/321 (14%), Positives = 101/321 (31%), Gaps = 46/321 (14%)

Query: 63  SSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVH-- 120
           S  S   +S+ N    Q +    +   + +   +    +   + +G G+   V+      
Sbjct: 32  SGLSKPVSSYPNTFEWQCKLPAIKPKTEFQ---LGSKLVYVHHLLGEGAFAQVYEATQGD 88

Query: 121 ---PPTSRVFALKVIYGNHEDSVRSQICR-EIEILRDVNHPNVVKCHDMYDRNGEIEVLL 176
                  + F LKV      +     I    +E L+       +K +  +       ++ 
Sbjct: 89  LNDAKNKQKFVLKVQ--KPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVG 146

Query: 177 EYMDGGSL---------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN 227
           E    G+L             +  + ++   A ++L  +  +H  +I+H DIKP N ++ 
Sbjct: 147 ELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILG 206

Query: 228 S-----------SKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKY 274
           +           S  + + D G S  +          +   T  +   E     L++  +
Sbjct: 207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEM----LSNKPW 262

Query: 275 DGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS 334
           + Y  D + +  ++     G +       G+         F + P           +F  
Sbjct: 263 N-YQIDYFGVAATVYCMLFGTYMKVKNEGGEC---KPEGLFRRLPHLDMWN-----EFFH 313

Query: 335 RCLQKDPHSRWPAAQLLQHPF 355
             L        P+  LL+   
Sbjct: 314 VMLNIPDCHHLPSLDLLRQKL 334

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  154 bits (391), Expect = 2e-44
 Identities = 72/291 (24%), Positives = 127/291 (43%), Gaps = 47/291 (16%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNVV 160
           +K  +IG G+ GTV++  +  T  + ALK +   + ++ V S   REI +L+++ H N+V
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64

Query: 161 KCHDMYDRNGEIEVLLEYMD----------GGSLEGAHIRQEHILSDLARQVLSGLAYLH 210
           + HD+   + ++ ++ E+ D           G L+   ++          Q+L GL + H
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS------FLFQLLKGLGFCH 118

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
            R ++HRD+KP NLLIN +  +K+A+FG++R     +   ++ V T+ Y  P+ +     
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL---FG 175

Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGR-----------------QGDW---ASLM 310
              Y   + D+WS G    E      P   G                  +  W     L 
Sbjct: 176 AKLY-STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 311 FAICFAQPPEAPEM------ASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
               +   P    +       +   RD +   L+ +P  R  A + LQHP+
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  153 bits (388), Expect = 1e-43
 Identities = 74/293 (25%), Positives = 126/293 (43%), Gaps = 52/293 (17%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
            K +++G G+  TV++     T  + ALK I   HE+       RE+ +L+D+ H N+V 
Sbjct: 5   IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 64

Query: 162 CHDMYDRNGEIEVLLEYMD----------GGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
            HD+      + ++ EY+D          G  +   +++          Q+L GLAY H+
Sbjct: 65  LHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKL------FLFQLLRGLAYCHR 118

Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
           +K++HRD+KP NLLIN    +K+ADFG++R  +      ++ V T+ Y  P+ +   L  
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDIL---LGS 175

Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FPFAVGR-QGDWASLMFAIC-------------- 314
             Y     D+W +G    E   GR  FP   G    +    +F I               
Sbjct: 176 TDY-STQIDMWGVGCIFYEMATGRPLFP---GSTVEEQLHFIFRILGTPTEETWPGILSN 231

Query: 315 -------FAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
                  + +               +  D +++ LQ +  +R  A   ++HPF
Sbjct: 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  151 bits (384), Expect = 3e-43
 Identities = 74/294 (25%), Positives = 128/294 (43%), Gaps = 45/294 (15%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           ++  ++G+G+  TV++ ++  T    ALK +  + E+   S   REI +++++ H N+V+
Sbjct: 8   KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVR 67

Query: 162 CHDMYDRNGEIEVLLEYMD----------GGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
            +D+     ++ ++ E+MD                  +    +      Q+L GLA+ H+
Sbjct: 68  LYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY-FQWQLLQGLAFCHE 126

Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            KI+HRD+KP NLLIN    +K+ DFG++R     ++  +S V T+ Y +P+ +   +  
Sbjct: 127 NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVL---MGS 183

Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC----------------- 314
             Y   + DIWS G  + E   G+  F      +   L+F I                  
Sbjct: 184 RTY-STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242

Query: 315 ---FAQPP----------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
                Q P             E       DF+   LQ +P  R  A Q L HP+
Sbjct: 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  150 bits (381), Expect = 6e-43
 Identities = 78/290 (26%), Positives = 125/290 (43%), Gaps = 47/290 (16%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNVV 160
               +IG G+ G V++  +      FALK I     ++ + S   REI IL+++ H N+V
Sbjct: 5   HGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 161 KCHDMYDRNGEIEVLLEYMD----------GGSLEGAHIRQEHILSDLARQVLSGLAYLH 210
           K +D+      + ++ E++D           G LE    +          Q+L+G+AY H
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKS------FLLQLLNGIAYCH 117

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
            R+++HRD+KP NLLIN    +KIADFG++R     +      + T+ Y +P+ +   + 
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL---MG 174

Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC---------------- 314
             KY     DIWS+G    E   G   F    + D    +F I                 
Sbjct: 175 SKKY-STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233

Query: 315 ----FAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
               F      P     +       D +S+ L+ DP+ R  A Q L+H +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  150 bits (380), Expect = 1e-42
 Identities = 77/291 (26%), Positives = 129/291 (44%), Gaps = 48/291 (16%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNVV 160
           QK  ++G G+ G V++       R+ ALK I     ++ + S   REI +L++++HPN+V
Sbjct: 24  QKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82

Query: 161 KCHDMYDRNGEIEVLLEYMD----------GGSLEGAHIRQEHILSDLARQVLSGLAYLH 210
              D+      + ++ E+M+             L+ + I+          Q+L G+A+ H
Sbjct: 83  SLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKI------YLYQLLRGVAHCH 136

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
           + +I+HRD+KP NLLINS   +K+ADFG++R     +      V T+ Y +P+ +   + 
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL---MG 193

Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC---------------- 314
             KY   + DIWS+G    E   G+  F      D    +F+I                 
Sbjct: 194 SKKY-STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252

Query: 315 -----FAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
                F    + P         +E  D +S  L  DP+ R  A   + HP+
Sbjct: 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  150 bits (380), Expect = 2e-42
 Identities = 71/298 (23%), Positives = 116/298 (38%), Gaps = 53/298 (17%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           ++   L+    IG G  G V++       R  A+KV    +  +  ++  + I  +  + 
Sbjct: 10  LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINE--KNIYRVPLME 65

Query: 156 HPNVVK---CHDMYDRNGEIEVLL--EYMDGGSLEG---AHIRQEHILSDLARQVLSGLA 207
           H N+ +     +    +G +E LL  EY   GSL      H         LA  V  GLA
Sbjct: 66  HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLA 125

Query: 208 YLH---------KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD--------PC 250
           YLH         K  I HRD+   N+L+ +     I+DFG+S  L               
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185

Query: 251 NSAVGTIAYMSPERINTDLNHGKYDGY--AGDIWSLGVSILEFYLG-------------R 295
            S VGTI YM+PE +   +N    +      D+++LG+   E ++              +
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245

Query: 296 FPFA--VGRQGDWASLMFAICFAQP-PEAPE------MASREFRDFISRCLQKDPHSR 344
             F   VG    +  +   +   +  P+ PE      +A R  ++ I  C  +D  +R
Sbjct: 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR 303

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  149 bits (378), Expect = 6e-42
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 50/293 (17%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVI----YGNHEDSVRSQICREIEILRDVNHP 157
           +K + +G G   TV++     T+++ A+K I        +D +     REI++L++++HP
Sbjct: 13  EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 72

Query: 158 NVVKCHDMYDRNGEIEVLLEYMD----------GGSLEGAHIRQEHILSDLARQVLSGLA 207
           N++   D +     I ++ ++M+             L  +HI+            L GL 
Sbjct: 73  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKA------YMLMTLQGLE 126

Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           YLH+  I+HRD+KP+NLL++ +  +K+ADFG+++            V T  Y +PE +  
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL-- 184

Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGR-----------------QGDW---A 307
                 Y     D+W++G  + E  L   PF  G                  +  W    
Sbjct: 185 -FGARMYGV-GVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241

Query: 308 SLMFAICFAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
           SL   + F   P  P       A  +  D I      +P +R  A Q L+  +
Sbjct: 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  150 bits (380), Expect = 9e-42
 Identities = 77/288 (26%), Positives = 127/288 (44%), Gaps = 25/288 (8%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSV-RSQICR---EIEILRDVNHPNVVKC 162
           IG G+   V  V    T +V+A+K++  N  D + R ++     E ++L + +   + + 
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIM--NKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126

Query: 163 HDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIVHR 217
           H  +     + +++EY  GG L     +    +  ++AR    +++  +  +H+   VHR
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHR 186

Query: 218 DIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPE---RINTDLNHGK 273
           DIKP N+L++   ++++ADFG   ++ A        AVGT  Y+SPE    +      G 
Sbjct: 187 DIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGS 246

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPF-AVGRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
           Y G   D W+LGV   E + G+ PF A      +  ++        P   E    E RDF
Sbjct: 247 Y-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDF 305

Query: 333 ISRCLQKDPH--SRWPAAQLLQHPFILRAGQSQVN-QNLRQILPPPRP 377
           I R L        R  A     HPF        ++   LR  +PP  P
Sbjct: 306 IQRLLCPPETRLGRGGAGDFRTHPFF-----FGLDWDGLRDSVPPFTP 348

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  150 bits (381), Expect = 1e-41
 Identities = 72/283 (25%), Positives = 121/283 (42%), Gaps = 17/283 (6%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIE--ILRDVNHPNVVKCHD 164
           IG G+ G V  V      +VFA+K++            C   E  +L + +   +   H 
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141

Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIVHRDI 219
            +  +  + ++++Y  GG L     + E  L  ++AR    +++  +  +H+   VHRDI
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDI 201

Query: 220 KPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           KP N+L++ + ++++ADFG   +++       + AVGT  Y+SPE +          G  
Sbjct: 202 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPE 261

Query: 279 GDIWSLGVSILEFYLGRFPF-AVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL 337
            D WSLGV + E   G  PF A      +  +M      Q P      S   +D I R +
Sbjct: 262 CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLI 321

Query: 338 QKDPH--SRWPAAQLLQHPFILRAGQSQVN-QNLRQILPPPRP 377
               H   +       +HPF      S ++  N+R    P  P
Sbjct: 322 CSREHRLGQNGIEDFKKHPFF-----SGIDWDNIRNCEAPYIP 359

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  147 bits (373), Expect = 2e-41
 Identities = 67/329 (20%), Positives = 127/329 (38%), Gaps = 57/329 (17%)

Query: 74  NHHPHQQQQNQTQNNHQNRHQLINPAEL------QKGNRIGSGSGGTVWRVVHPPTSRVF 127
           +HH H     + Q        +            ++  ++G G+ G V++ +   T+   
Sbjct: 3   HHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETV 62

Query: 128 ALKVI-YGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMD------ 180
           A+K I   + E+ V     RE+ +L+++ H N+++   +   N  + ++ EY +      
Sbjct: 63  AIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKY 122

Query: 181 ---GGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK-----NV 232
                 +    I+          Q+++G+ + H R+ +HRD+KP NLL++ S       +
Sbjct: 123 MDKNPDVSMRVIKS------FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL 176

Query: 233 KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY 292
           KI DFG++R     +      + T+ Y  PE +   L    Y   + DIWS+     E  
Sbjct: 177 KIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL---LGSRHY-STSVDIWSIACIWAEML 232

Query: 293 LGRFPFAVGRQGDWASLMFAIC--------------------FAQPP------EAPEMAS 326
           +    F    + D    +F +                     F +            +  
Sbjct: 233 MKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLD 292

Query: 327 REFRDFISRCLQKDPHSRWPAAQLLQHPF 355
            E  D ++  L+ DP  R  A   L+HP+
Sbjct: 293 DEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  149 bits (378), Expect = 2e-41
 Identities = 80/287 (27%), Positives = 136/287 (47%), Gaps = 27/287 (9%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSV-RSQICR---EIEILRDVNHPNVVKC 162
           IG G+ G V  V H  T +V+A+K++  +  + + RS       E +I+   N P VV+ 
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLL--SKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 163 HDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLAR----QVLSGLAYLHKRKIVHRD 218
              +  +  + +++EYM GG L    +    +    AR    +V+  L  +H    +HRD
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD 193

Query: 219 IKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           +KP N+L++ S ++K+ADFG   ++  + M  C++AVGT  Y+SPE + +    G Y G 
Sbjct: 194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYY-GR 252

Query: 278 AGDIWSLGVSILEFYLGRFPF-AVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
             D WS+GV + E  +G  PF A    G ++ +M        P+  ++ S+E ++ I   
Sbjct: 253 ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI-SKEAKNLICA- 310

Query: 337 LQKDPHSRWP---AAQLLQHPFILRAGQSQVN---QNLRQILPPPRP 377
              D   R       ++ +H F             + LR  + P  P
Sbjct: 311 FLTDREVRLGRNGVEEIKRHLFF-----KNDQWAWETLRDTVAPVVP 352

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  146 bits (371), Expect = 5e-41
 Identities = 74/301 (24%), Positives = 126/301 (41%), Gaps = 53/301 (17%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALK-VIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           +K  +IG G+ G V++  H  T +  ALK V+  N ++       REI+IL+ + H NVV
Sbjct: 20  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 79

Query: 161 KCHDM--------YDRNGEIEVLLEYMD---GGSLEGAHIR--QEHILSDLARQVLSGLA 207
              ++            G I ++ ++ +    G L    ++     I   + + +L+GL 
Sbjct: 80  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR-VMQMLLNGLY 138

Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA----VGTIAYMSPE 263
           Y+H+ KI+HRD+K +N+LI     +K+ADFG++R  +   +   +     V T+ Y  PE
Sbjct: 139 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 198

Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ-GDWASLMFAIC-------- 314
            +   L    Y G   D+W  G  + E +    P   G       +L+  +C        
Sbjct: 199 LL---LGERDY-GPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQLCGSITPEVW 253

Query: 315 -------FAQPPEAPEMASREFR-------------DFISRCLQKDPHSRWPAAQLLQHP 354
                    +  E  +   R+ +             D I + L  DP  R  +   L H 
Sbjct: 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313

Query: 355 F 355
           F
Sbjct: 314 F 314

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  145 bits (367), Expect = 6e-41
 Identities = 74/290 (25%), Positives = 133/290 (45%), Gaps = 46/290 (15%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSV-RSQICREIEILRDVNHPNVVK 161
           ++G G   TV+       +   A+K I       E+++ R +  RE+     ++H N+V 
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFE--REVHNSSQLSHQNIVS 75

Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYLHKRKIVH 216
             D+ + +    +++EY++G +L   +I     LS     +   Q+L G+ + H  +IVH
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLS-EYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVH 134

Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQ-TMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           RDIKP N+LI+S+K +KI DFG+++ L++ ++   N  +GT+ Y SPE+       G+  
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK-----GEAT 189

Query: 276 GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ----PPEAPEMA----SR 327
               DI+S+G+ + E  +G  PF     G+ A    +I         P           +
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPF----NGETA---VSIAIKHIQDSVPNVTTDVRKDIPQ 242

Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
              + I R  +KD  +R+   Q ++              +L  +L   R 
Sbjct: 243 SLSNVILRATEKDKANRYKTIQEMK-------------DDLSSVLHENRA 279

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  146 bits (371), Expect = 7e-41
 Identities = 73/311 (23%), Positives = 133/311 (42%), Gaps = 31/311 (9%)

Query: 60  SNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVV 119
           + +++  G           + +++  +             +  +   +G+GS G V  V 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61

Query: 120 HPPTSRVFALKVIYGNHEDSVRSQ----ICREIEILRDVNHPNVVKCHDMYDRNGEIEVL 175
           H  +   +A+K++  + +  V+ +       E  IL+ VN P +VK    +  N  + ++
Sbjct: 62  HKESGNHYAMKIL--DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119

Query: 176 LEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIVHRDIKPSNLLINSSK 230
           +EY+ GG +  +H+R+    S   AR    Q++    YLH   +++RD+KP NLLI+   
Sbjct: 120 MEYVAGGEM-FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG 178

Query: 231 NVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSIL 289
            +++ DFG + R+  +T   C    GT   ++PE I     + K    A D W+LGV I 
Sbjct: 179 YIQVTDFGFAKRVKGRTWTLC----GTPEALAPE-IILSKGYNK----AVDWWALGVLIY 229

Query: 290 EFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRW---- 345
           E   G  PF      D    ++    +     P   S + +D +   LQ D   R+    
Sbjct: 230 EMAAGYPPFF----ADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLK 285

Query: 346 -PAAQLLQHPF 355
                +  H +
Sbjct: 286 NGVNDIKNHKW 296

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  144 bits (366), Expect = 2e-40
 Identities = 77/290 (26%), Positives = 139/290 (47%), Gaps = 36/290 (12%)

Query: 107 IGSGSGGTVWRVVH---PPTSRVFALKVIYGNH---EDSVRSQICREIEILRDVNHPNVV 160
           +G GS G V+ V         +++A+KV+        D VR+++  E +IL +VNHP +V
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM--ERDILVEVNHPFIV 89

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIV 215
           K H  +   G++ ++L+++ GG L    + +E + + +  +    ++   L +LH   I+
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDL-FTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148

Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           +RD+KP N+L++   ++K+ DFG+S+          S  GT+ YM+PE +     H +  
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQ-- 205

Query: 276 GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISR 335
             + D WS GV + E   G  PF   +  D    M  I        P+  S E +  +  
Sbjct: 206 --SADWWSFGVLMFEMLTGTLPF---QGKDRKETMTMILK-AKLGMPQFLSPEAQSLLRM 259

Query: 336 CLQKDPHSR-----WPAAQLLQHPFILRAGQSQVN-QNL--RQILPPPRP 377
             +++P +R         ++ +H F      S ++   L  R+I PP +P
Sbjct: 260 LFKRNPANRLGAGPDGVEEIKRHSFF-----STIDWNKLYRREIHPPFKP 304

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  144 bits (366), Expect = 3e-40
 Identities = 78/287 (27%), Positives = 139/287 (48%), Gaps = 32/287 (11%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH---EDSVRSQICREIEILRDVNHPNVVKCH 163
           +G G+ G V  V    T R +A+K++       +D V   +  E  +L++  HP +    
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-ESRVLQNTRHPFLTALK 71

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIVHRD 218
             +  +  +  ++EY +GG L   H+ +E + + + AR    +++S L YLH R +V+RD
Sbjct: 72  YAFQTHDRLCFVMEYANGGELF-FHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130

Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           IK  NL+++   ++KI DFG+ +          +  GT  Y++PE +  D ++G+    A
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VLEDNDYGR----A 185

Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQ 338
            D W LGV + E   GR PF           +F +   +    P   S E +  ++  L+
Sbjct: 186 VDWWGLGVVMYEMMCGRLPF----YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241

Query: 339 KDPHSR-----WPAAQLLQHPFILRAGQSQVN-QNL--RQILPPPRP 377
           KDP  R       A ++++H F        +N Q++  +++LPP +P
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFF-----LSINWQDVVQKKLLPPFKP 283

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  143 bits (363), Expect = 5e-40
 Identities = 82/292 (28%), Positives = 139/292 (47%), Gaps = 38/292 (13%)

Query: 107 IGSGSGGTVWRVVHPP---TSRVFALKV-----IYGNHEDSVRSQICREIEILRDVNHPN 158
           +G G  G V++V       T ++FA+KV     I  N +D+  ++   E  IL +V HP 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA--ERNILEEVKHPF 82

Query: 159 VVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRK 213
           +V     +   G++ ++LEY+ GG L    + +E I   D A     ++   L +LH++ 
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELF-MQLEREGIFMEDTACFYLAEISMALGHLHQKG 141

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           I++RD+KP N+++N   +VK+ DFG+ +         ++  GTI YM+PE I     H +
Sbjct: 142 IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE-ILMRSGHNR 200

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
               A D WSLG  + +   G  PF      +    +  I        P   ++E RD +
Sbjct: 201 ----AVDWWSLGALMYDMLTGAPPF---TGENRKKTIDKILK-CKLNLPPYLTQEARDLL 252

Query: 334 SRCLQKDPHSR-----WPAAQLLQHPFILRAGQSQVN-QNL--RQILPPPRP 377
            + L+++  SR       A ++  HPF        +N + L  R++ PP +P
Sbjct: 253 KKLLKRNAASRLGAGPGDAGEVQAHPFF-----RHINWEELLARKVEPPFKP 299

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  143 bits (364), Expect = 6e-40
 Identities = 77/304 (25%), Positives = 129/304 (42%), Gaps = 65/304 (21%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVI--YGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
            +G G+ G V    H PT  + A+K I  +     ++R    REI+IL+   H N++   
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR--TLREIKILKHFKHENIITIF 75

Query: 164 DM-----YDRNGEIEVLLEYMD--------GGSLEGAHIRQEHILSDLARQVLSGLAYLH 210
           ++     ++   E+ ++ E M            L   HI+  + +     Q L  +  LH
Sbjct: 76  NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ--YFI----YQTLRAVKVLH 129

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYM---------- 260
              ++HRD+KPSNLLINS+ ++K+ DFG++RI+ ++    +   G  + M          
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189

Query: 261 SPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR--FP-----------FAV----GRQ 303
           +PE +   L   KY   A D+WS G  + E +L R  FP           F +       
Sbjct: 190 APEVM---LTSAKYS-RAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245

Query: 304 GDWASL--MFAICF--AQPPEAPE-------MASREFRDFISRCLQKDPHSRWPAAQLLQ 352
            D   +    A  +  + P              + +  D + R L  DP  R  A + L+
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305

Query: 353 HPFI 356
           HP++
Sbjct: 306 HPYL 309

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  142 bits (360), Expect = 1e-39
 Identities = 81/298 (27%), Positives = 120/298 (40%), Gaps = 54/298 (18%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQI----CREIEILRDVN-- 155
           +    IG G+ GTV++   P +    ALK +   +       +     RE+ +LR +   
Sbjct: 12  EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF 71

Query: 156 -HPNVVKCHDMY---DRNGEIEVLL--EYMDG------GSLEGAHIRQEHILSDLARQVL 203
            HPNVV+  D+      + EI+V L  E++D              +  E I   L RQ L
Sbjct: 72  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD-LMRQFL 130

Query: 204 SGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPE 263
            GL +LH   IVHRD+KP N+L+ S   VK+ADFG++RI +  M      V T+ Y +PE
Sbjct: 131 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-ALTPVVVTLWYRAPE 189

Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILEFYLGR--FPFAVGR-QGDWASLMFAIC------ 314
                L    Y     D+WS+G    E +  +  F    G  + D    +F +       
Sbjct: 190 V----LLQSTY-ATPVDMWSVGCIFAEMFRRKPLFC---GNSEADQLGKIFDLIGLPPED 241

Query: 315 ------------FAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
                       F      P               +   L  +PH R  A + LQH +
Sbjct: 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  143 bits (363), Expect = 1e-39
 Identities = 88/348 (25%), Positives = 155/348 (44%), Gaps = 45/348 (12%)

Query: 57  PPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPA--ELQKGNRIGSGSGGT 114
              +  +S+ G     Q      + +      H  +   +     EL K   +G+G+ G 
Sbjct: 15  SGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEK---VGIENFELLK--VLGTGAYGK 69

Query: 115 VWRVVHPP---TSRVFALKV-----IYGNHEDSVRSQICREIEILRDVNH-PNVVKCHDM 165
           V+ V       T +++A+KV     I    + +  ++   E ++L  +   P +V  H  
Sbjct: 70  VFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT--ERQVLEHIRQSPFLVTLHYA 127

Query: 166 YDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIVHRDIK 220
           +    ++ ++L+Y++GG L   H+ Q    +    +    +++  L +LHK  I++RDIK
Sbjct: 128 FQTETKLHLILDYINGGEL-FTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIK 186

Query: 221 PSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPERI-NTDLNHGKYDGYA 278
             N+L++S+ +V + DFG+S   +A   +      GTI YM+P+ +   D  H K    A
Sbjct: 187 LENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDK----A 242

Query: 279 GDIWSLGVSILEFYLGRFPF-AVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL 337
            D WSLGV + E   G  PF   G +   A +   I     P  P+  S   +D I R L
Sbjct: 243 VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSALAKDLIQRLL 301

Query: 338 QKDPHSR-----WPAAQLLQHPFILRAGQSQVN-QNL--RQILPPPRP 377
            KDP  R       A ++ +H F       ++N  +L  +++  P +P
Sbjct: 302 MKDPKKRLGCGPRDADEIKEHLFF-----QKINWDDLAAKKVPAPFKP 344

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  143 bits (363), Expect = 1e-39
 Identities = 82/340 (24%), Positives = 131/340 (38%), Gaps = 73/340 (21%)

Query: 64  SSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPT 123
           +      S +    ++Q+ N+T      R+Q ++P        +GSG+ G+V       T
Sbjct: 2   AHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSP--------VGSGAYGSVCAAFDTKT 53

Query: 124 SRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVKCHDM------YDRNGEIEVLL 176
               A+K +    +  + ++   RE+ +L+ + H NV+   D+       +   ++ ++ 
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113

Query: 177 EYMD--------GGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS 228
             M            L   H++       L  Q+L GL Y+H   I+HRD+KPSNL +N 
Sbjct: 114 HLMGADLNNIVKCQKLTDDHVQF------LIYQILRGLKYIHSADIIHRDLKPSNLAVNE 167

Query: 229 SKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSI 288
              +KI DFG++R  A  M      V T  Y +PE +   LN   Y+    DIWS+G  +
Sbjct: 168 DCELKILDFGLARHTADEMTG---YVATRWYRAPEIM---LNWMHYN-QTVDIWSVGCIM 220

Query: 289 LEFYLGR--FPFAVGRQGDWASLMFAIC------------FAQPPEAPEM---------- 324
            E   GR  FP   G   D    +  I                   A             
Sbjct: 221 AELLTGRTLFP---GT--DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKM 275

Query: 325 --------ASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                   A+    D + + L  D   R  AAQ L H + 
Sbjct: 276 NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  142 bits (360), Expect = 1e-39
 Identities = 69/291 (23%), Positives = 124/291 (42%), Gaps = 43/291 (14%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKV------IYGNHEDSVRSQICREIEILRDVNHPNVV 160
           +G+GS G V  +      R +A+KV      +     +        E  +L  V HP ++
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND----ERLMLSIVTHPFII 69

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIV 215
           +    +    +I ++++Y++GG L  + +R+       +A+    +V   L YLH + I+
Sbjct: 70  RMWGTFQDAQQIFMIMDYIEGGELF-SLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDII 128

Query: 216 HRDIKPSNLLINSSKNVKIADFGVS-RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           +RD+KP N+L++ + ++KI DFG +  +   T   C    GT  Y++PE + +   + K 
Sbjct: 129 YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPE-VVSTKPYNK- 182

Query: 275 DGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS 334
              + D WS G+ I E   G  PF            +          P   + + +D +S
Sbjct: 183 ---SIDWWSFGILIYEMLAGYTPF----YDSNTMKTYEKILNAELRFPPFFNEDVKDLLS 235

Query: 335 RCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVN-QNL--RQILPPPRP 377
           R + +D   R          +  HP+       +V  + L  R I  P  P
Sbjct: 236 RLITRDLSQRLGNLQNGTEDVKNHPWF-----KEVVWEKLLSRNIETPYEP 281

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  144 bits (366), Expect = 2e-39
 Identities = 83/361 (22%), Positives = 155/361 (42%), Gaps = 42/361 (11%)

Query: 43  IPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQ 102
           + +R   +  P      + +  +       Q       +     +N       ++ A+ +
Sbjct: 83  VIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPK 142

Query: 103 KGNR---------IGSGSGGTVWRVVHPPTSRVFALKVIYGNH---EDSVRSQICREIEI 150
                        +G G+ G V  V    T R +A+K++       +D V   +  E  +
Sbjct: 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT-ENRV 201

Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSG 205
           L++  HP +      +  +  +  ++EY +GG L   H+ +E + S D AR    +++S 
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF-FHLSRERVFSEDRARFYGAEIVSA 260

Query: 206 LAYLHKRK-IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPER 264
           L YLH  K +V+RD+K  NL+++   ++KI DFG+ +   +      +  GT  Y++PE 
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE- 319

Query: 265 INTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM 324
           +  D ++G+    A D W LGV + E   GR PF           +F +   +    P  
Sbjct: 320 VLEDNDYGR----AVDWWGLGVVMYEMMCGRLPF----YNQDHEKLFELILMEEIRFPRT 371

Query: 325 ASREFRDFISRCLQKDPHSR-----WPAAQLLQHPFILRAGQSQVN-QNL--RQILPPPR 376
              E +  +S  L+KDP  R       A +++QH F      + +  Q++  +++ PP +
Sbjct: 372 LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF-----AGIVWQHVYEKKLSPPFK 426

Query: 377 P 377
           P
Sbjct: 427 P 427

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  147 bits (372), Expect = 3e-39
 Identities = 64/265 (24%), Positives = 122/265 (46%), Gaps = 25/265 (9%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH---EDSVRSQICREIEILRDVN---HPNVV 160
           IG G  G V+      T +++A+K +       +      +  E  +L  V+    P +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN-ERIMLSLVSTGDCPFIV 255

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIV 215
                +    ++  +L+ M+GG L   H+ Q  + S    R    +++ GL ++H R +V
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLH-YHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314

Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           +RD+KP+N+L++   +V+I+D G++   ++     +++VGT  YM+PE +   + +    
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDS-- 370

Query: 276 GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISR 335
             + D +SLG  + +   G  PF   +  D   +          E P+  S E R  +  
Sbjct: 371 --SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AVELPDSFSPELRSLLEG 427

Query: 336 CLQKDPHSR-----WPAAQLLQHPF 355
            LQ+D + R       A ++ + PF
Sbjct: 428 LLQRDVNRRLGCLGRGAQEVKESPF 452

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  145 bits (367), Expect = 1e-38
 Identities = 50/253 (19%), Positives = 99/253 (39%), Gaps = 31/253 (12%)

Query: 106 RIGSGSGGTVWRVVHPP-TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
            I  G  G ++  +      R   LK +  + +   ++    E + L +V HP++V+  +
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 165 M---YDRNGEIEVLL--EYMDGGSL---EGAHIRQEHILSDLARQVLSGLAYLHKRKIVH 216
                DR+G+    +  EY+ G SL   +G  +     +     ++L  L+YLH   +V+
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAI-AYLLEILPALSYLHSIGLVY 205

Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
            D+KP N+++     +K+ D G    +           GT  + +PE + T         
Sbjct: 206 NDLKPENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRTGPTV----- 255

Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRC 336
            A DI+++G ++    L          G +   +         +        +   + R 
Sbjct: 256 -ATDIYTVGRTLAALTLDLPTR----NGRYVDGL------PEDDPVLKTYDSYGRLLRRA 304

Query: 337 LQKDPHSRWPAAQ 349
           +  DP  R+  A+
Sbjct: 305 IDPDPRQRFTTAE 317

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  143 bits (363), Expect = 1e-38
 Identities = 65/269 (24%), Positives = 110/269 (40%), Gaps = 30/269 (11%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKV------IYGNHEDSVRSQICREIEILRDVNHPNVV 160
           +G G  G V+      T +++A K                      E +IL  V+   +V
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV----EKKILAKVHSRFIV 248

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLAR----QVLSGLAYLHK 211
                ++   ++ +++  M+GG +   HI      +       A     Q++SGL +LH+
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIR-YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307

Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
           R I++RD+KP N+L++   NV+I+D G++  L           GT  +M+PE +     +
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE-LLLGEEY 366

Query: 272 GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD 331
                 + D ++LGV++ E    R PF    +      +      Q    P+  S   +D
Sbjct: 367 DF----SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422

Query: 332 FISRCLQKDPHSR-----WPAAQLLQHPF 355
           F    LQKDP  R          L  HP 
Sbjct: 423 FCEALLQKDPEKRLGFRDGSCDGLRTHPL 451

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  139 bits (353), Expect = 2e-38
 Identities = 77/320 (24%), Positives = 126/320 (39%), Gaps = 62/320 (19%)

Query: 78  HQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE 137
           ++Q  N+T       +             +GSG+ G+V   +   +    A+K +    +
Sbjct: 11  YKQDVNKTAWELPKTYVSPTH--------VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ 62

Query: 138 DSVRSQ-ICREIEILRDVNHPNVVKCHDM------YDRNGEIEVLLEYMDG--GSLEGAH 188
             + ++   RE+ +L+ + H NV+   D+           +  +++ +M      + G  
Sbjct: 63  SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK 122

Query: 189 IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD 248
             +E I   L  Q+L GL Y+H   +VHRD+KP NL +N    +KI DFG++R     M 
Sbjct: 123 FSEEKI-QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 181

Query: 249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR--FPFAVGRQGDW 306
                V T  Y +PE I   L+   Y+    DIWS+G  + E   G+  F    G+  D+
Sbjct: 182 G---YVVTRWYRAPEVI---LSWMHYN-QTVDIWSVGCIMAEMLTGKTLFK---GK--DY 229

Query: 307 ASLMFAIC------------FAQPPEAPEM------------------ASREFRDFISRC 336
              +  I                   A                     AS +  D + + 
Sbjct: 230 LDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKM 289

Query: 337 LQKDPHSRWPAAQLLQHPFI 356
           L+ D   R  AAQ L HPF 
Sbjct: 290 LELDVDKRLTAAQALTHPFF 309

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  139 bits (352), Expect = 2e-38
 Identities = 76/301 (25%), Positives = 123/301 (40%), Gaps = 62/301 (20%)

Query: 102 QKGNRIGSGSGGTVWRVVHP-PTSRVFALKVI-YGNHEDSVRSQICREIEILRDVN---H 156
           +    IG G+ G V++        R  ALK +     E+ +     RE+ +LR +    H
Sbjct: 14  ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 73

Query: 157 PNVVKCHDM-----YDRNGEIEVLLEYMD-----------GGSLEGAHIRQEHILSDLAR 200
           PNVV+  D+      DR  ++ ++ E++D              +    I+      D+  
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK------DMMF 127

Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYM 260
           Q+L GL +LH  ++VHRD+KP N+L+ SS  +K+ADFG++RI +  M   +  V T+ Y 
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYR 186

Query: 261 SPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR--FPFAVGRQ-GDWASLMFAIC--- 314
           +PE     L    Y     D+WS+G    E +  +  F    G    D    +  +    
Sbjct: 187 APEV----LLQSSY-ATPVDLWSVGCIFAEMFRRKPLFR---GSSDVDQLGKILDVIGLP 238

Query: 315 ---------------FAQPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHP 354
                          F      P            +D + +CL  +P  R  A   L HP
Sbjct: 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298

Query: 355 F 355
           +
Sbjct: 299 Y 299

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  138 bits (350), Expect = 4e-38
 Identities = 71/306 (23%), Positives = 117/306 (38%), Gaps = 69/306 (22%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALK-VIYGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
            +G G  G V+  V     +  A+K ++  + +        REI+I+R ++H N+VK  +
Sbjct: 18  PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKH--ALREIKIIRRLDHDNIVKVFE 75

Query: 165 M--------------YDRNGEIEVLLEYMD--------GGSLEGAHIRQEHILSDLARQV 202
           +                    + ++ EYM+         G L   H R          Q+
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL------FMYQL 129

Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSA---VGTIA 258
           L GL Y+H   ++HRD+KP+NL IN+    +KI DFG++RI+             + T  
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR--FP------------FAVGRQG 304
           Y SP  +   L+   Y   A D+W+ G    E   G+  F              ++    
Sbjct: 190 YRSPRLL---LSPNNYT-KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245

Query: 305 DWASLMFAIC-------FAQPPEAPE-------MASREFRDFISRCLQKDPHSRWPAAQL 350
           +       +             E  +         SRE  DF+ + L   P  R  A + 
Sbjct: 246 E--EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA 303

Query: 351 LQHPFI 356
           L HP++
Sbjct: 304 LSHPYM 309

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  142 bits (360), Expect = 7e-38
 Identities = 68/268 (25%), Positives = 115/268 (42%), Gaps = 31/268 (11%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKV------IYGNHEDSVRSQICREIEILRDVNHPNVV 160
           +G G  G V       T +++A K            E    +    E +IL  VN   VV
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN----EKQILEKVNSRFVV 247

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS---DLAR----QVLSGLAYLHKRK 213
                Y+    + ++L  M+GG L+  HI            A     ++  GL  LH+ +
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLK-FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           IV+RD+KP N+L++   +++I+D G++  + +        VGT+ YM+PE +  +  +  
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPE-VVKNERYTF 364

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPF-AVGRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
               + D W+LG  + E   G+ PF    ++     +   +    P E  E  S + R  
Sbjct: 365 ----SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK-EVPEEYSERFSPQARSL 419

Query: 333 ISRCLQKDPHSR-----WPAAQLLQHPF 355
            S+ L KDP  R       A ++ +HP 
Sbjct: 420 CSQLLCKDPAERLGCRGGSAREVKEHPL 447

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  136 bits (346), Expect = 9e-38
 Identities = 65/269 (24%), Positives = 114/269 (42%), Gaps = 38/269 (14%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSV-RSQICREIEILRDVNHPNV 159
           G  +G G    V         R  A+KV+            R +  RE +    +NHP +
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR--REAQNAAALNHPAI 74

Query: 160 VKCHDMYDRNGEIEVL----LEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYLH 210
           V  +D  +       L    +EY+DG +L    +  E  ++     ++       L + H
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLR-DIVHTEGPMTPKRAIEVIADACQALNFSH 133

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ---TMDPCNSAVGTIAYMSPERINT 267
           +  I+HRD+KP+N++I+++  VK+ DFG++R +A    ++    + +GT  Y+SPE+   
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR- 192

Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ-------PPE 320
               G       D++SLG  + E   G  PF     GD      ++ +         P  
Sbjct: 193 ----GDSVDARSDVYSLGCVLYEVLTGEPPF----TGDSP---VSVAYQHVREDPIPPSA 241

Query: 321 APEMASREFRDFISRCLQKDPHSRWPAAQ 349
             E  S +    + + L K+P +R+  A 
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENRYQTAA 270

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  138 bits (350), Expect = 2e-37
 Identities = 79/352 (22%), Positives = 134/352 (38%), Gaps = 58/352 (16%)

Query: 46  RDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGN 105
           R  + +      P    S+      S             T     +R Q ++  + +   
Sbjct: 4   RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV-- 61

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM 165
            IG+GS G V++     +  + A+K +    +D       RE++I+R ++H N+V+    
Sbjct: 62  -IGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKN--RELQIMRKLDHCNIVRLRYF 115

Query: 166 YDRNGE------IEVLLEYM--DGGSLEGAHIRQEHILSDL-----ARQVLSGLAYLHKR 212
           +  +GE      + ++L+Y+      +   + R +  L  +       Q+   LAY+H  
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175

Query: 213 KIVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
            I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I      
Sbjct: 176 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI---FGA 231

Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FPFAVGRQG------------------------D 305
             Y   + D+WS G  + E  LG+  FP   G  G                        +
Sbjct: 232 TDYTS-SIDVWSAGCVLAELLLGQPIFP---GDSGVDQLVEIIKVLGTPTREQIREMNPN 287

Query: 306 WASLMFAICFAQPPEA--PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
           +    F    A P           E     SR L+  P +R    +   H F
Sbjct: 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  137 bits (347), Expect = 2e-37
 Identities = 78/331 (23%), Positives = 126/331 (38%), Gaps = 66/331 (19%)

Query: 78  HQQQQNQTQNNHQNRHQLIN-----PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI 132
           H    +           +              + IG G+ G V            A+K I
Sbjct: 1   HHHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI 60

Query: 133 YGNHEDSVRSQ-ICREIEILRDVNHPNVVKCHDM-----YDRNGEIEVLLEYMD------ 180
               E     Q   REI+IL    H N++  +D+      ++  ++ ++ + M+      
Sbjct: 61  -SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKL 119

Query: 181 --GGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFG 238
                L   HI           Q+L GL Y+H   ++HRD+KPSNLL+N++ ++KI DFG
Sbjct: 120 LKTQHLSNDHICY------FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 173

Query: 239 VSRILAQTMDPCNSA---VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR 295
           ++R+     D        V T  Y +PE +   LN   Y   + DIWS+G  + E    R
Sbjct: 174 LARVADPDHDHTGFLTEYVATRWYRAPEIM---LNSKGYT-KSIDIWSVGCILAEMLSNR 229

Query: 296 --FPFAVGR-----------------QGDWASL--MFAICF--AQPPEAPE-------MA 325
             FP   G+                 Q D   +  + A  +  + P +           A
Sbjct: 230 PIFP---GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA 286

Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             +  D + + L  +PH R    Q L HP++
Sbjct: 287 DSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  135 bits (343), Expect = 7e-37
 Identities = 63/335 (18%), Positives = 111/335 (33%), Gaps = 79/335 (23%)

Query: 78  HQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE 137
             +      +  Q+ + +           I SGS G V   V      V A+K ++    
Sbjct: 9   AMRDLIAELHAMQSPYTVQRF--------ISSGSYGAVCAGVDSEGIPV-AIKRVFNTVS 59

Query: 138 DSVRSQ----------ICREIEILRDVNHPNVVKCHDM-----YDRNGEIEVLLEYMD-- 180
           D               + REI +L   +HPN++   D+          ++ ++ E M   
Sbjct: 60  DGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD 119

Query: 181 --------GGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNV 232
                      +   HI+  + +      +L GL  LH+  +VHRD+ P N+L+  + ++
Sbjct: 120 LAQVIHDQRIVISPQHIQ--YFM----YHILLGLHVLHEAGVVHRDLHPGNILLADNNDI 173

Query: 233 KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY 292
            I DF ++R            V    Y +PE +   +    +     D+WS G  + E +
Sbjct: 174 TICDFNLAREDTAD-ANKTHYVTHRWYRAPELV---MQFKGFT-KLVDMWSAGCVMAEMF 228

Query: 293 LGR--FPFAVGR------------------------QGDWASLMFAICFAQPPEAP---- 322
             +  F    G                             A        +  P       
Sbjct: 229 NRKALFR---GSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAV 285

Query: 323 -EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
              A     D I++ L+ +P  R    Q L+HP+ 
Sbjct: 286 VPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  135 bits (342), Expect = 1e-36
 Identities = 72/296 (24%), Positives = 113/296 (38%), Gaps = 59/296 (19%)

Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVKCH 163
             +GSG+ G V   V   T    A+K +Y   +  + ++   RE+ +L+ + H NV+   
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90

Query: 164 DM------YDRNGEIEVLLEYMD--------GGSLEGAHIRQEHILSDLARQVLSGLAYL 209
           D+       D   +  +++ +M            L    I+       L  Q+L GL Y+
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF------LVYQMLKGLRYI 144

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
           H   I+HRD+KP NL +N    +KI DFG++R     M      V T  Y +PE I   L
Sbjct: 145 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVI---L 198

Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGR--FP------------FAVGRQGDWASLMFAIC- 314
           N  +Y     DIWS+G  + E   G+  F                G        +  +  
Sbjct: 199 NWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA--EFVQRLQS 255

Query: 315 -------FAQPPEAPE-------MASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                     P    +        AS    + + + L  D   R  A + L HP+ 
Sbjct: 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  134 bits (340), Expect = 2e-36
 Identities = 76/285 (26%), Positives = 130/285 (45%), Gaps = 31/285 (10%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH---EDSVRSQICREIEIL-RDVNHPNVVKC 162
           +G GS G V+      T++ FA+K +  +    +D V   +  E  +L     HP +   
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMV-EKRVLSLAWEHPFLTHM 83

Query: 163 HDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIVHR 217
              +     +  ++EY++GG L   HI+  H      A     +++ GL +LH + IV+R
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDLM-YHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 142

Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           D+K  N+L++   ++KIADFG+ +         N+  GT  Y++PE I     +      
Sbjct: 143 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE-ILLGQKYNH---- 197

Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMF-AICFAQPPEAPEMASREFRDFISRC 336
           + D WS GV + E  +G+ PF     G     +F +I     P  P    +E +D + + 
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPF----HGQDEEELFHSIRM-DNPFYPRWLEKEAKDLLVKL 252

Query: 337 LQKDPHSRWPAAQ-LLQHPFILRAGQSQVN-QNL--RQILPPPRP 377
             ++P  R      + QHP        ++N + L  ++I PP RP
Sbjct: 253 FVREPEKRLGVRGDIRQHPLF-----REINWEELERKEIDPPFRP 292

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  134 bits (339), Expect = 4e-36
 Identities = 79/339 (23%), Positives = 136/339 (40%), Gaps = 68/339 (20%)

Query: 68  QSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF 127
            S S ++++ +  +   +      R+Q + P        IGSG+ G V         R  
Sbjct: 2   GSRSKRDNNFYSVEIGDSTFTVLKRYQNLKP--------IGSGAQGIVCAAYDAILERNV 53

Query: 128 ALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVKCHDM------YDRNGEIEVLLEYMD 180
           A+K +    ++   ++   RE+ +++ VNH N++   ++       +   ++ +++E MD
Sbjct: 54  AIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD 113

Query: 181 GGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIA 235
             +L    I+ E  L       L  Q+L G+ +LH   I+HRD+KPSN+++ S   +KI 
Sbjct: 114 A-NL-CQVIQME--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 169

Query: 236 DFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR 295
           DFG++R    +       V T  Y +PE I   L    Y     DIWS+G  + E   G 
Sbjct: 170 DFGLARTAGTSFMMTPY-VVTRYYRAPEVI---LGM-GYK-ENVDIWSVGCIMGEMIKGG 223

Query: 296 --FP------------------------------------FAVGRQGDWASLMFAICFAQ 317
             FP                                            +  L   + F  
Sbjct: 224 VLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPA 283

Query: 318 PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             E  ++ + + RD +S+ L  D   R    + LQHP+I
Sbjct: 284 DSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  134 bits (339), Expect = 4e-36
 Identities = 80/333 (24%), Positives = 136/333 (40%), Gaps = 36/333 (10%)

Query: 62  SSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHP 121
           S     +  +     P    Q        N H   +     K   IG GS G V    H 
Sbjct: 3   SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLK--VIGKGSFGKVLLARHK 60

Query: 122 PTSRVFALKVIYGNH---EDSVRSQICREIEIL-RDVNHPNVVKCHDMYDRNGEIEVLLE 177
                +A+KV+       +   +  +  E  +L ++V HP +V  H  +    ++  +L+
Sbjct: 61  AEEVFYAVKVLQKKAILKKKEEKHIMS-ERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119

Query: 178 YMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNV 232
           Y++GG L   H+++E       AR    ++ S L YLH   IV+RD+KP N+L++S  ++
Sbjct: 120 YINGGELF-YHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHI 178

Query: 233 KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY 292
            + DFG+ +   +     ++  GT  Y++PE +     + +      D W LG  + E  
Sbjct: 179 VLTDFGLCKENIEHNSTTSTFCGTPEYLAPE-VLHKQPYDR----TVDWWCLGAVLYEML 233

Query: 293 LGRFPFAVGRQGDWASLMF-AICFAQPPEAPEMASREFRDFISRCLQKDPHSR----WPA 347
            G  PF         + M+  I   +P +     +   R  +   LQKD   R       
Sbjct: 234 YGLPPF----YSRNTAEMYDNILN-KPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288

Query: 348 AQLLQHPFILRAGQSQVN-QNL--RQILPPPRP 377
            ++  H F      S +N  +L  ++I PP  P
Sbjct: 289 MEIKSHVFF-----SLINWDDLINKKITPPFNP 316

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  134 bits (340), Expect = 5e-36
 Identities = 68/320 (21%), Positives = 120/320 (37%), Gaps = 75/320 (23%)

Query: 103 KGNRIGSGSGGTVW--RVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVV 160
           +G ++G G+ G V+  +       + +ALK I       +    CREI +LR++ HPNV+
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI---EGTGISMSACREIALLRELKHPNVI 81

Query: 161 KCHDMYDRNGEIEVLL--EYMD-------------GGSLEGAHIRQEHILSDLARQVLSG 205
               ++  + + +V L  +Y +               + +   + +  + S L  Q+L G
Sbjct: 82  SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS-LLYQILDG 140

Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKN----VKIADFGVSRILA---QTMDPCNSAVGTIA 258
           + YLH   ++HRD+KP+N+L+         VKIAD G +R+     + +   +  V T  
Sbjct: 141 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 200

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR--FP-------FAVGRQGDWASL 309
           Y +PE +   L    Y   A DIW++G    E       F         +     D    
Sbjct: 201 YRAPELL---LGARHY-TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256

Query: 310 MFAIC-----------------------FAQPPEAPEMASREFR-----------DFISR 335
           +F +                        F +         +                + +
Sbjct: 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK 316

Query: 336 CLQKDPHSRWPAAQLLQHPF 355
            L  DP  R  + Q +Q P+
Sbjct: 317 LLTMDPIKRITSEQAMQDPY 336

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  133 bits (336), Expect = 7e-36
 Identities = 70/289 (24%), Positives = 127/289 (43%), Gaps = 35/289 (12%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH---EDSVRSQICREIEILRDV-NHPNVVKC 162
           +G GS G V       T  ++A+K++  +    +D V   +  E  +L      P + + 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV-EKRVLALPGKPPFLTQL 86

Query: 163 HDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIVHR 217
           H  +     +  ++EY++GG L   HI+Q        A     ++  GL +L  + I++R
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGDLMY-HIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 145

Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           D+K  N++++S  ++KIADFG+ +          +  GT  Y++PE I     +GK    
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE-IIAYQPYGK---- 200

Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMF-AICFAQPPEAPEMASREFRDFISRC 336
           + D W+ GV + E   G+ PF    +G+    +F +I        P+  S+E        
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPF----EGEDEDELFQSIMEH-NVAYPKSMSKEAVAICKGL 255

Query: 337 LQKDPHSR-----WPAAQLLQHPFILRAGQSQVN-QNL--RQILPPPRP 377
           + K P  R          + +H F        ++ + L  ++I PP +P
Sbjct: 256 MTKHPGKRLGCGPEGERDIKEHAFF-----RYIDWEKLERKEIQPPYKP 299

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  132 bits (335), Expect = 7e-36
 Identities = 78/295 (26%), Positives = 136/295 (46%), Gaps = 37/295 (12%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH---EDSVRSQICREIEILRDV-NHPNVVKC 162
           IG GS   V  V    T R++A+KV+       ++ +      E  +     NHP +V  
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT-EKHVFEQASNHPFLVGL 75

Query: 163 HDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIVHR 217
           H  +     +  ++EY++GG L   H++++  L  + AR    ++   L YLH+R I++R
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLM-FHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134

Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           D+K  N+L++S  ++K+ D+G+ +   +  D  ++  GT  Y++PE I    ++G     
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE-ILRGEDYGF---- 189

Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWA-----SLMF-AICFAQPPEAPEMASREFRD 331
           + D W+LGV + E   GR PF +    D         +F  I   +    P   S +   
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKAAS 248

Query: 332 FISRCLQKDPHSR------WPAAQLLQHPFILRAGQSQVNQNL---RQILPPPRP 377
            +   L KDP  R         A +  HPF        V+ ++   +Q++PP +P
Sbjct: 249 VLKSFLNKDPKERLGCHPQTGFADIQGHPFF-----RNVDWDMMEQKQVVPPFKP 298

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  132 bits (333), Expect = 1e-35
 Identities = 66/327 (20%), Positives = 127/327 (38%), Gaps = 76/327 (23%)

Query: 78  HQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE 137
              + +  +  +Q+ +QL+          +G G    V+  ++   +    +K++     
Sbjct: 23  WDYESHVVEWGNQDDYQLVRK--------LGRGKYSEVFEAINITNNEKVVVKIL--KPV 72

Query: 138 DSVRSQICREIEILRDV-NHPNVVKCHD-MYDRNGEIEVLL-EYMDG-------GSLEGA 187
              +  I REI+IL ++   PN++   D + D       L+ E+++         +L   
Sbjct: 73  KKKK--IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY 130

Query: 188 HIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS-KNVKIADFGVSRIL--A 244
            IR          ++L  L Y H   I+HRD+KP N++I+   + +++ D+G++      
Sbjct: 131 DIRF------YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184

Query: 245 QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGR-- 302
           Q     N  V +  +  PE +   +++  YD Y+ D+WSLG  +      + PF  G   
Sbjct: 185 QEY---NVRVASRYFKGPELL---VDYQMYD-YSLDMWSLGCMLASMIFRKEPFFHGHDN 237

Query: 303 --Q--------------------------------GDWASLMFAICFAQPPEAPEMASRE 328
             Q                                G  +   +        E   + S E
Sbjct: 238 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV--HSENQHLVSPE 295

Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPF 355
             DF+ + L+ D  SR  A + ++HP+
Sbjct: 296 ALDFLDKLLRYDHQSRLTAREAMEHPY 322

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  133 bits (337), Expect = 1e-35
 Identities = 86/344 (25%), Positives = 128/344 (37%), Gaps = 75/344 (21%)

Query: 62  SSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHP 121
           S++       +    P++  +    +      + I     +    IG+GS G V++    
Sbjct: 6   SNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKV---IGNGSFGVVFQAKLV 62

Query: 122 PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE------VL 175
            +  V A+K +    +D       RE++I+R V HPNVV     +  NG+ +      ++
Sbjct: 63  ESDEV-AIKKV---LQDKRF--KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116

Query: 176 LEYMD--------GGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN 227
           LEY+           +     +    I      Q+L  LAY+H   I HRDIKP NLL++
Sbjct: 117 LEYVPETVYRASRHYAKLKQTMPMLLIKL-YMYQLLRSLAYIHSIGICHRDIKPQNLLLD 175

Query: 228 SSKNV-KIADFGVSRILAQTMDPCNSAVGTIA---YMSPERINTDLNHGKYDGYAGDIWS 283
               V K+ DFG     A+ +      V  I    Y +PE I        Y     DIWS
Sbjct: 176 PPSGVLKLIDFG----SAKILIAGEPNVSYICSRYYRAPELI---FGATNYTT-NIDIWS 227

Query: 284 LGVSILEFYLGR--FPFAVGRQG-----------------DWASL-------MFAICFAQ 317
            G  + E   G+  FP   G  G                    ++        F      
Sbjct: 228 TGCVMAELMQGQPLFP---GESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPH 284

Query: 318 P------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
           P      P  P  A     D ISR L+  P +R  A + L HPF
Sbjct: 285 PFSKVFRPRTPPDA----IDLISRLLEYTPSARLTAIEALCHPF 324

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  131 bits (332), Expect = 2e-35
 Identities = 58/229 (25%), Positives = 108/229 (47%), Gaps = 34/229 (14%)

Query: 90  QNRHQLINPAELQKGNRIGSGSGGTVWR-VVHPPTSRVF---ALKVIYGNHEDSVRSQIC 145
           Q   +++   E +K   +GSG+ GTV++ +  P   +V    A+K +          +I 
Sbjct: 6   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 65

Query: 146 REIEILRDVNHPNVVK----CHD--MYDRNGEIEVLLEYMDGGSL------EGAHIRQEH 193
            E  ++  V++P+V +    C    +        ++ + M  G L         +I  ++
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-------LITQLMPFGCLLDYVREHKDNIGSQY 118

Query: 194 ILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA 253
           +L +   Q+  G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L    +    A
Sbjct: 119 LL-NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHA 176

Query: 254 VGT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
            G    I +M+ E I     H  Y  +  D+WS GV++ E    G  P+
Sbjct: 177 EGGKVPIKWMALESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPY 220

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  134 bits (338), Expect = 2e-35
 Identities = 70/276 (25%), Positives = 112/276 (40%), Gaps = 55/276 (19%)

Query: 55  PLPPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLIN---PAELQKGNRIGSGS 111
                 ++S +    +  Q     ++Q + ++          +   P   +  + IG+GS
Sbjct: 6   AAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGS 65

Query: 112 GGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVKCHDM----- 165
            G V         RV A+K I    ED +  + I REI IL  +NH +VVK  D+     
Sbjct: 66  YGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125

Query: 166 YDRNGEIEVLLEYMD---------GGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVH 216
            ++  E+ V+LE  D            L   HI+   +L      +L G+ Y+H   I+H
Sbjct: 126 VEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK--TLLY----NLLVGVKYVHSAGILH 179

Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA----------------------- 253
           RD+KP+N L+N   +VK+ DFG++R +    +  +                         
Sbjct: 180 RDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQ 239

Query: 254 ----VGTIAYMSPERINTDLNHGKYDGYAGDIWSLG 285
               V T  Y +PE I   L    Y   A D+WS+G
Sbjct: 240 LTGHVVTRWYRAPELI---LLQENYT-EAIDVWSIG 271

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  132 bits (334), Expect = 2e-35
 Identities = 81/329 (24%), Positives = 135/329 (41%), Gaps = 88/329 (26%)

Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVN-HPNVVKC 162
            ++G G+ G VW+ +   T  V A+K I+   ++S  +Q   REI IL +++ H N+V  
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74

Query: 163 HDMY--DRNGEIEVLLEYMD--------GGSLEGAHIRQEHILSDLARQVLSGLAYLHKR 212
            ++   D + ++ ++ +YM+           LE  H +  +++     Q++  + YLH  
Sbjct: 75  LNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQ--YVV----YQLIKVIKYLHSG 128

Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA------------------- 253
            ++HRD+KPSN+L+N+  +VK+ADFG+SR         N+                    
Sbjct: 129 GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188

Query: 254 --VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSIL-EFYLGR--FP----------- 297
             V T  Y +PE +   L   KY     D+WSLG  IL E   G+  FP           
Sbjct: 189 DYVATRWYRAPEIL---LGSTKYT-KGIDMWSLG-CILGEILCGKPIFPGSSTMNQLERI 243

Query: 298 FAV-------------------------GRQGDWASLMFAICFAQPPEAPEM-----ASR 327
             V                          +     S    I         ++      + 
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303

Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           E  D + + LQ +P+ R  A   L+HPF+
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFV 332

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  133 bits (336), Expect = 3e-35
 Identities = 81/363 (22%), Positives = 139/363 (38%), Gaps = 65/363 (17%)

Query: 44  PQRDPSLAVPLPLPPTSNSSSSSGQ---STSHQNHHPHQQQQNQTQNNHQNRHQLINPAE 100
           P  D  +A         + S  +     S S  ++  +  +   +      R+Q + P  
Sbjct: 12  PTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKP-- 69

Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNV 159
                 IGSG+ G V         R  A+K +    ++   ++   RE+ +++ VNH N+
Sbjct: 70  ------IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123

Query: 160 VKCHDM------YDRNGEIEVLLEYMDG--GSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           +   ++       +   ++ +++E MD     +    +  E + S L  Q+L G+ +LH 
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERM-SYLLYQMLCGIKHLHS 182

Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNH 271
             I+HRD+KPSN+++ S   +KI DFG++R    +       V T  Y +PE I   L  
Sbjct: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-VVTRYYRAPEVI---LGM 238

Query: 272 GKYDGYAGDIWSLGVSILEFYLGR--FP-------------------------------- 297
             Y     DIWS+G  + E    +  FP                                
Sbjct: 239 -GYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 296

Query: 298 ----FAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
                       +  L     F    E  ++ + + RD +S+ L  DP  R      LQH
Sbjct: 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356

Query: 354 PFI 356
           P+I
Sbjct: 357 PYI 359

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  131 bits (331), Expect = 4e-35
 Identities = 68/305 (22%), Positives = 108/305 (35%), Gaps = 64/305 (20%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           Q     G G+ GTV       T    A+K +  +     R    + ++ L  ++HPN+V+
Sbjct: 26  QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR--ELQIMQDLAVLHHPNIVQ 83

Query: 162 CHDMYDRNGEIE-------VLLEYM--DGGSLEGAHIRQEHILSDL-----ARQVLSGLA 207
               +   GE +       V++EY+          + R++     +       Q++  + 
Sbjct: 84  LQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIG 143

Query: 208 YLHKR--KIVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIA---YMS 261
            LH     + HRDIKP N+L+N +    K+ DFG     A+ + P    V  I    Y +
Sbjct: 144 CLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG----SAKKLSPSEPNVAYICSRYYRA 199

Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR--FPFAVGRQG--------------- 304
           PE I     +  Y   A DIWS+G    E  LG   F    G                  
Sbjct: 200 PELI---FGNQHYTT-AVDIWSVGCIFAEMMLGEPIFR---GDNSAGQLHEIVRVLGCPS 252

Query: 305 ---------DWASLMFAICFAQP-----PEAPEMASREFRDFISRCLQKDPHSRWPAAQL 350
                        +        P      +     ++E  D +S  LQ  P  R    + 
Sbjct: 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA 312

Query: 351 LQHPF 355
           L HP+
Sbjct: 313 LCHPY 317

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  132 bits (335), Expect = 4e-35
 Identities = 80/382 (20%), Positives = 128/382 (33%), Gaps = 115/382 (30%)

Query: 72  HQNHHPHQQQQNQTQNNHQN-----RHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRV 126
           H +HH    ++N      +N      + + +         IG GS G V+      T + 
Sbjct: 2   HHHHHHSSGRENLYFQGIKNVHVPDNYIIKHL--------IGRGSYGYVYLAYDKNTEKN 53

Query: 127 FALKVIYGNHEDSVRSQ-ICREIEILRDVNHPNVVKCHDM-----YDRNGEIEVLLEYMD 180
            A+K +    ED +  + I REI IL  +    +++ +D+       +  E+ ++LE  D
Sbjct: 54  VAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD 113

Query: 181 ---------GGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN 231
                       L   HI+   IL      +L G  ++H+  I+HRD+KP+N L+N   +
Sbjct: 114 SDLKKLFKTPIFLTEEHIK--TIL----YNLLLGENFIHESGIIHRDLKPANCLLNQDCS 167

Query: 232 VKIADFGVSRILAQTMDPCNSA----------------------VGTIAYMSPERINTDL 269
           VK+ DFG++R +    D                           V T  Y +PE I   L
Sbjct: 168 VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI---L 224

Query: 270 NHGKYDGYAGDIWSLG----------VSILEFYLGRFPFAVGRQGDWASLMFAICFAQ-- 317
               Y   + DIWS G           S +     RFP   G      S           
Sbjct: 225 LQENYT-KSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEK 283

Query: 318 ---------------PPEA-----------------PEMASREFR-----------DFIS 334
                          P E                  P       +           + + 
Sbjct: 284 SNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE 343

Query: 335 RCLQKDPHSRWPAAQLLQHPFI 356
             L+ +P+ R    Q L HP++
Sbjct: 344 SMLKFNPNKRITIDQALDHPYL 365

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  131 bits (332), Expect = 5e-35
 Identities = 82/352 (23%), Positives = 149/352 (42%), Gaps = 54/352 (15%)

Query: 68  QSTSHQNHHPHQQQQNQTQNNH-------QNRHQLINPAELQKGNR------------IG 108
               H +HH +     +            +   + +N  E  K +             IG
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIG 61

Query: 109 SGSGGTVWRVVHPPTSRVFALKVIYGNH---EDSVRSQICREIEILRDV-NHPNVVKCHD 164
            GS   V  V    T R++A++V+       ++ +      E  +     NHP +V  H 
Sbjct: 62  RGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQT-EKHVFEQASNHPFLVGLHS 120

Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIVHRDI 219
            +     +  ++EY++GG L   H++++  L  + AR    ++   L YLH+R I++RD+
Sbjct: 121 CFQTESRLFFVIEYVNGGDLM-FHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 179

Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
           K  N+L++S  ++K+ D+G+ +   +  D  ++  GT  Y++PE I    ++G     + 
Sbjct: 180 KLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE-ILRGEDYGF----SV 234

Query: 280 DIWSLGVSILEFYLGRFPFAVGRQGDWA-----SLMFAICFAQPPEAPEMASREFRDFIS 334
           D W+LGV + E   GR PF +    D         +F +   +    P   S +    + 
Sbjct: 235 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 294

Query: 335 RCLQKDPHSR------WPAAQLLQHPFILRAGQSQVNQNL---RQILPPPRP 377
             L KDP  R         A +  HPF        V+ ++   +Q++PP +P
Sbjct: 295 SFLNKDPKERLGCHPQTGFADIQGHPFF-----RNVDWDMMEQKQVVPPFKP 341

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  129 bits (327), Expect = 1e-34
 Identities = 74/286 (25%), Positives = 128/286 (44%), Gaps = 28/286 (9%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNH---EDSVRSQICREIEILRDV-NHPNVVKC 162
           +G GS G V       T  ++A+KV+  +    +D V   +  E  IL    NHP + + 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMT-EKRILSLARNHPFLTQL 89

Query: 163 HDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKIVHR 217
              +     +  ++E+++GG L   HI++        AR    +++S L +LH + I++R
Sbjct: 90  FCCFQTPDRLFFVMEFVNGGDLMF-HIQKSRRFDEARARFYAAEIISALMFLHDKGIIYR 148

Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY 277
           D+K  N+L++   + K+ADFG+ +          +  GT  Y++PE I  ++ +G     
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE-ILQEMLYGP---- 203

Query: 278 AGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCL 337
           A D W++GV + E   G  PF    + +    +F          P     +    +   +
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPF----EAENEDDLFEAILNDEVVYPTWLHEDATGILKSFM 259

Query: 338 QKDPHSR------WPAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
            K+P  R           +L+HPF      +Q+N   RQI PP RP
Sbjct: 260 TKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNH--RQIEPPFRP 303

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  133 bits (336), Expect = 2e-34
 Identities = 73/348 (20%), Positives = 134/348 (38%), Gaps = 38/348 (10%)

Query: 55  PLPPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNR-------- 106
                     S G     Q     +  Q       +  + +         +R        
Sbjct: 286 YFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNF 345

Query: 107 ---IGSGSGGTVWRVVHPPTSRVFALKVIYGNH---EDSVRSQICREIEILRDVN-HPNV 159
              +G GS G V       T  ++A+K++  +    +D V   +  E  +L      P +
Sbjct: 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV-EKRVLALPGKPPFL 404

Query: 160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-DLAR----QVLSGLAYLHKRKI 214
            + H  +     +  ++EY++GG L   HI+Q        A     ++  GL +L  + I
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDLMY-HIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 463

Query: 215 VHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
           ++RD+K  N++++S  ++KIADFG+ +          +  GT  Y++PE I     +GK 
Sbjct: 464 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE-IIAYQPYGK- 521

Query: 275 DGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS 334
              + D W+ GV + E   G+ PF    +G+    +F          P+  S+E      
Sbjct: 522 ---SVDWWAFGVLLYEMLAGQAPF----EGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 574

Query: 335 RCLQKDPHSR-----WPAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
             + K P  R          + +H F       ++ +  ++I PP +P
Sbjct: 575 GLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER--KEIQPPYKP 620

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  129 bits (327), Expect = 2e-34
 Identities = 65/301 (21%), Positives = 126/301 (41%), Gaps = 38/301 (12%)

Query: 74  NHHPHQQQQNQTQNNHQNRHQL------INPAELQKGNRIGSGSGGTVWR-VVHPPTSRV 126
           +H    QQ    ++       +      +N  +L  G +IG G+ G V+   +    + V
Sbjct: 83  DHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLV 142

Query: 127 FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-- 184
            A+K         ++++  +E  IL+  +HPN+V+   +  +   I +++E + GG    
Sbjct: 143 -AVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT 201

Query: 185 ----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS 240
               EGA +R + +L  +     +G+ YL  +  +HRD+   N L+     +KI+DFG+S
Sbjct: 202 FLRTEGARLRVKTLL-QMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260

Query: 241 RILAQTMDPCNSAVGTIAY--MSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFP 297
           R  A  +   +  +  +     +PE +    N+G+Y     D+WS G+ + E + LG  P
Sbjct: 261 REEADGVYAASGGLRQVPVKWTAPEAL----NYGRYS-SESDVWSFGILLWETFSLGASP 315

Query: 298 FA------VGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLL 351
           +            +    +           PE+        + +C   +P  R   + + 
Sbjct: 316 YPNLSNQQTREFVEKGGRL---------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIY 366

Query: 352 Q 352
           Q
Sbjct: 367 Q 367

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  127 bits (320), Expect = 7e-34
 Identities = 63/279 (22%), Positives = 118/279 (42%), Gaps = 31/279 (11%)

Query: 72  HQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTV----WRVVHPPTSRVF 127
           H +HH H     +          + +   L+K   +G G  G V    +   +  T  + 
Sbjct: 4   HHHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMV 63

Query: 128 ALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK----CHDMYDRNGEIEVLLEYMDGGS 183
           A+K +  +     RS   +EI+ILR + H +++K    C D       +++++EY+  GS
Sbjct: 64  AVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED--AGAASLQLVMEYVPLGS 121

Query: 184 LEGAHIRQEHI----LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGV 239
           L   ++ +  I    L   A+Q+  G+AYLH +  +HRD+   N+L+++ + VKI DFG+
Sbjct: 122 LRD-YLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGL 180

Query: 240 SRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRF 296
           ++ + +  +           + + +PE +       K+  YA D+WS GV++ E      
Sbjct: 181 AKAVPEGHEYYRVREDGDSPVFWYAPECL----KEYKFY-YASDVWSFGVTLYEL----- 230

Query: 297 PFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISR 335
                         F           +M      + + R
Sbjct: 231 -LTHCDSSQSPPTKFLELIGIAQ--GQMTVLRLTELLER 266

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  123 bits (312), Expect = 6e-33
 Identities = 58/257 (22%), Positives = 102/257 (39%), Gaps = 33/257 (12%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEIL 151
                L++   +G G  G V    + P    T    A+K +      +  + + +EIEIL
Sbjct: 18  FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEIL 77

Query: 152 RDVNHPNVVK----CHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQ 201
           R++ H N+VK    C +       I++++E++  GSL          I  +  L   A Q
Sbjct: 78  RNLYHENIVKYKGICTEDGGNG--IKLIMEFLPSGSLKEYLPKNKNKINLKQQL-KYAVQ 134

Query: 202 VLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IA 258
           +  G+ YL  R+ VHRD+   N+L+ S   VKI DFG+++ +    +           + 
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP 318
           + +PE +       K+   A D+WS GV++ E                   +F       
Sbjct: 195 WYAPECL----MQSKFY-IASDVWSFGVTLHEL------LTYCDSDSSPMALFLKMIGPT 243

Query: 319 PEAPEMASREFRDFISR 335
               +M      + +  
Sbjct: 244 H--GQMTVTRLVNTLKE 258

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  125 bits (315), Expect = 1e-32
 Identities = 78/350 (22%), Positives = 125/350 (35%), Gaps = 97/350 (27%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN----------- 155
           +G G   TVW       +   A+K++ G+           EI++L+ VN           
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 156 HPNVVKCHDMYDRNGEI--------EVLLEYMDGGSLEGAHIRQEH------ILSDLARQ 201
             +++K  D ++  G          EVL     G +L     + EH       +  +++Q
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVL-----GENLLALIKKYEHRGIPLIYVKQISKQ 139

Query: 202 VLSGLAYLHKR-KIVHRDIKPSNLLINSSK------NVKIADFGVSRILAQTMDPCNSAV 254
           +L GL Y+H+R  I+H DIKP N+L+           +KIAD G +    +      +++
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY---TNSI 196

Query: 255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY---------------------- 292
            T  Y SPE +   L    +     DIWS    I E                        
Sbjct: 197 QTREYRSPEVL---LGAP-WG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251

Query: 293 -----LGRFPFAVGRQGDWASLMFA-----------------ICFAQPPEAPEMASREFR 330
                LG  P  + R G +    F                      +  +  +  ++E  
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311

Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPLSS 380
           DF+S  LQ DP  R  A  L+ HP++           + +I  P R L  
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWLKDT------LGMEEIRVPDRELYG 355

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  123 bits (311), Expect = 1e-32
 Identities = 72/311 (23%), Positives = 137/311 (44%), Gaps = 36/311 (11%)

Query: 90  QNRHQLINPAELQKGNRIGSGSGGTVWR-VVHPPTSRVF---ALKVIYGNHEDSVRSQIC 145
           Q   +++   E +K   +GSG+ GTV++ +  P   +V    A+K +          +I 
Sbjct: 6   QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 65

Query: 146 REIEILRDVNHPNVVK----CHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHIL 195
            E  ++  V++P+V +    C         ++++ + M  G L         +I  +++L
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDNIGSQYLL 120

Query: 196 SDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVG 255
            +   Q+  G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L    +    A G
Sbjct: 121 -NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEG 178

Query: 256 T---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMF 311
               I +M+ E I     H  Y  +  D+WS GV++ E    G  P+  G     + +  
Sbjct: 179 GKVPIKWMALESI----LHRIYT-HQSDVWSYGVTVWELMTFGSKPYD-GIPA--SEISS 230

Query: 312 AICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPF--ILRAGQSQVNQNLR 369
            +   +    P + + +    + +C   D  SR P  + L   F  + R  Q  +     
Sbjct: 231 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSR-PKFRELIIEFSKMARDPQRYLVIQGD 289

Query: 370 QILPPPRPLSS 380
           + +  P P  S
Sbjct: 290 ERMHLPSPTDS 300

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  122 bits (308), Expect = 4e-32
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 21/217 (9%)

Query: 96  INPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEIL 151
           I  + +     IGSG  G V     RV       V A+K +   + +  R     E  I+
Sbjct: 46  IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPV-AIKALKAGYTERQRRDFLSEASIM 104

Query: 152 RDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSG 205
              +HPN+++   +  R     ++ EYM+ GSL               ++  + R V +G
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV-GMLRGVGAG 163

Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSP 262
           + YL     VHRD+   N+L++S+   K++DFG+SR+L    D   +  G    I + +P
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223

Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
           E I        +   A D+WS GV + E    G  P+
Sbjct: 224 EAI----AFRTFSS-ASDVWSFGVVMWEVLAYGERPY 255

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  121 bits (306), Expect = 4e-32
 Identities = 66/285 (23%), Positives = 114/285 (40%), Gaps = 51/285 (17%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPP----TSRVFALKVIYGNHEDSVRSQICREIEIL 151
                L+   ++G G+ G+V    + P    T  V A+K +  + E+ +R    REIEIL
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEIL 65

Query: 152 RDVNHPNVVK----CHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQ 201
           + + H N+VK    C+    RN  +++++EY+  GSL          I    +L     Q
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRN--LKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQ 122

Query: 202 VLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IA 258
           +  G+ YL  ++ +HRD+   N+L+ +   VKI DFG++++L Q  +           I 
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP 318
           + +PE +       K+   A D+WS GV + E       F    +       F       
Sbjct: 183 WYAPESLT----ESKFS-VASDVWSFGVVLYE------LFTYIEKSKSPPAEFMRMIGND 231

Query: 319 P-------------------EAPEMASREFRDFISRCLQKDPHSR 344
                                 P+    E    ++ C   + + R
Sbjct: 232 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR 276

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  122 bits (309), Expect = 7e-32
 Identities = 69/326 (21%), Positives = 115/326 (35%), Gaps = 93/326 (28%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY 166
           +G+GS G V  V    + + FALK +    +D       RE++I++ ++H N++K  D +
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVL---QDPRYKN--RELDIMKVLDHVNIIKLVDYF 69

Query: 167 DRNGEIEVLLEYMDGGSLEGAHIR-----------------------QEHILSDLAR--- 200
              G+ E           +                             E++   L +   
Sbjct: 70  YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK 129

Query: 201 -------------------QVLSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVS 240
                              Q+   + ++H   I HRDIKP NLL+NS    +K+ DFG  
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFG-- 187

Query: 241 RILAQTMDPCNSAVGTIA---YMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR-- 295
              A+ + P   +V  I    Y +PE +   L   +Y   + D+WS+G    E  LG+  
Sbjct: 188 --SAKKLIPSEPSVAYICSRFYRAPELM---LGATEYTP-SIDLWSIGCVFGELILGKPL 241

Query: 296 FPFAVGRQG------------------------DWASLMFAICFAQPPEA--PEMASREF 329
           F    G                            +  + F    A+      PE      
Sbjct: 242 FS---GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298

Query: 330 RDFISRCLQKDPHSRWPAAQLLQHPF 355
            D + + L+ +P  R    + + HPF
Sbjct: 299 IDLLEQILRYEPDLRINPYEAMAHPF 324

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  121 bits (306), Expect = 7e-32
 Identities = 63/281 (22%), Positives = 113/281 (40%), Gaps = 41/281 (14%)

Query: 73  QNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPP----TSRVFA 128
            +HH H  Q    Q+       +     L+  +++G G+ G+V    + P    T  + A
Sbjct: 2   GHHHHHHAQLYACQD-----PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVA 56

Query: 129 LKVIYGNHEDSVRSQICREIEILRDVNHPNVVK----CHDMYDRNGEIEVLLEYMDGGSL 184
           +K +  +  D  R    REI+IL+ ++   +VK     +    ++  + +++EY+  G L
Sbjct: 57  VKQLQHSGPDQQRD-FQREIQILKALHSDFIVKYRGVSYGPGRQS--LRLVMEYLPSGCL 113

Query: 185 ------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFG 238
                   A +    +L   + Q+  G+ YL  R+ VHRD+   N+L+ S  +VKIADFG
Sbjct: 114 RDFLQRHRARLDASRLL-LYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFG 172

Query: 239 VSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLG 294
           ++++L    D           I + +PE +    +   +     D+WS GV + E F   
Sbjct: 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESL----SDNIFS-RQSDVWSFGVVLYELFTYC 227

Query: 295 RFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISR 335
                        S           E    A     + +  
Sbjct: 228 DKSC---------SPSAEFLRMMGCERDVPALSRLLELLEE 259

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  120 bits (303), Expect = 8e-32
 Identities = 38/254 (14%), Positives = 71/254 (27%), Gaps = 43/254 (16%)

Query: 106 RIGSGSGGTVWRVVHPPTSRVFALKVIY--GNHEDSVRSQICREIEILRDVNHPNVVKCH 163
             G       W+ +     R  AL  +   G   D V  +       L  ++ P V +  
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHIL----SDLARQVLSGLAYLHKRKIVHRDI 219
           D+        V+ E++ GGSL    +              + + +     H+  +     
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSL--QEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSID 155

Query: 220 KPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAG 279
            PS + ++   +V +A                        M                   
Sbjct: 156 HPSRVRVSIDGDVVLAYPA--------------------TMPDA------------NPQD 183

Query: 280 DIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA---SREFRDFISRC 336
           DI  +G S+    + R+P          +        QP E  ++      +     +R 
Sbjct: 184 DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARS 243

Query: 337 LQKDPHSRWPAAQL 350
           +Q D   R  +  L
Sbjct: 244 VQGDGGIRSASTLL 257

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  120 bits (303), Expect = 1e-31
 Identities = 64/287 (22%), Positives = 112/287 (39%), Gaps = 58/287 (20%)

Query: 90  QNRHQLINPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNH--EDSVRSQ 143
           Q+   LI   +L+   ++G GS G V    W      T  V A+K +  +   +      
Sbjct: 9   QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDD 67

Query: 144 ICREIEILRDVNHPNVVK----CHD--MYDRNGEIEVLLEYMDGGSL------EGAHIRQ 191
             RE+  +  ++H N+++         M        ++ E    GSL         H   
Sbjct: 68  FIREVNAMHSLDHRNLIRLYGVVLTPPMK-------MVTELAPLGSLLDRLRKHQGHFLL 120

Query: 192 EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN 251
             +    A QV  G+ YL  ++ +HRD+   NLL+ +   VKI DFG+ R L Q  D   
Sbjct: 121 GTLS-RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 179

Query: 252 SAVGT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF--------- 298
                    A+ +PE +        +  +A D W  GV++ E F  G+ P+         
Sbjct: 180 MQEHRKVPFAWCAPESL----KTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 234

Query: 299 -AVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
             + ++G+    +      +P + P+    +  + + +C    P  R
Sbjct: 235 HKIDKEGE---RL-----PRPEDCPQ----DIYNVMVQCWAHKPEDR 269

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  121 bits (305), Expect = 1e-31
 Identities = 52/217 (23%), Positives = 105/217 (48%), Gaps = 20/217 (9%)

Query: 96  INPAELQKGNRIGSGSGGTVWR-VVHPPTSRVF---ALKVIYGNHEDSVRSQICREIEIL 151
           I+P+ + +   IG+G  G V++ ++   + +     A+K +   + +  R     E  I+
Sbjct: 41  IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 100

Query: 152 RDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSG 205
              +H N+++   +  +   + ++ EYM+ G+L      +        ++  + R + +G
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLV-GMLRGIAAG 159

Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSP 262
           + YL     VHRD+   N+L+NS+   K++DFG+SR+L    +   +  G    I + +P
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219

Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
           E I    ++ K+   A D+WS G+ + E    G  P+
Sbjct: 220 EAI----SYRKFTS-ASDVWSFGIVMWEVMTYGERPY 251

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  120 bits (304), Expect = 2e-31
 Identities = 71/321 (22%), Positives = 120/321 (37%), Gaps = 60/321 (18%)

Query: 69  STSHQNHHPHQQQQNQTQNNHQNRHQL---------INPAELQKGNRIGSGSGGTVWRVV 119
           S  H +HH             Q                   L+   ++G G+ G+V    
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCR 61

Query: 120 HPP----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK----CHDMYDRNGE 171
           + P    T  V A+K +  + E+ +R    REIEIL+ + H N+VK    C+    RN  
Sbjct: 62  YDPLQDNTGEVVAVKKLQHSTEEHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRN-- 118

Query: 172 IEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLL 225
           +++++EY+  GSL          I    +L     Q+  G+ YL  ++ +HRD+   N+L
Sbjct: 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLL-QYTSQICKGMEYLGTKRYIHRDLATRNIL 177

Query: 226 INSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYDGYAGDIW 282
           + +   VKI DFG++++L Q  +           I + +PE +       K+   A D+W
Sbjct: 178 VENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL----TESKFS-VASDVW 232

Query: 283 SLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP-------------------EAPE 323
           S GV + E       F    +       F                             P+
Sbjct: 233 SFGVVLYE------LFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD 286

Query: 324 MASREFRDFISRCLQKDPHSR 344
               E    ++ C   + + R
Sbjct: 287 GCPDEIYMIMTECWNNNVNQR 307

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  121 bits (305), Expect = 7e-31
 Identities = 77/325 (23%), Positives = 138/325 (42%), Gaps = 42/325 (12%)

Query: 64  SSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPT 123
           S       H+        + QTQ   ++  + I    L+   ++G G  G VW      T
Sbjct: 150 SKHADGLCHRLTTVCPTSKPQTQGLAKDAWE-IPRESLRLEVKLGQGCFGEVWMGTWNGT 208

Query: 124 SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGS 183
           +RV A+K +             +E ++++ + H  +V+ + +      I ++ EYM  GS
Sbjct: 209 TRV-AIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGS 264

Query: 184 L-------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIAD 236
           L        G ++R   ++ D+A Q+ SG+AY+ +   VHRD++ +N+L+  +   K+AD
Sbjct: 265 LLDFLKGETGKYLRLPQLV-DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVAD 323

Query: 237 FGVSRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FY 292
           FG++R++    +   +  G    I + +PE       +G++     D+WS G+ + E   
Sbjct: 324 FGLARLIED--NEYTARQGAKFPIKWTAPEAA----LYGRFTI-KSDVWSFGILLTELTT 376

Query: 293 LGRFPFA------VGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWP 346
            GR P+       V  Q +    M           P        D + +C +K+P  R  
Sbjct: 377 KGRVPYPGMVNREVLDQVERGYRM---------PCPPECPESLHDLMCQCWRKEPEERPT 427

Query: 347 AAQL---LQHPFILRAGQSQVNQNL 368
              L   L+  F     Q Q  +NL
Sbjct: 428 FEYLQAFLEDYFTSTEPQYQPGENL 452

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  119 bits (301), Expect = 7e-31
 Identities = 68/306 (22%), Positives = 116/306 (37%), Gaps = 36/306 (11%)

Query: 19  SSSSPSSSLANRRGQRRRPDLT-LPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHP 77
           S   P     +  G+RR      + +P+  P L     +   S S      S +      
Sbjct: 2   SPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGA 61

Query: 78  HQQQQNQTQNNHQNRHQL------INPAELQKGNRIGSGSGGTVWR----VVHPPTSRVF 127
           +    + +  N +    +       +   +     IG G  G V+               
Sbjct: 62  NTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC- 120

Query: 128 ALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK----CHDMYDRNGEIEVLLEYMDGGS 183
           A+K +    +    SQ   E  I++D +HPNV+     C       G   V+L YM  G 
Sbjct: 121 AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC---LRSEGSPLVVLPYMKHGD 177

Query: 184 L------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADF 237
           L      E  +   + ++     QV  G+ +L  +K VHRD+   N +++    VK+ADF
Sbjct: 178 LRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADF 236

Query: 238 GVSR-ILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FY 292
           G++R +  +  D  ++  G    + +M+ E     L   K+     D+WS GV + E   
Sbjct: 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALE----SLQTQKFT-TKSDVWSFGVLLWELMT 291

Query: 293 LGRFPF 298
            G  P+
Sbjct: 292 RGAPPY 297

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  119 bits (301), Expect = 7e-31
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 19/216 (8%)

Query: 96  INPAELQKGNRIGSGSGGTVWR-VVHPPTSRVF--ALKVIYGNHEDSVRSQICREIEILR 152
           ++   +     +G+G  G V    +  P+ +    A+K +   + +  R     E  I+ 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101

Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGL 206
             +HPN+++   +  ++  + ++ EYM+ GSL        A      ++  + R + SG+
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV-GMLRGIASGM 160

Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPE 263
            YL     VHRD+   N+LINS+   K++DFG+ R+L    +   +  G    I + SPE
Sbjct: 161 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE 220

Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
            I     + K+   A D+WS G+ + E    G  P+
Sbjct: 221 AI----AYRKFTS-ASDVWSYGIVLWEVMSYGERPY 251

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  117 bits (295), Expect = 1e-30
 Identities = 54/213 (25%), Positives = 100/213 (46%), Gaps = 21/213 (9%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           +   E+     +GSG  G V          V A+K+I          +  +E + +  ++
Sbjct: 5   LKREEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMI--KEGSMSEDEFFQEAQTMMKLS 61

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYL 209
           HP +VK + +  +   I ++ EY+  G L       G  +    +L ++   V  G+A+L
Sbjct: 62  HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL-EMCYDVCEGMAFL 120

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERIN 266
              + +HRD+   N L++    VK++DFG++R +    D   S+VGT   + + +PE   
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD--DQYVSSVGTKFPVKWSAPEVF- 177

Query: 267 TDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
              ++ KY     D+W+ G+ + E F LG+ P+
Sbjct: 178 ---HYFKYSS-KSDVWAFGILMWEVFSLGKMPY 206

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  116 bits (294), Expect = 2e-30
 Identities = 52/216 (24%), Positives = 101/216 (46%), Gaps = 20/216 (9%)

Query: 96  INPAELQKGN-RIGSGSGGTVWR-VVHPPTSRVF-ALKVIYGNHEDSVRSQICREIEILR 152
           +    L   +  +G G+ G+V + V      ++  A+KV+    E +   ++ RE +I+ 
Sbjct: 6   LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH 65

Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGL 206
            +++P +V+   +      + +++E   GG L      +   I   ++  +L  QV  G+
Sbjct: 66  QLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVA-ELLHQVSMGM 123

Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPE 263
            YL ++  VHRD+   N+L+ +    KI+DFG+S+ L        +       + + +PE
Sbjct: 124 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183

Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
            I    N  K+     D+WS GV++ E    G+ P+
Sbjct: 184 CI----NFRKFSS-RSDVWSYGVTMWEALSYGQKPY 214

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  116 bits (293), Expect = 2e-30
 Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 24/217 (11%)

Query: 96  INPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEIL 151
           I   ++     +G G  G V    +         V A+K    +     + +   E  I+
Sbjct: 9   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINV-AVKTCKKDCTLDNKEKFMSEAVIM 67

Query: 152 RDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSG 205
           ++++HP++VK   + +      +++E    G L          ++   ++   + Q+   
Sbjct: 68  KNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLV-LYSLQICKA 125

Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSP 262
           +AYL     VHRDI   N+L+ S + VK+ DFG+SR +    +    A  T   I +MSP
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED--EDYYKASVTRLPIKWMSP 183

Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
           E I    N  ++   A D+W   V + E    G+ PF
Sbjct: 184 ESI----NFRRFT-TASDVWMFAVCMWEILSFGKQPF 215

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  116 bits (292), Expect = 2e-30
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 21/213 (9%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQ-ICREIEILRDV 154
           I+P+EL     IGSG  G V         +V A+K I    E ++  +    E E++  +
Sbjct: 5   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTI---REGAMSEEDFIEEAEVMMKL 60

Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLARQVLSGLAYL 209
           +HP +V+ + +      I ++ E+M+ G L         +     L  +   V  G+AYL
Sbjct: 61  SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERIN 266
            +  ++HRD+   N L+  ++ +K++DFG++R +    D   S+ GT   + + SPE   
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPEVF- 177

Query: 267 TDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
              +  +Y     D+WS GV + E F  G+ P+
Sbjct: 178 ---SFSRYSS-KSDVWSFGVLMWEVFSEGKIPY 206

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  116 bits (292), Expect = 3e-30
 Identities = 54/265 (20%), Positives = 104/265 (39%), Gaps = 40/265 (15%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           +N  EL+    IG G  G V    +    +V A+K I     D+       E  ++  + 
Sbjct: 18  LNMKELKLLQTIGKGEFGDVMLGDYRGN-KV-AVKCI---KNDATAQAFLAEASVMTQLR 72

Query: 156 HPNVVK----CHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLS 204
           H N+V+         +  G + ++ EYM  GSL         + +  + +L   +  V  
Sbjct: 73  HSNLVQLLGVI---VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL-KFSLDVCE 128

Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMS 261
            + YL     VHRD+   N+L++     K++DFG+++      +  ++       + + +
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTA 182

Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQG-DWASLMFAICFAQPP 319
           PE +       K+     D+WS G+ + E +  GR P+           ++  +      
Sbjct: 183 PEAL----REKKFST-KSDVWSFGILLWEIYSFGRVPY----PRIPLKDVVPRVEKGYKM 233

Query: 320 EAPEMASREFRDFISRCLQKDPHSR 344
           +AP+       + +  C   D   R
Sbjct: 234 DAPDGCPPAVYEVMKNCWHLDAAMR 258

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  116 bits (293), Expect = 3e-30
 Identities = 51/222 (22%), Positives = 107/222 (48%), Gaps = 32/222 (14%)

Query: 96  INPAELQKGNR-IGSGSGGTVWR-VVHPPTSRVF-ALKVI-YGNHEDSVRSQICREIEIL 151
           ++   L   ++ +GSG+ GTV +            A+K++    ++ +++ ++  E  ++
Sbjct: 13  LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 72

Query: 152 RDVNHPNVVK----CHD--MYDRNGEIEVLLEYMDGGSL-----EGAHIRQEHILSDLAR 200
           + +++P +V+    C             +++E  + G L     +  H++ ++I+ +L  
Sbjct: 73  QQLDNPYIVRMIGICEAESWM-------LVMEMAELGPLNKYLQQNRHVKDKNII-ELVH 124

Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---I 257
           QV  G+ YL +   VHRD+   N+L+ +    KI+DFG+S+ L    +   +       +
Sbjct: 125 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 184

Query: 258 AYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
            + +PE I    N+ K+     D+WS GV + E F  G+ P+
Sbjct: 185 KWYAPECI----NYYKFS-SKSDVWSFGVLMWEAFSYGQKPY 221

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  116 bits (292), Expect = 4e-30
 Identities = 60/262 (22%), Positives = 116/262 (44%), Gaps = 28/262 (10%)

Query: 96  INPAELQKGNRIGSGSGGTVWR-VVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV 154
           +   ++   +++G G  G V+  V    +  V A+K +    +     +  +E  +++++
Sbjct: 10  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTV-AVKTL--KEDTMEVEEFLKEAAVMKEI 66

Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLA 207
            HPN+V+   +  R     ++ E+M  G+L           +    +L  +A Q+ S + 
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL-YMATQISSAME 125

Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPER 264
           YL K+  +HRD+   N L+  +  VK+ADFG+SR++    D   +  G    I + +PE 
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPES 183

Query: 265 INTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQG-DWASLMFAICFAQPPEAP 322
           +     + K+     D+W+ GV + E    G  P+     G D + +   +      E P
Sbjct: 184 L----AYNKFSI-KSDVWAFGVLLWEIATYGMSPY----PGIDLSQVYELLEKDYRMERP 234

Query: 323 EMASREFRDFISRCLQKDPHSR 344
           E    +  + +  C Q +P  R
Sbjct: 235 EGCPEKVYELMRACWQWNPSDR 256

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  119 bits (299), Expect = 6e-30
 Identities = 63/295 (21%), Positives = 122/295 (41%), Gaps = 38/295 (12%)

Query: 77  PHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWR-VVHPPTSRVFALKVIYGN 135
           P + +      +       +   ++   +++G G  G V+  V    +  V A+K +   
Sbjct: 198 PKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTV-AVKTL--K 254

Query: 136 HEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-------EGAH 188
            +     +  +E  +++++ HPN+V+   +  R     ++ E+M  G+L           
Sbjct: 255 EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 314

Query: 189 IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD 248
           +    +L  +A Q+ S + YL K+  +HR++   N L+  +  VK+ADFG+SR++    D
Sbjct: 315 VSAVVLL-YMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG--D 371

Query: 249 PCNSAVGT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGRFPFA----- 299
              +  G    I + +PE     L + K+     D+W+ GV + E    G  P+      
Sbjct: 372 TYTAHAGAKFPIKWTAPE----SLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLS 426

Query: 300 -VGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
            V    +    M         E PE    +  + +  C Q +P  R   A++ Q 
Sbjct: 427 QVYELLEKDYRM---------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA 472

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  116 bits (292), Expect = 8e-30
 Identities = 73/311 (23%), Positives = 132/311 (42%), Gaps = 43/311 (13%)

Query: 95  LINPAELQKGNRIGSGSGGTVWR-VVHPPTSRVF---ALKVIYGNHEDSVRSQICREIEI 150
           +    EL+K   +GSG  GTV + V  P    +     +KVI           +   +  
Sbjct: 9   IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68

Query: 151 LRDVNHPNVVK----CHD--MYDRNGEIEVLLEYMDGGSLEGAHIRQE------HILSDL 198
           +  ++H ++V+    C    +        ++ +Y+  GSL   H+RQ        +L + 
Sbjct: 69  IGSLDHAHIVRLLGLCPGSSLQ-------LVTQYLPLGSL-LDHVRQHRGALGPQLLLNW 120

Query: 199 ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT-- 256
             Q+  G+ YL +  +VHR++   N+L+ S   V++ADFGV+ +L    D          
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL-PPDDKQLLYSEAKT 179

Query: 257 -IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAIC 314
            I +M+ E I    + GKY  +  D+WS GV++ E    G  P+A G +   A +   + 
Sbjct: 180 PIKWMALESI----HFGKYT-HQSDVWSYGVTVWELMTFGAEPYA-GLRL--AEVPDLLE 231

Query: 315 FAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPF--ILRAGQSQV---NQNLR 369
             +    P++ + +    + +C   D + R P  + L + F  + R     +    ++  
Sbjct: 232 KGERLAQPQICTIDVYMVMVKCWMIDENIR-PTFKELANEFTRMARDPPRYLVIKRESGP 290

Query: 370 QILPPPRPLSS 380
            I P P P   
Sbjct: 291 GIAPGPEPHGL 301

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  114 bits (288), Expect = 1e-29
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 24/217 (11%)

Query: 96  INPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEIL 151
           I    ++ G  IG G  G V    +     P   V A+K       DSVR +  +E   +
Sbjct: 12  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAV-AIKTCKNCTSDSVREKFLQEALTM 70

Query: 152 RDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSG 205
           R  +HP++VK   +   N  + +++E    G L          +    ++   A Q+ + 
Sbjct: 71  RQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLI-LYAYQLSTA 128

Query: 206 LAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSP 262
           LAYL  ++ VHRDI   N+L++S+  VK+ DFG+SR +         A      I +M+P
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--STYYKASKGKLPIKWMAP 186

Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
           E I    N  ++   A D+W  GV + E    G  PF
Sbjct: 187 ESI----NFRRFT-SASDVWMFGVCMWEILMHGVKPF 218

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  118 bits (297), Expect = 2e-29
 Identities = 60/297 (20%), Positives = 116/297 (39%), Gaps = 29/297 (9%)

Query: 24  SSSLANRRGQRRRPDLTLPIPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQQQN 83
             +  N             +P    +L  P     T NS   + +     +    +    
Sbjct: 251 KEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPM 310

Query: 84  QTQNNHQN----------RHQLINPAELQKGNRIGSGSGGTVWR-VVHPPTSRVF-ALKV 131
            T                +  L     L     +G G+ G+V + V      ++  A+KV
Sbjct: 311 DTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV 370

Query: 132 IYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------E 185
           +    E +   ++ RE +I+  +++P +V+   +      + +++E   GG L      +
Sbjct: 371 LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGK 429

Query: 186 GAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ 245
              I   ++  +L  QV  G+ YL ++  VHR++   N+L+ +    KI+DFG+S+ L  
Sbjct: 430 REEIPVSNVA-ELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488

Query: 246 TMDPCNSAVGT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
                 +       + + +PE I    N  K+     D+WS GV++ E    G+ P+
Sbjct: 489 DDSYYTARSAGKWPLKWYAPECI----NFRKFS-SRSDVWSYGVTMWEALSYGQKPY 540

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  113 bits (285), Expect = 3e-29
 Identities = 55/214 (25%), Positives = 107/214 (50%), Gaps = 23/214 (10%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           +    L+   R+G+G  G VW   +   ++V A+K +              E  +++ + 
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL--KQGSMSPDAFLAEANLMKQLQ 66

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAY 208
           H  +V+ + +  +   I ++ EYM+ GSL        G  +    +L D+A Q+  G+A+
Sbjct: 67  HQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLL-DMAAQIAEGMAF 124

Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERI 265
           + +R  +HRD++ +N+L++ + + KIADFG++R++    +   +  G    I + +PE I
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAI 182

Query: 266 NTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
               N+G +     D+WS G+ + E    GR P+
Sbjct: 183 ----NYGTFT-IKSDVWSFGILLTEIVTHGRIPY 211

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  113 bits (285), Expect = 3e-29
 Identities = 53/213 (24%), Positives = 101/213 (47%), Gaps = 21/213 (9%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           I+P +L     +G+G  G V          V A+K+I          +   E +++ +++
Sbjct: 21  IDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMI--KEGSMSEDEFIEEAKVMMNLS 77

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYL 209
           H  +V+ + +  +   I ++ EYM  G L           + + +L ++ + V   + YL
Sbjct: 78  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL-EMCKDVCEAMEYL 136

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERIN 266
             ++ +HRD+   N L+N    VK++DFG+SR +    D   S+VG+   + +  PE + 
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVL- 193

Query: 267 TDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
               + K+     DIW+ GV + E + LG+ P+
Sbjct: 194 ---MYSKFSS-KSDIWAFGVLMWEIYSLGKMPY 222

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  116 bits (292), Expect = 5e-29
 Identities = 66/270 (24%), Positives = 121/270 (44%), Gaps = 46/270 (17%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           I    L+   ++G+G  G VW   +   ++V A+K +              E  +++ + 
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTM--KPGSMSVEAFLAEANVMKTLQ 241

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAY 208
           H  +VK H +  +   I ++ E+M  GSL       EG+      ++ D + Q+  G+A+
Sbjct: 242 HDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLI-DFSAQIAEGMAF 299

Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERI 265
           + +R  +HRD++ +N+L+++S   KIADFG++R++    +   +  G    I + +PE I
Sbjct: 300 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAI 357

Query: 266 NTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF----------AVGRQGDWASLMFAIC 314
               N G +     D+WS G+ ++E    GR P+          A+  +G     M    
Sbjct: 358 ----NFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYR---M---- 404

Query: 315 FAQPPEAPEMASREFRDFISRCLQKDPHSR 344
                  PE    E  + + RC +  P  R
Sbjct: 405 -----PRPENCPEELYNIMMRCWKNRPEER 429

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  111 bits (281), Expect = 1e-28
 Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 27/221 (12%)

Query: 96  INPAELQKGNRIGSGSGGTVWR-VVHPPTSRVF--ALKVIYGNHEDSVRSQICREIEILR 152
            +   +     IG G  G V+   +     +    A+K +    +    SQ   E  I++
Sbjct: 22  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMK 81

Query: 153 DVNHPNVVK----CHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQV 202
           D +HPNV+     C       G   V+L YM  G L      E  +   + ++     QV
Sbjct: 82  DFSHPNVLSLLGIC---LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG-FGLQV 137

Query: 203 LSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR-ILAQTMDPCNSAVGT---IA 258
             G+ YL  +K VHRD+   N +++    VK+ADFG++R +  +     ++  G    + 
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197

Query: 259 YMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
           +M+ E     L   K+     D+WS GV + E    G  P+
Sbjct: 198 WMALE----SLQTQKFT-TKSDVWSFGVLLWELMTRGAPPY 233

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  110 bits (278), Expect = 4e-28
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 25/216 (11%)

Query: 100 ELQKGNRIGSGSGGTVWR----VVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
                  IG G  G V+            +  A+K +    E        RE  ++R +N
Sbjct: 22  VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQC-AIKSLSRITEMQQVEAFLREGLLMRGLN 80

Query: 156 HPNVVKCHD-MYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAY 208
           HPNV+     M    G   VLL YM  G L         +   + ++     QV  G+ Y
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI-SFGLQVARGMEY 139

Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT-----IAYMSPE 263
           L ++K VHRD+   N +++ S  VK+ADFG++R +    +  +          + + + E
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR-EYYSVQQHRHARLPVKWTALE 198

Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
                L   ++     D+WS GV + E    G  P+
Sbjct: 199 ----SLQTYRFT-TKSDVWSFGVLLWELLTRGAPPY 229

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  110 bits (278), Expect = 7e-28
 Identities = 56/233 (24%), Positives = 95/233 (40%), Gaps = 43/233 (18%)

Query: 96  INPAELQKGNRIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQICREIE 149
           +   ++     +G GS G V+       V   P +RV A+K +        R +   E  
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFLNEAS 80

Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----------EGAHIRQEHILSDL 198
           ++++ N  +VV+   +  +     V++E M  G L               +     LS +
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140

Query: 199 ---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL---------AQT 246
              A ++  G+AYL+  K VHRD+   N ++     VKI DFG++R +          + 
Sbjct: 141 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 200

Query: 247 MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
           + P       + +MSPE     L  G +     D+WS GV + E   L   P+
Sbjct: 201 LLP-------VRWMSPE----SLKDGVFT-TYSDVWSFGVVLWEIATLAEQPY 241

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  112 bits (283), Expect = 7e-28
 Identities = 63/307 (20%), Positives = 114/307 (37%), Gaps = 59/307 (19%)

Query: 72  HQNHHPHQQQQNQTQNNHQNRHQ-LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALK 130
            +   P   +      +   R    +N  EL+    IG G  G V    +    +V A+K
Sbjct: 165 TRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGN-KV-AVK 222

Query: 131 VIYGNHEDSVRSQICREIEILRDVNHPNVVK----CHDMYDRNGEIEVLLEYMDGGSL-- 184
            I     D+       E  ++  + H N+V+         +  G + ++ EYM  GSL  
Sbjct: 223 CI---KNDATAQAFLAEASVMTQLRHSNLVQLLGVI---VEEKGGLYIVTEYMAKGSLVD 276

Query: 185 -----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGV 239
                  + +  + +L   +  V   + YL     VHRD+   N+L++     K++DFG+
Sbjct: 277 YLRSRGRSVLGGDCLL-KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335

Query: 240 SRILAQTMDPCNSAVGT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-LGR 295
           ++      +  ++       + + +PE +       K+     D+WS G+ + E Y  GR
Sbjct: 336 TK------EASSTQDTGKLPVKWTAPEAL----REKKFST-KSDVWSFGILLWEIYSFGR 384

Query: 296 FPF----------AVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRW 345
            P+           V  +G     M         +AP+       D +  C   D  +R 
Sbjct: 385 VPYPRIPLKDVVPRV-EKGYK---M---------DAPDGCPPAVYDVMKNCWHLDAATRP 431

Query: 346 PAAQLLQ 352
              QL +
Sbjct: 432 TFLQLRE 438

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  109 bits (275), Expect = 1e-27
 Identities = 57/259 (22%), Positives = 100/259 (38%), Gaps = 47/259 (18%)

Query: 74  NHHPHQQQQNQTQNNHQNRHQL----INPAELQKGNRIGSGSGGTVWR---VVHPPTSRV 126
           +HH H       + + + +++L    I+   L  G  +G G  G+V          TS  
Sbjct: 5   HHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLK 64

Query: 127 FALKVI-YGNHEDSVRSQICREIEILRDVNHPNVVK----CHDMYDRNGEIE-VLLEYMD 180
            A+K +   N       +   E   ++D +HPNV++    C +M  +      V+L +M 
Sbjct: 65  VAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK 124

Query: 181 GGSL-----------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS 229
            G L              HI  + +L      +  G+ YL  R  +HRD+   N ++   
Sbjct: 125 YGDLHTYLLYSRLETGPKHIPLQTLLK-FMVDIALGMEYLSNRNFLHRDLAARNCMLRDD 183

Query: 230 KNVKIADFGVSRIL---------AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
             V +ADFG+S+ +              P       + +++ E     L    Y     D
Sbjct: 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMP-------VKWIAIE----SLADRVYT-SKSD 231

Query: 281 IWSLGVSILE-FYLGRFPF 298
           +W+ GV++ E    G  P+
Sbjct: 232 VWAFGVTMWEIATRGMTPY 250

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  111 bits (279), Expect = 2e-27
 Identities = 73/323 (22%), Positives = 112/323 (34%), Gaps = 84/323 (26%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH------PNVV 160
           IG GS G V +       +  ALK++   +E     Q   EI IL  +         NV+
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV--RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 161 KCHDMYDRNGEI----EVLL----EYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKR 212
              + +     I    E+L     E +     +G  +     +   A  +L  L  LHK 
Sbjct: 163 HMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPL---VRKFAHSILQCLDALHKN 219

Query: 213 KIVHRDIKPSNLLINSSK--NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
           +I+H D+KP N+L+       +K+ DFG S    Q +    + + +  Y +PE I   L 
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV---YTYIQSRFYRAPEVI---LG 273

Query: 271 HGKYDGYAGDIWSLGVSILEFY---------------------LGRFPFAVGRQGDWASL 309
              Y     D+WSLG  + E                       LG     +      A  
Sbjct: 274 AR-YG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN 331

Query: 310 MFA---------------------------ICFAQPPEAPEMAS-------REFRDFISR 335
             +                                PPE+ E  +         F DF+ +
Sbjct: 332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQ 391

Query: 336 CLQKDPHSRWPAAQLLQHPFILR 358
           CL+ DP  R    Q L+HP++ R
Sbjct: 392 CLEWDPAVRMTPGQALRHPWLRR 414

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  112 bits (281), Expect = 3e-27
 Identities = 66/293 (22%), Positives = 117/293 (39%), Gaps = 35/293 (11%)

Query: 20  SSSPSSSLANRRGQRRRPDLTLP-IPQRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPH 78
           + +  S +   + +  R   ++P +   +        +  +     +           P 
Sbjct: 322 NGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPS 381

Query: 79  QQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTV----WRVVHPPTSRVFALKVIYG 134
            +               I    ++ G  IG G  G V    +     P   V A+K    
Sbjct: 382 TRDYE------------IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAV-AIKTCKN 428

Query: 135 NHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAH 188
              DSVR +  +E   +R  +HP++VK   +   N  + +++E    G L          
Sbjct: 429 CTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFS 487

Query: 189 IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD 248
           +    ++   A Q+ + LAYL  ++ VHRDI   N+L++S+  VK+ DFG+SR +  +  
Sbjct: 488 LDLASLI-LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-T 545

Query: 249 PCNSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
              ++ G   I +M+PE I    N  ++   A D+W  GV + E    G  PF
Sbjct: 546 YYKASKGKLPIKWMAPESI----NFRRFTS-ASDVWMFGVCMWEILMHGVKPF 593

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  110 bits (277), Expect = 6e-27
 Identities = 72/293 (24%), Positives = 128/293 (43%), Gaps = 41/293 (13%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           I    L+   ++G G  G VW      T+RV A+K +             +E ++++ + 
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMS--PEAFLQEAQVMKKLR 320

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAY 208
           H  +V+ + +      I ++ EYM  GSL        G ++R   ++ D+A Q+ SG+AY
Sbjct: 321 HEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAY 378

Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT---IAYMSPERI 265
           + +   VHRD++ +N+L+  +   K+ADFG++R++    +   +  G    I + +PE  
Sbjct: 379 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAA 436

Query: 266 NTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFA------VGRQGDWASLMFAICFAQP 318
                +G++     D+WS G+ + E    GR P+       V  Q +    M        
Sbjct: 437 ----LYGRFTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------- 483

Query: 319 PEAPEMASREFRDFISRCLQKDPHSRWPAAQL---LQHPFILRAGQSQVNQNL 368
              P        D + +C +K+P  R     L   L+  F     Q Q  +NL
Sbjct: 484 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 535

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  106 bits (267), Expect = 1e-26
 Identities = 54/233 (23%), Positives = 94/233 (40%), Gaps = 37/233 (15%)

Query: 96  INPAELQKGNRIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQICREIE 149
           I+ + ++    +G    G V++           T  V A+K +    E  +R +   E  
Sbjct: 6   ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAV-AIKTLKDKAEGPLREEFRHEAM 64

Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL-----------------EGAHIRQE 192
           +   + HPNVV    +  ++  + ++  Y   G L                 +   ++  
Sbjct: 65  LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124

Query: 193 HILSDL---ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP 249
               D      Q+ +G+ YL    +VH+D+   N+L+    NVKI+D G+ R +    D 
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA-DY 183

Query: 250 CNSAVGT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
                 +   I +M+PE I     +GK+     DIWS GV + E F  G  P+
Sbjct: 184 YKLLGNSLLPIRWMAPEAI----MYGKFS-IDSDIWSYGVVLWEVFSYGLQPY 231

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  106 bits (267), Expect = 2e-26
 Identities = 58/259 (22%), Positives = 99/259 (38%), Gaps = 45/259 (17%)

Query: 71  SHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWR------VVHPPTS 124
           +H +HH +       + +  +  + +    +     +G G+ G V+          P   
Sbjct: 2   AHHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPL 61

Query: 125 RVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL 184
           +V A+K +     +        E  I+   NH N+V+C  +  ++    +L+E M GG L
Sbjct: 62  QV-AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDL 120

Query: 185 ------------EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN- 231
                       + + +    +L  +AR +  G  YL +   +HRDI   N L+      
Sbjct: 121 KSFLRETRPRPSQPSSLAMLDLL-HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179

Query: 232 --VKIADFGVSRIL---------AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGD 280
              KI DFG++R +            M P       + +M PE        G +     D
Sbjct: 180 RVAKIGDFGMARDIYRASYYRKGGCAMLP-------VKWMPPEA----FMEGIFTS-KTD 227

Query: 281 IWSLGVSILE-FYLGRFPF 298
            WS GV + E F LG  P+
Sbjct: 228 TWSFGVLLWEIFSLGYMPY 246

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  107 bits (269), Expect = 2e-26
 Identities = 75/370 (20%), Positives = 124/370 (33%), Gaps = 98/370 (26%)

Query: 72  HQNHHPHQQQQNQTQNNHQNRHQLINPAELQKG-----NRIGSGSGGTVWRVVHPPTSRV 126
           H +HH   ++    Q + +  H       L         ++G G+ G V    H    + 
Sbjct: 3   HHHHHSSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKY 62

Query: 127 FALKVIYGNHEDSVRSQICREIEILR-----DVNHPNVVKCHDMYDRNGEI----EVL-- 175
           +A+KV+              E +IL+     D+N+ N+VK H  +     +    E L  
Sbjct: 63  YAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGP 120

Query: 176 --LEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK--- 230
              E +   +  G HI     +     ++L  L YL K  + H D+KP N+L++      
Sbjct: 121 SLYEIITRNNYNGFHIED---IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177

Query: 231 ----------------------NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
                                  +K+ DFG +   +       S + T  Y +PE I   
Sbjct: 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH---GSIINTRQYRAPEVI--- 231

Query: 269 LNHGKYDGYAGDIWSLGVSILEFY---------------------LGRFPFAVGRQGDWA 307
           LN G +D  + D+WS G  + E Y                     +   P  +  +    
Sbjct: 232 LNLG-WD-VSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKT 289

Query: 308 SLMFAI---------------------CFAQPPEAPEMASREFRDFISRCLQKDPHSRWP 346
           +    +                          P    +    F DF+   LQ DP  R  
Sbjct: 290 NGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS 349

Query: 347 AAQLLQHPFI 356
            A+LL+H F+
Sbjct: 350 PAELLKHKFL 359

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  105 bits (264), Expect = 5e-26
 Identities = 64/281 (22%), Positives = 107/281 (38%), Gaps = 40/281 (14%)

Query: 96  INPAELQKGNRIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQICREIE 149
                L  G  +G+G+ G V        +       V A+K++  +   + R  +  E++
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTV-AVKMLKPSAHLTEREALMSELK 78

Query: 150 ILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSL----------------------EG 186
           +L  + NH N+V         G   V+ EY   G L                      + 
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 187 AHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT 246
                   L   + QV  G+A+L  +  +HRD+   N+L+   +  KI DFG++R +   
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 247 MDPCNSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQ 303
            +          + +M+PE     + +  Y   + D+WS G+ + E F LG  P+  G  
Sbjct: 199 SNYVVKGNARLPVKWMAPES----IFNCVYTFES-DVWSYGIFLWELFSLGSSPYP-GMP 252

Query: 304 GDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
            D +     I       +PE A  E  D +  C   DP  R
Sbjct: 253 VD-SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  104 bits (261), Expect = 8e-26
 Identities = 41/226 (18%), Positives = 89/226 (39%), Gaps = 34/226 (15%)

Query: 96  INPAELQKGNRIGSGSGGTVWR--------VVHPPTSRVFALKVIYGNHEDSVRSQICRE 147
           I   +L     +G G+   +++              + V  LKV+   H +         
Sbjct: 5   IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEV-LLKVLDKAHRN-YSESFFEA 62

Query: 148 IEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQ 201
             ++  ++H ++V  + +     E  ++ E++  GSL          I     L ++A+Q
Sbjct: 63  ASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL-EVAKQ 121

Query: 202 VLSGLAYLHKRKIVHRDIKPSNLLINSSKN--------VKIADFGVSRILAQTMDPCNSA 253
           + + + +L +  ++H ++   N+L+   ++        +K++D G+S  +       +  
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----DIL 177

Query: 254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
              I ++ PE I     + K    A D WS G ++ E    G  P 
Sbjct: 178 QERIPWVPPECI----ENPKNLNLATDKWSFGTTLWEICSGGDKPL 219

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  105 bits (263), Expect = 8e-26
 Identities = 48/229 (20%), Positives = 89/229 (38%), Gaps = 32/229 (13%)

Query: 95  LINPAELQKGNRIGSGSGGTVWR---VVHPPTSRVFALKVI-YGNHEDSVRSQICREIEI 150
           LI   +   G  +G G  G+V          +    A+K++       S   +  RE   
Sbjct: 19  LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAAC 78

Query: 151 LRDVNHPNVVKC------HDMYDRNGEIEVLLEYMDGGSL-----------EGAHIRQEH 193
           +++ +HP+V K            R     V+L +M  G L              ++  + 
Sbjct: 79  MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138

Query: 194 ILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA 253
           ++      +  G+ YL  R  +HRD+   N ++     V +ADFG+SR +  + D     
Sbjct: 139 LVR-FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI-YSGDYYRQG 196

Query: 254 VGT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
             +   + +++ E     L    Y     D+W+ GV++ E    G+ P+
Sbjct: 197 CASKLPVKWLALE----SLADNLYT-VHSDVWAFGVTMWEIMTRGQTPY 240

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  105 bits (264), Expect = 1e-25
 Identities = 71/328 (21%), Positives = 113/328 (34%), Gaps = 91/328 (27%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHP------NVV 160
           IG GS G V +          A+K+I   ++ +  +Q   E+ +L  +N         +V
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKII--KNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119

Query: 161 KCHDMYDRNGEI----EVL----LEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKR 212
                +     +    E+L     + +   +  G  +         A+Q+ + L +L   
Sbjct: 120 HLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNL---TRKFAQQMCTALLFLATP 176

Query: 213 K--IVHRDIKPSNLLINSSKN--VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
           +  I+H D+KP N+L+ + K   +KI DFG S  L Q +      + +  Y SPE +   
Sbjct: 177 ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI---YQYIQSRFYRSPEVL--- 230

Query: 269 LNHGKYDGYAGDIWSLGVSILEFY---------------------LGRFPFAVGRQGDWA 307
           L    YD  A D+WSLG  ++E +                     LG  P  +  Q   A
Sbjct: 231 LGMP-YD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288

Query: 308 SLMF--AICFAQPPEAPEMASRE------------------------------------- 328
              F          +  +   RE                                     
Sbjct: 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK 348

Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFI 356
           F+D I R L  DP +R      LQH F 
Sbjct: 349 FKDLILRMLDYDPKTRIQPYYALQHSFF 376

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  104 bits (262), Expect = 1e-25
 Identities = 69/294 (23%), Positives = 105/294 (35%), Gaps = 87/294 (29%)

Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK--- 161
           N +G G  G V++        + A+K +          Q   E+E++    H N+++   
Sbjct: 36  NILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94

Query: 162 -CHDMYDRNGEIEVLL--EYMDGGSLEGA-HIRQEH-----------ILSDLARQVLSGL 206
            C    +R      LL   YM  GS+      R E            I    AR    GL
Sbjct: 95  FCMTPTER------LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR----GL 144

Query: 207 AYLHKR---KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV-----GTIA 258
           AYLH     KI+HRD+K +N+L++      + DFG    LA+ MD  ++ V     GTI 
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG----LAKLMDYKDTHVTTAVRGTIG 200

Query: 259 YMSPERINTDLNHGKYDGYA--------GDIWSLGVSILEFYLGRFPFAVGRQG------ 304
           +++PE             Y          D++  GV +LE   G+  F + R        
Sbjct: 201 HIAPE-------------YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247

Query: 305 --DWASLMFAICFAQPPEAPEMA---------SREFRDFI---SRCLQKDPHSR 344
             DW   +      +  +   +            E    I     C Q  P  R
Sbjct: 248 LLDWVKGLL-----KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMER 296

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  103 bits (258), Expect = 4e-25
 Identities = 60/248 (24%), Positives = 101/248 (40%), Gaps = 59/248 (23%)

Query: 96  INPAELQKGNRIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQICREIE 149
                L  G  +G G  G V +            + V A+K++  N   S    +  E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTV-AVKMLKENASPSELRDLLSEFN 78

Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------------------------- 184
           +L+ VNHP+V+K +    ++G + +++EY   GSL                         
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138

Query: 185 ----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS 240
               +   +    ++S  A Q+  G+ YL + K+VHRD+   N+L+   + +KI+DFG+S
Sbjct: 139 LDHPDERALTMGDLIS-FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197

Query: 241 RIL---------AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE- 290
           R +         +Q   P       + +M+ E     L    Y     D+WS GV + E 
Sbjct: 198 RDVYEEDSYVKRSQGRIP-------VKWMAIE----SLFDHIYTTQ-SDVWSFGVLLWEI 245

Query: 291 FYLGRFPF 298
             LG  P+
Sbjct: 246 VTLGGNPY 253

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  103 bits (259), Expect = 5e-25
 Identities = 63/300 (21%), Positives = 105/300 (35%), Gaps = 50/300 (16%)

Query: 31  RGQRRRPDLTLPIP-QRDPSLAVPLPLPPTSNSSSSSGQSTSHQNHHPHQQQQNQTQNNH 89
                  D+          ++   L  P    S   +    +  N  P+     +T +  
Sbjct: 6   HHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYN--PNYCFAGKTSSIS 63

Query: 90  QNRHQLINPAELQKGNRIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQ 143
             +   +    +     +G G+ G V+          P   +V A+K +     +     
Sbjct: 64  DLKE--VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQDELD 120

Query: 144 ICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------------EGAHIRQ 191
              E  I+   NH N+V+C  +  ++    +LLE M GG L            + + +  
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180

Query: 192 EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN---VKIADFGVSRIL----- 243
             +L  +AR +  G  YL +   +HRDI   N L+         KI DFG++R +     
Sbjct: 181 LDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 239

Query: 244 ----AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
                  M P       + +M PE        G +     D WS GV + E F LG  P+
Sbjct: 240 YRKGGCAMLP-------VKWMPPEA----FMEGIFTS-KTDTWSFGVLLWEIFSLGYMPY 287

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  102 bits (257), Expect = 5e-25
 Identities = 55/234 (23%), Positives = 90/234 (38%), Gaps = 58/234 (24%)

Query: 147 EIEILRDVNHPNVVK----CHDMYDRNGEIEVLL--EYMDGGSLEGAHIRQEHILSDLAR 200
           EI+++    H N+V+      D  D        L   YM  GSL       + +      
Sbjct: 80  EIKVMAKCQHENLVELLGFSSDGDDL------CLVYVYMPNGSLL------DRLSCLDGT 127

Query: 201 QVLS-------------GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM 247
             LS             G+ +LH+   +HRDIK +N+L++ +   KI+DFG++R   +  
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187

Query: 248 DPCNSA--VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG- 304
               ++  VGT AYM+PE +      G+    + DI+S GV +LE   G       R+  
Sbjct: 188 QTVMTSRIVGTTAYMAPEAL-----RGEITPKS-DIYSFGVVLLEIITGLPAVDEHREPQ 241

Query: 305 ---DWASLMFAICFAQPPEAPEMA--------SREFRDFI---SRCLQKDPHSR 344
              D    +      +     +          S          S+CL +  + R
Sbjct: 242 LLLDIKEEI----EDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKR 291

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  102 bits (257), Expect = 5e-25
 Identities = 64/292 (21%), Positives = 108/292 (36%), Gaps = 63/292 (21%)

Query: 96  INPAELQKGNRIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQICREIE 149
                L+ G  +G G+ G V                V A+K++      S    +  E++
Sbjct: 24  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV-AVKMLKEGATHSEHRALMSELK 82

Query: 150 ILRDV-NHPNVVK----CHDMYDRNGEIEVLLEYMDGGSL----------------EGAH 188
           IL  + +H NVV     C       G + V++E+   G+L                    
Sbjct: 83  ILIHIGHHLNVVNLLGAC---TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139

Query: 189 IRQEHI----LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL- 243
           + ++ +    L   + QV  G+ +L  RK +HRD+   N+L++    VKI DFG++R + 
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199

Query: 244 --------AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLG 294
                        P       + +M+PE     +    Y   + D+WS GV + E F LG
Sbjct: 200 KDPDYVRKGDARLP-------LKWMAPET----IFDRVYTIQS-DVWSFGVLLWEIFSLG 247

Query: 295 RFPFAVGRQG--DWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
             P+     G          +       AP+  + E    +  C   +P  R
Sbjct: 248 ASPY----PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 295

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  102 bits (257), Expect = 7e-25
 Identities = 58/285 (20%), Positives = 100/285 (35%), Gaps = 52/285 (18%)

Query: 96  INPAELQKGNRIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQICREIE 149
                LQ G  +G+G+ G V               +V A+K++        +  +  E++
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKV-AVKMLKSTAHADEKEALMSELK 101

Query: 150 ILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------------------EGAHIR 190
           I+  +  H N+V         G + V+ EY   G L                        
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161

Query: 191 QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC 250
               L   + QV  G+A+L  +  +HRD+   N+L+ +    KI DFG++R +    +  
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221

Query: 251 NSAVG--TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWA 307
                   + +M+PE     +    Y   + D+WS G+ + E F LG  P+  G   +  
Sbjct: 222 VKGNARLPVKWMAPE----SIFDCVYTVQS-DVWSYGILLWEIFSLGLNPYP-GILVNSK 275

Query: 308 SL--------MFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
                     M           P  A +     +  C   +P  R
Sbjct: 276 FYKLVKDGYQM---------AQPAFAPKNIYSIMQACWALEPTHR 311

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  101 bits (255), Expect = 1e-24
 Identities = 57/257 (22%), Positives = 101/257 (39%), Gaps = 47/257 (18%)

Query: 71  SHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWR--VVHPPTSRVFA 128
              +HH H +      N     + +++  +++  + IG G+ G V +  +         A
Sbjct: 2   KKHHHHHHGKN-----NPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAA 56

Query: 129 LKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSL--- 184
           +K +              E+E+L  + +HPN++      +  G + + +EY   G+L   
Sbjct: 57  IKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 116

Query: 185 -------------EGAHIRQEHI----LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN 227
                          A+     +    L   A  V  G+ YL +++ +HRD+   N+L+ 
Sbjct: 117 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176

Query: 228 SSKNVKIADFGVSRIL------AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDI 281
            +   KIADFG+SR             P       + +M+ E     LN+  Y     D+
Sbjct: 177 ENYVAKIADFGLSRGQEVYVKKTMGRLP-------VRWMAIE----SLNYSVYT-TNSDV 224

Query: 282 WSLGVSILE-FYLGRFP 297
           WS GV + E   LG  P
Sbjct: 225 WSYGVLLWEIVSLGGTP 241

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  100 bits (251), Expect = 5e-24
 Identities = 67/289 (23%), Positives = 112/289 (38%), Gaps = 51/289 (17%)

Query: 96  INPAELQKGNRIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQICREIE 149
                L+ G  +GSG+ G V             + +V A+K++    + S R  +  E++
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQV-AVKMLKEKADSSEREALMSELK 100

Query: 150 ILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------------------------ 184
           ++  + +H N+V        +G I ++ EY   G L                        
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160

Query: 185 ----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS 240
               +   +  E +L   A QV  G+ +L  +  VHRD+   N+L+   K VKI DFG++
Sbjct: 161 EEEEDLNVLTFEDLLC-FAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219

Query: 241 RILAQTMDPCNSAVGT--IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFP 297
           R +    +          + +M+PE     L  G Y   + D+WS G+ + E F LG  P
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPES----LFEGIYTIKS-DVWSYGILLWEIFSLGVNP 274

Query: 298 FAVGRQG--DWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
           +     G    A+    I      + P  A+ E    +  C   D   R
Sbjct: 275 Y----PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 319

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 99.2 bits (248), Expect = 6e-24
 Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 52/240 (21%)

Query: 96  INPAELQKGNRIGSGSGGTVWR------VVHPPTSRVFALKVIYGNHEDSVRSQICREIE 149
           I   ++     +G G+ G V+               V A+K +  +   + R    RE E
Sbjct: 12  IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLV-AVKAL-KDPTLAARKDFQREAE 69

Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSL---------------------EGAH 188
           +L ++ H ++VK + +      + ++ EYM  G L                         
Sbjct: 70  LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129

Query: 189 IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL----- 243
           +    +L  +A Q+ SG+ YL  +  VHRD+   N L+ ++  VKI DFG+SR +     
Sbjct: 130 LGLSQML-HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188

Query: 244 ----AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
                 TM P       I +M PE I     + K+     D+WS GV + E F  G+ P+
Sbjct: 189 YRVGGHTMLP-------IRWMPPESI----MYRKFT-TESDVWSFGVILWEIFTYGKQPW 236

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 65/326 (19%), Positives = 113/326 (34%), Gaps = 87/326 (26%)

Query: 107 IGSGSGGTVWRVV-HPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHP------NV 159
           +G G+ G V   + H       ALK+I        R     EI +L+ +           
Sbjct: 27  LGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLC 84

Query: 160 VKCHDMYDRNGEI----EVL----LEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK 211
           V   D ++ +G +    E+L     E++   + +   +     +  +A Q+   L +LH+
Sbjct: 85  VLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPH---VRHMAYQLCHALRFLHE 141

Query: 212 RKIVHRDIKPSNLLINSSKN-------------------VKIADFGVSRILAQTMDPCNS 252
            ++ H D+KP N+L  +S+                    +++ADFG +    +      +
Sbjct: 142 NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH---TT 198

Query: 253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY-------------------- 292
            V T  Y  PE I   L  G +     D+WS+G  + E+Y                    
Sbjct: 199 IVATRHYRPPEVI---LELG-WA-QPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253

Query: 293 -LGRFPFAVGRQG-----------DWASLMFAICFAQPPEAPEMAS--------REFRDF 332
            LG  P  +  +             W        + +    P  +          +  D 
Sbjct: 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 313

Query: 333 ISRCLQKDPHSRWPAAQLLQHPFILR 358
           + R L+ DP  R   A+ L HPF   
Sbjct: 314 MRRMLEFDPAQRITLAEALLHPFFAG 339

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 98.8 bits (247), Expect = 1e-23
 Identities = 71/299 (23%), Positives = 109/299 (36%), Gaps = 93/299 (31%)

Query: 58  PTSNSSSSSGQSTSHQNHH-PHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVW 116
            + N + SS      +++  P    +  T N                   IG G  G V+
Sbjct: 10  NSINDALSSSYLVPFESYRVPLVDLEEATNN-------------FDHKFLIGHGVFGKVY 56

Query: 117 RVVHPPTSRVFALKVIY-----GNHEDSVRSQICREIEILRDVNHPNVVK----CHDMYD 167
           + V    ++V ALK        G  E         EIE L    HP++V     C +   
Sbjct: 57  KGVLRDGAKV-ALKRRTPESSQGIEEFET------EIETLSFCRHPHLVSLIGFCDE--- 106

Query: 168 RNGEIEVLL--EYMDGGSLEGAHIRQEHIL-SDLARQVLS-------------GLAYLHK 211
                E++L  +YM+ G+L+       H+  SDL    +S             GL YLH 
Sbjct: 107 ---RNEMILIYKYMENGNLK------RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT 157

Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV-----GTIAYMSPERIN 266
           R I+HRD+K  N+L++ +   KI DFG+S+     +D   + +     GT+ Y+ PE   
Sbjct: 158 RAIIHRDVKSINILLDENFVPKITDFGISK-KGTELD--QTHLSTVVKGTLGYIDPE--- 211

Query: 267 TDLNHGKYDGYAG--------DIWSLGVSILEFYLGRFPFAVGRQG------DWASLMF 311
                     Y          D++S GV + E    R               +WA    
Sbjct: 212 ----------YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 65/289 (22%), Positives = 114/289 (39%), Gaps = 60/289 (20%)

Query: 56  LPPTSNSSSSSGQSTSHQNHHPHQQ-QQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGT 114
           +   + + ++          HP+   Q+     N +          ++    IG G+ G 
Sbjct: 3   MESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGR 62

Query: 115 VWR------VVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR 168
           V++      + + P + V A+K++       +++   RE  ++ + ++PN+VK   +   
Sbjct: 63  VFQARAPGLLPYEPFTMV-AVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121

Query: 169 NGEIEVLLEYMDGGSL-----------------------------EGAHIRQEHILSDLA 199
              + +L EYM  G L                                 +     L  +A
Sbjct: 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC-IA 180

Query: 200 RQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL---------AQTMDPC 250
           RQV +G+AYL +RK VHRD+   N L+  +  VKIADFG+SR +              P 
Sbjct: 181 RQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIP- 239

Query: 251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
                 I +M PE     + + +Y     D+W+ GV + E F  G  P+
Sbjct: 240 ------IRWMPPE----SIFYNRYT-TESDVWAYGVVLWEIFSYGLQPY 277

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 66/273 (24%), Positives = 103/273 (37%), Gaps = 50/273 (18%)

Query: 61  NSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWR--- 117
            S SS   +    +       +N    +    H  I   ++     +G G+ G V+    
Sbjct: 4   GSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHH-IKRRDIVLKWELGEGAFGKVFLAEC 62

Query: 118 ---VVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV 174
              +       V A+K +     +S R    RE E+L  + H ++V+   +      + +
Sbjct: 63  HNLLPEQDKMLV-AVKAL-KEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120

Query: 175 LLEYMDGGSL--------------EGAHIRQEHILS-----DLARQVLSGLAYLHKRKIV 215
           + EYM  G L               G        L       +A QV +G+ YL     V
Sbjct: 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFV 180

Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRIL---------AQTMDPCNSAVGTIAYMSPERIN 266
           HRD+   N L+     VKI DFG+SR +          +TM P       I +M PE I 
Sbjct: 181 HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP-------IRWMPPESI- 232

Query: 267 TDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPF 298
               + K+     D+WS GV + E F  G+ P+
Sbjct: 233 ---LYRKFT-TESDVWSFGVVLWEIFTYGKQPW 261

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 97.3 bits (243), Expect = 6e-23
 Identities = 64/327 (19%), Positives = 110/327 (33%), Gaps = 93/327 (28%)

Query: 107 IGSGSGGTVWRVV-HPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHP------NV 159
           +G G+ G V   + H    R  A+K++     D        EI++L  +N          
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRC 79

Query: 160 VKCHDMYDRNGEI----EVL-------LEYMDGGSLEGAHIRQEHILSDLARQVLSGLAY 208
           V+  + ++ +G I    E+L       ++          HIR+      +A Q+   + +
Sbjct: 80  VQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRK------MAYQICKSVNF 133

Query: 209 LHKRKIVHRDIKPSNLLINSSKN-------------------VKIADFGVSRILAQTMDP 249
           LH  K+ H D+KP N+L   S                     +K+ DFG +    +    
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-- 191

Query: 250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFY----------------- 292
            ++ V T  Y +PE I   L  G +     D+WS+G  ++E+Y                 
Sbjct: 192 -STLVSTRHYRAPEVI---LALG-WS-QPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245

Query: 293 ----LGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR-------------------EF 329
               LG  P  + ++                 +                           
Sbjct: 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL 305

Query: 330 RDFISRCLQKDPHSRWPAAQLLQHPFI 356
            D I + L+ DP  R    + L+HPF 
Sbjct: 306 FDLIQKMLEYDPAKRITLREALKHPFF 332

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 96.3 bits (240), Expect = 7e-23
 Identities = 56/216 (25%), Positives = 87/216 (40%), Gaps = 37/216 (17%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH-PNVVKC 162
           G +IGSGS G ++           A+K+       +   Q+  E +I + +     +   
Sbjct: 14  GRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 163 HDMYDRNGEIEVLLEYMD--GGSLEGAHIRQEHILS-----DLARQVLSGLAYLHKRKIV 215
                  G+  V++  M+  G SLE          S      LA Q++S + Y+H +  +
Sbjct: 71  RW-CGAEGDYNVMV--MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 127

Query: 216 HRDIKPSNLLI---NSSKNVKIADFGVSRILAQTMDPCN----------SAVGTIAYMSP 262
           HRD+KP N L+        V I DFG+++   +  D             +  GT  Y S 
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAK---KYRDARTHQHIPYRENKNLTGTARYAS- 183

Query: 263 ERINTDLNH-GKYDGYAGDIWSLGVSILEFYLGRFP 297
             INT   H G       D+ SLG  ++ F LG  P
Sbjct: 184 --INT---HLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 97.0 bits (242), Expect = 8e-23
 Identities = 54/241 (22%), Positives = 99/241 (41%), Gaps = 52/241 (21%)

Query: 96  INPAELQKGNRIGSGSGGTVWR-------VVHPPTSRVFALKVIYGNHEDSVRSQICREI 148
               +L  G  +G G+ G V            P  +   A+K++  +  +   S +  E+
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91

Query: 149 EILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSL---------------------EG 186
           E+++ +  H N++       ++G + V++EY   G+L                       
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151

Query: 187 AHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL--- 243
             +  + ++S    Q+  G+ YL  +K +HRD+   N+L+  +  +KIADFG++R +   
Sbjct: 152 EQMTFKDLVS-CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210

Query: 244 ------AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRF 296
                      P       + +M+PE     L    Y   + D+WS GV + E F LG  
Sbjct: 211 DYYKKTTNGRLP-------VKWMAPEA----LFDRVYTHQS-DVWSFGVLMWEIFTLGGS 258

Query: 297 P 297
           P
Sbjct: 259 P 259

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 95.9 bits (239), Expect = 1e-22
 Identities = 55/218 (25%), Positives = 90/218 (41%), Gaps = 39/218 (17%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKC 162
           G RIG GS G ++   +   ++  A+K        S   Q+  E    + +     +   
Sbjct: 15  GRRIGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 163 HDMYDRNGEIEVLLEYMD--GGSLEGAHIRQEHILS-----DLARQVLSGLAYLHKRKIV 215
           +  + + G   VL+  +D  G SLE          S       A+Q+L+ +  +H++ +V
Sbjct: 72  YY-FGQEGLHNVLV--IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 128

Query: 216 HRDIKPSNLLI-----NSSKNVKIADFGVSRILAQTMDPCN----------SAVGTIAYM 260
           +RDIKP N LI      ++  + + DFG+ +      DP            +  GT  YM
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVK---FYRDPVTKQHIPYREKKNLSGTARYM 185

Query: 261 SPERINTDLNH-GKYDGYAGDIWSLGVSILEFYLGRFP 297
           S   INT   H G+      D+ +LG   + F  G  P
Sbjct: 186 S---INT---HLGREQSRRDDLEALGHVFMYFLRGSLP 217

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 97.0 bits (242), Expect = 1e-22
 Identities = 61/289 (21%), Positives = 110/289 (38%), Gaps = 57/289 (19%)

Query: 96  INPAELQKGNRIGSGSGGTVWR-------VVHPPTSRVFALKVIYGNHEDSVRSQICREI 148
               +L  G  +G G  G V            P  +   A+K++  +  +   S +  E+
Sbjct: 78  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137

Query: 149 EILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSL---------------------EG 186
           E+++ +  H N++       ++G + V++EY   G+L                       
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197

Query: 187 AHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL--- 243
             +  + ++S    Q+  G+ YL  +K +HRD+   N+L+  +  +KIADFG++R +   
Sbjct: 198 EQMTFKDLVS-CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 256

Query: 244 ------AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRF 296
                      P       + +M+PE     L    Y  +  D+WS GV + E F LG  
Sbjct: 257 DYYKKTTNGRLP-------VKWMAPEA----LFDRVYT-HQSDVWSFGVLMWEIFTLGGS 304

Query: 297 PFAVGRQG-DWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
           P+     G     L   +      + P   + E    +  C    P  R
Sbjct: 305 PY----PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 349

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 96.3 bits (240), Expect = 1e-22
 Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 33/215 (15%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKC 162
           G +IG G+ G +    +  T+   A+K+       S   Q+  E    + + +   + + 
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 163 HDMYDRNGEIEVLLEYMD--GGSLEGAHIRQEHILS-----DLARQVLSGLAYLHKRKIV 215
           +  +   G+   ++  ++  G SLE      +   S      +A Q++S + Y+H + ++
Sbjct: 71  YY-FGPCGKYNAMV--LELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLI 127

Query: 216 HRDIKPSNLLI-----NSSKNVKIADFGVSR--ILAQT-----MDPCNSAVGTIAYMSPE 263
           +RD+KP N LI      + + + I DF +++  I  +T          S  GT  YMS  
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS-- 185

Query: 264 RINTDLNH-GKYDGYAGDIWSLGVSILEFYLGRFP 297
            INT   H GK      D+ +LG   + F  G  P
Sbjct: 186 -INT---HLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 56/236 (23%), Positives = 100/236 (42%), Gaps = 42/236 (17%)

Query: 96  INPAELQKGNRIGSGSGGTVWR--------VVHPPTSRVFALKVIYGNHEDSVRSQICRE 147
           +    L  G  +G G+ G V                ++V A+K++  +  +   S +  E
Sbjct: 66  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKV-AVKMLKSDATEKDLSDLISE 124

Query: 148 IEILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSL---------------------E 185
           +E+++ +  H N++       ++G + V++EY   G+L                      
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184

Query: 186 GAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ 245
              +  + ++S  A QV  G+ YL  +K +HRD+   N+L+     +KIADFG++R +  
Sbjct: 185 EEQLSSKDLVS-CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 243

Query: 246 TMDPCNSAVGT---IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFP 297
             D           + +M+PE     L    Y   + D+WS GV + E F LG  P
Sbjct: 244 I-DYYKKTTNGRLPVKWMAPEA----LFDRIYTHQS-DVWSFGVLLWEIFTLGGSP 293

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 93.4 bits (232), Expect = 3e-21
 Identities = 76/362 (20%), Positives = 115/362 (31%), Gaps = 123/362 (33%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILR-----DVNHPN--- 158
           +G G   TVW        +  A+KV+     +        EI +L+     D N PN   
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVV--KSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 159 VVKCHDMYD---RNGEIEVL-LEYMDGGSLEGAHIRQEH------ILSDLARQVLSGLAY 208
           VV+  D +     NG    +  E + G  L    I+  +       +  + +QVL GL Y
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161

Query: 209 LHKR-KIVHRDIKPSNLLINSS-------------------------------------- 229
           LH + +I+H DIKP N+L++ +                                      
Sbjct: 162 LHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221

Query: 230 -----------KNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
                        VKIAD G +  + +        + T  Y S E +   +  G      
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNACWVHKHFTED---IQTRQYRSLEVL---IGSGY--NTP 273

Query: 279 GDIWSLGVSILEFYLGRFPFAV-------------------------------------- 300
            DIWS      E   G + F                                        
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333

Query: 301 GRQGDW---ASLMFAICFAQPPEAPEMASRE---FRDFISRCLQKDPHSRWPAAQLLQHP 354
            ++GD      L     F    E  E +  E   F DF+   L+  P  R  AA+ L+HP
Sbjct: 334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP 393

Query: 355 FI 356
           ++
Sbjct: 394 WL 395

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 90.2 bits (224), Expect = 2e-20
 Identities = 54/271 (19%), Positives = 92/271 (33%), Gaps = 58/271 (21%)

Query: 72  HQNHHPHQQQQNQTQNNHQNRHQLINPAELQK--------GNRIGSGSGGTVWRVVHPPT 123
           H +HH        T+N +           L          G +IGSG  G ++       
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNK 61

Query: 124 SRVFALKVIYGNHEDSVRSQICREIEILRDVNH------------------PNVVKCHDM 165
               A  V+    E      +  E++  + V                    P        
Sbjct: 62  PEKDARHVV--KVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLT 119

Query: 166 YDRNGEIEVLLEYMD--GGSLEGAHIRQEH-------ILSDLARQVLSGLAYLHKRKIVH 216
             +      ++  M+  G  L+   I  ++       +L  L  ++L  L Y+H+ + VH
Sbjct: 120 EFKGRSYRFMV--MERLGIDLQ--KISGQNGTFKKSTVLQ-LGIRMLDVLEYIHENEYVH 174

Query: 217 RDIKPSNLLI--NSSKNVKIADFGVSRILAQT-------MDPCNSAVGTIAYMSPERINT 267
            DIK +NLL+   +   V +AD+G+S              +P     GTI + S   ++ 
Sbjct: 175 GDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS---LDA 231

Query: 268 DLNH-GKYDGYAGDIWSLGVSILEFYLGRFP 297
              H G       D+  LG  +L +  G+ P
Sbjct: 232 ---HKGVALSRRSDVEILGYCMLRWLCGKLP 259

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 84.7 bits (209), Expect = 5e-18
 Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 31/213 (14%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKC 162
           G +IGSGS G ++   +  T+   A+K+    +  +   Q+  E +I R +     +   
Sbjct: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 163 HDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYLHKRKIVHR 217
              +   G+  VL+  + G SLE         LS      LA Q+++ + ++H +  +HR
Sbjct: 69  RW-FGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127

Query: 218 DIKPSNLLI---NSSKNVKIADFGVSRILAQTMDPCN----------SAVGTIAYMSPER 264
           DIKP N L+     +  V I DFG+++   +  D             +  GT  Y S   
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK---KYRDTSTHQHIPYRENKNLTGTARYAS--- 181

Query: 265 INTDLNHGKYDGYAGDIWSLGVSILEFYLGRFP 297
           +NT L  G       D+ SLG  ++ F  G  P
Sbjct: 182 VNTHL--GIEQSRRDDLESLGYVLMYFLRGSLP 212

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 81.0 bits (200), Expect = 4e-17
 Identities = 50/232 (21%), Positives = 85/232 (36%), Gaps = 49/232 (21%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRV-----FALKVIYGNHEDSVRSQICREIEILRDVNHPN 158
           G  IG G  G ++      +  V       +KV   ++       +  E++  +    P 
Sbjct: 40  GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-----GPLFTELKFYQRAAKPE 94

Query: 159 VVKCHDMYDRNGEIEV------------LLEY----MD--GGSLEGAHIRQEHILSD--- 197
            ++      +   + V               Y    MD  G  L+  +       S    
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTV 154

Query: 198 --LARQVLSGLAYLHKRKIVHRDIKPSNLLIN--SSKNVKIADFGVSR--ILAQT----- 246
             L+ ++L  L Y+H+ + VH DIK SNLL+N  +   V + D+G++             
Sbjct: 155 LQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA 214

Query: 247 MDPCNSAVGTIAYMSPERINTDLNH-GKYDGYAGDIWSLGVSILEFYLGRFP 297
            DP     GTI + S   I+    H G      GD+  LG  ++++  G  P
Sbjct: 215 ADPKRCHDGTIEFTS---IDA---HNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 80.6 bits (199), Expect = 5e-17
 Identities = 43/277 (15%), Positives = 92/277 (33%), Gaps = 62/277 (22%)

Query: 72  HQNHHPHQQQQNQTQNNHQNRHQLINPAELQKG--------------NRIGSGSGGTVWR 117
           H +HH        T+N +       +   L  G              +     + G ++ 
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMT-TSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYE 60

Query: 118 VVHPPTSRV--------FALKV----IYGNHEDSVRSQICREIEI-----LRDVNHPNVV 160
                T           F+LK+        +E +   +  + +++     L       + 
Sbjct: 61  AAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120

Query: 161 KCHDMYDRNGEIEVLLEYMD--GGSLEGAHIRQE---HILS-----DLARQVLSGLAYLH 210
            C        +   L+  +   G SL+          H+LS      +A ++L  L +LH
Sbjct: 121 TCMGFGVHQDKYRFLV--LPSLGRSLQ--SALDVSPKHVLSERSVLQVACRLLDALEFLH 176

Query: 211 KRKIVHRDIKPSNLLINSSKNVKI--ADFGVSRILAQT-------MDPCNSAVGTIAYMS 261
           + + VH ++   N+ ++     ++  A +G +     +           +   G + ++S
Sbjct: 177 ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFIS 236

Query: 262 PERINTDLNH-GKYDGYAGDIWSLGVSILEFYLGRFP 297
              ++    H G       D+ SLG  +L++  G  P
Sbjct: 237 ---MDL---HKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 78.0 bits (192), Expect = 3e-16
 Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 10/153 (6%)

Query: 195 LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV 254
           L   + QV  G+ +L  RK +HRD+   N+L++    VKI DFG++R + +  D      
Sbjct: 195 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254

Query: 255 GT--IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMF 311
               + +M+PE     +    Y   + D+WS GV + E F LG  P+  G + D      
Sbjct: 255 ARLPLKWMAPE----TIFDRVYTIQS-DVWSFGVLLWEIFSLGASPYP-GVKID-EEFCR 307

Query: 312 AICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
            +       AP+  + E    +  C   +P  R
Sbjct: 308 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 340

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 52.6 bits (126), Expect = 7e-08
 Identities = 30/155 (19%), Positives = 56/155 (36%), Gaps = 7/155 (4%)

Query: 96  INPAELQKGNRIGSGSGGTVWR-----VVHPPTSRVFALKVIYGNHEDSVRSQICREIEI 150
                L+ G  +G G+ G V       +    T R  A+K++      S    +  E++I
Sbjct: 19  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 78

Query: 151 LRDV-NHPNVVKCH-DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAY 208
           L  + +H NVV          G + V++E+   G+L      + +       +       
Sbjct: 79  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQG 138

Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL 243
                 +  D+K     I SS++   + F   + L
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 68.8 bits (167), Expect = 4e-13
 Identities = 32/198 (16%), Positives = 59/198 (29%), Gaps = 52/198 (26%)

Query: 94  QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS-------QICR 146
             +   +LQ+  +IG G  G V++ +   T    A+K+I     D V         +I  
Sbjct: 15  HCLPTEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILP 72

Query: 147 EIEILR---------DVNHPNVVKC-----------------HDMYDRNGEIE------- 173
           EI I +                +                    D Y+             
Sbjct: 73  EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132

Query: 174 ------VLLEYMDGGSL---EGAHIRQEHILSDLARQVLSGLAYLHKR-KIVHRDIKPSN 223
                 ++LE+  GG         +        +  Q+ + LA      +  HRD+   N
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192

Query: 224 LLINSSKNVKIADFGVSR 241
           +L+  +   K+      +
Sbjct: 193 VLLKKTSLKKLHYTLNGK 210

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.5 bits (112), Expect = 5e-06
 Identities = 44/348 (12%), Positives = 91/348 (26%), Gaps = 120/348 (34%)

Query: 80  QQQNQTQNNHQ-------NRHQLINPA-----ELQKGNRIG----SGSGGTV-------- 115
           +Q+++  N++Q       +R Q          EL+    +      GSG T         
Sbjct: 114 EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLS 173

Query: 116 WRVVHPPTSRVFALKVIYGNHEDSVRSQ---ICREIE----------------------- 149
           ++V      ++F L +   N  ++V      +  +I+                       
Sbjct: 174 YKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAE 233

Query: 150 ---------------ILRDVNHPNVVKCHD------MYDRNGEI-EVLLEYMDGGSLEGA 187
                          +L +V +       +      +  R  ++ + L       +    
Sbjct: 234 LRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFL------SAATTT 287

Query: 188 HIRQEHILSDLA-RQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT 246
           HI  +H    L   +V S L      K +  D +P +L     + +      +S I    
Sbjct: 288 HISLDHHSMTLTPDEVKSLLL-----KYL--DCRPQDL---PREVLTTNPRRLSIIAESI 337

Query: 247 MDPCN----------SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRF 296
            D               + TI   S   +        +D  +  ++     I    L   
Sbjct: 338 RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLS--VFPPSAHIPTILLSLI 395

Query: 297 PFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSR 344
                    W  +              +   +        ++K P   
Sbjct: 396 ---------WFDV--------IKSDVMVVVNKLHK--YSLVEKQPKES 424

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 39.9 bits (93), Expect = 8e-04
 Identities = 33/152 (21%), Positives = 56/152 (36%), Gaps = 26/152 (17%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKV---------------IYGNHEDSVRSQIC--R 146
           G  +G G    V+            +K                 YG+   SV +      
Sbjct: 95  GKLMGEGKESAVFNCYSEKFGEC-VVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 153

Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGL 206
           E   L+ +    V K +  ++ N    VL+E +D   L    +R E+   ++   +L  +
Sbjct: 154 EFRALQKLQGLAVPKVYA-WEGN---AVLMELIDAKEL--YRVRVENPD-EVLDMILEEV 206

Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFG 238
           A  + R IVH D+   N+L++      I DF 
Sbjct: 207 AKFYHRGIVHGDLSQYNVLVSEEGIWII-DFP 237

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	380
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.82
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.52
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.44
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.41
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.2
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.14
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	99.0
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.84
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.79
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.64
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.64
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.62
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.46
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.34
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.14
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	98.1
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	98.07
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.99
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.97
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.9
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.86
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.83
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.81
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.73
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.71
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.57
3mes_A	424	Choline kinase; malaria, structural genomics, stru	97.27
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.01
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.32
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.47
1cja_A	342	Protein (actin-fragmin kinase); transferase; HET:	93.08
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	90.76
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	87.48

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.7e-67  Score=480.88  Aligned_cols=261  Identities=29%  Similarity=0.459  Sum_probs=225.8

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++.+..  .....+.+.+|+++|+.++|||||+++++|++++.+|+
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi  109 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF  109 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            4578999999999999999999999999999999996432  22335678999999999999999999999999999999


Q ss_pred             EEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc--CC
Q 016959          175 LLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT--MD  248 (380)
Q Consensus       175 v~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~  248 (380)
                      |||||.||+|.+++.    ..+..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.+...  ..
T Consensus       110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence            999999999977653    467889999999999999999999999999999999999999999999999987533  23


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHH
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE  328 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (380)
                      ...+.+||+.|||||++.+     ..|+.++|||||||+||||++|+.||...   +.......+.. ....++..++++
T Consensus       190 ~~~~~~GTp~YmAPEvl~~-----~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~-~~~~~p~~~s~~  260 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTE-----KSACKSSDLWALGCIIYQLVAGLPPFRAG---NEGLIFAKIIK-LEYDFPEKFFPK  260 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHH-----SCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH-TCCCCCTTCCHH
T ss_pred             cccCcccCcccCCHHHHcC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHc-CCCCCCcccCHH
Confidence            4567899999999999964     56788999999999999999999999643   33334333333 345677889999


Q ss_pred             HHHHHHHhcccCcCCCCCHHH------HhcCccccccCcccccc
Q 016959          329 FRDFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQ  366 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~e------il~hp~~~~~~~~~~~~  366 (380)
                      +++||.+||+.||++|+|++|      |++||||++++|..+.+
T Consensus       261 ~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~  304 (311)
T 4aw0_A          261 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ  304 (311)
T ss_dssp             HHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred             HHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcC
Confidence            999999999999999999988      58999999999987654

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.7e-67  Score=481.61  Aligned_cols=274  Identities=27%  Similarity=0.465  Sum_probs=224.9

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeC---CCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEee
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHP---PTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDR  168 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~---~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  168 (380)
                      ...+++++|++++.||+|+||+||+|++.   .+++.||||++.+.. .......+.+|+.+|++++|||||+++++|++
T Consensus        18 ~~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~   97 (304)
T 3ubd_A           18 HEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT   97 (304)
T ss_dssp             CCCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred             cccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            44577889999999999999999999874   468899999996543 11123457789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          169 NGEIEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      ++.+|+|||||.||+|.+++.    .++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus        98 ~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A           98 EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            999999999999999977654    3678899999999999999999999999999999999999999999999998776


Q ss_pred             ccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc
Q 016959          245 QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM  324 (380)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (380)
                      .......+.+||+.|||||++..     ..++.++|||||||+||||++|+.||...   +....+..+.. .....+..
T Consensus       178 ~~~~~~~~~~GT~~YmAPE~~~~-----~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~-~~~~~p~~  248 (304)
T 3ubd_A          178 DHEKKAYSFCGTVEYMAPEVVNR-----RGHTQSADWWSFGVLMFEMLTGTLPFQGK---DRKETMTMILK-AKLGMPQF  248 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHT-----SCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH-CCCCCCTT
T ss_pred             CCCccccccccCcccCCHHHhcc-----CCCCCCCcccchHHHHHHHHhCCCCCCCc---CHHHHHHHHHc-CCCCCCCc
Confidence            55555677899999999999863     56678999999999999999999999743   33334433333 34567788


Q ss_pred             ccHHHHHHHHHhcccCcCCCCC-----HHHHhcCccccccCcccccccccccCCCCCC
Q 016959          325 ASREFRDFISRCLQKDPHSRWP-----AAQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      +++++++||.+||+.||++|+|     ++|+++||||++++|..+..  +++.||++|
T Consensus       249 ~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~--~~~~pP~~P  304 (304)
T 3ubd_A          249 LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYR--REIHPPFKP  304 (304)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHT--TCSCCSSCC
T ss_pred             CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHh--CCCCcCcCC
Confidence            9999999999999999999998     58999999999998877654  566677766

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3e-66  Score=493.11  Aligned_cols=254  Identities=31%  Similarity=0.479  Sum_probs=221.6

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .+.|++.++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE  228 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  228 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence            35699999999999999999999999999999999654432 24568899999999999999999999999999999999


Q ss_pred             ccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCC
Q 016959          178 YMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV  254 (380)
Q Consensus       178 ~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (380)
                      ||.||+|.+++.   ..+..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+........+.+
T Consensus       229 y~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~  308 (423)
T 4fie_A          229 FLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV  308 (423)
T ss_dssp             CCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCE
T ss_pred             CCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccc
Confidence            999999976653   36788999999999999999999999999999999999999999999999998876656667889


Q ss_pred             CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC--CCCCccccHHHHHH
Q 016959          255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP--PEAPEMASREFRDF  332 (380)
Q Consensus       255 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l  332 (380)
                      ||+.|||||++..     ..|+.++||||||||+|||++|+.||...   .....+..+.....  ...+..+++++++|
T Consensus       309 GTp~YmAPEvl~~-----~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl  380 (423)
T 4fie_A          309 GTPYWMAPELISR-----LPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIRDNLPPRLKNLHKVSPSLKGF  380 (423)
T ss_dssp             ECTTTCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSCCCCCSCTTSSCHHHHHH
T ss_pred             cCcCcCCHHHHCC-----CCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCCCCCCcccccCCHHHHHH
Confidence            9999999999853     55688999999999999999999999743   33444444444433  33456789999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          333 ISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       333 i~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      |.+||+.||++|+|++|+|+||||++..
T Consensus       381 i~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          381 LDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            9999999999999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.9e-66  Score=480.26  Aligned_cols=254  Identities=31%  Similarity=0.479  Sum_probs=221.2

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .+.|++.++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            35699999999999999999999999999999999654322 23567899999999999999999999999999999999


Q ss_pred             ccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCC
Q 016959          178 YMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV  254 (380)
Q Consensus       178 ~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (380)
                      ||+||+|.+++.   ..+..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+........+.+
T Consensus       152 y~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~  231 (346)
T 4fih_A          152 FLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV  231 (346)
T ss_dssp             CCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred             CCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccc
Confidence            999999976643   46788999999999999999999999999999999999999999999999998876666667889


Q ss_pred             CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC--CCCCccccHHHHHH
Q 016959          255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP--PEAPEMASREFRDF  332 (380)
Q Consensus       255 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l  332 (380)
                      ||+.|||||++..     ..|+.++||||||||||||++|+.||...   +....+..+.....  ...+..+++++++|
T Consensus       232 GTp~YmAPEvl~~-----~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~~~~~~~~~~~s~~~~dl  303 (346)
T 4fih_A          232 GTPYWMAPELISR-----LPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIRDNLPPRLKNLHKVSPSLKGF  303 (346)
T ss_dssp             SCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSSCCCCSCGGGSCHHHHHH
T ss_pred             cCcCcCCHHHHCC-----CCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence            9999999999853     55688999999999999999999999743   33444444444333  34456789999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          333 ISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       333 i~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      |.+||+.||++|||++|+|+||||++..
T Consensus       304 i~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          304 LDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999999999764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.2e-66  Score=483.30  Aligned_cols=254  Identities=28%  Similarity=0.495  Sum_probs=218.8

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      .++|+++++||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|++|+|||||+++++|++++.+||||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            478999999999999999999999999999999996543 4455678999999999999999999999999999999999


Q ss_pred             eccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          177 EYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       177 e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      |||.||+|.+++.      ..+..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.......
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  182 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA  182 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence            9999999977653      2567788999999999999999999999999999999999999999999998776543334


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR  330 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (380)
                      .+.+||+.|||||++.     +..|+.++||||||||||||++|+.||..   .+....+..+.....+..+..++.+++
T Consensus       183 ~~~~GT~~YmAPE~l~-----~~~y~~~~DiwSlGvilyemltG~~PF~~---~~~~~~~~~i~~~~~~~~~~~~s~~~~  254 (350)
T 4b9d_A          183 RACIGTPYYLSPEICE-----NKPYNNKSDIWALGCVLYELCTLKHAFEA---GSMKNLVLKIISGSFPPVSLHYSYDLR  254 (350)
T ss_dssp             HHHHSCCTTCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHHTCCCCCCTTSCHHHH
T ss_pred             cccCCCccccCHHHHC-----CCCCCcHHHHHHHHHHHHHHHHCCCCCCC---cCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence            5678999999999985     35678899999999999999999999973   344555666666666677888999999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      +||.+||+.||++|||++|+|+||||++.
T Consensus       255 ~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          255 SLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            99999999999999999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.4e-64  Score=457.43  Aligned_cols=250  Identities=32%  Similarity=0.479  Sum_probs=200.6

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++|++.+.||+|+||+||+|++..+|+.||||++.+..  .......+.+|+.+|+.++|||||+++++|++.+.+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            58999999999999999999999999999999996543  2334567899999999999999999999999999999999


Q ss_pred             eccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          177 EYMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       177 e~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      ||| +|+|.+.+    ..++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+..... ....+
T Consensus        93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~  170 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKT  170 (275)
T ss_dssp             ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred             eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-CccCC
Confidence            999 56775543    3467889999999999999999999999999999999999999999999999876543 33456


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      .+||+.|||||++.+    ..+++.++|||||||++|+|++|+.||...   ........+. ......+..+++++++|
T Consensus       171 ~~GT~~Y~APE~~~~----~~y~~~~~DiwSlGvily~lltg~~PF~~~---~~~~~~~~i~-~~~~~~p~~~s~~~~~l  242 (275)
T 3hyh_A          171 SCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYVMLCRRLPFDDE---SIPVLFKNIS-NGVYTLPKFLSPGAAGL  242 (275)
T ss_dssp             ----CTTSCHHHHSS----SSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHH-HTCCCCCTTSCHHHHHH
T ss_pred             eeECcccCChhhhcC----CCCCCChhhhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHH-cCCCCCCCCCCHHHHHH
Confidence            789999999999864    245678999999999999999999999632   3333333333 33456678899999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccccc
Q 016959          333 ISRCLQKDPHSRWPAAQLLQHPFILR  358 (380)
Q Consensus       333 i~~~l~~dp~~R~t~~eil~hp~~~~  358 (380)
                      |.+||+.||++|||++|+|+||||+.
T Consensus       243 i~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          243 IKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHHccCChhHCcCHHHHHcCccccc
Confidence            99999999999999999999999974

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.3e-63  Score=452.31  Aligned_cols=248  Identities=27%  Similarity=0.470  Sum_probs=208.4

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEee----CCeEEEE
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDR----NGEIEVL  175 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv  175 (380)
                      |++.++||+|+||+||+|.+..+++.||||++.... .....+.+.+|+.+|++|+|||||+++++|++    .+.+|+|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            367788999999999999999999999999996543 34456789999999999999999999999865    3568999


Q ss_pred             EeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEc-CCCcEEEeeccccccccccCC
Q 016959          176 LEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRK--IVHRDIKPSNLLIN-SSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       176 ~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ||||.||+|.+++.    .++..+..++.||+.||+|||++|  |+||||||+||||+ .+|.+||+|||+|+....  .
T Consensus       108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--~  185 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--S  185 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--T
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--C
Confidence            99999999987654    367788899999999999999998  99999999999998 478999999999986543  2


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC-CCCCCccccH
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ-PPEAPEMASR  327 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  327 (380)
                      ...+.+||+.|||||++.+      .++.++|||||||+||||+||+.||...  .........+.... +...+..+++
T Consensus       186 ~~~~~~GTp~YmAPE~~~~------~y~~~~DiwSlGvilyelltg~~Pf~~~--~~~~~~~~~i~~~~~~~~~~~~~~~  257 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYEE------KYDESVDVYAFGMCMLEMATSEYPYSEC--QNAAQIYRRVTSGVKPASFDKVAIP  257 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT------CCCTHHHHHHHHHHHHHHHHSSCTTTTC--SSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             ccCCcccCccccCHHHcCC------CCCcHHHHHHHHHHHHHHHHCCCCCCCC--CcHHHHHHHHHcCCCCCCCCccCCH
Confidence            3457789999999998842      3678999999999999999999999632  23334444443333 2345566789


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILR  358 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~eil~hp~~~~  358 (380)
                      ++++||.+||+.||++|||++|+|+||||++
T Consensus       258 ~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            9999999999999999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.7e-62  Score=451.64  Aligned_cols=251  Identities=25%  Similarity=0.300  Sum_probs=210.5

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ..+.|++.++||+|+||+||+|+++.+|+.||||+++....      ..+|+.+|+.++|||||+++++|.+++.+||||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm  129 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM  129 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            44678999999999999999999999999999999965432      236999999999999999999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-cEEEeeccccccccccCC---
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMD---  248 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~---  248 (380)
                      |||+||+|.+++.    .++..++.++.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+.....   
T Consensus       130 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~  209 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS  209 (336)
T ss_dssp             CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred             eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence            9999999987654    36788999999999999999999999999999999999887 599999999987653221   


Q ss_pred             --CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcccc
Q 016959          249 --PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS  326 (380)
Q Consensus       249 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (380)
                        .....+||+.|||||++.     +..++.++||||||||||||++|+.||...........+.... ......+..++
T Consensus       210 ~~~~~~~~GT~~YmAPE~~~-----~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~s  283 (336)
T 4g3f_A          210 LLTGDYIPGTETHMAPEVVM-----GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP-PPIREIPPSCA  283 (336)
T ss_dssp             ----CCCCCCGGGCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC-CGGGGSCTTSC
T ss_pred             eecCCccccCccccCHHHHC-----CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC-CCchhcCccCC
Confidence              123468999999999985     3567889999999999999999999998655555443332211 11124667899


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHH-------------hcCcccccc
Q 016959          327 REFRDFISRCLQKDPHSRWPAAQL-------------LQHPFILRA  359 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t~~ei-------------l~hp~~~~~  359 (380)
                      +++.+||.+||+.||++|||+.|+             |+|||+...
T Consensus       284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            999999999999999999999997             579998775

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=6.3e-62  Score=447.28  Aligned_cols=254  Identities=22%  Similarity=0.354  Sum_probs=200.7

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC--------
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG--------  170 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------  170 (380)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.....+...+.+.+|+.+|++|+|||||+++++|.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            579999999999999999999999999999999976666666778999999999999999999999987544        


Q ss_pred             ----eEEEEEeccCCCCccccccc-------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccc
Q 016959          171 ----EIEVLLEYMDGGSLEGAHIR-------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGV  239 (380)
Q Consensus       171 ----~~~lv~e~~~~~~L~~~~~~-------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  239 (380)
                          .+|+|||||.||+|.+++..       .+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl  164 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL  164 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence                37999999999999776543       2345778999999999999999999999999999999999999999999


Q ss_pred             cccccccCC------------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHH
Q 016959          240 SRILAQTMD------------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWA  307 (380)
Q Consensus       240 a~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~  307 (380)
                      |+.+.....            ...+.+||+.|||||++.     +..++.++||||||||+|||++   ||..  ..+..
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~-----~~~y~~~~DiwSlGvilyell~---Pf~~--~~~~~  234 (299)
T 4g31_A          165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH-----GNSYSHKVDIFSLGLILFELLY---PFST--QMERV  234 (299)
T ss_dssp             C--------------------------CCCTTSCHHHHT-----TCCCCTHHHHHHHHHHHHHHHS---CCSS--HHHHH
T ss_pred             ceecCCCccccccccccccccccCCcccCccccCHHHHc-----CCCCCCHHHHHHHHHHHHHHcc---CCCC--ccHHH
Confidence            987654321            124568999999999985     3567889999999999999996   7742  11222


Q ss_pred             HHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          308 SLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      ..+........+..+...++++.+||.+||+.||++|||+.|+|+||||+++++-
T Consensus       235 ~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p  289 (299)
T 4g31_A          235 RTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP  289 (299)
T ss_dssp             HHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred             HHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence            3333343333334445567788999999999999999999999999999998763

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.8e-61  Score=478.94  Aligned_cols=276  Identities=23%  Similarity=0.386  Sum_probs=231.6

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-----chHHHHHHHHHHHHHHhCCCCceeeeEeEEe
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-----EDSVRSQICREIEILRDVNHPNVVKCHDMYD  167 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  167 (380)
                      ...++.++|+++++||+|+||+||+|+++.+|+.||||++.+..     .........+++.+++.++|||||+++++|.
T Consensus       183 ~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~  262 (689)
T 3v5w_A          183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH  262 (689)
T ss_dssp             TCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             CCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence            34578899999999999999999999999999999999995432     1222223334566777889999999999999


Q ss_pred             eCCeEEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          168 RNGEIEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       168 ~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                      +.+.+|||||||.||+|..++.    ..+..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence            9999999999999999976654    467889999999999999999999999999999999999999999999999877


Q ss_pred             cccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      ...  ...+.+||+.|||||++..    +..|+.++||||||||||||++|..||......+..... ..........+.
T Consensus       343 ~~~--~~~t~~GTp~YmAPEvl~~----~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~-~~i~~~~~~~p~  415 (689)
T 3v5w_A          343 SKK--KPHASVGTHGYMAPEVLQK----GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELPD  415 (689)
T ss_dssp             SSC--CCCSCCSCGGGCCHHHHST----TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH-HHHHHCCCCCCT
T ss_pred             CCC--CCCCccCCcCccCHHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HhhcCCCCCCCc
Confidence            543  3467899999999999853    356788999999999999999999999755444544433 333445667788


Q ss_pred             cccHHHHHHHHHhcccCcCCCCC-----HHHHhcCccccccCcccccccccccCCCCCC
Q 016959          324 MASREFRDFISRCLQKDPHSRWP-----AAQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      .+++++++||.+||+.||++|++     ++||++||||++++|..+..  +++.||++|
T Consensus       416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~--~~~~pP~~P  472 (689)
T 3v5w_A          416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFL--QKYPPPLIP  472 (689)
T ss_dssp             TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHT--TCSCCSCCC
T ss_pred             cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHc--CCCCcCccC
Confidence            89999999999999999999998     79999999999999988754  444455444

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-60  Score=455.23  Aligned_cols=257  Identities=28%  Similarity=0.368  Sum_probs=211.7

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEee------CCe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDR------NGE  171 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~  171 (380)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|+.|+|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999999999999999996543 33445678899999999999999999998753      467


Q ss_pred             EEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc-
Q 016959          172 IEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT-  246 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  246 (380)
                      +|||||||.| +|..++.    ..+..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+... 
T Consensus       134 ~~ivmE~~~g-~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~  212 (398)
T 4b99_A          134 VYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP  212 (398)
T ss_dssp             EEEEEECCSE-EHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred             EEEEEeCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence            9999999975 5655443    467889999999999999999999999999999999999999999999999876432 


Q ss_pred             ---CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC---
Q 016959          247 ---MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE---  320 (380)
Q Consensus       247 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  320 (380)
                         .....+.+||+.|||||++.+    ..+++.++||||||||+|||++|+.||...+..+....+..........   
T Consensus       213 ~~~~~~~~~~~GT~~Y~APEv~~~----~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          213 AEHQYFMTEYVATRWYRAPELMLS----LHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             ---CCCCCSSCCCCTTCCHHHHTT----CSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             cccccccccceeChHhcCHHHhcC----CCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence               223457899999999999853    2567889999999999999999999997554444444443333222111   


Q ss_pred             ------------------------CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          321 ------------------------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       321 ------------------------~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                                              ....++.+++|||.+||+.||++|+|++|+|+||||++..
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence                                    1124688999999999999999999999999999999864

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.1e-60  Score=440.44  Aligned_cols=250  Identities=25%  Similarity=0.374  Sum_probs=207.9

Q ss_pred             cCCCcccccccceecccCCceEEEEEeC-----CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHP-----PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR  168 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  168 (380)
                      ..+..++|.+.++||+|+||+||+|++.     .+++.||||+++... ....+.|.+|+++|++++|||||+++|+|.+
T Consensus        36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~  114 (329)
T 4aoj_A           36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTE  114 (329)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            4477889999999999999999999864     368899999997543 4456789999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCcccccc-------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q 016959          169 NGEIEVLLEYMDGGSLEGAHI-------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS  229 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~~-------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~  229 (380)
                      .+.+++|||||.+|+|.+++.                   ..+..+..|+.||+.||+|||+++||||||||+||||+.+
T Consensus       115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence            999999999999999977643                   3456788999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccccC--CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCH
Q 016959          230 KNVKIADFGVSRILAQTM--DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDW  306 (380)
Q Consensus       230 ~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~  306 (380)
                      +.+||+|||+|+.+....  ......+||+.|||||++.     +..++.++|||||||+||||+| |+.||...   ..
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~-----~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~---~~  266 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL-----YRKFTTESDVWSFGVVLWEIFTYGKQPWYQL---SN  266 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS---CH
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhc-----CCCCCccccccchHHHHHHHHcCCCCCCCCC---CH
Confidence            999999999998764332  2234567999999999985     3567889999999999999998 99999743   34


Q ss_pred             HHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          307 ASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .+.+..+......+.|..+++++.+||.+||+.||++|||+.||++
T Consensus       267 ~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~  312 (329)
T 4aoj_A          267 TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA  312 (329)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            4555556666677888899999999999999999999999999987

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2e-60  Score=436.79  Aligned_cols=255  Identities=25%  Similarity=0.400  Sum_probs=216.4

Q ss_pred             cCCCcccccccceecccCCceEEEEEeC-----CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHP-----PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR  168 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  168 (380)
                      ..|..++|.+.++||+|+||+||+|++.     .+++.||||+++... ....+.|.+|+++|++++|||||+++|+|.+
T Consensus         8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~   86 (299)
T 4asz_A            8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVE   86 (299)
T ss_dssp             CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            3477889999999999999999999875     357889999997543 4456789999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCcccccc-----------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc
Q 016959          169 NGEIEVLLEYMDGGSLEGAHI-----------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN  231 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~~-----------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~  231 (380)
                      .+.+++|||||++|+|.+++.                 .++..+..|+.||+.||+|||+++|+||||||+||||+.++.
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence            999999999999999987763                 356778999999999999999999999999999999999999


Q ss_pred             EEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHH
Q 016959          232 VKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWAS  308 (380)
Q Consensus       232 ~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~  308 (380)
                      +||+|||+|+.......  ......||+.|||||++..     ..++.++|||||||+||||+| |+.||...   ...+
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-----~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~---~~~~  238 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-----RKFTTESDVWSLGVVLWEIFTYGKQPWYQL---SNNE  238 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS---CHHH
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCC---CHHH
Confidence            99999999986644322  2234568999999999964     567889999999999999998 99999743   3445


Q ss_pred             HHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          309 LMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      .+..+........|..++.++.+||.+||+.||++|||+.|++  +|++.+
T Consensus       239 ~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~  287 (299)
T 4asz_A          239 VIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNL  287 (299)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHH
T ss_pred             HHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHH
Confidence            5566666677788889999999999999999999999999995  477654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.2e-60  Score=435.76  Aligned_cols=253  Identities=21%  Similarity=0.320  Sum_probs=216.4

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeC-----CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEe
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHP-----PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYD  167 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  167 (380)
                      ...++.+++++.++||+|+||+||+|.+.     .+++.||||+++........+.|.+|+.+|++++|||||+++|++.
T Consensus        20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            34577889999999999999999999864     3578999999976655555678999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCcccccc--------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc
Q 016959          168 RNGEIEVLLEYMDGGSLEGAHI--------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN  227 (380)
Q Consensus       168 ~~~~~~lv~e~~~~~~L~~~~~--------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~  227 (380)
                      +.+.+++|||||.+|+|.+++.                    ..+..+..|+.||+.||+|||+++||||||||+||||+
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence            9999999999999999977653                    24567889999999999999999999999999999999


Q ss_pred             CCCcEEEeeccccccccccC--CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 016959          228 SSKNVKIADFGVSRILAQTM--DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQG  304 (380)
Q Consensus       228 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~  304 (380)
                      +++++||+|||+|+.+....  ......+||+.|||||++..     ..++.++|||||||+||||+| |..||....  
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-----~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~--  252 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-----GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--  252 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCC--
Confidence            99999999999998764332  23455789999999999864     567889999999999999998 899997433  


Q ss_pred             CHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          305 DWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                       .......+......+.+..++.++.+||.+||+.||++|||+.||+++
T Consensus       253 -~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          253 -NQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             -HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -HHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             345555566666777888999999999999999999999999999873

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=7.8e-60  Score=433.13  Aligned_cols=254  Identities=24%  Similarity=0.410  Sum_probs=204.7

Q ss_pred             cccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           92 RHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      ..|.|+.++|.++++||+|+||+||+|++..   .||||+++... .....+.|.+|+.+|++++|||||++++++.+ +
T Consensus        29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~  104 (307)
T 3omv_A           29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D  104 (307)
T ss_dssp             CCCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred             cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence            3567889999999999999999999998743   58999986443 44556789999999999999999999998865 5


Q ss_pred             eEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      .++||||||+||+|.+++.     ..+..+..|+.||+.||+|||++|||||||||+||||+.++++||+|||+|+....
T Consensus       105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            6899999999999987653     35677889999999999999999999999999999999999999999999987653


Q ss_pred             cC--CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC----CC
Q 016959          246 TM--DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ----PP  319 (380)
Q Consensus       246 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----~~  319 (380)
                      ..  ......+||+.|||||++...  ....++.++|||||||+||||+||+.||......  ...........    ..
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~--~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~~~p~~~  260 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQ--DNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGYASPDLS  260 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCC--SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTCCCCCST
T ss_pred             CCcceeecccccCCCccCHHHhhcc--CCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCCCcc
Confidence            22  234567899999999998532  1234688999999999999999999999743332  22222222221    23


Q ss_pred             CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       320 ~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ..+..++.++.+||.+||+.||++|||+.||+++
T Consensus       261 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          261 KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            4566789999999999999999999999998764

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.9e-59  Score=437.69  Aligned_cols=255  Identities=24%  Similarity=0.372  Sum_probs=204.0

Q ss_pred             ccccccceecccCCceEEEEEeC---CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHP---PTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  174 (380)
                      ++|++.++||+|+||+||+|+++   .+++.||||++.....   ..++.+|+++|+.+ +|||||+++++|.+.+.+|+
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l   97 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI   97 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence            57999999999999999999864   4688999999865443   24577899999998 69999999999999999999


Q ss_pred             EEeccCCCCcccccc-cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CcEEEeeccccccccccC-----
Q 016959          175 LLEYMDGGSLEGAHI-RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS-KNVKIADFGVSRILAQTM-----  247 (380)
Q Consensus       175 v~e~~~~~~L~~~~~-~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~~-----  247 (380)
                      |||||+|++|.+.+. .++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+......     
T Consensus        98 vmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~  177 (361)
T 4f9c_A           98 AMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK  177 (361)
T ss_dssp             EEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGG
T ss_pred             EEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccc
Confidence            999999999977654 3678899999999999999999999999999999999876 799999999997553221     


Q ss_pred             -----------------------CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 016959          248 -----------------------DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG  304 (380)
Q Consensus       248 -----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~  304 (380)
                                             ....+.+||+.|||||++.+    ..+++.++||||+|||+|||++|+.||......
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~  253 (361)
T 4f9c_A          178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK----CPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD  253 (361)
T ss_dssp             GC--------------------------CCCCGGGCCHHHHTT----CSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred             cccccccccccccccccccccccccccccccCccccCHHHHcC----CCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence                                   11245689999999999853    245788999999999999999999999643321


Q ss_pred             -CHHHHHHHHh--------------------------------------------------hCCCCCCCccccHHHHHHH
Q 016959          305 -DWASLMFAIC--------------------------------------------------FAQPPEAPEMASREFRDFI  333 (380)
Q Consensus       305 -~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~~~~~li  333 (380)
                       +....+....                                                  .......+..++++++|||
T Consensus       254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl  333 (361)
T 4f9c_A          254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL  333 (361)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence             1111111100                                                  0001123456789999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCccccccC
Q 016959          334 SRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       334 ~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      .+||+.||++|+|++|+|+||||++++
T Consensus       334 ~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          334 DKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             HHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999999999999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.4e-58  Score=433.54  Aligned_cols=255  Identities=25%  Similarity=0.375  Sum_probs=217.1

Q ss_pred             cccCCCcccccccceecccCCceEEEEEeCCC-----CcEEEEEEecCCCchHHHHHHHHHHHHHHhCCC-CceeeeEeE
Q 016959           92 RHQLINPAELQKGNRIGSGSGGTVWRVVHPPT-----SRVFALKVIYGNHEDSVRSQICREIEILRDVNH-PNVVKCHDM  165 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~  165 (380)
                      ..|.|+.++|++++.||+|+||+||+|.+..+     ++.||||++.........+.+.+|+.+|++++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            34678899999999999999999999987644     468999999877666667889999999999975 899999999


Q ss_pred             Eee-CCeEEEEEeccCCCCcccccc--------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 016959          166 YDR-NGEIEVLLEYMDGGSLEGAHI--------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNL  224 (380)
Q Consensus       166 ~~~-~~~~~lv~e~~~~~~L~~~~~--------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Ni  224 (380)
                      |.+ ++.+++|||||.+|+|.+++.                    ..+..+..++.||+.||+|||+++||||||||+||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI  216 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  216 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence            865 457899999999999977654                    24567889999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 016959          225 LINSSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVG  301 (380)
Q Consensus       225 l~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~  301 (380)
                      |++.++.+||+|||+|+.+.....  .....+||+.|||||++..     ..++.++|||||||+||||+| |+.||...
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-----~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-----RVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-----CCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            999999999999999987654322  2345678999999999964     567889999999999999998 99999754


Q ss_pred             CCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          302 RQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ...  ......+.....+..+..+++++.+||.+||+.||++|||+.||++|
T Consensus       292 ~~~--~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          292 KID--EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             CCS--HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHH--HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            332  23344455566777888899999999999999999999999999987

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.6e-58  Score=460.42  Aligned_cols=259  Identities=28%  Similarity=0.470  Sum_probs=219.4

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .++|++++.||+|+||+||+|.++.+|+.||||++...... ..+.+.+|+.+|+.|+|||||+++++|.+.+.+|+|||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~-~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh-hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            36899999999999999999999999999999999765433 35678899999999999999999999999999999999


Q ss_pred             ccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC--CcEEEeeccccccccccCCCC
Q 016959          178 YMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS--KNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       178 ~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~--~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      ||.||+|.+++.     ..+..++.++.||+.||+|||++||+||||||+|||++.+  +.+||+|||+|+.+... ...
T Consensus       235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-~~~  313 (573)
T 3uto_A          235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSV  313 (573)
T ss_dssp             CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-SEE
T ss_pred             ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-Cce
Confidence            999999976543     3578899999999999999999999999999999999854  78999999999887543 334


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR  330 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (380)
                      ...+||+.|||||++.     +..++.++||||||||||||++|..||......+....+.......+...+..++.+++
T Consensus       314 ~~~~GT~~y~APEv~~-----~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  388 (573)
T 3uto_A          314 KVTTGTAEFAAPEVAE-----GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  388 (573)
T ss_dssp             EEECSSGGGCCHHHHT-----TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred             eeeEECccccCHHHhC-----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            5678999999999985     35678899999999999999999999974433322222222222333445567899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                      +||.+||+.||++|||+.|+|+||||+..++..
T Consensus       389 dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          389 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence            999999999999999999999999999876543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.4e-56  Score=414.96  Aligned_cols=271  Identities=28%  Similarity=0.453  Sum_probs=229.3

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      ++.++|++.+.||+|+||+||+|++..+|+.||||++.+..  .......+.+|+.+|+.++||||++++++|...+.+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            56789999999999999999999999999999999996432  1223456789999999999999999999999999999


Q ss_pred             EEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 016959          174 VLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  249 (380)
                      +||||+.|++|..++.    ..+..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++........
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            9999999999976543    357788899999999999999999999999999999999999999999999865444444


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      ....+||+.|+|||++..     ..++.++|||||||++|||++|..||...   +.......+. ......+..++.++
T Consensus       162 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~-~~~~~~p~~~s~~~  232 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELIL-MEEIRFPRTLSPEA  232 (337)
T ss_dssp             BCCCEECGGGCCGGGGSS-----SCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHH-HCCCCCCTTSCHHH
T ss_pred             ccccccChhhCChhhhcC-----CCCCchhhcccchhHHHHHhcCCCCCCCC---CHHHHHHHHH-cCCCCCCCCCCHHH
Confidence            567789999999999853     45678999999999999999999999643   2333333332 23455677889999


Q ss_pred             HHHHHHhcccCcCCCC-----CHHHHhcCccccccCcccccccccccCCCCCC
Q 016959          330 RDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~-----t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      .+||.+||+.||++|+     +++|+++||||+..++....+  +++.||++|
T Consensus       233 ~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~--~~~~pp~~p  283 (337)
T 1o6l_A          233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ--KKLLPPFKP  283 (337)
T ss_dssp             HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHT--TCSCCSCCC
T ss_pred             HHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHh--CCCCCCCCC
Confidence            9999999999999999     999999999999998887654  455666655

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.9e-56  Score=422.52  Aligned_cols=277  Identities=26%  Similarity=0.453  Sum_probs=231.1

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCC
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNG  170 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  170 (380)
                      ..+..++|++.++||+|+||+||+|+++.+++.||||++++..  .......+.+|..+++.+ +||||++++++|.+.+
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~  126 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES  126 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence            3467789999999999999999999999999999999996543  223345677899999877 8999999999999999


Q ss_pred             eEEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      .+|+||||+.||+|..++.    ..+..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            9999999999999866543    367788999999999999999999999999999999999999999999999865444


Q ss_pred             CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-----CHHHHHHHHhhCCCCCC
Q 016959          247 MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG-----DWASLMFAICFAQPPEA  321 (380)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~  321 (380)
                      .......+||+.|+|||++..     ..++.++|||||||++|||++|+.||......     .....+...........
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l~~-----~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~  281 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI  281 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC
T ss_pred             CCccccccCCcccCCchhhcC-----CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC
Confidence            455677889999999999853     55678999999999999999999999633211     12233334444556677


Q ss_pred             CccccHHHHHHHHHhcccCcCCCCCH------HHHhcCccccccCcccccccccccCCCCCC
Q 016959          322 PEMASREFRDFISRCLQKDPHSRWPA------AQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R~t~------~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      +..++.++++||.+||+.||++|+++      +|+++||||++++|....+  +++.||++|
T Consensus       282 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~--~~~~pp~~p  341 (396)
T 4dc2_A          282 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQ--KQVVPPFKP  341 (396)
T ss_dssp             CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHT--TCSCCSCCC
T ss_pred             CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHc--CCCCCCCcC
Confidence            88899999999999999999999984      8999999999999887755  566677766

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.9e-56  Score=418.21  Aligned_cols=272  Identities=26%  Similarity=0.387  Sum_probs=221.5

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCe
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  171 (380)
                      .+..++|++.+.||+|+||+||+|+++.+++.||||++.+..  .....+.+.+|..+++.+ +||||++++++|.+.+.
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            366789999999999999999999999999999999996532  223346678899999988 69999999999999999


Q ss_pred             EEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          172 IEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      +|+|||||.|++|..++.    ..+..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++......
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            999999999999976553    3677889999999999999999999999999999999999999999999998655444


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                      ......+||+.|+|||++..     ..++.++|||||||++|||++|..||....   .......+. ......+..++.
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i~-~~~~~~p~~~~~  249 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQE-----MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAIL-NDEVVYPTWLHE  249 (353)
T ss_dssp             -------CCGGGCCHHHHHH-----HHCTTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH-HCCCCCCTTSCH
T ss_pred             ccccccCCCcCeEChhhcCC-----CCcCCccCCCcchHHHHHHHhCCCCCCCCC---HHHHHHHHH-cCCCCCCCCCCH
Confidence            45567789999999999864     456789999999999999999999997433   233333333 234556677899


Q ss_pred             HHHHHHHHhcccCcCCCCCH------HHHhcCccccccCcccccccccccCCCCCC
Q 016959          328 EFRDFISRCLQKDPHSRWPA------AQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~------~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      ++.+||.+||+.||++|+++      +|+++||||++++|.....  +++.||++|
T Consensus       250 ~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~--~~~~~p~~p  303 (353)
T 3txo_A          250 DATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNH--RQIEPPFRP  303 (353)
T ss_dssp             HHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHT--TCSCCSCCC
T ss_pred             HHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhc--CcCCCCccC
Confidence            99999999999999999998      8999999999998887644  455555555

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.3e-54  Score=408.01  Aligned_cols=276  Identities=26%  Similarity=0.455  Sum_probs=230.0

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCe
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  171 (380)
                      .+..++|++.+.||+|+||+||+|+++.+++.||||++.+..  .......+.+|+.+++.+ +||||++++++|.+.+.
T Consensus         5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   84 (345)
T 3a8x_A            5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR   84 (345)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence            356789999999999999999999999999999999997543  344566788999999988 89999999999999999


Q ss_pred             EEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          172 IEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      +|+||||+.+++|..++.    ..+..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++......
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            999999999999976543    3577889999999999999999999999999999999999999999999998654444


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-----CHHHHHHHHhhCCCCCCC
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG-----DWASLMFAICFAQPPEAP  322 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~  322 (380)
                      ......+||+.|+|||++..     ..++.++|||||||++|||++|..||......     .....+...........+
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p  239 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRG-----EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP  239 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC
T ss_pred             CcccccCCCccccCccccCC-----CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC
Confidence            44567789999999999853     45678999999999999999999999642111     112222333333455677


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCH------HHHhcCccccccCcccccccccccCCCCCC
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPA------AQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~------~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      ..++.++.+||.+||+.||++|+++      .|+++||||++.+|....+  ++..||++|
T Consensus       240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~--~~~~~p~~p  298 (345)
T 3a8x_A          240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQ--KQVVPPFKP  298 (345)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHT--TCSCCSCCC
T ss_pred             CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHh--CCCCCCcCC
Confidence            7899999999999999999999995      8999999999998876644  455566555

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.4e-54  Score=410.86  Aligned_cols=279  Identities=24%  Similarity=0.445  Sum_probs=236.0

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      ...+..++|++.+.||+|+||+||+|.+..+++.||+|++....  .......+.+|+.+|+.++||||++++++|.+.+
T Consensus         9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   88 (384)
T 4fr4_A            9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE   88 (384)
T ss_dssp             CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            34577889999999999999999999999999999999985432  1223467889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      .+|+||||+.|++|..++.    ..+..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++..+...
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            9999999999999876553    467788999999999999999999999999999999999999999999999876543


Q ss_pred             CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcccc
Q 016959          247 MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS  326 (380)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (380)
                       ......+||+.|+|||++...  .+..++.++|||||||++|+|++|..||................ ......+..++
T Consensus       169 -~~~~~~~gt~~Y~aPE~~~~~--~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~p~~~s  244 (384)
T 4fr4_A          169 -TQITTMAGTKPYMAPEMFSSR--KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE-TTVVTYPSAWS  244 (384)
T ss_dssp             -CCBCCCCSCGGGCCGGGTCCC--SSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH-HCCCCCCTTSC
T ss_pred             -CceeccCCCccccCCeeeccC--CCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-hcccCCCCcCC
Confidence             334677899999999998531  23456789999999999999999999997655555544444433 34556677889


Q ss_pred             HHHHHHHHHhcccCcCCCCC-HHHHhcCccccccCcccccccccccCCCCCC
Q 016959          327 REFRDFISRCLQKDPHSRWP-AAQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t-~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      .++.+||.+||+.||++||+ ++++++||||.+.+|....+  +++.||+.|
T Consensus       245 ~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~--~~~~p~~~p  294 (384)
T 4fr4_A          245 QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQ--KRLIPGFIP  294 (384)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHT--TCSCCCCCC
T ss_pred             HHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHh--CCCCCCCCC
Confidence            99999999999999999998 99999999999999887755  556666655

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.2e-55  Score=410.36  Aligned_cols=272  Identities=25%  Similarity=0.411  Sum_probs=224.6

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCe
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  171 (380)
                      .+..++|.+.+.||+|+||+||+|+++.+++.||||++.+..  .......+..|..+++.+ +||||++++++|.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            356789999999999999999999999999999999996432  122345677899998877 89999999999999999


Q ss_pred             EEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          172 IEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      +|+||||+.||+|..++.    ..+..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence            999999999999976654    3677888999999999999999999999999999999999999999999998654444


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                      ......+||+.|+|||++.+     ..++.++|||||||++|||++|..||...   +.......+.. .....+..++.
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~-~~~~~p~~~s~  243 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLG-----QKYNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEELFHSIRM-DNPFYPRWLEK  243 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH-CCCCCCTTSCH
T ss_pred             CcccCCCCCcccCChhhhcC-----CCCCChhhhHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHHh-CCCCCCcccCH
Confidence            44567889999999999853     45678999999999999999999999643   33333333333 34556777899


Q ss_pred             HHHHHHHHhcccCcCCCCCHH-HHhcCccccccCcccccccccccCCCCCC
Q 016959          328 EFRDFISRCLQKDPHSRWPAA-QLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~-eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      ++.+||.+||+.||++||++. |+++||||+..+|.....  +++.||++|
T Consensus       244 ~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l~~--~~~~~p~~p  292 (345)
T 1xjd_A          244 EAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELER--KEIDPPFRP  292 (345)
T ss_dssp             HHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHHHT--TCSCC----
T ss_pred             HHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHHhh--CCCCCCcCC
Confidence            999999999999999999998 999999999999877644  445555544

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2e-54  Score=410.50  Aligned_cols=271  Identities=27%  Similarity=0.410  Sum_probs=219.6

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHH-HHhCCCCceeeeEeEEeeCCeE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEI-LRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      +..++|++.+.||+|+||+||+|+++.+++.||||++.+..  .......+.+|..+ ++.++||||++++++|.+.+.+
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~  114 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL  114 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence            55689999999999999999999999999999999996543  22334456677766 5678999999999999999999


Q ss_pred             EEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          173 EVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      |+||||+.|++|..++.    ..+..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus       115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~  194 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS  194 (373)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence            99999999999976654    35677888999999999999999999999999999999999999999999987554444


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHH
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE  328 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (380)
                      .....+||+.|+|||++..     ..++.++|||||||++|||++|..||...   +.......+. ......+..++.+
T Consensus       195 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~-~~~~~~~~~~~~~  265 (373)
T 2r5t_A          195 TTSTFCGTPEYLAPEVLHK-----QPYDRTVDWWCLGAVLYEMLYGLPPFYSR---NTAEMYDNIL-NKPLQLKPNITNS  265 (373)
T ss_dssp             CCCSBSCCCCCCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSCTTCCS---BHHHHHHHHH-HSCCCCCSSSCHH
T ss_pred             ccccccCCccccCHHHhCC-----CCCCchhhhHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHH-hcccCCCCCCCHH
Confidence            5567889999999999853     55678999999999999999999999643   2333333333 2345566778999


Q ss_pred             HHHHHHHhcccCcCCCCCH----HHHhcCccccccCcccccccccccCCCCCC
Q 016959          329 FRDFISRCLQKDPHSRWPA----AQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~----~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      +++||.+||+.||++|+++    .|+++||||+..+|.....  +++.||++|
T Consensus       266 ~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~--~~~~pp~~p  316 (373)
T 2r5t_A          266 ARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLIN--KKITPPFNP  316 (373)
T ss_dssp             HHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHT--TCSCCSCCC
T ss_pred             HHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHh--CCCCCCCCC
Confidence            9999999999999999986    6999999999999887754  455566555

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.2e-55  Score=419.58  Aligned_cols=282  Identities=26%  Similarity=0.359  Sum_probs=227.4

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      ...+..++|++.++||+|+||+||+|++..+++.||+|++.+...  ......+.+|+.+++.++||||++++++|.+.+
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            345778899999999999999999999999999999999854211  111234778999999999999999999999999


Q ss_pred             eEEEEEeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          171 EIEVLLEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      .+|+|||||.||+|..++.   ..+..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.+....
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  222 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence            9999999999999976653   3577788999999999999999999999999999999999999999999998765432


Q ss_pred             -CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcccc
Q 016959          248 -DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS  326 (380)
Q Consensus       248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (380)
                       ....+.+||+.|+|||++.... ...+++.++|||||||++|||++|+.||......+....+.........+....++
T Consensus       223 ~~~~~~~~gt~~Y~APE~l~~~~-~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s  301 (410)
T 3v8s_A          223 MVRCDTAVGTPDYISPEVLKSQG-GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  301 (410)
T ss_dssp             EEECCSCCSCGGGCCHHHHHTTT-TTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred             cccccCCcCCccccCHHHhhccC-CCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence             1235678999999999996421 11236779999999999999999999997443333323322222222333345689


Q ss_pred             HHHHHHHHHhcccCcCC--CCCHHHHhcCccccccCcccccccccccCCCCCC
Q 016959          327 REFRDFISRCLQKDPHS--RWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~--R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      .++++||.+||+.+|++  |++++||++||||++.+|.....  ++..||++|
T Consensus       302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~--~~~~~p~~p  352 (410)
T 3v8s_A          302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETL--RDTVAPVVP  352 (410)
T ss_dssp             HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTG--GGSCCSCCC
T ss_pred             HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhh--cccCCCCCC
Confidence            99999999999999988  99999999999999998776543  455566555

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.4e-54  Score=408.65  Aligned_cols=273  Identities=24%  Similarity=0.347  Sum_probs=228.1

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCe
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  171 (380)
                      .+..++|++.+.||+|+||+||+|++..+++.||||++.+..  .....+.+.+|..+++.+ +||||++++++|.+.+.
T Consensus        16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            356789999999999999999999999999999999996432  122345678899999988 79999999999999999


Q ss_pred             EEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          172 IEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      +|+||||+.||+|..++.    ..+..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            999999999999976654    3677889999999999999999999999999999999999999999999998654444


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                      ......+||+.|+|||++..     ..++.++|||||||++|||++|..||...   +.......+.. .....+..++.
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~-~~~~~p~~~s~  246 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAY-----QPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIME-HNVAYPKSMSK  246 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTT-----CCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH-CCCCCCTTSCH
T ss_pred             cccccccCCccccChhhhcC-----CCcCCcccccchHHHHHHHHcCCCCCCCC---CHHHHHHHHHh-CCCCCCCCCCH
Confidence            44567889999999999853     45678999999999999999999999643   33333333332 34556778999


Q ss_pred             HHHHHHHHhcccCcCCCCC-----HHHHhcCccccccCcccccccccccCCCCCCC
Q 016959          328 EFRDFISRCLQKDPHSRWP-----AAQLLQHPFILRAGQSQVNQNLRQILPPPRPL  378 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  378 (380)
                      ++.+||.+||+.||++|++     ++|+++||||+.++|.....  +++.||++|-
T Consensus       247 ~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~--~~~~~p~~p~  300 (353)
T 2i0e_A          247 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER--KEIQPPYKPK  300 (353)
T ss_dssp             HHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHT--TCSCCSCCCC
T ss_pred             HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHh--CCCCCCcCCC
Confidence            9999999999999999994     79999999999999887754  5666666663

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-54  Score=400.65  Aligned_cols=259  Identities=24%  Similarity=0.390  Sum_probs=221.3

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      +..++|++.+.||+|+||+||+|++..+|+.||+|++.+...  ....+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            456899999999999999999999999999999999864321  123456788999999999999999999999999999


Q ss_pred             EEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 016959          174 VLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  249 (380)
                      +||||+.|++|..++.    ..+..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....   
T Consensus        83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---  159 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  159 (318)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence            9999999999976654    357778899999999999999999999999999999999999999999999876532   


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      ....+||+.|+|||++..     ..++.++|||||||++|||++|..||...   +.......+.. .....+..++.++
T Consensus       160 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~-~~~~~p~~~~~~~  230 (318)
T 1fot_A          160 TYTLCGTPDYIAPEVVST-----KPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILN-AELRFPPFFNEDV  230 (318)
T ss_dssp             BCCCCSCTTTCCHHHHTT-----CCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHH-CCCCCCTTSCHHH
T ss_pred             cccccCCccccCHhHhcC-----CCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHh-CCCCCCCCCCHHH
Confidence            356789999999999853     45678999999999999999999999643   22333333332 3345667889999


Q ss_pred             HHHHHHhcccCcCCCC-----CHHHHhcCccccccCcccccc
Q 016959          330 RDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQ  366 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~-----t~~eil~hp~~~~~~~~~~~~  366 (380)
                      .+||.+||+.||++|+     +++|+++||||++..+.....
T Consensus       231 ~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~  272 (318)
T 1fot_A          231 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLS  272 (318)
T ss_dssp             HHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHT
T ss_pred             HHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHh
Confidence            9999999999999999     999999999999998877643

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1e-53  Score=399.22  Aligned_cols=254  Identities=28%  Similarity=0.449  Sum_probs=217.7

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||+++++++...+.+|+||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            468999999999999999999999999999999996543 3445677889999999999999999999999999999999


Q ss_pred             eccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          177 EYMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       177 e~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      ||+.+++|.+++    ...+..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++...... .....
T Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~  172 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDA  172 (328)
T ss_dssp             CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-CGGGT
T ss_pred             ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-Ccccc
Confidence            999999987664    3467788999999999999999999999999999999999999999999999866543 33456


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      .+||+.|+|||++.+    ..+++.++|||||||++|+|++|..||....   .......+. ......+..++.++.+|
T Consensus       173 ~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~-~~~~~~p~~~s~~~~~l  244 (328)
T 3fe3_A          173 FCGAPPYAAPELFQG----KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN---LKELRERVL-RGKYRIPFYMSTDCENL  244 (328)
T ss_dssp             TSSSGGGCCHHHHHT----CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH-HCCCCCCTTSCHHHHHH
T ss_pred             ccCCcceeCcccccC----CCcCCchhhhhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHH-hCCCCCCCCCCHHHHHH
Confidence            789999999999864    3445679999999999999999999997433   333333332 23345666789999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          333 ISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       333 i~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      |.+||+.||++|||++|+|+||||+...
T Consensus       245 i~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          245 LKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999999998754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.4e-54  Score=398.38  Aligned_cols=250  Identities=24%  Similarity=0.312  Sum_probs=190.7

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC----eEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG----EIEV  174 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~l  174 (380)
                      .+|.+.++||+|+||+||+|++  +|+.||||++......  ......|+..+..++|||||++++++.+.+    .+|+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            4688899999999999999998  6899999999544322  223345666677889999999999987654    5899


Q ss_pred             EEeccCCCCccccccc---chHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          175 LLEYMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKR--------KIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       175 v~e~~~~~~L~~~~~~---~~~~~~~i~~qi~~al~~LH~~--------~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                      |||||++|+|.+++..   .+..+..++.|++.||+|||++        +|+||||||+||||+.++++||+|||+|+..
T Consensus        79 V~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             EEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             EecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            9999999999877654   5677889999999999999987        9999999999999999999999999999876


Q ss_pred             cccCC----CCCCCCCCCccccccccccccCC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------------CCH
Q 016959          244 AQTMD----PCNSAVGTIAYMSPERINTDLNH-GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ------------GDW  306 (380)
Q Consensus       244 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------------~~~  306 (380)
                      .....    .....+||+.|||||++.+.... ...++.++|||||||+||||+||..||.....            ...
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            54322    22346799999999999643211 12356789999999999999999876642211            122


Q ss_pred             HHHHHHHh-hCCCCCCCcc-----ccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          307 ASLMFAIC-FAQPPEAPEM-----ASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       307 ~~~~~~~~-~~~~~~~~~~-----~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ........ ...++..+..     +...+.+||.+||+.||++|||+.||++
T Consensus       239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            22222222 2233444432     3457899999999999999999999987

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.4e-53  Score=398.33  Aligned_cols=274  Identities=27%  Similarity=0.438  Sum_probs=216.9

Q ss_pred             cCCCcccccccceecccCCceEEEEEeC---CCCcEEEEEEecCCC---chHHHHHHHHHHHHHHhCCCCceeeeEeEEe
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHP---PTSRVFALKVIYGNH---EDSVRSQICREIEILRDVNHPNVVKCHDMYD  167 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~---~~~~~~avK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  167 (380)
                      ..+..++|++.+.||+|+||+||+|++.   .+++.||+|++....   .......+.+|+.+|+.++||||+++++++.
T Consensus        12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            3467789999999999999999999985   689999999997543   2233456788999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          168 RNGEIEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       168 ~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                      ..+.+|+||||+.+++|..++.    ..+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            9999999999999999876654    356778899999999999999999999999999999999999999999999865


Q ss_pred             cccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      ..........+||+.|+|||++..     ..++.++|||||||++|+|++|..||....   .......+.. .....+.
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~-~~~~~p~  242 (327)
T 3a62_A          172 IHDGTVTHTFCGTIEYMAPEILMR-----SGHNRAVDWWSLGALMYDMLTGAPPFTGEN---RKKTIDKILK-CKLNLPP  242 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTT-----SCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHH-TCCCCCT
T ss_pred             ccCCccccccCCCcCccCHhhCcC-----CCCCCcccchhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHh-CCCCCCC
Confidence            444344456789999999999853     456789999999999999999999997433   2233333222 3345667


Q ss_pred             cccHHHHHHHHHhcccCcCCCC-----CHHHHhcCccccccCcccccccccccCCCCCCC
Q 016959          324 MASREFRDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRPL  378 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~-----t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  378 (380)
                      .++.++.+||.+||..||++||     ++.|+++||||+..++.....  ++..||++|.
T Consensus       243 ~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~--~~~~~p~~p~  300 (327)
T 3a62_A          243 YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLA--RKVEPPFKPL  300 (327)
T ss_dssp             TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHT--TCSCCSCCCC
T ss_pred             CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhh--ccCCCCCCCC
Confidence            7899999999999999999999     899999999999998876644  4555666654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.3e-53  Score=389.77  Aligned_cols=257  Identities=31%  Similarity=0.526  Sum_probs=219.1

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++....... .+.+.+|+.+++.++||||++++++|...+.+++||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   96 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence            3568999999999999999999999999999999986443322 456889999999999999999999999999999999


Q ss_pred             eccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          177 EYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       177 e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      ||+.+++|.+++.   ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............
T Consensus        97 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  176 (297)
T 3fxz_A           97 EYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  176 (297)
T ss_dssp             ECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred             ECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCc
Confidence            9999999977654   3577889999999999999999999999999999999999999999999998776555555667


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh--hCCCCCCCccccHHHHH
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC--FAQPPEAPEMASREFRD  331 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  331 (380)
                      .||+.|+|||++..     ..++.++|||||||++|+|++|..||.....   ........  .......+..++..+.+
T Consensus       177 ~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (297)
T 3fxz_A          177 VGTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGTPELQNPEKLSAIFRD  248 (297)
T ss_dssp             CSCGGGCCHHHHHC-----SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCSCCCSCGGGSCHHHHH
T ss_pred             cCCcCccChhhhcC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCCCCccccCHHHHH
Confidence            89999999999863     4567899999999999999999999964322   22222222  22234456778999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          332 FISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       332 li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      ||.+||+.||++|||+.|+|+||||+.....
T Consensus       249 li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  279 (297)
T 3fxz_A          249 FLNRCLEMDVEKRGSAKELLQHQFLKIAKPL  279 (297)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HHHHHccCChhHCcCHHHHhhChhhcccCcc
Confidence            9999999999999999999999999976443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.1e-53  Score=402.44  Aligned_cols=270  Identities=26%  Similarity=0.368  Sum_probs=227.1

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      .....++|++.+.||+|+||+||+|++..+|+.||||++.+..  .....+.+.+|+.+|+.++||||+++++++.+.+.
T Consensus        36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  115 (350)
T 1rdq_E           36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN  115 (350)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3466789999999999999999999999999999999985432  11234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          172 IEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      +|+||||+.|++|..++.    ..+..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... 
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            999999999999976654    367788999999999999999999999999999999999999999999999876533 


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                        ....+||+.|+|||++..     ..++.++|||||||++|||++|..||....   .......+.. .....+..++.
T Consensus       195 --~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~-~~~~~p~~~~~  263 (350)
T 1rdq_E          195 --TWTLCGTPEALAPEIILS-----KGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYEKIVS-GKVRFPSHFSS  263 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH-CCCCCCTTCCH
T ss_pred             --cccccCCccccCHHHhcC-----CCCCCcCCEecccHhHhHHhhCCCCCCCCC---HHHHHHHHHc-CCCCCCCCCCH
Confidence              346789999999999853     456789999999999999999999997432   3333333333 24556778899


Q ss_pred             HHHHHHHHhcccCcCCCCC-----HHHHhcCccccccCcccccccccccCCCCCC
Q 016959          328 EFRDFISRCLQKDPHSRWP-----AAQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      ++.+||.+||+.||++|++     ++|+++||||+..+|....+  ++..||+.|
T Consensus       264 ~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~--~~~~~p~~p  316 (350)
T 1rdq_E          264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQ--RKVEAPFIP  316 (350)
T ss_dssp             HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHT--TCSCCSCCC
T ss_pred             HHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhh--ccCCCCCCC
Confidence            9999999999999999998     99999999999998877643  334444443

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7e-54  Score=405.14  Aligned_cols=259  Identities=28%  Similarity=0.476  Sum_probs=216.1

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCch-----HHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED-----SVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .+.|++++.||+|+||+||+|.+..+|+.||+|++......     ...+.+.+|+.+|+.++||||++++++|.+.+.+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            35799999999999999999999999999999999654321     1346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----cEEEeecccccccc
Q 016959          173 EVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK----NVKIADFGVSRILA  244 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~----~~kl~Dfg~a~~~~  244 (380)
                      ++||||+.|++|.+++.    ..+..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||++..+.
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            99999999999977654    36788999999999999999999999999999999998777    79999999998765


Q ss_pred             ccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc
Q 016959          245 QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM  324 (380)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (380)
                      .. ......+||+.|+|||++..     ..++.++|||||||++|+|++|..||......+....+...........+..
T Consensus       171 ~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (361)
T 2yab_A          171 DG-VEFKNIFGTPEFVAPEIVNY-----EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ  244 (361)
T ss_dssp             TT-CCCCCCCSCGGGCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             CC-CccccCCCCccEECchHHcC-----CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccC
Confidence            43 23456789999999999853     4567899999999999999999999974332222222222222222233456


Q ss_pred             ccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          325 ASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      ++.++++||.+||..||++|||+.|+|+||||+...+.
T Consensus       245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~  282 (361)
T 2yab_A          245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQ  282 (361)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSHH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCchh
Confidence            88999999999999999999999999999999977653

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8.2e-54  Score=416.48  Aligned_cols=272  Identities=26%  Similarity=0.421  Sum_probs=219.0

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .+..++|++.+.||+|+||.||+|.+..+|+.||||++....  .......+.+|+.+++.++||||++++++|...+.+
T Consensus       144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~  223 (446)
T 4ejn_A          144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL  223 (446)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred             CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence            456789999999999999999999999999999999986431  223345677899999999999999999999999999


Q ss_pred             EEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          173 EVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHK-RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      ++||||+.+++|..++.    ..+..+..++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+++......
T Consensus       224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            99999999999866543    3577888999999999999998 999999999999999999999999999998655444


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                      ......+||+.|+|||++..     ..++.++|||||||++|||++|+.||....   .......+. ......+..++.
T Consensus       304 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~-~~~~~~p~~~~~  374 (446)
T 4ejn_A          304 ATMKTFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELIL-MEEIRFPRTLGP  374 (446)
T ss_dssp             ---CCSSSCGGGCCHHHHHT-----SCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH-HCCCCCCTTSCH
T ss_pred             cccccccCCccccCHhhcCC-----CCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHH-hCCCCCCccCCH
Confidence            44567889999999999853     556889999999999999999999996433   233333322 334556777899


Q ss_pred             HHHHHHHHhcccCcCCCC-----CHHHHhcCccccccCcccccccccccCCCCCC
Q 016959          328 EFRDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~-----t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      ++.+||.+||+.||++||     +++|+|+||||+++++.....  +++.||++|
T Consensus       375 ~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~--~~~~pp~~p  427 (446)
T 4ejn_A          375 EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYE--KKLSPPFKP  427 (446)
T ss_dssp             HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHT--TCSCCSCCC
T ss_pred             HHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhh--CcCCCCccC
Confidence            999999999999999999     999999999999998877654  556666665

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.5e-54  Score=416.29  Aligned_cols=283  Identities=22%  Similarity=0.323  Sum_probs=228.4

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      ...+..++|++.++||+|+||+||+|++..+++.||||++.+...  ......+.+|+.+++.++|+||++++++|.+.+
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  147 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN  147 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            345778899999999999999999999999999999999854221  111233788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      .+|+|||||.||+|..++..     .+..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.+..
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~  227 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  227 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence            99999999999999766543     5778889999999999999999999999999999999999999999999976654


Q ss_pred             cCC-CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH-hhCCCCCCCc
Q 016959          246 TMD-PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI-CFAQPPEAPE  323 (380)
Q Consensus       246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~  323 (380)
                      ... .....+||+.|+|||++......+..++.++|||||||++|||++|+.||......+....+... .....+....
T Consensus       228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  307 (437)
T 4aw2_A          228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT  307 (437)
T ss_dssp             TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred             CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence            322 23456899999999998532122345678999999999999999999999744333322222211 1222333445


Q ss_pred             cccHHHHHHHHHhcccCcCC--CCCHHHHhcCccccccCcccccccccccCCCC
Q 016959          324 MASREFRDFISRCLQKDPHS--RWPAAQLLQHPFILRAGQSQVNQNLRQILPPP  375 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~--R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~  375 (380)
                      .++.++++||.+||+.+|++  |++++|+++||||++++|..+.+..++++|..
T Consensus       308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~~~~~p~~P~~  361 (437)
T 4aw2_A          308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEV  361 (437)
T ss_dssp             CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGGGSCCSCCCCC
T ss_pred             cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHhhCCCCCCCcC
Confidence            68999999999999998888  99999999999999999998865555555543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.4e-53  Score=419.30  Aligned_cols=277  Identities=25%  Similarity=0.340  Sum_probs=230.9

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      ..+..++|.+.+.||+|+||+||+|+++.+|+.||||++.+...  ......+.+|+.+|+.++||||++++++|...+.
T Consensus       180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  259 (543)
T 3c4z_A          180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD  259 (543)
T ss_dssp             SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence            45778899999999999999999999999999999999954321  1224568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCccccc--------ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          172 IEVLLEYMDGGSLEGAH--------IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                      +|+||||+.|++|..++        ...+..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.+
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            99999999999986543        2456778899999999999999999999999999999999999999999999877


Q ss_pred             cccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      ..........+||+.|+|||++.+     ..++.++||||||||+|||++|..||...........+...........+.
T Consensus       340 ~~~~~~~~~~~GT~~Y~APE~l~~-----~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~  414 (543)
T 3c4z_A          340 KAGQTKTKGYAGTPGFMAPELLLG-----EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD  414 (543)
T ss_dssp             CTTCCCBCCCCSCTTTSCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT
T ss_pred             cCCCcccccccCCccccChhhhcC-----CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc
Confidence            655444456689999999999853     556789999999999999999999997554332223333333344556778


Q ss_pred             cccHHHHHHHHHhcccCcCCCCC-----HHHHhcCccccccCcccccccccccCCCCCC
Q 016959          324 MASREFRDFISRCLQKDPHSRWP-----AAQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t-----~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      .++.++.+||.+||+.||++||+     ++|+++||||+.++|.....  ++..||++|
T Consensus       415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~--~~~~pp~~P  471 (543)
T 3c4z_A          415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEA--GMLTPPFVP  471 (543)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHT--TCSCCSCCC
T ss_pred             ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHc--CCCCCCCCC
Confidence            89999999999999999999996     58999999999999877654  334444444

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.4e-53  Score=422.27  Aligned_cols=276  Identities=25%  Similarity=0.401  Sum_probs=232.0

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      ..+..++|++.+.||+|+||+||+|.+..+|+.||||++.+..  .......+.+|+.+|+.++||||++++++|.+.+.
T Consensus       179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  258 (576)
T 2acx_A          179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA  258 (576)
T ss_dssp             SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence            3477889999999999999999999999999999999985432  11224567899999999999999999999999999


Q ss_pred             EEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      +|+||||+.||+|..++.      ..+..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||++..+..
T Consensus       259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            999999999999965543      45778889999999999999999999999999999999999999999999987654


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                      . ......+||+.|+|||++..     ..++.++|||||||++|||++|..||...........+.......+..++..+
T Consensus       339 ~-~~~~~~~GT~~Y~APEvl~~-----~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~  412 (576)
T 2acx_A          339 G-QTIKGRVGTVGYMAPEVVKN-----ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERF  412 (576)
T ss_dssp             T-CCEECCCSCGGGCCHHHHTT-----CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             C-ccccccCCCccccCHHHHcC-----CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccC
Confidence            3 22345689999999999853     45678999999999999999999999865443333444444445566777889


Q ss_pred             cHHHHHHHHHhcccCcCCCC-----CHHHHhcCccccccCcccccccccccCCCCCC
Q 016959          326 SREFRDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~-----t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      +.++++||.+||+.||++|+     +++|+++||||++++|.....  ++..||++|
T Consensus       413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~--~~~~pp~~p  467 (576)
T 2acx_A          413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGA--GMLEPPFKP  467 (576)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHT--TCSCCSCCC
T ss_pred             CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhc--CCCCCCCCC
Confidence            99999999999999999999     899999999999999877654  344455444

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=8.8e-53  Score=390.18  Aligned_cols=258  Identities=29%  Similarity=0.452  Sum_probs=212.6

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      .++|++.++||+|+||+||+|.+. +++.||||++.... .......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            468999999999999999999995 58999999996543 2334567889999999999999999999999999999999


Q ss_pred             eccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCC
Q 016959          177 EYMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       177 e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      ||+.+ +|...+     ...+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~  177 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT  177 (311)
T ss_dssp             ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred             cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccccc
Confidence            99986 443332     245778889999999999999999999999999999999999999999999987765544455


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCC----------
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA----------  321 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------  321 (380)
                      ...||+.|+|||++.+    ...++.++|||||||++|+|++|+.||......+....+........+..          
T Consensus       178 ~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  253 (311)
T 3niz_A          178 HEVVTLWYRAPDVLMG----SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW  253 (311)
T ss_dssp             CCCCCCTTCCHHHHTT----CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred             CCcccCCcCCHHHhcC----CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence            6789999999999853    24567899999999999999999999987666666555555443322221          


Q ss_pred             ----------------CccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          322 ----------------PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       322 ----------------~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                                      ...+++++.+||.+||+.||++|||++|+|+||||++++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence                            1236789999999999999999999999999999998754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.6e-53  Score=409.13  Aligned_cols=257  Identities=28%  Similarity=0.415  Sum_probs=217.6

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            367999999999999999999999999999999997554 3344567899999999999999999999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc---CCCcEEEeeccccccccccCCC
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN---SSKNVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~---~~~~~kl~Dfg~a~~~~~~~~~  249 (380)
                      |||.|++|.+.+.    ..+..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.........
T Consensus        90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~  169 (444)
T 3soa_A           90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA  169 (444)
T ss_dssp             CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence            9999999865543    46778899999999999999999999999999999998   4678999999999877655455


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      ....+||+.|+|||++..     ..++.++|||||||++|+|++|..||...........+.......+...+..+++++
T Consensus       170 ~~~~~gt~~Y~APE~l~~-----~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  244 (444)
T 3soa_A          170 WFGFAGTPGYLSPEVLRK-----DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA  244 (444)
T ss_dssp             CCCSCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             eecccCCcccCCHHHhcC-----CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            566789999999999853     456789999999999999999999997544333333333333344455556789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      .+||.+||+.||++|||+.|+|+||||+..
T Consensus       245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          245 KDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            999999999999999999999999999764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-53  Score=408.17  Aligned_cols=281  Identities=24%  Similarity=0.335  Sum_probs=224.4

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      ...+..++|++.+.||+|+||+||+|+++.+|+.||||++.+..  .......+.+|+.++..++|+||++++++|.+.+
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  134 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN  134 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            34577899999999999999999999999999999999995432  1122345788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      .+|+||||+.||+|..++.     ..+..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++.+..
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~  214 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA  214 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence            9999999999999977653     35677889999999999999999999999999999999999999999999987654


Q ss_pred             cCC-CCCCCCCCCcccccccccccc--CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh-hCCCCCC
Q 016959          246 TMD-PCNSAVGTIAYMSPERINTDL--NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC-FAQPPEA  321 (380)
Q Consensus       246 ~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~  321 (380)
                      ... .....+||+.|+|||++....  ..+..++.++|||||||++|||++|+.||......+....+.... ....+..
T Consensus       215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  294 (412)
T 2vd5_A          215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV  294 (412)
T ss_dssp             TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred             CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence            322 234568999999999985311  012456789999999999999999999997443332222222211 1222334


Q ss_pred             CccccHHHHHHHHHhcccCcCCC---CCHHHHhcCccccccCcccccccccccCCC
Q 016959          322 PEMASREFRDFISRCLQKDPHSR---WPAAQLLQHPFILRAGQSQVNQNLRQILPP  374 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R---~t~~eil~hp~~~~~~~~~~~~~~~~~~~~  374 (380)
                      +..++.++++||.+||+ +|++|   ++++|+++||||++++|.......++++|.
T Consensus       295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~p~  349 (412)
T 2vd5_A          295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPD  349 (412)
T ss_dssp             --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCCCC
T ss_pred             ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCc
Confidence            46789999999999999 99998   499999999999999998886544444443

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.3e-53  Score=392.20  Aligned_cols=261  Identities=28%  Similarity=0.461  Sum_probs=201.0

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .++|++.+.||+|+||+||+|.+..+++.||||++...........+.+|+.+++.++||||+++++++..++.+++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            46899999999999999999999999999999999765544445678899999999999999999999999999999999


Q ss_pred             ccCCCCcccccc----------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          178 YMDGGSLEGAHI----------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       178 ~~~~~~L~~~~~----------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      |+.+ +|.+++.          ..+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  162 (317)
T 2pmi_A           84 FMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV  162 (317)
T ss_dssp             CCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred             ecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence            9985 6654432          3567788899999999999999999999999999999999999999999998776544


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC--------
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP--------  319 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--------  319 (380)
                      .......||+.|+|||++..    ...++.++|||||||++|+|++|+.||......+....+.........        
T Consensus       163 ~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (317)
T 2pmi_A          163 NTFSSEVVTLWYRAPDVLMG----SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK  238 (317)
T ss_dssp             CCCCCCCSCCTTCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred             ccCCCCcccccccCchHhhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence            44456789999999999853    245678999999999999999999999754443333333332211111        


Q ss_pred             ----------------------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          320 ----------------------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       320 ----------------------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                                            .....++.++.+||.+||+.||++|||+.|+|+||||++.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  304 (317)
T 2pmi_A          239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA  304 (317)
T ss_dssp             CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred             hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence                                  11224678999999999999999999999999999999875543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.1e-52  Score=389.70  Aligned_cols=258  Identities=24%  Similarity=0.334  Sum_probs=214.1

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .++|++.+.||+|+||+||+|.+..+++.||||++.........+.+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            36899999999999999999999999999999999655544445678899999999999999999999999999999999


Q ss_pred             ccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc--CCCCC
Q 016959          178 YMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT--MDPCN  251 (380)
Q Consensus       178 ~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~~~  251 (380)
                      ||.+++|.+++..    .+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...  .....
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  165 (323)
T 3tki_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN  165 (323)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence            9999999877653    57788999999999999999999999999999999999999999999999865422  22234


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD  331 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (380)
                      ..+||+.|+|||++..    ..+++.++|||||||++|+|++|..||.......... ............+..++.++.+
T Consensus       166 ~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  240 (323)
T 3tki_A          166 KMCGTLPYVAPELLKR----REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDWKEKKTYLNPWKKIDSAPLA  240 (323)
T ss_dssp             SCCSCGGGSCHHHHHC----SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH-HHHHTTCTTSTTGGGSCHHHHH
T ss_pred             CCccCcCccCcHHhcc----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH-HHHhcccccCCccccCCHHHHH
Confidence            6789999999999864    3445678999999999999999999997544433222 2222223333445678999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          332 FISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       332 li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      ||.+||+.||++|||+.|+|+||||+...
T Consensus       241 li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          241 LLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            99999999999999999999999998753

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.5e-52  Score=384.90  Aligned_cols=255  Identities=27%  Similarity=0.434  Sum_probs=210.7

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ++|++.++||+|+||+||+|.+..+++.||||++.... .......+.+|+.+++.++|+||+++++++.+++.+++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999999999999999996543 34455778899999999999999999999999999999999


Q ss_pred             ccCCCCcccc----cccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          178 YMDGGSLEGA----HIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       178 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      |+.++.+...    ....+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  161 (292)
T 3o0g_A           82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE  161 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSC
T ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCC
Confidence            9987544322    234677889999999999999999999999999999999999999999999998776554555667


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh---hCCC------------
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC---FAQP------------  318 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---~~~~------------  318 (380)
                      .||+.|+|||++.+    ...++.++|||||||++|+|++|..||....  +.......+.   ....            
T Consensus       162 ~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          162 VVTLWYRPPDVLFG----AKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             CSCGGGCCHHHHTT----CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCcChHHHcC----CCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            89999999999853    2446889999999999999999988864322  2222222221   1111            


Q ss_pred             -------------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          319 -------------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       319 -------------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                                   ......++.++++||.+||+.||++|||++|+|+||||++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence                         11223478899999999999999999999999999999874

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.8e-52  Score=384.29  Aligned_cols=258  Identities=30%  Similarity=0.498  Sum_probs=209.2

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCch-------------------------HHHHHHHHHHHH
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED-------------------------SVRSQICREIEI  150 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------------------------~~~~~~~~E~~~  150 (380)
                      +..++|++.+.||+|+||.||+|.+..+++.||||++......                         ...+.+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            4457899999999999999999999999999999998654311                         123568899999


Q ss_pred             HHhCCCCceeeeEeEEee--CCeEEEEEeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 016959          151 LRDVNHPNVVKCHDMYDR--NGEIEVLLEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLL  225 (380)
Q Consensus       151 l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil  225 (380)
                      ++.++||||+++++++.+  .+.+++||||+.+++|.....   ..+..++.++.||+.||+|||++||+||||||+|||
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil  169 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL  169 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence            999999999999999986  578999999999999877644   367788999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 016959          226 INSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD  305 (380)
Q Consensus       226 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~  305 (380)
                      ++.++.+||+|||++..............||+.|+|||++...  ...+++.++|||||||++|+|++|+.||...   .
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~---~  244 (298)
T 2zv2_A          170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSET--RKIFSGKALDVWAMGVTLYCFVFGQCPFMDE---R  244 (298)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTT--CCCEESHHHHHHHHHHHHHHHHHSSCSSCCS---S
T ss_pred             ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccC--CCCCCCchhhhHhHHHHHHHHHHCCCCCCCc---c
Confidence            9999999999999998776544444567899999999998531  1112467899999999999999999999633   2


Q ss_pred             HHHHHHHHhhC-CCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 016959          306 WASLMFAICFA-QPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR  358 (380)
Q Consensus       306 ~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~  358 (380)
                      .......+... ........++.++.+||.+||+.||++|||+.|+|+||||++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            33333332222 222233568899999999999999999999999999999964

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.6e-52  Score=396.36  Aligned_cols=256  Identities=29%  Similarity=0.433  Sum_probs=215.1

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            357999999999999999999999999999999996543 3445577899999999999999999999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---cEEEeeccccccccccCCC
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK---NVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~---~~kl~Dfg~a~~~~~~~~~  249 (380)
                      ||+.+++|.+.+.    ..+..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||++...... ..
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-~~  186 (362)
T 2bdw_A          108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EA  186 (362)
T ss_dssp             CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-CS
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-cc
Confidence            9999999865543    35778899999999999999999999999999999998654   5999999999876543 23


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      ....+||+.|+|||++..     ..++.++|||||||++|+|++|..||...........+.......+...+..++.++
T Consensus       187 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  261 (362)
T 2bdw_A          187 WHGFAGTPGYLSPEVLKK-----DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  261 (362)
T ss_dssp             CCCSCSCTTTCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred             cccCCCCccccCHHHHcc-----CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            356789999999999853     456789999999999999999999997443322233333322333344456789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      .+||.+||+.||++|||+.|+|+||||...
T Consensus       262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          262 KSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-53  Score=395.40  Aligned_cols=255  Identities=25%  Similarity=0.387  Sum_probs=212.5

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++....  .....+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            368999999999999999999999999999999986443  334668899999999999999999999999999999999


Q ss_pred             ccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC--CCcEEEeeccccccccccCCCC
Q 016959          178 YMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS--SKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       178 ~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~--~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      ||.+++|.+++.     ..+..+..++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++..+... ...
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-~~~  160 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNF  160 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CEE
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-Ccc
Confidence            999999876543     357788999999999999999999999999999999997  789999999999876543 223


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR  330 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (380)
                      ....||+.|+|||++..     ..++.++|||||||++|+|++|..||...........+...........+..++.++.
T Consensus       161 ~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T 1tki_A          161 RLLFTAPEYYAPEVHQH-----DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             EEEESCGGGSCHHHHTT-----CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             ccccCChhhcCcHHhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence            45679999999999853     4567899999999999999999999974333222222222211122222346789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      +||.+||..||++|||+.|+|+||||+...
T Consensus       236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          236 DFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            999999999999999999999999998753

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.1e-52  Score=426.89  Aligned_cols=273  Identities=24%  Similarity=0.359  Sum_probs=230.0

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCC
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNG  170 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  170 (380)
                      ..+..++|++.++||+|+||+||+|++..+++.||||++++..  .....+.+..|..+|..+ +|++|+.++++|.+.+
T Consensus       336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~  415 (674)
T 3pfq_A          336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD  415 (674)
T ss_dssp             ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred             ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence            3466789999999999999999999999999999999996432  122345677899999988 6999999999999999


Q ss_pred             eEEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      .+|+||||+.|++|..++.    ..+..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++.....
T Consensus       416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence            9999999999999976654    367788899999999999999999999999999999999999999999999865544


Q ss_pred             CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcccc
Q 016959          247 MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS  326 (380)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (380)
                      .......+||+.|+|||++..     ..++.++||||||||||||++|..||...   +.......+ ......++..++
T Consensus       496 ~~~~~~~~GT~~Y~APE~l~~-----~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~i-~~~~~~~p~~~s  566 (674)
T 3pfq_A          496 GVTTKTFCGTPDYIAPEIIAY-----QPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSI-MEHNVAYPKSMS  566 (674)
T ss_dssp             TCCBCCCCSCSSSCCHHHHTC-----CCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH-HSSCCCCCTTSC
T ss_pred             CcccccccCCCcccCHhhhcC-----CCCCccceEechHHHHHHHHcCCCCCCCC---CHHHHHHHH-HhCCCCCCccCC
Confidence            445567889999999999853     55688999999999999999999999743   333333333 344566778899


Q ss_pred             HHHHHHHHHhcccCcCCCCCH-----HHHhcCccccccCcccccccccccCCCCCC
Q 016959          327 REFRDFISRCLQKDPHSRWPA-----AQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t~-----~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      .++.+||.+||+.||++|+++     +||++||||+.++|..+..  +++.||++|
T Consensus       567 ~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~--~~~~pp~~p  620 (674)
T 3pfq_A          567 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER--KEIQPPYKP  620 (674)
T ss_dssp             HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTT--TCSCCSCCC
T ss_pred             HHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHh--CCCCCCCCC
Confidence            999999999999999999997     9999999999999888765  566777766

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.3e-53  Score=394.47  Aligned_cols=265  Identities=28%  Similarity=0.433  Sum_probs=206.8

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      ++|.+.+.||+|+||+||+|.+..+++.||||++...........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999999999999999996554333333456799999999999999999999999999999999


Q ss_pred             cCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          179 MDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       179 ~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      +.+ +|..++.     ..+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  160 (324)
T 3mtl_A           82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE  160 (324)
T ss_dssp             CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred             ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccc
Confidence            985 6544432     3567788999999999999999999999999999999999999999999998765444444566


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCC------------
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA------------  321 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------  321 (380)
                      .||+.|+|||++.+    ...++.++|||||||++|+|++|+.||......+....+...........            
T Consensus       161 ~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (324)
T 3mtl_A          161 VVTLWYRPPDILLG----STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT  236 (324)
T ss_dssp             --CGGGCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred             cCcccccChhhhcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence            78999999999853    24567899999999999999999999975444443333333322222111            


Q ss_pred             --------------CccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccccccc
Q 016959          322 --------------PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNL  368 (380)
Q Consensus       322 --------------~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~~~  368 (380)
                                    ...++.++.+||.+||+.||++|||++|+|+||||............
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~  297 (324)
T 3mtl_A          237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPD  297 (324)
T ss_dssp             TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCT
T ss_pred             cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCC
Confidence                          12367899999999999999999999999999999998665544433

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-52  Score=391.54  Aligned_cols=259  Identities=29%  Similarity=0.476  Sum_probs=215.1

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCch-----HHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED-----SVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .+.|.+.+.||+|+||.||+|.+..+++.||+|++......     ...+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            35799999999999999999999999999999999654321     1356788999999999999999999999999999


Q ss_pred             EEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----cEEEeecccccccc
Q 016959          173 EVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK----NVKIADFGVSRILA  244 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~----~~kl~Dfg~a~~~~  244 (380)
                      ++||||+.+++|.+++.    ..+..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||++....
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~  169 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  169 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence            99999999999977654    36778999999999999999999999999999999999877    79999999998765


Q ss_pred             ccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc
Q 016959          245 QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM  324 (380)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (380)
                      .. .......||+.|+|||++.     +..++.++|||||||++|+|++|..||......+....+...........+..
T Consensus       170 ~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (326)
T 2y0a_A          170 FG-NEFKNIFGTPEFVAPEIVN-----YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN  243 (326)
T ss_dssp             TT-SCCCCCCSCTTTCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred             CC-CccccccCCcCcCCceeec-----CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence            43 2335567999999999985     35567899999999999999999999964332222222222222222223346


Q ss_pred             ccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          325 ASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      ++..+.+||.+||+.||++|||+.|+|+||||+.....
T Consensus       244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  281 (326)
T 2y0a_A          244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ  281 (326)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSHH
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcch
Confidence            78899999999999999999999999999999987653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.5e-52  Score=400.23  Aligned_cols=250  Identities=25%  Similarity=0.425  Sum_probs=199.7

Q ss_pred             ccccccc-ceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHH-hCCCCceeeeEeEEee----CCe
Q 016959           98 PAELQKG-NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILR-DVNHPNVVKCHDMYDR----NGE  171 (380)
Q Consensus        98 ~~~~~~~-~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~----~~~  171 (380)
                      .++|.+. +.||+|+||+||+|.+..+++.||||++...      ..+.+|+.++. ..+|+||++++++|..    .+.
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            3567766 7899999999999999999999999998532      34567888874 4589999999999875    567


Q ss_pred             EEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCcEEEeecccccc
Q 016959          172 IEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS---SKNVKIADFGVSRI  242 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~---~~~~kl~Dfg~a~~  242 (380)
                      +|+|||||.|++|.+++.      ..+..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+++.
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence            999999999999976653      357788999999999999999999999999999999997   78899999999986


Q ss_pred             ccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC----HHHHHHHHhhCCC
Q 016959          243 LAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD----WASLMFAICFAQP  318 (380)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~~~~~~  318 (380)
                      .... ......+||+.|+|||++.     +..++.++||||||||+|+|++|..||.......    ....+.......+
T Consensus       214 ~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~  287 (400)
T 1nxk_A          214 TTSH-NSLTTPCYTPYYVAPEVLG-----PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  287 (400)
T ss_dssp             CC------------CTTCCGGGSC-----CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred             cCCC-CccccCCCCCCccCHhhcC-----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence            6533 2335678999999999985     3556789999999999999999999997543322    2333333333333


Q ss_pred             CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          319 PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       319 ~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ...+..++.++.+||.+||+.||++|||+.|+|+||||...
T Consensus       288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            44456789999999999999999999999999999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.2e-53  Score=397.29  Aligned_cols=254  Identities=28%  Similarity=0.438  Sum_probs=211.8

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC----chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH----EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....    .....+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            467999999999999999999999999999999985321    1112467889999999999999999999999999999


Q ss_pred             EEEeccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc---EEEeecccccc
Q 016959          174 VLLEYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN---VKIADFGVSRI  242 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~---~kl~Dfg~a~~  242 (380)
                      +|||||.+++|...+.        ..+..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++..
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            9999999999865432        366778899999999999999999999999999999987655   99999999987


Q ss_pred             ccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC---
Q 016959          243 LAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP---  319 (380)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---  319 (380)
                      ...........+||+.|+|||++..     ..++.++||||||||+|+|++|..||...    .......+......   
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~i~~~~~~~~~  253 (351)
T 3c0i_A          183 LGESGLVAGGRVGTPHFMAPEVVKR-----EPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLFEGIIKGKYKMNP  253 (351)
T ss_dssp             CCTTSCBCCCCCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSCSS----HHHHHHHHHHTCCCCCH
T ss_pred             ecCCCeeecCCcCCcCccCHHHHcC-----CCCCchHhhHHHHHHHHHHHHCCCCCCCc----HHHHHHHHHcCCCCCCc
Confidence            7655444456789999999999853     45678999999999999999999999642    22333333222221   


Q ss_pred             CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       320 ~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      ..+..++.++.+||.+||..||++|||+.|+|+||||+...
T Consensus       254 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          254 RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence            22246789999999999999999999999999999998753

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.2e-52  Score=382.11  Aligned_cols=255  Identities=29%  Similarity=0.434  Sum_probs=202.5

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ++|++.+.||+|+||+||+|.+ .+++.||+|++..... ......+.+|+.+++.++||||+++++++...+.+++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            5799999999999999999998 5789999999965432 2234667899999999999999999999999999999999


Q ss_pred             ccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          178 YMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       178 ~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      |+.+ +|...+.     ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++............
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH  159 (288)
T ss_dssp             CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence            9986 6544332     356778899999999999999999999999999999999999999999999876544344455


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC-------------
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP-------------  319 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------  319 (380)
                      ..||+.|+|||++..    ...++.++|||||||++|+|++|..||......+....+.........             
T Consensus       160 ~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 1ob3_A          160 EIVTLWYRAPDVLMG----SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (288)
T ss_dssp             --CCCTTCCHHHHTT----CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccccccccCchheeC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence            678999999999853    245678999999999999999999999744332222222221111100             


Q ss_pred             ------------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          320 ------------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       320 ------------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                                  .....++.++.+||.+||+.||++|||++|+|+||||++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                        1123478899999999999999999999999999999875

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3e-51  Score=391.56  Aligned_cols=269  Identities=22%  Similarity=0.296  Sum_probs=214.5

Q ss_pred             cccCCCcccccccceeccc--CCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEee
Q 016959           92 RHQLINPAELQKGNRIGSG--SGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDR  168 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G--~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  168 (380)
                      .......++|++.++||+|  +||+||+|++..+++.||||++.... .......+.+|+.+++.++||||++++++|.+
T Consensus        18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   97 (389)
T 3gni_B           18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA   97 (389)
T ss_dssp             CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence            3344677899999999999  99999999999999999999996543 34456778899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 016959          169 NGEIEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI  242 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  242 (380)
                      .+.+++|||||.+++|.+++.      ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            999999999999999876543      35678899999999999999999999999999999999999999999999865


Q ss_pred             ccccC-------CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh
Q 016959          243 LAQTM-------DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF  315 (380)
Q Consensus       243 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  315 (380)
                      .....       ......+||+.|+|||++..   ....++.++|||||||++|+|++|+.||......+..........
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  254 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ---NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV  254 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHST---TSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred             eccccccccccccccccccccccccCHHHHhc---cCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence            43211       12234578999999999853   124567899999999999999999999975444433221111000


Q ss_pred             ------------------------------------------CCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          316 ------------------------------------------AQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       316 ------------------------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                                                                ......+..++.++.+||.+||+.||++|||+.|+|+|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                                                      00112345578899999999999999999999999999


Q ss_pred             ccccccCccc
Q 016959          354 PFILRAGQSQ  363 (380)
Q Consensus       354 p~~~~~~~~~  363 (380)
                      |||+......
T Consensus       335 p~f~~~~~~~  344 (389)
T 3gni_B          335 SFFKQIKRRA  344 (389)
T ss_dssp             GGGGGC---C
T ss_pred             HHHHHHhhcc
Confidence            9999886543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.2e-52  Score=394.98  Aligned_cols=257  Identities=26%  Similarity=0.438  Sum_probs=207.6

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccC
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMD  180 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  180 (380)
                      +...+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+|+.++||||+++++++...+.+++||||+.
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~  169 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD  169 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence            3446789999999999999999999999999976543 345678999999999999999999999999999999999999


Q ss_pred             CCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE--cCCCcEEEeeccccccccccCCCCCCC
Q 016959          181 GGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI--NSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       181 ~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      +++|.+++.     ..+..+..++.||+.||+|||++||+||||||+|||+  +.++.+||+|||++..+... ......
T Consensus       170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~-~~~~~~  248 (373)
T 2x4f_A          170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVN  248 (373)
T ss_dssp             TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-CBCCCC
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-cccccc
Confidence            999866542     3567788899999999999999999999999999999  56778999999999876543 233456


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHH
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI  333 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  333 (380)
                      +||+.|+|||++.     +..++.++|||||||++|||++|..||......+....+...........+..++.++.+||
T Consensus       249 ~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  323 (373)
T 2x4f_A          249 FGTPEFLAPEVVN-----YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI  323 (373)
T ss_dssp             CSSCTTCCHHHHT-----TCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred             cCCCcEeChhhcc-----CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence            7999999999985     35678899999999999999999999974433222222222222223334456899999999


Q ss_pred             HHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          334 SRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       334 ~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                      .+||+.||++|||+.|+|+||||++......
T Consensus       324 ~~~L~~dp~~Rps~~e~l~hp~~~~~~~~~~  354 (373)
T 2x4f_A          324 SKLLIKEKSWRISASEALKHPWLSDHKLHSR  354 (373)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHCHHHHHH
T ss_pred             HHHcCCChhhCCCHHHHhcCcCcCCCchhhh
Confidence            9999999999999999999999998765443

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.3e-52  Score=388.54  Aligned_cols=262  Identities=23%  Similarity=0.409  Sum_probs=202.4

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      ...++|++.++||+|+||+||+|.+..+++.||||++..... ......+.+|+.+++.++|+||+++++++.+.+.+++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            345789999999999999999999999999999999965442 3345667899999999999999999999999999999


Q ss_pred             EEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-----CCCcEEEeeccccccccc
Q 016959          175 LLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN-----SSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       175 v~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~-----~~~~~kl~Dfg~a~~~~~  245 (380)
                      ||||+.+ +|.+++.    ..+..++.++.||+.||+|||++||+||||||+|||++     .++.+||+|||++..+..
T Consensus       111 v~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~  189 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI  189 (329)
T ss_dssp             EEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred             EEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence            9999986 6655443    35677889999999999999999999999999999995     445599999999987765


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCC----
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA----  321 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----  321 (380)
                      ........+||+.|+|||++..    ...++.++|||||||++|+|++|..||......+....+...........    
T Consensus       190 ~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (329)
T 3gbz_A          190 PIRQFTHEIITLWYRPPEILLG----SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV  265 (329)
T ss_dssp             ----------CCTTCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             cccccCCCcCCccccCHHHhcC----CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence            4444556678999999999853    24568899999999999999999999975433332222222211111110    


Q ss_pred             ----------------------CccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          322 ----------------------PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       322 ----------------------~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                                            ...++.++.+||.+||+.||++|||+.|+|+||||+..++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD  328 (329)
T ss_dssp             GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred             hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence                                  11267899999999999999999999999999999987653

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.7e-52  Score=389.58  Aligned_cols=252  Identities=31%  Similarity=0.469  Sum_probs=211.8

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      .++|++.+.||+|+||+||+|.++.+++.||||++......     ..+|++++.++ +||||+++++++.+.+.+|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            46799999999999999999999999999999999655422     34688888887 7999999999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-C---cEEEeeccccccccccCC
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS-K---NVKIADFGVSRILAQTMD  248 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~-~---~~kl~Dfg~a~~~~~~~~  248 (380)
                      |||.|++|.+.+.    ..+..+..++.||+.||+|||++||+||||||+|||+..+ +   .+||+|||++..+.....
T Consensus        96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~  175 (342)
T 2qr7_A           96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG  175 (342)
T ss_dssp             CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence            9999999876543    3677889999999999999999999999999999998533 3   499999999987765545


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC---CCCCCccc
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ---PPEAPEMA  325 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~  325 (380)
                      .....+||+.|+|||++..     ..++.++|||||||++|+|++|..||..............+....   ....+..+
T Consensus       176 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  250 (342)
T 2qr7_A          176 LLMTPCYTANFVAPEVLER-----QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV  250 (342)
T ss_dssp             CBCCSSCCSSCCCHHHHHH-----HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred             ceeccCCCccccCHHHhcC-----CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence            5567789999999999853     335678999999999999999999997554444444444443322   33345678


Q ss_pred             cHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      +.++++||.+||..||++|||+.|+|+||||...
T Consensus       251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            9999999999999999999999999999999764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7.7e-52  Score=386.29  Aligned_cols=251  Identities=21%  Similarity=0.336  Sum_probs=207.4

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC--------
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG--------  170 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------  170 (380)
                      ++|++.+.||+|+||.||+|++..+++.||||++.........+.+.+|+.+|++++||||++++++|.+.+        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            579999999999999999999999999999999976665556788999999999999999999999986543        


Q ss_pred             -------------------------------------------------eEEEEEeccCCCCccccccc-------chHH
Q 016959          171 -------------------------------------------------EIEVLLEYMDGGSLEGAHIR-------QEHI  194 (380)
Q Consensus       171 -------------------------------------------------~~~lv~e~~~~~~L~~~~~~-------~~~~  194 (380)
                                                                       .+++|||||.+++|.+++..       .+..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             38999999999999766543       2345


Q ss_pred             HHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC------------CCCCCCCCCCccccc
Q 016959          195 LSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM------------DPCNSAVGTIAYMSP  262 (380)
Q Consensus       195 ~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~gt~~y~aP  262 (380)
                      ++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......            ......+||+.|+||
T Consensus       166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  245 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP  245 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence            78899999999999999999999999999999999999999999998765432            123456799999999


Q ss_pred             cccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcC
Q 016959          263 ERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPH  342 (380)
Q Consensus       263 E~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  342 (380)
                      |++..     ..++.++|||||||++|+|++|..|+.     +.............+......++++.+||.+||+.||+
T Consensus       246 E~~~~-----~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  315 (332)
T 3qd2_B          246 EQIHG-----NNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPT  315 (332)
T ss_dssp             HHHHC-----CCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGG
T ss_pred             HHhcC-----CCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCC
Confidence            99863     456789999999999999999877662     22233333333333334455678899999999999999


Q ss_pred             CCCCHHHHhcCcccccc
Q 016959          343 SRWPAAQLLQHPFILRA  359 (380)
Q Consensus       343 ~R~t~~eil~hp~~~~~  359 (380)
                      +|||+.|+|+||||+++
T Consensus       316 ~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          316 ERPEATDIIENAIFENL  332 (332)
T ss_dssp             GSCCHHHHHHSTTCCCC
T ss_pred             cCCCHHHHhhchhhhcC
Confidence            99999999999999864

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-52  Score=393.15  Aligned_cols=279  Identities=26%  Similarity=0.433  Sum_probs=226.1

Q ss_pred             cCCCcccccccceecccCCceEEEEEeC---CCCcEEEEEEecCCC---chHHHHHHHHHHHHHHhC-CCCceeeeEeEE
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHP---PTSRVFALKVIYGNH---EDSVRSQICREIEILRDV-NHPNVVKCHDMY  166 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~---~~~~~~avK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~  166 (380)
                      ..+..++|++.+.||+|+||+||+|++.   .+++.||||++....   .....+.+.+|+.+++.+ +|+||+++++++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  128 (355)
T 1vzo_A           49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF  128 (355)
T ss_dssp             CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence            3466789999999999999999999984   589999999986432   122334567899999999 699999999999


Q ss_pred             eeCCeEEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 016959          167 DRNGEIEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI  242 (380)
Q Consensus       167 ~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  242 (380)
                      ...+.+++||||+.+++|.+++.    ..+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999999976654    35677889999999999999999999999999999999999999999999986


Q ss_pred             ccccC-CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCC
Q 016959          243 LAQTM-DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA  321 (380)
Q Consensus       243 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  321 (380)
                      +.... ......+||+.|+|||++..   ....++.++|||||||++|||++|..||...........+........+..
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  285 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRG---GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY  285 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTT---CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC
T ss_pred             cccCCCCcccCcccCcCccChhhhcC---CCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC
Confidence            54321 22345679999999999853   123457799999999999999999999975544443344444444455667


Q ss_pred             CccccHHHHHHHHHhcccCcCCCC-----CHHHHhcCccccccCcccccccccccCCCCCC
Q 016959          322 PEMASREFRDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R~-----t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      +..++..+.+||.+||..||++||     |++|+++||||++.++.....  +++-+|++|
T Consensus       286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~--~~~~~p~~p  344 (355)
T 1vzo_A          286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAA--KKVPAPFKP  344 (355)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHT--TCSCCSCCC
T ss_pred             CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhh--ccCCCCCCC
Confidence            788899999999999999999999     999999999999988776654  344444444

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1e-51  Score=393.72  Aligned_cols=256  Identities=29%  Similarity=0.435  Sum_probs=214.2

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++...... ....+.+|+.+|+.++|+||+++++++.+.+.+++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh-hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            36799999999999999999999999999999999655432 34578899999999999999999999999999999999


Q ss_pred             ccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC--CCcEEEeeccccccccccCCCC
Q 016959          178 YMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS--SKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       178 ~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~--~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      |+.+++|.+++.     ..+..+..++.||+.||+|||++||+||||||+|||++.  ++.+||+|||++..+.... ..
T Consensus       129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-~~  207 (387)
T 1kob_A          129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-IV  207 (387)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-CE
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-ce
Confidence            999999876553     357788999999999999999999999999999999974  4679999999998765432 22


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR  330 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (380)
                      ...+||+.|+|||++..     ..++.++|||||||++|+|++|..||......+....+...........+..++.++.
T Consensus       208 ~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  282 (387)
T 1kob_A          208 KVTTATAEFAAPEIVDR-----EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  282 (387)
T ss_dssp             EEECSSGGGCCHHHHTT-----CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             eeeccCCCccCchhccC-----CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            34579999999999853     5567899999999999999999999974332222222222222334445567899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      +||.+||+.||++|||+.|+|+||||+...
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            999999999999999999999999998753

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9.3e-52  Score=391.08  Aligned_cols=257  Identities=29%  Similarity=0.436  Sum_probs=201.9

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      ...++|++.+.||+|+||+||+|.+..+++.||||++......  .+.+.+|+.+++.++||||+++++++...+.+++|
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   94 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAII   94 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence            3457899999999999999999999999999999999654322  35577999999999999999999999999999999


Q ss_pred             EeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc--EEEeeccccccccccCCC
Q 016959          176 LEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN--VKIADFGVSRILAQTMDP  249 (380)
Q Consensus       176 ~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~  249 (380)
                      |||+.+++|..++.    ..+..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..... ..
T Consensus        95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-~~  173 (361)
T 3uc3_A           95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ  173 (361)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-CC
Confidence            99999999976643    467788999999999999999999999999999999987765  999999999754322 22


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-CHHHHHHHHhhCC-CCCCCccccH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG-DWASLMFAICFAQ-PPEAPEMASR  327 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~  327 (380)
                      ....+||+.|+|||++..    ..+.+.++|||||||++|+|++|+.||...... .....+....... .......++.
T Consensus       174 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  249 (361)
T 3uc3_A          174 PKSTVGTPAYIAPEVLLR----QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP  249 (361)
T ss_dssp             -------CTTSCHHHHHC----SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred             CCCCcCCCCcCChhhhcC----CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence            345679999999999864    244445599999999999999999999754433 3333333332221 2223335789


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ++.+||.+||+.||++|||+.|+++||||.+.
T Consensus       250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          250 ECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            99999999999999999999999999999664

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-51  Score=400.91  Aligned_cols=264  Identities=30%  Similarity=0.382  Sum_probs=195.1

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEee-----CCe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDR-----NGE  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~  171 (380)
                      .++|++.+.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+|+.++|+||+++++++..     .+.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            368999999999999999999999999999999986543 33445778899999999999999999999843     357


Q ss_pred             EEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          172 IEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      +|+||||+. ++|..++.    ..+..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  210 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE  210 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred             EEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence            999999986 46654433    4677889999999999999999999999999999999999999999999998764221


Q ss_pred             ---------------------------CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-------
Q 016959          248 ---------------------------DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-------  293 (380)
Q Consensus       248 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-------  293 (380)
                                                 ......+||+.|+|||++..    +..++.++||||||||||||++       
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~~~~DiwSlG~il~elltg~~~~~~  286 (458)
T 3rp9_A          211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL----QENYTEAIDVWSIGCIFAELLNMIKENVA  286 (458)
T ss_dssp             TCCCCCC---------------------------CCCTTCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred             ccccccccCccccccccccccccccccccccCCcccccccChHHhhC----CCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence                                       12345678999999998742    3567889999999999999998       


Q ss_pred             ----CCCCCCCCCC--------------------CCHHHHHHHHhhCC--------------------C-------CCCC
Q 016959          294 ----GRFPFAVGRQ--------------------GDWASLMFAICFAQ--------------------P-------PEAP  322 (380)
Q Consensus       294 ----g~~pf~~~~~--------------------~~~~~~~~~~~~~~--------------------~-------~~~~  322 (380)
                          |..+|.....                    .+....+.......                    +       ....
T Consensus       287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (458)
T 3rp9_A          287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF  366 (458)
T ss_dssp             SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred             ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence                6666643221                    01111111111000                    0       0122


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccccc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQ  366 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~  366 (380)
                      ..++.++.+||.+||..||++|+|++|+|+||||+...+.....
T Consensus       367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~  410 (458)
T 3rp9_A          367 PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVET  410 (458)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCC
T ss_pred             CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCC
Confidence            34688999999999999999999999999999999987766543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-51  Score=387.85  Aligned_cols=261  Identities=28%  Similarity=0.473  Sum_probs=210.1

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC----chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH----EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++....    .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            357999999999999999999999999999999985432    2344578899999999999999999999999999999


Q ss_pred             EEEeccCCCCccccccc--------------------------------------------chHHHHHHHHHHHHHHHHH
Q 016959          174 VLLEYMDGGSLEGAHIR--------------------------------------------QEHILSDLARQVLSGLAYL  209 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~~--------------------------------------------~~~~~~~i~~qi~~al~~L  209 (380)
                      +|||||.+++|.+++..                                            .+..++.++.||+.||+||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999766531                                            3556788999999999999


Q ss_pred             HhCCceecCCCCCcEEEcCCC--cEEEeeccccccccccCC----CCCCCCCCCccccccccccccCCCCCCCcchhHHH
Q 016959          210 HKRKIVHRDIKPSNLLINSSK--NVKIADFGVSRILAQTMD----PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWS  283 (380)
Q Consensus       210 H~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dvws  283 (380)
                      |++||+||||||+|||++.++  .+||+|||++..+.....    ......||+.|+|||++..   .+..++.++||||
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~~Diws  261 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT---TNESYGPKCDAWS  261 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC---SSSCCCTHHHHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc---CCCCCCcHHHHHH
Confidence            999999999999999998776  899999999986643221    2345679999999999853   2355678999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          284 LGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       284 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      |||++|+|++|..||......+....+..............++.++.+||.+||+.||++|||+.|+|+||||+....
T Consensus       262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence            999999999999999743332222222221111222233357899999999999999999999999999999998654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.2e-51  Score=373.45  Aligned_cols=262  Identities=28%  Similarity=0.422  Sum_probs=219.0

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++++++|+||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            468999999999999999999999999999999986543 3445577889999999999999999999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc---EEEeeccccccccccCCC
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDP  249 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~---~kl~Dfg~a~~~~~~~~~  249 (380)
                      ||+.+++|...+.    ..+..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++...... ..
T Consensus        85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-~~  163 (284)
T 3kk8_A           85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EA  163 (284)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-CB
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-cc
Confidence            9999999865433    357788899999999999999999999999999999986665   999999999766543 23


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      .....||+.|+|||++..     ..++.++|||||||++|+|++|..||...........+.......+...+..++.++
T Consensus       164 ~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKK-----DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  238 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             ccCCCCCcCCcCchhhcC-----CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence            345679999999999853     456789999999999999999999997544333333333333333444456789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccccccCccccc
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN  365 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~  365 (380)
                      .+||.+||+.||++|||+.|+|+||||+........
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~  274 (284)
T 3kk8_A          239 KSLIDSMLTVNPKKRITADQALKVPWICNRERVASA  274 (284)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred             HHHHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence            999999999999999999999999999987555443

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-51  Score=381.74  Aligned_cols=262  Identities=26%  Similarity=0.433  Sum_probs=207.5

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57999999999999999999999999999999986544 34456778899999999999999999999999999999999


Q ss_pred             ccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          178 YMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       178 ~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      |+.+++|..+..    ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............
T Consensus        83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  162 (311)
T 4agu_A           83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE  162 (311)
T ss_dssp             CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred             eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCC
Confidence            999988765433    4577889999999999999999999999999999999999999999999998776554445567


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC----------------
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ----------------  317 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----------------  317 (380)
                      .||..|+|||++.+    ...++.++|||||||++|+|++|..||......+....+.......                
T Consensus       163 ~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (311)
T 4agu_A          163 VATRWYRSPELLVG----DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG  238 (311)
T ss_dssp             ---GGGCCHHHHHT----CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred             cCCccccChHHHhc----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence            89999999999853    2456789999999999999999999997544333332222221110                


Q ss_pred             -CCC----------CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          318 -PPE----------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       318 -~~~----------~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                       ...          ....++.++.+||.+||+.||++|||++|+|+||||+.......
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  296 (311)
T 4agu_A          239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED  296 (311)
T ss_dssp             CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC----
T ss_pred             CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHH
Confidence             000          01347888999999999999999999999999999999865544

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-51  Score=375.84  Aligned_cols=252  Identities=28%  Similarity=0.490  Sum_probs=205.7

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .++|.+.++||+|+||+||+|.+..+++.||+|++.........+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            36799999999999999999999999999999999765544445778899999999999999999999999999999999


Q ss_pred             ccCCCCccccc--------ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCcEEEeecccccccccc
Q 016959          178 YMDGGSLEGAH--------IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI---NSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       178 ~~~~~~L~~~~--------~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      |+.+++|.+.+        ...+..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~  180 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD  180 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence            99999986654        24567788999999999999999999999999999999   45678999999999766543


Q ss_pred             CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC--CCcc
Q 016959          247 MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--APEM  324 (380)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~  324 (380)
                       .......||+.|+|||++.      ..++.++|||||||++|+|++|..||...   ................  ....
T Consensus       181 -~~~~~~~~t~~y~aPE~~~------~~~~~~~Di~slG~il~~ll~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~  250 (285)
T 3is5_A          181 -EHSTNAAGTALYMAPEVFK------RDVTFKCDIWSAGVVMYFLLTGCLPFTGT---SLEEVQQKATYKEPNYAVECRP  250 (285)
T ss_dssp             -------CTTGGGCCHHHHT------TCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCCC--CC
T ss_pred             -ccCcCcccccCcCChHHhc------cCCCcccCeehHHHHHHHHHhCCCCCCCC---CHHHHHhhhccCCcccccccCc
Confidence             2234567999999999984      34578999999999999999999999743   3333333333332221  2234


Q ss_pred             ccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          325 ASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      +++++.+||.+||+.||++|||+.|+|+||||+++
T Consensus       251 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a  285 (285)
T 3is5_A          251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA  285 (285)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence            68899999999999999999999999999999863

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.5e-51  Score=387.90  Aligned_cols=256  Identities=29%  Similarity=0.460  Sum_probs=197.7

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .+.|++.+.||+|+||+||+|.+..+++.||||++....   ..+.+.+|+.++++++|+||+++++++...+..++|||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            467999999999999999999999999999999996543   23567889999999999999999999999999999999


Q ss_pred             ccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCcEEEeeccccccccccCCCC
Q 016959          178 YMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS---SKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       178 ~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~---~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      |+.+++|.+++.    ..+..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++...... ...
T Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~  207 (349)
T 2w4o_A          129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-VLM  207 (349)
T ss_dssp             CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred             eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-ccc
Confidence            999999876554    357788999999999999999999999999999999975   889999999999866543 223


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC-HHHHHHHHhhCCCCCCCccccHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD-WASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      ...+||+.|+|||++..     ..++.++|||||||++|||++|..||....... ....+...........+..++.++
T Consensus       208 ~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  282 (349)
T 2w4o_A          208 KTVCGTPGYCAPEILRG-----CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA  282 (349)
T ss_dssp             -----CGGGSCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             ccccCCCCccCHHHhcC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHH
Confidence            45679999999999853     456789999999999999999999996433222 111111111222334456789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      .+||.+||+.||++|||+.|+|+||||.+....
T Consensus       283 ~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  315 (349)
T 2w4o_A          283 KDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN  315 (349)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence            999999999999999999999999999986544

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.3e-50  Score=377.37  Aligned_cols=253  Identities=33%  Similarity=0.522  Sum_probs=215.1

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEecc
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYM  179 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  179 (380)
                      .|...+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  124 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL  124 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence            467778999999999999999989999999999654433 3466889999999999999999999999999999999999


Q ss_pred             CCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCC
Q 016959          180 DGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGT  256 (380)
Q Consensus       180 ~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  256 (380)
                      .+++|.+++.   ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............||
T Consensus       125 ~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  204 (321)
T 2c30_A          125 QGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT  204 (321)
T ss_dssp             CSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSC
T ss_pred             CCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCC
Confidence            9999876654   3577889999999999999999999999999999999999999999999998776554445667899


Q ss_pred             CccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC--CCccccHHHHHHHH
Q 016959          257 IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--APEMASREFRDFIS  334 (380)
Q Consensus       257 ~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~  334 (380)
                      +.|+|||++..     ..++.++|||||||++|+|++|+.||...   ........+.....+.  ....++.++.+||.
T Consensus       205 ~~y~aPE~~~~-----~~~~~~~Dv~slG~il~el~~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  276 (321)
T 2c30_A          205 PYWMAPEVISR-----SLYATEVDIWSLGIMVIEMVDGEPPYFSD---SPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE  276 (321)
T ss_dssp             GGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHH
T ss_pred             ccccCHhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcCCCCCcCccccCCHHHHHHHH
Confidence            99999999853     45678999999999999999999999743   3333344443333332  34467899999999


Q ss_pred             HhcccCcCCCCCHHHHhcCccccccCc
Q 016959          335 RCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       335 ~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      +||+.||++|||+.|+|+||||.....
T Consensus       277 ~~l~~dp~~Rps~~ell~hp~~~~~~~  303 (321)
T 2c30_A          277 RMLVRDPQERATAQELLDHPFLLQTGL  303 (321)
T ss_dssp             HHSCSSTTTSCCHHHHHTSGGGGGCCC
T ss_pred             HHccCChhhCcCHHHHhcChhhccCCC
Confidence            999999999999999999999987643

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.9e-52  Score=391.55  Aligned_cols=252  Identities=29%  Similarity=0.455  Sum_probs=209.9

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      .++|.+.+.||+|+||+||+|.+..+++.||||++....  .......+.+|+.+++.++||||+++++++...+.+++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            468999999999999999999999999999999985432  112235688999999999999999999999999999999


Q ss_pred             EeccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCC
Q 016959          176 LEYMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       176 ~e~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      |||+ +|+|.+++    ...+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus        88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-~~~~  165 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLK  165 (336)
T ss_dssp             ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-BTTC
T ss_pred             EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-cccc
Confidence            9999 56665543    3467788999999999999999999999999999999999999999999999876543 2345


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD  331 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (380)
                      ..+||+.|+|||++.+    ..+.+.++|||||||++|+|++|..||...........    ........+..++.++.+
T Consensus       166 ~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~----i~~~~~~~p~~~s~~~~~  237 (336)
T 3h4j_B          166 TSCGSPNYAAPEVING----KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----VNSCVYVMPDFLSPGAQS  237 (336)
T ss_dssp             CCTTSTTTSCGGGSCC----SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC----CCSSCCCCCTTSCHHHHH
T ss_pred             cccCCcCcCCHHHHcC----CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH----HHcCCCCCcccCCHHHHH
Confidence            6789999999999853    23446799999999999999999999974433221111    112223456678999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          332 FISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       332 li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ||.+||+.||++|||++|+++||||+..
T Consensus       238 li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          238 LIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            9999999999999999999999999864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-51  Score=394.16  Aligned_cols=261  Identities=25%  Similarity=0.401  Sum_probs=199.0

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCC--eEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNG--EIE  173 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~--~~~  173 (380)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.+. |+||+++++++...+  .+|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            357999999999999999999999999999999986442 3445567889999999997 999999999997543  799


Q ss_pred             EEEeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc----
Q 016959          174 VLLEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT----  246 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  246 (380)
                      +|||||.+ +|...+.   ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+...    
T Consensus        88 lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  166 (388)
T 3oz6_A           88 LVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT  166 (388)
T ss_dssp             EEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCC
T ss_pred             EEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccc
Confidence            99999985 6654443   356678889999999999999999999999999999999999999999999865321    


Q ss_pred             -----------------CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHH
Q 016959          247 -----------------MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASL  309 (380)
Q Consensus       247 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~  309 (380)
                                       .......+||+.|+|||++.+    ...++.++||||||||+|||++|+.||......+....
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  242 (388)
T 3oz6_A          167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG----STKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER  242 (388)
T ss_dssp             CCGGGCCC---------------CCCGGGGCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccccccccccccccccccccccCCcccCCcCCHHHhcC----CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence                             112345689999999999853    25577899999999999999999999975443333222


Q ss_pred             HHHHhhCCC------------------------------C-------------CCCccccHHHHHHHHHhcccCcCCCCC
Q 016959          310 MFAICFAQP------------------------------P-------------EAPEMASREFRDFISRCLQKDPHSRWP  346 (380)
Q Consensus       310 ~~~~~~~~~------------------------------~-------------~~~~~~~~~~~~li~~~l~~dp~~R~t  346 (380)
                      +........                              .             ..+..++.++.+||.+||+.||++|||
T Consensus       243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t  322 (388)
T 3oz6_A          243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS  322 (388)
T ss_dssp             HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence            222111000                              0             011256889999999999999999999


Q ss_pred             HHHHhcCccccccCccc
Q 016959          347 AAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       347 ~~eil~hp~~~~~~~~~  363 (380)
                      ++|+|+||||+......
T Consensus       323 ~~e~l~Hp~~~~~~~~~  339 (388)
T 3oz6_A          323 ANDALKHPFVSIFHNPN  339 (388)
T ss_dssp             HHHHTTSTTTTTTCCGG
T ss_pred             HHHHhCCHHHHHhcCCc
Confidence            99999999998764433

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.2e-51  Score=402.38  Aligned_cols=256  Identities=27%  Similarity=0.360  Sum_probs=200.5

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC------C
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN------G  170 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~  170 (380)
                      .++|++.+.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+|+.++||||++++++|...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999999999999999996543 344567788999999999999999999999654      4


Q ss_pred             eEEEEEeccCCCCccccc-ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 016959          171 EIEVLLEYMDGGSLEGAH-IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  249 (380)
                      .+|+||||+.++.+.... ...+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus       141 ~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~  219 (464)
T 3ttj_A          141 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FM  219 (464)
T ss_dssp             EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C-CC
T ss_pred             eEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC-cc
Confidence            679999999876443221 2467778899999999999999999999999999999999999999999999876543 23


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC-----------
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP-----------  318 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  318 (380)
                      ....+||+.|+|||++.+     ..++.++||||||||+|||++|+.||......+....+........           
T Consensus       220 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~  294 (464)
T 3ttj_A          220 MTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  294 (464)
T ss_dssp             C----CCCTTCCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred             cCCCcccccccCHHHHcC-----CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence            456789999999999853     4567899999999999999999999975443333222222111100           


Q ss_pred             -------CC---------CCc-----------cccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          319 -------PE---------APE-----------MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       319 -------~~---------~~~-----------~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                             +.         .+.           ..+.++++||.+||+.||++|||++|+|+||||+..
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence                   00         000           115689999999999999999999999999999854

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9.3e-51  Score=380.46  Aligned_cols=256  Identities=27%  Similarity=0.419  Sum_probs=218.4

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      ...+|.+.+.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.+++.++|+||+++++++.+.+.+++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            3468999999999999999999999999999999986542  34556788999999999999999999999999999999


Q ss_pred             EEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          175 LLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       175 v~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      ||||+.+++|.+++.    ..+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus       119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  198 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  198 (335)
T ss_dssp             EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence            999999999876643    3577889999999999999999999999999999999999999999999998775444444


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR  330 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (380)
                      ....||..|+|||++..     ..++.++|||||||++|+|++|..||....   .......... .....+..++.++.
T Consensus       199 ~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~-~~~~~~~~~~~~~~  269 (335)
T 2owb_A          199 KVLCGTPNYIAPEVLSK-----KGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIKK-NEYSIPKHINPVAA  269 (335)
T ss_dssp             CCCCSCCSSCCHHHHHT-----SCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHH-TCCCCCTTSCHHHH
T ss_pred             cccCCCccccCHHHhcc-----CCCCchhhHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHhc-CCCCCCccCCHHHH
Confidence            56779999999999853     456789999999999999999999996432   2222222222 23445667889999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      +||.+||+.||++|||+.|+|+||||.....
T Consensus       270 ~li~~~l~~dp~~Rps~~ell~~~~~~~~~~  300 (335)
T 2owb_A          270 SLIQKMLQTDPTARPTINELLNDEFFTSGYI  300 (335)
T ss_dssp             HHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence            9999999999999999999999999987643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.5e-51  Score=372.51  Aligned_cols=259  Identities=29%  Similarity=0.504  Sum_probs=214.4

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .+..++|++.+.||+|+||+||+|.+..+++.||||++.....  ......+.+|+.+++.++||||+++++++.+.+..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (279)
T 3fdn_A            5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   84 (279)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence            3567899999999999999999999999999999999854321  22346688999999999999999999999999999


Q ss_pred             EEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          173 EVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ++||||+.+++|.+.+.    ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......  
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--  162 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  162 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc--
Confidence            99999999999866543    367778899999999999999999999999999999999999999999998655432  


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHH
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE  328 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (380)
                      ......|++.|+|||++.     +..++.++||||||+++|+|++|..||....   .......+. ......+..++.+
T Consensus       163 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~-~~~~~~~~~~~~~  233 (279)
T 3fdn_A          163 RRTDLCGTLDYLPPEMIE-----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKRIS-RVEFTFPDFVTEG  233 (279)
T ss_dssp             -----CCCCTTCCHHHHT-----TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHH-HTCCCCCTTSCHH
T ss_pred             cccccCCCCCccCHhHhc-----cCCCCccchhHhHHHHHHHHHHCCCCCCCCc---HHHHHHHHH-hCCCCCCCcCCHH
Confidence            224567999999999985     3556779999999999999999999997433   333333222 2344566778999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          329 FRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                      +.+||.+||+.||++|||+.|+|+||||+.......
T Consensus       234 ~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~~  269 (279)
T 3fdn_A          234 ARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS  269 (279)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSCC
T ss_pred             HHHHHHHHhccChhhCCCHHHHhhCccccCCccCcc
Confidence            999999999999999999999999999998654443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.7e-51  Score=399.06  Aligned_cols=257  Identities=29%  Similarity=0.466  Sum_probs=217.7

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc--hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      ..+..++|.+++.||+|+||+||+|.+..+|+.||||++.....  ......+.+|+.+++.++||||+++++++...+.
T Consensus        11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~   90 (476)
T 2y94_A           11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD   90 (476)
T ss_dssp             SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            34556789999999999999999999999999999999854321  1234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          172 IEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      +++||||+.+++|.+++.    ..+..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++...... 
T Consensus        91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-  169 (476)
T 2y94_A           91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-  169 (476)
T ss_dssp             EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence            999999999999877654    357788999999999999999999999999999999999999999999999876543 


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                      ......+||+.|+|||++.+    ..+.+.++|||||||++|+|++|..||.....   ......+. ......+..++.
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~-~~~~~~p~~~s~  241 (476)
T 2y94_A          170 EFLRTSCGSPNYAAPEVISG----RLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLFKKIC-DGIFYTPQYLNP  241 (476)
T ss_dssp             CCBCCCCSCSTTCCHHHHTT----CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHHHHHH-TTCCCCCTTCCH
T ss_pred             ccccccCCCcCeEChhhccC----CCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHHHHHh-cCCcCCCccCCH
Confidence            33456789999999999864    23456799999999999999999999974332   23333332 223445667899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ++.+||.+||+.||++|||+.|+++||||+..
T Consensus       242 ~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          242 SVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            99999999999999999999999999999863

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.4e-50  Score=375.45  Aligned_cols=256  Identities=22%  Similarity=0.392  Sum_probs=209.8

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEee--CCe
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDR--NGE  171 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~  171 (380)
                      ....++|++.+.||+|+||+||+|.+..+++.||||++....    ...+.+|+.+++.++ |+||+++++++.+  ...
T Consensus        32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           32 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             CEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             ccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            345688999999999999999999999999999999986433    356789999999997 9999999999987  678


Q ss_pred             EEEEEeccCCCCcccccc-cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-cEEEeeccccccccccCCC
Q 016959          172 IEVLLEYMDGGSLEGAHI-RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~-~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~  249 (380)
                      .++||||+.+++|..+.. ..+..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...... ..
T Consensus       108 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~  186 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QE  186 (330)
T ss_dssp             EEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT-CC
T ss_pred             eEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC-Cc
Confidence            999999999999876654 36677889999999999999999999999999999999776 8999999999876543 23


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh-------------hC
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC-------------FA  316 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-------------~~  316 (380)
                      .....|+..|+|||++..    ...++.++|||||||++|+|++|..||......  ...+....             ..
T Consensus       187 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          187 YNVRVASRYFKGPELLVD----YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             CCSCCSCGGGCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             cccccccccccChhhhcC----CCcCCchhhHHHHHHHHHHHHhCCCCcccCCch--HHHHHHHHHhcCCchhhhHHHHh
Confidence            355679999999999853    255678999999999999999999999643221  11111000             00


Q ss_pred             -----------------------CCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          317 -----------------------QPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       317 -----------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                                             ........++.++.+||.+||+.||++|||++|+|+||||+....
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence                                   011122337899999999999999999999999999999998754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.4e-50  Score=364.43  Aligned_cols=257  Identities=24%  Similarity=0.338  Sum_probs=215.7

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      ++|++.+.||+|+||.||+|.+..+++.||||++.........+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            67999999999999999999999999999999996555445567889999999999999999999999999999999999


Q ss_pred             cCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC--CCCCC
Q 016959          179 MDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM--DPCNS  252 (380)
Q Consensus       179 ~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~  252 (380)
                      +.+++|.+++..    .+..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......  .....
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  166 (276)
T 2yex_A           87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK  166 (276)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCC
T ss_pred             cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccC
Confidence            999999877653    567789999999999999999999999999999999999999999999998654321  22345


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      ..|+..|+|||++..    ..+++.++|||||||++|+|++|..||............ ..........+..++.++.+|
T Consensus       167 ~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l  241 (276)
T 2yex_A          167 MCGTLPYVAPELLKR----REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-WKEKKTYLNPWKKIDSAPLAL  241 (276)
T ss_dssp             CCSCGGGCCGGGGTC----SSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH-HHTTCTTSTTGGGSCHHHHHH
T ss_pred             CccccCccChHHHhc----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-hhhcccccCchhhcCHHHHHH
Confidence            679999999999853    234467899999999999999999999754443322111 111222223345689999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          333 ISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       333 i~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      |.+||+.||++|||+.|+++||||++..
T Consensus       242 i~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          242 LHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHCCCCchhCCCHHHHhcCccccChh
Confidence            9999999999999999999999998763

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-51  Score=382.41  Aligned_cols=260  Identities=25%  Similarity=0.397  Sum_probs=206.4

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc----hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE----DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++.....    ......+.+|+.+++.++|+||+++++++.+.+..+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            4679999999999999999999999999999999864332    122346789999999999999999999999999999


Q ss_pred             EEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          174 VLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      +||||+.+ +|...+.     ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus        89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  167 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence            99999987 5543332     35677889999999999999999999999999999999999999999999987765544


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCC-------
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA-------  321 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------  321 (380)
                      .....+||+.|+|||++.+    ...++.++|||||||++|+|++|..||......+....+...........       
T Consensus       168 ~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  243 (346)
T 1ua2_A          168 AYTHQVVTRWYRAPELLFG----ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL  243 (346)
T ss_dssp             CCCCSCCCCTTCCHHHHTT----CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             cCCcccccccccCchHhhC----CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence            5566789999999999853    24567899999999999999999999975433332222222221111110       


Q ss_pred             -----------------CccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          322 -----------------PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       322 -----------------~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                                       ...++.++.+||.+||+.||++|||+.|+|+||||......
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence                             13457899999999999999999999999999999876543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.1e-50  Score=382.33  Aligned_cols=265  Identities=25%  Similarity=0.360  Sum_probs=214.4

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEee-------
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDR-------  168 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------  168 (380)
                      ..++|++.+.||+|+||+||+|++..+|+.||||++.... .......+.+|+.+++.++|+||+++++++..       
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            3578999999999999999999999999999999985443 22234567789999999999999999999876       


Q ss_pred             -CCeEEEEEeccCCCCccc----ccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          169 -NGEIEVLLEYMDGGSLEG----AHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       169 -~~~~~lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                       .+.+++||||+.++.+..    .....+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus        95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  174 (351)
T 3mi9_A           95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  174 (351)
T ss_dssp             --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence             456899999998633221    123467789999999999999999999999999999999999999999999999876


Q ss_pred             ccc----CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC
Q 016959          244 AQT----MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP  319 (380)
Q Consensus       244 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  319 (380)
                      ...    ........||+.|+|||++.+    ...++.++|||||||++|+|++|..||......+....+.........
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          175 SLAKNSQPNRYTNRVVTLWYRPPELLLG----ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CCCSSSSCCCCCSSCSCGGGCCHHHHTT----CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccCCcccccCccCchhhcC----CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            422    122345678999999999853    245678999999999999999999999865554455555555544444


Q ss_pred             CCCcc----------------------------ccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccccc
Q 016959          320 EAPEM----------------------------ASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN  365 (380)
Q Consensus       320 ~~~~~----------------------------~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~  365 (380)
                      ..+..                            .++++.+||.+||+.||++|||++|+|+||||.........
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  324 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDL  324 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCCS
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcccc
Confidence            43332                            26789999999999999999999999999999987655543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.6e-51  Score=384.01  Aligned_cols=249  Identities=29%  Similarity=0.454  Sum_probs=188.7

Q ss_pred             cceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEEEEeccCCC
Q 016959          104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEVLLEYMDGG  182 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~  182 (380)
                      .+.||+|+||+||+|.+..+++.||||++...    ....+.+|+.+++.+. ||||+++++++.+.+..++||||+.++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            47899999999999999999999999998543    2456778999999997 999999999999999999999999999


Q ss_pred             Ccccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---cEEEeeccccccccccCCCCCCCCC
Q 016959          183 SLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK---NVKIADFGVSRILAQTMDPCNSAVG  255 (380)
Q Consensus       183 ~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~g  255 (380)
                      +|.+++.    ..+..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||++.............+|
T Consensus        92 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  171 (325)
T 3kn6_A           92 ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF  171 (325)
T ss_dssp             BHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCC
Confidence            9876654    36778899999999999999999999999999999998766   7999999999876655445566789


Q ss_pred             CCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----CCHHHHHHHHhhCCCC---CCCccccHH
Q 016959          256 TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ----GDWASLMFAICFAQPP---EAPEMASRE  328 (380)
Q Consensus       256 t~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~~~~---~~~~~~~~~  328 (380)
                      |+.|+|||++..     ..++.++|||||||++|+|++|..||.....    .........+......   ..+..++.+
T Consensus       172 t~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  246 (325)
T 3kn6_A          172 TLHYAAPELLNQ-----NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQE  246 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHH
T ss_pred             CcCccCHHHhcC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHH
Confidence            999999999853     5567899999999999999999999974332    1223333333332221   122457999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          329 FRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      +++||.+||+.||++|||+.|+++||||+....
T Consensus       247 ~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          247 AKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             HHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             HHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence            999999999999999999999999999997643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.7e-51  Score=381.75  Aligned_cols=257  Identities=29%  Similarity=0.478  Sum_probs=214.7

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCch-----HHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED-----SVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++......     ...+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            46799999999999999999999999999999999654321     1356788999999999999999999999999999


Q ss_pred             EEEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----cEEEeecccccccc
Q 016959          173 EVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK----NVKIADFGVSRILA  244 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~----~~kl~Dfg~a~~~~  244 (380)
                      ++||||+.+++|.+++..    .+..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~  170 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence            999999999999776543    5778899999999999999999999999999999999888    79999999998765


Q ss_pred             ccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC---CCCC
Q 016959          245 QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ---PPEA  321 (380)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~  321 (380)
                      ... ......||+.|+|||++..     ..++.++|||||||++|+|++|..||.....   ......+....   +...
T Consensus       171 ~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~  241 (321)
T 2a2a_A          171 DGV-EFKNIFGTPEFVAPEIVNY-----EPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANITSVSYDFDEEF  241 (321)
T ss_dssp             TTC-CCCCCCSCGGGCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHTTCCCCCHHH
T ss_pred             ccc-cccccCCCCCccCcccccC-----CCCCCccccHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcccccChhh
Confidence            432 2345679999999999853     5567899999999999999999999964332   23333322221   1122


Q ss_pred             CccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                      +..++..+.+||.+||..||++|||+.|+|+||||+......
T Consensus       242 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~~  283 (321)
T 2a2a_A          242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ  283 (321)
T ss_dssp             HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHHH
T ss_pred             hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCccc
Confidence            345788999999999999999999999999999999876544

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.5e-51  Score=385.03  Aligned_cols=253  Identities=26%  Similarity=0.388  Sum_probs=206.3

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-----CCceeeeEeEEee
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-----HPNVVKCHDMYDR  168 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~  168 (380)
                      ..+-.++|.+.++||+|+||+||+|++..+++.||||++...  ......+..|+.+++.+.     |+||+++++++..
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~  107 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY  107 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence            334457899999999999999999999999999999999532  344566778999999986     9999999999999


Q ss_pred             CCeEEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC--------------
Q 016959          169 NGEIEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS--------------  228 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~--------------  228 (380)
                      .+..++||||+ +++|.+++.      ..+..++.++.||+.||+|||++||+||||||+|||++.              
T Consensus       108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence            99999999999 888866543      356778899999999999999999999999999999975              


Q ss_pred             -----------CCcEEEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 016959          229 -----------SKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFP  297 (380)
Q Consensus       229 -----------~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~p  297 (380)
                                 ++.+||+|||++......   .....||+.|+|||++..     ..++.++|||||||++|+|++|+.|
T Consensus       187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p  258 (360)
T 3llt_A          187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILN-----LGWDVSSDMWSFGCVLAELYTGSLL  258 (360)
T ss_dssp             TCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcC-----CCCCCccchHHHHHHHHHHHHCCCC
Confidence                       788999999999865432   356789999999999853     4567899999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHhhCCCC------------------------------------------CCCccccHHHHHHHHH
Q 016959          298 FAVGRQGDWASLMFAICFAQPP------------------------------------------EAPEMASREFRDFISR  335 (380)
Q Consensus       298 f~~~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~li~~  335 (380)
                      |......+....+.......+.                                          ......+..+.+||.+
T Consensus       259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  338 (360)
T 3llt_A          259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS  338 (360)
T ss_dssp             CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred             CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence            9754433333333222211110                                          0001123678899999


Q ss_pred             hcccCcCCCCCHHHHhcCcccc
Q 016959          336 CLQKDPHSRWPAAQLLQHPFIL  357 (380)
Q Consensus       336 ~l~~dp~~R~t~~eil~hp~~~  357 (380)
                      ||+.||++|||+.|+|+||||+
T Consensus       339 ~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          339 ILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HhcCChhhCCCHHHHhcCcccC
Confidence            9999999999999999999996

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.7e-50  Score=367.55  Aligned_cols=258  Identities=26%  Similarity=0.417  Sum_probs=219.6

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      ...++|.+.+.||+|+||+||+|.+..+++.||+|++....  .....+.+.+|+.+++.++|+||+++++++.+.+..+
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence            34578999999999999999999999999999999986542  3455678899999999999999999999999999999


Q ss_pred             EEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 016959          174 VLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  249 (380)
                      +||||+.+++|.++..    ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  171 (294)
T 2rku_A           92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  171 (294)
T ss_dssp             EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence            9999999999876643    357788999999999999999999999999999999999999999999999876544444


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      .....||+.|+|||++..     ..++.++||||||+++|+|++|..||....   ......... ......+..++..+
T Consensus       172 ~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~-~~~~~~~~~~~~~~  242 (294)
T 2rku_A          172 KKVLCGTPNYIAPEVLSK-----KGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIK-KNEYSIPKHINPVA  242 (294)
T ss_dssp             BCCCCSCCSSCCHHHHTT-----SCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHH-TTCCCCCTTSCHHH
T ss_pred             cccccCCCCcCCcchhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHh-hccCCCccccCHHH
Confidence            456779999999999853     456789999999999999999999996432   222322222 33345667789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      .+||.+||+.||++|||++|+++||||......
T Consensus       243 ~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  275 (294)
T 2rku_A          243 ASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  275 (294)
T ss_dssp             HHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             HHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence            999999999999999999999999999876543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.4e-50  Score=387.93  Aligned_cols=262  Identities=26%  Similarity=0.346  Sum_probs=205.3

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC-----Ce
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN-----GE  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~  171 (380)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++|+||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            578999999999999999999999999999999996543 334557789999999999999999999998765     57


Q ss_pred             EEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          172 IEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      +|+||||+.+ +|...+.    ..+..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus       105 ~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  183 (432)
T 3n9x_A          105 LYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK  183 (432)
T ss_dssp             EEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred             EEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence            9999999975 7755543    4677899999999999999999999999999999999999999999999998765332


Q ss_pred             C----------------------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCC------
Q 016959          248 D----------------------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFA------  299 (380)
Q Consensus       248 ~----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~------  299 (380)
                      .                      .....+||+.|+|||++..    +..++.++||||||||+|||++|..||.      
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~----~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~  259 (432)
T 3n9x_A          184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL----QENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR  259 (432)
T ss_dssp             ---------------------------CCCCCTTCCHHHHTT----CSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred             cccccccccccccccccccchhccccCCCCCccccCHHHHhc----CCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence            1                      2356789999999998743    3557889999999999999998544443      


Q ss_pred             -----CCCC-----------------CCHHHHHHHHh--------------------hCCCCC-------CCccccHHHH
Q 016959          300 -----VGRQ-----------------GDWASLMFAIC--------------------FAQPPE-------APEMASREFR  330 (380)
Q Consensus       300 -----~~~~-----------------~~~~~~~~~~~--------------------~~~~~~-------~~~~~~~~~~  330 (380)
                           ....                 .+....+....                    ...+..       ....+++++.
T Consensus       260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  339 (432)
T 3n9x_A          260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI  339 (432)
T ss_dssp             CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred             cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence                 1110                 00111111111                    011111       1134789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                      +||.+||+.||++|||++|+|+||||+...+...
T Consensus       340 dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~  373 (432)
T 3n9x_A          340 NLLESMLKFNPNKRITIDQALDHPYLKDVRKKKL  373 (432)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTT
T ss_pred             HHHHHHhcCCcccCCCHHHHhcChhhhhccCccc
Confidence            9999999999999999999999999999876554

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.6e-51  Score=381.84  Aligned_cols=264  Identities=27%  Similarity=0.430  Sum_probs=210.1

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            4578999999999999999999999999999999986544 344566788999999999999999999999999999999


Q ss_pred             EeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCC
Q 016959          176 LEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       176 ~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      |||+.+++|..+..    ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+........
T Consensus       103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  182 (331)
T 4aaa_A          103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD  182 (331)
T ss_dssp             EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred             EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccC
Confidence            99999988765532    35678889999999999999999999999999999999999999999999987665444445


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC--------------
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ--------------  317 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------------  317 (380)
                      ...||..|+|||++.+    ...++.++|||||||++|+|++|..||......+....+.......              
T Consensus       183 ~~~~t~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          183 DEVATRWYRAPELLVG----DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             -CCCCCTTCCHHHHTT----CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             CCcCCccccCcccccC----CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence            6779999999999853    2356789999999999999999999997543322222221111100              


Q ss_pred             ----CCC---------CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          318 ----PPE---------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       318 ----~~~---------~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                          .+.         ....++.++.+||.+||+.||++|||+.|+|+||||+..++...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~  318 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAER  318 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHHHH
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChhhh
Confidence                000         11246889999999999999999999999999999998765543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1e-50  Score=383.82  Aligned_cols=268  Identities=38%  Similarity=0.664  Sum_probs=221.6

Q ss_pred             cccccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC
Q 016959           90 QNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRN  169 (380)
Q Consensus        90 ~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  169 (380)
                      ......+..++|++.+.||+|+||+||+|.+..+++.||+|++...........+.+|+.+++.++|+||+++++++...
T Consensus        24 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  103 (360)
T 3eqc_A           24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD  103 (360)
T ss_dssp             HHTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred             hhcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence            34455677899999999999999999999999999999999998776666778899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKR-KIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      +.+++||||+.+++|.+++.    ..+..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus       104 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            99999999999999977654    35677889999999999999996 99999999999999999999999999997664


Q ss_pred             ccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCH------------------
Q 016959          245 QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDW------------------  306 (380)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------------------  306 (380)
                      ...  .....||+.|+|||++..     ..++.++|||||||++|+|++|..||......+.                  
T Consensus       184 ~~~--~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (360)
T 3eqc_A          184 DSM--ANSFVGTRSYMSPERLQG-----THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR  256 (360)
T ss_dssp             HHC------CCCCTTCCHHHHTT-----CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred             ccc--ccCCCCCCCeECHHHHcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence            332  245679999999999853     5567899999999999999999999974332211                  


Q ss_pred             ---------------------HHHHHHHhhCCCCC-CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          307 ---------------------ASLMFAICFAQPPE-APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       307 ---------------------~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                                           ............+. ....++.++.+||.+||+.||++|||++|+|+||||++......
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  336 (360)
T 3eqc_A          257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV  336 (360)
T ss_dssp             -----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSCC
T ss_pred             cccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhhh
Confidence                                 11111122222222 22347889999999999999999999999999999998765544

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.6e-50  Score=377.56  Aligned_cols=262  Identities=27%  Similarity=0.419  Sum_probs=214.4

Q ss_pred             cccccc-ceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEEE
Q 016959           99 AELQKG-NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        99 ~~~~~~-~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  175 (380)
                      +.|.+. +.||+|+||+||+|.+..+++.||||++.... .......+.+|+.+++.+. ||||+++++++.+.+.+++|
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv  107 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI  107 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence            456666 88999999999999999999999999986543 2233567889999999995 79999999999999999999


Q ss_pred             EeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCcEEEeecccccccccc
Q 016959          176 LEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS---SKNVKIADFGVSRILAQT  246 (380)
Q Consensus       176 ~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~---~~~~kl~Dfg~a~~~~~~  246 (380)
                      |||+.+++|.+++.      ..+..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||++......
T Consensus       108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  187 (327)
T 3lm5_A          108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA  187 (327)
T ss_dssp             EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence            99999999877653      356778999999999999999999999999999999997   789999999999876543


Q ss_pred             CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcccc
Q 016959          247 MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS  326 (380)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (380)
                      . ......||+.|+|||++.     +..++.++|||||||++|+|++|..||......+....+...........+..++
T Consensus       188 ~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  261 (327)
T 3lm5_A          188 C-ELREIMGTPEYLAPEILN-----YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS  261 (327)
T ss_dssp             -------CCCGGGCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred             c-ccccccCCcCccCCeeec-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccC
Confidence            2 234567999999999985     3556789999999999999999999997544333333333333444555566789


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccccc
Q 016959          327 REFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQ  366 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~  366 (380)
                      ..+.+||.+||+.||++|||++|+|+||||+..++.....
T Consensus       262 ~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~~~  301 (327)
T 3lm5_A          262 QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFH  301 (327)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC--
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccccC
Confidence            9999999999999999999999999999999987766543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-50  Score=374.59  Aligned_cols=258  Identities=28%  Similarity=0.445  Sum_probs=200.8

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC----chHHHHHHHHHHHHHHhC---CCCceeeeEeEEee
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH----EDSVRSQICREIEILRDV---NHPNVVKCHDMYDR  168 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~  168 (380)
                      +..++|++.++||+|+||+||+|++..+++.||||++....    .......+.+|+.+++.+   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            34578999999999999999999999999999999985322    111123455677776666   59999999999987


Q ss_pred             CC-----eEEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeec
Q 016959          169 NG-----EIEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADF  237 (380)
Q Consensus       169 ~~-----~~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  237 (380)
                      ..     .+++||||+.+ +|.+++.      ..+..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence            55     58999999985 7655432      467788999999999999999999999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC
Q 016959          238 GVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ  317 (380)
Q Consensus       238 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  317 (380)
                      |++...... .......||+.|+|||++..     ..++.++|||||||++|+|++|..||......+....+.......
T Consensus       165 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (308)
T 3g33_A          165 GLARIYSYQ-MALTPVVVTLWYRAPEVLLQ-----STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP  238 (308)
T ss_dssp             SCTTTSTTC-CCSGGGGCCCSSCCHHHHHT-----SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccCCC-cccCCccccccccCchHHcC-----CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999866533 23355679999999999853     456789999999999999999999997544433333333322211


Q ss_pred             CCC-----------------------CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          318 PPE-----------------------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       318 ~~~-----------------------~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      ...                       ....++.++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            111                       1134778999999999999999999999999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.3e-50  Score=367.78  Aligned_cols=254  Identities=29%  Similarity=0.491  Sum_probs=214.8

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .+..++|++.+.||+|+||.||+|.+..+++.||||++....  .......+.+|+.+++.++|+||+++++++.+.+..
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence            466789999999999999999999999999999999985432  122246788999999999999999999999999999


Q ss_pred             EEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          173 EVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ++||||+.+++|.+++.    ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--  167 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--  167 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc--
Confidence            99999999999876554    357788899999999999999999999999999999999999999999998765432  


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHH
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE  328 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (380)
                      ......|++.|+|||++..     ..++.++||||||+++|+|++|..||.....   ......+ .......+..++.+
T Consensus       168 ~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~-~~~~~~~~~~~~~~  238 (284)
T 2vgo_A          168 RRRTMCGTLDYLPPEMIEG-----KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH---TETHRRI-VNVDLKFPPFLSDG  238 (284)
T ss_dssp             CBCCCCSCGGGCCHHHHTT-----CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHH-HTTCCCCCTTSCHH
T ss_pred             ccccccCCCCcCCHHHhcc-----CCCCcccchhhHHHHHHHHHHCCCCCCCCCH---hHHHHHH-hccccCCCCcCCHH
Confidence            2345679999999999853     4557799999999999999999999964332   2222222 23344566778999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          329 FRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      +.+||.+||..||++|||+.|+++||||+..
T Consensus       239 ~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          239 SKDLISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence            9999999999999999999999999999853

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=8.8e-51  Score=370.12  Aligned_cols=251  Identities=28%  Similarity=0.412  Sum_probs=210.5

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++....... .+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            357999999999999999999999999999999986543322 4678899999999999999999999999999999999


Q ss_pred             ccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCcEEEeeccccccccccCCCC
Q 016959          178 YMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI---NSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       178 ~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      |+.+++|.+.+.    ..+..++.++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++...... ...
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~-~~~  165 (277)
T 3f3z_A           87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMM  165 (277)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-SCB
T ss_pred             ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-cch
Confidence            999999866543    3577889999999999999999999999999999999   78889999999999876543 233


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCC---CccccH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA---PEMASR  327 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  327 (380)
                      ....||+.|+|||++.+      .++.++|||||||++|+|++|..||.....   ......+........   ...++.
T Consensus       166 ~~~~~t~~y~aPE~~~~------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  236 (277)
T 3f3z_A          166 RTKVGTPYYVSPQVLEG------LYGPECDEWSAGVMMYVLLCGYPPFSAPTD---SEVMLKIREGTFTFPEKDWLNVSP  236 (277)
T ss_dssp             CCCCSCTTTCCHHHHTT------CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred             hccCCCCCccChHHhcc------cCCchhhehhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCCCCCCchhhhcCCH
Confidence            55679999999999842      367799999999999999999999974332   333333332222211   125789


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence            99999999999999999999999999999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8e-51  Score=399.60  Aligned_cols=257  Identities=30%  Similarity=0.454  Sum_probs=212.4

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      .++|++.++||+|+||+||+|.+..+++.||||++.... .......+.+|+.+|+.++||||+++++++.+.+.+++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            367999999999999999999999999999999985322 1122467889999999999999999999999999999999


Q ss_pred             eccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc---CCCcEEEeeccccccccccCCC
Q 016959          177 EYMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN---SSKNVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       177 e~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~---~~~~~kl~Dfg~a~~~~~~~~~  249 (380)
                      |||.+++|.+.+    ...+..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...... ..
T Consensus       101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~  179 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TK  179 (486)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred             EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-Cc
Confidence            999999986554    336778899999999999999999999999999999995   4567999999999866543 23


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      ....+||+.|+|||++.+      .++.++||||||||+|+|++|..||......+....+.........+.+..++.++
T Consensus       180 ~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  253 (486)
T 3mwu_A          180 MKDRIGTAYYIAPEVLRG------TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA  253 (486)
T ss_dssp             --CCTTGGGGCCGGGGGS------CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred             cCCCcCCCCCCCHHHhCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHH
Confidence            356679999999999852      36789999999999999999999997543333333333322333334456789999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      ++||.+||+.||++|||+.|+|+||||+....
T Consensus       254 ~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence            99999999999999999999999999997644

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.6e-50  Score=369.66  Aligned_cols=256  Identities=34%  Similarity=0.537  Sum_probs=221.7

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .+.|++.+.||+|+||.||+|.+..+++.||||++.........+.+.+|+.+++.++|+||+++++++.+.+.+++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            35689999999999999999999999999999999765544456788999999999999999999999999999999999


Q ss_pred             ccCCCCccccccc---chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCC
Q 016959          178 YMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV  254 (380)
Q Consensus       178 ~~~~~~L~~~~~~---~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (380)
                      |+.+++|.+++..   .+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............
T Consensus       101 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  180 (303)
T 3a7i_A          101 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV  180 (303)
T ss_dssp             CCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCC
T ss_pred             eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCccC
Confidence            9999998776543   5778889999999999999999999999999999999999999999999987765444445677


Q ss_pred             CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHH
Q 016959          255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS  334 (380)
Q Consensus       255 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  334 (380)
                      ||+.|+|||++..     ..++.++|||||||++|+|++|..||...   .................+..++..+.+||.
T Consensus       181 ~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  252 (303)
T 3a7i_A          181 GTPFWMAPEVIKQ-----SAYDSKADIWSLGITAIELARGEPPHSEL---HPMKVLFLIPKNNPPTLEGNYSKPLKEFVE  252 (303)
T ss_dssp             SCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSCCCCCCSSCCHHHHHHHH
T ss_pred             CCcCccCHHHHhc-----CCCCchhhhHHHHHHHHHHccCCCCCCCc---CHHHHHHHhhcCCCCCCccccCHHHHHHHH
Confidence            9999999999853     45567999999999999999999999633   333444444455566677788999999999


Q ss_pred             HhcccCcCCCCCHHHHhcCccccccCc
Q 016959          335 RCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       335 ~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      +||+.||++|||+.|+++||||.+...
T Consensus       253 ~~l~~dp~~Rps~~~ll~~~~~~~~~~  279 (303)
T 3a7i_A          253 ACLNKEPSFRPTAKELLKHKFILRNAK  279 (303)
T ss_dssp             HHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred             HHcCCChhhCcCHHHHhhChhhhcCCC
Confidence            999999999999999999999987643

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-50  Score=383.33  Aligned_cols=257  Identities=27%  Similarity=0.384  Sum_probs=204.2

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC------C
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN------G  170 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~  170 (380)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++|+||+++++++...      .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467999999999999999999999999999999985543 344567788999999999999999999999765      3


Q ss_pred             eEEEEEeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          171 EIEVLLEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      .+|+||||+ +++|..++.   ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-  181 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-  181 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred             eEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc-
Confidence            469999999 677766543   357778899999999999999999999999999999999999999999999876533 


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC---------
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP---------  318 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------  318 (380)
                        ....+||+.|+|||++.+    ...++.++||||||||+|||++|+.||......+....+.......+         
T Consensus       182 --~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          182 --MTGYVVTRWYRAPEVILN----WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             --CCSSCSCGGGCCTHHHHT----TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             --cCcCcCCCCcCCHHHHhC----CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence              356789999999999853    24567899999999999999999999975443332222222111110         


Q ss_pred             ------------------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          319 ------------------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       319 ------------------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                                        ......++.++.+||.+||+.||++|||+.|+|+||||+.....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence                              01234568899999999999999999999999999999987543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.7e-51  Score=400.08  Aligned_cols=254  Identities=30%  Similarity=0.457  Sum_probs=208.8

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ++|++.++||+|+||+||+|++..+++.||||++.... .......+.+|+.+++.++||||++++++|.+.+.+++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            57999999999999999999999999999999996543 12234678899999999999999999999999999999999


Q ss_pred             ccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CcEEEeeccccccccccCCCC
Q 016959          178 YMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS---KNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       178 ~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~---~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      ||.+++|.+.+    ...+..+..++.||+.||.|||++||+||||||+|||++..   +.+||+|||++...... ...
T Consensus       117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-~~~  195 (494)
T 3lij_A          117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKM  195 (494)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-BCB
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-ccc
Confidence            99999986544    33577888999999999999999999999999999999764   45999999999876543 233


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR  330 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (380)
                      ...+||+.|+|||++.      ..++.++|||||||++|+|++|..||......+....+...........+..++.+++
T Consensus       196 ~~~~gt~~y~aPE~l~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  269 (494)
T 3lij_A          196 KERLGTAYYIAPEVLR------KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK  269 (494)
T ss_dssp             CCCCSCTTTCCHHHHT------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred             cccCCCcCeeCHHHHc------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence            5677999999999984      3467799999999999999999999975443333333333333333344567899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      +||.+||+.||++|||+.|+|+||||+..
T Consensus       270 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          270 DLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            99999999999999999999999999875

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1e-50  Score=391.38  Aligned_cols=263  Identities=29%  Similarity=0.457  Sum_probs=203.2

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-------chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-------EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      .++|.+.+.||+|+||+||+|.+..+++.||||++....       .......+.+|+.+|++++||||+++++++.. +
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            467999999999999999999999999999999986432       11223357899999999999999999999864 5


Q ss_pred             eEEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---cEEEeeccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK---NVKIADFGVSRIL  243 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~---~~kl~Dfg~a~~~  243 (380)
                      .+++||||+.+++|.+++.    ..+..++.++.||+.||+|||++||+||||||+|||++.++   .+||+|||+++..
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            6899999999999977654    35778889999999999999999999999999999997544   4999999999876


Q ss_pred             cccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-CHHHHHHHHhhCCCCCCC
Q 016959          244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG-DWASLMFAICFAQPPEAP  322 (380)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  322 (380)
                      ... ......+||+.|+|||++...  ....++.++|||||||++|+|++|..||...... .....+........+..+
T Consensus       293 ~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~  369 (419)
T 3i6u_A          293 GET-SLMRTLCGTPTYLAPEVLVSV--GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  369 (419)
T ss_dssp             C------------CTTCCTTTTC------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred             CCC-ccccccCCCCCccCceeeecC--CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence            543 233567899999999998421  1244577999999999999999999999754333 233333222222222333


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                      ..++.++.+||.+||+.||++|||++|+|+||||++......
T Consensus       370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~  411 (419)
T 3i6u_A          370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK  411 (419)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHHHH
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHHHH
Confidence            567899999999999999999999999999999998655443

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.8e-51  Score=401.78  Aligned_cols=258  Identities=28%  Similarity=0.424  Sum_probs=215.2

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      -.++|++.+.||+|+||+||+|.+..+++.||||++....  .......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3468999999999999999999999999999999986442  23345678899999999999999999999999999999


Q ss_pred             EEeccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCcEEEeeccccccccccC
Q 016959          175 LLEYMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI---NSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       175 v~e~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      |||||.+++|.+.+    ...+..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..+... 
T Consensus       104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-  182 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-  182 (484)
T ss_dssp             EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC-
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc-
Confidence            99999999986544    33677889999999999999999999999999999999   46788999999999876543 


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                      ......+||+.|+|||++.+      .++.++|||||||++|+|++|..||......+....+...........+..++.
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  256 (484)
T 3nyv_A          183 KKMKDKIGTAYYIAPEVLHG------TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE  256 (484)
T ss_dssp             CSHHHHTTGGGTCCHHHHHT------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred             cccccCCCCccccCceeecC------CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence            22345679999999999852      367799999999999999999999974433333333322222233344567899


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      ++++||.+||+.||++|||+.|+|+||||+....
T Consensus       257 ~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          257 SAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence            9999999999999999999999999999998654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1e-50  Score=400.49  Aligned_cols=258  Identities=29%  Similarity=0.440  Sum_probs=210.9

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCch------------HHHHHHHHHHHHHHhCCCCceeeeEeE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED------------SVRSQICREIEILRDVNHPNVVKCHDM  165 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~~~  165 (380)
                      .++|.+.++||+|+||+||+|.+..+++.||||++......            ...+.+.+|+.+|+.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            46799999999999999999999999999999999654311            235678899999999999999999999


Q ss_pred             EeeCCeEEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---cEEEeecc
Q 016959          166 YDRNGEIEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK---NVKIADFG  238 (380)
Q Consensus       166 ~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~---~~kl~Dfg  238 (380)
                      |.+.+.+++|||||.+++|.+.+.    ..+..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  194 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG  194 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence            999999999999999999866543    36778899999999999999999999999999999999776   69999999


Q ss_pred             ccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC
Q 016959          239 VSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP  318 (380)
Q Consensus       239 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  318 (380)
                      ++...... ......+||+.|+|||++.      ..++.++|||||||++|+|++|..||......+....+........
T Consensus       195 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  267 (504)
T 3q5i_A          195 LSSFFSKD-YKLRDRLGTAYYIAPEVLK------KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD  267 (504)
T ss_dssp             TCEECCTT-SCBCCCCSCTTTCCHHHHT------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             CCEEcCCC-CccccccCCcCCCCHHHhc------cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            99876543 2335667999999999984      3367799999999999999999999974433322222222211122


Q ss_pred             CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          319 PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       319 ~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      ...+..++.++++||.+||+.||++|||+.|+|+||||++....
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  311 (504)
T 3q5i_A          268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN  311 (504)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred             ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence            22335689999999999999999999999999999999876543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1e-50  Score=369.93  Aligned_cols=255  Identities=27%  Similarity=0.485  Sum_probs=191.8

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      .++|++.+.||+|+||.||+|++..+++.||||++....  .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            468999999999999999999999899999999985432  112246788999999999999999999999999999999


Q ss_pred             EeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          176 LEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       176 ~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      |||+.+++|..++.     ..+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  169 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH  169 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence            99999999876543     3577889999999999999999999999999999999999999999999998765443334


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR  330 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (380)
                      ....||+.|+|||++..     ..++.++|||||||++|+|++|..||..........   .. .......+..++.++.
T Consensus       170 ~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~  240 (278)
T 3cok_A          170 YTLCGTPNYISPEIATR-----SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN---KV-VLADYEMPSFLSIEAK  240 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------C-CSSCCCCCTTSCHHHH
T ss_pred             eeccCCCCcCCcchhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH---HH-hhcccCCccccCHHHH
Confidence            45679999999999853     456779999999999999999999997544332211   11 1222345667899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      +||.+||+.||++|||+.|+|+||||.+...
T Consensus       241 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          241 DLIHQLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             HHHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence            9999999999999999999999999987543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.6e-50  Score=381.84  Aligned_cols=256  Identities=31%  Similarity=0.500  Sum_probs=211.5

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-------hHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCC
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-------DSVRSQICREIEILRDV-NHPNVVKCHDMYDRNG  170 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  170 (380)
                      ++|.+.+.||+|+||.||+|.+..+|+.||||++.....       ....+.+.+|+.+++.+ +||||+++++++...+
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            568999999999999999999998999999999865431       23356788999999999 7999999999999999


Q ss_pred             eEEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      ..++||||+.+++|.+++.    ..+..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+...
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~  253 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG  253 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence            9999999999999876653    356778899999999999999999999999999999999999999999999877543


Q ss_pred             CCCCCCCCCCCccccccccccccC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC---CCCC
Q 016959          247 MDPCNSAVGTIAYMSPERINTDLN-HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP---PEAP  322 (380)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~  322 (380)
                       ......+||+.|+|||++..... ....++.++|||||||++|+|++|..||....   .......+.....   ...+
T Consensus       254 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~  329 (365)
T 2y7j_A          254 -EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILMLRMIMEGQYQFSSPEW  329 (365)
T ss_dssp             -CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCHHHH
T ss_pred             -cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCCCccc
Confidence             23356789999999999853211 12346779999999999999999999996432   2222222222221   1122


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR  358 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~  358 (380)
                      ..++.++.+||.+||+.||++|||+.|+|+||||++
T Consensus       330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            457889999999999999999999999999999974

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5.8e-50  Score=371.24  Aligned_cols=248  Identities=28%  Similarity=0.375  Sum_probs=197.5

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      .++|++.++||+|+||+||+|.+..+++.||||++.... ..........|+..+..+ +|+||++++++|.+.+.+++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            467999999999999999999999999999999986543 233334455556555554 899999999999999999999


Q ss_pred             EeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          176 LEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       176 ~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      |||+ +++|...+.     ..+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~~~  213 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAG  213 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-CCC
Confidence            9999 456654432     467788999999999999999999999999999999999999999999999876543 223


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR  330 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (380)
                      ....||+.|+|||++.+      .++.++|||||||++|||++|..+|...   +  ..........+...+..++.++.
T Consensus       214 ~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~el~~g~~~~~~~---~--~~~~~~~~~~~~~~~~~~~~~l~  282 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQG------SYGTAADVFSLGLTILEVACNMELPHGG---E--GWQQLRQGYLPPEFTAGLSSELR  282 (311)
T ss_dssp             -CCCCCGGGCCGGGGGT------CCSTHHHHHHHHHHHHHHHHTCCCCSSH---H--HHHHHTTTCCCHHHHTTSCHHHH
T ss_pred             cccCCCccccCHhHhcC------CCCchhhHHHHHHHHHHHHhCCCCCCCc---c--HHHHHhccCCCcccccCCCHHHH
Confidence            45669999999999852      4677999999999999999997776421   1  11111111222234456789999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccccc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFILR  358 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~~~  358 (380)
                      +||.+||+.||++|||+.|+|+||||++
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          283 SVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            9999999999999999999999999975

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=9.3e-51  Score=376.98  Aligned_cols=260  Identities=29%  Similarity=0.428  Sum_probs=202.3

Q ss_pred             cccccc-ceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKG-NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~-~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      +.|++. +.||+|+||+||+|.+..+++.||||++..... .....+.+|+.+++++ +||||+++++++.+.+.+++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            568874 789999999999999999999999999965533 2346788999999985 7999999999999999999999


Q ss_pred             eccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc---EEEeeccccccccccC--
Q 016959          177 EYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN---VKIADFGVSRILAQTM--  247 (380)
Q Consensus       177 e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~---~kl~Dfg~a~~~~~~~--  247 (380)
                      ||+.+++|.+++.    ..+..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++.......  
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~  170 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC  170 (316)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred             EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence            9999999876653    356778899999999999999999999999999999998776   9999999987654221  


Q ss_pred             -----CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC------------HHHHH
Q 016959          248 -----DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD------------WASLM  310 (380)
Q Consensus       248 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------------~~~~~  310 (380)
                           ......+||+.|+|||++.........++.++|||||||++|+|++|..||......+            .....
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  250 (316)
T 2ac3_A          171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF  250 (316)
T ss_dssp             -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred             ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence                 1123456999999999985311111345678999999999999999999997543322            11122


Q ss_pred             HHHhhCCCCCCC----ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          311 FAICFAQPPEAP----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       311 ~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      ..+... ....+    ..++.++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       251 ~~i~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          251 ESIQEG-KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHHC-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             HHHhcc-CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence            222222 22222    35788999999999999999999999999999999753

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6.4e-50  Score=379.71  Aligned_cols=251  Identities=22%  Similarity=0.363  Sum_probs=213.6

Q ss_pred             cCCCcccccccceecccCCceEEEEEeC-------CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeE
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHP-------PTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDM  165 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~  165 (380)
                      +.+..++|.+++.||+|+||+||+|++.       .++..||||+++........+.+.+|+.+++.+ +||||++++++
T Consensus        76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  155 (370)
T 2psq_A           76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  155 (370)
T ss_dssp             TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred             ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            4467789999999999999999999864       345679999998776666678899999999999 89999999999


Q ss_pred             EeeCCeEEEEEeccCCCCcccccc--------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 016959          166 YDRNGEIEVLLEYMDGGSLEGAHI--------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLL  225 (380)
Q Consensus       166 ~~~~~~~~lv~e~~~~~~L~~~~~--------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil  225 (380)
                      +.+.+.+|+||||+.+++|.+++.                    .....+..++.||+.||+|||++||+||||||+|||
T Consensus       156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl  235 (370)
T 2psq_A          156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL  235 (370)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence            999999999999999999976643                    245678889999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 016959          226 INSSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGR  302 (380)
Q Consensus       226 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~  302 (380)
                      ++.++.+||+|||+++.+.....  ......+|+.|+|||++..     ..++.++|||||||++|||++ |..||....
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-----RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-----CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999999999999986654321  2234567889999999853     567889999999999999999 999997544


Q ss_pred             CCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          303 QGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..+   ....+........+..++.++.+||.+||+.||++|||+.|+++
T Consensus       311 ~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~  357 (370)
T 2psq_A          311 VEE---LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  357 (370)
T ss_dssp             GGG---HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHH---HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            433   33444445566677789999999999999999999999999997

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.5e-50  Score=385.72  Aligned_cols=270  Identities=29%  Similarity=0.387  Sum_probs=208.4

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC------e
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG------E  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~  171 (380)
                      ..+|.+.+.||+|+||+||+|++..+++ ||+|++......     ..+|+.+++.++|+||++++++|...+      .
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            4679999999999999999999987666 788877543321     236999999999999999999985443      3


Q ss_pred             EEEEEeccCCCCcccc-------cccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCcEEEeeccccccc
Q 016959          172 IEVLLEYMDGGSLEGA-------HIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN-SSKNVKIADFGVSRIL  243 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~  243 (380)
                      +++||||+.++.+...       ....+..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.+
T Consensus       113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            8899999997654322       2235677889999999999999999999999999999999 7999999999999876


Q ss_pred             cccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC-----
Q 016959          244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP-----  318 (380)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----  318 (380)
                      ... .......||+.|+|||++.+    ...++.++|||||||++|||++|+.||......+....+........     
T Consensus       193 ~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          193 IAG-EPNVSYICSRYYRAPELIFG----ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             CTT-CCCCSSCSCGGGCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cCC-CCCcccccCcCccCHHHHcC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            543 23356678999999999853    24578899999999999999999999975433322222222110000     


Q ss_pred             -----------C---------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccccccccccCCCCCCC
Q 016959          319 -----------P---------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPL  378 (380)
Q Consensus       319 -----------~---------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  378 (380)
                                 +         ..+..++.++.+||.+||+.||++|||+.|+|+||||+.+............+|+...|
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~  347 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNW  347 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTSSCCCCSCCC
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCCCCCCCcCCC
Confidence                       0         12234788999999999999999999999999999999987665544334455554444

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.4e-50  Score=384.46  Aligned_cols=255  Identities=26%  Similarity=0.412  Sum_probs=202.1

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee-------
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR-------  168 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------  168 (380)
                      ...++|++++.||+|+||+||+|.+..+|+.||||++......     ..+|+.+++.++|+||++++++|..       
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            3456899999999999999999999999999999998654322     2369999999999999999999843       


Q ss_pred             -------------------------------CCeEEEEEeccCCCCccccc--------ccchHHHHHHHHHHHHHHHHH
Q 016959          169 -------------------------------NGEIEVLLEYMDGGSLEGAH--------IRQEHILSDLARQVLSGLAYL  209 (380)
Q Consensus       169 -------------------------------~~~~~lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~al~~L  209 (380)
                                                     ...+++||||+.+ +|.+.+        ...+..++.++.||+.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           3348899999985 543332        245677889999999999999


Q ss_pred             HhCCceecCCCCCcEEEc-CCCcEEEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHH
Q 016959          210 HKRKIVHRDIKPSNLLIN-SSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSI  288 (380)
Q Consensus       210 H~~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il  288 (380)
                      |++||+||||||+|||++ .++.+||+|||+++.+... .......||+.|+|||++.+    ...++.++|||||||++
T Consensus       158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLG----ATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTT----CSSCCTHHHHHHHHHHH
T ss_pred             HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcC----CCCCCcchhhhhHHHHH
Confidence            999999999999999998 6889999999999876543 23356678999999999853    24467899999999999


Q ss_pred             HHHHhCCCCCCCCCCCCHHHHHHHHhhCCC----------------C---------CCCccccHHHHHHHHHhcccCcCC
Q 016959          289 LEFYLGRFPFAVGRQGDWASLMFAICFAQP----------------P---------EAPEMASREFRDFISRCLQKDPHS  343 (380)
Q Consensus       289 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----------------~---------~~~~~~~~~~~~li~~~l~~dp~~  343 (380)
                      |+|++|+.||......+....+........                +         ..+..++.++.+||.+||+.||++
T Consensus       233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  312 (383)
T 3eb0_A          233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL  312 (383)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence            999999999975433332222222111100                0         033457889999999999999999


Q ss_pred             CCCHHHHhcCccccccCc
Q 016959          344 RWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       344 R~t~~eil~hp~~~~~~~  361 (380)
                      |||+.|+|+||||+.+..
T Consensus       313 R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          313 RINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             SCCHHHHHTSGGGHHHHH
T ss_pred             CCCHHHHhcCHHHHHHHh
Confidence            999999999999988643

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.8e-50  Score=370.33  Aligned_cols=265  Identities=31%  Similarity=0.515  Sum_probs=213.4

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      ....+.|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus        15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   93 (302)
T 2j7t_A           15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI   93 (302)
T ss_dssp             SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred             cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH-HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence            3445789999999999999999999999999999999865432 234678899999999999999999999999999999


Q ss_pred             EEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 016959          175 LLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       175 v~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  249 (380)
                      ||||+.+++|..++.     ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  173 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK  173 (302)
T ss_dssp             EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred             EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence            999999999876533     357788999999999999999999999999999999999999999999998654332222


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC--CCCccccH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP--EAPEMASR  327 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  327 (380)
                      .....||..|+|||++......+..++.++|||||||++|+|++|..||...   +.............+  ..+..++.
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  250 (302)
T 2j7t_A          174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL---NPMRVLLKIAKSDPPTLLTPSKWSV  250 (302)
T ss_dssp             -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred             cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC---CHHHHHHHHhccCCcccCCccccCH
Confidence            3456799999999998532223456678999999999999999999999743   223333333333332  23566889


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                      ++.+||.+||+.||++|||+.|+++||||+......
T Consensus       251 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  286 (302)
T 2j7t_A          251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK  286 (302)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCH
T ss_pred             HHHHHHHHHcccChhhCCCHHHHhcChHHhhhccch
Confidence            999999999999999999999999999999876544

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.4e-50  Score=366.18  Aligned_cols=262  Identities=31%  Similarity=0.495  Sum_probs=200.5

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchH-HHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      .+..++|++.+.||+|+||+||+|.+..+++.||||++....... ....+.++...++.++||||+++++++.+.+..+
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            466789999999999999999999999999999999997654333 3344455556688889999999999999999999


Q ss_pred             EEEeccCCCCccccc--------ccchHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          174 VLLEYMDGGSLEGAH--------IRQEHILSDLARQVLSGLAYLHKR-KIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       174 lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      +||||+.+ +|.+++        ...+..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus        83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999986 553332        346778889999999999999998 99999999999999999999999999998765


Q ss_pred             ccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc
Q 016959          245 QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM  324 (380)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (380)
                      ... ......||+.|+|||++... ..+..++.++|||||||++|+|++|..||.... .....................
T Consensus       162 ~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~  238 (290)
T 3fme_A          162 DDV-AKDIDAGCKPYMAPERINPE-LNQKGYSVKSDIWSLGITMIELAILRFPYDSWG-TPFQQLKQVVEEPSPQLPADK  238 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCC-TTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS-CHHHHHHHHHHSCCCCCCTTT
T ss_pred             ccc-cccccCCCccccChhhcChh-hcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC-chHHHHHHHhccCCCCccccc
Confidence            432 22345799999999997431 124567789999999999999999999996322 222223333333333444457


Q ss_pred             ccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          325 ASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      ++.++.+||.+||+.||++|||+.|+++||||+...
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             CCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence            899999999999999999999999999999998753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=8.7e-50  Score=367.25  Aligned_cols=266  Identities=29%  Similarity=0.468  Sum_probs=216.2

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--------chHHHHHHHHHHHHHHhCC-CCceeeeEeEEee
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--------EDSVRSQICREIEILRDVN-HPNVVKCHDMYDR  168 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--------~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~  168 (380)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....        .....+.+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            468999999999999999999999999999999996442        1234567889999999995 9999999999999


Q ss_pred             CCeEEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          169 NGEIEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      .+..++||||+.+++|.+++.    ..+..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  175 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  175 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence            999999999999999977654    3567889999999999999999999999999999999999999999999998765


Q ss_pred             ccCCCCCCCCCCCccccccccccccC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          245 QTMDPCNSAVGTIAYMSPERINTDLN-HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      .. .......|++.|+|||++..... ....++.++|||||||++|+|++|..||...........+...........+.
T Consensus       176 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (298)
T 1phk_A          176 PG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD  254 (298)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred             CC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccccc
Confidence            43 23355679999999999853211 12445779999999999999999999997443322222222222222333445


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                      .++.++.+||.+||+.||++|||+.|+|+||||++......
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  295 (298)
T 1phk_A          255 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV  295 (298)
T ss_dssp             GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC----
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhh
Confidence            78999999999999999999999999999999998765443

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.9e-50  Score=379.25  Aligned_cols=257  Identities=26%  Similarity=0.357  Sum_probs=213.3

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC-----CeE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRN-----GEI  172 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~  172 (380)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++...........+.+|+.+++.++|+||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            368999999999999999999999999999999997665566667889999999999999999999998654     468


Q ss_pred             EEEEeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-
Q 016959          173 EVLLEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-  248 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-  248 (380)
                      ++||||+.+ +|.+++.   ..+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus       106 ~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  184 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH  184 (364)
T ss_dssp             EEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred             EEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCc
Confidence            999999985 6655433   35778889999999999999999999999999999999999999999999987654322 


Q ss_pred             --CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC-------
Q 016959          249 --PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP-------  319 (380)
Q Consensus       249 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  319 (380)
                        .....+||+.|+|||++..    +..++.++|||||||++|+|++|+.||......+....+.........       
T Consensus       185 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  260 (364)
T 3qyz_A          185 TGFLTEYVATRWYRAPEIMLN----SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  260 (364)
T ss_dssp             CCTTCCCCSCGGGCCHHHHHT----BCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred             cccccccccccCCCCCHHhcC----CCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence              2345689999999998753    345678999999999999999999999866555544444332211110       


Q ss_pred             ---------------C-----CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          320 ---------------E-----APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       320 ---------------~-----~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                                     .     ....++.++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence                           0     113468899999999999999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.1e-49  Score=363.57  Aligned_cols=254  Identities=26%  Similarity=0.469  Sum_probs=209.9

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEee----CC
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDR----NG  170 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~  170 (380)
                      .+...|.+.+.||+|+||+||+|.+..++..||+|++.... .......+.+|+.+++.++||||+++++++..    ..
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence            45566899999999999999999999999999999986543 34556788999999999999999999999875    45


Q ss_pred             eEEEEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEc-CCCcEEEeeccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRK--IVHRDIKPSNLLIN-SSKNVKIADFGVSRIL  243 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~  243 (380)
                      .+++||||+.+++|.+++..    .+..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++...
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            68999999999999776543    56778899999999999999999  99999999999998 7889999999999755


Q ss_pred             cccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC-CCCCCC
Q 016959          244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA-QPPEAP  322 (380)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~  322 (380)
                      ...  ......||+.|+|||++.      ..++.++|||||||++|+|++|..||....  ............ .+...+
T Consensus       183 ~~~--~~~~~~~t~~y~aPE~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~  252 (290)
T 1t4h_A          183 RAS--FAKAVIGTPEFMAPEMYE------EKYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGVKPASFD  252 (290)
T ss_dssp             CTT--SBEESCSSCCCCCGGGGG------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHHTTTCCCGGGG
T ss_pred             ccc--ccccccCCcCcCCHHHHh------ccCCCcchHHHHHHHHHHHHhCCCCCCCcC--cHHHHHHHHhccCCccccC
Confidence            432  234567999999999874      236789999999999999999999996432  233333333322 223345


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ...++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       253 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            5677899999999999999999999999999999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.3e-49  Score=374.49  Aligned_cols=253  Identities=31%  Similarity=0.465  Sum_probs=210.4

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      +.|.+.+.||+|+||+||+|.+..+++.||||++....  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            56899999999999999999999999999999996543  3444567889999999999999999999999999999999


Q ss_pred             eccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCC
Q 016959          177 EYMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       177 e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      ||+.| +|.+.+     ...+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......    .
T Consensus       134 e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----~  208 (348)
T 1u5q_A          134 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----N  208 (348)
T ss_dssp             ECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----C
T ss_pred             ecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----C
Confidence            99985 554332     2356778899999999999999999999999999999999999999999999766433    4


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC-CCCCCccccHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ-PPEAPEMASREFR  330 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  330 (380)
                      ..+||+.|+|||++...  .+..++.++|||||||++|||++|..||....   ............ +......++..+.
T Consensus       209 ~~~gt~~y~aPE~~~~~--~~~~~~~~~DiwslG~il~ell~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~  283 (348)
T 1u5q_A          209 SFVGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQNESPALQSGHWSEYFR  283 (348)
T ss_dssp             CCCSCGGGCCHHHHHTT--SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred             cccCCcceeCHhhhccc--cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            56799999999998421  13456779999999999999999999996432   223333333333 3334556889999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      +||.+||+.||++|||++|+|+||||.....
T Consensus       284 ~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~  314 (348)
T 1u5q_A          284 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  314 (348)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred             HHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence            9999999999999999999999999987543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2e-49  Score=362.41  Aligned_cols=248  Identities=27%  Similarity=0.387  Sum_probs=206.9

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++|++.+.||+|+||+||+|.+..+++.||||++.... .......+.+|+..+..+ +||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            67999999999999999999999999999999997543 233456788899999999 8999999999999999999999


Q ss_pred             eccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC------------------
Q 016959          177 EYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK------------------  230 (380)
Q Consensus       177 e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~------------------  230 (380)
                      ||+.+++|.+++.        ..+..++.++.||+.||+|||++||+||||||+|||++.++                  
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~  170 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK  170 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence            9999999987654        35677899999999999999999999999999999998444                  


Q ss_pred             -cEEEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHH
Q 016959          231 -NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASL  309 (380)
Q Consensus       231 -~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~  309 (380)
                       .+||+|||++......    ....||..|+|||++..    ...++.++|||||||++|+|++|..++..   .+   .
T Consensus       171 ~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~~~~~~~~---~~---~  236 (289)
T 1x8b_A          171 VMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQE----NYTHLPKADIFALALTVVCAAGAEPLPRN---GD---Q  236 (289)
T ss_dssp             CCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTT----CCTTHHHHHHHHHHHHHHHHTTCCCCCSS---SH---H
T ss_pred             eEEEEcccccccccCCc----cccCCCccccChhHhcC----CCCCCchhhHHHHHHHHHHHhcCCCCCcc---hh---H
Confidence             7999999999876543    34569999999999853    23455799999999999999999987742   11   2


Q ss_pred             HHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          310 MFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      .........+..+..++.++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          237 WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            333444555667778999999999999999999999999999999999753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.8e-50  Score=378.47  Aligned_cols=247  Identities=28%  Similarity=0.474  Sum_probs=208.5

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-------hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-------DSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      .++|++.+.||+|+||+||+|.+..+++.||||++.....       ......+.+|+.+++.++|+||++++++|.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            3679999999999999999999999999999999965431       112345678999999999999999999999999


Q ss_pred             eEEEEEeccCCC-Cccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          171 EIEVLLEYMDGG-SLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       171 ~~~lv~e~~~~~-~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      .+++||||+.+| +|..++    ...+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  182 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER  182 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence            999999999766 776554    346778899999999999999999999999999999999999999999999987654


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                      . ......+||+.|+|||++..    ..+++.++|||||||++|+|++|..||.....          ........+..+
T Consensus       183 ~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~~~~~~~~~~  247 (335)
T 3dls_A          183 G-KLFYTFCGTIEYCAPEVLMG----NPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAAIHPPYLV  247 (335)
T ss_dssp             T-CCBCEECSCGGGCCHHHHTT----CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GTTTCCCCSSCC
T ss_pred             C-CceeccCCCccccChhhhcC----CCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HHhhccCCCccc
Confidence            3 22345679999999999853    24457789999999999999999999963111          112233445668


Q ss_pred             cHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      +.++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       248 ~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          248 SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            9999999999999999999999999999999874

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.5e-50  Score=369.95  Aligned_cols=255  Identities=30%  Similarity=0.437  Sum_probs=211.1

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .++|.+.+.||+|+||+||+|.+..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            46799999999999999999999999999999999754322 24568899999999999999999999999999999999


Q ss_pred             ccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCcEEEeeccccccccccCCCC
Q 016959          178 YMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI---NSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       178 ~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      |+.+++|.+.+.    ..+..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......  ..
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--~~  164 (304)
T 2jam_A           87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IM  164 (304)
T ss_dssp             CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--TT
T ss_pred             cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--cc
Confidence            999999876543    3577888999999999999999999999999999999   77889999999998754432  12


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR  330 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (380)
                      ....||+.|+|||++.     +..++.++|||||||++|+|++|..||...........+...........+..++.++.
T Consensus       165 ~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  239 (304)
T 2jam_A          165 STACGTPGYVAPEVLA-----QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK  239 (304)
T ss_dssp             HHHHSCCCBCCTTTBS-----SCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred             ccccCCCCccChHHhc-----cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence            3456899999999985     35567899999999999999999999974433333333332222333445567899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      +||.+||..||++|||+.|+|+||||++..
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          240 DFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            999999999999999999999999998753

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.4e-50  Score=383.93  Aligned_cols=256  Identities=26%  Similarity=0.446  Sum_probs=189.0

Q ss_pred             ccccc-cceecccCCceEEEEEeC--CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEe--eCCeEE
Q 016959           99 AELQK-GNRIGSGSGGTVWRVVHP--PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYD--RNGEIE  173 (380)
Q Consensus        99 ~~~~~-~~~LG~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~  173 (380)
                      +.|++ +++||+|+||+||+|.+.  .+++.||||++.....   ...+.+|+.+|+.++||||++++++|.  ....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            45665 668999999999999965  5688999999965432   235778999999999999999999995  467899


Q ss_pred             EEEeccCCCCcccccc-------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----cCCCcEEEee
Q 016959          174 VLLEYMDGGSLEGAHI-------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI----NSSKNVKIAD  236 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~-------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~----~~~~~~kl~D  236 (380)
                      +||||+.+ +|...+.             ..+..++.++.||+.||.|||++||+||||||+||||    +.++.+||+|
T Consensus        97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A           97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            99999986 4443332             5667789999999999999999999999999999999    6778999999


Q ss_pred             ccccccccccC---CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC---------
Q 016959          237 FGVSRILAQTM---DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG---------  304 (380)
Q Consensus       237 fg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---------  304 (380)
                      ||+++.+....   ......+||+.|+|||++..    ...++.++||||||||+|+|++|..||......         
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG----ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTT----CCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcC----CCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            99998765322   22345679999999999853    245788999999999999999999999643321         


Q ss_pred             CHHHHHHHHhhCCCCCCCc----------------------------------cccHHHHHHHHHhcccCcCCCCCHHHH
Q 016959          305 DWASLMFAICFAQPPEAPE----------------------------------MASREFRDFISRCLQKDPHSRWPAAQL  350 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~li~~~l~~dp~~R~t~~ei  350 (380)
                      +....+...........+.                                  ..+.++.+||.+||+.||++|||++|+
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            1222222222211111111                                  126789999999999999999999999


Q ss_pred             hcCccccccCcc
Q 016959          351 LQHPFILRAGQS  362 (380)
Q Consensus       351 l~hp~~~~~~~~  362 (380)
                      |+||||+.....
T Consensus       332 L~hp~f~~~~~~  343 (405)
T 3rgf_A          332 MQDPYFLEDPLP  343 (405)
T ss_dssp             HTSGGGTSSSCC
T ss_pred             hcChhhccCCCC
Confidence            999999886543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5e-50  Score=386.68  Aligned_cols=255  Identities=24%  Similarity=0.329  Sum_probs=199.4

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC------Ce
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRN------GE  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~  171 (380)
                      ..+|++.+.||+|+||+||+|++..+|+.||||++.....     ...+|+++|+.++|+||++++++|...      ..
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            4579999999999999999999999999999999865432     234699999999999999999988532      23


Q ss_pred             EEEEEeccCCCCccc-------ccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-CcEEEeeccccccc
Q 016959          172 IEVLLEYMDGGSLEG-------AHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS-KNVKIADFGVSRIL  243 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~-------~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~  243 (380)
                      +++||||+.++.+..       .....+..++.++.||+.||+|||++||+||||||+||||+.+ +.+||+|||+++.+
T Consensus       128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            678999998743211       1223566788999999999999999999999999999999965 56899999999876


Q ss_pred             cccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC------
Q 016959          244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ------  317 (380)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~------  317 (380)
                      ... ......+||+.|+|||++.+    ...++.++||||||||+|||++|+.||......+....+.......      
T Consensus       208 ~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          208 VRG-EPNVSYICSRYYRAPELIFG----ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             CTT-CCCCSCCSCTTSCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccC-CCceeeeeCCCcCCHHHHcC----CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            543 23345689999999999853    2357789999999999999999999997543322222222111000      


Q ss_pred             -------CCC------------CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          318 -------PPE------------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       318 -------~~~------------~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                             ...            ++..++.++.+||.+||+.||++|||+.|+|+||||+.+...
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  346 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  346 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence                   000            223468899999999999999999999999999999887543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=365.37  Aligned_cols=261  Identities=33%  Similarity=0.498  Sum_probs=212.3

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      +..++|.....||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++|+||+++++++...+..++|
T Consensus        19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   97 (295)
T 2clq_A           19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF   97 (295)
T ss_dssp             ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch-HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence            444556666799999999999999999999999999865533 3456788999999999999999999999999999999


Q ss_pred             EeccCCCCccccccc-------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCcEEEeeccccccccccC
Q 016959          176 LEYMDGGSLEGAHIR-------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS-SKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       176 ~e~~~~~~L~~~~~~-------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~~~  247 (380)
                      |||+.+++|.+++..       .+..+..++.||+.||.|||++||+|+||||+|||++. ++.+||+|||++.......
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            999999998766432       36678889999999999999999999999999999997 8999999999998765443


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                      .......|++.|+|||++...   ...++.++|||||||++|+|++|..||...... .............+..+..++.
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  253 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKG---PRGYGKAADIWSLGCTIIEMATGKPPFYELGEP-QAAMFKVGMFKVHPEIPESMSA  253 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHG---GGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH-HHHHHHHHHHCCCCCCCTTSCH
T ss_pred             CcccccCCCccccChhhhcCC---CCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch-hHHHHhhccccccccccccCCH
Confidence            334566799999999998531   123678999999999999999999999632221 1222333344556677788999


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      ++.+||.+||+.||++|||+.|+|+||||+....
T Consensus       254 ~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          254 EAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             HHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence            9999999999999999999999999999987643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.3e-50  Score=380.35  Aligned_cols=256  Identities=28%  Similarity=0.383  Sum_probs=193.3

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC------C
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN------G  170 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~  170 (380)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++|+||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            468999999999999999999999999999999996543 344567788999999999999999999998654      5


Q ss_pred             eEEEEEeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          171 EIEVLLEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      .+++|+|++ +++|..++.   ..+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-  185 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-  185 (367)
T ss_dssp             CCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred             eEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc-
Confidence            689999999 577776654   457788999999999999999999999999999999999999999999999865433 


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC---------
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP---------  318 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------  318 (380)
                        ....+||+.|+|||++.+    ...++.++||||||||+|||++|+.||......+....+........         
T Consensus       186 --~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          186 --MTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -------CCCTTCCHHHHTT----CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             --CCCcCcCcCccChHHHcC----CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence              345689999999999853    24567899999999999999999999975443333333222211100         


Q ss_pred             -------------CC-----CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          319 -------------PE-----APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       319 -------------~~-----~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                                   +.     ....++.++.+||.+||+.||++|||+.|+|+||||+....
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence                         00     11245788999999999999999999999999999997643

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.9e-50  Score=368.92  Aligned_cols=258  Identities=29%  Similarity=0.500  Sum_probs=210.8

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCch-----HHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED-----SVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++......     ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            35799999999999999999999999999999998654321     1356788999999999999999999999999999


Q ss_pred             EEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----cEEEeecccccccc
Q 016959          173 EVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK----NVKIADFGVSRILA  244 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~----~~kl~Dfg~a~~~~  244 (380)
                      ++||||+.+++|.+++.    ..+..+..++.||+.||.|||++||+||||||+||+++.++    .+||+|||++....
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            99999999999977653    35778899999999999999999999999999999998877    79999999998765


Q ss_pred             ccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC---CCCC
Q 016959          245 QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ---PPEA  321 (380)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~  321 (380)
                      ... ......|++.|+|||++..     ..++.++||||||+++|+|++|..||.....   ...........   ....
T Consensus       164 ~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~  234 (283)
T 3bhy_A          164 AGN-EFKNIFGTPEFVAPEIVNY-----EPLGLEADMWSIGVITYILLSGASPFLGETK---QETLTNISAVNYDFDEEY  234 (283)
T ss_dssp             ---------CCCGGGCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTTCCCCCHHH
T ss_pred             CCC-cccccCCCcCccCcceecC-----CCCCcchhhhhHHHHHHHHHHCCCCCCCcch---HHHHHHhHhcccCCcchh
Confidence            432 2345679999999999853     4567899999999999999999999974332   22332222221   1122


Q ss_pred             CccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                      +..++..+.+||.+||..||++|||+.|+|+||||+.......
T Consensus       235 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  277 (283)
T 3bhy_A          235 FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV  277 (283)
T ss_dssp             HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC
T ss_pred             cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhh
Confidence            3457889999999999999999999999999999998755443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.1e-50  Score=373.82  Aligned_cols=264  Identities=31%  Similarity=0.491  Sum_probs=190.4

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      +.+..++|++.+.||+|+||.||+|.+..+++.||||++...........+.+|+.+++.++||||+++++++...+..+
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            45777899999999999999999999988999999999865544445667889999999999999999999999999999


Q ss_pred             EEEeccCCCCcccccc------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          174 VLLEYMDGGSLEGAHI------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                      +||||+.+++|.+++.            ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            9999999999876654            4577889999999999999999999999999999999999999999999987


Q ss_pred             cccccCC-----CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC
Q 016959          242 ILAQTMD-----PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA  316 (380)
Q Consensus       242 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  316 (380)
                      .......     ......||+.|+|||++..    ...++.++|||||||++|+|++|..||...........   ....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~  242 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQ----VRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML---TLQN  242 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHH----HHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH---HHTS
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhcc----ccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH---Hhcc
Confidence            6543211     1234579999999999853    13457799999999999999999999975443332211   1111


Q ss_pred             CC---------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          317 QP---------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       317 ~~---------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                      ..         ......++.++.+||.+||+.||++|||+.|+++||||+.......
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  299 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEF  299 (303)
T ss_dssp             SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--------
T ss_pred             CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCcc
Confidence            11         1233457889999999999999999999999999999998765543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.3e-49  Score=366.81  Aligned_cols=251  Identities=28%  Similarity=0.429  Sum_probs=202.2

Q ss_pred             cccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           92 RHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      ....+..++|++.+.||+|+||+||+|++  +++.||||++.... .......+.+|+.++++++||||+++++++.+.+
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            34557788999999999999999999988  68899999986544 3445677899999999999999999999999999


Q ss_pred             eEEEEEeccCCCCcccccc-------cchHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHI-------RQEHILSDLARQVLSGLAYLHKRK--IVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~-------~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                      .+++||||+.+++|.+++.       ..+..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            9999999999999977654       345668889999999999999999  9999999999999999999999999998


Q ss_pred             cccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH-hhCCCCC
Q 016959          242 ILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAI-CFAQPPE  320 (380)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~~~~  320 (380)
                      .............||+.|+|||++..     ..++.++|||||||++|+|++|..||....   ........ .......
T Consensus       188 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~Pf~~~~---~~~~~~~~~~~~~~~~  259 (309)
T 3p86_A          188 LKASTFLSSKSAAGTPEWMAPEVLRD-----EPSNEKSDVYSFGVILWELATLQQPWGNLN---PAQVVAAVGFKCKRLE  259 (309)
T ss_dssp             --------------CCTTSCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHCCCTTTTSC---HHHHHHHHHHSCCCCC
T ss_pred             cccccccccccCCCCccccChhhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcCCCCC
Confidence            66544334456789999999999853     556789999999999999999999997432   23333333 2344566


Q ss_pred             CCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          321 APEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       321 ~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .+..++.++.+||.+||..||++|||+.|+++
T Consensus       260 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            77889999999999999999999999999997

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-50  Score=372.03  Aligned_cols=259  Identities=25%  Similarity=0.375  Sum_probs=210.9

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC--eEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG--EIE  173 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~  173 (380)
                      +..++|.+.+.||+|+||+||+|.+..+++.||||++.........+.+.+|++++++++||||+++++++...+  ..+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            456789999999999999999999999999999999975544444567789999999999999999999988655  789


Q ss_pred             EEEeccCCCCcccccc-------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----cCCCcEEEeecccccc
Q 016959          174 VLLEYMDGGSLEGAHI-------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI----NSSKNVKIADFGVSRI  242 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~-------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~----~~~~~~kl~Dfg~a~~  242 (380)
                      +||||+.+++|.+++.       ..+..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||+++.
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            9999999999876654       4567788999999999999999999999999999999    7777899999999987


Q ss_pred             ccccCCCCCCCCCCCcccccccccccc---CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-CCHHHHHHHHhhCCC
Q 016959          243 LAQTMDPCNSAVGTIAYMSPERINTDL---NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ-GDWASLMFAICFAQP  318 (380)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~  318 (380)
                      ..... ......||+.|+|||++....   ..+..++.++|||||||++|||++|..||..... ......+..+....+
T Consensus       166 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          166 LEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             CCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             cCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            65442 334567999999999985211   1135667899999999999999999999964332 222333444333332


Q ss_pred             C------------------------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcc
Q 016959          319 P------------------------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPF  355 (380)
Q Consensus       319 ~------------------------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~  355 (380)
                      .                        .....++..+.+||.+||+.||++|||++|+|+||-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            1                        233456778999999999999999999999999874

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=8.5e-50  Score=363.28  Aligned_cols=256  Identities=29%  Similarity=0.447  Sum_probs=206.6

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .+..++|.+.+.||+|+||.||+|.+..+++.||||++....  .....+.+.+|+.+++.++|+||+++++++...+..
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (276)
T 2h6d_A            7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF   86 (276)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence            355678999999999999999999999899999999985432  122346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          173 EVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ++||||+.+++|.+++.    ..+..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...... .
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-~  165 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-E  165 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC-c
Confidence            99999999999976653    357788899999999999999999999999999999999999999999999876543 2


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHH
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE  328 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (380)
                      ......|++.|+|||++..    ..+.+.++||||||+++|+|++|..||...   ........+. ......+..++.+
T Consensus       166 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~~~~~~-~~~~~~~~~~~~~  237 (276)
T 2h6d_A          166 FLRTSCGSPNYAAPEVISG----RLYAGPEVDIWSCGVILYALLCGTLPFDDE---HVPTLFKKIR-GGVFYIPEYLNRS  237 (276)
T ss_dssp             -----------CCTGGGTT----SCCCHHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHH-HCCCCCCTTSCHH
T ss_pred             ceecccCCccccCHHHHcC----CCCCCccchHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHhh-cCcccCchhcCHH
Confidence            2345678999999999853    233467899999999999999999999643   3333333332 2334456678899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          329 FRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      +.+||.+||+.||++|||+.|+++||||++.
T Consensus       238 l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          238 VATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            9999999999999999999999999999864

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.3e-49  Score=377.78  Aligned_cols=252  Identities=27%  Similarity=0.363  Sum_probs=195.1

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC------
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG------  170 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------  170 (380)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999999999999999996543 3445677889999999999999999999997654      


Q ss_pred             eEEEEEeccCCCCcccccc--cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          171 EIEVLLEYMDGGSLEGAHI--RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      .+++||||+.+ +|.+.+.  ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-~  181 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-F  181 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---------
T ss_pred             ceEEEEEcCCC-CHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc-c
Confidence            78999999986 4544332  356778899999999999999999999999999999999999999999999866533 2


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC----------
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP----------  318 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----------  318 (380)
                      .....+||+.|+|||++..     ..++.++|||||||++|+|++|..||.....   ......+.....          
T Consensus       182 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          182 MMTPYVVTRYYRAPEVILG-----MGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             --------CTTCCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHC-CCCCCHHHHTTS
T ss_pred             ccCCceecCCccCHHHhcC-----CCCCchHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHHHHHh
Confidence            2345679999999999853     4567899999999999999999999974332   222222211100          


Q ss_pred             -----------CCC--------------------CccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          319 -----------PEA--------------------PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       319 -----------~~~--------------------~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                                 +..                    ....+.++++||.+||+.||++|||++|+|+||||+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence                       000                    01125689999999999999999999999999999864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-49  Score=372.69  Aligned_cols=261  Identities=23%  Similarity=0.393  Sum_probs=206.6

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCC--CceeeeEeEEeeCCe
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNH--PNVVKCHDMYDRNGE  171 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~  171 (380)
                      .+....|++.+.||+|+||+||+|.+. +++.||||++.... .....+.+.+|+.+|+.++|  +||+++++++...+.
T Consensus         5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            356678999999999999999999985 68899999986543 34456788999999999976  999999999999999


Q ss_pred             EEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          172 IEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      +++||| +.+++|.+++.    ..+..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+....
T Consensus        84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            999999 55678766543    35677889999999999999999999999999999997 6889999999998765432


Q ss_pred             C--CCCCCCCCCccccccccccccC------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC
Q 016959          248 D--PCNSAVGTIAYMSPERINTDLN------HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP  319 (380)
Q Consensus       248 ~--~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  319 (380)
                      .  .....+||+.|+|||++.....      ....++.++|||||||++|+|++|+.||.... ................
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~~~~~~~~~~  240 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-NQISKLHAIIDPNHEI  240 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-SHHHHHHHHHCTTSCC
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-hHHHHHHHHhcCCccc
Confidence            2  2345679999999999853110      12456789999999999999999999996322 1222222233334445


Q ss_pred             CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       320 ~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ..+...+.++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            6677788899999999999999999999999999999854

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.7e-49  Score=364.60  Aligned_cols=259  Identities=34%  Similarity=0.554  Sum_probs=212.1

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++.....   ...+.+|+.+++.++|+||+++++++...+.+++|
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            345689999999999999999999999999999999965432   35678899999999999999999999999999999


Q ss_pred             EeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          176 LEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       176 ~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      |||+.+++|.+++.     ..+..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..........
T Consensus       103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  182 (314)
T 3com_A          103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR  182 (314)
T ss_dssp             EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCB
T ss_pred             eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcccc
Confidence            99999999877653     3577889999999999999999999999999999999999999999999998776544444


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC--CCCCccccHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP--PEAPEMASRE  328 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  328 (380)
                      ....|+..|+|||++..     ..++.++|||||||++|+|++|..||....   .............  ...+..++.+
T Consensus       183 ~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  254 (314)
T 3com_A          183 NTVIGTPFWMAPEVIQE-----IGYNCVADIWSLGITAIEMAEGKPPYADIH---PMRAIFMIPTNPPPTFRKPELWSDN  254 (314)
T ss_dssp             CCCCSCGGGCCHHHHSS-----SCBCTTHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCCCCCSSGGGSCHH
T ss_pred             CccCCCCCccChhhcCC-----CCCCccccHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHhcCCCcccCCcccCCHH
Confidence            56779999999999853     446778999999999999999999996332   2222322222222  2335567899


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCccccccCccccc
Q 016959          329 FRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN  365 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~  365 (380)
                      +.+||.+||..||++|||+.|+|+||||+........
T Consensus       255 l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~~  291 (314)
T 3com_A          255 FTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSIL  291 (314)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGGG
T ss_pred             HHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcchHH
Confidence            9999999999999999999999999999987655443

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.9e-49  Score=376.80  Aligned_cols=258  Identities=27%  Similarity=0.393  Sum_probs=205.8

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE----
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI----  172 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~----  172 (380)
                      .++|.+.+.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.+++.++|+||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            368999999999999999999999999999999996543 344567788999999999999999999999876654    


Q ss_pred             --EEEEeccCCCCcccccc--cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          173 --EVLLEYMDGGSLEGAHI--RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       173 --~lv~e~~~~~~L~~~~~--~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                        ++||||+.+ +|.....  ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....  
T Consensus       121 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--  197 (371)
T 4exu_A          121 DFYLVMPFMQT-DLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--  197 (371)
T ss_dssp             CCEEEEECCCE-EHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--------
T ss_pred             eEEEEEccccc-cHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC--
Confidence              999999984 5654433  467788999999999999999999999999999999999999999999999866433  


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC-----------
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ-----------  317 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-----------  317 (380)
                       ....+||+.|+|||++.+    ...++.++|||||||++|+|++|..||......+....+.......           
T Consensus       198 -~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          198 -MTGYVVTRWYRAPEVILS----WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             ---CTTCCCTTSCHHHHSC----CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             -cCCcccCccccCHHHhcC----CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence             345678999999999853    2456789999999999999999999997443322222222111100           


Q ss_pred             ---------CC-------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          318 ---------PP-------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       318 ---------~~-------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                               ..       ..+..++.++.+||.+||+.||++|||+.|+|+||||+......
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  334 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE  334 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcc
Confidence                     00       01234688999999999999999999999999999999865443

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.8e-49  Score=373.99  Aligned_cols=261  Identities=28%  Similarity=0.415  Sum_probs=210.1

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC-----CeE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRN-----GEI  172 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~  172 (380)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++...........+.+|+.+++.++|+||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999999999999999997665566667888999999999999999999987654     679


Q ss_pred             EEEEeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-
Q 016959          173 EVLLEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-  248 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-  248 (380)
                      ++||||+.+ +|...+.   ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... 
T Consensus        90 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  168 (353)
T 2b9h_A           90 YIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD  168 (353)
T ss_dssp             EEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred             EEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccccc
Confidence            999999985 6655433   45778889999999999999999999999999999999999999999999987643211 


Q ss_pred             ---------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC-
Q 016959          249 ---------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP-  318 (380)
Q Consensus       249 ---------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-  318 (380)
                               .....+||+.|+|||++..    +..++.++|||||||++|+|++|..||......+....+........ 
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  244 (353)
T 2b9h_A          169 NSEPTGQQSGMVEFVATRWYRAPEVMLT----SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS  244 (353)
T ss_dssp             -----------CCCCCCGGGCCHHHHHS----CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred             ccCccccccchhhccccccccCCeeecc----CCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence                     1234578999999998753    35577899999999999999999999974432222222222111100 


Q ss_pred             -------------------C--------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          319 -------------------P--------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       319 -------------------~--------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                                         +        .....++.++.+||.+||+.||++|||+.|+|+||||+......
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence                               0        01235788999999999999999999999999999999876544

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-49  Score=370.50  Aligned_cols=262  Identities=29%  Similarity=0.491  Sum_probs=206.1

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEee------C
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDR------N  169 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~------~  169 (380)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++......  ...+.+|+.+++++ +|+||+++++++..      .
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   99 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   99 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST--THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc--HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence            456899999999999999999999999999999998654322  35688999999999 79999999999976      5


Q ss_pred             CeEEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                      +.+++||||+.+++|.+++.      ..+..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  179 (326)
T 2x7f_A          100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  179 (326)
T ss_dssp             CEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred             ceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence            68999999999999876643      356778899999999999999999999999999999999999999999999876


Q ss_pred             cccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh-CCCCCCC
Q 016959          244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF-AQPPEAP  322 (380)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~  322 (380)
                      ...........||+.|+|||++......+..++.++|||||||++|+|++|..||....   .......... ..+....
T Consensus       180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~  256 (326)
T 2x7f_A          180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH---PMRALFLIPRNPAPRLKS  256 (326)
T ss_dssp             -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCCCCCSC
T ss_pred             CcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhhcCccccCCc
Confidence            54433345667999999999986432234567789999999999999999999996332   2222222222 2233345


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                      ..++..+.+||.+||..||++|||+.|+++||||+......
T Consensus       257 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~  297 (326)
T 2x7f_A          257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNER  297 (326)
T ss_dssp             SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTHH
T ss_pred             cccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcccc
Confidence            56789999999999999999999999999999999876544

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-49  Score=377.77  Aligned_cols=261  Identities=22%  Similarity=0.321  Sum_probs=218.1

Q ss_pred             cCCCcccccccceecccCCceEEEEEe-----CCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVH-----PPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR  168 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  168 (380)
                      ..+..++|.+.+.||+|+||+||+|.+     ..+++.||||++...........+.+|+.+++.++|+||+++++++.+
T Consensus        66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            456778999999999999999999994     456789999999766566666778899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCcccccc-----------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---cEEE
Q 016959          169 NGEIEVLLEYMDGGSLEGAHI-----------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK---NVKI  234 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~~-----------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~---~~kl  234 (380)
                      .+..++|||||.+++|.+++.           .....++.++.||+.||+|||++||+||||||+|||++.++   .+||
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence            999999999999999876643           34567889999999999999999999999999999999555   4999


Q ss_pred             eeccccccccccC--CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHH
Q 016959          235 ADFGVSRILAQTM--DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMF  311 (380)
Q Consensus       235 ~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~  311 (380)
                      +|||+++.+....  .......||+.|+|||++..     ..++.++|||||||++|||++ |..||...   .......
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DvwslG~il~ellt~g~~pf~~~---~~~~~~~  297 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-----GIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLE  297 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHHH
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHH
Confidence            9999998653321  22344568999999999853     456789999999999999998 99999743   3444555


Q ss_pred             HHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          312 AICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      .+........+..++..+.+||.+||+.||++|||+.|+++|.++......
T Consensus       298 ~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          298 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence            555555666777889999999999999999999999999999887665443

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.5e-49  Score=384.23  Aligned_cols=252  Identities=27%  Similarity=0.375  Sum_probs=202.9

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC------CCCceeeeEeEEeeCCe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV------NHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~  171 (380)
                      ..+|++.++||+|+||+||+|.+..+++.||||++...  ......+.+|+.+++.+      +|+||+++++++...+.
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            35799999999999999999999999999999999543  34456677888888877      57799999999999999


Q ss_pred             EEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc--EEEeeccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN--VKIADFGVSRIL  243 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~  243 (380)
                      +++||||+.+ +|.+++.      ..+..++.++.||+.||+|||++||+||||||+||||+.++.  +||+|||++...
T Consensus       174 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~  252 (429)
T 3kvw_A          174 ICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE  252 (429)
T ss_dssp             EEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence            9999999975 6654432      356778899999999999999999999999999999999887  999999999765


Q ss_pred             cccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC---
Q 016959          244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE---  320 (380)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  320 (380)
                      ...   ....+||+.|+|||++..     ..++.++||||||||+|||++|..||......+....+.......+..   
T Consensus       253 ~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          253 HQR---VYTYIQSRFYRAPEVILG-----ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             TCC---CCSSCSCGGGCCHHHHHT-----BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             CCc---ccccCCCCCccChHHHhC-----CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            432   356789999999999863     456889999999999999999999997544333333322221110000   


Q ss_pred             ----------------------------------------------------CCccccHHHHHHHHHhcccCcCCCCCHH
Q 016959          321 ----------------------------------------------------APEMASREFRDFISRCLQKDPHSRWPAA  348 (380)
Q Consensus       321 ----------------------------------------------------~~~~~~~~~~~li~~~l~~dp~~R~t~~  348 (380)
                                                                          .....++++.+||.+||+.||++|||++
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence                                                                1112377899999999999999999999


Q ss_pred             HHhcCccccccC
Q 016959          349 QLLQHPFILRAG  360 (380)
Q Consensus       349 eil~hp~~~~~~  360 (380)
                      |+|+||||++..
T Consensus       405 e~L~Hpw~~~~~  416 (429)
T 3kvw_A          405 QALRHPWLRRRL  416 (429)
T ss_dssp             HHHTSTTTC---
T ss_pred             HHhCChhhccCC
Confidence            999999999753

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.5e-49  Score=362.31  Aligned_cols=254  Identities=28%  Similarity=0.455  Sum_probs=213.9

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEe--eCCeEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYD--RNGEIEV  174 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~l  174 (380)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.  ..+.+++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999999999999999996543 4455678999999999999999999999874  4678999


Q ss_pred             EEeccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          175 LLEYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKRK-----IVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       175 v~e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~~-----ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                      ||||+.+++|.+++.        .++..++.++.||+.||+|||++|     |+||||||+|||++.++.+||+|||++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999977654        456778999999999999999999     9999999999999999999999999998


Q ss_pred             cccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCC
Q 016959          242 ILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA  321 (380)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  321 (380)
                      .............|+..|+|||++..     ..++.++|||||||++|+|++|..||...   ........+........
T Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~i~~~~~~~~  236 (279)
T 2w5a_A          165 ILNHDTSFAKTFVGTPYYMSPEQMNR-----MSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREGKFRRI  236 (279)
T ss_dssp             HC---CHHHHHHHSCCTTCCHHHHHC-----C-CCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCCC
T ss_pred             eeccccccccccCCCccccChHHhcc-----CCCCchhhHHHHHHHHHHHHHCCCCCccc---CHHHHHHHHhhcccccC
Confidence            76543222234568999999999853     45678999999999999999999999743   33344444445555567


Q ss_pred             CccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      +..++.++.+||.+||+.||++|||+.|+|+|+|+..-
T Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            77889999999999999999999999999999999874

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.6e-50  Score=373.58  Aligned_cols=261  Identities=30%  Similarity=0.466  Sum_probs=207.3

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-------chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-------EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++....       .......+.+|+.+++.++||||+++++++...+ 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            57999999999999999999999999999999986432       1223345789999999999999999999987655 


Q ss_pred             EEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc---EEEeecccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN---VKIADFGVSRILA  244 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~---~kl~Dfg~a~~~~  244 (380)
                      +++||||+.+++|.+.+.    ..+..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++....
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  168 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  168 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred             eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence            899999999999866543    356778899999999999999999999999999999987665   9999999998664


Q ss_pred             ccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-CHHHHHHHHhhCCCCCCCc
Q 016959          245 QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG-DWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~  323 (380)
                      ... ......||+.|+|||++...  .+..++.++|||||||++|+|++|..||...... .....+........+..+.
T Consensus       169 ~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (322)
T 2ycf_A          169 ETS-LMRTLCGTPTYLAPEVLVSV--GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA  245 (322)
T ss_dssp             CCH-HHHHHHSCCTTCCHHHHHHT--TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHT
T ss_pred             ccc-ccccccCCcCccCchhhccC--CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhh
Confidence            321 12345689999999997421  1345678999999999999999999999754433 3333333322222222335


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                      .++.++.+||.+||..||++|||+.|+|+||||+......
T Consensus       246 ~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~~~  285 (322)
T 2ycf_A          246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR  285 (322)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHHHH
T ss_pred             hcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHHHH
Confidence            6789999999999999999999999999999999875543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.1e-49  Score=377.56  Aligned_cols=260  Identities=23%  Similarity=0.402  Sum_probs=206.8

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCC--CCceeeeEeEEeeCCeE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVN--HPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~  172 (380)
                      +...+|.+.+.||+|+||+||+|.+.. ++.||||++.... .....+.+.+|+.+|+.++  |+||+++++++...+.+
T Consensus        53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~  131 (390)
T 2zmd_A           53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  131 (390)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence            445679999999999999999999865 8999999996543 4455678999999999996  59999999999999999


Q ss_pred             EEEEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          173 EVLLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ++||| +.+++|.+++..    .+..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+.....
T Consensus       132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            99999 567787665433    4567888999999999999999999999999999996 68999999999987653322


Q ss_pred             --CCCCCCCCCccccccccccccC------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHH-HhhCCCC
Q 016959          249 --PCNSAVGTIAYMSPERINTDLN------HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFA-ICFAQPP  319 (380)
Q Consensus       249 --~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~-~~~~~~~  319 (380)
                        .....+||+.|+|||++.....      ....++.++||||||||+|||++|..||....  +....+.. .......
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~--~~~~~~~~~~~~~~~~  287 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISKLHAIIDPNHEI  287 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC--CHHHHHHHHHCTTSCC
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh--HHHHHHHHHhCccccC
Confidence              2345679999999999853111      12357889999999999999999999996322  22222222 2223344


Q ss_pred             CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       320 ~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      ..+...+.++.+||.+||+.||++|||+.|+|+||||+...
T Consensus       288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            55666788999999999999999999999999999998643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.2e-49  Score=367.68  Aligned_cols=255  Identities=25%  Similarity=0.366  Sum_probs=213.9

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCc---EEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSR---VFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      .+..++|.+.+.||+|+||+||+|.+..+++   .||||++.........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            4677899999999999999999999976554   5999999876666667889999999999999999999999999999


Q ss_pred             EEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      .++||||+.+++|.+++.     ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            999999999999977653     356778899999999999999999999999999999999999999999999876543


Q ss_pred             CCC---CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCC
Q 016959          247 MDP---CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAP  322 (380)
Q Consensus       247 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  322 (380)
                      ...   .....+|..|+|||++..     ..++.++|||||||++|+|++ |..||..   .........+........+
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~ell~~g~~p~~~---~~~~~~~~~~~~~~~~~~~  276 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAF-----RTFSSASDVWSFGVVMWEVLAYGERPYWN---MTNRDVISSVEEGYRLPAP  276 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHH-----CEECHHHHHHHHHHHHHHHHTTSCCTTTT---SCHHHHHHHHHTTCCCCCC
T ss_pred             ccceeeccCCCCcccccCHhHhcC-----CCCCcHHHHHHHHHHHHHHHcCCCCCccc---CCHHHHHHHHHcCCCCCCC
Confidence            221   223446778999999853     456789999999999999998 9999964   3344455555555666777


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ..++.++.+||.+||..||++|||+.|+++  .+..+
T Consensus       277 ~~~~~~l~~li~~~l~~dp~~Rps~~eil~--~L~~l  311 (325)
T 3kul_A          277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVS--VLDAL  311 (325)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             CCcCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence            789999999999999999999999999997  44443

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.9e-49  Score=362.91  Aligned_cols=256  Identities=27%  Similarity=0.458  Sum_probs=208.1

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc---hHHHHHHHHHHHHHHhCCCCceeeeEeEE--eeCCeEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE---DSVRSQICREIEILRDVNHPNVVKCHDMY--DRNGEIE  173 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~  173 (380)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....   ......+.+|+.+++.++|+||+++++++  .+.+..+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            579999999999999999999999999999999854321   23456789999999999999999999998  4556899


Q ss_pred             EEEeccCCCCcccc------cccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc-
Q 016959          174 VLLEYMDGGSLEGA------HIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT-  246 (380)
Q Consensus       174 lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  246 (380)
                      +||||+.++ |.+.      ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~  163 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA  163 (305)
T ss_dssp             EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred             EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence            999999987 3222      22356778899999999999999999999999999999999999999999999876432 


Q ss_pred             -CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          247 -MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       247 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                       ........||..|+|||++..   ....++.++|||||||++|+|++|..||...   ........+.. .....+..+
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~i~~-~~~~~~~~~  236 (305)
T 2wtk_C          164 ADDTCRTSQGSPAFQPPEIANG---LDTFSGFKVDIWSAGVTLYNITTGLYPFEGD---NIYKLFENIGK-GSYAIPGDC  236 (305)
T ss_dssp             SSCEECCCCSCGGGCCHHHHTC---CSCEESHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHH-CCCCCCSSS
T ss_pred             cccccccCCCCCCCcChhhccC---cccCCcchhhHHHHHHHHHHHHhCCCCCCCc---hHHHHHHHHhc-CCCCCCCcc
Confidence             122345679999999999853   1233467899999999999999999999743   33333333332 234566778


Q ss_pred             cHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      +.++.+||.+||+.||++|||+.|+++||||++....
T Consensus       237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  273 (305)
T 2wtk_C          237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP  273 (305)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence            9999999999999999999999999999999986443

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.9e-48  Score=367.25  Aligned_cols=258  Identities=26%  Similarity=0.377  Sum_probs=206.8

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe-----
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE-----  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----  171 (380)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467999999999999999999999999999999996543 34456778899999999999999999999987653     


Q ss_pred             -EEEEEeccCCCCcccccc--cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          172 -IEVLLEYMDGGSLEGAHI--RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       172 -~~lv~e~~~~~~L~~~~~--~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                       +++||||+.+ +|.....  ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--  179 (353)
T 3coi_A          103 DFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--  179 (353)
T ss_dssp             CCEEEEECCSE-EGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC------
T ss_pred             eEEEEeccccC-CHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC--
Confidence             5999999984 7765543  467788999999999999999999999999999999999999999999999865432  


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC------------
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA------------  316 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~------------  316 (380)
                       .....||+.|+|||++..    ...++.++|||||||++|+|++|..||......+....+......            
T Consensus       180 -~~~~~~t~~y~aPE~~~~----~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  254 (353)
T 3coi_A          180 -MTGYVVTRWYRAPEVILS----WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  254 (353)
T ss_dssp             -----CCSBCCSCHHHHSC----CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred             -ccccccCcCcCCHHHHhC----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence             245678999999999853    245677999999999999999999999754332222222111100            


Q ss_pred             ---------------CCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          317 ---------------QPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       317 ---------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                                     ........++.++.+||.+||+.||++|||+.|+|+||||+......
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~  316 (353)
T 3coi_A          255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE  316 (353)
T ss_dssp             HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCcc
Confidence                           01123346789999999999999999999999999999999865443

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.5e-50  Score=373.63  Aligned_cols=255  Identities=24%  Similarity=0.389  Sum_probs=203.7

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC----e
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG----E  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~  171 (380)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....  .......+.+|+.+++.++||||+++++++....    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            467999999999999999999999999999999997543  3455677899999999999999999999987643    3


Q ss_pred             EEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          172 IEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      .|+||||+.+++|.+++.    ..+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  170 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  170 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence            599999999999977654    3577788999999999999999999999999999999999999999999998664332


Q ss_pred             C---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC---CC
Q 016959          248 D---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP---EA  321 (380)
Q Consensus       248 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~  321 (380)
                      .   ......||+.|+|||++..     ..++.++|||||||++|+|++|+.||....   ..............   ..
T Consensus       171 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~ll~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~  242 (311)
T 3ork_A          171 NSVTQTAAVIGTAQYLSPEQARG-----DSVDARSDVYSLGCVLYEVLTGEPPFTGDS---PVSVAYQHVREDPIPPSAR  242 (311)
T ss_dssp             -----------CCTTCCHHHHHT-----CCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCCCCCHHHH
T ss_pred             cccccccccCcCcccCCHHHhcC-----CCCCchHhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHhcCCCCCcccc
Confidence            1   2234569999999999853     556789999999999999999999996432   22222222222221   12


Q ss_pred             CccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      ...++.++.+||.+||+.||++||+..++|.|+|++..+
T Consensus       243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            345789999999999999999999999999999998654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.9e-49  Score=372.65  Aligned_cols=261  Identities=24%  Similarity=0.332  Sum_probs=195.2

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe------
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE------  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------  171 (380)
                      .++|++.+.||+|+||+||+|.+..+++.||||++.....  ......+|+..++.++|+||++++++|...+.      
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   99 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI   99 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence            4689999999999999999999999999999999855432  12345677888888999999999999865433      


Q ss_pred             -EEEEEeccCCCCcc-------cccccchHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEEcC-CCcEEEeecccc
Q 016959          172 -IEVLLEYMDGGSLE-------GAHIRQEHILSDLARQVLSGLAYLH--KRKIVHRDIKPSNLLINS-SKNVKIADFGVS  240 (380)
Q Consensus       172 -~~lv~e~~~~~~L~-------~~~~~~~~~~~~i~~qi~~al~~LH--~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a  240 (380)
                       +++||||+.++.+.       ......+..+..++.||+.||.|||  ++||+||||||+|||++. ++.+||+|||++
T Consensus       100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a  179 (360)
T 3e3p_A          100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA  179 (360)
T ss_dssp             EEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence             88999999975332       1223356778889999999999999  999999999999999996 899999999999


Q ss_pred             ccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC--
Q 016959          241 RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP--  318 (380)
Q Consensus       241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--  318 (380)
                      ..+.... ......||+.|+|||++.+    ...++.++|||||||++|+|++|..||...........+........  
T Consensus       180 ~~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  254 (360)
T 3e3p_A          180 KKLSPSE-PNVAYICSRYYRAPELIFG----NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE  254 (360)
T ss_dssp             BCCCTTS-CCCSTTSCGGGCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             eecCCCC-CcccccCCcceeCHHHHcC----CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence            8765432 3345678999999999853    24467899999999999999999999975433322222222111000  


Q ss_pred             --------------------------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccccc
Q 016959          319 --------------------------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVN  365 (380)
Q Consensus       319 --------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~  365 (380)
                                                .......+.++.+||.+||+.||++|||+.|+|+||||+........
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~  327 (360)
T 3e3p_A          255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATK  327 (360)
T ss_dssp             HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCC
T ss_pred             HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcccc
Confidence                                      11122256799999999999999999999999999999998655443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.3e-50  Score=385.65  Aligned_cols=253  Identities=18%  Similarity=0.222  Sum_probs=198.8

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCC--CchHHHHHHHHHHH---HHHhCCCCceeeeE-------
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIE---ILRDVNHPNVVKCH-------  163 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~E~~---~l~~l~h~~iv~~~-------  163 (380)
                      ...++|++.+.||+|+||+||+|.+..+|+.||||++...  ......+.+.+|+.   +++.++|||||+++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            3457899999999999999999999889999999999643  23345677889995   45555799999998       


Q ss_pred             eEEeeCCe-----------------EEEEEeccCCCCccccccc----c-------hHHHHHHHHHHHHHHHHHHhCCce
Q 016959          164 DMYDRNGE-----------------IEVLLEYMDGGSLEGAHIR----Q-------EHILSDLARQVLSGLAYLHKRKIV  215 (380)
Q Consensus       164 ~~~~~~~~-----------------~~lv~e~~~~~~L~~~~~~----~-------~~~~~~i~~qi~~al~~LH~~~iv  215 (380)
                      +++++.+.                 .|+||||+ +|+|.+++..    .       +..+..|+.||+.||+|||++||+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  228 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  228 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence            77665542                 88999999 5788776553    2       256778999999999999999999


Q ss_pred             ecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCCccccccccccc------cCCCCCCCcchhHHHHHHHHH
Q 016959          216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD------LNHGKYDGYAGDIWSLGVSIL  289 (380)
Q Consensus       216 H~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~~~~~DvwslG~il~  289 (380)
                      ||||||+|||++.++.+||+|||+++....   .....+| +.|+|||++...      ......++.++|||||||++|
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            999999999999999999999999986443   2345678 999999998641      000015678999999999999


Q ss_pred             HHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          290 EFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       290 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      ||++|+.||...........        ....+..++.++.+||.+||+.||++|||+.|+|+||||+.+..
T Consensus       305 elltg~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  368 (377)
T 3byv_A          305 WIWCADLPITKDAALGGSEW--------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT  368 (377)
T ss_dssp             HHHHSSCCC------CCSGG--------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred             HHHHCCCCCcccccccchhh--------hhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence            99999999964332221111        11223567899999999999999999999999999999998643

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.7e-49  Score=372.69  Aligned_cols=254  Identities=25%  Similarity=0.393  Sum_probs=212.5

Q ss_pred             ccCCCcccccccceecccCCceEEEEE-----eCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEE
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVV-----HPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMY  166 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~  166 (380)
                      .+.+..++|++++.||+|+||.||+|.     +..+++.||||++.........+.+.+|+.+++++ +||||+++++++
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~   95 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC   95 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence            455788999999999999999999998     55677999999998766666677899999999999 799999999998


Q ss_pred             eeCC-eEEEEEeccCCCCcccccc--------------------------------------------------------
Q 016959          167 DRNG-EIEVLLEYMDGGSLEGAHI--------------------------------------------------------  189 (380)
Q Consensus       167 ~~~~-~~~lv~e~~~~~~L~~~~~--------------------------------------------------------  189 (380)
                      .+.+ .+++|||||.+++|.+++.                                                        
T Consensus        96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence            8754 4899999999999865543                                                        


Q ss_pred             --------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC--CCCCC
Q 016959          190 --------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD--PCNSA  253 (380)
Q Consensus       190 --------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~  253 (380)
                                    ..+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....  .....
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  255 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA  255 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence                          44566888999999999999999999999999999999999999999999986643222  23445


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHH
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF  332 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (380)
                      .||+.|+|||++..     ..++.++|||||||++|||++ |..||......+  ..............+..++.++.++
T Consensus       256 ~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~l  328 (359)
T 3vhe_A          256 RLPLKWMAPETIFD-----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTRMRAPDYTTPEMYQT  328 (359)
T ss_dssp             EECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred             CCCceeEChhhhcC-----CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            68899999999863     556789999999999999998 999997544332  3333444455666777889999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcC
Q 016959          333 ISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       333 i~~~l~~dp~~R~t~~eil~h  353 (380)
                      |.+||..||++|||+.|+++|
T Consensus       329 i~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          329 MLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCChhhCCCHHHHHHH
Confidence            999999999999999999984

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.8e-49  Score=364.89  Aligned_cols=265  Identities=22%  Similarity=0.353  Sum_probs=195.2

Q ss_pred             cccCCCcccccccceecccCCceEEEEEeCCCCc---EEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEe
Q 016959           92 RHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSR---VFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYD  167 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~---~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  167 (380)
                      ....+..++|++.+.||+|+||+||+|.+..++.   .||||++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus        16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   95 (323)
T 3qup_A           16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL   95 (323)
T ss_dssp             CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred             hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence            3445777899999999999999999999887765   89999986543 3344678899999999999999999999998


Q ss_pred             eCCeE------EEEEeccCCCCccccc----------ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc
Q 016959          168 RNGEI------EVLLEYMDGGSLEGAH----------IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN  231 (380)
Q Consensus       168 ~~~~~------~lv~e~~~~~~L~~~~----------~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~  231 (380)
                      ..+..      ++||||+.+++|.+++          ...+..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC
Confidence            76655      9999999999997665          2456778999999999999999999999999999999999999


Q ss_pred             EEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHH
Q 016959          232 VKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWAS  308 (380)
Q Consensus       232 ~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~  308 (380)
                      +||+|||++........  ......+++.|+|||++..     ..++.++|||||||++|+|++ |..||......+.  
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--  248 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-----NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--  248 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcC-----CCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--
Confidence            99999999986643321  2234456789999999854     557789999999999999999 9999975544433  


Q ss_pred             HHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCC-------HHHHhcCccccccCcccc
Q 016959          309 LMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWP-------AAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-------~~eil~hp~~~~~~~~~~  364 (380)
                       ............+..++.++.+||.+||+.||++|||       ++++++|+|+....+..+
T Consensus       249 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl  310 (323)
T 3qup_A          249 -YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL  310 (323)
T ss_dssp             -HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred             -HHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence             3334444556667788999999999999999999999       888999999998655443

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.3e-49  Score=374.43  Aligned_cols=252  Identities=21%  Similarity=0.357  Sum_probs=213.5

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .+.++.++|.+.+.||+|+||+||+|.+..+++.||||++...........+.+|+.+|+.++||||+++++++...+.+
T Consensus       108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  187 (377)
T 3cbl_A          108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI  187 (377)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence            45678899999999999999999999999899999999997665555667788999999999999999999999999999


Q ss_pred             EEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          173 EVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      ++||||+.+++|.+++.     .....+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            99999999999977654     3456788999999999999999999999999999999999999999999997654321


Q ss_pred             CC--CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc
Q 016959          248 DP--CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEM  324 (380)
Q Consensus       248 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (380)
                      ..  .....++..|+|||++..     ..++.++|||||||++|||++ |..||....   ................+..
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~t~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~  339 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNY-----GRYSSESDVWSFGILLWETFSLGASPYPNLS---NQQTREFVEKGGRLPCPEL  339 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHH-----CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC---HHHHHHHHHTTCCCCCCTT
T ss_pred             eeecCCCCCCCcCcCCHhHhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCCCCCCC
Confidence            11  112235678999999853     446779999999999999998 999997433   3334444445556667778


Q ss_pred             ccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          325 ASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ++.++.+||.+||+.||++|||+.|+++
T Consensus       340 ~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            8999999999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=9.3e-50  Score=378.83  Aligned_cols=260  Identities=18%  Similarity=0.146  Sum_probs=192.8

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhC--CCCceeeeE-------eE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDV--NHPNVVKCH-------DM  165 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l--~h~~iv~~~-------~~  165 (380)
                      ...+|.+.+.||+|+||+||+|.+..+++.||||++....  .....+.+.+|+.+++.+  +||||++++       ++
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred             CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence            3456999999999999999999999999999999997654  334556778885544444  699988755       45


Q ss_pred             EeeC-----------------CeEEEEEeccCCCCccccccc-----chHHH------HHHHHHHHHHHHHHHhCCceec
Q 016959          166 YDRN-----------------GEIEVLLEYMDGGSLEGAHIR-----QEHIL------SDLARQVLSGLAYLHKRKIVHR  217 (380)
Q Consensus       166 ~~~~-----------------~~~~lv~e~~~~~~L~~~~~~-----~~~~~------~~i~~qi~~al~~LH~~~ivH~  217 (380)
                      +...                 ..+++|||||. ++|.+++..     .+..+      ..++.||+.||+|||++||+||
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr  218 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG  218 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence            5433                 33899999999 788776553     22334      5677999999999999999999


Q ss_pred             CCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 016959          218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFP  297 (380)
Q Consensus       218 Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~p  297 (380)
                      ||||+||||+.++.+||+|||+++......   ....+|+.|+|||++..   ....++.++|||||||++|||++|+.|
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~---~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNA---STATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTC---SEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccC---CCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999998664322   24557799999999842   124568899999999999999999999


Q ss_pred             CCCCCCCCHHHH-----HHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          298 FAVGRQGDWASL-----MFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       298 f~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                      |...........     ............+..++.++.+||.+||+.||++|||+.|+|+||||+...+..
T Consensus       293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  363 (371)
T 3q60_A          293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEI  363 (371)
T ss_dssp             TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHH
T ss_pred             CCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHH
Confidence            975422210000     000001111223347899999999999999999999999999999999876543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-48  Score=370.40  Aligned_cols=253  Identities=23%  Similarity=0.369  Sum_probs=217.0

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCC-------CcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEe
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPT-------SRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHD  164 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~-------~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~  164 (380)
                      .+.+..++|.+++.||+|+||+||+|.+..+       +..||||++...........+.+|+++++.+ +||||+++++
T Consensus        63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  142 (382)
T 3tt0_A           63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG  142 (382)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence            3457788999999999999999999997533       3579999998776666678899999999999 8999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCcccccc--------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 016959          165 MYDRNGEIEVLLEYMDGGSLEGAHI--------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNL  224 (380)
Q Consensus       165 ~~~~~~~~~lv~e~~~~~~L~~~~~--------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Ni  224 (380)
                      ++...+..++||||+.+++|.+++.                    ..+..++.++.||+.||.|||++||+||||||+||
T Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  222 (382)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence            9999999999999999999876543                    45678899999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccccC--CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 016959          225 LINSSKNVKIADFGVSRILAQTM--DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVG  301 (380)
Q Consensus       225 l~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~  301 (380)
                      ||+.++.+||+|||+++......  .......+|..|+|||++.     +..++.++|||||||++|+|++ |..||.. 
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~DiwslG~il~ellt~g~~p~~~-  296 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-----DRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-  296 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHH-----SCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCC-
Confidence            99999999999999998765432  2234456788999999985     3567889999999999999999 9999963 


Q ss_pred             CCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          302 RQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                        .........+........+..++.++.+||.+||+.||++|||+.|++++
T Consensus       297 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          297 --VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             --CCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --CCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              34455555566666677778899999999999999999999999999984

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.3e-49  Score=370.06  Aligned_cols=260  Identities=23%  Similarity=0.403  Sum_probs=213.7

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCch----------------HHHHHHHHHHHHHHhCCCCce
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED----------------SVRSQICREIEILRDVNHPNV  159 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----------------~~~~~~~~E~~~l~~l~h~~i  159 (380)
                      +..++|.+.+.||+|+||.||+|.+  +++.||||++......                ...+.+.+|+.+++.++||||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            4467899999999999999999999  8999999998532111                112678899999999999999


Q ss_pred             eeeEeEEeeCCeEEEEEeccCCCCcccc------cc------cchHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEE
Q 016959          160 VKCHDMYDRNGEIEVLLEYMDGGSLEGA------HI------RQEHILSDLARQVLSGLAYLHK-RKIVHRDIKPSNLLI  226 (380)
Q Consensus       160 v~~~~~~~~~~~~~lv~e~~~~~~L~~~------~~------~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~Nil~  226 (380)
                      +++++++.+.+..++||||+.+++|.++      +.      ..+..++.++.||+.||.|||+ +||+||||||+|||+
T Consensus       106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM  185 (348)
T ss_dssp             CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred             ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence            9999999999999999999999999876      33      2567788999999999999999 999999999999999


Q ss_pred             cCCCcEEEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 016959          227 NSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGY-AGDIWSLGVSILEFYLGRFPFAVGRQGD  305 (380)
Q Consensus       227 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~DvwslG~il~ell~g~~pf~~~~~~~  305 (380)
                      +.++.+||+|||++......  ......|+..|+|||++..    ...++. ++|||||||++|+|++|..||...... 
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~----~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-  258 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSN----ESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-  258 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSS----CCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-
T ss_pred             cCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcC----CCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-
Confidence            99999999999999876433  2355679999999999853    113333 899999999999999999999744331 


Q ss_pred             HHHHHHHHhhCCCCCCC-------------------ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccccc
Q 016959          306 WASLMFAICFAQPPEAP-------------------EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQ  366 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~  366 (380)
                       ......+... ....+                   ..++.++.+||.+||+.||++|||+.|+|+||||+..++.....
T Consensus       259 -~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~~~~  336 (348)
T 2pml_X          259 -VELFNNIRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLRE  336 (348)
T ss_dssp             -HHHHHHHTSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHHHHH
T ss_pred             -HHHHHHHhcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHHHHH
Confidence             2233333222 22223                   56889999999999999999999999999999999987766544

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.7e-48  Score=361.21  Aligned_cols=253  Identities=25%  Similarity=0.384  Sum_probs=214.5

Q ss_pred             ccCCCcccccccceecccCCceEEEEEe-----CCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEe
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVH-----PPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYD  167 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  167 (380)
                      .+.+..++|.+.+.||+|+||.||+|.+     ..+++.||||++.........+.+.+|+.+++.++||||+++++++.
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            4457788999999999999999999987     34568999999977666666788999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCcccccc----------------------------cchHHHHHHHHHHHHHHHHHHhCCceecCC
Q 016959          168 RNGEIEVLLEYMDGGSLEGAHI----------------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDI  219 (380)
Q Consensus       168 ~~~~~~lv~e~~~~~~L~~~~~----------------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dl  219 (380)
                      +.+..++||||+.+++|.+++.                            ..+..++.++.||+.||.|||++||+||||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di  176 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL  176 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence            9999999999999999876643                            345678899999999999999999999999


Q ss_pred             CCCcEEEcCCCcEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCC
Q 016959          220 KPSNLLINSSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRF  296 (380)
Q Consensus       220 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~  296 (380)
                      ||+|||++.++.+||+|||++........  ......+++.|+|||++..     ..++.++|||||||++|+|++ |..
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-----HIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-----CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-----CCcCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999986643322  2234457889999999853     456789999999999999999 999


Q ss_pred             CCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          297 PFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       297 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ||........   ............+..++.++.+||.+||+.||++|||+.|++++
T Consensus       252 p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          252 PYPGIPPERL---FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             SSTTCCGGGH---HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHH---HHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9975544433   33344445566777889999999999999999999999999874

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.7e-48  Score=352.32  Aligned_cols=250  Identities=24%  Similarity=0.403  Sum_probs=212.8

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .+.++.++|++.+.||+|+||+||+|.+. +++.||+|++......  .+.+.+|+.++++++||||+++++++.+.+..
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (269)
T 4hcu_A            4 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   80 (269)
T ss_dssp             -CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             cEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence            45688899999999999999999999987 5778999999755433  35688999999999999999999999999999


Q ss_pred             EEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          173 EVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      ++||||+.+++|.+++.     ..+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            99999999999876653     3567788999999999999999999999999999999999999999999998654321


Q ss_pred             -CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          248 -DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                       .......+|..|+|||++..     ..++.++|||||||++|+|++ |..||..   ..................+..+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~ll~~g~~p~~~---~~~~~~~~~~~~~~~~~~~~~~  232 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSF-----SRYSSKSDVWSFGVLMWEVFSEGKIPYEN---RSNSEVVEDISTGFRLYKPRLA  232 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTT---CCHHHHHHHHHTTCCCCCCTTS
T ss_pred             cccccCcccccccCCHHHhcC-----CCCCchhhhHHHHHHHHHHhcCCCCCCCC---CCHHHHHHHHhcCccCCCCCcC
Confidence             12344557889999999853     456789999999999999999 9999973   3444555555555666777778


Q ss_pred             cHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          326 SREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      +.++.+||.+||+.||++|||+.|+++|
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          233 STHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            9999999999999999999999999984

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.7e-49  Score=364.15  Aligned_cols=253  Identities=26%  Similarity=0.433  Sum_probs=208.8

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      .+..++|.++++||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus         6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   84 (310)
T 3s95_A            6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF   84 (310)
T ss_dssp             EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEE
Confidence            46678999999999999999999999999999999998543 34456789999999999999999999999999999999


Q ss_pred             EEeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 016959          175 LLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       175 v~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  249 (380)
                      ||||+.+++|.+++..     .+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            9999999999776543     56778899999999999999999999999999999999999999999999876433221


Q ss_pred             --------------CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHH---HHHHH
Q 016959          250 --------------CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWA---SLMFA  312 (380)
Q Consensus       250 --------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~~~~  312 (380)
                                    ....+||+.|+|||++.     +..++.++|||||||++|+|++|..||.........   .....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~  239 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN-----GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF  239 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHT-----TCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred             ccccccccccccccccccCCCcceeCHHHhc-----CCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence                          12567999999999985     356678999999999999999999999643222110   01111


Q ss_pred             HhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          313 ICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ..    ...+..++.++.+||.+||+.||++|||+.|+++  |++.+
T Consensus       240 ~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l  280 (310)
T 3s95_A          240 LD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL  280 (310)
T ss_dssp             HH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             cc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence            11    1234567789999999999999999999999998  66655

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.2e-48  Score=365.48  Aligned_cols=253  Identities=25%  Similarity=0.393  Sum_probs=205.3

Q ss_pred             CcccccccceecccCCceEEEEEe-CCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCC------ceeeeEeEEeeC
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVH-PPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHP------NVVKCHDMYDRN  169 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~  169 (380)
                      -.++|++.+.||+|+||+||+|.+ ..+++.||||++...  ....+.+.+|+.+++.++|+      +++++++++...
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            356899999999999999999998 567899999999543  34457788999999988654      599999999999


Q ss_pred             CeEEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---------------
Q 016959          170 GEIEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS---------------  228 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~---------------  228 (380)
                      +.+++||||+ +++|.+++.      ..+..+..++.||+.||+|||++||+||||||+|||++.               
T Consensus        90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~  168 (339)
T 1z57_A           90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE  168 (339)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred             CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence            9999999999 777765543      346778899999999999999999999999999999987               


Q ss_pred             ----CCcEEEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 016959          229 ----SKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG  304 (380)
Q Consensus       229 ----~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~  304 (380)
                          ++.+||+|||++......   .....||+.|+|||++.     +..++.++|||||||++|||++|..||......
T Consensus       169 ~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          169 RTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVIL-----ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             EEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHT-----TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             ccccCCCceEeeCcccccCccc---cccccCCccccChHHhh-----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                667999999999765432   34567999999999985     355678999999999999999999999754433


Q ss_pred             CHHHHHHHHhhCCCC----------------------------------------CCCccccHHHHHHHHHhcccCcCCC
Q 016959          305 DWASLMFAICFAQPP----------------------------------------EAPEMASREFRDFISRCLQKDPHSR  344 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~li~~~l~~dp~~R  344 (380)
                      +....+.......+.                                        ......+.++.+||.+||+.||++|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            333333332221110                                        1122346789999999999999999


Q ss_pred             CCHHHHhcCccccccC
Q 016959          345 WPAAQLLQHPFILRAG  360 (380)
Q Consensus       345 ~t~~eil~hp~~~~~~  360 (380)
                      ||+.|+|+||||+...
T Consensus       321 pt~~ell~hp~f~~~~  336 (339)
T 1z57_A          321 ITLREALKHPFFDLLK  336 (339)
T ss_dssp             CCHHHHTTSGGGGGGG
T ss_pred             cCHHHHhcCHHHHHHh
Confidence            9999999999999764

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4e-49  Score=361.19  Aligned_cols=257  Identities=30%  Similarity=0.455  Sum_probs=209.8

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      .++|++.+.||+|+||+||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            468999999999999999999999999999999985432 2233567889999999999999999999999999999999


Q ss_pred             eccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC---CcEEEeeccccccccccCCC
Q 016959          177 EYMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS---KNVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       177 e~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~---~~~kl~Dfg~a~~~~~~~~~  249 (380)
                      ||+.+++|.+.+    ...+..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++....... .
T Consensus       101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~-~  179 (287)
T 2wei_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-K  179 (287)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS-S
T ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC-c
Confidence            999999986554    23577889999999999999999999999999999999754   469999999998665432 2


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      .....|++.|+|||++.+      .++.++||||||+++|+|++|..||......+....+...........+..++.++
T Consensus       180 ~~~~~~~~~y~aPE~~~~------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (287)
T 2wei_A          180 MKDRIGTAYYIAPEVLRG------TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA  253 (287)
T ss_dssp             CSCHHHHHTTCCHHHHTT------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred             cccccCcccccChHHhcC------CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence            234468999999999852      36779999999999999999999997433322222222211112222335678999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      .+||.+||..||++|||+.|+|+||||++...
T Consensus       254 ~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             HHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence            99999999999999999999999999987643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.8e-48  Score=357.03  Aligned_cols=258  Identities=25%  Similarity=0.410  Sum_probs=206.6

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCC--CchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      +-.++|++.+.||+|+||.||+|.+..+++.||+|++...  ......+.+.+|+.+++.++||||+++++++...+.++
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            4457899999999999999999999999999999998543  24455678999999999999999999999999999999


Q ss_pred             EEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-C
Q 016959          174 VLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM-D  248 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~  248 (380)
                      +||||+.+++|.+++.    ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus        88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  167 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT  167 (294)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence            9999999999977654    3677889999999999999999999999999999999999999999999998765332 2


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC----CCCcc
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP----EAPEM  324 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~  324 (380)
                      ......||+.|+|||++..     ..++.++|||||||++|+|++|+.||...   ..............+    ..+..
T Consensus       168 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~ll~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~~  239 (294)
T 4eqm_A          168 QTNHVLGTVQYFSPEQAKG-----EATDECTDIYSIGIVLYEMLVGEPPFNGE---TAVSIAIKHIQDSVPNVTTDVRKD  239 (294)
T ss_dssp             -------CCSSCCHHHHHT-----CCCCTTHHHHHHHHHHHHHHHSSCSSCSS---CHHHHHHHHHSSCCCCHHHHSCTT
T ss_pred             ccCccccCccccCHhHhcC-----CCCCchHhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHhhccCCCcchhcccC
Confidence            2345679999999999853     55678899999999999999999999632   222222222222222    23456


Q ss_pred             ccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          325 ASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      ++..+.++|.+||..||++||+..+.+.+.|..-+..
T Consensus       240 ~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          240 IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence            7899999999999999999996666666666655433

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-48  Score=364.89  Aligned_cols=256  Identities=25%  Similarity=0.379  Sum_probs=215.8

Q ss_pred             cCCCcccccccceecccCCceEEEEEeC-----CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHP-----PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR  168 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  168 (380)
                      ..+..++|++.+.||+|+||.||+|.+.     .+++.||||++.........+.+.+|+.+++.++||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            4567789999999999999999999986     34589999999876666667889999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCcccccc----------------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 016959          169 NGEIEVLLEYMDGGSLEGAHI----------------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIK  220 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~~----------------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlk  220 (380)
                      .+..++||||+.+++|.+++.                            ..+..++.++.||+.||.|||++||+|||||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  201 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  201 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            999999999999999876543                            3456788899999999999999999999999


Q ss_pred             CCcEEEcCCCcEEEeeccccccccccC--CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 016959          221 PSNLLINSSKNVKIADFGVSRILAQTM--DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFP  297 (380)
Q Consensus       221 p~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~p  297 (380)
                      |+|||++.++.+||+|||++.......  .......||+.|+|||++..     ..++.++|||||||++|+|++ |..|
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-----NRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-----CCcCcccccHHHHHHHHHHHhcCCCc
Confidence            999999999999999999998654322  22344568899999999853     456789999999999999998 9999


Q ss_pred             CCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          298 FAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       298 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      |...   ........+........+..++.++.+||.+||+.||++|||+.|+++  +|+++
T Consensus       277 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~--~L~~~  333 (343)
T 1luf_A          277 YYGM---AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQRM  333 (343)
T ss_dssp             TTTS---CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             CCCC---ChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH--HHHHH
Confidence            9633   344455555555556677889999999999999999999999999987  55544

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.4e-49  Score=375.64  Aligned_cols=251  Identities=25%  Similarity=0.371  Sum_probs=202.1

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC--------CCceeeeEeEEe--
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN--------HPNVVKCHDMYD--  167 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~iv~~~~~~~--  167 (380)
                      .++|++.++||+|+||+||+|.+..+++.||||++...  ....+.+.+|+.+++.++        |+||++++++|.  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            47899999999999999999999999999999999543  345677889999999885        788999999987  


Q ss_pred             --eCCeEEEEEeccCCCCcccc-----cccchHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCC---------
Q 016959          168 --RNGEIEVLLEYMDGGSLEGA-----HIRQEHILSDLARQVLSGLAYLHKR-KIVHRDIKPSNLLINSSK---------  230 (380)
Q Consensus       168 --~~~~~~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~Nil~~~~~---------  230 (380)
                        ....+++||||+.++.+...     ....+..++.++.||+.||+|||++ ||+||||||+|||++.++         
T Consensus       114 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~  193 (397)
T 1wak_A          114 GVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE  193 (397)
T ss_dssp             ETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred             CCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence              55689999999965444322     2245778899999999999999998 999999999999999775         


Q ss_pred             ----------------------------------------cEEEeeccccccccccCCCCCCCCCCCccccccccccccC
Q 016959          231 ----------------------------------------NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN  270 (380)
Q Consensus       231 ----------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  270 (380)
                                                              .+||+|||++......   ....+||+.|+|||++..   
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~---  267 (397)
T 1wak_A          194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIG---  267 (397)
T ss_dssp             HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHT---
T ss_pred             hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcC---
Confidence                                                    7999999999876543   345679999999999863   


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCH------HHHHHHHhhCC---------------------------
Q 016959          271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDW------ASLMFAICFAQ---------------------------  317 (380)
Q Consensus       271 ~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~~~---------------------------  317 (380)
                        ..++.++|||||||++|+|++|+.||......+.      ...+.......                           
T Consensus       268 --~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          268 --SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             --SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             --CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence              4567899999999999999999999975443321      11111111110                           


Q ss_pred             -----------CCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 016959          318 -----------PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR  358 (380)
Q Consensus       318 -----------~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~  358 (380)
                                 ....+...+.++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                       01223445678999999999999999999999999999973

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.6e-48  Score=362.95  Aligned_cols=263  Identities=21%  Similarity=0.310  Sum_probs=219.7

Q ss_pred             cCCCcccccccceecccCCceEEEEEeC-----CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHP-----PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR  168 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  168 (380)
                      +.+..++|.+.+.||+|+||.||+|.+.     .+++.||||++...........+.+|+.+++.++|+||+++++++.+
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            3466789999999999999999999875     35788999999766665666788999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCccccccc--------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEE
Q 016959          169 NGEIEVLLEYMDGGSLEGAHIR--------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKI  234 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~~~--------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl  234 (380)
                      .+..++||||+.+++|.+++..              .+..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl  179 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  179 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence            9999999999999999776543              45678889999999999999999999999999999999999999


Q ss_pred             eeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHH
Q 016959          235 ADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMF  311 (380)
Q Consensus       235 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~  311 (380)
                      +|||++........  ......||+.|+|||++..     ..++.++|||||||++|+|++ |..||...   .......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~~~~~~  251 (322)
T 1p4o_A          180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-----GVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLR  251 (322)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CHHHHHH
T ss_pred             CcCccccccccccccccccCCCCCCCccChhhhcc-----CCCCchhhHHHHHHHHHHHHhcCCCccccC---CHHHHHH
Confidence            99999986543321  1234457889999999853     456789999999999999999 89999643   3344444


Q ss_pred             HHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC------ccccccCcccc
Q 016959          312 AICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH------PFILRAGQSQV  364 (380)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h------p~~~~~~~~~~  364 (380)
                      ..........+..++.++.+||.+||+.||++|||+.|+++|      ++|+...+...
T Consensus       252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~~~  310 (322)
T 1p4o_A          252 FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS  310 (322)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCSTTS
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccccccc
Confidence            444555566677889999999999999999999999999986      66666554443

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-48  Score=360.14  Aligned_cols=255  Identities=28%  Similarity=0.457  Sum_probs=201.8

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee----------
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR----------  168 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----------  168 (380)
                      ++|++.+.||+|+||.||+|.+..+++.||||++..  .......+.+|+.+++.++||||+++++++.+          
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE--EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec--cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            579999999999999999999999999999999853  33455778899999999999999999998754          


Q ss_pred             ---CCeEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccc
Q 016959          169 ---NGEIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS  240 (380)
Q Consensus       169 ---~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  240 (380)
                         .+..++||||+.+++|.+++.     ..+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  163 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA  163 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcch
Confidence               457899999999999977654     245678889999999999999999999999999999999999999999999


Q ss_pred             cccccc--------------CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCH
Q 016959          241 RILAQT--------------MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDW  306 (380)
Q Consensus       241 ~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~  306 (380)
                      ......              ........||+.|+|||++..    ...++.++|||||||++|+|++   ||...  .+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~---p~~~~--~~~  234 (303)
T 1zy4_A          164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG----TGHYNEKIDMYSLGIIFFEMIY---PFSTG--MER  234 (303)
T ss_dssp             SCTTC-------------------------CTTSCHHHHTS----CSCCCTHHHHHHHHHHHHHHHS---CCSSH--HHH
T ss_pred             hhcccccchhccccccccccccccccCCCcccccCcccccC----CCCCcchhhHHHHHHHHHHHHh---ccCCc--hhH
Confidence            765422              112245678999999999853    2356789999999999999998   55321  111


Q ss_pred             HHHHHHH---hhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          307 ASLMFAI---CFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       307 ~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                      .......   ....+.......+..+.+||.+||+.||++|||+.|+++||||+.......
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  295 (303)
T 1zy4_A          235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEV  295 (303)
T ss_dssp             HHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHHHH
T ss_pred             HHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChHHH
Confidence            1222222   223344455667788999999999999999999999999999987655443

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.5e-48  Score=363.55  Aligned_cols=272  Identities=28%  Similarity=0.441  Sum_probs=205.0

Q ss_pred             cccccccceecccCCceEEEEEeC-CCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhC---CCCceeeeEeEEe-----
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHP-PTSRVFALKVIYGNHE-DSVRSQICREIEILRDV---NHPNVVKCHDMYD-----  167 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~-----  167 (380)
                      .++|++.+.||+|+||+||+|.+. .+++.||||++..... ......+.+|+.+++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            468999999999999999999995 6789999999864321 11123455677776665   8999999999987     


Q ss_pred             eCCeEEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          168 RNGEIEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       168 ~~~~~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                      .....++||||+.+ +|.+++.      ..+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        90 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           90 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             SEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             CCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence            55679999999985 7755432      3567788999999999999999999999999999999999999999999998


Q ss_pred             cccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC---
Q 016959          242 ILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP---  318 (380)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---  318 (380)
                      ...... ......||..|+|||++..     ..++.++|||||||++|+|++|+.||......+....+........   
T Consensus       169 ~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (326)
T 1blx_A          169 IYSFQM-ALTSVVVTLWYRAPEVLLQ-----SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  242 (326)
T ss_dssp             CCCGGG-GGCCCCCCCTTCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             cccCCC-CccccccccceeCHHHHhc-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence            665332 2345679999999999853     4567899999999999999999999974433222222222111000   


Q ss_pred             --------------------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccccccccccCCCCCCC
Q 016959          319 --------------------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPL  378 (380)
Q Consensus       319 --------------------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~  378 (380)
                                          ......++.++.+||.+||+.||++|||+.|+|+||||+......  .++...+|+..+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~--~~~~~~~~~~~~~  320 (326)
T 1blx_A          243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK--ENLDSHLPPSQNT  320 (326)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC--CC-----------
T ss_pred             CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh--hhhccCCCCcccc
Confidence                                112345788999999999999999999999999999999886544  3345555554433

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=8.3e-48  Score=352.26  Aligned_cols=251  Identities=23%  Similarity=0.371  Sum_probs=209.6

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc---hHH---HHHHHHHHHHHHhCCCCceeeeEeEEe
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE---DSV---RSQICREIEILRDVNHPNVVKCHDMYD  167 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~  167 (380)
                      ..+..++|++.+.||+|+||+||+|.+..+++.||||++.....   ...   ...+.+|+.+++.++|+||+++++++.
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (287)
T 4f0f_A           14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH   93 (287)
T ss_dssp             CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred             hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence            34667899999999999999999999999999999999854332   111   167889999999999999999999997


Q ss_pred             eCCeEEEEEeccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCc-----EEEe
Q 016959          168 RNGEIEVLLEYMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRK--IVHRDIKPSNLLINSSKN-----VKIA  235 (380)
Q Consensus       168 ~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~Nil~~~~~~-----~kl~  235 (380)
                      +..  ++||||+.+++|.+.+     ...+..+..++.||+.||+|||++|  |+||||||+|||++.++.     +||+
T Consensus        94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence            665  6999999999986544     2356778899999999999999999  999999999999988776     9999


Q ss_pred             eccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh
Q 016959          236 DFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF  315 (380)
Q Consensus       236 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  315 (380)
                      |||++.....   ......||+.|+|||++..   .+..++.++|||||||++|+|++|..||.................
T Consensus       172 Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  245 (287)
T 4f0f_A          172 DFGLSQQSVH---SVSGLLGNFQWMAPETIGA---EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE  245 (287)
T ss_dssp             CCTTCBCCSS---CEECCCCCCTTSCGGGSSC---SSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred             CCCccccccc---cccccCCCccccCchhhcc---CCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence            9999975443   2345679999999999842   234567899999999999999999999976555444334444445


Q ss_pred             CCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          316 AQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       316 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ......+..++.++.+||.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            5566777889999999999999999999999999987

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.4e-48  Score=364.15  Aligned_cols=266  Identities=30%  Similarity=0.537  Sum_probs=192.4

Q ss_pred             cccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHH-HHHhCCCCceeeeEeEEeeCC
Q 016959           92 RHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIE-ILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      ..+.+..++|++.+.||+|+||.||+|.+..+|+.||||++...........+..|+. +++.++||||+++++++...+
T Consensus        15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~   94 (327)
T 3aln_A           15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG   94 (327)
T ss_dssp             EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred             HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence            4556788999999999999999999999999999999999976655555555666666 677789999999999999999


Q ss_pred             eEEEEEeccCCCCccccc---------ccchHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEeecccc
Q 016959          171 EIEVLLEYMDGGSLEGAH---------IRQEHILSDLARQVLSGLAYLHKR-KIVHRDIKPSNLLINSSKNVKIADFGVS  240 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~---------~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  240 (380)
                      ..++||||+.+ +|.++.         ...+..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~  173 (327)
T 3aln_A           95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS  173 (327)
T ss_dssp             EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred             ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence            99999999986 543322         235677889999999999999999 9999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC
Q 016959          241 RILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE  320 (380)
Q Consensus       241 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  320 (380)
                      ....... ......||+.|+|||++... ..+..++.++|||||||++|+|++|..||.....  .............+.
T Consensus       174 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~  249 (327)
T 3aln_A          174 GQLVDSI-AKTRDAGCRPYMAPERIDPS-ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS--VFDQLTQVVKGDPPQ  249 (327)
T ss_dssp             CC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCSCCCC
T ss_pred             eeccccc-ccccCCCCccccCceeeccc-cCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcch--HHHHHHHHhcCCCCC
Confidence            8765432 22344799999999998431 1234567899999999999999999999964221  111111111122222


Q ss_pred             ----CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          321 ----APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       321 ----~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                          ....++.++.+||.+||+.||++|||+.|+++||||......
T Consensus       250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  295 (327)
T 3aln_A          250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER  295 (327)
T ss_dssp             CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred             CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhh
Confidence                224578999999999999999999999999999999876544

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.5e-48  Score=359.66  Aligned_cols=265  Identities=28%  Similarity=0.510  Sum_probs=196.4

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchH-HHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS-VRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      ...+..++|++.+.||+|+||.||+|.+..+|+.||||++....... ....+.++..+++.++|+||+++++++...+.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~   98 (318)
T 2dyl_A           19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD   98 (318)
T ss_dssp             EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence            34466789999999999999999999999999999999997655433 33445555567888899999999999999999


Q ss_pred             EEEEEeccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKR-KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      +++||||+ ++.+....     ...+..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus        99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            99999999 44443222     235777889999999999999995 999999999999999999999999999976644


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCC--c
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAP--E  323 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~  323 (380)
                      .. ......||+.|+|||++......+..++.++|||||||++|+|++|..||....  .................+  .
T Consensus       178 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~  254 (318)
T 2dyl_A          178 DK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK--TDFEVLTKVLQEEPPLLPGHM  254 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC--SHHHHHHHHHHSCCCCCCSSS
T ss_pred             Cc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC--ccHHHHHHHhccCCCCCCccC
Confidence            32 234557999999999985432234556789999999999999999999997422  233344444444443333  3


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      .++.++.+||.+||+.||++|||++|+++||||++...
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (318)
T 2dyl_A          255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET  292 (318)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence            57899999999999999999999999999999997643

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.3e-48  Score=362.86  Aligned_cols=261  Identities=22%  Similarity=0.328  Sum_probs=212.2

Q ss_pred             ccCCCcccccccceecccCCceEEEEE-----eCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEe
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVV-----HPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYD  167 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  167 (380)
                      ...+..++|++.+.||+|+||.||+|.     +..+++.||||++...........+.+|+.+++.++||||+++++++.
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            344778899999999999999999999     455788999999976655566678899999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCcccccc-----------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCcEE
Q 016959          168 RNGEIEVLLEYMDGGSLEGAHI-----------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS---SKNVK  233 (380)
Q Consensus       168 ~~~~~~lv~e~~~~~~L~~~~~-----------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~---~~~~k  233 (380)
                      ..+..++||||+.+++|.+++.           ..+..++.++.||+.||.|||++||+||||||+|||++.   +..+|
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence            9999999999999999876653           345678899999999999999999999999999999984   44599


Q ss_pred             EeeccccccccccC--CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHH
Q 016959          234 IADFGVSRILAQTM--DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLM  310 (380)
Q Consensus       234 l~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~  310 (380)
                      |+|||++.......  .......||+.|+|||++..     ..++.++|||||||++|+|++ |..||...   ......
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g~~p~~~~---~~~~~~  255 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-----GIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVL  255 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHH
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCc---CHHHHH
Confidence            99999997654322  12234567899999999853     456789999999999999998 99999643   334444


Q ss_pred             HHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          311 FAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      ..+........+..++..+.+||.+||+.||++|||+.|+++|.|+.....
T Consensus       256 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          256 EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            445555556667788999999999999999999999999999988766433

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.3e-48  Score=363.65  Aligned_cols=258  Identities=23%  Similarity=0.362  Sum_probs=205.5

Q ss_pred             CcccccccceecccCCceEEEEEeCCCC-cEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCc------eeeeEeEEeeC
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTS-RVFALKVIYGNHEDSVRSQICREIEILRDVNHPN------VVKCHDMYDRN  169 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~~~~~~~~~  169 (380)
                      -.++|++.+.||+|+||+||+|.+..++ +.||||++...  ....+.+.+|+.+++.++|++      ++.+++++...
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            3578999999999999999999998776 78999999543  344567888999999987654      99999999999


Q ss_pred             CeEEEEEeccCCCCcccc-----cccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE------------------
Q 016959          170 GEIEVLLEYMDGGSLEGA-----HIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI------------------  226 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~------------------  226 (380)
                      +.+++||||+.++.+...     ....+..++.++.||+.||+|||++||+||||||+|||+                  
T Consensus        95 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~  174 (355)
T 2eu9_A           95 GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK  174 (355)
T ss_dssp             TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred             CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence            999999999955443322     124567889999999999999999999999999999999                  


Q ss_pred             -cCCCcEEEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 016959          227 -NSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD  305 (380)
Q Consensus       227 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~  305 (380)
                       +.++.+||+|||++......   .....||+.|+|||++..     ..++.++|||||||++|||++|..||......+
T Consensus       175 ~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          175 SVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILE-----LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             EESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeec-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence             56788999999999765432   345679999999999853     456789999999999999999999997544333


Q ss_pred             HHHHHHHHhhCCCC----------------------------------------CCCccccHHHHHHHHHhcccCcCCCC
Q 016959          306 WASLMFAICFAQPP----------------------------------------EAPEMASREFRDFISRCLQKDPHSRW  345 (380)
Q Consensus       306 ~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~li~~~l~~dp~~R~  345 (380)
                      ....+.......+.                                        ......+.++.+||.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            33333332221110                                        01112355899999999999999999


Q ss_pred             CHHHHhcCccccccCcccc
Q 016959          346 PAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       346 t~~eil~hp~~~~~~~~~~  364 (380)
                      |+.|+|+||||++......
T Consensus       327 t~~e~l~hp~f~~~~~~~~  345 (355)
T 2eu9_A          327 TLAEALLHPFFAGLTPEER  345 (355)
T ss_dssp             CHHHHTTSGGGGGCCHHHH
T ss_pred             CHHHHhcChhhcCCChhhc
Confidence            9999999999999865543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.2e-48  Score=360.23  Aligned_cols=254  Identities=22%  Similarity=0.359  Sum_probs=214.1

Q ss_pred             ccccCCCcccccccceecccCCceEEEEEeC-------CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeee
Q 016959           91 NRHQLINPAELQKGNRIGSGSGGTVWRVVHP-------PTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKC  162 (380)
Q Consensus        91 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~  162 (380)
                      ...+.+..++|.+.+.||+|+||+||+|.+.       .+++.||||++...........+.+|+.+++.+ +||||+++
T Consensus        27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  106 (334)
T 2pvf_A           27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL  106 (334)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence            4445678899999999999999999999975       356789999997766666677899999999999 89999999


Q ss_pred             EeEEeeCCeEEEEEeccCCCCcccccc--------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 016959          163 HDMYDRNGEIEVLLEYMDGGSLEGAHI--------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPS  222 (380)
Q Consensus       163 ~~~~~~~~~~~lv~e~~~~~~L~~~~~--------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~  222 (380)
                      ++++...+.+++||||+.+++|.+++.                    ..+..++.++.||+.||.|||++||+||||||+
T Consensus       107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~  186 (334)
T 2pvf_A          107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  186 (334)
T ss_dssp             EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence            999999999999999999999876543                    345678899999999999999999999999999


Q ss_pred             cEEEcCCCcEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 016959          223 NLLINSSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFA  299 (380)
Q Consensus       223 Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~  299 (380)
                      |||++.++.+||+|||++........  ......+|+.|+|||++..     ..++.++|||||||++|+|++ |..||.
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g~~p~~  261 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-----RVYTHQSDVWSFGVLMWEIFTLGGSPYP  261 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-----CEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-----CCcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence            99999999999999999986654321  2234457889999999853     456789999999999999999 999996


Q ss_pred             CCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          300 VGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..   ........+........+..++.++.+||.+||..||++|||+.|+++
T Consensus       262 ~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  311 (334)
T 2pvf_A          262 GI---PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  311 (334)
T ss_dssp             TC---CHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cC---CHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            43   344444455555566677788999999999999999999999999998

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.9e-49  Score=365.44  Aligned_cols=259  Identities=24%  Similarity=0.390  Sum_probs=213.4

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCch-----HHHHHHHHHHHHHHhCC--CCceeeeEeEEee
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED-----SVRSQICREIEILRDVN--HPNVVKCHDMYDR  168 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~  168 (380)
                      .-.++|++.+.||+|+||.||+|.+..+++.||||++......     .....+.+|+.+++++.  |+||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            4457899999999999999999999999999999998644211     12245667999999996  5999999999999


Q ss_pred             CCeEEEEEeccCC-CCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCcEEEeecccccc
Q 016959          169 NGEIEVLLEYMDG-GSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN-SSKNVKIADFGVSRI  242 (380)
Q Consensus       169 ~~~~~lv~e~~~~-~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~  242 (380)
                      .+..++|||++.+ ++|.+++.    ..+..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~  199 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  199 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence            9999999999986 77766543    35777889999999999999999999999999999999 788999999999987


Q ss_pred             ccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCC
Q 016959          243 LAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAP  322 (380)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  322 (380)
                      ....  ......||+.|+|||++..    ..+++.++|||||||++|||++|..||...     ...     .......+
T Consensus       200 ~~~~--~~~~~~gt~~y~aPE~~~~----~~~~~~~~Di~slG~il~el~~g~~pf~~~-----~~~-----~~~~~~~~  263 (320)
T 3a99_A          200 LKDT--VYTDFDGTRVYSPPEWIRY----HRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----EEI-----IRGQVFFR  263 (320)
T ss_dssp             CCSS--CBCCCCSCGGGSCHHHHHH----SCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HHH-----HHCCCCCS
T ss_pred             cccc--cccCCCCCccCCChHHhcc----CCCCCccchHHhHHHHHHHHHHCCCCCCCh-----hhh-----hccccccc
Confidence            6543  2345679999999999854    244567899999999999999999999521     111     11233455


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccccccccc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQ  370 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~~~~~  370 (380)
                      ..++.++.+||.+||+.||++|||+.|+++||||+..........+..
T Consensus       264 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~~~~~~~~  311 (320)
T 3a99_A          264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHL  311 (320)
T ss_dssp             SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHHHHHHHHT
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCccccccccc
Confidence            678999999999999999999999999999999999866555444443

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5e-48  Score=352.87  Aligned_cols=251  Identities=27%  Similarity=0.387  Sum_probs=200.6

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCC---CcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPT---SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRN  169 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  169 (380)
                      ...+..++|++.+.||+|+||+||+|.+..+   +..||+|++.........+.+.+|+.+++.++||||+++++++. +
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   87 (281)
T 1mp8_A            9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   87 (281)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence            3457788999999999999999999998653   45799999876666667788999999999999999999999985 4


Q ss_pred             CeEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      +..++||||+.+++|.+++.     ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence            57899999999999977654     3567788999999999999999999999999999999999999999999998765


Q ss_pred             ccCC-CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCC
Q 016959          245 QTMD-PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAP  322 (380)
Q Consensus       245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  322 (380)
                      .... ......+++.|+|||++..     ..++.++|||||||++|||++ |..||......+..   ..+........+
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~~i~~~~~~~~~  239 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINF-----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIENGERLPMP  239 (281)
T ss_dssp             -----------CCGGGCCHHHHHH-----CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHTTCCCCCC
T ss_pred             cccccccccCCCcccccChhhccc-----CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---HHHHcCCCCCCC
Confidence            4321 1233456789999999853     456789999999999999996 99999755444433   333444555677


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..++.++.+||.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  269 (281)
T 1mp8_A          240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKA  269 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            788999999999999999999999999987

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.4e-48  Score=357.91  Aligned_cols=255  Identities=28%  Similarity=0.413  Sum_probs=199.4

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEe----------
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYD----------  167 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----------  167 (380)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            467999999999999999999999999999999986543 344577889999999999999999999873          


Q ss_pred             ----eCCeEEEEEeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCcEEEeeccc
Q 016959          168 ----RNGEIEVLLEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN-SSKNVKIADFGV  239 (380)
Q Consensus       168 ----~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg~  239 (380)
                          +.+..++||||+.+ +|.+++.   ..+..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus        89 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~  167 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL  167 (320)
T ss_dssp             --CCSCSEEEEEEECCSE-EHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ccccccCceeEEeeccCC-CHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence                44688999999984 7765543   35677889999999999999999999999999999997 567899999999


Q ss_pred             cccccccC---CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC
Q 016959          240 SRILAQTM---DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA  316 (380)
Q Consensus       240 a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  316 (380)
                      +.......   .......+|..|+|||++..    +..++.++|||||||++|+|++|+.||......   .....+...
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~~~~~  240 (320)
T 2i6l_A          168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS----PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL---EQMQLILES  240 (320)
T ss_dssp             CBCC--------CCCGGGSCCTTCCHHHHHC----TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHH
T ss_pred             ccccCCCcccccccccccccccccCcHHhcC----cccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHh
Confidence            98764321   12234567999999998753    245678999999999999999999999743322   222211111


Q ss_pred             CC------------------------C-----CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          317 QP------------------------P-----EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       317 ~~------------------------~-----~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      .+                        +     .....++.++.+||.+||+.||++|||+.|+|+||||+...+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence            10                        0     112357889999999999999999999999999999997654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.1e-47  Score=350.67  Aligned_cols=250  Identities=22%  Similarity=0.342  Sum_probs=209.1

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .+.+..++|++.+.||+|+||+||+|.+. +++.||||++......  .+.+.+|+.+++.++|+||+++++++.+.+.+
T Consensus        18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   94 (283)
T 3gen_A           18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI   94 (283)
T ss_dssp             TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence            44578889999999999999999999886 6778999999755433  35688999999999999999999999999999


Q ss_pred             EEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          173 EVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      ++||||+.+++|.+++.     ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            99999999999876653     3567789999999999999999999999999999999999999999999998654321


Q ss_pred             -CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          248 -DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                       .......+|+.|+|||++..     ..++.++|||||||++|+|++ |..||...   ........+........+..+
T Consensus       175 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~  246 (283)
T 3gen_A          175 YTSSVGSKFPVRWSPPEVLMY-----SKFSSKSDIWAFGVLMWEIYSLGKMPYERF---TNSETAEHIAQGLRLYRPHLA  246 (283)
T ss_dssp             HHSTTSTTSCGGGCCHHHHHH-----CCCSHHHHHHHHHHHHHHHHTTTCCTTTTS---CHHHHHHHHHTTCCCCCCTTC
T ss_pred             cccccCCccCcccCCHHHhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCcccc---ChhHHHHHHhcccCCCCCCcC
Confidence             12234557889999999863     456789999999999999998 99999633   344455555555666677788


Q ss_pred             cHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          326 SREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      +..+.+||.+||+.||++|||+.|+++|
T Consensus       247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          247 SEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            9999999999999999999999999985

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.5e-48  Score=366.73  Aligned_cols=251  Identities=24%  Similarity=0.370  Sum_probs=199.7

Q ss_pred             cCCCcccccccceecccCCceEEEEEeC---CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHP---PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      ..+..++|.+.+.||+|+||+||+|++.   .++..||||+++........+.+.+|+.+++.++||||+++++++.+.+
T Consensus        40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            3467789999999999999999999886   4577899999977666666788999999999999999999999999999


Q ss_pred             eEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      ..++||||+.+++|.+++.     ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            9999999999999987653     35667889999999999999999999999999999999999999999999987654


Q ss_pred             cCCC---CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCC
Q 016959          246 TMDP---CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEA  321 (380)
Q Consensus       246 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  321 (380)
                      ....   .....++..|+|||++..     ..++.++|||||||++|||++ |..||....   .......+........
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~---~~~~~~~i~~~~~~~~  271 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAY-----RKFTSASDVWSYGIVLWEVMSYGERPYWEMS---NQDVIKAVDEGYRLPP  271 (373)
T ss_dssp             --------------CTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC---HHHHHHHHHTTEECCC
T ss_pred             CCccceeccCCCcCCCccChhhhcc-----CCcCchhcHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCCCCC
Confidence            3221   122345778999999853     456789999999999999997 999997433   3334444444444555


Q ss_pred             CccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      +..++.++.+||.+||+.||++||++.|+++
T Consensus       272 ~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            6678899999999999999999999999987

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.3e-47  Score=353.29  Aligned_cols=251  Identities=30%  Similarity=0.479  Sum_probs=196.7

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCC--CchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGN--HEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++...  ........+.+|+.+++.++|+||+++++++...+..+
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence            3456899999999999999999999989999999999643  23455678899999999999999999999999999999


Q ss_pred             EEEeccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          174 VLLEYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      +||||+.+++|.+++.        ..+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            9999999999976653        35677889999999999999999999999999999999999999999999987655


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC-CCCCCcc
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ-PPEAPEM  324 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~  324 (380)
                      .........|+..|+|||++..     ..++.++|||||||++|+|++|..||..... ............. +......
T Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~  262 (310)
T 2wqm_A          189 KTTAAHSLVGTPYYMSPERIHE-----NGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYPPLPSDH  262 (310)
T ss_dssp             ----------CCSSCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCTTC---C-CHHHHHHHHHTTCSCCCCTTT
T ss_pred             CCccccccCCCeeEeChHHhCC-----CCCCchhhHHHHHHHHHHHHhCCCCCcccch-hHHHHHHHhhcccCCCCcccc
Confidence            4444455679999999999853     4567899999999999999999999964332 2333333333322 2233366


Q ss_pred             ccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          325 ASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ++.++.+||.+||+.||++|||+.|+++
T Consensus       263 ~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          263 YSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            8899999999999999999999999997

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=8.2e-48  Score=356.42  Aligned_cols=254  Identities=24%  Similarity=0.351  Sum_probs=213.5

Q ss_pred             cccCCCcccccccceecccCCceEEEEEe-----CCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeE
Q 016959           92 RHQLINPAELQKGNRIGSGSGGTVWRVVH-----PPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDM  165 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~  165 (380)
                      ..+.+..++|.+.+.||+|+||+||+|.+     ..+++.||||++.........+.+.+|+.+++.+ +||||++++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            33557788999999999999999999984     4578899999997766656678899999999999 89999999999


Q ss_pred             EeeCCeEEEEEeccCCCCcccccc----------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q 016959          166 YDRNGEIEVLLEYMDGGSLEGAHI----------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSN  223 (380)
Q Consensus       166 ~~~~~~~~lv~e~~~~~~L~~~~~----------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~N  223 (380)
                      +...+..++||||+.+++|.+++.                      ..+..++.++.||+.||.|||++||+||||||+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  175 (313)
T 1t46_A           96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (313)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence            999999999999999999876543                      4567788999999999999999999999999999


Q ss_pred             EEEcCCCcEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCC
Q 016959          224 LLINSSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAV  300 (380)
Q Consensus       224 il~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~  300 (380)
                      ||++.++.+||+|||++........  ......||+.|+|||++..     ..++.++|||||||++|+|++ |..||..
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g~~p~~~  250 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-----CVYTFESDVWSYGIFLWELFSLGSSPYPG  250 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-----CCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            9999999999999999987654322  1234457889999999853     456789999999999999998 9999975


Q ss_pred             CCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          301 GRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ......  .............+..++.++.+||.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  300 (313)
T 1t46_A          251 MPVDSK--FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (313)
T ss_dssp             CCSSHH--HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccchhH--HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            443322  22233334445556778999999999999999999999999998

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-48  Score=363.33  Aligned_cols=255  Identities=24%  Similarity=0.324  Sum_probs=209.9

Q ss_pred             ccCCCcccccccceecccCCceEEEEEe-----CCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEE
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVH-----PPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMY  166 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~  166 (380)
                      .+.+..++|.+.+.||+|+||+||+|.+     ..+++.||||++.........+.+.+|+.+++.+ +||||+++++++
T Consensus        39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            4567889999999999999999999997     3467789999997655555567889999999999 899999999999


Q ss_pred             eeCCeEEEEEeccCCCCcccccc---------------------------cchHHHHHHHHHHHHHHHHHHhCCceecCC
Q 016959          167 DRNGEIEVLLEYMDGGSLEGAHI---------------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDI  219 (380)
Q Consensus       167 ~~~~~~~lv~e~~~~~~L~~~~~---------------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dl  219 (380)
                      ...+..++||||+.+++|.+++.                           ..+..++.++.||+.||+|||++||+||||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di  198 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  198 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            99999999999999999876543                           245668889999999999999999999999


Q ss_pred             CCCcEEEcCCCcEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCC
Q 016959          220 KPSNLLINSSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRF  296 (380)
Q Consensus       220 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~  296 (380)
                      ||+|||++.++.+||+|||++........  ......||+.|+|||++..     ..++.++|||||||++|+|++ |..
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~t~g~~  273 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-----GIYTIKSDVWSYGILLWEIFSLGVN  273 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-----CCCChhHhHHHHHHHHHHHHcCCCC
Confidence            99999999999999999999986654322  1233457889999999853     456789999999999999998 999


Q ss_pred             CCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCc
Q 016959          297 PFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHP  354 (380)
Q Consensus       297 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp  354 (380)
                      ||.......  ..............+..++.++.+||.+||+.||++|||+.|+++|.
T Consensus       274 p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          274 PYPGIPVDA--NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             SSTTCCCSH--HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CcccCCcHH--HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            997544332  22333334445566777899999999999999999999999999854

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.5e-47  Score=347.13  Aligned_cols=249  Identities=21%  Similarity=0.354  Sum_probs=210.3

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      ..+..++|++.+.||+|+||.||+|.+. ++..||||++......  ...+.+|+.+++.++||||+++++++.+.+..+
T Consensus         3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence            3567889999999999999999999886 5778999999654432  356889999999999999999999999999999


Q ss_pred             EEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          174 VLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      +||||+.+++|.+++.     ..+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            9999999999876653     35677889999999999999999999999999999999999999999999986643321


Q ss_pred             -CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCcccc
Q 016959          249 -PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS  326 (380)
Q Consensus       249 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (380)
                       ......+|..|+|||++..     ..++.++||||||+++|+|++ |..||..   ..................+..++
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~~g~~p~~~---~~~~~~~~~~~~~~~~~~~~~~~  231 (268)
T 3sxs_A          160 VSSVGTKFPVKWSAPEVFHY-----FKYSSKSDVWAFGILMWEVFSLGKMPYDL---YTNSEVVLKVSQGHRLYRPHLAS  231 (268)
T ss_dssp             EECCSCCCCGGGCCHHHHHH-----SEEETTHHHHHHHHHHHHHHTTTCCTTTT---SCHHHHHHHHHTTCCCCCCTTSC
T ss_pred             hcccCCCcCcccCCHHHHhc-----cCCchhhhhHHHHHHHHHHHcCCCCCccc---cChHHHHHHHHcCCCCCCCCcCh
Confidence             2234456778999999853     445678999999999999998 9999963   33444555555566666777789


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          327 REFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      .++.+||.+||+.||++|||+.|++++
T Consensus       232 ~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          232 DTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999999984

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.7e-48  Score=368.56  Aligned_cols=252  Identities=25%  Similarity=0.338  Sum_probs=200.2

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CC-----ceeeeEeEEeeCCe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HP-----NVVKCHDMYDRNGE  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~iv~~~~~~~~~~~  171 (380)
                      .++|++.+.||+|+||+||+|.+..+++.||||++...  ......+.+|+.+++.++ |+     +|+++++++...+.
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            46899999999999999999999999999999999643  344566778998888885 54     49999999999999


Q ss_pred             EEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEEc--CCCcEEEeeccccc
Q 016959          172 IEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLH--KRKIVHRDIKPSNLLIN--SSKNVKIADFGVSR  241 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH--~~~ivH~Dlkp~Nil~~--~~~~~kl~Dfg~a~  241 (380)
                      +++||||+.+ +|.+++.      ..+..++.++.||+.||.|||  ++||+||||||+|||++  .++.+||+|||++.
T Consensus       131 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~  209 (382)
T 2vx3_A          131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC  209 (382)
T ss_dssp             EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence            9999999975 7655433      356778899999999999999  57999999999999995  47789999999998


Q ss_pred             cccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC--
Q 016959          242 ILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP--  319 (380)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--  319 (380)
                      .....   ....+||+.|+|||++..     ..++.++|||||||++|||++|+.||......+....+.......+.  
T Consensus       210 ~~~~~---~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  281 (382)
T 2vx3_A          210 QLGQR---IYQYIQSRFYRSPEVLLG-----MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI  281 (382)
T ss_dssp             ETTCC---CCSSCSCGGGCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ecccc---cccccCCccccChHHHcC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            76533   356789999999999853     45678999999999999999999999754433333333222111000  


Q ss_pred             ----------------CC------------------------------------------CccccHHHHHHHHHhcccCc
Q 016959          320 ----------------EA------------------------------------------PEMASREFRDFISRCLQKDP  341 (380)
Q Consensus       320 ----------------~~------------------------------------------~~~~~~~~~~li~~~l~~dp  341 (380)
                                      ..                                          ......++.+||.+||+.||
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  361 (382)
T 2vx3_A          282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP  361 (382)
T ss_dssp             HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred             HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence                            00                                          00011478999999999999


Q ss_pred             CCCCCHHHHhcCccccccC
Q 016959          342 HSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       342 ~~R~t~~eil~hp~~~~~~  360 (380)
                      ++|||+.|+|+||||++..
T Consensus       362 ~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          362 KTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             TTSCCHHHHTTSGGGCC--
T ss_pred             hhCCCHHHHhcCcccccCC
Confidence            9999999999999998753

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6.4e-48  Score=361.34  Aligned_cols=251  Identities=25%  Similarity=0.407  Sum_probs=179.3

Q ss_pred             Ccccccccc-eecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee----CCe
Q 016959           97 NPAELQKGN-RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR----NGE  171 (380)
Q Consensus        97 ~~~~~~~~~-~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~  171 (380)
                      -.++|.+.+ .||+|+||+||+|.+..+++.||||++....  ...   .+....++.++|+||+++++++..    ...
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--KAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--HHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--HHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            346788855 6999999999999999999999999985432  111   222334667789999999999876    456


Q ss_pred             EEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCcEEEeecccccc
Q 016959          172 IEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS---SKNVKIADFGVSRI  242 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~---~~~~kl~Dfg~a~~  242 (380)
                      +++||||+.+++|.+++.      ..+..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++..
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~  180 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE  180 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence            899999999999876543      457788999999999999999999999999999999986   44599999999986


Q ss_pred             ccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHH----HHHHHHhhCCC
Q 016959          243 LAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWA----SLMFAICFAQP  318 (380)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~~~~~~  318 (380)
                      ....  ......||+.|+|||++.     +..++.++|||||||++|+|++|..||.........    ..+.......+
T Consensus       181 ~~~~--~~~~~~~t~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (336)
T 3fhr_A          181 TTQN--ALQTPCYTPYYVAPEVLG-----PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP  253 (336)
T ss_dssp             C-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred             cccc--ccccCCCCcCccChhhhC-----CCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence            5532  234567899999999984     345677999999999999999999999754433221    11222222333


Q ss_pred             CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          319 PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       319 ~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ...+..++.++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            44446789999999999999999999999999999999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=361.39  Aligned_cols=248  Identities=28%  Similarity=0.426  Sum_probs=199.5

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCch-----HHHHHHHHHHHHHHhC----CCCceeeeEeEEee
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED-----SVRSQICREIEILRDV----NHPNVVKCHDMYDR  168 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~E~~~l~~l----~h~~iv~~~~~~~~  168 (380)
                      .++|++.+.||+|+||.||+|.+..+++.||||++......     .....+.+|+.+++++    +|+||+++++++..
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~  109 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET  109 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence            46799999999999999999999999999999999654321     1233456799999988    89999999999998


Q ss_pred             CCeEEEEEec-cCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-CCCcEEEeecccccc
Q 016959          169 NGEIEVLLEY-MDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN-SSKNVKIADFGVSRI  242 (380)
Q Consensus       169 ~~~~~lv~e~-~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~  242 (380)
                      .+..++|||+ +.+++|.+++.    ..+..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..
T Consensus       110 ~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~  189 (312)
T 2iwi_A          110 QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL  189 (312)
T ss_dssp             ---CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEE
T ss_pred             CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhh
Confidence            8999999999 78888876654    46778899999999999999999999999999999999 889999999999987


Q ss_pred             ccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCC
Q 016959          243 LAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAP  322 (380)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  322 (380)
                      ....  ......|+..|+|||++..    ..+.+.++|||||||++|+|++|+.||...     ... .    ......+
T Consensus       190 ~~~~--~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~-~----~~~~~~~  253 (312)
T 2iwi_A          190 LHDE--PYTDFDGTRVYSPPEWISR----HQYHALPATVWSLGILLYDMVCGDIPFERD-----QEI-L----EAELHFP  253 (312)
T ss_dssp             CCSS--CBCCCCSCTTTSCHHHHHH----SCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HHH-H----HTCCCCC
T ss_pred             cccC--cccccCCcccccCceeeec----CCCCCccchHHHHHHHHHHHHHCCCCCCCh-----HHH-h----hhccCCc
Confidence            6543  2345679999999999864    244456899999999999999999999521     111 1    1234456


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      ..++.++.+||.+||+.||++|||+.|+++||||+....
T Consensus       254 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence            678999999999999999999999999999999998644

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.5e-48  Score=366.61  Aligned_cols=256  Identities=22%  Similarity=0.314  Sum_probs=195.2

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC----------chHHHHHHHHHHHHHHhCCCCceeeeEeEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH----------EDSVRSQICREIEILRDVNHPNVVKCHDMYD  167 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  167 (380)
                      .++|.+.+.||+|+||.||+|.+.. ++.||||++....          .....+.+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            4689999999999999999999864 8999999985322          2233477899999999999999999999984


Q ss_pred             e-----CCeEEEEEeccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeec
Q 016959          168 R-----NGEIEVLLEYMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADF  237 (380)
Q Consensus       168 ~-----~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  237 (380)
                      .     ...+++||||+.+ +|...+     ...+..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       100 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             ECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred             eccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence            3     3468999999985 554332     2356788999999999999999999999999999999999999999999


Q ss_pred             cccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC
Q 016959          238 GVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ  317 (380)
Q Consensus       238 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  317 (380)
                      |++...... .......||+.|+|||++..    ...++.++|||||||++|+|++|+.||......+....+.......
T Consensus       179 g~~~~~~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (362)
T 3pg1_A          179 NLAREDTAD-ANKTHYVTHRWYRAPELVMQ----FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP  253 (362)
T ss_dssp             TC----------------CGGGCCHHHHTT----CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             Ccccccccc-cccceecccceecCcHHhcC----CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            999755433 22345678999999999853    2456789999999999999999999997443222222221111100


Q ss_pred             --------------------CC--------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          318 --------------------PP--------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       318 --------------------~~--------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                                          ..        .....++..+.+||.+||+.||++|||+.|+|+||||+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence                                00        01234578899999999999999999999999999999873

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.3e-48  Score=360.82  Aligned_cols=251  Identities=23%  Similarity=0.362  Sum_probs=204.5

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcE----EEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRV----FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRN  169 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  169 (380)
                      ..+..++|++.+.||+|+||+||+|.+..+++.    ||+|++...........+.+|+.+++.++|+||+++++++. +
T Consensus         8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   86 (325)
T 3kex_A            8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G   86 (325)
T ss_dssp             CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred             hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence            346678999999999999999999999888776    77777754433333345678999999999999999999987 4


Q ss_pred             CeEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      +..++||||+.+++|.+++.     ..+..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++.+.
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            56899999999999976543     3467788999999999999999999999999999999999999999999998765


Q ss_pred             ccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCC
Q 016959          245 QTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEA  321 (380)
Q Consensus       245 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  321 (380)
                      ....  ......|+..|+|||++..     ..++.++|||||||++|+|++ |..||........   ...+........
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~~~~~~~  238 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHF-----GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV---PDLLEKGERLAQ  238 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH---HHHHHTTCBCCC
T ss_pred             cccccccccCCCCcccccChHHhcc-----CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH---HHHHHcCCCCCC
Confidence            4322  2344567889999999863     456789999999999999999 9999975444333   333344445566


Q ss_pred             CccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      +..++.++.+||.+||..||++|||+.|+++|
T Consensus       239 ~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          239 PQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            67788899999999999999999999999985

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.6e-48  Score=359.46  Aligned_cols=250  Identities=22%  Similarity=0.380  Sum_probs=200.4

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcE----EEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRV----FALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      .+..++|++.+.||+|+||+||+|.+..+++.    ||+|.+...........+.+|+.+++.++||||+++++++....
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred             hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence            46678999999999999999999999877765    47777755444445577899999999999999999999998754


Q ss_pred             eEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                       .++|+||+.+++|.+++.     ..+..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+..
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence             789999999999876543     35677889999999999999999999999999999999999999999999987654


Q ss_pred             cCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCC
Q 016959          246 TMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAP  322 (380)
Q Consensus       246 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  322 (380)
                      ...  ......||..|+|||++..     ..++.++|||||||++|||++ |..||.........   ...........+
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~~~~~~~~~~~  241 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILH-----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILEKGERLPQP  241 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHTTCCCCCC
T ss_pred             CcccccccCCCccccccChHHhcc-----CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH---HHHHcCCCCCCC
Confidence            322  2234456889999999863     567889999999999999999 99999755444433   333344455667


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ..++.++.+|+.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          242 PICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            7789999999999999999999999999975

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.3e-47  Score=353.45  Aligned_cols=253  Identities=23%  Similarity=0.344  Sum_probs=207.8

Q ss_pred             CCCcccccccceecccCCceEEEEE----eCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC-
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVV----HPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRN-  169 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-  169 (380)
                      .+....|++.+.||+|+||.||+|+    +..+++.||||++...........+.+|+.+++.++|+||+++++++... 
T Consensus        17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG   96 (302)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred             hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence            3556779999999999999999999    56789999999997655444557789999999999999999999999876 


Q ss_pred             -CeEEEEEeccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          170 -GEIEVLLEYMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       170 -~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                       ..+++||||+.+++|.+++     ...+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence             6789999999999998765     2356778899999999999999999999999999999999999999999999876


Q ss_pred             cccCC---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC------------CCCCHHH
Q 016959          244 AQTMD---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVG------------RQGDWAS  308 (380)
Q Consensus       244 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~------------~~~~~~~  308 (380)
                      .....   ......||..|+|||++..     ..++.++|||||||++|+|++|..|+...            .......
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQ-----SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR  251 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHH-----CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecC-----CCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence            54321   2345568889999999854     44567899999999999999999987421            1122333


Q ss_pred             HHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          309 LMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .............+..++.++.+||.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            44445555566677889999999999999999999999999987

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.5e-47  Score=357.26  Aligned_cols=250  Identities=24%  Similarity=0.357  Sum_probs=207.4

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEE--EEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCe
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF--ALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~--avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~  171 (380)
                      .++.++|++.+.||+|+||.||+|++..++..+  |+|++.........+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  100 (327)
T 1fvr_A           21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY  100 (327)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence            367789999999999999999999998888765  999987655555567789999999999 89999999999999999


Q ss_pred             EEEEEeccCCCCcccccc--------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc
Q 016959          172 IEVLLEYMDGGSLEGAHI--------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN  231 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~--------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~  231 (380)
                      .++||||+.+++|.+++.                    ..+..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred             eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence            999999999999876653                    356778899999999999999999999999999999999999


Q ss_pred             EEEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHH
Q 016959          232 VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLM  310 (380)
Q Consensus       232 ~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~  310 (380)
                      +||+|||++....... ......++..|+|||++..     ..++.++|||||||++|+|++ |..||..   .......
T Consensus       181 ~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g~~pf~~---~~~~~~~  251 (327)
T 1fvr_A          181 AKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNY-----SVYTTNSDVWSYGVLLWEIVSLGGTPYCG---MTCAELY  251 (327)
T ss_dssp             EEECCTTCEESSCEEC-CC----CCTTTCCHHHHHH-----CEECHHHHHHHHHHHHHHHHTTSCCTTTT---CCHHHHH
T ss_pred             EEEcccCcCccccccc-cccCCCCCccccChhhhcc-----ccCCchhcchHHHHHHHHHHcCCCCCCCC---CcHHHHH
Confidence            9999999997543322 2234457889999999853     456789999999999999998 9999963   3344455


Q ss_pred             HHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          311 FAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ..+........+..++.++.+||.+||..||++|||+.|++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          252 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            5555555566777889999999999999999999999999984

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-47  Score=347.81  Aligned_cols=253  Identities=23%  Similarity=0.360  Sum_probs=211.8

Q ss_pred             cCCCcccccccc-eecccCCceEEEEEeC--CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           94 QLINPAELQKGN-RIGSGSGGTVWRVVHP--PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        94 ~~~~~~~~~~~~-~LG~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      ..+..++|.+.+ .||+|+||.||+|.+.  .+++.||||++.........+.+.+|+.+++.++||||+++++++. .+
T Consensus         4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~   82 (287)
T 1u59_A            4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE   82 (287)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS
T ss_pred             ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CC
Confidence            446678888887 9999999999999864  4688899999987666667788999999999999999999999994 56


Q ss_pred             eEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      ..++||||+.+++|.+++.     ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            7999999999999877653     35677899999999999999999999999999999999999999999999987643


Q ss_pred             cCC---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCC
Q 016959          246 TMD---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEA  321 (380)
Q Consensus       246 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  321 (380)
                      ...   ......||+.|+|||++..     ..++.++|||||||++|+|++ |..||.....   ......+........
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~i~~~~~~~~  234 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINF-----RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRMEC  234 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHH-----CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHTTCCCCC
T ss_pred             CcceeeccccccccccccCHHHhcc-----CCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHhcCCcCCC
Confidence            321   1234457899999999853     456789999999999999998 9999974433   334444455556677


Q ss_pred             CccccHHHHHHHHHhcccCcCCCCCHHHHhcCcc
Q 016959          322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPF  355 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~  355 (380)
                      +..++.++.+||.+||+.||++||++.|+++|.+
T Consensus       235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            7889999999999999999999999999998543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.2e-47  Score=357.48  Aligned_cols=258  Identities=21%  Similarity=0.288  Sum_probs=202.8

Q ss_pred             ccccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           91 NRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        91 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      .....+..++|++.++||+|+||+||+|++  .++.||||++....  .......+|+.+++.++||||+++++++....
T Consensus        16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (322)
T 3soc_A           16 TENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT   91 (322)
T ss_dssp             CCCEEETTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             ccccccchhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence            344557788999999999999999999998  48999999995433  33445567999999999999999999998743


Q ss_pred             ----eEEEEEeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhC----------CceecCCCCCcEEEcCCCcEE
Q 016959          171 ----EIEVLLEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKR----------KIVHRDIKPSNLLINSSKNVK  233 (380)
Q Consensus       171 ----~~~lv~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~----------~ivH~Dlkp~Nil~~~~~~~k  233 (380)
                          .+++||||+.+++|.+++.   ..+..++.++.||+.||.|||++          ||+||||||+|||++.++.+|
T Consensus        92 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A           92 SVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             CCCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence                4799999999999987654   35678899999999999999999          999999999999999999999


Q ss_pred             EeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-------
Q 016959          234 IADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG-------  304 (380)
Q Consensus       234 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------  304 (380)
                      |+|||+++.+.....  ......||+.|+|||++.........++.++|||||||++|||++|+.||......       
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            999999987654322  23446799999999998643222234556889999999999999999999743221       


Q ss_pred             ------CHHHHHHHHhhC-CCCCCCc-----cccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          305 ------DWASLMFAICFA-QPPEAPE-----MASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       305 ------~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                            ............ ..+....     ..+.++.+||.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                  112222222111 1222222     23456999999999999999999999987

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.1e-48  Score=365.25  Aligned_cols=254  Identities=27%  Similarity=0.427  Sum_probs=201.6

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-----------CCceeeeEe
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-----------HPNVVKCHD  164 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~~~~  164 (380)
                      +..++|.+.+.||+|+||+||+|.+..+++.||||++...  ....+.+.+|+.++++++           |+||+++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            4567899999999999999999999999999999999543  334567889999998886           899999999


Q ss_pred             EEeeCC----eEEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcC-----
Q 016959          165 MYDRNG----EIEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKR-KIVHRDIKPSNLLINS-----  228 (380)
Q Consensus       165 ~~~~~~----~~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~Nil~~~-----  228 (380)
                      ++...+    .+++|||++ +++|.+++.      ..+..+..++.||+.||+|||++ ||+||||||+|||++.     
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence            987654    789999999 778765543      35677889999999999999998 9999999999999953     


Q ss_pred             -CCcEEEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCH-
Q 016959          229 -SKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDW-  306 (380)
Q Consensus       229 -~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-  306 (380)
                       .+.+||+|||++......   .....||+.|+|||++..     ..++.++|||||||++|||++|..||........ 
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  244 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLG-----APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  244 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHT-----CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             CcceEEEcccccccccCCC---CCCCCCCccccCcHHHhC-----CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence             347999999999876543   245679999999999863     4567899999999999999999999974432211 


Q ss_pred             -----HHHHHHHhhC--------------------------------------CCCCCCccccHHHHHHHHHhcccCcCC
Q 016959          307 -----ASLMFAICFA--------------------------------------QPPEAPEMASREFRDFISRCLQKDPHS  343 (380)
Q Consensus       307 -----~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~  343 (380)
                           ...+......                                      .....+..++.++.+||.+||+.||++
T Consensus       245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence                 1111111100                                      011234556789999999999999999


Q ss_pred             CCCHHHHhcCccccccC
Q 016959          344 RWPAAQLLQHPFILRAG  360 (380)
Q Consensus       344 R~t~~eil~hp~~~~~~  360 (380)
                      |||+.|+|+||||++..
T Consensus       325 Rpt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          325 RADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             CBCHHHHHTCGGGTTCT
T ss_pred             cCCHHHHhhChhhhccc
Confidence            99999999999999863

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.8e-47  Score=350.21  Aligned_cols=253  Identities=23%  Similarity=0.351  Sum_probs=203.5

Q ss_pred             cCCCcccccccceecccCCceEEEEE----eCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee-
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVV----HPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR-  168 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-  168 (380)
                      ..+..++|++.+.||+|+||+||+|+    +..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.. 
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            34677899999999999999999998    56689999999996543 3445678999999999999999999999854 


Q ss_pred             -CCeEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 016959          169 -NGEIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI  242 (380)
Q Consensus       169 -~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  242 (380)
                       ...+++||||+.+++|.+++.     ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence             356899999999999977653     35667889999999999999999999999999999999999999999999987


Q ss_pred             ccccCC---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----------CC---H
Q 016959          243 LAQTMD---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ----------GD---W  306 (380)
Q Consensus       243 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----------~~---~  306 (380)
                      ......   ......++..|+|||++..     ..++.++|||||||++|+|++|..||.....          ..   .
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTE-----SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV  238 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcC-----CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence            643321   1233457788999999864     4567899999999999999999999852110          00   1


Q ss_pred             HHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          307 ASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ...............+..++.++.+||.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            1223333444556677788999999999999999999999999986

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.7e-47  Score=357.49  Aligned_cols=246  Identities=21%  Similarity=0.242  Sum_probs=203.2

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++.....   ...+.+|+.+++.+ +|+||+++++++...+..++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv   83 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV   83 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence            34689999999999999999999999999999999865432   23577899999999 899999999999999999999


Q ss_pred             EeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc-----EEEeeccccccccc
Q 016959          176 LEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN-----VKIADFGVSRILAQ  245 (380)
Q Consensus       176 ~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~-----~kl~Dfg~a~~~~~  245 (380)
                      |||+ +++|.+++.     ..+..+..++.||+.||+|||++||+||||||+|||++.++.     +||+|||++..+..
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence            9999 888876644     357788999999999999999999999999999999998887     99999999987644


Q ss_pred             cCC-------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC--
Q 016959          246 TMD-------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA--  316 (380)
Q Consensus       246 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--  316 (380)
                      ...       .....+||+.|+|||++..     ..++.++|||||||++|||++|..||......+.......+...  
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~  237 (330)
T 2izr_A          163 PETKKHIPYREHKSLTGTARYMSINTHLG-----KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR  237 (330)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred             CCCCccccccccCCcCCCccccChHHHcC-----CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence            322       1246789999999999853     55688999999999999999999999876656555444443221  


Q ss_pred             -CCCC-CCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          317 -QPPE-APEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       317 -~~~~-~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                       .+.. ....++ ++.+||.+||..||++||+++++++
T Consensus       238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence             1111 112234 9999999999999999999999886

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.1e-47  Score=343.74  Aligned_cols=248  Identities=24%  Similarity=0.400  Sum_probs=210.8

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      +.++.++|++.+.||+|+||.||+|.+. +++.||+|++......  .+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (267)
T 3t9t_A            3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   79 (267)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence            5678899999999999999999999986 6778999999765433  356889999999999999999999999999999


Q ss_pred             EEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-
Q 016959          174 VLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM-  247 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  247 (380)
                      +||||+.+++|.+++.     ..+..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence            9999999999976654     3567788999999999999999999999999999999999999999999998654321 


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCcccc
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS  326 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (380)
                      .......++..|+|||++..     ..++.++||||||+++|+|++ |..||...   ........+........+..++
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~~g~~p~~~~---~~~~~~~~i~~~~~~~~~~~~~  231 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSF-----SRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFRLYKPRLAS  231 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHTTCCCCCCTTSC
T ss_pred             cccccccccccccChhhhcC-----CCccchhchhhhHHHHHHHhccCCCCCCCC---CHHHHHHHHhcCCcCCCCccCc
Confidence            12234567889999999853     456789999999999999999 89999643   3444455555555566677789


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          327 REFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .++.+||.+||+.||++|||+.|+++
T Consensus       232 ~~l~~li~~~l~~~p~~Rps~~~ll~  257 (267)
T 3t9t_A          232 THVYQIMNHCWRERPEDRPAFSRLLR  257 (267)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999999997

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.6e-47  Score=353.14  Aligned_cols=251  Identities=24%  Similarity=0.318  Sum_probs=203.9

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ..++|++.+.||+|+||+||+|.+. +++.||||++..... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  114 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY  114 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred             HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            3468999999999999999999975 688999999865433 34567889999999999999999999999999999999


Q ss_pred             eccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          177 EYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       177 e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ||+.+++|.+++.        ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  194 (321)
T 2qkw_B          115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ  194 (321)
T ss_dssp             ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC
T ss_pred             EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            9999999987653        34577889999999999999999999999999999999999999999999976543221


Q ss_pred             --CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHH---HHh-h-------
Q 016959          249 --PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMF---AIC-F-------  315 (380)
Q Consensus       249 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~~-~-------  315 (380)
                        ......||+.|+|||++..     ..++.++|||||||++|+|++|+.||......+......   ... .       
T Consensus       195 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (321)
T 2qkw_B          195 THLSTVVKGTLGYIDPEYFIK-----GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV  269 (321)
T ss_dssp             CCCBCCCEEETTTCCHHHHHH-----CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred             cccccccCCCccccCHHHhcC-----CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence              2234568999999999853     456789999999999999999999997544333211111   100 0       


Q ss_pred             --CCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCc
Q 016959          316 --AQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHP  354 (380)
Q Consensus       316 --~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp  354 (380)
                        .........++..+.+++.+||+.||++|||+.|+++|.
T Consensus       270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence              011223445677899999999999999999999999854

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.7e-47  Score=369.12  Aligned_cols=245  Identities=23%  Similarity=0.349  Sum_probs=207.1

Q ss_pred             cccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC-
Q 016959           92 RHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG-  170 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-  170 (380)
                      ..+.+..++|++.+.||+|+||+||+|.+  .++.||||+++...   ..+.+.+|+.+|++++||||+++++++...+ 
T Consensus       186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  260 (450)
T 1k9a_A          186 SGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG  260 (450)
T ss_dssp             TTCBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred             cccccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence            34668889999999999999999999998  47899999996543   3457889999999999999999999976654 


Q ss_pred             eEEEEEeccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      .+++||||+.+++|.+++..      .+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            79999999999999776542      556788999999999999999999999999999999999999999999998554


Q ss_pred             ccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          245 QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      ...   ....++..|+|||++..     ..++.++|||||||++|||++ |..||......+...   .+........+.
T Consensus       341 ~~~---~~~~~~~~y~aPE~~~~-----~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~---~i~~~~~~~~p~  409 (450)
T 1k9a_A          341 STQ---DTGKLPVKWTAPEALRE-----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP---RVEKGYKMDAPD  409 (450)
T ss_dssp             ---------CCCTTTSCHHHHHS-----SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH---HHHTTCCCCCCT
T ss_pred             ccc---cCCCCCcceeCHHHhcC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHcCCCCCCCC
Confidence            322   23467899999999853     557789999999999999998 999998655555433   334445666778


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .++.++.+||.+||+.||++|||+.|+++
T Consensus       410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          410 GCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            89999999999999999999999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.8e-47  Score=350.04  Aligned_cols=250  Identities=23%  Similarity=0.368  Sum_probs=212.9

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .+.+..++|++.+.||+|+||+||+|.+..+++.||+|++....  ...+.+.+|+.+++.++|+||+++++++.+.+.+
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            45577889999999999999999999999899999999996543  3356788999999999999999999999999999


Q ss_pred             EEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          173 EVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      ++||||+.+++|.+++.      ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            99999999999876653      356778899999999999999999999999999999999999999999999876533


Q ss_pred             CC-CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc
Q 016959          247 MD-PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEM  324 (380)
Q Consensus       247 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (380)
                      .. ......+|+.|+|||++..     ..++.++||||||+++|+|++ |..||........   ............+..
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~  236 (288)
T 3kfa_A          165 TYTAHAGAKFPIKWTAPESLAY-----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLEKDYRMERPEG  236 (288)
T ss_dssp             SSEEETTEEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHHTTCCCCCCTT
T ss_pred             ccccccCCccccCcCChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHhccCCCCCCCC
Confidence            21 2233456789999999853     456789999999999999999 9999975444433   333444455667778


Q ss_pred             ccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          325 ASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ++.++.+||.+||..||++|||+.|+++
T Consensus       237 ~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          237 CPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            8999999999999999999999999987

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.7e-47  Score=376.32  Aligned_cols=255  Identities=22%  Similarity=0.360  Sum_probs=214.5

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .+.+..++|.+.++||+|+||+||+|.+..+++.||||++......  .+.+.+|+.+|++++||||+++++++...+.+
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc--hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            3556778899999999999999999999988999999999655432  46788999999999999999999999999999


Q ss_pred             EEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          173 EVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      ++||||+.+++|.+++.      ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            99999999999977654      245678889999999999999999999999999999999999999999999876432


Q ss_pred             C-CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc
Q 016959          247 M-DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEM  324 (380)
Q Consensus       247 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (380)
                      . .......++..|+|||++..     ..++.++|||||||+||||++ |..||........   ...+........+..
T Consensus       372 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~  443 (495)
T 1opk_A          372 TYTAHAGAKFPIKWTAPESLAY-----NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLEKDYRMERPEG  443 (495)
T ss_dssp             CEECCTTCCCCGGGCCHHHHHH-----CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHHTTCCCCCCTT
T ss_pred             ceeecCCCcCCcceeCHhHHhc-----CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCCCCCCCC
Confidence            1 12234456789999999853     446789999999999999998 9999975544433   333444555667788


Q ss_pred             ccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          325 ASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ++.++.+||.+||+.||++|||+.|+++  .|..+
T Consensus       444 ~~~~l~~li~~cl~~dP~~RPs~~el~~--~L~~~  476 (495)
T 1opk_A          444 CPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  476 (495)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHTS
T ss_pred             CCHHHHHHHHHHcCcChhHCcCHHHHHH--HHHHH
Confidence            9999999999999999999999999987  44443

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.3e-47  Score=356.80  Aligned_cols=257  Identities=22%  Similarity=0.348  Sum_probs=214.0

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCc-----EEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEe
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSR-----VFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYD  167 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~  167 (380)
                      ..+..++|.+.+.||+|+||+||+|.+..+++     .||+|++.........+.+.+|+.+++.+ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            45777899999999999999999999876654     79999997766666678899999999999 8999999999999


Q ss_pred             eCCeEEEEEeccCCCCccccccc------------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q 016959          168 RNGEIEVLLEYMDGGSLEGAHIR------------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS  229 (380)
Q Consensus       168 ~~~~~~lv~e~~~~~~L~~~~~~------------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~  229 (380)
                      ..+.+++||||+.+++|.+++..                  .+..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence            99999999999999999776542                  456788999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCH
Q 016959          230 KNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDW  306 (380)
Q Consensus       230 ~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~  306 (380)
                      +.+||+|||++........  ......||..|+|||++..     ..++.++|||||||++|+|++ |..||........
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-----CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhcc-----CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence            9999999999986643322  1234457889999999853     456789999999999999998 9999975443332


Q ss_pred             HHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          307 ASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                        .............+..++.++.+||.+||+.||++|||+.|+++  +++..
T Consensus       276 --~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~L~~~  324 (333)
T 2i1m_A          276 --FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS--FLQEQ  324 (333)
T ss_dssp             --HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             --HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH--HHHHH
Confidence              22223334445566678899999999999999999999999998  55443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.3e-47  Score=382.22  Aligned_cols=249  Identities=23%  Similarity=0.371  Sum_probs=203.6

Q ss_pred             CCCcccccccc-eecccCCceEEEEEeC--CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           95 LINPAELQKGN-RIGSGSGGTVWRVVHP--PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        95 ~~~~~~~~~~~-~LG~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      .+..+++.+.+ .||+|+||+||+|.+.  .++..||||+++........+.+.+|+++|+.++|||||++++++.. +.
T Consensus       331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~  409 (613)
T 2ozo_A          331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA  409 (613)
T ss_dssp             BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred             eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence            35556666666 8999999999999875  35677999999766555556789999999999999999999999976 56


Q ss_pred             EEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      +++|||||.+++|.+++.     ..+..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            999999999999977653     356778899999999999999999999999999999999999999999999876432


Q ss_pred             CC---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCC
Q 016959          247 MD---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAP  322 (380)
Q Consensus       247 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  322 (380)
                      ..   ......++..|+|||++..     ..++.++|||||||+||||++ |+.||.....   ......+........+
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~-----~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~~~~~~~p  561 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINF-----RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRMECP  561 (613)
T ss_dssp             ------------CCTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS---HHHHHHHHTTCCCCCC
T ss_pred             CceeeeccCCCCccceeCHhhhcC-----CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHcCCCCCCC
Confidence            21   1123345689999999853     556789999999999999998 9999975443   3344455556667778


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..++.++.+||.+||+.||++||++.++++
T Consensus       562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          562 PECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             TTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            889999999999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.3e-47  Score=353.88  Aligned_cols=254  Identities=25%  Similarity=0.391  Sum_probs=211.4

Q ss_pred             ccCCCcccccccceecccCCceEEEEEe-----CCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEE
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVH-----PPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMY  166 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~  166 (380)
                      .+.+..++|.+.+.||+|+||+||+|.+     ..+++.||||++...........+.+|+.+++.+ +||||+++++++
T Consensus        21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  100 (316)
T 2xir_A           21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC  100 (316)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence            3456788999999999999999999984     4567899999998766666667899999999999 699999999998


Q ss_pred             eeCC-eEEEEEeccCCCCcccccc--------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 016959          167 DRNG-EIEVLLEYMDGGSLEGAHI--------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLL  225 (380)
Q Consensus       167 ~~~~-~~~lv~e~~~~~~L~~~~~--------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil  225 (380)
                      ...+ .+++||||+.+++|.+++.                    ..+..+..++.||+.||.|||++||+||||||+|||
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil  180 (316)
T 2xir_A          101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  180 (316)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence            7654 5899999999999866543                    356678899999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 016959          226 INSSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGR  302 (380)
Q Consensus       226 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~  302 (380)
                      ++.++.+||+|||++........  ......||+.|+|||++..     ..++.++|||||||++|+|++ |..||....
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-----ccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence            99999999999999986643322  1234457889999999853     456789999999999999998 999997544


Q ss_pred             CCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          303 QGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ...  ..............+..++.++.++|.+||+.||++|||+.|+++|
T Consensus       256 ~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          256 IDE--EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             CSH--HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhH--HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            332  3333344445556677789999999999999999999999999985

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.3e-47  Score=351.92  Aligned_cols=256  Identities=21%  Similarity=0.311  Sum_probs=202.0

Q ss_pred             ccccccCCCcccccccceecccCCceEEEEEeCC---CCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEe
Q 016959           89 HQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPP---TSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHD  164 (380)
Q Consensus        89 ~~~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~---~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~  164 (380)
                      .......+..++|.+.+.||+|+||.||+|.+..   +++.||||++.... .....+.+.+|+.+++.++||||+++++
T Consensus        24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~  103 (313)
T 3brb_A           24 NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG  103 (313)
T ss_dssp             CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred             hhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence            3445566788999999999999999999998754   56689999986543 3445677899999999999999999999


Q ss_pred             EEeeCC-----eEEEEEeccCCCCccccc----------ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC
Q 016959          165 MYDRNG-----EIEVLLEYMDGGSLEGAH----------IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS  229 (380)
Q Consensus       165 ~~~~~~-----~~~lv~e~~~~~~L~~~~----------~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~  229 (380)
                      ++...+     ..++||||+.+++|..++          ...+..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus       104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~  183 (313)
T 3brb_A          104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD  183 (313)
T ss_dssp             EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT
T ss_pred             EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC
Confidence            987654     359999999999987654          23567889999999999999999999999999999999999


Q ss_pred             CcEEEeeccccccccccC--CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCH
Q 016959          230 KNVKIADFGVSRILAQTM--DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDW  306 (380)
Q Consensus       230 ~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~  306 (380)
                      +.+||+|||++.......  .......+++.|+|||++..     ..++.++|||||||++|+|++ |..||........
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  258 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-----RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM  258 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHS-----SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcC-----CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence            999999999998664332  11233457889999999853     556789999999999999999 9999975544433


Q ss_pred             HHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          307 ASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                         ............+..++.++.+||.+||..||++|||+.|+++
T Consensus       259 ---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  301 (313)
T 3brb_A          259 ---YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL  301 (313)
T ss_dssp             ---HHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ---HHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence               3334444556677788999999999999999999999999987

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4e-47  Score=344.67  Aligned_cols=247  Identities=29%  Similarity=0.464  Sum_probs=194.6

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc---hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE---DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      ++.++|++.+.||+|+||.||+|.+  +++.||||++.....   ....+.+.+|+.+++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL   81 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred             cchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence            5678899999999999999999998  588999999865432   22346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEEcC--------CCcEEEeecc
Q 016959          173 EVLLEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRK---IVHRDIKPSNLLINS--------SKNVKIADFG  238 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~Nil~~~--------~~~~kl~Dfg  238 (380)
                      ++||||+.+++|..++.   ..+..++.++.||+.||.|||++|   |+||||||+|||++.        ++.+||+|||
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            99999999999876643   357788999999999999999999   999999999999986        6789999999


Q ss_pred             ccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC
Q 016959          239 VSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP  318 (380)
Q Consensus       239 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  318 (380)
                      ++........  ....||+.|+|||++..     ..++.++||||||+++|+|++|+.||....  ..............
T Consensus       162 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~  232 (271)
T 3dtc_A          162 LAREWHRTTK--MSAAGAYAWMAPEVIRA-----SMFSKGSDVWSYGVLLWELLTGEVPFRGID--GLAVAYGVAMNKLA  232 (271)
T ss_dssp             C---------------CCGGGSCHHHHHH-----CCCSHHHHHHHHHHHHHHHHHCCCTTTTSC--HHHHHHHHHTSCCC
T ss_pred             cccccccccc--cCCCCccceeCHHHhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHhhhcCCCC
Confidence            9986654322  35679999999999853     556789999999999999999999996432  22222222333344


Q ss_pred             CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          319 PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       319 ~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ...+..++.++.+||.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            55677889999999999999999999999999974

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-47  Score=353.40  Aligned_cols=251  Identities=24%  Similarity=0.386  Sum_probs=204.9

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCC----cEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTS----RVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRN  169 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  169 (380)
                      ..+..++|.+.+.||+|+||+||+|.+..++    ..||||++...........+.+|+.+++.++|+||+++++++...
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  118 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY  118 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            3567789999999999999999999876543    459999997766666677899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      +..++||||+.+++|.+++.     ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            99999999999999977654     3567788999999999999999999999999999999999999999999998765


Q ss_pred             ccCC---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCC
Q 016959          245 QTMD---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPE  320 (380)
Q Consensus       245 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  320 (380)
                      ....   ......+|..|+|||++..     ..++.++|||||||++|+|++ |..||...   ........+.......
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~ellt~g~~pf~~~---~~~~~~~~~~~~~~~~  270 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISY-----RKFTSASDVWSFGIVMWEVMTYGERPYWEL---SNHEVMKAINDGFRLP  270 (333)
T ss_dssp             ------------CCCGGGSCHHHHHS-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHTTCCCC
T ss_pred             cccccccccCCCCccccccCchhccc-----CCCCchhhhHHHHHHHHHHHcCCCCCcccC---CHHHHHHHHHCCCcCC
Confidence            4321   1123346789999999853     556789999999999999998 99999643   3344444555555556


Q ss_pred             CCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          321 APEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       321 ~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .+..++.++.+||.+||+.||++||++.|+++
T Consensus       271 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  302 (333)
T 1mqb_A          271 TPMDCPSAIYQLMMQCWQQERARRPKFADIVS  302 (333)
T ss_dssp             CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            67778999999999999999999999999987

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.2e-47  Score=350.93  Aligned_cols=262  Identities=23%  Similarity=0.389  Sum_probs=204.9

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCC--CCceeeeEeEEeeCCe
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVN--HPNVVKCHDMYDRNGE  171 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~  171 (380)
                      .+..++|.+.+.||+|+||.||+|.+. +++.||||++.... .......+.+|+.++++++  |+||+++++++...+.
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            355678999999999999999999986 58899999996543 4455678899999999997  5999999999999999


Q ss_pred             EEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          172 IEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      .++||| +.+++|.+++.    ..+..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+....
T Consensus       103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-----
T ss_pred             EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcc
Confidence            999999 56678765543    35667889999999999999999999999999999996 5899999999998765332


Q ss_pred             C--CCCCCCCCCccccccccccccC------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC
Q 016959          248 D--PCNSAVGTIAYMSPERINTDLN------HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP  319 (380)
Q Consensus       248 ~--~~~~~~gt~~y~aPE~~~~~~~------~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  319 (380)
                      .  ......||+.|+|||++.....      ....++.++|||||||++|+|++|..||..... ...............
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~  259 (313)
T 3cek_A          181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIIDPNHEI  259 (313)
T ss_dssp             ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-HHHHHHHHHCTTSCC
T ss_pred             ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-HHHHHHHHHhccccc
Confidence            2  1234579999999999853111      113567899999999999999999999964322 122222222233344


Q ss_pred             CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       320 ~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      ..+...+.++.+||.+||..||++|||+.|+|+||||+...
T Consensus       260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            56667789999999999999999999999999999998753

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=366.20  Aligned_cols=256  Identities=25%  Similarity=0.367  Sum_probs=207.2

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC--eEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG--EIE  173 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~  173 (380)
                      +..++|.+.++||+|+||+||+|.+..+++.||||++.........+.+.+|++++++++|+||+++++++...+  ..+
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            446789999999999999999999999999999999975444444567789999999999999999999998654  789


Q ss_pred             EEEeccCCCCcccccc-------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----cCCCcEEEeecccccc
Q 016959          174 VLLEYMDGGSLEGAHI-------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI----NSSKNVKIADFGVSRI  242 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~-------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~----~~~~~~kl~Dfg~a~~  242 (380)
                      +|||||.+++|.+++.       ..+..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||+++.
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            9999999999876654       4567788999999999999999999999999999999    7777899999999987


Q ss_pred             ccccCCCCCCCCCCCccccccccccccCC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-CCHHHHHHHHhhCCC
Q 016959          243 LAQTMDPCNSAVGTIAYMSPERINTDLNH---GKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQ-GDWASLMFAICFAQP  318 (380)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~  318 (380)
                      ..... ......||+.|+|||++......   +..++.++|||||||++|||++|..||..... ......+..+....+
T Consensus       166 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p  244 (396)
T 4eut_A          166 LEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (396)
T ss_dssp             CCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred             ccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence            65432 23456799999999998531111   13456789999999999999999999964322 333444444444433


Q ss_pred             CC------------------------CCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          319 PE------------------------APEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       319 ~~------------------------~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..                        ....++..+.+||.+||+.||++|+|++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            21                        22446678999999999999999999999865

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=7.9e-47  Score=344.82  Aligned_cols=251  Identities=24%  Similarity=0.334  Sum_probs=207.0

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCC---CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPP---TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      ..+..++|.+.+.||+|+||+||+|.+..   ++..||+|++.........+.+.+|+.+++.++||||+++++++.++ 
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   85 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-   85 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-
Confidence            45778899999999999999999998643   34569999997766666678899999999999999999999998764 


Q ss_pred             eEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      ..++||||+.+++|.+++.     ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            5689999999999976653     35667889999999999999999999999999999999999999999999987654


Q ss_pred             cCC-CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          246 TMD-PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      ... ......++..|+|||++..     ..++.++|||||||++|+|++ |..||......+....   .........+.
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~---~~~~~~~~~~~  237 (281)
T 3cc6_A          166 EDYYKASVTRLPIKWMSPESINF-----RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV---LEKGDRLPKPD  237 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH---HHHTCCCCCCT
T ss_pred             ccccccccCCCCcceeCchhhcc-----CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH---HhcCCCCCCCC
Confidence            321 2234457889999999853     456789999999999999998 9999975554444333   33344555667


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      .++..+.+||.+||..||++|||+.|++++
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            789999999999999999999999999973

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.6e-48  Score=352.07  Aligned_cols=245  Identities=18%  Similarity=0.289  Sum_probs=201.3

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCC-------cEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEe
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTS-------RVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYD  167 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~-------~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  167 (380)
                      .+..++|.+.+.||+|+||+||+|.+..++       +.||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-NYSESFFEAASMMSKLSHKHLVLNYGVCV   82 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG-GGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            467789999999999999999999988776       4799999865433 34567889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc--------EEE
Q 016959          168 RNGEIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN--------VKI  234 (380)
Q Consensus       168 ~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~--------~kl  234 (380)
                      +.+..++||||+.+++|.+++.     ..+..+..++.||+.||.|||++||+||||||+|||++.++.        +||
T Consensus        83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence            9999999999999999977654     345678899999999999999999999999999999998887        999


Q ss_pred             eeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh
Q 016959          235 ADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC  314 (380)
Q Consensus       235 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  314 (380)
                      +|||++......    ....||..|+|||++..    ...++.++|||||||++|+|++|..|+...  .+........ 
T Consensus       163 ~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~~~~~~--~~~~~~~~~~-  231 (289)
T 4fvq_A          163 SDPGISITVLPK----DILQERIPWVPPECIEN----PKNLNLATDKWSFGTTLWEICSGGDKPLSA--LDSQRKLQFY-  231 (289)
T ss_dssp             CCCCSCTTTSCH----HHHHHTTTTSCHHHHHC----GGGCCHHHHHHHHHHHHHHHHTTTCCTTTT--SCHHHHHHHH-
T ss_pred             ccCcccccccCc----cccCCcCcccCHHHhCC----CCCCCchhHHHHHHHHHHHHHcCCCCCccc--cchHHHHHHh-
Confidence            999998755432    23457889999999853    245678999999999999999965555322  2222222222 


Q ss_pred             hCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          315 FAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       315 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                       ......+...+.++.+||.+||+.||++|||+.|+++
T Consensus       232 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  268 (289)
T 4fvq_A          232 -EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIR  268 (289)
T ss_dssp             -HTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -hccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence             2344455566789999999999999999999999998

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1e-46  Score=367.18  Aligned_cols=253  Identities=24%  Similarity=0.397  Sum_probs=211.4

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .+.+..++|.+.+.||+|+||+||+|.+. ++..||||+++....  ..+.+.+|+.+|+.++||||+++++++. .+.+
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB--CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc--cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence            45678899999999999999999999986 467899999975443  2567899999999999999999999987 5678


Q ss_pred             EEEEeccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          173 EVLLEYMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      ++||||+.+|+|.+++..      ....+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            999999999999877653      35567889999999999999999999999999999999999999999999876432


Q ss_pred             C-CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc
Q 016959          247 M-DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEM  324 (380)
Q Consensus       247 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (380)
                      . .......++..|+|||++..     ..++.++|||||||+||||++ |+.||...   ........+........+..
T Consensus       338 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~el~t~g~~P~~~~---~~~~~~~~i~~~~~~~~~~~  409 (454)
T 1qcf_A          338 EYTAREGAKFPIKWTAPEAINF-----GSFTIKSDVWSFGILLMEIVTYGRIPYPGM---SNPEVIRALERGYRMPRPEN  409 (454)
T ss_dssp             HHHTTCSSSSCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHHHHHHHTCCCCCCTT
T ss_pred             ceeccCCCcccccccCHHHhcc-----CCCCcHHHHHhHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCCCCCCCC
Confidence            1 11234456789999999853     456789999999999999999 99999743   33444445555566667788


Q ss_pred             ccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          325 ASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ++.++.+||.+||..||++|||++++++  .+..+
T Consensus       410 ~~~~l~~li~~cl~~dp~~RPt~~~i~~--~L~~~  442 (454)
T 1qcf_A          410 CPEELYNIMMRCWKNRPEERPTFEYIQS--VLDDF  442 (454)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHTS
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHH--HHHHH
Confidence            9999999999999999999999999986  44444

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.3e-46  Score=351.06  Aligned_cols=255  Identities=23%  Similarity=0.349  Sum_probs=211.3

Q ss_pred             cccCCCcccccccceecccCCceEEEEE----eCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEe
Q 016959           92 RHQLINPAELQKGNRIGSGSGGTVWRVV----HPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYD  167 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  167 (380)
                      ....+..++|++.+.||+|+||+||+|+    +..+++.||||++.... ....+.+.+|+++++.++|+||+++++++.
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   94 (327)
T 3lxl_A           16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSY   94 (327)
T ss_dssp             -CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEe
Confidence            3455788999999999999999999999    56789999999996553 344567899999999999999999999886


Q ss_pred             --eCCeEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccc
Q 016959          168 --RNGEIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS  240 (380)
Q Consensus       168 --~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  240 (380)
                        +.+.+++||||+.+++|.+++.     ..+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A           95 GPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             CSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             cCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccc
Confidence              4567999999999999977654     356778899999999999999999999999999999999999999999999


Q ss_pred             ccccccCC---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC------------CCC
Q 016959          241 RILAQTMD---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGR------------QGD  305 (380)
Q Consensus       241 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~------------~~~  305 (380)
                      ........   ......||..|+|||++..     ..++.++|||||||++|+|++|..||....            ...
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  249 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSD-----NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA  249 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHH-----CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCH
T ss_pred             eecccCCccceeeccCCccccccCHHHhcc-----CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccccccc
Confidence            87643322   2234568889999999853     455779999999999999999999995221            111


Q ss_pred             HHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          306 WASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ................+..++.++.+||.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  296 (327)
T 3lxl_A          250 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP  296 (327)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            23334444455566677889999999999999999999999999976

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.2e-46  Score=341.13  Aligned_cols=249  Identities=18%  Similarity=0.268  Sum_probs=207.2

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC--
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN--  169 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--  169 (380)
                      ...+..++|++.+.||+|+||+||+|.+  .++.||||++.... .....+.+.+|+.+++.++||||+++++++.+.  
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (271)
T 3kmu_A            4 HSGIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA   81 (271)
T ss_dssp             CCCCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred             cCCCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence            3457788999999999999999999999  58899999997543 344567799999999999999999999999876  


Q ss_pred             CeEEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRK--IVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                      +..++||||+.+++|.+++.      .++..+..++.||+.||.|||++|  |+||||||+|||++.++.++|+|||++.
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence            78899999999999976654      356788999999999999999999  9999999999999999999999999875


Q ss_pred             cccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCC
Q 016959          242 ILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA  321 (380)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  321 (380)
                      ....     ....||+.|+|||++....  ...++.++|||||||++|+|++|+.||.....  .............+..
T Consensus       162 ~~~~-----~~~~~t~~y~aPE~~~~~~--~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~  232 (271)
T 3kmu_A          162 SFQS-----PGRMYAPAWVAPEALQKKP--EDTNRRSADMWSFAVLLWELVTREVPFADLSN--MEIGMKVALEGLRPTI  232 (271)
T ss_dssp             TTSC-----TTCBSCGGGSCHHHHHSCG--GGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH--HHHHHHHHHSCCCCCC
T ss_pred             eecc-----cCccCCccccChhhhccCC--CCCCCchhhHHHHHHHHHHHHhCCCCccccCh--HHHHHHHHhcCCCCCC
Confidence            4322     3457899999999986421  12223479999999999999999999964322  2222333334556677


Q ss_pred             CccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      +..++.++.+||.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7889999999999999999999999999997

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.7e-47  Score=353.58  Aligned_cols=249  Identities=22%  Similarity=0.379  Sum_probs=201.1

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEE----EEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF----ALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~----avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      .+..++|++.+.||+|+||+||+|.+..+++.+    |+|.+...........+.+|+.+++.++||||+++++++....
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred             ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence            356788999999999999999999998887765    6666654444445677889999999999999999999998754


Q ss_pred             eEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                       .++|++++.+++|.+++.     ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence             789999999999876653     35677889999999999999999999999999999999999999999999987643


Q ss_pred             cCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCC
Q 016959          246 TMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAP  322 (380)
Q Consensus       246 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  322 (380)
                      ...  ......+|..|+|||++.+     ..++.++|||||||++|+|++ |..||........   ............+
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~~~~~~~~~~~~  241 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILH-----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSILEKGERLPQP  241 (327)
T ss_dssp             ----------CCCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHTTCCCCCC
T ss_pred             ccccccccCCCccccccCHHHHcC-----CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHHHHcCCCCCCC
Confidence            322  2234456889999999863     567789999999999999999 9999975544443   3334444556667


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..++.++.+||.+||..||++|||+.|+++
T Consensus       242 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          242 PICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             TTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            778999999999999999999999999997

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.8e-46  Score=345.06  Aligned_cols=248  Identities=19%  Similarity=0.225  Sum_probs=205.4

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l  174 (380)
                      +..++|++.+.||+|+||+||+|.+..+++.||||++.....   ...+.+|+.+++.+ +|+|++++++++......++
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence            445789999999999999999999999999999999864432   23467899999999 79999999999999999999


Q ss_pred             EEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc-----EEEeecccccccc
Q 016959          175 LLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN-----VKIADFGVSRILA  244 (380)
Q Consensus       175 v~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~-----~kl~Dfg~a~~~~  244 (380)
                      ||||+ +++|.+++.     .++..+..++.||+.||.|||++||+||||||+|||++.++.     +||+|||++....
T Consensus        84 v~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           84 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             EEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99999 889877654     457788999999999999999999999999999999987776     9999999998765


Q ss_pred             ccCC-------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh--
Q 016959          245 QTMD-------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF--  315 (380)
Q Consensus       245 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--  315 (380)
                      ....       ......||+.|+|||++..     ..++.++|||||||++|+|++|+.||..............+..  
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLG-----REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccCccCCCCCcccCCchhhcC-----CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            4322       2345679999999999853     5568899999999999999999999986554444333332221  


Q ss_pred             --CCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          316 --AQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       316 --~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                        .........++.++.+||.+||+.||++|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence              1222233467889999999999999999999999987

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.8e-46  Score=343.02  Aligned_cols=250  Identities=22%  Similarity=0.355  Sum_probs=205.7

Q ss_pred             cCCCcccccccc-eecccCCceEEEEE--eCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC
Q 016959           94 QLINPAELQKGN-RIGSGSGGTVWRVV--HPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN  169 (380)
Q Consensus        94 ~~~~~~~~~~~~-~LG~G~~g~V~~~~--~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  169 (380)
                      ..++.++|.+.+ .||+|+||+||+|.  ...+++.||||++.... .....+.+.+|+.+++.++||||+++++++ ..
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~   89 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA   89 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence            346778899988 99999999999994  45678899999996543 234467899999999999999999999999 56


Q ss_pred             CeEEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      +..++||||+.+++|.+++.    ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            67899999999999876654    35677889999999999999999999999999999999999999999999987643


Q ss_pred             cCC---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCC
Q 016959          246 TMD---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEA  321 (380)
Q Consensus       246 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  321 (380)
                      ...   ......++..|+|||++..     ..++.++|||||||++|+|++ |..||...   ........+........
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~~g~~p~~~~---~~~~~~~~~~~~~~~~~  241 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINY-----YKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLEKGERMGC  241 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHH-----CEEEHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHHTTCCCCC
T ss_pred             CCCcccccccCCCCceeeChHHhcc-----CCCChhhhHHHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCCCC
Confidence            322   1223446789999999853     445679999999999999999 99999743   33444445555556667


Q ss_pred             CccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      +..++.++.++|.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          242 PAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7889999999999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=346.12  Aligned_cols=242  Identities=27%  Similarity=0.432  Sum_probs=197.8

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      .++.++|++.+.||+|+||+||+|.+  .++.||||++...   ...+.+.+|+.++++++||||+++++++.+  ..++
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~l   76 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCL   76 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEE
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEE
Confidence            46778999999999999999999998  5789999998543   345678899999999999999999998874  4789


Q ss_pred             EEeccCCCCccccccc-------chHHHHHHHHHHHHHHHHHHh---CCceecCCCCCcEEEcCCCc-EEEeeccccccc
Q 016959          175 LLEYMDGGSLEGAHIR-------QEHILSDLARQVLSGLAYLHK---RKIVHRDIKPSNLLINSSKN-VKIADFGVSRIL  243 (380)
Q Consensus       175 v~e~~~~~~L~~~~~~-------~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~Nil~~~~~~-~kl~Dfg~a~~~  243 (380)
                      ||||+.+++|.+++..       ....+..++.||+.||+|||+   +||+||||||+|||++.++. +||+|||++...
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            9999999999766543       456788899999999999999   89999999999999998887 799999999765


Q ss_pred             cccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      ...   .....||+.|+|||++..     ..++.++|||||||++|+|++|+.||..... ..............+..+.
T Consensus       157 ~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~  227 (307)
T 2eva_A          157 QTH---MTNNKGSAAWMAPEVFEG-----SNYSEKCDVFSWGIILWEVITRRKPFDEIGG-PAFRIMWAVHNGTRPPLIK  227 (307)
T ss_dssp             -----------CCTTSSCHHHHTC-----CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS-SHHHHHHHHHTTCCCCCBT
T ss_pred             ccc---cccCCCCCceEChhhhCC-----CCCCcHHHHHHHHHHHHHHHHCCCCchhhCc-cHHHHHHHHhcCCCCCccc
Confidence            432   234569999999999853     4567899999999999999999999974433 2333444455556667777


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .++..+.+||.+||+.||++|||+.|+++
T Consensus       228 ~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          228 NLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            88999999999999999999999999997

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=6e-46  Score=338.52  Aligned_cols=248  Identities=23%  Similarity=0.393  Sum_probs=207.8

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .+.+..++|++.+.||+|+||+||+|.+. +++.||||++......  .+.+.+|+++++.++|+||+++++++.. +..
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~   82 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI   82 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc--HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCc
Confidence            45677889999999999999999999985 5678999999654322  4578899999999999999999999874 468


Q ss_pred             EEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          173 EVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      ++||||+.+++|.+++.      ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            99999999999987764      345678899999999999999999999999999999999999999999999876533


Q ss_pred             C-CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc
Q 016959          247 M-DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEM  324 (380)
Q Consensus       247 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (380)
                      . .......++..|+|||++..     ..++.++|||||||++|+|++ |..||...   ........+........+..
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~  234 (279)
T 1qpc_A          163 EYTAREGAKFPIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQNLERGYRMVRPDN  234 (279)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHH-----CEECHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHHTTCCCCCCTT
T ss_pred             ccccccCCCCccCccChhhhcc-----CCCCchhhhHHHHHHHHHHHhCCCCCCccc---CHHHHHHHHhcccCCCCccc
Confidence            2 12234457889999999853     456789999999999999999 99999643   33344445555555666778


Q ss_pred             ccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          325 ASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ++.++.+||.+||..||++|||+.++++
T Consensus       235 ~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          235 CPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            8999999999999999999999999987

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-46  Score=348.06  Aligned_cols=247  Identities=24%  Similarity=0.389  Sum_probs=195.2

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....  .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            468999999999999999999999999999999986543  344567889999999999999999999999999999999


Q ss_pred             EeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-CCC
Q 016959          176 LEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM-DPC  250 (380)
Q Consensus       176 ~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~~~  250 (380)
                      |||+.+++|.+++.    ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  192 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL  192 (309)
T ss_dssp             EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccc
Confidence            99999999877654    3567788999999999999999999999999999999999999999999997664332 223


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC--CCCCCccccHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ--PPEAPEMASRE  328 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  328 (380)
                      ....|++.|+|||++..     ..++.++||||||+++|+|++|..||....   ............  ....+..++.+
T Consensus       193 ~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  264 (309)
T 2h34_A          193 GNTVGTLYYMAPERFSE-----SHATYRADIYALTCVLYECLTGSPPYQGDQ---LSVMGAHINQAIPRPSTVRPGIPVA  264 (309)
T ss_dssp             ----CCGGGCCGGGTCC---------CCCHHHHHHHHHHHHHHSSCSSCSCH---HHHHHHHHHSCCCCGGGTSTTCCTH
T ss_pred             cccCCCcCccCHHHHcC-----CCCCchHhHHHHHHHHHHHHHCCCCCCCch---HHHHHHHhccCCCCccccCCCCCHH
Confidence            45679999999999853     556779999999999999999999996322   122222222111  22345668889


Q ss_pred             HHHHHHHhcccCcCCCC-CHHHHhc
Q 016959          329 FRDFISRCLQKDPHSRW-PAAQLLQ  352 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~-t~~eil~  352 (380)
                      +.+||.+||+.||++|| +++++++
T Consensus       265 l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          265 FDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHHhccCCHHHHHHhHHHHHH
Confidence            99999999999999999 7888775

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-46  Score=342.56  Aligned_cols=251  Identities=24%  Similarity=0.303  Sum_probs=204.8

Q ss_pred             cccccceecccCCceEEEEEeCCCCc---EEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE-EEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSR---VFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI-EVL  175 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~lv  175 (380)
                      .|.+.++||+|+||+||+|.+..+++   .||+|++.........+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45667999999999999999755443   79999997766666678899999999999999999999999766554 999


Q ss_pred             EeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc----
Q 016959          176 LEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT----  246 (380)
Q Consensus       176 ~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----  246 (380)
                      |||+.+++|.+++..     .+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......    
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  181 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS  181 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence            999999998766543     46778899999999999999999999999999999999999999999999765432    


Q ss_pred             CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcccc
Q 016959          247 MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS  326 (380)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (380)
                      ........++..|+|||.+.     +..++.++|||||||++|+|++|..||....  +................+..++
T Consensus       182 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~il~~l~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  254 (298)
T 3pls_A          182 VQQHRHARLPVKWTALESLQ-----TYRFTTKSDVWSFGVLLWELLTRGAPPYRHI--DPFDLTHFLAQGRRLPQPEYCP  254 (298)
T ss_dssp             SCCSSCTTCGGGGSCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CGGGHHHHHHTTCCCCCCTTCC
T ss_pred             cccCcCCCCCccccChhhhc-----cCCCChhhchhhHHHHHHHHhhCCCCCCccC--CHHHHHHHhhcCCCCCCCccch
Confidence            12234556889999999985     3556789999999999999999665554222  2223333444455566677789


Q ss_pred             HHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          327 REFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       327 ~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      .++.+||.+||+.||++|||+.|+++  .++.+
T Consensus       255 ~~l~~li~~~l~~~p~~Rps~~~ll~--~l~~~  285 (298)
T 3pls_A          255 DSLYQVMQQCWEADPAVRPTFRVLVG--EVEQI  285 (298)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence            99999999999999999999999998  44443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2e-46  Score=341.58  Aligned_cols=244  Identities=23%  Similarity=0.358  Sum_probs=198.5

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee-CCe
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR-NGE  171 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~  171 (380)
                      .+.+..++|++.+.||+|+||+||+|.+  +|+.||||++....   ..+.+.+|+.+++.++|+||+++++++.. .+.
T Consensus        15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           15 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             cccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence            4557789999999999999999999998  58899999986443   34678899999999999999999998754 457


Q ss_pred             EEEEEeccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      .++||||+.+++|.+++..      .+..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            8999999999999877653      4566889999999999999999999999999999999999999999999876543


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEM  324 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (380)
                      ..   ....++..|+|||++..     ..++.++|||||||++|+|++ |..||......+   .............+..
T Consensus       170 ~~---~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~  238 (278)
T 1byg_A          170 TQ---DTGKLPVKWTAPEALRE-----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKGYKMDAPDG  238 (278)
T ss_dssp             ---------CCTTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTTTCCCCCCTT
T ss_pred             cc---cCCCccccccCHHHhCC-----CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcCCCCCCccc
Confidence            32   34467899999999853     456789999999999999998 999997544433   3333444455666778


Q ss_pred             ccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          325 ASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ++.++.++|.+||+.||++|||+.|+++
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          239 CPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            8999999999999999999999999987

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.4e-46  Score=364.26  Aligned_cols=248  Identities=23%  Similarity=0.372  Sum_probs=203.7

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .+.+..++|++.++||+|+||+||+|.+.. +..||||++......  .+.+.+|+.+|+.++||||+++++++.+ +..
T Consensus       178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~  253 (452)
T 1fmk_A          178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  253 (452)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence            356788899999999999999999999964 467999999754422  4578899999999999999999999876 678


Q ss_pred             EEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          173 EVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      ++||||+.+++|.+++.      ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            99999999999987765      345678899999999999999999999999999999999999999999999876432


Q ss_pred             C-CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc
Q 016959          247 M-DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEM  324 (380)
Q Consensus       247 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (380)
                      . .......++..|+|||++..     ..++.++|||||||++|||++ |..||...   ........+........+..
T Consensus       334 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvwslG~~l~el~t~g~~P~~~~---~~~~~~~~i~~~~~~~~~~~  405 (452)
T 1fmk_A          334 EYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVERGYRMPCPPE  405 (452)
T ss_dssp             ---------CCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHHTTCCCCCCTT
T ss_pred             ceecccCCcccccccCHhHHhc-----CCCCccccHHhHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCCCCCCCC
Confidence            2 12234457789999999853     456789999999999999999 99999643   33444445555556667788


Q ss_pred             ccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          325 ASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ++.++.+||.+||+.||++|||++++++
T Consensus       406 ~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          406 CPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            9999999999999999999999999987

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.4e-46  Score=349.61  Aligned_cols=258  Identities=23%  Similarity=0.354  Sum_probs=209.6

Q ss_pred             CCCcccccccceecccCCceEEEEEe----CCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee--
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVH----PPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR--  168 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~----~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--  168 (380)
                      .+....|++.+.||+|+||+||++..    ..+++.||||++...........+.+|+.+++.++||||+++++++.+  
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG  106 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence            34445569999999999999988754    457899999999877666667889999999999999999999999987  


Q ss_pred             CCeEEEEEeccCCCCccccccc---chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          169 NGEIEVLLEYMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      ...+++||||+.+++|.+++..   .+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             CceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            4678999999999999877654   5678889999999999999999999999999999999999999999999987654


Q ss_pred             cCC---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC------------CHHHHH
Q 016959          246 TMD---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG------------DWASLM  310 (380)
Q Consensus       246 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------------~~~~~~  310 (380)
                      ...   ......||..|+|||++..     ..++.++|||||||++|+|++|..||......            ......
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  261 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKE-----YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT  261 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHH-----CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             cccccccccCCCCCceeeChHHhcC-----CCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence            321   2234568889999999853     44567999999999999999999999632110            111223


Q ss_pred             HHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          311 FAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ...........+..++.++.+||.+||+.||++|||+.|+++  +++.+
T Consensus       262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~--~L~~l  308 (318)
T 3lxp_A          262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP--ILKTV  308 (318)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH--HHHHH
Confidence            333444556677788999999999999999999999999997  55554

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.6e-46  Score=377.54  Aligned_cols=248  Identities=22%  Similarity=0.359  Sum_probs=201.4

Q ss_pred             CCccccccc-ceecccCCceEEEEEe--CCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           96 INPAELQKG-NRIGSGSGGTVWRVVH--PPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        96 ~~~~~~~~~-~~LG~G~~g~V~~~~~--~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      ++...+.+. ++||+|+||+||+|.+  ..+++.||||+++... .....+.+.+|+.+|+.++|+|||++++++.. +.
T Consensus       365 ~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~  443 (635)
T 4fl3_A          365 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES  443 (635)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             ccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CC
Confidence            444445443 4799999999999954  4567899999996543 23446789999999999999999999999975 46


Q ss_pred             EEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          172 IEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      +++|||||.+++|.+++.    ..+..+..|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus       444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  523 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred             EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence            899999999999977653    3567788999999999999999999999999999999999999999999998765432


Q ss_pred             C---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          248 D---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       248 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      .   ......+|..|+|||++..     ..++.++|||||||++|||++ |+.||...   ........+........+.
T Consensus       524 ~~~~~~~~~~~t~~y~APE~~~~-----~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~---~~~~~~~~i~~~~~~~~p~  595 (635)
T 4fl3_A          524 NYYKAQTHGKWPVKWYAPECINY-----YKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLEKGERMGCPA  595 (635)
T ss_dssp             -----------CGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHHTTCCCCCCT
T ss_pred             cccccccCCCCceeeeChhhhcC-----CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCCCCCCC
Confidence            1   2233456789999999853     556789999999999999998 99999743   3344555555666677788


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .++.++.+||.+||+.||++|||+.++++
T Consensus       596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          596 GCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            89999999999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.4e-47  Score=365.86  Aligned_cols=259  Identities=26%  Similarity=0.364  Sum_probs=192.7

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeE
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  172 (380)
                      ..+...+|.+.+.||+|+||+||... ..+++.||||++......    .+.+|+.+|+.+ +|||||++++++.+.+..
T Consensus        19 ~~i~~~~y~~~~~LG~G~~G~V~~~~-~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~   93 (432)
T 3p23_A           19 VIVGKISFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQ   93 (432)
T ss_dssp             EEETTEEEEEEEEEEECGGGCEEEEE-ESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred             EEEccEEEecCCeeecCcCEEEEEEE-EeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence            34566789999999999999966433 347899999998654322    245799999999 799999999999999999


Q ss_pred             EEEEeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---C--CcEEEeecccccc
Q 016959          173 EVLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS---S--KNVKIADFGVSRI  242 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~---~--~~~kl~Dfg~a~~  242 (380)
                      |+|||||.+ +|.+++..     .+..+..++.||+.||+|||++||+||||||+|||++.   +  ..+||+|||+++.
T Consensus        94 ~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           94 YIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             EEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             EEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            999999975 77555432     23356789999999999999999999999999999953   2  3588999999987


Q ss_pred             ccccC---CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCC
Q 016959          243 LAQTM---DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQP  318 (380)
Q Consensus       243 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  318 (380)
                      +....   ......+||+.|+|||++...  .+..++.++|||||||++|||++ |..||...... .............
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-~~~~~~~~~~~~~  249 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSED--CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-QANILLGACSLDC  249 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC-----CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-HHHHHTTCCCCTT
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcc--cccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-HHHHHhccCCccc
Confidence            65332   223456799999999998531  12445678999999999999999 99999532211 1111111101111


Q ss_pred             CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          319 PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       319 ~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      .......+..+.+||.+||+.||++|||+.|+|+||||....+
T Consensus       250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~  292 (432)
T 3p23_A          250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK  292 (432)
T ss_dssp             SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred             cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence            1223345667899999999999999999999999999987654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3e-46  Score=342.54  Aligned_cols=251  Identities=24%  Similarity=0.420  Sum_probs=193.5

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      ..+..++|++.++||+|+||+||+|.+..   .||||++.... .....+.+.+|+.+++.++|+||+++++++ ..+..
T Consensus        19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~   94 (289)
T 3og7_A           19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL   94 (289)
T ss_dssp             CBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred             CccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence            45778899999999999999999998743   49999986544 445567889999999999999999999965 45678


Q ss_pred             EEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc-
Q 016959          173 EVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT-  246 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-  246 (380)
                      ++||||+.+++|.+++.     ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence            99999999999876653     345678899999999999999999999999999999999999999999999765432 


Q ss_pred             -CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC----CCCC
Q 016959          247 -MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ----PPEA  321 (380)
Q Consensus       247 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~  321 (380)
                       ........||+.|+|||++...  .+..++.++|||||||++|+|++|+.||......+  ..........    ....
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~  250 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQ--DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGRGSLSPDLSKV  250 (289)
T ss_dssp             ---------CCCTTCCHHHHC------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHHHTSCCCCTTSS
T ss_pred             ccccccccCCCccccCchhhccc--CCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhcccccCcchhhc
Confidence             1223456799999999998521  23456779999999999999999999997543322  2222222221    1223


Q ss_pred             CccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ...++.++.+||.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          251 RSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            4568899999999999999999999999987

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.9e-46  Score=342.25  Aligned_cols=243  Identities=24%  Similarity=0.409  Sum_probs=203.5

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee---------
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR---------  168 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---------  168 (380)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++....     +.+.+|+.+++.++||||+++++++..         
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            357999999999999999999999899999999996553     245689999999999999999998864         


Q ss_pred             -------CCeEEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEe
Q 016959          169 -------NGEIEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIA  235 (380)
Q Consensus       169 -------~~~~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~  235 (380)
                             ...+++||||+.+++|.+++.      ..+..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~  164 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG  164 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence                   455899999999999977653      3567788999999999999999999999999999999999999999


Q ss_pred             eccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh
Q 016959          236 DFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF  315 (380)
Q Consensus       236 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  315 (380)
                      |||++....... ......||+.|+|||++..     ..++.++|||||||++|+|++|..||..     ..........
T Consensus       165 Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~~~~~~~~-----~~~~~~~~~~  233 (284)
T 2a19_B          165 DFGLVTSLKNDG-KRTRSKGTLRYMSPEQISS-----QDYGKEVDLYALGLILAELLHVCDTAFE-----TSKFFTDLRD  233 (284)
T ss_dssp             CCTTCEESSCCS-CCCCCCSCCTTSCHHHHHC-----SCCCTHHHHHHHHHHHHHHHSCCSSHHH-----HHHHHHHHHT
T ss_pred             cchhheeccccc-cccccCCcccccChhhhcc-----CCCcchhhhHHHHHHHHHHHhcCCcchh-----HHHHHHHhhc
Confidence            999998765432 2345679999999999853     4567899999999999999999988841     1112222221


Q ss_pred             CCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          316 AQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       316 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                         ...+..++.++.+||.+||+.||++|||+.|+++|.+....
T Consensus       234 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          234 ---GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             ---TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             ---ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence               23456678899999999999999999999999999887654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.7e-47  Score=352.20  Aligned_cols=258  Identities=20%  Similarity=0.292  Sum_probs=203.4

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      +..++|.+.+.||+|+||+||+|.+. +++.||||++...........+.+|+.+++.++|+||+++++++...+..++|
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  105 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV  105 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEE
T ss_pred             HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEE
Confidence            55678999999999999999999864 68899999996554333334688999999999999999999999999999999


Q ss_pred             EeccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          176 LEYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKR---KIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       176 ~e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      |||+.+++|.+++.        ..+..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++....
T Consensus       106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  185 (326)
T 3uim_A          106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD  185 (326)
T ss_dssp             EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccC
Confidence            99999999876543        35667889999999999999999   99999999999999999999999999998765


Q ss_pred             ccCC-CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC-----CCCCCHHHHHHHHhhC--
Q 016959          245 QTMD-PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAV-----GRQGDWASLMFAICFA--  316 (380)
Q Consensus       245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-----~~~~~~~~~~~~~~~~--  316 (380)
                      .... ......||+.|+|||++..     ..++.++|||||||++|+|++|..||..     ................  
T Consensus       186 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (326)
T 3uim_A          186 YKDTHVTTAVRGTIGHIAPEYLST-----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK  260 (326)
T ss_dssp             SSSSCEECCCCSCGGGCCHHHHHH-----SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred             cccccccccccCCcCccCHHHhcc-----CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence            3322 2344569999999999853     4467899999999999999999999951     1111111111111100  


Q ss_pred             --------CCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          317 --------QPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       317 --------~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                              .........+..+.+|+.+||+.||++|||+.|+++|-.-...
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence                    1112334456789999999999999999999999997654444

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.1e-47  Score=352.59  Aligned_cols=255  Identities=22%  Similarity=0.288  Sum_probs=201.9

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEe----e
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYD----R  168 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~  168 (380)
                      ...+..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.    .
T Consensus        23 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (317)
T 2buj_A           23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGA  101 (317)
T ss_dssp             EEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred             EEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence            34467789999999999999999999999999999999986543 344677889999999999999999999986    2


Q ss_pred             CCeEEEEEeccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccc
Q 016959          169 NGEIEVLLEYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVS  240 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  240 (380)
                      ....++||||+.+++|.+++.        ..+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            347899999999999866543        357788999999999999999999999999999999999999999999998


Q ss_pred             ccccccCCC---------CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--CCCCHHHH
Q 016959          241 RILAQTMDP---------CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVG--RQGDWASL  309 (380)
Q Consensus       241 ~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~--~~~~~~~~  309 (380)
                      .........         .....||+.|+|||++...  ....++.++|||||||++|+|++|..||...  ........
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  259 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ--SHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA  259 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC--SEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccC--CCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence            765321110         1223479999999998531  1122567999999999999999999999521  11122211


Q ss_pred             HHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          310 MFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                         ............++.++.+||.+||+.||++|||+.|++++
T Consensus       260 ---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          260 ---VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             ---HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence               12222334445678999999999999999999999999984

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.9e-46  Score=342.31  Aligned_cols=247  Identities=24%  Similarity=0.331  Sum_probs=201.1

Q ss_pred             cccccccceecccCCceEEEEEeCCC---CcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEE-eeCCeEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPT---SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY-DRNGEIE  173 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~  173 (380)
                      ..+|++.+.||+|+||+||+|.+..+   ...+|+|++.........+.+.+|+.++++++||||+++++++ ..++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            45688999999999999999997543   3468999997766666678899999999999999999999985 4566889


Q ss_pred             EEEeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-
Q 016959          174 VLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM-  247 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  247 (380)
                      +||||+.+++|.+++..     .+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  183 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY  183 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence            99999999999776533     467788999999999999999999999999999999999999999999998664321 


Q ss_pred             ---CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          248 ---DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       248 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                         .......||+.|+|||++..     ..++.++|||||||++|+|++ |..||......+..   ...........+.
T Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  255 (298)
T 3f66_A          184 YSVHNKTGAKLPVKWMALESLQT-----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYLLQGRRLLQPE  255 (298)
T ss_dssp             CBC-----CCBCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH---HHHHTTCCCCCCT
T ss_pred             hccccccCCCCCccccChHHhcC-----CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH---HHHhcCCCCCCCc
Confidence               12344567889999999853     456789999999999999999 56666544443332   3333344555667


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .++..+.++|.+||+.||++|||+.|+++
T Consensus       256 ~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          256 YCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            78999999999999999999999999987

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=351.01  Aligned_cols=256  Identities=18%  Similarity=0.218  Sum_probs=196.4

Q ss_pred             CCcccccccceecccCCceEEEEEeCC---CCcEEEEEEecCCCchHH----------HHHHHHHHHHHHhCCCCceeee
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPP---TSRVFALKVIYGNHEDSV----------RSQICREIEILRDVNHPNVVKC  162 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~----------~~~~~~E~~~l~~l~h~~iv~~  162 (380)
                      +..++|.+.+.||+|+||+||+|.+..   ++..+|||++........          ...+.+|+..++.++|+||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            456789999999999999999999987   788999999875542211          1235678899999999999999


Q ss_pred             EeEEee----CCeEEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC--cE
Q 016959          163 HDMYDR----NGEIEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK--NV  232 (380)
Q Consensus       163 ~~~~~~----~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~--~~  232 (380)
                      ++++..    ....++||||+ +++|.+++.    ..+..++.++.||+.||+|||++||+||||||+|||++.++  .+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence            999887    77899999999 889877664    36778999999999999999999999999999999999887  99


Q ss_pred             EEeeccccccccccCC-------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 016959          233 KIADFGVSRILAQTMD-------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD  305 (380)
Q Consensus       233 kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~  305 (380)
                      ||+|||+++.+.....       ......||..|+|||++..     ..++.++|||||||++|||++|..||.......
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-----VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-----CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-----CCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            9999999987643221       1245679999999999863     557889999999999999999999996322221


Q ss_pred             H--HHHHHHHhhCCCCC-----CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          306 W--ASLMFAICFAQPPE-----APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       306 ~--~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      .  ...........+..     ....++.++.+||.+||..||++|||++|+++  .|+..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~L~~~  326 (345)
T 2v62_A          268 VAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK--ILNPH  326 (345)
T ss_dssp             HHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH--HHCTT
T ss_pred             HHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH--HHhcc
Confidence            1  11111111111110     01167889999999999999999999999988  55544

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.6e-46  Score=341.27  Aligned_cols=251  Identities=24%  Similarity=0.383  Sum_probs=194.4

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHh--CCCCceeeeEeEEee----C
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRD--VNHPNVVKCHDMYDR----N  169 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~----~  169 (380)
                      +..++|++.+.||+|+||+||+|.+  +++.||||++....    ...+..|.+++..  ++||||+++++++..    .
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~   78 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSS   78 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence            4567899999999999999999998  78999999985432    2344556666666  789999999998654    3


Q ss_pred             CeEEEEEeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEEcCCCcEEEeecc
Q 016959          170 GEIEVLLEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLH--------KRKIVHRDIKPSNLLINSSKNVKIADFG  238 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH--------~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  238 (380)
                      ..+++||||+.+++|.+++.   ..+..+..++.||+.||+|||        ++||+||||||+|||++.++.+||+|||
T Consensus        79 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  158 (301)
T 3q4u_A           79 TQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG  158 (301)
T ss_dssp             EEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             ceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence            56899999999999987664   356778899999999999999        9999999999999999999999999999


Q ss_pred             ccccccccCCC----CCCCCCCCccccccccccccCCCC-CCCcchhHHHHHHHHHHHHhC----------CCCCCCCCC
Q 016959          239 VSRILAQTMDP----CNSAVGTIAYMSPERINTDLNHGK-YDGYAGDIWSLGVSILEFYLG----------RFPFAVGRQ  303 (380)
Q Consensus       239 ~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~-~~~~~~DvwslG~il~ell~g----------~~pf~~~~~  303 (380)
                      ++.........    .....||+.|+|||++........ .++.++|||||||++|||++|          ..||.....
T Consensus       159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~  238 (301)
T 3q4u_A          159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP  238 (301)
T ss_dssp             TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence            99765443221    234579999999999864211111 234689999999999999999          888864322


Q ss_pred             C--CHHHHHHHHhhC-CCCCCC-----ccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          304 G--DWASLMFAICFA-QPPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       304 ~--~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .  ............ ..+..+     ..++.++.+||.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            2  222222222221 222222     235678999999999999999999999987

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.1e-46  Score=369.81  Aligned_cols=247  Identities=23%  Similarity=0.375  Sum_probs=207.4

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      +.+..++|++.++||+|+||+||+|.+.. +..||||+++.....  .+.+.+|+.+|+.++|+||+++++++.+ +.++
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            44677889999999999999999999964 467999999754422  4578899999999999999999999876 6789


Q ss_pred             EEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          174 VLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      +||||+.+++|.+++.      ..+..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus       338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            9999999999987765      3456788999999999999999999999999999999999999999999998664321


Q ss_pred             -CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          248 -DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                       .......++..|+|||++..     ..++.++|||||||+||||++ |..||...   ........+........+..+
T Consensus       418 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvwSlGv~l~el~t~g~~P~~~~---~~~~~~~~i~~~~~~~~~~~~  489 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVERGYRMPCPPEC  489 (535)
T ss_dssp             HHTTCSTTSCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHTTTTCCSSTTC---CHHHHHHHHHTTCCCCCCTTC
T ss_pred             eecccCCcCcccccCHHHhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCCCCCCCCC
Confidence             11234457889999999853     456789999999999999999 99999643   334444455555566677789


Q ss_pred             cHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          326 SREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      +.++.+||.+||+.||++|||++++++
T Consensus       490 ~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          490 PESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-46  Score=356.85  Aligned_cols=246  Identities=24%  Similarity=0.318  Sum_probs=194.7

Q ss_pred             ccccccceecccCCceEEEEEeCCC---CcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEe-eCCeEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPT---SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYD-RNGEIEV  174 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~l  174 (380)
                      ..|.+.+.||+|+||+||+|.+..+   +..||||++.........+.+.+|+.++++++||||+++++++. .++..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            4578889999999999999987533   34689999876655566788999999999999999999999864 4567899


Q ss_pred             EEeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-
Q 016959          175 LLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-  248 (380)
Q Consensus       175 v~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-  248 (380)
                      ||||+.+++|.+++..     .+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..... 
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~  248 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  248 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence            9999999999876543     4567888999999999999999999999999999999999999999999986543211 


Q ss_pred             ---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc
Q 016959          249 ---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEM  324 (380)
Q Consensus       249 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (380)
                         ......+|..|+|||++..     ..++.++|||||||++|||++ |..||......+....   .........+..
T Consensus       249 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~---~~~~~~~~~p~~  320 (373)
T 3c1x_A          249 SVHNKTGAKLPVKWMALESLQT-----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQGRRLLQPEY  320 (373)
T ss_dssp             ---------CCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH---HHTTCCCCCCTT
T ss_pred             cccccCCCCCcccccChHHhcC-----CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH---HHcCCCCCCCCC
Confidence               1234457889999999853     556789999999999999999 7788875555554333   333445556677


Q ss_pred             ccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          325 ASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ++..+.++|.+||+.||++|||+.|+++
T Consensus       321 ~~~~l~~li~~cl~~dp~~RPs~~ell~  348 (373)
T 3c1x_A          321 CPDPLYEVMLKCWHPKAEMRPSFSELVS  348 (373)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            8999999999999999999999999987

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.5e-46  Score=353.30  Aligned_cols=251  Identities=19%  Similarity=0.224  Sum_probs=193.4

Q ss_pred             CCcccccccceecccCCceEEEEEeCCC-----CcEEEEEEecCCCchHHH----------HHHHHHHHHHHhCCCCcee
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPT-----SRVFALKVIYGNHEDSVR----------SQICREIEILRDVNHPNVV  160 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~-----~~~~avK~~~~~~~~~~~----------~~~~~E~~~l~~l~h~~iv  160 (380)
                      +..++|++.+.||+|+||+||+|.+..+     ++.||||++.........          ..+..|+..++.++|+||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            4567899999999999999999998764     588999998655421111          1234566677788899999


Q ss_pred             eeEeEEeeC----CeEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc--CC
Q 016959          161 KCHDMYDRN----GEIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN--SS  229 (380)
Q Consensus       161 ~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~--~~  229 (380)
                      ++++++...    ...++||||+ +++|.+++.     ..+..+..++.||+.||+|||++||+||||||+|||++  .+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            999998764    4589999999 889876643     35778899999999999999999999999999999999  88


Q ss_pred             CcEEEeeccccccccccCC-------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 016959          230 KNVKIADFGVSRILAQTMD-------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGR  302 (380)
Q Consensus       230 ~~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  302 (380)
                      +.+||+|||+++.+.....       ......||+.|+|||++..     ..++.++|||||||++|||++|+.||....
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-----VAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-----CCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            9999999999987643321       1234569999999999853     557889999999999999999999997432


Q ss_pred             CCCHHHHHHHHhh-CCCCC------CCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          303 QGDWASLMFAICF-AQPPE------APEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       303 ~~~~~~~~~~~~~-~~~~~------~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ............. .....      ....++.++.+||.+||..||++||++.++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          266 KDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             TCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            2221111111110 00000      12456889999999999999999999999886

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.8e-45  Score=340.00  Aligned_cols=245  Identities=24%  Similarity=0.366  Sum_probs=199.5

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC---chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH---EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  176 (380)
                      .|..++.||+|+||.||+|.+  +++.||||++....   .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  109 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY  109 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence            355668999999999999998  68899999986432   3445678999999999999999999999999999999999


Q ss_pred             eccCCCCcccccc-------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-
Q 016959          177 EYMDGGSLEGAHI-------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-  248 (380)
Q Consensus       177 e~~~~~~L~~~~~-------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-  248 (380)
                      ||+.+++|.+++.       ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  189 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT  189 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence            9999999876553       35677889999999999999999999999999999999999999999999986643222 


Q ss_pred             -CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh-----------C
Q 016959          249 -PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF-----------A  316 (380)
Q Consensus       249 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-----------~  316 (380)
                       ......||+.|+|||++.+      .++.++|||||||++|+|++|..||...........+.....           .
T Consensus       190 ~~~~~~~g~~~y~aPE~~~~------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (307)
T 2nru_A          190 VMTSRIVGTTAYMAPEALRG------EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDK  263 (307)
T ss_dssp             EECSSCCSCGGGCCHHHHTT------EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCS
T ss_pred             ccccccCCCcCcCChHHhcC------CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccc
Confidence             1234579999999998853      256799999999999999999999975444332222211111           1


Q ss_pred             CCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          317 QPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       317 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .....+...+..+.+++.+||+.||++|||+.|+++
T Consensus       264 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~  299 (307)
T 2nru_A          264 KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ  299 (307)
T ss_dssp             SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            122334456678999999999999999999999997

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.7e-47  Score=379.43  Aligned_cols=270  Identities=26%  Similarity=0.374  Sum_probs=211.9

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee------CCe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR------NGE  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~  171 (380)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++.........+.+.+|+.+++.++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            36899999999999999999999999999999999776666667889999999999999999999998765      677


Q ss_pred             EEEEEeccCCCCcccccc-------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCc---EEEeeccccc
Q 016959          172 IEVLLEYMDGGSLEGAHI-------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN---VKIADFGVSR  241 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~-------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~---~kl~Dfg~a~  241 (380)
                      .++|||||.+++|.+++.       ..+..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++.
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            899999999999976543       356778899999999999999999999999999999997765   9999999998


Q ss_pred             cccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCH------HHHHHHHh-
Q 016959          242 ILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDW------ASLMFAIC-  314 (380)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~-  314 (380)
                      ..... .......||..|+|||++.     +..++.++|||||||++|+|++|..||........      ........ 
T Consensus       173 ~~~~~-~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          173 ELDQG-ELCTEFVGTLQYLAPELLE-----QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             BTTSC-CCCCCCCSCCTTCSSCSSC-----CSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             ccccc-cccccccCCcccCChHHhc-----cCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            76543 2335678999999999985     35667899999999999999999999963210000      00000000 


Q ss_pred             -------------hCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccccccccccCC
Q 016959          315 -------------FAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILP  373 (380)
Q Consensus       315 -------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~~~~~~~~~~  373 (380)
                                   ...+......++..+.+||.+||..||++|||+.|+|+||||+.+......+.+..+..
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~kil~~f~~  318 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNM  318 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCCEEECCCS
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhccccccccc
Confidence                         00111234457889999999999999999999999999999999866666555444433

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.6e-45  Score=336.93  Aligned_cols=250  Identities=21%  Similarity=0.255  Sum_probs=200.2

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEE-eeCCeEEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY-DRNGEIEVLL  176 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~  176 (380)
                      .++|++.+.||+|+||+||+|++..+++.||||++......   ..+.+|+.+++.++|++++..++++ ...+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            36799999999999999999999999999999998654332   3577899999999988766665554 6677889999


Q ss_pred             eccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCcEEEeeccccccccccCC
Q 016959          177 EYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI---NSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       177 e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ||+ +++|.+++.     ..+..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++........
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence            999 888876654     3577889999999999999999999999999999999   4888999999999987654322


Q ss_pred             -------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC---CHHHHHHHHhhCC-
Q 016959          249 -------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG---DWASLMFAICFAQ-  317 (380)
Q Consensus       249 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~-  317 (380)
                             ......||+.|+|||++..     ..++.++|||||||++|+|++|+.||......   .....+....... 
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASINTHLG-----IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             ccccccccccccccccccCChhhhcC-----CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence                   1245679999999999853     55788999999999999999999999753322   2222222222211 


Q ss_pred             CCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 016959          318 PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR  358 (380)
Q Consensus       318 ~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~  358 (380)
                      .......++.++.+||.+||+.||++|||+.|+++  .|+.
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~l~~  277 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ--LFRN  277 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH--HHHH
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH--HHHH
Confidence            12233567889999999999999999999999987  4443

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.4e-46  Score=360.02  Aligned_cols=253  Identities=27%  Similarity=0.349  Sum_probs=189.7

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEEEe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      +.|.+.+.||+|+||+||.+.. .+|+.||||++....    .+.+.+|+.+++++ +||||+++++++.+.+.+++|||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             heeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            3456678899999999987543 479999999985432    34567899999876 89999999999999999999999


Q ss_pred             ccCCCCcccccccc-----------hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC-------------CcEE
Q 016959          178 YMDGGSLEGAHIRQ-----------EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS-------------KNVK  233 (380)
Q Consensus       178 ~~~~~~L~~~~~~~-----------~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~-------------~~~k  233 (380)
                      ||. ++|.+++...           +..++.++.||+.||+|||++||+||||||+|||++.+             +.+|
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence            996 4886665432           11245799999999999999999999999999999754             4799


Q ss_pred             EeeccccccccccCC----CCCCCCCCCccccccccccccC--CCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCH
Q 016959          234 IADFGVSRILAQTMD----PCNSAVGTIAYMSPERINTDLN--HGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDW  306 (380)
Q Consensus       234 l~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~  306 (380)
                      |+|||+++.+.....    .....+||+.|+|||++.....  ....++.++|||||||++|||++ |..||.....  .
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--~  246 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS--R  246 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT--H
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh--h
Confidence            999999987654322    1234579999999999854211  12457889999999999999998 9999963322  1


Q ss_pred             HHHHHHHhhCCCC---CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          307 ASLMFAICFAQPP---EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       307 ~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ...+.........   .....++.++.+||.+||+.||++|||+.|+++||||...
T Consensus       247 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             HHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             HHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence            1111111111111   1123456899999999999999999999999999999754

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.9e-45  Score=337.65  Aligned_cols=251  Identities=21%  Similarity=0.252  Sum_probs=197.1

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEE-eeCCeEEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMY-DRNGEIEVLL  176 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~  176 (380)
                      .++|++.+.||+|+||+||+|++..+++.||||++.....   ...+.+|+.+++.++|++++..++.+ ...+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            4679999999999999999999999999999998754332   23477899999999987766666554 6778899999


Q ss_pred             eccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCcEEEeeccccccccccCC
Q 016959          177 EYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI---NSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       177 e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ||+ +++|.+++.     ..+..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++........
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence            999 888876654     3677889999999999999999999999999999999   7889999999999987654322


Q ss_pred             -------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC---HHHHHHHHhhCC-
Q 016959          249 -------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD---WASLMFAICFAQ-  317 (380)
Q Consensus       249 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~-  317 (380)
                             ......||+.|+|||++..     ..++.++|||||||++|+|++|+.||.......   ............ 
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLG-----IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             CccCCCCcccccCCCccccchHHhcC-----CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence                   2245679999999999853     557889999999999999999999997543332   222222222111 


Q ss_pred             CCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          318 PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       318 ~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      .......++.++.+||.+||+.||++|||+.|+++  .|+.+
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~~  278 (296)
T 4hgt_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ--LFRNL  278 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH--HHHHH
T ss_pred             hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH--HHHHH
Confidence            11223456889999999999999999999999987  44443

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.3e-45  Score=357.64  Aligned_cols=259  Identities=21%  Similarity=0.265  Sum_probs=206.6

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCC-CceeeeEeEEeeCCeEEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH-PNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~  176 (380)
                      .++|++.++||+|+||.||+|++..+++.||||++......   ..+.+|+++++.++| ++|..+..++...+..++||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            46899999999999999999999999999999998544322   346789999999986 56666666677888999999


Q ss_pred             eccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---cCCCcEEEeeccccccccccCC
Q 016959          177 EYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI---NSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       177 e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ||+ +++|.+++.     ..+..++.|+.||+.||+|||++||+||||||+||||   +.++.+||+|||+++.+.....
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence            999 888876654     3577889999999999999999999999999999999   6889999999999987654322


Q ss_pred             -------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh----CC
Q 016959          249 -------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF----AQ  317 (380)
Q Consensus       249 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~----~~  317 (380)
                             ......||..|+|||++.     +..++.++||||||||||||++|..||...........+..+..    ..
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASVNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             ccccccccccccCCCccccCHHHhc-----CCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence                   123677999999999985     35678899999999999999999999986555544433333221    11


Q ss_pred             CCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc----------CccccccCccccc
Q 016959          318 PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ----------HPFILRAGQSQVN  365 (380)
Q Consensus       318 ~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~----------hp~~~~~~~~~~~  365 (380)
                      .......++.++.+||.+||..||++||++.+|++          ++|+....|....
T Consensus       237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~  294 (483)
T 3sv0_A          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILK  294 (483)
T ss_dssp             HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHT
T ss_pred             HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhc
Confidence            11223457889999999999999999999988765          5555555555443

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.6e-46  Score=349.42  Aligned_cols=247  Identities=16%  Similarity=0.237  Sum_probs=197.0

Q ss_pred             CcccccccceecccCCceEEEEEeCCC--------CcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceee-------
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPT--------SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK-------  161 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~--------~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-------  161 (380)
                      ..++|.+.+.||+|+||+||+|++..+        ++.||||++...      ..+.+|+.++++++|+||++       
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            457999999999999999999999874        889999998644      35778999999999999887       


Q ss_pred             --------eEeEEee-CCeEEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q 016959          162 --------CHDMYDR-NGEIEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLI  226 (380)
Q Consensus       162 --------~~~~~~~-~~~~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~  226 (380)
                              +++++.. .+..++||||+ +++|.+++.      ..+..+..++.||+.||.|||++||+||||||+|||+
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV  192 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred             CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence                    6677765 77899999999 899977654      3577889999999999999999999999999999999


Q ss_pred             cCCC--cEEEeeccccccccccCC-------CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 016959          227 NSSK--NVKIADFGVSRILAQTMD-------PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFP  297 (380)
Q Consensus       227 ~~~~--~~kl~Dfg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~p  297 (380)
                      +.++  .+||+|||+++.+.....       ......||+.|+|||++.+     ..++.++|||||||++|+|++|+.|
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-----CGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-----CCCCchhhHHHHHHHHHHHHhCCCC
Confidence            9988  899999999987653321       1234579999999999853     4578899999999999999999999


Q ss_pred             CCCCCCCC--HHHHHHHHhhCCCCCC------CccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 016959          298 FAVGRQGD--WASLMFAICFAQPPEA------PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR  358 (380)
Q Consensus       298 f~~~~~~~--~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~  358 (380)
                      |.......  ......... ......      +..++.++.+||.+||..||++|||++|+++  .|..
T Consensus       268 f~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~L~~  333 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFV-DKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN--NLEA  333 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHH-HSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH--HHHH
T ss_pred             cccCCcCHHHHHHHHHhcc-CChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH--HHHH
Confidence            97543221  111221111 222221      2356899999999999999999999999987  4444

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-45  Score=340.50  Aligned_cols=250  Identities=25%  Similarity=0.427  Sum_probs=190.4

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC--CCCceeeeEeEEeeC----Ce
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV--NHPNVVKCHDMYDRN----GE  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~----~~  171 (380)
                      .++|++.+.||+|+||.||+|.+  +++.||||++....    ...+..|.+++..+  +|+||+++++++...    ..
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             ccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            46899999999999999999998  48999999985432    23344455555554  899999999999877    78


Q ss_pred             EEEEEeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEcCCCcEEEeecccc
Q 016959          172 IEVLLEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKR--------KIVHRDIKPSNLLINSSKNVKIADFGVS  240 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~--------~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  240 (380)
                      +++||||+.+++|.+++.   ..+..+..++.||+.||.|||++        ||+||||||+|||++.++.+||+|||++
T Consensus       110 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a  189 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  189 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             eEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence            999999999999987754   35677889999999999999999        9999999999999999999999999999


Q ss_pred             ccccccCCC----CCCCCCCCccccccccccccCCCC-CCCcchhHHHHHHHHHHHHhC----------CCCCCCCCCC-
Q 016959          241 RILAQTMDP----CNSAVGTIAYMSPERINTDLNHGK-YDGYAGDIWSLGVSILEFYLG----------RFPFAVGRQG-  304 (380)
Q Consensus       241 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~-~~~~~~DvwslG~il~ell~g----------~~pf~~~~~~-  304 (380)
                      ..+......    .....||+.|+|||++........ ..+.++|||||||++|||++|          ..||...... 
T Consensus       190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  269 (337)
T 3mdy_A          190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD  269 (337)
T ss_dssp             EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence            766433221    235679999999999864211111 001248999999999999999          7777532222 


Q ss_pred             -CHHHHHHHHhh-CCCCCCCc-----cccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          305 -DWASLMFAICF-AQPPEAPE-----MASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       305 -~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                       ........... ...+..+.     .++.++.+||.+||+.||++|||+.|+++|
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence             22222222222 22223332     567789999999999999999999999983

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.8e-45  Score=337.09  Aligned_cols=255  Identities=25%  Similarity=0.386  Sum_probs=197.5

Q ss_pred             CCCcccccccceecccCCceEEEEEeCC-CC--cEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPP-TS--RVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN  169 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~-~~--~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  169 (380)
                      .+..++|++.+.||+|+||+||+|++.. ++  ..||||++....  .....+.+.+|+.+++.++|+||+++++++...
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            4667899999999999999999998643 33  368999986542  334567889999999999999999999999876


Q ss_pred             CeEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      . .++||||+.+++|.+++.     ..+..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            5 899999999999876653     3567788999999999999999999999999999999999999999999998765


Q ss_pred             ccCC---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHh-hCCCC
Q 016959          245 QTMD---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAIC-FAQPP  319 (380)
Q Consensus       245 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~-~~~~~  319 (380)
                      ....   ......+|..|+|||++..     ..++.++|||||||++|+|++ |..||....   ......... .....
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~~~~~~  244 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKT-----RTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHKIDKEGERL  244 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHH-----CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTSCCCC
T ss_pred             ccccchhhhccCCCCceeeCchhhcC-----CCCCchhhHHHHHHHHHHHHhCCCCCcccCC---HHHHHHHHHccCCCC
Confidence            4322   1234457889999999853     445679999999999999999 999997433   233333332 22344


Q ss_pred             CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       320 ~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      ..+..++.++.++|.+||..||++|||+.|+++  +|+.+.
T Consensus       245 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~~  283 (291)
T 1u46_A          245 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQ  283 (291)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHC
T ss_pred             CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHHhC
Confidence            556678999999999999999999999999998  565543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=343.65  Aligned_cols=251  Identities=22%  Similarity=0.331  Sum_probs=185.2

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEe------
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYD------  167 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~------  167 (380)
                      .+...+|++.++||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++++. |+||+++++++.      
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            455678999999999999999999999999999999985543 334567889999999996 999999999983      


Q ss_pred             --eCCeEEEEEeccCCCCcccccc-------cchHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcCCCcEEEee
Q 016959          168 --RNGEIEVLLEYMDGGSLEGAHI-------RQEHILSDLARQVLSGLAYLHKRK--IVHRDIKPSNLLINSSKNVKIAD  236 (380)
Q Consensus       168 --~~~~~~lv~e~~~~~~L~~~~~-------~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~D  236 (380)
                        ....+++||||+. |+|.+++.       ..+..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|
T Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEec
Confidence              3455899999997 46654432       466788999999999999999999  99999999999999999999999


Q ss_pred             ccccccccccCCC------------CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC
Q 016959          237 FGVSRILAQTMDP------------CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG  304 (380)
Q Consensus       237 fg~a~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~  304 (380)
                      ||++.........            .....||+.|+|||++..  ..+..++.++|||||||++|+|++|..||......
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDL--YSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------C--CTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhc--cccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            9999876533211            124568999999999842  12455678999999999999999999999643221


Q ss_pred             CHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcc
Q 016959          305 DWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPF  355 (380)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~  355 (380)
                      .   ..   ............+..+.+||.+||+.||++|||+.|+++|-+
T Consensus       260 ~---~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          260 R---IV---NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             H---hh---cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            1   11   112223344556778999999999999999999999998643

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.6e-45  Score=337.99  Aligned_cols=229  Identities=27%  Similarity=0.448  Sum_probs=182.0

Q ss_pred             cccccc-ceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHH-HhCCCCceeeeEeEEee----CCeE
Q 016959           99 AELQKG-NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEIL-RDVNHPNVVKCHDMYDR----NGEI  172 (380)
Q Consensus        99 ~~~~~~-~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~----~~~~  172 (380)
                      ++|.+. +.||+|+||.||+|.+..+++.||||++...      ..+.+|+.++ +.++|+||+++++++..    .+.+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            567776 7899999999999999999999999998532      3456788887 55689999999999876    6789


Q ss_pred             EEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCcEEEeeccccccc
Q 016959          173 EVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS---SKNVKIADFGVSRIL  243 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~---~~~~kl~Dfg~a~~~  243 (380)
                      ++||||+.+++|.+++.      ..+..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  170 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  170 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence            99999999999876543      457788999999999999999999999999999999997   788999999998643


Q ss_pred             cccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCC-
Q 016959          244 AQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAP-  322 (380)
Q Consensus       244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-  322 (380)
                      ..                           ..++.++|||||||++|+|++|..||.......................+ 
T Consensus       171 ~~---------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  223 (299)
T 3m2w_A          171 TG---------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  223 (299)
T ss_dssp             TT---------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred             cc---------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence            21                           23456899999999999999999999643221110000000001111112 


Q ss_pred             ---ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          323 ---EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       323 ---~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                         ..++.++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence               45789999999999999999999999999999998754

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=8.3e-45  Score=367.86  Aligned_cols=252  Identities=27%  Similarity=0.387  Sum_probs=209.1

Q ss_pred             cccCCCcccccccceecccCCceEEEEEeCCC---CcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee
Q 016959           92 RHQLINPAELQKGNRIGSGSGGTVWRVVHPPT---SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR  168 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  168 (380)
                      ....+..++|++.+.||+|+||+||+|.+..+   +..||||++.........+.+.+|+.+++.++||||+++++++.+
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  462 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE  462 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            34456778999999999999999999998643   567999998766666677889999999999999999999999854


Q ss_pred             CCeEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          169 NGEIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                       +..++||||+.+++|.+++.     ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence             56899999999999977654     346678889999999999999999999999999999999999999999999876


Q ss_pred             cccCC-CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCC
Q 016959          244 AQTMD-PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEA  321 (380)
Q Consensus       244 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  321 (380)
                      ..... ......+|+.|+|||++..     ..++.++|||||||++|||++ |..||...   ........+........
T Consensus       542 ~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ellt~g~~Pf~~~---~~~~~~~~i~~~~~~~~  613 (656)
T 2j0j_A          542 EDSTYYKASKGKLPIKWMAPESINF-----RRFTSASDVWMFGVCMWEILMHGVKPFQGV---KNNDVIGRIENGERLPM  613 (656)
T ss_dssp             CC----------CCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHHTCCCCC
T ss_pred             CCCcceeccCCCCCcceeCHHHhcC-----CCCCchhhHHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHcCCCCCC
Confidence            54321 1233457789999999853     456789999999999999997 99999743   33444455555566677


Q ss_pred             CccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      +..++.++.+||.+||..||++|||+.|+++
T Consensus       614 ~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8889999999999999999999999999987

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.9e-45  Score=340.25  Aligned_cols=252  Identities=23%  Similarity=0.367  Sum_probs=204.3

Q ss_pred             CCCcccccccceecccCCceEEEEE----eCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVV----HPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      .+..++|++.+.||+|+||.||+|.    +..+++.||||++.... ....+.+.+|+.+++.++|+||+++++++...+
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG  115 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence            4667889999999999999999998    45689999999997543 344577899999999999999999999986543


Q ss_pred             --eEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          171 --EIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       171 --~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                        .+++||||+.+++|.+++.     ..+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence              7899999999999977653     356678899999999999999999999999999999999999999999999876


Q ss_pred             cccCC---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----------CC-CH--H
Q 016959          244 AQTMD---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGR----------QG-DW--A  307 (380)
Q Consensus       244 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~----------~~-~~--~  307 (380)
                      .....   ......++..|+|||++..     ..++.++|||||||++|+|++|..||....          .. ..  .
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTE-----SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  270 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHH-----CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcC-----CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence            54322   1233457788999999854     445779999999999999999999985210          00 00  1


Q ss_pred             HHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          308 SLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..............+..++.++.+||.+||..||++|||+.|+++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            122223333445567788999999999999999999999999987

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=348.49  Aligned_cols=243  Identities=16%  Similarity=0.191  Sum_probs=193.1

Q ss_pred             ccCCCcccccccceecccCCceEEEEE-----eCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC---CCceeeeEe
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVV-----HPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN---HPNVVKCHD  164 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~  164 (380)
                      ...+..++|.+.++||+|+||+||+|.     +..+++.||||++....    ...+.+|+.+++.++   |+||+.+++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            334667889999999999999999994     66789999999996543    345677888888886   999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCcccccc---------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-------
Q 016959          165 MYDRNGEIEVLLEYMDGGSLEGAHI---------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS-------  228 (380)
Q Consensus       165 ~~~~~~~~~lv~e~~~~~~L~~~~~---------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~-------  228 (380)
                      ++...+..++|||||.+|+|.+++.         ..+..+..++.||+.||+|||++||+||||||+||||+.       
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence            9999999999999999999977653         356778999999999999999999999999999999998       


Q ss_pred             ----CCcEEEeeccccccccc--cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 016959          229 ----SKNVKIADFGVSRILAQ--TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGR  302 (380)
Q Consensus       229 ----~~~~kl~Dfg~a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  302 (380)
                          ++.+||+|||+|+.+..  ........+||+.|+|||++.+     ..++.++|||||||++|||++|+.||....
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~  289 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-----KPWNYQIDYFGVAATVYCMLFGTYMKVKNE  289 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-----CCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-----CCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence                89999999999976542  1223356789999999999853     456789999999999999999999996332


Q ss_pred             CCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          303 QGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .....        ..........+..+.+++.+||+.+|.+|++..+.|.
T Consensus       290 ~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          290 GGECK--------PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             TTEEE--------ECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             CCcee--------echhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence            21100        0001111124668899999999999999976544443

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=344.23  Aligned_cols=252  Identities=27%  Similarity=0.382  Sum_probs=188.3

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHH--HHhCCCCceeeeEeEEee----
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEI--LRDVNHPNVVKCHDMYDR----  168 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~--l~~l~h~~iv~~~~~~~~----  168 (380)
                      .++.++|++.+.||+|+||+||+|++  +++.||||++.....    ..+..|.++  +..++|+||+++++.+..    
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR----QNFINEKNIYRVPLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch----hhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence            46778999999999999999999988  789999999854332    233334444  455899999999986542    


Q ss_pred             -CCeEEEEEeccCCCCccccccc---chHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCcEEEcCCCcEEEe
Q 016959          169 -NGEIEVLLEYMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHKR---------KIVHRDIKPSNLLINSSKNVKIA  235 (380)
Q Consensus       169 -~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~i~~qi~~al~~LH~~---------~ivH~Dlkp~Nil~~~~~~~kl~  235 (380)
                       ...+++|||||.+++|.+++..   .+..+..++.||+.||.|||++         ||+||||||+|||++.++.+||+
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             CCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence             3367899999999999876543   4567888999999999999999         99999999999999999999999


Q ss_pred             eccccccccccC--------CCCCCCCCCCccccccccccccCCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC-
Q 016959          236 DFGVSRILAQTM--------DPCNSAVGTIAYMSPERINTDLNHG--KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG-  304 (380)
Q Consensus       236 Dfg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-  304 (380)
                      |||++..+....        ......+||+.|+|||++.+.....  ..++.++|||||||++|||++|..||...... 
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            999998764321        1223557999999999985421111  23456899999999999999998877532221 


Q ss_pred             --------------CHHHHHHHHh-hCCCCCCCc------cccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          305 --------------DWASLMFAIC-FAQPPEAPE------MASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       305 --------------~~~~~~~~~~-~~~~~~~~~------~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                                    .......... ....+..+.      .++.++.+||.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence                          1111111111 111222222      25568999999999999999999999965

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=339.33  Aligned_cols=263  Identities=20%  Similarity=0.287  Sum_probs=204.2

Q ss_pred             ccccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC
Q 016959           91 NRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN  169 (380)
Q Consensus        91 ~~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  169 (380)
                      ...+.+..++|++.+.||+|+||.||+|.+..   .+|+|++.... .....+.+.+|+.+++.++|+||+++++++.+.
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            34556788999999999999999999999853   48999986432 222334577899999999999999999999999


Q ss_pred             CeEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      +.+++||||+.+++|.+++.     ..+..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++....
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            99999999999999876654     35678899999999999999999999999999999998 7899999999987543


Q ss_pred             cc-----CCCCCCCCCCCccccccccccccC----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh
Q 016959          245 QT-----MDPCNSAVGTIAYMSPERINTDLN----HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF  315 (380)
Q Consensus       245 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  315 (380)
                      ..     ........|+..|+|||++.....    ....++.++|||||||++|+|++|..||...   ...........
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~---~~~~~~~~~~~  257 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ---PAEAIIWQMGT  257 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC---CHHHHHHHHHT
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHhcc
Confidence            21     122344568999999999853211    1234678999999999999999999999643   33333333333


Q ss_pred             CCCCC-CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          316 AQPPE-APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       316 ~~~~~-~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      ...+. ....++.++.+||.+||..||++|||+.|+++  .|+.+...
T Consensus       258 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~~  303 (319)
T 2y4i_B          258 GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPKR  303 (319)
T ss_dssp             TCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC---
T ss_pred             CCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHHh
Confidence            33333 23357889999999999999999999999998  66665433

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6.8e-46  Score=347.49  Aligned_cols=241  Identities=20%  Similarity=0.258  Sum_probs=187.9

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-------chHHHHHHHHHHHHHHhCC---------CCce
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-------EDSVRSQICREIEILRDVN---------HPNV  159 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-------~~~~~~~~~~E~~~l~~l~---------h~~i  159 (380)
                      +..++|++.+.||+|+||+||+|++  +|+.||||++....       .....+.+.+|+.+++.++         |+||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            5568899999999999999999998  78999999996542       2223467888999988885         7777


Q ss_pred             eeeEeEE-----------------ee-------------CCeEEEEEeccCCCCcccccc---cchHHHHHHHHHHHHHH
Q 016959          160 VKCHDMY-----------------DR-------------NGEIEVLLEYMDGGSLEGAHI---RQEHILSDLARQVLSGL  206 (380)
Q Consensus       160 v~~~~~~-----------------~~-------------~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al  206 (380)
                      +++.+++                 .+             .+.+|+|||||.+|++...+.   ..+..++.++.||+.||
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence            7766653                 22             678999999999986544432   36788999999999999


Q ss_pred             HHHH-hCCceecCCCCCcEEEcCCC--------------------cEEEeeccccccccccCCCCCCCCCCCcccccccc
Q 016959          207 AYLH-KRKIVHRDIKPSNLLINSSK--------------------NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERI  265 (380)
Q Consensus       207 ~~LH-~~~ivH~Dlkp~Nil~~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~  265 (380)
                      +||| ++||+||||||+|||++.++                    .+||+|||+|+.....     ..+||+.|+|||++
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~  249 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLF  249 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGG
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhh
Confidence            9999 99999999999999999887                    8999999999876532     34799999999998


Q ss_pred             ccccCCCCCCCcchhHHHHHHH-HHHHHhCCCCCCCCCCCCHHH-HHHHHhh--CCC----CCCCccccHHHHHHHHHhc
Q 016959          266 NTDLNHGKYDGYAGDIWSLGVS-ILEFYLGRFPFAVGRQGDWAS-LMFAICF--AQP----PEAPEMASREFRDFISRCL  337 (380)
Q Consensus       266 ~~~~~~~~~~~~~~DvwslG~i-l~ell~g~~pf~~~~~~~~~~-~~~~~~~--~~~----~~~~~~~~~~~~~li~~~l  337 (380)
                      .+     .. +.++||||||++ .++++.|..||..   ..+.. .......  ...    ...+..+++++++||.+||
T Consensus       250 ~g-----~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L  320 (336)
T 2vuw_A          250 TG-----DG-DYQFDIYRLMKKENNNRWGEYHPYSN---VLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTML  320 (336)
T ss_dssp             CC-----CS-SHHHHHHHHHHHHHTTCTTSCCTHHH---HHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred             cC-----CC-ccceehhhhhCCCCcccccccCCCcc---hhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHh
Confidence            53     33 679999998777 7778889999941   11101 1111111  111    1123457889999999999


Q ss_pred             ccCcCCCCCHHHHh-cCcccc
Q 016959          338 QKDPHSRWPAAQLL-QHPFIL  357 (380)
Q Consensus       338 ~~dp~~R~t~~eil-~hp~~~  357 (380)
                      +.|     |++|+| +||||+
T Consensus       321 ~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          321 NFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             GSS-----SHHHHHHHCGGGC
T ss_pred             ccC-----CHHHHHhcCCCcC
Confidence            987     999999 999995

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.5e-45  Score=351.35  Aligned_cols=252  Identities=18%  Similarity=0.209  Sum_probs=189.4

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCch--HHHHHHHHHHHHHHhCCC-Cce---------ee---
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED--SVRSQICREIEILRDVNH-PNV---------VK---  161 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~E~~~l~~l~h-~~i---------v~---  161 (380)
                      ....|..++.||+|+||+||+|.+..+|+.||||++......  ...+.+.+|+.+++.+.| .|.         +.   
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            345688899999999999999999999999999998743322  225678899999999976 211         11   


Q ss_pred             ---------eEeEEee-----CCeEEEEEeccCCCCcccccc-----------cchHHHHHHHHHHHHHHHHHHhCCcee
Q 016959          162 ---------CHDMYDR-----NGEIEVLLEYMDGGSLEGAHI-----------RQEHILSDLARQVLSGLAYLHKRKIVH  216 (380)
Q Consensus       162 ---------~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~-----------~~~~~~~~i~~qi~~al~~LH~~~ivH  216 (380)
                               ++.++..     ...++++|+++. ++|.+++.           ..+..+..++.||+.||+|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence                     1111111     224567777664 57765552           234567788899999999999999999


Q ss_pred             cCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCCcccccccccccc-----CCCCCCCcchhHHHHHHHHHHH
Q 016959          217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL-----NHGKYDGYAGDIWSLGVSILEF  291 (380)
Q Consensus       217 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~~~DvwslG~il~el  291 (380)
                      |||||+||||+.++.+||+|||+++.....   ....+| +.|+|||++....     ..+..++.++|||||||++|||
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            999999999999999999999999876544   355678 9999999984211     0234567799999999999999


Q ss_pred             HhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          292 YLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       292 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      ++|+.||...........+        ......++.++.+||.+||+.||++|||+.|+|+||||+.+..
T Consensus       311 ltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~  372 (413)
T 3dzo_A          311 WCADLPNTDDAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT  372 (413)
T ss_dssp             HHSSCCCCTTGGGSCSGGG--------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             HHCCCCCCCcchhhhHHHH--------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHH
Confidence            9999999744332211111        1122356889999999999999999999999999999998744

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.4e-44  Score=334.99  Aligned_cols=250  Identities=25%  Similarity=0.367  Sum_probs=197.6

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHh--CCCCceeeeEeEEeeCC----e
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRD--VNHPNVVKCHDMYDRNG----E  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~----~  171 (380)
                      .++|.+.+.||+|+||+||+|.+  +++.||||++....    ...+.+|+++++.  ++||||+++++++...+    .
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            36799999999999999999998  68999999985432    3456788888887  68999999999998765    7


Q ss_pred             EEEEEeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEEcCCCcEEEeecccc
Q 016959          172 IEVLLEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLH--------KRKIVHRDIKPSNLLINSSKNVKIADFGVS  240 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH--------~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  240 (380)
                      +++||||+.+++|.+++.   ..+..++.++.||+.||.|||        ++||+||||||+|||++.++.+||+|||++
T Consensus       115 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~  194 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  194 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             eEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCc
Confidence            999999999999987654   356778899999999999999        899999999999999999999999999999


Q ss_pred             ccccccCC----CCCCCCCCCccccccccccccCCCC-CCCcchhHHHHHHHHHHHHhC----------CCCCCCCCCC-
Q 016959          241 RILAQTMD----PCNSAVGTIAYMSPERINTDLNHGK-YDGYAGDIWSLGVSILEFYLG----------RFPFAVGRQG-  304 (380)
Q Consensus       241 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~~~DvwslG~il~ell~g----------~~pf~~~~~~-  304 (380)
                      ........    ......||+.|+|||++........ .++.++|||||||++|||++|          ..||...... 
T Consensus       195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  274 (342)
T 1b6c_B          195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  274 (342)
T ss_dssp             EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence            87654322    2345679999999999864211111 123689999999999999999          7888643322 


Q ss_pred             -CHHHHHHHHhh-CCCCCCCc-----cccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          305 -DWASLMFAICF-AQPPEAPE-----MASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       305 -~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                       ........... ...+..+.     .+...+.+||.+||+.||++|||+.|+++|
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence             22333332222 22233332     345689999999999999999999999984

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.8e-44  Score=363.81  Aligned_cols=242  Identities=19%  Similarity=0.297  Sum_probs=200.6

Q ss_pred             CcccccccceecccCCceEEEEEeCC-CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe----
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPP-TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE----  171 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----  171 (380)
                      -.++|++.+.||+|+||+||+|.+.. +++.||||++...........+.+|+.++++++||||+++++++...+.    
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            34789999999999999999999976 7899999998766556667788999999999999999999999987655    


Q ss_pred             -EEEEEeccCCCCcccccc--cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          172 -IEVLLEYMDGGSLEGAHI--RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       172 -~~lv~e~~~~~~L~~~~~--~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                       .|+||||+.|++|.+...  .++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.....  
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~--  234 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF--  234 (681)
T ss_dssp             EEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC--
T ss_pred             eeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC--
Confidence             799999999999987654  3677889999999999999999999999999999999975 8999999999876543  


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHH
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE  328 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (380)
                        ....||+.|+|||++..     . ++.++|||||||++|+|++|..||........          .........+..
T Consensus       235 --~~~~gt~~y~aPE~~~~-----~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~~~~~~~~~~~~  296 (681)
T 2pzi_A          235 --GYLYGTPGFQAPEIVRT-----G-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PEDDPVLKTYDS  296 (681)
T ss_dssp             --SCCCCCTTTSCTTHHHH-----C-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------CTTCHHHHHCHH
T ss_pred             --CccCCCccccCHHHHcC-----C-CCCceehhhhHHHHHHHHhCCCCCcccccccc----------cccccccccCHH
Confidence              45679999999999853     2 27799999999999999999988863211110          000111224678


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          329 FRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      +.+||.+||+.||++||+..+++.|+|+.-+
T Consensus       297 l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          297 YGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            9999999999999999999999999998654

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.2e-43  Score=324.93  Aligned_cols=229  Identities=17%  Similarity=0.179  Sum_probs=185.2

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....  .......+.+|+.+++.++|+||+++++++.+.+..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            467999999999999999999999999999999997553  245567889999999999999999999999999999999


Q ss_pred             EeccCCCCccccccc--chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          176 LEYMDGGSLEGAHIR--QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       176 ~e~~~~~~L~~~~~~--~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      |||+.|++|.+++..  ....+..++.||+.||+|||++||+||||||+|||++.+|.+||+++|.              
T Consensus       110 ~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~--------------  175 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT--------------  175 (286)
T ss_dssp             EECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC--------------
T ss_pred             EEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc--------------
Confidence            999999999877544  3445778999999999999999999999999999999999999985542              


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC---CCCccccHHHH
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP---EAPEMASREFR  330 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  330 (380)
                            ++|            ++.++|||||||++|||++|+.||......+..............   .....++.++.
T Consensus       176 ------~~~------------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  237 (286)
T 3uqc_A          176 ------MPD------------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS  237 (286)
T ss_dssp             ------CTT------------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred             ------cCC------------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence                  222            356899999999999999999999754432210000000000001   12345788999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      +||.+||+.||++| |+.|+++  .+.....
T Consensus       238 ~li~~~l~~dP~~R-s~~el~~--~L~~~~~  265 (286)
T 3uqc_A          238 AVAARSVQGDGGIR-SASTLLN--LMQQATA  265 (286)
T ss_dssp             HHHHHHHCTTSSCC-CHHHHHH--HHHHHHC
T ss_pred             HHHHHHcccCCccC-CHHHHHH--HHHHHhc
Confidence            99999999999999 9999998  5655433

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=3.4e-37  Score=306.86  Aligned_cols=186  Identities=16%  Similarity=0.135  Sum_probs=133.1

Q ss_pred             eecccCCceEEEEEeCCCCcEEEEEEecCCC---------chHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCCeEEEE
Q 016959          106 RIGSGSGGTVWRVVHPPTSRVFALKVIYGNH---------EDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus       106 ~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~---------~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      .++.|+.|.+..++..-.|+.||+|++.+..         .+...+++.+|+++|+++ .|+||+++++++++++.+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            4677777777777766679999999996542         233456799999999999 699999999999999999999


Q ss_pred             EeccCCCCcccccccch-HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCC
Q 016959          176 LEYMDGGSLEGAHIRQE-HILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV  254 (380)
Q Consensus       176 ~e~~~~~~L~~~~~~~~-~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (380)
                      ||||+|++|.+.+.... -...+|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+........+.+
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~v  400 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLV  400 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHH
T ss_pred             EecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCce
Confidence            99999999988765421 12346899999999999999999999999999999999999999999988766555556778


Q ss_pred             CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 016959          255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFP  297 (380)
Q Consensus       255 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~p  297 (380)
                      ||+.|||||++.+      .+..++|+|++|++++++.++..+
T Consensus       401 GTp~YmAPE~l~g------~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          401 QSFFVFVNELFAE------NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             HHHHHHHHHHC-----------------------CCCCTTHHH
T ss_pred             echhhccHHHhCC------CCCCcccccccccchhhhccccch
Confidence            9999999999853      234579999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.3e-30  Score=258.01  Aligned_cols=185  Identities=18%  Similarity=0.174  Sum_probs=142.5

Q ss_pred             ccceecccCCceEEEEEeCCCCcEEEEEEecCCC-------chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959          103 KGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-------EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus       103 ~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      ..+.||+|+||+||+|..  .++.+++|++....       .....+++.+|+++|++++|+||+++..++...+..|+|
T Consensus       340 ~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            356899999999999965  67889999864322       112245689999999999999999655555566777999


Q ss_pred             EeccCCCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC------
Q 016959          176 LEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP------  249 (380)
Q Consensus       176 ~e~~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~------  249 (380)
                      |||+++++|.+++..    +..++.||+.||+|||++||+||||||+|||++.  ++||+|||+++........      
T Consensus       418 mE~~~ggsL~~~l~~----~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~  491 (540)
T 3en9_A          418 MSYINGKLAKDVIED----NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIV  491 (540)
T ss_dssp             EECCCSEEHHHHSTT----CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHH
T ss_pred             EECCCCCCHHHHHHH----HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhh
Confidence            999999999888776    5679999999999999999999999999999998  9999999999877543211      


Q ss_pred             -CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 016959          250 -CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF  298 (380)
Q Consensus       250 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf  298 (380)
                       ....+||+.|||||++...   ...|+..+|+|+..+-..+-+.++-+|
T Consensus       492 ~~~~~~GT~~y~APEv~~~~---~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          492 FKKAVLSTHHEKFDEIWERF---LEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHCGGGHHHHHHHH---HHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             hhhhhcCCCCcCCHHHHHHH---HHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence             1356799999999999531   123455789999999888888777666

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=8.6e-27  Score=212.22  Aligned_cols=142  Identities=20%  Similarity=0.213  Sum_probs=117.0

Q ss_pred             ccceecccCCceEEEEEeCCCCcEEEEEEecCCCch-----------------HHHHHHHHHHHHHHhCCCCceeeeEeE
Q 016959          103 KGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED-----------------SVRSQICREIEILRDVNHPNVVKCHDM  165 (380)
Q Consensus       103 ~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~h~~iv~~~~~  165 (380)
                      +++.||+|+||.||+|.+ .+|+.||||+++.....                 .....+.+|+.++++++  | +++.++
T Consensus        94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~  169 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV  169 (282)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred             ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence            449999999999999999 78999999999643211                 13567889999999998  5 667776


Q ss_pred             EeeCCeEEEEEeccCCCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          166 YDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       166 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      +.. +..++||||++|++|.+ +..  .....++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.   
T Consensus       170 ~~~-~~~~lvmE~~~g~~L~~-l~~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~---  241 (282)
T 1zar_A          170 YAW-EGNAVLMELIDAKELYR-VRV--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE---  241 (282)
T ss_dssp             EEE-ETTEEEEECCCCEEGGG-CCC--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEE---
T ss_pred             Eec-cceEEEEEecCCCcHHH-cch--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE---
Confidence            654 45699999999999988 333  23457999999999999999999999999999999 99999999999852   


Q ss_pred             cCCCCCCCCCCCccccccccc
Q 016959          246 TMDPCNSAVGTIAYMSPERIN  266 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~  266 (380)
                                +..++|||++.
T Consensus       242 ----------~~~~~a~e~l~  252 (282)
T 1zar_A          242 ----------VGEEGWREILE  252 (282)
T ss_dssp             ----------TTSTTHHHHHH
T ss_pred             ----------CCCCCHHHHHH
Confidence                      34578999873

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=4.5e-23  Score=185.33  Aligned_cols=137  Identities=18%  Similarity=0.195  Sum_probs=105.4

Q ss_pred             ccccceecccCCceEEEEEeCCCCcE--EEEEEecCCCch-----------------------HHHHHHHHHHHHHHhCC
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRV--FALKVIYGNHED-----------------------SVRSQICREIEILRDVN  155 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~--~avK~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~  155 (380)
                      |.+.+.||+|+||.||+|.+..+|+.  ||||+++.....                       .....+.+|+.+|+.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56788999999999999998778888  999997543211                       12246789999999998


Q ss_pred             CCce--eeeEeEEeeCCeEEEEEeccCC-C----Ccccccc-cchHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEE
Q 016959          156 HPNV--VKCHDMYDRNGEIEVLLEYMDG-G----SLEGAHI-RQEHILSDLARQVLSGLAYLH-KRKIVHRDIKPSNLLI  226 (380)
Q Consensus       156 h~~i--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~-~~~~~~~~i~~qi~~al~~LH-~~~ivH~Dlkp~Nil~  226 (380)
                      |+++  ..++++    +..++||||+.+ |    .|.+... ..+..+..++.||+.||.||| ++||+||||||+|||+
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl  204 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMY  204 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEE
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE
Confidence            7754  334432    356899999942 3    3443322 123457789999999999999 9999999999999999


Q ss_pred             cCCCcEEEeeccccccc
Q 016959          227 NSSKNVKIADFGVSRIL  243 (380)
Q Consensus       227 ~~~~~~kl~Dfg~a~~~  243 (380)
                      +.  .++|+|||+|...
T Consensus       205 ~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          205 ID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SS--SEEECCCTTCEET
T ss_pred             cC--cEEEEECcccccC
Confidence            97  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.82  E-value=6.1e-20  Score=171.90  Aligned_cols=138  Identities=17%  Similarity=0.209  Sum_probs=100.8

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-----------------hHH----HHHHHHHHHHHHhCCCCce
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-----------------DSV----RSQICREIEILRDVNHPNV  159 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----------------~~~----~~~~~~E~~~l~~l~h~~i  159 (380)
                      |.+++.||+|+||.||+|.+. +|+.||||+++....                 ...    +.....|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            778899999999999999985 699999999753210                 000    1112357777777754433


Q ss_pred             eeeEeEEeeCCeEEEEEeccCCCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC---------
Q 016959          160 VKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK---------  230 (380)
Q Consensus       160 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~---------  230 (380)
                      .. ...+... ..++||||++|..|..+....  ....++.||+.+|.|||++|||||||||.|||++++|         
T Consensus       176 ~v-p~p~~~~-~~~LVME~i~G~~L~~l~~~~--~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~  251 (397)
T 4gyi_A          176 PV-PEPIAQS-RHTIVMSLVDALPMRQVSSVP--DPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSIT  251 (397)
T ss_dssp             SC-CCEEEEE-TTEEEEECCSCEEGGGCCCCS--CHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEE
T ss_pred             CC-Ceeeecc-CceEEEEecCCccHhhhcccH--HHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccc
Confidence            21 1112111 237999999998887665433  3456889999999999999999999999999998777         


Q ss_pred             -cEEEeeccccccc
Q 016959          231 -NVKIADFGVSRIL  243 (380)
Q Consensus       231 -~~kl~Dfg~a~~~  243 (380)
                       .+.|+||+-+...
T Consensus       252 ~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          252 LTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEECCCTTCEET
T ss_pred             cceEEEEeCCcccC
Confidence             3899999987643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.52  E-value=2.2e-14  Score=128.56  Aligned_cols=138  Identities=17%  Similarity=0.175  Sum_probs=109.2

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEEEEec
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      .|.+...+|.|+++.||++..  .++.+++|+...... .....+.+|+.+++.+. +..+.++++++...+..|+|||+
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            577788899999999999986  467899999854211 11235788999999885 67788899999988999999999


Q ss_pred             cCCCCcccccccchHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 016959          179 MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK-----------------------------------------------  211 (380)
Q Consensus       179 ~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~-----------------------------------------------  211 (380)
                      ++|.+|..... .......++.++..+|..||+                                               
T Consensus        92 i~G~~l~~~~~-~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  170 (263)
T 3tm0_A           92 ADGVLCSEEYE-DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL  170 (263)
T ss_dssp             CSSEEHHHHCC-TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred             cCCeehhhccC-CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence            99988865432 122234688999999999998                                               


Q ss_pred             ------------CCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          212 ------------RKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       212 ------------~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                                  ..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                        458999999999999866556799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.44  E-value=1.9e-13  Score=122.06  Aligned_cols=132  Identities=15%  Similarity=0.146  Sum_probs=98.1

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCc--eeeeEeEEeeCCeEEEEEec
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN--VVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +.+....+.|..+.||++.. .+|+.+++|+.....    ...+.+|+.+++.+.+.+  +.+++++...++..++||||
T Consensus        22 ~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEecccCCCCceEEEEec-CCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            33333334666699999975 457789999975431    245678999998885434  56688888887889999999


Q ss_pred             cCCCCcccccccchHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 016959          179 MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRK---------------------------------------------  213 (380)
Q Consensus       179 ~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~---------------------------------------------  213 (380)
                      ++|.+|. .....   ...++.+++..|..||+..                                             
T Consensus        97 i~G~~l~-~~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (264)
T 1nd4_A           97 VPGQDLL-SSHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  172 (264)
T ss_dssp             CSSEETT-TSCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             cCCcccC-cCcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence            9998885 22211   2357788888888888754                                             


Q ss_pred             -------------ceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          214 -------------IVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       214 -------------ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                                   ++|+|++|.|||++.++.+.|+|||.+.
T Consensus       173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                         9999999999999876667799999874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.41  E-value=9.5e-13  Score=123.54  Aligned_cols=138  Identities=15%  Similarity=0.264  Sum_probs=104.1

Q ss_pred             ccceecccCCceEEEEEeCCCCcEEEEEEec--CCCchHHHHHHHHHHHHHHhCC--CCceeeeEeEEeeC---CeEEEE
Q 016959          103 KGNRIGSGSGGTVWRVVHPPTSRVFALKVIY--GNHEDSVRSQICREIEILRDVN--HPNVVKCHDMYDRN---GEIEVL  175 (380)
Q Consensus       103 ~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~--~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~---~~~~lv  175 (380)
                      ..+.|+.|.++.||++..  .+..+++|+..  ..........+.+|+.+++.+.  +..+.+++.++.+.   +..++|
T Consensus        42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            456799999999999987  35678999875  3322222456788999999996  45678888888766   458999


Q ss_pred             EeccCCCCcccc--cccchHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 016959          176 LEYMDGGSLEGA--HIRQEHILSDLARQVLSGLAYLHK------------------------------------------  211 (380)
Q Consensus       176 ~e~~~~~~L~~~--~~~~~~~~~~i~~qi~~al~~LH~------------------------------------------  211 (380)
                      |||++|..+.+.  ..........++.+++.+|..||+                                          
T Consensus       120 me~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (359)
T 3dxp_A          120 MEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS  199 (359)
T ss_dssp             EECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred             EEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence            999999887532  223456677889999999999997                                          


Q ss_pred             ----------------CCceecCCCCCcEEEcCCCc--EEEeecccccc
Q 016959          212 ----------------RKIVHRDIKPSNLLINSSKN--VKIADFGVSRI  242 (380)
Q Consensus       212 ----------------~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~  242 (380)
                                      .+++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                            36899999999999997754  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.20  E-value=9.8e-12  Score=113.85  Aligned_cols=186  Identities=16%  Similarity=0.147  Sum_probs=116.9

Q ss_pred             cceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCc--eeeeEeEEeeCC---eEEEEEe
Q 016959          104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPN--VVKCHDMYDRNG---EIEVLLE  177 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~--iv~~~~~~~~~~---~~~lv~e  177 (380)
                      .+.++.|.+..||++.     ..+++|+...   ......+.+|..+|+.+. +..  +.+++......+   ..|+||+
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~---~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKH---SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESS---HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCC---cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            4569999999999864     4589998632   234567889999998884 322  344444433322   3478999


Q ss_pred             ccCCCCcccc--cccchHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 016959          178 YMDGGSLEGA--HIRQEHILSDLARQVLSGLAYLHK--------------------------------------------  211 (380)
Q Consensus       178 ~~~~~~L~~~--~~~~~~~~~~i~~qi~~al~~LH~--------------------------------------------  211 (380)
                      +++|..|...  ...+......++.|++..+..||+                                            
T Consensus        97 ~i~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  176 (304)
T 3sg8_A           97 KIKGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF  176 (304)
T ss_dssp             CCCCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred             ccCCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence            9999887642  222445566778888888888885                                            


Q ss_pred             --------------CCceecCCCCCcEEEcC--CCcEEEeeccccccccccCCCCCCCCCCCcccccccccccc-CCCCC
Q 016959          212 --------------RKIVHRDIKPSNLLINS--SKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL-NHGKY  274 (380)
Q Consensus       212 --------------~~ivH~Dlkp~Nil~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~  274 (380)
                                    ..++|+|+++.|||++.  ++.+.|+||+.+..-....+........ .-..++...... .++..
T Consensus       177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~~~~~~l~~Y~~~  255 (304)
T 3sg8_A          177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGMEFVSKILNHYKHK  255 (304)
T ss_dssp             HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHHHHHHHHHHHTCS
T ss_pred             HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHHHHHHHHHHcCCC
Confidence                          13799999999999997  4568899999886432211100000000 001222211000 00000


Q ss_pred             --------CCcchhHHHHHHHHHHHHhCCCCC
Q 016959          275 --------DGYAGDIWSLGVSILEFYLGRFPF  298 (380)
Q Consensus       275 --------~~~~~DvwslG~il~ell~g~~pf  298 (380)
                              .....++|++|.++|.+.+|..+|
T Consensus       256 ~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          256 DIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                    011268999999999999998776

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=99.00  E-value=3.7e-09  Score=94.72  Aligned_cols=132  Identities=19%  Similarity=0.200  Sum_probs=97.8

Q ss_pred             eecccCCc-eEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEEEEeccCCCC
Q 016959          106 RIGSGSGG-TVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEVLLEYMDGGS  183 (380)
Q Consensus       106 ~LG~G~~g-~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~  183 (380)
                      .+..|..| .||+......+..+++|+-..    .....+.+|..+|+.+. +--+.++++++.+.+..++|||+++|.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            35556555 699998877788899998632    23456788999998885 4346778888888899999999999987


Q ss_pred             cccccccchHHHHHHHHHHHHHHHHHHhC---------------------------------------------------
Q 016959          184 LEGAHIRQEHILSDLARQVLSGLAYLHKR---------------------------------------------------  212 (380)
Q Consensus       184 L~~~~~~~~~~~~~i~~qi~~al~~LH~~---------------------------------------------------  212 (380)
                      +.............++.++...|..||..                                                   
T Consensus       107 ~~~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  186 (272)
T 4gkh_A          107 AFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKL  186 (272)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTT
T ss_pred             ccccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhc
Confidence            65543333333445666677777777731                                                   


Q ss_pred             -------CceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          213 -------KIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       213 -------~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                             .++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       187 ~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          187 LPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             CCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                   15999999999999977767799999874

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.84  E-value=3e-08  Score=90.68  Aligned_cols=132  Identities=19%  Similarity=0.221  Sum_probs=91.5

Q ss_pred             cceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCC---ceeeeEeEEe-eCCeEEEEEecc
Q 016959          104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHP---NVVKCHDMYD-RNGEIEVLLEYM  179 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~  179 (380)
                      .+.++.|....||++     ++.+++|+-.   .......+.+|..+|+.+.+.   .+.+.+.+.. ..+..++|||++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i   95 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV   95 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence            456888999999988     4568889842   233456788999999999642   3556666653 455678999999


Q ss_pred             CCCCcccc--cccchHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 016959          180 DGGSLEGA--HIRQEHILSDLARQVLSGLAYLHKR---------------------------------------------  212 (380)
Q Consensus       180 ~~~~L~~~--~~~~~~~~~~i~~qi~~al~~LH~~---------------------------------------------  212 (380)
                      +|..+...  ..........++.++...|..||+.                                             
T Consensus        96 ~G~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  175 (306)
T 3tdw_A           96 QGQILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR  175 (306)
T ss_dssp             CSEECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred             CCeECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence            99877542  1123333444555555555555532                                             


Q ss_pred             ---------------CceecCCCCCcEEEcC---CCc-EEEeeccccccc
Q 016959          213 ---------------KIVHRDIKPSNLLINS---SKN-VKIADFGVSRIL  243 (380)
Q Consensus       213 ---------------~ivH~Dlkp~Nil~~~---~~~-~kl~Dfg~a~~~  243 (380)
                                     .++|+|+++.|||++.   ++. +.|+||+.+..-
T Consensus       176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                           3599999999999997   455 589999987643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.64  E-value=4.7e-08  Score=91.21  Aligned_cols=85  Identities=12%  Similarity=0.139  Sum_probs=56.5

Q ss_pred             ccccee-cccCCceEEEEEeC--C----CCcEEEEEEecCCCc--hHHHHHHHHHHHHHHhCC-C--CceeeeEeEEeeC
Q 016959          102 QKGNRI-GSGSGGTVWRVVHP--P----TSRVFALKVIYGNHE--DSVRSQICREIEILRDVN-H--PNVVKCHDMYDRN  169 (380)
Q Consensus       102 ~~~~~L-G~G~~g~V~~~~~~--~----~~~~~avK~~~~~~~--~~~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~  169 (380)
                      ...+.| +.|....+|++...  .    +++.+++|+......  ......+.+|+.+++.+. +  -.+.+++.+..+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            344668 88889999998752  0    166889998643220  000134667888888774 3  3566777776654


Q ss_pred             ---CeEEEEEeccCCCCccc
Q 016959          170 ---GEIEVLLEYMDGGSLEG  186 (380)
Q Consensus       170 ---~~~~lv~e~~~~~~L~~  186 (380)
                         +..++|||+++|..+..
T Consensus       103 ~~~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TTTSSCEEEEECCCCBCCCB
T ss_pred             CccCCceEEEEecCCCChhh
Confidence               45689999999877654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.64  E-value=1.7e-08  Score=95.77  Aligned_cols=78  Identities=14%  Similarity=0.100  Sum_probs=49.5

Q ss_pred             ccceecccCCceEEEEEeCCCCcEEEEEEecCCCc------hHHHHHHHHHHHHHHhCCC--C-ceeeeEeEEeeCCeEE
Q 016959          103 KGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE------DSVRSQICREIEILRDVNH--P-NVVKCHDMYDRNGEIE  173 (380)
Q Consensus       103 ~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~E~~~l~~l~h--~-~iv~~~~~~~~~~~~~  173 (380)
                      ..+.||.|.++.||++....+++.++||.......      .....++..|.++|+.+..  + .+.+++.+  +.+..+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            35679999999999998765678899998642211      0112456678888887732  3 34455543  334568


Q ss_pred             EEEeccCCC
Q 016959          174 VLLEYMDGG  182 (380)
Q Consensus       174 lv~e~~~~~  182 (380)
                      +|||++.+.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.46  E-value=1.1e-06  Score=81.16  Aligned_cols=130  Identities=15%  Similarity=0.196  Sum_probs=76.4

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-----CCceeeeE-e--EEeeCCeEEEEE
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-----HPNVVKCH-D--MYDRNGEIEVLL  176 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~-~--~~~~~~~~~lv~  176 (380)
                      +.|+.|..+.||++...  +..+++|+....  .   ..+..|+.+++.|.     .|.++... |  +....+..+++|
T Consensus        38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~--~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~  110 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP--E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY  110 (346)
T ss_dssp             EECC----CEEEEEEET--TEEEEEEEECSC--H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred             eeccccccCcEEEEEeC--CCCEEEEecCCC--H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence            45677788999999873  345899998542  1   23334555555442     24443311 1  223467789999


Q ss_pred             eccCCCCccc----------------------cc-c---------cchH--------H----------------------
Q 016959          177 EYMDGGSLEG----------------------AH-I---------RQEH--------I----------------------  194 (380)
Q Consensus       177 e~~~~~~L~~----------------------~~-~---------~~~~--------~----------------------  194 (380)
                      +|++|..+..                      .. .         ....        .                      
T Consensus       111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  190 (346)
T 2q83_A          111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ  190 (346)
T ss_dssp             ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred             EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence            9999865420                      00 0         0000        0                      


Q ss_pred             -HHHHHHHHHHHHHHHHh-------------CCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          195 -LSDLARQVLSGLAYLHK-------------RKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       195 -~~~i~~qi~~al~~LH~-------------~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                       +..+..++..++++|+.             .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus       191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence             01111223445666652             579999999999999888889999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.34  E-value=7.4e-06  Score=74.75  Aligned_cols=77  Identities=18%  Similarity=0.207  Sum_probs=60.4

Q ss_pred             cccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC---CCceeeeEeEEeeCCeEEEEEec
Q 016959          102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN---HPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       102 ~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      .-.+.|+.|.+..+|++..  +++.++||+....    ....+..|...|+.|.   ...+.+.+.+....+..++|||+
T Consensus        39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~  112 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA  112 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred             eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence            3456799999999999986  5678899986432    2456788998888883   35678888888777889999999


Q ss_pred             cCCCCc
Q 016959          179 MDGGSL  184 (380)
Q Consensus       179 ~~~~~L  184 (380)
                      ++|..+
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            998754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.14  E-value=1.7e-06  Score=82.63  Aligned_cols=82  Identities=11%  Similarity=0.127  Sum_probs=46.9

Q ss_pred             HhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCC-CCCccccccccccccCCCCCCCcchhHHHHHHHH
Q 016959          210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV-GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSI  288 (380)
Q Consensus       210 H~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~-gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il  288 (380)
                      +...++|+|+++.|||++.++ ++|+||+.+..-....+...... -...|.+++.....  .+.......++..+...+
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQ--ENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCS--SCCSHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhccccccc--ccchHHHHHHHHHHHHHH
Confidence            356799999999999999776 99999998864322111000000 01245555544210  001112235556777777


Q ss_pred             HHHHhC
Q 016959          289 LEFYLG  294 (380)
Q Consensus       289 ~ell~g  294 (380)
                      |+.+++
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            777654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=98.10  E-value=1e-05  Score=74.00  Aligned_cols=135  Identities=13%  Similarity=0.224  Sum_probs=77.2

Q ss_pred             cccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-----CCceeeeE-e--EEeeCCeEE
Q 016959          102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-----HPNVVKCH-D--MYDRNGEIE  173 (380)
Q Consensus       102 ~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~-~--~~~~~~~~~  173 (380)
                      .-.+.|+.|....+|++...  +..+++|+.....   ..+.+..|+.+++.|.     -|.++... |  +....+..+
T Consensus        25 ~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~   99 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA   99 (322)
T ss_dssp             EEEEEECC---EEEEEEEES--SCCEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred             eEeeccCCCcccceEEEEeC--CccEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence            34456888888999999863  3368899985421   1234556777776663     23333211 1  122346789


Q ss_pred             EEEeccCCCCccccc----------------------cc-----c---hHH-HHH-----------HHHHHHHHHHHHHh
Q 016959          174 VLLEYMDGGSLEGAH----------------------IR-----Q---EHI-LSD-----------LARQVLSGLAYLHK  211 (380)
Q Consensus       174 lv~e~~~~~~L~~~~----------------------~~-----~---~~~-~~~-----------i~~qi~~al~~LH~  211 (380)
                      ++|++++|..+....                      ..     .   ... ...           +...+...+++|+.
T Consensus       100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~  179 (322)
T 2ppq_A          100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  179 (322)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence            999999986542110                      00     0   000 000           00123445555552


Q ss_pred             -------CCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          212 -------RKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       212 -------~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                             .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus       180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                   369999999999999976656899999774

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=98.07  E-value=1.4e-05  Score=74.97  Aligned_cols=140  Identities=17%  Similarity=0.261  Sum_probs=83.2

Q ss_pred             CCcccccccceecccCCceEEEEEeCC-------CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEe
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPP-------TSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYD  167 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~  167 (380)
                      ++.+++.+ +.|..|-...+|++....       +++.|++|+.....  .....+.+|..+++.|. +.-..++++++.
T Consensus        48 ~~~~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~  124 (379)
T 3feg_A           48 VQPEELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVFP  124 (379)
T ss_dssp             CCGGGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred             CCcCceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcC
Confidence            44455553 567778888999998742       35789999862211  12345568999988884 333456676665


Q ss_pred             eCCeEEEEEeccCCCCcccccccc----------------------------hHHHHHHHHHHH----------------
Q 016959          168 RNGEIEVLLEYMDGGSLEGAHIRQ----------------------------EHILSDLARQVL----------------  203 (380)
Q Consensus       168 ~~~~~~lv~e~~~~~~L~~~~~~~----------------------------~~~~~~i~~qi~----------------  203 (380)
                      +    .+||||++|..|.......                            ...+.++..++.                
T Consensus       125 ~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~  200 (379)
T 3feg_A          125 E----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMY  200 (379)
T ss_dssp             T----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHT
T ss_pred             C----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhH
Confidence            3    2999999986653211000                            112233333221                


Q ss_pred             ---HHHHHHH----h----CCceecCCCCCcEEEcCC----CcEEEeecccccc
Q 016959          204 ---SGLAYLH----K----RKIVHRDIKPSNLLINSS----KNVKIADFGVSRI  242 (380)
Q Consensus       204 ---~al~~LH----~----~~ivH~Dlkp~Nil~~~~----~~~kl~Dfg~a~~  242 (380)
                         ..++.|.    .    ..++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       201 ~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          201 SLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             THHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               2233333    2    258999999999999876    6899999998853

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.99  E-value=2.4e-05  Score=74.76  Aligned_cols=74  Identities=18%  Similarity=0.205  Sum_probs=49.8

Q ss_pred             cceecccCCceEEEEEeCC-------CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEEE
Q 016959          104 GNRIGSGSGGTVWRVVHPP-------TSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  175 (380)
                      .+.|+.|....||++....       +++.+++|+......   .+.+.+|+.+++.|. +.-..++++.+.+    .+|
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v  150 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  150 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence            4578889899999998642       257899998743211   134457888888874 3333567766542    389


Q ss_pred             EeccCCCCc
Q 016959          176 LEYMDGGSL  184 (380)
Q Consensus       176 ~e~~~~~~L  184 (380)
                      +||++|..|
T Consensus       151 ~e~l~G~~l  159 (429)
T 1nw1_A          151 EEYIPSRPL  159 (429)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeCCccc
Confidence            999987544

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.97  E-value=1.4e-05  Score=72.58  Aligned_cols=125  Identities=14%  Similarity=0.146  Sum_probs=74.6

Q ss_pred             cceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCce-eeeEeEEeeCCeEEEEEecc-CC
Q 016959          104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV-VKCHDMYDRNGEIEVLLEYM-DG  181 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~-~~  181 (380)
                      .+.|+.|....+|++      +.+++|+.......  .....+|+.+++.+...++ .+++++..  +.-++++||+ .|
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g   92 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGA   92 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCC
Confidence            678999999999999      45889987543211  1122457777776642122 45555433  2347899999 66


Q ss_pred             CCcccccccchHHHHHHHHHHHHHHHHHHh--------------------------------------------------
Q 016959          182 GSLEGAHIRQEHILSDLARQVLSGLAYLHK--------------------------------------------------  211 (380)
Q Consensus       182 ~~L~~~~~~~~~~~~~i~~qi~~al~~LH~--------------------------------------------------  211 (380)
                      ..+.......   ...++.+++..|.-||+                                                  
T Consensus        93 ~~l~~~~~~~---~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~  169 (301)
T 3dxq_A           93 QTMSPEKFKT---RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH  169 (301)
T ss_dssp             EECCHHHHHH---STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred             ccCCHhhHhh---hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence            5553210000   00123333333333332                                                  


Q ss_pred             ---CCceecCCCCCcEEEcCCCcEEEeecccccc
Q 016959          212 ---RKIVHRDIKPSNLLINSSKNVKIADFGVSRI  242 (380)
Q Consensus       212 ---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  242 (380)
                         ..++|+|+.+.||| ..++.+.|+||..+..
T Consensus       170 ~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          170 PLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence               13799999999999 5577899999998754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.90  E-value=2.2e-05  Score=72.28  Aligned_cols=31  Identities=32%  Similarity=0.485  Sum_probs=27.1

Q ss_pred             CCceecCCCCCcEEEcCC----CcEEEeecccccc
Q 016959          212 RKIVHRDIKPSNLLINSS----KNVKIADFGVSRI  242 (380)
Q Consensus       212 ~~ivH~Dlkp~Nil~~~~----~~~kl~Dfg~a~~  242 (380)
                      ..++|||+.+.|||++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            479999999999999874    6799999998764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.86  E-value=7.5e-05  Score=67.15  Aligned_cols=78  Identities=13%  Similarity=0.108  Sum_probs=53.6

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-C--CceeeeEeEEeeCCeEEEEE
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-H--PNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~~~~~lv~  176 (380)
                      ++.-.+.+|.|..+.||+++.. +|+.|+||+-..... .....+..|+..|+.|. .  -.+.+++++.    ..++||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~   89 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM   89 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence            4555678999999999999874 678999998643321 11235678999988884 2  2344555432    237899


Q ss_pred             eccCCCC
Q 016959          177 EYMDGGS  183 (380)
Q Consensus       177 e~~~~~~  183 (380)
                      |++.++.
T Consensus        90 e~l~~~~   96 (288)
T 3f7w_A           90 EWVDERP   96 (288)
T ss_dssp             ECCCCCC
T ss_pred             EeecccC
Confidence            9998764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.83  E-value=3.6e-05  Score=71.94  Aligned_cols=75  Identities=15%  Similarity=0.220  Sum_probs=44.2

Q ss_pred             cceecccCCceEEEEEeCC--------CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCc-eeeeEeEEeeCCeEEE
Q 016959          104 GNRIGSGSGGTVWRVVHPP--------TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN-VVKCHDMYDRNGEIEV  174 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~--------~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~l  174 (380)
                      .+.|+.|....+|++....        .++.+++|+.......  ......|..+++.+...+ +.++++.+  .+  ++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~  111 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GR  111 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEec--CC--cE
Confidence            4567888889999998743        1268899986433211  112356888888774222 44666544  23  68


Q ss_pred             EEeccCCCCc
Q 016959          175 LLEYMDGGSL  184 (380)
Q Consensus       175 v~e~~~~~~L  184 (380)
                      ||||++|..+
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            9999987544

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.81  E-value=0.00013  Score=66.78  Aligned_cols=76  Identities=13%  Similarity=0.144  Sum_probs=47.7

Q ss_pred             ceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-C-CceeeeEeE-----EeeCCeEEEEEe
Q 016959          105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-H-PNVVKCHDM-----YDRNGEIEVLLE  177 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h-~~iv~~~~~-----~~~~~~~~lv~e  177 (380)
                      ..|+ |....||++... +|+.+++|+......  ....+..|..+++.+. + -.+.+++..     ...++..+++|+
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence            4566 888899988653 466799999853211  1245666887777763 1 123334332     233567788999


Q ss_pred             ccCCCCc
Q 016959          178 YMDGGSL  184 (380)
Q Consensus       178 ~~~~~~L  184 (380)
                      +++|..+
T Consensus       108 ~i~G~~~  114 (328)
T 1zyl_A          108 SVGGRQF  114 (328)
T ss_dssp             CCCCEEC
T ss_pred             ecCCCCC
Confidence            9988543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.73  E-value=0.00017  Score=69.38  Aligned_cols=75  Identities=17%  Similarity=0.181  Sum_probs=47.8

Q ss_pred             cceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCce-eeeEeEEeeCCeEEEEEeccCCC
Q 016959          104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNV-VKCHDMYDRNGEIEVLLEYMDGG  182 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~  182 (380)
                      .+.|+.|-...+|++.....++.|++|+........ . .-.+|..+++.|...++ .++++++.  +  .+||||++|.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-I-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-S-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-c-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence            456888889999999885445789999874322111 0 11478888888864333 56777663  2  2599999875


Q ss_pred             Cc
Q 016959          183 SL  184 (380)
Q Consensus       183 ~L  184 (380)
                      .|
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.71  E-value=0.00025  Score=65.41  Aligned_cols=32  Identities=22%  Similarity=0.443  Sum_probs=28.0

Q ss_pred             CCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       212 ~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                      ..++|+|+.+.|||++.++.+.|+||+.+..-
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            46999999999999998888999999887643

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=97.27  E-value=0.00064  Score=64.53  Aligned_cols=75  Identities=13%  Similarity=0.105  Sum_probs=47.7

Q ss_pred             cceecccCCceEEEEEeCCC-------CcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEEE
Q 016959          104 GNRIGSGSGGTVWRVVHPPT-------SRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~~-------~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  175 (380)
                      .+.|..|-...+|++.....       ++.|++|+...... . .-...+|..+++.+. +.-..++++.+  .+  ++|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I  148 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-K-FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRI  148 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-h-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEE
Confidence            45677788889999987521       57899998643221 1 112346888887774 33344556543  22  689


Q ss_pred             EeccCCCCc
Q 016959          176 LEYMDGGSL  184 (380)
Q Consensus       176 ~e~~~~~~L  184 (380)
                      |||++|..|
T Consensus       149 ~efI~G~~l  157 (424)
T 3mes_A          149 EEFIDGEPL  157 (424)
T ss_dssp             EECCCSEEC
T ss_pred             EEEeCCccC
Confidence            999998654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.01  E-value=0.011  Score=50.21  Aligned_cols=122  Identities=13%  Similarity=0.056  Sum_probs=79.4

Q ss_pred             chHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCCCCCcccccccccccc
Q 016959          191 QEHILSDLARQVLSGLAYLHK-RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL  269 (380)
Q Consensus       191 ~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  269 (380)
                      .|.++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|+|-+.+ +.+.            .....+.+||...   
T Consensus        47 sEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~~~~~~pe~~~---  110 (229)
T 2yle_A           47 NEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGEPPPVAGKLGY---  110 (229)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------------CCSS---
T ss_pred             CHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------ccccCCCChhhcc---
Confidence            688999999999999877622 2212333446899999999987663 1110            1234566888752   


Q ss_pred             CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccC---------
Q 016959          270 NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKD---------  340 (380)
Q Consensus       270 ~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d---------  340 (380)
                         ...+.+.-|||||+++|.-+-                     ++.+...+..+++.+..||..|...+         
T Consensus       111 ---~~~te~~~IysLG~tLY~ALD---------------------ygL~e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG  166 (229)
T 2yle_A          111 ---SQCMETEVIESLGIIIYKALD---------------------YGLKENEERELSPPLEQLIDHMANTVEADGSNDEG  166 (229)
T ss_dssp             ---SSSCHHHHHHHHHHHHHHHHT---------------------TTCCTTEEECCCHHHHHHHHHHTTCCC--------
T ss_pred             ---ccchHHHHHHHHHHHHHHHhh---------------------cCCCcccchhhCHHHHHHHHHHHhccccccccccc
Confidence               233568899999999998763                     23334456678999999999997552         


Q ss_pred             ----------------cCCCCCHHHHhc
Q 016959          341 ----------------PHSRWPAAQLLQ  352 (380)
Q Consensus       341 ----------------p~~R~t~~eil~  352 (380)
                                      +..|.++++|++
T Consensus       167 ~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          167 YEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             ------------CCSCCCCCCSHHHHHH
T ss_pred             ccccccccccccccccccCcCCHHHHHH
Confidence                            357888988875

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.32  E-value=0.021  Score=53.74  Aligned_cols=29  Identities=24%  Similarity=0.492  Sum_probs=25.0

Q ss_pred             ceecCCCCCcEEE------cCCCcEEEeecccccc
Q 016959          214 IVHRDIKPSNLLI------NSSKNVKIADFGVSRI  242 (380)
Q Consensus       214 ivH~Dlkp~Nil~------~~~~~~kl~Dfg~a~~  242 (380)
                      ++|+|+.+.|||+      ++++.+.|+||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999      3456799999999864

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.47  E-value=0.39  Score=40.54  Aligned_cols=115  Identities=8%  Similarity=0.084  Sum_probs=78.6

Q ss_pred             CCCceeeeEeEEeeCCeEEEEEeccC-CCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEE
Q 016959          155 NHPNVVKCHDMYDRNGEIEVLLEYMD-GGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVK  233 (380)
Q Consensus       155 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~k  233 (380)
                      .||+++.. .+-+.++.+.+.++.-. +.++...........++++.+|+....++  ..-+|--|+|+||+++.++.++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~~p~  119 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDGLPI  119 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTSCEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCCCEE
Confidence            58888876 56666676666666654 33455555666777888888888877444  4457788999999999999999


Q ss_pred             EeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 016959          234 IADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFA  299 (380)
Q Consensus       234 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~  299 (380)
                      +.-.|+-..+                 +|.-+          +...=+-..=|++..++.++..|.
T Consensus       120 i~~RGik~~l-----------------~P~~~----------~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          120 AKTRGLQNVV-----------------DPLPV----------SEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ESCCEETTTB-----------------SCCCC----------CHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEccCccCC-----------------CCCCC----------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9977764322                 22211          111223356688888999988884

>1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3

Probab=93.08  E-value=1.8  Score=39.05  Aligned_cols=134  Identities=17%  Similarity=0.207  Sum_probs=74.5

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeE-------------Ee
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDM-------------YD  167 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-------------~~  167 (380)
                      +..++..-.|..| ||.+..  ++..|+||-.  .  .-..+.+-.++...-.+..|+.--+...             +.
T Consensus        71 v~~I~~s~~Gstg-vff~~t--d~~~~VVK~s--~--~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~~L~~~~  143 (342)
T 1cja_A           71 FKGIERSEKGTEG-LFFVET--ESGVFIVKRS--T--NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAAID  143 (342)
T ss_dssp             EEEEEECCSTTSC-EEEEEE--SSCEEEEECC--T--THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHHHC
T ss_pred             eeEEEeccCCCCC-eEEEEe--CCCEEEEeCc--H--HHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHHHHHHhh
Confidence            4455556666654 555555  4678899954  1  2234444455544444555553322211             00


Q ss_pred             ---------eCCeEEEEEeccCCCCcccccccchH--HHHHHHHHH--HHHHHHHHhCC-----ceecCCCCCcEEEcCC
Q 016959          168 ---------RNGEIEVLLEYMDGGSLEGAHIRQEH--ILSDLARQV--LSGLAYLHKRK-----IVHRDIKPSNLLINSS  229 (380)
Q Consensus       168 ---------~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~i~~qi--~~al~~LH~~~-----ivH~Dlkp~Nil~~~~  229 (380)
                               ..+...++|+|..|..|.........  .-.+.+.++  +-+++.+..++     +-+.--.+.|||++.+
T Consensus       144 ~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~LG~Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~~~  223 (342)
T 1cja_A          144 KSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSER  223 (342)
T ss_dssp             SSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESB
T ss_pred             hhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHHhhchhheehhhhcCCccCcccccCCCChhheEEeCC
Confidence                     12356799999998776554333111  112233333  45677777653     1222357899999865


Q ss_pred             Cc-EEEeeccccc
Q 016959          230 KN-VKIADFGVSR  241 (380)
Q Consensus       230 ~~-~kl~Dfg~a~  241 (380)
                      +. +.++|-+++.
T Consensus       224 n~~~~~IDhn~af  236 (342)
T 1cja_A          224 GATVVPIDSKIIP  236 (342)
T ss_dssp             TTCEEECSCCCCC
T ss_pred             CCeEEEEcCCccc
Confidence            55 8899998874

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=90.76  E-value=0.024  Score=54.39  Aligned_cols=63  Identities=11%  Similarity=0.027  Sum_probs=18.6

Q ss_pred             cccceecccCCceEEEEEeCCCCcEEEE------EEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEe
Q 016959          102 QKGNRIGSGSGGTVWRVVHPPTSRVFAL------KVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYD  167 (380)
Q Consensus       102 ~~~~~LG~G~~g~V~~~~~~~~~~~~av------K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  167 (380)
                      .+.+.||   ||.||++........||+      |..+... .......+.+|..+++.++|+|+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            3456787   999999998755567888      6654322 2233456778888899999999999988754

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=87.48  E-value=1.1  Score=37.83  Aligned_cols=112  Identities=14%  Similarity=0.208  Sum_probs=72.5

Q ss_pred             CCCceeeeEeEEeeCCeEEEEEeccCC-CCcccccccchHHHHHHHHHHHHHHH-HHHhCCceecCCCCCcEEEcCCCcE
Q 016959          155 NHPNVVKCHDMYDRNGEIEVLLEYMDG-GSLEGAHIRQEHILSDLARQVLSGLA-YLHKRKIVHRDIKPSNLLINSSKNV  232 (380)
Q Consensus       155 ~h~~iv~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~i~~qi~~al~-~LH~~~ivH~Dlkp~Nil~~~~~~~  232 (380)
                      .||++  -..+-.+++.+.+.++.-.+ .++...........++++.+|+.... ++  ..-+|--|+|+||+++.++.+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~~p  123 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRALEP  123 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTCCE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCCcE
Confidence            47777  23344666777776766533 33444455566667777777766655 44  456778899999999999999


Q ss_pred             EEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhH-HHHHHHHHHHHhCCCCC
Q 016959          233 KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDI-WSLGVSILEFYLGRFPF  298 (380)
Q Consensus       233 kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dv-wslG~il~ell~g~~pf  298 (380)
                      ++.-.|+-..                 ++|.-+.           ..|. -..=|++..++.++..|
T Consensus       124 ~i~hRGi~~~-----------------lpP~e~~-----------ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          124 FFLHVGVKES-----------------LPPDEWD-----------DERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             EESCCEETTT-----------------BSSCSCC-----------HHHHHHHHHHHHHHHTTCSSCH
T ss_pred             EEEEcCCccc-----------------CCCCCCC-----------HHHHHHHHHHHHHHHHcCCCCH
Confidence            9998776322                 2333221           1233 35668888888887776

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	380
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-84
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-77
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-76
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-74
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-73
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-73
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-73
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-69
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-69
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-69
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-68
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-68
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-68
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-66
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-66
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-65
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-65
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-63
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-63
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-62
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-62
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-62
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-61
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-61
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-60
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-60
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-60
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-60
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-60
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	9e-60
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-59
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-59
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-59
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-59
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-58
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-58
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-58
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-58
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-58
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-58
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-57
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-57
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-56
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-55
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-55
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-54
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-54
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-54
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-54
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-53
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-52
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-52
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-52
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-49
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-48
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-48
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-48
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-46
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-39
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-27

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  255 bits (653), Expect = 4e-84
 Identities = 87/286 (30%), Positives = 154/286 (53%), Gaps = 16/286 (5%)

Query: 96  INPAEL-QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV 154
           +NP +  +    +G G+ G V++  +  TS + A KVI    E+ +      EI+IL   
Sbjct: 8   LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASC 66

Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYL 209
           +HPN+VK  D +     + +L+E+  GG+++   +  E  L++     + +Q L  L YL
Sbjct: 67  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
           H  KI+HRD+K  N+L     ++K+ADFGVS    +T+   +S +GT  +M+PE +  + 
Sbjct: 127 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 186

Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP--EAPEMASR 327
           +  +   Y  D+WSLG++++E      P     + +   ++  I  ++PP    P   S 
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPH---HELNPMRVLLKIAKSEPPTLAQPSRWSS 243

Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILP 373
            F+DF+ +CL+K+  +RW  +QLLQHPF+        N+ +R+++ 
Sbjct: 244 NFKDFLKKCLEKNVDARWTTSQLLQHPFV----TVDSNKPIRELIA 285

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (613), Expect = 1e-77
 Identities = 102/315 (32%), Positives = 161/315 (51%), Gaps = 52/315 (16%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           +   + +K + +G+G+GG V++V H P+  V A K+I+   + ++R+QI RE+++L + N
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLH- 210
            P +V  +  +  +GEI + +E+MDGGSL+    +     E IL  ++  V+ GL YL  
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLN 270
           K KI+HRD+KPSN+L+NS   +K+ DFGVS  L  +M   NS VGT +YMSPER+     
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQG--- 177

Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE------- 323
              Y     DIWS+G+S++E  +GR+P       +   +          E P        
Sbjct: 178 -THYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235

Query: 324 ---------------------------------MASREFRDFISRCLQKDPHSRWPAAQL 350
                                            + S EF+DF+++CL K+P  R    QL
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

Query: 351 LQHPFILRAGQSQVN 365
           + H FI R+   +V+
Sbjct: 296 MVHAFIKRSDAEEVD 310

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  236 bits (603), Expect = 2e-76
 Identities = 88/282 (31%), Positives = 137/282 (48%), Gaps = 17/282 (6%)

Query: 97  NPAEL-QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIY--GNHEDSVRSQICREIEILRD 153
           +P +L      IG GS G V+       S V A+K +   G   +     I +E+  L+ 
Sbjct: 12  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71

Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYL 209
           + HPN ++    Y R     +++EY  G + +   + +    E  ++ +    L GLAYL
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDL 269
           H   ++HRD+K  N+L++    VK+ DFG + I    M P NS VGT  +M+PE I    
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANSFVGTPYWMAPEVILAM- 186

Query: 270 NHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA-SRE 328
           + G+YDG   D+WSLG++ +E    + P       +  S ++ I   + P       S  
Sbjct: 187 DEGQYDGKV-DVWSLGITCIELAERKPPL---FNMNAMSALYHIAQNESPALQSGHWSEY 242

Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQ 370
           FR+F+  CLQK P  R  +  LL+H F+LR     V  +L Q
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQ 284

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (585), Expect = 8e-74
 Identities = 82/281 (29%), Positives = 134/281 (47%), Gaps = 20/281 (7%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
            +  +IG G+ GTV+  +   T +  A++ +    +   +  I  EI ++R+  +PN+V 
Sbjct: 23  TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVN 81

Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ---EHILSDLARQVLSGLAYLHKRKIVHRD 218
             D Y    E+ V++EY+ GGSL          E  ++ + R+ L  L +LH  +++HRD
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141

Query: 219 IKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYA 278
           IK  N+L+    +VK+ DFG    +       ++ VGT  +M+PE +        Y    
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR----KAYG-PK 196

Query: 279 GDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--APEMASREFRDFISRC 336
            DIWSLG+  +E   G  P+      +    ++ I     PE   PE  S  FRDF++RC
Sbjct: 197 VDIWSLGIMAIEMIEGEPPY---LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253

Query: 337 LQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           L  D   R  A +LLQH F+      ++ + L  + P    
Sbjct: 254 LDMDVEKRGSAKELLQHQFL------KIAKPLSSLTPLIAA 288

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (579), Expect = 3e-73
 Identities = 74/274 (27%), Positives = 128/274 (46%), Gaps = 26/274 (9%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPN 158
           + +    IG+GS G   ++      ++   K + YG+  ++ +  +  E+ +LR++ HPN
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 159 VVKCHDMY--DRNGEIEVLLEYMDGGSLEGAHIRQ---------EHILSDLARQVLSGLA 207
           +V+ +D      N  + +++EY +GG L  + I +         E  +  +  Q+   L 
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLA-SVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 208 YLHKR-----KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSP 262
             H+R      ++HRD+KP+N+ ++  +NVK+ DFG++RIL        + VGT  YMSP
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAP 322
           E     +N   Y+    DIWSLG  + E      PF          L   I   +    P
Sbjct: 184 E----QMNRMSYN-EKSDIWSLGCLLYELCALMPPF---TAFSQKELAGKIREGKFRRIP 235

Query: 323 EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
              S E  + I+R L    + R    ++L++P I
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 5e-73
 Identities = 74/263 (28%), Positives = 127/263 (48%), Gaps = 17/263 (6%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           + + G  +G G  G V+      +  + ALKV++     +  V  Q+ RE+EI   + HP
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRK 213
           N+++ +  +     + ++LEY   G++     +     E   +    ++ + L+Y H ++
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           ++HRDIKP NLL+ S+  +KIADFG S     +        GT+ Y+ PE I      G+
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL--CGTLDYLPPEMIE-----GR 179

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                 D+WSLGV   EF +G+ PF    + +     +          P+  +   RD I
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFVTEGARDLI 235

Query: 334 SRCLQKDPHSRWPAAQLLQHPFI 356
           SR L+ +P  R    ++L+HP+I
Sbjct: 236 SRLLKHNPSQRPMLREVLEHPWI 258

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (578), Expect = 5e-73
 Identities = 61/261 (23%), Positives = 105/261 (40%), Gaps = 11/261 (4%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
                +G G+ G V   V+  T    A+K++           I +EI I + +NH NVVK
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67

Query: 162 CHDMYDRNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHR 217
            +          + LEY  GG     +E      E        Q+++G+ YLH   I HR
Sbjct: 68  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 127

Query: 218 DIKPSNLLINSSKNVKIADFGVSRIL--AQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           DIKP NLL++   N+KI+DFG++ +          N   GT+ Y++PE +       ++ 
Sbjct: 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR----REFH 183

Query: 276 GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISR 335
               D+WS G+ +     G  P+            +           ++        + +
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-DSAPLALLHK 242

Query: 336 CLQKDPHSRWPAAQLLQHPFI 356
            L ++P +R     + +  + 
Sbjct: 243 ILVENPSARITIPDIKKDRWY 263

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  217 bits (555), Expect = 4e-69
 Identities = 78/282 (27%), Positives = 129/282 (45%), Gaps = 17/282 (6%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
              + +G+G+   V       T ++ A+K I     +     +  EI +L  + HPN+V 
Sbjct: 12  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71

Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIVH 216
             D+Y+  G + ++++ + GG L    I ++   ++     L  QVL  + YLH   IVH
Sbjct: 72  LDDIYESGGHLYLIMQLVSGGELF-DRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 130

Query: 217 RDIKPSNLLINSSK---NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           RD+KP NLL  S      + I+DFG+S++        ++A GT  Y++PE +       K
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLA-----QK 184

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
               A D WS+GV       G  PF           +    +       +  S   +DFI
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFI 244

Query: 334 SRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPP 375
              ++KDP  R+   Q LQHP+I  AG + +++N+ Q +   
Sbjct: 245 RHLMEKDPEKRFTCEQALQHPWI--AGDTALDKNIHQSVSEQ 284

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (552), Expect = 4e-69
 Identities = 70/268 (26%), Positives = 123/268 (45%), Gaps = 21/268 (7%)

Query: 101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNV 159
           L+    IG GS  TV++ +   T+   A   +       S R +   E E+L+ + HPN+
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 160 VKCHDMY----DRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHK 211
           V+ +D +         I ++ E M  G+L+    R       +L    RQ+L GL +LH 
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 212 RK--IVHRDIKPSNLLINS-SKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
           R   I+HRD+K  N+ I   + +VKI D G++ +   +     + +GT  +M+PE     
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYE-- 186

Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
               KYD  + D+++ G+ +LE     +P++   Q             +P    ++A  E
Sbjct: 187 ---EKYD-ESVDVYAFGMCMLEMATSEYPYS-ECQNAAQIYRRVTSGVKPASFDKVAIPE 241

Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            ++ I  C++++   R+    LL H F 
Sbjct: 242 VKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  216 bits (552), Expect = 4e-69
 Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 17/270 (6%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDS--------VRSQICREIEILRD 153
           +    +G G    V R +H PT + +A+K+I      S        +R    +E++ILR 
Sbjct: 6   EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65

Query: 154 VN-HPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLA 207
           V+ HPN+++  D Y+ N    ++ + M  G L   ++ ++  LS      + R +L  + 
Sbjct: 66  VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-DYLTEKVTLSEKETRKIMRALLEVIC 124

Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
            LHK  IVHRD+KP N+L++   N+K+ DFG S  L    +      GT +Y++PE I  
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIEC 183

Query: 268 DLNHG-KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS 326
            +N      G   D+WS GV +     G  PF   +Q     ++ +  +       +  S
Sbjct: 184 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 243

Query: 327 REFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
              +D +SR L   P  R+ A + L HPF 
Sbjct: 244 DTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  217 bits (553), Expect = 2e-68
 Identities = 74/286 (25%), Positives = 126/286 (44%), Gaps = 18/286 (6%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
                +G+G+ G V RV    T   FA K +   HE   +  + +EI+ +  + HP +V 
Sbjct: 29  DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD-KETVRKEIQTMSVLRHPTLVN 87

Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYLHKRKIVH 216
            HD ++ + E+ ++ E+M GG L      + + +S     +  RQV  GL ++H+   VH
Sbjct: 88  LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVH 147

Query: 217 RDIKPSNLLINSSKN--VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKY 274
            D+KP N++  + ++  +K+ DFG++  L           GT  + +PE        GK 
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVA-----EGKP 201

Query: 275 DGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFIS 334
            GY  D+WS+GV       G  PF      +    + +  +     A    S + +DFI 
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261

Query: 335 RCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPLSS 380
           + L  DP++R    Q L+HP++               +P  R    
Sbjct: 262 KLLLADPNTRMTIHQALEHPWL----TPGNAPGRDSQIPSSRYTKI 303

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 3e-68
 Identities = 81/296 (27%), Positives = 133/296 (44%), Gaps = 27/296 (9%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRD 153
             P + + G  +G GS  TV       TSR +A+K++   H  +++    + RE +++  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 154 VNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYL 209
           ++HP  VK +  +  + ++   L Y   G L     +     E        +++S L YL
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA--QTMDPCNSAVGTIAYMSPERINT 267
           H + I+HRD+KP N+L+N   +++I DFG +++L+        NS VGT  Y+SPE +  
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT- 183

Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR 327
                K    + D+W+LG  I +   G  PF   R G+   +   I      + PE    
Sbjct: 184 ----EKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKII-KLEYDFPEKFFP 235

Query: 328 EFRDFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPPPRP 377
           + RD + + L  D   R    +      L  HPF     +S   +NL Q  PP   
Sbjct: 236 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF----ESVTWENLHQQTPPKLT 287

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  216 bits (550), Expect = 6e-68
 Identities = 81/301 (26%), Positives = 138/301 (45%), Gaps = 28/301 (9%)

Query: 92  RHQLINPAELQKGN---------RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRS 142
           +  +  P E+++G+          +GSG+ G V R V   T RVF  K I   +    + 
Sbjct: 13  KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KY 71

Query: 143 QICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----D 197
            +  EI I+  ++HP ++  HD ++   E+ ++LE++ GG L      +++ +S     +
Sbjct: 72  TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 131

Query: 198 LARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKN--VKIADFGVSRILAQTMDPCNSAVG 255
             RQ   GL ++H+  IVH DIKP N++  + K   VKI DFG++  L    +       
Sbjct: 132 YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTA 190

Query: 256 TIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF 315
           T  + +PE ++      +  G+  D+W++GV       G  PFA     +    +    +
Sbjct: 191 TAEFAAPEIVD-----REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW 245

Query: 316 AQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPP 375
               +A    S E +DFI   LQK+P  R      L+HP++        + NL   +P  
Sbjct: 246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL-----KGDHSNLTSRIPSS 300

Query: 376 R 376
           R
Sbjct: 301 R 301

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 1e-66
 Identities = 64/268 (23%), Positives = 117/268 (43%), Gaps = 16/268 (5%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSV-RSQICREIEILRDV 154
           I   ++  G RIGSGS GTV++          A+K++               E+ +LR  
Sbjct: 5   IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61

Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYL 209
            H N++     Y    ++ ++ ++ +G SL       E         D+ARQ   G+ YL
Sbjct: 62  RHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINT 267
           H + I+HRD+K +N+ ++    VKI DFG++ + ++           G+I +M+PE I  
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP--PEAPEMA 325
             +   Y  +  D+++ G+ + E   G+ P++     D    M    +  P   +     
Sbjct: 181 Q-DKNPYS-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238

Query: 326 SREFRDFISRCLQKDPHSRWPAAQLLQH 353
            +  +  ++ CL+K    R    Q+L  
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 7e-66
 Identities = 69/287 (24%), Positives = 120/287 (41%), Gaps = 18/287 (6%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
                +G G  G V R V   + + +  K +     D  +  + +EI IL    H N++ 
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILH 65

Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLSGLAYLHKRKIV 215
            H+ ++   E+ ++ E++ G  +    I        E  +     QV   L +LH   I 
Sbjct: 66  LHESFESMEELVMIFEFISGLDIF-ERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 216 HRDIKPSNLLINSSKN--VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           H DI+P N++  + ++  +KI +FG +R L    D          Y +PE     ++   
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPE-----VHQHD 178

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
               A D+WSLG  +     G  PF           +    +    EA +  S E  DF+
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238

Query: 334 SRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPLSS 380
            R L K+  SR  A++ LQHP++ +  + +V+  + + L   R   +
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQKIE-RVSTKVIRTLKHRRYYHT 284

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 2e-65
 Identities = 72/286 (25%), Positives = 126/286 (44%), Gaps = 27/286 (9%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVI---YGNHEDSVRSQICREIEILRDVNHPNVV 160
              +G GS G V+      T++ FA+K +       +D V   +  +  +     HP + 
Sbjct: 7   HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYLHKRKIV 215
                +     +  ++EY++GG L   HI+  H          A +++ GL +LH + IV
Sbjct: 67  HMFCTFQTKENLFFVMEYLNGGDLM-YHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIV 125

Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           +RD+K  N+L++   ++KIADFG+ +         N+  GT  Y++PE +      G+  
Sbjct: 126 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL-----LGQKY 180

Query: 276 GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISR 335
            ++ D WS GV + E  +G+ PF     G     +F       P  P    +E +D + +
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPF----HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 236

Query: 336 CLQKDPHSRWPAA-QLLQHPFILRAGQSQVNQNL---RQILPPPRP 377
              ++P  R      + QHP        ++N      ++I PP RP
Sbjct: 237 LFVREPEKRLGVRGDIRQHPLF-----REINWEELERKEIDPPFRP 277

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 6e-65
 Identities = 77/287 (26%), Positives = 127/287 (44%), Gaps = 21/287 (7%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-----YGNHEDSVRSQICREIEILRDVNH 156
             G  +GSG    V +     T   +A K I       +     R  I RE+ IL+++ H
Sbjct: 13  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72

Query: 157 PNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKR 212
           PNV+  H++Y+   ++ ++LE + GG L      +    E   ++  +Q+L+G+ YLH  
Sbjct: 73  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 132

Query: 213 KIVHRDIKPSNLLINS----SKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
           +I H D+KP N+++         +KI DFG++  +    +   +  GT  +++PE +N  
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVN-- 189

Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
               +  G   D+WS+GV       G  PF    + +  + + A+ +    E     S  
Sbjct: 190 ---YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246

Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPP 375
            +DFI R L KDP  R      LQHP+I      Q          P 
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS--SAWSHPQ 291

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 2e-63
 Identities = 58/266 (21%), Positives = 106/266 (39%), Gaps = 24/266 (9%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           +N  EL+    IG G  G V    +       A+K I     D+       E  ++  + 
Sbjct: 4   LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI---KNDATAQAFLAEASVMTQLR 58

Query: 156 HPNVVKCHD-MYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAY 208
           H N+V+    + +  G + ++ EYM  GSL       G  +     L   +  V   + Y
Sbjct: 59  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118

Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
           L     VHRD+   N+L++     K++DFG+++  + T D   +    + + +PE +   
Sbjct: 119 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKLPVKWTAPEALRE- 174

Query: 269 LNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR 327
               K+     D+WS G+ + E +  GR P+    +     ++  +      +AP+    
Sbjct: 175 ---KKFS-TKSDVWSFGILLWEIYSFGRVPYP---RIPLKDVVPRVEKGYKMDAPDGCPP 227

Query: 328 EFRDFISRCLQKDPHSRWPAAQLLQH 353
              + +  C   D   R    QL + 
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 2e-63
 Identities = 61/265 (23%), Positives = 111/265 (41%), Gaps = 16/265 (6%)

Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDV 154
           +I+P+EL     IGSG  G V         +V A+K I              E E++  +
Sbjct: 1   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTI--REGAMSEEDFIEEAEVMMKL 57

Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLSGLAYL 209
           +HP +V+ + +      I ++ E+M+ G L      Q        L  +   V  G+AYL
Sbjct: 58  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ-TMDPCNSAVGTIAYMSPERINTD 268
            +  ++HRD+   N L+  ++ +K++DFG++R +              + + SPE     
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV---- 173

Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
            +  +Y     D+WS GV + E +         R    + ++  I        P +AS  
Sbjct: 174 FSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVEDISTGFRLYKPRLASTH 230

Query: 329 FRDFISRCLQKDPHSRWPAAQLLQH 353
               ++ C ++ P  R   ++LL+ 
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 2e-62
 Identities = 58/265 (21%), Positives = 107/265 (40%), Gaps = 18/265 (6%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           I+P +L     +G+G  G V            A+K+I          +   E +++ +++
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMI--KEGSMSEDEFIEEAKVMMNLS 57

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYLH 210
           H  +V+ + +  +   I ++ EYM  G L        H        ++ + V   + YL 
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 211 KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ-TMDPCNSAVGTIAYMSPERINTDL 269
            ++ +HRD+   N L+N    VK++DFG+SR +          +   + +  PE     L
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV----L 173

Query: 270 NHGKYDGYAGDIWSLGVSILEFY-LGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
            + K+     DIW+ GV + E Y LG+ P+    +   +     I        P +AS +
Sbjct: 174 MYSKFS-SKSDIWAFGVLMWEIYSLGKMPYE---RFTNSETAEHIAQGLRLYRPHLASEK 229

Query: 329 FRDFISRCLQKDPHSRWPAAQLLQH 353
               +  C  +    R     LL +
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSN 254

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 2e-62
 Identities = 64/268 (23%), Positives = 114/268 (42%), Gaps = 29/268 (10%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-----YGNHEDSVRSQICREIEILRDVN- 155
           Q G  +GSG  G+V+  +    +   A+K +         E    +++  E+ +L+ V+ 
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66

Query: 156 -HPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYL 209
               V++  D ++R     ++LE  +        I +   L          QVL  + + 
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126

Query: 210 HKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTD 268
           H   ++HRDIK  N+LI+ ++  +K+ DFG   +L  T+       GT  Y  PE I   
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIR-- 182

Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
             + +Y G +  +WSLG+ + +   G  PF    + D   +   + F       +  S E
Sbjct: 183 --YHRYHGRSAAVWSLGILLYDMVCGDIPF----EHDEEIIRGQVFF------RQRVSSE 230

Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            +  I  CL   P  R    ++  HP++
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  201 bits (511), Expect = 6e-62
 Identities = 63/290 (21%), Positives = 123/290 (42%), Gaps = 23/290 (7%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-----YGNHEDSVRSQICREIEILRDVNH 156
                IG G  G V+      T +++A+K +          +++       + ++   + 
Sbjct: 7   SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66

Query: 157 PNVVKCHDMYDRNGEIEVLLEYMDGGSLEGA----HIRQEHILSDLARQVLSGLAYLHKR 212
           P +V     +    ++  +L+ M+GG L        +  E  +   A +++ GL ++H R
Sbjct: 67  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 126

Query: 213 KIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
            +V+RD+KP+N+L++   +V+I+D G++   ++     +  VGT  YM+PE +      G
Sbjct: 127 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVL----QKG 180

Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDF 332
                + D +SLG  + +   G  PF    +      +  +      E P+  S E R  
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 239

Query: 333 ISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           +   LQ+D + R       A ++ + PF            L++  PP  P
Sbjct: 240 LEGLLQRDVNRRLGCLGRGAQEVKESPFF--RSLDWQMVFLQKYPPPLIP 287

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  199 bits (506), Expect = 1e-61
 Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 31/292 (10%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           + Q    +G+GS G V  +      R +A+KV+                E  +L  V HP
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64

Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLE----GAHIRQEHILSDLARQVLSGLAYLHKRK 213
            +++    +    +I ++++Y++GG L      +      +    A +V   L YLH + 
Sbjct: 65  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           I++RD+KP N+L++ + ++KI DFG ++ +    D   +  GT  Y++PE ++T      
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPDYIAPEVVST----KP 177

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
           Y+  + D WS G+ I E   G  PF            +          P   + + +D +
Sbjct: 178 YN-KSIDWWSFGILIYEMLAGYTPF----YDSNTMKTYEKILNAELRFPPFFNEDVKDLL 232

Query: 334 SRCLQKDPHSRWP-----AAQLLQHPFILRAGQSQVNQN---LRQILPPPRP 377
           SR + +D   R          +  HP+       +V       R I  P  P
Sbjct: 233 SRLITRDLSQRLGNLQNGTEDVKNHPWF-----KEVVWEKLLSRNIETPYEP 279

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 3e-61
 Identities = 66/284 (23%), Positives = 119/284 (41%), Gaps = 36/284 (12%)

Query: 105 NRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH----EDSVRSQICREIEILRDVNHPNVV 160
           + +G G   TV++     T+++ A+K I   H    +D +     REI++L++++HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSL----EGAHIRQEHILSDLARQVLSGLAYLHKRKIVH 216
              D +     I ++ ++M+        + + +     +       L GL YLH+  I+H
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123

Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KP+NLL++ +  +K+ADFG+++            V T  Y +PE     L   +  G
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL----LFGARMYG 179

Query: 277 YAGDIWSLGVSILEFYLGRFPFA-------------------VGRQGDWASLMFAICFAQ 317
              D+W++G  + E  L                           +  D  SL   + F  
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 318 PPEAP-----EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
            P  P       A  +  D I      +P +R  A Q L+  + 
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 1e-60
 Identities = 74/289 (25%), Positives = 125/289 (43%), Gaps = 22/289 (7%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHP 157
           +      +G G+ G V  V    T R +A+K++           +    E  +L++  HP
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 158 NVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRK 213
            +      +  +  +  ++EY +GG L     R+    E        +++S L YLH R 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           +V+RDIK  NL+++   ++KI DFG+ +          +  GT  Y++PE +        
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL-----EDN 180

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
             G A D W LGV + E   GR PF           +F +   +    P   S E +  +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELILMEEIRFPRTLSPEAKSLL 236

Query: 334 SRCLQKDPHSRWP-----AAQLLQHPFILRAGQSQVNQNLRQILPPPRP 377
           +  L+KDP  R       A ++++H F L      V Q  +++LPP +P
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ--KKLLPPFKP 283

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 1e-60
 Identities = 59/265 (22%), Positives = 118/265 (44%), Gaps = 23/265 (8%)

Query: 105 NRIGSGSGGTVWRVVHP--PTSRVFALKVIYGNHED-SVRSQICREIEILRDVNHPNVVK 161
             +GSG+ GTV +  +      +  A+K++     D +++ ++  E  +++ +++P +V+
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHI----LSDLARQVLSGLAYLHKRKIVHR 217
              + +    + V+ E  + G L     +  H+    + +L  QV  G+ YL +   VHR
Sbjct: 73  MIGICEAESWMLVM-EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131

Query: 218 DIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS---AVGTIAYMSPERINTDLNHGKY 274
           D+   N+L+ +    KI+DFG+S+ L    +   +       + + +PE IN        
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN-----YYK 186

Query: 275 DGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI 333
                D+WS GV + E F  G+ P+   R    + +   +   +    P    RE  D +
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPY---RGMKGSEVTAMLEKGERMGCPAGCPREMYDLM 243

Query: 334 SRCLQKDPHSRWPAAQL---LQHPF 355
           + C   D  +R   A +   L++ +
Sbjct: 244 NLCWTYDVENRPGFAAVELRLRNYY 268

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 1e-60
 Identities = 61/300 (20%), Positives = 124/300 (41%), Gaps = 22/300 (7%)

Query: 94  QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKV----IYGNHEDSVRSQICREIE 149
           +++   E +K   +GSG+ GTV++ +  P      + V    +          +I  E  
Sbjct: 4   RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63

Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLS 204
           ++  V++P+V +          ++++ + M  G L               L +   Q+  
Sbjct: 64  VMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122

Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS--AVGTIAYMSP 262
           G+ YL  R++VHRD+   N+L+ + ++VKI DFG++++L       ++      I +M+ 
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 263 ERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEA 321
           E     + H  Y  +  D+WS GV++ E    G  P+        + +   +   +    
Sbjct: 183 E----SILHRIYT-HQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGERLPQ 234

Query: 322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHP-FILRAGQSQVNQNLRQILPPPRPLSS 380
           P + + +    + +C   D  SR    +L+     + R  Q  +     + +  P P  S
Sbjct: 235 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 294

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  195 bits (496), Expect = 2e-60
 Identities = 65/291 (22%), Positives = 119/291 (40%), Gaps = 29/291 (9%)

Query: 90  QNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSR---VFALKVIYGNHEDSVRSQICR 146
           +   + I+ + ++    IG+G  G V         +     A+K +   + +  R     
Sbjct: 17  REFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLS 76

Query: 147 EIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQ 201
           E  I+   +HPNV+    +  ++  + ++ E+M+ GSL+    +         L  + R 
Sbjct: 77  EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 136

Query: 202 VLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA-----QTMDPCNSAVGT 256
           + +G+ YL     VHRD+   N+L+NS+   K++DFG+SR L       T          
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196

Query: 257 IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICF 315
           I + +P      + + K+   A D+WS G+ + E    G  P+      D   ++ AI  
Sbjct: 197 IRWTAP----EAIQYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQD---VINAIEQ 248

Query: 316 AQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQ-------LLQHPFILRA 359
                 P          +  C QKD + R    Q       ++++P  L+A
Sbjct: 249 DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKA 299

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 3e-60
 Identities = 60/271 (22%), Positives = 112/271 (41%), Gaps = 23/271 (8%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           +    L+   R+G+G  G VW   +       A+K +              E  +++ + 
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQ 66

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLSGLAYL 209
           H  +V+ + +      I ++ EYM+ GSL              + L D+A Q+  G+A++
Sbjct: 67  HQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT-MDPCNSAVGTIAYMSPERINTD 268
            +R  +HRD++ +N+L++ + + KIADFG++R++          A   I + +PE IN  
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY- 184

Query: 269 LNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR 327
                      D+WS G+ + E    GR P+          ++  +        P+    
Sbjct: 185 ----GTFTIKSDVWSFGILLTEIVTHGRIPY---PGMTNPEVIQNLERGYRMVRPDNCPE 237

Query: 328 EFRDFISRCLQKDPHSRWPAAQL---LQHPF 355
           E    +  C ++ P  R     L   L+  F
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 9e-60
 Identities = 83/306 (27%), Positives = 128/306 (41%), Gaps = 44/306 (14%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVI-YGNHEDSVRSQICREIEILRDVNHPNVV 160
           QK  +IG G+ G V++  +  T  V ALK I      + V S   REI +L+++NHPN+V
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD-----LARQVLSGLAYLHKRKIV 215
           K  D+     ++ ++ E++     +         +          Q+L GLA+ H  +++
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124

Query: 216 HRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYD 275
           HRD+KP NLLIN+   +K+ADFG++R     +      V T+ Y +PE     L   KY 
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI----LLGCKYY 180

Query: 276 GYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP---------------- 319
             A DIWSLG    E    R  F    + D    +F                        
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240

Query: 320 ---------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQ 370
                    +       + R  +S+ L  DP+ R  A   L HPF          Q++ +
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF---------QDVTK 291

Query: 371 ILPPPR 376
            +P  R
Sbjct: 292 PVPHLR 297

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 2e-59
 Identities = 66/283 (23%), Positives = 118/283 (41%), Gaps = 21/283 (7%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           I    L+   ++G G  G VW      T+RV A+K +             +E ++++ + 
Sbjct: 14  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL--KPGTMSPEAFLQEAQVMKKLR 70

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYL 209
           H  +V+ + +      I ++ EYM  GSL      E     +   L D+A Q+ SG+AY+
Sbjct: 71  HEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT-MDPCNSAVGTIAYMSPERINTD 268
            +   VHRD++ +N+L+  +   K+ADFG++R++          A   I + +P      
Sbjct: 130 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP----EA 185

Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
             +G++     D+WS G+ + E          G       ++  +        P      
Sbjct: 186 ALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVERGYRMPCPPECPES 242

Query: 329 FRDFISRCLQKDPHSRWPAAQL---LQHPFILRAGQSQVNQNL 368
             D + +C +K+P  R     L   L+  F     Q Q  +NL
Sbjct: 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 285

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 3e-59
 Identities = 60/297 (20%), Positives = 119/297 (40%), Gaps = 33/297 (11%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTS----RVFALKVIYGNHEDSVRSQICREIEIL 151
           I+P+ + +   IG+G  G V++ +   +S       A+K +   + +  R     E  I+
Sbjct: 4   IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63

Query: 152 RDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGL 206
              +H N+++   +  +   + ++ EYM+ G+L+     ++   S      + R + +G+
Sbjct: 64  GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123

Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS---AVGTIAYMSPE 263
            YL     VHRD+   N+L+NS+   K++DFG+SR+L    +   +       I + +PE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 264 RINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE 323
            I+             D+WS G+ + E                  +M AI        P 
Sbjct: 184 AISYRKFTSA-----SDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAINDGFRLPTPM 236

Query: 324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPLSS 380
                    + +C Q++   R   A ++                L +++  P  L +
Sbjct: 237 DCPSAIYQLMMQCWQQERARRPKFADIVSI--------------LDKLIRAPDSLKT 279

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  191 bits (486), Expect = 3e-59
 Identities = 75/285 (26%), Positives = 121/285 (42%), Gaps = 35/285 (12%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED-SVRSQICREIEILRDVNHPNVV 160
               +IG G+ G V++  +      FALK I    ED  + S   REI IL+++ H N+V
Sbjct: 5   HGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKIVH 216
           K +D+      + ++ E++D    +   + +             Q+L+G+AY H R+++H
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123

Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KP NLLIN    +KIADFG++R     +      + T+ Y +P+     L   K   
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD----VLMGSKKYS 179

Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA--------------- 321
              DIWS+G    E   G   F    + D    +F I      +                
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239

Query: 322 ----------PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                      +       D +S+ L+ DP+ R  A Q L+H + 
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  190 bits (484), Expect = 7e-59
 Identities = 60/264 (22%), Positives = 113/264 (42%), Gaps = 16/264 (6%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN 155
           +   ++   +++G G  G V+  V    S   A+K +    +     +  +E  +++++ 
Sbjct: 14  MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIK 71

Query: 156 HPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------EHILSDLARQVLSGLAYL 209
           HPN+V+   +  R     ++ E+M  G+L               +L  +A Q+ S + YL
Sbjct: 72  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131

Query: 210 HKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ-TMDPCNSAVGTIAYMSPERINTD 268
            K+  +HRD+   N L+  +  VK+ADFG+SR++   T      A   I + +P      
Sbjct: 132 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP----ES 187

Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
           L + K+     D+W+ GV + E          G   D + +   +      E PE    +
Sbjct: 188 LAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPEGCPEK 244

Query: 329 FRDFISRCLQKDPHSRWPAAQLLQ 352
             + +  C Q +P  R   A++ Q
Sbjct: 245 VYELMRACWQWNPSDRPSFAEIHQ 268

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 1e-58
 Identities = 66/273 (24%), Positives = 118/273 (43%), Gaps = 30/273 (10%)

Query: 107 IGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEIL-RDVNHPNVVKCHDM 165
           +G G  G V ++ +  T   FALK++          +  RE+E+  R    P++V+  D+
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKML------QDCPKARREVELHWRASQCPHIVRIVDV 73

Query: 166 YD----RNGEIEVLLEYMDGGSL------EGAHIRQEHILSDLARQVLSGLAYLHKRKIV 215
           Y+        + +++E +DGG L       G     E   S++ + +   + YLH   I 
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 133

Query: 216 HRDIKPSNLLINSSKN---VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHG 272
           HRD+KP NLL  S +    +K+ DFG ++    + +   +   T  Y++PE +       
Sbjct: 134 HRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPYYVAPEVLG-----P 187

Query: 273 KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC----FAQPPEAPEMASRE 328
           +    + D+WSLGV +     G  PF        +  M        +  P       S E
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247

Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ 361
            +  I   L+ +P  R    + + HP+I+++ +
Sbjct: 248 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 1e-58
 Identities = 66/300 (22%), Positives = 117/300 (39%), Gaps = 49/300 (16%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIY-GNHEDSVRSQICREIEILRDVNHPNVV 160
           +K  +IG G+ G V++  H  T +  ALK +   N ++       REI+IL+ + H NVV
Sbjct: 13  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72

Query: 161 KCHDMY--------DRNGEIEVLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLAY 208
              ++            G I ++ ++ +                     + + +L+GL Y
Sbjct: 73  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 132

Query: 209 LHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT----MDPCNSAVGTIAYMSPER 264
           +H+ KI+HRD+K +N+LI     +K+ADFG++R  +       +   + V T+ Y  PE 
Sbjct: 133 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192

Query: 265 INTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA--- 321
           +  +    +  G   D+W  G  + E +          +    +L+  +C +  PE    
Sbjct: 193 LLGE----RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 322 -------------------------PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                                      +      D I + L  DP  R  +   L H F 
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 2e-58
 Identities = 64/267 (23%), Positives = 112/267 (41%), Gaps = 17/267 (6%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSR---VFALKVIYGNHEDSVRSQICREIEILR 152
           I    ++ G  IG G  G V + ++          A+K       DSVR +  +E   +R
Sbjct: 4   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63

Query: 153 DVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLA 207
             +HP++VK   +   N  + +++E    G L      +++ L        A Q+ + LA
Sbjct: 64  QFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122

Query: 208 YLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL-AQTMDPCNSAVGTIAYMSPERIN 266
           YL  ++ VHRDI   N+L++S+  VK+ DFG+SR +   T    +     I +M+PE   
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES-- 180

Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMAS 326
             +N  ++   + D+W  GV + E  +       G       ++  I   +    P    
Sbjct: 181 --INFRRFTSAS-DVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIENGERLPMPPNCP 235

Query: 327 REFRDFISRCLQKDPHSRWPAAQLLQH 353
                 +++C   DP  R    +L   
Sbjct: 236 PTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 3e-58
 Identities = 58/271 (21%), Positives = 117/271 (43%), Gaps = 23/271 (8%)

Query: 107 IGSGSGGTVWRVVHPPTSR--VFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHD 164
           +G G+ G+V + V+    +    A+KV+    E +   ++ RE +I+  +++P +V+   
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 165 MYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYLHKRKIVHRDI 219
           +      + +++E   GG L    + +   +      +L  QV  G+ YL ++  VHRD+
Sbjct: 77  VCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 135

Query: 220 KPSNLLINSSKNVKIADFGVSRILA---QTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
              N+L+ +    KI+DFG+S+ L          ++    + + +PE IN      +   
Sbjct: 136 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN-----FRKFS 190

Query: 277 YAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISR 335
              D+WS GV++ E    G+ P+   ++     +M  I   +  E P     E    +S 
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPY---KKMKGPEVMAFIEQGKRMECPPECPPELYALMSD 247

Query: 336 CLQKDPHSRWPAAQL---LQHPFILRAGQSQ 363
           C       R     +   ++  +   A + +
Sbjct: 248 CWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  188 bits (478), Expect = 4e-58
 Identities = 63/273 (23%), Positives = 116/273 (42%), Gaps = 19/273 (6%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNV 159
           + G  +G G    V         R  A+KV+  +   + S   +  RE +    +NHP +
Sbjct: 10  ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69

Query: 160 VKCHDMY----DRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHK 211
           V  +D             +++EY+DG +L      +         ++       L + H+
Sbjct: 70  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 129

Query: 212 RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP---CNSAVGTIAYMSPERINTD 268
             I+HRD+KP+N++I+++  VK+ DFG++R +A + +      + +GT  Y+SPE+    
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG- 188

Query: 269 LNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE 328
                 D  + D++SLG  + E   G  PF        A          P    E  S +
Sbjct: 189 ---DSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244

Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPFI-LRAG 360
               + + L K+P +R+  A  ++   + +  G
Sbjct: 245 LDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 277

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (482), Expect = 7e-58
 Identities = 71/293 (24%), Positives = 116/293 (39%), Gaps = 43/293 (14%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
              + IG G+ G V            A+K I      +   +  REI+IL    H N++ 
Sbjct: 11  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 70

Query: 162 CHDMYD----RNGEIEVLLEYMDGGS----LEGAHIRQEHILSDLARQVLSGLAYLHKRK 213
            +D+         +   L+ ++ G      L+  H+  +HI      Q+L GL Y+H   
Sbjct: 71  INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHIC-YFLYQILRGLKYIHSAN 129

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQ---TMDPCNSAVGTIAYMSPERINTDLN 270
           ++HRD+KPSNLL+N++ ++KI DFG++R+              V T  Y +PE     + 
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI----ML 185

Query: 271 HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM------ 324
           + K    + DIWS+G  + E    R  F      D  + +  I  +   E          
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245

Query: 325 ---------------------ASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                                A  +  D + + L  +PH R    Q L HP++
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 4e-57
 Identities = 74/286 (25%), Positives = 126/286 (44%), Gaps = 35/286 (12%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED-SVRSQICREIEILRDVNHPNVV 160
           +K  +IG G+ GTV++  +  T  + ALK +  + +D  V S   REI +L+++ H N+V
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKIVH 216
           + HD+   + ++ ++ E+ D    +            I+     Q+L GL + H R ++H
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLH 124

Query: 217 RDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDG 276
           RD+KP NLLIN +  +K+A+FG++R     +   ++ V T+ Y  P+     L   K   
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD----VLFGAKLYS 180

Query: 277 YAGDIWSLGVSILEFYLGRFPFAVGR-----------------QGDWASLMFAICFAQPP 319
            + D+WS G    E      P   G                  +  W S+     +   P
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 320 EAPEM---------ASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
             P            +   RD +   L+ +P  R  A + LQHP+ 
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 5e-57
 Identities = 64/304 (21%), Positives = 118/304 (38%), Gaps = 34/304 (11%)

Query: 92  RHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF--ALKVIYGNHEDSVRSQICREIE 149
            + +++  +++  + IG G+ G V +            A+K +              E+E
Sbjct: 3   IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 62

Query: 150 ILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS------------ 196
           +L  + +HPN++      +  G + + +EY   G+L    +R+  +L             
Sbjct: 63  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL-DFLRKSRVLETDPAFAIANSTA 121

Query: 197 ---------DLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM 247
                      A  V  G+ YL +++ +HRD+   N+L+  +   KIADFG+SR   +  
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVY 180

Query: 248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWA 307
                    + +M+ E +N             D+WS GV + E          G     A
Sbjct: 181 VKKTMGRLPVRWMAIESLN-----YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCA 233

Query: 308 SLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH-PFILRAGQSQVNQ 366
            L   +      E P     E  D + +C ++ P+ R   AQ+L     +L   ++ VN 
Sbjct: 234 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 293

Query: 367 NLRQ 370
            L +
Sbjct: 294 TLYE 297

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 6e-57
 Identities = 65/294 (22%), Positives = 108/294 (36%), Gaps = 43/294 (14%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSR-----VFALKVIYGNHEDSVRSQICREIEI 150
                L+ G  +GSG+ G V        S+       A+K++    + S R  +  E+++
Sbjct: 34  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 93

Query: 151 LRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSL------------------------- 184
           +  + +H N+V        +G I ++ EY   G L                         
Sbjct: 94  MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 185 --EGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI 242
             E  ++     L   A QV  G+ +L  +  VHRD+   N+L+   K VKI DFG++R 
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 243 LA--QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFA 299
           +          +A   + +M+PE +              D+WS G+ + E F LG  P+ 
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLF-----EGIYTIKSDVWSYGILLWEIFSLGVNPYP 268

Query: 300 VGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
                  A+    I      + P  A+ E    +  C   D   R     L   
Sbjct: 269 --GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-56
 Identities = 63/274 (22%), Positives = 111/274 (40%), Gaps = 24/274 (8%)

Query: 95  LINPAELQKGNRIGSGSGGTVWRVVHPPTS---RVFALKVIYGNH--EDSVRSQICREIE 149
           LI   +L+   ++G GS G V R      S      A+K +  +   +        RE+ 
Sbjct: 4   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63

Query: 150 ILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQVLS 204
            +  ++H N+++ + +      ++++ E    GSL     +         LS  A QV  
Sbjct: 64  AMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122

Query: 205 GLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP---CNSAVGTIAYMS 261
           G+ YL  ++ +HRD+   NLL+ +   VKI DFG+ R L Q  D            A+ +
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182

Query: 262 PERINTDLNHGKYDGYAGDIWSLGVSILE-FYLGRFPFAVGRQGDWASLMFAICFAQP-P 319
           PE +       +   +A D W  GV++ E F  G+ P+      + + ++  I       
Sbjct: 183 PESLK-----TRTFSHASDTWMFGVTLWEMFTYGQEPWI---GLNGSQILHKIDKEGERL 234

Query: 320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
             PE   ++  + + +C    P  R     L   
Sbjct: 235 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (461), Expect = 3e-55
 Identities = 73/293 (24%), Positives = 117/293 (39%), Gaps = 44/293 (15%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTS-RVFALKVI-YGNHEDSVRSQICREIEILR---DVNH 156
           +    IG G+ G V++        R  ALK +     E+ +     RE+ +LR      H
Sbjct: 10  ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69

Query: 157 PNVVKCHDMY-----DRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGL 206
           PNVV+  D+      DR  ++ ++ E++D           E  +      D+  Q+L GL
Sbjct: 70  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129

Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN 266
            +LH  ++VHRD+KP N+L+ SS  +K+ADFG++RI         S V T+ Y +PE + 
Sbjct: 130 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPEVLL 188

Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA----- 321
                  Y     D+WS+G    E +  +  F      D    +  +      E      
Sbjct: 189 Q----SSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243

Query: 322 ------------------PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                                     +D + +CL  +P  R  A   L HP+ 
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  180 bits (458), Expect = 6e-55
 Identities = 57/277 (20%), Positives = 99/277 (35%), Gaps = 30/277 (10%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
           + G +IGSGS G ++           A+K+       +   Q+  E +I + +     + 
Sbjct: 10  RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE---CVKTKHPQLHIESKIYKMMQGGVGIP 66

Query: 162 CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLARQVLSGLAYLHKRKIVH 216
                   G+  V++  + G SLE          S      LA Q++S + Y+H +  +H
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126

Query: 217 RDIKPSNLLINSS---KNVKIADFGVSRILAQT-------MDPCNSAVGTIAYMSPERIN 266
           RD+KP N L+        V I DFG+++                 +  GT  Y S     
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 267 TDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ----PPEAP 322
                G       D+ SLG  ++ F LG  P+   +          I   +         
Sbjct: 187 -----GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241

Query: 323 EMASREFRDFISRCLQKDPHSRWPAA---QLLQHPFI 356
           +    EF  +++ C       +   +   QL ++ F 
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 1e-54
 Identities = 74/317 (23%), Positives = 138/317 (43%), Gaps = 27/317 (8%)

Query: 79  QQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVH---PPTSRVFALKVI--- 132
            + +      H  +   +     +    +G+G+ G V+ V       T +++A+KV+   
Sbjct: 7   HELRTANLTGHAEK---VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA 63

Query: 133 YGNHEDSVRSQICREIEILRDVNH-PNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ 191
               +         E ++L  +   P +V  H  +    ++ ++L+Y++GG L   H+ Q
Sbjct: 64  TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL-FTHLSQ 122

Query: 192 EHILSDL-----ARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL-AQ 245
               ++        +++  L +LHK  I++RDIK  N+L++S+ +V + DFG+S+   A 
Sbjct: 123 RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182

Query: 246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD 305
             +      GTI YM+P+ +            A D WSLGV + E   G  PF V  + +
Sbjct: 183 ETERAYDFCGTIEYMAPDIV---RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239

Query: 306 WASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWP-----AAQLLQHPFILRAG 360
             + +        P  P+  S   +D I R L KDP  R       A ++ +H F  +  
Sbjct: 240 SQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299

Query: 361 QSQVNQNLRQILPPPRP 377
              +    +++  P +P
Sbjct: 300 WDDLAA--KKVPAPFKP 314

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 1e-54
 Identities = 61/277 (22%), Positives = 106/277 (38%), Gaps = 22/277 (7%)

Query: 92  RHQLINPAEL--QKGNRIGSGSGGTVWRVVHPPTSR---VFALKVIYGNHEDSVRSQICR 146
           +H +I P+ L       IG G  G V+              A+K +    +    SQ   
Sbjct: 18  QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT 77

Query: 147 EIEILRDVNHPNVVKCHDM-YDRNGEIEVLLEYMDGGSLEGAHIRQEHILS-----DLAR 200
           E  I++D +HPNV+    +     G   V+L YM  G L      + H  +         
Sbjct: 78  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 137

Query: 201 QVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL----AQTMDPCNSAVGT 256
           QV  G+ +L  +K VHRD+   N +++    VK+ADFG++R +      ++     A   
Sbjct: 138 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197

Query: 257 IAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA 316
           + +M+ E + T     +      D+WS GV + E      P       +   +   +   
Sbjct: 198 VKWMALESLQT-----QKFTTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLLQG 250

Query: 317 QPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
           +    PE       + + +C       R   ++L+  
Sbjct: 251 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  179 bits (455), Expect = 2e-54
 Identities = 66/288 (22%), Positives = 113/288 (39%), Gaps = 42/288 (14%)

Query: 100 ELQKGNRIGSGSGGTVWRVVHP-----PTSRVFALKVIYGNHEDSVRSQICREIEILRDV 154
            ++    IG G+ G V++   P         + A+K++       +++   RE  ++ + 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73

Query: 155 NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLE----------------------------G 186
           ++PN+VK   +      + +L EYM  G L                             G
Sbjct: 74  DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 187 AHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL--A 244
                      +ARQV +G+AYL +RK VHRD+   N L+  +  VKIADFG+SR +  A
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193

Query: 245 QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG 304
                  +    I +M PE I  +    +Y     D+W+ GV + E +        G   
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYN----RYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH 248

Query: 305 DWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
           +   +++ +        PE    E  + +  C  K P  R     + +
Sbjct: 249 EE--VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  179 bits (455), Expect = 8e-54
 Identities = 71/329 (21%), Positives = 128/329 (38%), Gaps = 25/329 (7%)

Query: 60  SNSSSSSGQSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVV 119
           + +++  G           + +++  +             +  +   +G+GS G V  V 
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61

Query: 120 HPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE 177
           H  +   +A+K++      +         E  IL+ VN P +VK    +  N  + +++E
Sbjct: 62  HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121

Query: 178 YMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVK 233
           Y+ GG +     R     E      A Q++    YLH   +++RD+KP NLLI+    ++
Sbjct: 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181

Query: 234 IADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL 293
           + DFG ++   +      +  GT   ++PE I       K    A D W+LGV I E   
Sbjct: 182 VTDFGFAK---RVKGRTWTLCGTPEALAPEII-----LSKGYNKAVDWWALGVLIYEMAA 233

Query: 294 GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWP-----AA 348
           G  PF      D    ++    +     P   S + +D +   LQ D   R+        
Sbjct: 234 GYPPF----FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVN 289

Query: 349 QLLQHPFILRAGQSQVNQNLRQILPPPRP 377
            +  H +        + Q  R++  P  P
Sbjct: 290 DIKNHKWFATTDWIAIYQ--RKVEAPFIP 316

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 6e-53
 Identities = 70/315 (22%), Positives = 120/315 (38%), Gaps = 51/315 (16%)

Query: 78  HQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE 137
           ++Q+  +T    +  ++ +          +GSG+ G V   V   T    A+K +Y   +
Sbjct: 5   YRQEVTKTAWEVRAVYRDLQ--------PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ 56

Query: 138 D-SVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----- 191
                 +  RE+ +L+ + H NV+   D++  +  ++   ++       G  + +     
Sbjct: 57  SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE 116

Query: 192 ---EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD 248
              E  +  L  Q+L GL Y+H   I+HRD+KP NL +N    +KI DFG++R     M 
Sbjct: 117 KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM- 175

Query: 249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWAS 308
                V T  Y +PE I     +        DIWS+G  + E   G+  F      D   
Sbjct: 176 --TGYVVTRWYRAPEVI----LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 229

Query: 309 LMFAICFAQPPEAPEM---------------------------ASREFRDFISRCLQKDP 341
            +  +    P E  +                            AS    + + + L  D 
Sbjct: 230 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 289

Query: 342 HSRWPAAQLLQHPFI 356
             R  A + L HP+ 
Sbjct: 290 EQRVTAGEALAHPYF 304

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 1e-52
 Identities = 63/287 (21%), Positives = 106/287 (36%), Gaps = 36/287 (12%)

Query: 96  INPAELQKGNRIGSGSGGTVWRV-----VHPPTSRVFALKVIYGNHEDSVRSQICREIEI 150
                L  G  +G+G+ G V        +    +   A+K++  +   + R  +  E+++
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79

Query: 151 LRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ------------------ 191
           L  + NH N+V         G   V+ EY   G L     R+                  
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 192 ----EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA--Q 245
                  L   + QV  G+A+L  +  +HRD+   N+L+   +  KI DFG++R +    
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD 305
                 +A   + +M+PE I           +  D+WS G+ + E +        G   D
Sbjct: 200 NYVVKGNARLPVKWMAPESI-----FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254

Query: 306 WASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
                  I       +PE A  E  D +  C   DP  R    Q++Q
Sbjct: 255 SK-FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (443), Expect = 2e-52
 Identities = 55/279 (19%), Positives = 106/279 (37%), Gaps = 28/279 (10%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHP-----PTSRVFALKVIYGNHEDSVRSQICREIEI 150
           +   ++     +G GS G V+  V             A+K +        R +   E  +
Sbjct: 17  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76

Query: 151 LRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSD------------- 197
           +++ N  +VV+   +  +     V++E M  G L+         +++             
Sbjct: 77  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 198 -LARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL--AQTMDPCNSAV 254
            +A ++  G+AYL+  K VHRD+   N ++     VKI DFG++R +            +
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC 314
             + +MSPE     L  G +  Y  D+WS GV + E          G   +   ++  + 
Sbjct: 197 LPVRWMSPE----SLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQ--VLRFVM 249

Query: 315 FAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
                + P+       + +  C Q +P  R    +++  
Sbjct: 250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-52
 Identities = 67/294 (22%), Positives = 112/294 (38%), Gaps = 49/294 (16%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
                IG+GS G V++     +  + A+K +  +          RE++I+R ++H N+V+
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVR 77

Query: 162 CHDMYDRNGE------IEVLLEYMDGGSLEGA--HIRQEHILS-----DLARQVLSGLAY 208
               +  +GE      + ++L+Y+       A  + R +  L          Q+   LAY
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 209 LHKRKIVHRDIKPSNLLINSSKNV-KIADFGVSRILAQTMDPCNSAVGTIAYMSPERINT 267
           +H   I HRDIKP NLL++    V K+ DFG ++ L +  +P  S + +  Y +PE I  
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIF- 195

Query: 268 DLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA------ 321
                     + D+WS G  + E  LG+  F      D    +  +      E       
Sbjct: 196 ---GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252

Query: 322 -------------------PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI 356
                                    E     SR L+  P +R    +   H F 
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  174 bits (442), Expect = 4e-52
 Identities = 58/327 (17%), Positives = 131/327 (40%), Gaps = 50/327 (15%)

Query: 68  QSTSHQNHHPHQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVF 127
           ++  + + + H+ ++     +H    +  N  + Q   ++G G    V+  ++   +   
Sbjct: 6   RARVYTDVNTHRPREYWDYESHVV--EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 63

Query: 128 ALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMY--DRNGEIEVLLEYMDGGSL 184
            +K++    +   + +I REI+IL ++   PN++   D+     +    ++ E+++    
Sbjct: 64  VVKIL----KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 119

Query: 185 EGAHIR-QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS-KNVKIADFGVSRI 242
           +  +    ++ +     ++L  L Y H   I+HRD+KP N++I+   + +++ D+G++  
Sbjct: 120 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179

Query: 243 LAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGR 302
                   N  V +  +  PE +       +   Y+ D+WSLG  +      + PF  G 
Sbjct: 180 Y-HPGQEYNVRVASRYFKGPELLVDY----QMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234

Query: 303 -QGDWASLMFAICFAQ---------------------------------PPEAPEMASRE 328
              D    +  +   +                                   E   + S E
Sbjct: 235 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 294

Query: 329 FRDFISRCLQKDPHSRWPAAQLLQHPF 355
             DF+ + L+ D  SR  A + ++HP+
Sbjct: 295 ALDFLDKLLRYDHQSRLTAREAMEHPY 321

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 3e-50
 Identities = 59/289 (20%), Positives = 110/289 (38%), Gaps = 39/289 (13%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVVHPPTSR-------VFALKVIYGNHEDSVRSQICREI 148
           +    L  G  +G G+ G V         +         A+K++  +  +   S +  E+
Sbjct: 10  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69

Query: 149 EILRDV-NHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ---------------- 191
           E+++ +  H N++       ++G + V++EY   G+L   +++                 
Sbjct: 70  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR-EYLQARRPPGLEYSYNPSHNP 128

Query: 192 -----EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT 246
                   L   A QV  G+ YL  +K +HRD+   N+L+     +KIADFG++R +   
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 247 MDPCNSAV--GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG 304
                +      + +M+PE     L    Y  +  D+WS GV + E +        G   
Sbjct: 189 DYYKKTTNGRLPVKWMAPEA----LFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPV 243

Query: 305 DWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
           +   L   +      + P   + E    +  C    P  R    QL++ 
Sbjct: 244 EE--LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 5e-49
 Identities = 61/288 (21%), Positives = 108/288 (37%), Gaps = 44/288 (15%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCH 163
              IG G  G VWR          A+K+     E S   +   EI     + H N++   
Sbjct: 8   QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 63

Query: 164 DMYDRNG----EIEVLLEYMDGGSLEGAHIRQEHILSD----LARQVLSGLAYLH----- 210
              +++     ++ ++ +Y + GSL   ++ +  +  +    LA    SGLA+LH     
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLF-DYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 211 ---KRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD----PCNSAVGTIAYMSPE 263
              K  I HRD+K  N+L+  +    IAD G++       D      N  VGT  YM+PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 264 RINTDLNHGKYD-GYAGDIWSLGVSILEFYLGRFPFAVGRQGDW------------ASLM 310
            ++  +N   ++     DI+++G+   E         +                    + 
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 311 FAICFAQ-PPEAPEM-----ASREFRDFISRCLQKDPHSRWPAAQLLQ 352
             +C  +  P  P       A R     +  C   +  +R  A ++ +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 2e-48
 Identities = 71/301 (23%), Positives = 119/301 (39%), Gaps = 52/301 (17%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHED-SVRSQICREIEILRDVNHPNVV 160
           Q    IGSG+ G V         R  A+K +    ++ +   +  RE+ +++ VNH N++
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79

Query: 161 KCHDMYDRNGEIE------VLLEYMDGGSLEGAHIRQ-EHILSDLARQVLSGLAYLHKRK 213
              +++     +E      +++E MD    +   +      +S L  Q+L G+ +LH   
Sbjct: 80  SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG 139

Query: 214 IVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGK 273
           I+HRD+KPSN+++ S   +KI DFG++R    +       V T  Y +PE I      G 
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVI-----LGM 193

Query: 274 YDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE------------- 320
                 DIWS+G  + E    +  F      D  + +        PE             
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253

Query: 321 -------------------------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPF 355
                                      ++ + + RD +S+ L  DP  R      LQHP+
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 313

Query: 356 I 356
           I
Sbjct: 314 I 314

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-48
 Identities = 77/315 (24%), Positives = 126/315 (40%), Gaps = 51/315 (16%)

Query: 78  HQQQQNQTQNNHQNRHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE 137
           ++Q+ N+T      R+Q ++         +GSG+ G+V       T    A+K +    +
Sbjct: 5   YRQELNKTIWEVPERYQNLS--------PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 56

Query: 138 DSV-RSQICREIEILRDVNHPNVVKCHDMYDRNGEIE-----VLLEYMDGGSLEGAHIRQ 191
             +   +  RE+ +L+ + H NV+   D++     +E      L+ ++ G  L      Q
Sbjct: 57  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 116

Query: 192 ---EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD 248
              +  +  L  Q+L GL Y+H   I+HRD+KPSNL +N    +KI DFG++R    T D
Sbjct: 117 KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDD 173

Query: 249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWAS 308
                V T  Y +PE     + +  +     DIWS+G  + E   GR  F      D   
Sbjct: 174 EMTGYVATRWYRAPEI----MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 229

Query: 309 LMFAICFAQPPEAPEM---------------------------ASREFRDFISRCLQKDP 341
           L+  +      E  +                            A+    D + + L  D 
Sbjct: 230 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 289

Query: 342 HSRWPAAQLLQHPFI 356
             R  AAQ L H + 
Sbjct: 290 DKRITAAQALAHAYF 304

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  162 bits (410), Expect = 8e-48
 Identities = 45/272 (16%), Positives = 91/272 (33%), Gaps = 29/272 (10%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH-PNVV 160
           + G RIG GS G ++   +   ++  A+K        S   Q+  E    + +     + 
Sbjct: 8   KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE---PRRSDAPQLRDEYRTYKLLAGCTGIP 64

Query: 161 KCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ----EHILSDLARQVLSGLAYLHKRKIVH 216
             +          ++++ +     +   +         ++  A+Q+L+ +  +H++ +V+
Sbjct: 65  NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124

Query: 217 RDIKPSNLLINS-----SKNVKIADFGVSRILA-------QTMDPCNSAVGTIAYMSPER 264
           RDIKP N LI       +  + + DFG+ +                 +  GT  YMS   
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 265 INTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ----PPE 320
                  G+      D+ +LG   + F  G  P+   +          I   +      E
Sbjct: 185 HL-----GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239

Query: 321 APEMASREFRDFISRCLQKDPHSRWPAAQLLQ 352
                  EF  ++         +      L  
Sbjct: 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 1e-46
 Identities = 65/288 (22%), Positives = 111/288 (38%), Gaps = 37/288 (12%)

Query: 96  INPAELQKGNRIGSGSGGTVWRVV-----HPPTSRVFALKVIYGNHEDSVRSQICREIEI 150
                L+ G  +G G+ G V            T R  A+K++      S    +  E++I
Sbjct: 10  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69

Query: 151 L-RDVNHPNVVKCHD-MYDRNGEIEVLLEYMDGGSLEGAHIRQ----------------- 191
           L    +H NVV          G + V++E+   G+L   ++R                  
Sbjct: 70  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS-TYLRSKRNEFVPYKVAPEDLYK 128

Query: 192 ----EHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM 247
                  L   + QV  G+ +L  RK +HRD+   N+L++    VKI DFG++R + +  
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188

Query: 248 DP--CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD 305
           D      A   + +M+PE I       +      D+WS GV + E +        G + D
Sbjct: 189 DYVRKGDARLPLKWMAPETIF-----DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243

Query: 306 WASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH 353
                  +       AP+  + E    +  C   +P  R   ++L++H
Sbjct: 244 EE-FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  140 bits (352), Expect = 7e-39
 Identities = 69/350 (19%), Positives = 118/350 (33%), Gaps = 87/350 (24%)

Query: 102 QKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVK 161
               ++G G   TVW       +   A+K++    +         EI++L+ VN  +  K
Sbjct: 16  ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 162 ---------------CHDMYDRNGEIEVLLEYMDGGSLEGAHIRQ-----EHILSDLARQ 201
                           +        + ++ E +    L      +        +  +++Q
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 202 VLSGLAYLH-KRKIVHRDIKPSNLLINSSK------NVKIADFGVSRILAQTMDPCNSAV 254
           +L GL Y+H +  I+H DIKP N+L+           +KIAD G +       +   +++
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---WYDEHYTNSI 190

Query: 255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPF------AVGRQGDWAS 308
            T  Y SPE +      G   G   DIWS    I E   G F F      +  +  D  +
Sbjct: 191 QTREYRSPEVL-----LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245

Query: 309 LMFAICFAQPPEA--------------------------------------PEMASREFR 330
            +  +    P                                          +  ++E  
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305

Query: 331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQVNQNLRQILPPPRPLSS 380
           DF+S  LQ DP  R  A  L+ HP++      +    + +I  P R L  
Sbjct: 306 DFLSPMLQLDPRKRADAGGLVNHPWL------KDTLGMEEIRVPDRELYG 349

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  104 bits (260), Expect = 3e-27
 Identities = 34/204 (16%), Positives = 65/204 (31%), Gaps = 34/204 (16%)

Query: 104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICRE---------------- 147
           G  +G G    V+            +K     H    + +  R+                
Sbjct: 5   GKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 148 -IEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGL 206
               L+ +    V K +  ++ N  +      M+    +  +  +     ++   +L  +
Sbjct: 64  EFRALQKLQGLAVPKVYA-WEGNAVL------MELIDAKELYRVRVENPDEVLDMILEEV 116

Query: 207 AYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERIN 266
           A  + R IVH D+   N+L+ S + + I DF  S  + +           I       I 
Sbjct: 117 AKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWR------EILERDVRNII 169

Query: 267 TDLNHGKYDGYAGDIWSLGVSILE 290
           T  +  +      DI S    IL+
Sbjct: 170 TYFS--RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	380
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.76
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.49
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.41
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.69
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.66
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.46

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-64  Score=452.71  Aligned_cols=256  Identities=24%  Similarity=0.340  Sum_probs=215.3

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.........+.+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            46899999999999999999999999999999999766554555678999999999999999999999999999999999


Q ss_pred             ccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC--CCCC
Q 016959          178 YMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM--DPCN  251 (380)
Q Consensus       178 ~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~  251 (380)
                      ||.+|+|.+++..    ++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.+....  ....
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~  163 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN  163 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccccc
Confidence            9999999877654    577889999999999999999999999999999999999999999999998765332  2345


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD  331 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (380)
                      ..+||+.|||||++.+    ..+++.++|||||||++|||++|+.||........... ...........+..++.++.+
T Consensus       164 ~~~GT~~Y~APE~~~~----~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~~  238 (271)
T d1nvra_         164 KMCGTLPYVAPELLKR----REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-DWKEKKTYLNPWKKIDSAPLA  238 (271)
T ss_dssp             CCCSCGGGSCTHHHHC----SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH-HHHTTCTTSTTGGGSCHHHHH
T ss_pred             ceeeCcCccCHhHhcC----CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH-HHhcCCCCCCccccCCHHHHH
Confidence            6789999999999864    34567789999999999999999999975544433222 222223333445678999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccccc
Q 016959          332 FISRCLQKDPHSRWPAAQLLQHPFILR  358 (380)
Q Consensus       332 li~~~l~~dp~~R~t~~eil~hp~~~~  358 (380)
                      ||.+||+.||++|||++|+|+||||++
T Consensus       239 li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         239 LLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            999999999999999999999999975

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-63  Score=460.87  Aligned_cols=271  Identities=27%  Similarity=0.452  Sum_probs=231.3

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      |+.++|++++.||+|+||+||+|+++.+|+.||||++.+..  .....+.+.+|+.+|+.++||||++++++|.+.+.+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            67789999999999999999999999999999999996442  2223567889999999999999999999999999999


Q ss_pred             EEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 016959          174 VLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  249 (380)
                      +|||||.||+|..++.    ..+..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+........
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence            9999999999966544    367788999999999999999999999999999999999999999999999977655555


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      ....+||+.|||||++.+     ..++.++|||||||++|||++|+.||...+   ........ .......|..+++++
T Consensus       162 ~~~~~GT~~Y~aPE~~~~-----~~y~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~~~i-~~~~~~~p~~~s~~~  232 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLED-----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELI-LMEEIRFPRTLSPEA  232 (337)
T ss_dssp             BCCCEECGGGCCGGGGSS-----SCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH-HHCCCCCCTTSCHHH
T ss_pred             cccceeCHHHhhhhhccC-----CCCChhhcccchhhHHHHHHHCCCCCCCcC---HHHHHHHH-hcCCCCCCccCCHHH
Confidence            677889999999999853     556789999999999999999999997433   33333333 334567788899999


Q ss_pred             HHHHHHhcccCcCCCC-----CHHHHhcCccccccCcccccccccccCCCCCC
Q 016959          330 RDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~-----t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      ++||.+||++||++|+     +++|+++||||++.++....+  ++..||.+|
T Consensus       233 ~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~--~~~~~p~~P  283 (337)
T d1o6la_         233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ--KKLLPPFKP  283 (337)
T ss_dssp             HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHT--TCSCCSCCC
T ss_pred             HHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHh--CCCCCCCCC
Confidence            9999999999999999     499999999999998776643  344455444

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-63  Score=453.99  Aligned_cols=267  Identities=29%  Similarity=0.460  Sum_probs=223.4

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      ..+++|++++.||+|+||+||+|+++.+|+.||||++.+..  .....+.+.+|+++|++++|||||+++++|.+++.+|
T Consensus         5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   84 (288)
T d1uu3a_           5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY   84 (288)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred             CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence            45689999999999999999999999999999999986432  2233467889999999999999999999999999999


Q ss_pred             EEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC--
Q 016959          174 VLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM--  247 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--  247 (380)
                      +|||||.||+|.+++.    .++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+....  
T Consensus        85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            9999999999976543    3678889999999999999999999999999999999999999999999998775332  


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                      ....+.+||+.|||||++.+     ..++.++|||||||++|||++|..||...   +.......+. ......+..+++
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~-----~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~-~~~~~~p~~~s~  235 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTE-----KSACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQKII-KLEYDFPEKFFP  235 (288)
T ss_dssp             -----CCCCGGGCCHHHHHT-----CCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHH-TTCCCCCTTCCH
T ss_pred             cccccccCCccccCceeecc-----CCCCcccceehhhHHHHHHhhCCCCCCCc---CHHHHHHHHH-cCCCCCCccCCH
Confidence            23456789999999999863     56688999999999999999999999743   3333333333 334567788999


Q ss_pred             HHHHHHHHhcccCcCCCCCHHH------HhcCccccccCcccccccccccCCCC
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQ------LLQHPFILRAGQSQVNQNLRQILPPP  375 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~e------il~hp~~~~~~~~~~~~~~~~~~~~~  375 (380)
                      ++++||.+||+.||++|||++|      +++||||++++|..+.+    ..||+
T Consensus       236 ~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~----~~pP~  285 (288)
T d1uu3a_         236 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ----QTPPK  285 (288)
T ss_dssp             HHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG----SCCCC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhc----CCCCC
Confidence            9999999999999999999988      58999999998876654    35663

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-63  Score=450.30  Aligned_cols=253  Identities=32%  Similarity=0.536  Sum_probs=218.3

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .++|++.++||+|+||+||+|++..+|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+.+.+|+|||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   97 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH-HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence            357999999999999999999999999999999986544332 4678899999999999999999999999999999999


Q ss_pred             ccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCC
Q 016959          178 YMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV  254 (380)
Q Consensus       178 ~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (380)
                      ||.||+|..+..   ..+..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+..........+
T Consensus        98 y~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~  177 (293)
T d1yhwa1          98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV  177 (293)
T ss_dssp             CCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCC
T ss_pred             ecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccc
Confidence            999999976644   35778999999999999999999999999999999999999999999999998766555567778


Q ss_pred             CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhh--CCCCCCCccccHHHHHH
Q 016959          255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICF--AQPPEAPEMASREFRDF  332 (380)
Q Consensus       255 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l  332 (380)
                      ||+.|||||++.+     ..++.++|||||||++|+|++|+.||....   ....+.....  ......+..++.++++|
T Consensus       178 gt~~Y~aPE~~~~-----~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  249 (293)
T d1yhwa1         178 GTPYWMAPEVVTR-----KAYGPKVDIWSLGIMAIEMIEGEPPYLNEN---PLRALYLIATNGTPELQNPEKLSAIFRDF  249 (293)
T ss_dssp             SCGGGCCHHHHSS-----SCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHHCSCCCSSGGGSCHHHHHH
T ss_pred             cCCCccChhhhcC-----CCCCchhceehHhHHHHHHhhCCCCCCCCC---HHHHHHHHHhCCCCCCCCcccCCHHHHHH
Confidence            9999999999853     556789999999999999999999996432   2223322222  22345567899999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          333 ISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       333 i~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      |.+||+.||++|||++|+|+||||+..
T Consensus       250 i~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         250 LNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             HHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-63  Score=446.51  Aligned_cols=253  Identities=29%  Similarity=0.516  Sum_probs=217.8

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      +..++|++++.||+|+||+||+|+++.+++.||||++.+..  .....+.+.+|+.+++.++|||||++++++.+++.+|
T Consensus         3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   82 (263)
T d2j4za1           3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   82 (263)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence            35689999999999999999999999999999999985432  2233567889999999999999999999999999999


Q ss_pred             EEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCC
Q 016959          174 VLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDP  249 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  249 (380)
                      +|||||.+|+|.+++.    ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|......  .
T Consensus        83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--~  160 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--R  160 (263)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--C
T ss_pred             EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC--c
Confidence            9999999999876543    367789999999999999999999999999999999999999999999999876543  2


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREF  329 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (380)
                      ....+||+.|||||++.+     ..++.++|||||||+||||++|+.||...   ........+. ......+..+++++
T Consensus       161 ~~~~~Gt~~Y~APE~~~~-----~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~-~~~~~~p~~~s~~~  231 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEG-----RMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRIS-RVEFTFPDFVTEGA  231 (263)
T ss_dssp             CEETTEEGGGCCHHHHTT-----CCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHH-TTCCCCCTTSCHHH
T ss_pred             ccccCCCCcccCHHHHcC-----CCCCchhhhhhHhHHHHHHhcCCCCCCCC---CHHHHHHHHH-cCCCCCCccCCHHH
Confidence            356789999999999863     55678999999999999999999999633   3333333333 34456777899999


Q ss_pred             HHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          330 RDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       330 ~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ++||.+||+.||++|||++|+|+||||+..
T Consensus       232 ~~li~~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         232 RDLISRLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence            999999999999999999999999999753

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-63  Score=451.43  Aligned_cols=260  Identities=31%  Similarity=0.541  Sum_probs=221.0

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      +.|++.+.||+|+||+||+|++..+++.||||++...... ..+.+.+|+++|+.++|||||+++++|.+.+.+++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE-ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG-GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH-HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            4589999999999999999999999999999999765433 346788999999999999999999999999999999999


Q ss_pred             cCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          179 MDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       179 ~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      |.+|+|..++.     .++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+..........+.
T Consensus        91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~  170 (288)
T d2jfla1          91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF  170 (288)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCC
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccccc
Confidence            99999876532     3677889999999999999999999999999999999999999999999998765443334567


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC--CCCCccccHHHHH
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP--PEAPEMASREFRD  331 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  331 (380)
                      +||+.|||||++......+..++.++|||||||++|||++|+.||......+.   ...+.....  ...+..+++++++
T Consensus       171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~~~s~~~~~  247 (288)
T d2jfla1         171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---LLKIAKSEPPTLAQPSRWSSNFKD  247 (288)
T ss_dssp             CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---HHHHHcCCCCCCCccccCCHHHHH
Confidence            89999999999965544566778899999999999999999999975444333   333333332  3445678999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          332 FISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       332 li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                      ||.+||+.||++|||++|+|+||||+.....
T Consensus       248 li~~~L~~dp~~R~t~~ell~hp~~~~~~~~  278 (288)
T d2jfla1         248 FLKKCLEKNVDARWTTSQLLQHPFVTVDSNK  278 (288)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTSGGGCCCCCH
T ss_pred             HHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            9999999999999999999999999865433

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-62  Score=443.06  Aligned_cols=251  Identities=28%  Similarity=0.454  Sum_probs=206.7

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEee--CCeEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDR--NGEIEV  174 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l  174 (380)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.... .+...+.+.+|+++|++++|||||++++++.+  .+.+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            478999999999999999999999999999999996554 44556778999999999999999999999864  456899


Q ss_pred             EEeccCCCCcccccc--------cchHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          175 LLEYMDGGSLEGAHI--------RQEHILSDLARQVLSGLAYLHKRK-----IVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       175 v~e~~~~~~L~~~~~--------~~~~~~~~i~~qi~~al~~LH~~~-----ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                      |||||.+|+|.+++.        .++..++.++.||+.||+|||++|     |+||||||+|||++.++.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            999999999987653        357789999999999999999976     9999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCC
Q 016959          242 ILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEA  321 (380)
Q Consensus       242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  321 (380)
                      .+........+.+||+.|||||++..     ..++.++|||||||++|||++|+.||..   .+.......+........
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~~~~~DIwSlGvilyel~tg~~Pf~~---~~~~~~~~~i~~~~~~~~  234 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNR-----MSYNEKSDIWSLGCLLYELCALMPPFTA---FSQKELAGKIREGKFRRI  234 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHHSSCSCCC---SSHHHHHHHHHHTCCCCC
T ss_pred             ecccCCCccccCCCCcccCCHHHHcC-----CCCChHHHHHhhCHHHHHHhhCCCCCCC---CCHHHHHHHHHcCCCCCC
Confidence            87665555567889999999999853     5568899999999999999999999963   334455555555666677


Q ss_pred             CccccHHHHHHHHHhcccCcCCCCCHHHHhcCccc
Q 016959          322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFI  356 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~  356 (380)
                      +..+++++.+||.+||+.||++|||++|+|+|||+
T Consensus       235 ~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         235 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            78899999999999999999999999999999996

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-63  Score=456.68  Aligned_cols=261  Identities=39%  Similarity=0.686  Sum_probs=218.0

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      +..++|++.++||+|+||+||+|++..+|+.||+|+++..........+.+|+.+|+.++|||||+++++|.+.+.+|+|
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            45689999999999999999999999999999999997766666678899999999999999999999999999999999


Q ss_pred             EeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          176 LEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHK-RKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       176 ~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      ||||.||+|.+++.    ..+..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+.+....  .
T Consensus        83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--~  160 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--A  160 (322)
T ss_dssp             EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--C
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--c
Confidence            99999999977653    4678899999999999999997 599999999999999999999999999998775432  3


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHH-----------------------
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWA-----------------------  307 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-----------------------  307 (380)
                      .+.+||+.|||||++.+     ..++.++||||||||+|||++|+.||...+.....                       
T Consensus       161 ~~~~GT~~Y~APEvl~~-----~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         161 NSFVGTRSYMSPERLQG-----THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             ---CCSSCCCCHHHHHC-----SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             ccccCCccccCchHHcC-----CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence            56789999999999963     56788999999999999999999999754332111                       


Q ss_pred             ----------------HHHHHHhhCCCCCCC-ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          308 ----------------SLMFAICFAQPPEAP-EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       308 ----------------~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                                      ..........++..+ ..++.++.|||.+||+.||++|||++|+|+||||++.+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~  308 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE  308 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSC
T ss_pred             cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCccc
Confidence                            111111111222222 23688999999999999999999999999999999865443

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.8e-62  Score=448.01  Aligned_cols=256  Identities=25%  Similarity=0.413  Sum_probs=220.4

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  174 (380)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++.+..  .....+.+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            4578999999999999999999999999999999996432  22235678899999999999999999999999999999


Q ss_pred             EEeccCCCCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          175 LLEYMDGGSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       175 v~e~~~~~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      |||||.|++|......    .+..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.....   .
T Consensus        82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---~  158 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---T  158 (316)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---B
T ss_pred             EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc---c
Confidence            9999999997655433    56677889999999999999999999999999999999999999999999877543   3


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR  330 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (380)
                      .+.+||+.|||||++.+     ..++.++|||||||++|||++|+.||...   +.......+... ....+..+++++.
T Consensus       159 ~~~~Gt~~Y~APE~l~~-----~~y~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~-~~~~p~~~s~~~~  229 (316)
T d1fota_         159 YTLCGTPDYIAPEVVST-----KPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNA-ELRFPPFFNEDVK  229 (316)
T ss_dssp             CCCCSCTTTCCHHHHTT-----CCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHC-CCCCCTTSCHHHH
T ss_pred             ccccCcccccCHHHHcC-----CCCCchhhccccchhHHHHHhCCCCCCCc---CHHHHHHHHHcC-CCCCCCCCCHHHH
Confidence            56789999999999853     55678999999999999999999999743   333444443333 3466778899999


Q ss_pred             HHHHHhcccCcCCCC-----CHHHHhcCccccccCcccc
Q 016959          331 DFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       331 ~li~~~l~~dp~~R~-----t~~eil~hp~~~~~~~~~~  364 (380)
                      ++|.+||..||++|+     |++|+|+||||++.++..+
T Consensus       230 ~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l  268 (316)
T d1fota_         230 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL  268 (316)
T ss_dssp             HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred             HHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHH
Confidence            999999999999996     9999999999999988765

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-62  Score=449.28  Aligned_cols=256  Identities=29%  Similarity=0.449  Sum_probs=198.8

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .+.|++.+.||+|+||+||+|+++.+|+.||||++...........+.+|+.+|+.++|||||+++++|.+++.+|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            35699999999999999999999999999999999766544455678899999999999999999999999999999999


Q ss_pred             ccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc---CCCcEEEeeccccccccccCCCC
Q 016959          178 YMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN---SSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       178 ~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~---~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      ||+||+|.+++.    .++..+..++.||+.||+|||++||+||||||+|||+.   .++.+||+|||+|+..... ...
T Consensus        88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-~~~  166 (307)
T d1a06a_          88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVL  166 (307)
T ss_dssp             CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred             ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC-Cee
Confidence            999999976653    46788999999999999999999999999999999995   5788999999999866543 334


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR  330 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (380)
                      .+.+||+.|||||++.+     ..++.++|||||||+||||++|+.||......+....+...........+..+++++.
T Consensus       167 ~~~~GT~~y~APE~~~~-----~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  241 (307)
T d1a06a_         167 STACGTPGYVAPEVLAQ-----KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK  241 (307)
T ss_dssp             ------CTTSCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             eeeeeCccccCcHHHcC-----CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence            56789999999999853     4567899999999999999999999974332222222222222333445567899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      +||.+||+.||++|||++|+|+||||++.
T Consensus       242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         242 DFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999999999864

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.9e-61  Score=451.93  Aligned_cols=263  Identities=23%  Similarity=0.380  Sum_probs=222.4

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-----chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-----EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      +.++|++.+.||+|+||+||+|++..+|+.||||++.+..     .........+|+.+++.++|||||+++++|.+.+.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            4578999999999999999999999999999999985322     11112223345777888899999999999999999


Q ss_pred             EEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          172 IEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      +|+|||||.||+|..++.    ..+..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+... 
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-  160 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-  160 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred             EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence            999999999999976654    356788999999999999999999999999999999999999999999999876543 


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccH
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASR  327 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (380)
                       .....+||+.|||||++..    +..++.++|||||||+||||++|+.||......+.... ...........+..+++
T Consensus       161 -~~~~~~GT~~y~APE~~~~----~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-~~~~~~~~~~~~~~~s~  234 (364)
T d1omwa3         161 -KPHASVGTHGYMAPEVLQK----GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTLTMAVELPDSFSP  234 (364)
T ss_dssp             -CCCSCCSCGGGCCHHHHST----TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH-HHHSSSCCCCCCSSSCH
T ss_pred             -cccccccccccchhHHhhc----CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcccCCCCCCCCCCH
Confidence             2356789999999999853    45678899999999999999999999986655554443 33445556677788999


Q ss_pred             HHHHHHHHhcccCcCCCCC-----HHHHhcCccccccCcccccc
Q 016959          328 EFRDFISRCLQKDPHSRWP-----AAQLLQHPFILRAGQSQVNQ  366 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t-----~~eil~hp~~~~~~~~~~~~  366 (380)
                      ++++||.+||+.||++|||     ++|+++||||++.+|.....
T Consensus       235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~  278 (364)
T d1omwa3         235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFL  278 (364)
T ss_dssp             HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHT
T ss_pred             HHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhc
Confidence            9999999999999999999     79999999999998876633

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-61  Score=443.72  Aligned_cols=257  Identities=29%  Similarity=0.482  Sum_probs=213.5

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-----chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-----EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIE  173 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  173 (380)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..     .....+.+.+|+.+|++++|||||+++++|.+.+.+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            56999999999999999999999999999999986432     1223577899999999999999999999999999999


Q ss_pred             EEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC----cEEEeeccccccccc
Q 016959          174 VLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK----NVKIADFGVSRILAQ  245 (380)
Q Consensus       174 lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~----~~kl~Dfg~a~~~~~  245 (380)
                      +|||||.+|+|.+++.    ..+..++.++.||+.||+|||++||+||||||+|||++.++    .+||+|||+|..+..
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~  169 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  169 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence            9999999999976643    36778899999999999999999999999999999998776    499999999987754


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC---CCCCC
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ---PPEAP  322 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~  322 (380)
                      . ....+..||+.|+|||++..     ..++.++|||||||++|||++|+.||....   .......+....   +...+
T Consensus       170 ~-~~~~~~~~t~~y~APE~~~~-----~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~  240 (293)
T d1jksa_         170 G-NEFKNIFGTPEFVAPEIVNY-----EPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSAVNYEFEDEYF  240 (293)
T ss_dssp             S-CBCSCCCCCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHTTCCCCCHHHH
T ss_pred             C-ccccccCCCCcccCHHHHcC-----CCCCCcccchhhhHHHHHHHcCCCCCCCCC---HHHHHHHHHhcCCCCCchhc
Confidence            3 33456789999999999853     566789999999999999999999997433   233333333222   22233


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcccc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQV  364 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~~  364 (380)
                      ..++.++++||.+||+.||++|||++|+|+||||+..++.+.
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~  282 (293)
T d1jksa_         241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA  282 (293)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC------
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhHh
Confidence            568899999999999999999999999999999998766554

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-61  Score=451.77  Aligned_cols=260  Identities=25%  Similarity=0.361  Sum_probs=223.2

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      ....++|++++.||+|+||+||+|+++.+|+.||||++.+..  .....+.+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus        37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  116 (350)
T d1rdqe_          37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence            345689999999999999999999999999999999985432  223346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          173 EVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ++||||+.+|+|...+.    ..+..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+...  
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            99999999999865543    467889999999999999999999999999999999999999999999999877643  


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHH
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE  328 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (380)
                       ..+.+||+.|||||++.+     ..++.++|||||||++|||++|+.||...   +.......+.. .....+..++++
T Consensus       195 -~~~~~Gt~~Y~APE~~~~-----~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~-~~~~~p~~~s~~  264 (350)
T d1rdqe_         195 -TWTLCGTPEALAPEIILS-----KGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVS-GKVRFPSHFSSD  264 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHH-CCCCCCTTCCHH
T ss_pred             -cccccCccccCCHHHHcC-----CCCCccccccchhHHHHHHHhCCCCCCCc---CHHHHHHHHhc-CCCCCCccCCHH
Confidence             356789999999999853     55678999999999999999999999643   33344444433 345567789999


Q ss_pred             HHHHHHHhcccCcCCCC-----CHHHHhcCccccccCcccccc
Q 016959          329 FRDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQ  366 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~-----t~~eil~hp~~~~~~~~~~~~  366 (380)
                      +.+||.+||+.||++|+     |++|+++||||++.++....+
T Consensus       265 ~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~  307 (350)
T d1rdqe_         265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQ  307 (350)
T ss_dssp             HHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHT
T ss_pred             HHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHh
Confidence            99999999999999995     999999999999998876643

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.4e-61  Score=449.73  Aligned_cols=257  Identities=28%  Similarity=0.467  Sum_probs=217.4

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .++|++++.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|++++|||||+++++|.+++.+|+|||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH-HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh-hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            36899999999999999999999999999999999765433 35678999999999999999999999999999999999


Q ss_pred             ccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC--CCcEEEeeccccccccccCCCC
Q 016959          178 YMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS--SKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       178 ~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~--~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      ||.||+|.+++.     .++..++.++.||+.||+|||++||+||||||+|||++.  ++.+||+|||+|+.+... ...
T Consensus       104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~~  182 (350)
T d1koaa2         104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSV  182 (350)
T ss_dssp             CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-SCE
T ss_pred             cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-ccc
Confidence            999999866542     467889999999999999999999999999999999964  578999999999877543 333


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHH
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFR  330 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (380)
                      ....||+.|||||++.+     ..++.++|||||||++|+|++|+.||......+....+.......+......++++++
T Consensus       183 ~~~~gT~~Y~aPEv~~~-----~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  257 (350)
T d1koaa2         183 KVTTGTAEFAAPEVAEG-----KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  257 (350)
T ss_dssp             EEECSCTTTCCHHHHHT-----CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred             ceecCcccccCHHHHcC-----CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            56789999999999863     5567899999999999999999999974433333333322223333444567899999


Q ss_pred             HHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          331 DFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       331 ~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                      +||.+||+.||++|||++|+|+||||+..+.
T Consensus       258 ~li~~~L~~dP~~R~t~~eil~hp~~~~~~~  288 (350)
T d1koaa2         258 DFIRKLLLADPNTRMTIHQALEHPWLTPGNA  288 (350)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            9999999999999999999999999997654

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.9e-61  Score=439.68  Aligned_cols=251  Identities=31%  Similarity=0.462  Sum_probs=213.6

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      .|++.+.||+|+||+||+|++..+|+.||||++....  .....+.+.+|+.+|++++|||||+++++|.+.+.+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            5899999999999999999999999999999997553  34455678999999999999999999999999999999999


Q ss_pred             ccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          178 YMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       178 ~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      ||.+|+|..+.    ..++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....    ...
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~----~~~  171 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSF  171 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----CCC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC----Ccc
Confidence            99999875432    3467889999999999999999999999999999999999999999999999866543    456


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC-CCCCccccHHHHHH
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP-PEAPEMASREFRDF  332 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l  332 (380)
                      +||+.|||||++...  ....++.++|||||||++|||++|..||...   .....+..+..... ...+..+++++++|
T Consensus       172 ~GT~~Y~APE~~~~~--~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~s~~~~~l  246 (309)
T d1u5ra_         172 VGTPYWMAPEVILAM--DEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNESPALQSGHWSEYFRNF  246 (309)
T ss_dssp             CSCGGGCCHHHHTTT--TSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSCCCCCSCTTSCHHHHHH
T ss_pred             ccCccccCHHHHhcc--CCCCcCchhhhhhHHHHHHHHHHCCCCCCCC---CHHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence            899999999998531  1234677999999999999999999999633   23334444433333 33455689999999


Q ss_pred             HHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          333 ISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       333 i~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      |.+||+.||++|||++|+|+||||++.
T Consensus       247 i~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         247 VDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             HHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence            999999999999999999999999864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.1e-61  Score=448.38  Aligned_cols=254  Identities=29%  Similarity=0.446  Sum_probs=216.7

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      ++|++.+.||+|+||+||+|++..+|+.||||++...... ....+.+|+.+|++++|||||+++++|.+++.+|+||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            5799999999999999999999999999999999765433 356788999999999999999999999999999999999


Q ss_pred             cCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc--CCCcEEEeeccccccccccCCCCC
Q 016959          179 MDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLIN--SSKNVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       179 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~--~~~~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      |+||+|.+.+     ..++..++.|+.||+.||+|||++||+||||||+||||+  .++.+||+|||+|+.+... ....
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-~~~~  186 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVK  186 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SCEE
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-Ccee
Confidence            9999986543     246788999999999999999999999999999999998  6789999999999877643 2335


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD  331 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (380)
                      ...||+.|||||++.+     ..++.++|||||||++|+|+||+.||......+....+.......+...+..+++++.+
T Consensus       187 ~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  261 (352)
T d1koba_         187 VTTATAEFAAPEIVDR-----EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD  261 (352)
T ss_dssp             EECSSGGGCCHHHHTT-----CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred             eccCcccccCHHHHcC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence            5679999999999853     56788999999999999999999999743333332333333333344556779999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          332 FISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       332 li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ||.+||+.||++|||++|+|+||||++.
T Consensus       262 li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         262 FIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999999999864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-60  Score=429.51  Aligned_cols=247  Identities=27%  Similarity=0.473  Sum_probs=207.4

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEee----CCeEEEE
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDR----NGEIEVL  175 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv  175 (380)
                      |++.++||+|+||+||+|++..+++.||+|++.... .....+.+.+|+++|++++|||||+++++|++    ...+|+|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            467778999999999999999999999999986543 44556789999999999999999999999865    3568999


Q ss_pred             EeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEc-CCCcEEEeeccccccccccCC
Q 016959          176 LEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRK--IVHRDIKPSNLLIN-SSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       176 ~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      ||||.+|+|.+++.    .++..++.++.||+.||+|||++|  |+||||||+|||++ +++.+||+|||+|+.....  
T Consensus        91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~--  168 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--  168 (270)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred             EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC--
Confidence            99999999977653    356788899999999999999999  99999999999997 5789999999999865432  


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC-CCCCCccccH
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ-PPEAPEMASR  327 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  327 (380)
                      ...+.+||+.|||||++..      .++.++|||||||++|||++|+.||...  .+.......+.... +...+..+++
T Consensus       169 ~~~~~~GT~~Y~aPE~~~~------~~~~~~DIwSlGvilyel~~g~~Pf~~~--~~~~~~~~~i~~~~~~~~~~~~~~~  240 (270)
T d1t4ha_         169 FAKAVIGTPEFMAPEMYEE------KYDESVDVYAFGMCMLEMATSEYPYSEC--QNAAQIYRRVTSGVKPASFDKVAIP  240 (270)
T ss_dssp             SBEESCSSCCCCCGGGGGT------CCCTHHHHHHHHHHHHHHHHSSCTTTTC--SSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             ccCCcccCccccCHHHhCC------CCCCcCchhhHHHHHHHHHHCCCCCCCc--ccHHHHHHHHHcCCCCcccCccCCH
Confidence            2356789999999999852      3678999999999999999999999632  23334444443333 2345566889


Q ss_pred             HHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 016959          328 EFRDFISRCLQKDPHSRWPAAQLLQHPFIL  357 (380)
Q Consensus       328 ~~~~li~~~l~~dp~~R~t~~eil~hp~~~  357 (380)
                      ++.+||.+||+.||++|||++|+|+||||+
T Consensus       241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            999999999999999999999999999996

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-61  Score=441.96  Aligned_cols=257  Identities=25%  Similarity=0.393  Sum_probs=218.9

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHH-HhCCCCceeeeEeEEeeCCeEEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEIL-RDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..  .....+.+..|..++ +.++|||||++++++.+++.+|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            68999999999999999999999999999999996432  122234555666665 468999999999999999999999


Q ss_pred             EeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCC
Q 016959          176 LEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       176 ~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      ||||.+|+|..++.    .++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++..........
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~  161 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN  161 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccccc
Confidence            99999999976653    35778899999999999999999999999999999999999999999999987765555566


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD  331 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (380)
                      ..+||+.|+|||++.+     ..++.++|||||||++|||++|+.||...   ........+. ...+..+..+++++.+
T Consensus       162 ~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~-~~~~~~p~~~s~~~~d  232 (320)
T d1xjda_         162 TFCGTPDYIAPEILLG-----QKYNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEELFHSIR-MDNPFYPRWLEKEAKD  232 (320)
T ss_dssp             CCCSCGGGCCHHHHTT-----CCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHH-HCCCCCCTTSCHHHHH
T ss_pred             ccCCCCCcCCHHHHcC-----CCCCchhhhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHH-cCCCCCCccCCHHHHH
Confidence            7889999999999963     55678999999999999999999999643   3334444443 3445677889999999


Q ss_pred             HHHHhcccCcCCCCCHH-HHhcCccccccCcccc
Q 016959          332 FISRCLQKDPHSRWPAA-QLLQHPFILRAGQSQV  364 (380)
Q Consensus       332 li~~~l~~dp~~R~t~~-eil~hp~~~~~~~~~~  364 (380)
                      ||.+||+.||++|||+. |+++||||++.++...
T Consensus       233 li~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~l  266 (320)
T d1xjda_         233 LLVKLFVREPEKRLGVRGDIRQHPLFREINWEEL  266 (320)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHH
T ss_pred             HHHHhcccCCCCCcCHHHHHHhCchhccCCHHHH
Confidence            99999999999999995 8999999999887654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=7.3e-60  Score=427.16  Aligned_cols=260  Identities=29%  Similarity=0.477  Sum_probs=218.6

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc--------hHHHHHHHHHHHHHHhCC-CCceeeeEeEEee
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE--------DSVRSQICREIEILRDVN-HPNVVKCHDMYDR  168 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~  168 (380)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.....        ....+.+.+|+.+|++++ |||||+++++|.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            3689999999999999999999999999999999865431        234567889999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          169 NGEIEVLLEYMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      ++.+|+|||||++|+|.+++    ..++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            99999999999999997665    33678899999999999999999999999999999999999999999999998876


Q ss_pred             ccCCCCCCCCCCCccccccccccccC-CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          245 QTMDPCNSAVGTIAYMSPERINTDLN-HGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      ... .....+||..|+|||++..... ....++.++||||+||++|||++|+.||......+....+.......+.....
T Consensus       162 ~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (277)
T d1phka_         162 PGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD  240 (277)
T ss_dssp             TTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred             CCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence            542 3456789999999999864321 22346779999999999999999999997544333332333322233344556


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR  358 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~  358 (380)
                      .+++++++||.+||+.||++|||++|+|+||||++
T Consensus       241 ~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            79999999999999999999999999999999986

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-60  Score=432.82  Aligned_cols=255  Identities=25%  Similarity=0.390  Sum_probs=208.8

Q ss_pred             ccceecccCCceEEEEEeCCCCcEEEEEEecCCCc----hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959          103 KGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE----DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       103 ~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      .+++||+|+||+||+|+++.+|+.||||++.....    +.....+.+|+.+|+.++|||||+++++|.+++.+|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            45789999999999999999999999999965432    22235688999999999999999999999999999999999


Q ss_pred             cCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCCC
Q 016959          179 MDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSAV  254 (380)
Q Consensus       179 ~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  254 (380)
                      |.++++....    ...+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+............+
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~  161 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  161 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence            9988765433    245678899999999999999999999999999999999999999999999988776655566778


Q ss_pred             CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC--------------
Q 016959          255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE--------------  320 (380)
Q Consensus       255 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------  320 (380)
                      ||+.|+|||++..    +..++.++|||||||++|||++|..||......+....+..........              
T Consensus       162 gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         162 VTRWYRAPELLFG----ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCCTTCCHHHHTT----CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             cChhhccHHHHcc----CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence            9999999999853    3567889999999999999999999997544433333333332211110              


Q ss_pred             ----------CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          321 ----------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       321 ----------~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                                ....+++++.+||.+||+.||++|||++|+|+||||+..+.
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~  288 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  288 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence                      01246789999999999999999999999999999987543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-58  Score=424.92  Aligned_cols=257  Identities=31%  Similarity=0.455  Sum_probs=211.1

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-hHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-DSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ++|++.++||+|+||+||+|++..+|+.||||+++.... +.....+.+|+++|++++|||||+++++|.+.+.+|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            689999999999999999999999999999999965432 2335678899999999999999999999999999999999


Q ss_pred             ccCCCCccc-----ccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCC
Q 016959          178 YMDGGSLEG-----AHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNS  252 (380)
Q Consensus       178 ~~~~~~L~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~  252 (380)
                      ||.++.+..     ....++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...........
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~  161 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH  161 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTC
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccccee
Confidence            998765432     223467889999999999999999999999999999999999999999999999887666556667


Q ss_pred             CCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC------------
Q 016959          253 AVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE------------  320 (380)
Q Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------  320 (380)
                      ..||+.|+|||++..    ..+++.++|||||||++|+|++|+.||...+..+....+..........            
T Consensus       162 ~~gt~~y~apE~~~~----~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T d1gz8a_         162 EVVTLWYRAPEILLG----CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK  237 (298)
T ss_dssp             CBCCCTTCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ecccceeeehhhhcc----ccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence            789999999999754    3566789999999999999999999997543322222222211111100            


Q ss_pred             -------------CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          321 -------------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       321 -------------~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                                   ....++.++.+||.+||+.||++|||++|+|+||||+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence                         112467899999999999999999999999999999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-59  Score=433.99  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=212.0

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEec
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      ++|++++.||+|+||+||+|.++.+++.||||++.....+  ...+.+|+++|+.++|||||+++++|++++.+|+||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH--HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc--HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            6799999999999999999999999999999999765433  35688999999999999999999999999999999999


Q ss_pred             cCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCC--CcEEEeeccccccccccCCCCC
Q 016959          179 MDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSS--KNVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       179 ~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~--~~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      |.|++|.+++.     .++..++.++.||+.||+|||++||+||||||+|||++.+  ..+||+|||+++..... ....
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-~~~~  161 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFR  161 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CEEE
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-Cccc
Confidence            99999876543     3678899999999999999999999999999999999854  47999999999876543 2334


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHH
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRD  331 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (380)
                      ...||+.|+|||.+.     +..++.++|||||||++|+|++|..||......+....+.......+...+..++.++++
T Consensus       162 ~~~~t~~y~ape~~~-----~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T d1tkia_         162 LLFTAPEYYAPEVHQ-----HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             EEESCGGGSCHHHHT-----TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             ccccccccccchhcc-----CCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence            567999999999985     356778999999999999999999999754333322222222222222233468999999


Q ss_pred             HHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          332 FISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       332 li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ||.+||+.||++|||++|+|+||||++.
T Consensus       237 li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         237 FVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            9999999999999999999999999753

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.7e-58  Score=417.19  Aligned_cols=256  Identities=22%  Similarity=0.341  Sum_probs=218.0

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .+.++.++|++.++||+|+||+||+|++..+++.||||++..+...  .+.+.+|+.+|++++|||||+++++|.+++.+
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch--HHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            3568889999999999999999999999999999999999655433  45789999999999999999999999999999


Q ss_pred             EEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          173 EVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      ++|||||.+|+|..++.      .++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            99999999999876543      356778899999999999999999999999999999999999999999999876543


Q ss_pred             CC-CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          247 MD-PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       247 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                      .. ......|++.|+|||++..     ..++.++|||||||++|||++|..||..  ..+.......+.....+..+..+
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~-----~~~~~k~DiwS~Gv~l~ell~~~~p~~~--~~~~~~~~~~i~~~~~~~~~~~~  241 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAY-----NKFSIKSDVWAFGVLLWEIATYGMSPYP--GIDLSQVYELLEKDYRMERPEGC  241 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHH-----CCCSHHHHHHHHHHHHHHHHTTSCCSST--TCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             CceeeccccccccccChHHHcC-----CCCCchhhhhhHHHHHHHHHhCCCCCCC--cchHHHHHHHHhcCCCCCCCccc
Confidence            22 2233458899999999864     4567899999999999999998777753  23344455555566677888889


Q ss_pred             cHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      +.++.+||.+||+.||++|||++|+++  +|+.+
T Consensus       242 ~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         242 PEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence            999999999999999999999999976  55544

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-58  Score=423.60  Aligned_cols=277  Identities=26%  Similarity=0.441  Sum_probs=231.3

Q ss_pred             CCcccccccceecccCCceEEEEEe---CCCCcEEEEEEecCCC---chHHHHHHHHHHHHHHhCCC-CceeeeEeEEee
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVH---PPTSRVFALKVIYGNH---EDSVRSQICREIEILRDVNH-PNVVKCHDMYDR  168 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~---~~~~~~~avK~~~~~~---~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~  168 (380)
                      ++.++|++++.||+|+||+||+|.+   +.+|+.||||++....   .....+.+.+|+++|++++| |||+++++++.+
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            5678999999999999999999987   4478999999986432   22234567899999999976 899999999999


Q ss_pred             CCeEEEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          169 NGEIEVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      ...++++|||+.+++|...+.    ..+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            999999999999999976543    3567788899999999999999999999999999999999999999999998764


Q ss_pred             cc-CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          245 QT-MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       245 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      .. .....+..|++.|++||.+..   ...+++.++|||||||+||+|++|..||......+....+........+..+.
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~---~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~  257 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRG---GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ  257 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTT---CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred             ccccccccccccccccchhHHhhc---CCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence            32 223456779999999999853   23456789999999999999999999998776666666666666666777788


Q ss_pred             cccHHHHHHHHHhcccCcCCCC-----CHHHHhcCccccccCcccccccccccCCCCCC
Q 016959          324 MASREFRDFISRCLQKDPHSRW-----PAAQLLQHPFILRAGQSQVNQNLRQILPPPRP  377 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~-----t~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~  377 (380)
                      .++.++.+||.+||+.||++|+     |++|+|+||||++.++.....  +++-||++|
T Consensus       258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~--~~~~~p~~p  314 (322)
T d1vzoa_         258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAA--KKVPAPFKP  314 (322)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHT--TCSCCSCCC
T ss_pred             cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHh--CCCCcCCCC
Confidence            8999999999999999999999     589999999999988765543  444455555

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=411.36  Aligned_cols=252  Identities=24%  Similarity=0.420  Sum_probs=202.3

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      |.|+.++|+++++||+|+||+||+|++.   ..||||+++... .....+.+.+|+.+|++++|||||++++++.+ +.+
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~   78 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL   78 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence            4678899999999999999999999874   359999996543 34456789999999999999999999998754 568


Q ss_pred             EEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          173 EVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      ++|||||++|+|.+++.     .++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+......
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            99999999999977653     2567788999999999999999999999999999999999999999999998765322


Q ss_pred             --CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC----CCC
Q 016959          248 --DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP----PEA  321 (380)
Q Consensus       248 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~  321 (380)
                        ....+..||+.|||||++...  ....++.++|||||||+||||+||+.||......  ............    ...
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~--~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~--~~~~~~~~~~~~~p~~~~~  234 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQ--DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYLSPDLSKV  234 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTC--SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHHTSCCCCGGGS
T ss_pred             CcccccccccCcccCCHHHHhcc--cCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCCcchhc
Confidence              233566899999999998532  1234678999999999999999999999743332  222222222222    234


Q ss_pred             CccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          322 PEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       322 ~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      +..+++++.+||.+||+.||++|||++|++++
T Consensus       235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            56688999999999999999999999999985

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-58  Score=416.11  Aligned_cols=246  Identities=25%  Similarity=0.407  Sum_probs=205.9

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-----hHHHHHHHHHHHHHHhCC--CCceeeeEeEEeeCCe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-----DSVRSQICREIEILRDVN--HPNVVKCHDMYDRNGE  171 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~  171 (380)
                      ++|+++++||+|+||+||+|++..+|+.||||++.....     .....++.+|+.+|++++  |||||+++++|.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            579999999999999999999999999999999864321     111234668999999996  8999999999999999


Q ss_pred             EEEEEeccCC-CCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-CCcEEEeeccccccccc
Q 016959          172 IEVLLEYMDG-GSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS-SKNVKIADFGVSRILAQ  245 (380)
Q Consensus       172 ~~lv~e~~~~-~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~  245 (380)
                      +++||||+.+ +++..++    ...+..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+....
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~  163 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD  163 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence            9999999986 4554332    3467889999999999999999999999999999999985 47899999999986543


Q ss_pred             cCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          246 TMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                      .  ...+.+||+.|+|||++..    ..+++.++|||||||++|||++|+.||...     ....     ......+..+
T Consensus       164 ~--~~~~~~GT~~y~aPE~~~~----~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~i~-----~~~~~~~~~~  227 (273)
T d1xwsa_         164 T--VYTDFDGTRVYSPPEWIRY----HRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----EEII-----RGQVFFRQRV  227 (273)
T ss_dssp             S--CBCCCCSCGGGSCHHHHHH----SCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HHHH-----HCCCCCSSCC
T ss_pred             c--cccccccCCCcCCHHHHcC----CCCCCcccccccceeeehhHhhCCCCCCCc-----hHHh-----hcccCCCCCC
Confidence            3  3356789999999999864    355677899999999999999999999631     1111     2234566778


Q ss_pred             cHHHHHHHHHhcccCcCCCCCHHHHhcCccccccC
Q 016959          326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAG  360 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~  360 (380)
                      +.++++||.+||+.||++|||++|+|+||||++..
T Consensus       228 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            99999999999999999999999999999998864

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-57  Score=422.30  Aligned_cols=250  Identities=25%  Similarity=0.410  Sum_probs=202.8

Q ss_pred             cccccccc-eecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHh-CCCCceeeeEeEEee----CCe
Q 016959           98 PAELQKGN-RIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRD-VNHPNVVKCHDMYDR----NGE  171 (380)
Q Consensus        98 ~~~~~~~~-~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~----~~~  171 (380)
                      .++|.+.. .||+|+||+||+|++..+++.||||++...      ..+.+|+.++.+ ++|||||+++++|++    ...
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            46798865 599999999999999999999999999542      346689988655 489999999999875    467


Q ss_pred             EEEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCcEEEeecccccc
Q 016959          172 IEVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS---SKNVKIADFGVSRI  242 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~---~~~~kl~Dfg~a~~  242 (380)
                      +|+|||||.||+|.+++.      .++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||+|+.
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence            999999999999976653      367889999999999999999999999999999999985   45799999999987


Q ss_pred             ccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC---
Q 016959          243 LAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP---  319 (380)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---  319 (380)
                      .... ......+||+.|||||++.+     ..++.++|||||||+||+|+||+.||...........+.........   
T Consensus       164 ~~~~-~~~~~~~gt~~y~aPE~~~~-----~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~  237 (335)
T d2ozaa1         164 TTSH-NSLTTPCYTPYYVAPEVLGP-----EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP  237 (335)
T ss_dssp             CCCC-CCCCCCSCCCSSCCCCCCCG-----GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred             ccCC-CccccccCCcccCCcHHHcC-----CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence            6544 33456789999999999853     55678999999999999999999999755444333332222222222   


Q ss_pred             -CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          320 -EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       320 -~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                       ..+..+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       238 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence             2234689999999999999999999999999999999764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-57  Score=410.33  Aligned_cols=255  Identities=23%  Similarity=0.360  Sum_probs=215.1

Q ss_pred             CCCcccccccce-ecccCCceEEEEEeCC--CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           95 LINPAELQKGNR-IGSGSGGTVWRVVHPP--TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        95 ~~~~~~~~~~~~-LG~G~~g~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      .+..++|.+.+. ||+|+||+||+|.++.  ++..||||+++........+.+.+|+++|++++|||||+++|++.. +.
T Consensus         4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            466778888884 9999999999998754  4557999999877666677889999999999999999999999875 46


Q ss_pred             EEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      +|+|||||++|+|.+++.     .++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+...
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            899999999999976543     256778899999999999999999999999999999999999999999999876543


Q ss_pred             C---CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCC
Q 016959          247 M---DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAP  322 (380)
Q Consensus       247 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  322 (380)
                      .   .......||+.|||||++..     ..++.++|||||||++|||+| |+.||.....   .+....+.....+..+
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~~i~~~~~~~~p  234 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINF-----RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRMECP  234 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHH-----CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHTTCCCCCC
T ss_pred             ccccccccccccCccccChHHHhC-----CCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCCC
Confidence            2   12345568999999999864     456789999999999999997 9999974432   3445555666777888


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHH---hcCccccc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQL---LQHPFILR  358 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~ei---l~hp~~~~  358 (380)
                      ..++.++.+||.+||+.||++|||+.+|   |+|+|+.-
T Consensus       235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            8999999999999999999999999888   67888754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-57  Score=408.42  Aligned_cols=256  Identities=22%  Similarity=0.340  Sum_probs=215.6

Q ss_pred             cccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           92 RHQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        92 ~~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      ..+.|+.++|++.++||+|+||+||+|.++ +++.||||++......  .+.+.+|+.+|++++|||||++++++.+ +.
T Consensus         6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~   81 (272)
T d1qpca_           6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP   81 (272)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             CCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC--HHHHHHHHHHHHhCCCCCEeEEEeeecc-CC
Confidence            345688899999999999999999999986 5778999999654432  3578999999999999999999998865 56


Q ss_pred             EEEEEeccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      +++|||||.+|+|.+++..      ++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+..
T Consensus        82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence            7999999999999765433      4567889999999999999999999999999999999999999999999987754


Q ss_pred             cC-CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCcc
Q 016959          246 TM-DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEM  324 (380)
Q Consensus       246 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (380)
                      .. .......||+.|||||++..     ..++.++|||||||++|||+||..|+..  ..........+.....+..+..
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~-----~~~~~~sDvwS~Gvvl~ellt~~~~~~~--~~~~~~~~~~i~~~~~~~~p~~  234 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINY-----GTFTIKSDVWSFGILLTEIVTHGRIPYP--GMTNPEVIQNLERGYRMVRPDN  234 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHH-----CEECHHHHHHHHHHHHHHHHTTTCCSST--TCCHHHHHHHHHTTCCCCCCTT
T ss_pred             CccccccccCCcccccChHHHhC-----CCCCchhhhhhhHHHHHHHHhCCCCCCC--CCCHHHHHHHHHhcCCCCCccc
Confidence            32 22345678999999999864     4567899999999999999996665542  3344555666666677778889


Q ss_pred             ccHHHHHHHHHhcccCcCCCCCHHHHhc--Cccccc
Q 016959          325 ASREFRDFISRCLQKDPHSRWPAAQLLQ--HPFILR  358 (380)
Q Consensus       325 ~~~~~~~li~~~l~~dp~~R~t~~eil~--hp~~~~  358 (380)
                      ++.++.+||.+||+.||++|||++|+++  |+||..
T Consensus       235 ~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            9999999999999999999999999998  788853

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7e-57  Score=412.34  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=204.0

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCCc---EEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTSR---VFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~---~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      .++.++|++.++||+|+||+||+|.++.+++   .||||++.........+.+.+|+.+|++++|||||+++|++...+.
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            4778899999999999999999999977664   5899998776666667889999999999999999999999999999


Q ss_pred             EEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      +++|||||.+|+|..++.     .++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+.+...
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            999999999999976443     356778899999999999999999999999999999999999999999999876543


Q ss_pred             CC-----CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCC
Q 016959          247 MD-----PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPE  320 (380)
Q Consensus       247 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  320 (380)
                      ..     ......||+.|||||++..     ..++.++|||||||+||||+| |..||...   ........+......+
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~---~~~~~~~~i~~~~~~~  253 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQY-----RKFTSASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIEQDYRLP  253 (299)
T ss_dssp             --------------CGGGSCHHHHHS-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHTTCCCC
T ss_pred             CCcceeeecccccCCccccCHHHHhc-----CCCCcccccccchHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCCCC
Confidence            22     1123457899999999863     556789999999999999997 89999743   3345555566666677


Q ss_pred             CCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          321 APEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       321 ~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      .+..++.++.+||.+||+.||++|||+.||+++
T Consensus       254 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            788899999999999999999999999999874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-57  Score=420.71  Aligned_cols=254  Identities=24%  Similarity=0.328  Sum_probs=211.6

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCc-----EEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEE
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSR-----VFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMY  166 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~-----~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~  166 (380)
                      .+.++.++|+++++||+|+||+||+|++..+++     .||+|++...........+.+|+.+|+++ +|||||++++++
T Consensus        31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~  110 (325)
T d1rjba_          31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  110 (325)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence            456888999999999999999999999865543     69999987665555567789999999998 899999999999


Q ss_pred             eeCCeEEEEEeccCCCCcccccc---------------------------cchHHHHHHHHHHHHHHHHHHhCCceecCC
Q 016959          167 DRNGEIEVLLEYMDGGSLEGAHI---------------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDI  219 (380)
Q Consensus       167 ~~~~~~~lv~e~~~~~~L~~~~~---------------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dl  219 (380)
                      .+.+.+++|||||++|+|.+++.                           .++..++.++.||+.||+|||++||+||||
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl  190 (325)
T d1rjba_         111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  190 (325)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            99999999999999999976653                           245668889999999999999999999999


Q ss_pred             CCCcEEEcCCCcEEEeeccccccccccCCC--CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCC
Q 016959          220 KPSNLLINSSKNVKIADFGVSRILAQTMDP--CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRF  296 (380)
Q Consensus       220 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~  296 (380)
                      ||+|||++.++++||+|||+|+........  ..+..||+.|||||++..     ..++.++|||||||++|||++ |..
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwS~Gvil~emlt~g~~  265 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-----GIYTIKSDVWSYGILLWEIFSLGVN  265 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-----CCCCcceeccchhHHHHHHHhCCCC
Confidence            999999999999999999999876544322  234568999999999864     567889999999999999997 899


Q ss_pred             CCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          297 PFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       297 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ||.......  .....+........+..+++++++||.+||+.||++|||++||++|
T Consensus       266 Pf~~~~~~~--~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         266 PYPGIPVDA--NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             SSTTCCCSH--HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHH--HHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            997543332  2333344455667788899999999999999999999999999985

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.4e-57  Score=413.65  Aligned_cols=255  Identities=28%  Similarity=0.419  Sum_probs=206.9

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ++|++.++||+|+||+||+|+++ +|+.||||++.... .+...+.+.+|+.+|++++|||||+++++|...+..+++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            58999999999999999999986 78999999996553 23345678899999999999999999999999999999999


Q ss_pred             ccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          178 YMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       178 ~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      ++.++++....    ..++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  160 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE  160 (286)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence            99988764433    34678899999999999999999999999999999999999999999999998776554555666


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC---------------
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP---------------  318 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------------  318 (380)
                      .|++.|+|||.+..    ..+++.++|||||||++|||++|+.||......+....+........               
T Consensus       161 ~~~~~y~~pE~~~~----~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T d1ob3a_         161 IVTLWYRAPDVLMG----SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (286)
T ss_dssp             -CCCTTCCHHHHTT----CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cccchhhhHHHHhC----CCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence            79999999999854    35678899999999999999999999974433222222222211111               


Q ss_pred             ----------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 016959          319 ----------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR  358 (380)
Q Consensus       319 ----------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~  358 (380)
                                ......++++++|||++||+.||++|||++|+|+||||++
T Consensus       237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                      0123457889999999999999999999999999999984

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-56  Score=400.91  Aligned_cols=247  Identities=23%  Similarity=0.355  Sum_probs=213.0

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      +++++|+++++||+|+||+||+|+++ +++.||||+++.....  .+.+.+|+.++++++||||++++|++.+.+.+++|
T Consensus         1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           1 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred             CChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC--HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence            45789999999999999999999985 7889999999765433  35789999999999999999999999999999999


Q ss_pred             EeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-C
Q 016959          176 LEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-P  249 (380)
Q Consensus       176 ~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~  249 (380)
                      |||+.+|+|..+...     .+..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+++.+..... .
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            999999998655332     4567889999999999999999999999999999999999999999999986654322 2


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE  328 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (380)
                      .....||+.|+|||++..     ..++.++|||||||++|||+| |+.||...   ...+....+........+..++.+
T Consensus       158 ~~~~~~t~~y~aPE~~~~-----~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~---~~~~~~~~i~~~~~~~~p~~~~~~  229 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMY-----SKFSSKSDIWAFGVLMWEIYSLGKMPYERF---TNSETAEHIAQGLRLYRPHLASEK  229 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTS---CHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             ecccCCCCCcCCcHHhcC-----CCCCcceeecccchhhHhHHhcCCCCCCCC---CHHHHHHHHHhCCCCCCcccccHH
Confidence            334678999999999864     456789999999999999998 89999743   344555556666677788899999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          329 FRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      +.+||.+||+.||++|||++|+|+|
T Consensus       230 l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         230 VYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHHH
Confidence            9999999999999999999999987

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-57  Score=404.49  Aligned_cols=247  Identities=23%  Similarity=0.403  Sum_probs=201.2

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEE
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVL  175 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  175 (380)
                      |++++|++.+.||+|+||+||+|.+. +++.||||++......  .+.+.+|++++++++|||||+++|++...+.+++|
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc--HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence            56789999999999999999999986 5678999999754433  35789999999999999999999999999999999


Q ss_pred             EeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC-C
Q 016959          176 LEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD-P  249 (380)
Q Consensus       176 ~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~  249 (380)
                      ||||.+|+|.+++..     .+..+..++.||+.||+|||+++|+||||||+|||++.++++||+|||+++....... .
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            999999999765433     4667888999999999999999999999999999999999999999999987654322 2


Q ss_pred             CCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHH
Q 016959          250 CNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLG-RFPFAVGRQGDWASLMFAICFAQPPEAPEMASRE  328 (380)
Q Consensus       250 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (380)
                      .....||..|+|||++..     ..++.++|||||||++|||+|+ ..||.   ..........+........+..++.+
T Consensus       159 ~~~~~gt~~y~aPE~l~~-----~~~~~k~DVwS~Gvil~el~t~~~~~~~---~~~~~~~~~~i~~~~~~~~p~~~~~~  230 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSF-----SRYSSKSDVWSFGVLMWEVFSEGKIPYE---NRSNSEVVEDISTGFRLYKPRLASTH  230 (263)
T ss_dssp             ------CTTSCCHHHHTT-----CCCCHHHHHHHHHHHHHHHHTTSCCTTC---SCCHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             ecceecCcccCChHHhcC-----CCCCchhhhcchHHHHHHHHHCCCCCCC---CCCHHHHHHHHHhcCCCCCccccCHH
Confidence            234678999999999853     5578899999999999999995 55553   33445555666666777788889999


Q ss_pred             HHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          329 FRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       329 ~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      +.+||.+||+.||++|||++|+++|
T Consensus       231 l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         231 VYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHHH
Confidence            9999999999999999999999985

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-57  Score=414.48  Aligned_cols=260  Identities=26%  Similarity=0.406  Sum_probs=205.2

Q ss_pred             cccccccceecccCCceEEEEEeCCC-CcEEEEEEecCCC-chHHHHHHHHHHHHHHhC---CCCceeeeEeEEee----
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPT-SRVFALKVIYGNH-EDSVRSQICREIEILRDV---NHPNVVKCHDMYDR----  168 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~-~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~----  168 (380)
                      .++|++.++||+|+||+||+|++..+ ++.||||+++... .+.....+.+|+.+|+.|   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999999755 6789999985432 122223455677776655   79999999999853    


Q ss_pred             -CCeEEEEEeccCCCCcccc-----cccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccc
Q 016959          169 -NGEIEVLLEYMDGGSLEGA-----HIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRI  242 (380)
Q Consensus       169 -~~~~~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  242 (380)
                       ...++++||+|.++.+...     ...++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence             3578999999998865322     2345778889999999999999999999999999999999999999999999876


Q ss_pred             ccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC----
Q 016959          243 LAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP----  318 (380)
Q Consensus       243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----  318 (380)
                      .... ......+||+.|||||++.+     ..++.++|||||||++|||++|+.||......+....+........    
T Consensus       166 ~~~~-~~~~~~~gT~~Y~APE~~~~-----~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         166 YSFQ-MALTSVVVTLWYRAPEVLLQ-----SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             CCGG-GGGCCCCCCCTTCCHHHHTT-----CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hccc-ccCCCcccChhhcCcchhcC-----CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence            5433 23456789999999999853     5568899999999999999999999975443333333322211110    


Q ss_pred             -------------------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          319 -------------------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       319 -------------------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                                         ......+++++.+||.+||+.||++|||++|+|+||||+++...+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~k  303 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  303 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhhC
Confidence                               113345788999999999999999999999999999999986543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.1e-55  Score=408.55  Aligned_cols=256  Identities=21%  Similarity=0.382  Sum_probs=209.7

Q ss_pred             CcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEee--CCeEE
Q 016959           97 NPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDR--NGEIE  173 (380)
Q Consensus        97 ~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~  173 (380)
                      ..++|+++++||+|+||+||+|++..+|+.||||+++...    .+.+.+|+.+|+.+. ||||++++++|..  ...++
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            5678999999999999999999999999999999996543    356789999999995 9999999999974  45699


Q ss_pred             EEEeccCCCCccccc-ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-cEEEeeccccccccccCCCCC
Q 016959          174 VLLEYMDGGSLEGAH-IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILAQTMDPCN  251 (380)
Q Consensus       174 lv~e~~~~~~L~~~~-~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~  251 (380)
                      +|||||.+++|.... ...+..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+.+... ....
T Consensus       109 ~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-~~~~  187 (328)
T d3bqca1         109 LVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYN  187 (328)
T ss_dssp             EEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-CCCC
T ss_pred             EEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-Cccc
Confidence            999999999987764 346888999999999999999999999999999999998655 5999999999876544 3346


Q ss_pred             CCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC-HHHHHHHHhh---------------
Q 016959          252 SAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD-WASLMFAICF---------------  315 (380)
Q Consensus       252 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~---------------  315 (380)
                      ..+||+.|+|||.+..    ...++.++|||||||++|+|++|+.||....... ....+.....               
T Consensus       188 ~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  263 (328)
T d3bqca1         188 VRVASRYFKGPELLVD----YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  263 (328)
T ss_dssp             SCCSCGGGCCHHHHTT----CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             ccccCccccCcccccC----CCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence            6789999999999854    3456789999999999999999999997443221 1111111100               


Q ss_pred             ------------------CCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          316 ------------------AQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       316 ------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                                        .........+++++.|||++||+.||++|+|++|+|+||||+.+.+
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence                              0011123447889999999999999999999999999999998754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=406.67  Aligned_cols=247  Identities=22%  Similarity=0.372  Sum_probs=203.4

Q ss_pred             ceecccCCceEEEEEeC--CCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEeccCC
Q 016959          105 NRIGSGSGGTVWRVVHP--PTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLEYMDG  181 (380)
Q Consensus       105 ~~LG~G~~g~V~~~~~~--~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  181 (380)
                      ++||+|+||+||+|.+.  .+++.||||+++... .....+.+.+|+.+|++++|||||+++++++. +..++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999854  456889999996543 34456789999999999999999999999975 457899999999


Q ss_pred             CCccccccc----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC---CCCCCC
Q 016959          182 GSLEGAHIR----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD---PCNSAV  254 (380)
Q Consensus       182 ~~L~~~~~~----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~  254 (380)
                      |+|.+++..    ++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.....   ......
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~  171 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK  171 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence            999766443    5678899999999999999999999999999999999999999999999987653322   123456


Q ss_pred             CCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHH
Q 016959          255 GTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFI  333 (380)
Q Consensus       255 gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  333 (380)
                      ||+.|||||++..     ..++.++|||||||++|||++ |+.||...   ...+....+.....+..+..++.++.+||
T Consensus       172 gt~~y~APE~l~~-----~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~---~~~~~~~~i~~~~~~~~p~~~~~~~~~li  243 (277)
T d1xbba_         172 WPVKWYAPECINY-----YKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLEKGERMGCPAGCPREMYDLM  243 (277)
T ss_dssp             CCGGGCCHHHHHH-----CEEEHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             CCceecCchhhcC-----CCCCchhhhccchhhhhHHhhCCCCCCCCC---CHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence            8999999999864     456789999999999999997 89999743   33445555556677788889999999999


Q ss_pred             HHhcccCcCCCCCHHHH---hcCccccccC
Q 016959          334 SRCLQKDPHSRWPAAQL---LQHPFILRAG  360 (380)
Q Consensus       334 ~~~l~~dp~~R~t~~ei---l~hp~~~~~~  360 (380)
                      .+||+.||++|||++||   |+|+|+.-.+
T Consensus       244 ~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~  273 (277)
T d1xbba_         244 NLCWTYDVENRPGFAAVELRLRNYYYDVVN  273 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhCHHhhcCC
Confidence            99999999999999998   5777776543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-56  Score=409.51  Aligned_cols=258  Identities=25%  Similarity=0.384  Sum_probs=206.6

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEee--------
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDR--------  168 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------  168 (380)
                      .++|++.++||+|+||+||+|++..+|+.||||++.... .+.....+.+|+++|++++|+||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            478999999999999999999999999999999985443 23345668899999999999999999998754        


Q ss_pred             CCeEEEEEeccCCCCccc----ccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          169 NGEIEVLLEYMDGGSLEG----AHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      .+.+|+|||||.++++..    .....+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~  168 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  168 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence            456899999998876532    2334677889999999999999999999999999999999999999999999997664


Q ss_pred             ccC----CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC
Q 016959          245 QTM----DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE  320 (380)
Q Consensus       245 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  320 (380)
                      ...    ....+.+||+.|+|||++..    ...++.++|||||||++|||++|+.||...........+..........
T Consensus       169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~----~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         169 LAKNSQPNRYTNRVVTLWYRPPELLLG----ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             C-----CCCCCSCCSCGGGCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             cccccccccccceecCHHHhhHHHHcC----CCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            321    22345679999999999853    2467789999999999999999999997544444444444444333222


Q ss_pred             CCc----------------------------cccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          321 APE----------------------------MASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       321 ~~~----------------------------~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ...                            ..++++.|||.+||+.||++|+|++|+|+||||+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            111                            136688999999999999999999999999999863

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-56  Score=416.30  Aligned_cols=258  Identities=27%  Similarity=0.385  Sum_probs=204.9

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC------
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG------  170 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------  170 (380)
                      .++|++.++||+|+||+||+|.++.+|+.||||+++... .+...+.+.+|+++|+.++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            578999999999999999999999999999999997543 4455678899999999999999999999997654      


Q ss_pred             eEEEEEeccCCCCccccc---ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC
Q 016959          171 EIEVLLEYMDGGSLEGAH---IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM  247 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  247 (380)
                      .+|+||||| +.+|....   ..++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... 
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-  174 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-  174 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred             eEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCc-
Confidence            579999999 44554332   3567889999999999999999999999999999999999999999999999876543 


Q ss_pred             CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC---------
Q 016959          248 DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP---------  318 (380)
Q Consensus       248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------  318 (380)
                        ....+||+.|+|||++.+    ..+++.++|||||||++|+|++|+.||...+..+............+         
T Consensus       175 --~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (346)
T d1cm8a_         175 --MTGYVVTRWYRAPEVILN----WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  248 (346)
T ss_dssp             --CCSSCSCGGGCCTHHHHT----TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             --cccccccccccCHHHHcC----CCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence              356789999999999853    35667899999999999999999999975433222222222111110         


Q ss_pred             ------------------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCccc
Q 016959          319 ------------------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQSQ  363 (380)
Q Consensus       319 ------------------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~~  363 (380)
                                        ......+++++.|||.+||+.||++|||++|+|+||||+.+....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~  311 (346)
T d1cm8a_         249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE  311 (346)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred             hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcc
Confidence                              112345788999999999999999999999999999999875443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-56  Score=415.22  Aligned_cols=254  Identities=24%  Similarity=0.343  Sum_probs=203.9

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee------CCeE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR------NGEI  172 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~~  172 (380)
                      .+|...++||+|+||+||+|++..+|+.||||++......     +.+|+.+|++++|+||++++++|..      ...+
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            3689999999999999999999999999999999655422     2379999999999999999999853      3358


Q ss_pred             EEEEeccCCCCcccc-------cccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC-cEEEeecccccccc
Q 016959          173 EVLLEYMDGGSLEGA-------HIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK-NVKIADFGVSRILA  244 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~-------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~  244 (380)
                      ++|||||.++++...       ....+..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+.
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            999999987753322       2246778999999999999999999999999999999999775 89999999998775


Q ss_pred             ccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC-------
Q 016959          245 QTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ-------  317 (380)
Q Consensus       245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------  317 (380)
                      .. ....+.+||..|+|||.+..    ...++.++|||||||++|||++|..||......+....+.......       
T Consensus       175 ~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         175 RG-EPNVSYICSRYYRAPELIFG----ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             TT-SCCCSCCSCTTSCCHHHHTT----CSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             CC-cccccccccccccChHHhhc----ccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            43 33456789999999998753    3567889999999999999999999997544333222222211100       


Q ss_pred             ----------C--------CCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCcc
Q 016959          318 ----------P--------PEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQS  362 (380)
Q Consensus       318 ----------~--------~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~~  362 (380)
                                +        ......+++++.+||.+||+.||++|||+.|+|+||||+.+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  312 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  312 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence                      0        01123478899999999999999999999999999999987443

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=400.47  Aligned_cols=251  Identities=23%  Similarity=0.345  Sum_probs=205.9

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCCC----cEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPTS----RVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      .|.+++|++.++||+|+||+||+|.++.++    ..||||++.....+.....+.+|+.+|++++|||||+++|++.+.+
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence            466788999999999999999999987554    4799999977766666778999999999999999999999999999


Q ss_pred             eEEEEEeccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      ..++|||||.++++....     ...+..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            999999999999876543     235667889999999999999999999999999999999999999999999987654


Q ss_pred             cCC---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCC
Q 016959          246 TMD---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAP  322 (380)
Q Consensus       246 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  322 (380)
                      ...   ......||+.|||||++..     ..++.++|||||||++|||++|..||...  .........+.....++.+
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~~~~sDI~S~Gvil~el~t~~~~~~~~--~~~~~~~~~i~~~~~~~~~  235 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISY-----RKFTSASDVWSFGIVMWEVMTYGERPYWE--LSNHEVMKAINDGFRLPTP  235 (283)
T ss_dssp             -----------CCCGGGSCHHHHHS-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHHHHTTCCCCCC
T ss_pred             CCccceEeccCCCCccccCHHHHcc-----CCCCCcccccccHHHHHHHHhCCCCcccc--CCHHHHHHHHhccCCCCCc
Confidence            322   1234568999999999853     56778999999999999999976666432  2344555666666777788


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ..++.++.+||.+||+.||++|||+.||++
T Consensus       236 ~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         236 MDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             TTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            889999999999999999999999999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=400.35  Aligned_cols=256  Identities=22%  Similarity=0.326  Sum_probs=209.3

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeE
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEI  172 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  172 (380)
                      .+.|+.++|++++.||+|+||+||+|+++.+ +.||||++......  .+.+.+|+.+|++++|+|||++++++.+ +.+
T Consensus        11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~   86 (285)
T d1fmka3          11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI   86 (285)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             ceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC--HHHHHHHHHHHHhcccCCEeEEEEEEec-CCe
Confidence            4568889999999999999999999999755 56999999655433  3678999999999999999999999865 567


Q ss_pred             EEEEeccCCCCcccccc------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          173 EVLLEYMDGGSLEGAHI------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      ++|||||.+|+|.....      .++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+.+...
T Consensus        87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence            99999999999865543      356788999999999999999999999999999999999999999999999876533


Q ss_pred             CC-CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          247 MD-PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       247 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                      .. ......||+.|+|||++..     ..++.++|||||||++|||++|..||...  .........+......+.+..+
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDI~S~Giil~el~t~~~p~~~~--~~~~~~~~~i~~~~~~~~~~~~  239 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALY-----GRFTIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQVERGYRMPCPPEC  239 (285)
T ss_dssp             ---------CCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCCCCCCTTS
T ss_pred             CceeeccccccccccChHHHhC-----CCCCcHHhhhcchHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCCCCCCccc
Confidence            22 2234668999999999864     55678999999999999999977666532  3344455555566677788899


Q ss_pred             cHHHHHHHHHhcccCcCCCCCHHHHhc--Ccccccc
Q 016959          326 SREFRDFISRCLQKDPHSRWPAAQLLQ--HPFILRA  359 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~t~~eil~--hp~~~~~  359 (380)
                      ++++++||.+||+.||++|||+++|++  |+||...
T Consensus       240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            999999999999999999999999987  7888654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-56  Score=400.28  Aligned_cols=251  Identities=27%  Similarity=0.397  Sum_probs=203.2

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCC---CcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPT---SRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG  170 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~---~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  170 (380)
                      +.|..++|++++.||+|+||+||+|++..+   +..||||+++....+...+.+.+|+.+|++++|||||++++++.+ +
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~   80 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N   80 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            457889999999999999999999998654   356899998776667777889999999999999999999999964 6


Q ss_pred             eEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccc
Q 016959          171 EIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQ  245 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  245 (380)
                      .+++|||||.+|+|..+..     .++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+..
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            7899999999999865432     35677889999999999999999999999999999999999999999999987654


Q ss_pred             cCC-CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          246 TMD-PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      ... ......||+.|+|||++..     ..++.++|||||||++|||++ |..||......+   ....+......+.+.
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~-----~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i~~~~~~~~~~  232 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINF-----RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENGERLPMPP  232 (273)
T ss_dssp             ----------CCGGGCCHHHHHH-----CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHTTCCCCCCT
T ss_pred             CcceeccceecCcccchhhHhcc-----CCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCCCCCCCC
Confidence            322 2345568999999999863     566789999999999999987 899997555444   334445566677888


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      .++.++.+||.+||+.||++|||+.||++|
T Consensus       233 ~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-55  Score=399.96  Aligned_cols=257  Identities=27%  Similarity=0.434  Sum_probs=214.0

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCeEEEEEe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  177 (380)
                      ++|++.++||+|+||+||+|++..+++.||||+++... .+....++.+|+.+|+.++|+||++++++|.+....++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999999999999999996543 44567889999999999999999999999999999999999


Q ss_pred             ccCCCCccccc----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCCCCC
Q 016959          178 YMDGGSLEGAH----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPCNSA  253 (380)
Q Consensus       178 ~~~~~~L~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (380)
                      ++.+++|....    ...+..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++............
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~  161 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE  161 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSC
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceee
Confidence            99998875432    33567789999999999999999999999999999999999999999999999877655555666


Q ss_pred             CCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCC-HHHHHHHHhhCC---------------
Q 016959          254 VGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGD-WASLMFAICFAQ---------------  317 (380)
Q Consensus       254 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~---------------  317 (380)
                      .++..|+|||++..    ..+++.++|||||||++|||++|+.||....... ....+.......               
T Consensus       162 ~~~~~~~~pe~~~~----~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         162 VVTLWYRPPDVLFG----AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CSCGGGCCHHHHTT----CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ccccchhhhhHhcc----CCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            78899999999854    3456789999999999999999999985432211 112222211111               


Q ss_pred             ----------CCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          318 ----------PPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       318 ----------~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                                .......+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence                      112334578899999999999999999999999999999863

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.7e-56  Score=402.58  Aligned_cols=251  Identities=25%  Similarity=0.408  Sum_probs=199.0

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC----eE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG----EI  172 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~  172 (380)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++...  .......+.+|+.+|+.++|||||++++++...+    .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            57999999999999999999999999999999997543  3455678999999999999999999999987643    48


Q ss_pred             EEEEeccCCCCcccccc----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC-
Q 016959          173 EVLLEYMDGGSLEGAHI----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM-  247 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-  247 (380)
                      |+|||||+|++|.....    ..+..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... 
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~  166 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN  166 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence            99999999999875543    3677889999999999999999999999999999999999999999999987654322 


Q ss_pred             --CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCC---CCCC
Q 016959          248 --DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQP---PEAP  322 (380)
Q Consensus       248 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~  322 (380)
                        ......+||+.|||||++.     +..++.++|||||||++|||+||+.||....   .............   ...+
T Consensus       167 ~~~~~~~~~Gt~~Y~aPE~~~-----~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~  238 (277)
T d1o6ya_         167 SVTQTAAVIGTAQYLSPEQAR-----GDSVDARSDVYSLGCVLYEVLTGEPPFTGDS---PVSVAYQHVREDPIPPSARH  238 (277)
T ss_dssp             ------------TTCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCCCCCGGGTS
T ss_pred             cccccccccCcccccCHHHHc-----CCCCCcceecccchHHHHHHHhCCCCCCCcC---HHHHHHHHHhcCCCCCchhc
Confidence              2345668999999999985     3556789999999999999999999996432   2333333322222   2345


Q ss_pred             ccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccc
Q 016959          323 EMASREFRDFISRCLQKDPHSRWPAAQLLQHPFIL  357 (380)
Q Consensus       323 ~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~  357 (380)
                      ..+++++.+||.+||+.||++||+..+.|.|+|.+
T Consensus       239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            67899999999999999999999544455566664

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-55  Score=408.82  Aligned_cols=259  Identities=26%  Similarity=0.341  Sum_probs=206.7

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC----eEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG----EIEV  174 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~l  174 (380)
                      ++|+++++||+|+||+||+|.+..+|+.||||++.........+.+.+|+.+|+.++||||+++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            469999999999999999999999999999999977666666778999999999999999999999986543    2345


Q ss_pred             EEeccCCCCccccc---ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccC---C
Q 016959          175 LLEYMDGGSLEGAH---IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTM---D  248 (380)
Q Consensus       175 v~e~~~~~~L~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~  248 (380)
                      +++++.+++|.+++   ..++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......   .
T Consensus        88 l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~  167 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG  167 (345)
T ss_dssp             EEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCC
T ss_pred             EEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccce
Confidence            55666788987665   34678899999999999999999999999999999999999999999999998664332   2


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCC-----------
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQ-----------  317 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-----------  317 (380)
                      .....+||+.|+|||++..    +..++.++||||+||++|+|++|+.||......+............           
T Consensus       168 ~~~~~~gt~~y~aPE~l~~----~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T d1pmea_         168 FLTEYVATRWYRAPEIMLN----SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  243 (345)
T ss_dssp             TTCCCCSCGGGCCGGGTTT----BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             eeccccccceechHHHhhc----CCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence            2356679999999999853    3566789999999999999999999997543322222222111110           


Q ss_pred             ---------CC-------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccccCc
Q 016959          318 ---------PP-------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRAGQ  361 (380)
Q Consensus       318 ---------~~-------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~~~  361 (380)
                               ..       .....++.++++||.+||+.||++|||++|+|+||||+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence                     00       012346789999999999999999999999999999986533

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-55  Score=403.63  Aligned_cols=250  Identities=22%  Similarity=0.369  Sum_probs=203.1

Q ss_pred             CCcccccccceecccCCceEEEEEeCCCCc----EEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCCe
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPPTSR----VFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNGE  171 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  171 (380)
                      +..++|++.++||+|+||+||+|.+..+|+    .||+|++.........+.+.+|+.+|++++|||||+++|++.++ .
T Consensus         6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~   84 (317)
T d1xkka_           6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   84 (317)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred             CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence            455789999999999999999999987776    58888886555555567899999999999999999999999865 5


Q ss_pred             EEEEEeccCCCCccccc-----ccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          172 IEVLLEYMDGGSLEGAH-----IRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      .++++|++.+++|.+..     ..++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.+...
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            67888999998875433     2356778899999999999999999999999999999999999999999999876543


Q ss_pred             CC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCc
Q 016959          247 MD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPE  323 (380)
Q Consensus       247 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  323 (380)
                      ..  ......||+.|||||++..     ..++.++|||||||++|||+| |..||......+.   ...+.....+..+.
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~---~~~i~~~~~~~~p~  236 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILH-----RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSILEKGERLPQPP  236 (317)
T ss_dssp             CC--------CCTTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH---HHHHHHTCCCCCCT
T ss_pred             cccccccccccCccccChHHHhc-----CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH---HHHHHcCCCCCCCc
Confidence            22  2234568999999999864     557889999999999999998 8999975444443   33344456677788


Q ss_pred             cccHHHHHHHHHhcccCcCCCCCHHHHhcCc
Q 016959          324 MASREFRDFISRCLQKDPHSRWPAAQLLQHP  354 (380)
Q Consensus       324 ~~~~~~~~li~~~l~~dp~~R~t~~eil~hp  354 (380)
                      .++.++.+||.+||..||++|||+.|+++|.
T Consensus       237 ~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence            8999999999999999999999999999874

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=396.08  Aligned_cols=254  Identities=25%  Similarity=0.367  Sum_probs=202.6

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCC-----CCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEE
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPP-----TSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMY  166 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~  166 (380)
                      .+.|..++|+++++||+|+||+||+|.+..     +++.||||++.........+.+.+|..++.++ +|+||+.+++++
T Consensus         7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~   86 (299)
T d1ywna1           7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC   86 (299)
T ss_dssp             HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence            345788999999999999999999999653     45789999997666555667788888888777 689999999987


Q ss_pred             ee-CCeEEEEEeccCCCCcccccc--------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q 016959          167 DR-NGEIEVLLEYMDGGSLEGAHI--------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLL  225 (380)
Q Consensus       167 ~~-~~~~~lv~e~~~~~~L~~~~~--------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil  225 (380)
                      .. ++.+++|||||++|+|.+++.                    .++..+..++.||+.||+|||++||+||||||+|||
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL  166 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  166 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence            65 456899999999999976653                    345678899999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCC
Q 016959          226 INSSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR-FPFAVGR  302 (380)
Q Consensus       226 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~-~pf~~~~  302 (380)
                      |+.++++||+|||+|+.......  ......||+.|||||++..     ..++.++|||||||++|||++|. .||....
T Consensus       167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-----RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-----CCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999987654322  2345679999999999864     56788999999999999999864 5775433


Q ss_pred             CCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          303 QGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ..  ......+.....+..+..+++++.+||.+||+.||++|||++|+++|
T Consensus       242 ~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         242 ID--EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             CS--HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HH--HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            22  33444455566777888899999999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4e-54  Score=394.89  Aligned_cols=255  Identities=25%  Similarity=0.369  Sum_probs=215.8

Q ss_pred             cCCCcccccccceecccCCceEEEEEeC-----CCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHP-----PTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR  168 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  168 (380)
                      ..+..++|++.+.||+|+||+||+|+++     .+++.||||++.........+.+.+|+.+|+.++|+||+++++++..
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            4467789999999999999999999875     35678999999877666677889999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCCcccccc----------------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 016959          169 NGEIEVLLEYMDGGSLEGAHI----------------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIK  220 (380)
Q Consensus       169 ~~~~~lv~e~~~~~~L~~~~~----------------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlk  220 (380)
                      .+..+++|||+.+|+|.+++.                            .....+..|+.||+.||+|||++||||||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK  167 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  167 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence            999999999999999876553                            2455688899999999999999999999999


Q ss_pred             CCcEEEcCCCcEEEeeccccccccccC--CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCC-CC
Q 016959          221 PSNLLINSSKNVKIADFGVSRILAQTM--DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR-FP  297 (380)
Q Consensus       221 p~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~-~p  297 (380)
                      |+||||+.++.+||+|||+|+.+....  ....+..||+.|+|||++..     ..++.++|||||||++|||++|. .|
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-----NRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-----CCCChhhhhccchhhHHHHHccCCCC
Confidence            999999999999999999998664332  22345678999999999864     56788999999999999999986 56


Q ss_pred             CCCCCCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 016959          298 FAVGRQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR  358 (380)
Q Consensus       298 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~  358 (380)
                      |..   .+..+....+.....+..+..++.++.+||.+||+.||++|||+.||++  ++++
T Consensus       243 ~~~---~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~--~L~~  298 (301)
T d1lufa_         243 YYG---MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQR  298 (301)
T ss_dssp             TTT---SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             CCC---CCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHH
Confidence            753   3444555566666677788889999999999999999999999999976  5544

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=387.88  Aligned_cols=248  Identities=23%  Similarity=0.344  Sum_probs=203.1

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee-CCeE
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR-NGEI  172 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~  172 (380)
                      |.|+.++|+++++||+|+||.||+|.+  .|+.||||+++.+.   ..+.+.+|++++++++||||++++|++.+ .+.+
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            678899999999999999999999999  57789999996543   34678899999999999999999998854 5678


Q ss_pred             EEEEeccCCCCccccccc------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccccc
Q 016959          173 EVLLEYMDGGSLEGAHIR------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQT  246 (380)
Q Consensus       173 ~lv~e~~~~~~L~~~~~~------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  246 (380)
                      ++||||+.+|+|.+++..      ++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence            999999999999877543      56678899999999999999999999999999999999999999999999866543


Q ss_pred             CCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHhhCCCCCCCccc
Q 016959          247 MDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAICFAQPPEAPEMA  325 (380)
Q Consensus       247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (380)
                      .   ....+|..|+|||++.+     ..++.++|||||||++|||+| |..||......   .....+.....++.+..+
T Consensus       157 ~---~~~~~~~~y~aPE~l~~-----~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~~~~~~~~~~~~  225 (262)
T d1byga_         157 Q---DTGKLPVKWTAPEALRE-----KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEKGYKMDAPDGC  225 (262)
T ss_dssp             --------CCTTTSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHTTTCCCCCCTTC
T ss_pred             C---ccccccccCCChHHHhC-----CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCCCCCCccC
Confidence            2   45568999999999864     456889999999999999998 78888644333   344445556677888889


Q ss_pred             cHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          326 SREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       326 ~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                      ++++.+||.+||+.||++|||+.|+++  +++.+
T Consensus       226 ~~~~~~li~~cl~~dP~~Rps~~~l~~--~L~~i  257 (262)
T d1byga_         226 PPAVYEVMKNCWHLDAAMRPSFLQLRE--QLEHI  257 (262)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             CHHHHHHHHHHcccCHhHCcCHHHHHH--HHHHH
Confidence            999999999999999999999999988  44443

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-54  Score=391.77  Aligned_cols=252  Identities=23%  Similarity=0.368  Sum_probs=212.2

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCCCC-------cEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEe
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPPTS-------RVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHD  164 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~-------~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~  164 (380)
                      .+.|+.++|++++.||+|+||.||+|+...++       ..||||++...........+.+|...+.++ +|||||++++
T Consensus         7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~   86 (299)
T d1fgka_           7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG   86 (299)
T ss_dssp             TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence            46788999999999999999999999876554       479999998777666677888999999888 7999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCcccccc--------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 016959          165 MYDRNGEIEVLLEYMDGGSLEGAHI--------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNL  224 (380)
Q Consensus       165 ~~~~~~~~~lv~e~~~~~~L~~~~~--------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Ni  224 (380)
                      +|.+++.+++|||||.+|+|.+++.                    ..+..+..++.||+.||+|||++|||||||||+||
T Consensus        87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni  166 (299)
T d1fgka_          87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  166 (299)
T ss_dssp             EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence            9999999999999999999976653                    35677889999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 016959          225 LINSSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVG  301 (380)
Q Consensus       225 l~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~  301 (380)
                      |++.++.+||+|||+++.......  ......||+.|+|||.+.+     ..++.++|||||||++|||++ |..||.. 
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-----~~y~~k~DiwS~Gvvl~ell~~g~~p~~~-  240 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-----RIYTHQSDVWSFGVLLWEIFTLGGSPYPG-  240 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSSTT-
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-----CCCCchhhhHHhHHHHHHhccCCCCCCCC-
Confidence            999999999999999987754332  2345678999999999864     567889999999999999997 7888863 


Q ss_pred             CCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          302 RQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                        .........+.....+..+..+++++.+||.+||+.||++|||+.||++
T Consensus       241 --~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         241 --VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             --CCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --CCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence              3344455555566777888889999999999999999999999999987

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=406.02  Aligned_cols=255  Identities=27%  Similarity=0.351  Sum_probs=205.6

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEee-----CCe
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDR-----NGE  171 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~  171 (380)
                      .++|++.++||+|+||+||+|++..+|+.||||++.... .....+.+.+|+.+|+.++|+|||+++++|..     ...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            478999999999999999999999999999999997543 34455678899999999999999999999863     334


Q ss_pred             EEEEEeccCCCCcccccc---cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCC
Q 016959          172 IEVLLEYMDGGSLEGAHI---RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMD  248 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~~~---~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  248 (380)
                      .+++|+++.+++|.+++.   .++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++......  
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~--  174 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--  174 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG--
T ss_pred             eEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc--
Confidence            566777888999876653   467889999999999999999999999999999999999999999999999766533  


Q ss_pred             CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCC---------
Q 016959          249 PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPP---------  319 (380)
Q Consensus       249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------  319 (380)
                       ..+..||+.|+|||++..    ..+++.++|||||||++|+|++|+.||...........+.........         
T Consensus       175 -~~~~~g~~~y~apE~~~~----~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  249 (348)
T d2gfsa1         175 -MTGYVATRWYRAPEIMLN----WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  249 (348)
T ss_dssp             -GSSSCHHHHTSCHHHHTT----CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred             -cccccccccccCchhhcC----CccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence             356779999999998753    356678999999999999999999999754333222222222111110         


Q ss_pred             ----------C--------CCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          320 ----------E--------APEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       320 ----------~--------~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                                .        ....++++++|||.+||+.||++|+|+.|+|+||||+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence                      0        113478899999999999999999999999999999975

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-54  Score=393.91  Aligned_cols=261  Identities=21%  Similarity=0.311  Sum_probs=220.1

Q ss_pred             ccCCCcccccccceecccCCceEEEEEeCC-----CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEe
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVHPP-----TSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYD  167 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  167 (380)
                      .+.|+.++|++++.||+|+||+||+|.+..     ++..||||++...........+.+|+.++++++|||||++++++.
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            367889999999999999999999998752     357899999976666666678999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCCccccccc--------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEE
Q 016959          168 RNGEIEVLLEYMDGGSLEGAHIR--------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVK  233 (380)
Q Consensus       168 ~~~~~~lv~e~~~~~~L~~~~~~--------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~k  233 (380)
                      .++..++|||||.+|+|.+++..              ....+..++.||+.||.|||+++|+||||||+|||++.++++|
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEE
Confidence            99999999999999999776543              3456788999999999999999999999999999999999999


Q ss_pred             EeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCCCCHHHHH
Q 016959          234 IADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGR-FPFAVGRQGDWASLM  310 (380)
Q Consensus       234 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~-~pf~~~~~~~~~~~~  310 (380)
                      |+|||+|+.+.....  ......||+.|+|||.+.+     ..++.++|||||||++|||+||. .||..   ....+..
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-----~~~~~~~Dv~S~G~il~El~t~~~~p~~~---~~~~~~~  245 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-----GVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSNEQVL  245 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHHTSCCTTTT---SCHHHHH
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHcc-----CCCCcccccccHHHHHHHHHhCCCCCCCC---CCHHHHH
Confidence            999999987654322  2244568999999999864     56678999999999999999985 66753   3444455


Q ss_pred             HHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc------CccccccCc
Q 016959          311 FAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ------HPFILRAGQ  361 (380)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~------hp~~~~~~~  361 (380)
                      ..+.....+..+..++..+.+||.+||+.||++|||+.||++      +|+|+..++
T Consensus       246 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~~  302 (308)
T d1p4oa_         246 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF  302 (308)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCS
T ss_pred             HHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCCC
Confidence            555556667778889999999999999999999999999998      677665443

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-54  Score=393.90  Aligned_cols=251  Identities=24%  Similarity=0.343  Sum_probs=209.4

Q ss_pred             cCCCcccccccceecccCCceEEEEEeCCCCcE--EEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEEeeCC
Q 016959           94 QLINPAELQKGNRIGSGSGGTVWRVVHPPTSRV--FALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMYDRNG  170 (380)
Q Consensus        94 ~~~~~~~~~~~~~LG~G~~g~V~~~~~~~~~~~--~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~  170 (380)
                      ..|+-++|++.++||+|+||+||+|+++.+|..  ||||++.........+.+.+|+++|+++ +|||||++++++.+++
T Consensus         5 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   84 (309)
T d1fvra_           5 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   84 (309)
T ss_dssp             SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             CccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence            347778999999999999999999999888764  6778776554455567799999999999 7999999999999999


Q ss_pred             eEEEEEeccCCCCccccccc--------------------chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCC
Q 016959          171 EIEVLLEYMDGGSLEGAHIR--------------------QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSK  230 (380)
Q Consensus       171 ~~~lv~e~~~~~~L~~~~~~--------------------~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~  230 (380)
                      .+++|||||.+|+|.+++..                    ++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence            99999999999999776532                    4566889999999999999999999999999999999999


Q ss_pred             cEEEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCCCHHHH
Q 016959          231 NVKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRF-PFAVGRQGDWASL  309 (380)
Q Consensus       231 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~-pf~~~~~~~~~~~  309 (380)
                      .+||+|||+++....... .....||..|+|||.+..     ..++.++|||||||++|||++|.. ||.   ..+....
T Consensus       165 ~~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~-----~~~~~~sDvwSfGvil~ell~~~~~p~~---~~~~~~~  235 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNY-----SVYTTNSDVWSYGVLLWEIVSLGGTPYC---GMTCAEL  235 (309)
T ss_dssp             CEEECCTTCEESSCEECC-C----CCTTTCCHHHHHH-----CEECHHHHHHHHHHHHHHHHTTSCCTTT---TCCHHHH
T ss_pred             ceEEcccccccccccccc-ccceecCCcccchHHhcc-----CCCCccceeehhHHHHHHHHhcCCCCCC---CCCHHHH
Confidence            999999999986654432 245568999999999864     456789999999999999999765 564   3345556


Q ss_pred             HHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          310 MFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      ...+.....+..+..+++++.+||.+||+.||++|||+.||++|
T Consensus       236 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         236 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            66666667788888899999999999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-54  Score=403.24  Aligned_cols=255  Identities=27%  Similarity=0.364  Sum_probs=196.6

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCC-chHHHHHHHHHHHHHHhCCCCceeeeEeEEee------CCe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNH-EDSVRSQICREIEILRDVNHPNVVKCHDMYDR------NGE  171 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~  171 (380)
                      ++|++.++||+|+||+||+|++..+|+.||||++.... ......++.+|+.+|+.++|||||+++++|..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999999999999999997543 34455678999999999999999999999953      468


Q ss_pred             EEEEEeccCCCCcccc-cccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccccccCCCC
Q 016959          172 IEVLLEYMDGGSLEGA-HIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILAQTMDPC  250 (380)
Q Consensus       172 ~~lv~e~~~~~~L~~~-~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~  250 (380)
                      +|+|||||.++++... ...++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++..... ...
T Consensus        97 ~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~-~~~  175 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMM  175 (355)
T ss_dssp             EEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred             eEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc-ccc
Confidence            9999999988766433 23367889999999999999999999999999999999999999999999998866543 334


Q ss_pred             CCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhC--------------
Q 016959          251 NSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFA--------------  316 (380)
Q Consensus       251 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------------  316 (380)
                      ...+||+.|+|||++.     +..++.++||||+||++|+|++|+.||...........+......              
T Consensus       176 ~~~~~t~~y~aPE~l~-----~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (355)
T d2b1pa1         176 TPYVVTRYYRAPEVIL-----GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_dssp             -----CCTTCCHHHHT-----TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred             ccccccccccChhhhc-----CCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence            5667999999999985     356778999999999999999999999744322222222111110              


Q ss_pred             -----CCC-------------------CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCcccccc
Q 016959          317 -----QPP-------------------EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILRA  359 (380)
Q Consensus       317 -----~~~-------------------~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~~  359 (380)
                           ...                   ......+.++++||.+||..||++|||++|+|+||||+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence                 000                   0011256789999999999999999999999999999874

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-53  Score=387.29  Aligned_cols=253  Identities=24%  Similarity=0.343  Sum_probs=213.2

Q ss_pred             ccCCCcccccccceecccCCceEEEEEe-----CCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhC-CCCceeeeEeEE
Q 016959           93 HQLINPAELQKGNRIGSGSGGTVWRVVH-----PPTSRVFALKVIYGNHEDSVRSQICREIEILRDV-NHPNVVKCHDMY  166 (380)
Q Consensus        93 ~~~~~~~~~~~~~~LG~G~~g~V~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~  166 (380)
                      .+.++.++|+++++||+|+||.||+|++     ..+++.||||+++..........+.+|+.+++++ +|||||++++++
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            4568889999999999999999999985     3467899999998777666677899999999999 699999999999


Q ss_pred             eeCCeEEEEEeccCCCCcccccc----------------------cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q 016959          167 DRNGEIEVLLEYMDGGSLEGAHI----------------------RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNL  224 (380)
Q Consensus       167 ~~~~~~~lv~e~~~~~~L~~~~~----------------------~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Ni  224 (380)
                      .+.+.+++|||||.+|+|..++.                      ..+..+..++.||+.||+|||++||+||||||+||
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI  176 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI  176 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence            99999999999999999866543                      34567889999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccccccccccCC--CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCC
Q 016959          225 LINSSKNVKIADFGVSRILAQTMD--PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLG-RFPFAVG  301 (380)
Q Consensus       225 l~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g-~~pf~~~  301 (380)
                      |++.++.+||+|||+++.......  .....+||+.|+|||++..     ..++.++|||||||++|||+|+ ..||...
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DIwS~G~~l~ellt~g~p~~~~~  251 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-----CVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-----CCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence            999999999999999987654322  2344678999999999863     5678899999999999999985 5545433


Q ss_pred             CCCCHHHHHHHHhhCCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          302 RQGDWASLMFAICFAQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ...  ......+.....+..+..++.++.+||.+||+.||++|||++||++
T Consensus       252 ~~~--~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         252 PVD--SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             CSS--HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHH--HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            322  2233334455667777888999999999999999999999999997

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-53  Score=383.47  Aligned_cols=253  Identities=25%  Similarity=0.388  Sum_probs=198.2

Q ss_pred             CCCcccccccceecccCCceEEEEEeCCC-C--cEEEEEEecCCC--chHHHHHHHHHHHHHHhCCCCceeeeEeEEeeC
Q 016959           95 LINPAELQKGNRIGSGSGGTVWRVVHPPT-S--RVFALKVIYGNH--EDSVRSQICREIEILRDVNHPNVVKCHDMYDRN  169 (380)
Q Consensus        95 ~~~~~~~~~~~~LG~G~~g~V~~~~~~~~-~--~~~avK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  169 (380)
                      .|+.++|++.+.||+|+||+||+|+.... +  ..||||++....  .+...+.+.+|+.+|++++|||||+++|++.+ 
T Consensus         4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-   82 (273)
T d1u46a_           4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-   82 (273)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence            46778999999999999999999986433 3  468999986542  34456789999999999999999999999976 


Q ss_pred             CeEEEEEeccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      +.+++|||||.++++.+...     .++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus        83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            46789999999999865432     4567788999999999999999999999999999999999999999999999775


Q ss_pred             ccCC---CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCCCHHHHHHHH-hhCCCC
Q 016959          245 QTMD---PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYL-GRFPFAVGRQGDWASLMFAI-CFAQPP  319 (380)
Q Consensus       245 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~-~~~~~~  319 (380)
                      ....   ......|+..|+|||++..     ..++.++|||||||++|||+| |..||...   ........+ .....+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~---~~~~~~~~i~~~~~~~  234 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKT-----RTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKIDKEGERL  234 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHH-----CEEEHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHTSCCCC
T ss_pred             cCCCcceecCccccCcccCCHHHHhC-----CCCCcchhhhhhHHHHHHHHhCCCCCCCCc---CHHHHHHHHHhCCCCC
Confidence            4332   2234567889999999964     566789999999999999997 89999633   333333333 334456


Q ss_pred             CCCccccHHHHHHHHHhcccCcCCCCCHHHHhcCccccc
Q 016959          320 EAPEMASREFRDFISRCLQKDPHSRWPAAQLLQHPFILR  358 (380)
Q Consensus       320 ~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~hp~~~~  358 (380)
                      +.+..++.++.+||.+||+.||++|||+.||++  +|++
T Consensus       235 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~--~L~~  271 (273)
T d1u46a_         235 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLE  271 (273)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH--HHHh
Confidence            677889999999999999999999999999975  5544

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-52  Score=382.74  Aligned_cols=251  Identities=24%  Similarity=0.318  Sum_probs=204.4

Q ss_pred             CCccccc--ccceecccCCceEEEEEeCCCC---cEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEee-C
Q 016959           96 INPAELQ--KGNRIGSGSGGTVWRVVHPPTS---RVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDR-N  169 (380)
Q Consensus        96 ~~~~~~~--~~~~LG~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~  169 (380)
                      +..+.+.  ..++||+|+||+||+|++..++   ..||||++.........+.+.+|+++|++++|||||+++|++.+ +
T Consensus        22 ~~~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~  101 (311)
T d1r0pa_          22 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE  101 (311)
T ss_dssp             CCGGGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT
T ss_pred             eChHHceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC
Confidence            4444443  3678999999999999986543   36899999766666667889999999999999999999999765 5


Q ss_pred             CeEEEEEeccCCCCccccccc-----chHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeecccccccc
Q 016959          170 GEIEVLLEYMDGGSLEGAHIR-----QEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRILA  244 (380)
Q Consensus       170 ~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  244 (380)
                      +.+++|||||.+++|.++...     .+..+..++.|++.||.|||++||+||||||+|||+++++.+||+|||+++.+.
T Consensus       102 ~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         102 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  181 (311)
T ss_dssp             TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred             CceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence            689999999999999765543     356678999999999999999999999999999999999999999999998765


Q ss_pred             ccCC----CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHhhCCCCC
Q 016959          245 QTMD----PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAICFAQPPE  320 (380)
Q Consensus       245 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  320 (380)
                      ....    ......||..|+|||.+..     ..++.++|||||||++|||++|..||.....  .......+.....+.
T Consensus       182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i~~g~~~~  254 (311)
T d1r0pa_         182 DKEFDSVHNKTGAKLPVKWMALESLQT-----QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQGRRLL  254 (311)
T ss_dssp             TTTCCCTTCTTCSSCCGGGSCHHHHHH-----CCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCCCC
T ss_pred             ccccccceecccccccccccChHHHhc-----CCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCCCC
Confidence            4322    2234568999999999864     4568899999999999999998888864322  222333444556677


Q ss_pred             CCccccHHHHHHHHHhcccCcCCCCCHHHHhcC
Q 016959          321 APEMASREFRDFISRCLQKDPHSRWPAAQLLQH  353 (380)
Q Consensus       321 ~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~h  353 (380)
                      .+..++.++.+||.+||+.||++||++.||++|
T Consensus       255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            778899999999999999999999999999987

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-50  Score=367.23  Aligned_cols=250  Identities=24%  Similarity=0.303  Sum_probs=189.0

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCceeeeEeEEeeCC----eEEE
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPNVVKCHDMYDRNG----EIEV  174 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~l  174 (380)
                      .+|.+.++||+|+||.||+|++  +|+.||||++.....  .......|+..++.++|||||++++++.+.+    .+++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~--~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            5788899999999999999998  789999999854332  2222334555566789999999999987643    6899


Q ss_pred             EEeccCCCCccccccc---chHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          175 LLEYMDGGSLEGAHIR---QEHILSDLARQVLSGLAYLHK--------RKIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       175 v~e~~~~~~L~~~~~~---~~~~~~~i~~qi~~al~~LH~--------~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                      |||||.+|+|..++..   ++..+..++.|++.||+|||+        +||+||||||+||||+.++++||+|||+++..
T Consensus        79 v~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             EEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             EEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            9999999999877654   466778999999999999996        59999999999999999999999999999876


Q ss_pred             cccCC----CCCCCCCCCccccccccccccCCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCC------------CH
Q 016959          244 AQTMD----PCNSAVGTIAYMSPERINTDLNHG-KYDGYAGDIWSLGVSILEFYLGRFPFAVGRQG------------DW  306 (380)
Q Consensus       244 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------------~~  306 (380)
                      .....    ......||+.|||||++....... ..++.++|||||||+||||+||..||......            ..
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            54322    234567999999999986432111 12456899999999999999999887532211            11


Q ss_pred             HHHHHHHhh-CCCCCCCcc-----ccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          307 ASLMFAICF-AQPPEAPEM-----ASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       307 ~~~~~~~~~-~~~~~~~~~-----~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      ......... ...+..+..     ....+.+|+.+||+.||++|||+.||++
T Consensus       239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            222222211 222333332     3346899999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-49  Score=364.76  Aligned_cols=251  Identities=20%  Similarity=0.233  Sum_probs=193.6

Q ss_pred             ccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCCCc-eeeeEeEEeeCCeEEEEEe
Q 016959           99 AELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNHPN-VVKCHDMYDRNGEIEVLLE  177 (380)
Q Consensus        99 ~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e  177 (380)
                      ++|++++.||+|+||+||+|++..+|+.||||++......   ..+..|+++++.++|+| |+.+.+++.+.+..++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            4699999999999999999999999999999998654322   34678999999998665 5555666778889999999


Q ss_pred             ccCCCCcccc----cccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC---CCcEEEeeccccccccccCC--
Q 016959          178 YMDGGSLEGA----HIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS---SKNVKIADFGVSRILAQTMD--  248 (380)
Q Consensus       178 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~---~~~~kl~Dfg~a~~~~~~~~--  248 (380)
                      |+.++.+...    ...++..+..++.||+.||+|||++||+||||||+|||++.   +..+||+|||+|+.+.....  
T Consensus        84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~  163 (299)
T d1ckia_          84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  163 (299)
T ss_dssp             CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred             EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence            9965433221    23467788999999999999999999999999999999863   45699999999987654321  


Q ss_pred             -----CCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh----hCCCC
Q 016959          249 -----PCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC----FAQPP  319 (380)
Q Consensus       249 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~----~~~~~  319 (380)
                           .....+||+.|||||++.     +..++.++|||||||++|||++|..||......+.........    .....
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ckia_         164 HIPYRENKNLTGTARYASINTHL-----GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  238 (299)
T ss_dssp             BCCCCBCCSCCCCSSSCCHHHHT-----TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred             ceeccccCCcCCCccccCHHHHh-----CCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence                 234567999999999985     3567889999999999999999999997544433222221111    11222


Q ss_pred             CCCccccHHHHHHHHHhcccCcCCCCCHHH---HhcCcccc
Q 016959          320 EAPEMASREFRDFISRCLQKDPHSRWPAAQ---LLQHPFIL  357 (380)
Q Consensus       320 ~~~~~~~~~~~~li~~~l~~dp~~R~t~~e---il~hp~~~  357 (380)
                      .....+++++.+||.+||..||++||++++   +|+|+|.+
T Consensus       239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            334568899999999999999999999875   46776653

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.3e-48  Score=356.62  Aligned_cols=246  Identities=20%  Similarity=0.233  Sum_probs=199.3

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCC-CceeeeEeEEeeCCeEEEEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH-PNVVKCHDMYDRNGEIEVLL  176 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~  176 (380)
                      .++|+++++||+|+||+||+|++..+|+.||||++......   ..+.+|++.++.++| +|++.+++++......++||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            46799999999999999999999999999999998554322   346678899999975 89999999999999999999


Q ss_pred             eccCCCCcccccc-----cchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcC-----CCcEEEeecccccccccc
Q 016959          177 EYMDGGSLEGAHI-----RQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINS-----SKNVKIADFGVSRILAQT  246 (380)
Q Consensus       177 e~~~~~~L~~~~~-----~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~-----~~~~kl~Dfg~a~~~~~~  246 (380)
                      ||+ +++|.....     .....+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+.+...
T Consensus        81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~  159 (293)
T d1csna_          81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  159 (293)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence            999 567654432     356678889999999999999999999999999999974     567999999999876532


Q ss_pred             C-------CCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHh----h
Q 016959          247 M-------DPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDWASLMFAIC----F  315 (380)
Q Consensus       247 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~----~  315 (380)
                      .       ......+||+.|||||++.     +..++.++|||||||++|||++|..||..............+.    .
T Consensus       160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~-----~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         160 VTKQHIPYREKKNLSGTARYMSINTHL-----GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHT-----TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccceeecccCceEEchhhcCHHHhc-----CCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            1       1234567999999999985     3567889999999999999999999998655554433332221    1


Q ss_pred             CCCCCCCccccHHHHHHHHHhcccCcCCCCCHHHHhc
Q 016959          316 AQPPEAPEMASREFRDFISRCLQKDPHSRWPAAQLLQ  352 (380)
Q Consensus       316 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~eil~  352 (380)
                      .........+++++.+++..|+..+|++||+++.+.+
T Consensus       235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            2222234567889999999999999999999887765

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-47  Score=361.20  Aligned_cols=253  Identities=26%  Similarity=0.395  Sum_probs=193.8

Q ss_pred             cccccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-----------CCceeeeEeEE
Q 016959           98 PAELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-----------HPNVVKCHDMY  166 (380)
Q Consensus        98 ~~~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~~~~~~  166 (380)
                      .++|+++++||+|+||+||+|++..+|+.||||+++..  ....+.+.+|+.+++.++           |+||+++++++
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            35699999999999999999999999999999999644  334466788999888875           57899999987


Q ss_pred             ee--CCeEEEEEeccCCCCc-------ccccccchHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEcCCCc-----
Q 016959          167 DR--NGEIEVLLEYMDGGSL-------EGAHIRQEHILSDLARQVLSGLAYLHK-RKIVHRDIKPSNLLINSSKN-----  231 (380)
Q Consensus       167 ~~--~~~~~lv~e~~~~~~L-------~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~Nil~~~~~~-----  231 (380)
                      ..  ....+++|+++..+..       .......+..++.++.||+.||+|||+ +||+||||||+|||++.++.     
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence            54  4567777777765542       122334567889999999999999998 89999999999999986654     


Q ss_pred             -EEEeeccccccccccCCCCCCCCCCCccccccccccccCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCCCH---H
Q 016959          232 -VKIADFGVSRILAQTMDPCNSAVGTIAYMSPERINTDLNHGKYDGYAGDIWSLGVSILEFYLGRFPFAVGRQGDW---A  307 (380)
Q Consensus       232 -~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~  307 (380)
                       ++++|||.+......   ....+||+.|+|||++..     ..++.++|||||||++++|++|+.||........   .
T Consensus       170 ~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~  241 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLG-----APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  241 (362)
T ss_dssp             EEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHT-----CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             eeeEeecccccccccc---cccccccccccChhhccc-----cCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence             999999999866543   256789999999999863     4567899999999999999999999974332211   0


Q ss_pred             ---HHHHHHhhC--------------------------------------CCCCCCccccHHHHHHHHHhcccCcCCCCC
Q 016959          308 ---SLMFAICFA--------------------------------------QPPEAPEMASREFRDFISRCLQKDPHSRWP  346 (380)
Q Consensus       308 ---~~~~~~~~~--------------------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~t  346 (380)
                         .........                                      .........++++.|||.+||+.||++|||
T Consensus       242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence               111011000                                      011223346778999999999999999999


Q ss_pred             HHHHhcCccccccC
Q 016959          347 AAQLLQHPFILRAG  360 (380)
Q Consensus       347 ~~eil~hp~~~~~~  360 (380)
                      ++|+|+||||++..
T Consensus       322 a~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         322 AGGLVNHPWLKDTL  335 (362)
T ss_dssp             HHHHHTCGGGTTCT
T ss_pred             HHHHhcCcccCCCC
Confidence            99999999999654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=5.7e-28  Score=205.33  Aligned_cols=135  Identities=21%  Similarity=0.217  Sum_probs=106.6

Q ss_pred             ccccceecccCCceEEEEEeCCCCcEEEEEEecCCCc-----------------hHHHHHHHHHHHHHHhCCCCceeeeE
Q 016959          101 LQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHE-----------------DSVRSQICREIEILRDVNHPNVVKCH  163 (380)
Q Consensus       101 ~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----------------~~~~~~~~~E~~~l~~l~h~~iv~~~  163 (380)
                      +.++++||+|+||+||+|++. +|+.||||+++....                 ........+|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            356889999999999999985 689999998753210                 11123456788899999999999887


Q ss_pred             eEEeeCCeEEEEEeccCCCCcccccccchHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcCCCcEEEeeccccccc
Q 016959          164 DMYDRNGEIEVLLEYMDGGSLEGAHIRQEHILSDLARQVLSGLAYLHKRKIVHRDIKPSNLLINSSKNVKIADFGVSRIL  243 (380)
Q Consensus       164 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  243 (380)
                      ++..    .+++|||+.+..+...   .......++.||+.+|.|||++||+||||||+|||++++ .++|+|||+|+..
T Consensus        81 ~~~~----~~lvme~~~~~~~~~l---~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~  152 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELYRV---RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEV  152 (191)
T ss_dssp             EEET----TEEEEECCCCEEGGGC---CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEET
T ss_pred             EecC----CEEEEEeeccccccch---hhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccC
Confidence            6532    2799999998766543   234456789999999999999999999999999999954 5999999999765


Q ss_pred             c
Q 016959          244 A  244 (380)
Q Consensus       244 ~  244 (380)
                      .
T Consensus       153 ~  153 (191)
T d1zara2         153 G  153 (191)
T ss_dssp             T
T ss_pred             C
Confidence            4

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.76  E-value=1.5e-08  Score=88.03  Aligned_cols=138  Identities=16%  Similarity=0.167  Sum_probs=90.0

Q ss_pred             cccccceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEeeCCeEEEEEec
Q 016959          100 ELQKGNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYDRNGEIEVLLEY  178 (380)
Q Consensus       100 ~~~~~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~  178 (380)
                      .|+..+..+-|+.+.||++..  +++.++||+....... ....+.+|..+++.+. +--+.+++.+..+++..++||++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~   91 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence            445555444455568999875  6667888987433211 1234567888887774 44466778888888999999999


Q ss_pred             cCCCCcccccccchHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 016959          179 MDGGSLEGAHIRQEHILSDLARQVLSGLAYLHK-----------------------------------------------  211 (380)
Q Consensus       179 ~~~~~L~~~~~~~~~~~~~i~~qi~~al~~LH~-----------------------------------------------  211 (380)
                      +.|..+....... .....++.++...+..||+                                               
T Consensus        92 l~G~~~~~~~~~~-~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (263)
T d1j7la_          92 ADGVLCSEEYEDE-QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL  170 (263)
T ss_dssp             CSSEEHHHHTTTC-SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHH
T ss_pred             ccccccccccccc-ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHH
Confidence            9987764322111 1122234444444444442                                               


Q ss_pred             ------------CCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          212 ------------RKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       212 ------------~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                                  ..++|+|+.+.|||+++++.+-|+||+.+.
T Consensus       171 ~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                        126999999999999976666799999774

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.49  E-value=5.3e-07  Score=77.54  Aligned_cols=127  Identities=17%  Similarity=0.203  Sum_probs=83.0

Q ss_pred             eecccCC-ceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC--CCceeeeEeEEeeCCeEEEEEeccCCC
Q 016959          106 RIGSGSG-GTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN--HPNVVKCHDMYDRNGEIEVLLEYMDGG  182 (380)
Q Consensus       106 ~LG~G~~-g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~  182 (380)
                      .+..|.. +.||++... ++..+++|.-.....    ..+..|...|+.+.  .-.+.+++.+..+.+..++||++++|.
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence            3445554 578999864 566688898654432    23567777777763  334667788888888899999999987


Q ss_pred             CcccccccchHHHHHHHHHHHHHHHHHH---------------------------------------------------h
Q 016959          183 SLEGAHIRQEHILSDLARQVLSGLAYLH---------------------------------------------------K  211 (380)
Q Consensus       183 ~L~~~~~~~~~~~~~i~~qi~~al~~LH---------------------------------------------------~  211 (380)
                      ++.........    ++.++...|.-||                                                   .
T Consensus        92 ~~~~~~~~~~~----~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  167 (255)
T d1nd4a_          92 DLLSSHLAPAE----KVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA  167 (255)
T ss_dssp             ETTTSCCCHHH----HHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred             ccccccccHHH----HHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHH
Confidence            76543222111    1122222222222                                                   2


Q ss_pred             C-------CceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          212 R-------KIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       212 ~-------~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                      .       .++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       168 ~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         168 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            1       26999999999999977667899999764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.41  E-value=6.5e-08  Score=89.30  Aligned_cols=78  Identities=14%  Similarity=0.075  Sum_probs=48.6

Q ss_pred             cceecccCCceEEEEEeCCCCcEEEEEEecC------CCchHHHHHHHHHHHHHHhCC-C--CceeeeEeEEeeCCeEEE
Q 016959          104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYG------NHEDSVRSQICREIEILRDVN-H--PNVVKCHDMYDRNGEIEV  174 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~------~~~~~~~~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~~~~~l  174 (380)
                      .+.||.|....||++.+..+++.++||.-..      ........+...|...|+.+. +  ..+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4568999999999999887888999997421      111112234556888887663 2  345556544  3345578


Q ss_pred             EEeccCCCC
Q 016959          175 LLEYMDGGS  183 (380)
Q Consensus       175 v~e~~~~~~  183 (380)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997643

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.69  E-value=7.1e-05  Score=66.47  Aligned_cols=69  Identities=14%  Similarity=0.197  Sum_probs=44.4

Q ss_pred             ceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCCC-----CceeeeE--eEEeeCCeEEEEEeccCCCCc
Q 016959          113 GTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVNH-----PNVVKCH--DMYDRNGEIEVLLEYMDGGSL  184 (380)
Q Consensus       113 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~h-----~~iv~~~--~~~~~~~~~~lv~e~~~~~~L  184 (380)
                      -.||++... +|..|++|+.+....  ..+++..|...+..|..     +..+..-  ..+..++..+.+++++.|..+
T Consensus        36 N~vy~v~~~-dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          36 NRVYQFQDE-DRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SEEEEECCT-TCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             ceeEEEEcC-CCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            479999873 678899999854432  23557778888877742     1111111  134556788899999987543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.66  E-value=0.00013  Score=66.63  Aligned_cols=82  Identities=18%  Similarity=0.231  Sum_probs=54.1

Q ss_pred             CCcccccccceecccCCceEEEEEeCC-------CCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-CCceeeeEeEEe
Q 016959           96 INPAELQKGNRIGSGSGGTVWRVVHPP-------TSRVFALKVIYGNHEDSVRSQICREIEILRDVN-HPNVVKCHDMYD  167 (380)
Q Consensus        96 ~~~~~~~~~~~LG~G~~g~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~  167 (380)
                      ++.+++++ +.|+.|-.-.+|++....       ..+.|.+++.-. ....  ....+|..+++.+. +.-..++++++.
T Consensus        40 ~~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~--idr~~E~~i~~~ls~~gl~Pkll~~~~  115 (395)
T d1nw1a_          40 VPLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETE--SHLVAESVIFTLLSERHLGPKLYGIFS  115 (395)
T ss_dssp             CCGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCH--HHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred             CCccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchh--hHHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence            44555555 568888888999998643       345677777642 2222  23557888888885 444457777764


Q ss_pred             eCCeEEEEEeccCCCCcc
Q 016959          168 RNGEIEVLLEYMDGGSLE  185 (380)
Q Consensus       168 ~~~~~~lv~e~~~~~~L~  185 (380)
                      .    .+|+||+.|..|.
T Consensus       116 ~----g~I~efi~g~~l~  129 (395)
T d1nw1a_         116 G----GRLEEYIPSRPLS  129 (395)
T ss_dssp             T----EEEECCCCEEECC
T ss_pred             C----ceEEEEeccccCC
Confidence            3    5899999886553

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.46  E-value=0.00048  Score=60.47  Aligned_cols=133  Identities=15%  Similarity=0.207  Sum_probs=71.7

Q ss_pred             cceecccCCceEEEEEeCCCCcEEEEEEecCCCchHHHHHHHHHHHHHHhCC-----CCceeeeEe---EEeeCCeEEEE
Q 016959          104 GNRIGSGSGGTVWRVVHPPTSRVFALKVIYGNHEDSVRSQICREIEILRDVN-----HPNVVKCHD---MYDRNGEIEVL  175 (380)
Q Consensus       104 ~~~LG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~~~~---~~~~~~~~~lv  175 (380)
                      .+.|..|---+.|++...  +..|++|+......   .+.+..|++++..|.     .|..+...+   +....+....+
T Consensus        23 ~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~   97 (316)
T d2ppqa1          23 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL   97 (316)
T ss_dssp             EEEECC---EEEEEEEES--SCCEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred             eecCCCCcccCeEEEEEC--CCcEEEEEcCCCCC---HHHHHHHHHHHHhhhhccccccccceecCCCcceeeeccccee
Confidence            344666766788999874  34589999854322   234455666666663     222222111   12334556677


Q ss_pred             EeccCCCCccccccc---------------------------c------------------hHHHHHHHHHHHHHHHHHH
Q 016959          176 LEYMDGGSLEGAHIR---------------------------Q------------------EHILSDLARQVLSGLAYLH  210 (380)
Q Consensus       176 ~e~~~~~~L~~~~~~---------------------------~------------------~~~~~~i~~qi~~al~~LH  210 (380)
                      +.+..+.........                           .                  ...+...+..+...+.-.+
T Consensus        98 ~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  177 (316)
T d2ppqa1          98 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW  177 (316)
T ss_dssp             EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred             eeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccC
Confidence            777766443111000                           0                  0001122222333333333


Q ss_pred             h----CCceecCCCCCcEEEcCCCcEEEeeccccc
Q 016959          211 K----RKIVHRDIKPSNLLINSSKNVKIADFGVSR  241 (380)
Q Consensus       211 ~----~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  241 (380)
                      .    .|+||+|+.++||+++.++..-|+||+.+.
T Consensus       178 ~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         178 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccccccCCcchhhhhcccccceeEecccccc
Confidence            2    479999999999999988777899999874